Citrus Sinensis ID: 021227
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | 2.2.26 [Sep-21-2011] | |||||||
| P28583 | 508 | Calcium-dependent protein | yes | no | 0.946 | 0.586 | 0.865 | 1e-151 | |
| Q42396 | 490 | Calcium-dependent protein | yes | no | 0.946 | 0.608 | 0.805 | 1e-142 | |
| Q38869 | 501 | Calcium-dependent protein | no | no | 0.946 | 0.594 | 0.818 | 1e-142 | |
| Q39016 | 495 | Calcium-dependent protein | no | no | 0.946 | 0.602 | 0.808 | 1e-141 | |
| Q38870 | 646 | Calcium-dependent protein | no | no | 0.946 | 0.461 | 0.748 | 1e-135 | |
| Q06850 | 610 | Calcium-dependent protein | no | no | 0.946 | 0.488 | 0.741 | 1e-132 | |
| A5A7I7 | 557 | Calcium-dependent protein | N/A | no | 0.946 | 0.535 | 0.728 | 1e-129 | |
| A5A7I8 | 535 | Calcium-dependent protein | N/A | no | 0.946 | 0.557 | 0.731 | 1e-129 | |
| Q38871 | 556 | Calcium-dependent protein | no | no | 0.946 | 0.535 | 0.718 | 1e-126 | |
| Q9ZV15 | 583 | Calcium-dependent protein | no | no | 0.946 | 0.511 | 0.711 | 1e-126 |
| >sp|P28583|CDPK_SOYBN Calcium-dependent protein kinase SK5 OS=Glycine max PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 534 bits (1375), Expect = e-151, Method: Compositional matrix adjust.
Identities = 258/298 (86%), Positives = 276/298 (92%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH +VVRI TYED + VH+VMELCEGGELFDRIV+KG+YSER+AA+L+KTIV V
Sbjct: 86 MHHLSEHANVVRIEGTYEDSTAVHLVMELCEGGELFDRIVQKGHYSERQAARLIKTIVEV 145
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF ++DEDA LKATDFGLSVFYKP E F DVVGSPYYVAPE
Sbjct: 146 VEACHSLGVMHRDLKPENFLFDTIDEDAKLKATDFGLSVFYKPGESFCDVVGSPYYVAPE 205
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRK YGPE+DVWSAGVILYILLSGVPPFWAE+E GIFRQIL GK+DF SEPWP+IS+SA
Sbjct: 206 VLRKLYGPESDVWSAGVILYILLSGVPPFWAESEPGIFRQILLGKLDFHSEPWPSISDSA 265
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRKMLDQNPK RLTAHEVL HPWIVDD +APDKPLDSAVLSRLK FSAMNKLKKMAL
Sbjct: 266 KDLIRKMLDQNPKTRLTAHEVLRHPWIVDDNIAPDKPLDSAVLSRLKQFSAMNKLKKMAL 325
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAERL+EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS+LMESEIKDLMDA
Sbjct: 326 RVIAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 383
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Glycine max (taxid: 3847) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q42396|CDPKC_ARATH Calcium-dependent protein kinase 12 OS=Arabidopsis thaliana GN=CPK12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 503 bits (1295), Expect = e-142, Method: Compositional matrix adjust.
Identities = 240/298 (80%), Positives = 269/298 (90%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSE+ +VVRI YED VH+VMELCEGGELFDRIVK+G+YSEREAAKL+KTIVGV
Sbjct: 74 MHHLSEYPNVVRIESAYEDTKNVHLVMELCEGGELFDRIVKRGHYSEREAAKLIKTIVGV 133
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF S DEDA+LK+TDFGLSVF P E FS++VGS YYVAPE
Sbjct: 134 VEACHSLGVVHRDLKPENFLFSSSDEDASLKSTDFGLSVFCTPGEAFSELVGSAYYVAPE 193
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL KHYGPE DVWSAGVILYILL G PPFWAE+EIGIFR+IL+GK++FE PWP+ISESA
Sbjct: 194 VLHKHYGPECDVWSAGVILYILLCGFPPFWAESEIGIFRKILQGKLEFEINPWPSISESA 253
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLI+KML+ NPK+RLTAH+VLCHPWIVDDKVAPDKPLD AV+SRLK FSAMNKLKKMAL
Sbjct: 254 KDLIKKMLESNPKKRLTAHQVLCHPWIVDDKVAPDKPLDCAVVSRLKKFSAMNKLKKMAL 313
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAERL+EEEIGGLKELFKMIDTD SGTITF+ELKD ++RVGS+LMESEI++L+ A
Sbjct: 314 RVIAERLSEEEIGGLKELFKMIDTDKSGTITFEELKDSMRRVGSELMESEIQELLRAA 371
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q38869|CDPK4_ARATH Calcium-dependent protein kinase 4 OS=Arabidopsis thaliana GN=CPK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 503 bits (1295), Expect = e-142, Method: Compositional matrix adjust.
Identities = 244/298 (81%), Positives = 265/298 (88%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH +VVRI TYED VHIVME+CEGGELFDRIV KG +SEREAAKL+KTI+GV
Sbjct: 77 MHHLSEHPNVVRIKGTYEDSVFVHIVMEVCEGGELFDRIVSKGCFSEREAAKLIKTILGV 136
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF S +DA LKATDFGLSVFYKP + DVVGSPYYVAPE
Sbjct: 137 VEACHSLGVMHRDLKPENFLFDSPSDDAKLKATDFGLSVFYKPGQYLYDVVGSPYYVAPE 196
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL+K YGPE DVWSAGVILYILLSGVPPFWAETE GIFRQIL+GKIDF+S+PWP ISE A
Sbjct: 197 VLKKCYGPEIDVWSAGVILYILLSGVPPFWAETESGIFRQILQGKIDFKSDPWPTISEGA 256
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLI KMLD++PK+R++AHE LCHPWIVD+ APDKPLD AVLSRLK FS MNK+KKMAL
Sbjct: 257 KDLIYKMLDRSPKKRISAHEALCHPWIVDEHAAPDKPLDPAVLSRLKQFSQMNKIKKMAL 316
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAERL+EEEIGGLKELFKMIDTDNSGTITF+ELK GLKRVGS+LMESEIK LMDA
Sbjct: 317 RVIAERLSEEEIGGLKELFKMIDTDNSGTITFEELKAGLKRVGSELMESEIKSLMDAA 374
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Functions as regulator of the calcium-mediated abscisic acid (ABA) signaling pathway. Phosphorylates ABA-responsive transcription factors ABF1 and ABF4 in vitro. Phosphorylates the nuclear zinc finger Di19 in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39016|CDPKB_ARATH Calcium-dependent protein kinase 11 OS=Arabidopsis thaliana GN=CPK11 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 501 bits (1289), Expect = e-141, Method: Compositional matrix adjust.
Identities = 241/298 (80%), Positives = 267/298 (89%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH +VVRI TYED VHIVME+CEGGELFDRIV KG++SEREA KL+KTI+GV
Sbjct: 78 MHHLSEHPNVVRIKGTYEDSVFVHIVMEVCEGGELFDRIVSKGHFSEREAVKLIKTILGV 137
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF S +DA LKATDFGLSVFYKP + DVVGSPYYVAPE
Sbjct: 138 VEACHSLGVMHRDLKPENFLFDSPKDDAKLKATDFGLSVFYKPGQYLYDVVGSPYYVAPE 197
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL+K YGPE DVWSAGVILYILLSGVPPFWAETE GIFRQIL+GK+DF+S+PWP ISE+A
Sbjct: 198 VLKKCYGPEIDVWSAGVILYILLSGVPPFWAETESGIFRQILQGKLDFKSDPWPTISEAA 257
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLI KML+++PK+R++AHE LCHPWIVD++ APDKPLD AVLSRLK FS MNK+KKMAL
Sbjct: 258 KDLIYKMLERSPKKRISAHEALCHPWIVDEQAAPDKPLDPAVLSRLKQFSQMNKIKKMAL 317
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAERL+EEEIGGLKELFKMIDTDNSGTITF+ELK GLKRVGS+LMESEIK LMDA
Sbjct: 318 RVIAERLSEEEIGGLKELFKMIDTDNSGTITFEELKAGLKRVGSELMESEIKSLMDAA 375
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Functions as regulator of the calcium-mediated abscisic acid (ABA) signaling pathway. Phosphorylates ABA-responsive transcription factors ABF1 and ABF4 in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q38870|CDPK2_ARATH Calcium-dependent protein kinase 2 OS=Arabidopsis thaliana GN=CPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 481 bits (1237), Expect = e-135, Method: Compositional matrix adjust.
Identities = 223/298 (74%), Positives = 259/298 (86%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHL+ H +V+ I YED VH+VMELC GGELFDRI+++G+Y+ER+AA+L +TIVGV
Sbjct: 238 MHHLAGHPNVISIKGAYEDVVAVHLVMELCSGGELFDRIIQRGHYTERKAAELARTIVGV 297
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+E CHSLGV HRDLKPENFLF+S +ED+ LK DFGLS+F+KPDEVF+DVVGSPYYVAPE
Sbjct: 298 LEACHSLGVMHRDLKPENFLFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYVAPE 357
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRK YGPE+DVWSAGVI+YILLSGVPPFWAETE GIF Q+L G +DF S+PWP+ISESA
Sbjct: 358 VLRKRYGPESDVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESA 417
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDL+RKML ++PKRRLTAH+VLCHPW+ D VAPDKPLDSAVLSR+K FSAMNK KKMAL
Sbjct: 418 KDLVRKMLVRDPKRRLTAHQVLCHPWVQIDGVAPDKPLDSAVLSRMKQFSAMNKFKKMAL 477
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAE L+EEEI GLK++FKMID DNSG ITF+ELK GLKRVG+ L ESEI DLM A
Sbjct: 478 RVIAESLSEEEIAGLKQMFKMIDADNSGQITFEELKAGLKRVGANLKESEILDLMQAA 535
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06850|CDPK1_ARATH Calcium-dependent protein kinase 1 OS=Arabidopsis thaliana GN=CPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 472 bits (1214), Expect = e-132, Method: Compositional matrix adjust.
Identities = 221/298 (74%), Positives = 255/298 (85%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHL+ H +V+ I YED VH+VME C GGELFDRI+++G+Y+ER+AA+L +TIVGV
Sbjct: 202 MHHLAGHPNVISIKGAYEDVVAVHLVMECCAGGELFDRIIQRGHYTERKAAELTRTIVGV 261
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF+S ED+ LK DFGLS+F+KPD+VF+DVVGSPYYVAPE
Sbjct: 262 VEACHSLGVMHRDLKPENFLFVSKHEDSLLKTIDFGLSMFFKPDDVFTDVVGSPYYVAPE 321
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRK YGPEADVWSAGVI+YILLSGVPPFWAETE GIF Q+L G +DF S+PWP+ISESA
Sbjct: 322 VLRKRYGPEADVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESA 381
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDL+RKML ++PK+RLTAH+VLCHPW+ D VAPDKPLDSAVLSR+K FSAMNK KKMAL
Sbjct: 382 KDLVRKMLVRDPKKRLTAHQVLCHPWVQVDGVAPDKPLDSAVLSRMKQFSAMNKFKKMAL 441
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAE L+EEEI GLKE+F MID D SG ITF+ELK GLKRVG+ L ESEI DLM A
Sbjct: 442 RVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAA 499
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Phosphorylates the Ca(2+)-ATPase ACA2 resulting in the inhibition of its calcium activation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A5A7I7|CDPK4_SOLTU Calcium-dependent protein kinase 4 OS=Solanum tuberosum GN=CPK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1187), Expect = e-129, Method: Compositional matrix adjust.
Identities = 217/298 (72%), Positives = 254/298 (85%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLS H+++V I YED VHIVME+C GGELFDRI+++G+YSER+AA+L K IVGV
Sbjct: 146 MHHLSGHRNIVTIKGAYEDPLYVHIVMEICSGGELFDRIIQRGHYSERKAAELTKIIVGV 205
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFL ++ D D +LKA DFGLSVF+KP ++F+DVVGSPYYVAPE
Sbjct: 206 VEACHSLGVMHRDLKPENFLLVNKDNDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 265
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL KHYGPEADVW+AGVILYILLSGVPPFWAET+ GIF +L+G IDF+S+PWP ISESA
Sbjct: 266 VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFDSDPWPLISESA 325
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRKML P RLTAHEVLCHPWI ++ VAPD+ LD AVLSRLK FSAMNKLKKMAL
Sbjct: 326 KDLIRKMLCMQPSERLTAHEVLCHPWICENGVAPDRALDPAVLSRLKQFSAMNKLKKMAL 385
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAE L+EEEI GL+E+FK +DTD+SG ITFDELK GL++ GS L ++EI++LMDA
Sbjct: 386 RVIAESLSEEEIAGLREMFKAMDTDSSGAITFDELKAGLRKYGSTLKDTEIRELMDAA 443
|
Regulates the production of reactive oxygen species (ROS) by NADPH oxidase. Solanum tuberosum (taxid: 4113) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A5A7I8|CDPK5_SOLTU Calcium-dependent protein kinase 5 OS=Solanum tuberosum GN=CPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 460 bits (1184), Expect = e-129, Method: Compositional matrix adjust.
Identities = 218/298 (73%), Positives = 254/298 (85%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHL+ H+++V I YED VHIVMELC GGELFDRI+++G+Y+ER+AA L K IVGV
Sbjct: 124 MHHLAGHKNIVSIKGAYEDPLYVHIVMELCGGGELFDRIIQRGHYTERKAADLTKIIVGV 183
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFL ++ D+D +LKA DFGLSVF+KP ++F+DVVGSPYYVAPE
Sbjct: 184 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 243
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL KHYGPEADVW+AGVILYILLSGVPPFWAET+ GIF +L+G IDF+S+PWP +SESA
Sbjct: 244 VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFDSDPWPLLSESA 303
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRKML P RLTAHEVLCHPWI ++ VAPD+ LD AVLSRLKHFSAMNKLKKMAL
Sbjct: 304 KDLIRKMLCMRPSERLTAHEVLCHPWICENGVAPDRALDPAVLSRLKHFSAMNKLKKMAL 363
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAE L+EEEI GLKE+FK +DTDNSG ITFDELK GL++ GS L + EI++LMDA
Sbjct: 364 RVIAESLSEEEIAGLKEMFKAMDTDNSGAITFDELKAGLRKYGSTLKDIEIRELMDAA 421
|
Regulates the production of reactive oxygen species (ROS) by NADPH oxidase. Solanum tuberosum (taxid: 4113) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q38871|CDPK5_ARATH Calcium-dependent protein kinase 5 OS=Arabidopsis thaliana GN=CPK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1164), Expect = e-126, Method: Compositional matrix adjust.
Identities = 214/298 (71%), Positives = 250/298 (83%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHL+ H +V I YED VHIVMELC GGELFDRI+++G+YSER+AA+L K IVGV
Sbjct: 149 MHHLAGHGSIVTIKGAYEDSLYVHIVMELCAGGELFDRIIQRGHYSERKAAELTKIIVGV 208
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFL ++ D+D +LKA DFGLSVF+KP ++F+DVVGSPYYVAPE
Sbjct: 209 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 268
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL K YGPEADVW+AGVILYILLSGVPPFWAET+ GIF +L+G IDFES+PWP IS+SA
Sbjct: 269 VLLKRYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGYIDFESDPWPVISDSA 328
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIR+ML P RLTAHEVL HPWI ++ VAPD+ LD AVLSRLK FSAMNKLKKMAL
Sbjct: 329 KDLIRRMLSSKPAERLTAHEVLRHPWICENGVAPDRALDPAVLSRLKQFSAMNKLKKMAL 388
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+VIAE L+EEEI GL+E+F+ +DTDNSG ITFDELK GL++ GS L ++EI DLMDA
Sbjct: 389 KVIAESLSEEEIAGLREMFQAMDTDNSGAITFDELKAGLRKYGSTLKDTEIHDLMDAA 446
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZV15|CDPKK_ARATH Calcium-dependent protein kinase 20 OS=Arabidopsis thaliana GN=CPK20 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-126, Method: Compositional matrix adjust.
Identities = 212/298 (71%), Positives = 252/298 (84%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLS H +V++I YED VH+VME+C GGELFDRI+++G+Y+E++AA+L + IVGV
Sbjct: 186 MHHLSGHPNVIQIVGAYEDAVAVHVVMEICAGGELFDRIIQRGHYTEKKAAELARIIVGV 245
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+E CHSLGV HRDLKPENFLF+S DE+AALK DFGLSVF+KP E F+DVVGSPYYVAPE
Sbjct: 246 IEACHSLGVMHRDLKPENFLFVSGDEEAALKTIDFGLSVFFKPGETFTDVVGSPYYVAPE 305
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRKHY E DVWSAGVI+YILLSGVPPFW ETE GIF Q+L+G +DF SEPWP++SESA
Sbjct: 306 VLRKHYSHECDVWSAGVIIYILLSGVPPFWDETEQGIFEQVLKGDLDFISEPWPSVSESA 365
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDL+R+ML ++PK+R+T HEVLCHPW D VA DKPLDSAVLSRL+ FSAMNKLKK+A+
Sbjct: 366 KDLVRRMLIRDPKKRMTTHEVLCHPWARVDGVALDKPLDSAVLSRLQQFSAMNKLKKIAI 425
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+VIAE L+EEEI GLKE+FKMIDTDNSG IT +ELK GL RVG+ L +SEI LM A
Sbjct: 426 KVIAESLSEEEIAGLKEMFKMIDTDNSGHITLEELKKGLDRVGADLKDSEILGLMQAA 483
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | ||||||
| 224145672 | 503 | calcium dependent protein kinase 12 [Pop | 0.946 | 0.592 | 0.885 | 1e-155 | |
| 449459202 | 503 | PREDICTED: calcium-dependent protein kin | 0.946 | 0.592 | 0.885 | 1e-154 | |
| 363808098 | 507 | calcium-dependent protein kinase SK5-lik | 0.946 | 0.587 | 0.879 | 1e-151 | |
| 15289760 | 496 | calcium dependent protein kinase [Solanu | 0.946 | 0.600 | 0.875 | 1e-151 | |
| 357520279 | 503 | Calcium-dependent protein kinase [Medica | 0.946 | 0.592 | 0.872 | 1e-150 | |
| 356516443 | 497 | PREDICTED: calcium-dependent protein kin | 0.946 | 0.599 | 0.859 | 1e-149 | |
| 402746619 | 508 | calcium-dependent protein kinase SK5 [Gl | 0.946 | 0.586 | 0.865 | 1e-149 | |
| 356508898 | 496 | PREDICTED: calcium-dependent protein kin | 0.946 | 0.600 | 0.855 | 1e-149 | |
| 39598579 | 497 | calcium-dependent protein kinase [Vitis | 0.946 | 0.599 | 0.859 | 1e-149 | |
| 359480923 | 540 | PREDICTED: calcium-dependent protein kin | 0.946 | 0.551 | 0.859 | 1e-148 |
| >gi|224145672|ref|XP_002325726.1| calcium dependent protein kinase 12 [Populus trichocarpa] gi|222862601|gb|EEF00108.1| calcium dependent protein kinase 12 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 552 bits (1423), Expect = e-155, Method: Compositional matrix adjust.
Identities = 264/298 (88%), Positives = 283/298 (94%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH HVVRI YED SCVH+VMELCEGGELFDRIVKKG+YSE+EAAKLMKTIVGV
Sbjct: 86 MHHLSEHPHVVRISGAYEDISCVHLVMELCEGGELFDRIVKKGHYSEKEAAKLMKTIVGV 145
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFL SV+EDA LKATDFGLSVFYKP E F DVVGSPYYVAPE
Sbjct: 146 VEACHSLGVMHRDLKPENFLLHSVEEDAPLKATDFGLSVFYKPGETFCDVVGSPYYVAPE 205
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRKHYGPEADVWSAG+ILYILLSGVPPFWAETEIGIF+QIL+GK+DFESEPWP+IS+SA
Sbjct: 206 VLRKHYGPEADVWSAGIILYILLSGVPPFWAETEIGIFKQILQGKLDFESEPWPSISDSA 265
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRKML++NPK+RLTAHEVLCHPWIVDD++APDKPLDSAVLSRLK FSAMNKLKKMAL
Sbjct: 266 KDLIRKMLERNPKKRLTAHEVLCHPWIVDDRIAPDKPLDSAVLSRLKQFSAMNKLKKMAL 325
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIA+RL+EEEIGGLKELFKMIDTDNSGTITFDELKDGL+RVGS+LMESEIKDLMDA
Sbjct: 326 RVIADRLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLRRVGSELMESEIKDLMDAA 383
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449459202|ref|XP_004147335.1| PREDICTED: calcium-dependent protein kinase SK5-like [Cucumis sativus] gi|449508715|ref|XP_004163390.1| PREDICTED: calcium-dependent protein kinase SK5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 549 bits (1414), Expect = e-154, Method: Compositional matrix adjust.
Identities = 264/298 (88%), Positives = 279/298 (93%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH ++VRI TYED VH+VMELCEGGELFDRIV+KG YSEREAAKL+ IV V
Sbjct: 82 MHHLSEHPNIVRIKGTYEDPVSVHLVMELCEGGELFDRIVQKGQYSEREAAKLIGVIVSV 141
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+E CHSLGV HRDLKPENFLF SVDEDAALKATDFGLSVFYKP E FSDVVGSPYYVAP+
Sbjct: 142 LESCHSLGVMHRDLKPENFLFQSVDEDAALKATDFGLSVFYKPGETFSDVVGSPYYVAPD 201
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRKHYGPE+DVWSAGVILYILLSGVPPFWAETEIGIFRQIL+G++DFESEPWP IS SA
Sbjct: 202 VLRKHYGPESDVWSAGVILYILLSGVPPFWAETEIGIFRQILQGRLDFESEPWPGISASA 261
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRKMLD+NPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLK FSAMNKLKKMAL
Sbjct: 262 KDLIRKMLDRNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKQFSAMNKLKKMAL 321
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAERL+EEEIGGLKELFKMIDTDNSGTITFDELK+GLKRVGS+LMESEIKDLMDA
Sbjct: 322 RVIAERLSEEEIGGLKELFKMIDTDNSGTITFDELKEGLKRVGSELMESEIKDLMDAA 379
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363808098|ref|NP_001241962.1| calcium-dependent protein kinase SK5-like [Glycine max] gi|29892113|gb|AAP03012.1| seed calcium dependent protein kinase a [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1392), Expect = e-151, Method: Compositional matrix adjust.
Identities = 262/298 (87%), Positives = 277/298 (92%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH HVVRI TYED S VH+VMELCEGGELFDRIV+KG+YSER+AA+L+KTIV V
Sbjct: 85 MHHLSEHAHVVRIEGTYEDSSAVHLVMELCEGGELFDRIVQKGHYSERQAARLIKTIVEV 144
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF +VDEDA LKATDFGLSVFYKP E F DVVGSPYYVAPE
Sbjct: 145 VEACHSLGVMHRDLKPENFLFDTVDEDAKLKATDFGLSVFYKPGESFCDVVGSPYYVAPE 204
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRKHYGPE+DVWSAGVILYILLSGVPPFWAE+E GIFRQIL GK+DF SEPWP+IS+SA
Sbjct: 205 VLRKHYGPESDVWSAGVILYILLSGVPPFWAESEPGIFRQILLGKLDFHSEPWPSISDSA 264
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRKMLDQNPK RLTAHEVL HPWIVDD +APDKPLDSAVLSRLK FSAMNKLKKMAL
Sbjct: 265 KDLIRKMLDQNPKTRLTAHEVLRHPWIVDDNIAPDKPLDSAVLSRLKQFSAMNKLKKMAL 324
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAERL+EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS+LMESEIKDLMDA
Sbjct: 325 RVIAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 382
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15289760|dbj|BAB63464.1| calcium dependent protein kinase [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1387), Expect = e-151, Method: Compositional matrix adjust.
Identities = 261/298 (87%), Positives = 278/298 (93%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH +VVRI TYED VHIVMELC GGELFDRIV+KG+YSEREAAKL+KTIVGV
Sbjct: 80 MHHLSEHPNVVRIKGTYEDALYVHIVMELCAGGELFDRIVEKGHYSEREAAKLIKTIVGV 139
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLFLS DEDAALKATDFGLSVFYKP E FSDVVGSPYYVAPE
Sbjct: 140 VEACHSLGVMHRDLKPENFLFLSSDEDAALKATDFGLSVFYKPGETFSDVVGSPYYVAPE 199
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL KHYG E+DVWSAGVILYILLSGVPPFWAET++GIFRQIL GK+D ESEPWP IS+SA
Sbjct: 200 VLCKHYGHESDVWSAGVILYILLSGVPPFWAETDMGIFRQILRGKLDLESEPWPGISDSA 259
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRK+LD+NPKRRLTAHEVLCHPWIVDD VAPDKPLDSAVLSRLK FSAMNKLKKMAL
Sbjct: 260 KDLIRKILDRNPKRRLTAHEVLCHPWIVDDTVAPDKPLDSAVLSRLKQFSAMNKLKKMAL 319
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAERL+EEEIGGLKELFKM+DTDNSGTITF+ELK+GL+RVGS+LMESEIKDLMDA
Sbjct: 320 RVIAERLSEEEIGGLKELFKMLDTDNSGTITFEELKEGLRRVGSELMESEIKDLMDAA 377
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357520279|ref|XP_003630428.1| Calcium-dependent protein kinase [Medicago truncatula] gi|355524450|gb|AET04904.1| Calcium-dependent protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1379), Expect = e-150, Method: Compositional matrix adjust.
Identities = 260/298 (87%), Positives = 277/298 (92%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH HVVRI TYED + VHIVMELCEGGELFDRIVKKG+YSER+AA L+KTIV V
Sbjct: 82 MHHLSEHPHVVRIEGTYEDSTAVHIVMELCEGGELFDRIVKKGHYSERQAAGLIKTIVEV 141
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF +VDEDA LKATDFGLSVFYKP E FSDVVGSPYYVAPE
Sbjct: 142 VESCHSLGVMHRDLKPENFLFDTVDEDAKLKATDFGLSVFYKPGESFSDVVGSPYYVAPE 201
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRK YGPE+DVWSAGVILYILLSGVPPFWAETE GIFRQIL GK+DF+SEPWP+IS+SA
Sbjct: 202 VLRKLYGPESDVWSAGVILYILLSGVPPFWAETEPGIFRQILLGKLDFQSEPWPSISDSA 261
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRKMLDQNP+ RLTAHEVL HPWIVDD +APDKP+DSAVLSRLK FSAMNKLKKMAL
Sbjct: 262 KDLIRKMLDQNPRTRLTAHEVLRHPWIVDDNIAPDKPIDSAVLSRLKQFSAMNKLKKMAL 321
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAERL+EEEIGGLKELFKMIDTD+SGTITFDELKDGLKRVGS+LMESEI+DLMDA
Sbjct: 322 RVIAERLSEEEIGGLKELFKMIDTDSSGTITFDELKDGLKRVGSELMESEIQDLMDAA 379
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516443|ref|XP_003526904.1| PREDICTED: calcium-dependent protein kinase SK5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1377), Expect = e-149, Method: Compositional matrix adjust.
Identities = 256/298 (85%), Positives = 277/298 (92%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH +VVRIH TYED + VH+VMELCEGGELFDRIV+KG+YSER+AAKL+KTIV V
Sbjct: 83 MHHLSEHPNVVRIHGTYEDAASVHLVMELCEGGELFDRIVQKGHYSERQAAKLIKTIVEV 142
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF +V+E A LK TDFGLSVFYKP E F DVVGSPYYVAPE
Sbjct: 143 VEACHSLGVMHRDLKPENFLFDTVEEGAKLKTTDFGLSVFYKPGETFCDVVGSPYYVAPE 202
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRKHYGPEADVWSAGVILYILLSGVPPFWAETE GIFRQIL G+IDF+SEPWP+IS+SA
Sbjct: 203 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEQGIFRQILLGRIDFQSEPWPSISDSA 262
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRKMLD+NPK R+TAH+VLCHPWIVDD +APDKPLDSAVLSRLK FSAMNKLKKMAL
Sbjct: 263 KDLIRKMLDRNPKTRVTAHQVLCHPWIVDDNIAPDKPLDSAVLSRLKQFSAMNKLKKMAL 322
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAERL+EEEIGGLKELF+MID DNSGTITFDELK+GLKRVGS+LMESEIKDLMDA
Sbjct: 323 RVIAERLSEEEIGGLKELFRMIDADNSGTITFDELKEGLKRVGSELMESEIKDLMDAA 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|402746619|ref|NP_001238517.2| calcium-dependent protein kinase SK5 [Glycine max] gi|116054|sp|P28583.1|CDPK_SOYBN RecName: Full=Calcium-dependent protein kinase SK5; Short=CDPK gi|169931|gb|AAB00806.1| calmcium/calmodulin-dependent protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 534 bits (1375), Expect = e-149, Method: Compositional matrix adjust.
Identities = 258/298 (86%), Positives = 276/298 (92%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH +VVRI TYED + VH+VMELCEGGELFDRIV+KG+YSER+AA+L+KTIV V
Sbjct: 86 MHHLSEHANVVRIEGTYEDSTAVHLVMELCEGGELFDRIVQKGHYSERQAARLIKTIVEV 145
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF ++DEDA LKATDFGLSVFYKP E F DVVGSPYYVAPE
Sbjct: 146 VEACHSLGVMHRDLKPENFLFDTIDEDAKLKATDFGLSVFYKPGESFCDVVGSPYYVAPE 205
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRK YGPE+DVWSAGVILYILLSGVPPFWAE+E GIFRQIL GK+DF SEPWP+IS+SA
Sbjct: 206 VLRKLYGPESDVWSAGVILYILLSGVPPFWAESEPGIFRQILLGKLDFHSEPWPSISDSA 265
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRKMLDQNPK RLTAHEVL HPWIVDD +APDKPLDSAVLSRLK FSAMNKLKKMAL
Sbjct: 266 KDLIRKMLDQNPKTRLTAHEVLRHPWIVDDNIAPDKPLDSAVLSRLKQFSAMNKLKKMAL 325
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAERL+EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS+LMESEIKDLMDA
Sbjct: 326 RVIAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 383
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508898|ref|XP_003523190.1| PREDICTED: calcium-dependent protein kinase SK5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1374), Expect = e-149, Method: Compositional matrix adjust.
Identities = 255/298 (85%), Positives = 277/298 (92%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSE +VVRIH TYED + VH+VMELCEGGELFDRIV+KG+YSER+AAKL+KTIV V
Sbjct: 82 MHHLSEQPNVVRIHGTYEDAASVHLVMELCEGGELFDRIVRKGHYSERQAAKLIKTIVEV 141
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF +V+EDA LK TDFGLSVFYKP E F DVVGSPYYVAPE
Sbjct: 142 VEACHSLGVMHRDLKPENFLFDTVEEDAKLKTTDFGLSVFYKPGETFCDVVGSPYYVAPE 201
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRKHYGPEADVWSAGVILYILLSGVPPFWAETE GIFRQIL G++DF+SEPWP+IS+SA
Sbjct: 202 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEQGIFRQILLGRLDFQSEPWPSISDSA 261
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRKMLD+NPK R+TAH+VLCHPWIVDD +APDKPLDSAVLSRLK FSAMNKLKKMAL
Sbjct: 262 KDLIRKMLDRNPKTRVTAHQVLCHPWIVDDNIAPDKPLDSAVLSRLKQFSAMNKLKKMAL 321
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAERL+EEEIGGLKELF+MID DNSGTITFDELK+GLKRVGS+LMESEIKDLMDA
Sbjct: 322 RVIAERLSEEEIGGLKELFRMIDADNSGTITFDELKEGLKRVGSELMESEIKDLMDAA 379
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|39598579|gb|AAR28766.1| calcium-dependent protein kinase [Vitis labrusca x Vitis vinifera] gi|147799573|emb|CAN70726.1| hypothetical protein VITISV_011381 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 532 bits (1370), Expect = e-149, Method: Compositional matrix adjust.
Identities = 256/298 (85%), Positives = 278/298 (93%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH +VVRI TYED VH+VMELCEGGELFDRIV++G+YSEREAAKL+KTIVGV
Sbjct: 82 MHHLSEHPNVVRIRGTYEDPVFVHLVMELCEGGELFDRIVQRGHYSEREAAKLIKTIVGV 141
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF + EDAALKATDFGLSVFYKP E FSDVVGSPYYVAPE
Sbjct: 142 VEGCHSLGVMHRDLKPENFLFDTTAEDAALKATDFGLSVFYKPGETFSDVVGSPYYVAPE 201
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL KHYGPEADVWSAGVILYILLSGVPPFWAETE GIFRQIL+GK+DFESEPWP ISE+A
Sbjct: 202 VLCKHYGPEADVWSAGVILYILLSGVPPFWAETETGIFRQILQGKLDFESEPWPCISETA 261
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
K+L+RKMLD+NPK+RLTAHEVL HPW+VDD++APDKPLDSAVLSRLK FSAMNKLKKMAL
Sbjct: 262 KELLRKMLDRNPKKRLTAHEVLSHPWVVDDRMAPDKPLDSAVLSRLKQFSAMNKLKKMAL 321
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAE L+EEEIGGL+ELFKMIDTDNSGTITFDELKDGLKRVGS+LMESEI+DLM+A
Sbjct: 322 RVIAEGLSEEEIGGLRELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIRDLMNAA 379
|
Source: Vitis labrusca x Vitis vinifera Species: Vitis labrusca x Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480923|ref|XP_003632543.1| PREDICTED: calcium-dependent protein kinase SK5-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 531 bits (1369), Expect = e-148, Method: Compositional matrix adjust.
Identities = 256/298 (85%), Positives = 278/298 (93%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH +VVRI TYED VH+VMELCEGGELFDRIV++G+YSEREAAKL+KTIVGV
Sbjct: 125 MHHLSEHPNVVRIRGTYEDPVFVHLVMELCEGGELFDRIVQRGHYSEREAAKLIKTIVGV 184
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF + EDAALKATDFGLSVFYKP E FSDVVGSPYYVAPE
Sbjct: 185 VEGCHSLGVMHRDLKPENFLFDTTAEDAALKATDFGLSVFYKPGETFSDVVGSPYYVAPE 244
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL KHYGPEADVWSAGVILYILLSGVPPFWAETE GIFRQIL+GK+DFESEPWP ISE+A
Sbjct: 245 VLCKHYGPEADVWSAGVILYILLSGVPPFWAETETGIFRQILQGKLDFESEPWPCISETA 304
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
K+L+RKMLD+NPK+RLTAHEVL HPW+VDD++APDKPLDSAVLSRLK FSAMNKLKKMAL
Sbjct: 305 KELLRKMLDRNPKKRLTAHEVLSHPWVVDDRMAPDKPLDSAVLSRLKQFSAMNKLKKMAL 364
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
RVIAE L+EEEIGGL+ELFKMIDTDNSGTITFDELKDGLKRVGS+LMESEI+DLM+A
Sbjct: 365 RVIAEGLSEEEIGGLRELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIRDLMNAA 422
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | ||||||
| TAIR|locus:2136917 | 501 | CPK4 "calcium-dependent protei | 0.942 | 0.592 | 0.821 | 1.2e-129 | |
| TAIR|locus:2171726 | 490 | CDPK9 "calmodulin-like domain | 0.942 | 0.606 | 0.808 | 1.5e-129 | |
| TAIR|locus:2014691 | 495 | CDPK2 "AT1G35670" [Arabidopsis | 0.942 | 0.6 | 0.811 | 3.2e-129 | |
| TAIR|locus:2075885 | 646 | CPK2 "calmodulin-domain protei | 0.942 | 0.459 | 0.750 | 8.3e-122 | |
| TAIR|locus:2175503 | 610 | CPK1 "calcium dependent protei | 0.942 | 0.486 | 0.744 | 4.1e-120 | |
| TAIR|locus:2065021 | 583 | CPK20 "calcium-dependent prote | 0.942 | 0.509 | 0.713 | 3.9e-115 | |
| TAIR|locus:2827528 | 544 | CPK6 "calcium dependent protei | 0.942 | 0.545 | 0.717 | 1.3e-114 | |
| TAIR|locus:2122063 | 556 | CPK5 "calmodulin-domain protei | 0.942 | 0.534 | 0.720 | 1.7e-114 | |
| TAIR|locus:2128409 | 529 | CDPK6 "calcium-dependent prote | 0.942 | 0.561 | 0.666 | 4.9e-108 | |
| TAIR|locus:2150225 | 523 | CPK34 "AT5G19360" [Arabidopsis | 0.942 | 0.567 | 0.666 | 1.3e-107 |
| TAIR|locus:2136917 CPK4 "calcium-dependent protein kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1272 (452.8 bits), Expect = 1.2e-129, P = 1.2e-129
Identities = 244/297 (82%), Positives = 265/297 (89%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH +VVRI TYED VHIVME+CEGGELFDRIV KG +SEREAAKL+KTI+GV
Sbjct: 77 MHHLSEHPNVVRIKGTYEDSVFVHIVMEVCEGGELFDRIVSKGCFSEREAAKLIKTILGV 136
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF S +DA LKATDFGLSVFYKP + DVVGSPYYVAPE
Sbjct: 137 VEACHSLGVMHRDLKPENFLFDSPSDDAKLKATDFGLSVFYKPGQYLYDVVGSPYYVAPE 196
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL+K YGPE DVWSAGVILYILLSGVPPFWAETE GIFRQIL+GKIDF+S+PWP ISE A
Sbjct: 197 VLKKCYGPEIDVWSAGVILYILLSGVPPFWAETESGIFRQILQGKIDFKSDPWPTISEGA 256
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLI KMLD++PK+R++AHE LCHPWIVD+ APDKPLD AVLSRLK FS MNK+KKMAL
Sbjct: 257 KDLIYKMLDRSPKKRISAHEALCHPWIVDEHAAPDKPLDPAVLSRLKQFSQMNKIKKMAL 316
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
RVIAERL+EEEIGGLKELFKMIDTDNSGTITF+ELK GLKRVGS+LMESEIK LMDA
Sbjct: 317 RVIAERLSEEEIGGLKELFKMIDTDNSGTITFEELKAGLKRVGSELMESEIKSLMDA 373
|
|
| TAIR|locus:2171726 CDPK9 "calmodulin-like domain protein kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1271 (452.5 bits), Expect = 1.5e-129, P = 1.5e-129
Identities = 240/297 (80%), Positives = 269/297 (90%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSE+ +VVRI YED VH+VMELCEGGELFDRIVK+G+YSEREAAKL+KTIVGV
Sbjct: 74 MHHLSEYPNVVRIESAYEDTKNVHLVMELCEGGELFDRIVKRGHYSEREAAKLIKTIVGV 133
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF S DEDA+LK+TDFGLSVF P E FS++VGS YYVAPE
Sbjct: 134 VEACHSLGVVHRDLKPENFLFSSSDEDASLKSTDFGLSVFCTPGEAFSELVGSAYYVAPE 193
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL KHYGPE DVWSAGVILYILL G PPFWAE+EIGIFR+IL+GK++FE PWP+ISESA
Sbjct: 194 VLHKHYGPECDVWSAGVILYILLCGFPPFWAESEIGIFRKILQGKLEFEINPWPSISESA 253
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLI+KML+ NPK+RLTAH+VLCHPWIVDDKVAPDKPLD AV+SRLK FSAMNKLKKMAL
Sbjct: 254 KDLIKKMLESNPKKRLTAHQVLCHPWIVDDKVAPDKPLDCAVVSRLKKFSAMNKLKKMAL 313
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
RVIAERL+EEEIGGLKELFKMIDTD SGTITF+ELKD ++RVGS+LMESEI++L+ A
Sbjct: 314 RVIAERLSEEEIGGLKELFKMIDTDKSGTITFEELKDSMRRVGSELMESEIQELLRA 370
|
|
| TAIR|locus:2014691 CDPK2 "AT1G35670" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1268 (451.4 bits), Expect = 3.2e-129, P = 3.2e-129
Identities = 241/297 (81%), Positives = 267/297 (89%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLSEH +VVRI TYED VHIVME+CEGGELFDRIV KG++SEREA KL+KTI+GV
Sbjct: 78 MHHLSEHPNVVRIKGTYEDSVFVHIVMEVCEGGELFDRIVSKGHFSEREAVKLIKTILGV 137
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF S +DA LKATDFGLSVFYKP + DVVGSPYYVAPE
Sbjct: 138 VEACHSLGVMHRDLKPENFLFDSPKDDAKLKATDFGLSVFYKPGQYLYDVVGSPYYVAPE 197
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL+K YGPE DVWSAGVILYILLSGVPPFWAETE GIFRQIL+GK+DF+S+PWP ISE+A
Sbjct: 198 VLKKCYGPEIDVWSAGVILYILLSGVPPFWAETESGIFRQILQGKLDFKSDPWPTISEAA 257
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLI KML+++PK+R++AHE LCHPWIVD++ APDKPLD AVLSRLK FS MNK+KKMAL
Sbjct: 258 KDLIYKMLERSPKKRISAHEALCHPWIVDEQAAPDKPLDPAVLSRLKQFSQMNKIKKMAL 317
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
RVIAERL+EEEIGGLKELFKMIDTDNSGTITF+ELK GLKRVGS+LMESEIK LMDA
Sbjct: 318 RVIAERLSEEEIGGLKELFKMIDTDNSGTITFEELKAGLKRVGSELMESEIKSLMDA 374
|
|
| TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1198 (426.8 bits), Expect = 8.3e-122, P = 8.3e-122
Identities = 223/297 (75%), Positives = 259/297 (87%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHL+ H +V+ I YED VH+VMELC GGELFDRI+++G+Y+ER+AA+L +TIVGV
Sbjct: 238 MHHLAGHPNVISIKGAYEDVVAVHLVMELCSGGELFDRIIQRGHYTERKAAELARTIVGV 297
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+E CHSLGV HRDLKPENFLF+S +ED+ LK DFGLS+F+KPDEVF+DVVGSPYYVAPE
Sbjct: 298 LEACHSLGVMHRDLKPENFLFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYVAPE 357
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRK YGPE+DVWSAGVI+YILLSGVPPFWAETE GIF Q+L G +DF S+PWP+ISESA
Sbjct: 358 VLRKRYGPESDVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESA 417
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDL+RKML ++PKRRLTAH+VLCHPW+ D VAPDKPLDSAVLSR+K FSAMNK KKMAL
Sbjct: 418 KDLVRKMLVRDPKRRLTAHQVLCHPWVQIDGVAPDKPLDSAVLSRMKQFSAMNKFKKMAL 477
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
RVIAE L+EEEI GLK++FKMID DNSG ITF+ELK GLKRVG+ L ESEI DLM A
Sbjct: 478 RVIAESLSEEEIAGLKQMFKMIDADNSGQITFEELKAGLKRVGANLKESEILDLMQA 534
|
|
| TAIR|locus:2175503 CPK1 "calcium dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1182 (421.1 bits), Expect = 4.1e-120, P = 4.1e-120
Identities = 221/297 (74%), Positives = 255/297 (85%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHL+ H +V+ I YED VH+VME C GGELFDRI+++G+Y+ER+AA+L +TIVGV
Sbjct: 202 MHHLAGHPNVISIKGAYEDVVAVHLVMECCAGGELFDRIIQRGHYTERKAAELTRTIVGV 261
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFLF+S ED+ LK DFGLS+F+KPD+VF+DVVGSPYYVAPE
Sbjct: 262 VEACHSLGVMHRDLKPENFLFVSKHEDSLLKTIDFGLSMFFKPDDVFTDVVGSPYYVAPE 321
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRK YGPEADVWSAGVI+YILLSGVPPFWAETE GIF Q+L G +DF S+PWP+ISESA
Sbjct: 322 VLRKRYGPEADVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESA 381
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDL+RKML ++PK+RLTAH+VLCHPW+ D VAPDKPLDSAVLSR+K FSAMNK KKMAL
Sbjct: 382 KDLVRKMLVRDPKKRLTAHQVLCHPWVQVDGVAPDKPLDSAVLSRMKQFSAMNKFKKMAL 441
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
RVIAE L+EEEI GLKE+F MID D SG ITF+ELK GLKRVG+ L ESEI DLM A
Sbjct: 442 RVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQA 498
|
|
| TAIR|locus:2065021 CPK20 "calcium-dependent protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1135 (404.6 bits), Expect = 3.9e-115, P = 3.9e-115
Identities = 212/297 (71%), Positives = 252/297 (84%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLS H +V++I YED VH+VME+C GGELFDRI+++G+Y+E++AA+L + IVGV
Sbjct: 186 MHHLSGHPNVIQIVGAYEDAVAVHVVMEICAGGELFDRIIQRGHYTEKKAAELARIIVGV 245
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+E CHSLGV HRDLKPENFLF+S DE+AALK DFGLSVF+KP E F+DVVGSPYYVAPE
Sbjct: 246 IEACHSLGVMHRDLKPENFLFVSGDEEAALKTIDFGLSVFFKPGETFTDVVGSPYYVAPE 305
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRKHY E DVWSAGVI+YILLSGVPPFW ETE GIF Q+L+G +DF SEPWP++SESA
Sbjct: 306 VLRKHYSHECDVWSAGVIIYILLSGVPPFWDETEQGIFEQVLKGDLDFISEPWPSVSESA 365
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDL+R+ML ++PK+R+T HEVLCHPW D VA DKPLDSAVLSRL+ FSAMNKLKK+A+
Sbjct: 366 KDLVRRMLIRDPKKRMTTHEVLCHPWARVDGVALDKPLDSAVLSRLQQFSAMNKLKKIAI 425
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
+VIAE L+EEEI GLKE+FKMIDTDNSG IT +ELK GL RVG+ L +SEI LM A
Sbjct: 426 KVIAESLSEEEIAGLKEMFKMIDTDNSGHITLEELKKGLDRVGADLKDSEILGLMQA 482
|
|
| TAIR|locus:2827528 CPK6 "calcium dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1130 (402.8 bits), Expect = 1.3e-114, P = 1.3e-114
Identities = 213/297 (71%), Positives = 252/297 (84%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHL+ H+++V I YED VHIVMELC GGELFDRI+ +G+YSER+AA+L K IVGV
Sbjct: 137 MHHLAGHKNIVTIKGAYEDPLYVHIVMELCAGGELFDRIIHRGHYSERKAAELTKIIVGV 196
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFL ++ D+D +LKA DFGLSVF+KP ++F DVVGSPYYVAPE
Sbjct: 197 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFKDVVGSPYYVAPE 256
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL KHYGPEADVW+AGVILYILLSGVPPFWAET+ GIF +L+G IDF+++PWP IS+SA
Sbjct: 257 VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGYIDFDTDPWPVISDSA 316
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIRKML +P RLTAHEVL HPWI ++ VAPD+ LD AVLSRLK FSAMNKLKKMAL
Sbjct: 317 KDLIRKMLCSSPSERLTAHEVLRHPWICENGVAPDRALDPAVLSRLKQFSAMNKLKKMAL 376
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
+VIAE L+EEEI GL+ +F+ +DTDNSG ITFDELK GL+R GS L ++EI+DLM+A
Sbjct: 377 KVIAESLSEEEIAGLRAMFEAMDTDNSGAITFDELKAGLRRYGSTLKDTEIRDLMEA 433
|
|
| TAIR|locus:2122063 CPK5 "calmodulin-domain protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 1.7e-114, P = 1.7e-114
Identities = 214/297 (72%), Positives = 250/297 (84%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHL+ H +V I YED VHIVMELC GGELFDRI+++G+YSER+AA+L K IVGV
Sbjct: 149 MHHLAGHGSIVTIKGAYEDSLYVHIVMELCAGGELFDRIIQRGHYSERKAAELTKIIVGV 208
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE CHSLGV HRDLKPENFL ++ D+D +LKA DFGLSVF+KP ++F+DVVGSPYYVAPE
Sbjct: 209 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 268
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL K YGPEADVW+AGVILYILLSGVPPFWAET+ GIF +L+G IDFES+PWP IS+SA
Sbjct: 269 VLLKRYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGYIDFESDPWPVISDSA 328
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDLIR+ML P RLTAHEVL HPWI ++ VAPD+ LD AVLSRLK FSAMNKLKKMAL
Sbjct: 329 KDLIRRMLSSKPAERLTAHEVLRHPWICENGVAPDRALDPAVLSRLKQFSAMNKLKKMAL 388
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
+VIAE L+EEEI GL+E+F+ +DTDNSG ITFDELK GL++ GS L ++EI DLMDA
Sbjct: 389 KVIAESLSEEEIAGLREMFQAMDTDNSGAITFDELKAGLRKYGSTLKDTEIHDLMDA 445
|
|
| TAIR|locus:2128409 CDPK6 "calcium-dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 4.9e-108, P = 4.9e-108
Identities = 198/297 (66%), Positives = 246/297 (82%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHLS H+++V + YED+ V+++MELCEGGELFDRI+ KG YSER AA L + +V V
Sbjct: 130 MHHLSGHRNIVDLKGAYEDRHSVNLIMELCEGGELFDRIISKGLYSERAAADLCRQMVMV 189
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
V CHS+GV HRDLKPENFLFLS DE++ LKATDFGLSVF+KP + F D+VGS YYVAPE
Sbjct: 190 VHSCHSMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDKFKDLVGSAYYVAPE 249
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL+++YGPEAD+WSAGVILYILLSGVPPFW E E GIF IL+G++DF ++PWP +S+ A
Sbjct: 250 VLKRNYGPEADIWSAGVILYILLSGVPPFWGENETGIFDAILQGQLDFSADPWPALSDGA 309
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDL+RKML +PK RLTA EVL HPWI +D A DKPLD+AVLSR+K F AMNKLKKMAL
Sbjct: 310 KDLVRKMLKYDPKDRLTAAEVLNHPWIREDGEASDKPLDNAVLSRMKQFRAMNKLKKMAL 369
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
+VIAE L+EEEI GLKE+FK +DTDN+G +T +EL+ GL ++GS++ E+EI+ LM+A
Sbjct: 370 KVIAENLSEEEIIGLKEMFKSLDTDNNGIVTLEELRTGLPKLGSKISEAEIRQLMEA 426
|
|
| TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 198/297 (66%), Positives = 241/297 (81%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MHHL+ ++V + YEDK VH+VMELC GGELFDRI+ KG+YSER AA L++TIV +
Sbjct: 120 MHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTIVQI 179
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ CHS+GV HRDLKPENFL LS DE++ LKATDFGLSVFYKP EVF D+VGS YY+APE
Sbjct: 180 IHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPE 239
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLR+ YGPEAD+WS GV+LYILL GVPPFWAE+E GIF IL G++DF S+PWP IS A
Sbjct: 240 VLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVISPQA 299
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240
KDL+RKML+ +PK+RLTA +VL HPWI +D APD PLD+AV+SRLK F AMN KK+AL
Sbjct: 300 KDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFKKVAL 359
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
RVIA L+EEEI GLKE+FK +DTDNSGTIT +EL+ GL + G++L E E++ LM+A
Sbjct: 360 RVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQGTRLSEYEVQQLMEA 416
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q42396 | CDPKC_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8053 | 0.9460 | 0.6081 | yes | no |
| P28583 | CDPK_SOYBN | 2, ., 7, ., 1, 1, ., 1 | 0.8657 | 0.9460 | 0.5866 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CPK12 | calcium dependent protein kinase 12 (503 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | eugene3.01330027 | hypothetical protein (876 aa) | • | 0.800 | |||||||
 | eugene3.00121046 | hypothetical protein (907 aa) | • | 0.800 | |||||||
 | eugene3.00010578 | hypothetical protein (927 aa) | • | 0.800 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 315 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-83 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-80 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-55 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-53 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-48 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-44 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-40 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-39 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-39 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-38 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-34 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-34 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-34 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-33 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-33 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-33 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-33 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-32 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-32 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-32 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-31 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-30 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-30 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-30 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-29 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-29 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-28 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-28 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-28 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-27 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-27 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-27 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-26 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-26 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-26 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-26 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-25 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-25 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-25 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-25 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-24 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-24 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-24 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-24 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-24 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-24 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-23 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-23 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-22 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-22 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-22 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-21 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-21 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-21 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-20 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-20 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-18 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-17 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-16 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-12 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-12 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| cd00051 | 63 | cd00051, EFh, EF-hand, calcium binding motif; A di | 4e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-07 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| pfam13405 | 30 | pfam13405, EF_hand_4, EF-hand domain | 5e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-06 | |
| cd00051 | 63 | cd00051, EFh, EF-hand, calcium binding motif; A di | 7e-06 | |
| smart00054 | 29 | smart00054, EFh, EF-hand, calcium binding motif | 7e-06 | |
| pfam00036 | 29 | pfam00036, efhand, EF hand | 8e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-05 | |
| PTZ00184 | 149 | PTZ00184, PTZ00184, calmodulin; Provisional | 8e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 9e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-04 | |
| COG5126 | 160 | COG5126, FRQ1, Ca2+-binding protein (EF-Hand super | 1e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| pfam13499 | 60 | pfam13499, EF_hand_5, EF-hand domain pair | 2e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| pfam13833 | 53 | pfam13833, EF_hand_6, EF-hand domain pair | 3e-04 | |
| PTZ00183 | 158 | PTZ00183, PTZ00183, centrin; Provisional | 3e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-04 | |
| pfam13202 | 25 | pfam13202, EF_hand_3, EF hand | 6e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| COG5126 | 160 | COG5126, FRQ1, Ca2+-binding protein (EF-Hand super | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| PTZ00183 | 158 | PTZ00183, PTZ00183, centrin; Provisional | 0.003 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 0.003 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.003 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 1e-83
Identities = 96/209 (45%), Positives = 137/209 (65%), Gaps = 6/209 (2%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ +H ++VR++D +ED+ +++VME CEGG+LFD + K+G SE EA ++ I+
Sbjct: 50 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSA 109
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+E HS G+ HRDLKPEN L +DED +K DFGL+ P E + VG+P Y+APE
Sbjct: 110 LEYLHSKGIVHRDLKPENIL---LDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166
Query: 121 VL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG-IFRQILEGKIDFESEPWPNISE 178
VL K YG D+WS GVILY LL+G PPF + ++ +F++I + K F W +IS
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEW-DISP 225
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
AKDLIRK+L ++P++RLTA E L HP+
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 244 bits (624), Expect = 3e-80
Identities = 98/213 (46%), Positives = 136/213 (63%), Gaps = 10/213 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ LS H ++VR+ D +EDK +++VME CEGG+LFD + + G SE EA K+ I+
Sbjct: 52 LRRLS-HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRG 110
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAP 119
+E HS G+ HRDLKPEN L +DE+ +K DFGL+ K + VG+P+Y+AP
Sbjct: 111 LEYLHSNGIIHRDLKPENIL---LDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
Query: 120 EVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIG---IFRQILEGKIDFESEPWP 174
EVL YGP+ DVWS GVILY LL+G PPF E + + R+IL ++F+ W
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS 227
Query: 175 NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ SE AKDLI+K L+++P +R TA E+L HPW
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 7e-55
Identities = 81/220 (36%), Positives = 121/220 (55%), Gaps = 18/220 (8%)
Query: 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
++ +VV+++ +++ K +++VME GG+L + G+ E A + IV +E
Sbjct: 48 SQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALE 107
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVF-------YKPDEVFSD--VVGS 113
HS G+ HRDLKP+N L +D + LK TDFGLS D+ D +VG+
Sbjct: 108 YLHSNGIIHRDLKPDNIL---IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 114 PYYVAPEV-LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEP 172
P Y+APEV L + + D WS G ILY L G+PPF ET IF+ IL GKI++ +
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED- 223
Query: 173 WPNISESAKDLIRKMLDQNPKRRLTAH---EVLCHPWIVD 209
+S+ A DLI K+L +P++RL A E+ HP+
Sbjct: 224 -VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-53
Identities = 79/208 (37%), Positives = 116/208 (55%), Gaps = 12/208 (5%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
H +V++H ++ + +++V+E GGELF + K+G +SE A IV +E
Sbjct: 49 RINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEY 108
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL 122
HSLG+ +RDLKPEN L D D +K TDFGL+ + G+P Y+APEVL
Sbjct: 109 LHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL 165
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
K YG D WS GV+LY +L+G PPF+AE I+ +IL+ + F P +S A+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---P-EFLSPEAR 221
Query: 182 DLIRKMLDQNPKRRLTAHEVLC---HPW 206
DLI +L ++P +RL + HP+
Sbjct: 222 DLISGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-51
Identities = 75/232 (32%), Positives = 117/232 (50%), Gaps = 33/232 (14%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L+ H +++++ T++D+ ++ V+E GEL I K G+ E+ I+
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA 114
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-------------- 106
+E HS G+ HRDLKPEN L D+D +K TDFG + P+
Sbjct: 115 LEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 107 -------FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158
F+ VG+ YV+PE+L K G +D+W+ G I+Y +L+G PPF E F
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231
Query: 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAH----EVLCHPW 206
++IL+ + F PN AKDLI K+L +P+ RL + E+ HP+
Sbjct: 232 QKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 7e-48
Identities = 72/203 (35%), Positives = 107/203 (52%), Gaps = 41/203 (20%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCH 65
H ++V+++ +ED++ +++VME CEGG L D + + G SE E +++ I+ +E H
Sbjct: 50 HPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH 109
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR- 123
S G+ HRDLKPEN L S + L DFGLS D+ + +VG+P Y+APEVL
Sbjct: 110 SNGIIHRDLKPENILLDSDNGKVKL--ADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG 167
Query: 124 -KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
+Y ++D+WS GVILY L KD
Sbjct: 168 KGYYSEKSDIWSLGVILYEL-----------------------------------PELKD 192
Query: 183 LIRKMLDQNPKRRLTAHEVLCHP 205
LIRKML ++P++R +A E+L H
Sbjct: 193 LIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 78/211 (36%), Positives = 120/211 (56%), Gaps = 17/211 (8%)
Query: 4 LSEHQH--VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
L +H +V ++ +++D S +++VME GGELF + K G + E A +V +
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL 114
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV 121
E HSL + +RDLKPEN L +D D +K TDFG + ++ + G+P Y+APE+
Sbjct: 115 EYLHSLDIVYRDLKPENLL---LDSDGYIKITDFGFAK-RVKGRTYT-LCGTPEYLAPEI 169
Query: 122 -LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
L K YG D W+ G+++Y +L+G PPF+ + I I+ +ILEGK+ F S S A
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDA 225
Query: 181 KDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
KDLIR +L + +RL +++ HPW
Sbjct: 226 KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 7e-45
Identities = 60/208 (28%), Positives = 113/208 (54%), Gaps = 14/208 (6%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI----VKKGNYSEREAAKLMKTIVGVVE 62
H ++++ ++++E+K + IVME +GG+L +I + + E + + ++
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF-SDVVGSPYYVAPEV 121
HS + HRD+KP+N +FL + +K DFG+S VVG+PYY++PE+
Sbjct: 118 YLHSRKILHRDIKPQN-IFL--TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 122 LR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI-SES 179
+ K Y ++D+WS G +LY L + PF E + + +IL+G+ P P+ S
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP----PIPSQYSSE 230
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
++L+ +L ++P+ R + ++L P+I
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 8e-44
Identities = 70/232 (30%), Positives = 110/232 (47%), Gaps = 35/232 (15%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVGVVECC 64
+H +VV++ D + S +VME +L + + + E + M+ ++ V
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVL 122
H+ G+ HRDLKP N L + D LK DFGL+ + +E ++S V + +Y APE+L
Sbjct: 116 HANGIMHRDLKPANLL---ISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 123 --RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQI--------------- 161
+ Y P D+W+ G I LL+G P F E +I +FR +
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232
Query: 162 LEGKIDFES---EPW----PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
KI F P P+ S A DL++ +L +P +RL+A E L HP+
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 7e-41
Identities = 76/209 (36%), Positives = 119/209 (56%), Gaps = 15/209 (7%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H +V+++ T++DK ++++ME C GGEL+ + +G + E A + +V E H+
Sbjct: 52 HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV-LRKH 125
G+ +RDLKPEN L +D + +K DFG + K + G+P YVAPE+ L K
Sbjct: 112 RGIIYRDLKPENLL---LDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 126 YGPEADVWSAGVILYILLSGVPPFWAETE--IGIFRQILEGKIDFESEPWPN-ISESAKD 182
Y D WS G++LY LL+G PPF + E + I+ IL+G E +PN I ++AKD
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKD 225
Query: 183 LIRKMLDQNPKRRL-----TAHEVLCHPW 206
LI+++L +NP+ RL ++ H W
Sbjct: 226 LIKQLLRRNPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 8e-40
Identities = 78/217 (35%), Positives = 115/217 (52%), Gaps = 19/217 (8%)
Query: 1 MHHLSEHQHVVRIHDTY--EDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIV 58
+ L H ++VR + + E+K+ ++I +E GG L + K G E K + I+
Sbjct: 53 LSSLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL 111
Query: 59 GVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVF---YKPDEVFSDVVGSPY 115
+ HS G+ HRD+K N L VD D +K DFG + + E V G+PY
Sbjct: 112 EGLAYLHSNGIVHRDIKGANIL---VDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 116 YVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP 174
++APEV+R + YG AD+WS G + + +G PP+ E+G L KI EP P
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS---ELGNPMAAL-YKIGSSGEP-P 223
Query: 175 NI----SESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
I SE AKD +RK L ++PK+R TA E+L HP++
Sbjct: 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 74/229 (32%), Positives = 117/229 (51%), Gaps = 36/229 (15%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
+V+++ +++D+ +++VME GG+L + +++K + E A + +V ++ H LG
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGLS---------VFYKPDEV-------------- 106
HRD+KP+N L +D D +K DFGL +Y D
Sbjct: 123 IHRDIKPDNIL---IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 107 -------FSDVVGSPYYVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158
+ VG+P Y+APEVLR YG E D WS GVILY +L G PPF+++T +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-AHEVLCHPW 206
+I+ K P P +S A DLI ++L +P+ RL E+ HP+
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 142 bits (357), Expect = 2e-39
Identities = 80/318 (25%), Positives = 136/318 (42%), Gaps = 26/318 (8%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK---KGNYSEREAAKLMKTI 57
+ L+ ++V+++D ++D+ +++VME +GG L D + K KG SE EA ++ I
Sbjct: 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI 110
Query: 58 VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-------FSDV 110
+ +E HS G+ HRD+KPEN L + +K DFGL+ S
Sbjct: 111 LSALEYLHSKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 111 VGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG-- 164
VG+P Y+APEVL + +D+WS G+ LY LL+G+PPF E Q L+
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228
Query: 165 -------KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKP 217
IS++A DL++K+L ++PK RL++ L H + K+
Sbjct: 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
Query: 218 LDSAVLSRLKH-FSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELK 276
D ++ + + + L + + +G +
Sbjct: 289 SDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNS 348
Query: 277 DGLKRVGSQLMESEIKDL 294
L + S + +
Sbjct: 349 SSLLLSTASSKRSSLPKI 366
|
Length = 384 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-39
Identities = 72/210 (34%), Positives = 109/210 (51%), Gaps = 10/210 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M E +V +++ +++ K +++VME GG+ I G E A + + +V
Sbjct: 50 MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG 109
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
VE H G+ HRD+KPEN L +D+ LK TDFGLS + VG+P Y+APE
Sbjct: 110 VEDLHQRGIIHRDIKPENLL---IDQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPE 163
Query: 121 VLRKHYGPEA-DVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
+ + D WS G +++ L G PPF AET +F IL +I++ E S
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPE 223
Query: 180 AKDLIRKMLDQNPKRRLTAH---EVLCHPW 206
A DLI ++L +P +RL A+ E+ HP+
Sbjct: 224 AVDLINRLLCMDPAKRLGANGYQEIKSHPF 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-38
Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 41/234 (17%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFD--RIVKK--GNYSEREAAKLMKTIVGVVE 62
H ++V++ D + +++V E C+ D + + K G S +M ++ +
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEV 121
CHS + HRDLKP+N L ++ D LK DFGL+ + P ++ V + +Y APE+
Sbjct: 113 YCHSHRILHRDLKPQNIL---INRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
Query: 122 L--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQIL------------- 162
L KHY D+WS G I +++G P F ++EI IF QIL
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF-QILGTPTEESWPGVTK 228
Query: 163 --EGKIDF---ESEPW----PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ K F + P + DL+ KML NP +R++A E L HP+
Sbjct: 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 78/233 (33%), Positives = 124/233 (53%), Gaps = 21/233 (9%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
H ++R+ T D+ ++++ME GGELF + G +S IV +E H
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKP--DEVFSDVVGSPYYVAPEVL- 122
S + +RDLKPEN L +D++ +K TDFG F K D ++ + G+P Y+APEV+
Sbjct: 119 SKEIVYRDLKPENIL---LDKEGHIKLTDFG---FAKKLRDRTWT-LCGTPEYLAPEVIQ 171
Query: 123 RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
K + D W+ G+++Y +L G PPF+ + GI+ +IL GK++F ++ AKD
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKD 227
Query: 183 LIRKMLDQNPKRRL-----TAHEVLCHPWI--VDDKVAPDKPLDSAVLSRLKH 228
LI+K+L + RRL A +V H W VD P + L ++ ++ H
Sbjct: 228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSH 280
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ +L +H ++V+ + E ++I++E E G L I K G + E A + ++
Sbjct: 53 LKNL-KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG 111
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVVGSPYYVAP 119
+ H GV HRD+K N L +D +K DFG++ + + VVG+PY++AP
Sbjct: 112 LAYLHEQGVIHRDIKAANIL---TTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168
Query: 120 EVLRKHYGPEA-DVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EV+ A D+WS G + LL+G PP++ + +I++ D IS
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---DDHPPLPEGISP 225
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
KD + + ++P R TA ++L HPWI
Sbjct: 226 ELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-34
Identities = 71/208 (34%), Positives = 104/208 (50%), Gaps = 16/208 (7%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
+ +V++ ++D +++ ME GG+ + G SE A M + V+ H
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE 119
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS---DVVGSPYYVAPEVLR 123
LG HRDLKPENFL +D +K TDFGLS + + VVGSP Y+APEVLR
Sbjct: 120 LGYIHRDLKPENFL---IDASGHIKLTDFGLS-----KGIVTYANSVVGSPDYMAPEVLR 171
Query: 124 -KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFE----SEPWPNISE 178
K Y D WS G +LY L G PPF T + + K + +P N+S+
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
A DLI K+++ +R + ++ HP+
Sbjct: 232 EAWDLITKLINDPSRRFGSLEDIKNHPF 259
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-34
Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 36/233 (15%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY--SEREAAKLMKTIVGVVEC 63
H +++++ D + K +++V E + +++K E + ++ +
Sbjct: 56 NHPNIIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAF 113
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL 122
CHS G+ HRDLKPEN L ++ + LK DFGL+ F P ++ V + +Y APE+L
Sbjct: 114 CHSHGILHRDLKPENLL---INTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170
Query: 123 --RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQI--------------- 161
K Y D+WS G I LLS P F ++EI IFR +
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 162 LEGKIDFESEP-------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
K F + +PN S A DL+ +ML +P +R+TA + L HP+
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 65/206 (31%), Positives = 113/206 (54%), Gaps = 13/206 (6%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
+V +H ++ + +H++++ GGELF + ++ +++E E + IV ++ H LG+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGI 126
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS--DVVGSPYYVAPEVLRKH-- 125
+RD+K EN L +D + + TDFGLS + +E G+ Y+APEV+R
Sbjct: 127 IYRDIKLENIL---LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 126 -YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN-ISESAKDL 183
+ D WS GV+ + LL+G PF + E +I +I P+P +S A+D
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-RILKSKPPFPKTMSAEARDF 242
Query: 184 IRKMLDQNPKRRL---TAHEVLCHPW 206
I+K+L+++PK+RL A E+ HP+
Sbjct: 243 IQKLLEKDPKKRLGANGADEIKNHPF 268
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 34/229 (14%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECC 64
H +++ + D + KS +++V E E ++++K + + + M + +E
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL- 122
HS + HRDLKP N L D LK DFGL+ F P+ + V + +Y APE+L
Sbjct: 119 HSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLF 175
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQI-------------LEG 164
+HYG D+WS G I LL VP +++I IF + L
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235
Query: 165 KIDFESEP-------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
++F+ P +P S+ A DL++++L NP +R+TA + L HP+
Sbjct: 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 10/210 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVG 59
+ +H ++V+ + +Y K + IVME C GG L D + +E + A + K ++
Sbjct: 50 ILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLK 109
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
+E HS G+ HRD+K N L + D +K DFGLS + + +VG+PY++AP
Sbjct: 110 GLEYLHSNGIIHRDIKAANIL---LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE-GKIDFESEPWP-NI 176
EV+ K Y +AD+WS G+ L G PP+ +E+ + + + P
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKW 223
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
S+ KD ++K L +NP++R TA ++L HP+
Sbjct: 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 6e-33
Identities = 72/215 (33%), Positives = 112/215 (52%), Gaps = 21/215 (9%)
Query: 7 HQHVVRIHDTYEDKS--CVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGV 60
H ++VR +D D+S ++IVME CEGG+L I K + E +++ ++
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117
Query: 61 VECCHSLG-----VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF-SDVVGSP 114
+ CH+ V HRDLKP N +FL D + +K DFGL+ D F VG+P
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPAN-IFL--DANNNVKLGDFGLAKILGHDSSFAKTYVGTP 174
Query: 115 YYVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW 173
YY++PE L Y ++D+WS G ++Y L + PPF A ++ + +I EGK
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR----RI 230
Query: 174 PNI-SESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
P S ++I+ ML+ +P +R + E+L P I
Sbjct: 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-33
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKL-MKTIVGVVECC 64
H +V + +++D+ +++V++L GG+L + +K +SE E K + IV +E
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-EQVKFWICEIVLALEYL 116
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL-R 123
HS G+ HRD+KP+N L DE + TDF ++ PD + + G+P Y+APEVL R
Sbjct: 117 HSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI--FRQILEGKIDFESEPWPNISESAK 181
+ Y D WS GV Y L G P+ + R E W A
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWS---TEAI 230
Query: 182 DLIRKMLDQNPKRRL--TAHEVLCHPWI 207
D I K+L+++P++RL ++ HP+
Sbjct: 231 DAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 68/193 (35%), Positives = 109/193 (56%), Gaps = 14/193 (7%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H +V + +++D++ V+ ++E GGELF + K G + A +V E HS
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK--PDEVFSDVVGSPYYVAPEVLR- 123
+ +RDLKPEN L +D +K TDFG F K PD F+ + G+P Y+APEV++
Sbjct: 137 KDIIYRDLKPENLL---LDNKGHVKVTDFG---FAKKVPDRTFT-LCGTPEYLAPEVIQS 189
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDL 183
K +G D W+ GV+LY ++G PPF+ +T I+ +IL G++ F + W A+DL
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDL 245
Query: 184 IRKMLDQNPKRRL 196
++ +L + +RL
Sbjct: 246 VKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 9/210 (4%)
Query: 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
E +VV+ + + + + IV+E +GG L D + K G E A + + I+ ++
Sbjct: 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLD 113
Query: 63 CCHS-LGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPE 120
H+ + HRD+KP N L ++ +K DFG+S V + + VG+ Y++PE
Sbjct: 114 YLHTKRHIIHRDIKPSNLL---INSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
Query: 121 VLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP--NIS 177
++ + Y AD+WS G+ L G PF F ++++ D P S
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPF-LPPGQPSFFELMQAICDGPPPSLPAEEFS 229
Query: 178 ESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+D I L ++PK+R +A E+L HP+I
Sbjct: 230 PEFRDFISACLQKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 80/249 (32%), Positives = 125/249 (50%), Gaps = 29/249 (11%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY--SEREAAKLMKTIVGVVECCHSL 67
+V++H ++D +++VME GG+L + + NY E+ A +V ++ HS+
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTAEVVLALDAIHSM 161
Query: 68 GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSD-VVGSPYYVAPEVLRK- 124
G HRD+KP+N L +D+ LK DFG + + V D VG+P Y++PEVL+
Sbjct: 162 GFIHRDVKPDNML---LDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 125 ----HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
+YG E D WS GV LY +L G PF+A++ +G + +I++ K IS+ A
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278
Query: 181 KDLIRKMLDQNPKR--RLTAHEVLCHPWIVDDK---------VAPDKP-LDSAVLSRLKH 228
KDLI L R R E+ HP+ +D+ VAP P L S + + +
Sbjct: 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTS--N 336
Query: 229 FSAMNKLKK 237
F + K
Sbjct: 337 FDDIEDDDK 345
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-32
Identities = 68/208 (32%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY-SEREAAKLMKTIVGVVEC 63
+H ++V +D+Y + +VME +GG L D I + +E + A + + ++ +E
Sbjct: 72 CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVVGSPYYVAPEV- 121
HS V HRD+K +N L + +D ++K DFG + K + VVG+PY++APEV
Sbjct: 132 LHSQNVIHRDIKSDNIL---LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188
Query: 122 LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKI-DF-ESEPWPNISES 179
RK YGP+ D+WS G++ + G PP+ E + I I E W S
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW---SPE 245
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
KD + K L ++P++R +A E+L HP++
Sbjct: 246 FKDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-32
Identities = 80/230 (34%), Positives = 112/230 (48%), Gaps = 32/230 (13%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
+E+ VV + ++E K + +VME EGG+ + G A V +E
Sbjct: 57 FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEY 116
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS---------VFY-----KPDEVFSD 109
H+ G+ HRDLKP+N L S+ +K TDFGLS Y K F D
Sbjct: 117 LHNYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 110 --VVGSPYYVAPEV-LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKI 166
V G+P Y+APEV LR+ YG D W+ G+ILY L G PF+ +T +F Q++ I
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 233
Query: 167 DFESEPWPNISES----AKDLIRKMLDQNPKRRL---TAHEVLCHPWIVD 209
+ WP E+ A+DLI ++L QNP RL A EV H + +
Sbjct: 234 E-----WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 71/245 (28%), Positives = 113/245 (46%), Gaps = 52/245 (21%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
VV+++ +++DK ++ VM+ GG++ +++ G + E A + + +E H +G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGL---------SVFYK-----------PDEVFSD 109
HRD+KP+N L +D D +K TDFGL S +Y+ P E +S+
Sbjct: 123 IHRDIKPDNIL---IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 110 V------------------------VGSPYYVAPEVL-RKHYGPEADVWSAGVILYILLS 144
+ VG+P Y+APEVL R Y D WS GVILY +L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 145 GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAH---EV 201
G PPF A+T +++ + +S A DLI + L + RL + E+
Sbjct: 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEI 298
Query: 202 LCHPW 206
HP+
Sbjct: 299 KAHPF 303
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 63/209 (30%), Positives = 111/209 (53%), Gaps = 17/209 (8%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H ++V ++ +Y + +VME EGG L D IV +E + A + ++ + H
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLH 132
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV------VGSPYYVAP 119
+ GV HRD+K ++ L S D +K +DFG +V +V VG+PY++AP
Sbjct: 133 AQGVIHRDIKSDSILLTS---DGRVKLSDFGFCA-----QVSKEVPRRKSLVGTPYWMAP 184
Query: 120 EVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EV+ R YG E D+WS G+++ ++ G PP++ E + ++I + +S
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSP 243
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ + +ML ++P +R TA E+L HP++
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 71/239 (29%), Positives = 110/239 (46%), Gaps = 46/239 (19%)
Query: 7 HQHVVRIHD--TYEDKSCVHIVMELCE---GGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
H ++VR+ + T + K +++V E + G L VK ++E + MK ++ +
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLEGL 113
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAP 119
+ HS G+ HRD+K N L ++ D LK DFGL+ Y +++ V + +Y P
Sbjct: 114 QYLHSNGILHRDIKGSNIL---INNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170
Query: 120 EVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE--GKIDFESEPWPN 175
E+L YGPE D+WS G IL L G P F TE+ +I E G E+ WP
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN--WPG 228
Query: 176 ---------------------------ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
I SA DL+ K+L +PK+R++A + L H +
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 69/248 (27%), Positives = 120/248 (48%), Gaps = 53/248 (21%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+++ VV+++ +++D++ ++++ME GG++ ++KK ++E E + + ++
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI 117
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGL---------SVFY----------KPDE 105
H LG HRD+KP+N L D +K +DFGL + FY D
Sbjct: 118 HKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 106 VFS--------------------DVVGSPYYVAPEVLRKH-YGPEADVWSAGVILYILLS 144
+ VG+P Y+APEV + Y E D WS GVI+Y +L
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 145 GVPPFWAETEIGIFRQILEGKIDFESEPWP---NISESAKDLIRKMLDQNPKRRL---TA 198
G PPF ++ +R+I+ K E+ +P +S AKDLI+++ +RRL
Sbjct: 235 GYPPFCSDNPQETYRKIINWK---ETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGV 290
Query: 199 HEVLCHPW 206
+E+ HP+
Sbjct: 291 NEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 69/233 (29%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 6 EHQHVVRIHD---TYEDKSC--VHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKTIV 58
EH ++VR+ D + +V E + + K G LM+ ++
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLL 117
Query: 59 GVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVA 118
V+ HS + HRDLKP+N L V D +K DFGL+ Y + + VV + +Y A
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNIL---VTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 119 PEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESE------ 171
PEVL + Y D+WS G I L P F +E +I + I SE
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD-VIGLPSEEEWPRN 233
Query: 172 ---PW---------------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
P P I E DL++KML NP +R++A E L HP+
Sbjct: 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 12/205 (5%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
+V + +++ +++V+ GGELF + ++G + A ++ +E H V
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNV 114
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGL-SVFYKPDEVFSDVVGSPYYVAPEVLRKH-YG 127
+RDLKPEN L +D + DFGL + K D+ + G+P Y+APE+L H Y
Sbjct: 115 IYRDLKPENIL---LDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 128 PEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKM 187
D W+ GV+LY +L+G+PPF+ E ++R+IL+ + F AKDL+ +
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGL 227
Query: 188 LDQNPKRRL---TAHEVLCHPWIVD 209
L ++P RRL A E+ HP+
Sbjct: 228 LSRDPTRRLGYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 71/210 (33%), Positives = 112/210 (53%), Gaps = 18/210 (8%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H +V + ++ +++++E GGELF + ++G + E A + I +E H
Sbjct: 58 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGL---SVFYKPDEVFSDVVGSPYYVAPEVL 122
G+ +RDLKPEN L +D +K TDFGL S+ V G+ Y+APE+L
Sbjct: 118 QQGIIYRDLKPENIL---LDAQGHVKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEIL 172
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
R +G D WS G ++Y +L+G PPF AE +IL+GK++ P ++ A+
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEAR 228
Query: 182 DLIRKMLDQNPKRRL-----TAHEVLCHPW 206
DL++K+L +NP RL A EV HP+
Sbjct: 229 DLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 66/235 (28%), Positives = 106/235 (45%), Gaps = 38/235 (16%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVV 61
L+EH ++V++ + + + ++ V E EG L+ + + +SE ++ I+ +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS--VFYKPDEVFSDVVGSPYYVAP 119
H G FHRDLKPEN L + +K DFGL+ + +P ++D V + +Y AP
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPP--YTDYVSTRWYRAP 167
Query: 120 EVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW---- 173
E+L Y D+W+ G I+ L + P F +EI +I + W
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227
Query: 174 ----------------------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
PN S A DLI+ ML +PK+R TA + L HP+
Sbjct: 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK--KGNYSEREAAKLMKTIVGVVEC 63
+ +++R ++++ DK ++IVME E G+L + E + + I+ +
Sbjct: 57 DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD-VVGSPYYVAPEVL 122
HS + HRD+K N LFL D +K D G++ + F++ +VG+PYY++PE+
Sbjct: 117 LHSKKILHRDIKSLN-LFL--DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173
Query: 123 R-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
K Y ++DVW+ GV+LY +G PF A + + +I+ G S+ + S+
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMY---SQQLA 230
Query: 182 DLIRKMLDQNPKRRLTAHEVLCHP 205
LI + L ++ ++R ++L +P
Sbjct: 231 QLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFD---RIVKKGNYSEREAAKLMKTIVGV 60
H +VV+ + ++ + +VM GG L D +G E A ++K ++
Sbjct: 55 QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVF-YKP----DEVFSDVVGSPY 115
+E HS G HRD+K N L + ED ++K DFG+S +V VG+P
Sbjct: 115 LEYLHSNGQIHRDIKAGNIL---LGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 116 YVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG---KIDFES 170
++APEV+ + Y +AD+WS G+ L +G P+ + + L+ ++ +
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA 231
Query: 171 EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ S+S + +I L ++P +R TA E+L H +
Sbjct: 232 DYKK-YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 70/216 (32%), Positives = 112/216 (51%), Gaps = 19/216 (8%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
L E +V + +++ S +++V + GGELF + K+G +SE A + +V +E
Sbjct: 52 LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEH 111
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV----GSPYYVAP 119
H + +RDLKPEN L +D + DFGLS K + + G+ Y+AP
Sbjct: 112 LHKYDIVYRDLKPENIL---LDATGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLAP 165
Query: 120 EVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNIS 177
EVL K Y D WS GV+++ + G PF+AE ++R I GK+ F P +S
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLS 222
Query: 178 ESAKDLIRKMLDQNPKRRLTAH----EVLCHPWIVD 209
+ + ++ +L++NP+ RL AH E+ HP+ D
Sbjct: 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-28
Identities = 68/217 (31%), Positives = 117/217 (53%), Gaps = 15/217 (6%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ H+ + +V +H ++ + +H++++ GGELF + ++ + E+E IV
Sbjct: 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA 117
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVA 118
+E H LG+ +RD+K EN L +D + + TDFGLS + DEV G+ Y+A
Sbjct: 118 LEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 119 PEVLR---KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP- 174
P+++R + D WS GV++Y LL+G PF + E +I +I P+P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR-RILKSEPPYPQ 233
Query: 175 NISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
+S AKD+I+++L ++PK+RL A E+ HP+
Sbjct: 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
H V ++ +++D+S +++V+E GGE F + + + IV + E
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK- 124
SL + +RDLKPEN L +D+D +K TDFG + D + G+P Y+APE+L
Sbjct: 149 SLNIVYRDLKPENLL---LDKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLNV 203
Query: 125 HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLI 184
+G AD W+ G+ +Y +L G PPF+A + I+++ILEG I F + + K L+
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLM 259
Query: 185 RKMLDQNPKRRL-----TAHEVLCHPW 206
+K+L + +R A V HPW
Sbjct: 260 KKLLSHDLTKRYGNLKKGAQNVKEHPW 286
|
Length = 340 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 72/240 (30%), Positives = 114/240 (47%), Gaps = 42/240 (17%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFD-RIVKKGNYSEREAAKL-MKTIVGVV 61
+H + ++ +++ ++ + +VM+ C GGELF + G E A+ ++ +
Sbjct: 57 TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS----------------------V 99
E H LG+ +RDLKPEN L + E + +DF LS V
Sbjct: 117 EYLHLLGIVYRDLKPENIL---LHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 100 FYKPDEVFSDV--------VGSPYYVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFW 150
P E FS+ VG+ Y+APEV+ +G D W+ G++LY +L G PF
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233
Query: 151 AETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL----TAHEVLCHPW 206
F IL+ ++ F P +S SA+DLIRK+L ++P +RL A E+ HP+
Sbjct: 234 GSNRDETFSNILKKEVTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-28
Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H ++V+ T ++ ++I +EL GG L + K G++ E + I+ +E H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-- 124
HRD+K N L VD + +K DFG++ GSPY++APEV+ +
Sbjct: 121 RNTVHRDIKGANIL---VDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 125 HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN-ISESAKDL 183
YG AD+WS G + + +G PP+ + +I K E P P+ +S+ AKD
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK---ELPPIPDHLSDEAKDF 234
Query: 184 IRKMLDQNPKRRLTAHEVLCHPWI 207
I K L ++P R TA E+L HP++
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 7e-28
Identities = 69/224 (30%), Positives = 123/224 (54%), Gaps = 24/224 (10%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ H+ + +V +H ++ ++ +H++++ GGE+F + ++ N+SE E I+
Sbjct: 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA 117
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYV 117
+E H LG+ +RD+K EN L +D + + TDFGLS + +E +S G+ Y+
Sbjct: 118 LEHLHKLGIVYRDIKLENIL---LDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYM 173
Query: 118 APEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAE----TEIGIFRQILEGKIDFESE 171
APE++R +G D WS G++++ LL+G PF E T+ + R+IL+
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-----DP 228
Query: 172 PWPN-ISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209
P+P+ I A+DL+ K+L ++PK+RL A E+ HP+
Sbjct: 229 PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 10/204 (4%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV--KKGNYSEREAAKLMKTIVGVVEC 63
+H +++ ++ + D + + I ME GG L+D+IV K + E + IV V
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD-VVGSPYYVAPEVL 122
H G+ HRD+K N +FL+ + +K DFG+S + ++ VVG+PYY++PE+
Sbjct: 117 IHKAGILHRDIKTLN-IFLT--KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173
Query: 123 R-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
+ Y ++D+W+ G +LY LL+ F A + + +I++G + S
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELI 230
Query: 182 DLIRKMLDQNPKRRLTAHEVLCHP 205
L+ +L Q+P++R TA EVL P
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 20/211 (9%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+H + ++H ++ K + VME GG+L I + G + E A IV ++
Sbjct: 53 GKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK----PDEVFSDVVGSPYYVAPE 120
H G+ +RDLK +N L +D + +K DFG+ K S G+P Y+APE
Sbjct: 113 HERGIIYRDLKLDNVL---LDSEGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPE 166
Query: 121 VLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
+L YGP D W+ GV+LY +L+G PF + E +F+ ILE ++ + +S+
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKE 222
Query: 180 AKDLIRKMLDQNPKRRLTAH-----EVLCHP 205
AK +++ L +NP++RL ++ HP
Sbjct: 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H ++V+ + + V+I ME C GG L + + E ++ + HS
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD-----EVFSDVVGSPYYVAPEV 121
G+ HRD+KP N D + +K DFG +V K + E + G+P Y+APEV
Sbjct: 118 HGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 122 LR----KHYGPEADVWSAGVILYILLSGVPPFWAE--TEIGIFRQILEGKIDFESEPWP- 174
+ K +G AD+WS G ++ + +G P W+E E I + G P P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAG----HKPPIPD 229
Query: 175 --NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+S KD + + L+ +PK+R TA E+L HP++
Sbjct: 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 68/198 (34%), Positives = 100/198 (50%), Gaps = 22/198 (11%)
Query: 19 DKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78
D+ C VME GGELF + ++ +SE A IV + HS V +RDLK EN
Sbjct: 68 DRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLEN 125
Query: 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV----GSPYYVAPEVLRKH-YGPEADVW 133
+ +D+D +K TDFGL K + G+P Y+APEVL + YG D W
Sbjct: 126 LM---LDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 134 SAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPK 193
GV++Y ++ G PF+ + +F IL +I F +S AK L+ +L ++PK
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPK 235
Query: 194 RRL-----TAHEVLCHPW 206
+RL A E++ H +
Sbjct: 236 QRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 72/252 (28%), Positives = 115/252 (45%), Gaps = 62/252 (24%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
VV ++ +++D ++++ME GG+L ++K +SE M V +E H LG
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF 122
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDE----------------------- 105
HRD+KP+N L +D +K +DFGLS F+K +
Sbjct: 123 IHRDIKPDNIL---IDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179
Query: 106 -------------------------VFSDVVGSPYYVAPEVLRKH-YGPEADVWSAGVIL 139
+S V G+P Y+APE+ + YG E D WS G I+
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTV-GTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 140 YILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN---ISESAKDLIRKMLDQNPKR-- 194
+ L G PPF +E +R+I+ + E+ +P+ +S A+DLIR+++ R
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWR---ETLYFPDDIHLSVEAEDLIRRLITNAENRLG 295
Query: 195 RLTAHEVLCHPW 206
R AHE+ HP+
Sbjct: 296 RGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-27
Identities = 69/218 (31%), Positives = 120/218 (55%), Gaps = 14/218 (6%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H ++V D+Y + +VME GG L D +V + E + A + + + +E H
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVL-R 123
S V HRD+K +N L + D ++K TDFG P++ S +VG+PY++APEV+ R
Sbjct: 133 SNQVIHRDIKSDNIL---LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEI-GIFRQILEGKIDFESEPWPNISESAKD 182
K YGP+ D+WS G++ ++ G PP+ E + ++ G + ++ +S +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRD 247
Query: 183 LIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDS 220
+ + L+ + ++R +A E+L HP++ K+A KPL S
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFL---KIA--KPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-27
Identities = 63/204 (30%), Positives = 115/204 (56%), Gaps = 7/204 (3%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H++VV ++++Y + +VME EGG L D IV +E + A + ++ + H
Sbjct: 75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLH 133
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVVGSPYYVAPEVL-R 123
+ GV HRD+K ++ L + D +K +DFG K +VG+PY++APE++ R
Sbjct: 134 AQGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR 190
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDL 183
YGPE D+WS G+++ ++ G PP++ E + + I + + + + +S S K
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPKLKNLHKVSPSLKGF 249
Query: 184 IRKMLDQNPKRRLTAHEVLCHPWI 207
+ ++L ++P +R TA E+L HP++
Sbjct: 250 LDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 63/211 (29%), Positives = 117/211 (55%), Gaps = 19/211 (9%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+HQ+VV ++ +Y + ++ME +GG L D IV + +E + A + ++++ + H
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLH 134
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVL-R 123
S GV HRD+K ++ L + D +K +DFG D +VG+PY++APEV+ R
Sbjct: 135 SQGVIHRDIKSDSIL---LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 191
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK-- 181
YG E D+WS G+++ ++ G PP+++++ + +++ P P + + K
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-------RDSPPPKLKNAHKIS 244
Query: 182 ----DLIRKMLDQNPKRRLTAHEVLCHPWIV 208
D + +ML + P+ R TA E+L HP+++
Sbjct: 245 PVLRDFLERMLTREPQERATAQELLDHPFLL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVE 62
H +++ + + D + + IVME G+L I K + E+E ++ ++ ++
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL 122
H + HRDLK N L ++ D +K D G+S K + + +G+P+Y+APEV
Sbjct: 118 ALHEQKILHRDLKSANILLVANDL---VKIGDLGISKVLKKNMAKT-QIGTPHYMAPEVW 173
Query: 123 RKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI-SESA 180
+ Y ++D+WS G +LY + + PPF A + + ++ GK P P I S+
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP----PIPPIYSQDL 229
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHP 205
++ IR ML PK R ++L P
Sbjct: 230 QNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 66/216 (30%), Positives = 119/216 (55%), Gaps = 19/216 (8%)
Query: 8 QHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKL-MKTIVGVVECCHS 66
+ + +H ++D++ +++VM+ GG+L + K + + A+ + +V ++ H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDV-VGSPYYVAPEVLRK 124
LG HRD+KP+N L +D++ ++ DFG + D V S+V VG+P Y++PE+L+
Sbjct: 121 LGYVHRDIKPDNVL---LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 125 ------HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL--EGKIDFESEPWPNI 176
YGPE D WS GV +Y +L G PF+AE+ + + +I+ + F + ++
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDV 236
Query: 177 SESAKDLIRKMLDQNPKRRL---TAHEVLCHPWIVD 209
SE AKDLIR+++ +P+ RL + HP+
Sbjct: 237 SEEAKDLIRRLI-CSPETRLGRNGLQDFKDHPFFEG 271
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 17 YEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLK 75
++DK +++VME GG+L + + + + E A + +V + H +G HRD+K
Sbjct: 70 FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIK 129
Query: 76 PENFLFLSVDEDAALKATDFGLSVFYKPDE-VFSDV-VGSPYYVAPEVL-------RKHY 126
PEN L +D +K DFG + ++ V S + VG+P Y+APEVL + Y
Sbjct: 130 PENVL---IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186
Query: 127 GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGK--IDFESEPWPNISESAKDLI 184
G E D WS GVI Y ++ G PF T + I+ + + F + P +S DLI
Sbjct: 187 GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED--PKVSSDFLDLI 244
Query: 185 RKMLDQNPKRRLTAHEVLCHPW 206
+ +L K RL + CHP+
Sbjct: 245 QSLL-CGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-26
Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 39/235 (16%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGG--ELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
H+++V + + + K +++V E E EL + G + ++ +
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAY 115
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFY--KPDEVFSDVVGSPYYVAPEV 121
CHS + HRD+KPEN L V E LK DFG + +P +D V + +Y APE+
Sbjct: 116 CHSHNIIHRDIKPENIL---VSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172
Query: 122 LRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIG---IFRQIL-----EGKIDFESE 171
L +YG DVW+ G I+ LL G P F +++I + ++ L + F S
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 172 P------WPNISE--------------SAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
P +P S+ A D ++ L +PK RLT E+L HP+
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-26
Identities = 62/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H +V +H +++ ++ V++ GGELF + ++ + E A I + H
Sbjct: 54 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGL-SVFYKPDEVFSDVVGSPYYVAPEVLRK 124
SL + +RDLKPEN L +D + TDFGL + + S G+P Y+APEVL K
Sbjct: 114 SLNIVYRDLKPENIL---LDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK 170
Query: 125 H-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDL 183
Y D W G +LY +L G+PPF++ ++ IL + + PNI+ SA+ L
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHL 226
Query: 184 IRKMLDQNPKRRLTA 198
+ +L ++ +RL A
Sbjct: 227 LEGLLQKDRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 76/254 (29%), Positives = 119/254 (46%), Gaps = 56/254 (22%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
++++ VVR++ +++DK ++ VM+ GG++ +++ G + E A + + VE
Sbjct: 58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGL---------SVFYKP-DEVFSD----- 109
H +G HRD+KP+N L +D D +K TDFGL S +Y+ D V D
Sbjct: 118 HKMGFIHRDIKPDNIL---IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 110 ---------------------------------VVGSPYYVAPEV-LRKHYGPEADVWSA 135
+VG+P Y+APEV LR Y D WS
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 136 GVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRR 195
GVILY +L G PPF A+T + +++ + P +S A DLI K+ + P+ R
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDR 293
Query: 196 L---TAHEVLCHPW 206
L A E+ HP+
Sbjct: 294 LGKNGADEIKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 61/195 (31%), Positives = 108/195 (55%), Gaps = 11/195 (5%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H +V++H ++ + ++++++ GG+LF R+ K+ ++E + + + ++ HS
Sbjct: 57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLS--VFYKPDEVFSDVVGSPYYVAPEVL-R 123
LG+ +RDLKPEN L +DE+ +K TDFGLS + +S G+ Y+APEV+ R
Sbjct: 117 LGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNR 172
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDL 183
+ + AD WS GV+++ +L+G PF + IL+ K+ +S A+ L
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSL 228
Query: 184 IRKMLDQNPKRRLTA 198
+R + +NP RL A
Sbjct: 229 LRALFKRNPANRLGA 243
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 62/195 (31%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H +V +H +++ ++ V++ GGELF + ++ + E A + + H
Sbjct: 54 KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH 113
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGL-SVFYKPDEVFSDVVGSPYYVAPEVLRK 124
SL + +RDLKPEN L +D + TDFGL +P+E S G+P Y+APEVLRK
Sbjct: 114 SLNIIYRDLKPENIL---LDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 125 H-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDL 183
Y D W G +LY +L G+PPF++ ++ IL + + +A DL
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDL 226
Query: 184 IRKMLDQNPKRRLTA 198
+ +L ++ +RRL A
Sbjct: 227 LVGLLHKDQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H +V +H +++ ++ V++ GGELF + ++ ++ E A I + HS
Sbjct: 55 HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGL-SVFYKPDEVFSDVVGSPYYVAPEVLRKH 125
L + +RDLKPEN L +D + TDFGL + + S G+P Y+APEVLRK
Sbjct: 115 LNIIYRDLKPENIL---LDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 126 -YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLI 184
Y D W G +LY +L G+PPF++ ++ IL + + PNIS SA+ L+
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLL 227
Query: 185 RKMLDQNPKRRLTAHE 200
+L ++ +RL A +
Sbjct: 228 EGLLQKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 72/236 (30%), Positives = 109/236 (46%), Gaps = 42/236 (17%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
VV++ +++DK ++++ME GG++ ++KK SE + V ++ H LG
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGLSV---------FYK-----PDEVFS------- 108
HRD+KP+N L +D +K +DFGL FY+ P FS
Sbjct: 123 IHRDIKPDNLL---LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 109 ---------------DVVGSPYYVAPEV-LRKHYGPEADVWSAGVILYILLSGVPPFWAE 152
VG+P Y+APEV ++ Y D WS GVI+Y +L G PPF +E
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKR--RLTAHEVLCHPW 206
T +R+++ K P ISE AKDLI + + R E+ HP+
Sbjct: 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPF 295
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 69/197 (35%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 19 DKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78
D+ C VME GGELF + ++ ++E A IV +E HS V +RD+K EN
Sbjct: 68 DRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 125
Query: 79 FLFLSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRKH-YGPEADVWSAG 136
L +D+D +K TDFGL D G+P Y+APEVL + YG D W G
Sbjct: 126 ---LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 137 VILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL 196
V++Y ++ G PF+ + +F IL +I F +S AK L+ +L ++PK+RL
Sbjct: 183 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRL 238
Query: 197 -----TAHEVLCHPWIV 208
A EV+ H + +
Sbjct: 239 GGGPSDAKEVMEHRFFL 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-25
Identities = 68/209 (32%), Positives = 115/209 (55%), Gaps = 19/209 (9%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H++VV ++++Y + +VME EGG L D IV +E + A + +++ + H+
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHN 136
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVVGSPYYVAPEVL-RK 124
GV HRD+K ++ L S D +K +DFG K +VG+PY++APEV+ R
Sbjct: 137 QGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL 193
Query: 125 HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK--D 182
YG E D+WS G+++ ++ G PP++ E + R+I ++ P P + +S K
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR------DNLP-PRVKDSHKVSS 246
Query: 183 LIRKMLD----QNPKRRLTAHEVLCHPWI 207
++R LD + P +R TA E+L HP++
Sbjct: 247 VLRGFLDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-25
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 8 QHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL 67
++ + + ++ S + I+ME C GG D ++K G E A +++ ++ +E H
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 68 GVFHRDLKPENFLFLSVDEDAALKATDFGLS-----VFYKPDEVFSDVVGSPYYVAPEVL 122
G HRD+K N L + E+ +K DFG+S K + VG+P+++APEV+
Sbjct: 118 GKIHRDIKAANIL---LSEEGDVKLADFGVSGQLTSTMSKRN----TFVGTPFWMAPEVI 170
Query: 123 RKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
++ Y +AD+WS G+ L G PP + + I + S S+ K
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFK 228
Query: 182 DLIRKMLDQNPKRRLTAHEVLCHPWI 207
D + L+++PK R +A E+L H +I
Sbjct: 229 DFVSLCLNKDPKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 70/206 (33%), Positives = 106/206 (51%), Gaps = 16/206 (7%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN----YSEREAAKLMKTIVGVV 61
+H +V+ D ++ + ++ME GG+L +I ++ + E E L IV +
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVA 118
+ HS + HRDLK N + +K DFG S Y +V S G+PYY+A
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPT---GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 119 PEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP-NI 176
PE+ RK Y +AD+WS GVILY LL+ PF ++ I +Q+L GK D P+P +
Sbjct: 240 PELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----PFPCPV 295
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEVL 202
S K L+ +L +NP R T ++L
Sbjct: 296 SSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 70/223 (31%), Positives = 111/223 (49%), Gaps = 29/223 (13%)
Query: 7 HQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKK-----GNYSEREAAKLMKTIVG 59
++V+ + + D+ S + I ME CEGG L D I KK G E+ K+ ++++
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV----VGSPY 115
+ HS + HRD+KP N L + +K DFG+S E+ + + G+ +
Sbjct: 117 GLSYLHSRKIIHRDIKPSNIL---LTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSF 168
Query: 116 YVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE-----IGIFRQILEGKI-DF 168
Y+APE ++ K Y +DVWS G+ L + PF E E I + I+ +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228
Query: 169 ESEPWPNI--SESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
+ EP I SE KD I++ L+++P RR T ++L HPWI
Sbjct: 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 65/238 (27%), Positives = 113/238 (47%), Gaps = 39/238 (16%)
Query: 1 MHHLSEHQHVVRIHDTYEDKS--CVHIVMELCEGGELFDRIVKKGNY-SEREAAKLMKTI 57
+ LS H +++R+ + D+ + +V EL + L++ I + E+ M +
Sbjct: 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQL 109
Query: 58 VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFG--LSVFYKPDEVFSDVVGSPY 115
+ ++ H G+FHRD+KPEN L + +D LK DFG ++ KP +++ + + +
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENIL---IKDD-ILKLADFGSCRGIYSKPP--YTEYISTRW 163
Query: 116 YVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEI------------------ 155
Y APE L +YGP+ D+W+ G + + +LS P F E+
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL 223
Query: 156 GIFRQILEGKIDFESE-----PW--PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
FR+ +F S+ PN S DL++K+L +P R+TA + L HP+
Sbjct: 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 69/218 (31%), Positives = 116/218 (53%), Gaps = 12/218 (5%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+++ ++V D+Y + +VME GG L D +V + E + A + + + +E
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFL 132
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVL- 122
HS V HRD+K +N L + D ++K TDFG P++ S +VG+PY++APEV+
Sbjct: 133 HSNQVIHRDIKSDNIL---LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 123 RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
RK YGP+ D+WS G++ ++ G PP+ E + I P +S +D
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRD 248
Query: 183 LIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDS 220
+ + LD + ++R +A E+L H ++ K+A KPL S
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQHQFL---KIA--KPLSS 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 68/221 (30%), Positives = 114/221 (51%), Gaps = 13/221 (5%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
VV++ ++D +++VME GG+L + ++ + E+ A +V ++ HS+G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGF 163
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVLRK--- 124
HRD+KP+N L +D+ LK DFG + + + VG+P Y++PEVL+
Sbjct: 164 IHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 125 --HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
+YG E D WS GV LY +L G PF+A++ +G + +I+ K +IS+ AK+
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280
Query: 183 LIRKMLDQNPKR--RLTAHEVLCHPWIVDDKVAPDKPLDSA 221
LI L R R E+ H + +D+ A + D+
Sbjct: 281 LICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV 321
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 2e-24
Identities = 69/218 (31%), Positives = 116/218 (53%), Gaps = 12/218 (5%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+++ ++V D+Y + +VME GG L D +V + E + A + + + ++
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFL 131
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVL- 122
HS V HRD+K +N L + D ++K TDFG P++ S +VG+PY++APEV+
Sbjct: 132 HSNQVIHRDIKSDNIL---LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 123 RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
RK YGP+ D+WS G++ ++ G PP+ E + I P +S +D
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ERLSAVFRD 247
Query: 183 LIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDS 220
+ + L+ + RR +A E+L HP++ K+A KPL S
Sbjct: 248 FLNRCLEMDVDRRGSAKELLQHPFL---KLA--KPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-24
Identities = 68/236 (28%), Positives = 108/236 (45%), Gaps = 45/236 (19%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKT------IV 58
H+++VR+HD ++ + +V E + +KK + R A ++
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDKD------LKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 59 GVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYV 117
+ CH V HRDLKP+N L +++ LK DFGL+ F P FS+ V + +Y
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLL---INKRGELKLADFGLARAFGIPVNTFSNEVVTLWYR 167
Query: 118 APEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETE----IGIFR------------ 159
AP+VL + Y D+WS G I+ +++G P F + IFR
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPG 227
Query: 160 --QILEGKIDFESEP-------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
Q+ E K F P +P+ DL+ ++L NP+ R++AH+ L HPW
Sbjct: 228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 71/253 (28%), Positives = 117/253 (46%), Gaps = 54/253 (21%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
++++ VV+++ +++DK ++ VM+ GG++ +++ + E A + + +E
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGL---------SVFYK-----------PD 104
H +G HRD+KP+N L +D D +K TDFGL S +Y+ P
Sbjct: 118 HKMGFIHRDIKPDNIL---IDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 105 EVFSDV----------------------------VGSPYYVAPEV-LRKHYGPEADVWSA 135
+++ DV VG+P Y+APEV LRK Y D WS
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234
Query: 136 GVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKR- 194
GVIL+ +L G PPF A T +++ + P +S A DLI K+ +R
Sbjct: 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERL 294
Query: 195 -RLTAHEVLCHPW 206
R A ++ HP+
Sbjct: 295 GRNGADDIKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
+ + + +Y + I+ME EGG + ++K G +E+ + +++ ++ ++ H +GV
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKVGV 122
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVVGSPYYVAPEVLR--KHY 126
HRD+K N L V +K DFG++ + S VG+PY++APEV+ K+Y
Sbjct: 123 IHRDIKAANIL---VTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 127 GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI-LEGKIDFESEPWPNISESAKDLIR 185
+AD+WS G+ +Y + +G PP+ +++ FR + L K S+ ++ +
Sbjct: 180 DTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236
Query: 186 KMLDQNPKRRLTAHEVLCHPWI 207
LD+ PK RL+A E+L WI
Sbjct: 237 ACLDEEPKERLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-24
Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 23/196 (11%)
Query: 26 VMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85
VME GG+L I K + E A I + H G+ +RDLK +N L +D
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVL---LD 130
Query: 86 EDAALKATDFGLSVFYKPDEVFSDVV-----GSPYYVAPEVLRKH-YGPEADVWSAGVIL 139
+ K DFG+ + +F+ G+P Y+APE+L++ YGP D W+ GV+L
Sbjct: 131 HEGHCKLADFGMC----KEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLL 186
Query: 140 YILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA- 198
Y +L G PF AE E +F IL ++ + + W +S+ A D+++ + +NP RL +
Sbjct: 187 YEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LSQDAVDILKAFMTKNPTMRLGSL 242
Query: 199 -----HEVLCHPWIVD 209
+L HP+ +
Sbjct: 243 TLGGEEAILRHPFFKE 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 71/213 (33%), Positives = 115/213 (53%), Gaps = 17/213 (7%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
VV++ ++D +++VME GG+L + ++ + E+ A +V ++ HS+G+
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDV-VGSPYYVAPEVLRK- 124
HRD+KP+N L +D+ LK DFG + K DE V D VG+P Y++PEVL+
Sbjct: 164 IHRDVKPDNML---LDKHGHLKLADFGTCM--KMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 125 ----HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
+YG E D WS GV L+ +L G PF+A++ +G + +I++ K IS+ A
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278
Query: 181 KDLIRKMLDQNPKR--RLTAHEVLCHPWIVDDK 211
K+LI L R R E+ HP+ +D+
Sbjct: 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-24
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H +V +H +++ ++ V++ GGELF + ++ ++ E A I + H
Sbjct: 54 KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV----GSPYYVAPEV 121
S+ + +RDLKPEN L +D + TDFGL K SD G+P Y+APEV
Sbjct: 114 SINIVYRDLKPENIL---LDSQGHVVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 122 LRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
+RK Y D W G +LY +L G+PPF+ ++ IL + P S +A
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTA 223
Query: 181 KDLIRKMLDQNPKRRLTAHE 200
++ ++L+++ +RRL A E
Sbjct: 224 WSILEELLEKDRQRRLGAKE 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 7e-24
Identities = 64/198 (32%), Positives = 93/198 (46%), Gaps = 42/198 (21%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL-- 122
HS G+ HRDLKP N ++V+ED LK DFGL+ D+ + V + +Y APE++
Sbjct: 135 HSAGIIHRDLKPSN---IAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAPEIMLN 189
Query: 123 RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE----------GKIDFES-- 170
HY D+WS G I+ LL+G F I ++I+ KI ES
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249
Query: 171 ---------------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV------D 209
E + + A DL+ KML +P +R+TA E L HP++ D
Sbjct: 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309
Query: 210 DKVAP--DKPLDSAVLSR 225
+ VAP D+ +S L+
Sbjct: 310 EPVAPPYDQSFESRDLTV 327
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 9e-24
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 14/214 (6%)
Query: 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK--KGNYSEREAAKLMKTIV-G 59
H ++V + + + + I ME +GG L D+I+K +G ER K+ ++ G
Sbjct: 54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKG 112
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
+ + HRD+KP N L V+ +K DFG+S + + VG+ Y+AP
Sbjct: 113 LTYLHEKHKIIHRDVKPSNIL---VNSRGQIKLCDFGVSG-QLVNSLAKTFVGTSSYMAP 168
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSG-VP-PFWAETEIGIFRQILEGKIDFESEPWPN- 175
E ++ Y ++D+WS G+ L L +G P P + GIF ++L+ ++ P+
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNEPPPRLPSG 227
Query: 176 -ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208
S +D + L ++P+ R + E+L HP+I
Sbjct: 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-23
Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 40/212 (18%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
VV++ +++DK ++++ME GG++ ++KK +E E + V ++ H LG
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGLSV---------FYK-------PDEVFSDV--- 110
HRD+KP+N L +D +K +DFGL FY+ D F ++
Sbjct: 123 IHRDIKPDNLL---LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 111 -----------------VGSPYYVAPEV-LRKHYGPEADVWSAGVILYILLSGVPPFWAE 152
VG+P Y+APEV ++ Y D WS GVI+Y +L G PPF +E
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLI 184
T +++++ K P ISE AKDLI
Sbjct: 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-23
Identities = 69/242 (28%), Positives = 99/242 (40%), Gaps = 50/242 (20%)
Query: 7 HQHVVRIHD--TYEDKSC---VHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
H++++ + D V+IV EL E +++K + ++ + +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDH---IQYFLYQI 112
Query: 62 ECC----HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGS 113
HS V HRDLKP N L V+ + LK DFGL+ PDE ++ V +
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNIL---VNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 114 PYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQI----LE 163
+Y APE+L Y D+WS G I LL+ P F I I + E
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229
Query: 164 GKIDFESE---------------PW----PNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204
SE P P S A DL+ KML +PK+R+TA E L H
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289
Query: 205 PW 206
P+
Sbjct: 290 PY 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 2e-23
Identities = 67/217 (30%), Positives = 116/217 (53%), Gaps = 12/217 (5%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
++ ++V D++ + +VME GG L D +V + E + A + + + +E H
Sbjct: 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVL-R 123
+ V HRD+K +N L + D ++K TDFG P++ S +VG+PY++APEV+ R
Sbjct: 133 ANQVIHRDIKSDNVL---LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDL 183
K YGP+ D+WS G++ ++ G PP+ E + I P +S +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPIFRDF 248
Query: 184 IRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDS 220
+ + L+ + ++R +A E+L HP++ K+A KPL S
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFL---KLA--KPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-23
Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H+ +V+ + D + I ME GG + D++ G +E K + I+ VE H
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFG----LSVFYKPDEVFSDVVGSPYYVAPEV 121
S + HRD+K N L D +K DFG L V G+PY+++PEV
Sbjct: 122 SNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 122 LRKH-YGPEADVWSAGVILYILLSGVPPFWAETE--IGIFRQILEGKIDFESEPW--PNI 176
+ YG +ADVWS G + +L+ PP WAE E IF+ + + P ++
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPQLPSHV 232
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
S A++ +R+ +N K+R +A E+L H ++
Sbjct: 233 SPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-23
Identities = 60/193 (31%), Positives = 107/193 (55%), Gaps = 13/193 (6%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKL-MKTIVGVVECC 64
++Q + +H ++D++ +++VM+ GG+L + K + + A+ + +V ++
Sbjct: 59 DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVL 122
H L HRD+KP+N L +D + ++ DFG + D S VG+P Y++PE+L
Sbjct: 119 HQLHYVHRDIKPDNIL---MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 123 ------RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFE-SEPWPN 175
+ YGPE D WS GV +Y +L G PF+AE+ + + +I+ K F+ +
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235
Query: 176 ISESAKDLIRKML 188
+SE AKDLIR+++
Sbjct: 236 VSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 29/215 (13%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFD--RIVKKGNYSEREAAKLMKTIVGVVECC 64
++V+ + +Y + + IVME C G + D +I K +E E A ++ + +E
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYL 115
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-----VFYKPDEVFSDVVGSPYYVAP 119
HS HRD+K N L ++E+ K DFG+S K + V +G+P+++AP
Sbjct: 116 HSNKKIHRDIKAGNIL---LNEEGQAKLADFGVSGQLTDTMAKRNTV----IGTPFWMAP 168
Query: 120 EVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EV+++ Y +AD+WS G+ + G PP+ ++I R I ++P P +S+
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIFMIP----NKPPPTLSD 221
Query: 179 SAK------DLIRKMLDQNPKRRLTAHEVLCHPWI 207
K D ++K L ++P+ R +A ++L HP+I
Sbjct: 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-23
Identities = 61/195 (31%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEG---GELFDRIV-KKGNYSEREAAKLMKTIVGVVE 62
H ++VR + T+ + ++IVM+L EG GE F+ + KK ++E + +V +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 63 CCH-SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV 121
H + HRDL P N + + ED + TDFGL+ +P+ + VVG+ Y PE+
Sbjct: 128 YLHKEKRIVHRDLTPNNIM---LGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEI 184
Query: 122 LRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
++ YG +ADVW+ G ILY + + PPF++ + + +I+E +E P SE
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV--YEPLPEGMYSEDV 242
Query: 181 KDLIRKMLDQNPKRR 195
D+I L + + R
Sbjct: 243 TDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 6e-23
Identities = 56/191 (29%), Positives = 100/191 (52%), Gaps = 13/191 (6%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
+ ++H ++ ++ VME GG+L I + G + E A I + HS G+
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGL---SVFYKPDEVFSDVVGSPYYVAPE-VLRKH 125
+RDLK +N + +D + +K DFG+ ++F + G+P Y+APE + +
Sbjct: 123 IYRDLKLDNVM---LDAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQP 177
Query: 126 YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIR 185
YG D W+ GV+LY +L+G PPF E E +F+ I+E + + ++S+ A + +
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK 233
Query: 186 KMLDQNPKRRL 196
+L ++P +RL
Sbjct: 234 GLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-23
Identities = 65/205 (31%), Positives = 113/205 (55%), Gaps = 16/205 (7%)
Query: 8 QHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKL-MKTIVGVVECCHS 66
Q + +H ++D++ +++VM+ GG+L + K + + A+ + +V + H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDV-VGSPYYVAPEVLRK 124
L HRD+KP+N L +D + ++ DFG + D V S V VG+P Y++PE+L+
Sbjct: 121 LHYVHRDIKPDNVL---LDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 125 ------HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL--EGKIDFESEPWPNI 176
YGPE D WS GV +Y +L G PF+AE+ + + +I+ E + F S ++
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI-TDV 236
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEV 201
SE AKDLI++++ +RRL + +
Sbjct: 237 SEEAKDLIQRLICSR-ERRLGQNGI 260
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-22
Identities = 72/256 (28%), Positives = 115/256 (44%), Gaps = 46/256 (17%)
Query: 1 MHHLSEHQHVVRIHDTY----EDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKT 56
+ HL H++++ + D + ED ++ V EL G R++ ++ +
Sbjct: 63 LKHL-RHENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQ 116
Query: 57 IVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY 116
I+ ++ HS GV HRDLKP N L ++E+ LK DFGL+ P + V + YY
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNIL---INENCDLKICDFGLARIQDPQ--MTGYVSTRYY 171
Query: 117 VAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE----------- 163
APE++ + Y E D+WSAG I +L G P F + + F I +
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231
Query: 164 -----------------GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
+ F SE + N SA DL+ KML +P++R++A E L HP+
Sbjct: 232 TICSENTLRFVQSLPKREPVPF-SEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
Query: 207 IVDDKVAPDKPLDSAV 222
+ D+P+
Sbjct: 291 LAPYHDPTDEPVAEEK 306
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-22
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVGVVECCH 65
H ++V +++ Y ++ + I++E C+GG L +++ +E + + + ++ + H
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVL-- 122
S V HRDLK N L D +K DFG+S K + +G+PY++APEV+
Sbjct: 121 SHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177
Query: 123 ----RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEP--WPNI 176
Y +AD+WS G+ L L PP + + +IL+ + +P W
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW--- 234
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
S S D ++ L ++P R TA E+L HP++ D
Sbjct: 235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-22
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
++H + +H ++ K + VME GG+L +I + + E + + +
Sbjct: 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGL-SVFYKPDEVFSDVVGSPYYVAPEVLR 123
H GV +RDLK +N L +D + K DFG+ + G+P Y+APE+L+
Sbjct: 113 HRHGVIYRDLKLDNIL---LDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 124 K-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
+ YGP D W+ GV++Y +++G PPF A+ E +F IL + + W +S+ A
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--W--LSKEAVS 225
Query: 183 LIRKMLDQNPKRRL-------TAHEVLCHPW 206
+++ + +NP +RL + HP+
Sbjct: 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-22
Identities = 71/246 (28%), Positives = 105/246 (42%), Gaps = 52/246 (21%)
Query: 4 LSEHQHVVRIHD---TYED--KSCVHIVMELCEGGELFDRIVKK---GNYS-------ER 48
LSE ++VR+ D E K +++V E D +KK N +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEY------LDSDLKKFMDSNGRGPGRPLPAK 110
Query: 49 EAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAA-LKATDFGLS-VFYKPDEV 106
M ++ V CH GV HRDLKP+N L VD+ LK D GL F P +
Sbjct: 111 TIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLL---VDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 107 FSDVVGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEI----GIFR- 159
++ + + +Y APEVL HY D+WS G I + P F ++E+ IF+
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227
Query: 160 ------QILEGKIDFE-------------SEPWPNISESAKDLIRKMLDQNPKRRLTAHE 200
Q+ G S P++S DL++KML +P +R++A
Sbjct: 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287
Query: 201 VLCHPW 206
L HP+
Sbjct: 288 ALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-22
Identities = 65/196 (33%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
EH + + T++ K + VME GG+L I G + E A I+ ++
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFL 112
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGL-SVFYKPDEVFSDVVGSPYYVAPEVLR 123
H G+ +RDLK +N L +D+D +K DFG+ + S G+P Y+APE+L+
Sbjct: 113 HKKGIIYRDLKLDNVL---LDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK 169
Query: 124 -KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW-PN-ISESA 180
+ Y D WS GV+LY +L G PF E E +F IL P P IS+ A
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL------NDRPHFPRWISKEA 223
Query: 181 KDLIRKMLDQNPKRRL 196
KD + K+ +++P +RL
Sbjct: 224 KDCLSKLFERDPTKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 36/217 (16%)
Query: 23 VHIVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81
+++VME E +L + K + + E LM ++ V H + HRDLK N L
Sbjct: 81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLL- 138
Query: 82 LSVDEDAALKATDFGLSVFY-KPDEVFSDVVGSPYYVAPEVL--RKHYGPEADVWSAGVI 138
++ LK DFGL+ Y P + ++ +V + +Y APE+L K Y D+WS G I
Sbjct: 139 --LNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCI 196
Query: 139 LYILLSGVPPFWAETEIGIFRQILE-------------------GKIDFESEPW------ 173
LL+ P F ++EI +I + K F P+
Sbjct: 197 FAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKK 256
Query: 174 ---PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
++S++ DL+ ++L +P +R++A + L HP+
Sbjct: 257 FPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-21
Identities = 66/196 (33%), Positives = 104/196 (53%), Gaps = 15/196 (7%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
E+ + ++ T++ K + VME GG+L I KG + A IV ++ H
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGL---SVFYKPDEVFSDVVGSPYYVAPEVL 122
S G+ +RDLK +N + +D D +K DFG+ +VF D S G+P Y+APE+L
Sbjct: 114 SKGIIYRDLKLDNVM---LDRDGHIKIADFGMCKENVF--GDNRASTFCGTPDYIAPEIL 168
Query: 123 R-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEP-WPNISESA 180
+ Y D WS GV+LY +L G PF + E +F I ++D P W I++ +
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RVDTPHYPRW--ITKES 223
Query: 181 KDLIRKMLDQNPKRRL 196
KD++ K+ +++P RRL
Sbjct: 224 KDILEKLFERDPTRRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 64/239 (26%), Positives = 107/239 (44%), Gaps = 52/239 (21%)
Query: 7 HQHVVRIHDTYEDKSCVHIV-----------MELCEGGELFDRIVKKGNYSEREAAKLMK 55
H ++VR+ D ++ +++V M+ L ++K +
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS----------YLY 106
Query: 56 TIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSP 114
++ + CHS V HRDLKP+N L +D + ALK DFGL+ F P ++ V +
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLL---IDREGALKLADFGLARAFGVPVRTYTHEVVTL 163
Query: 115 YYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQI------- 161
+Y APE+L + Y D+WS G I +++ P F ++EI IFR +
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223
Query: 162 ---LEGKIDFES-----------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
+ D++ + PN+ E DL+ KML +P +R++A L HP+
Sbjct: 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-21
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 8 QHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECCH 65
Q VV + YE K + +V+ + GG+L I GN + E A I+ +E H
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-K 124
+RDLKPEN L +D+ ++ +D GL+V E VG+ Y+APEVL +
Sbjct: 120 RENTVYRDLKPENIL---LDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 125 HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP-NISESAKDL 183
Y D W G ++Y ++ G PF E + R+ ++ ++ E + SE AK +
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-KVKREEVDRRVLETEEVYSAKFSEEAKSI 235
Query: 184 IRKMLDQNPKRRL-----TAHEVLCHPWI 207
+ +L ++PK+RL A EV HP+
Sbjct: 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+ H + + +++ K + VME GGELF + ++ +SE IV ++
Sbjct: 52 TRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYL 111
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR 123
HS + +RDLK EN + +D+D +K TDFGL D G+P Y+APEVL
Sbjct: 112 HSGKIVYRDLKLENLM---LDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168
Query: 124 KH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
+ YG D W GV++Y ++ G PF+ + +F IL I F +S AK
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKS 224
Query: 183 LIRKMLDQNPKRRL-----TAHEVLCHPW--------IVDDKVAP 214
L+ +L ++P +RL A E++ H + + D K+ P
Sbjct: 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP 269
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-21
Identities = 52/206 (25%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVEC 63
+H ++V+ +++E+ ++IVM+ CEGG+L+ +I + + E + I ++
Sbjct: 57 KHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKH 116
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL 122
H + HRD+K +N +FL+ +D +K DFG++ V E+ +G+PYY++PE+
Sbjct: 117 VHDRKILHRDIKSQN-IFLT--KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC 173
Query: 123 R-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
+ Y ++D+W+ G +LY + + F A + +I+ G + + S +
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--YPPVS-SHYSYDLR 230
Query: 182 DLIRKMLDQNPKRRLTAHEVLCHPWI 207
+L+ ++ +NP+ R + + +L +I
Sbjct: 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-21
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 8/205 (3%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVV 61
L H +++ ++ + + + IVME GG L + I K+ N E I+ +
Sbjct: 55 LLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV 121
H+ + HRDLK +N L +K DFG+S VVG+P Y++PE+
Sbjct: 115 HHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPEL 172
Query: 122 LR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
K Y ++D+W+ G +LY L S F A + +I+ G S+ S
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDL 229
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHP 205
+ LI ML+ +P +R +++ P
Sbjct: 230 RQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 78/247 (31%), Positives = 115/247 (46%), Gaps = 49/247 (19%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAK---LMKT----IV 58
+H ++VR+ D + +++V E D +KK S + AK L+KT I+
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 59 GVVECCHSLGVFHRDLKPENFLFLSVDEDA-ALKATDFGLS-VFYKPDEVFSDVVGSPYY 116
+ CHS V HRDLKP+N L +D ALK DFGL+ F P F+ V + +Y
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLL---IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWY 169
Query: 117 VAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQILEGKIDFES 170
APE+L +HY D+WS G I +++ P F ++EI IFR + G + E+
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR--ILGTPNEET 227
Query: 171 EP--------------W---------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
P W P + + DL+ KML +P +R+TA L H +
Sbjct: 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
Query: 208 VDDKVAP 214
D AP
Sbjct: 288 KDLGDAP 294
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 65/251 (25%), Positives = 101/251 (40%), Gaps = 63/251 (25%)
Query: 7 HQHVVRIHDTYEDKSCV------------------HIVMELCEGGELFDRIVKKGNYSER 48
H+++V + + DK H +M L E G + ++SE
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--------HFSED 116
Query: 49 EAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-- 106
MK ++ + CH HRD+K N L ++ +K DFGL+ Y +E
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL---LNNKGQIKLADFGLARLYNSEESRP 173
Query: 107 FSDVVGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164
+++ V + +Y PE+L + YGP DVWS G IL L + P F A E+ I
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI--S 231
Query: 165 KIDFESEP--WPNISE--------------------------SAKDLIRKMLDQNPKRRL 196
++ P WP++ + A DL+ ML +P +R
Sbjct: 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291
Query: 197 TAHEVLCHPWI 207
TA E L PW+
Sbjct: 292 TAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-21
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 12/202 (5%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-VKKGN-YSEREAAKLMKTIVGVVEC 63
+H ++V +++E ++IVME C+GG+L +I +++G + E + + V+
Sbjct: 56 KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL 122
H V HRD+K +N +FL+ ++ +K DFG + + P VG+PYYV PE+
Sbjct: 116 IHEKRVLHRDIKSKN-IFLT--QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW 172
Query: 123 RKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP-NISESA 180
Y ++D+WS G ILY L + PF A + + ++ +G P P + S
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYSYEL 228
Query: 181 KDLIRKMLDQNPKRRLTAHEVL 202
+ LI++M +NP+ R +A +L
Sbjct: 229 RSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 7e-21
Identities = 69/208 (33%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
S H + + +++ + VME GGELF + ++ +SE A IV ++
Sbjct: 52 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 111
Query: 65 HS-LGVFHRDLKPENFLFLSVDEDAALKATDFGL-SVFYKPDEVFSDVVGSPYYVAPEVL 122
HS V +RDLK EN L +D+D +K TDFGL K G+P Y+APEVL
Sbjct: 112 HSEKNVVYRDLKLEN---LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 168
Query: 123 RKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
+ YG D W GV++Y ++ G PF+ + +F IL +I F +S AK
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAK 224
Query: 182 DLIRKMLDQNPKRRL-----TAHEVLCH 204
L+ +L ++PK+RL A E++ H
Sbjct: 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-20
Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 35/232 (15%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMEL--CEGGELFDRIVKKGNYSEREAAK-LMKTIVGVVE 62
+H ++V + D +S ++++ E + + D + KG Y + E K + I+ +
Sbjct: 57 QHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL-PKGQYMDAELVKSYLYQILQGIL 115
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEV 121
CHS V HRDLKP+N L +D +K DFGL+ F P V++ V + +Y APEV
Sbjct: 116 FCHSRRVLHRDLKPQNLL---IDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 122 L--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQI----------LEGK 165
L Y D+WS G I + + P F ++EI IFR + +
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232
Query: 166 IDFESE--PW---------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
D+++ W N+ E DL+ KML +P +R++A + L HP+
Sbjct: 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECCHSL 67
+V + +E K + +VM L GG+L I G + E A I+ +E H
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR 114
Query: 68 GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH-Y 126
+ +RDLKPEN L +D+ ++ +D GL+V K + G+P Y+APEVL+ Y
Sbjct: 115 RIVYRDLKPENVL---LDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 127 GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN-ISESAKDLIR 185
D ++ G LY +++G PF E + ++ L+ + + +P+ S AKDL
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKE-KVEKEELKRRTLEMAVEYPDKFSPEAKDLCE 230
Query: 186 KMLDQNPKRRL-----TAHEVLCHP 205
+L ++P++RL +A EV HP
Sbjct: 231 ALLQKDPEKRLGCRGGSADEVREHP 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-20
Identities = 60/208 (28%), Positives = 112/208 (53%), Gaps = 13/208 (6%)
Query: 6 EHQHVVRIHDTYEDKSC-VHIVMELCEGGELFDRIV-KKGN-YSEREAAKLMKTIVGVVE 62
+H ++V +++E + ++IVM CEGG+L+ ++ +KG E + + I ++
Sbjct: 57 KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEV 121
H + HRDLK +N +FL+ +K D G++ V ++ S ++G+PYY++PE+
Sbjct: 117 YLHEKHILHRDLKTQN-VFLT--RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 122 L-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP-NISES 179
K Y ++DVW+ G +Y + + F A+ + +I+EGK+ P P + S
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL----PPMPKDYSPE 229
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+LI ML + P++R + +L P+I
Sbjct: 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-20
Identities = 57/207 (27%), Positives = 108/207 (52%), Gaps = 17/207 (8%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-----KGNYSEREAAKLMKTIVGV 60
+H +V++ ++ + + ++IV+EL + G+L R++K K ER K +
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFY--KPDEVFSDVVGSPYYVA 118
+E HS + HRD+KP N + +K D GL F+ K S +VG+PYY++
Sbjct: 119 LEHMHSKRIMHRDIKPANVF---ITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMS 174
Query: 119 PEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAE--TEIGIFRQILEGKIDFESEPWPN 175
PE + ++ Y ++D+WS G +LY + + PF+ + + ++I + D+ P +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADH 232
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVL 202
SE +DL+ + ++ +P++R VL
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-20
Identities = 69/258 (26%), Positives = 111/258 (43%), Gaps = 50/258 (19%)
Query: 6 EHQHVVRIHDTYEDKS--------------CVHIVMELCEGGELFDRIVKKGNYSEREAA 51
+H ++V++++ V+IV E E ++++G SE A
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHAR 117
Query: 52 KLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE----VF 107
M ++ ++ HS V HRDLKP N +F++ ED LK DFGL+ P
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPAN-VFINT-EDLVLKIGDFGLARIVDPHYSHKGYL 175
Query: 108 SDVVGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG- 164
S+ + + +Y +P +L +Y D+W+AG I +L+G P F E+ + ILE
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235
Query: 165 -KIDFE-----------------SEP-------WPNISESAKDLIRKMLDQNPKRRLTAH 199
+ E EP P ++ A D + ++L NP RLTA
Sbjct: 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295
Query: 200 EVLCHPWIVDDKVAPDKP 217
E L HP++ D+P
Sbjct: 296 EALMHPYMSCYSCPFDEP 313
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-20
Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 55/286 (19%)
Query: 1 MHHLSEHQHVVRIHD----TYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMK 55
+ H H+++ ++D + + +++ EL E +I++ G ++ +
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIY 112
Query: 56 TIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-----VFYKPDEVFSDV 110
I+ ++ HS V HRDLKP N L V+ D LK DFGL+ + ++
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLL---VNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 111 VGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE----- 163
V + +Y APE++ + Y DVWS G IL LL P F + + QIL+
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229
Query: 164 -----------------------GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHE 200
K FES +PN + A DL+ K+L +P +R++ E
Sbjct: 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEE 288
Query: 201 VLCHPWIV-----DDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALR 241
L HP++ DD+ KP D + + +M +L+ M +
Sbjct: 289 ALEHPYLAIWHDPDDEPVCQKPFDFS----FESEDSMEELRDMIIE 330
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 7e-20
Identities = 55/189 (29%), Positives = 101/189 (53%), Gaps = 9/189 (4%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
+ ++H ++ ++ VME GG+L I + G + E +A I + H G+
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV-VGSPYYVAPEVLR-KHYG 127
+RDLK +N + +D + +K DFG+ + D V + G+P Y+APE++ + YG
Sbjct: 123 IYRDLKLDNVM---LDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179
Query: 128 PEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKM 187
D W+ GV+LY +L+G PPF E E +F+ I+E + + ++S+ A + + +
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGL 235
Query: 188 LDQNPKRRL 196
+ ++P +RL
Sbjct: 236 MTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 8e-20
Identities = 55/189 (29%), Positives = 100/189 (52%), Gaps = 9/189 (4%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
+ ++H ++ ++ VME GG+L +I + G + E A I + HS G+
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV-VGSPYYVAPEVLR-KHYG 127
+RDLK +N + +D + +K DFG+ D V + G+P Y+APE++ + YG
Sbjct: 123 IYRDLKLDNVM---LDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179
Query: 128 PEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKM 187
D W+ GV+LY +L+G PF E E +F+ I+E + + ++S+ A + + +
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGL 235
Query: 188 LDQNPKRRL 196
+ ++P +RL
Sbjct: 236 MTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 9e-20
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
S H +V +H ++ +S + V+E GG+L + ++ E A I +
Sbjct: 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 112
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGL-SVFYKPDEVFSDVVGSPYYVAPEVLR 123
H G+ +RDLK +N L +D + +K TD+G+ +P + S G+P Y+APE+LR
Sbjct: 113 HERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169
Query: 124 -KHYGPEADVWSAGVILYILLSGVPPF---------WAETEIGIFRQILEGKIDFESEPW 173
+ YG D W+ GV+++ +++G PF TE +F+ ILE +I
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 226
Query: 174 PNISESAKDLIRKMLDQNPKRRL 196
++S A +++ L+++PK RL
Sbjct: 227 -SLSVKAASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-19
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H+++V+ + D ++I +E GG + + G + E ++ I+ + H
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS----------DVVGSPY 115
+ G+ HRD+K N L VD +K +DFG+S K E S + GS +
Sbjct: 124 NRGIIHRDIKGANIL---VDNKGGIKISDFGIS---KKLEANSLSTKTNGARPSLQGSVF 177
Query: 116 YVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEI-GIFRQILEGKIDFESEPW 173
++APEV+++ Y +AD+WS G ++ +L+G PF T++ IF+ + E
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK--IGENA--SPEIP 233
Query: 174 PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
NIS A D + K + + +R TA E+L HP++
Sbjct: 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-19
Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 24/240 (10%)
Query: 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMK-----TI 57
H + ++V + + + V++ ME + G L D++ G +E +++ +
Sbjct: 54 HKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVV 112
Query: 58 VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
G+ + HRD+KP N L V+ + +K DFG+S +++ G Y+
Sbjct: 113 KGLKFLKEEHNIIHRDVKPTNVL---VNGNGQVKLCDFGVSGNLVASLAKTNI-GCQSYM 168
Query: 118 APEVLRKH-------YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ---ILEGKID 167
APE ++ Y ++DVWS G+ + + G P+ ET IF Q I++G D
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG--D 226
Query: 168 FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLK 227
+ P S+ A+D + K L++ P RR T ++L HPW+V K D + V LK
Sbjct: 227 PPTLP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK-NADVDMAEWVTGALK 284
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 70/252 (27%), Positives = 118/252 (46%), Gaps = 43/252 (17%)
Query: 1 MHHLSEHQHVVRIHDTY------EDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLM 54
+ H+ +H++V+ + D + E+ + V++V L G + IVK S+ L+
Sbjct: 68 LKHM-KHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLI 124
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
++ ++ HS G+ HRDLKP N ++V+ED L+ DFGL+ + D+ + V +
Sbjct: 125 YQLLRGLKYIHSAGIIHRDLKPSN---VAVNEDCELRILDFGLA--RQADDEMTGYVATR 179
Query: 115 YYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE--------- 163
+Y APE++ HY D+WS G I+ LL G F I ++I+E
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239
Query: 164 -GKIDFES-----EPWPNISES------------AKDLIRKMLDQNPKRRLTAHEVLCHP 205
KI E + P++ + A DL+ KML + +R++A E L HP
Sbjct: 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299
Query: 206 WIVDDKVAPDKP 217
+ D+P
Sbjct: 300 YFSQYHDPEDEP 311
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-19
Identities = 63/239 (26%), Positives = 110/239 (46%), Gaps = 52/239 (21%)
Query: 7 HQHVVRIHDTYEDKSCVHIV-----------MELCEGGELFDRIVKKGNYSEREAAKLMK 55
H ++V++ D ++ +++V M+ + ++K +Y L +
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SY-------LFQ 108
Query: 56 TIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSP 114
+ G+ CHS V HRDLKP+N L ++ + A+K DFGL+ F P ++ V +
Sbjct: 109 LLQGLA-FCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVTL 164
Query: 115 YYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFR--------- 159
+Y APE+L K+Y D+WS G I +++ F ++EI IFR
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 224
Query: 160 -----QILEGKIDFE-------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
+ + K F S+ P + E +DL+ +ML +P +R++A L HP+
Sbjct: 225 WPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 66/235 (28%), Positives = 107/235 (45%), Gaps = 44/235 (18%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-----GNYSEREAAK-LMKTIVGV 60
H+++VR++D + +V E C D+ +KK + E K M ++
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYC------DQDLKKYFDSCNGDIDPEIVKSFMFQLLKG 111
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAP 119
+ CHS V HRDLKP+N L ++++ LK DFGL+ F P +S V + +Y P
Sbjct: 112 LAFCHSHNVLHRDLKPQNLL---INKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 168
Query: 120 EVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG-----IFRQI----------- 161
+VL K Y D+WSAG I L + P + ++ IFR +
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228
Query: 162 --LEGKIDFESEP----W----PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
L + P P ++ + +DL++ +L NP +R++A E L HP+
Sbjct: 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 16/197 (8%)
Query: 18 EDKSCVHIVMELCEGGELFDRIVKKGN----YSEREAAKLMKTIVGVVECCHSLGVFHRD 73
E+ + +V++ G+L I + + E EA L ++ V HS + HRD
Sbjct: 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168
Query: 74 LKPENFLFLSVDEDAALKATDFGLSVFYK---PDEVFSDVVGSPYYVAPEVLR-KHYGPE 129
+K N L S + +K DFG S Y D+V G+PYYVAPE+ R K Y +
Sbjct: 169 IKSANILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK 225
Query: 130 ADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP-NISESAKDLIRKML 188
AD++S GV+LY LL+ PF E + + L G+ D P P +IS ++++ +L
Sbjct: 226 ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD----PLPPSISPEMQEIVTALL 281
Query: 189 DQNPKRRLTAHEVLCHP 205
+PKRR ++ ++L P
Sbjct: 282 SSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-19
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECCHSL 67
VV + YE K + +V+ L GG+L I G + E A I +E H
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 68 GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHY 126
+ +RDLKPEN L +D+ ++ +D GL+V + VG+ Y+APEV++ + Y
Sbjct: 122 RIVYRDLKPENIL---LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 178
Query: 127 GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKI-DFESEPWPNISESAKDLIR 185
D W+ G +LY +++G PF + + I R+ +E + + + E S A+ L +
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237
Query: 186 KMLDQNPKRRL-----TAHEVLCHP 205
+L ++PK RL A EV HP
Sbjct: 238 MLLCKDPKERLGCQGGGAREVKEHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-19
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
S + +V +H ++ S + +V+E GG+L + ++ E A I +
Sbjct: 53 SSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFL 112
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGL-SVFYKPDEVFSDVVGSPYYVAPEVLR 123
H G+ +RDLK +N L +D D +K TD+G+ P + S G+P Y+APE+LR
Sbjct: 113 HERGIIYRDLKLDNVL---LDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 124 -KHYGPEADVWSAGVILYILLSGVPPF-------WAETEIGIFRQILEGKIDFESEPWPN 175
+ YG D W+ GV+++ +++G PF TE +F+ ILE I
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----F 225
Query: 176 ISESAKDLIRKMLDQNPKRRL 196
+S A +++ L+++PK RL
Sbjct: 226 LSVKASHVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 6e-19
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H +V + ++ + V VME GG+L I +SE A +V ++ H
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV----GSPYYVAPEVL 122
+ +RDLK +N L +D + +K DFGL K F D G+P ++APEVL
Sbjct: 120 NKIVYRDLKLDNLL---LDTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVL 173
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP-NISESA 180
Y D W GV++Y +L G PF + E +F I+ + +P +S A
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSREA 228
Query: 181 KDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
++R++L +NP+RRL A +V P+
Sbjct: 229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-19
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGEL--FDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H ++V + + + K +H+V E C+ L ++ + E K++ + V C
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVP--EHLIKKIIWQTLQAVNFC 116
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL- 122
H HRD+KPEN L + + +K DFG + + P + ++D V + +Y APE+L
Sbjct: 117 HKHNCIHRDVKPENIL---ITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG------------IFR--QILEGKID 167
YGP DVW+ G + LL+G P + ++++ I R QI
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233
Query: 168 F---------ESEP----WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
F EP +PNIS A ++ L +P RL+ E+L HP+
Sbjct: 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 7e-19
Identities = 62/194 (31%), Positives = 96/194 (49%), Gaps = 11/194 (5%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
EH + ++ T++ K + VME GG+L I + A I+ ++ H
Sbjct: 54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGL-SVFYKPDEVFSDVVGSPYYVAPEVLR- 123
S G+ +RDLK +N L +D D +K DFG+ D G+P Y+APE+L
Sbjct: 114 SKGIVYRDLKLDNIL---LDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEP-WPNISESAKD 182
+ Y D WS GV+LY +L G PF E +F+ I ++D P W ++ AKD
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI---RMDNPCYPRW--LTREAKD 225
Query: 183 LIRKMLDQNPKRRL 196
++ K+ + P+RRL
Sbjct: 226 ILVKLFVREPERRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-19
Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 9/206 (4%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVEC 63
+H ++V ++++ + IVME C+GG+L RI ++ +SE + I ++
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKH 116
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL 122
H + HRD+K +N +FLS + A K DFG++ E+ VG+PYY++PE+
Sbjct: 117 IHDRKILHRDIKSQN-IFLSKNGMVA-KLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174
Query: 123 R-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
+ + Y + D+WS G +LY L + PF + +I +G S PN S +
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS---PNFSRDLR 231
Query: 182 DLIRKMLDQNPKRRLTAHEVLCHPWI 207
LI ++ +P+ R + +L P++
Sbjct: 232 SLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-19
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECCHSL 67
VV + YE K + +V+ + GG+L I GN + E+ A + +E
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 68 GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHY 126
+ +RDLKPEN L +D+ ++ +D GL+V E VG+ Y+APEV+ + Y
Sbjct: 122 RIVYRDLKPENIL---LDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 127 GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN-ISESAKDLIR 185
D W G ++Y ++ G PF E + R+ ++ ++ + E + SE AK + R
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSPFRKRKE-RVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237
Query: 186 KMLDQNPKRRL-----TAHEVLCHP 205
+L +NPK RL A V HP
Sbjct: 238 MLLTKNPKERLGCRGNGAAGVKQHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 59/180 (32%), Positives = 81/180 (45%), Gaps = 38/180 (21%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS------VFYKPDEVFSDVVGSPYYVA 118
HS V HRDLKP N L ++ D +K DFGL+ + V +D V + +Y A
Sbjct: 124 HSGNVIHRDLKPSNIL---LNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 119 PEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG-----KIDFES- 170
PE+L Y D+WS G IL +L G P F + + +I+E D ES
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240
Query: 171 ---------------------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
E P S+ A DL++K+L NP +RLTA E L HP++
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 13/207 (6%)
Query: 8 QHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECCH 65
+ VV + YE K + +V+ L GG+L I GN + E A I +E H
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-K 124
+ +RDLKPEN L +D+ ++ +D GL+V E VG+ Y+APEV++ +
Sbjct: 120 RERIVYRDLKPENIL---LDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE 176
Query: 125 HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN-ISESAKDL 183
Y D W G ++Y ++ G PF E + R+ +E ++ + E + SE+A+ +
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVKREEVERRVKEDQEEYSEKFSEAARSI 235
Query: 184 IRKMLDQNPKRRL-----TAHEVLCHP 205
R++L ++P RL A EV HP
Sbjct: 236 CRQLLTKDPGFRLGCRGEGAEEVKAHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 38/236 (16%)
Query: 7 HQHVVRIHDTYEDKS--CVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
H ++V + + K + +VME CE L D + +SE + LM ++ ++
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM--PTPFSESQVKCLMLQLLRGLQ 122
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEV 121
H + HRDLK N L + LK DFGL+ + P + + V + +Y APE+
Sbjct: 123 YLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179
Query: 122 L--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI------------------ 161
L Y D+W+ G IL LL+ P ++EI I
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239
Query: 162 -LEGKIDFESEPWPN-------ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
L GK +P+ N +SE+ L+ +L +PK+R TA E L + +
Sbjct: 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
S H +V +H ++ +S + V+E GG+L + ++ E A I +
Sbjct: 53 SNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFL 112
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGL-SVFYKPDEVFSDVVGSPYYVAPEVLR 123
H G+ +RDLK +N L +D + +K TD+G+ +P + S G+P Y+APE+LR
Sbjct: 113 HERGIIYRDLKLDNVL---LDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 124 -KHYGPEADVWSAGVILYILLSGVPPF---------WAETEIGIFRQILEGKIDFESEPW 173
+ YG D W+ GV+++ +++G PF TE +F+ ILE +I
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--- 226
Query: 174 PNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205
++S A +++ L+++PK RL CHP
Sbjct: 227 -SLSVKASSVLKGFLNKDPKERLG-----CHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 79/277 (28%), Positives = 123/277 (44%), Gaps = 54/277 (19%)
Query: 7 HQHVVRIHD-----TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
H++++ I D ++E + V+IV EL E +L+ +++K + S + I+ +
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGL 119
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS----DVVGSPYYV 117
+ HS V HRDLKP N L ++ + LK DFGL+ P+ + + V + +Y
Sbjct: 120 KYIHSANVLHRDLKPSNLL---LNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 118 APEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE-----GKIDFES 170
APE++ K Y D+WS G IL +LS P F + + IL + D
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 171 ------------------EPW----PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI- 207
PW PN A DL+ KML NP +R+T E L HP++
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296
Query: 208 -----VDDKVAPDK-PLDSAVLSRLKHFSAMNKLKKM 238
D+ VA + P D + L KLK++
Sbjct: 297 QYHDPSDEPVAEEPFPFDFELFDDL----PKEKLKEL 329
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-18
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 6 EHQHVVRIHDTYEDKS--CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
+H+ +V+ + D++ + I ME GG + D++ G +E K + I+ +
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFG----LSVFYKPDEVFSDVVGSPYYVAP 119
HS + HRD+K N L D +K DFG L V G+PY+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN-IS 177
EV+ + YG +ADVWS G + +L+ PP WAE E I + + P+ IS
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTNPQLPSHIS 235
Query: 178 ESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
E A+D + + + + R +A E+L HP+
Sbjct: 236 EHARDFLGCIFVE-ARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-18
Identities = 57/208 (27%), Positives = 107/208 (51%), Gaps = 13/208 (6%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI--VKKGN--YSEREAAKLMKTIVGVV 61
+H +V+ H ++ ++ I+ E CEG +L ++ +K SE + + ++ V
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPE 120
H + HRDLK +N +FL ++ LK DFG+S ++ + G+PYY++PE
Sbjct: 120 HYMHQRRILHRDLKAKN-IFL---KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
Query: 121 VLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
L+ + Y ++D+WS G ILY + F + + + +I+EG E +
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYS---RQ 232
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+++ ML+++P R +A E+L +P+I
Sbjct: 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 7 HQHVVRIHDTYE-DKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
H ++V + D+ E + V E G L + + G E +LM ++ + C H
Sbjct: 37 HPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAH 96
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV----FYKPDEV----FSDVVGSPYYV 117
+ G+ HRDLKP+N + K DFG+ D ++V+G+P Y
Sbjct: 97 NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYC 156
Query: 118 APEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAET--EIGIFRQILEGKIDFESEPWP 174
APE LR + P +D+++ G+I L+G + EI +++Q+ +D PW
Sbjct: 157 APEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEI-LYQQL--SPVDVSLPPWI 213
Query: 175 NISESAKDLIRKMLDQNPKRR 195
++RK L+++P++R
Sbjct: 214 A-GHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 4e-18
Identities = 76/260 (29%), Positives = 116/260 (44%), Gaps = 48/260 (18%)
Query: 6 EHQHVVRIHDTY------EDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVG 59
+H++V+ + D + E+ + V++V L G + IVK ++ L+ I+
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 131
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
++ HS + HRDLKP N L+V+ED LK DFGL+ D+ + V + +Y AP
Sbjct: 132 GLKYIHSADIIHRDLKPSN---LAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 186
Query: 120 EVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE----------GKID 167
E++ HY D+WS G I+ LL+G F I + IL KI
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246
Query: 168 FESE----------PWPNISE-------SAKDLIRKMLDQNPKRRLTAHEVLCHPWIV-- 208
ES P N + A DL+ KML + +R+TA + L H +
Sbjct: 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306
Query: 209 ---DDKVAPDKPLDSAVLSR 225
DD+ D P D + SR
Sbjct: 307 HDPDDEPVAD-PYDQSFESR 325
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-18
Identities = 68/236 (28%), Positives = 119/236 (50%), Gaps = 36/236 (15%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGEL------FDRIVKKGNYSEREAAKLMKTIVG 59
H ++V++ + + I++E C GG + DR + E + + + ++
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT-----EPQIQVICRQMLE 121
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVVGSPYYVA 118
++ HS+ + HRDLK N L L++D D +K DFG+S K + +G+PY++A
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVL-LTLDGD--IKLADFGVSAKNVKTLQRRDSFIGTPYWMA 178
Query: 119 PEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEP 172
PEV+ Y +AD+WS G+ L + PP E+ R +L KI +SEP
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP---HHELNPMRVLL--KIA-KSEP 232
Query: 173 WPNISESAK------DLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAV 222
P +S+ +K D ++ LD++P+ R +A ++L HP++ V ++PL V
Sbjct: 233 -PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV--SSVTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-18
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M L H H++R+ + S ++ +E GG + + K G + E + ++
Sbjct: 57 MARL-NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRG 115
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-----FYKPDEVFSDVVGSPY 115
+ H + HRD+K N L S + L+ DFG + E ++G+
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 116 YVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP 174
++APEVLR + YG DVWS G ++ + + PP W + ++ KI + P
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP-WNAEKHSNHLALIF-KIASATTA-P 230
Query: 175 NISES----AKDLIRKMLDQNPKRRLTAHEVLCHP 205
+I E +D+ + L+ P+ R + E+L HP
Sbjct: 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 16/217 (7%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L +H ++V+ + + I +E GG + + G + E+ + ++
Sbjct: 62 LKDL-DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV-----GSPY 115
+ HS G+ HRDLK +N L VD D K +DFG+S K D+++ + GS +
Sbjct: 121 LAYLHSKGILHRDLKADNLL---VDADGICKISDFGIS--KKSDDIYDNDQNMSMQGSVF 175
Query: 116 YVAPEVL---RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI--LEGKIDFES 170
++APEV+ + Y + D+WS G ++ + +G P+ E I ++
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235
Query: 171 EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ N+S A D + NP R TA E+L HP+I
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 64/197 (32%), Positives = 89/197 (45%), Gaps = 42/197 (21%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK 124
HS G+ HRDLKP N L+V+ED LK DFGL+ D + V + +Y APEV+
Sbjct: 134 HSAGIIHRDLKPGN---LAVNEDCELKILDFGLA--RHADAEMTGYVVTRWYRAPEVILN 188
Query: 125 --HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL-----------------EGK 165
HY D+WS G I+ +L+G F + + QIL K
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248
Query: 166 IDFESEP----------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI-----VDD 210
+S P +P S A DL+ KML+ + +RLTA E L HP+ D+
Sbjct: 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE 308
Query: 211 KVAP---DKPLDSAVLS 224
+ D L++ LS
Sbjct: 309 ETEQQPYDDSLENEKLS 325
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 48/228 (21%)
Query: 19 DKSCVHIVMELCE---GGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLK 75
K ++V E CE G L ++ VK ++ E K+MK ++ + H + HRD+K
Sbjct: 90 YKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKVMKMLLNGLYYIHRNKILHRDMK 146
Query: 76 PENFLFLSVDEDAALKATDFGLS-VFYKPDE----VFSDVVGSPYYVAPEVL--RKHYGP 128
N L + +D LK DFGL+ F +++ V + +Y PE+L + YGP
Sbjct: 147 AANIL---ITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGP 203
Query: 129 EADVWSAGVILYILLSGVPPFWAETEIGIFRQI--LEGKIDFESEPWPNI---------- 176
D+W AG I+ + + P TE I L G I E WP +
Sbjct: 204 PIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT--PEVWPGVDKLELFKKME 261
Query: 177 ------------------SESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
A DLI K+L +P +R+ A L H +
Sbjct: 262 LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-17
Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG 68
+V + + +Y + + I+ME GG D +++ G + E + A ++K I+ ++ HS
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 69 VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV-VGSPYYVAPEVLRKH-Y 126
HRD+K N L + E +K DFG++ ++ + VG+P+++APEV+++ Y
Sbjct: 122 KIHRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 127 GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI----SESAKD 182
+AD+WS G+ L G PP +++ R + P + S+ K+
Sbjct: 179 DSKADIWSLGITAIELAKGEPP---NSDMHPMRVLFL----IPKNNPPTLTGEFSKPFKE 231
Query: 183 LIRKMLDQNPKRRLTAHEVLCHPWIV 208
I L+++P R TA E+L H +IV
Sbjct: 232 FIDACLNKDPSFRPTAKELLKHKFIV 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 64/255 (25%), Positives = 99/255 (38%), Gaps = 55/255 (21%)
Query: 7 HQHVVRIHDTYEDKS--CVHIVMELCEGGEL----FDRIVKKGNYSEREAAKLMKTIVGV 60
H++VV + + + + + V+++ + E F R K+ + L+ I+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 61 VECCHSLGVFHRDLKPENFLFLS-VDEDAALKATDFGLS-VFYKPDEVFSD---VVGSPY 115
V HS V HRDLKP N L + E +K D GL+ +F P + +D VV + +
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 116 YVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETE-------------IGIFR- 159
Y APE+L +HY D+W+ G I LL+ P F IF
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 160 -----------------------QILEGKIDFES-----EPWPNISESAKDLIRKMLDQN 191
S E DL+RK+L+ +
Sbjct: 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300
Query: 192 PKRRLTAHEVLCHPW 206
P +R+TA E L HP+
Sbjct: 301 PTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 53/173 (30%), Positives = 77/173 (44%), Gaps = 33/173 (19%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVLR 123
HS V HRDLKP N L ++ + LK DFGL+ + + ++ V + +Y APE+L
Sbjct: 125 HSANVLHRDLKPSNLL---LNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 124 --KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE----------GKIDFE-- 169
Y DVWS G I LL P F + + + I E G I E
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241
Query: 170 ---------------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ +P+ + A DL+ KML +P +R+T E L HP++
Sbjct: 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVGVVECCH 65
H ++V +Y + + IVME C GG L D V +G SE + A + + + + H
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS---DVVGSPYYVAPEVL 122
G HRD+K N L + ED +K DFG+S + + +G+PY++APEV
Sbjct: 119 ETGKIHRDIKGANIL---LTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVA 173
Query: 123 ----RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
+ Y + D+W+ G+ L PP + ++ R + I + P P + +
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMF---DLHPMRALF--LISKSNFPPPKLKD 228
Query: 179 SAK------DLIRKMLDQNPKRRLTAHEVLCHP 205
K D I+K L ++PK+R TA ++L HP
Sbjct: 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-17
Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYS---EREAAKLMKTIVGVVECCHS 66
+V + +E K+ + +VM L GG+L I G ER + G++ HS
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL-HS 113
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KH 125
+ + +RD+KPEN L +D+ + +D GL+V K + + G+ Y+APE+L+ +
Sbjct: 114 MDIVYRDMKPENVL---LDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 126 YGPEADVWSAGVILYILLSGVPPFWAETEI----GIFRQILEGKIDFESEPWPNISESAK 181
Y D ++ G +Y +++G PF E + R+ LE ++ FE + N +E +K
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEESK 227
Query: 182 DLIRKMLDQNPKRRLTAHE 200
D+ R L + P+ RL + E
Sbjct: 228 DICRLFLAKKPEDRLGSRE 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 62/250 (24%), Positives = 103/250 (41%), Gaps = 61/250 (24%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
+H++++ + D Y + +++VM++ ++ DR ++ +E + ++ I+ +
Sbjct: 78 KHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR---LTESQVKCILLQILNGLNV 134
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF---------------- 107
H HRDL P N ++ K DFGL+ Y
Sbjct: 135 LHKWYFMHRDLSPANIF---INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 108 SDVVGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGK 165
S VV + +Y APE+L + Y D+WS G I LL+G P F E EI Q+ G+
Sbjct: 192 SKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI---DQL--GR 245
Query: 166 IDF-----ESEPWP------------------------NISESAKDLIRKMLDQNPKRRL 196
I + WP N S+ A DL++ +L NP R+
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305
Query: 197 TAHEVLCHPW 206
+A E L H +
Sbjct: 306 SAKEALKHEY 315
|
Length = 335 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 29/217 (13%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK--KGNYSEREAAKLMKTIVGVVECCHS 66
++V+ + + S V I MEL D+++K +G E K+ V +V+ H
Sbjct: 75 YIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKM---TVAIVKALHY 129
Query: 67 L----GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL 122
L GV HRD+KP N L D +K DFG+S + + G Y+APE +
Sbjct: 130 LKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERI 186
Query: 123 -----RKHYGPEADVWSAGVILYILLSGVPPF-WAETEIGIFRQILEGKIDFESEPWPNI 176
Y ADVWS G+ L L +G P+ +TE + +IL+ E P
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ-----EEPPSLPP 241
Query: 177 SES----AKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
+E + L ++ ++R E+L HP+I
Sbjct: 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-17
Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV----KKGNYSEREAAKLMKTIVGVVE 62
H +V++ D++ + + ++IV+EL + G+L I +K ER K + VE
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS-DVVGSPYYVAPEV 121
HS V HRD+KP N + +K D GL F+ + +VG+PYY++PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 122 LRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFR--QILEGKIDFESEPWPNISE 178
+ ++ Y ++D+WS G +LY + + PF+ + ++ +F Q +E + D+ P + SE
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLFSLCQKIE-QCDYPPLPTEHYSE 235
Query: 179 SAKDLIRKMLDQNPKRR 195
++L+ + +P +R
Sbjct: 236 KLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-17
Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H ++V+ T D + + I ME GG + + + G E K K I+ V H
Sbjct: 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFG-------LSVFYKPDEVFSDVVGSPYYVA 118
+ V HRD+K N + + + +K DFG + + + + G+PY++A
Sbjct: 120 NNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 119 PEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNIS 177
PEV+ + YG ++D+WS G ++ + +G PP + + I + P + S
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP-DSFS 235
Query: 178 ESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+A D + L ++ R +A ++L H ++
Sbjct: 236 AAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (198), Expect = 1e-16
Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 35/228 (15%)
Query: 6 EHQHVVRIHDTYEDKSC--VHIVMELCEGGELFDRIVKK----GNYSEREAAKLMKTIVG 59
+H+++VR D + +K+ ++I+ME C+ G+L I K G E + + ++
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 60 VVECCHSLG-------VFHRDLKPENFLFLS---------------VDEDAALKATDFGL 97
+ CH+L V HRDLKP+N +FLS ++ K DFGL
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQN-IFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 98 SVFYKPDEVFSDVVGSPYYVAPEVL---RKHYGPEADVWSAGVILYILLSGVPPFWAETE 154
S + + VG+PYY +PE+L K Y ++D+W+ G I+Y L SG PF
Sbjct: 189 SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248
Query: 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
F Q++ P S+ LI+ +L+ + K R +A + L
Sbjct: 249 ---FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
H +VV+ HD ++ + +++E +GG L + E+ A + + I+ + H
Sbjct: 130 NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI----ADEQFLADVARQILSGIAYLH 185
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVLR- 123
+ HRD+KP N L ++ +K DFG+S + + + + VG+ Y++PE +
Sbjct: 186 RRHIVHRDIKPSNLL---INSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242
Query: 124 -----KHYGPEADVWSAGVILYILLSGVPPF-------WAETEIGI-FRQILEGKIDFES 170
+ G D+WS GV + G PF WA I Q
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ--------PP 294
Query: 171 EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208
E S + I L + P +R +A ++L HP+I+
Sbjct: 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL 332
|
Length = 353 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 33/228 (14%)
Query: 3 HLSEHQHVVRIHDTY--EDKSCVH----IVMELCEGG---ELFDRIVKKGN-YSEREAAK 52
S H ++ + + ++ +VMELC GG +L + KKG E A
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVV 111
+++ + + H V HRD+K +N L + ++A +K DFG+S + +
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 112 GSPYYVAPEV------LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGK 165
G+PY++APEV Y +DVWS G+ L G PP + +I
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP--- 231
Query: 166 IDFESEPWPNISESAK------DLIRKMLDQNPKRRLTAHEVLCHPWI 207
P P + D I + L +N ++R E+L HP+I
Sbjct: 232 ----RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG 68
++ R + +Y + + I+ME GG D ++K G E A +++ I+ ++ HS
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 69 VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV-VGSPYYVAPEVLRKH-Y 126
HRD+K N L + E +K DFG++ ++ + VG+P+++APEV+++ Y
Sbjct: 122 KIHRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 127 GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI-------LEGKIDFESEPWPNISES 179
+AD+WS G+ L G PP + + I LEG+ S+P+
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ---YSKPF------ 229
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208
K+ + L+++P+ R TA E+L H +I
Sbjct: 230 -KEFVEACLNKDPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-16
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 7 HQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H+ +V+ + D + + I ME GG + D++ G +E K + I+ V
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFG----LSVFYKPDEVFSDVVGSPYYVAPE 120
HS + HRD+K N L D +K DFG L V G+PY+++PE
Sbjct: 123 HSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 121 VLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE--IGIFRQILEGKIDFESEPW---- 173
V+ + YG +AD+WS G + +L+ PP WAE E IF+ ++P
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFEAMAAIFK--------IATQPTNPVL 230
Query: 174 -PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
P++S+ +D ++++ + K R +A E+L H ++
Sbjct: 231 PPHVSDHCRDFLKRIFVE-AKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 3e-16
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY-SERE-------AAK 52
M L H +VV++ ++ ++IVME EGG+L + K S + A+
Sbjct: 55 MRKLD-HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG 112
M+ + S HRDL N L V E+ +K +DFGLS D+ + G
Sbjct: 114 GMEYL-------ESKNFIHRDLAARNCL---VGENLVVKISDFGLSRDLYDDDYYRKRGG 163
Query: 113 -SPY-YVAPEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDF 168
P ++APE L++ + ++DVWS GV+L+ + + G P+ + + + G
Sbjct: 164 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR-- 221
Query: 169 ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
PN DL+ + ++P+ R T E++
Sbjct: 222 -LPQPPNCPPELYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 36/199 (18%)
Query: 38 RIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGL 97
+++K SE L+ ++ ++ H+ G+ HRDLKP N L+V+ED LK DFGL
Sbjct: 108 KLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGN---LAVNEDCELKILDFGL 164
Query: 98 SVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEI 155
+ + D + V + +Y APEV+ HY D+WS G I+ +L+G P F +
Sbjct: 165 A--RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
Query: 156 GIFRQILE----------------------------GKIDFESEPWPNISESAKDLIRKM 187
+I++ K DF S PN + A +++ KM
Sbjct: 223 DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRS-LLPNANPLAVNVLEKM 281
Query: 188 LDQNPKRRLTAHEVLCHPW 206
L + + R+TA E L HP+
Sbjct: 282 LVLDAESRITAAEALAHPY 300
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 56/176 (31%), Positives = 80/176 (45%), Gaps = 37/176 (21%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEV 121
HS G+ HRD+KP N L V+ + LK DFGL+ +PDE + +VV + YY APE+
Sbjct: 120 HSAGILHRDIKPGNLL---VNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEI 175
Query: 122 L--RKHYGPEADVWSAGVILYILLSGVPPFWAETEI-----------------------G 156
L +HY D+WS G I LL F A++ I G
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235
Query: 157 IFRQILEGKIDFESEPW-----PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
IL G S P + A L+ +ML +P +R++A + L HP++
Sbjct: 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-16
Identities = 54/180 (30%), Positives = 77/180 (42%), Gaps = 29/180 (16%)
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG 112
LM+ + ++ H+ + HRDLKPEN L V +K DFGL+ Y + VV
Sbjct: 113 LMRQFLRGLDFLHANCIVHRDLKPENIL---VTSGGQVKLADFGLARIYSCQMALTPVVV 169
Query: 113 SPYYVAPEV-LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESE 171
+ +Y APEV L+ Y D+WS G I + P F +E +I + I E
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD-LIGLPPE 228
Query: 172 -PW-----------------------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
W P I ES L+ +ML NP +R++A L HP+
Sbjct: 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 7 HQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H +V+ + D + + I +E GG + D++ G +E + + I+ V
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS----VFYKPDEVFSDVVGSPYYVAPE 120
HS + HRD+K N L D +K DFG S V G+PY+++PE
Sbjct: 123 HSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 121 VLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE--IGIFRQILEGKIDFESEPW--PN 175
V+ + YG +ADVWS + +L+ PP WAE E IF+ + ++P
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYEAMAAIFKIATQ-----PTKPMLPDG 233
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+S++ +D ++++ + KRR TA +L HP++
Sbjct: 234 VSDACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 54/199 (27%), Positives = 105/199 (52%), Gaps = 17/199 (8%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-----KGNYSEREAAKLMKTIVGVV 61
H +V++ + ++ + + ++IV+EL + G+L R++K K E+ K + +
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS-DVVGSPYYVAPE 120
E HS V HRD+KP N + +K D GL F+ + +VG+PYY++PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 121 VLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKI---DFESEPWPNI 176
+ ++ Y ++D+WS G +LY + + PF+ + ++ ++ L KI D+ P +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYS--LCKKIEQCDYPPLPSDHY 233
Query: 177 SESAKDLIRKMLDQNPKRR 195
SE + L+ ++ +P++R
Sbjct: 234 SEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 59/223 (26%), Positives = 113/223 (50%), Gaps = 16/223 (7%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECC 64
+H ++V++ D + ++ + I++E C GG + +++ + +E + + K + +
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVVGSPYYVAPEVLR 123
H + HRDLK N LF ++D D +K DFG+S + + +G+PY++APEV+
Sbjct: 120 HENKIIHRDLKAGNILF-TLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 124 ------KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEP--WPN 175
+ Y +ADVWS G+ L + PP + + +I + + ++P W
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW-- 234
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPL 218
S KD ++K L++N R T ++L HP++ + P + L
Sbjct: 235 -SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIREL 276
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-16
Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG 68
+V + + +Y + + I+ME GG D +++ G E + A +++ I+ ++ HS
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 69 VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV-VGSPYYVAPEVLRKH-Y 126
HRD+K N L + E +K DFG++ ++ + VG+P+++APEV+++ Y
Sbjct: 122 KIHRDIKAANVL---LSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 127 GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRK 186
+AD+WS G+ L G PP +E+ + + + N S+ K+ +
Sbjct: 179 DSKADIWSLGITAIELAKGEPP---HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 235
Query: 187 MLDQNPKRRLTAHEVLCHPWIV 208
L++ P R TA E+L H +IV
Sbjct: 236 CLNKEPSFRPTAKELLKHKFIV 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 2 HHL-SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
H L ++ + ++++ + ++M+ + G+LFD + K+G SE E K+++ +V
Sbjct: 62 HQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEA 121
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKAT---DFGLSVFYKPDEVFSDVVGSPY-- 115
+ H + H D+K EN L+ D A D+GL ++G+P
Sbjct: 122 LNDLHKHNIIHNDIKLENVLY-----DRAKDRIYLCDYGLCK----------IIGTPSCY 166
Query: 116 -----YVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFE 169
Y +PE ++ H Y D W+ GV+ Y LL+G PF + + + + L + +
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK 226
Query: 170 SEPWPNISESAKDLIRKMLDQNPKRRLTAH-EVLCHPWI 207
N+S++A D ++ ML N RLT + E++ HP++
Sbjct: 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-15
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY--SERE-------AA 51
M L H ++V++ ++ + IVME GG+L D + K S + A
Sbjct: 55 MRKLD-HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 52 KLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV 111
+ M+ + S HRDL N L V E+ +K +DFGLS D+ +
Sbjct: 114 RGMEYL-------ESKNFIHRDLAARNCL---VGENLVVKISDFGLSRDLYDDDYYKVKG 163
Query: 112 G-SPY-YVAPEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKID 167
G P ++APE L++ + ++DVWS GV+L+ + + G P+ + + + +G
Sbjct: 164 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR- 222
Query: 168 FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
PN L+ + ++P+ R T E++
Sbjct: 223 --LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-15
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 33/230 (14%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H+++V + + + K +++V E + L D E K + I+ +E CHS
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLRK- 124
+ HRD+KPEN L V + +K DFG + P EV++D V + +Y APE+L
Sbjct: 119 HNIIHRDIKPENIL---VSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 125 -HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDF--------------- 168
YG D+W+ G ++ +L+G P F +++I I++ +
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235
Query: 169 --------ESEP----WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
E EP +P +S DL ++ L +P R ++ ++L H +
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-15
Identities = 52/178 (29%), Positives = 75/178 (42%), Gaps = 41/178 (23%)
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGL----SVFYKPDEVFSDVVGSPYYVAP 119
CH V HRDLKP+N L + E LK DFGL SV P + +S+ V + +Y P
Sbjct: 119 CHQRRVLHRDLKPQNLL---ISERGELKLADFGLARAKSV---PSKTYSNEVVTLWYRPP 172
Query: 120 EVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG-----IFRQI----------- 161
+VL Y D+W G I Y + +G P F T++ IFR +
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232
Query: 162 --LEGKI-----DFESEP----WPNIS--ESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
+ P P + ++L K L PK+R++A E + HP+
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-15
Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 16/208 (7%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRI--VKKGN--YSEREAAKLMKTIVGVVECCH 65
+V + ++ K+ + +VM + GG+L I V + N + E A I+ +E H
Sbjct: 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD-VVGSPYYVAPEVLR- 123
+ +RDLKPEN L +D D ++ +D GL+V K + + G+P ++APE+L+
Sbjct: 115 QRRIIYRDLKPENVL---LDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG 171
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN-ISESAKD 182
+ Y D ++ GV LY +++ PF A E + + L+ +I +S +P+ S ++K
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGE-KVENKELKQRILNDSVTYPDKFSPASKS 230
Query: 183 LIRKMLDQNPKRRL-----TAHEVLCHP 205
+L ++P++RL + HP
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHP 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 51/246 (20%)
Query: 7 HQHVVRI------HDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
H++++ + + E+ V++VMEL + +++ ER + L + + G+
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGI 136
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
HS G+ HRDLKP N + V D LK DFGL+ + + + V + YY APE
Sbjct: 137 KHL-HSAGIIHRDLKPSNIV---VKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 121 V-LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE----GKIDF------- 168
V L Y D+WS G I+ L+ G F I + +++E +F
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252
Query: 169 -----ESEP-------------WPNISES---------AKDLIRKMLDQNPKRRLTAHEV 201
E+ P W SES A+DL+ KML +P +R++ E
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 202 LCHPWI 207
L HP+I
Sbjct: 313 LRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H ++V +Y + + I ME C GG L D G SE + A + + + + H
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVL-- 122
S G HRD+K N L + ++ +K DFG+S +G+PY++APEV
Sbjct: 124 SKGKMHRDIKGANIL---LTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 123 --RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI-LEGKIDFESEPWPNISES 179
+ Y D+W+ G+ L PP + ++ R + L K +F+ P + +
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMF---DLHPMRALFLMTKSNFQP---PKLKDK 234
Query: 180 AK------DLIRKMLDQNPKRRLTAHEVLCHPW 206
K ++ L +NPK+R TA ++L HP+
Sbjct: 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H + + Y + +VME C G ++ + V K E E A + + +
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYL 131
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL-- 122
HS HRD+K N L + E +K DFG + P F VG+PY++APEV+
Sbjct: 132 HSHERIHRDIKAGNIL---LTEPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILA 185
Query: 123 --RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKI-DFESEPWPNISES 179
Y + DVWS G+ L PP + + I + S W S+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDY 242
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
++ + L + P+ R ++ E+L H +++ ++
Sbjct: 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 53/166 (31%), Positives = 73/166 (43%), Gaps = 27/166 (16%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV-LR 123
HS V HRDLKP+N L V +K DFGL+ Y + VV + +Y APEV L+
Sbjct: 127 HSHRVVHRDLKPQNIL---VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN-------- 175
Y D+WS G I + P F +++ +IL+ E WP
Sbjct: 184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 243
Query: 176 ---------------ISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
I E KDL+ K L NP +R++A+ L HP+
Sbjct: 244 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKL-MKTIVGVVECC 64
+H ++V +HD + C+ +V E + +L + GN K+ M ++ + C
Sbjct: 61 KHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVL- 122
H + HRDLKP+N L ++E LK DFGL+ P + +S+ V + +Y P+VL
Sbjct: 120 HKRKILHRDLKPQNLL---INEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAET---EIGIFRQILEGKIDFESEPWPNISE 178
Y D+W G ILY + +G P F T E+ + ++L + E WP I+
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE---ETWPGITS 233
Query: 179 SAK--------------------------DLIRKMLDQNPKRRLTAHEVLCHPW 206
+ + DL+ +L K R++A L H +
Sbjct: 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 19 DKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78
DK +++L GG+L + + G +SE E I+ +E H+ V +RDLKP N
Sbjct: 70 DKLS--FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPAN 127
Query: 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAG 136
L +DE ++ +D GL+ + + + VG+ Y+APEVL+K Y AD +S G
Sbjct: 128 IL---LDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLG 183
Query: 137 VILYILLSGVPPF---WAETEIGIFRQILEGKIDFESEPWPN-ISESAKDLIRKMLDQNP 192
+L+ LL G PF + + I R L ++ P+ S + L+ +L ++
Sbjct: 184 CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-----LPDSFSPELRSLLEGLLQRDV 238
Query: 193 KRRLTAH-----EVLCHPWIVD 209
RRL EV HP+
Sbjct: 239 NRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 56/177 (31%), Positives = 79/177 (44%), Gaps = 39/177 (22%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS--VFYK-PDEVF-SDVVGSPYYVAPE 120
H+ VFHRDLKP+N L + D LK DFGL+ F P +F +D V + +Y APE
Sbjct: 120 HTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176
Query: 121 V---LRKHYGPEADVWSAGVILYILLSGVPPF-------------------WAETEIGI- 157
+ Y P D+WS G I +L+G P F ET +
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236
Query: 158 ------FRQILEGK--IDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
+ + K + F S+ +PN A L+ ++L +PK R TA E L P+
Sbjct: 237 NEKARRYLSSMRKKQPVPF-SQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 66/232 (28%), Positives = 100/232 (43%), Gaps = 41/232 (17%)
Query: 23 VHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82
V++VM+L E +L I +E + ++ ++ HS V HRDLKP N L
Sbjct: 83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLL-- 139
Query: 83 SVDEDAALKATDFGL--SVFYKPDEV---FSDVVGSPYYVAPEVL--RKHYGPEADVWSA 135
V+ED L+ DFG+ + P E ++ V + +Y APE+L Y D+WS
Sbjct: 140 -VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSV 198
Query: 136 GVI-------------------LYILLS--GVPPFWAETEIG--IFRQILEGKIDFESEP 172
G I L ++LS G P IG R+ ++ + P
Sbjct: 199 GCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVP 258
Query: 173 W----PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI---VDDKVAPDKP 217
W P S A DL+ +ML +P+ R+T + L HP++ D P P
Sbjct: 259 WSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCP 310
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 61/235 (25%), Positives = 95/235 (40%), Gaps = 39/235 (16%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H ++V +HD K + V E I G M ++ + H
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVL-- 122
+ HRDLKP+N L + E LK DFGL+ P + +S V + +Y P+VL
Sbjct: 121 GQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLG 177
Query: 123 RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE--GKIDFESEP-WPNISE- 178
Y D+W AG I +L G P F ++ +F Q+ + + +E WP +S+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 179 ---------------------------SAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
A+DL +ML PK R++A + L HP+
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 67/235 (28%), Positives = 106/235 (45%), Gaps = 35/235 (14%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MH ++V + + +++ + + ME + G L DRI KKG E L K V V
Sbjct: 57 MHE-CRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEI--LGKIAVAV 112
Query: 61 VECCHSL----GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV----VG 112
VE L + HRD+KP N L S + +K DFG+S E+ + + VG
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADTFVG 164
Query: 113 SPYYVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ-----ILEGKI 166
+ Y++PE ++ Y ++DVWS G+ + L G P +A + I Q IL+
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP-FAFSNIDDDGQDDPMGILDLLQ 223
Query: 167 DFESEPWPNISES-----AKDLIRKMLDQNPKRRLTAHEVLC--HPWIVDDKVAP 214
EP P + S +D + L ++P R T + LC P+I + +
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ-LCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 40/234 (17%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKL-MKTIVGVVECC 64
+H ++V +HD + + +V E + +L + GN KL + ++ + C
Sbjct: 62 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVL- 122
H V HRDLKP+N L ++E LK DFGL+ P + +S+ V + +Y P++L
Sbjct: 121 HRRKVLHRDLKPQNLL---INERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL 177
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPF---WAETEIGIFRQILEGKIDFESEPWPNISE 178
Y + D+W G I Y + +G P F E ++ +IL + E WP I
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE---ETWPGILS 234
Query: 179 SAK--------------------------DLIRKMLDQNPKRRLTAHEVLCHPW 206
+ + +L+ K+L ++R++A E + HP+
Sbjct: 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 66/237 (27%), Positives = 102/237 (43%), Gaps = 56/237 (23%)
Query: 16 TYEDKSCVHIVME-----LCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVF 70
+ E+ V++VME LC+ +++ ER + L + + G+ + HS G+
Sbjct: 89 SLEEFQDVYLVMELMDANLCQ-------VIQMDLDHERMSYLLYQMLCGI-KHLHSAGII 140
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV-LRKHYGPE 129
HRDLKP N + V D LK DFGL+ + + V + YY APEV L Y
Sbjct: 141 HRDLKPSNIV---VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 197
Query: 130 ADVWSAGVILYILLSGVPPFWAETEIGIFRQILE--GKID-------------------- 167
D+WS G I+ ++ G F I + +I+E G
Sbjct: 198 VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPK 257
Query: 168 ---------FESEPWPNISES--------AKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
F +P SES A+DL+ KML +P++R++ + L HP+I
Sbjct: 258 YAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 3e-13
Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 47/232 (20%)
Query: 16 TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLK 75
+ E+ V++VMEL + ++++ ER + L + + G+ + HS G+ HRDLK
Sbjct: 90 SLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLK 146
Query: 76 PENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV-LRKHYGPEADVWS 134
P N + V D LK DFGL+ + + V + YY APEV L Y D+WS
Sbjct: 147 PSNIV---VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 203
Query: 135 AGVIL------YILLSG-----------------VPPFWAETEIGIFRQILEGKIDFESE 171
G I+ IL G P F + + + R +E + +
Sbjct: 204 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV-RNYVENRPKYAGL 262
Query: 172 PWPNI----------------SESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+P + + A+DL+ KML +P +R++ E L HP+I
Sbjct: 263 TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H ++V +Y + + I ME C GG L D G SE + A + + + + H
Sbjct: 64 KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS---DVVGSPYYVAPEV- 121
S G HRD+K N L + ++ +K DFG++ K + +G+PY++APEV
Sbjct: 124 SKGKMHRDIKGANIL---LTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVA 178
Query: 122 -LRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI-LEGKIDFESEPWPNIS 177
+ K+ Y D+W+ G+ L PP + ++ R + L K +F+ P +
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMF---DLHPMRALFLMSKSNFQP---PKLK 232
Query: 178 ESAK------DLIRKMLDQNPKRRLTAHEVLCH 204
+ K + ++ L +NPK+R TA +L H
Sbjct: 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 14/216 (6%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLM--KTI 57
+H +H+++V+ + + I ME GG L + K G + E + K I
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 58 VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVVGSPYY 116
+ ++ H + HRD+K +N L + +K +DFG S + G+ Y
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGINPCTETFTGTLQY 175
Query: 117 VAPEVLRKH---YGPEADVWSAGVILYILLSGVPPFW--AETEIGIFRQILEGKIDFESE 171
+APEV+ K YG AD+WS G + + +G PPF E + +F+ G E
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV---GMFKIHPE 232
Query: 172 PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
++S AK+ I + + +P +R +AH++L P++
Sbjct: 233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 56/186 (30%), Positives = 92/186 (49%), Gaps = 15/186 (8%)
Query: 19 DKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78
DK C +++L GG+L + + G +SE+E I+ +E H+ V +RDLKP N
Sbjct: 70 DKLC--FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPAN 127
Query: 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAG 136
L +DE ++ +D GL+ + + + VG+ Y+APEVL+K Y AD +S G
Sbjct: 128 IL---LDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLG 183
Query: 137 VILYILLSGVPPFW---AETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPK 193
+L+ LL G PF + + I R L ++ P + K L+ +L ++
Sbjct: 184 CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPEL----KSLLEGLLQRDVS 239
Query: 194 RRLTAH 199
+RL
Sbjct: 240 KRLGCL 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 38/101 (37%), Positives = 58/101 (57%), Gaps = 10/101 (9%)
Query: 110 VVGSPYYVAPEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDF 168
++G+P Y+APE+L K +GP D W+ GV L+ L+G+PPF ET +F+ IL I
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-- 597
Query: 169 ESEPWPN----ISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205
PWP +S +A++ I +L +P +R E+ HP
Sbjct: 598 ---PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 4 LSEHQHVVRIHDTYEDKSCVH-----IVMELCEGGELFDRI---VKKGN-YSEREAAKLM 54
LS+H +VV+ + Y K + +V+ELC GG + D + +K+G E A ++
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV-VGS 113
+ ++ H HRD+K N L + + +K DFG+S + + VG+
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSVGT 187
Query: 114 PYYVAPEV------LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKID 167
P+++APEV L Y DVWS G+ L G PP ++ R + +
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFK---- 240
Query: 168 FESEPWPNI------SESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
P P + S D IRK L ++ ++R T ++L H +I
Sbjct: 241 IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 52/240 (21%)
Query: 6 EHQHVVRIHD-TYEDKSCVHIVMELCEGGELFDRIVKK-----GNYSEREAAKL-MKTIV 58
+H ++V +HD + DKS + E D+ +K+ GN K+ + I+
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVF-------EYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL 114
Query: 59 GVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYV 117
+ CH V HRDLKP+N L ++E LK DFGL+ P + +S+ V + +Y
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLL---INERGELKLADFGLARAKSVPTKTYSNEVVTLWYR 171
Query: 118 APEVL--RKHYGPEADVWSAGVILYILLSGVPPF---WAETEIGIFRQILEGKIDFESEP 172
P+VL Y + D+W G I + + SG P F E E+ + ++L + E
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE---ET 228
Query: 173 WPNISESAK--------------------------DLIRKMLDQNPKRRLTAHEVLCHPW 206
WP IS + + +L+ K L K+R++A E + H +
Sbjct: 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H + + Y + +VME C G V K E E A + + + H
Sbjct: 83 KHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL--- 122
S + HRD+K N L + E +K DFG + P F VG+PY++APEV+
Sbjct: 143 SHNMIHRDIKAGNIL---LTEPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAM 196
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKI-DFESEPWPNISESA 180
Y + DVWS G+ L PP + + I + + +S W S+
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYF 253
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
++ + L + P+ R T+ E+L H +++ ++
Sbjct: 254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 1e-12
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 20/195 (10%)
Query: 25 IVMELCEGGELFDRIVK-KGNYSERE-AAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82
+VME C G + D I KGN + E A + + I+ + H V HRD+K +N L
Sbjct: 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL-- 143
Query: 83 SVDEDAALKATDFGLSVFYKPDEVF---SDVVGSPYYVAPEVLRKHYGPEA------DVW 133
+ E+A +K DFG+S + D + +G+PY++APEV+ P+A D+W
Sbjct: 144 -LTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 200
Query: 134 SAGVILYILLSGVPPFWAETEI-GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNP 192
S G+ + G PP + +F +S+ W S+ + I L +N
Sbjct: 201 SLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNH 257
Query: 193 KRRLTAHEVLCHPWI 207
+R T +++ HP+I
Sbjct: 258 SQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 20/154 (12%)
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE-VLRK 124
SL + HRD+KP N L V+ +K DFG+S + + VG+ Y+APE + +
Sbjct: 113 SLKILHRDVKPSNML---VNTRGQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERISGE 168
Query: 125 HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR--------QILEGKIDFESEPWP-- 174
YG +DVWS G+ L G P+ I + Q+L+ +D + P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPY-----PQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223
Query: 175 NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208
SE I + + + PK R ++ HP+IV
Sbjct: 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 42/236 (17%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIV-GVVECCHS 66
++V + + + I ME +GG L D+++KK G E K+ ++ G+
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KH 125
+ HRD+KP N L V+ +K DFG+S D + + VG+ Y++PE L+ H
Sbjct: 119 HKIMHRDVKPSNIL---VNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 174
Query: 126 YGPEADVWSAGVILYILLSGVPPFWAETEIGI------FRQILEGKID------------ 167
Y ++D+WS G+ L + G P + E K
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234
Query: 168 -----FE------SEPWPNI-----SESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
FE +EP P + S+ +D + K L +NPK R E+ HP+I
Sbjct: 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 14/211 (6%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H + + Y + +VME C G V K E E A + + + H
Sbjct: 79 KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL--- 122
S + HRD+K N L + E +K DFG + P F VG+PY++APEV+
Sbjct: 139 SHNMIHRDIKAGNIL---LTEPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAM 192
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKI-DFESEPWPNISESA 180
Y + DVWS G+ L PP + + I + +S W ++S
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSF 249
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
+ + L + P+ R + E+L H ++ D+
Sbjct: 250 RGFVDYCLQKIPQERPASAELLRHDFVRRDR 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 5e-12
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M L H +VVR+ ++ +++V+E EGG+L D + K + +
Sbjct: 50 MKKLG-HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108
Query: 61 ---VECC------HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV 111
++ S HRDL N L V ED +K +DFGLS D+ +
Sbjct: 109 SFAIQIAKGMEYLASKKFVHRDLAARNCL---VGEDLVVKISDFGLSRDVYDDDYYRKKT 165
Query: 112 GSPYYV---APEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG-K 165
G + APE L+ + ++DVWS GV+L+ + + G P+ + + + +G +
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR 225
Query: 166 IDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
+ P + +L+ +P+ R T E++
Sbjct: 226 LPK---P-EYCPDELYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 37/224 (16%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK--------KGNYSEREAAK----LM 54
H +V ++ D V+ M EG L ++K +E+ + +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLF------LSVDEDAAL----KATDFGLSVFYKPD 104
I +E HS GV HRDLKP+N L + +D AA+ + D + +
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 105 EVFSD------VVGSPYYVAPEVLRKHYGPEA-DVWSAGVILYILLSGVPPFWAETEIGI 157
+S +VG+P Y+APE L E+ D+++ GVILY +L+ P+ +
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK---- 235
Query: 158 FRQI-LEGKIDFESE--PWPNISESAKDLIRKMLDQNPKRRLTA 198
R+I I E P+ I + K L +P R ++
Sbjct: 236 GRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS 279
|
Length = 932 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 7e-12
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 45/224 (20%)
Query: 23 VHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82
V+IVMEL + ++++ ER + L + + G+ + HS G+ HRDLKP N +
Sbjct: 104 VYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIV-- 158
Query: 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV-LRKHYGPEADVWSAGVILYI 141
V D LK DFGL+ + + V + YY APEV L Y D+WS G I+
Sbjct: 159 -VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 142 LLSGVPPFWAETEIGIFRQILEG----------------KIDFESEP----------WPN 175
++ G F I + +++E + E+ P +P+
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPD 277
Query: 176 I------------SESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ + A+DL+ KML + +R++ E L HP+I
Sbjct: 278 VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 8e-12
Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 45/219 (20%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKL-MKTIVG 59
M LS H ++VR+ ++IV E GG+L D + K G KL +K ++
Sbjct: 55 MKKLS-HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-------KLTLKDLLQ 106
Query: 60 VVE--CC-----HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG 112
+ S HRDL N L V E+ +K +DFGLS D+
Sbjct: 107 MALQIAKGMEYLESKNFVHRDLAARNCL---VTENLVVKISDFGLS---------RDIYE 154
Query: 113 SPYYV------------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158
YY APE L+ + ++DVWS GV+L+ + + G P+ + +
Sbjct: 155 DDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL 214
Query: 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT 197
+ +G N + +L+ + +P+ R T
Sbjct: 215 ELLEDGYR---LPRPENCPDELYELMLQCWAYDPEDRPT 250
|
Length = 258 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 14/210 (6%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H + ++ Y + +VME C G V K E E A + + + HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL---- 122
+ HRD+K N L + E +K DFG + P F VG+PY++APEV+
Sbjct: 134 HNMIHRDVKAGNIL---LSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMD 187
Query: 123 RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKID-FESEPWPNISESAK 181
Y + DVWS G+ L PP + + I + + +S W SE +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFR 244
Query: 182 DLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
+ + L + P+ R T+ +L H +++ ++
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCH 65
H ++VR+ K ++IVMEL +GG+ + +G +E ++++ +E
Sbjct: 52 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE 111
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY----YVAPEV 121
S HRDL N L V E LK +DFG+S + D V++ G + APE
Sbjct: 112 SKHCIHRDLAARNCL---VTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 122 LR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
L Y E+DVWS G++L+ S G P+ + R+ +E + ++
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQGVRL--PCPELCPDA 224
Query: 180 AKDLIRKMLDQNPKRR---LTAHEVL 202
L+ + + +P +R T H+ L
Sbjct: 225 VYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 20/195 (10%)
Query: 25 IVMELCEGGELFDRIVK-KGN-YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82
+VME C G + D + KGN E A + + I+ + H+ V HRD+K +N L
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVL-- 153
Query: 83 SVDEDAALKATDFGLSVFYKPDEVF---SDVVGSPYYVAPEVLRKHYGPEA------DVW 133
+ E+A +K DFG+S + D + +G+PY++APEV+ P+A D+W
Sbjct: 154 -LTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW 210
Query: 134 SAGVILYILLSGVPPFWAETEI-GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNP 192
S G+ + G PP + +F +S+ W S+ D I L +N
Sbjct: 211 SLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW---SKKFIDFIEGCLVKNY 267
Query: 193 KRRLTAHEVLCHPWI 207
R + ++L HP+I
Sbjct: 268 LSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 47/194 (24%), Positives = 79/194 (40%), Gaps = 45/194 (23%)
Query: 54 MKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKP--------- 103
M ++ + H + HRD+K N L +D LK DFGL+ + P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANIL---IDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 104 --DEVFSDVVGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG--- 156
++++V + +Y PE+L + Y D+W G + + + P +++I
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237
Query: 157 -IFR-------------QIL---EGKIDFESEP-------WPNISESAKDLIRKMLDQNP 192
IF+ + L EG F + P E DL+ K+L +P
Sbjct: 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGL-DLLSKLLSLDP 296
Query: 193 KRRLTAHEVLCHPW 206
+RLTA + L HP+
Sbjct: 297 YKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 58/233 (24%), Positives = 104/233 (44%), Gaps = 38/233 (16%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGG--ELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
+ +++V + + + + +++V E E EL + + G E+ + + + ++ +
Sbjct: 58 KQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHW 115
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS--VFYKPDEVFSDVVGSPYYVAPEV 121
CH + HRD+KPEN L + + LK DFG + + + +++ V + +Y +PE+
Sbjct: 116 CHKNDIVHRDIKPENLL---ISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
Query: 122 LR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIG---IFRQIL-----EGKIDFESEP 172
L YG D+WS G IL L G P F E+EI +++L E F S P
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232
Query: 173 ------WPNISESAK--------------DLIRKMLDQNPKRRLTAHEVLCHP 205
+P ++ DL++ +L NP R + L HP
Sbjct: 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 29/203 (14%)
Query: 23 VHIVMELCEGG--ELFDRIVKKGNYSEREA-AKLMKTIVGVVECCHS-LGVFHRDLKPEN 78
V I ME+ + + + ++ KG + K+ +IV +E HS L V HRD+KP N
Sbjct: 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSN 134
Query: 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDV-VGSPYYVAPEVL-----RKHYGPEADV 132
L ++ + +K DFG+S Y D V + G Y+APE + +K Y ++DV
Sbjct: 135 VL---INRNGQVKLCDFGIS-GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDV 190
Query: 133 WSAGVILYILLSGVPPF--WAETEIGIFRQILEGKIDFESEPWPNI-----SESAKDLIR 185
WS G+ + L +G P+ W +T +Q++E EP P + S +D +
Sbjct: 191 WSLGITMIELATGRFPYDSW-KTPFQQLKQVVE-------EPSPQLPAEKFSPEFQDFVN 242
Query: 186 KMLDQNPKRRLTAHEVLCHPWIV 208
K L +N K R E+L HP+
Sbjct: 243 KCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-11
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 24/225 (10%)
Query: 1 MHHLSEHQHVVRIHDT-YEDKSCVH----IVMELCEGG---ELFDRIVKKGN-YSEREAA 51
+ L H +VV+ + Y+ V +V+ELC GG EL ++ G E +
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 52 KLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV- 110
++ + ++ H+ + HRD+K N L + + +K DFG+S + +
Sbjct: 132 YILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 111 VGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164
VG+P+++APEV+ Y DVWS G+ L G PP + + +I
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248
Query: 165 KID--FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
E W S I + L ++ + R + +L HP+I
Sbjct: 249 PPPTLLHPEKW---CRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC- 64
+H ++V++ K ++IVMEL GG L + KK N + K + ++
Sbjct: 50 DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAA 104
Query: 65 -----HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY---- 115
S HRDL N L V E+ LK +DFG+S + +++ G
Sbjct: 105 GMEYLESKNCIHRDLAARNCL---VGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIK 160
Query: 116 YVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPF 149
+ APE L Y E+DVWS G++L+ S G P+
Sbjct: 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 9/167 (5%)
Query: 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKL-MKTIVGVV 61
H ++V + + + I ME +GG L + K G E+ K+ + I G+
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 117
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV 121
+ HRD+KP N L V+ +K DFG+S D + + VG+ Y++PE
Sbjct: 118 YLREKHKIMHRDVKPSNIL---VNSRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPER 173
Query: 122 LR-KHYGPEADVWSAGVILYILLSG---VPPFWAETEIGIFRQILEG 164
L+ HY ++D+WS G+ L + G +PP A+ +F +EG
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG 220
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 48/166 (28%), Positives = 70/166 (42%), Gaps = 14/166 (8%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSER--EAAKLMKTIVGVVECC 64
H+H++ + V+I+ EL E G L + + + A L+ V E
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAEGM 117
Query: 65 HSL---GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY-YVAPE 120
L HRDL N L V ED K DFGL+ K D S PY + APE
Sbjct: 118 AYLEEQNSIHRDLAARNIL---VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPE 174
Query: 121 VL-RKHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
+ ++DVWS G++LY + + G P+ ++ QI G
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-10
Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 12/167 (7%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVEC 63
+H +++ + V IV E E G L D ++K G ++ + +++ I ++
Sbjct: 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK--PDEVFSDVVGS-PY-YVAP 119
+G HRDL N L V+ + K +DFGLS + P+ ++ G P + AP
Sbjct: 122 LSDMGYVHRDLAARNIL---VNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178
Query: 120 EVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
E + + + +DVWS G++++ ++S G P+W + + + I EG
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 49/243 (20%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVME-----LCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+H ++V +HD K + +V E LC+ D+ G + ++
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHTDLCQ---YMDK--HPGGLHPENVKLFLFQLLRG 115
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAP 119
+ H + HRDLKP+N L + + LK DFGL+ P +S+ V + +Y P
Sbjct: 116 LSYIHQRYILHRDLKPQNLL---ISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172
Query: 120 EVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG-----IFRQILEGKIDFESEP 172
+VL Y D+W G I ++ GV F +I IF ++ G + ++ P
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF--LVLGTPNEDTWP 230
Query: 173 ------------------------WPNIS--ESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
W +S A+DL K+L PK RL+A L H +
Sbjct: 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290
Query: 207 IVD 209
D
Sbjct: 291 FSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 29/184 (15%)
Query: 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
H ++V + + + I ME +GG L D+++K EA ++ + I+G V
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLK-------EAKRIPEEILGKVS 109
Query: 63 CCHSLG---------VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS 113
G + HRD+KP N L V+ +K DFG+S D + + VG+
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNIL---VNSRGEIKLCDFGVS-GQLIDSMANSFVGT 165
Query: 114 PYYVAPEVLR-KHYGPEADVWSAGVILYILLSG---VPPFWAETEIGIF-RQILEGKIDF 168
Y++PE L+ HY ++D+WS G+ L L G +PP A+ IF R +++G+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGE--- 222
Query: 169 ESEP 172
E EP
Sbjct: 223 EGEP 226
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG 68
++V +H + V +V++ EGG+L+ I K N E + +V ++ H G
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105
Query: 69 VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGP 128
+ RDL P N L +D+ ++ T F + + V Y APEV
Sbjct: 106 IVCRDLNPNNIL---LDDRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEET 160
Query: 129 EA-DVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKM 187
EA D WS G IL+ LL+G GI ++ SE A+ L++++
Sbjct: 161 EACDWWSLGAILFELLTGKTLVECHPS-GINTHTTLNIPEWVSEE-------ARSLLQQL 212
Query: 188 LDQNPKRRLTA-----HEVLCHPW 206
L NP RL A ++ HP+
Sbjct: 213 LQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-09
Identities = 20/44 (45%), Positives = 28/44 (63%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
L+E F++ D D GTI+ DELK LK +G L E EI +++ V
Sbjct: 2 LREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREV 45
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 48/199 (24%), Positives = 80/199 (40%), Gaps = 44/199 (22%)
Query: 48 REAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF 107
+A + K I+ + H+ + HRD+K EN VD+ + D G + F F
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ---VCIGDLGAAQFPVVAPAF 213
Query: 108 SDVVGSPYYVAPEVL-RKHYGPEADVWSAGVILYILL-----------SGVPPFWAETEI 155
+ G+ APEVL R Y +AD+WSAG++L+ +L S +
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273
Query: 156 GIFRQILEGKI---DFESEP---------------------WP-----NISESAKDLIRK 186
+ + I K+ +F +P +P N+ + L+ K
Sbjct: 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK 333
Query: 187 MLDQNPKRRLTAHEVLCHP 205
ML + R +A E+L +P
Sbjct: 334 MLTFDAAMRPSAEEILNYP 352
|
Length = 357 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 29/203 (14%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVGVVECC 64
+H ++V++ + ++IVMEL GG+ + KK + ++ K +
Sbjct: 50 DHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL 109
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD--VVGSPY-YVAPEV 121
S HRDL N L V E+ LK +DFG+S + D ++S + P + APE
Sbjct: 110 ESKNCIHRDLAARNCL---VGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEA 165
Query: 122 LR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG--------------K 165
L Y E+DVWS G++L+ S GV P+ T Q+ +G K
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK 225
Query: 166 I-----DFESEPWPNISESAKDL 183
+ D++ E P SE K+L
Sbjct: 226 VMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 39/234 (16%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVG 59
M LS H +V+++ ++S + +V E E G L D + ++G +S+ + +
Sbjct: 53 MMKLS-HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCE 111
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV-- 117
+ S V HRDL N L V E+ +K +DFG++ F D+ ++ G+ + V
Sbjct: 112 GMAYLESSNVIHRDLAARNCL---VGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKW 167
Query: 118 -APEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN 175
+PEV Y ++DVWS GV+++ + S EGK +E+ +
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFS------------------EGKTPYENR---S 206
Query: 176 ISESAKDLIRKMLDQNPKRRLTA-HEVLCHPWIVDDKVAPDKPLDSAVLSRLKH 228
SE + + P+ + +E++ H W ++P D S L H
Sbjct: 207 NSEVVETINAGFRLYKPRLASQSVYELMQHCW-------KERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 35/217 (16%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGEL--FDRIVKKGNYSER--EAAKLMKTIVGVV 61
H ++V++ +I+MEL EGG+L + R + + +L+ + V
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 62 ECCHSLG---VFHRDLKPENFLFLSVDEDA--ALKATDFGLSVFYKPDEVFSDVVGSPYY 116
+ C L HRDL N L DA +K DFGL+ D+ S YY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSDYY 167
Query: 117 ------------VAPEVLRKH-YGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQIL 162
+APE L + ++DVWS GV+++ IL G P+ A + + +
Sbjct: 168 RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227
Query: 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAH 199
G + N + L+ Q+P R T
Sbjct: 228 AGG---RLQKPENCPDKIYQLMTNCWAQDPSERPTFD 261
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 49/167 (29%), Positives = 67/167 (40%), Gaps = 35/167 (20%)
Query: 1 MHHLSEHQHVVR-IHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTI-- 57
M L +H +VR I + +VMEL G L + K+ + +L +
Sbjct: 50 MAQL-DHPCIVRLIGVCKGEPLM--LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAM 106
Query: 58 -VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY 116
+ +E H + HRDL N L V+ A K +DFG+S GS YY
Sbjct: 107 GMAYLESKHFV---HRDLAARNVLL--VNRHQA-KISDFGMSRALGA--------GSDYY 152
Query: 117 VAPEVLR---KHYGPE----------ADVWSAGVILYILLS-GVPPF 149
A R K Y PE +DVWS GV L+ S G P+
Sbjct: 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 34/117 (29%), Positives = 60/117 (51%), Gaps = 4/117 (3%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
LS+ +V ++ + + + V++VME GG++ + G + E A K + + ++
Sbjct: 60 LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDY 119
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAP 119
H G+ HRDLKP+N L + + +K TDFGLS V + D++ +P P
Sbjct: 120 LHRHGIIHRDLKPDNML---ISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H ++VR+ + + IV E G L D ++K + + A +LM + G+
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRK-HEGQLVAGQLMGMLPGLASGMK 121
Query: 66 SL---GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG-SP-YYVAPE 120
L G H+ L L V+ D K + F K + +++ + G SP + APE
Sbjct: 122 YLSEMGYVHKGLAAHKVL---VNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 121 VLR-KHYGPEADVWSAGVILYILLS-GVPPFW 150
++ H+ +DVWS G++++ ++S G P+W
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 12/166 (7%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECC 64
H +++R+ I+ E E G L D+ ++ G +S + +++ I ++
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK--PDEVFSDVVGS-PY-YVAPE 120
+ HRDL N L V+ + K +DFGLS + P+ ++ G P + APE
Sbjct: 124 SDMNYVHRDLAARNIL---VNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 121 VLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
+ + + +DVWS G++++ ++S G P+W + + + I +G
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 45/132 (34%), Positives = 62/132 (46%), Gaps = 12/132 (9%)
Query: 18 EDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL---GVFHRDL 74
E+K ++IV E G L D + +G S L+K + V E L HRDL
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDL 128
Query: 75 KPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY-YVAPEVLR-KHYGPEADV 132
N L V ED K +DFGL+ K D P + APE LR K + ++DV
Sbjct: 129 AARNVL---VSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 133 WSAGVILYILLS 144
WS G++L+ + S
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY--SEREAAKLMKTIVGVVEC 63
+H H+V++ + V IVMEL GEL +Y + + L I+ +
Sbjct: 65 DHPHIVKLIGVITENP-VWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQL 116
Query: 64 C------HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS-PY- 115
S HRD+ N L S D +K DFGLS + + + + G P
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 116 YVAPEVLR-KHYGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEGKIDFESEPW 173
++APE + + + +DVW GV ++ IL+ GV PF + +I G E P
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG----ERLPM 229
Query: 174 P-NISESAKDLIRKMLDQNPKRRLTAHEVLC 203
P N + L+ K +P +R E+
Sbjct: 230 PPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 13/152 (8%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H +++R+ V I+ E E G L D+ +++ N + +L+ + G+
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRE-NDGKFTVGQLVGMLRGIASGMKY 121
Query: 67 L---GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG--SPY-YVAPE 120
L HRDL N L V+ + K +DFGLS + E G P + APE
Sbjct: 122 LSEMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178
Query: 121 VLR-KHYGPEADVWSAGVILYILLS-GVPPFW 150
+ + + +DVWS G++++ ++S G P+W
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 14/155 (9%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGEL--FDRIVKKGNYSEREAAKLMKTIVGVVEC 63
+H +++ + V I+ E E G L F R G ++ + +++ I ++
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKY 121
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK---PDEVFSDVVGSPY---YV 117
+ HRDL N L V+ + K +DFGLS F + D ++ +G +
Sbjct: 122 LSEMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 118 APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFW 150
APE + + + +DVWS G++++ ++S G P+W
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 59/224 (26%), Positives = 85/224 (37%), Gaps = 53/224 (23%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------NYSEREA 50
MH L +H++++R++ + +V EL G L DR+ K +Y+ +
Sbjct: 50 MHSL-DHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ-- 105
Query: 51 AKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV 110
I + S HRDL N L S D +K DFGL
Sbjct: 106 ------IANGMRYLESKRFIHRDLAARNILLAS---DDKVKIGDFGLMRALP-------- 148
Query: 111 VGSPYYV------------APEVLRK-HYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156
+YV APE LR + +DVW GV L+ + + G P+ +
Sbjct: 149 QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS- 207
Query: 157 IFRQILEGKIDFESEPWPNISESAKDLIRKML---DQNPKRRLT 197
QIL+ KID E E +D+ ML NP R T
Sbjct: 208 ---QILK-KIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 23 VHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV---VECCHSLGVFHRDLKPENF 79
++IVMEL G L + + +G +L++ + V +E S + HRDL N
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRALV-SVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNI 131
Query: 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY-YVAPEVLR-KHYGPEADVWSAGV 137
L V ED K +DFGL+ + + D P + APE L+ K + ++DVWS GV
Sbjct: 132 L---VSEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGV 185
Query: 138 ILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL 196
+L+ + S G P+ + + + +G + EP L+ + PK+R
Sbjct: 186 LLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYVLMTSCWETEPKKRP 242
Query: 197 TAHEV 201
+ H++
Sbjct: 243 SFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 10/149 (6%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSE-REAAKLMKTIVG 59
M LS H+ +V+++ + ++IV E G L + + + G + + ++ K +
Sbjct: 53 MMKLS-HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCE 111
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV-- 117
+ S HRDL N L VD+ +K +DFGLS + DE S VGS + V
Sbjct: 112 GMAYLESKQFIHRDLAARNCL---VDDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRW 167
Query: 118 -APEVLR-KHYGPEADVWSAGVILYILLS 144
PEVL + ++DVW+ GV+++ + S
Sbjct: 168 SPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 47/174 (27%), Positives = 75/174 (43%), Gaps = 28/174 (16%)
Query: 46 SEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE 105
+E E + ++C +L HR K N + L+ D LK G F P++
Sbjct: 15 NEEEIWAV------CLQCLGALRELHRQAKSGN-ILLT--WDGLLKL--DGSVAFKTPEQ 63
Query: 106 VFSDVVGSPYYVAPEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164
D PY++APEV+ + Y +AD++S G+ LY L P+ E E+ ILE
Sbjct: 64 SRPD----PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL---SAILEI 116
Query: 165 KIDFESEPWP-------NISE--SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
++ P +S S +D +R + P+RR A+ L H +
Sbjct: 117 LLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALF 170
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 18/155 (11%)
Query: 1 MHHLSEHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMK--- 55
+ L H+++V+ E + ++ME G L R + + + +L+
Sbjct: 60 LRTLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSS 116
Query: 56 TIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP- 114
I ++ S HRDL N L V+ + +K +DFGL+ D+ + V P
Sbjct: 117 QICKGMDYLGSQRYIHRDLAARNIL---VESEDLVKISDFGLAKVLPEDKDYY-YVKEPG 172
Query: 115 ----YYVAPEVLRKH-YGPEADVWSAGVILYILLS 144
++ APE LR + +DVWS GV LY L +
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 40/143 (27%), Positives = 63/143 (44%), Gaps = 10/143 (6%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY--SEREAAKLMKTIVGVVEC 63
H ++V++ + ++IV E G L D + +G + + + +E
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY-YVAPEVL 122
HRDL N L V ED K +DFGL+ K D P + APE L
Sbjct: 118 LEEKNFVHRDLAARNVL---VSEDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPEAL 171
Query: 123 R-KHYGPEADVWSAGVILYILLS 144
R K + ++DVWS G++L+ + S
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVG 59
M LS H +V+++ + ++IV E E G L + + ++G S+ + + +
Sbjct: 53 MMKLS-HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCE 111
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV-- 117
+E HRDL N L V +K +DFG++ + DE S G+ + V
Sbjct: 112 GMEYLERNSFIHRDLAARNCL---VSSTGVVKVSDFGMTRYVLDDEYTSSS-GAKFPVKW 167
Query: 118 -APEVLR-KHYGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEG 164
PEV Y ++DVWS GV+++ + G PF ++ + I G
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 36/109 (33%), Positives = 51/109 (46%), Gaps = 7/109 (6%)
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD-EDAALKATDFGLSVFY----KPDEVF 107
L+ I+ + H+ V HRDLKP N L + E +K D G + + KP
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 108 SDVVGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETE 154
VV + +Y APE+L +HY D+W+ G I LL+ P F E
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 36/109 (33%), Positives = 51/109 (46%), Gaps = 7/109 (6%)
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD-EDAALKATDFGLSVFY----KPDEVF 107
L+ I+ + H+ V HRDLKP N L + E +K D G + + KP
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 108 SDVVGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETE 154
VV + +Y APE+L +HY D+W+ G I LL+ P F E
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 15/138 (10%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLSV------FYKPDEVFSDVVGSPYYVAPEVLRK 124
HRDL N L V E+ +K DFGLS +YK E +D + + +
Sbjct: 153 HRDLATRNCL---VGENMVVKIADFGLSRNIYSADYYKASE--NDAIPIRWMPPESIFYN 207
Query: 125 HYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDL 183
Y E+DVW+ GV+L+ + S G+ P++ + + +G + S P N +L
Sbjct: 208 RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV--LSCP-DNCPLELYNL 264
Query: 184 IRKMLDQNPKRRLTAHEV 201
+R + P R + +
Sbjct: 265 MRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 11/170 (6%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVG 59
M LS H ++V+++ + + IV E G L + + +KG + +
Sbjct: 53 MMKLS-HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCE 111
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV-- 117
+E S G HRDL N L V ED +K +DFGL+ + D+ S G+ + V
Sbjct: 112 AMEYLESNGFIHRDLAARNCL---VGEDNVVKVSDFGLARYVLDDQYTSSQ-GTKFPVKW 167
Query: 118 -APEVL-RKHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
PEV + ++DVWS GV+++ + S G P+ + + + G
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 49 EAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK---PDE 105
+ + + ++ ++ H G+ HRD+K EN + ++ ED L DFG + F +
Sbjct: 261 QVTAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFARGSWSTP 317
Query: 106 VFSDVVGSPYYVAPEVLRKH-YGPEADVWSAGVILY 140
+ G+ APEVL Y P D+WSAG++++
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 39/140 (27%), Positives = 67/140 (47%), Gaps = 12/140 (8%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H+ ++ + Y KS V +VM + +LF + + G +A + + ++ + H
Sbjct: 145 HRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG 203
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-----FYKPDEVFSDVVGSPYYVAPEV 121
G+ HRD+K EN +FL E+A L DFG + P G+ +PE+
Sbjct: 204 RGIIHRDVKTEN-IFLDEPENAVLG--DFGAACKLDAHPDTPQCY--GWSGTLETNSPEL 258
Query: 122 LR-KHYGPEADVWSAGVILY 140
L Y + D+WSAG++L+
Sbjct: 259 LALDPYCAKTDIWSAGLVLF 278
|
Length = 392 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 35/222 (15%)
Query: 7 HQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H+++V+ + + + ++ME G L + + + N ++ + +K V + +
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGM 122
Query: 65 HSLG---VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF---SDVVGSP-YYV 117
LG HRDL N L V+ + +K DFGL+ + D+ + D + SP ++
Sbjct: 123 DYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 118 APEVL-RKHYGPEADVWSAGVILYILLSGV---------------PPFWAETEIGIFRQI 161
APE L + + +DVWS GV LY LL+ P T + R +
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239
Query: 162 LEGKIDFESEPWP-NISESAKDLIRKMLDQNPKRRLTAHEVL 202
EGK P P N E L+RK + P +R T ++
Sbjct: 240 EEGK----RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 18/100 (18%)
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
++++ ++ H + HRD+K EN +F++ D L DFG + F P D+ +
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAEN-IFINHPGDVCLG--DFGAACF--P----VDINANK 239
Query: 115 YY--------VAPEVL-RKHYGPEADVWSAGVILYILLSG 145
YY APE+L R YGP D+WSAG++L+ + +
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-------------GNYSEREA 50
L H +++ + E++ ++I +E G L D + K G S +
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 51 AKLMKTIVGVVECCHSLG---VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF 107
+L++ V L HRDL N L V E+ A K DFGLS + +EV+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVL---VGENLASKIADFGLS---RGEEVY 172
Query: 108 -SDVVGS-PY-YVAPEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQIL 162
+G P ++A E L Y ++DVWS GV+L+ ++S G P+ T ++ ++
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232
Query: 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRR 195
+G + E N + +L+R+ P R
Sbjct: 233 QG---YRMEKPRNCDDEVYELMRQCWRDRPYER 262
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 46/152 (30%), Positives = 67/152 (44%), Gaps = 26/152 (17%)
Query: 25 IVMELCEGG-ELFDRIV---KKGNYSEREAAKLMKTIVGVVECCH----SLGVFHRDLKP 76
I MEL + + F + V K E L K V V+ + L + HRD+KP
Sbjct: 80 ICMELMDISLDKFYKYVYEVLKSVIPEE---ILGKIAVATVKALNYLKEELKIIHRDVKP 136
Query: 77 ENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV-VGSPYYVAPEVL----RKHYGPEAD 131
N L +D + +K DFG+S D + G Y+APE + R Y +D
Sbjct: 137 SNIL---LDRNGNIKLCDFGIS-GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSD 192
Query: 132 VWSAGVILYILLSGVPPF--WAETEIGIFRQI 161
VWS G+ LY + +G P+ W +F Q+
Sbjct: 193 VWSLGITLYEVATGKFPYPKWNS----VFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 52 KLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFS-D 109
+MK ++ VE H + HRD+K EN +FL+ D L DFG ++ F K E F
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYG 327
Query: 110 VVGSPYYVAPEVL-RKHYGPEADVWSAGVILYILLS 144
VG+ +PE+L Y D+WS G+IL +LS
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|205583 pfam13405, EF_hand_4, EF-hand domain | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 5e-06
Identities = 12/29 (41%), Positives = 19/29 (65%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVG 283
L+E FK+ D D G I+ +EL+ L+ +G
Sbjct: 2 LREAFKLFDKDGDGYISAEELRKALRSLG 30
|
Length = 30 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-06
Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 7 HQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H+++V+ ++ + ++ME G L D + K + + + I +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV---GSP-YYVAPE 120
HS HRDL N L +D D +K DFGL+ + V SP ++ A E
Sbjct: 124 HSQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 121 VLRKH-YGPEADVWSAGVILYILLS 144
L+++ + +DVWS GV LY LL+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 31/173 (17%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDA-ALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL- 122
HS + HRDLKP+N L +D + LK DFG + + + S +Y APE++
Sbjct: 187 HSKFICHRDLKPQNLL---IDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML 243
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL------------EGKIDFE 169
+Y D+WS G I+ ++ G P F ++ + +I+ E ++
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303
Query: 170 SEPWPNIS-------------ESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
+P++ + A + I + L P +RL E L P+ D
Sbjct: 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356
|
Length = 440 |
| >gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 7e-06
Identities = 16/44 (36%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 237 KMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLK 280
K AL+ + E L+EEEI E+ + +D D G I F+E + +
Sbjct: 23 KAALKSLGEGLSEEEI---DEMIREVDKDGDGKIDFEEFLELMA 63
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63 |
| >gnl|CDD|197492 smart00054, EFh, EF-hand, calcium binding motif | Back alignment and domain information |
|---|
Score = 42.0 bits (100), Expect = 7e-06
Identities = 14/28 (50%), Positives = 18/28 (64%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRV 282
LKE F++ D D G I F+E KD LK +
Sbjct: 2 LKEAFRLFDKDGDGKIDFEEFKDLLKAL 29
|
EF-hands are calcium-binding motifs that occur at least in pairs. Links between disease states and genes encoding EF-hands, particularly the S100 subclass, are emerging. Each motif consists of a 12 residue loop flanked on either side by a 12 residue alpha-helix. EF-hands undergo a conformational change unpon binding calcium ions. Length = 29 |
| >gnl|CDD|200946 pfam00036, efhand, EF hand | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 8e-06
Identities = 14/28 (50%), Positives = 19/28 (67%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRV 282
LKE FK D D G I+F+E K+ LK++
Sbjct: 2 LKEAFKEFDKDGDGKISFEEFKELLKKL 29
|
The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE---C 63
H +V+++ ++ ++IV E G L D +K G + +L+ + E
Sbjct: 60 HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD-FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY---YVAPE 120
S HRDL N L V E+ K DFGL+ + DE ++ G+ + + APE
Sbjct: 119 LESRNYIHRDLAARNIL---VGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPE 174
Query: 121 VLRKHYGP---EADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI 176
YG ++DVWS G++L I+ G P+ T + Q+ G + PN
Sbjct: 175 AAN--YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG---YRMPRPPNC 229
Query: 177 SESAKDLIRKMLDQNPKRRLT 197
E DL+ + D++P+ R T
Sbjct: 230 PEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 38/162 (23%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGG---ELFDRIVKKGNYSEREAAKLMKTI 57
L +H +++ ++ S +++V L G +L +G E A ++K +
Sbjct: 53 SRQL-QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDV 110
Query: 58 VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP--- 114
+ ++ HS G HR +K + L LS D L + +S+ K + V P
Sbjct: 111 LNALDYIHSKGFIHRSVKASHIL-LSGDGKVVLSGLRYSVSMI-KHGKRQRVVHDFPKSS 168
Query: 115 ----YYVAPEVLRKH---YGPEADVWSAGVILYILLSGVPPF 149
+++PEVL+++ Y ++D++S G+ L +G PF
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H +VR++ + ++I+ E E G L D +K + KL+ + E
Sbjct: 59 QHPRLVRLYAVVT-QEPIYIITEYMENGSLVD-FLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 66 SLGV---FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY---YVAP 119
+ HRDL+ N L V E K DFGL+ + +E ++ G+ + + AP
Sbjct: 117 FIERKNYIHRDLRAANIL---VSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAP 172
Query: 120 EVLRKHYGP---EADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP- 174
E + +YG ++DVWS G++L I+ G P+ T + + + G P P
Sbjct: 173 EAI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY----RMPRPD 226
Query: 175 NISESAKDLIRKMLDQNPKRRLT 197
N E +L+R + P+ R T
Sbjct: 227 NCPEELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 8/84 (9%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLS--VFYKPDEVFSDVVGSPY-YVAPE-VLRKHY 126
HRDL N L + E+ +K DFGL+ ++ PD V P ++APE + K Y
Sbjct: 197 HRDLAARNIL---LSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253
Query: 127 GPEADVWSAGVILYILLS-GVPPF 149
++DVWS GV+L+ + S G P+
Sbjct: 254 TTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------------GNYSE 47
L H +++ + E + +++ +E G L D + K S
Sbjct: 52 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 111
Query: 48 REAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF 107
++ + ++ HRDL N L V E+ K DFGLS + EV+
Sbjct: 112 QQLLHFAADVARGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLS---RGQEVY 165
Query: 108 -SDVVGS-PY-YVAPEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQIL 162
+G P ++A E L Y +DVWS GV+L+ ++S G P+ T ++ ++
Sbjct: 166 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 225
Query: 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRR 195
+G + E N + DL+R+ + P R
Sbjct: 226 QG---YRLEKPLNCDDEVYDLMRQCWREKPYER 255
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 11/134 (8%)
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVVGS-PY-YVAPEVLR 123
+ + HRDL N L V E +K +DFGLS Y+ D G P ++A E L
Sbjct: 146 MKLVHRDLAARNVL---VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202
Query: 124 KH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
H Y ++DVWS GV+L+ +++ G P+ +F + K + E N SE
Sbjct: 203 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL---KTGYRMERPENCSEEMY 259
Query: 182 DLIRKMLDQNPKRR 195
+L+ Q P +R
Sbjct: 260 NLMLTCWKQEPDKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 48/214 (22%), Positives = 84/214 (39%), Gaps = 60/214 (28%)
Query: 46 SEREAA---KLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALK------ATDFG 96
ERE +M+ I+ ++ HS G+ HRD+KP+N +F + + K A D
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF--SEGSGSFKIIDLGAAADLR 307
Query: 97 LSVFYKPDEVFSDVVGSPYYVAPE-VLRKHYGPEA----------------------DVW 133
+ + Y P E D P Y APE + P A D++
Sbjct: 308 VGINYIPKEFLLD----PRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363
Query: 134 SAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK------------ 181
SAG+I L P +++ + F + L+ + D++ W + E
Sbjct: 364 SAGLIF--LQMAFPNLRSDSNLIQFNRQLK-RNDYDLVAWRKLVEPRASPDLRRGFEVLD 420
Query: 182 -------DLIRKMLDQNPKRRLTAHEVLCHPWIV 208
+L++ M+ ++R++A L HP+
Sbjct: 421 LDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454
|
Length = 566 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG 68
++VR+ E +S + +VMEL E G L + K + +E+ +L+ + ++
Sbjct: 57 YIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 69 VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS---PY-YVAPEVLRK 124
HRDL N L V + A K +DFGLS DE + P + APE +
Sbjct: 116 FVHRDLAARNVLL--VTQHYA-KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 125 H-YGPEADVWSAGVILYILLS-GVPPF 149
+ + ++DVWS GV+++ S G P+
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKL--MKT-IVGVVE 62
+H ++V++ + +I+ E G L D +++ N E A L M T I +E
Sbjct: 60 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAME 118
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY---YVAP 119
HRDL N L V E+ +K DFGLS + ++ G+ + + AP
Sbjct: 119 YLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 174
Query: 120 EVLRKH-YGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEGKID--FESEPWPN 175
E L + + ++DVW+ GV+L+ I G+ P+ GI + ++ + E
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKGYRMERPEG 229
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEV 201
+L+R NP R + E+
Sbjct: 230 CPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 6e-05
Identities = 38/153 (24%), Positives = 75/153 (49%), Gaps = 16/153 (10%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECC 64
+H ++VR+ S + +V +L G L D + + + + + +L+ V + +
Sbjct: 67 DHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQ---RLLNWCVQIAKGM 122
Query: 65 HSL---GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVA 118
+ L + HR+L N L S D+ ++ DFG++ PD+ +S+ ++A
Sbjct: 123 YYLEEHRMVHRNLAARNILLKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 119 PE-VLRKHYGPEADVWSAGVILYILLS-GVPPF 149
E +L Y ++DVWS GV ++ ++S G P+
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 8/84 (9%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLS--VFYKPDEVFSDVVGSPY-YVAPE-VLRKHY 126
HRDL N L + E+ +K DFGL+ ++ PD V P ++APE + K Y
Sbjct: 196 HRDLAARNIL---LSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY 252
Query: 127 GPEADVWSAGVILYILLS-GVPPF 149
++DVWS GV+L+ + S G P+
Sbjct: 253 TTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-05
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 17/154 (11%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H +VR++ + ++I+ E G L D +K + KL+ + E
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD-FLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 66 SL---GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY---YVAP 119
+ HRDL+ N L V E K DFGL+ + +E ++ G+ + + AP
Sbjct: 118 YIERKNYIHRDLRAANVL---VSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 173
Query: 120 EVLRKHYGP---EADVWSAGVILY-ILLSGVPPF 149
E + ++G ++DVWS G++LY I+ G P+
Sbjct: 174 EAI--NFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 8/84 (9%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLS--VFYKPDEVFSDVVGSPY-YVAPE-VLRKHY 126
HRDL N L + E+ +K DFGL+ ++ PD V P ++APE + + Y
Sbjct: 202 HRDLAARNIL---LSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258
Query: 127 GPEADVWSAGVILYILLS-GVPPF 149
++DVWS GV+L+ + S G P+
Sbjct: 259 TIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 8e-05
Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------------GNYSERE 49
+HQH+VR + + + +V E G+L +R ++ G + +
Sbjct: 65 QHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123
Query: 50 AAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD 109
+ I + SL HRDL N L V + +K DFG+S D
Sbjct: 124 MLAIASQIASGMVYLASLHFVHRDLATRNCL---VGQGLVVKIGDFGMS---------RD 171
Query: 110 VVGSPYY------------VAPE-VLRKHYGPEADVWSAGVILY-ILLSGVPPFWAETEI 155
+ + YY + PE +L + + E+D+WS GV+L+ I G P++ +
Sbjct: 172 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231
Query: 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEV 201
I +G+ E E +++ + P++R+ ++
Sbjct: 232 EAIECITQGR---ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 8e-05
Identities = 21/56 (37%), Positives = 35/56 (62%)
Query: 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+A++L EE+I KE F + D D GTIT EL ++ +G E+E++D+++ V
Sbjct: 1 MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 56
|
Length = 149 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG 112
+M+ ++ + H +G+ HRD+KPEN L V D +K DFG +V F+ + G
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLL---VTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 113 --SPYYVAPEVL 122
P Y PE L
Sbjct: 371 MLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 39/188 (20%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGEL--FDR-------IVKKGN----YSEREAAK 52
+H+H+V+ + + + +V E + G+L F R ++ +GN ++ +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG 112
+ + I + S HRDL N L V E+ +K DFG+S DV
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCL---VGENLLVKIGDFGMS---------RDVYS 172
Query: 113 SPYY------------VAPE-VLRKHYGPEADVWSAGVILY-ILLSGVPPFWAETEIGIF 158
+ YY + PE ++ + + E+DVWS GV+L+ I G P++ + +
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
Query: 159 RQILEGKI 166
I +G++
Sbjct: 233 ECITQGRV 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 42/164 (25%), Positives = 69/164 (42%), Gaps = 30/164 (18%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIV----GVVE 62
HQ++VR+ ++ I++EL GG+L + + ER ++ MK ++ V +
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 63 CCHSL---GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY--- 116
C L HRD+ N L K DFG++ D+ + YY
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYYRKG 178
Query: 117 ---------VAPEV-LRKHYGPEADVWSAGVILYILLS-GVPPF 149
+ PE L + + DVWS GV+L+ + S G P+
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H +V++H K ++I+ E G L D +K S++ KL+ + E
Sbjct: 59 QHDKLVKLHAVVT-KEPIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 66 SL---GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY---YVAP 119
+ HRDL+ N L V K DFGL+ + +E ++ G+ + + AP
Sbjct: 117 FIEQRNYIHRDLRAANIL---VSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 172
Query: 120 EVLRKHYGP---EADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPN 175
E + ++G ++DVWS G++L +++ G P+ + + R + G E P
Sbjct: 173 EAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP- 229
Query: 176 ISESAKDLIRKMLDQNPKRRLT 197
E +++ + P+ R T
Sbjct: 230 --EELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 41/175 (23%), Positives = 74/175 (42%), Gaps = 42/175 (24%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H ++V + + ++ E G+L + +V+ +S+ A +T+ ++C
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 66 SLGV----------------FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD 109
L + HRDL N L V E +K +DFGLS D
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCL---VGEGLTVKISDFGLS---------RD 173
Query: 110 VVGSPYY------------VAPE-VLRKHYGPEADVWSAGVILYILLS-GVPPFW 150
+ + YY + PE +L + E+D+WS GV+L+ + S G+ P++
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 38/152 (25%), Positives = 65/152 (42%), Gaps = 29/152 (19%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY-------- 116
+ HRDL N + V ED +K DFG++ D+ + YY
Sbjct: 136 AAKKFVHRDLAARNCM---VAEDLTVKIGDFGMT---------RDIYETDYYRKGGKGLL 183
Query: 117 ----VAPEVLRK-HYGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEGKIDFES 170
+APE L+ + ++DVWS GV+L+ + P+ + + + +++G
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP 243
Query: 171 EPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
E P+ +L+R NPK R T E++
Sbjct: 244 ENCPDK---LLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 44/222 (19%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGEL--FDRIVKKGNYSEREAAKLMKTIVGVVEC- 63
H++VVR+ + ++++E + G+L F R K + + K V +
Sbjct: 67 HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 64 CHSLG------VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY- 116
+ HRDL N L S +K + LS DV S YY
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSS---QREVKVSLLSLS---------KDVYNSEYYK 174
Query: 117 ----------VAPEVLRKH-YGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEG 164
+APE +++ + ++DVWS GV+++ + G PF+ ++ + ++ G
Sbjct: 175 LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234
Query: 165 KIDFESEPWPNISESAKDLIRKML----DQNPKRRLTAHEVL 202
K++ P + E + K++ NPK R + E++
Sbjct: 235 KLE-----LP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 1e-04
Identities = 20/53 (37%), Positives = 31/53 (58%)
Query: 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+L EE+I LKE F++ D D+ G I +EL L+ +G E+EI L + +
Sbjct: 13 QLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEI 65
|
Length = 160 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 39/219 (17%)
Query: 8 QHVVRIHDTYEDKSCVHIVMELCEGGEL--FDRIVKKG--NYSEREAAKLMKTIVGVVEC 63
HVVR+ +VMEL G+L + R ++ N R L + I E
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 64 CHSLGVF------HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY- 116
+ HRDL N + V D +K DFG++ D+ + YY
Sbjct: 129 ADGMAYLNAKKFVHRDLAARNCM---VAHDFTVKIGDFGMT---------RDIYETDYYR 176
Query: 117 -----------VAPEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILE 163
+APE L+ + +D+WS GV+L+ + S P+ + + + +++
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236
Query: 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
G + +P N E DL+R NPK R T E++
Sbjct: 237 G--GYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 38/128 (29%), Positives = 59/128 (46%), Gaps = 21/128 (16%)
Query: 35 LFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLFLSVD-------- 85
L D I+K G +S R A+++ ++ H+ L + H DLKPEN L + D
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277
Query: 86 -----EDAALKATDFGLSVFYKPDEVFSD--VVGSPYYVAPEV-LRKHYGPEADVWSAGV 137
+ ++ D G DE S +V + +Y +PEV L + D+WS G
Sbjct: 278 RALPPDPCRVRICDLGGCC----DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC 333
Query: 138 ILYILLSG 145
I+Y L +G
Sbjct: 334 IIYELYTG 341
|
Length = 467 |
| >gnl|CDD|222177 pfam13499, EF_hand_5, EF-hand domain pair | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 2e-04
Identities = 14/43 (32%), Positives = 26/43 (60%)
Query: 260 KMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIF 302
K++D D G I +EL+ LK +G +L + E+++L++A
Sbjct: 1 KLLDKDGDGYIDVEELRKLLKALGLKLTDEEVEELIEADFNEI 43
|
Length = 60 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 41/128 (32%), Positives = 60/128 (46%), Gaps = 13/128 (10%)
Query: 25 IVMELCEGGELFDRIVKKGNYSEREAAKLM---KTIVGVVECCHSLGVFHRDLKPENFLF 81
+VME G L D + K + + KL+ I +E S HRDL N L
Sbjct: 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNIL- 140
Query: 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVV---GSP-YYVAPEVLRKH-YGPEADVWSAG 136
V+ + +K DFGL+ D+ + V SP ++ APE L + + +DVWS G
Sbjct: 141 --VESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFG 198
Query: 137 VILYILLS 144
V+LY L +
Sbjct: 199 VVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 39/219 (17%)
Query: 8 QHVVRIHDTYEDKSCVHIVMELCEGGELFDRI----VKKGNYSEREAAKLMKTIVGVVEC 63
HVVR+ ++MEL G+L + + N + L K I E
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 64 CHSLGVF------HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY- 116
+ HRDL N + V ED +K DFG++ D+ + YY
Sbjct: 129 ADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMT---------RDIYETDYYR 176
Query: 117 -----------VAPEVLRKH-YGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILE 163
++PE L+ + +DVWS GV+L+ I P+ + + R ++E
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
Query: 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
G + + + P++ +L+R NPK R + E++
Sbjct: 237 GGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|222407 pfam13833, EF_hand_6, EF-hand domain pair | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 3e-04
Identities = 18/45 (40%), Positives = 26/45 (57%), Gaps = 3/45 (6%)
Query: 237 KMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR 281
K AL ++ L+EEE+ LF+ DTD G I+F+E L+R
Sbjct: 11 KRALALLGISLSEEEV---DILFREFDTDGDGKISFEEFCVLLQR 52
|
Length = 53 |
| >gnl|CDD|185503 PTZ00183, PTZ00183, centrin; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 20/54 (37%), Positives = 32/54 (59%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK 300
L E++ ++E F + DTD SGTI ELK ++ +G + + EIK ++ V K
Sbjct: 11 LTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDK 64
|
Length = 158 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 14/137 (10%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF-SDVVGS-PY-YVAPEVLRKH-Y 126
HRDL N L V E+ K DFGLS + EV+ +G P ++A E L Y
Sbjct: 147 HRDLAARNIL---VGENYVAKIADFGLS---RGQEVYVKKTMGRLPVRWMAIESLNYSVY 200
Query: 127 GPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIR 185
+DVWS GV+L+ ++S G P+ T ++ ++ +G + E N + DL+R
Sbjct: 201 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMR 257
Query: 186 KMLDQNPKRRLTAHEVL 202
+ + P R + ++L
Sbjct: 258 QCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 26/164 (15%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKT---- 56
M HL H+++V + + ++ E C G+L N+ R+ +
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL-------NFLRRKRESFLTLEDLL 144
Query: 57 -----IVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV 111
+ + S HRDL N L + +K DFGL+ D + V
Sbjct: 145 SFSYQVAKGMAFLASKNCIHRDLAARNVL---LTHGKIVKICDFGLARDIMNDSNYV-VK 200
Query: 112 GSPY----YVAPE-VLRKHYGPEADVWSAGVILYILLS-GVPPF 149
G+ ++APE + Y E+DVWS G++L+ + S G P+
Sbjct: 201 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 11/99 (11%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS--VFYKPDEVFSDVVGSPY-YVAPEV 121
H GV H+D+ N + +DE+ +K TD LS +F D P ++A E
Sbjct: 134 HKRGVIHKDIAARNCV---IDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALES 190
Query: 122 L-RKHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158
L K Y +DVWS GV+L+ L++ G P+ EI F
Sbjct: 191 LVNKEYSSASDVWSFGVLLWELMTLGQTPY---VEIDPF 226
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 42/156 (26%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV-KKGNYSEREAAKLMKTIVG 59
MH L ++VR+ E ++ + +VME+ GG L + KK + +LM +
Sbjct: 49 MHQLDN-PYIVRMIGVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM 106
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPY--- 115
++ HRDL N L V++ A K +DFGLS D + +
Sbjct: 107 GMKYLEGKNFVHRDLAARNVLL--VNQHYA-KISDFGLSKALGADDSYYKARSAGKWPLK 163
Query: 116 YVAPEVLRKH-YGPEADVWSAGVILYILLS-GVPPF 149
+ APE + + +DVWS G+ ++ S G P+
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|205383 pfam13202, EF_hand_3, EF hand | Back alignment and domain information |
|---|
Score = 36.1 bits (85), Expect = 6e-04
Identities = 11/22 (50%), Positives = 16/22 (72%)
Query: 255 LKELFKMIDTDNSGTITFDELK 276
LK+LF+ DT+ G I+ +ELK
Sbjct: 1 LKDLFRQFDTNGDGKISKEELK 22
|
Length = 25 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 12/132 (9%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY---YVAPEVLR-KHY 126
HRDL N L V E+ K DFGL+ K D + G+ + + APE +
Sbjct: 126 HRDLAARNVL---VGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRF 181
Query: 127 GPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIR 185
++DVWS G++L I+ G P+ T + +Q+ +G + P + D++
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG---YRMPCPPGCPKELYDIML 238
Query: 186 KMLDQNPKRRLT 197
++P R T
Sbjct: 239 DCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 38/145 (26%), Positives = 63/145 (43%), Gaps = 29/145 (20%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY------------VA 118
HRDL N L V + +K DFG+S DV + YY +
Sbjct: 146 HRDLATRNCL---VGANLLVKIGDFGMS---------RDVYSTDYYRVGGHTMLPIRWMP 193
Query: 119 PE-VLRKHYGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI 176
PE ++ + + E+DVWS GVIL+ I G P++ + + I +G++ P
Sbjct: 194 PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCP-- 251
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEV 201
+ D++ + P++RL E+
Sbjct: 252 -KEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 9e-04
Identities = 35/135 (25%), Positives = 57/135 (42%), Gaps = 9/135 (6%)
Query: 21 SCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79
S V +V +L G L D + + K ++ I + + + HRDL N
Sbjct: 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNV 140
Query: 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP----YYVAPEVLRKHYGPEADVWSA 135
L V +K TDFGL+ DE G + +L + + ++DVWS
Sbjct: 141 L---VKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY 197
Query: 136 GVILYILLS-GVPPF 149
GV ++ L++ G P+
Sbjct: 198 GVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 32/111 (28%), Positives = 50/111 (45%), Gaps = 28/111 (25%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY-------------- 116
HRDL N + +DE +K DFGL+ D+ YY
Sbjct: 121 HRDLAARNCM---LDESFTVKVADFGLA---------RDIYDKEYYSVHNHTGAKLPVKW 168
Query: 117 VAPEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGK 165
+A E L+ + ++DVWS GV+L+ L++ G PP+ I +L+G+
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR 219
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 26/81 (32%), Positives = 37/81 (45%), Gaps = 8/81 (9%)
Query: 25 IVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84
IVME EG L D ++ E E ++ + +VG + HS G+ H DL N +
Sbjct: 76 IVMEYIEGEPLKD-LINSNGMEELELSREIGRLVGKL---HSAGIIHGDLTTSNMIL--- 128
Query: 85 DEDAALKATDFGLSVFYKPDE 105
+ DFGL+ F K E
Sbjct: 129 -SGGKIYLIDFGLAEFSKDLE 148
|
Length = 211 |
| >gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 20/60 (33%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 239 ALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ V +R ++EE L+E FK+ D D+ G I+ EL+ LK +G +L + E++ L+
Sbjct: 80 VMSVKLKRGDKEE--ELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEY 137
|
Length = 160 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 36/108 (33%), Positives = 48/108 (44%), Gaps = 26/108 (24%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY------------VA 118
HRDL N L V ED +K DFGL+ DV YY +A
Sbjct: 157 HRDLAARNVL---VTEDNVMKIADFGLA---------RDVHNIDYYKKTTNGRLPVKWMA 204
Query: 119 PEVL-RKHYGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEG 164
PE L + Y ++DVWS GV+L+ I G P+ +F+ + EG
Sbjct: 205 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|185503 PTZ00183, PTZ00183, centrin; Provisional | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.003
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 3/54 (5%)
Query: 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
+ ER EEI + F++ D D +G I+ LK K +G + + E+++++D
Sbjct: 83 LGERDPREEI---LKAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMID 133
|
Length = 158 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 32/99 (32%), Positives = 47/99 (47%), Gaps = 8/99 (8%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY---YVAPEVL-RKHY 126
HRDL N L V ED +K DFGL+ + + ++APE L + Y
Sbjct: 163 HRDLAARNVL---VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219
Query: 127 GPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEG 164
++DVWS GV+L+ I G P+ +F+ + EG
Sbjct: 220 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 32/92 (34%), Positives = 41/92 (44%), Gaps = 27/92 (29%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY------------VA 118
HRDL N L V ED +K DFGL+ D+ YY +A
Sbjct: 155 HRDLAARNVL---VTEDHVMKIADFGLA---------RDIHHIDYYRKTTNGRLPVKWMA 202
Query: 119 PEVL-RKHYGPEADVWSAGVILY--ILLSGVP 147
PE L + Y ++DVWS GV+L+ L G P
Sbjct: 203 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 27/83 (32%), Positives = 38/83 (45%), Gaps = 25/83 (30%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY------------VA 118
HRDL N L V D +K DFG+S DV + YY +
Sbjct: 145 HRDLATRNCL---VGYDLVVKIGDFGMS---------RDVYTTDYYRVGGHTMLPIRWMP 192
Query: 119 PE-VLRKHYGPEADVWSAGVILY 140
PE ++ + + E+DVWS GV+L+
Sbjct: 193 PESIMYRKFTTESDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.47 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.47 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.45 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.43 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.28 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.22 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.11 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.06 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.96 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.94 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 98.93 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 98.88 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.86 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.84 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 98.83 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 98.82 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 98.8 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.74 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 98.73 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.72 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 98.72 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 98.71 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.7 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 98.66 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.64 | |
| PF14658 | 66 | EF-hand_9: EF-hand domain | 98.63 | |
| cd00213 | 88 | S-100 S-100: S-100 domain, which represents the la | 98.62 | |
| cd00052 | 67 | EH Eps15 homology domain; found in proteins implic | 98.59 | |
| cd05023 | 89 | S-100A11 S-100A11: S-100A11 domain found in protei | 98.52 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.48 | |
| PF13833 | 54 | EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A | 98.48 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.42 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.38 | |
| PTZ00184 | 149 | calmodulin; Provisional | 98.38 | |
| KOG0041 | 244 | consensus Predicted Ca2+-binding protein, EF-Hand | 98.37 | |
| cd00051 | 63 | EFh EF-hand, calcium binding motif; A diverse supe | 98.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.32 | |
| PTZ00183 | 158 | centrin; Provisional | 98.28 | |
| PF00036 | 29 | EF-hand_1: EF hand; InterPro: IPR018248 Many calci | 98.21 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 98.21 | |
| PTZ00183 | 158 | centrin; Provisional | 98.19 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.18 | |
| cd00252 | 116 | SPARC_EC SPARC_EC; extracellular Ca2+ binding doma | 98.17 | |
| cd05030 | 88 | calgranulins Calgranulins: S-100 domain found in p | 98.11 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 98.06 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 98.05 | |
| PTZ00184 | 149 | calmodulin; Provisional | 98.04 | |
| KOG0037 | 221 | consensus Ca2+-binding protein, EF-Hand protein su | 97.97 | |
| PF13405 | 31 | EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J | 97.83 | |
| KOG0377 | 631 | consensus Protein serine/threonine phosphatase RDG | 97.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.78 | |
| KOG0034 | 187 | consensus Ca2+/calmodulin-dependent protein phosph | 97.72 | |
| PLN02964 | 644 | phosphatidylserine decarboxylase | 97.71 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.67 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 97.65 | |
| PF13202 | 25 | EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ | 97.64 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.62 | |
| KOG0036 | 463 | consensus Predicted mitochondrial carrier protein | 97.62 | |
| cd05024 | 91 | S-100A10 S-100A10: A subgroup of the S-100A10 doma | 97.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.51 |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-58 Score=366.49 Aligned_cols=242 Identities=41% Similarity=0.754 Sum_probs=224.6
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
++++|||||++.+.+.+++..|+|+|++.||+|+.-|.++.-++|..+-.+++||++||.|||.+||||||+||+|+++.
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLA 144 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLA 144 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeee
Confidence 45699999999999999999999999999999988787777899999999999999999999999999999999999998
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.+...-+||+|||+|.....+...-...|||.|||||+++ ..|+..+||||.|||+|.|+.|.+||++.+...++++|
T Consensus 145 SK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I 224 (355)
T KOG0033|consen 145 SKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI 224 (355)
T ss_pred eccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 88888899999999999988777778899999999999997 45999999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHhhHhhhHHHHHHHH
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALR 241 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (315)
+.+.+.++.+.|+++++++++|+++||..||.+|+|+.|+|+|||+.+.......--.+..+..+++|.+..+++..++.
T Consensus 225 ~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLt 304 (355)
T KOG0033|consen 225 KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILT 304 (355)
T ss_pred hccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999998765444444456778999999999999999988
Q ss_pred HHh
Q 021227 242 VIA 244 (315)
Q Consensus 242 ~i~ 244 (315)
.+.
T Consensus 305 av~ 307 (355)
T KOG0033|consen 305 TVI 307 (355)
T ss_pred HHH
Confidence 765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-58 Score=394.09 Aligned_cols=210 Identities=41% Similarity=0.702 Sum_probs=195.9
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
|++| .|||||+++++|+.....||||||++||+|++++..++.+.|..-..+++|++.|+.|||+.||+||||||+|||
T Consensus 230 LkkL-~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNIL 308 (475)
T KOG0615|consen 230 LKKL-SHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENIL 308 (475)
T ss_pred HHhc-CCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEE
Confidence 4566 899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc----CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH----YGPEADVWSAGVILYILLSGVPPFWAETEI- 155 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 155 (315)
+.+......+||+|||+|+.......+.+.+|||.|.|||++.+. +..++|+||+||++|.+++|.+||.+....
T Consensus 309 l~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 309 LSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred eccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 877667789999999999999888889999999999999999532 456899999999999999999999886544
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
...++|.+|++.+.+..|..+|.++++||.+||..||++|||++|+|+||||+...
T Consensus 389 sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 389 SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 48999999999999999999999999999999999999999999999999998654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=372.41 Aligned_cols=263 Identities=60% Similarity=1.011 Sum_probs=241.8
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
|+++..|||||.++++|++...+|+|||+|.||.|++.+.+. .++|..++.+++|+++|++|||+.||+||||||+|+|
T Consensus 89 l~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L 167 (382)
T KOG0032|consen 89 LQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLL 167 (382)
T ss_pred HHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHee
Confidence 456766999999999999999999999999999999999887 5999999999999999999999999999999999999
Q ss_pred eccCCC-CCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 81 FLSVDE-DAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 81 ~~~~~~-~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
+..... ++.+|++|||++.....+....+.+||+.|+|||++. ..|+..+||||+||++|.|++|.+||++.+..+..
T Consensus 168 ~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~ 247 (382)
T KOG0032|consen 168 LASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF 247 (382)
T ss_pred eccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH
Confidence 876544 4699999999999988877788899999999999998 67999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHhhHhhhHHHHH
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKM 238 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (315)
..|..+.+.|+.+.|+.+|..+++||.+||..||.+|+|+.++|+|||+......+..+.......+.+++..++++++.
T Consensus 248 ~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (382)
T KOG0032|consen 248 LAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKL 327 (382)
T ss_pred HHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999887777777777777888888899999888
Q ss_pred HHHHHhhhhhhhhhccHHHHhcccCCCCC
Q 021227 239 ALRVIAERLNEEEIGGLKELFKMIDTDNS 267 (315)
Q Consensus 239 ~~~~i~~~l~~e~~~~l~~~F~~~d~~~~ 267 (315)
.++..+.... +..+++.|..+|.+++
T Consensus 328 ~~~~~~~~~~---~~~~~~~~~~~~~~~~ 353 (382)
T KOG0032|consen 328 ALRVLAESLS---ISGLKEMFKLMDTDNN 353 (382)
T ss_pred HHHHHhhhhh---HHHHHHHHHhhccccc
Confidence 7777777666 7788888999988777
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-53 Score=375.59 Aligned_cols=202 Identities=37% Similarity=0.620 Sum_probs=189.9
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
+-++|||||+++++|+|.++.|||+|+|+.|+|..++.++++++|.+|+.+++||+.||.|||+++|+|||||..|++
T Consensus 73 r~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlf-- 150 (592)
T KOG0575|consen 73 RSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLF-- 150 (592)
T ss_pred HhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhee--
Confidence 345999999999999999999999999999999999998999999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
.+++..|||+|||+|..+... +...+.+|||.|+|||++. ...+..+||||+||++|-|++|++||...+-.+.+.+
T Consensus 151 -L~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~ 229 (592)
T KOG0575|consen 151 -LNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK 229 (592)
T ss_pred -ecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH
Confidence 678899999999999988744 6678899999999999997 4589999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
|....+.+|. .+|.++++||.+||+++|.+|||++++|.|+||+...
T Consensus 230 Ik~~~Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 230 IKLNEYSMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred HHhcCccccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 9999888876 6899999999999999999999999999999996543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-54 Score=348.55 Aligned_cols=207 Identities=39% Similarity=0.793 Sum_probs=198.1
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
|+++..||||+++.++|+.+..+++|+|.|+.|.|+|++.+.-.+||+..+.+++|+++|+.|||.++||||||||+|||
T Consensus 76 LRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENIL 155 (411)
T KOG0599|consen 76 LRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENIL 155 (411)
T ss_pred HHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhhee
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-------hcCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-------KHYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
.+++..+||+|||++..+.+++.....+|||+|.|||.+. ..|+..+|+||+|||+|-|+.|.+||+...
T Consensus 156 ---lddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk 232 (411)
T KOG0599|consen 156 ---LDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK 232 (411)
T ss_pred ---eccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence 6788999999999999999999999999999999999873 348999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
..-+++.|++|++.|.++.|.++|...+++|++||+.||.+|+|++|+|.||||...
T Consensus 233 QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 233 QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 999999999999999999999999999999999999999999999999999999643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=374.69 Aligned_cols=221 Identities=39% Similarity=0.705 Sum_probs=200.8
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
+|..|||++++|++++++.++|+|.||++||.|++++.++|+++|.+++++++||+.|+.|||..+|+|||+||+|+|
T Consensus 67 kLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlL-- 144 (786)
T KOG0588|consen 67 KLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLL-- 144 (786)
T ss_pred HHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhh--
Confidence 355999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
++..+.|||+|||+|..-.++....+.||+|+|.|||++.+. -+.++||||+|||+|.|+||+.||.+.+...++.+
T Consensus 145 -Ld~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlK 223 (786)
T KOG0588|consen 145 -LDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLK 223 (786)
T ss_pred -hhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 566666999999999988888999999999999999999754 57899999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC------------------CCCCCHHH
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAP------------------DKPLDSAV 222 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~------------------~~~~~~~~ 222 (315)
+.+|.+.+|. .+|+++++||.+||..||.+|+|.+|+++|||+......+ ...+++.+
T Consensus 224 V~~G~f~MPs----~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps~~~IDp~I 299 (786)
T KOG0588|consen 224 VQRGVFEMPS----NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPSIQEIDPLI 299 (786)
T ss_pred HHcCcccCCC----cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCCcccCCHHH
Confidence 9999988874 7999999999999999999999999999999998654332 22456677
Q ss_pred HHHHHhhH
Q 021227 223 LSRLKHFS 230 (315)
Q Consensus 223 ~~~~~~~~ 230 (315)
+..+.-..
T Consensus 300 l~~l~iLw 307 (786)
T KOG0588|consen 300 LQHLCILW 307 (786)
T ss_pred Hhhhhhee
Confidence 77665444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=352.13 Aligned_cols=203 Identities=25% Similarity=0.428 Sum_probs=182.1
Q ss_pred CCCCCCCCcceEEEEEEeCCe-EEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCce
Q 021227 2 HHLSEHQHVVRIHDTYEDKSC-VHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENF 79 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~-~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~ni 79 (315)
+.. +|||||++|+.|.+++. ++|+||||+||+|.+.+...++++|.....++.+++.||.|||+ ++||||||||+||
T Consensus 132 ~~~-~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNl 210 (364)
T KOG0581|consen 132 RSC-QSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNL 210 (364)
T ss_pred hhC-CCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHe
Confidence 344 89999999999999995 99999999999999999888999999999999999999999995 9999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC-----C
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE-----T 153 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~ 153 (315)
| ++..|.|||||||.+..+.+. ...+++||..|||||.+.+ .|+.++||||||+.++|+.+|+.||... +
T Consensus 211 L---vNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~ 286 (364)
T KOG0581|consen 211 L---VNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD 286 (364)
T ss_pred e---eccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC
Confidence 9 678999999999999887666 6688999999999999985 5999999999999999999999999874 6
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
..+++..|..+..+--+. ..+|+++++||.+||++||.+|||+.|+++|||++...
T Consensus 287 ~~~Ll~~Iv~~ppP~lP~--~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 287 IFELLCAIVDEPPPRLPE--GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHhcCCCCCCCc--ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 778888888764322221 14899999999999999999999999999999998653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=359.09 Aligned_cols=201 Identities=44% Similarity=0.797 Sum_probs=186.4
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+++..||||+++++++.....+|+|||||.||+|++++.++++++|..++.+++|+++|++|||++||+||||||+|||+
T Consensus 74 ~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill 153 (370)
T KOG0583|consen 74 RRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL 153 (370)
T ss_pred HHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe
Confidence 45545999999999999999999999999999999999999999999999999999999999999999999999999995
Q ss_pred ccCCCC-CCEEEeeccCcccC-CCCCcccccccCccccchhhhhhc--C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 82 LSVDED-AALKATDFGLSVFY-KPDEVFSDVVGSPYYVAPEVLRKH--Y-GPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 82 ~~~~~~-~~ikl~Dfg~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
+.+ +.+||+|||++... .......+.+||+.|+|||++.+. | +.++||||+||++|.|++|..||...+...
T Consensus 154 ---d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~ 230 (370)
T KOG0583|consen 154 ---DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN 230 (370)
T ss_pred ---cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH
Confidence 455 99999999999887 566778899999999999999753 4 689999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCC-CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 157 IFRQILEGKIDFESEPWPNI-SESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~-s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
++..|..+.+.++. .+ |+++++++.+||..||.+|+|+.+++.||||+.
T Consensus 231 l~~ki~~~~~~~p~----~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 231 LYRKIRKGEFKIPS----YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHhcCCccCCC----CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99999999888775 34 999999999999999999999999999999997
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=353.83 Aligned_cols=202 Identities=39% Similarity=0.686 Sum_probs=187.3
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
|.+|.+||.|++||..|+|+..+|+|+||+++|+|.++|.+-|.|+|.-++.++.||+.||+|||++|||||||||+|||
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENIL 206 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENIL 206 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhhee
Confidence 34567999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc--------------ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV--------------FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSG 145 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~--------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g 145 (315)
++.++++||+|||.|+.+.+... ..+++||..|.+||++.. ..++.+|+|+||||+|+|+.|
T Consensus 207 ---Ld~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG 283 (604)
T KOG0592|consen 207 ---LDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAG 283 (604)
T ss_pred ---EcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcC
Confidence 78899999999999987643211 145899999999999974 578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 146 VPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 146 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.+||.+.++.-++++|+.-.+.|+. .+++.+++||+++|..||.+|+|++|+-+||||..
T Consensus 284 ~PPFra~NeyliFqkI~~l~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 284 QPPFRAANEYLIFQKIQALDYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCCCccccHHHHHHHHHHhcccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 9999999999999999999888875 68899999999999999999999999999999964
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-51 Score=333.11 Aligned_cols=217 Identities=47% Similarity=0.829 Sum_probs=199.6
Q ss_pred CCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 5 SEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
..|||||.++++|++ ...+.+|||.++||.|++.+..++. |+|.++..|++||..|+.|||+.+|.||||||+|
T Consensus 112 s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpEN 191 (400)
T KOG0604|consen 112 SGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPEN 191 (400)
T ss_pred cCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhh
Confidence 579999999999975 4678899999999999999998865 9999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAET---- 153 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---- 153 (315)
+|+.+...+..+||+|||+|+.-.......+.+-||.|.|||++. ++|+..+|+||+||++|.|++|++||+...
T Consensus 192 LLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai 271 (400)
T KOG0604|consen 192 LLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271 (400)
T ss_pred eeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC
Confidence 999988899999999999999877777778889999999999996 679999999999999999999999998643
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHH
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSA 221 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~ 221 (315)
...+..+|..+.+.|+.+.|..+|++++++|+++|..+|.+|.|+++++.|||+......+..++...
T Consensus 272 spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~ 339 (400)
T KOG0604|consen 272 SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTS 339 (400)
T ss_pred ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhh
Confidence 34678899999999999999999999999999999999999999999999999999888877776543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=335.94 Aligned_cols=200 Identities=37% Similarity=0.679 Sum_probs=184.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||.||+++..|++...+|+|+||+.||.|+..+.+.+.|+|..++-++..|+.||.|||++|||||||||+||| +
T Consensus 82 v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENIL---L 158 (357)
T KOG0598|consen 82 IKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENIL---L 158 (357)
T ss_pred CCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHee---e
Confidence 4899999999999999999999999999999999999999999999999999999999999999999999999999 7
Q ss_pred CCCCCEEEeeccCcccC-CCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFY-KPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+..|.|+|+|||+++.. ..+....+.+||+.|||||++. ..|+..+|.||||+++|+|++|.+||.+.+...+.++|.
T Consensus 159 d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~ 238 (357)
T KOG0598|consen 159 DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL 238 (357)
T ss_pred cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh
Confidence 88999999999999854 4445667789999999999986 569999999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC----CHHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL----TAHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~----s~~~~l~h~~~~~~ 210 (315)
.++...++. .+|++++++++++|++||++|. ++.++-+||||...
T Consensus 239 ~~k~~~~p~---~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 239 KGKLPLPPG---YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred cCcCCCCCc---cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 998544442 4799999999999999999995 79999999999753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=324.69 Aligned_cols=196 Identities=39% Similarity=0.717 Sum_probs=184.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
..||+++++++.|.+.+++|+||||..||.|+.++.+.++|+|..++-++.||+.||+|||+++|++||+||+||| +
T Consensus 101 v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiL---l 177 (355)
T KOG0616|consen 101 VSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLL---L 177 (355)
T ss_pred ccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHee---e
Confidence 3799999999999999999999999999999999999999999999999999999999999999999999999999 7
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
+.+|.+||+|||+|+..... ..+.||||.|+|||++. +.|+.++|.|||||++|||+.|.+||.+.++..++++|.+
T Consensus 178 D~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~ 255 (355)
T KOG0616|consen 178 DQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE 255 (355)
T ss_pred ccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh
Confidence 88999999999999876543 56899999999999987 5699999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
++..||. .+|+++++||+++|+.|-.+|. ...++.+||||..
T Consensus 256 ~~v~fP~----~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 256 GKVKFPS----YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred CcccCCc----ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999986 6899999999999999999994 5779999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=335.84 Aligned_cols=208 Identities=35% Similarity=0.679 Sum_probs=188.6
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.+ +|||||+++++.++++.+|+|||||.||+|.+|+.+++.++|..++.++.|++.||++||+++||||||||+|||+
T Consensus 64 kel-~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLL 142 (429)
T KOG0595|consen 64 KEL-KHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILL 142 (429)
T ss_pred Hhc-CCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEe
Confidence 345 7999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC---CCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 82 LSVDED---AALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 82 ~~~~~~---~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
.....+ ..+||+|||+|+.+.++....+.+|+|.|||||++. ++|+.|+|+||+|+|+|++++|++||...+..+.
T Consensus 143 s~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 143 STTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred ccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 754233 679999999999999988889999999999999995 7899999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
+..+.++.-..+... ..+++...+++...|+.+|..|.+..+.+.|++.....
T Consensus 223 ~~~~~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 223 LLYIKKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HHHHhccccccCchh-hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 998888765443322 34677788999999999999999999999999987654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=340.32 Aligned_cols=207 Identities=29% Similarity=0.520 Sum_probs=182.9
Q ss_pred CCCCCCCCCcceEEEEEEeCC-eEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 1 MHHLSEHQHVVRIHDTYEDKS-CVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~-~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
|++|..|||||++.|++.+.. ++|+|||||+. +|++.+..+ ..|+|..++.|+.||+.||+|+|++|+.|||+||+|
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPEN 140 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPEN 140 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhh
Confidence 467867999999999998887 99999999975 899988765 579999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
|| +..+..|||+|||+|+........+.++.|.||+|||++. +.|+.+.|+||+|||++|+.+-++.|.|.++.+
T Consensus 141 iL---i~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D 217 (538)
T KOG0661|consen 141 IL---ISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID 217 (538)
T ss_pred eE---ecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH
Confidence 99 4557899999999999999988889999999999999974 569999999999999999999999999999988
Q ss_pred HHHHHHhCCCCCCCCC--------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 157 IFRQILEGKIDFESEP--------------------------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~--------------------------~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
++-+|.+--..+.... .++.++++.++|.+||.+||.+||||.|+|+||||+..
T Consensus 218 qi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 218 QIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 8877765222211111 34578999999999999999999999999999999864
Q ss_pred C
Q 021227 211 K 211 (315)
Q Consensus 211 ~ 211 (315)
.
T Consensus 298 ~ 298 (538)
T KOG0661|consen 298 R 298 (538)
T ss_pred c
Confidence 3
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=334.46 Aligned_cols=201 Identities=35% Similarity=0.621 Sum_probs=180.4
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.++|+||++|..|++..++||||||++||++..+|.+.+.|+|..++.++.+++.|+.-||+.|+|||||||+|+| +
T Consensus 198 ~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlL---i 274 (550)
T KOG0605|consen 198 VDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLL---I 274 (550)
T ss_pred cCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhhee---e
Confidence 5899999999999999999999999999999999999999999999999999999999999999999999999999 7
Q ss_pred CCCCCEEEeeccCcccCCC----------------------C--C------------------------cccccccCccc
Q 021227 85 DEDAALKATDFGLSVFYKP----------------------D--E------------------------VFSDVVGSPYY 116 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~----------------------~--~------------------------~~~~~~gt~~y 116 (315)
+..|++||+|||++..+.. . . .....+|||.|
T Consensus 275 D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDY 354 (550)
T KOG0605|consen 275 DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDY 354 (550)
T ss_pred cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccc
Confidence 8999999999999853211 0 0 01135799999
Q ss_pred cchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 021227 117 VAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRR 195 (315)
Q Consensus 117 ~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R 195 (315)
||||++.+ .|+..||.||||||+||||.|.+||.+.++.+.+++|...+..+..+.-..+|++++|||.+||. ||.+|
T Consensus 355 iAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 355 IAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 99999874 49999999999999999999999999999999999999887555444445789999999999999 99999
Q ss_pred C---CHHHHhcCCCccC
Q 021227 196 L---TAHEVLCHPWIVD 209 (315)
Q Consensus 196 ~---s~~~~l~h~~~~~ 209 (315)
. +++|+-.||||+.
T Consensus 434 LG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 434 LGSKGAEEIKKHPFFKG 450 (550)
T ss_pred cCcccHHHHhcCCcccc
Confidence 7 5999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=339.03 Aligned_cols=202 Identities=31% Similarity=0.564 Sum_probs=177.6
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.+ +|||||++++.|-.+..+++||||++||+|.+.+.. ..++|.+++.|++.++.||+|||.+||+|||||.+|||
T Consensus 325 ~~~-~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnIL- 401 (550)
T KOG0578|consen 325 RDL-HHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNIL- 401 (550)
T ss_pred Hhc-cchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeE-
Confidence 344 899999999999999999999999999999987744 46999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
.+.+|.+||+|||+|..+.... ...+.+|||+|||||++. ..|++++||||||+++.||+-|++||...++...+.
T Consensus 402 --L~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly 479 (550)
T KOG0578|consen 402 --LTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 479 (550)
T ss_pred --eccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH
Confidence 6778889999999998887655 445688999999999996 569999999999999999999999999877766666
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.|.... .+....+..+|+++++|+.+||+.|+.+|+||.|+|+||||+.
T Consensus 480 LIa~ng-~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 480 LIATNG-TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHhhcC-CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 555422 2333445689999999999999999999999999999999954
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=329.73 Aligned_cols=257 Identities=32% Similarity=0.604 Sum_probs=219.1
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
|.+|||||++|++......+|+|+|+-+||+|++||.++ ..++|..+.+++.||+.|+.|||+..+|||||||+||.|
T Consensus 73 LVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVF- 151 (864)
T KOG4717|consen 73 LVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVF- 151 (864)
T ss_pred HhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEE-
Confidence 458999999999999999999999999999999999887 579999999999999999999999999999999999998
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH-Y-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
...-|.|||+|||++..+.+++...+.+|+..|.|||++.+. | .+++||||||||+|.|++|++||...++.+.+..
T Consensus 152 -FEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm 230 (864)
T KOG4717|consen 152 -FEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM 230 (864)
T ss_pred -eeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh
Confidence 457899999999999999999999999999999999998654 4 5789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHhhHhhhHHHHHHH
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMAL 240 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (315)
|+..++..|. .+|.+|++||..||+.||++|.|.+++..++|++.........+.- +.+ ..+....-
T Consensus 231 ImDCKYtvPs----hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPL--vsr-------~~L~ee~H 297 (864)
T KOG4717|consen 231 IMDCKYTVPS----HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPL--VSR-------HHLPEEAH 297 (864)
T ss_pred hhcccccCch----hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCce--eeh-------hhCChHHH
Confidence 9999888775 7899999999999999999999999999999998765443322111 111 11222233
Q ss_pred HHHhhhhhhhhhccHHHHhcccCCCCCCcccHHHH
Q 021227 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDEL 275 (315)
Q Consensus 241 ~~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el 275 (315)
..|.+++-...+..-.++.+.++.|.-+.|+..=+
T Consensus 298 a~IIq~Mv~G~IAs~e~Il~aLe~n~YNhiTATYf 332 (864)
T KOG4717|consen 298 ATIIQQMVAGAIASEEDILRALENNEYNHITATYF 332 (864)
T ss_pred HHHHHHHhcccccCHHHHHHHHhccccchhhhHHH
Confidence 44455555566666678888889998888885544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=316.65 Aligned_cols=202 Identities=27% Similarity=0.590 Sum_probs=176.1
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.| +|||+|.++++|..+..+|+|+|||+. ++.+-+.+ ...++++.+..+++|++.|+.|||+++++||||||+|||
T Consensus 56 KqL-kH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENIL 133 (396)
T KOG0593|consen 56 KQL-KHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENIL 133 (396)
T ss_pred Hhc-ccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheE
Confidence 344 999999999999999999999999987 55555544 467999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
++.++.+||||||+|+.+. ++...+.++.|.||.|||.+-+ +|++.+||||+||++.||++|.+.|+|.++.++
T Consensus 134 ---it~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ 210 (396)
T KOG0593|consen 134 ---ITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ 210 (396)
T ss_pred ---EecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH
Confidence 6789999999999999887 6777788999999999999864 599999999999999999999999999999888
Q ss_pred HHHHHhCCCC-------------------CCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 158 FRQILEGKID-------------------FES--------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 158 ~~~i~~~~~~-------------------~~~--------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
+..|...-.. +|. ...++++.-+.+|+++||..||++|+|.+|+|.|+||.
T Consensus 211 Ly~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 211 LYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred HHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 7777651111 111 12456788899999999999999999999999999994
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=319.49 Aligned_cols=207 Identities=29% Similarity=0.484 Sum_probs=179.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+|.+||||++++..|..+..+|+||.||.+|++.+.+... ..++|..++.+.++++.||.|||.+|.||||||+.|||
T Consensus 79 sl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 79 SLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL 158 (516)
T ss_pred hhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence 3569999999999999999999999999999999998764 46999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC-c----ccccccCccccchhhhh---hcCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE-V----FSDVVGSPYYVAPEVLR---KHYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~-~----~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
++.+|.|||+|||.+..+.... . ..+++||+.|||||++. ..|+.|+||||||++..||.+|..||...
T Consensus 159 ---i~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~ 235 (516)
T KOG0582|consen 159 ---IDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY 235 (516)
T ss_pred ---EcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence 6789999999999876553321 1 25678999999999964 35999999999999999999999999999
Q ss_pred CHHHHHHHHHhCCCCC------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 153 TEIGIFRQILEGKIDF------ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~------~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
.+.+++-.-.++.++. +......++..++.++..||++||.+|||++++|+|+||+..+.
T Consensus 236 pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 236 PPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 8888776666665532 22223457889999999999999999999999999999987653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=322.08 Aligned_cols=205 Identities=31% Similarity=0.510 Sum_probs=169.6
Q ss_pred CCCCCCCCcceEEEEEEeCC--eEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 2 HHLSEHQHVVRIHDTYEDKS--CVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
++| +|||||++++...... .+++.|||++||+|.+++.+.+ +++|..++.+.+|+++||.|||++|||||||||+|
T Consensus 69 ~~l-~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~N 147 (313)
T KOG0198|consen 69 SRL-NHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPAN 147 (313)
T ss_pred HhC-CCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccce
Confidence 456 4999999999865544 6999999999999999999877 79999999999999999999999999999999999
Q ss_pred eeeccCCC-CCCEEEeeccCcccCCC----CCcccccccCccccchhhhhhcC--CCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 79 FLFLSVDE-DAALKATDFGLSVFYKP----DEVFSDVVGSPYYVAPEVLRKHY--GPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 79 il~~~~~~-~~~ikl~Dfg~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
||+ +. ++.+||+|||.+..... ........||+.|||||++.... .+++||||+||++.||+||..||..
T Consensus 148 iLl---~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 148 ILL---DPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred EEE---eCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 994 55 78999999999887653 12234578999999999997432 3499999999999999999999987
Q ss_pred -CCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 152 -ETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 152 -~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
....+..-.+......+ .....+|+++++||.+|+..+|.+||||+++|+|||......
T Consensus 225 ~~~~~~~~~~ig~~~~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 225 FFEEAEALLLIGREDSLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred hcchHHHHHHHhccCCCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 34333333343333211 233469999999999999999999999999999999976543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=311.62 Aligned_cols=210 Identities=38% Similarity=0.676 Sum_probs=187.9
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.++.+|+||++++++|+++..+|+|||-+.||+|...|.++..|+|.++..+++.|+.||.+||.+||.|||+||+|||.
T Consensus 130 ~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC 209 (463)
T KOG0607|consen 130 YQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILC 209 (463)
T ss_pred HHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceee
Confidence 35679999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCEEEeeccCcccCCCC--------CcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCC
Q 021227 82 LSVDEDAALKATDFGLSVFYKPD--------EVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~--------~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~ 147 (315)
.+-+.-.-||||||.+....... ....+.+|+..|||||+.. ..|+.++|.||||||+|.|++|++
T Consensus 210 ~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYp 289 (463)
T KOG0607|consen 210 ESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYP 289 (463)
T ss_pred cCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCC
Confidence 66566678999999887554321 2234678999999999863 248999999999999999999999
Q ss_pred CCCCCC---------------HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 148 PFWAET---------------EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 148 pf~~~~---------------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
||.|.. ...+++.|.+|.+.||...|..+|.+++++++.+|..++.+|.++.++++|||+....
T Consensus 290 PFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 290 PFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred CccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 996532 3568999999999999999999999999999999999999999999999999997543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=321.92 Aligned_cols=206 Identities=31% Similarity=0.573 Sum_probs=180.1
Q ss_pred CCCCCCCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 1 MHHLSEHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
|++| +||||+++.++..+. +.+|+|+|||+. +|.-++... -.|++.++..+++|++.||.|||.+||+|||||.+
T Consensus 170 Lr~l-~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~S 247 (560)
T KOG0600|consen 170 LRRL-DHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGS 247 (560)
T ss_pred HHhc-CCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeecccccc
Confidence 3556 999999999988776 789999999986 777666553 37999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
||| ++.+|.+||+|||+|+++.... ..+..+-|.||.|||.+.+ .|+..+|+||+|||+.||++|++.|.|.+
T Consensus 248 NiL---idn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 248 NIL---IDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred ceE---EcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 999 7889999999999999775543 4567788999999999864 59999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCC-------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 154 EIGIFRQILEGKIDFESEPWP-------------------------NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~-------------------------~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
+.+++..|.+-...+....|+ .+++.+.+|+.+||..||.+|.||.++|+++||.
T Consensus 325 EveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 325 EVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred HHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 999999998855544444443 3678899999999999999999999999999995
Q ss_pred CCC
Q 021227 209 DDK 211 (315)
Q Consensus 209 ~~~ 211 (315)
...
T Consensus 405 t~p 407 (560)
T KOG0600|consen 405 TEP 407 (560)
T ss_pred cCC
Confidence 443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=307.13 Aligned_cols=191 Identities=28% Similarity=0.559 Sum_probs=167.4
Q ss_pred CCCCCCCCcceEEE-EEEeCCe-EEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--Ccc
Q 021227 2 HHLSEHQHVVRIHD-TYEDKSC-VHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHS--LG--VFH 71 (315)
Q Consensus 2 ~~l~~Hpniv~~~~-~~~~~~~-~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~--~~--ivH 71 (315)
+.| +|||||++++ .|.+++. ++||||||++|+|...+.. ++.++|..+++++.|++.||.+||. .+ |+|
T Consensus 73 kQL-~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmH 151 (375)
T KOG0591|consen 73 KQL-NHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMH 151 (375)
T ss_pred Hhc-CCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceee
Confidence 445 9999999998 5555444 9999999999999987753 4579999999999999999999998 55 999
Q ss_pred ccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCC
Q 021227 72 RDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPF 149 (315)
Q Consensus 72 ~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf 149 (315)
|||||.||+ ++.+|.|||+|||+++.+..... ..+.+|||.|||||.+. ..|+.++||||+||++|||+.-++||
T Consensus 152 RDIKPaNIF---l~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 152 RDIKPANIF---LTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred ccCcchheE---EcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 999999999 67899999999999998876543 45689999999999997 55999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 021227 150 WAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA 198 (315)
Q Consensus 150 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~ 198 (315)
.|.+..++-++|.++.++.-+ -..+|.++..+|..|+..||..||+.
T Consensus 229 ~g~n~~~L~~KI~qgd~~~~p--~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 229 YGDNLLSLCKKIEQGDYPPLP--DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ccccHHHHHHHHHcCCCCCCc--HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 999999999999998654222 14689999999999999999999986
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=314.99 Aligned_cols=196 Identities=41% Similarity=0.710 Sum_probs=185.4
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
++||||+.+|++|++...+.|||||.+||.|++|+..++.++|.+++.+++||++|+.|||+++++|||||.+||| +
T Consensus 110 LNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENIL---L 186 (668)
T KOG0611|consen 110 LNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENIL---L 186 (668)
T ss_pred cCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhhee---e
Confidence 4999999999999999999999999999999999999999999999999999999999999999999999999999 7
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++++||+|||++..+......++++|+|.|.+||++++. -++.+|.|||||++|-|+.|.+||.|.+-..++++|.
T Consensus 187 D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs 266 (668)
T KOG0611|consen 187 DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS 266 (668)
T ss_pred cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh
Confidence 88999999999999998888899999999999999999865 5899999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
+|.+.-+. -+.++.-||+.||..+|++|.|++++..|=|..
T Consensus 267 ~GaYrEP~-----~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 267 RGAYREPE-----TPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred cccccCCC-----CCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 99876543 467889999999999999999999999998875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=328.05 Aligned_cols=200 Identities=30% Similarity=0.600 Sum_probs=184.3
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.| +|||||++++.|+...++++|.|||.| +|+.++...+.++|+.++.++.|+++||.|||+.+|.|||+||.|||
T Consensus 56 r~l-kHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniL- 132 (808)
T KOG0597|consen 56 RSL-KHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNIL- 132 (808)
T ss_pred Hhc-CCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceee-
Confidence 344 899999999999999999999999987 99999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
.+..+.+|+||||+|+....+.. .....|||.|||||.+.+ .|+..+|.||+|||+||+++|++||...+..+..+
T Consensus 133 --l~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~ 210 (808)
T KOG0597|consen 133 --LEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVK 210 (808)
T ss_pred --ecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHH
Confidence 78899999999999998765544 455779999999999975 49999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.|......++. ..|.+++.|+..+|.+||.+|.|+.+++.|||++..
T Consensus 211 ~I~~d~v~~p~----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 211 SILKDPVKPPS----TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHhcCCCCCcc----cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 99887665554 789999999999999999999999999999999764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=318.67 Aligned_cols=205 Identities=35% Similarity=0.679 Sum_probs=178.4
Q ss_pred CCCCCCCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 1 MHHLSEHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
|++| +|||||+|+++..+. ..+|||+|||+.|.+...-.....+++.+++.|++.++.||.|||.+|||||||||+|
T Consensus 162 lKkl-~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsN 240 (576)
T KOG0585|consen 162 LKKL-HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSN 240 (576)
T ss_pred HHhc-CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence 4667 899999999999865 6799999999999885433222339999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCC------CCcccccccCccccchhhhhh---c--CCCchhHHHHHHHHHHHHhCCC
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKP------DEVFSDVVGSPYYVAPEVLRK---H--YGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~------~~~~~~~~gt~~y~aPE~~~~---~--~~~~~DiwslG~il~~ll~g~~ 147 (315)
+| ++.+|.|||+|||.+..... .......+|||.|+|||.+.+ . -+.+.||||+||++|.|+.|+.
T Consensus 241 LL---l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 241 LL---LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred eE---EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 99 56779999999999876522 223445789999999999864 1 4678999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 148 PFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
||.+....+++..|.+..+.++.. +.++++++++|.+||.+||.+|+++.++..|||.....
T Consensus 318 PF~~~~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 318 PFFDDFELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred CcccchHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 999999999999999998888765 36899999999999999999999999999999998653
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=308.12 Aligned_cols=210 Identities=33% Similarity=0.552 Sum_probs=178.9
Q ss_pred CCCCCCCCCcceEEEEEEe-----CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 021227 1 MHHLSEHQHVVRIHDTYED-----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLK 75 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dik 75 (315)
|+++ +|+||+.+.+++.. -+.+|+|+|+| +.+|...+.....+++..+..+++|++.||.|+|+.|++|||+|
T Consensus 75 Lr~~-~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLK 152 (359)
T KOG0660|consen 75 LRHL-RHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLK 152 (359)
T ss_pred HHHh-cCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccc
Confidence 3556 69999999999965 46799999999 45888888777679999999999999999999999999999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCC---CCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKP---DEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
|.|++ ++.+..+|+||||+|+.... ...++..+.|.+|.|||++. ..|++..||||+|||+.||++|++.|.
T Consensus 153 PsNll---~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 153 PSNLL---LNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred hhhee---eccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 99999 67889999999999998753 45567788999999999874 569999999999999999999999999
Q ss_pred CCCHHHHHHHHHhCCCC-----------------------CCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 151 AETEIGIFRQILEGKID-----------------------FESE----PWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 151 ~~~~~~~~~~i~~~~~~-----------------------~~~~----~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|.+...++..|..-... .+.. .+++.++.+.+|+.+||..||.+|+|++|+|.
T Consensus 230 G~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 230 GKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 98887777776552211 1111 24678999999999999999999999999999
Q ss_pred CCCccCCCCCCC
Q 021227 204 HPWIVDDKVAPD 215 (315)
Q Consensus 204 h~~~~~~~~~~~ 215 (315)
|||+.......+
T Consensus 310 hPYl~~~hdp~d 321 (359)
T KOG0660|consen 310 HPYLAPYHDPED 321 (359)
T ss_pred ChhhhhhcCCcc
Confidence 999986544433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=320.77 Aligned_cols=197 Identities=34% Similarity=0.587 Sum_probs=177.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++++++.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+ ++
T Consensus 53 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIl---l~ 129 (323)
T cd05571 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLM---LD 129 (323)
T ss_pred CCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEE---EC
Confidence 899999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCC-CCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++.... .........||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+..
T Consensus 130 ~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~ 209 (323)
T cd05571 130 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209 (323)
T ss_pred CCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 67899999999987532 223334567999999999986 4589999999999999999999999999888888888877
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
+...++ ..++++++++|.+||+.||++|| ++.++++||||..
T Consensus 210 ~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 210 EEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCC----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 765554 35899999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=292.01 Aligned_cols=203 Identities=33% Similarity=0.553 Sum_probs=179.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+.++++|-+...+.+|+||++. +|...+..+ ..++...+..++.+++.|++|||++.|+||||||.|+|
T Consensus 58 l~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLL--- 133 (318)
T KOG0659|consen 58 LKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLL--- 133 (318)
T ss_pred ccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceE---
Confidence 3899999999999999999999999975 888877654 56999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcc-cccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVF-SDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
++.+|.+||+|||+|+.+.+.... ...+-|.+|.|||.+- +.|+..+||||+|||+.||+.|.+.|.|.++.+++..
T Consensus 134 is~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~ 213 (318)
T KOG0659|consen 134 ISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK 213 (318)
T ss_pred EcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH
Confidence 678999999999999988655433 3347899999999884 5699999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCC------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 161 ILEGKIDFESEPWP------------------------NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 161 i~~~~~~~~~~~~~------------------------~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
|.+.-.++....|+ ..++++.+|+.+||..||.+|+|+.|+|+|+||++..
T Consensus 214 If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 214 IFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 98855554444444 3578899999999999999999999999999998743
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=289.73 Aligned_cols=198 Identities=32% Similarity=0.619 Sum_probs=183.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV--KKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
++||||+++|++|-|....|+++||..+|+++..+. +.++++|..++.+++|++.||.|||.++++||||||+|+|
T Consensus 79 L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlL-- 156 (281)
T KOG0580|consen 79 LRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLL-- 156 (281)
T ss_pred cCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhc--
Confidence 489999999999999999999999999999999998 5678999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
.+..+.+|++|||.+.... .....+.+||..|.+||+..+. ++..+|+|++|++.||++.|.+||...+..+.+++|
T Consensus 157 -lg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI 234 (281)
T KOG0580|consen 157 -LGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI 234 (281)
T ss_pred -cCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH
Confidence 6778999999999887654 3444678999999999999754 899999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+....++ ..+|.+++|+|.+||.++|.+|.+..|++.|||+...
T Consensus 235 ~k~~~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 235 RKVDLKFP----STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHccccCC----cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 99988887 3799999999999999999999999999999999753
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=314.83 Aligned_cols=195 Identities=35% Similarity=0.653 Sum_probs=176.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+|+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+||+ .+
T Consensus 59 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIl---i~ 135 (291)
T cd05612 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENIL---LD 135 (291)
T ss_pred CCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE---EC
Confidence 899999999999999999999999999999999988889999999999999999999999999999999999999 46
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 164 (315)
.++.+||+|||++...... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+..+.+..+
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 213 (291)
T cd05612 136 KEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213 (291)
T ss_pred CCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 6789999999998765432 234579999999999864 4889999999999999999999999999988888888887
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 165 KIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 165 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
...++. .+++.++++|++||+.||.+|++ ++++++||||..
T Consensus 214 ~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 214 KLEFPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CcCCCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 766553 46899999999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=317.00 Aligned_cols=199 Identities=31% Similarity=0.571 Sum_probs=178.3
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||||+++++++++.+.+|+||||++||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 52 ~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIl--- 128 (320)
T cd05590 52 ARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVL--- 128 (320)
T ss_pred ccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeE---
Confidence 45899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||++.... .........||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+
T Consensus 129 i~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i 208 (320)
T cd05590 129 LDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208 (320)
T ss_pred ECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 5677899999999987542 223334567999999999986 45899999999999999999999999999998888888
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCccC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA------HEVLCHPWIVD 209 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~------~~~l~h~~~~~ 209 (315)
..+...++. .++++++++|.+||+.||.+||++ +++++||||..
T Consensus 209 ~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 209 LNDEVVYPT----WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred hcCCCCCCC----CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 877655442 579999999999999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=319.54 Aligned_cols=196 Identities=34% Similarity=0.638 Sum_probs=177.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++.+++.+|+||||+.||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||| +
T Consensus 88 l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL---l 164 (340)
T PTZ00426 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLL---L 164 (340)
T ss_pred CCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEE---E
Confidence 3899999999999999999999999999999999988889999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
+.++.+||+|||++...... ..+..||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+..
T Consensus 165 ~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 242 (340)
T PTZ00426 165 DKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE 242 (340)
T ss_pred CCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc
Confidence 67889999999998765432 245679999999999864 489999999999999999999999999998888888888
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
+...++. .++++++++|++||+.+|.+|+ |++++++||||..
T Consensus 243 ~~~~~p~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 243 GIIYFPK----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred CCCCCCC----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 7665543 5789999999999999999995 8999999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=315.45 Aligned_cols=198 Identities=32% Similarity=0.613 Sum_probs=177.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+|+||||++||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||+ .+
T Consensus 51 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nil---i~ 127 (312)
T cd05585 51 NCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENIL---LD 127 (312)
T ss_pred CCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeE---EC
Confidence 899999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCC-CCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++..... ........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 128 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~ 207 (312)
T cd05585 128 YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207 (312)
T ss_pred CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence 788999999999875432 223345679999999999864 589999999999999999999999999888888888887
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRL---TAHEVLCHPWIVDD 210 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~---s~~~~l~h~~~~~~ 210 (315)
....++ ..++++++++|.+||+.||.+|| ++.++++||||...
T Consensus 208 ~~~~~~----~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 EPLRFP----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCCCC----CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 765544 36899999999999999999997 58999999999753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=326.26 Aligned_cols=198 Identities=30% Similarity=0.555 Sum_probs=182.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||.+++++..|+...++|+||||+.||++. .+...+.|+|..++-|+..|+.||.|||++||||||||.+||| +
T Consensus 426 ~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiL---L 501 (694)
T KOG0694|consen 426 NRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLL---L 501 (694)
T ss_pred ccCCeEeecccccccCCeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheE---E
Confidence 47999999999999999999999999999954 3445678999999999999999999999999999999999999 7
Q ss_pred CCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+..|.+||+|||+++..- .+....+++|||.|||||++.+ .|+..+|.|||||++|||+.|+.||.|.++.++++.|.
T Consensus 502 D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~ 581 (694)
T KOG0694|consen 502 DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV 581 (694)
T ss_pred cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 889999999999998654 5667788999999999999974 59999999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~~ 210 (315)
.....+|. .+|.++.++++++|.++|++|.. ++++..||||...
T Consensus 582 ~d~~~yP~----~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 582 NDEVRYPR----FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred cCCCCCCC----cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 98887775 68999999999999999999984 6889999999753
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=318.01 Aligned_cols=195 Identities=33% Similarity=0.633 Sum_probs=176.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+|+||||+.||+|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+||+ ++
T Consensus 76 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIl---l~ 152 (329)
T PTZ00263 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL---LD 152 (329)
T ss_pred CCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEE---EC
Confidence 899999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 164 (315)
.++.+||+|||++....... .+..||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+..+.+..+
T Consensus 153 ~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 230 (329)
T PTZ00263 153 NKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230 (329)
T ss_pred CCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence 78899999999987654332 34679999999999864 4889999999999999999999999999988888888887
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 165 KIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 165 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
...++. .+++.+++||.+||+.||.+|++ ++++++||||..
T Consensus 231 ~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 231 RLKFPN----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred CcCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 665543 47899999999999999999997 799999999975
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=298.45 Aligned_cols=204 Identities=29% Similarity=0.478 Sum_probs=176.7
Q ss_pred CCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 6 EHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 6 ~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
+|||||.+-++... -+.+|+|||||+. +|...+..-+ +|++.++..++.|++.|++|||.+.|+||||||+|+|
T Consensus 133 ~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLL-- 209 (419)
T KOG0663|consen 133 RHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLL-- 209 (419)
T ss_pred CCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhhee--
Confidence 79999999998864 4679999999986 8888887654 8999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
.+..|.+|++|||+|+.+... ...+..+-|.+|.|||.+. ..|++..|+||+|||+.||+++.+.|.|.++.+++.
T Consensus 210 -m~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~ 288 (419)
T KOG0663|consen 210 -LSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD 288 (419)
T ss_pred -eccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH
Confidence 678999999999999987654 4456677899999999986 459999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCC----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 160 QILEGKIDFESEPWPN----------------------------ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~----------------------------~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.|.+-...+....|+. +|....+|+..+|..||.+|.||+|+|+|.||.+..
T Consensus 289 ~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 289 KIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred HHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 9987433333222221 458899999999999999999999999999998754
Q ss_pred CC
Q 021227 212 VA 213 (315)
Q Consensus 212 ~~ 213 (315)
..
T Consensus 369 ~p 370 (419)
T KOG0663|consen 369 LP 370 (419)
T ss_pred CC
Confidence 43
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=314.87 Aligned_cols=198 Identities=32% Similarity=0.583 Sum_probs=176.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||++++++++++..+|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||| +
T Consensus 52 l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIl---l 128 (328)
T cd05593 52 TRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLM---L 128 (328)
T ss_pred CCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeE---E
Confidence 3899999999999999999999999999999999988888999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++..... ........||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+.
T Consensus 129 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~ 208 (328)
T cd05593 129 DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (328)
T ss_pred CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc
Confidence 6788999999999875322 22334567999999999986 458999999999999999999999999988888877777
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
.....++ ..+++++.++|.+||++||.+|+ ++.++++||||..
T Consensus 209 ~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 209 MEDIKFP----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred cCCccCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 6655544 35899999999999999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=313.35 Aligned_cols=199 Identities=29% Similarity=0.565 Sum_probs=178.4
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||||+++++++++++.+|+||||++||+|..++.+.+.+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nil--- 128 (321)
T cd05591 52 AAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNIL--- 128 (321)
T ss_pred ccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE---
Confidence 45899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||++..... ........||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+....+
T Consensus 129 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i 208 (321)
T cd05591 129 LDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208 (321)
T ss_pred ECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 56788999999999875432 223345679999999999864 5899999999999999999999999999999999888
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-------CHHHHhcCCCccC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-------TAHEVLCHPWIVD 209 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-------s~~~~l~h~~~~~ 209 (315)
..+...++. .+++++.++|.+||+.||++|+ +++++++||||..
T Consensus 209 ~~~~~~~p~----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 209 LHDDVLYPV----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HcCCCCCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 877655442 4789999999999999999999 9999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=313.61 Aligned_cols=198 Identities=33% Similarity=0.587 Sum_probs=176.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||++++++|.++..+|+||||+.||+|..++.+.+.+++..++.++.|++.||+|||++||+||||||+||+ ++
T Consensus 53 ~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl---l~ 129 (323)
T cd05595 53 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LD 129 (323)
T ss_pred CCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE---Ec
Confidence 899999999999999999999999999999999988888999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++..... ........||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+.......+..
T Consensus 130 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~ 209 (323)
T cd05595 130 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 209 (323)
T ss_pred CCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 778999999999875322 22334567999999999986 4589999999999999999999999999888888888777
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVDD 210 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~~ 210 (315)
....++. .++++++++|.+||+.||.+|+ ++.++++|+||...
T Consensus 210 ~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 210 EEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCC----CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 6655543 5899999999999999999998 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=311.60 Aligned_cols=200 Identities=32% Similarity=0.529 Sum_probs=176.5
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||||+++++++++++++|+||||+.||+|..++.+.+.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil--- 128 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM--- 128 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE---
Confidence 45899999999999999999999999999999999988888999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||++..... ........||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+..+.+
T Consensus 129 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~ 208 (316)
T cd05620 129 LDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208 (316)
T ss_pred ECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56678999999999864322 22334567999999999986 45899999999999999999999999999888888888
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-HHHhcCCCccCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA-HEVLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~-~~~l~h~~~~~~ 210 (315)
......++. .++++++++|.+||+.||.+|+++ +++++||||...
T Consensus 209 ~~~~~~~~~----~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 209 RVDTPHYPR----WITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HhCCCCCCC----CCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 766544432 478999999999999999999998 588899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=315.96 Aligned_cols=202 Identities=32% Similarity=0.543 Sum_probs=172.8
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||++++++++++..+|+|||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||| +
T Consensus 58 ~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NIL---i 134 (363)
T cd05628 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLL---L 134 (363)
T ss_pred CCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeE---E
Confidence 3899999999999999999999999999999999988889999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCC------------------------------------cccccccCccccchhhhh-hcCC
Q 021227 85 DEDAALKATDFGLSVFYKPDE------------------------------------VFSDVVGSPYYVAPEVLR-KHYG 127 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~ 127 (315)
+.++.+||+|||++....... .....+||+.|+|||++. ..++
T Consensus 135 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~ 214 (363)
T cd05628 135 DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN 214 (363)
T ss_pred CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC
Confidence 567899999999987542210 012457999999999986 4589
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCC---CCCCHHHHhcC
Q 021227 128 PEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPK---RRLTAHEVLCH 204 (315)
Q Consensus 128 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~---~R~s~~~~l~h 204 (315)
.++||||+||++|+|++|..||.+.+..+....+.........+....++++++++|.+|+. +|. .||+++|+++|
T Consensus 215 ~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 215 KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 99999999999999999999999999888888887654333323334589999999999875 454 45899999999
Q ss_pred CCccCC
Q 021227 205 PWIVDD 210 (315)
Q Consensus 205 ~~~~~~ 210 (315)
|||...
T Consensus 294 p~f~~~ 299 (363)
T cd05628 294 PFFEGV 299 (363)
T ss_pred CCCCCC
Confidence 999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=313.30 Aligned_cols=200 Identities=35% Similarity=0.564 Sum_probs=176.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++++++.+|+||||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+ ++
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil---~~ 135 (333)
T cd05600 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFL---ID 135 (333)
T ss_pred CCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE---EC
Confidence 699999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 164 (315)
.++.+||+|||++..... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 136 ~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 213 (333)
T cd05600 136 ASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213 (333)
T ss_pred CCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc
Confidence 788999999999876543 334567999999999986 45899999999999999999999999998888887777654
Q ss_pred CCCCCCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 165 KIDFESEPW----PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 165 ~~~~~~~~~----~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
...+..+.+ ..+|+++.++|.+||..+|.+|||++++++||||...
T Consensus 214 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 214 KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred cccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 433222222 2579999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=311.51 Aligned_cols=199 Identities=35% Similarity=0.602 Sum_probs=177.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++++.+|+||||+.||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||+ +
T Consensus 57 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil---~ 133 (323)
T cd05584 57 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENIL---L 133 (323)
T ss_pred CCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE---E
Confidence 3899999999999999999999999999999999988889999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++..... ........||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~ 213 (323)
T cd05584 134 DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213 (323)
T ss_pred CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 6788999999999865432 22334467999999999986 448899999999999999999999999998888888888
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~~ 210 (315)
.+....+ +.++++++++|.+||+++|.+|| ++++++.||||...
T Consensus 214 ~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 214 KGKLNLP----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred cCCCCCC----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 7765544 35789999999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=310.41 Aligned_cols=200 Identities=32% Similarity=0.607 Sum_probs=177.9
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||||+++++++++.+.+|+||||+.||+|..++.+.+.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 52 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil--- 128 (318)
T cd05570 52 AGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVL--- 128 (318)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeE---
Confidence 45899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
.+.++.+||+|||++.... ........+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+
T Consensus 129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i 208 (318)
T cd05570 129 LDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208 (318)
T ss_pred ECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 5667899999999986532 222334467999999999986 45899999999999999999999999998888888888
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCccCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA-----HEVLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~-----~~~l~h~~~~~~ 210 (315)
......++ ..+++++.++|.+||+.||.+|||+ .+++.||||...
T Consensus 209 ~~~~~~~~----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 209 LEDEVRYP----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HcCCCCCC----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 77665544 3579999999999999999999999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=309.12 Aligned_cols=194 Identities=29% Similarity=0.422 Sum_probs=170.8
Q ss_pred CCCCCcceEEEEEEeCC-eEEEEEeccCCCchhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-CccccCCCCcee
Q 021227 5 SEHQHVVRIHDTYEDKS-CVHIVMELCEGGELFDRIVK--KGNYSEREAAKLMKTIVGVVECCHSLG-VFHRDLKPENFL 80 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~-~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dikp~nil 80 (315)
++|||||++++++.+.. .+++||||+++|+|.+++.+ .+.++...+..++.||+.|+.|||+++ ||||||||+|||
T Consensus 96 l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiL 175 (362)
T KOG0192|consen 96 LRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNIL 175 (362)
T ss_pred CCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEE
Confidence 49999999999999888 79999999999999999988 578999999999999999999999999 999999999999
Q ss_pred eccCCCCC-CEEEeeccCcccCCCC-CcccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 81 FLSVDEDA-ALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 81 ~~~~~~~~-~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
++... .+||+|||+++..... .......||+.|||||++++ .|+.++||||+|+++|||+||..||.+....
T Consensus 176 ---v~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~ 252 (362)
T KOG0192|consen 176 ---VDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV 252 (362)
T ss_pred ---EcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH
Confidence 55665 9999999999876654 33444789999999999984 3999999999999999999999999998887
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+....+.....++..+ ..+++.+..+|.+||..||.+||+..+++.
T Consensus 253 ~~~~~v~~~~~Rp~~p--~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 253 QVASAVVVGGLRPPIP--KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHhcCCCCCCC--ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 7777776555444432 238999999999999999999999988863
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=309.45 Aligned_cols=200 Identities=33% Similarity=0.568 Sum_probs=176.5
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||||++++++++++..+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nil--- 128 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVL--- 128 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeE---
Confidence 45899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||++..... ........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+
T Consensus 129 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i 208 (316)
T cd05592 129 LDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208 (316)
T ss_pred ECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56778999999999875432 223345679999999999864 5899999999999999999999999999988888887
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-HHHhcCCCccCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA-HEVLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~-~~~l~h~~~~~~ 210 (315)
......++ ..+++++.+++.+||+.+|.+||++ .++++||||...
T Consensus 209 ~~~~~~~~----~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 209 LNDRPHFP----RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HcCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 76554443 3578999999999999999999986 588899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=305.29 Aligned_cols=199 Identities=28% Similarity=0.477 Sum_probs=166.4
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.+++..|+||||+.| +|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 60 l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil--- 135 (288)
T cd07871 60 LKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLL--- 135 (288)
T ss_pred CCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE---
Confidence 3899999999999999999999999975 8888886654 5799999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
.+.++.+||+|||++...... .......|++.|+|||++.+ .++.++||||+||++|+|++|++||.+.+..+.+..
T Consensus 136 ~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~ 215 (288)
T cd07871 136 INEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215 (288)
T ss_pred ECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 566789999999998754322 22344678999999998853 489999999999999999999999998887766655
Q ss_pred HHhCCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 161 ILEGKIDFES--------------------------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 161 i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+.......+. ...+.+++++++||++||+.||.+|||++|+++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 5432111110 0123568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=316.44 Aligned_cols=201 Identities=32% Similarity=0.609 Sum_probs=175.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||++++++|++++.+|+|||||.||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||| ++
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl---~~ 135 (364)
T cd05599 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLL---LD 135 (364)
T ss_pred CCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE---EC
Confidence 799999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCC---------------------------------------cccccccCccccchhhhh-hc
Q 021227 86 EDAALKATDFGLSVFYKPDE---------------------------------------VFSDVVGSPYYVAPEVLR-KH 125 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~-~~ 125 (315)
.++.+||+|||++....... ...+.+||+.|+|||++. ..
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (364)
T cd05599 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215 (364)
T ss_pred CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC
Confidence 78899999999986542211 011346999999999986 45
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHh
Q 021227 126 YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT---AHEVL 202 (315)
Q Consensus 126 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s---~~~~l 202 (315)
++.++||||+||++|+|++|..||.+.+..+....+......+..+....+|++++++|.+||. +|.+|++ +.+++
T Consensus 216 ~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 216 YNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred CCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 8999999999999999999999999998888888877655444433334689999999999997 9999998 99999
Q ss_pred cCCCccCC
Q 021227 203 CHPWIVDD 210 (315)
Q Consensus 203 ~h~~~~~~ 210 (315)
.||||+..
T Consensus 295 ~h~~~~~~ 302 (364)
T cd05599 295 SHPFFKGV 302 (364)
T ss_pred cCCCcCCC
Confidence 99999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=311.63 Aligned_cols=200 Identities=31% Similarity=0.573 Sum_probs=171.0
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+.+||||+++++++++++.+|+|||||+||+|.+++.+.+++++..++.++.|++.||.|||++||+||||||+||+
T Consensus 51 ~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil-- 128 (329)
T cd05588 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVL-- 128 (329)
T ss_pred hccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE--
Confidence 345899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccC-CCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC--------
Q 021227 83 SVDEDAALKATDFGLSVFY-KPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE-------- 152 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-------- 152 (315)
++.++.+||+|||++... .........+||+.|+|||++.+ .++.++|+||+||++|+|++|..||...
T Consensus 129 -i~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~ 207 (329)
T cd05588 129 -LDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207 (329)
T ss_pred -ECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccc
Confidence 566789999999998753 22333455789999999999864 5899999999999999999999999631
Q ss_pred -CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCccC
Q 021227 153 -TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT------AHEVLCHPWIVD 209 (315)
Q Consensus 153 -~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s------~~~~l~h~~~~~ 209 (315)
......+.+.......+ ..+++++.++|.+||+.||.+|+| ++++++||||..
T Consensus 208 ~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 208 NTEDYLFQVILEKQIRIP----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred cchHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 12224445555544433 357899999999999999999987 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=308.27 Aligned_cols=200 Identities=31% Similarity=0.504 Sum_probs=176.5
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||||+++++++.++..+|+||||++||+|.+++.+...+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil--- 128 (316)
T cd05619 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL--- 128 (316)
T ss_pred ccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEE---
Confidence 45899999999999999999999999999999999988888999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
.+.++.+||+|||++..... ........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+..+.+
T Consensus 129 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i 208 (316)
T cd05619 129 LDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208 (316)
T ss_pred ECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56678999999999875322 223345679999999999864 5899999999999999999999999999888888887
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCccCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAH-EVLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~-~~l~h~~~~~~ 210 (315)
......++ ..++.++++++.+||+.+|.+||++. ++++||||...
T Consensus 209 ~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 209 RMDNPCYP----RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred HhCCCCCC----ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 76654433 24789999999999999999999996 89999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=310.90 Aligned_cols=198 Identities=33% Similarity=0.597 Sum_probs=176.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++++.+|+||||+.||+|..++.+.+.+++..+..++.||+.||+|||++||+||||||+||+ +
T Consensus 53 l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIl---l 129 (323)
T cd05575 53 VKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENIL---L 129 (323)
T ss_pred CCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeE---E
Confidence 4899999999999999999999999999999999988889999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++..... ........||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 209 (323)
T cd05575 130 DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209 (323)
T ss_pred CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 6788999999999865322 23334567999999999986 458999999999999999999999999998888888888
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCccC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA----HEVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~----~~~l~h~~~~~ 209 (315)
.+....+ +.+++++.++|.+||+.||.+||++ .++++||||..
T Consensus 210 ~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 210 NKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred cCCCCCC----CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 7655443 3679999999999999999999987 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=305.60 Aligned_cols=202 Identities=29% Similarity=0.444 Sum_probs=169.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+++.+++||||+.||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 58 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil--- 134 (285)
T cd05631 58 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL--- 134 (285)
T ss_pred CCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEE---
Confidence 8999999999999999999999999999998877543 46899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
.+.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+.........+.
T Consensus 135 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (285)
T cd05631 135 LDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214 (285)
T ss_pred ECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH
Confidence 4567899999999998765444445667999999999986 458999999999999999999999998765432222222
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~~ 210 (315)
.............+|+++.+|+.+||+.||.+||| ++++++||||...
T Consensus 215 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 215 RRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 21111122223468999999999999999999997 8999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=314.75 Aligned_cols=201 Identities=33% Similarity=0.603 Sum_probs=175.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++++.+|+|||||+||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||| +
T Consensus 100 ~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL---l 175 (370)
T cd05596 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML---L 175 (370)
T ss_pred CCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE---E
Confidence 4899999999999999999999999999999998754 46899999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh-----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK-----HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+....
T Consensus 176 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 255 (370)
T cd05596 176 DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (370)
T ss_pred cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH
Confidence 678899999999987654332 2235679999999999852 378899999999999999999999999998888
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKR--RLTAHEVLCHPWIVD 209 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~--R~s~~~~l~h~~~~~ 209 (315)
+..+......+..+....+|.+++++|.+||+.+|.+ |+|++++++||||+.
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 256 YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 8888776544443344568999999999999999988 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=312.78 Aligned_cols=198 Identities=34% Similarity=0.596 Sum_probs=176.6
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.++..+|+||||+.||+|..++.+.+.+++..+..++.||+.||.|||+ +||+||||||+||+
T Consensus 52 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIl--- 128 (325)
T cd05594 52 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM--- 128 (325)
T ss_pred CCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEE---
Confidence 38999999999999999999999999999999999888889999999999999999999997 89999999999999
Q ss_pred CCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||++.... .........||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+.......+
T Consensus 129 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i 208 (325)
T cd05594 129 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208 (325)
T ss_pred ECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH
Confidence 5678899999999987532 223334567999999999986 45899999999999999999999999998888888887
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
......++. .+++++.++|.+||+.||++|+ ++.++++||||..
T Consensus 209 ~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 209 LMEEIRFPR----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hcCCCCCCC----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 776655543 5799999999999999999997 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=294.81 Aligned_cols=205 Identities=28% Similarity=0.532 Sum_probs=177.4
Q ss_pred CCCCCCCC-cceEEEEEEeCC------eEEEEEeccCCCchhHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 021227 2 HHLSEHQH-VVRIHDTYEDKS------CVHIVMELCEGGELFDRIVKKG----NYSEREAAKLMKTIVGVVECCHSLGVF 70 (315)
Q Consensus 2 ~~l~~Hpn-iv~~~~~~~~~~------~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iv 70 (315)
++| +|+| ||++++++...+ .+++|+||++. +|..++.... .++...+..+++||+.||+|||++||+
T Consensus 65 k~L-~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~Il 142 (323)
T KOG0594|consen 65 KRL-SHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGIL 142 (323)
T ss_pred HHh-CCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 445 8999 999999998877 89999999975 8999987654 578889999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCC
Q 021227 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 71 H~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~ 147 (315)
||||||+||| ++..|.+||+|||+|+... +.....+.++|.+|.|||++-+ .|++..||||+|||++||+++++
T Consensus 143 HRDLKPQNlL---i~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~ 219 (323)
T KOG0594|consen 143 HRDLKPQNLL---ISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP 219 (323)
T ss_pred cccCCcceEE---ECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC
Confidence 9999999999 5669999999999998765 4455677889999999999864 49999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCC--------------------------CCCHHHHHHHHHhcccCCCCCCCHHHH
Q 021227 148 PFWAETEIGIFRQILEGKIDFESEPWP--------------------------NISESAKDLIRKMLDQNPKRRLTAHEV 201 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~~~~~~~~~--------------------------~~s~~~~~li~~~l~~~p~~R~s~~~~ 201 (315)
.|.|.++.+++..|.+-...+....|+ ..+++..+++.+||+.+|.+|.|++.+
T Consensus 220 LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a 299 (323)
T KOG0594|consen 220 LFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA 299 (323)
T ss_pred CCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH
Confidence 999999999988887744333333333 234689999999999999999999999
Q ss_pred hcCCCccCCC
Q 021227 202 LCHPWIVDDK 211 (315)
Q Consensus 202 l~h~~~~~~~ 211 (315)
|.||||....
T Consensus 300 l~h~yf~~~~ 309 (323)
T KOG0594|consen 300 LTHPYFSELP 309 (323)
T ss_pred hcChhhcccc
Confidence 9999998653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=299.62 Aligned_cols=201 Identities=36% Similarity=0.607 Sum_probs=180.3
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+++||.++.||..|+.+..+|+|||||+||+|.....+. +.|++..++-++..++.||+|||-.|||+|||||+|||
T Consensus 133 ~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENIL- 211 (459)
T KOG0610|consen 133 LLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENIL- 211 (459)
T ss_pred hcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeE-
Confidence 469999999999999999999999999999998877654 57999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCC---------------------------------C-C----------------------
Q 021227 82 LSVDEDAALKATDFGLSVFYKP---------------------------------D-E---------------------- 105 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~---------------------------------~-~---------------------- 105 (315)
+.++|.|-|+||.++..... . .
T Consensus 212 --vredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~ 289 (459)
T KOG0610|consen 212 --VREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTG 289 (459)
T ss_pred --EecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCC
Confidence 67899999999998643210 0 0
Q ss_pred -cccccccCccccchhhhhhc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHH
Q 021227 106 -VFSDVVGSPYYVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDL 183 (315)
Q Consensus 106 -~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 183 (315)
....++||-.|.|||++++. .+.++|.|+|||++|||+.|..||.|.+..+.+.+|......|+... .+|..++||
T Consensus 290 ~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDL 367 (459)
T KOG0610|consen 290 ARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDL 367 (459)
T ss_pred ccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHH
Confidence 01236789999999999865 88999999999999999999999999999999999999988888764 789999999
Q ss_pred HHHhcccCCCCCCC----HHHHhcCCCccC
Q 021227 184 IRKMLDQNPKRRLT----AHEVLCHPWIVD 209 (315)
Q Consensus 184 i~~~l~~~p~~R~s----~~~~l~h~~~~~ 209 (315)
|+++|.+||.+|.. |.|+-+||||+.
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred HHHHhccChhhhhccccchHHhhcCccccC
Confidence 99999999999998 999999999975
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=301.99 Aligned_cols=206 Identities=28% Similarity=0.466 Sum_probs=176.2
Q ss_pred CCCCCCcceEEEEEEeC--C---eEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 4 LSEHQHVVRIHDTYEDK--S---CVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~--~---~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
..+|||||++.-+|... + ...+||||++. +|.+.+.. +.+++...++-+..||+.||+|||+.||+||||
T Consensus 73 ~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDI 151 (364)
T KOG0658|consen 73 KLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDI 151 (364)
T ss_pred hcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCC
Confidence 34999999999988643 2 45689999975 89888764 567899999999999999999999999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
||+|+|+ ....+.+||||||.|+.+..++...++..|..|.|||.+- ..|+.+.||||.||++.||+-|++.|.|.
T Consensus 152 KPqNlLv--D~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 152 KPQNLLV--DPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred ChheEEE--cCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 9999997 5567999999999999999888888899999999999885 45999999999999999999999999999
Q ss_pred CHHHHHHHHHhCCC--------------------CCCCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 153 TEIGIFRQILEGKI--------------------DFESEP-----WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 153 ~~~~~~~~i~~~~~--------------------~~~~~~-----~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+..+++..|.+--. .+.... ....++++.+|+.++|+.+|.+|.|+.|++.||||
T Consensus 230 s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fF 309 (364)
T KOG0658|consen 230 SSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFF 309 (364)
T ss_pred CHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhh
Confidence 98888777765111 111111 23578999999999999999999999999999999
Q ss_pred cCCCC
Q 021227 208 VDDKV 212 (315)
Q Consensus 208 ~~~~~ 212 (315)
.....
T Consensus 310 delr~ 314 (364)
T KOG0658|consen 310 DELRD 314 (364)
T ss_pred HHhhC
Confidence 86543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=312.49 Aligned_cols=201 Identities=33% Similarity=0.603 Sum_probs=171.2
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+++.+||||+++++++++++.+|+||||+.||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil- 137 (332)
T cd05614 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL- 137 (332)
T ss_pred HhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE-
Confidence 3456799999999999999999999999999999999988888999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCC----C
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAE----T 153 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~----~ 153 (315)
++.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||... .
T Consensus 138 --i~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 215 (332)
T cd05614 138 --LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215 (332)
T ss_pred --ECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC
Confidence 5667899999999987653322 2234679999999999864 3788999999999999999999999643 2
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
.......+......+ ...+++.+++++.+||+.||++|| +++++++||||+.
T Consensus 216 ~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 216 QSEVSRRILKCDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 334444444443332 246899999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=311.59 Aligned_cols=200 Identities=33% Similarity=0.581 Sum_probs=177.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||++++++++++..+|+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+ +
T Consensus 53 ~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nil---i 129 (330)
T cd05586 53 DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENIL---L 129 (330)
T ss_pred CCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE---E
Confidence 3899999999999999999999999999999999988889999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.++.+||+|||++..... ........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+
T Consensus 130 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 130 DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 6678999999999875422 233345679999999999853 3789999999999999999999999999888888888
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC----CHHHHhcCCCccCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL----TAHEVLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~----s~~~~l~h~~~~~~ 210 (315)
..+...++. ..++++++++|.+||+.||.+|| ++.++++||||...
T Consensus 210 ~~~~~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 210 AFGKVRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HcCCCCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 877665553 24789999999999999999998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=306.13 Aligned_cols=197 Identities=31% Similarity=0.537 Sum_probs=174.6
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++++.+|+||||++||+|...+. .+.+++..+..++.|++.||+|||++||+||||||+||+ +
T Consensus 59 l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nil---l 134 (324)
T cd05589 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLL---L 134 (324)
T ss_pred cCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeE---E
Confidence 379999999999999999999999999999988774 467999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++..... ........||+.|+|||.+. ..++.++||||+||++|+|++|..||.+.+..+....+.
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~ 214 (324)
T cd05589 135 DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214 (324)
T ss_pred CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6788999999998865322 22334567999999999986 458999999999999999999999999999888888888
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
.+...++ ..+++++.++|.+||+.||.+|| ++.++++||||..
T Consensus 215 ~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 215 NDEVRYP----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred hCCCCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 7765544 35799999999999999999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.88 Aligned_cols=201 Identities=35% Similarity=0.636 Sum_probs=173.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+|||||++++++.++..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||| +
T Consensus 58 ~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NIL---l 134 (382)
T cd05625 58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL---I 134 (382)
T ss_pred CCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE---E
Confidence 3899999999999999999999999999999999988888999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC------------------------------------------------CcccccccCccc
Q 021227 85 DEDAALKATDFGLSVFYKPD------------------------------------------------EVFSDVVGSPYY 116 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~------------------------------------------------~~~~~~~gt~~y 116 (315)
+.++.+||+|||++...... ....+.+||+.|
T Consensus 135 ~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (382)
T cd05625 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNY 214 (382)
T ss_pred CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCccc
Confidence 67889999999987532100 001235799999
Q ss_pred cchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 021227 117 VAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRR 195 (315)
Q Consensus 117 ~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R 195 (315)
+|||++. ..++.++||||+||++|+|++|.+||.+.+..+....+.........+....+++++.++|.+|+ .+|.+|
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 215 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred CCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHc
Confidence 9999986 45899999999999999999999999998887777777665444444445578999999999987 599999
Q ss_pred CC---HHHHhcCCCccC
Q 021227 196 LT---AHEVLCHPWIVD 209 (315)
Q Consensus 196 ~s---~~~~l~h~~~~~ 209 (315)
++ ++++++||||+.
T Consensus 294 ~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 294 LGKNGADEIKAHPFFKT 310 (382)
T ss_pred CCCCCHHHHhcCCCcCC
Confidence 97 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=314.69 Aligned_cols=201 Identities=34% Similarity=0.606 Sum_probs=171.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||++++++|+++..+|+|||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+ .
T Consensus 58 l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIl---l 134 (377)
T cd05629 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNIL---I 134 (377)
T ss_pred CCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE---E
Confidence 3899999999999999999999999999999999988888999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCC------------------------------------------------cccccccCccc
Q 021227 85 DEDAALKATDFGLSVFYKPDE------------------------------------------------VFSDVVGSPYY 116 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~------------------------------------------------~~~~~~gt~~y 116 (315)
+.++.+||+|||+++...... .....+||+.|
T Consensus 135 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 214 (377)
T cd05629 135 DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDY 214 (377)
T ss_pred CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccc
Confidence 578899999999986321100 00124699999
Q ss_pred cchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 021227 117 VAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRR 195 (315)
Q Consensus 117 ~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R 195 (315)
+|||++. ..++.++||||+||++|+|++|.+||.+.+..+.+..+.........+....+++++++||.+||. +|.+|
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 215 IAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred cCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhc
Confidence 9999986 458999999999999999999999999988888877777543333333334689999999999998 67765
Q ss_pred ---CCHHHHhcCCCccC
Q 021227 196 ---LTAHEVLCHPWIVD 209 (315)
Q Consensus 196 ---~s~~~~l~h~~~~~ 209 (315)
+|+.+++.||||..
T Consensus 294 ~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 294 LGRGGAHEIKSHPFFRG 310 (377)
T ss_pred CCCCCHHHHhcCCCcCC
Confidence 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.24 Aligned_cols=200 Identities=31% Similarity=0.570 Sum_probs=170.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+.+||||+++++++++++.+|+||||++||+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 51 ~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nil-- 128 (329)
T cd05618 51 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL-- 128 (329)
T ss_pred hcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE--
Confidence 345899999999999999999999999999999999888889999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCC---------
Q 021227 83 SVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWA--------- 151 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~--------- 151 (315)
++.++.+||+|||++.... .........||+.|+|||++. ..++.++||||+||++|+|++|..||..
T Consensus 129 -i~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (329)
T cd05618 129 -LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207 (329)
T ss_pred -ECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc
Confidence 5678899999999987532 223334567999999999986 4589999999999999999999999952
Q ss_pred CCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCccC
Q 021227 152 ETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT------AHEVLCHPWIVD 209 (315)
Q Consensus 152 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s------~~~~l~h~~~~~ 209 (315)
.......+.+......++ ..++.+++++|.+||+.||.+||| +.++++||||..
T Consensus 208 ~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 208 NTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred ccHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 112234445555544443 357899999999999999999998 589999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=313.27 Aligned_cols=202 Identities=32% Similarity=0.556 Sum_probs=170.8
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||++++++++++.++|+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||+.||+||||||+||+ +
T Consensus 58 l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nil---i 134 (381)
T cd05626 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL---I 134 (381)
T ss_pred cCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEE---E
Confidence 3899999999999999999999999999999999988888999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCC------------------------------------------------CcccccccCccc
Q 021227 85 DEDAALKATDFGLSVFYKPD------------------------------------------------EVFSDVVGSPYY 116 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~------------------------------------------------~~~~~~~gt~~y 116 (315)
+.++.+||+|||++...... ....+.+||+.|
T Consensus 135 ~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (381)
T cd05626 135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNY 214 (381)
T ss_pred CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccc
Confidence 66789999999987532100 001235799999
Q ss_pred cchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcc--cCCC
Q 021227 117 VAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLD--QNPK 193 (315)
Q Consensus 117 ~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~--~~p~ 193 (315)
+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+.........+.+..++++++++|.+|+. .+|.
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 215 IAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERL 294 (381)
T ss_pred cCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCccccc
Confidence 9999986 458999999999999999999999999888777666666543333333445689999999999664 4555
Q ss_pred CCCCHHHHhcCCCccC
Q 021227 194 RRLTAHEVLCHPWIVD 209 (315)
Q Consensus 194 ~R~s~~~~l~h~~~~~ 209 (315)
.|+|++++++||||..
T Consensus 295 ~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 295 GRNGADDIKAHPFFSE 310 (381)
T ss_pred CCCCHHHHhcCcccCC
Confidence 5999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=306.12 Aligned_cols=200 Identities=28% Similarity=0.529 Sum_probs=176.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+.+|++|+++++++.+.+.+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nil-- 133 (324)
T cd05587 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM-- 133 (324)
T ss_pred hcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE--
Confidence 344566799999999999999999999999999999988888999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
++.++.+||+|||++.... .........||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+....
T Consensus 134 -l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (324)
T cd05587 134 -LDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212 (324)
T ss_pred -EcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5667899999999986432 2233345679999999999864 589999999999999999999999999998888888
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCccC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA-----HEVLCHPWIVD 209 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~-----~~~l~h~~~~~ 209 (315)
+......++. .+++++.+++.+||.+||.+|++. +++++||||..
T Consensus 213 i~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 213 IMEHNVSYPK----SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHcCCCCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 8877655543 589999999999999999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=309.81 Aligned_cols=197 Identities=31% Similarity=0.577 Sum_probs=176.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++++++.+|+||||+.||+|.+++.+...+++..+..++.|++.||+|||++||+||||||+||+ ++
T Consensus 56 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil---~~ 132 (318)
T cd05582 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENIL---LD 132 (318)
T ss_pred CCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeE---EC
Confidence 899999999999999999999999999999999988888999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 133 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~ 212 (318)
T cd05582 133 EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212 (318)
T ss_pred CCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 6789999999998765433 23345679999999999864 588999999999999999999999999988888888877
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
....++ ..++++++++|.+||+.||.+||| +.+++.||||..
T Consensus 213 ~~~~~p----~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 213 AKLGMP----QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred CCCCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 765544 357999999999999999999999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=301.98 Aligned_cols=200 Identities=26% Similarity=0.445 Sum_probs=165.2
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++++.+|+||||+.++.+..+....+.+++..++.++.|++.||.|||+.|++||||||+||+ +
T Consensus 57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil---l 133 (287)
T cd07848 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLL---I 133 (287)
T ss_pred CCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE---E
Confidence 3899999999999999999999999998877655544567999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|++||.+.+..+....+
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 134 SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 677899999999997754322 223457899999999986 45899999999999999999999999987765544433
Q ss_pred HhCCCC-------------------CCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 162 LEGKID-------------------FES---------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 162 ~~~~~~-------------------~~~---------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
...... ++. .....+|+++++||++||++||++|||++++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 321100 000 0112378899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=312.20 Aligned_cols=202 Identities=33% Similarity=0.588 Sum_probs=174.2
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++++.+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||| +
T Consensus 100 ~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NIL---l 175 (370)
T cd05621 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNML---L 175 (370)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE---E
Confidence 4899999999999999999999999999999998854 46899999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhhh-----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLRK-----HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+.++.+||+|||++........ ..+..||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+....
T Consensus 176 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~ 255 (370)
T cd05621 176 DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT 255 (370)
T ss_pred CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH
Confidence 6788999999999976543322 235679999999999853 278899999999999999999999999998888
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKR--RLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~--R~s~~~~l~h~~~~~~ 210 (315)
+..+......+..+....+++.+++++.+||..++.+ |+|+.++++||||+..
T Consensus 256 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 8888775544433333468999999999999865544 8999999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=314.53 Aligned_cols=201 Identities=32% Similarity=0.599 Sum_probs=173.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++.|++++.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+ +
T Consensus 58 l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil---l 134 (376)
T cd05598 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL---I 134 (376)
T ss_pred CCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEE---E
Confidence 3899999999999999999999999999999999988888999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC--------------------------------------------CcccccccCccccchh
Q 021227 85 DEDAALKATDFGLSVFYKPD--------------------------------------------EVFSDVVGSPYYVAPE 120 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~--------------------------------------------~~~~~~~gt~~y~aPE 120 (315)
+.++.+||+|||++..+... ......+||+.|+|||
T Consensus 135 ~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 214 (376)
T cd05598 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE 214 (376)
T ss_pred CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHH
Confidence 67889999999987432100 0011357999999999
Q ss_pred hhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---
Q 021227 121 VLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL--- 196 (315)
Q Consensus 121 ~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~--- 196 (315)
++.+ .++.++||||+||++|+|++|..||.+.+..+....+.........+.+..+++++.++|.+|+ .+|.+|+
T Consensus 215 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~ 293 (376)
T cd05598 215 VLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN 293 (376)
T ss_pred HHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence 9864 5899999999999999999999999998887777777665444444445578999999999987 5999999
Q ss_pred CHHHHhcCCCccC
Q 021227 197 TAHEVLCHPWIVD 209 (315)
Q Consensus 197 s~~~~l~h~~~~~ 209 (315)
|+.++++||||..
T Consensus 294 t~~ell~h~~~~~ 306 (376)
T cd05598 294 GADEIKAHPFFKG 306 (376)
T ss_pred CHHHHhCCCCcCC
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=312.20 Aligned_cols=201 Identities=36% Similarity=0.662 Sum_probs=176.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++++++|+||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+ +
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIl---l 134 (350)
T cd05573 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNIL---I 134 (350)
T ss_pred cCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE---E
Confidence 3799999999999999999999999999999999988889999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCC------------------------------cccccccCccccchhhhhh-cCCCchhHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE------------------------------VFSDVVGSPYYVAPEVLRK-HYGPEADVW 133 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Diw 133 (315)
+.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 214 (350)
T cd05573 135 DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWW 214 (350)
T ss_pred CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeE
Confidence 678899999999987654332 2234679999999999864 589999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCccC
Q 021227 134 SAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-AHEVLCHPWIVD 209 (315)
Q Consensus 134 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-~~~~l~h~~~~~ 209 (315)
||||++|+|++|..||.+.+..+....+.........+....++++++++|.+||. +|.+|++ ++++++||||..
T Consensus 215 SlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 215 SLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred ecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 99999999999999999998888888887733333333334589999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=305.58 Aligned_cols=200 Identities=27% Similarity=0.505 Sum_probs=178.4
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+.+||+|+++++++++.+.+|+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nil-- 133 (323)
T cd05616 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM-- 133 (323)
T ss_pred hccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeE--
Confidence 345799999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
++.++.+||+|||++..... ........||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+..+....
T Consensus 134 -l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 212 (323)
T cd05616 134 -LDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212 (323)
T ss_pred -ECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56788999999999875432 22334567999999999986 4589999999999999999999999999999888888
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
+......++. .+++++++++.+||+.+|.+|++ ..++++||||..
T Consensus 213 i~~~~~~~p~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 213 IMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHhCCCCCCC----cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 8887665543 58999999999999999999998 489999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=299.49 Aligned_cols=198 Identities=31% Similarity=0.489 Sum_probs=167.0
Q ss_pred CCCCcceEEEEEE-----eCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 6 EHQHVVRIHDTYE-----DKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 6 ~Hpniv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+||||+++++++. ....+++||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 62 ~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~N 140 (290)
T cd07862 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 140 (290)
T ss_pred CCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHH
Confidence 7999999999985 3456999999996 5888888653 458999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|+ .+.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..+.
T Consensus 141 il---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~ 217 (290)
T cd07862 141 IL---VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217 (290)
T ss_pred EE---EcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 99 5667899999999987665444445567899999999985 4589999999999999999999999999888777
Q ss_pred HHHHHhCCCCCCCC-----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 158 FRQILEGKIDFESE-----------------------PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 158 ~~~i~~~~~~~~~~-----------------------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+..+.......... ..+.+++.+++++.+||+.||++|||+.++|+||||
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 218 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 77765432111111 123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=307.91 Aligned_cols=198 Identities=33% Similarity=0.572 Sum_probs=182.0
Q ss_pred CCCCCcceEEEEEEeCCe-EEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 5 SEHQHVVRIHDTYEDKSC-VHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~-~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
..|||||.+.+.|+.++. .+|||+||+||++.+.+.+. ..|+|+.+..|+-|++.|++|||+++|+|||||+.||+
T Consensus 60 ~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nif- 138 (426)
T KOG0589|consen 60 LLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIF- 138 (426)
T ss_pred ccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhh-
Confidence 489999999999998888 99999999999999998764 46999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
.+.++.|||+|||+|+.+.+.. ...+.+|||.||+||++.+ .|+.++|||||||++|||++-+++|.+.+...+..
T Consensus 139 --ltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ 216 (426)
T KOG0589|consen 139 --LTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL 216 (426)
T ss_pred --ccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH
Confidence 6778889999999999988776 6678999999999999975 59999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
+|..+...+-+ ...|.+++.+|+.||..+|..||++.++|.+|...
T Consensus 217 ki~~~~~~Plp---~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 217 KINRGLYSPLP---SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHhhccCCCCC---ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 99998854433 36899999999999999999999999999998775
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=301.58 Aligned_cols=201 Identities=28% Similarity=0.481 Sum_probs=161.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.++...|+||||+. ++|.+++.+. +.+++..++.++.|++.||+|||++||+||||||+||+ +
T Consensus 61 ~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nil---l 136 (303)
T cd07869 61 KHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLL---I 136 (303)
T ss_pred CCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE---E
Confidence 89999999999999999999999996 5777777654 67999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETE-IGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~ 160 (315)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+... .+.+..
T Consensus 137 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 216 (303)
T cd07869 137 SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER 216 (303)
T ss_pred CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 66789999999998654322 22344678999999998853 478899999999999999999999987533 333333
Q ss_pred HHhCCCC--------------CCCCC------------C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 161 ILEGKID--------------FESEP------------W--PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 161 i~~~~~~--------------~~~~~------------~--~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+...... +.... | ...++++++|+.+||+.||++|||++|+++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 217 IFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred HHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 3221000 00000 0 1245789999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=307.41 Aligned_cols=198 Identities=31% Similarity=0.587 Sum_probs=176.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||++++++++.++.+|+||||+.||+|..++.+.+.+++..+..++.||+.||+|||++||+||||||+||+ +
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIl---l 129 (325)
T cd05604 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENIL---L 129 (325)
T ss_pred CCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE---E
Confidence 4899999999999999999999999999999999988889999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++..... ........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+..+.+.
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~ 209 (325)
T cd05604 130 DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209 (325)
T ss_pred CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence 6788999999999875322 223345679999999999864 58999999999999999999999999998888888887
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCccC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA----HEVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~----~~~l~h~~~~~ 209 (315)
....... +..+..+.++|.+||..+|.+||++ .++++||||..
T Consensus 210 ~~~~~~~----~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 210 HKPLVLR----PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCccCC----CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 7654433 3588999999999999999999976 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=306.32 Aligned_cols=198 Identities=32% Similarity=0.593 Sum_probs=175.8
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++++.+|+||||+.||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+ +
T Consensus 53 ~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nil---i 129 (325)
T cd05602 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL---L 129 (325)
T ss_pred CCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE---E
Confidence 4899999999999999999999999999999999988888999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++.... .........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.+..+.
T Consensus 130 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (325)
T cd05602 130 DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209 (325)
T ss_pred CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 567899999999987542 2223345679999999999864 58899999999999999999999999998888888887
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH----HHhcCCCccC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAH----EVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~----~~l~h~~~~~ 209 (315)
.....++ +.++++++++|.+||+.+|.+|+++. ++++|+||..
T Consensus 210 ~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 210 NKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred hCCcCCC----CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 7654433 46899999999999999999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=304.18 Aligned_cols=201 Identities=30% Similarity=0.531 Sum_probs=170.8
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+.+||||+++++++++.+.+|+||||++||+|..++.+.+.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 51 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil-- 128 (327)
T cd05617 51 QASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVL-- 128 (327)
T ss_pred hhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE--
Confidence 456899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccC-CCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCC-------C
Q 021227 83 SVDEDAALKATDFGLSVFY-KPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAE-------T 153 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~ 153 (315)
++.++.+||+|||++... .........+||+.|+|||++. ..++.++||||+||++|+|++|..||... .
T Consensus 129 -i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~ 207 (327)
T cd05617 129 -LDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207 (327)
T ss_pred -EeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc
Confidence 566789999999998753 2233344577999999999986 45899999999999999999999999532 2
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCccCC
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT------AHEVLCHPWIVDD 210 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s------~~~~l~h~~~~~~ 210 (315)
.......+.......+ ..+|+.+.+++.+||+.||.+|++ ++++++||||...
T Consensus 208 ~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 208 EDYLFQVILEKPIRIP----RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 2334444544433333 357899999999999999999998 5799999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=310.24 Aligned_cols=202 Identities=34% Similarity=0.593 Sum_probs=173.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++.+++++.+|+|||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||+ +
T Consensus 58 l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIl---i 134 (360)
T cd05627 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL---L 134 (360)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEE---E
Confidence 3899999999999999999999999999999999988889999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCC------------------------------------cccccccCccccchhhhh-hcCC
Q 021227 85 DEDAALKATDFGLSVFYKPDE------------------------------------VFSDVVGSPYYVAPEVLR-KHYG 127 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~ 127 (315)
+.++.+||+|||++....... .....+||+.|+|||++. ..++
T Consensus 135 ~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~ 214 (360)
T cd05627 135 DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN 214 (360)
T ss_pred CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC
Confidence 678899999999986542110 012357999999999986 4589
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcC
Q 021227 128 PEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL---TAHEVLCH 204 (315)
Q Consensus 128 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~---s~~~~l~h 204 (315)
.++||||+||++|+|++|..||.+.+..+....+.........+....++++++++|.+|+. +|.+|+ ++++++.|
T Consensus 215 ~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 215 KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 99999999999999999999999999888888877644332222223579999999999874 999998 58999999
Q ss_pred CCccCC
Q 021227 205 PWIVDD 210 (315)
Q Consensus 205 ~~~~~~ 210 (315)
|||...
T Consensus 294 p~f~~~ 299 (360)
T cd05627 294 PFFEGV 299 (360)
T ss_pred CCCCCC
Confidence 999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=306.96 Aligned_cols=202 Identities=31% Similarity=0.539 Sum_probs=175.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++++++.+|+||||++||+|.+++.+. +.+++..++.++.|++.||.|||+.||+||||||+||+
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIl--- 134 (330)
T cd05601 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL--- 134 (330)
T ss_pred CCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheE---
Confidence 48999999999999999999999999999999999876 68999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-------KHYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
++.++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.
T Consensus 135 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 135 IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred ECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 56788999999999976644332 22357899999999984 2478899999999999999999999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
...+..+.........+..+.+++++++++.+||. +|.+|||++++++||||...
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 215 AKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 88888777654333223334689999999999998 99999999999999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=307.94 Aligned_cols=202 Identities=33% Similarity=0.572 Sum_probs=174.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++.+++.+|+|||||+||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+ +
T Consensus 100 ~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIl---l 175 (371)
T cd05622 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML---L 175 (371)
T ss_pred CCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEE---E
Confidence 4899999999999999999999999999999998854 46899999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh-----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK-----HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+....
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 255 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH
Confidence 668899999999987664332 2235679999999999853 278899999999999999999999999998888
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKR--RLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~--R~s~~~~l~h~~~~~~ 210 (315)
+..+......+..+....+|++++++|.+||..++.+ |++++++++|+||+..
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 256 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 8888876544444444578999999999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=303.68 Aligned_cols=198 Identities=32% Similarity=0.571 Sum_probs=174.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++.+..|+|||||+||+|...+.+.+.+++..+..++.||+.||.|||++||+||||||+||+ +
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIl---l 129 (321)
T cd05603 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENIL---L 129 (321)
T ss_pred CCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE---E
Confidence 4899999999999999999999999999999999988888999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++.... .........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+.
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (321)
T cd05603 130 DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209 (321)
T ss_pred CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh
Confidence 678899999999987532 2223345679999999999864 58999999999999999999999999998888888887
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCccC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA----HEVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~----~~~l~h~~~~~ 209 (315)
.....++ +..+.++.+++.+||+.+|.+|+++ .++++|+||..
T Consensus 210 ~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 210 HKPLQLP----GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCC----CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 7654443 3578999999999999999999875 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=307.45 Aligned_cols=218 Identities=26% Similarity=0.449 Sum_probs=183.2
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.++|||.++|+.|..+..++++||||.||++.+.+.....+.|..+..++++++.||.|||.++.+|||||+.||++
T Consensus 68 ~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~--- 144 (467)
T KOG0201|consen 68 CDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL--- 144 (467)
T ss_pred cCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE---
Confidence 48999999999999999999999999999999999777777999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCcc-cccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVF-SDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~-~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
...|.+||+|||.+..+...... .+++|||.|||||++.+ .|+.++||||||++++||++|.+|+....+...+-.|-
T Consensus 145 s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp 224 (467)
T KOG0201|consen 145 SESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP 224 (467)
T ss_pred eccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc
Confidence 45599999999999887655433 68999999999999985 69999999999999999999999998887755544444
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHhhHh
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSA 231 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (315)
+..++ ..-..+|+.+++||..||++||+.||||.++|+|+|++... .......++.+.++++.
T Consensus 225 k~~PP---~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~---k~s~L~~~i~r~~~~~~ 287 (467)
T KOG0201|consen 225 KSAPP---RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK---KTSELKELIDRYKRWRV 287 (467)
T ss_pred CCCCC---ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC---CchHHHHHHHHHHHHhh
Confidence 43222 22236899999999999999999999999999999998732 22233444555555443
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=303.71 Aligned_cols=204 Identities=29% Similarity=0.476 Sum_probs=165.8
Q ss_pred CCCCCcceEEEEEEeC-----CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 5 SEHQHVVRIHDTYEDK-----SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
.+||||+++++++... ..+|+|||||. ++|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||
T Consensus 56 l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 134 (338)
T cd07859 56 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNI 134 (338)
T ss_pred CCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 3899999999988543 35899999995 68999998888899999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhh---hcCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLR---KHYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
+ .+.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|++||.+.
T Consensus 135 l---l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 135 L---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred E---ECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 9 5678899999999987543221 123467999999999985 35899999999999999999999999887
Q ss_pred CHHHHHHHHHh---------------------------CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021227 153 TEIGIFRQILE---------------------------GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205 (315)
Q Consensus 153 ~~~~~~~~i~~---------------------------~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~ 205 (315)
+.......+.. .........++.+++++.+++.+||+.||++|||++++++||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 212 NVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 65443322211 011111122356789999999999999999999999999999
Q ss_pred CccCCCC
Q 021227 206 WIVDDKV 212 (315)
Q Consensus 206 ~~~~~~~ 212 (315)
||+....
T Consensus 292 ~f~~~~~ 298 (338)
T cd07859 292 YFKGLAK 298 (338)
T ss_pred hhhhcCc
Confidence 9976544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=295.82 Aligned_cols=198 Identities=28% Similarity=0.487 Sum_probs=166.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+||||+++.+++..+..+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 50 l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 129 (280)
T cd05608 50 VHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVL 129 (280)
T ss_pred CCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 3899999999999999999999999999999877743 356999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEI--- 155 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--- 155 (315)
+ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||......
T Consensus 130 i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 206 (280)
T cd05608 130 L---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 206 (280)
T ss_pred E---CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH
Confidence 4 567899999999987654332 223457899999999986 45889999999999999999999999865432
Q ss_pred -HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 156 -GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 156 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
.....+..... .....+|+++++++.+||+.||.+|| |++++++||||+.
T Consensus 207 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 207 KELKQRILNDSV----TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHHHhhcccCC----CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 22233322222 22246899999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=315.75 Aligned_cols=199 Identities=34% Similarity=0.536 Sum_probs=174.6
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+|||||++++++++++++|+||||++||+|.+++.. ..++++..+..++.|++.||.|||++||+||||||+||+
T Consensus 122 l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIl 201 (478)
T PTZ00267 122 CDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201 (478)
T ss_pred CCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEE
Confidence 4899999999999999999999999999999887753 457999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
++.++.+||+|||++....... .....+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+
T Consensus 202 ---l~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~ 278 (478)
T PTZ00267 202 ---LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE 278 (478)
T ss_pred ---ECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5668899999999998654332 234567999999999986 458999999999999999999999999988888
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
....+..+.....+ ..++++++++|.+||..+|++|||+.+++.|+|++.
T Consensus 279 ~~~~~~~~~~~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 279 IMQQVLYGKYDPFP---CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHhCCCCCCC---ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 88888776543221 357899999999999999999999999999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=300.70 Aligned_cols=202 Identities=23% Similarity=0.345 Sum_probs=168.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL-GVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++.+++||||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+||+ +
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil---~ 137 (331)
T cd06649 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL---V 137 (331)
T ss_pred CCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEE---E
Confidence 89999999999999999999999999999999998888899999999999999999999986 6999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
+.++.+||+|||++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...+..+....+..
T Consensus 138 ~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~ 216 (331)
T cd06649 138 NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR 216 (331)
T ss_pred cCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 66789999999998765432 2345679999999999864 589999999999999999999999987665444322211
Q ss_pred CCC--------------------------------------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 021227 164 GKI--------------------------------------------DFESEPWPNISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 164 ~~~--------------------------------------------~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
... ..+......+++++++||.+||++||++|||+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ 296 (331)
T cd06649 217 PVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLK 296 (331)
T ss_pred cccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHH
Confidence 000 000111124788999999999999999999999
Q ss_pred HHhcCCCccCCC
Q 021227 200 EVLCHPWIVDDK 211 (315)
Q Consensus 200 ~~l~h~~~~~~~ 211 (315)
++++||||+...
T Consensus 297 ell~h~~~~~~~ 308 (331)
T cd06649 297 MLMNHTFIKRSE 308 (331)
T ss_pred HHhcChHHhhcc
Confidence 999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=300.31 Aligned_cols=200 Identities=28% Similarity=0.530 Sum_probs=176.8
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||+|+++++++++++.+|+||||++||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 57 ~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nil--- 133 (323)
T cd05615 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVM--- 133 (323)
T ss_pred ccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE---
Confidence 44678999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||++...... .......||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+.....+.+
T Consensus 134 l~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (323)
T cd05615 134 LDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213 (323)
T ss_pred ECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 567789999999998754322 2234567999999999986 45899999999999999999999999999988888888
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~~ 210 (315)
......++ ..+++++.+++.+||+++|.+|++ .+++++||||...
T Consensus 214 ~~~~~~~p----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 214 MEHNVSYP----KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HhCCCCCC----ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 87766544 357899999999999999999997 5789999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=313.77 Aligned_cols=202 Identities=23% Similarity=0.363 Sum_probs=163.7
Q ss_pred CCCCcceEEEEEEeC--------CeEEEEEeccCCCchhHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 021227 6 EHQHVVRIHDTYEDK--------SCVHIVMELCEGGELFDRIV----KKGNYSEREAAKLMKTIVGVVECCHSLGVFHRD 73 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~--------~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 73 (315)
+|||||+++++|... ..+++||||+++ +|.+++. ....+++..++.++.|++.||+|||++||+|||
T Consensus 117 ~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrD 195 (440)
T PTZ00036 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRD 195 (440)
T ss_pred CCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCC
Confidence 899999999987432 247799999975 6666554 346799999999999999999999999999999
Q ss_pred CCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 74 LKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 74 ikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
|||+||++. ...+.+||+|||+++............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+
T Consensus 196 LKp~NILl~--~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 196 LKPQNLLID--PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred cCHHHEEEc--CCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999962 2445799999999987765555556788999999998753 589999999999999999999999999
Q ss_pred CCHHHHHHHHHhCCC-----------------CCCCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021227 152 ETEIGIFRQILEGKI-----------------DFESEP--------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206 (315)
Q Consensus 152 ~~~~~~~~~i~~~~~-----------------~~~~~~--------~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~ 206 (315)
.+..+.+..+..... .++... ....|+++++||.+||++||.+|||+.|+|+|||
T Consensus 274 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 274 QSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 877666655543211 111100 1236789999999999999999999999999999
Q ss_pred ccCC
Q 021227 207 IVDD 210 (315)
Q Consensus 207 ~~~~ 210 (315)
|...
T Consensus 354 f~~~ 357 (440)
T PTZ00036 354 FDDL 357 (440)
T ss_pred HHhh
Confidence 9754
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=303.90 Aligned_cols=205 Identities=20% Similarity=0.363 Sum_probs=163.8
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
++| +|||||+++++|..+...++|+|++. ++|..++...+.+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 138 ~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIl- 214 (391)
T PHA03212 138 RAI-NHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIF- 214 (391)
T ss_pred HhC-CCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEE-
Confidence 345 89999999999999999999999995 689898888888999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCC--CcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCC-----
Q 021227 82 LSVDEDAALKATDFGLSVFYKPD--EVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAET----- 153 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----- 153 (315)
++..+.+||+|||++...... .......||+.|+|||++. ..++.++||||+||++|+|++|..||....
T Consensus 215 --l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~ 292 (391)
T PHA03212 215 --INHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD 292 (391)
T ss_pred --EcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccccc
Confidence 567789999999998653221 2234567999999999986 458999999999999999999998875421
Q ss_pred --HHHHHHHHHhCCC--------------------------C--CCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHH
Q 021227 154 --EIGIFRQILEGKI--------------------------D--FESEPW---PNISESAKDLIRKMLDQNPKRRLTAHE 200 (315)
Q Consensus 154 --~~~~~~~i~~~~~--------------------------~--~~~~~~---~~~s~~~~~li~~~l~~~p~~R~s~~~ 200 (315)
....+..+..... . .....| ..++.++.++|.+||+.||.+|||++|
T Consensus 293 ~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e 372 (391)
T PHA03212 293 CDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA 372 (391)
T ss_pred CchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH
Confidence 1111221111000 0 000111 135678999999999999999999999
Q ss_pred HhcCCCccCCC
Q 021227 201 VLCHPWIVDDK 211 (315)
Q Consensus 201 ~l~h~~~~~~~ 211 (315)
+|+||||+...
T Consensus 373 lL~hp~f~~~~ 383 (391)
T PHA03212 373 LLDFAAFQDIP 383 (391)
T ss_pred HhcChhhccCC
Confidence 99999998643
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=293.80 Aligned_cols=203 Identities=30% Similarity=0.471 Sum_probs=170.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
++ +||||+++++++.++..+|+||||+.||+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus 56 ~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 134 (285)
T cd05605 56 KV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134 (285)
T ss_pred hc-CCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEE
Confidence 44 8999999999999999999999999999998887654 46999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
.++++.++|+|||++.............|++.|+|||++. ..++.++||||+||++|++++|..||.+.+.....+
T Consensus 135 ---~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~ 211 (285)
T cd05605 135 ---LDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE 211 (285)
T ss_pred ---ECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH
Confidence 5667899999999987765444444567899999999986 458899999999999999999999998876544333
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
.+..............+++.+++++.+||+.||.+|| +++++++||||..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 212 EVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 3322211112222346899999999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=308.55 Aligned_cols=202 Identities=39% Similarity=0.683 Sum_probs=188.7
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
|+.| +|||||+++++.+....+|+||||+.||.+++++.+++...+..++.++.|+++|++|||+++|||||||++|||
T Consensus 109 mk~l-~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNil 187 (596)
T KOG0586|consen 109 MKSL-NHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENIL 187 (596)
T ss_pred HHhc-CCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcc
Confidence 3455 999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
++.+.++||+|||++..+..+....+++|++.|.|||++.+. -++++|+||+|+++|-|+.|.+||.|.+..+.-
T Consensus 188 ---L~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr 264 (596)
T KOG0586|consen 188 ---LDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR 264 (596)
T ss_pred ---cccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc
Confidence 677888999999999999988888999999999999999743 689999999999999999999999999998888
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.....+++..+. .+|.+|.++|+++|.++|.+|++.+++..|.|....
T Consensus 265 ~rvl~gk~rIp~----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 265 PRVLRGKYRIPF----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred chheeeeecccc----eeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 888888877664 478999999999999999999999999999999754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=291.24 Aligned_cols=200 Identities=28% Similarity=0.483 Sum_probs=168.3
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+ +||||++++++++++.++|+||||++||+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus 49 ~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nil 127 (277)
T cd05607 49 KV-NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127 (277)
T ss_pred hc-CCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEE
Confidence 44 8999999999999999999999999999998887554 35889999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH----H
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE----I 155 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~ 155 (315)
.+.++.++|+|||++.............|++.|+|||++. ..++.++||||+||++|+|++|..||.+... .
T Consensus 128 ---i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~ 204 (277)
T cd05607 128 ---LDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE 204 (277)
T ss_pred ---EcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH
Confidence 5667899999999987765544444567899999999986 4589999999999999999999999976432 3
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCccC
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA----HEVLCHPWIVD 209 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~----~~~l~h~~~~~ 209 (315)
+....+......+. ...+++++++++.+||++||.+|||+ +++++||||+.
T Consensus 205 ~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 205 ELKRRTLEDEVKFE---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HHHHHhhccccccc---cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 33343333333222 23689999999999999999999999 77889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=304.28 Aligned_cols=198 Identities=37% Similarity=0.597 Sum_probs=172.6
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
..+||||+++.+++.++.+.|+|||++.|+.+.+.+.+...+. ..+..|++||+.|+.|||++|+|||||||+|||+.
T Consensus 372 ~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~- 449 (612)
T KOG0603|consen 372 VRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD- 449 (612)
T ss_pred hcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-
Confidence 4689999999999999999999999999999999887776665 88899999999999999999999999999999963
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEI-GIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i 161 (315)
+..+.++|+|||.++..... ..+.+-|..|.|||++. ..|+.+||+||||+++|+|++|+.||...... ++..++
T Consensus 450 -~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i 526 (612)
T KOG0603|consen 450 -GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI 526 (612)
T ss_pred -CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence 67889999999999876555 34556688999999997 45999999999999999999999999876554 566666
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
..+... ..+|.++++||++||+.||.+|+++.+++.||||.+...
T Consensus 527 ~~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t 571 (612)
T KOG0603|consen 527 QMPKFS------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPT 571 (612)
T ss_pred cCCccc------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence 555433 468999999999999999999999999999999944433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=296.59 Aligned_cols=194 Identities=26% Similarity=0.403 Sum_probs=169.8
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK--KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
|+.| +|+|||++++++..+..+||||||++.|+|.+++.. .+.++..+...++.||++|++||.++++|||||...|
T Consensus 255 Mk~L-~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARN 333 (468)
T KOG0197|consen 255 MKKL-RHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARN 333 (468)
T ss_pred HHhC-cccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhh
Confidence 4566 899999999999998899999999999999999987 4679999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCccccccc---Cccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG---SPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAET 153 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~g---t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 153 (315)
|| ++++..+||+|||+|+....... ....| ...|.|||++. +.++.++|||||||++||++| |+.||.+.+
T Consensus 334 iL---V~~~~~vKIsDFGLAr~~~d~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms 409 (468)
T KOG0197|consen 334 IL---VDEDLVVKISDFGLARLIGDDEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS 409 (468)
T ss_pred ee---eccCceEEEcccccccccCCCce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence 99 67888999999999995443332 12222 34699999997 779999999999999999998 999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
..++++.+.+|---+ ....+|+++.++|..||..+|++|||++.+.
T Consensus 410 n~ev~~~le~GyRlp---~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 410 NEEVLELLERGYRLP---RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHhccCcCC---CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 999999998874322 2357999999999999999999999998654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=289.66 Aligned_cols=198 Identities=31% Similarity=0.511 Sum_probs=164.4
Q ss_pred CCCCcceEEEEEEe-----CCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 6 EHQHVVRIHDTYED-----KSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 6 ~Hpniv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+||||+++++++.+ ...+++|+||+.+ +|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 60 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~N 138 (288)
T cd07863 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPEN 138 (288)
T ss_pred CCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 79999999999865 3468999999975 888887654 358999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|+ .+.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..+.
T Consensus 139 il---i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~ 215 (288)
T cd07863 139 IL---VTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 215 (288)
T ss_pred EE---ECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH
Confidence 99 5667899999999987765444444567899999999985 4589999999999999999999999988877665
Q ss_pred HHHHHhCCCC----------------CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 158 FRQILEGKID----------------FE-------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 158 ~~~i~~~~~~----------------~~-------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
...+...... +. ....+.++.++++++.+||++||.+|||+.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 216 LGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 5555431100 00 01124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=286.06 Aligned_cols=198 Identities=27% Similarity=0.478 Sum_probs=165.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++.|..++.+|+||||++||+|.+++.+.+.+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 66 ~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~--- 142 (267)
T PHA03390 66 KDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY--- 142 (267)
T ss_pred hcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---
Confidence 47999999999999999999999999999999999888899999999999999999999999999999999999995
Q ss_pred CCCC-CEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHH
Q 021227 85 DEDA-ALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIF-RQI 161 (315)
Q Consensus 85 ~~~~-~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i 161 (315)
+.++ .++|+|||++...... ....|+..|+|||++. ..++.++|+||+||++|+|++|..||......... ...
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219 (267)
T ss_pred eCCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH
Confidence 4444 8999999988765432 2346889999999986 45889999999999999999999999865433221 111
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCccC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-AHEVLCHPWIVD 209 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-~~~~l~h~~~~~ 209 (315)
.... ......++.+|+.++++|.+||+.+|.+||+ ++++|+||||+.
T Consensus 220 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 220 LKRQ-QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHhh-cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 1111 2222334578999999999999999999996 699999999963
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=287.99 Aligned_cols=194 Identities=19% Similarity=0.267 Sum_probs=168.0
Q ss_pred CCCCCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCC
Q 021227 2 HHLSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKP 76 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp 76 (315)
+++ +|||||++++++.+ ...+++|||||+||+|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||
T Consensus 73 ~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp 151 (283)
T PHA02988 73 RRI-DSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTS 151 (283)
T ss_pred Hhc-CCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCCh
Confidence 345 89999999999977 45789999999999999999888889999999999999999999998 4999999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
+||+ .+.++.+||+|||++....... ....|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+
T Consensus 152 ~nil---l~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 152 VSFL---VTENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred hhEE---ECCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 9999 5667899999999987654322 34568999999999863 58999999999999999999999999988
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+....+......++.+ ..+++++++++.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 227 TKEIYDLIINKNNSLKLP--LDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHHHhcCCCCCCC--CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 888888776554443322 257899999999999999999999999974
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=294.92 Aligned_cols=201 Identities=24% Similarity=0.407 Sum_probs=155.4
Q ss_pred CCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 6 EHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKK---------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 6 ~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
+||||+++++++.+ +..+|+|+||+. ++|.+++... ..+++..++.++.|++.||+|||++||+||||
T Consensus 56 ~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDl 134 (317)
T cd07868 56 KHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 134 (317)
T ss_pred CCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCC
Confidence 89999999999964 567899999996 4787776532 25899999999999999999999999999999
Q ss_pred CCCceeeccC-CCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCC
Q 021227 75 KPENFLFLSV-DEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 75 kp~nil~~~~-~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~ 147 (315)
||+|||+... +..+.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+
T Consensus 135 kp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (317)
T cd07868 135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred CHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999997432 356789999999997654321 2335678999999998853 48999999999999999999999
Q ss_pred CCCCCCH---------HHHHHHHHhCCCCCC----------------------------------CCCCCCCCHHHHHHH
Q 021227 148 PFWAETE---------IGIFRQILEGKIDFE----------------------------------SEPWPNISESAKDLI 184 (315)
Q Consensus 148 pf~~~~~---------~~~~~~i~~~~~~~~----------------------------------~~~~~~~s~~~~~li 184 (315)
||.+... ...+..+........ .......+.++.++|
T Consensus 215 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 294 (317)
T cd07868 215 IFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294 (317)
T ss_pred CccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHH
Confidence 9975432 112222211100000 000112356789999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCc
Q 021227 185 RKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 185 ~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+||+.||.+|||++|+|+||||
T Consensus 295 ~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 295 QKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHhccCcccCCCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.20 Aligned_cols=201 Identities=35% Similarity=0.527 Sum_probs=177.7
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
..+||||+++++++++++.+|+|+||+.|++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~-- 130 (260)
T cd05611 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI-- 130 (260)
T ss_pred cCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--
Confidence 348999999999999999999999999999999999888889999999999999999999999999999999999994
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++..... .....|++.|+|||.+.+ .++.++||||+|+++|+|++|..||...+.......+.
T Consensus 131 -~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 206 (260)
T cd05611 131 -DQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206 (260)
T ss_pred -CCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 5678999999998865433 234568899999999864 37899999999999999999999999988888888887
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT---AHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s---~~~~l~h~~~~~~ 210 (315)
.+...++......+++++.+++.+||+.+|++||| ++|++.||||...
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 207 SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred hcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 77666665555578999999999999999999995 5799999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=293.36 Aligned_cols=202 Identities=32% Similarity=0.621 Sum_probs=170.6
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++++++++|+||||+.||+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil--- 134 (331)
T cd05597 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVL--- 134 (331)
T ss_pred CCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEE---
Confidence 4899999999999999999999999999999999976 457999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcc--cccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
++.++.+||+|||++......... ....||+.|+|||++. +.++.++||||+||++|+|++|+.||.+.+..
T Consensus 135 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 214 (331)
T cd05597 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH
Confidence 567889999999998765433221 2346899999999985 34788999999999999999999999998887
Q ss_pred HHHHHHHhCCCCCC-CCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccC
Q 021227 156 GIFRQILEGKIDFE-SEPWPNISESAKDLIRKMLDQNPKR--RLTAHEVLCHPWIVD 209 (315)
Q Consensus 156 ~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~l~~~p~~--R~s~~~~l~h~~~~~ 209 (315)
+....+......+. ....+.+|+++++++.+||..++.+ |++++++++||||..
T Consensus 215 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 77777765433222 1223458999999999999765544 789999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=282.60 Aligned_cols=199 Identities=30% Similarity=0.477 Sum_probs=170.1
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
++ +||||++++++++++..+++|+||++|++|.+.+.+.+.+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 60 ~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv- 137 (263)
T cd06625 60 NL-QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR- 137 (263)
T ss_pred hC-CCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-
Confidence 44 8999999999999999999999999999999999888889999999999999999999999999999999999994
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcc----cccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVF----SDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+.++.++|+|||++......... ....|+..|+|||.+.+ .++.++||||+|+++|++++|+.||...+....
T Consensus 138 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 215 (263)
T cd06625 138 --DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215 (263)
T ss_pred --cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH
Confidence 56789999999998755332111 23567889999999864 488999999999999999999999988766555
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
...+........ ....++.++.+++.+||..+|.+|||+.++++|+||
T Consensus 216 ~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 216 IFKIATQPTNPQ--LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHhccCCCCC--CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 555544332222 224688999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=297.14 Aligned_cols=200 Identities=25% Similarity=0.422 Sum_probs=161.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++++.+|+||||+.||+|.+. ...++..+..++.||+.||.|||++||+||||||+||+ +
T Consensus 129 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl---l 201 (353)
T PLN00034 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLL---I 201 (353)
T ss_pred CCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEE---E
Confidence 3899999999999999999999999999998542 34678889999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK------HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+.++.+||+|||++....... ......||..|+|||++.. ..+.++|||||||++|+|++|+.||......+.
T Consensus 202 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 281 (353)
T PLN00034 202 NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW 281 (353)
T ss_pred cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 677899999999987654322 2345679999999998742 245689999999999999999999975332222
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
...+..............+++++++||.+||+.||++|||+.|+++||||....
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 282 ASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 221111111112222346899999999999999999999999999999998753
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=291.30 Aligned_cols=202 Identities=27% Similarity=0.463 Sum_probs=166.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++.+|+||||+.+ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+ +
T Consensus 62 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nil---l 137 (309)
T cd07872 62 KHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLL---I 137 (309)
T ss_pred CCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE---E
Confidence 899999999999999999999999975 787877654 45899999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.++.+||+|||++...... .......+|+.|+|||++.+ .++.++||||+||++|+|+||.+||.+.+..+....+
T Consensus 138 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 217 (309)
T cd07872 138 NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217 (309)
T ss_pred CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 66789999999998754322 22334568899999998853 4889999999999999999999999887766555444
Q ss_pred HhCCC-------------------CCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 162 LEGKI-------------------DFES-------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 162 ~~~~~-------------------~~~~-------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
..... .++. ...+.++++++++|.+||+.||.+|||+.|+++||||....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 218 FRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred HHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 33110 0010 11235789999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=293.11 Aligned_cols=202 Identities=32% Similarity=0.600 Sum_probs=172.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++++...+|+||||+.||+|.+++.+ .+.+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nil--- 134 (332)
T cd05623 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL--- 134 (332)
T ss_pred CCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE---
Confidence 4899999999999999999999999999999999977 467999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
.+.++.+||+|||++........ .....||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+..
T Consensus 135 i~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 135 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred ECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 56778999999999876533222 22357999999999884 34789999999999999999999999999888
Q ss_pred HHHHHHHhCCCCCCC-CCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccC
Q 021227 156 GIFRQILEGKIDFES-EPWPNISESAKDLIRKMLDQNPKR--RLTAHEVLCHPWIVD 209 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~--R~s~~~~l~h~~~~~ 209 (315)
+....+......++. .....+|+++++++++||..++.+ |++++++++||||..
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 888888765433321 223468999999999999765554 689999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=293.03 Aligned_cols=199 Identities=24% Similarity=0.384 Sum_probs=165.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL-GVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++.+|+||||+.||+|.+++.+.+.+++..+..++.|++.||.|||+. +++||||||+||++
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili--- 137 (333)
T cd06650 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV--- 137 (333)
T ss_pred CCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---
Confidence 89999999999999999999999999999999998888899999999999999999999975 79999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI-- 161 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-- 161 (315)
+.++.+||+|||++...... ......||+.|+|||++.+ .++.++|+||+||++|+|++|..||...........+
T Consensus 138 ~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 216 (333)
T cd06650 138 NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGC 216 (333)
T ss_pred cCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcC
Confidence 56788999999998755322 2234578999999999864 5889999999999999999999999765543322111
Q ss_pred ------------------------------------------HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 021227 162 ------------------------------------------LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 162 ------------------------------------------~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
..... +......+++++++||.+||++||.+|||+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ 294 (333)
T cd06650 217 PVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLK 294 (333)
T ss_pred cccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCHH
Confidence 00000 0001123678999999999999999999999
Q ss_pred HHhcCCCccCC
Q 021227 200 EVLCHPWIVDD 210 (315)
Q Consensus 200 ~~l~h~~~~~~ 210 (315)
|++.||||+..
T Consensus 295 ell~h~~~~~~ 305 (333)
T cd06650 295 QLMVHAFIKRS 305 (333)
T ss_pred HHhhCHHHhcC
Confidence 99999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=316.97 Aligned_cols=199 Identities=33% Similarity=0.606 Sum_probs=180.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+.+-|+.++-.|+|+.++|+||||++||+|..++.+.+++||..|+.|+..|+.||.-||+.|+|||||||+||| +
T Consensus 132 ~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvL---l 208 (1317)
T KOG0612|consen 132 GNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVL---L 208 (1317)
T ss_pred CCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeE---e
Confidence 3567899999999999999999999999999999998889999999999999999999999999999999999999 7
Q ss_pred CCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
+..|+|||+|||.+..+...+. ....+|||.|+|||++. +.|++.||.||+||++|||+.|..||+..+..+
T Consensus 209 d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve 288 (1317)
T KOG0612|consen 209 DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE 288 (1317)
T ss_pred cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH
Confidence 8899999999999988764443 34578999999999984 359999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccC
Q 021227 157 IFRQILEG--KIDFESEPWPNISESAKDLIRKMLDQNPKRRLT---AHEVLCHPWIVD 209 (315)
Q Consensus 157 ~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s---~~~~l~h~~~~~ 209 (315)
.+.+|++- .+.|| .-..+|+++++||.+++. +|..|.. ++++-+||||..
T Consensus 289 TY~KIm~hk~~l~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 289 TYGKIMNHKESLSFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHhchhhhcCCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 99999986 55565 234699999999999987 7889888 999999999964
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=287.85 Aligned_cols=198 Identities=30% Similarity=0.497 Sum_probs=166.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++.+.+++.+|+||||+.||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 58 ~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil--- 134 (285)
T cd05630 58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENIL--- 134 (285)
T ss_pred CCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEE---
Confidence 8999999999999999999999999999999888554 35999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEI---GIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~ 159 (315)
.+.++.++|+|||++.............|++.|+|||++. ..++.++||||+||++|+|++|..||...... +...
T Consensus 135 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~ 214 (285)
T cd05630 135 LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 214 (285)
T ss_pred ECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence 4567889999999987654444444567999999999986 45899999999999999999999999875432 1222
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
.+... ........+++++++++.+||+.||.+||| ++|+++||||..
T Consensus 215 ~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 215 RLVKE---VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred hhhhh---hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 22111 111223468899999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=298.36 Aligned_cols=202 Identities=24% Similarity=0.450 Sum_probs=175.1
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
|++| +||||+++.+++.....||||||||..|.|...+.....++......|..+|+.|++|||.+.|||||||.-|||
T Consensus 166 LRkL-kH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiL 244 (904)
T KOG4721|consen 166 LRKL-KHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNIL 244 (904)
T ss_pred HHhc-cCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceE
Confidence 3556 999999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
+..+..|||+|||.++.+........+.||..|||||+++.. .+.|+|||||||+||||+||..||..-+...++-
T Consensus 245 ---Is~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw 321 (904)
T KOG4721|consen 245 ---ISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW 321 (904)
T ss_pred ---eeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE
Confidence 556778999999999877766666679999999999999854 8999999999999999999999998765544433
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
-+=...+.++.+ ..+++-++-||+.||+-.|..|||+.++|.|-=+.
T Consensus 322 GVGsNsL~LpvP--stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 322 GVGSNSLHLPVP--STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred eccCCcccccCc--ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 333333333332 46889999999999999999999999999985443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=299.05 Aligned_cols=199 Identities=30% Similarity=0.469 Sum_probs=168.1
Q ss_pred CCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 8 QHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 8 pniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
-|||+++++|...+|.|||+|.++ -+|.+++..+ .+++...++.++.||+.||..||+.||||+||||+|||+.+-+
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK 326 (586)
T ss_pred eeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC
Confidence 389999999999999999999995 5999999876 4799999999999999999999999999999999999986544
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 164 (315)
...||++|||.+......- .+++-+..|.|||++.+ .|+.+.||||||||++||++|.+.|.|.++.+++..|.+-
T Consensus 327 -r~~vKVIDFGSSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~ 403 (586)
T KOG0667|consen 327 -RSRIKVIDFGSSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV 403 (586)
T ss_pred -cCceeEEecccccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence 3489999999987654333 37888999999999864 6999999999999999999999999999999999888761
Q ss_pred CC---------------CCCC-CC-------------------------------CC------------CCCHHHHHHHH
Q 021227 165 KI---------------DFES-EP-------------------------------WP------------NISESAKDLIR 185 (315)
Q Consensus 165 ~~---------------~~~~-~~-------------------------------~~------------~~s~~~~~li~ 185 (315)
.. .|.. .. .+ .-...+.+||+
T Consensus 404 lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk 483 (586)
T KOG0667|consen 404 LGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLK 483 (586)
T ss_pred hCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHH
Confidence 10 0000 00 00 01245789999
Q ss_pred HhcccCCCCCCCHHHHhcCCCccCC
Q 021227 186 KMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 186 ~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+||.+||.+|+|+.|+|+|||+...
T Consensus 484 ~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 484 RCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred HHhccCchhcCCHHHHhcCcccccc
Confidence 9999999999999999999999843
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.32 Aligned_cols=199 Identities=30% Similarity=0.458 Sum_probs=162.8
Q ss_pred CCCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 5 SEHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
.+||||+++++++... ..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|
T Consensus 80 l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~N 156 (364)
T cd07875 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156 (364)
T ss_pred cCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHH
Confidence 4899999999988643 467999999975 67666643 48899999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|+ ++.++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.
T Consensus 157 Il---l~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 233 (364)
T cd07875 157 IV---VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 233 (364)
T ss_pred EE---ECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99 56678999999999987655444456779999999999864 589999999999999999999999998877666
Q ss_pred HHHHHhCCCCCC--------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 021227 158 FRQILEGKIDFE--------------------------------------SEPWPNISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 158 ~~~i~~~~~~~~--------------------------------------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
+..+......+. .......+++++++|.+||+.||.+|||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~ 313 (364)
T cd07875 234 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313 (364)
T ss_pred HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHH
Confidence 655543111100 000112356899999999999999999999
Q ss_pred HHhcCCCccC
Q 021227 200 EVLCHPWIVD 209 (315)
Q Consensus 200 ~~l~h~~~~~ 209 (315)
++|+||||..
T Consensus 314 e~L~hp~~~~ 323 (364)
T cd07875 314 EALQHPYINV 323 (364)
T ss_pred HHhcCccccc
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=294.04 Aligned_cols=199 Identities=30% Similarity=0.504 Sum_probs=160.2
Q ss_pred CCCCCcceEEEEEEeCC------eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 5 SEHQHVVRIHDTYEDKS------CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
.+||||+++++++.... .+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 77 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~N 153 (359)
T cd07876 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 153 (359)
T ss_pred CCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 38999999999997543 57999999976 5655553 358999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|+ ++.++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+....
T Consensus 154 Il---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 230 (359)
T cd07876 154 IV---VKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230 (359)
T ss_pred EE---ECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99 56788999999999976554444455678999999999864 589999999999999999999999988765443
Q ss_pred HHHHHhC----------------------CCCCCC----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 021227 158 FRQILEG----------------------KIDFES----------------EPWPNISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 158 ~~~i~~~----------------------~~~~~~----------------~~~~~~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
+..+... ...++. ......++++++||.+||+.||++|||+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~ 310 (359)
T cd07876 231 WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310 (359)
T ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHH
Confidence 3322211 111110 00112467899999999999999999999
Q ss_pred HHhcCCCccC
Q 021227 200 EVLCHPWIVD 209 (315)
Q Consensus 200 ~~l~h~~~~~ 209 (315)
|+|+||||..
T Consensus 311 e~l~hp~~~~ 320 (359)
T cd07876 311 EALRHPYITV 320 (359)
T ss_pred HHhcCchhhh
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.01 Aligned_cols=197 Identities=39% Similarity=0.723 Sum_probs=175.3
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
++ +||||+++++++.+++.+|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||+.|++||||+|.||+
T Consensus 57 ~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nil-- 133 (290)
T cd05580 57 SI-RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLL-- 133 (290)
T ss_pred hC-CCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE--
Confidence 44 799999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||++...... .....|++.|+|||.+. ..++.++|+||+|+++|+|++|..||...+.......+
T Consensus 134 -i~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 210 (290)
T cd05580 134 -LDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210 (290)
T ss_pred -ECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 456789999999998776444 23456899999999885 45788999999999999999999999988877777777
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
..+...++. .+++.+++++.+||..+|.+|+ +++++++||||..
T Consensus 211 ~~~~~~~~~----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 211 LEGKVRFPS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred hcCCccCCc----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 766554443 4689999999999999999999 9999999999965
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=285.84 Aligned_cols=202 Identities=25% Similarity=0.448 Sum_probs=167.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++.+++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+ +
T Consensus 62 ~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil---~ 137 (301)
T cd07873 62 KHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLL---I 137 (301)
T ss_pred CCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEE---E
Confidence 89999999999999999999999997 5888887654 56899999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.++.+||+|||++...... .......+++.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+....+
T Consensus 138 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 138 NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217 (301)
T ss_pred CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 66789999999998754322 22234567899999998853 4788999999999999999999999988776665544
Q ss_pred HhCCCCC-------------------CC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 162 LEGKIDF-------------------ES-------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 162 ~~~~~~~-------------------~~-------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
....... +. ...+.++++++++|.+||+.||.+|||++++++||||....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 218 FRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred HHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 3321110 00 01235788999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.34 Aligned_cols=202 Identities=26% Similarity=0.475 Sum_probs=175.4
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||+||++++.|..++.++|..|||.||-+...+..- ..++|.++..+++|++.||.|||+++|||||||..|||
T Consensus 86 CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL--- 162 (1187)
T KOG0579|consen 86 CDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNIL--- 162 (1187)
T ss_pred CCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceE---
Confidence 48999999999999999999999999999987776654 57999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 84 VDEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
..-+|.|+|+|||.+..... .....+++|||+|||||+.. ..|+.++||||||+++.+|.-+.+|-..-++..
T Consensus 163 ~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR 242 (1187)
T KOG0579|consen 163 LTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 242 (1187)
T ss_pred EEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH
Confidence 56789999999998754322 23345789999999999862 459999999999999999999999999999988
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
++-.|.+..++.-.. ....|..+.||+.+||.+||..||++.++|+|||+++.
T Consensus 243 VllKiaKSePPTLlq-PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 243 VLLKIAKSEPPTLLQ-PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHhhcCCCcccC-cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 888887765432221 23578899999999999999999999999999999854
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=290.89 Aligned_cols=202 Identities=30% Similarity=0.584 Sum_probs=172.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++++++..|+||||+.||+|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 58 ~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nil--- 134 (331)
T cd05624 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL--- 134 (331)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEE---
Confidence 4899999999999999999999999999999999977 467999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcc--cccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
++.++.+||+|||++......... ....||+.|+|||++. +.++.++||||+||++|+|++|+.||.+.+..
T Consensus 135 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 135 LDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred EcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 567789999999998765433221 2356999999999885 34788999999999999999999999998888
Q ss_pred HHHHHHHhCCCCCC-CCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccC
Q 021227 156 GIFRQILEGKIDFE-SEPWPNISESAKDLIRKMLDQNPKR--RLTAHEVLCHPWIVD 209 (315)
Q Consensus 156 ~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~l~~~p~~--R~s~~~~l~h~~~~~ 209 (315)
+....+......++ +..+..+++++++++.+||..++++ |++++++++||||..
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 88887776543332 1223467999999999999876655 569999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=280.38 Aligned_cols=199 Identities=28% Similarity=0.474 Sum_probs=166.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++.+++.+|+|+||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+ .
T Consensus 63 l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil---i 139 (267)
T cd06645 63 CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANIL---L 139 (267)
T ss_pred CCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE---E
Confidence 3899999999999999999999999999999999988889999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||++...... .......|++.|+|||++. +.++.++|+||+||++|+|++|..||..........
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~ 219 (267)
T cd06645 140 TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF 219 (267)
T ss_pred CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH
Confidence 66788999999998654322 1223457899999999873 348889999999999999999999997655444333
Q ss_pred HHHhCCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021227 160 QILEGKIDFES-EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206 (315)
Q Consensus 160 ~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~ 206 (315)
.........+. .....++..+++++.+||+.+|++|||++++++|||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 220 LMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred hhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 33333222211 112257889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=283.80 Aligned_cols=202 Identities=31% Similarity=0.477 Sum_probs=171.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+++..|+||||+.||+|.+.+... .++++..+..++.|++.||.|||++||+||||||+||++
T Consensus 58 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili-- 135 (285)
T cd05632 58 NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL-- 135 (285)
T ss_pred CCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE--
Confidence 8999999999999999999999999999998887653 369999999999999999999999999999999999994
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++.............|++.|+|||++. ..++.++|+||+||++|+|++|..||.+.........+.
T Consensus 136 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~ 214 (285)
T cd05632 136 -DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 214 (285)
T ss_pred -CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 567889999999987654444444567899999999986 458999999999999999999999998876654444443
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~~ 210 (315)
.............+++++.+|+.+||+.+|.+||| +.+++.|+||...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 215 RRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 32222222333568899999999999999999999 8899999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=296.14 Aligned_cols=203 Identities=31% Similarity=0.484 Sum_probs=168.6
Q ss_pred CCCCCcceEEEEEEeCC-----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 5 SEHQHVVRIHDTYEDKS-----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
.+||||+++++++.... ..|+|+||+. ++|.+.+...+.+++..+..++.|++.||.|||++|++||||||+||
T Consensus 56 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Ni 134 (372)
T cd07853 56 FKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNL 134 (372)
T ss_pred CCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHE
Confidence 38999999999998876 8999999996 57888887778899999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
+ ++.++.+||+|||++....... ......+|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..
T Consensus 135 l---i~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 211 (372)
T cd07853 135 L---VNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211 (372)
T ss_pred E---ECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence 9 5678899999999987653322 2234568899999999864 3789999999999999999999999988876
Q ss_pred HHHHHHHhCC-----------------------CCCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 156 GIFRQILEGK-----------------------IDFES-----EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 156 ~~~~~i~~~~-----------------------~~~~~-----~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+.+..+.... ...+. ......++++.+||.+||+.||.+|||+.|+++||||
T Consensus 212 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 291 (372)
T cd07853 212 QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291 (372)
T ss_pred HHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence 6665554311 11100 1123468899999999999999999999999999999
Q ss_pred cCCC
Q 021227 208 VDDK 211 (315)
Q Consensus 208 ~~~~ 211 (315)
....
T Consensus 292 ~~~~ 295 (372)
T cd07853 292 DEGR 295 (372)
T ss_pred CCCc
Confidence 8643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=304.15 Aligned_cols=204 Identities=27% Similarity=0.447 Sum_probs=174.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNY--SEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~--~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
++|.|||++.+.+..++.+-|.||.++||+|.+++..+ |++ +|..+..+.+||++||.|||++.|||||||-+|||+
T Consensus 629 LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLv 708 (1226)
T KOG4279|consen 629 LRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLV 708 (1226)
T ss_pred HhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEE
Confidence 48999999999999999999999999999999999776 788 899999999999999999999999999999999998
Q ss_pred ccCCCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh---hcCCCchhHHHHHHHHHHHHhCCCCCCCC-CH-H
Q 021227 82 LSVDEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR---KHYGPEADVWSAGVILYILLSGVPPFWAE-TE-I 155 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~-~ 155 (315)
+.-.|.+||+|||.++.+.. +.+..++.||..|||||++. ..|++.+|||||||++.||.||++||..- ++ .
T Consensus 709 --NTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA 786 (1226)
T KOG4279|consen 709 --NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA 786 (1226)
T ss_pred --eeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH
Confidence 66889999999999987643 45566789999999999996 34999999999999999999999999642 22 2
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVA 213 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~ 213 (315)
.++ .-|.+..-++....+|.+++.||.+|+.+||..||+|.++|.+||++..+..
T Consensus 787 AMF---kVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 787 AMF---KVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred hhh---hhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence 232 2233333333334689999999999999999999999999999999876433
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=297.11 Aligned_cols=203 Identities=24% Similarity=0.417 Sum_probs=164.8
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+ +|||||++++++..+..+|+|||++. ++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 142 ~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nil-- 217 (392)
T PHA03207 142 TI-SHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF-- 217 (392)
T ss_pred hc-CCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE--
Confidence 44 89999999999999999999999995 588888877788999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH---H
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE---I 155 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~ 155 (315)
++..+.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+... .
T Consensus 218 -l~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 296 (392)
T PHA03207 218 -LDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296 (392)
T ss_pred -EcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence 5678899999999987654322 123467999999999986 4589999999999999999999999977532 2
Q ss_pred HHHHHHHhC----CCCCCC-----------------------CC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021227 156 GIFRQILEG----KIDFES-----------------------EP---WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205 (315)
Q Consensus 156 ~~~~~i~~~----~~~~~~-----------------------~~---~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~ 205 (315)
..+..+.+. ...++. +. ...++.+++++|.+||..||++|||+.++|.||
T Consensus 297 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred HHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 222222211 000000 00 013567899999999999999999999999999
Q ss_pred CccCC
Q 021227 206 WIVDD 210 (315)
Q Consensus 206 ~~~~~ 210 (315)
||+..
T Consensus 377 ~f~~~ 381 (392)
T PHA03207 377 LFTKE 381 (392)
T ss_pred hhhcc
Confidence 99753
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.50 Aligned_cols=200 Identities=29% Similarity=0.467 Sum_probs=161.4
Q ss_pred CCCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 5 SEHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
.+||||+++++++... ...|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|
T Consensus 73 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 149 (355)
T cd07874 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149 (355)
T ss_pred hCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHH
Confidence 4899999999998654 357999999976 56666643 58899999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|+ ++.++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.
T Consensus 150 il---l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 226 (355)
T cd07874 150 IV---VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226 (355)
T ss_pred EE---ECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99 56678999999999987655444456789999999999864 589999999999999999999999988775544
Q ss_pred HHHHHhCC----------------------CCC----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 021227 158 FRQILEGK----------------------IDF----------------ESEPWPNISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 158 ~~~i~~~~----------------------~~~----------------~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
+..+.... ..+ ........+.+++++|.+||+.||.+|||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ 306 (355)
T cd07874 227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306 (355)
T ss_pred HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHH
Confidence 43332210 000 0011122467889999999999999999999
Q ss_pred HHhcCCCccCC
Q 021227 200 EVLCHPWIVDD 210 (315)
Q Consensus 200 ~~l~h~~~~~~ 210 (315)
|+|+||||...
T Consensus 307 ell~hp~~~~~ 317 (355)
T cd07874 307 EALQHPYINVW 317 (355)
T ss_pred HHhcCcchhcc
Confidence 99999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=294.16 Aligned_cols=203 Identities=23% Similarity=0.421 Sum_probs=180.5
Q ss_pred CCCCCCCCcceEEEEEEeCCe--EEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCC
Q 021227 2 HHLSEHQHVVRIHDTYEDKSC--VHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG--VFHRDLKPE 77 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~--~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dikp~ 77 (315)
+.| +|||||++|+++.+..+ +.+|+|.+.+|+|..|+.+.+..+...+..|++||+.||.|||++. |+|||||.+
T Consensus 96 KsL-~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCD 174 (632)
T KOG0584|consen 96 KSL-KHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCD 174 (632)
T ss_pred ccC-CCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccc
Confidence 445 99999999999987655 8899999999999999999999999999999999999999999875 999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHH
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWA-ETEIG 156 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~ 156 (315)
||++ .+..|.|||+|+|+|........ ...+|||.|||||+....|...+||||||+.+.||+|+..||.- .++.+
T Consensus 175 NIFi--nG~~G~VKIGDLGLAtl~r~s~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ 251 (632)
T KOG0584|consen 175 NIFV--NGNLGEVKIGDLGLATLLRKSHA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ 251 (632)
T ss_pred eEEE--cCCcCceeecchhHHHHhhcccc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH
Confidence 9998 66789999999999987755443 44899999999999999999999999999999999999999964 67888
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
+++++..|..+-..... -.+++++||.+||.. ..+|+|+.|+|+||||....
T Consensus 252 IYKKV~SGiKP~sl~kV--~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 252 IYKKVTSGIKPAALSKV--KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred HHHHHHcCCCHHHhhcc--CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 99999988765433322 268999999999998 99999999999999998753
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=280.29 Aligned_cols=203 Identities=26% Similarity=0.473 Sum_probs=171.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++..++..|+|+||+++|+|..++.+ .+++++..+..++.|++.||.|||+.|++||||||+||+
T Consensus 59 l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nil--- 135 (282)
T cd06643 59 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNIL--- 135 (282)
T ss_pred CCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEE---
Confidence 3899999999999999999999999999999887765 467999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
.+.++.+||+|||++...... .......|++.|+|||++. ..++.++|+||+||++|+|++|.+||...+..+
T Consensus 136 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 215 (282)
T cd06643 136 FTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215 (282)
T ss_pred EccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH
Confidence 466789999999998654322 2223456899999999873 237789999999999999999999999887777
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
....+........ .....++.+++++|.+||+.+|.+|||++++++||||....
T Consensus 216 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 216 VLLKIAKSEPPTL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHhhcCCCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 6666655432211 12235789999999999999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=279.13 Aligned_cols=200 Identities=36% Similarity=0.653 Sum_probs=173.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.++..+|+|+||++|++|.+++.+...+++..+..++.|++.||+|||++|++|+||+|+||++ +
T Consensus 51 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~ 127 (262)
T cd05572 51 NHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---D 127 (262)
T ss_pred CCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---c
Confidence 8999999999999999999999999999999999888889999999999999999999999999999999999994 5
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAET--EIGIFRQIL 162 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~ 162 (315)
.++.++|+|||.+.............|++.|+|||.+. ..++.++|+||+|+++|++++|..||.... ..+....+.
T Consensus 128 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 207 (262)
T cd05572 128 SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207 (262)
T ss_pred CCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh
Confidence 67899999999988765443334457899999999885 458899999999999999999999998876 666666666
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~~ 210 (315)
.+......+ ...+++++++|.+||+.+|.+||| ++|+++||||++.
T Consensus 208 ~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 208 KGNGKLEFP--NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ccCCCCCCC--cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 432222221 235899999999999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=287.88 Aligned_cols=203 Identities=20% Similarity=0.308 Sum_probs=162.2
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+||||+++++++.+++..|+|+||+++|+|.+++..+ ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 56 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil-- 133 (327)
T cd08227 56 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHIL-- 133 (327)
T ss_pred cCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEE--
Confidence 48999999999999999999999999999999998653 45899999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCC--------cccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE--------VFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
++.++.++++||+.+....... ......++..|+|||++.+ .++.++||||+||++|+|++|..||..
T Consensus 134 -~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 134 -ISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred -EecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 4567889999998654332111 1122346778999999863 488999999999999999999999987
Q ss_pred CCHHHHHHHHHhCCCCCC------------------------------------------CCCCCCCCHHHHHHHHHhcc
Q 021227 152 ETEIGIFRQILEGKIDFE------------------------------------------SEPWPNISESAKDLIRKMLD 189 (315)
Q Consensus 152 ~~~~~~~~~i~~~~~~~~------------------------------------------~~~~~~~s~~~~~li~~~l~ 189 (315)
............+..... .+....+++++++|+.+||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 292 (327)
T cd08227 213 MPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQ 292 (327)
T ss_pred cchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHh
Confidence 554443333322211100 00112357889999999999
Q ss_pred cCCCCCCCHHHHhcCCCccCC
Q 021227 190 QNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 190 ~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.||++|||++++++||||+..
T Consensus 293 ~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 293 RNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hCchhcCCHHHHhcChhhhhc
Confidence 999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=282.01 Aligned_cols=201 Identities=31% Similarity=0.496 Sum_probs=168.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||++++++++..+.+|+|+||++|++|.+++.+.+ .+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus 51 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil--- 127 (277)
T cd05577 51 SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVL--- 127 (277)
T ss_pred CCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE---
Confidence 79999999999999999999999999999999987765 7999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
.+.++.+||+|||.+.............++..|+|||++. +.++.++|+||+||++|+|++|+.||...........+.
T Consensus 128 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 207 (277)
T cd05577 128 LDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207 (277)
T ss_pred ECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH
Confidence 5667899999999887654443444566788999999985 448889999999999999999999997754422222222
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
......+....+.++++++++|.+||+.+|.+|| ++.+++.||||..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 208 RRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 2222222233346799999999999999999999 8999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.44 Aligned_cols=204 Identities=25% Similarity=0.410 Sum_probs=162.5
Q ss_pred CCCCCcceEEEEEEeC-CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDK-SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil~~ 82 (315)
.+|++|++++++|..+ .++|+|||++ |++|.+++.+.+.+++..+..++.||+.||.|||+ .||+||||||+|||+.
T Consensus 188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~ 266 (467)
T PTZ00284 188 ADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILME 266 (467)
T ss_pred ccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEe
Confidence 4678899999999865 5799999998 77899999888899999999999999999999997 5999999999999974
Q ss_pred cCC-------------CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCC
Q 021227 83 SVD-------------EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPP 148 (315)
Q Consensus 83 ~~~-------------~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 148 (315)
..+ ....+||+|||.+.... ......+||+.|+|||++.+ .++.++|||||||++|+|++|++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 321 12359999999875432 22345789999999999864 599999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCCCC------------------------------------CCC--CCCHHHHHHHHHhccc
Q 021227 149 FWAETEIGIFRQILEGKIDFESE------------------------------------PWP--NISESAKDLIRKMLDQ 190 (315)
Q Consensus 149 f~~~~~~~~~~~i~~~~~~~~~~------------------------------------~~~--~~s~~~~~li~~~l~~ 190 (315)
|.+.+..+.+..+......++.. .+. ..++.+.+||.+||++
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 99887766555443321111100 000 0145678999999999
Q ss_pred CCCCCCCHHHHhcCCCccCCC
Q 021227 191 NPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 191 ~p~~R~s~~~~l~h~~~~~~~ 211 (315)
||.+|||++|+|+||||....
T Consensus 425 dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 425 DRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred ChhhCCCHHHHhcCccccccC
Confidence 999999999999999998643
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=281.80 Aligned_cols=199 Identities=42% Similarity=0.731 Sum_probs=168.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+....++||||+.+++|.+++.+.+.+++..+..++.|++.||.+||++|++|+||||+||+ .+
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl---~~ 132 (260)
T PF00069_consen 56 RHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENIL---LD 132 (260)
T ss_dssp TBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEE---ES
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc
Confidence 799999999999999999999999999999999987889999999999999999999999999999999999999 55
Q ss_pred CCCCEEEeeccCcccC-CCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH
Q 021227 86 EDAALKATDFGLSVFY-KPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAET---EIGIFR 159 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~-~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~ 159 (315)
.++.++|+|||.+... ..........+++.|+|||++. ..++.++|+||+|+++|+|++|..||.... ......
T Consensus 133 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 133 ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 7889999999998753 3334445677899999999987 458999999999999999999999999873 333333
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.................++++.++|.+||+.||++|||+.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 213 KILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred hcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 333322222222222235899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=278.82 Aligned_cols=200 Identities=28% Similarity=0.472 Sum_probs=171.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.++..+|+|+||+.+++|.+++... ++++..+..++.|++.|+.|||+.|++||||+|+||+ ++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~---i~ 132 (274)
T cd06609 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANIL---LS 132 (274)
T ss_pred CCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE---EC
Confidence 7999999999999999999999999999999988665 8999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.++|+|||++...... .......|++.|+|||.+. ..++.++||||+||++|+|++|..||...+.......+..
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 212 (274)
T cd06609 133 EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK 212 (274)
T ss_pred CCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh
Confidence 6889999999998776543 2234467889999999986 4489999999999999999999999988776666555554
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
...... ....+++++.+++.+||..+|++|||++++++||||....
T Consensus 213 ~~~~~~--~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 213 NNPPSL--EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred cCCCCC--cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 432211 1123789999999999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=278.16 Aligned_cols=200 Identities=27% Similarity=0.447 Sum_probs=165.4
Q ss_pred CCCCCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 3 HLSEHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
.+.+||||+++++++... ..+|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||
T Consensus 58 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl 137 (272)
T cd06637 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI 137 (272)
T ss_pred HhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence 445899999999998753 4689999999999999988764 46899999999999999999999999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~ 147 (315)
+|+||+ .+.++.+||+|||++...... .......|++.|+|||++. ..++.++|+||+||++|+|++|..
T Consensus 138 ~~~nil---i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 138 KGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred CHHHEE---ECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999 567788999999998765332 2234467899999999874 247889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 148 PFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
||...........+.... ........++.++++|+.+||+.+|.+|||+.++++||||
T Consensus 215 p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 215 PLCDMHPMRALFLIPRNP--APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CccccCHHHHHHHHhcCC--CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 998766554444433322 1222234678999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=292.72 Aligned_cols=201 Identities=25% Similarity=0.395 Sum_probs=158.2
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.+....++|+||+. |+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 114 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nil--- 189 (357)
T PHA03209 114 VNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIF--- 189 (357)
T ss_pred CCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE---
Confidence 389999999999999999999999996 578887765 467999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCC-CCCCH-------
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPF-WAETE------- 154 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~------- 154 (315)
++..+.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|+++..|+ .....
T Consensus 190 l~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~ 269 (357)
T PHA03209 190 INDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269 (357)
T ss_pred ECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHH
Confidence 5677889999999987544444444567999999999986 45899999999999999999855444 32111
Q ss_pred --HHHHHHHHhC-CC---CCC--------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 155 --IGIFRQILEG-KI---DFE--------------------------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 155 --~~~~~~i~~~-~~---~~~--------------------------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
...+..+... .. .++ ......++.++.++|.+||+.||.+|||+.|+|
T Consensus 270 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l 349 (357)
T PHA03209 270 SCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349 (357)
T ss_pred HHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence 0111111110 00 001 000124677888999999999999999999999
Q ss_pred cCCCccC
Q 021227 203 CHPWIVD 209 (315)
Q Consensus 203 ~h~~~~~ 209 (315)
+||||++
T Consensus 350 ~hp~f~~ 356 (357)
T PHA03209 350 NYPMFAQ 356 (357)
T ss_pred cCchhcc
Confidence 9999974
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=275.17 Aligned_cols=196 Identities=27% Similarity=0.482 Sum_probs=171.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+++.+|+|+||++|++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili-- 134 (256)
T cd08529 57 DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL-- 134 (256)
T ss_pred CCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE--
Confidence 8999999999999999999999999999999998764 578999999999999999999999999999999999994
Q ss_pred CCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.++.++|+|||++........ .....|++.|+|||++. +.++.++|+||+||++|+|++|..||...+.......+
T Consensus 135 -~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 213 (256)
T cd08529 135 -DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI 213 (256)
T ss_pred -eCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5678999999999876544322 23456889999999986 45889999999999999999999999988887777777
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
..+...... ..++.++.+++.+||+.+|++||++.++++|||+
T Consensus 214 ~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 214 IRGVFPPVS---QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HcCCCCCCc---cccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 665433222 2578999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=277.19 Aligned_cols=196 Identities=30% Similarity=0.520 Sum_probs=168.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+....++|+||++|++|.+++.+.+.+++..+..++.|++.||+|||+.|++||||+|+||+ .+
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil---~~ 140 (267)
T cd06628 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL---VD 140 (267)
T ss_pred CCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEE---Ec
Confidence 899999999999999999999999999999999988888999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCC-------cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDE-------VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
.++.+||+|||.+....... ......|+..|+|||.+. ..++.++|+||+||++|+|++|..||.+.+....
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 220 (267)
T cd06628 141 NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA 220 (267)
T ss_pred CCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH
Confidence 78899999999987654211 112345788999999986 4588899999999999999999999988766555
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
...+..... ......++.+++++|.+||+.+|.+||++.++++||||
T Consensus 221 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 221 IFKIGENAS---PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHhccCC---CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 555444221 12224578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=280.56 Aligned_cols=201 Identities=28% Similarity=0.431 Sum_probs=166.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+.+++++..++.+++||||+.||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+ .
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil---~ 130 (279)
T cd05633 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANIL---L 130 (279)
T ss_pred CCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEE---E
Confidence 4799999999999999999999999999999999988889999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.++|+|||++....... .....|++.|+|||.+. ..++.++|+||+||++|+|++|..||........ ..+.
T Consensus 131 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~ 208 (279)
T cd05633 131 DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEID 208 (279)
T ss_pred CCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHH
Confidence 677899999999986543322 23456899999999885 3478999999999999999999999975432111 1111
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~~ 210 (315)
......+......++++++++|.+||..||.+|+ |++++++||||+..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 209 RMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 1111222223346899999999999999999999 69999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=280.31 Aligned_cols=200 Identities=29% Similarity=0.547 Sum_probs=166.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||++++++++++..+++||||+++++|..++.....+++..+..++.|++.||.|||+.|++||||||+||+ +
T Consensus 57 ~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil---~ 133 (286)
T cd07847 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENIL---I 133 (286)
T ss_pred CCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEE---E
Confidence 3799999999999999999999999999888877766678999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.++.+||+|||++....... ......++..|+|||++.+ .++.++|+||+||++|+|++|..||.+.+..+....+
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 213 (286)
T cd07847 134 TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213 (286)
T ss_pred cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 567899999999987765433 2234567889999999753 4788999999999999999999999887765544443
Q ss_pred HhCCC-------------------CCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 162 LEGKI-------------------DFES--------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 162 ~~~~~-------------------~~~~--------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
..... ..+. ..++.++..+.+|+.+||+.+|++|||+.|++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 214 RKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 22100 0000 0124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=283.46 Aligned_cols=203 Identities=25% Similarity=0.380 Sum_probs=167.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil~ 81 (315)
++ +||||+++++++.+++.+|+|+||++|++|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||+|+||++
T Consensus 55 ~l-~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~ 133 (308)
T cd06615 55 EC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV 133 (308)
T ss_pred hC-CCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE
Confidence 45 8999999999999999999999999999999999888889999999999999999999997 699999999999994
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++...... ......|++.|+|||++.+ .++.++|+||+||++|+|++|..||...+.......
T Consensus 134 ---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 209 (308)
T cd06615 134 ---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209 (308)
T ss_pred ---ecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHh
Confidence 56788999999988655322 2345678999999999864 488999999999999999999999976654333322
Q ss_pred HHhCCCCC----------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021227 161 ILEGKIDF----------------------------------ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206 (315)
Q Consensus 161 i~~~~~~~----------------------------------~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~ 206 (315)
+....... +..+...+++++++++.+||..+|++|||+.++++|||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 21110000 00011236789999999999999999999999999999
Q ss_pred ccCC
Q 021227 207 IVDD 210 (315)
Q Consensus 207 ~~~~ 210 (315)
|...
T Consensus 290 ~~~~ 293 (308)
T cd06615 290 IKRA 293 (308)
T ss_pred hhhc
Confidence 9754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=279.66 Aligned_cols=201 Identities=30% Similarity=0.568 Sum_probs=166.3
Q ss_pred CCCCCCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 2 HHLSEHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+++.+||||+++++++.++ +.+++|+||+.| +|.+.+... +.+++..+..++.|++.||.|||+.|++||||+|+|
T Consensus 52 ~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~n 130 (282)
T cd07831 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPEN 130 (282)
T ss_pred hhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHH
Confidence 4555799999999999988 899999999975 777777653 578999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
|++ +. +.+||+|||++.............+++.|+|||.+. +.++.++||||+||++|+|++|.+||.+.+..+
T Consensus 131 i~l---~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~ 206 (282)
T cd07831 131 ILI---KD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206 (282)
T ss_pred EEE---cC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH
Confidence 996 34 899999999998765444444566899999999764 347889999999999999999999999887766
Q ss_pred HHHHHHhCCC------------------CCCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 157 IFRQILEGKI------------------DFESE-------PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 157 ~~~~i~~~~~------------------~~~~~-------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+..+..... .++.. ..+.+|.++.++|.+||+++|.+|||++++++||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 207 QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 5555433110 01110 013568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=285.75 Aligned_cols=202 Identities=24% Similarity=0.393 Sum_probs=154.6
Q ss_pred CCCCCcceEEEEEE--eCCeEEEEEeccCCCchhHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 021227 5 SEHQHVVRIHDTYE--DKSCVHIVMELCEGGELFDRIVKK---------GNYSEREAAKLMKTIVGVVECCHSLGVFHRD 73 (315)
Q Consensus 5 ~~Hpniv~~~~~~~--~~~~~~lv~E~~~gg~L~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 73 (315)
.+||||+++++++. .+..+++|+||+.+ +|.+++... ..+++..+..++.|++.||.|||+.||+|||
T Consensus 55 l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~D 133 (317)
T cd07867 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRD 133 (317)
T ss_pred CCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 38999999999985 45678999999965 777776421 2588999999999999999999999999999
Q ss_pred CCCCceeeccC-CCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCC
Q 021227 74 LKPENFLFLSV-DEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGV 146 (315)
Q Consensus 74 ikp~nil~~~~-~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~ 146 (315)
|||+||++... +.++.+||+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|+||.
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~ 213 (317)
T cd07867 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213 (317)
T ss_pred CCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCC
Confidence 99999997432 456789999999997654322 2234578999999999853 4789999999999999999999
Q ss_pred CCCCCCCHH---------HHHHHHHhCCCCCC----------------------------------CCCCCCCCHHHHHH
Q 021227 147 PPFWAETEI---------GIFRQILEGKIDFE----------------------------------SEPWPNISESAKDL 183 (315)
Q Consensus 147 ~pf~~~~~~---------~~~~~i~~~~~~~~----------------------------------~~~~~~~s~~~~~l 183 (315)
+||...... .....+........ .......+..+.++
T Consensus 214 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 293 (317)
T cd07867 214 PIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLL 293 (317)
T ss_pred CCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHH
Confidence 999754321 11111111000000 00011245678899
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCc
Q 021227 184 IRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 184 i~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+.+||+.||.+|||++|+|+||||
T Consensus 294 l~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 294 LQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHhccCcccccCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=280.48 Aligned_cols=198 Identities=29% Similarity=0.475 Sum_probs=161.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK---GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
+||||+++++++.++..+|+||||+. ++|.+++... +.+++..++.++.|++.||+|||++|++||||+|+||+
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil-- 133 (285)
T cd07861 57 QHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLL-- 133 (285)
T ss_pred CCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEE--
Confidence 79999999999999999999999997 5787877542 56899999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
.+.++.+||+|||++....... ......+++.|+|||++.+ .++.++||||+||++|+|+||.+||.+.+......
T Consensus 134 -~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~ 212 (285)
T cd07861 134 -IDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212 (285)
T ss_pred -EcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 5668899999999987543222 2233467889999998853 47889999999999999999999998876544333
Q ss_pred HHHhCCCC-------------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 160 QILEGKID-------------------------FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 160 ~i~~~~~~-------------------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+...... ........++++++++|.+||+.||.+|||+.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 213 RIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 32211000 0011134578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=281.50 Aligned_cols=202 Identities=35% Similarity=0.578 Sum_probs=174.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++.+..++.+|+||||++|++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+ +
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIl---l 134 (305)
T cd05609 58 AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLL---I 134 (305)
T ss_pred CCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEE---E
Confidence 4899999999999999999999999999999999988888999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCC----------------cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCC
Q 021227 85 DEDAALKATDFGLSVFYKPDE----------------VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~ 147 (315)
+.++.+||+|||+++...... ......|+..|+|||.+. ..++.++|+||+||++|++++|..
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~ 214 (305)
T cd05609 135 TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214 (305)
T ss_pred CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 678899999999876321000 011245788999999875 458999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCC
Q 021227 148 PFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT---AHEVLCHPWIVDD 210 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s---~~~~l~h~~~~~~ 210 (315)
||.+.+..+....+..+....+... ..+|++++++|.+||+.+|++||| +.++++||||...
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 215 PFFGDTPEELFGQVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred CCCCCCHHHHHHHHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 9999888888888777655444433 268999999999999999999997 7999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=276.73 Aligned_cols=198 Identities=33% Similarity=0.597 Sum_probs=185.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||.+..+--.|+....+|+||||..||.|+-.+.+...|+|..++-+...|++||.|||+++||+||||.+|.| .
T Consensus 225 ~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLl---L 301 (516)
T KOG0690|consen 225 CRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLL---L 301 (516)
T ss_pred ccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhe---e
Confidence 4899999999999999999999999999999999988899999999999999999999999999999999999999 7
Q ss_pred CCCCCEEEeeccCccc-CCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVF-YKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~-~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.+|.|||+|||+++. +..+....+++|||.|.|||++. ..|+..+|.|.+||++|||++|+.||+..+...+++-|.
T Consensus 302 DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl 381 (516)
T KOG0690|consen 302 DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL 381 (516)
T ss_pred ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence 8999999999999975 34556678899999999999997 569999999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
...+.||. .+|++++.|+..+|.+||.+|. .+.|+.+|+||..
T Consensus 382 ~ed~kFPr----~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 382 MEDLKFPR----TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred hhhccCCc----cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 99888885 6899999999999999999997 4899999999975
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=283.34 Aligned_cols=198 Identities=28% Similarity=0.522 Sum_probs=161.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+.+.+|+|+||+.+ +|.+++.+ .+.+++..++.++.||+.||.|||++|++||||||+||+ .
T Consensus 57 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil---~ 132 (284)
T cd07839 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLL---I 132 (284)
T ss_pred CCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE---E
Confidence 899999999999999999999999975 77777755 467999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPF-WAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~ 160 (315)
+.++.+||+|||++...... .......+++.|+|||++.+ .++.++||||+||++|+|++|..|+ .+.+..+.++.
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~ 212 (284)
T cd07839 133 NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 212 (284)
T ss_pred cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence 56789999999998765432 22234567899999998854 3789999999999999999988875 45555555444
Q ss_pred HHhCCCC-----------------CC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 161 ILEGKID-----------------FE--------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 161 i~~~~~~-----------------~~--------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+...... ++ ....+.++++++++|.+||+.||.+|||++++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 213 IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 4321100 00 01123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=275.91 Aligned_cols=198 Identities=26% Similarity=0.437 Sum_probs=168.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+...+++|+||++|++|.+++.+.+++++..+..++.|++.||+|||+.|++|+||+|+||++ +
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~ 136 (265)
T cd06631 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---M 136 (265)
T ss_pred CCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---C
Confidence 7999999999999999999999999999999999888889999999999999999999999999999999999994 5
Q ss_pred CCCCEEEeeccCcccCCC-------CCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 86 EDAALKATDFGLSVFYKP-------DEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
.++.+||+|||.+..... ........|+..|+|||++.+ .++.++|+||+||++|+|++|..||...+....
T Consensus 137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 216 (265)
T cd06631 137 PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216 (265)
T ss_pred CCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH
Confidence 678999999998865421 112234568899999999864 478999999999999999999999987666554
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
...+.......+ .....++.++.+++.+||..+|.+|||+.+++.||||
T Consensus 217 ~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 217 MFYIGAHRGLMP-RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHhhhccCCCC-CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 444443322221 1224688999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=283.34 Aligned_cols=201 Identities=33% Similarity=0.586 Sum_probs=172.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+||||+++++++.++...|+||||+.|++|.+++.+. ..+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 58 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili- 136 (316)
T cd05574 58 LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL- 136 (316)
T ss_pred CCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE-
Confidence 37999999999999999999999999999999988754 569999999999999999999999999999999999994
Q ss_pred cCCCCCCEEEeeccCcccCCCCC------------------------------cccccccCccccchhhhhh-cCCCchh
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE------------------------------VFSDVVGSPYYVAPEVLRK-HYGPEAD 131 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~D 131 (315)
+.++.++|+|||++....... ......||..|+|||++.+ .++.++|
T Consensus 137 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D 214 (316)
T cd05574 137 --HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVD 214 (316)
T ss_pred --cCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHH
Confidence 567899999999876542211 1123468889999999864 4889999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCCCc
Q 021227 132 VWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT----AHEVLCHPWI 207 (315)
Q Consensus 132 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s----~~~~l~h~~~ 207 (315)
|||+|+++|+|++|..||.+.+....+..+......++.. ..+++++++++.+||..+|++||| ++++++||||
T Consensus 215 i~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 215 WWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred HHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 9999999999999999999888877777777655544432 237999999999999999999999 9999999999
Q ss_pred cCC
Q 021227 208 VDD 210 (315)
Q Consensus 208 ~~~ 210 (315)
+..
T Consensus 293 ~~~ 295 (316)
T cd05574 293 RGV 295 (316)
T ss_pred hcC
Confidence 864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=277.87 Aligned_cols=203 Identities=29% Similarity=0.508 Sum_probs=171.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+ +||||+++++++.++..+|+||||++|++|.+++.+. ..+++..++.++.|++.||.|||+.||+||||+|+||+
T Consensus 58 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nil- 135 (280)
T cd06611 58 EC-KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNIL- 135 (280)
T ss_pred hC-CCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE-
Confidence 45 7999999999999999999999999999999988764 57999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
.+.++.++|+|||++...... .......|++.|+|||.+. ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 136 --i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 136 --LTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred --ECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 566789999999987654322 2223456899999999874 2367799999999999999999999998877
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
......+..+.... ......++.++.+++.+||+.+|.+|||+.++++||||...
T Consensus 214 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 214 MRVLLKILKSEPPT-LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhcCCCCC-cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 77666666543221 11123578999999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=299.90 Aligned_cols=199 Identities=31% Similarity=0.552 Sum_probs=170.9
Q ss_pred CCCCCcceEEEEEEeCC--------eEEEEEeccCCCchhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 021227 5 SEHQHVVRIHDTYEDKS--------CVHIVMELCEGGELFDRIVKK----GNYSEREAAKLMKTIVGVVECCHSLGVFHR 72 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~--------~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 72 (315)
.+||||+++++.+.... .+++||||+.+|+|.+++... ..+++..++.++.|++.||.|||++||+||
T Consensus 88 ~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHr 167 (496)
T PTZ00283 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHR 167 (496)
T ss_pred CCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 38999999998875432 378999999999999988643 469999999999999999999999999999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCC---CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCC
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPP 148 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 148 (315)
||||+||+ ++.++.+||+|||+++..... ....+..||+.|+|||++.+ .++.++||||+||++|+|++|..|
T Consensus 168 DLKP~NIL---l~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~P 244 (496)
T PTZ00283 168 DIKSANIL---LCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244 (496)
T ss_pred CCCHHHEE---EeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999 456789999999998765322 22345679999999999874 589999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 149 FWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 149 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
|.+.+..+....+..+..... .+.+++++++++.+||+.+|.+|||+.++++|||++.
T Consensus 245 f~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 245 FDGENMEEVMHKTLAGRYDPL---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 999988888888776654322 2468999999999999999999999999999999864
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=311.04 Aligned_cols=203 Identities=31% Similarity=0.540 Sum_probs=166.6
Q ss_pred CCCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCcc
Q 021227 5 SEHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSL-------GVFH 71 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-------~ivH 71 (315)
++|||||+++++|.+ ...+|||||||++|+|.+++.. .+.+++..++.|+.||+.||.|||+. +|||
T Consensus 69 L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVH 148 (1021)
T PTZ00266 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLH 148 (1021)
T ss_pred cCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCcee
Confidence 389999999999854 4679999999999999998865 25799999999999999999999984 4999
Q ss_pred ccCCCCceeeccC--------------CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh---hcCCCchhHHH
Q 021227 72 RDLKPENFLFLSV--------------DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR---KHYGPEADVWS 134 (315)
Q Consensus 72 ~dikp~nil~~~~--------------~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Diws 134 (315)
|||||+|||+... +..+.+||+|||++.............||+.|+|||++. ..++.++||||
T Consensus 149 RDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWS 228 (1021)
T PTZ00266 149 RDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228 (1021)
T ss_pred ccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHH
Confidence 9999999998431 234569999999998765444445668999999999984 34889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 135 AGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 135 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
|||++|+|++|..||...+....+.........+ .....++++.+||..||+.+|.+|||+.|+|.|+|++..
T Consensus 229 LG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 229 LGCIIYELCSGKTPFHKANNFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 9999999999999998765444333333322222 224578999999999999999999999999999999743
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=290.29 Aligned_cols=199 Identities=30% Similarity=0.518 Sum_probs=163.0
Q ss_pred CCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+||||+++++++... ..+|+++|++ |++|.+++ +.+.+++..+..++.|++.||.|||++||+||||||+||
T Consensus 72 ~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Ni 149 (343)
T cd07878 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIV-KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV 149 (343)
T ss_pred CCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhE
Confidence 899999999988643 4579999998 77887766 456799999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+ ++.++.+||+|||++...... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.
T Consensus 150 l---~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 224 (343)
T cd07878 150 A---VNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ 224 (343)
T ss_pred E---ECCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9 567889999999998765432 345678999999999864 488999999999999999999999988776555
Q ss_pred HHHHHhCCCC-----------------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKID-----------------------FES----EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~-----------------------~~~----~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+..+...... .+. ..+...++.+.+||.+||+.||.+|||+.|++.||||...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 225 LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 5544321110 000 0123467789999999999999999999999999999864
Q ss_pred C
Q 021227 211 K 211 (315)
Q Consensus 211 ~ 211 (315)
.
T Consensus 305 ~ 305 (343)
T cd07878 305 H 305 (343)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=286.38 Aligned_cols=195 Identities=23% Similarity=0.336 Sum_probs=156.8
Q ss_pred CCCCCCCcceEEEEEEeC-CeEEEEEeccCCCchhHHHHhC---------------------------------------
Q 021227 3 HLSEHQHVVRIHDTYEDK-SCVHIVMELCEGGELFDRIVKK--------------------------------------- 42 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~--------------------------------------- 42 (315)
.+.+||||+++++++... +.+++||||++||+|.+++...
T Consensus 66 ~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (338)
T cd05102 66 HIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVL 145 (338)
T ss_pred HhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcc
Confidence 345899999999988764 4689999999999999988642
Q ss_pred -----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcc
Q 021227 43 -----------------------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV 99 (315)
Q Consensus 43 -----------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~ 99 (315)
.++++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~ 222 (338)
T cd05102 146 FSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLAR 222 (338)
T ss_pred ccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeeccccc
Confidence 247788899999999999999999999999999999994 567899999999987
Q ss_pred cCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHhCCCCCCCCCC
Q 021227 100 FYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI-GIFRQILEGKIDFESEPW 173 (315)
Q Consensus 100 ~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 173 (315)
....... .....+++.|+|||++. ..++.++||||+||++|+|++ |..||.+.... .....+..+... . ..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~--~~ 299 (338)
T cd05102 223 DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-R--AP 299 (338)
T ss_pred ccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-C--CC
Confidence 6533221 12234567899999886 458999999999999999997 99999875543 333334433221 1 12
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 174 PNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 174 ~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+++++.+++.+||+.||.+|||+.++++
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 300 ENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 467899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.80 Aligned_cols=202 Identities=30% Similarity=0.543 Sum_probs=171.4
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++.++..+|+|+||+.|++|.+++.+ ..+++..+..++.|++.||+|||++|++||||+|+||++
T Consensus 73 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili--- 148 (296)
T cd06655 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL--- 148 (296)
T ss_pred cCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---
Confidence 3899999999999999999999999999999988754 468999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++........ .....|++.|+|||.+. +.++.++|+||+||++|+|++|..||.+.+.......+.
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~ 228 (296)
T cd06655 149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228 (296)
T ss_pred CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5678999999998876543322 23356889999999886 448899999999999999999999999887766555554
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
..... .......+++.++++|.+||..+|.+|||+.+++.||||....
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 229 TNGTP-ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred hcCCc-ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 33221 2222346889999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=272.36 Aligned_cols=196 Identities=27% Similarity=0.552 Sum_probs=167.8
Q ss_pred CCCCcceEEEEEEe-CCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 6 EHQHVVRIHDTYED-KSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 6 ~Hpniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
+|||++++++.+.. ++.+|+|+||++|++|.+++... ..+++.++..++.|++.|+++||+.|++||||+|+||+
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil-- 134 (257)
T cd08223 57 KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF-- 134 (257)
T ss_pred CCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEE--
Confidence 79999999998874 45689999999999999988763 45899999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
.+.++.++|+|||++...... .......|++.|+|||++. ..++.++|+||+||++|+|++|..||.+.+.......
T Consensus 135 -~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~ 213 (257)
T cd08223 135 -LTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR 213 (257)
T ss_pred -EecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 456789999999998765432 2233456899999999986 4588999999999999999999999998887776666
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+..+.... ....+++++.+++.+||+.+|.+|||+.++++||||
T Consensus 214 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 214 IIEGKLPP---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHhcCCCC---CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 66654422 124688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.82 Aligned_cols=202 Identities=30% Similarity=0.537 Sum_probs=169.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++.+.++...|+||||++|++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+||++
T Consensus 74 ~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill--- 149 (296)
T cd06654 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--- 149 (296)
T ss_pred CCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---
Confidence 4899999999999999999999999999999998854 468999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++....... ......|++.|+|||.+.+ .++.++||||+||++|+|++|+.||...+.......+.
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~ 229 (296)
T cd06654 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229 (296)
T ss_pred cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh
Confidence 567899999999887654332 1234568899999998864 48899999999999999999999998877654443333
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.... ........+++.+.+++.+||..+|.+|||+.+++.||||....
T Consensus 230 ~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 230 TNGT-PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred cCCC-CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 2221 12122346889999999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=276.62 Aligned_cols=215 Identities=27% Similarity=0.473 Sum_probs=175.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+|+||||++||+|.+++. .+++++..+..++.|++.||.|||+.+++|+||+|+||++ +
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~ 135 (277)
T cd06640 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---S 135 (277)
T ss_pred CCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---c
Confidence 89999999999999999999999999999999885 4678999999999999999999999999999999999994 5
Q ss_pred CCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.++++|||++........ .....++..|+|||++. ..++.++|+||+||++|+|++|..||...........+..
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 215 (277)
T cd06640 136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK 215 (277)
T ss_pred CCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc
Confidence 678899999999876543322 23346788999999986 4588999999999999999999999988776665555433
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHhh
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHF 229 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (315)
... ......++..+.+++.+||+.+|++|||+.++++|+||...... ......++.++++|
T Consensus 216 ~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~--~~~~~~~~~~~~~~ 276 (277)
T cd06640 216 NNP---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK--TSYLTELIDRFKRW 276 (277)
T ss_pred CCC---CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh--hhHHHHHHHHHHhc
Confidence 321 12223578899999999999999999999999999999765432 22334445555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=273.78 Aligned_cols=199 Identities=30% Similarity=0.489 Sum_probs=168.8
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.++..+|++|||+.|++|.+++... .++++..+..++.|++.||.|||++|++||||+|+||+
T Consensus 57 ~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~--- 133 (262)
T cd06613 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANIL--- 133 (262)
T ss_pred CCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEE---
Confidence 38999999999999999999999999999999988776 78999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-h---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-K---HYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
.+.++.+||+|||.+....... ......++..|+|||.+. . .++.++|+||+||++|+|++|..||...+.....
T Consensus 134 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~ 213 (262)
T cd06613 134 LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213 (262)
T ss_pred ECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4567889999999987654322 223457888999999875 3 5788999999999999999999999887766655
Q ss_pred HHHHhCCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021227 159 RQILEGKIDFES-EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206 (315)
Q Consensus 159 ~~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~ 206 (315)
..+.......+. .....++.++++++.+||..+|.+|||+.+++.|+|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 214 FLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 555444322211 112346789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=276.19 Aligned_cols=198 Identities=29% Similarity=0.459 Sum_probs=168.2
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++.++..+|+||||+.||+|.+++.+.+.+++..+..++.|++.|+.|||+.+++||||||+||+ .
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nil---i 130 (278)
T cd05606 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANIL---L 130 (278)
T ss_pred CCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEE---E
Confidence 4799999999999999999999999999999999988888999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-h-cCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-K-HYGPEADVWSAGVILYILLSGVPPFWAE---TEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~ 159 (315)
+.++.+||+|||++....... .....|+..|+|||++. + .++.++||||+||++|+|++|..||.+. .......
T Consensus 131 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~ 209 (278)
T cd05606 131 DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (278)
T ss_pred CCCCCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence 567889999999987553322 23457899999999985 3 4889999999999999999999999875 3333333
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVDD 210 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~~ 210 (315)
.+...... ....+|+++.+++.+||..+|.+|| ++.++++||||...
T Consensus 210 ~~~~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 210 MTLTMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HhhccCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 33222222 2235789999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.43 Aligned_cols=198 Identities=28% Similarity=0.460 Sum_probs=167.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.++..+|+++||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+ .
T Consensus 56 ~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~---~ 132 (256)
T cd06612 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNIL---L 132 (256)
T ss_pred CCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE---E
Confidence 899999999999999999999999999999999875 457899999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++....... ......|+..|+|||++.+ .++.++||||+||++|+|++|..||...........+.
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~ 212 (256)
T cd06612 133 NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP 212 (256)
T ss_pred CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc
Confidence 567889999999987665433 2234558889999999864 58899999999999999999999998776655444433
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
..... .......++.++.+++.+||+.+|.+|||+.+++.||||
T Consensus 213 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 213 NKPPP-TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred cCCCC-CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 32111 111123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=271.78 Aligned_cols=199 Identities=30% Similarity=0.553 Sum_probs=174.2
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+++ +||||+++++++.+.+.+++||||++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||+|+||
T Consensus 54 ~~~-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni 132 (256)
T cd08221 54 SLL-QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNI 132 (256)
T ss_pred HhC-CCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhE
Confidence 344 8999999999999999999999999999999998765 4689999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
++ +.++.+||+|||++....... ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...+..+.
T Consensus 133 ~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~ 209 (256)
T cd08221 133 FL---TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL 209 (256)
T ss_pred EE---eCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 94 567889999999987654333 3345678999999998864 478899999999999999999999999888888
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
...+..+...... ..++.++.+++.+||..+|.+|||+.++++|+|+
T Consensus 210 ~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 210 VVKIVQGNYTPVV---SVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHcCCCCCCc---cccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 8888776554332 4678999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=272.10 Aligned_cols=197 Identities=26% Similarity=0.459 Sum_probs=171.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++.+..++.+++|+||++|++|.+++.+. ..+++..+..++.|++.||+|||++|++||||+|+||++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~-- 134 (256)
T cd08220 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL-- 134 (256)
T ss_pred CCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--
Confidence 8999999999999999999999999999999999764 358999999999999999999999999999999999996
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
...++.+||+|||.+.............|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.+.......+.
T Consensus 135 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 214 (256)
T cd08220 135 DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM 214 (256)
T ss_pred cCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH
Confidence 23456789999999987655544445678999999999864 47889999999999999999999999888777777766
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+..... ...+++++++++.+||..+|.+|||+.|++.||||
T Consensus 215 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 215 SGTFAPI---SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred hcCCCCC---CCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 5543221 23578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=279.61 Aligned_cols=205 Identities=31% Similarity=0.522 Sum_probs=170.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.+++..++||||+ +|+|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus 59 ~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil--- 134 (298)
T cd07841 59 LKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLL--- 134 (298)
T ss_pred cCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEE---
Confidence 37999999999999999999999999 889999997765 7999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
.+.++.+||+|||++...... .......+++.|+|||.+.+ .++.++|+||+||++|+|++|.+||.+.+..+.+..
T Consensus 135 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~ 214 (298)
T cd07841 135 IASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK 214 (298)
T ss_pred EcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH
Confidence 456889999999998765443 22333457888999998853 478999999999999999999999988776665555
Q ss_pred HHhCCCCCC------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 021227 161 ILEGKIDFE------------------------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVA 213 (315)
Q Consensus 161 i~~~~~~~~------------------------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~ 213 (315)
+........ ...+...+.++.++|.+||+++|++|||+.+++.|+||.+....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 215 IFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred HHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 543211100 00123467899999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=292.25 Aligned_cols=202 Identities=23% Similarity=0.424 Sum_probs=161.3
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
++ +|||||++++++..++..++|||++. ++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 216 ~L-~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NIL- 292 (461)
T PHA03211 216 RL-SHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL- 292 (461)
T ss_pred HC-CCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEE-
Confidence 44 89999999999999999999999995 6888887654 56999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC-----
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE----- 152 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~----- 152 (315)
++.++.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+...
T Consensus 293 --l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~ 370 (461)
T PHA03211 293 --VNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370 (461)
T ss_pred --ECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence 4567889999999987653321 1224569999999999864 5899999999999999999987655322
Q ss_pred ---CHHHHHHHHHhCCCC---C------------------------CCCCCC---CCCHHHHHHHHHhcccCCCCCCCHH
Q 021227 153 ---TEIGIFRQILEGKID---F------------------------ESEPWP---NISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 153 ---~~~~~~~~i~~~~~~---~------------------------~~~~~~---~~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
...++.+.+...... + ....|. .++.++.+||.+||+.||.+|||+.
T Consensus 371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~ 450 (461)
T PHA03211 371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAA 450 (461)
T ss_pred cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHH
Confidence 123333333332211 0 111122 4567899999999999999999999
Q ss_pred HHhcCCCccC
Q 021227 200 EVLCHPWIVD 209 (315)
Q Consensus 200 ~~l~h~~~~~ 209 (315)
|+|+||||+.
T Consensus 451 elL~hp~f~~ 460 (461)
T PHA03211 451 ELLRLPLFQS 460 (461)
T ss_pred HHhhCcccCC
Confidence 9999999974
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=284.30 Aligned_cols=200 Identities=29% Similarity=0.495 Sum_probs=162.2
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
..|.+|.+||++|+|-..++.+|+||||=+ .+|...+.+... .+.-.++.+..|++.|+.++|.+||||.||||.|+|
T Consensus 414 ~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFL 492 (677)
T KOG0596|consen 414 NKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFL 492 (677)
T ss_pred HHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEE
Confidence 467899999999999999999999999864 489888877654 333588999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhhh------------cCCCchhHHHHHHHHHHHHhC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLRK------------HYGPEADVWSAGVILYILLSG 145 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g 145 (315)
+. .|.+||+|||.|..+.+... ..+.+||+.|||||.+.. +.+.++||||||||+|+|+.|
T Consensus 493 lV----kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYg 568 (677)
T KOG0596|consen 493 LV----KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYG 568 (677)
T ss_pred EE----eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhc
Confidence 73 58999999999988765542 235789999999998831 157789999999999999999
Q ss_pred CCCCCCCC-HHHHHHHHHhCCC--CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 146 VPPFWAET-EIGIFRQILEGKI--DFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 146 ~~pf~~~~-~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
++||.... ...-+..|..... .|+.- +. ..++.++++.||..||++|||+.++|+|||.+-
T Consensus 569 ktPf~~~~n~~aKl~aI~~P~~~Iefp~~--~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 569 KTPFGQIINQIAKLHAITDPNHEIEFPDI--PE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCchHHHHHHHHHHHhhcCCCccccccCC--CC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 99996532 4444455554422 23221 11 234999999999999999999999999999864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=275.21 Aligned_cols=199 Identities=26% Similarity=0.449 Sum_probs=165.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++..+..+|+||||+++++|.+++.+.+++++..+..++.|++.||.|||+.||+||||+|+||++
T Consensus 63 ~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill--- 139 (267)
T cd06646 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL--- 139 (267)
T ss_pred cCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---
Confidence 38999999999999999999999999999999999888889999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||++....... ......|++.|+|||.+. ..++.++|+||+||++|+|++|..||..........
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~ 219 (267)
T cd06646 140 TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF 219 (267)
T ss_pred CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe
Confidence 567889999999987653322 223456889999999873 337789999999999999999999997655443333
Q ss_pred HHHhCCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021227 160 QILEGKIDFES-EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206 (315)
Q Consensus 160 ~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~ 206 (315)
.+.......+. .....++..+.+++.+||+.+|.+|||++++++|+|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 220 LMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred eeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 33222222211 111346899999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=273.88 Aligned_cols=200 Identities=30% Similarity=0.501 Sum_probs=169.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK---GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+||||+++++.+.+++.+|+|+|++.|++|.+++... ..+++..++.++.|++.||.|||+.|++||||+|+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~ 135 (267)
T cd06610 56 CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL 135 (267)
T ss_pred cCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE
Confidence 48999999999999999999999999999999998764 458999999999999999999999999999999999994
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCc-----ccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEV-----FSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
++++.++|+|||++........ .....|+..|+|||++.. .++.++|+||+||++|+|++|+.||...+.
T Consensus 136 ---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 136 ---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred ---cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 5678899999999876543322 133568899999999863 488999999999999999999999988776
Q ss_pred HHHHHHHHhCCCC-CCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 155 IGIFRQILEGKID-FESE-PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 155 ~~~~~~i~~~~~~-~~~~-~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+....+...... +... .+..+++++++++.+||..+|++|||+.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 213 MKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred hhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 6655555544322 1111 124688999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=275.35 Aligned_cols=202 Identities=28% Similarity=0.572 Sum_probs=173.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++...+..++|+||+.|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+ .
T Consensus 73 ~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil---~ 148 (285)
T cd06648 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSIL---L 148 (285)
T ss_pred cCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEE---E
Confidence 3899999999999999999999999999999998876 67999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.++|+|||.+....... ......|++.|+|||.+.+ .++.++|+||+||++|+|++|..||...+.......+.
T Consensus 149 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~ 228 (285)
T cd06648 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228 (285)
T ss_pred cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 667899999999876543221 2233568999999999864 48899999999999999999999998888777777766
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
....... .....++..+.+++.+||+.+|++|||+.+++.||||....
T Consensus 229 ~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 229 DNLPPKL-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred hcCCCCC-cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 6532222 12234789999999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=277.07 Aligned_cols=200 Identities=26% Similarity=0.431 Sum_probs=164.2
Q ss_pred CCCCCCCcceEEEEEE------eCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 3 HLSEHQHVVRIHDTYE------DKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~------~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
++.+||||+++++++. ....+|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||+.|++||||
T Consensus 68 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl 147 (282)
T cd06636 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDI 147 (282)
T ss_pred HhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 4458999999999985 356789999999999999988653 45889999999999999999999999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~ 147 (315)
+|+||+ ++.++.++|+|||++...... .......|++.|+|||.+. ..++.++|+||+||++|+|++|..
T Consensus 148 ~~~nil---i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~ 224 (282)
T cd06636 148 KGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224 (282)
T ss_pred CHHHEE---ECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCC
Confidence 999999 456788999999998754322 2234467899999999874 247889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 148 PFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
||...........+..... .......+++++.++|.+||+.||.+|||+.|+++||||
T Consensus 225 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 225 PLCDMHPMRALFLIPRNPP--PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CccccCHHhhhhhHhhCCC--CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 9987665544443333211 112224578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=276.14 Aligned_cols=202 Identities=25% Similarity=0.471 Sum_probs=168.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++..++.+|+||||++|++|..++.+ ...+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 66 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili-- 143 (292)
T cd06644 66 CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL-- 143 (292)
T ss_pred CCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE--
Confidence 3899999999999999999999999999999887755 4578999999999999999999999999999999999994
Q ss_pred CCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
+.++.+||+|||++...... .......+++.|+|||.+. ..++.++|+||+||++|+|++|..||...+...
T Consensus 144 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 222 (292)
T cd06644 144 -TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222 (292)
T ss_pred -cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH
Confidence 56789999999988654322 2223456889999999873 236789999999999999999999998877766
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
....+...... .......++.++.+++.+||+.+|++||+++++++||||...
T Consensus 223 ~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 223 VLLKIAKSEPP-TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHhcCCCc-cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 66555543322 111224578999999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.24 Aligned_cols=199 Identities=33% Similarity=0.595 Sum_probs=166.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.++..+|+|+||+ |++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~--- 132 (286)
T cd07832 57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI--- 132 (286)
T ss_pred CCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---
Confidence 7999999999999999999999999 99999988653 579999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
+.++.++|+|||.+....... ......|+..|+|||.+.+ .++.++||||+||++|+|++|.+||.+.+..+.+..
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 133 SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 557899999999987664432 2344678999999998753 368999999999999999999999988777666555
Q ss_pred HHhCCCC-------------------CCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 161 ILEGKID-------------------FES-------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 161 i~~~~~~-------------------~~~-------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
+...... ++. ..++..+.++.++|.+||..+|.+|||++++++||||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 4432110 100 11235678999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=275.92 Aligned_cols=202 Identities=24% Similarity=0.404 Sum_probs=165.8
Q ss_pred CCCCCCCcceEEEEEEeC-----CeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 021227 3 HLSEHQHVVRIHDTYEDK-----SCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRD 73 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 73 (315)
.+.+||||+++++++... ..+|+|+||+.||+|.+++.. ...+++..++.++.|++.||+|||++|++|||
T Consensus 74 ~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~d 153 (291)
T cd06639 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRD 153 (291)
T ss_pred HhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 345899999999998753 468999999999999988753 35789999999999999999999999999999
Q ss_pred CCCCceeeccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh------cCCCchhHHHHHHHHHHHHhCC
Q 021227 74 LKPENFLFLSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK------HYGPEADVWSAGVILYILLSGV 146 (315)
Q Consensus 74 ikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~ 146 (315)
|||+||++ +.++.+||+|||++....... ......|+..|+|||++.. .++.++||||+||++|+|++|+
T Consensus 154 lkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~ 230 (291)
T cd06639 154 VKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230 (291)
T ss_pred CCHHHEEE---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCC
Confidence 99999994 567889999999987654322 2234568899999998742 2678999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 147 PPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 147 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
.||......+....+....... .......+..+.++|.+||+.+|++|||+.+++.||||+
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 231 PPLFDMHPVKTLFKIPRNPPPT-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcHHHHHHHHhcCCCCC-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 9998877766665555442211 111234678999999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=276.72 Aligned_cols=203 Identities=26% Similarity=0.385 Sum_probs=166.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK---GNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLF 81 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil~ 81 (315)
+||||+++++++..++.+|+||||++|++|..++... ..+++..+..++.|++.||.|||+ .|++||||+|+||++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~ 136 (286)
T cd06622 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV 136 (286)
T ss_pred CCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE
Confidence 8999999999999999999999999999998887653 379999999999999999999996 599999999999995
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-------cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-------HYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
+.++.+||+|||.+...... ......|++.|+|||.+.+ .++.++|+||+||++|+|++|..||.....
T Consensus 137 ---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 212 (286)
T cd06622 137 ---NGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212 (286)
T ss_pred ---CCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence 55789999999998765322 2234568889999998742 257899999999999999999999977655
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
......+.......+....+.++++++++|.+||+.+|.+||++.+++.||||.....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 213 ANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred hhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 4444333221111122223458999999999999999999999999999999976643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=279.08 Aligned_cols=204 Identities=29% Similarity=0.560 Sum_probs=171.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++.+..++..|+||||++|++|.+++. .+.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 76 l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill--- 151 (292)
T cd06658 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL--- 151 (292)
T ss_pred CCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---
Confidence 389999999999999999999999999999988774 4578999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++...... .......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.+.......+.
T Consensus 152 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 231 (292)
T cd06658 152 TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR 231 (292)
T ss_pred cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 56789999999988654322 22234568999999999864 58899999999999999999999999887766666554
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVA 213 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~ 213 (315)
.... ........++..+++++.+||..+|.+|||++++++||||......
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 232 DNLP-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred hcCC-CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 4321 1112223578999999999999999999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.69 Aligned_cols=199 Identities=25% Similarity=0.446 Sum_probs=164.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+.+++++|+||+.|++|.+++.+.+++++..+..++.|++.||+|||++|++||||+|+||++. .
T Consensus 61 ~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~ 138 (268)
T cd06630 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--S 138 (268)
T ss_pred CCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--C
Confidence 89999999999999999999999999999999998888899999999999999999999999999999999999962 2
Q ss_pred CCCCEEEeeccCcccCCCCC-----cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
.+..+||+|||.+....... ......|+..|+|||.+. ..++.++|+||+||++|+|++|..||..........
T Consensus 139 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 218 (268)
T cd06630 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA 218 (268)
T ss_pred CCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH
Confidence 33469999999987654321 112346788999999986 458899999999999999999999997544322222
Q ss_pred ---HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 160 ---QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 160 ---~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
.+..... .......+++++++++.+||..+|.+|||+.++++||||+
T Consensus 219 ~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 219 LIFKIASATT--APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHhccCC--CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 2222111 1222235789999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=277.19 Aligned_cols=205 Identities=30% Similarity=0.536 Sum_probs=169.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++..+..+|+||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||+ +
T Consensus 73 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nil---i 148 (297)
T cd06656 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNIL---L 148 (297)
T ss_pred CCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE---E
Confidence 4899999999999999999999999999999998854 56899999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.++|+|||++........ .....+++.|+|||.+. ..++.++|+||+||++|++++|..||.+.+.......+.
T Consensus 149 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~ 228 (297)
T cd06656 149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228 (297)
T ss_pred CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec
Confidence 5678999999999876543322 23456889999999986 448899999999999999999999998876544333222
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAP 214 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~ 214 (315)
... .........+++.+++++.+||..+|.+|||+.++++||||......+
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 229 TNG-TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred cCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 221 111112245788999999999999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=289.29 Aligned_cols=203 Identities=35% Similarity=0.604 Sum_probs=186.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK--KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+||.||.+-..|+.....++|||-+.| +..+.|.. +++++|.....++.||+.||.|||-+||+|+||||+|||+.
T Consensus 620 l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLa 698 (888)
T KOG4236|consen 620 LHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLA 698 (888)
T ss_pred cCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeec
Confidence 4899999999999999999999999976 55555533 47899999999999999999999999999999999999998
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.+.-..+||||||+|+.+.......+.+|||.|.|||+++ +.|...-|+||+|||+|.-++|..||.. .+++-++|
T Consensus 699 s~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQI 776 (888)
T KOG4236|consen 699 SASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQI 776 (888)
T ss_pred cCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHh
Confidence 88888999999999999998888888899999999999997 5599999999999999999999999965 35677888
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+..+-+++.+|..+|+++.+||..+|+..-.+|+|.++.|.|||++..
T Consensus 777 QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 777 QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999999999999999999999999999864
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=277.36 Aligned_cols=204 Identities=29% Similarity=0.454 Sum_probs=167.5
Q ss_pred CCCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 5 SEHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+||||+++++++.+. +.+++||||+.+ +|.+++.. ...+++..+..++.|++.||+|||+.|++||||+|+||+
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil- 140 (309)
T cd07845 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLL- 140 (309)
T ss_pred CCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE-
Confidence 3899999999999765 568999999975 78777765 367999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
.+.++.+||+|||.+...... .......+++.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+
T Consensus 141 --~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~ 218 (309)
T cd07845 141 --LTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL 218 (309)
T ss_pred --ECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 566789999999998765433 22233456788999998853 4789999999999999999999999998888777
Q ss_pred HHHHhCCCCC-------------------CCCC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 159 RQILEGKIDF-------------------ESEP-------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 159 ~~i~~~~~~~-------------------~~~~-------~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
..+....... +... ....++++.++|.+||+.||++|||+++++.||||+....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 219 DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred HHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 7665522111 1000 1235889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=273.49 Aligned_cols=195 Identities=26% Similarity=0.438 Sum_probs=161.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++..++..++|+||+++|+|..+ ..+++..+..++.|++.||.|||+.||+|+||||+||+ .+
T Consensus 57 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil---l~ 129 (279)
T cd06619 57 DSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNML---VN 129 (279)
T ss_pred CCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEE---EC
Confidence 899999999999999999999999999988644 35789999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHH
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE-------IGI 157 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~ 157 (315)
.++.+||+|||++...... ......||+.|+|||++. ..++.++|+||+||++|+|++|..||..... ...
T Consensus 130 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 208 (279)
T cd06619 130 TRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL 208 (279)
T ss_pred CCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH
Confidence 6889999999998765432 234467899999999986 4589999999999999999999999965321 122
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
...+..... +.......++++++++.+||+.+|.+||+++++++||||...
T Consensus 209 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 209 LQCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHhccCC--CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 232222211 111224578999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=273.87 Aligned_cols=194 Identities=22% Similarity=0.347 Sum_probs=166.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------------GNYSEREAAKLMKTIVGVVECCHSLG 68 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~ 68 (315)
.+||||+++++++.+....|++|||+++|+|.+++... ..+++..+..++.|++.||+|||++|
T Consensus 65 l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~ 144 (283)
T cd05048 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH 144 (283)
T ss_pred cCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 38999999999999999999999999999999998764 45788999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh
Q 021227 69 VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS 144 (315)
Q Consensus 69 ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 144 (315)
++||||||+||+ ++.++.+||+|||++....... ......+++.|+|||.+. +.++.++||||+||++|+|++
T Consensus 145 i~H~dlkp~Nil---~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~ 221 (283)
T cd05048 145 FVHRDLAARNCL---VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221 (283)
T ss_pred eeccccccceEE---EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHc
Confidence 999999999999 4567899999999987553322 123345678899999875 568999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 145 -GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 145 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
|..||.+.+..+....+..+..... ...+|+++.+++.+||+.+|.+|||+.+++++
T Consensus 222 ~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 222 YGLQPYYGFSNQEVIEMIRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999888888877776544322 24689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=273.96 Aligned_cols=197 Identities=31% Similarity=0.532 Sum_probs=169.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
++ +||||++++++++++...++|+||+.|++|.+++.+..++++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 56 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil-- 132 (258)
T cd05578 56 EL-NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL-- 132 (258)
T ss_pred hC-CCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE--
Confidence 44 899999999999999999999999999999999988788999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE---IGIF 158 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~ 158 (315)
.+.++.++|+|||.+.............|+..|+|||.+. ..++.++|+||+|+++|+|++|..||...+. ....
T Consensus 133 -~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (258)
T cd05578 133 -LDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211 (258)
T ss_pred -EcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence 5677899999999987765544445567889999999986 4479999999999999999999999987663 3333
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH--HHHhcCCCc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA--HEVLCHPWI 207 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~--~~~l~h~~~ 207 (315)
......... ....+++++.++|.+||+.+|.+||++ +|+++||||
T Consensus 212 ~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 212 AKQETADVL----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHhcccccc----CcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 332222222 223578999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=270.93 Aligned_cols=199 Identities=28% Similarity=0.468 Sum_probs=167.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++...+.+++|+||+.||+|.+++.+.+.+++..+..++.|++.||.|||++|++||||+|+||+ .+
T Consensus 66 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil---~~ 142 (272)
T cd06629 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLL---VD 142 (272)
T ss_pred CCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEE---Ec
Confidence 799999999999999999999999999999999988888999999999999999999999999999999999999 45
Q ss_pred CCCCEEEeeccCcccCCCC---CcccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
.++.++|+|||++...... .......|+..|+|||.+.. .++.++|+||+|+++|++++|..||......+...
T Consensus 143 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 222 (272)
T cd06629 143 ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF 222 (272)
T ss_pred CCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH
Confidence 6889999999998754321 11233568889999998853 37889999999999999999999997665544443
Q ss_pred HHHhC--CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 160 QILEG--KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 160 ~i~~~--~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+... ...++....+.++.++++++.+||.++|.+|||++++++|||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 223 KLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 33322 2223333345679999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=272.69 Aligned_cols=201 Identities=28% Similarity=0.462 Sum_probs=164.9
Q ss_pred CCCCCCCcceEEEEEEeCC------eEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 021227 3 HLSEHQHVVRIHDTYEDKS------CVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHR 72 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~------~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 72 (315)
++.+||||+++++++.+.. .+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||
T Consensus 58 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~ 137 (275)
T cd06608 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHR 137 (275)
T ss_pred HhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence 4558999999999997654 48999999999999988764 3579999999999999999999999999999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhC
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSG 145 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g 145 (315)
||+|+||+ .+.++.+||+|||.+...... .......|++.|+|||++. ..++.++||||+||++|+|++|
T Consensus 138 ~l~p~ni~---~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g 214 (275)
T cd06608 138 DIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214 (275)
T ss_pred CCCHHHEE---EccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC
Confidence 99999999 456789999999988654332 2223466899999999874 2367889999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 146 VPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 146 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
..||...........+....... ......++.++++++.+||..||.+|||+.+++.|||+
T Consensus 215 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 215 KPPLCDMHPMRALFKIPRNPPPT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCccccchHHHHHHhhccCCCC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 99998766655555555442211 11112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=272.35 Aligned_cols=199 Identities=39% Similarity=0.641 Sum_probs=174.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++.++.+..+|+|+||+.|++|.+++.+.+.+++..+..++.|++.||+|||+.|++||||+|+||+ .+
T Consensus 51 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil---~~ 127 (265)
T cd05579 51 QSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL---ID 127 (265)
T ss_pred CCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeE---Ec
Confidence 699999999999999999999999999999999988788999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCC---------cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 86 EDAALKATDFGLSVFYKPDE---------VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
.++.++|+|||++....... ......++..|+|||... ..++.++|+||+|+++|++++|..||......
T Consensus 128 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 207 (265)
T cd05579 128 SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207 (265)
T ss_pred CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 78899999999886543321 122356788999999875 44888999999999999999999999998888
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCCCccC
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA---HEVLCHPWIVD 209 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~---~~~l~h~~~~~ 209 (315)
+....+..+...++.. ..+++.+.+++.+||+.+|.+|||+ .++++||||.+
T Consensus 208 ~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 208 EIFQNILNGKIEWPED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHHHHhcCCcCCCcc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 8888887765554432 1358999999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=274.88 Aligned_cols=203 Identities=29% Similarity=0.470 Sum_probs=163.3
Q ss_pred CCCCCCCcceEEEEEEeCCe-----EEEEEeccCCCchhHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 021227 3 HLSEHQHVVRIHDTYEDKSC-----VHIVMELCEGGELFDRIVKK-----GNYSEREAAKLMKTIVGVVECCHSLGVFHR 72 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~-----~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 72 (315)
.+.+||||+++++++..... .|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++|++||
T Consensus 56 ~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~ 134 (295)
T cd07837 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHR 134 (295)
T ss_pred HccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 45578999999999987665 8999999986 788877543 358999999999999999999999999999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCC
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPF 149 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 149 (315)
||+|+||++. ..++.+||+|||++...... .......+++.|+|||++.+ .++.++|+||+|+++|+|++|..||
T Consensus 135 dl~~~nil~~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~ 212 (295)
T cd07837 135 DLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212 (295)
T ss_pred CCChHHEEEe--cCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC
Confidence 9999999962 23789999999998754322 22233457889999998753 4789999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCCC------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021227 150 WAETEIGIFRQILEGKIDFES------------------------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205 (315)
Q Consensus 150 ~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~ 205 (315)
.+.+..+....+......... ...+.+++++.+||.+||.++|.+|||+.+++.||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~ 292 (295)
T cd07837 213 PGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292 (295)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCC
Confidence 988776655544332111100 11245789999999999999999999999999999
Q ss_pred Ccc
Q 021227 206 WIV 208 (315)
Q Consensus 206 ~~~ 208 (315)
||+
T Consensus 293 ~~~ 295 (295)
T cd07837 293 YFD 295 (295)
T ss_pred CcC
Confidence 984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=274.90 Aligned_cols=201 Identities=28% Similarity=0.434 Sum_probs=162.5
Q ss_pred CCCCCCCcceEEEEEE-----eCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 021227 3 HLSEHQHVVRIHDTYE-----DKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRD 73 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 73 (315)
.+.+||||+++++++. ++..+++||||++||+|.+++.. ...+++..+..++.|++.||.|||+++++|||
T Consensus 70 ~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 149 (286)
T cd06638 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRD 149 (286)
T ss_pred HHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccC
Confidence 3457999999999883 45679999999999999887653 35689999999999999999999999999999
Q ss_pred CCCCceeeccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCC
Q 021227 74 LKPENFLFLSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGV 146 (315)
Q Consensus 74 ikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~ 146 (315)
|||+||++ +.++.+||+|||++....... ......|++.|+|||++. ..++.++||||+||++|+|++|.
T Consensus 150 lkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~ 226 (286)
T cd06638 150 VKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226 (286)
T ss_pred CCHHhEEE---CCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCC
Confidence 99999994 567789999999987654322 223456899999999874 23788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 147 PPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 147 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.||...........+..... ........++.++.+++.+||+.+|++|||+.++++|+||
T Consensus 227 ~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 227 PPLADLHPMRALFKIPRNPP-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCCCCchhHHHhhccccCC-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 99987765444433332211 1111112467899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=276.28 Aligned_cols=203 Identities=29% Similarity=0.595 Sum_probs=172.6
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++..++.+|+|+||++|++|.+++. ...+++..+..++.|++.||+|||+.|++||||+|+||+ .
T Consensus 75 l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nil---l 150 (297)
T cd06659 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSIL---L 150 (297)
T ss_pred CCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeE---E
Confidence 389999999999999999999999999999988664 457899999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++....... ......|++.|+|||++. ..++.++|+||+||++|+|++|..||...+..+....+.
T Consensus 151 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 230 (297)
T cd06659 151 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230 (297)
T ss_pred ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 677899999999886543322 223456899999999986 458999999999999999999999998887777666655
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
..... ....+..+++++.++|.+||+.+|.+|||++++++||||.....
T Consensus 231 ~~~~~-~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 231 DSPPP-KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred ccCCC-CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 43322 22234568899999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=262.08 Aligned_cols=203 Identities=28% Similarity=0.441 Sum_probs=173.6
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCCCCceee
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK--KGNYSEREAAKLMKTIVGVVECCH-SLGVFHRDLKPENFLF 81 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dikp~nil~ 81 (315)
.+.|+||+.+++|..+...++.||.|.. -.+.+.+ .++++|..+.++...++.||.||. ++||+|||+||+|||
T Consensus 148 ~dcpyIV~c~GyFi~n~dV~IcMelMs~--C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNIL- 224 (391)
T KOG0983|consen 148 HDCPYIVQCFGYFITNTDVFICMELMST--CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL- 224 (391)
T ss_pred cCCCeeeeeeeEEeeCchHHHHHHHHHH--HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceE-
Confidence 4689999999999999999999999943 3344433 478999999999999999999998 678999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAE-TEIG 156 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~ 156 (315)
.++.|.|||||||.+-.+......+...|-+.|||||.+. .+|+.++||||||+.++||.||+.||.+. .+.+
T Consensus 225 --lDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe 302 (391)
T KOG0983|consen 225 --LDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE 302 (391)
T ss_pred --EccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH
Confidence 6889999999999998887777667778999999999984 35999999999999999999999999984 5677
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVA 213 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~ 213 (315)
++..|.+..++ ..+.-.++|+++++|+..||++|+.+||...++|+|||+..+...
T Consensus 303 ~ltkvln~ePP-~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 303 VLTKVLNEEPP-LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred HHHHHHhcCCC-CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 88888775442 222223589999999999999999999999999999999876533
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=270.50 Aligned_cols=197 Identities=29% Similarity=0.472 Sum_probs=162.8
Q ss_pred CCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+ +..+++++||+++++|.+++.+.+.+++..+..++.|++.||+|||+.|++||||+|+||+
T Consensus 62 ~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil--- 138 (266)
T cd06651 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANIL--- 138 (266)
T ss_pred CCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE---
Confidence 89999999999876 4678999999999999999988788999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCC----CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPD----EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
.+.++.+||+|||++...... .......++..|+|||.+.+ .++.++|+||+||++|+|++|..||......+..
T Consensus 139 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~ 218 (266)
T cd06651 139 RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI 218 (266)
T ss_pred ECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH
Confidence 566788999999998754321 11223558889999999864 4889999999999999999999999877655544
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
..+...... ......+++.+++++ +||..+|++|||++|+++||||+
T Consensus 219 ~~~~~~~~~--~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 219 FKIATQPTN--PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHhcCCCC--CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 444332211 111235788999999 56778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=267.91 Aligned_cols=197 Identities=31% Similarity=0.491 Sum_probs=169.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.++..+|+|+||++|++|.+++.+.+.+++..+..++.|++.||+|||+.|++|+||+|+||+ .+
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~---~~ 136 (258)
T cd06632 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANIL---VD 136 (258)
T ss_pred CCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE---EC
Confidence 899999999999999999999999999999999988888999999999999999999999999999999999999 45
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||.+.............|++.|+|||.+. .. ++.++|+||+||++|+|++|..||...........+..
T Consensus 137 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 216 (258)
T cd06632 137 TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR 216 (258)
T ss_pred CCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence 67899999999987665444345567899999999875 33 78999999999999999999999987765555444443
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.... ......+++++++++.+||+.+|.+|||+.+++.|||+
T Consensus 217 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 217 SKEL--PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred cccC--CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 1111 11224678999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=268.49 Aligned_cols=196 Identities=25% Similarity=0.549 Sum_probs=170.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++++.+..|+|+||+.|++|.+++... ..+++..+..++.|++.|+.|||++|++|+||+|+||+
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil--- 133 (256)
T cd08218 57 KHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF--- 133 (256)
T ss_pred CCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE---
Confidence 7999999999999999999999999999999988764 35899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
.+.++.++|+|||++........ .....|++.|+|||++. +.++.++|+||+||++|+|++|..||...+..+....+
T Consensus 134 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08218 134 LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213 (256)
T ss_pred EcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH
Confidence 45678899999999876543321 22356888999999986 45788999999999999999999999988888887777
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
..+...... ..++.+++++|.+||+.+|.+||++.+++.||||
T Consensus 214 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 214 IRGSYPPVS---SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hcCCCCCCc---ccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 766543222 3578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=275.50 Aligned_cols=198 Identities=28% Similarity=0.488 Sum_probs=163.7
Q ss_pred CCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 6 EHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
+||||+++++++..+ ...|+|+||+.+ +|.+++... ..+++..++.++.|++.||+|||++|++||||+|+||+
T Consensus 62 ~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nil-- 138 (293)
T cd07843 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLL-- 138 (293)
T ss_pred CCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEE--
Confidence 799999999999877 899999999975 888888764 45999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
++.++.+||+|||++...... .......+++.|+|||.+.+ .++.++|+||+|+++|+|++|.+||.+.+......
T Consensus 139 -i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~ 217 (293)
T cd07843 139 -LNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN 217 (293)
T ss_pred -ECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 566789999999998765443 22334567889999998853 36889999999999999999999999887766655
Q ss_pred HHHhCCCCC--------------------------CCCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 160 QILEGKIDF--------------------------ESEPWPN--ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 160 ~i~~~~~~~--------------------------~~~~~~~--~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+....... ....++. +++.++++|.+||+.+|++|||+.|++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 218 KIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 543321100 0011222 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=275.04 Aligned_cols=198 Identities=27% Similarity=0.494 Sum_probs=162.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK--KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||++++++++++..+++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+.|++||||+|+||+
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nil--- 132 (284)
T cd07860 57 NHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL--- 132 (284)
T ss_pred CCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE---
Confidence 89999999999999999999999996 578888765 356899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
.+.++.+||+|||++....... ......+++.|+|||++.+ .++.++||||+||++|+|+||..||.+.+......+
T Consensus 133 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 212 (284)
T cd07860 133 INTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212 (284)
T ss_pred ECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 5677899999999987553322 2233457889999998753 368899999999999999999999988776554444
Q ss_pred HHhCCCC------------------CCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 161 ILEGKID------------------FES-------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 161 i~~~~~~------------------~~~-------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+...... ++. ...+.++++++++|.+||+.||.+|||+++++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 213 IFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 3321111 000 0123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=271.94 Aligned_cols=199 Identities=26% Similarity=0.431 Sum_probs=166.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++..++.+++|+||+.|++|.+++... ..+++..+..++.|++.||+|||+ .|++||||+|+||++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~-- 134 (265)
T cd06605 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV-- 134 (265)
T ss_pred CCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE--
Confidence 6999999999999999999999999999999999876 789999999999999999999999 999999999999994
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE-----TEIGI 157 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~ 157 (315)
+.++.++|+|||.+........ ....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||... ...+.
T Consensus 135 -~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (265)
T cd06605 135 -NSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL 212 (265)
T ss_pred -CCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHH
Confidence 5678999999998865533222 22678899999999864 5889999999999999999999999764 23334
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+.+...... ......++++++++|.+||..+|.+|||+.+++.||||+..
T Consensus 213 ~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 213 LQYIVNEPPP--RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHhcCCCC--CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 4444433211 11111278999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.52 Aligned_cols=192 Identities=19% Similarity=0.363 Sum_probs=163.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++..++..++||||+++|+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+ +
T Consensus 64 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nil---i 140 (266)
T cd05064 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVL---V 140 (266)
T ss_pred CCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEE---E
Confidence 8999999999999999999999999999999998764 57899999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCCccc--ccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFS--DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 160 (315)
+.++.+|++|||.+.......... ...++..|+|||.+. +.++.++||||+||++|++++ |..||.+.+..+....
T Consensus 141 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~ 220 (266)
T cd05064 141 NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA 220 (266)
T ss_pred cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 668899999999875543222111 233467899999886 568999999999999999775 9999999888888777
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+..+.... ....++..+.+++.+||+.+|.+|||++++++
T Consensus 221 ~~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 221 VEDGFRLP---APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHCCCCCC---CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 76653322 23468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=271.35 Aligned_cols=194 Identities=23% Similarity=0.398 Sum_probs=165.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCC
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-------------NYSEREAAKLMKTIVGVVECCHSLGV 69 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~i 69 (315)
.+ +||||+++++++.+.+.+++|+||+.+++|.+++...+ .+++..+..++.|++.||+|||++|+
T Consensus 63 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i 141 (288)
T cd05093 63 NL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF 141 (288)
T ss_pred hC-CCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44 79999999999999999999999999999999987543 48999999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-
Q 021227 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS- 144 (315)
Q Consensus 70 vH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 144 (315)
+||||||+||+ .+.++.+||+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++
T Consensus 142 ~H~dlkp~Nil---i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~ 218 (288)
T cd05093 142 VHRDLATRNCL---VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 218 (288)
T ss_pred eecccCcceEE---EccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999 56788999999999876533221 12334577899999986 458999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 145 GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 145 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|..||.+....+....+..+...... ..+++++.+++.+||+.+|.+|||+.+++.
T Consensus 219 g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 219 GKQPWYQLSNNEVIECITQGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCCCHHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999988888888888776543222 357899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=287.18 Aligned_cols=196 Identities=27% Similarity=0.484 Sum_probs=172.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.|||+|.+-++|-.+.+.++|||||-| +-.|.+.- ++++.|.+++.|..+.+.||+|||+++.||||||..|||
T Consensus 83 l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNIL--- 158 (948)
T KOG0577|consen 83 LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNIL--- 158 (948)
T ss_pred ccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceE---
Confidence 3899999999999999999999999975 67777654 468999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
.++.|.|||+|||.|....+. ++++|||+|||||++. +.|+-++||||||++..+|...++|+...+....+.
T Consensus 159 Lse~g~VKLaDFGSAsi~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY 235 (948)
T KOG0577|consen 159 LSEPGLVKLADFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 235 (948)
T ss_pred ecCCCeeeeccccchhhcCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH
Confidence 678999999999988765543 5689999999999973 679999999999999999999999998888877777
Q ss_pred HHHhCCC-CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 160 QILEGKI-DFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 160 ~i~~~~~-~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.|..... .+.. +..|..++.||..||++-|.+|||.+++|+|+|+...
T Consensus 236 HIAQNesPtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 236 HIAQNESPTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHhcCCCCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 7766543 3333 3568999999999999999999999999999999754
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=269.41 Aligned_cols=200 Identities=28% Similarity=0.530 Sum_probs=168.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
.||||+++++++.++..+|+||||+.|++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+||++ +
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~ 135 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---T 135 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---c
Confidence 599999999999999999999999999999998854 589999999999999999999999999999999999995 5
Q ss_pred CCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
..+.++|+|||.+....... ......|+..|+|||.+.+ .++.++|+||+||++|+|++|..||.+.........+.
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~ 215 (277)
T cd06917 136 NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215 (277)
T ss_pred CCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc
Confidence 68899999999987664432 2234578999999998853 36889999999999999999999998876655444333
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
... .+......+++++.+++.+||+.+|++|||+.+++.|+||+...
T Consensus 216 ~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 216 KSK--PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred cCC--CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 221 11112223789999999999999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=274.81 Aligned_cols=200 Identities=28% Similarity=0.528 Sum_probs=166.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++.+++.+|+|+||+.+++|..+....+.+++..+..++.|++.||+|||+.|++||||+|+||+ .
T Consensus 57 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~---~ 133 (286)
T cd07846 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENIL---V 133 (286)
T ss_pred cCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE---E
Confidence 3899999999999999999999999999988887766667999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.++.++|+|||++...... .......++..|+|||++.+ .++.++||||+||++|+|++|.+||.+....+....+
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~ 213 (286)
T cd07846 134 SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213 (286)
T ss_pred CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 66889999999998765433 22334568899999998853 4778999999999999999999999877655544443
Q ss_pred HhCCCCC-------------------C--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 162 LEGKIDF-------------------E--------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 162 ~~~~~~~-------------------~--------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
......+ + ...++.++..+.+++.+||+.+|.+|||+.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 214 IKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 3211100 0 01134678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=277.36 Aligned_cols=203 Identities=21% Similarity=0.328 Sum_probs=162.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.++...+++|||+.+|+|.+++.+. ..+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili-- 134 (314)
T cd08216 57 QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL-- 134 (314)
T ss_pred CCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE--
Confidence 7999999999999999999999999999999988764 468999999999999999999999999999999999994
Q ss_pred CCCCCCEEEeeccCcccCCCCC--------cccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 84 VDEDAALKATDFGLSVFYKPDE--------VFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
+.++.+|++|||.+....... ......++..|+|||++.. .++.++|+||+||++|+|++|..||...
T Consensus 135 -~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 135 -SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred -ecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 567899999999876543211 1223456788999999853 4889999999999999999999999876
Q ss_pred CHHHHHHHHHhCCCCC------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 153 TEIGIFRQILEGKIDF------------------------------ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~------------------------------~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
...........+.... .......++.++.+++.+||+.||++|||+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 293 (314)
T cd08216 214 PATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293 (314)
T ss_pred CHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh
Confidence 5443332222211100 0000112457899999999999999999999999
Q ss_pred cCCCccCCC
Q 021227 203 CHPWIVDDK 211 (315)
Q Consensus 203 ~h~~~~~~~ 211 (315)
+||||+...
T Consensus 294 ~~p~~~~~~ 302 (314)
T cd08216 294 NHSFFKQCK 302 (314)
T ss_pred cCchHhhhc
Confidence 999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.12 Aligned_cols=203 Identities=30% Similarity=0.469 Sum_probs=163.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.++..+|+||||++ ++|.+.+.... .+++..+..++.||+.||+|||++|++||||+|+||++.
T Consensus 59 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~- 136 (294)
T PLN00009 59 QHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID- 136 (294)
T ss_pred cCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE-
Confidence 89999999999999999999999996 47877776543 357888999999999999999999999999999999963
Q ss_pred CCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
..++.+||+|||++...... .......+++.|+|||++.+ .++.++||||+||++|+|+||.+||.+.+..+...+
T Consensus 137 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~ 215 (294)
T PLN00009 137 -RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215 (294)
T ss_pred -CCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 24567999999998754322 22234567889999998854 478899999999999999999999988776655554
Q ss_pred HHhCCCCC---------------------CCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 161 ILEGKIDF---------------------ESE----PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 161 i~~~~~~~---------------------~~~----~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
+....... ... ..+.+++++.+++.+||+.+|.+||++.+++.||||....
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 216 IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 43211000 000 1245789999999999999999999999999999997643
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=283.41 Aligned_cols=196 Identities=20% Similarity=0.315 Sum_probs=159.3
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----------------------------------------
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK---------------------------------------- 42 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------------------------------- 42 (315)
.+.+|||||++++++.+.+..|+|||||++|+|.+++.+.
T Consensus 97 ~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (374)
T cd05106 97 HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQ 176 (374)
T ss_pred hhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccc
Confidence 4458999999999999999999999999999999988542
Q ss_pred ------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEE
Q 021227 43 ------------------------------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKA 92 (315)
Q Consensus 43 ------------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl 92 (315)
.++++..++.++.|++.||.|||++||+||||||+||++ +.++.+||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL 253 (374)
T cd05106 177 GSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKI 253 (374)
T ss_pred ccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEE
Confidence 247888999999999999999999999999999999995 56788999
Q ss_pred eeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCC
Q 021227 93 TDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKID 167 (315)
Q Consensus 93 ~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 167 (315)
+|||++........ ..+..+++.|+|||++. +.++.++||||+||++|+|++ |..||...........+......
T Consensus 254 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~ 333 (374)
T cd05106 254 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333 (374)
T ss_pred eeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC
Confidence 99999876543321 11233456799999885 568999999999999999997 99999876554444344333322
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 168 FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 168 ~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
... ...+|+++++++.+||+.||.+|||+.++++
T Consensus 334 ~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 334 MSR--PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ccC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222 2346899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=270.03 Aligned_cols=203 Identities=24% Similarity=0.375 Sum_probs=168.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.+...+++|+||++||+|.+++.+.+.+++..+..++.|++.||.|||+ .|++||||+|+||+
T Consensus 60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil--- 136 (284)
T cd06620 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL--- 136 (284)
T ss_pred cCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEE---
Confidence 38999999999999999999999999999999998888889999999999999999999996 69999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEI------- 155 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------- 155 (315)
.+.++.++|+|||++...... ......|+..|+|||++. +.++.++|+||+||++|++++|..||......
T Consensus 137 ~~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~ 215 (284)
T cd06620 137 VNSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215 (284)
T ss_pred ECCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh
Confidence 456789999999988654322 223457899999999875 56889999999999999999999999865432
Q ss_pred ----HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 021227 156 ----GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVA 213 (315)
Q Consensus 156 ----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~ 213 (315)
+....+..... +......++.++.+++.+||+.||.+|||++|+++|+||......
T Consensus 216 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~ 275 (284)
T cd06620 216 MGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA 275 (284)
T ss_pred hHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 22333332211 111112378899999999999999999999999999999775543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=270.46 Aligned_cols=200 Identities=29% Similarity=0.518 Sum_probs=159.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+ +||||+++++++.++...|+||||+.+ +|.+++.+. +.+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus 59 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil- 135 (291)
T cd07844 59 DL-KHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLL- 135 (291)
T ss_pred hC-CCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEE-
Confidence 44 899999999999999999999999975 898888664 46899999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAET-EIGI 157 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~ 157 (315)
.+.++.+||+|||++...... .......++..|+|||++.+ .++.++||||+||++|+|++|..||.+.. ..+.
T Consensus 136 --~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~ 213 (291)
T cd07844 136 --ISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213 (291)
T ss_pred --EcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 566789999999988654321 11223456889999998853 47889999999999999999999997665 3333
Q ss_pred HHHHHhCCCC-------------------CC-------CCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 158 FRQILEGKID-------------------FE-------SEPWPNIS--ESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 158 ~~~i~~~~~~-------------------~~-------~~~~~~~s--~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
...+.+.... .. ...++.++ .++.+++.+||+.+|.+|||+.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 214 LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 3322211000 00 00112344 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=274.54 Aligned_cols=196 Identities=24% Similarity=0.356 Sum_probs=161.9
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------NYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
++.+||||+++++++.+++.+|+||||++||+|.+++.+.+ .+++..+..++.|++.||+|||+
T Consensus 63 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 142 (303)
T cd05088 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 142 (303)
T ss_pred HhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh
Confidence 45689999999999999999999999999999999986542 47899999999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHh-
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLS- 144 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~- 144 (315)
+|++||||||+||+ .+.++.+||+|||++.............++..|+|||.+.+ .++.++||||+||++|+|+|
T Consensus 143 ~gi~H~dlkp~Nil---i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 219 (303)
T cd05088 143 KQFIHRDLAARNIL---VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 219 (303)
T ss_pred CCccccccchheEE---ecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhc
Confidence 99999999999999 56678999999998864321111111234567999998864 48899999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 145 GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 145 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
|..||.+.+..+....+..+. .......+++++.+++.+||+.+|++|||+++++.+
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 220 GGTPYCGMTCAELYEKLPQGY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCcccCChHHHHHHHhcCC---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999998887777766664432 111223578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=268.94 Aligned_cols=192 Identities=21% Similarity=0.372 Sum_probs=165.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--------------NYSEREAAKLMKTIVGVVECCHSLGVFH 71 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH 71 (315)
+||||+++++++......++||||++||+|.+++...+ .+++..+..++.|++.|+.|||++|++|
T Consensus 66 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h 145 (280)
T cd05049 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVH 145 (280)
T ss_pred CCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeec
Confidence 79999999999999999999999999999999987542 4789999999999999999999999999
Q ss_pred ccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CC
Q 021227 72 RDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GV 146 (315)
Q Consensus 72 ~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~ 146 (315)
|||||+||+ .+.++.+||+|||++....... ......+++.|+|||++. +.++.++||||+||++|+|++ |.
T Consensus 146 ~dlkp~nil---i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~ 222 (280)
T cd05049 146 RDLATRNCL---VGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222 (280)
T ss_pred cccccceEE---EcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCC
Confidence 999999999 5667999999999987543222 112344578899999986 558999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 147 PPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 147 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.||.+.+..+....+..+...... ..++..+++++.+||+.+|.+|||+.|+++
T Consensus 223 ~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 223 QPWYGLSNEEVIECITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCHHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999988888888888766554332 358899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=265.82 Aligned_cols=200 Identities=29% Similarity=0.490 Sum_probs=166.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
++ +||||+++++++.+.+.+++|+||+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 55 ~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~- 132 (264)
T cd06626 55 LL-KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL- 132 (264)
T ss_pred hC-CCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE-
Confidence 44 8999999999999999999999999999999999887779999999999999999999999999999999999995
Q ss_pred cCCCCCCEEEeeccCcccCCCCCc-----ccccccCccccchhhhhh-c---CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEV-----FSDVVGSPYYVAPEVLRK-H---YGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~---~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
+.++.+||+|||++........ .....+++.|+|||++.+ . ++.++||||+|+++|++++|..||....
T Consensus 133 --~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 133 --DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred --CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 5688999999999876543322 123567889999999863 2 7889999999999999999999997653
Q ss_pred -HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 154 -EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 154 -~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.......+.. ......+.+..+++.+.+++.+||+.+|.+|||+.+++.|||+
T Consensus 211 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 211 NEFQIMFHVGA-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred chHHHHHHHhc-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 3333333333 2222223344568999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=272.18 Aligned_cols=204 Identities=26% Similarity=0.357 Sum_probs=162.3
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHH---HH--hCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCC
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDR---IV--KKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKP 76 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~---l~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp 76 (315)
++.+||||+++++++.++...+++|||+.+ ++.++ +. ..+.+++..+..++.|++.||+|||+ .|++||||||
T Consensus 58 ~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp 136 (288)
T cd06616 58 RSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKP 136 (288)
T ss_pred HhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCH
Confidence 455699999999999999999999999964 44433 22 23679999999999999999999997 4999999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh----cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK----HYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
+||++ +.++.+||+|||++.............|++.|+|||++.+ .++.++||||+||++|+|++|..||...
T Consensus 137 ~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 137 SNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred HHEEE---ccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 99994 5678899999999876544333344568899999999853 4889999999999999999999999765
Q ss_pred CH-HHHHHHHHhCC-CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 153 TE-IGIFRQILEGK-IDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 153 ~~-~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.. .+....+..+. .......+..+++++.+|+.+||+.+|.+|||++++++||||...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 214 NSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred chHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 42 22223332222 122222234589999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=271.40 Aligned_cols=199 Identities=31% Similarity=0.525 Sum_probs=164.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+++|+||+.++.+..+..+...+++..+..++.|++.||.|||+.|++||||+|+||+ .+
T Consensus 58 ~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~---~~ 134 (288)
T cd07833 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENIL---VS 134 (288)
T ss_pred CCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE---EC
Confidence 699999999999999999999999998777766666677999999999999999999999999999999999999 45
Q ss_pred CCCCEEEeeccCcccCCCCC--cccccccCccccchhhhh-h-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLR-K-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
.++.+||+|||++....... ......++..|+|||++. . .++.++|+||+|+++|+|++|.+||.+.+..+....+
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 214 (288)
T cd07833 135 ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI 214 (288)
T ss_pred CCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 68899999999987765433 334467889999999985 3 5789999999999999999999999887665544333
Q ss_pred HhCCCC-------------------CCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 162 LEGKID-------------------FESE---------PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 162 ~~~~~~-------------------~~~~---------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
...... ++.. ....+++++++++.+||..+|++|||++++++||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 215 QKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 221000 0000 011248899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=268.81 Aligned_cols=203 Identities=32% Similarity=0.526 Sum_probs=162.7
Q ss_pred CCCCCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 021227 3 HLSEHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKP 76 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp 76 (315)
++ +||||++++++|.+ .+.+|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|
T Consensus 55 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~ 133 (287)
T cd06621 55 SC-KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKP 133 (287)
T ss_pred hC-CCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 44 89999999999864 4578999999999999887653 35689999999999999999999999999999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCC---
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAE--- 152 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--- 152 (315)
+||++ +.++.++|+|||++........ ....++..|+|||.+. ..++.++||||+||++|+|++|..||...
T Consensus 134 ~nil~---~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 134 SNILL---TRKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred HHEEE---ecCCeEEEeecccccccccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 99995 5677899999999865433221 2345788999999886 45899999999999999999999999765
Q ss_pred --CHHHHHHHHHhCCCC-CCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 153 --TEIGIFRQILEGKID-FESEP--WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 153 --~~~~~~~~i~~~~~~-~~~~~--~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
...+....+...... .+... -...++++.+++.+||..+|.+|||+.|+++||||+..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 234444444432211 11111 12356889999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=269.81 Aligned_cols=192 Identities=22% Similarity=0.370 Sum_probs=164.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------NYSEREAAKLMKTIVGVVECCHSLGV 69 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~~~i 69 (315)
+||||+++++++.+....++||||++|++|.+++...+ .+++..++.++.|++.||+|||++|+
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 144 (291)
T cd05094 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF 144 (291)
T ss_pred CCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 89999999999999999999999999999999987542 38899999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-
Q 021227 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS- 144 (315)
Q Consensus 70 vH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 144 (315)
+||||||+||+ .+.++.+||+|||++........ .....++..|+|||.+. ..++.++||||+||++|+|+|
T Consensus 145 ~H~dlkp~Nil---~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 221 (291)
T cd05094 145 VHRDLATRNCL---VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 221 (291)
T ss_pred eecccCcceEE---EccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999 45678999999999875543221 22345678899999886 458899999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 145 GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 145 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|..||...+..+..+.+..+..... ....|.++.+++.+||+.+|.+|||+.++++
T Consensus 222 g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 222 GKQPWFQLSNTEVIECITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCCHHHHHHHHhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 9999988888777777766544322 2357899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=264.18 Aligned_cols=196 Identities=22% Similarity=0.358 Sum_probs=165.9
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.+...+++||||+.+|+|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus 54 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nil 132 (256)
T cd05113 54 MKL-SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCL 132 (256)
T ss_pred hcC-CCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEE
Confidence 344 8999999999999999999999999999999998764 46899999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcc--cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 156 (315)
+ +.++.+||+|||.+......... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||...+..+
T Consensus 133 i---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05113 133 V---DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209 (256)
T ss_pred E---cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 4 56789999999988765433221 1223456799999986 458899999999999999998 999998888777
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
....+..+...+.. ...++.+++++.+||+.+|.+|||+.+++.+
T Consensus 210 ~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 210 TVEKVSQGLRLYRP---HLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 77777765443322 2468999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=267.92 Aligned_cols=197 Identities=19% Similarity=0.294 Sum_probs=163.4
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-------NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
.+||||+++++++.+....++||||+.||+|.+++.+.+ .+++..+..++.||+.||+|||++|++||||||+
T Consensus 66 l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~ 145 (277)
T cd05036 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAAR 145 (277)
T ss_pred CCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchh
Confidence 389999999999999999999999999999999987653 4899999999999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAE 152 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 152 (315)
||++...+....+||+|||++........ .....++..|+|||++. ..++.++||||+||++|+|++ |..||.+.
T Consensus 146 nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 146 NCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred eEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99975444456799999999876532221 11223356799999986 559999999999999999997 99999988
Q ss_pred CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
+..+....+..... . .....+++.+.+++.+||+.+|++|||+.++++|
T Consensus 226 ~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 226 TNQEVMEFVTGGGR-L--DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CHHHHHHHHHcCCc-C--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 87777666554321 1 1124678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=271.84 Aligned_cols=201 Identities=33% Similarity=0.606 Sum_probs=168.8
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+.+||||++++++++.+..+|+|+||++|++|.+++....++++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~- 138 (290)
T cd05613 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL- 138 (290)
T ss_pred hcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE-
Confidence 4557999999999999999999999999999999999888889999999999999999999999999999999999994
Q ss_pred cCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWAET---- 153 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~---- 153 (315)
+.++.+||+|||++....... ......|+..|+|||.+.. .++.++||||+|+++|+|++|..||...+
T Consensus 139 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~ 216 (290)
T cd05613 139 --DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216 (290)
T ss_pred --CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc
Confidence 567899999999987654322 2234568899999998852 46789999999999999999999996432
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVDD 210 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~~ 210 (315)
..+....+......++ ..+++.+.+++.+||+.+|.+|| ++++++.||||...
T Consensus 217 ~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 217 QAEISRRILKSEPPYP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhhccCCCCC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 2334444443332222 35789999999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=267.90 Aligned_cols=198 Identities=28% Similarity=0.470 Sum_probs=168.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.++..+|+|+||++|++|.+++. .+.+++..+..++.|++.|+.|||+.|++|+||+|+||+ .+
T Consensus 60 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~---i~ 135 (277)
T cd06641 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVL---LS 135 (277)
T ss_pred CCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEE---EC
Confidence 89999999999999999999999999999998875 457899999999999999999999999999999999999 45
Q ss_pred CCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.++|+|||++....... ......|+..|+|||.+. ..++.++|+||+||++|+|++|..||...........+..
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 215 (277)
T cd06641 136 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK 215 (277)
T ss_pred CCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc
Confidence 67889999999886654322 123356888999999886 4578899999999999999999999988776666665544
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.... .....++.++.+++.+||+.+|.+||++.++++||||...
T Consensus 216 ~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 216 NNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred CCCC---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 3221 1123578999999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=271.14 Aligned_cols=198 Identities=30% Similarity=0.504 Sum_probs=163.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+++..|+|+||+. ++|.+++.... .+++..+..++.|++.||+|||++|++||||+|+||++
T Consensus 56 ~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~-- 132 (283)
T cd07835 56 NHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI-- 132 (283)
T ss_pred CCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE--
Confidence 79999999999999999999999995 68998887665 78999999999999999999999999999999999995
Q ss_pred CCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
+.++.++|+|||.+...... .......+++.|+|||++.+ .++.++|+||+||++|+|++|.+||.+.+.......
T Consensus 133 -~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 133 -DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred -cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 55889999999998754322 22233456889999998753 368899999999999999999999988776554444
Q ss_pred HHhCCCC-------------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 161 ILEGKID-------------------------FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 161 i~~~~~~-------------------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+.+.... ......+.+++++.+++.+||+.+|.+|||+++++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 3321100 0011134678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=312.32 Aligned_cols=200 Identities=30% Similarity=0.482 Sum_probs=172.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+|||+|++|++-.+....+|.||||+||+|.+.+...+-.+|...+.+..|+++|++|||++|||||||||.||+ +
T Consensus 1291 lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~---L 1367 (1509)
T KOG4645|consen 1291 LNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANIL---L 1367 (1509)
T ss_pred ccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCcccee---e
Confidence 4899999999999999999999999999999998877677888888999999999999999999999999999999 6
Q ss_pred CCCCCEEEeeccCcccCCCC-----CcccccccCccccchhhhhhc----CCCchhHHHHHHHHHHHHhCCCCCCC-CCH
Q 021227 85 DEDAALKATDFGLSVFYKPD-----EVFSDVVGSPYYVAPEVLRKH----YGPEADVWSAGVILYILLSGVPPFWA-ETE 154 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~-~~~ 154 (315)
+.+|.+|++|||.|..+.+. +..+...||+.|||||++.+. -.-+.|||||||+..||+||+.||.. .+.
T Consensus 1368 d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1368 DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 77889999999999877543 234567899999999999632 45689999999999999999999965 445
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
..+.-.+-.|..+..+ ..+|++.++||..||+.||++|+++.|++.|.|-+..
T Consensus 1448 ~aIMy~V~~gh~Pq~P---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1448 WAIMYHVAAGHKPQIP---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred hHHHhHHhccCCCCCc---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 5555555555443332 2499999999999999999999999999999987654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=265.55 Aligned_cols=189 Identities=27% Similarity=0.390 Sum_probs=159.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
.||||+++++++.+...+++||||++||+|.+++.+..++++..+..++.|++.||.|||++|++||||||+||+ .+
T Consensus 43 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil---~~ 119 (237)
T cd05576 43 CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL---LD 119 (237)
T ss_pred CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE---Ec
Confidence 599999999999999999999999999999999988888999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 164 (315)
.++.++++|||.+...... .....++..|+|||.+. +.++.++|+||+||++|+|++|..|+...... +. .
T Consensus 120 ~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~-~ 191 (237)
T cd05576 120 DRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----IN-T 191 (237)
T ss_pred CCCCEEEecccchhccccc--cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc-c
Confidence 6788999999987654432 23345677899999886 45889999999999999999999887643221 00 0
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCc
Q 021227 165 KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA-----HEVLCHPWI 207 (315)
Q Consensus 165 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~-----~~~l~h~~~ 207 (315)
..... ..+.+++.++++|.+||+.||.+|||+ +++++||||
T Consensus 192 ~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 HTTLN--IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccccC--CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 11111 113578999999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=295.13 Aligned_cols=195 Identities=33% Similarity=0.522 Sum_probs=163.0
Q ss_pred CCCCCCCCCcceEEE-EEEe---C---CeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--C
Q 021227 1 MHHLSEHQHVVRIHD-TYED---K---SCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLG--V 69 (315)
Q Consensus 1 l~~l~~Hpniv~~~~-~~~~---~---~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i 69 (315)
||.|..|||||.+++ .... + -.+.|.||||.||.|.|++.++ ..|+|.++.+|++|+++|+++||... |
T Consensus 88 MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPi 167 (738)
T KOG1989|consen 88 MKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPI 167 (738)
T ss_pred HHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCcc
Confidence 678999999999999 3321 1 3578999999999999999854 56999999999999999999999988 9
Q ss_pred ccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC-cc---------cccccCccccchhhhh---h-cCCCchhHHHH
Q 021227 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE-VF---------SDVVGSPYYVAPEVLR---K-HYGPEADVWSA 135 (315)
Q Consensus 70 vH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~-~~---------~~~~gt~~y~aPE~~~---~-~~~~~~Diwsl 135 (315)
||||||.+||| ++.++.+||||||.+....... .. -....|+.|+|||++. + ..+.|+|||||
T Consensus 168 IHRDLKiENvL---ls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWAL 244 (738)
T KOG1989|consen 168 IHRDLKIENVL---LSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWAL 244 (738)
T ss_pred chhhhhhhheE---EcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHH
Confidence 99999999999 6778899999999886432221 10 1234689999999984 2 38999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 136 GVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 136 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
||+||.|+....||.+.... .|..+++.+|.. +.+|..+++||..||+.||.+||++.|++.+
T Consensus 245 GclLYkLCy~t~PFe~sg~l----aIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 245 GCLLYKLCYFTTPFEESGKL----AILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HHHHHHHHHhCCCcCcCcce----eEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 99999999999999887553 466777777654 6899999999999999999999999999754
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=271.32 Aligned_cols=195 Identities=23% Similarity=0.343 Sum_probs=161.8
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------NYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
++.+||||+++++++.+.+.+|+|+||+++|+|.+++.+.. .+++..++.++.|++.||+|||+
T Consensus 58 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~ 137 (297)
T cd05089 58 KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE 137 (297)
T ss_pred hhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45579999999999999999999999999999999986532 48899999999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS- 144 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 144 (315)
+|++||||||+||++ +.++.+||+|||++..............+..|+|||++. +.++.++|||||||++|+|++
T Consensus 138 ~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~ 214 (297)
T cd05089 138 KQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSL 214 (297)
T ss_pred CCcccCcCCcceEEE---CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 999999999999995 567889999999886432211111122345799999886 458999999999999999997
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 145 GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 145 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|..||.+....+....+..+.. . .....+++++++++.+||+.+|.+|||++++++
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 215 GGTPYCGMTCAELYEKLPQGYR-M--EKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred CCCCCCCCCHHHHHHHHhcCCC-C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999888777777665422 1 112358899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=265.49 Aligned_cols=196 Identities=34% Similarity=0.590 Sum_probs=169.1
Q ss_pred CCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCccccC
Q 021227 6 EHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCH-----SLGVFHRDL 74 (315)
Q Consensus 6 ~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-----~~~ivH~di 74 (315)
+||||+++++++.. +...|+++||+++++|.+++.. ..++++..++.++.|++.||.||| +.+++||||
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl 136 (265)
T cd08217 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDL 136 (265)
T ss_pred CCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCC
Confidence 89999999998754 4678999999999999998865 357999999999999999999999 999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
+|+||++ +.++.+||+|||++........ .....|++.|+|||.+. ..++.++|+||+|+++|+|++|..||...
T Consensus 137 ~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 137 KPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred CHHHEEE---ecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 9999994 5678999999999887654433 34567899999999986 44888999999999999999999999988
Q ss_pred CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+.....+.+..+..... ...++.++.+++.+||+.+|.+|||+.++++|||+
T Consensus 214 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 214 NQLQLASKIKEGKFRRI---PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CHHHHHHHHhcCCCCCC---ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 87777777766544321 23678999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=275.80 Aligned_cols=204 Identities=29% Similarity=0.490 Sum_probs=169.6
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++..+...|+||||+. |+|.+++.....+++..+..++.|++.||+|||++|++||||+|+||+ +
T Consensus 77 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nil---l 152 (335)
T PTZ00024 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIF---I 152 (335)
T ss_pred CCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeE---E
Confidence 389999999999999999999999997 589999988888999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC---------------CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCC
Q 021227 85 DEDAALKATDFGLSVFYKPD---------------EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~ 147 (315)
+.++.+||+|||.+...... .......+++.|+|||.+.+ .++.++|+||+||++|+|++|.+
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 66789999999988654411 11123456888999998854 37899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCC------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 148 PFWAETEIGIFRQILEGKIDFESE------------------------PWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
||.+.+..+....+.......... ..+..+.++.++|.+||+.+|++|||+++++.
T Consensus 233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 999888777666654421111110 12345788999999999999999999999999
Q ss_pred CCCccCCCC
Q 021227 204 HPWIVDDKV 212 (315)
Q Consensus 204 h~~~~~~~~ 212 (315)
||||.....
T Consensus 313 ~~~~~~~~~ 321 (335)
T PTZ00024 313 HEYFKSDPL 321 (335)
T ss_pred CcccCCCCC
Confidence 999986643
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=270.11 Aligned_cols=203 Identities=29% Similarity=0.579 Sum_probs=171.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++..+++.++||||+++++|.+++ ..+.+++..+..++.|++.||+|||+.|++||||+|+||+ +
T Consensus 74 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nil---v 149 (292)
T cd06657 74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSIL---L 149 (292)
T ss_pred cCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE---E
Confidence 37999999999999999999999999999998876 4457899999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.++|+|||++....... ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.+....+....+.
T Consensus 150 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~ 229 (292)
T cd06657 150 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 229 (292)
T ss_pred CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 567889999999876553322 223356889999999885 458899999999999999999999998887766665554
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
..... .......+++.+.+++.+||+.+|.+||++.+++.||||.....
T Consensus 230 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 230 DNLPP-KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred hhCCc-ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 43221 22223467899999999999999999999999999999987663
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=267.47 Aligned_cols=194 Identities=23% Similarity=0.328 Sum_probs=163.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------NYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
.+||||+++++++.++...++||||+++|+|.+++.+.. .+++..+..++.|++.||.|||+.|++||||
T Consensus 66 l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dl 145 (277)
T cd05062 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDL 145 (277)
T ss_pred CCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCc
Confidence 389999999999999999999999999999999986532 3577889999999999999999999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPF 149 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf 149 (315)
||+||++ +.++.+||+|||++........ .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||
T Consensus 146 kp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~ 222 (277)
T cd05062 146 AARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 222 (277)
T ss_pred chheEEE---cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 9999994 5678999999999875533221 11234577899999986 458999999999999999999 78999
Q ss_pred CCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 150 WAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 150 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.+.+..+....+......... ..+++.+++++.+||+.+|++|||+.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 223 QGMSNEQVLRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCHHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 988888877777665432222 3578899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=265.75 Aligned_cols=197 Identities=28% Similarity=0.475 Sum_probs=164.0
Q ss_pred CCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+. ..+++||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 62 ~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil--- 138 (265)
T cd06652 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANIL--- 138 (265)
T ss_pred CCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE---
Confidence 899999999998763 578899999999999999988788999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCC----CcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPD----EVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
.+.++.++|+|||.+...... .......|+..|+|||++. ..++.++|+||+||++|+|++|..||.........
T Consensus 139 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 218 (265)
T cd06652 139 RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI 218 (265)
T ss_pred ecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH
Confidence 567889999999988754321 1123356888999999885 45889999999999999999999999876655555
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
..+...... ....+.++..+.+++.+|+. +|++|||++++++|||+.
T Consensus 219 ~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 219 FKIATQPTN--PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHhcCCCC--CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 444432211 11223578899999999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=271.52 Aligned_cols=198 Identities=27% Similarity=0.457 Sum_probs=167.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+|+|+||++|++|.+++. .+.+++..+..++.|++.|+.|||++|++|+||+|+||++ +
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~ 135 (277)
T cd06642 60 DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---S 135 (277)
T ss_pred CCCccHhhhcccccCCceEEEEEccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---e
Confidence 89999999999999999999999999999998874 4678999999999999999999999999999999999995 5
Q ss_pred CCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.++|+|||++........ .....|+..|+|||.+.+ .++.++|+||+||++|+|++|..||...........+..
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 215 (277)
T cd06642 136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK 215 (277)
T ss_pred CCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc
Confidence 678899999999876543322 223468889999999864 488899999999999999999999987666555544433
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.... .....++.++.+++.+||+.+|.+|||+.++++||||...
T Consensus 216 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 216 NSPP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 3221 1113578899999999999999999999999999998653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=281.07 Aligned_cols=194 Identities=23% Similarity=0.341 Sum_probs=157.7
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------------------------------
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG---------------------------------------- 43 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------------------------------- 43 (315)
+.+||||+++++++.+....++|||||+||+|.+++....
T Consensus 95 l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (375)
T cd05104 95 LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPG 174 (375)
T ss_pred hcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCC
Confidence 4489999999999999999999999999999999886421
Q ss_pred -----------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCC
Q 021227 44 -----------------------------------NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDA 88 (315)
Q Consensus 44 -----------------------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~ 88 (315)
.+++..+..++.||+.||+|||++||+||||||+||++ +.++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~ 251 (375)
T cd05104 175 VSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGR 251 (375)
T ss_pred cccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCC
Confidence 46788899999999999999999999999999999995 5678
Q ss_pred CEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHH
Q 021227 89 ALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI-GIFRQIL 162 (315)
Q Consensus 89 ~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~-~~~~~i~ 162 (315)
.+||+|||++........ .....++..|+|||++. ..++.++||||+||++|+|++ |..||.+.... .....+.
T Consensus 252 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~ 331 (375)
T cd05104 252 ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK 331 (375)
T ss_pred cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH
Confidence 899999999876543221 11233456799999986 458999999999999999998 89999876543 3334344
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+. .... ....+.++++++.+||+.||++|||+.++++
T Consensus 332 ~~~-~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 332 EGY-RMLS--PECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred hCc-cCCC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 332 2221 2346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=263.81 Aligned_cols=192 Identities=23% Similarity=0.390 Sum_probs=164.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.++..+++||||++||+|.+++... +.+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 57 ~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i--- 133 (256)
T cd05114 57 SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV--- 133 (256)
T ss_pred CCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---
Confidence 8999999999999999999999999999999988653 568999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCCcc--cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||.+......... ....++..|+|||++. ..++.++|+||+|+++|+|++ |+.||...+..+....
T Consensus 134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~ 213 (256)
T cd05114 134 SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM 213 (256)
T ss_pred cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 56788999999988765332221 1223456899999986 458899999999999999999 9999999888888888
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+..+.....+ ...+.++.+++.+||+.+|.+|||++++++
T Consensus 214 i~~~~~~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 214 ISRGFRLYRP---KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHCCCCCCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8776433222 246789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=270.35 Aligned_cols=194 Identities=20% Similarity=0.264 Sum_probs=157.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHH
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-------------------NYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-------------------~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
+||||+++++++.+.+..++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 89999999999999999999999999999999886531 36778899999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHH
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYIL 142 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 142 (315)
+||+||||||+||+ ++.++.+||+|||++........ .....++..|+|||++. +.++.++||||+||++|+|
T Consensus 157 ~~ivH~dlkp~Nil---l~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 LNFVHRDLATRNCL---VGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred CCccccCcchhheE---EcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 99999999999999 55678999999999876543321 12344578899999875 5689999999999999999
Q ss_pred Hh--CCCCCCCCCHHHHHHHHHhC----CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 143 LS--GVPPFWAETEIGIFRQILEG----KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 143 l~--g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
++ |..||.+.+..+....+... .........+.+++.+.+++.+||+.+|.+|||+.++.
T Consensus 234 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 234 LMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 86 66788877666655544321 11111112245789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=263.78 Aligned_cols=193 Identities=26% Similarity=0.378 Sum_probs=167.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK---------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKP 76 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp 76 (315)
+||||+++++++.++..+++||||++|++|.+++... ..+++..+..++.|++.||+|||++|++||||+|
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p 133 (262)
T cd00192 54 GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAA 133 (262)
T ss_pred CCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCc
Confidence 6999999999999999999999999999999999875 7799999999999999999999999999999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWA 151 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~ 151 (315)
+||+ .+.++.+||+|||.+....... ......+++.|+|||.+. ..++.++||||+||++|+|++ |..||.+
T Consensus 134 ~nil---i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 210 (262)
T cd00192 134 RNCL---VGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210 (262)
T ss_pred ceEE---ECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence 9999 5667999999999987765432 223455788999999886 468999999999999999999 6999999
Q ss_pred CCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 152 ETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 152 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
....+..+.+..+... .....+|+++.+++.+||..+|.+|||+.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 211 LSNEEVLEYLRKGYRL---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCHHHHHHHHHcCCCC---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 8888888877764322 1224578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=264.69 Aligned_cols=195 Identities=40% Similarity=0.731 Sum_probs=172.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++.++++...|+||||+.+++|.+++.+...+++..+..++.|++.||.|||+.+++|+||+|+||++ +
T Consensus 51 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~ 127 (250)
T cd05123 51 NHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---D 127 (250)
T ss_pred CCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---c
Confidence 7999999999999999999999999999999999888889999999999999999999999999999999999994 5
Q ss_pred CCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.++|+|||.+...... .......++..|+|||...+ .++.++|+||+|+++|++++|..||...+.......+..
T Consensus 128 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 207 (250)
T cd05123 128 ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207 (250)
T ss_pred CCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 6788999999998765443 23345668889999998864 478899999999999999999999988887777777766
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCCCc
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA---HEVLCHPWI 207 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~---~~~l~h~~~ 207 (315)
....++. ..+.++.+++.+||..||++|||+ +++++||||
T Consensus 208 ~~~~~~~----~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 DPLRFPE----FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCCCCC----CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 5444333 468999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=269.59 Aligned_cols=198 Identities=29% Similarity=0.548 Sum_probs=163.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK---GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
+||||+++++++.+.+..++||||+.| +|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus 56 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~-- 132 (284)
T cd07836 56 KHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLL-- 132 (284)
T ss_pred cCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE--
Confidence 899999999999999999999999985 888877654 36899999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
.+.++.++|+|||++...... .......+++.|+|||++.+ .++.++|+||+||++|+|++|..||.+.+..+...
T Consensus 133 -~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 211 (284)
T cd07836 133 -INKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211 (284)
T ss_pred -ECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 456789999999998754332 12234567889999998753 36889999999999999999999998877666555
Q ss_pred HHHhCCCCCCCC-------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 160 QILEGKIDFESE-------------------------PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 160 ~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+.......... ..+.+++++++++.+||+.+|.+|||+.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 212 KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 543321100000 012467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=266.12 Aligned_cols=199 Identities=28% Similarity=0.440 Sum_probs=160.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNY--SEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~--~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+||||+++++++.+++.+++|+||++|++|.+++... +.+ ++..+..++.|++.||+|||++||+||||||+||++
T Consensus 62 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~ 141 (268)
T cd06624 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141 (268)
T ss_pred cCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 38999999999999999999999999999999988764 455 888999999999999999999999999999999996
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWAETEIG- 156 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~- 156 (315)
. ...+.++|+|||.+....... ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.......
T Consensus 142 ~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~ 219 (268)
T cd06624 142 N--TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA 219 (268)
T ss_pred c--CCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh
Confidence 2 346789999999887553322 2233468899999999853 37889999999999999999999997543221
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
....+... .........+++++++++.+||+.+|.+|||+.+++.||||
T Consensus 220 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 220 AMFKVGMF--KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred hHhhhhhh--ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 11111110 11111223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=272.10 Aligned_cols=199 Identities=29% Similarity=0.486 Sum_probs=158.8
Q ss_pred CCCCCcceEEEEEEeCC--------eEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 021227 5 SEHQHVVRIHDTYEDKS--------CVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLK 75 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~--------~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dik 75 (315)
.+||||+++++++.... .+++||||+.+ +|.+.+.+. ..+++..+..++.|++.||+|||++|++|+||+
T Consensus 68 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~ 146 (310)
T cd07865 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMK 146 (310)
T ss_pred CCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 38999999999987643 46999999965 777777654 378999999999999999999999999999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCCCC-----cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCC
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPP 148 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~p 148 (315)
|+||+ ++.++.+||+|||++....... ......++..|+|||.+.+ .++.++||||+|+++|+|++|..|
T Consensus 147 p~nil---~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~ 223 (310)
T cd07865 147 AANIL---ITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223 (310)
T ss_pred HHHEE---ECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence 99999 5677899999999987653221 1223567889999998754 378899999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCCCCCC----------------------------CCCCHHHHHHHHHhcccCCCCCCCHHH
Q 021227 149 FWAETEIGIFRQILEGKIDFESEPW----------------------------PNISESAKDLIRKMLDQNPKRRLTAHE 200 (315)
Q Consensus 149 f~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~~li~~~l~~~p~~R~s~~~ 200 (315)
|.+.+.......+......++...+ ...++.++++|.+||..||.+|||+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 224 MQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 9887766555444332111111100 113577889999999999999999999
Q ss_pred HhcCCCc
Q 021227 201 VLCHPWI 207 (315)
Q Consensus 201 ~l~h~~~ 207 (315)
+++||||
T Consensus 304 ~l~h~~f 310 (310)
T cd07865 304 ALNHDFF 310 (310)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=276.84 Aligned_cols=204 Identities=18% Similarity=0.265 Sum_probs=161.8
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+||||++++++|+.+..+++|+||+.+|+|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 56 l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill- 134 (328)
T cd08226 56 FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI- 134 (328)
T ss_pred CCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-
Confidence 48999999999999999999999999999999988764 358999999999999999999999999999999999994
Q ss_pred cCCCCCCEEEeeccCcccCCCCCc--------ccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEV--------FSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
+..+.+|++||+.+........ .....++..|+|||++.+ .++.++||||+||++|+|++|..||.+
T Consensus 135 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 135 --SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred --eCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5678999999975432211110 011234567999999853 378999999999999999999999987
Q ss_pred CCHHHHHHHHHhCCCCCC-------------------------------------------CCCCCCCCHHHHHHHHHhc
Q 021227 152 ETEIGIFRQILEGKIDFE-------------------------------------------SEPWPNISESAKDLIRKML 188 (315)
Q Consensus 152 ~~~~~~~~~i~~~~~~~~-------------------------------------------~~~~~~~s~~~~~li~~~l 188 (315)
.........+.......+ .+....+++.+++|+.+||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 292 (328)
T cd08226 213 MLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCL 292 (328)
T ss_pred cChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHc
Confidence 765554444333211100 0111235778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCccCCC
Q 021227 189 DQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 189 ~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
+.||.+|||++++++||||....
T Consensus 293 ~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 293 QQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cCCcccCCCHHHHhhCHHHHHHH
Confidence 99999999999999999996543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=273.53 Aligned_cols=199 Identities=32% Similarity=0.525 Sum_probs=177.2
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
...|.||.+--.|+....+|+|+..|.||+|.-.|.+.+ .|+|+.++-++.+|+.||.+||+.+||+||+||+|||
T Consensus 242 V~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNIL-- 319 (591)
T KOG0986|consen 242 VSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENIL-- 319 (591)
T ss_pred hccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhhee--
Confidence 367899999999999999999999999999988887776 7999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE----IGI 157 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~ 157 (315)
.++.|+|+|+|+|+|..+..++.....+||..|||||++. +.|+...|.||+||++|+|+.|+.||..... +++
T Consensus 320 -LDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv 398 (591)
T KOG0986|consen 320 -LDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV 398 (591)
T ss_pred -eccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH
Confidence 7889999999999999998888888889999999999996 5599999999999999999999999987543 344
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~~ 210 (315)
-+.+......++ .++|++++++.+.+|++||.+|. +++++-+||||+.-
T Consensus 399 drr~~~~~~ey~----~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 399 DRRTLEDPEEYS----DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHhcchhhcc----cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 444544444444 47899999999999999999996 57899999999863
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=268.64 Aligned_cols=201 Identities=28% Similarity=0.368 Sum_probs=163.9
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSL-GVFHRDLKPEN 78 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dikp~n 78 (315)
..+||||+++++++..++..|+||||++ |+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|
T Consensus 56 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~n 134 (283)
T cd06617 56 SVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSN 134 (283)
T ss_pred HcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHH
Confidence 4589999999999999999999999997 577776653 24689999999999999999999997 99999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-----hcCCCchhHHHHHHHHHHHHhCCCCCCCC-
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-----KHYGPEADVWSAGVILYILLSGVPPFWAE- 152 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~- 152 (315)
|+ .+.++.+||+|||++.............|+..|+|||.+. ..++.++|+||+||++|+|++|+.||...
T Consensus 135 il---~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (283)
T cd06617 135 VL---INRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK 211 (283)
T ss_pred EE---ECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc
Confidence 99 5678899999999987654433333456889999999874 23688999999999999999999999653
Q ss_pred CHHHHHHHHHhC-CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 153 TEIGIFRQILEG-KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 153 ~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
...+....+..+ ....+ ...+|+++.++|.+||..+|.+|||+.+++.||||....
T Consensus 212 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 212 TPFQQLKQVVEEPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHHHHHhcCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 223333333332 22222 135789999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=288.51 Aligned_cols=201 Identities=21% Similarity=0.309 Sum_probs=155.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-----GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+|||||++++++++.+..|+|+|++. ++|.+++... .......++.++.|++.||.|||++||+||||||+|||
T Consensus 221 ~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL 299 (501)
T PHA03210 221 NHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF 299 (501)
T ss_pred CCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 89999999999999999999999995 5777766432 23456778899999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCC-C--CH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWA-E--TE 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~--~~ 154 (315)
++.++.+||+|||++..+..... .....||+.|+|||++. ..++.++||||+||++|+|++|..++.+ . ..
T Consensus 300 ---l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 300 ---LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred ---ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 56678999999999976643322 23467999999999986 4589999999999999999998765432 2 22
Q ss_pred HHHHHHHHhCCC----CCCC------------------C------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021227 155 IGIFRQILEGKI----DFES------------------E------PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206 (315)
Q Consensus 155 ~~~~~~i~~~~~----~~~~------------------~------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~ 206 (315)
...+..+..... .++. . ....++.++.++|.+||+.||.+|||+.|+|.|||
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 222222222100 0000 0 00135678889999999999999999999999999
Q ss_pred ccCC
Q 021227 207 IVDD 210 (315)
Q Consensus 207 ~~~~ 210 (315)
|...
T Consensus 457 f~~~ 460 (501)
T PHA03210 457 FSAE 460 (501)
T ss_pred hhcC
Confidence 9754
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=263.18 Aligned_cols=192 Identities=24% Similarity=0.286 Sum_probs=162.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||++++++++. ..+++||||+.+|+|.+++.+.+.+++..+..++.|++.||+|||++|++||||||.||++
T Consensus 53 l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill--- 128 (257)
T cd05116 53 LDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL--- 128 (257)
T ss_pred CCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---
Confidence 389999999998864 4678999999999999999888889999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
+.++.+||+|||++........ .....+++.|+|||.+. ..++.++|+||+||++|+|++ |..||.+.+..+..
T Consensus 129 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 208 (257)
T cd05116 129 VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208 (257)
T ss_pred cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 5678899999999876543321 11223457899999886 458889999999999999998 99999988888877
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+.++... + ....++++++++|.+||+.||++|||+.++..
T Consensus 209 ~~i~~~~~~-~--~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 209 QMIESGERM-E--CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHCCCCC-C--CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 777765432 1 22468999999999999999999999988853
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=268.28 Aligned_cols=202 Identities=32% Similarity=0.567 Sum_probs=172.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++..+...|+|+||+.|++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus 72 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~--- 148 (286)
T cd06614 72 CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNIL--- 148 (286)
T ss_pred CCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEE---
Confidence 389999999999999999999999999999999998876 8999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
.+.++.++|+|||++....... ......+++.|+|||.+. ..++.++|+||+||++|+|++|..||...+.......+
T Consensus 149 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~ 228 (286)
T cd06614 149 LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228 (286)
T ss_pred EcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4567899999999876543322 223445788999999886 44889999999999999999999999887776665555
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
...... .......++.+++++|.+||+.+|.+|||+.+++.|+||...
T Consensus 229 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 229 TTKGIP-PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HhcCCC-CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 543322 112223478999999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=266.17 Aligned_cols=195 Identities=24% Similarity=0.368 Sum_probs=161.3
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------NYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
++.+||||+++++++...+.+|+||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+
T Consensus 51 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~ 130 (270)
T cd05047 51 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 130 (270)
T ss_pred hhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45589999999999999999999999999999999986532 47899999999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS- 144 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 144 (315)
+|++||||||+||+ .+.++.+||+|||++..............+..|+|||++. ..++.++|||||||++|+|++
T Consensus 131 ~~i~H~dikp~nil---i~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~ 207 (270)
T cd05047 131 KQFIHRDLAARNIL---VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 207 (270)
T ss_pred CCEeecccccceEE---EcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999999 5678899999999885332111111122356799999885 458899999999999999997
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 145 GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 145 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|..||.+.+..+....+..+. .. .....++.++.+++.+||..+|.+|||+.+++.
T Consensus 208 g~~pf~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 208 GGTPYCGMTCAELYEKLPQGY-RL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCccccCHHHHHHHHhCCC-CC--CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 999998888777777665432 11 122357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=264.97 Aligned_cols=199 Identities=29% Similarity=0.483 Sum_probs=171.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++..++.+++|+||++|++|.+++.....+++..+..++.|++.|++|||+ .|++||||+|+||+ +
T Consensus 57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~---~ 133 (264)
T cd06623 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLL---I 133 (264)
T ss_pred CCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEE---E
Confidence 6999999999999999999999999999999999888889999999999999999999999 99999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcc-cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVF-SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAE---TEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~ 159 (315)
+.++.++|+|||.+......... ....++..|+|||.+. +.++.++|+||||+++|+|++|..||... ...+...
T Consensus 134 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (264)
T cd06623 134 NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ 213 (264)
T ss_pred CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH
Confidence 66889999999998766443322 2456889999999886 45888999999999999999999999776 4455555
Q ss_pred HHHhCCCCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 160 QILEGKIDFESEPWPN-ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~-~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+........ ... ++..+.++|.+||..+|++|||+.++++|||++..
T Consensus 214 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 214 AICDGPPPSL---PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHhcCCCCCC---CcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 5554322211 123 78999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=263.39 Aligned_cols=193 Identities=28% Similarity=0.537 Sum_probs=166.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++++++.+|+|+||++||+|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+
T Consensus 56 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nil--- 132 (255)
T cd08219 56 KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIF--- 132 (255)
T ss_pred CCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEE---
Confidence 8999999999999999999999999999999988653 45899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
.+.++.++++|||.+....... ......|++.|+|||++. ..++.++|+||+|+++|+|++|..||...+.......+
T Consensus 133 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 212 (255)
T cd08219 133 LTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212 (255)
T ss_pred ECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH
Confidence 4667899999999987654322 223466899999999986 44889999999999999999999999988877777777
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
..+.....+ ..++..+++++.+||+.+|.+|||+.+++.-
T Consensus 213 ~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 213 CQGSYKPLP---SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred hcCCCCCCC---cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 665543222 3578999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=263.82 Aligned_cols=198 Identities=27% Similarity=0.530 Sum_probs=168.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+||||+++++.+.++..+|+|+||+.+++|.+++.+.. .+++..+..++.|++.||.|||+.+++|+||+|+||++.
T Consensus 56 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~ 135 (257)
T cd08225 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS 135 (257)
T ss_pred CCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc
Confidence 389999999999999999999999999999999887643 479999999999999999999999999999999999962
Q ss_pred cCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
+....+||+|||.+....... ......|++.|+|||++. ..++.++|+||+|+++|++++|..||...+..+....
T Consensus 136 --~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 213 (257)
T cd08225 136 --KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213 (257)
T ss_pred --CCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 233467999999887654332 223356889999999886 4588999999999999999999999988777776666
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+..+..... .+.++.++++++.+||..+|++|||+.++++||||
T Consensus 214 ~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 214 ICQGYFAPI---SPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhcccCCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 655443322 24578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=278.03 Aligned_cols=199 Identities=29% Similarity=0.481 Sum_probs=161.0
Q ss_pred CCCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 5 SEHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
.+||||++++++|... ...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++|++||||||+|
T Consensus 72 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~N 148 (353)
T cd07850 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 148 (353)
T ss_pred cCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 3899999999998644 357999999965 787777544 8999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|+ .+.++.+||+|||++.............+++.|+|||.+. ..++.++||||+||++|+|++|..||.+.+....
T Consensus 149 il---~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~ 225 (353)
T cd07850 149 IV---VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225 (353)
T ss_pred EE---ECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99 5667899999999998765444444567889999999986 4589999999999999999999999988776554
Q ss_pred HHHHHhCCCC----------------------CC---------CC--------CCCCCCHHHHHHHHHhcccCCCCCCCH
Q 021227 158 FRQILEGKID----------------------FE---------SE--------PWPNISESAKDLIRKMLDQNPKRRLTA 198 (315)
Q Consensus 158 ~~~i~~~~~~----------------------~~---------~~--------~~~~~s~~~~~li~~~l~~~p~~R~s~ 198 (315)
+..+...... .. .. .....++.++++|.+||+.||++|||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 305 (353)
T cd07850 226 WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV 305 (353)
T ss_pred HHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH
Confidence 4444321100 00 00 011346678999999999999999999
Q ss_pred HHHhcCCCccC
Q 021227 199 HEVLCHPWIVD 209 (315)
Q Consensus 199 ~~~l~h~~~~~ 209 (315)
.|+|.||||..
T Consensus 306 ~eiL~~~~~~~ 316 (353)
T cd07850 306 DDALQHPYINV 316 (353)
T ss_pred HHHhcChhHhh
Confidence 99999998864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=280.21 Aligned_cols=199 Identities=33% Similarity=0.599 Sum_probs=185.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+.|.||++|-.|.+....|+.||-|-||.|+..+..++.|.+..++-++.=+++|+.|||++|||+|||||+|.+ .+
T Consensus 478 ~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENll---Ld 554 (732)
T KOG0614|consen 478 RSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLL---LD 554 (732)
T ss_pred CchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhee---ec
Confidence 689999999999999999999999999999999999999999999999999999999999999999999999999 78
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 164 (315)
.+|.+||+|||+|+.+..+....+++|||.|.|||++. +..+.++|.||||+++|||++|.+||.+.++...+..|.++
T Consensus 555 ~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG 634 (732)
T KOG0614|consen 555 NRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG 634 (732)
T ss_pred cCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh
Confidence 89999999999999999998889999999999999874 56889999999999999999999999999999999999987
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 165 KIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 165 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
.-....+ +.++..+.++|+++...+|.+|.. +.++-+|.||..
T Consensus 635 id~i~~P--r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 635 IDKIEFP--RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred hhhhhcc--cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 5433332 468999999999999999999985 899999999964
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=263.42 Aligned_cols=192 Identities=23% Similarity=0.338 Sum_probs=163.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++..+..+++||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil--- 136 (263)
T cd05052 60 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL--- 136 (263)
T ss_pred CCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE---
Confidence 8999999999999999999999999999999998654 35899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCccc--ccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFS--DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
.+.++.+||+|||++.......... ...+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 137 ~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~ 216 (263)
T cd05052 137 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 216 (263)
T ss_pred EcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 4678899999999987654332211 123456799999886 458899999999999999998 999999888877777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+.. ......+|+++.+++.+||+.+|++|||+.++++
T Consensus 217 ~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 217 LLEKGYR---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHCCCC---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7665421 2222468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=277.46 Aligned_cols=207 Identities=29% Similarity=0.483 Sum_probs=166.0
Q ss_pred CCCCCCCCcceEEEEEE----eCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 2 HHLSEHQHVVRIHDTYE----DKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
+++ +||||+++++++. +...+|+|+||+. |+|.+++...+.+++..+..++.|++.||+|||++||+||||||+
T Consensus 59 ~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~ 136 (334)
T cd07855 59 RHF-KHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPS 136 (334)
T ss_pred Hhc-CCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 344 7999999999886 3457899999995 589888877778999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCC-----cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
||+ .+.++.+||+|||++....... ......|+..|+|||.+.+ .++.++||||+||++|+|++|+.||.
T Consensus 137 Nil---~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 137 NLL---VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred HEE---EcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence 999 5678899999999987653322 1224578899999998753 48899999999999999999999998
Q ss_pred CCCHHHHHHHHHhCC-----------------------CCCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 151 AETEIGIFRQILEGK-----------------------IDFESE----PWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 151 ~~~~~~~~~~i~~~~-----------------------~~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+.+.......+.... ...... .++..+++++++|.+||+.+|.+|||+.+++.
T Consensus 214 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 214 GKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred CCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 776544333222210 000011 12457899999999999999999999999999
Q ss_pred CCCccCCCCC
Q 021227 204 HPWIVDDKVA 213 (315)
Q Consensus 204 h~~~~~~~~~ 213 (315)
||||......
T Consensus 294 ~~~~~~~~~~ 303 (334)
T cd07855 294 HPFLAQYHDP 303 (334)
T ss_pred ChhhhhccCC
Confidence 9999765443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=269.06 Aligned_cols=198 Identities=37% Similarity=0.663 Sum_probs=172.9
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
++.+||||+++++++.+++.+++||||+.+++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 57 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~-- 134 (280)
T cd05581 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENIL-- 134 (280)
T ss_pred hcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE--
Confidence 443599999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCC---------------------cccccccCccccchhhhh-hcCCCchhHHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE---------------------VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILY 140 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ 140 (315)
++.++.++|+|||++....... ......|+..|+|||+.. ..++.++|+||+|++++
T Consensus 135 -i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~ 213 (280)
T cd05581 135 -LDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIY 213 (280)
T ss_pred -ECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHH
Confidence 4567899999999987654322 112345788999999875 45888999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCc
Q 021227 141 ILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA----HEVLCHPWI 207 (315)
Q Consensus 141 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~----~~~l~h~~~ 207 (315)
++++|..||...+....+..+......++. .+++.+.+++.+||+.+|.+|||+ +++++||||
T Consensus 214 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 214 QMLTGKPPFRGSNEYLTFQKILKLEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHhCCCCCCCccHHHHHHHHHhcCCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 999999999988877777777655544443 578999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=259.54 Aligned_cols=197 Identities=34% Similarity=0.562 Sum_probs=167.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++..+...++++||++|++|.+++... ..+++..+..++.|++.||.+||+.|++||||+|+||++
T Consensus 55 ~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i--- 131 (253)
T cd05122 55 KHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL--- 131 (253)
T ss_pred CCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---
Confidence 6999999999999999999999999999999998776 689999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
+.++.++|+|||.+.............|+..|+|||.+. ..++.++|+||+|+++|+|++|..||...+.......+..
T Consensus 132 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 211 (253)
T cd05122 132 TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT 211 (253)
T ss_pred ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Confidence 567899999999987765543234567889999999986 4478899999999999999999999988755554444443
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~ 206 (315)
..... ......++..+.+++.+||+.+|++|||+.+++.|||
T Consensus 212 ~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 NGPPG-LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred cCCCC-cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 22111 1111234899999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=265.70 Aligned_cols=198 Identities=32% Similarity=0.534 Sum_probs=165.5
Q ss_pred CCCCcceEEEEEEeCCe-----EEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 6 EHQHVVRIHDTYEDKSC-----VHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~-----~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+||||+++++++.+... ++++|||+.+ +|.+++.+.. .+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus 59 ~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~n 137 (287)
T cd07838 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQN 137 (287)
T ss_pred CCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence 69999999999988776 9999999975 7888886643 58999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|++ +.++.+||+|||.+.............++..|+|||++. ..++.++|+||+||++|+|++|.+||.+.+..+.
T Consensus 138 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~ 214 (287)
T cd07838 138 ILV---TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ 214 (287)
T ss_pred EEE---ccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH
Confidence 994 566899999999987765444444456788999999986 4588999999999999999999999998887777
Q ss_pred HHHHHhCCCC-----CC------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 158 FRQILEGKID-----FE------------------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 158 ~~~i~~~~~~-----~~------------------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
...+...... ++ ....+.+++.+.+++.+||+.||.+||++.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 215 LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 6666542110 00 00112456889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=286.62 Aligned_cols=192 Identities=25% Similarity=0.434 Sum_probs=170.6
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--------------NYSEREAAKLMKTIVGVVECCHSLGVF 70 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~iv 70 (315)
.+|||||++++++..++.+|+|+|||..|+|.+++..++ +++..+...|+.||+.|+.||-++.+|
T Consensus 546 l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FV 625 (774)
T KOG1026|consen 546 LQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFV 625 (774)
T ss_pred ccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCccc
Confidence 489999999999999999999999999999999986432 288999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccc---cccCccccchhhh-hhcCCCchhHHHHHHHHHHHHh-C
Q 021227 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD---VVGSPYYVAPEVL-RKHYGPEADVWSAGVILYILLS-G 145 (315)
Q Consensus 71 H~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~---~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~-g 145 (315)
||||...|+| ++++..|||+|||+++.....+.... ..-..+|||||.+ .++++.++||||+||++||+++ |
T Consensus 626 HRDLATRNCL---Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 626 HRDLATRNCL---VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred ccchhhhhce---eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccc
Confidence 9999999999 77899999999999987765543221 2234689999987 4889999999999999999997 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 146 VPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 146 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
..||.+-+.+++++.|.+++. ++.+ .++|.++.+||..||+.+|++|||++|+-
T Consensus 703 ~QPy~glSn~EVIe~i~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 703 KQPYYGLSNQEVIECIRAGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCcccccchHHHHHHHHcCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999999999999999999988 4333 47999999999999999999999999873
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=268.59 Aligned_cols=198 Identities=26% Similarity=0.465 Sum_probs=165.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.++...|+|+||+.| ++.+.+.. .+.+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus 72 l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl--- 147 (307)
T cd06607 72 LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNIL--- 147 (307)
T ss_pred CCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEE---
Confidence 3899999999999999999999999975 66666654 457999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
.+.++.+||+|||++...... ....|++.|+|||++. +.++.++||||+|+++|+|++|..||.+.+......
T Consensus 148 ~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~ 224 (307)
T cd06607 148 LTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (307)
T ss_pred ECCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH
Confidence 566789999999988654332 3456888999999873 458889999999999999999999998877766555
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.+..... +......++.++++++.+||+.+|.+|||+.+++.||||....
T Consensus 225 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 225 HIAQNDS--PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHhcCCC--CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 5443321 1111234688999999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=266.54 Aligned_cols=198 Identities=28% Similarity=0.495 Sum_probs=156.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.++...|+|+||+. ++|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 61 ~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~--- 136 (291)
T cd07870 61 KHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--- 136 (291)
T ss_pred CCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---
Confidence 89999999999999999999999996 566666654 3568899999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETE-IGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~ 160 (315)
+.++.+||+|||++...... .......+++.|+|||.+.+ .++.++||||+||++|+|++|..||.+.+. .+.+..
T Consensus 137 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 216 (291)
T cd07870 137 SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216 (291)
T ss_pred cCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Confidence 56789999999988754322 22234557899999998853 478899999999999999999999976543 222222
Q ss_pred HHhCC--------------CCCCC------------CCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 161 ILEGK--------------IDFES------------EPWP--NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 161 i~~~~--------------~~~~~------------~~~~--~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+.... ..+.. ..+. ..++++.+++.+||..||.+|||+.|++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 21100 00000 0011 136789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=267.43 Aligned_cols=197 Identities=21% Similarity=0.335 Sum_probs=162.0
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+++.+||||+++++++...+..|+||||+.+|+|.+++.+.. .+++..+..++.|++.||.|||++|++|+||||+||
T Consensus 93 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Ni 172 (302)
T cd05055 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172 (302)
T ss_pred HhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceE
Confidence 345589999999999999999999999999999999987643 389999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETE 154 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 154 (315)
++ +.++.+||+|||++........ .....+++.|+|||.+. +.++.++||||+||++|+|++ |..||.+...
T Consensus 173 l~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~ 249 (302)
T cd05055 173 LL---THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249 (302)
T ss_pred EE---cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc
Confidence 95 5678899999999876543221 11234567899999886 458999999999999999998 9999988765
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+.+........... .....++++.+++.+||+++|++|||+.+++.
T Consensus 250 ~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 250 DSKFYKLIKEGYRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred hHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 554444433322222 22357899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=264.71 Aligned_cols=198 Identities=24% Similarity=0.347 Sum_probs=164.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------NYSEREAAKLMKTIVGVVECCHSLGVFHRDLK 75 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dik 75 (315)
+||||+++++++.+....|+||||+++|+|.+++.+.+ ..+...+..++.|++.||.|||++|++|||||
T Consensus 67 ~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dik 146 (288)
T cd05061 67 TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLA 146 (288)
T ss_pred CCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCC
Confidence 89999999999999999999999999999999996532 34567889999999999999999999999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCC
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFW 150 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~ 150 (315)
|+||++ +.++.+||+|||+++....... .....++..|+|||.+. +.++.++|+||+||++|+|++ |..||.
T Consensus 147 p~nili---~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 147 ARNCMV---AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred hheEEE---cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 999994 5678999999999875433221 11234567899999986 558999999999999999998 789998
Q ss_pred CCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCccC
Q 021227 151 AETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC------HPWIVD 209 (315)
Q Consensus 151 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~------h~~~~~ 209 (315)
+....+....+..+...... ..+++.+++++.+||+.+|++|||+.++++ ||||..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 224 GLSNEQVLKFVMDGGYLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCHHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 88877777766654332211 256899999999999999999999999986 888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=268.31 Aligned_cols=195 Identities=22% Similarity=0.339 Sum_probs=163.4
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------------GNYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
.+.+||||+++++++.+++.+|+||||+.+|+|.+++... ..+++..+..++.|++.||.|||+
T Consensus 73 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 152 (314)
T cd05099 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES 152 (314)
T ss_pred hccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 4557999999999999999999999999999999998653 348889999999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHH
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYIL 142 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 142 (315)
+|++||||||+||++ +.++.+||+|||.++....... .....++..|+|||++. +.++.++||||+||++|+|
T Consensus 153 ~gi~H~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el 229 (314)
T cd05099 153 RRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229 (314)
T ss_pred CCeeeccccceeEEE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHH
Confidence 999999999999995 5678999999999976543211 11223456799999986 4589999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 143 LS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 143 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
++ |..||.+.+..+....+..+... .....++.++++++.+||+.+|.+|||+.++++
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 230 FTLGGSPYPGIPVEELFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99 89999988888777777655321 122467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=260.10 Aligned_cols=192 Identities=26% Similarity=0.363 Sum_probs=159.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+...+|+||||+.|++|.+++.+.+ .+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 51 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~--- 127 (252)
T cd05084 51 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV--- 127 (252)
T ss_pred CCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---
Confidence 89999999999999999999999999999999987654 58999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCCccc---ccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFS---DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||++.......... ...++..|+|||.+. +.++.++||||+||++|++++ |..||..........
T Consensus 128 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~ 207 (252)
T cd05084 128 TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207 (252)
T ss_pred cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH
Confidence 567889999999987543321111 112245699999886 458999999999999999997 999998777666665
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+...... .....++..+.+++.+||+.+|++|||+.++++
T Consensus 208 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 208 AIEQGVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHcCCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55543221 122357899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=275.34 Aligned_cols=201 Identities=31% Similarity=0.482 Sum_probs=164.1
Q ss_pred CCCCcceEEEEEEeC-----CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDK-----SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+||||+++++++... ...|+|+||+. ++|.+++...+++++..+..++.|++.||.|||++|++||||||+||+
T Consensus 62 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil 140 (337)
T cd07858 62 DHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLL 140 (337)
T ss_pred CCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 899999999988654 35899999996 689888888888999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
.+.++.+||+|||++...... .......++..|+|||.+. ..++.++||||+||++|+|++|++||.+.+....
T Consensus 141 ---~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 217 (337)
T cd07858 141 ---LNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ 217 (337)
T ss_pred ---EcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 456789999999998765433 2234456889999999875 3588999999999999999999999987665443
Q ss_pred HHHHHhCCC-----------------------CCC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKI-----------------------DFE----SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~-----------------------~~~----~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
...+..... ..+ ....+.++++++++|.+||+.+|.+|||++++++||||...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 218 LKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 333221000 000 01134688999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=260.41 Aligned_cols=196 Identities=29% Similarity=0.580 Sum_probs=170.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+|||++++++.+.++...++|+||++|++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 57 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~ 136 (258)
T cd08215 57 NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL 136 (258)
T ss_pred CCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE
Confidence 7999999999999999999999999999999988763 679999999999999999999999999999999999995
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
+.++.++|+|||.+....... ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||...+..+...
T Consensus 137 ---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 213 (258)
T cd08215 137 ---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL 213 (258)
T ss_pred ---cCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH
Confidence 567899999999987654433 233457889999999875 458899999999999999999999998888777777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
..........+ ..++.++.+++.+||..+|++|||+.++++||||
T Consensus 214 ~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 214 KILKGQYPPIP---SQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 76655433222 2678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=275.44 Aligned_cols=204 Identities=34% Similarity=0.507 Sum_probs=171.6
Q ss_pred CCCCcceEEEEEEeCC-----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDKS-----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+||||+++++++.+.. .+|+||||+. ++|.+++.+..++++..+..++.|++.||+|||++||+||||||+||+
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nil 135 (330)
T cd07834 57 RHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNIL 135 (330)
T ss_pred CCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 7999999999998775 7999999997 489888887778999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhh-h-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLR-K-HYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
++.++.++|+|||.+....... ......+++.|+|||.+. . .++.++|+||+|+++|+|++|.+||.+.+.
T Consensus 136 ---i~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 136 ---VNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred ---EcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 5567999999999988765432 234456889999999985 3 588999999999999999999999999887
Q ss_pred HHHHHHHHhCCCCCCCC---------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 155 IGIFRQILEGKIDFESE---------------------------PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~---------------------------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+....+......++.. ..+.+++++.++|.+||+++|.+|||+++++.||||
T Consensus 213 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 77666665532211111 123468899999999999999999999999999999
Q ss_pred cCCCCC
Q 021227 208 VDDKVA 213 (315)
Q Consensus 208 ~~~~~~ 213 (315)
......
T Consensus 293 ~~~~~~ 298 (330)
T cd07834 293 AQLHDP 298 (330)
T ss_pred Hhhccc
Confidence 865544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=267.85 Aligned_cols=201 Identities=32% Similarity=0.537 Sum_probs=167.0
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+.+||||+++++++.+++..|+||||+ +|+|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+
T Consensus 53 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~ 131 (283)
T cd07830 53 KLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLL 131 (283)
T ss_pred hccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence 4434999999999999999999999999 779998887764 7899999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
.+.++.++|+|||.+.............++..|+|||++. ..++.++|+||+|+++++|++|.+||.+.+..+..
T Consensus 132 ---i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~ 208 (283)
T cd07830 132 ---VSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL 208 (283)
T ss_pred ---EcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH
Confidence 5668999999999988765544445567899999999874 34789999999999999999999999887765555
Q ss_pred HHHHhCCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 159 RQILEGKIDFES--------------------------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 159 ~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
..+......... ...+..++++.+++.+||+.+|.+|||++|++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 209 YKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 443321111000 0112346889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.20 Aligned_cols=194 Identities=22% Similarity=0.359 Sum_probs=163.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.+.+..|+||||++|++|.+++..+ +.+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~--- 132 (256)
T cd05059 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCL--- 132 (256)
T ss_pred CCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEE---
Confidence 38999999999999999999999999999999998764 46899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcc--cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
.+.++.+||+|||.+......... ....++..|+|||.+. ..++.++|+||+|+++|++++ |..||.+.+..+...
T Consensus 133 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05059 133 VGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE 212 (256)
T ss_pred ECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Confidence 456789999999998765432211 1122345799999886 558999999999999999998 899998888777777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.+..+... .....+|+++.+++.+||..+|++|||+.++++.
T Consensus 213 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 213 SVSAGYRL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHcCCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 76654221 1224579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=263.63 Aligned_cols=192 Identities=20% Similarity=0.349 Sum_probs=162.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG---------------NYSEREAAKLMKTIVGVVECCHSLGVF 70 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~iv 70 (315)
+||||+++++++.+...+++||||+.+|+|.+++...+ .+++..+..++.|++.|++|||++|++
T Consensus 65 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~ 144 (280)
T cd05092 65 QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFV 144 (280)
T ss_pred CCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 89999999999999999999999999999999987643 488999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-C
Q 021227 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-G 145 (315)
Q Consensus 71 H~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g 145 (315)
||||||+||++ ++++.+||+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++ |
T Consensus 145 H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 221 (280)
T cd05092 145 HRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYG 221 (280)
T ss_pred cccccHhhEEE---cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCC
Confidence 99999999995 5678999999999865433221 12234567899999876 458999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 146 VPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 146 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+||......+....+..+.... ....+|+.+.+++.+||+.||.+||++.+++.
T Consensus 222 ~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 222 KQPWYQLSNTEAIECITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCCCccCCHHHHHHHHHcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99998877777777766554321 22368899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=267.73 Aligned_cols=196 Identities=23% Similarity=0.362 Sum_probs=164.4
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------------GNYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
++.+||||+++++++..++.+++||||+.+|+|.+++... +.+++..+..++.|++.||+|||+
T Consensus 71 ~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 150 (293)
T cd05053 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS 150 (293)
T ss_pred hhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 3448999999999999999999999999999999998542 468899999999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHH
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYIL 142 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 142 (315)
+||+||||||+||++ +.++.+||+|||++........ .....++..|+|||++. ..++.++||||+||++|++
T Consensus 151 ~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 227 (293)
T cd05053 151 KKCIHRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227 (293)
T ss_pred CCccccccceeeEEE---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHH
Confidence 999999999999994 5678999999999876543321 11223456799999875 5589999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 143 LS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 143 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
++ |..||.+....+....+..+... . ....++.++.+++.+||..+|++|||+.+++++
T Consensus 228 ~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 228 FTLGGSPYPGIPVEELFKLLKEGYRM-E--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred hcCCCCCCCCCCHHHHHHHHHcCCcC-C--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 97 99999988887777776655322 1 123578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=275.19 Aligned_cols=202 Identities=32% Similarity=0.534 Sum_probs=167.3
Q ss_pred CCCCcceEEEEEEeCCe------EEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYEDKSC------VHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~------~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+||||+++++++..+.. .|+|+||+ |++|.+++.. .++++..+..++.|++.||+|||+.||+||||+|+||
T Consensus 72 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Ni 149 (343)
T cd07851 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI 149 (343)
T ss_pred cCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 89999999998876654 89999999 6799887754 5799999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+ .+.++.+||+|||++...... .....++..|+|||.+.+ .++.++||||+||++|++++|+.||.+.+..+.
T Consensus 150 l---l~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~ 224 (343)
T cd07851 150 A---VNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ 224 (343)
T ss_pred E---ECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 9 456789999999998765432 344568899999998853 478899999999999999999999998877766
Q ss_pred HHHHHhCCCCCCC---------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDFES---------------------------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+..+.......+. ..+..+++++.++|.+||+.+|.+|||+.+++.||||...
T Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 225 LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 6665443211110 0113468999999999999999999999999999999876
Q ss_pred CCCC
Q 021227 211 KVAP 214 (315)
Q Consensus 211 ~~~~ 214 (315)
....
T Consensus 305 ~~~~ 308 (343)
T cd07851 305 HDPE 308 (343)
T ss_pred CCCc
Confidence 5443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=269.19 Aligned_cols=201 Identities=31% Similarity=0.555 Sum_probs=167.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++...+..|+|+||++|++|.+++.+ ..+++..+..++.|++.||+|||++|++||||+|+||+ .+
T Consensus 74 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nil---i~ 149 (293)
T cd06647 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL---LG 149 (293)
T ss_pred CCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEE---Ec
Confidence 799999999999999999999999999999998855 46889999999999999999999999999999999999 45
Q ss_pred CCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++....... ......|++.|+|||.+. +.++.++|+||+||++|++++|..||...+.......+..
T Consensus 150 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 229 (293)
T cd06647 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229 (293)
T ss_pred CCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc
Confidence 67899999999886554332 223356888999999875 4588999999999999999999999987765544333322
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
... .....+..++..+++++.+||..+|.+||++.+++.|+||+..+
T Consensus 230 ~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 230 NGT-PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CCC-CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 211 11112335788999999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=266.13 Aligned_cols=198 Identities=33% Similarity=0.571 Sum_probs=165.1
Q ss_pred CCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 6 EHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
+||||+++++++.++ +..++|+||+++ +|.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil-- 132 (287)
T cd07840 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNIL-- 132 (287)
T ss_pred cCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeE--
Confidence 799999999999988 899999999975 888888665 57999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
.+.++.+||+|||.+....... ......++..|+|||.+.+ .++.++||||+|+++|+|++|..||...+.....
T Consensus 133 -~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~ 211 (287)
T cd07840 133 -INNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211 (287)
T ss_pred -EcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 5668899999999987664433 2234567889999997653 4789999999999999999999999988876666
Q ss_pred HHHHhCCCCCCCCCC--------------------------CC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 159 RQILEGKIDFESEPW--------------------------PN-ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~--------------------------~~-~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
..+...........| .. +++++.+++.+||+.+|.+|||+.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 655542221111111 12 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=266.35 Aligned_cols=197 Identities=26% Similarity=0.459 Sum_probs=165.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+|||++++++++.++...|+||||+.| ++.+.+.. ..++++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 79 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili--- 154 (313)
T cd06633 79 KHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL--- 154 (313)
T ss_pred CCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---
Confidence 799999999999999999999999964 77777655 4578999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++..... .....|+..|+|||++. +.++.++||||+||++|+|++|..||...+.......
T Consensus 155 ~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~ 231 (313)
T cd06633 155 TEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 231 (313)
T ss_pred CCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 5678899999998764322 23467899999999873 4588899999999999999999999988776666655
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
+..... +......++..+++++.+||+.+|.+|||+.+++.||||....
T Consensus 232 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 232 IAQNDS--PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHhcCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 554332 2222245778899999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=263.61 Aligned_cols=196 Identities=19% Similarity=0.347 Sum_probs=164.0
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHH
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-----------------GNYSEREAAKLMKTIVGVVECC 64 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----------------~~~~~~~~~~~~~qi~~~l~~l 64 (315)
+.+ +||||+++++++..+...|+||||+.+|+|.+++... ..+++..+..++.|++.||.||
T Consensus 62 ~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 62 AEL-HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred hhC-CCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 345 8999999999999999999999999999999988532 2478889999999999999999
Q ss_pred HHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHH
Q 021227 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILY 140 (315)
Q Consensus 65 H~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ 140 (315)
|++|++||||||+||++ +.++.+||+|||++....... ......++..|+|||.+. +.++.++|+||+||++|
T Consensus 141 H~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 217 (283)
T cd05090 141 SSHFFVHKDLAARNILI---GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLW 217 (283)
T ss_pred HhcCeehhccccceEEE---cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHH
Confidence 99999999999999994 567889999999987654322 122344567899999885 55899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 141 ILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 141 ~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
+|++ |..||.+.+.....+.+....... ....+++.+++++.+||+.+|.+||++.+++++
T Consensus 218 el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 218 EIFSFGLQPYYGFSNQEVIEMVRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9998 999998887777766666544321 224678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=265.93 Aligned_cols=194 Identities=29% Similarity=0.441 Sum_probs=159.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+ +||||+++++++.+.+.+++|+|||++|+|.+++... ..+++..+..++.|++.||.|||+++++||+|+++||+
T Consensus 57 ~l-~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nil 135 (259)
T PF07714_consen 57 KL-RHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNIL 135 (259)
T ss_dssp TH-SBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEE
T ss_pred cc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 45 8999999999999888899999999999999999886 68999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLS-GVPPFWAETEI 155 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 155 (315)
++.++.+||+|||++........ .....+...|+|||.+.. .++.++||||||+++||+++ |..||...+..
T Consensus 136 ---l~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~ 212 (259)
T PF07714_consen 136 ---LDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE 212 (259)
T ss_dssp ---EETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH
T ss_pred ---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 55678999999999877632221 123446678999999864 48999999999999999999 78999998888
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+....+.++..... ...++..+.++|.+||..+|.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~---~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 213 EIIEKLKQGQRLPI---PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHTTEETTS---BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccccccccccccee---ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 88888866544222 2368999999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=267.92 Aligned_cols=201 Identities=32% Similarity=0.574 Sum_probs=166.3
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+.+||||+++++.+..+..+|+||||+.||+|.+++.+.+.+++..+..++.|++.||.|||+.|++||||+|.||++
T Consensus 60 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~- 138 (288)
T cd05583 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL- 138 (288)
T ss_pred hccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE-
Confidence 4558999999999999999999999999999999999887889999999999999999999999999999999999995
Q ss_pred cCCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhhhc---CCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLRKH---YGPEADVWSAGVILYILLSGVPPFWAET---- 153 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~---- 153 (315)
+.++.++|+|||++........ .....|+..|+|||.+.+. .+.++|+||+|+++|+|++|..||....
T Consensus 139 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 216 (288)
T cd05583 139 --DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216 (288)
T ss_pred --CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch
Confidence 5678899999999876543321 1234688999999987532 6889999999999999999999996432
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCC
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT---AHEVLCHPWIVDD 210 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s---~~~~l~h~~~~~~ 210 (315)
..+..+.+...... ....+++++++++.+||+.+|++||| +.++|+||||+..
T Consensus 217 ~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 217 QSEISRRILKSKPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHHHccCCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 23333333333222 22357899999999999999999998 5677999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=270.95 Aligned_cols=205 Identities=30% Similarity=0.463 Sum_probs=165.0
Q ss_pred CCCCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 3 HLSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
++.+||||+++++.... ...+|+++||+. ++|.+.+.....+++..++.++.|++.||.|||++|++||||||+|
T Consensus 57 ~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~N 135 (332)
T cd07857 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGN 135 (332)
T ss_pred HhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 45579999999997542 256889999985 6899988888889999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCC-----cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
|+ .+.++.+||+|||++....... ......||+.|+|||.+.+ .++.++|+||+||++|++++|.+||.+
T Consensus 136 il---i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 136 LL---VNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred eE---EcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 99 5667899999999987654321 1233578999999998753 478999999999999999999999988
Q ss_pred CCHHHHHHHHHhCCCC-----------------------CC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 152 ETEIGIFRQILEGKID-----------------------FE----SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 152 ~~~~~~~~~i~~~~~~-----------------------~~----~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.+....+..+...... .+ ...++..+.++++++.+||+.+|.+|||+.+++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 213 KDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 7655544433321100 00 11234568899999999999999999999999999
Q ss_pred CCccCCC
Q 021227 205 PWIVDDK 211 (315)
Q Consensus 205 ~~~~~~~ 211 (315)
||+.+..
T Consensus 293 ~~~~~~~ 299 (332)
T cd07857 293 PYLAIWH 299 (332)
T ss_pred hhhhhhc
Confidence 9997554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=263.15 Aligned_cols=192 Identities=23% Similarity=0.328 Sum_probs=162.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------NYSEREAAKLMKTIVGVVECCHSLGVFHRDLK 75 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dik 75 (315)
+||||+++++++.+....++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++|||||
T Consensus 67 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~ 146 (277)
T cd05032 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLA 146 (277)
T ss_pred CCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence 89999999999999999999999999999999986532 36788999999999999999999999999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCC
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFW 150 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~ 150 (315)
|+||+ .+.++.+||+|||++........ .....++..|+|||.+. +.++.++|||||||++|++++ |..||.
T Consensus 147 p~nil---l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 147 ARNCM---VAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred hheEE---EcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 99999 56788999999999876543321 12345678899999886 558999999999999999998 999999
Q ss_pred CCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 151 AETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 151 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+.+..+....+..+..... ...+++++.+++.+||+.+|++|||+.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 224 GLSNEEVLKFVIDGGHLDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred cCCHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8888887777764432211 1346899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=262.77 Aligned_cols=193 Identities=18% Similarity=0.336 Sum_probs=164.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------------GNYSEREAAKLMKTIVGVVECCHSLG 68 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~ 68 (315)
.+||||+++++++.+....++++||+.+++|.+++... ..+++..+..++.|++.||.|||++|
T Consensus 65 l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g 144 (283)
T cd05091 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH 144 (283)
T ss_pred CCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC
Confidence 48999999999999999999999999999999988532 34788899999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh
Q 021227 69 VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS 144 (315)
Q Consensus 69 ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 144 (315)
++||||||+||++ ++++.+||+|||+++....... .....+++.|+|||.+. +.++.++||||+||++|+|++
T Consensus 145 i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 221 (283)
T cd05091 145 VVHKDLATRNVLV---FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221 (283)
T ss_pred ccccccchhheEe---cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHc
Confidence 9999999999994 5678899999999876533221 12344678899999875 568999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 145 -GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 145 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|..||.+....+..+.+..+...... ..+++++.+++.+||+.+|.+|||+.+++.
T Consensus 222 ~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 222 YGLQPYCGYSNQDVIEMIRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 89999998888888888776543222 368899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=267.25 Aligned_cols=195 Identities=22% Similarity=0.342 Sum_probs=162.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------NYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
.+.+||||+++++++.++..+|+||||+.+|+|.+++.+.+ .+++..+..++.|++.||+|||+
T Consensus 79 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 158 (307)
T cd05098 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158 (307)
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 34589999999999999999999999999999999997642 47889999999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHH
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYIL 142 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 142 (315)
+|++||||||+||++ +.++.+||+|||.+........ .....+++.|+|||++. ..++.++|+||+||++|+|
T Consensus 159 ~gi~H~dlkp~Nill---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el 235 (307)
T cd05098 159 KKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235 (307)
T ss_pred CCcccccccHHheEE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHH
Confidence 999999999999994 5678999999999876533221 11123456899999886 4589999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 143 LS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 143 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
++ |..||.+.+..+....+..+... .....++.++++++.+||..+|.+|||+.++++
T Consensus 236 ~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 236 FTLGGSPYPGVPVEELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HcCCCCCCCcCCHHHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 98 89999888877777666554321 222467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.92 Aligned_cols=198 Identities=29% Similarity=0.552 Sum_probs=182.2
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+-|.+++++.+|+.-..+|+||||+.||+|.-.+.+-+.|.|..|.-++..|+.||=+||++||++||||.+||+ +
T Consensus 407 ~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvm---L 483 (683)
T KOG0696|consen 407 GKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM---L 483 (683)
T ss_pred CCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceE---e
Confidence 4567899999999999999999999999999999999999999999999999999999999999999999999999 7
Q ss_pred CCCCCEEEeeccCcccC-CCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFY-KPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+..|.|||+|||+++.. ..+....+++|||.|+|||++. +.|+.++|.||+||++|||+.|++||.|.++.++++.|.
T Consensus 484 d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ 563 (683)
T KOG0696|consen 484 DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM 563 (683)
T ss_pred ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 88999999999999753 4455667899999999999885 779999999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
+....++. .+|.++.++.+.+|.+.|.+|.. -.++-.||||..
T Consensus 564 ehnvsyPK----slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 564 EHNVSYPK----SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HccCcCcc----cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 99888875 68999999999999999999974 367889999964
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=257.53 Aligned_cols=196 Identities=30% Similarity=0.534 Sum_probs=168.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+|||++++++++.+++.+++|+||+.|++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||++ +
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~ 133 (254)
T cd06627 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---T 133 (254)
T ss_pred CCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---C
Confidence 7999999999999999999999999999999999888899999999999999999999999999999999999995 5
Q ss_pred CCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.++|+|||.+........ .....++..|+|||... ..++.++|+||+|+++|+|++|..||...+.......+..
T Consensus 134 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 213 (254)
T cd06627 134 KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ 213 (254)
T ss_pred CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 578999999999876654332 23456889999999875 3478899999999999999999999987766554444433
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.... .....+++.+++++.+||..+|++|||+.+++.||||
T Consensus 214 ~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 214 DDHP---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred cCCC---CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 2221 1224678999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=260.32 Aligned_cols=192 Identities=21% Similarity=0.347 Sum_probs=163.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+....++|+||+.||+|.+++.+. ..+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus 59 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil--- 135 (261)
T cd05072 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVL--- 135 (261)
T ss_pred CCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEE---
Confidence 8999999999999999999999999999999988653 56889999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
.+.++.+||+|||++........ .....++..|+|||.+. +.++.++||||+||++|+|++ |..||.+........
T Consensus 136 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 215 (261)
T cd05072 136 VSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS 215 (261)
T ss_pred ecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHH
Confidence 56778999999999976543221 12234567899999886 558889999999999999998 999999888877777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+.. . +....++.++.+++.+||..+|++|||++++++
T Consensus 216 ~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 216 ALQRGYR-M--PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHcCCC-C--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 7765432 2 223468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=258.31 Aligned_cols=208 Identities=29% Similarity=0.476 Sum_probs=169.1
Q ss_pred CCCCCcceEEEEEEe-CCeEEEEEeccCCCchhHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 5 SEHQHVVRIHDTYED-KSCVHIVMELCEGGELFDRIVKK-----GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
.+||||+.+..+|-. +...++++||.+. +|.+.|.-+ +.++...+..++.||+.|+.|||++-|+||||||.|
T Consensus 84 l~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaN 162 (438)
T KOG0666|consen 84 LKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPAN 162 (438)
T ss_pred hcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcce
Confidence 489999999999976 8999999999986 888877532 468999999999999999999999999999999999
Q ss_pred eeeccC-CCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 79 FLFLSV-DEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 79 il~~~~-~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
||+... .+.|.|||+|+|+++.+...- .....+-|.+|.|||.+.+ .|+++.||||+|||+.||+|-.+.|.+
T Consensus 163 IlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 163 ILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred EEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 997432 235999999999998765431 2234567999999999864 599999999999999999999999976
Q ss_pred CCH---------HHHHHHHHhCCCCCCCCCCCC---------------------------------CCHHHHHHHHHhcc
Q 021227 152 ETE---------IGIFRQILEGKIDFESEPWPN---------------------------------ISESAKDLIRKMLD 189 (315)
Q Consensus 152 ~~~---------~~~~~~i~~~~~~~~~~~~~~---------------------------------~s~~~~~li~~~l~ 189 (315)
... ..++.+|.+-...+....|+. -++...+|+.+||+
T Consensus 243 ~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~ 322 (438)
T KOG0666|consen 243 REEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLT 322 (438)
T ss_pred hhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhc
Confidence 432 345666665433333333331 25568899999999
Q ss_pred cCCCCCCCHHHHhcCCCccCCCCC
Q 021227 190 QNPKRRLTAHEVLCHPWIVDDKVA 213 (315)
Q Consensus 190 ~~p~~R~s~~~~l~h~~~~~~~~~ 213 (315)
.||.+|+|++++|+|+||.+....
T Consensus 323 yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 323 YDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred cCchhhccHHHHhcccccccCCCC
Confidence 999999999999999999876544
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=259.40 Aligned_cols=194 Identities=23% Similarity=0.314 Sum_probs=161.0
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||++++++++. ..+++||||++||+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 50 ~~l-~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil 127 (257)
T cd05115 50 HQL-DNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVL 127 (257)
T ss_pred Hhc-CCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEE
Confidence 344 89999999999864 478999999999999998875 457999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcc----cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVF----SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETE 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 154 (315)
+ +.++.+||+|||++......... ....+++.|+|||.+. +.++.++|||||||++|++++ |..||.+...
T Consensus 128 ~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 204 (257)
T cd05115 128 L---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204 (257)
T ss_pred E---cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 4 56789999999998755332211 1122356899999886 458899999999999999996 9999998888
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+....+..+.... ..+..++++.+++.+||+.+|++||++.++.+
T Consensus 205 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 205 PEVMSFIEQGKRLD---CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHHCCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 77777766654321 22467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=258.40 Aligned_cols=197 Identities=35% Similarity=0.563 Sum_probs=167.3
Q ss_pred CCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++.+.+. ..+++|+||+++++|.+++.+...+++..+..++.|++.||+|||+.|++|+||+|+||++
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i-- 134 (260)
T cd06606 57 QHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV-- 134 (260)
T ss_pred CCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--
Confidence 799999999999988 8999999999999999999888899999999999999999999999999999999999995
Q ss_pred CCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAET-EIGIF 158 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~ 158 (315)
+.++.++|+|||.+........ .....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||.... .....
T Consensus 135 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (260)
T cd06606 135 -DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213 (260)
T ss_pred -cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 5578999999999877655442 345678899999999864 48999999999999999999999998765 33333
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
..+...... ......++.++++++.+||+.+|.+|||+.++++||||
T Consensus 214 ~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 214 YKIGSSGEP--PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhccccCCC--cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 333321111 11223568999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=258.97 Aligned_cols=191 Identities=21% Similarity=0.306 Sum_probs=161.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||++++++++. ..+++||||+.+|+|.+++.+.+.+++..+..++.|++.||+|||+.|++||||||+||+ .+
T Consensus 54 ~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nil---i~ 129 (257)
T cd05060 54 DHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVL---LV 129 (257)
T ss_pred CCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEE---Ec
Confidence 89999999998764 468999999999999999988888999999999999999999999999999999999999 46
Q ss_pred CCCCEEEeeccCcccCCCCCcc----cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDEVF----SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
.++.+||+|||.+......... ....++..|+|||.+. ..++.++|||||||++|++++ |..||...+..+...
T Consensus 130 ~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~ 209 (257)
T cd05060 130 NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA 209 (257)
T ss_pred CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 6889999999998765433221 1122346799999886 458999999999999999998 999998888777777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+...... .....+++.+++++.+||..+|++|||+.++++
T Consensus 210 ~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 210 MLESGERL---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHcCCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 76655322 223467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=266.09 Aligned_cols=195 Identities=20% Similarity=0.320 Sum_probs=164.6
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------------GNYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
.+.+||||+++++++......|+||||+.+|+|.+++.+. ..++...+..++.|++.||.|||+
T Consensus 76 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~ 155 (304)
T cd05101 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS 155 (304)
T ss_pred hhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH
Confidence 3458999999999999999999999999999999998763 247788899999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHH
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYIL 142 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 142 (315)
+|++||||||+||++ +.++.+||+|||++........ .....+++.|+|||++. ..++.++||||+||++|++
T Consensus 156 ~givH~dlkp~Nili---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 232 (304)
T cd05101 156 QKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232 (304)
T ss_pred CCeeecccccceEEE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHH
Confidence 999999999999994 5678999999999876543221 12234567899999886 4589999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 143 LS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 143 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
++ |..||.+.+..+....+..+.... ....++.++++++.+||..+|.+|||+.++++
T Consensus 233 ~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 233 FTLGGSPYPGIPVEELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HcCCCCCcccCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 98 889999888888888776554222 12467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=272.08 Aligned_cols=202 Identities=34% Similarity=0.547 Sum_probs=160.4
Q ss_pred CCCCcceEEEEEEeC-----CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDK-----SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+||||+++++++... ...|+|+||+.+ +|.+.+ ..+.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 61 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nil 138 (336)
T cd07849 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLL 138 (336)
T ss_pred CCCCcCchhheeecccccccceEEEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence 799999999987654 358999999964 787766 4467999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
.+.++.+||+|||++....... ......||+.|+|||.+. ..++.++||||+||++|+|++|+.||.+.+.
T Consensus 139 ---l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 139 ---LNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred ---ECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5678899999999987653322 123356899999999864 3588999999999999999999999987665
Q ss_pred HHHHHHHHhCCC----------------------CC-CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 155 IGIFRQILEGKI----------------------DF-ES----EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 155 ~~~~~~i~~~~~----------------------~~-~~----~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
......+..... .. .. ...+..++++.++|.+||+.+|.+|||+.++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~ 295 (336)
T cd07849 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295 (336)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 443332221000 00 00 0123568899999999999999999999999999999
Q ss_pred cCCCC
Q 021227 208 VDDKV 212 (315)
Q Consensus 208 ~~~~~ 212 (315)
.....
T Consensus 296 ~~~~~ 300 (336)
T cd07849 296 EQYHD 300 (336)
T ss_pred cccCC
Confidence 86543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=265.95 Aligned_cols=204 Identities=27% Similarity=0.394 Sum_probs=165.1
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil 80 (315)
.+.+||||+++++++.++...|+||||+. +++.+.+.. .+.+++..+..++.|++.|++|||+ .||+||||+|+||+
T Consensus 69 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nil 147 (296)
T cd06618 69 KSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNIL 147 (296)
T ss_pred hccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEE
Confidence 34579999999999999999999999985 466666654 4579999999999999999999997 69999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-----cCCCchhHHHHHHHHHHHHhCCCCCCCCC-H
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-----HYGPEADVWSAGVILYILLSGVPPFWAET-E 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~-~ 154 (315)
+ +.++.+||+|||++.............+++.|+|||.+.+ .++.++||||+|+++|+|++|+.||.... .
T Consensus 148 l---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 224 (296)
T cd06618 148 L---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224 (296)
T ss_pred E---cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH
Confidence 4 5688999999999876644433344567889999998853 27889999999999999999999997643 2
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.+....+....... .+....+++++.+++.+||..+|.+|||+++++.||||....
T Consensus 225 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 225 FEVLTKILQEEPPS-LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHHHHhcCCCCC-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 34444444433221 111224789999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=276.21 Aligned_cols=202 Identities=34% Similarity=0.586 Sum_probs=172.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+++-||+||-.|+|+.++|+||||++||++..++.+.+-|+|..++.++..+..|+.+.|+.|+|||||||+||| +
T Consensus 686 ADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNIL---I 762 (1034)
T KOG0608|consen 686 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL---I 762 (1034)
T ss_pred cCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceE---E
Confidence 4788999999999999999999999999999999999999999999999999999999999999999999999999 7
Q ss_pred CCCCCEEEeeccCcccCC---------CC------------------Cc----------------ccccccCccccchhh
Q 021227 85 DEDAALKATDFGLSVFYK---------PD------------------EV----------------FSDVVGSPYYVAPEV 121 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~---------~~------------------~~----------------~~~~~gt~~y~aPE~ 121 (315)
+.+|.|||+|||+|..+. .+ .+ ....+||+.|+|||+
T Consensus 763 DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapev 842 (1034)
T KOG0608|consen 763 DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEV 842 (1034)
T ss_pred ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHH
Confidence 889999999999986431 00 00 013579999999999
Q ss_pred hh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---C
Q 021227 122 LR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL---T 197 (315)
Q Consensus 122 ~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~---s 197 (315)
+. ..|+..||.||.|||||+|+.|++||...++.+...++.+-.-.+....-.++|+++.++|.++.. +++.|. .
T Consensus 843 l~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng 921 (1034)
T KOG0608|consen 843 LARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNG 921 (1034)
T ss_pred hcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhcccc
Confidence 85 569999999999999999999999999888777665555433333333345799999999998865 788887 4
Q ss_pred HHHHhcCCCccCC
Q 021227 198 AHEVLCHPWIVDD 210 (315)
Q Consensus 198 ~~~~l~h~~~~~~ 210 (315)
++|+-.||||+..
T Consensus 922 ~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 922 ADQVKAHPFFKGI 934 (1034)
T ss_pred hhhhhcCcccccc
Confidence 7889999999753
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=266.31 Aligned_cols=198 Identities=31% Similarity=0.576 Sum_probs=165.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.++..+++|+||+++ +|.+++..+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+ .
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nil---i 131 (283)
T cd05118 56 NHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLL---I 131 (283)
T ss_pred cCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEE---E
Confidence 799999999999999999999999975 887777664 68999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.++.+||+|||.+....... ......++..|+|||.+.+ .++.++|+||+|+++|+|++|+.||.+.+..+....+
T Consensus 132 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 132 NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 567899999999987665443 2334567889999998853 5889999999999999999999999888776655544
Q ss_pred HhCCCCC-------------------C-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 162 LEGKIDF-------------------E-------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 162 ~~~~~~~-------------------~-------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
....... + ...++.++.+++++|.+||++||.+||++.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 3321110 0 01123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=269.05 Aligned_cols=202 Identities=30% Similarity=0.466 Sum_probs=156.6
Q ss_pred CCCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 5 SEHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKK-----GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
.+||||+++++++.+. ..+++||||+.+ +|.+.+... ..+++..+..++.|++.||+|||+.||+||||||+
T Consensus 59 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~ 137 (316)
T cd07842 59 LKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPA 137 (316)
T ss_pred cCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHH
Confidence 3899999999999988 889999999975 666655432 36899999999999999999999999999999999
Q ss_pred ceeecc-CCCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 78 NFLFLS-VDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 78 nil~~~-~~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
||++.. .+.++.+||+|||++....... ......+++.|+|||++.+ .++.++||||+||++|+|++|.+||.
T Consensus 138 Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 138 NILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred HEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 999632 1127899999999987653322 1234567899999998753 47899999999999999999999997
Q ss_pred CCCHHH---------HHHHHHhC--------------------------CCCCCC-------CCCCCCCHHHHHHHHHhc
Q 021227 151 AETEIG---------IFRQILEG--------------------------KIDFES-------EPWPNISESAKDLIRKML 188 (315)
Q Consensus 151 ~~~~~~---------~~~~i~~~--------------------------~~~~~~-------~~~~~~s~~~~~li~~~l 188 (315)
+..... ....+... ...++. ..+...+.++.+++.+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 297 (316)
T cd07842 218 GREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297 (316)
T ss_pred CCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHh
Confidence 654321 11111110 000010 001156788999999999
Q ss_pred ccCCCCCCCHHHHhcCCCc
Q 021227 189 DQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 189 ~~~p~~R~s~~~~l~h~~~ 207 (315)
+.||++|||+.|++.||||
T Consensus 298 ~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 298 EYDPTKRITAEEALEHPYF 316 (316)
T ss_pred cCCcccCcCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.05 Aligned_cols=197 Identities=28% Similarity=0.497 Sum_probs=170.4
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
.+ +||||+++++++.++..+|+|+||++|++|.+++.+ ...+++..+..++.|++.||+|||+.|++||||+|+|
T Consensus 55 ~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~n 133 (256)
T cd08530 55 SV-NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSAN 133 (256)
T ss_pred hC-CCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcce
Confidence 44 799999999999999999999999999999998866 3568999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|++ +.++.+||+|||++...... ......+++.|+|||.+.+ .++.++|+||+|+++|+|++|+.||...+..+.
T Consensus 134 i~~---~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~ 209 (256)
T cd08530 134 ILL---VANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL 209 (256)
T ss_pred EEE---ecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 995 45788999999998766544 3344568899999999864 488899999999999999999999999888777
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
...+..+...... ..++.++++++.+||+.+|.+|||+.++++||+.
T Consensus 210 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 210 RYKVQRGKYPPIP---PIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHhcCCCCCCc---hhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 7666655433222 2578999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=259.43 Aligned_cols=192 Identities=19% Similarity=0.250 Sum_probs=155.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++..+...++||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||++..
T Consensus 56 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~ 135 (258)
T cd05078 56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIR 135 (258)
T ss_pred CCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEec
Confidence 389999999999999999999999999999999987654 5899999999999999999999999999999999999743
Q ss_pred CC-----CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhC-CCCCCCCCHH
Q 021227 84 VD-----EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSG-VPPFWAETEI 155 (315)
Q Consensus 84 ~~-----~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~ 155 (315)
.+ ..+.++++|||.+...... ....+++.|+|||++.+ .++.++||||+||++|+|++| .+||......
T Consensus 136 ~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~ 212 (258)
T cd05078 136 EEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212 (258)
T ss_pred ccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH
Confidence 21 1234899999988655432 23567889999999864 478899999999999999998 4666655554
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.... +......++. ..+.++.+++.+||+.+|++|||++++++.
T Consensus 213 ~~~~-~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 213 KKLQ-FYEDRHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHH-HHHccccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 4332 3333333332 356889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=260.11 Aligned_cols=192 Identities=19% Similarity=0.250 Sum_probs=155.4
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.++...++||||+.+|+|..++.+. +.+++..+..++.|++.||+|||++||+||||||+||++..
T Consensus 61 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 140 (262)
T cd05077 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAR 140 (262)
T ss_pred CCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEec
Confidence 48999999999999999999999999999998888654 56999999999999999999999999999999999999743
Q ss_pred CC----CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHH
Q 021227 84 VD----EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILL-SGVPPFWAETEIG 156 (315)
Q Consensus 84 ~~----~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~ 156 (315)
.. ....+|++|||++...... ....++..|+|||.+. ..++.++||||+||++|+|+ +|..||......+
T Consensus 141 ~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 141 EGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred CCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 21 1124899999988654322 2356788999999885 45889999999999999997 5888887765444
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.. .......... ...++++++++.+||+.||.+||++.+++++
T Consensus 218 ~~-~~~~~~~~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 218 KE-RFYEGQCMLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HH-HHHhcCccCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 32 2222222211 2346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=260.27 Aligned_cols=192 Identities=21% Similarity=0.240 Sum_probs=156.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.++...++||||++||+|..++.+ .+.+++..+..++.|++.||+|||++||+||||||+||++..
T Consensus 73 l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 73 VSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152 (274)
T ss_pred CCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEec
Confidence 4899999999999999999999999999999888865 467899999999999999999999999999999999999753
Q ss_pred C----CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHH
Q 021227 84 V----DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILL-SGVPPFWAETEIG 156 (315)
Q Consensus 84 ~----~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~ 156 (315)
. .....+|++|||.+...... ....++..|+|||.+.+ .++.++||||+||++|+++ +|..||.+....+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 2 12345899999987543222 22457888999998853 4899999999999999984 7999998876655
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
...... .....+. ..++++.+++.+||+.+|.+|||+.+++++
T Consensus 230 ~~~~~~-~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 230 KERFYE-KKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHH-hccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 433322 2222222 346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=250.91 Aligned_cols=204 Identities=29% Similarity=0.539 Sum_probs=172.5
Q ss_pred CCCCCCcceEEEEEEe--------CCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 4 LSEHQHVVRIHDTYED--------KSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
+++|+|++.+++++.. ...+|+||.+|+. +|.-.+... -+++..++.+++.++++||.|+|+..|+|||+
T Consensus 72 ~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDm 150 (376)
T KOG0669|consen 72 LLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDM 150 (376)
T ss_pred HhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcc
Confidence 4589999999987743 3469999999976 787777655 57999999999999999999999999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCC-----CcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPD-----EVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~-----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~ 147 (315)
||.|+| ++.++.+||+|||+++.+... ......+-|.+|.+||.+. ..|+++.|||+.|||+.+|+||.+
T Consensus 151 KaaNvL---It~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 151 KAANVL---ITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred cHhhEE---EcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence 999999 678899999999999765322 2234456799999999885 459999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCCCC-------------------------------CHHHHHHHHHhcccCCCCCC
Q 021227 148 PFWAETEIGIFRQILEGKIDFESEPWPNI-------------------------------SESAKDLIRKMLDQNPKRRL 196 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-------------------------------s~~~~~li~~~l~~~p~~R~ 196 (315)
.+.+.+.+.++..|..-......+.||++ .+++.+++.++|..||.+|+
T Consensus 228 imqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~ 307 (376)
T KOG0669|consen 228 IMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI 307 (376)
T ss_pred cccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc
Confidence 99999999998888775555555555542 34788999999999999999
Q ss_pred CHHHHhcCCCccCCC
Q 021227 197 TAHEVLCHPWIVDDK 211 (315)
Q Consensus 197 s~~~~l~h~~~~~~~ 211 (315)
+++++++|.||....
T Consensus 308 ~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 308 DADQALNHDFFWKDP 322 (376)
T ss_pred chHhhhchhhhhcCC
Confidence 999999999998643
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=265.92 Aligned_cols=198 Identities=31% Similarity=0.554 Sum_probs=161.7
Q ss_pred CCCCcceEEEEEEeCC----------eEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 6 EHQHVVRIHDTYEDKS----------CVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~----------~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
+||||+++++++.+.. .+++|+||+.+ ++...+... ..+++..++.++.|++.||+|||+.||+||||
T Consensus 64 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl 142 (302)
T cd07864 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDI 142 (302)
T ss_pred CCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 8999999999987655 89999999986 666666553 47999999999999999999999999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
+|+||+ .+.++.+||+|||.+....... ......++..|+|||.+.+ .++.++||||+||++|+|++|++||.
T Consensus 143 ~p~nil---i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 143 KCSNIL---LNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred CHHHEE---ECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999 5678899999999987654332 1222356788999998753 47889999999999999999999998
Q ss_pred CCCHHHHHHHHHhCCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 151 AETEIGIFRQILEGKIDFES--------------------------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 151 ~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
..+..+....+......... ..+..+|+.+.+++.+||+.+|.+|||+.+++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 220 ANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 87776666555442111110 1123478999999999999999999999999999
Q ss_pred CCc
Q 021227 205 PWI 207 (315)
Q Consensus 205 ~~~ 207 (315)
|||
T Consensus 300 ~~~ 302 (302)
T cd07864 300 PWL 302 (302)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=274.49 Aligned_cols=196 Identities=22% Similarity=0.342 Sum_probs=158.5
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC---------------------------------------
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--------------------------------------- 42 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--------------------------------------- 42 (315)
+++..||||+++++++.+....|+|||||+||+|.+++.+.
T Consensus 95 ~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (400)
T cd05105 95 THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK 174 (400)
T ss_pred HhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence 34546999999999999999999999999999999887542
Q ss_pred ---------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 021227 43 ---------------------------------------------------------GNYSEREAAKLMKTIVGVVECCH 65 (315)
Q Consensus 43 ---------------------------------------------------------~~~~~~~~~~~~~qi~~~l~~lH 65 (315)
..+++..+..++.|++.||.|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 254 (400)
T cd05105 175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA 254 (400)
T ss_pred ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 23778888999999999999999
Q ss_pred HCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHH
Q 021227 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYI 141 (315)
Q Consensus 66 ~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ 141 (315)
+.||+||||||+||++ +.++.+||+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+
T Consensus 255 ~~~ivH~dikp~Nill---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~e 331 (400)
T cd05105 255 SKNCVHRDLAARNVLL---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331 (400)
T ss_pred hCCeeCCCCChHhEEE---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHH
Confidence 9999999999999994 5678899999999876533221 12345678899999886 458999999999999999
Q ss_pred HHh-CCCCCCCCCHHH-HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 142 LLS-GVPPFWAETEIG-IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 142 ll~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|++ |..||.+..... ....+..+ ..++ ....+++++++++.+||+.+|++|||+.++.+
T Consensus 332 llt~g~~P~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 332 IFSLGGTPYPGMIVDSTFYNKIKSG-YRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHCCCCCCcccchhHHHHHHHhcC-CCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 997 999998754433 33333333 2222 22467899999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=262.94 Aligned_cols=195 Identities=21% Similarity=0.263 Sum_probs=162.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-----------NYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
+||||+++++++.++..+++|+||+.+++|.+++.+.. .+++..+..++.|++.||+|||++|++||||
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dl 156 (296)
T cd05051 77 SDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDL 156 (296)
T ss_pred CCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence 89999999999999999999999999999999987765 6899999999999999999999999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh--CCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS--GVPP 148 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~--g~~p 148 (315)
||+||+ .+.++.++|+|||++....... ......+++.|+|||.+. +.++.++||||+||++|+|++ |..|
T Consensus 157 kp~Nil---i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 157 ATRNCL---VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred chhcee---ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 999999 5566899999999987653322 122345677899999886 468999999999999999998 7888
Q ss_pred CCCCCHHHHHHHHHhC----CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 149 FWAETEIGIFRQILEG----KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 149 f~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|...+....+..+... .........+.+|+++.+++.+||+.+|.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 234 YEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 8877776666665543 111111122357899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=261.15 Aligned_cols=195 Identities=28% Similarity=0.527 Sum_probs=166.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+||||+++++++.+...+++|+||+++++|.+++.+ ...+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili 139 (260)
T cd08222 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL 139 (260)
T ss_pred CCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEe
Confidence 899999999999999999999999999999887753 3579999999999999999999999999999999999996
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
. ++.+||+|||++....... ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.+........
T Consensus 140 ~----~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~ 215 (260)
T cd08222 140 K----NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL 215 (260)
T ss_pred e----cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 3 3569999999887654332 233456889999999875 447889999999999999999999998877777666
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+..+.... ....++.++.++|.+||..+|++||++.++++||||
T Consensus 216 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 216 RIVEGPTPS---LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHcCCCCC---CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 665543221 123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=258.78 Aligned_cols=193 Identities=20% Similarity=0.407 Sum_probs=164.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++.+.+++..++||||+.+|+|.+++... +.+++..+..++.|++.||+|||++||+||||+|+||+ +
T Consensus 63 ~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nil---i 139 (266)
T cd05033 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNIL---V 139 (266)
T ss_pred CCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE---E
Confidence 8999999999999999999999999999999998764 57899999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCC-CCccc--ccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKP-DEVFS--DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~-~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||++..... ..... ...+++.|+|||.+. ..++.++||||+|+++|+|++ |..||......+...
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~ 219 (266)
T cd05033 140 NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK 219 (266)
T ss_pred cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHH
Confidence 6788999999999987642 11111 223457899999886 458999999999999999998 999998888777777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.+..+..... ...+++.+.+++.+||+.+|++|||+.+++++
T Consensus 220 ~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 220 AVEDGYRLPP---PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7765432221 23578999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=256.52 Aligned_cols=194 Identities=24% Similarity=0.342 Sum_probs=163.6
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
++ +||||+++++++.+ ..+++|+||+++|+|.+++.+.. .+++..+..++.|++.||+|||++|++||||+|+||+
T Consensus 52 ~l-~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil 129 (257)
T cd05040 52 SL-DHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNIL 129 (257)
T ss_pred hc-CCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEE
Confidence 44 89999999999998 89999999999999999987754 6899999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETE 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 154 (315)
.+.++.+||+|||++........ .....++..|+|||.+. ..++.++||||+||++|+|++ |..||...+.
T Consensus 130 ---~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 206 (257)
T cd05040 130 ---LASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG 206 (257)
T ss_pred ---EecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 45668999999999876643211 11245677899999986 458999999999999999998 9999988887
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+....+......... ...+|..+.+++.+||+.+|++|||+.+++.
T Consensus 207 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 207 SQILKKIDKEGERLER--PEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHHhcCCcCCC--CccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 7777766643322222 1357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=259.49 Aligned_cols=191 Identities=20% Similarity=0.313 Sum_probs=159.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.. ...++|+||+++|+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+ .
T Consensus 67 ~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nil---i 142 (279)
T cd05111 67 DHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL---L 142 (279)
T ss_pred CCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEE---E
Confidence 89999999998764 4578899999999999999764 57899999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||.++...... ......++..|+|||.+. +.++.++|||||||++|++++ |..||.+.......+
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~ 222 (279)
T cd05111 143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222 (279)
T ss_pred cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 678899999999987653322 122345677899999985 568999999999999999998 999998887776666
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+...... ..++.++.+++.+||..+|.+|||+.++++
T Consensus 223 ~~~~~~~~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 223 LLEKGERLAQP---QICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHCCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 55544332221 246789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=260.05 Aligned_cols=193 Identities=28% Similarity=0.523 Sum_probs=160.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+||||+++++++.+.+.+++|+||+++|+|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~ 139 (267)
T cd08228 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred CCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE
Confidence 899999999999999999999999999999887753 3458999999999999999999999999999999999994
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAET--EIGI 157 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~ 157 (315)
+.++.++|+|||++........ .....|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.... ....
T Consensus 140 ---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~ 216 (267)
T cd08228 140 ---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216 (267)
T ss_pred ---cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH
Confidence 5678899999998876543322 23456889999999886 458889999999999999999999997643 3444
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
...+.... ++......++..+++++.+||..+|.+|||+.++++
T Consensus 217 ~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 217 CQKIEQCD--YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHhcCC--CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 44444332 222223357889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=257.18 Aligned_cols=191 Identities=24% Similarity=0.343 Sum_probs=160.5
Q ss_pred CCCCCcceEEEEE-EeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 5 SEHQHVVRIHDTY-EDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 5 ~~Hpniv~~~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+||||+++++++ .+++..|+|+||+++|+|.+++.+.+ .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil- 134 (256)
T cd05082 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVL- 134 (256)
T ss_pred CCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEE-
Confidence 3899999999975 45678999999999999999987653 4889999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
.+.++.+||+|||++....... ....++..|+|||++. ..++.++||||+||++|+|++ |..||...+..+...
T Consensus 135 --~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~ 210 (256)
T cd05082 135 --VSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 210 (256)
T ss_pred --EcCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5678899999999887543322 2334566899999986 458899999999999999997 999998888777777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+.. ....+.+++.+++++.+||+.+|++|||+.++++
T Consensus 211 ~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 211 RVEKGYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHhcCCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 6655422 2223468999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=270.53 Aligned_cols=202 Identities=32% Similarity=0.518 Sum_probs=160.7
Q ss_pred CCCCcceEEEEEEeC--------------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 021227 6 EHQHVVRIHDTYEDK--------------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFH 71 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~--------------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 71 (315)
+||||+++++++... ..+|+|+||+. ++|.+++. .+.+++..++.++.|++.||.|||+.|++|
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH 137 (342)
T cd07854 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLH 137 (342)
T ss_pred CCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 899999999877654 35899999997 58887774 457999999999999999999999999999
Q ss_pred ccCCCCceeeccCCCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhC
Q 021227 72 RDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSG 145 (315)
Q Consensus 72 ~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g 145 (315)
|||||+||++. ..++.+||+|||.+....... ......|+..|+|||.+. ..++.++||||+||++|+|++|
T Consensus 138 ~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 215 (342)
T cd07854 138 RDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215 (342)
T ss_pred CCCCHHHEEEc--CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhC
Confidence 99999999963 356789999999987553221 112345788999999874 3478899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCC----------------------CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 021227 146 VPPFWAETEIGIFRQILEGKIDF----------------------ES----EPWPNISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 146 ~~pf~~~~~~~~~~~i~~~~~~~----------------------~~----~~~~~~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
..||.+.+..+....+....... .. ...+.++.++++||.+||+.||.+|||+.
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 295 (342)
T cd07854 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295 (342)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHH
Confidence 99998877655554443321100 00 01235788999999999999999999999
Q ss_pred HHhcCCCccCCC
Q 021227 200 EVLCHPWIVDDK 211 (315)
Q Consensus 200 ~~l~h~~~~~~~ 211 (315)
+++.||||+...
T Consensus 296 ell~h~~~~~~~ 307 (342)
T cd07854 296 EALMHPYMSCYS 307 (342)
T ss_pred HHhCCCcccccc
Confidence 999999998543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=257.77 Aligned_cols=196 Identities=28% Similarity=0.462 Sum_probs=164.5
Q ss_pred CCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+. +.+++|+||++|++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 62 ~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~--- 138 (264)
T cd06653 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANIL--- 138 (264)
T ss_pred CCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE---
Confidence 899999999998764 568999999999999999988788999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCC----CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPD----EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
.+.++.++|+|||++...... .......|+..|+|||.+.+ .++.++|+||+||++|+|++|..||......+..
T Consensus 139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 218 (264)
T cd06653 139 RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI 218 (264)
T ss_pred EcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH
Confidence 456788999999998765321 11234568899999999864 4889999999999999999999999887666555
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.++...... ......+++++++++.+||+ +|.+|||+.+++.|||.
T Consensus 219 ~~~~~~~~~--~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 219 FKIATQPTK--PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHcCCCC--CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 554432221 22234688999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=270.14 Aligned_cols=203 Identities=33% Similarity=0.513 Sum_probs=164.5
Q ss_pred CCCCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 4 LSEHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.+||||+++++++.. ...+|+||||+. ++|.+++.+. .+++..+..++.|++.||.|||++||+||||+|+||+
T Consensus 63 l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nil- 139 (337)
T cd07852 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNIL- 139 (337)
T ss_pred hcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE-
Confidence 3489999999999864 346899999997 4898888655 7899999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC------cccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE------VFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
++.++.+||+|||++....... ......||+.|+|||.+. ..++.++|+||+||++|+|++|+.||.+..
T Consensus 140 --l~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 140 --LNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred --EcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 5678899999999987653321 223456899999999874 347889999999999999999999998776
Q ss_pred HHHHHHHHHhCCC---------------------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021227 154 EIGIFRQILEGKI---------------------------DFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206 (315)
Q Consensus 154 ~~~~~~~i~~~~~---------------------------~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~ 206 (315)
..+....+..... .......+.++.++.+++.+||+.+|.+|||+.++++|||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~ 297 (337)
T cd07852 218 TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297 (337)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence 5554444322211 1111223457899999999999999999999999999999
Q ss_pred ccCCC
Q 021227 207 IVDDK 211 (315)
Q Consensus 207 ~~~~~ 211 (315)
+....
T Consensus 298 ~~~~~ 302 (337)
T cd07852 298 VAQFH 302 (337)
T ss_pred hhhhc
Confidence 97643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=236.06 Aligned_cols=202 Identities=30% Similarity=0.569 Sum_probs=174.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
++|.|||+++++...++.+-+|+|||+. +|..++.. ++.+..+.++.++.|++.||.++|++++.|||+||+|.+
T Consensus 58 lkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnll--- 133 (292)
T KOG0662|consen 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLL--- 133 (292)
T ss_pred hhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEE---
Confidence 3899999999999999999999999975 78877765 478999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
++.+|.+||+|||+++.+.-+ .+.+.-+-|.+|.+|.++-+ -|+...|+||.|||+.|+.. |.+.|+|.+..+++.
T Consensus 134 in~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk 213 (292)
T KOG0662|consen 134 INRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_pred eccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH
Confidence 788999999999999876543 34555677999999999853 49999999999999999985 899999999999988
Q ss_pred HHHhCCCCCCCCCCC-------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 160 QILEGKIDFESEPWP-------------------------NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~-------------------------~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+|...-..+....|+ +++...+++++++|.-+|.+|++++++++||||...
T Consensus 214 rif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 214 RIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred HHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 887643333333333 345678999999999999999999999999999754
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=261.65 Aligned_cols=202 Identities=28% Similarity=0.461 Sum_probs=170.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV-KKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+.|++|++|+.|-....+++|||||..|++.+.+. ++++++|.++..+++.-+.||+|||...-+|||||..|||
T Consensus 85 C~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNIL--- 161 (502)
T KOG0574|consen 85 CKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNIL--- 161 (502)
T ss_pred cCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEE---
Confidence 389999999999999999999999999999999886 4578999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++-.|..||+|||.+-.+...- ..++.+|||.|||||++.. .|..++||||||++..||..|++||.+-.+...+-.|
T Consensus 162 LNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI 241 (502)
T KOG0574|consen 162 LNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI 241 (502)
T ss_pred EcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec
Confidence 6778999999999997765432 2356889999999999975 5999999999999999999999999876554322222
Q ss_pred HhC-CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 162 LEG-KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 162 ~~~-~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
-.. .+.|.. ....|.++-+|+++||.+.|++|.|+.++++|||+++.+
T Consensus 242 PT~PPPTF~K--PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 242 PTKPPPTFKK--PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred cCCCCCCCCC--hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 111 111111 123688999999999999999999999999999998754
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=258.19 Aligned_cols=192 Identities=21% Similarity=0.316 Sum_probs=162.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++...+..|+||||+.|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 59 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil--- 135 (261)
T cd05068 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVL--- 135 (261)
T ss_pred CCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEE---
Confidence 79999999999999999999999999999999987654 6899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcc--cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
.+.++.+||+|||++......... ....++..|+|||.+. ..++.++|+||+|+++|+|++ |+.||.+.+......
T Consensus 136 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 215 (261)
T cd05068 136 VGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ 215 (261)
T ss_pred EcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 556789999999998766432211 1122235799999886 458999999999999999999 999999888877777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..... .+ ....++..+.+++.+||+.+|.+||++.+++.
T Consensus 216 ~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 216 QVDQGYR-MP--CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHcCCC-CC--CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 7655422 21 22357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=268.89 Aligned_cols=196 Identities=25% Similarity=0.357 Sum_probs=157.3
Q ss_pred CCCCCCCcceEEEEEEe-CCeEEEEEeccCCCchhHHHHhC---------------------------------------
Q 021227 3 HLSEHQHVVRIHDTYED-KSCVHIVMELCEGGELFDRIVKK--------------------------------------- 42 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--------------------------------------- 42 (315)
++.+||||+++++++.. +..+++|+||++||+|.+++...
T Consensus 66 ~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (337)
T cd05054 66 HIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASS 145 (337)
T ss_pred hhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccccc
Confidence 45589999999998764 56789999999999999888542
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCccc
Q 021227 43 ----------------------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVF 100 (315)
Q Consensus 43 ----------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~ 100 (315)
.++++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~ 222 (337)
T cd05054 146 GFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARD 222 (337)
T ss_pred ccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchh
Confidence 267899999999999999999999999999999999995 5678899999999976
Q ss_pred CCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhCCCCCCCCCCC
Q 021227 101 YKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF-RQILEGKIDFESEPWP 174 (315)
Q Consensus 101 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~ 174 (315)
+..... .....++..|+|||++. ..++.++||||+||++|+|++ |..||.+....+.+ ..+..+.. ... ..
T Consensus 223 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~ 299 (337)
T cd05054 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-MRA--PE 299 (337)
T ss_pred cccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-CCC--Cc
Confidence 533221 12244567899999875 559999999999999999998 99999875443333 33333322 111 13
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 175 NISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 175 ~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
..++++.+++.+||+.+|++|||+.++++|
T Consensus 300 ~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=257.41 Aligned_cols=195 Identities=23% Similarity=0.336 Sum_probs=165.3
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+.+ +||||+++++++.+...+++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++|++||||+|+||
T Consensus 57 ~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~ni 135 (261)
T cd05148 57 KRL-RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNI 135 (261)
T ss_pred hcC-CCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceE
Confidence 345 8999999999999999999999999999999998753 4689999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 156 (315)
+ ++.++.+||+|||.+........ .....++..|+|||.+. +.++.++||||+|+++|+|++ |..||.+.+..+
T Consensus 136 l---v~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~ 212 (261)
T cd05148 136 L---VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212 (261)
T ss_pred E---EcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9 56678999999999876543221 12334567899999886 458899999999999999998 899999888888
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+..+.. . +....+++++.+++.+||+.+|.+|||+.++++
T Consensus 213 ~~~~~~~~~~-~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 213 VYDQITAGYR-M--PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHhCCc-C--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 8877775422 1 222468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=275.46 Aligned_cols=197 Identities=24% Similarity=0.353 Sum_probs=169.1
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
|+. .+|||||++||+..++..+++|||+|.||+|.+++.+.+ .++..+...++.+.+.||+|||+++++||||-..|+
T Consensus 215 Mr~-l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNc 293 (474)
T KOG0194|consen 215 MRQ-LNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNC 293 (474)
T ss_pred HHh-CCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHh
Confidence 344 499999999999999999999999999999999998876 499999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCccc-ccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFS-DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 156 (315)
| .+.++.+||+|||+++....-.... ...-...|+|||.+. +.|+.++||||+||++||+++ |..||.+....+
T Consensus 294 L---~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~ 370 (474)
T KOG0194|consen 294 L---YSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE 370 (474)
T ss_pred e---ecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH
Confidence 9 5566779999999987654222111 112346799999996 569999999999999999998 899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+...|....++.+.+ ...++++..++.+||..+|++|||+.++.+
T Consensus 371 v~~kI~~~~~r~~~~--~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 371 VKAKIVKNGYRMPIP--SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhcCccCCCC--CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 999996655554443 367899999999999999999999988864
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=259.71 Aligned_cols=194 Identities=26% Similarity=0.518 Sum_probs=160.6
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+||||+++++++.+++.+++|+||+.|++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 59 ~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nil 138 (267)
T cd08229 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 138 (267)
T ss_pred ccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 3899999999999999999999999999999988763 356899999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE--IG 156 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~ 156 (315)
+ +.++.++|+|||++........ .....|+..|+|||.+. ..++.++|+||+|+++|+|++|..||.+... .+
T Consensus 139 i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T cd08229 139 I---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215 (267)
T ss_pred E---cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH
Confidence 4 5678999999998876543322 23456889999999986 4588899999999999999999999976543 33
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
....+.... ++......+++++++++.+||..+|.+|||+.++++
T Consensus 216 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 216 LCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HhhhhhcCC--CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 444444332 222233468899999999999999999999997763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=262.60 Aligned_cols=198 Identities=32% Similarity=0.590 Sum_probs=165.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+...+++|+||+. ++|.+++.+. ..+++..+..++.|++.||+|||+.||+||||+|+||+ .
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~---~ 131 (282)
T cd07829 56 KHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNIL---I 131 (282)
T ss_pred CCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEE---E
Confidence 79999999999999999999999997 5899999876 58999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-h-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-K-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.++.+||+|||.+....... ......++..|+|||.+. . .++.++|+||+||++|++++|.+||.+.+..+.+..+
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 132 NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 568899999999987654332 223345678899999875 3 5889999999999999999999999888766655554
Q ss_pred HhCCC------------------CCC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 162 LEGKI------------------DFE-------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 162 ~~~~~------------------~~~-------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
..... .++ ...++.++.++.+++.+||..+|.+||++.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 212 FQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 33110 000 01233467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=257.99 Aligned_cols=195 Identities=18% Similarity=0.288 Sum_probs=157.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-----NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
.+||||+++++.+.+...+|+||||+++|+|.+++.+.. ..++..+..++.|++.||+|||++||+||||||+||
T Consensus 52 l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 131 (269)
T cd05042 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131 (269)
T ss_pred CCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhhe
Confidence 389999999999999999999999999999999987642 246788899999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhhh--------cCCCchhHHHHHHHHHHHHh-CCC
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLRK--------HYGPEADVWSAGVILYILLS-GVP 147 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~-g~~ 147 (315)
+ ++.++.+||+|||++........ .....+++.|+|||++.. .++.++||||+||++|+|++ |..
T Consensus 132 l---l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 208 (269)
T cd05042 132 Q---LTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ 208 (269)
T ss_pred E---ecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCC
Confidence 9 56688999999999865432211 122345678999998742 36789999999999999999 788
Q ss_pred CCCCCCHHHHHHHHHh-CCCCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 148 PFWAETEIGIFRQILE-GKIDFESEP-WPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~-~~~~~~~~~-~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
||......+....+.. ....++.+. ...+++.+.+++..|+ .||++|||++++++
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 209 PYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 9988776665555443 333333222 2357889999999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=262.68 Aligned_cols=197 Identities=26% Similarity=0.465 Sum_probs=166.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+|||++++++++.++...++||||+.| +|.+.+.. ..++++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 83 ~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~--- 158 (317)
T cd06635 83 KHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL--- 158 (317)
T ss_pred CCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---
Confidence 899999999999999999999999975 77776654 4679999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++...... ....|++.|+|||.+. +.++.++|+||+||++|+|++|..||...........
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 235 (317)
T cd06635 159 TEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 235 (317)
T ss_pred CCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 56789999999987654322 3456889999999873 4588899999999999999999999988777666666
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
+........ ....+++.+++++.+||+.+|.+|||+.++++|+|+....
T Consensus 236 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 236 IAQNESPTL--QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHhccCCCC--CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 655433221 1235788999999999999999999999999999997544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=255.83 Aligned_cols=194 Identities=27% Similarity=0.416 Sum_probs=166.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+ +||||+++++++.+.+.+++||||++|++|.+++..... +++..+..++.|++.||+|||+.|++||||+|+||+
T Consensus 57 ~l-~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil 135 (258)
T smart00219 57 KL-DHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135 (258)
T ss_pred hc-CCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEE
Confidence 45 899999999999999999999999999999999876544 999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCccc--ccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFS--DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 156 (315)
.+.++.++|+|||++.......... ...+++.|+|||.+. ..++.++|+||+|+++|+|++ |.+||...+...
T Consensus 136 ---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 136 ---VGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred ---EccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 5667799999999987665432222 123678999999885 458999999999999999998 899998888888
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+.+......... ..++.++.+++.+||..+|.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 213 VLEYLKKGYRLPKP---ENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHhcCCCCCCC---CcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 88877766543222 347999999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=260.70 Aligned_cols=192 Identities=23% Similarity=0.325 Sum_probs=161.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC------------------------CCCCHHHHHHHHHHHHHHH
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK------------------------GNYSEREAAKLMKTIVGVV 61 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l 61 (315)
+||||+++++.+..++..++|+||+.+|+|.+++... .++++..+..++.|++.||
T Consensus 61 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l 140 (290)
T cd05045 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGM 140 (290)
T ss_pred CCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHH
Confidence 7999999999999999999999999999999987642 2478899999999999999
Q ss_pred HHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHH
Q 021227 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGV 137 (315)
Q Consensus 62 ~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~ 137 (315)
.|||++|++||||||+||++ ++++.+||+|||++........ .....++..|+|||.+. ..++.++||||+|+
T Consensus 141 ~~LH~~~ivH~dikp~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~ 217 (290)
T cd05045 141 QYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217 (290)
T ss_pred HHHHHCCeehhhhhhheEEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHH
Confidence 99999999999999999995 5678999999999875533221 12234567899999875 45899999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 138 ILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 138 il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
++|+|++ |..||.+....+....+.... ..+ ....++.++.+++.+||+.+|.+|||+.++++
T Consensus 218 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 218 LLWEIVTLGGNPYPGIAPERLFNLLKTGY-RME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999998 999999888877777665442 221 22467899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=263.22 Aligned_cols=196 Identities=27% Similarity=0.454 Sum_probs=164.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+|||++++++++.+....++|+||+. |++.+.+.. ..++++..+..++.|++.|+.|||++|++||||+|+||++
T Consensus 73 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~--- 148 (308)
T cd06634 73 RHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL--- 148 (308)
T ss_pred CCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---
Confidence 89999999999999999999999996 577776644 4568999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++...... ....|++.|+|||.+. +.++.++||||+||++|+|++|..||...+..+....
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 225 (308)
T cd06634 149 SEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225 (308)
T ss_pred CCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH
Confidence 56789999999988765432 3456889999999873 3578899999999999999999999987766555554
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+..+..... ....++..++++|.+||+.+|.+|||++++++|||+...
T Consensus 226 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 226 IAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HhhcCCCCc--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 444332211 123578999999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=258.82 Aligned_cols=192 Identities=22% Similarity=0.328 Sum_probs=158.7
Q ss_pred CCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 021227 6 EHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVK------KGNYSEREAAKLMKTIVGVVECCHSLGVFHRD 73 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 73 (315)
+||||+++++++... ...++|+||+.+|+|.+++.. ...+++..+..++.|++.||+|||++||+|||
T Consensus 58 ~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 137 (272)
T cd05075 58 DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRD 137 (272)
T ss_pred CCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 899999999976422 357899999999999887742 23488999999999999999999999999999
Q ss_pred CCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCC
Q 021227 74 LKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPP 148 (315)
Q Consensus 74 ikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~p 148 (315)
|||+||+ .+.++.+||+|||++........ .....+++.|+|||.+. ..++.++||||+||++|+|++ |..|
T Consensus 138 lkp~Nil---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 138 LAARNCM---LNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred cchhheE---EcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999 56788999999999876543321 11234567899999986 458999999999999999999 8999
Q ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 149 FWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 149 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|.+....+....+..+.... ..+.++..+++++.+||+.+|++|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 215 YPGVENSEIYDYLRQGNRLK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred CCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99888877777777654321 12367899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=265.99 Aligned_cols=198 Identities=25% Similarity=0.444 Sum_probs=158.6
Q ss_pred CCCCcceEEEEEEeC--------CeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 021227 6 EHQHVVRIHDTYEDK--------SCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKP 76 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp 76 (315)
+||||+++++++.+. ..+++|+||+.+ +|...+.. ...+++..+..++.|+++||+|||++|++||||||
T Consensus 65 ~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p 143 (311)
T cd07866 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKA 143 (311)
T ss_pred CCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 899999999987543 357999999975 66666654 45799999999999999999999999999999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCCCCc------------ccccccCccccchhhhhh--cCCCchhHHHHHHHHHHH
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKPDEV------------FSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYIL 142 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l 142 (315)
+||+ .+.++.+||+|||++........ .....|++.|+|||.+.+ .++.++||||+||++|+|
T Consensus 144 ~nil---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el 220 (311)
T cd07866 144 ANIL---IDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220 (311)
T ss_pred HHEE---ECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHH
Confidence 9999 56788999999999875432211 123456888999998753 478999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCCCCCC
Q 021227 143 LSGVPPFWAETEIGIFRQILEGKIDFES--------------------------EPWPNISESAKDLIRKMLDQNPKRRL 196 (315)
Q Consensus 143 l~g~~pf~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~l~~~p~~R~ 196 (315)
++|.+||.+.+.....+.+......... ..+..+++++.+++.+||+.+|.+||
T Consensus 221 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 300 (311)
T cd07866 221 FTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300 (311)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc
Confidence 9999999988876665555432111000 01234567899999999999999999
Q ss_pred CHHHHhcCCCc
Q 021227 197 TAHEVLCHPWI 207 (315)
Q Consensus 197 s~~~~l~h~~~ 207 (315)
|+.+++.||||
T Consensus 301 t~~ell~~~~f 311 (311)
T cd07866 301 TASDALEHPYF 311 (311)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=257.46 Aligned_cols=192 Identities=22% Similarity=0.430 Sum_probs=162.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++..|+||||++||+|.+++.+. +.+++..+..++.|++.||+|||+.|++||||||+||+ .
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nil---i 139 (267)
T cd05066 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNIL---V 139 (267)
T ss_pred CCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEE---E
Confidence 8999999999999999999999999999999998765 56899999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCCc-c---cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV-F---SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~-~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
+.++.++|+|||++........ . ....++..|+|||.+. +.++.++|+||+||++|++++ |..||.+....+..
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~ 219 (267)
T cd05066 140 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219 (267)
T ss_pred CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH
Confidence 5678999999999876543221 1 1122356799999986 468999999999999999886 99999988777777
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+.++. ..+ ....+++.+++++.+||+.+|.+|||+.++++
T Consensus 220 ~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 220 KAIEEGY-RLP--APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHhCCC-cCC--CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 7776552 222 22467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=253.56 Aligned_cols=192 Identities=26% Similarity=0.366 Sum_probs=161.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+....++||||++||+|.+++... ..+++..+..++.|++.||.|+|++|++||||+|+||++
T Consensus 50 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili--- 126 (250)
T cd05085 50 DHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV--- 126 (250)
T ss_pred CCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---
Confidence 8999999999999999999999999999999988654 468999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCCcc--cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++......... ....+++.|+|||++. +.++.++||||+|+++|++++ |..||.+.........
T Consensus 127 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~ 206 (250)
T cd05085 127 GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ 206 (250)
T ss_pred cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 56789999999998654332211 1123456799999986 558899999999999999998 9999988877776666
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+..+.. ......++.++.+++.+||+.+|++|||+.++++
T Consensus 207 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 207 VEKGYR---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHcCCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 654421 1222457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=254.67 Aligned_cols=190 Identities=23% Similarity=0.337 Sum_probs=162.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+....|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 58 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nil--- 134 (256)
T cd05039 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVL--- 134 (256)
T ss_pred CCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEE---
Confidence 79999999999999999999999999999999997765 6999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 161 (315)
.+.++.+||+|||.+........ ...++..|+|||.+. +.++.++|+||+|+++|++++ |..||...+.......+
T Consensus 135 i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 212 (256)
T cd05039 135 VSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV 212 (256)
T ss_pred EeCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 56788999999999876632221 233456799999885 568889999999999999997 99999888877776666
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+.. . .....+|+++.+++.+||..+|.+|||+.+++.
T Consensus 213 ~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 213 EKGYR-M--EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred hcCCC-C--CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 55421 1 122357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=268.06 Aligned_cols=201 Identities=30% Similarity=0.501 Sum_probs=164.0
Q ss_pred CCCCCCCcceEEEEEEeCC------eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 021227 3 HLSEHQHVVRIHDTYEDKS------CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKP 76 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp 76 (315)
.+ +||||+++++++..+. .+++|+||+ |++|.+++. ...+++..+..++.|++.||+|||+.||+||||||
T Consensus 70 ~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp 146 (343)
T cd07880 70 HM-KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKP 146 (343)
T ss_pred hc-CCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 44 8999999999997654 468999999 778877764 46799999999999999999999999999999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
+||+ .+.++.+||+|||++...... .....+++.|+|||.+.+ .++.++|+||+||++|++++|..||.+.+.
T Consensus 147 ~Nil---l~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 221 (343)
T cd07880 147 GNLA---VNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221 (343)
T ss_pred HHEE---EcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999 456788999999998765332 234567899999998863 478899999999999999999999988776
Q ss_pred HHHHHHHHhCCCCC-----------------------C----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 155 IGIFRQILEGKIDF-----------------------E----SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 155 ~~~~~~i~~~~~~~-----------------------~----~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
......+....... . ...++.+++++.++|.+||+.||.+|||+.+++.||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~ 301 (343)
T cd07880 222 LDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301 (343)
T ss_pred HHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence 55544443321110 0 01124678899999999999999999999999999999
Q ss_pred cCCC
Q 021227 208 VDDK 211 (315)
Q Consensus 208 ~~~~ 211 (315)
+...
T Consensus 302 ~~~~ 305 (343)
T cd07880 302 EEFH 305 (343)
T ss_pred hhhc
Confidence 8653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=262.10 Aligned_cols=199 Identities=31% Similarity=0.509 Sum_probs=161.1
Q ss_pred CcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC--
Q 021227 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV-- 84 (315)
Q Consensus 9 niv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~-- 84 (315)
-+|.+.++|+..++.|||+|.+ |.|+++++..+ .+++...++.+++|+++++++||+.+++|-||||+|||+.+.
T Consensus 152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEY 230 (415)
T ss_pred EEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccce
Confidence 3688889999999999999998 66999999775 479999999999999999999999999999999999998531
Q ss_pred ---------------CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCC
Q 021227 85 ---------------DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPP 148 (315)
Q Consensus 85 ---------------~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 148 (315)
..+..|+++|||.|+.-.... .+.+.|..|.|||++.+ .|+..|||||+|||++|++||...
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 135679999999998754433 67788999999999875 599999999999999999999999
Q ss_pred CCCCCHHH---HHHHHHh------------------CCCCCCCCCCC------------------CC---CHHHHHHHHH
Q 021227 149 FWAETEIG---IFRQILE------------------GKIDFESEPWP------------------NI---SESAKDLIRK 186 (315)
Q Consensus 149 f~~~~~~~---~~~~i~~------------------~~~~~~~~~~~------------------~~---s~~~~~li~~ 186 (315)
|++.+..+ +.+.|.. +++.++....+ .. -.++.|||++
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 99877555 3333332 11111110000 01 1347799999
Q ss_pred hcccCCCCCCCHHHHhcCCCccCC
Q 021227 187 MLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 187 ~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
||..||.+|+|+.|||.||||+..
T Consensus 389 mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHccCccccccHHHHhcCHHhhcC
Confidence 999999999999999999999754
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=255.26 Aligned_cols=192 Identities=21% Similarity=0.385 Sum_probs=162.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+....|+||||+.+++|.+++..+ +.+++..+..++.|++.|++|||+.|++||||||+||++
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili--- 140 (268)
T cd05063 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV--- 140 (268)
T ss_pred CCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---
Confidence 8999999999999999999999999999999998764 578999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCCcc--c--ccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVF--S--DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~--~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
+.++.+||+|||++......... . ....++.|+|||++. +.++.++||||+||++|++++ |..||...+..+..
T Consensus 141 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~ 220 (268)
T cd05063 141 NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM 220 (268)
T ss_pred cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence 56789999999998765332211 1 112345799999886 558999999999999999997 99999988888888
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+..+.... ....+++++.+++.+||+.+|++||++.++++
T Consensus 221 ~~i~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 221 KAINDGFRLP---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHhcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8776653221 12357899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=263.78 Aligned_cols=193 Identities=22% Similarity=0.284 Sum_probs=159.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++... ..++|+||+.+|+|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 66 l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nil--- 141 (316)
T cd05108 66 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVL--- 141 (316)
T ss_pred CCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheE---
Confidence 3899999999998765 567999999999999998774 46899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcc---cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVF---SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
++.++.+||+|||++......... ....++..|+|||.+. ..++.++||||+||++|+|++ |..||.+....+..
T Consensus 142 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~ 221 (316)
T cd05108 142 VKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221 (316)
T ss_pred ecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 566788999999999876543321 1223456799999886 558999999999999999997 99999887766654
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
..+..+ ..++. .+.++.++.+++.+||..+|.+|||+.+++.+
T Consensus 222 ~~~~~~-~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 222 SILEKG-ERLPQ--PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHhCC-CCCCC--CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 444333 22222 23578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=265.13 Aligned_cols=196 Identities=21% Similarity=0.337 Sum_probs=163.8
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------NYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
++.+||||+++++++.++...++|+||+.+|+|.+++.+.. .++...+..++.|++.||.|||+
T Consensus 73 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 152 (334)
T cd05100 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS 152 (334)
T ss_pred hhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 44589999999999999999999999999999999987532 37788899999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHH
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYIL 142 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 142 (315)
+|++||||||+||++ +.++.+||+|||+++....... .....++..|+|||++. ..++.++||||+||++|+|
T Consensus 153 ~givH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 229 (334)
T cd05100 153 QKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229 (334)
T ss_pred CCeeccccccceEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHH
Confidence 999999999999994 5678999999999876543221 11223456799999986 4589999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 143 LS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 143 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
++ |..||.+.+..+....+..+... .....++.++.+++.+||+.+|.+|||+.+++.+
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 230 FTLGGSPYPGIPVEELFKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 98 89999998888877777654322 1123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=257.40 Aligned_cols=193 Identities=21% Similarity=0.304 Sum_probs=160.2
Q ss_pred CCCCcceEEEEEEeCCe------EEEEEeccCCCchhHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 021227 6 EHQHVVRIHDTYEDKSC------VHIVMELCEGGELFDRIVKK------GNYSEREAAKLMKTIVGVVECCHSLGVFHRD 73 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~------~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 73 (315)
+||||+++++++..... .++|+||+.+|+|..++... ..+++..+..++.|++.||.|||+.|++|||
T Consensus 59 ~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~d 138 (273)
T cd05035 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRD 138 (273)
T ss_pred CCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 89999999998865543 79999999999998887442 3689999999999999999999999999999
Q ss_pred CCCCceeeccCCCCCCEEEeeccCcccCCCCCcc---cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCC
Q 021227 74 LKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF---SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPP 148 (315)
Q Consensus 74 ikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~p 148 (315)
|||+||++ ++++.+||+|||+++........ ....++..|+|||.+. ..++.++||||+||++|+|++ |..|
T Consensus 139 lkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p 215 (273)
T cd05035 139 LAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215 (273)
T ss_pred cchheEEE---CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 99999994 56789999999998765433211 1123466899999986 458999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 149 FWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 149 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
|.+....+....+..+.... ....+++++.+++.+||+.||.+|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 216 YPGVENHEIYDYLRHGNRLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCHHHHHHHHHcCCCCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99888877777776653221 123678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=255.97 Aligned_cols=195 Identities=23% Similarity=0.333 Sum_probs=160.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+||||+++++++.+....++||||++||+|.+++.+. ..+++..+..++.|++.||+|||+.+++|+||+|+|
T Consensus 57 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~n 136 (269)
T cd05044 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARN 136 (269)
T ss_pred CCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChhe
Confidence 8999999999999999999999999999999998642 347889999999999999999999999999999999
Q ss_pred eeeccCC--CCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 021227 79 FLFLSVD--EDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWA 151 (315)
Q Consensus 79 il~~~~~--~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~ 151 (315)
|++...+ ....+||+|||++........ .....++..|+|||.+. +.++.++|||||||++|+|++ |..||..
T Consensus 137 il~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 137 CLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred EEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 9974322 223899999999875533221 12234567899999886 558999999999999999998 9999988
Q ss_pred CCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 152 ETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 152 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+....+..+... .....+|+.+.+++.+||+.+|.+|||++++++
T Consensus 217 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 217 LNNQEVLQHVTAGGRL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cCHHHHHHHHhcCCcc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8777766666543211 122467899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=257.40 Aligned_cols=196 Identities=21% Similarity=0.364 Sum_probs=166.8
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG---------NYSEREAAKLMKTIVGVVECCHSLGVFHRD 73 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 73 (315)
++ +||||+++++++.+....|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+.||+|||
T Consensus 64 ~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~d 142 (275)
T cd05046 64 KL-SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRD 142 (275)
T ss_pred hc-CCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCc
Confidence 44 89999999999999999999999999999999997655 689999999999999999999999999999
Q ss_pred CCCCceeeccCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCC
Q 021227 74 LKPENFLFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPF 149 (315)
Q Consensus 74 ikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf 149 (315)
|||+||++ +..+.++++|||++....... ......++..|+|||.+. +.++.++||||+|+++|++++ |..||
T Consensus 143 lkp~Nili---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~ 219 (275)
T cd05046 143 LAARNCLV---SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219 (275)
T ss_pred CccceEEE---eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99999994 567899999999886543221 123345677899999875 458889999999999999998 88999
Q ss_pred CCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 150 WAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 150 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.+.........+..+...++.. ..+++.+.+++.+||+.+|.+|||+.+++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 220 YGLSDEEVLNRLQAGKLELPVP--EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cccchHHHHHHHHcCCcCCCCC--CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 8877777777777665544332 3678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=254.16 Aligned_cols=191 Identities=22% Similarity=0.327 Sum_probs=159.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.. +..++||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus 59 ~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nil--- 134 (260)
T cd05069 59 RHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANIL--- 134 (260)
T ss_pred CCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE---
Confidence 89999999998864 5678999999999999998764 34889999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
++.++.++|+|||.+........ .....++..|+|||... +.++.++||||+||++|+|++ |..||.+....+...
T Consensus 135 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05069 135 VGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE 214 (260)
T ss_pred EcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 56688999999999876543321 12234567899999886 458899999999999999999 999999988877777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..... .......+..+++++.+||.++|.+|||++++++
T Consensus 215 ~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 215 QVERGYR---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHcCCC---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 7665422 1222467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=258.52 Aligned_cols=192 Identities=21% Similarity=0.324 Sum_probs=162.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHH
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------------NYSEREAAKLMKTIVGVVEC 63 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------------~~~~~~~~~~~~qi~~~l~~ 63 (315)
+||||+++++++.++..+++|+||+++|+|.+++.... .+++..+..++.|++.||.|
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~ 145 (288)
T cd05050 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAY 145 (288)
T ss_pred CCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 89999999999999999999999999999999986432 47788899999999999999
Q ss_pred HHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHH
Q 021227 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVIL 139 (315)
Q Consensus 64 lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il 139 (315)
||++|++||||||+||+ .+.++.+||+|||++........ .....++..|+|||.+. ..++.++||||+||++
T Consensus 146 lH~~~i~H~dl~p~nil---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 222 (288)
T cd05050 146 LSERKFVHRDLATRNCL---VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222 (288)
T ss_pred HHhCCeecccccHhheE---ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHH
Confidence 99999999999999999 56788999999999875433221 12233466799999876 5689999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 140 YILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 140 ~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|+|++ |..||.+.+..+....+..+..... ...++.++.+++.+||+.+|.+|||+.|+++
T Consensus 223 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 223 WEIFSYGMQPYYGMAHEEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99997 8899988888888777776654321 1357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=254.88 Aligned_cols=195 Identities=19% Similarity=0.308 Sum_probs=156.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+||||+++++.+.+....|+||||+++|+|.+++.+. ...++..+..++.|++.||+|||+++++||||||+||+
T Consensus 52 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil 131 (268)
T cd05086 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131 (268)
T ss_pred cCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEE
Confidence 48999999999999999999999999999999998754 34667788899999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhhh--------cCCCchhHHHHHHHHHHHHh-CCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLRK--------HYGPEADVWSAGVILYILLS-GVPP 148 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~-g~~p 148 (315)
.+.++.+||+|||++....... ......++..|+|||++.. .++.++||||+||++|+|++ |..|
T Consensus 132 ---~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 208 (268)
T cd05086 132 ---LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208 (268)
T ss_pred ---EcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCC
Confidence 4667889999999875432211 1234567889999998732 25778999999999999997 5778
Q ss_pred CCCCCHHHHHHHHHhCC-CCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 149 FWAETEIGIFRQILEGK-IDFES-EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 149 f~~~~~~~~~~~i~~~~-~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|...+..+.+..+..+. ..... .....+++.+.+++..|| .+|++|||++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 209 YSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 88777766666654432 22222 222357889999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=252.79 Aligned_cols=193 Identities=22% Similarity=0.338 Sum_probs=157.5
Q ss_pred CCCCCcceEEEEEE-eCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYE-DKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~-~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+||||+++++++. .++..++|+||+.+|+|.+++.+. ...++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 53 l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili- 131 (262)
T cd05058 53 FSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML- 131 (262)
T ss_pred CCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE-
Confidence 38999999999765 566789999999999999998764 456788889999999999999999999999999999994
Q ss_pred cCCCCCCEEEeeccCcccCCCCC-----cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI 155 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 155 (315)
+.++.+||+|||++....... ......+++.|+|||.+. ..++.++||||+||++|+|++ |.+||...+..
T Consensus 132 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~ 209 (262)
T cd05058 132 --DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF 209 (262)
T ss_pred --cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 567889999999987543221 112234567899999885 558899999999999999999 57778777777
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+....+..+...... ..+|+.+.+++.+||..+|++||++.++++
T Consensus 210 ~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 210 DITVYLLQGRRLLQP---EYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 766666554322211 246889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=252.90 Aligned_cols=193 Identities=25% Similarity=0.423 Sum_probs=163.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+...+++|+||+.|++|.+++... +.+++..+..++.|++.|++|||+.|++||||||+||+ .
T Consensus 57 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~---i 133 (256)
T cd05112 57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCL---V 133 (256)
T ss_pred CCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEE---E
Confidence 8999999999999999999999999999999988764 56899999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||.+........ .....++..|+|||.+. +.++.++|+||+|+++|+|++ |..||......+....
T Consensus 134 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 213 (256)
T cd05112 134 GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET 213 (256)
T ss_pred cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 5678999999998875533221 11223456899999886 568899999999999999998 9999998888888877
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
+..+...+.. ...+..+.+++.+||+.+|++|||+.++++.
T Consensus 214 ~~~~~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 214 INAGFRLYKP---RLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HhCCCCCCCC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 7665332222 2468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=256.30 Aligned_cols=192 Identities=21% Similarity=0.247 Sum_probs=159.4
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++... ..++++||+++|+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 66 ~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~-- 142 (279)
T cd05109 66 VGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV-- 142 (279)
T ss_pred cCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE--
Confidence 3799999999998764 467999999999999998764 569999999999999999999999999999999999995
Q ss_pred CCCCCCEEEeeccCcccCCCCCcc---cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVF---SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
+.++.+||+|||+++........ ....+++.|+|||.+. ..++.++||||+||++|+|++ |..||.........
T Consensus 143 -~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 221 (279)
T cd05109 143 -KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP 221 (279)
T ss_pred -cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 56778999999998766433221 1223467899999885 558999999999999999998 99999887776666
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+..+.... ....+++++.+++.+||..||++|||+.+++.
T Consensus 222 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 222 DLLEKGERLP---QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHCCCcCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6555543221 12467899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=254.81 Aligned_cols=196 Identities=29% Similarity=0.499 Sum_probs=167.5
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPEN 78 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~n 78 (315)
..+||||+++++++.+++..++||||++|++|.+++.. ...+++..++.++.|++.||.|||+ .|++||||+|+|
T Consensus 65 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~n 144 (269)
T cd08528 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNN 144 (269)
T ss_pred cCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHH
Confidence 35899999999999999999999999999999887743 3568999999999999999999995 789999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|++ +..+.+||+|||.+.............|+..|+|||.+. +.++.++|+||+|+++|+|++|..||........
T Consensus 145 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~ 221 (269)
T cd08528 145 IML---GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL 221 (269)
T ss_pred EEE---CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH
Confidence 994 567899999999987765544445567899999999986 4488999999999999999999999988887777
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
...+......... ...+++++.+++.+||+.||++|||+.|+..+
T Consensus 222 ~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 222 ATKIVEAVYEPLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHhhccCCcCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 7776665443222 23578999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=254.34 Aligned_cols=190 Identities=19% Similarity=0.203 Sum_probs=153.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.. ...++|+||+.+|+|.+++.+.. .+++..+..++.|++.||+|||++||+||||||+||++..
T Consensus 58 l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~ 136 (259)
T cd05037 58 LSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVAR 136 (259)
T ss_pred CCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEec
Confidence 389999999999988 77899999999999999997765 7999999999999999999999999999999999999643
Q ss_pred CC----CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 021227 84 VD----EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLS-GVPPFWAETEI 155 (315)
Q Consensus 84 ~~----~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 155 (315)
.. ....+||+|||++..... .....++..|+|||++.+ .++.++||||+||++|+|++ |..||...+..
T Consensus 137 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 137 YGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred CccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 22 112799999999876543 223456788999999863 48899999999999999999 58888776543
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+........ ...+. ..+..+.+++.+||..+|.+|||+.++++
T Consensus 214 ~~~~~~~~~-~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 214 EKERFYQDQ-HRLPM----PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred hHHHHHhcC-CCCCC----CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 333332211 11111 12378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=254.76 Aligned_cols=194 Identities=20% Similarity=0.298 Sum_probs=154.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-----GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+||||+++++++.+...+++||||+++|+|.+++... ...++..+..++.|++.||+|||+.|++||||||+||+
T Consensus 53 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil 132 (269)
T cd05087 53 QHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCL 132 (269)
T ss_pred CCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEE
Confidence 8999999999999999999999999999999988653 24567788899999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhhh--------cCCCchhHHHHHHHHHHHHh-CCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLRK--------HYGPEADVWSAGVILYILLS-GVPP 148 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~-g~~p 148 (315)
.+.++.+||+|||.+........ .....+++.|+|||++.+ .++.++|+||+||++|+|++ |..|
T Consensus 133 ---~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p 209 (269)
T cd05087 133 ---LTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209 (269)
T ss_pred ---EcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCC
Confidence 45678999999999865432221 123456788999998852 25789999999999999996 9999
Q ss_pred CCCCCHHHHHHHH-HhCCCCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 149 FWAETEIGIFRQI-LEGKIDFESEPW-PNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 149 f~~~~~~~~~~~i-~~~~~~~~~~~~-~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|......+..... .......+.+.. ...++.+.+++.+|+ .+|++|||+++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 210 YRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 9876655544332 222232332221 246788999999998 58999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=254.95 Aligned_cols=193 Identities=21% Similarity=0.425 Sum_probs=161.4
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.++..+++||||+.+|+|.+++... +.+++..++.++.|++.||+|||++|++||||||+||+
T Consensus 62 l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nil--- 138 (269)
T cd05065 62 FDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNIL--- 138 (269)
T ss_pred CCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEE---
Confidence 38999999999999999999999999999999988764 56899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcc---cccc---cCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVF---SDVV---GSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI 155 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~---gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 155 (315)
++.++.+||+|||++......... .... .+..|+|||.+. +.++.++||||+||++|++++ |..||...+..
T Consensus 139 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 139 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred EcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 466789999999988755332211 1111 135799999986 558999999999999999886 99999988887
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+....+.... .. +....++.++.+++.+||+.+|.+||++.+++.
T Consensus 219 ~~~~~i~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 219 DVINAIEQDY-RL--PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHcCC-cC--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7777765432 22 222467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=253.15 Aligned_cols=191 Identities=24% Similarity=0.338 Sum_probs=159.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.. ...|+||||+.+|+|.+++.+. ..+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus 59 ~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nil--- 134 (262)
T cd05071 59 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL--- 134 (262)
T ss_pred CCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEE---
Confidence 79999999998855 4578999999999999999763 35889999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcc--cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
.+.++.+||+|||.+......... ....++..|+|||... +.++.++|+||+||++|++++ |..||.+....+...
T Consensus 135 l~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~ 214 (262)
T cd05071 135 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 214 (262)
T ss_pred EcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH
Confidence 456788999999998765433221 2234567899999875 558999999999999999999 899998887777777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+... + ....+++.+.+++.+||+++|++|||+.+++.
T Consensus 215 ~~~~~~~~-~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 215 QVERGYRM-P--CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHhcCCCC-C--CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66554321 1 12468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=253.97 Aligned_cols=198 Identities=30% Similarity=0.525 Sum_probs=165.8
Q ss_pred CCCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 5 SEHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
..|+||++++++|.-. ...|+|||++++ +|...+. ..+.-+.+..+..|++.|++|||+.||+||||||+|
T Consensus 72 v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsn 148 (369)
T KOG0665|consen 72 VNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSN 148 (369)
T ss_pred hcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccc
Confidence 4899999999999643 468999999975 8888776 457888999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|+ +...+.+|+.|||+|+.-...-..+.++.|..|.|||++- -.|...+||||+||++.||++|...|.|.+..++
T Consensus 149 iv---v~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ 225 (369)
T KOG0665|consen 149 IV---VNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ 225 (369)
T ss_pred ce---ecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence 99 6788999999999998766665667788999999999875 3499999999999999999999999999887776
Q ss_pred HHHHHhCCCC-------------------------------CCCCCCC-------CCCHHHHHHHHHhcccCCCCCCCHH
Q 021227 158 FRQILEGKID-------------------------------FESEPWP-------NISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 158 ~~~i~~~~~~-------------------------------~~~~~~~-------~~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
+.++.+.... ++...|+ .-+..+++++.+||..+|++|.|++
T Consensus 226 ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~ 305 (369)
T KOG0665|consen 226 WNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVD 305 (369)
T ss_pred HHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHH
Confidence 6666541111 1111121 1245689999999999999999999
Q ss_pred HHhcCCCcc
Q 021227 200 EVLCHPWIV 208 (315)
Q Consensus 200 ~~l~h~~~~ 208 (315)
++|+|||++
T Consensus 306 daL~HPY~~ 314 (369)
T KOG0665|consen 306 DALRHPYIK 314 (369)
T ss_pred HHhcCCeee
Confidence 999999996
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=266.23 Aligned_cols=200 Identities=32% Similarity=0.505 Sum_probs=161.6
Q ss_pred CCCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 5 SEHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
.+||||+++++++... ..+|+|+||+.+ +|..+. ...+++..+..++.|++.||+|||++|++||||||+|
T Consensus 71 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~N 147 (342)
T cd07879 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGN 147 (342)
T ss_pred cCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 3899999999998754 357999999964 666554 3468999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
|+ .+.++.+||+|||++..... ......+++.|+|||.+.+ .++.++|+||+||++|+|++|+.||.+.+...
T Consensus 148 Il---l~~~~~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~ 222 (342)
T cd07879 148 LA---VNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222 (342)
T ss_pred EE---ECCCCCEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99 56688999999999875432 2234567889999999853 48889999999999999999999999887655
Q ss_pred HHHHHHhCCC-----------------------CCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 157 IFRQILEGKI-----------------------DFESE----PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 157 ~~~~i~~~~~-----------------------~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.+..+..... ..+.. .++..++++.++|.+||+.||.+|||+++++.||||..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 223 QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 5554433110 00111 12457889999999999999999999999999999987
Q ss_pred CCC
Q 021227 210 DKV 212 (315)
Q Consensus 210 ~~~ 212 (315)
...
T Consensus 303 ~~~ 305 (342)
T cd07879 303 FRD 305 (342)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=284.40 Aligned_cols=195 Identities=27% Similarity=0.367 Sum_probs=155.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-----------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
+||||+++++++.+++..|+||||++||+|.+++.+. .+++...+..++.|++.||+|||++||+||||
T Consensus 60 ~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDL 139 (932)
T PRK13184 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDL 139 (932)
T ss_pred CCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 7999999999999999999999999999999988641 23566778899999999999999999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCC-------------------CcccccccCccccchhhhh-hcCCCchhHHH
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPD-------------------EVFSDVVGSPYYVAPEVLR-KHYGPEADVWS 134 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Diws 134 (315)
||+||+ ++.++.+||+|||++...... ......+||+.|+|||++. ..++.++||||
T Consensus 140 KPeNIL---Ld~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWS 216 (932)
T PRK13184 140 KPDNIL---LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYA 216 (932)
T ss_pred chheEE---EcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHH
Confidence 999999 567789999999998765210 0112356999999999986 45899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 135 AGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 135 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
+||++|+|+||..||.+............. .......+..+|+.+.+++.+||..||++|++..+.+.+
T Consensus 217 LGVILyELLTG~~PF~~~~~~ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 217 LGVILYQMLTLSFPYRRKKGRKISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred HHHHHHHHHHCCCCCCCcchhhhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999876544332221111 111112335689999999999999999999876665543
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=252.67 Aligned_cols=193 Identities=21% Similarity=0.319 Sum_probs=160.1
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+.+ +||||+++++++.. ...|+||||+.+++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||
T Consensus 56 ~~l-~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Ni 133 (260)
T cd05070 56 KKL-RHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANI 133 (260)
T ss_pred Hhc-CCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceE
Confidence 344 89999999998864 5678999999999999988753 4589999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI 155 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 155 (315)
++ +.++.++|+|||.+........ .....++..|+|||.+. ..++.++|+||||+++|+|++ |.+||.+.+..
T Consensus 134 li---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 134 LV---GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred EE---eCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 95 5678999999999876543221 11233556799999875 458899999999999999999 99999988887
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
+....+..+.. . +.....+..+++++.+||.++|++|||+.++.
T Consensus 211 ~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 211 EVLEQVERGYR-M--PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred HHHHHHHcCCC-C--CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 77777765422 1 22246789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=261.38 Aligned_cols=202 Identities=32% Similarity=0.530 Sum_probs=161.3
Q ss_pred CCCCCcceEEEEEEe-CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYED-KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||++++++|.. ....|+|+||+ +++|.+++. .+++++..+..++.|+++||+|||+.|++||||+|+||+
T Consensus 66 l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nil--- 140 (328)
T cd07856 66 LRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL--- 140 (328)
T ss_pred cCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEe---
Confidence 389999999999976 56789999999 568877664 457899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
.+.++.+||+|||.+..... ......+++.|+|||.+.+ .++.++|+||+||++|+|++|.+||.+.........+
T Consensus 141 i~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~ 218 (328)
T cd07856 141 INENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218 (328)
T ss_pred ECCCCCEEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 45678999999998875432 2234567889999998753 5899999999999999999999999876653322222
Q ss_pred HhC---------------------------CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 021227 162 LEG---------------------------KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVA 213 (315)
Q Consensus 162 ~~~---------------------------~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~ 213 (315)
.+. .........+.++++++++|.+||+.+|++|||+++++.||||......
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 110 0000011124578999999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=257.11 Aligned_cols=194 Identities=19% Similarity=0.282 Sum_probs=157.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG------------NYSEREAAKLMKTIVGVVECCHSLGVFHRD 73 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 73 (315)
+||||+++++++..++..++||||+.|++|.+++.... .+++..+..++.|++.||+|||++|++|||
T Consensus 75 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~d 154 (295)
T cd05097 75 KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRD 154 (295)
T ss_pred CCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence 89999999999999999999999999999999886532 368889999999999999999999999999
Q ss_pred CCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh--CCC
Q 021227 74 LKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS--GVP 147 (315)
Q Consensus 74 ikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~--g~~ 147 (315)
|||+||++ +.++.+||+|||++........ .....+++.|+|||++. +.++.++|+|||||++|+|++ |..
T Consensus 155 lkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~ 231 (295)
T cd05097 155 LATRNCLV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ 231 (295)
T ss_pred cChhhEEE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCC
Confidence 99999994 5677899999999876533221 12234567899999875 568999999999999999988 678
Q ss_pred CCCCCCHHHHHHHHHh-----CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 148 PFWAETEIGIFRQILE-----GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
||...+..+....+.. ....+ ....+.+++.+.+++.+||+.+|.+|||++++++
T Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 232 PYSLLSDEQVIENTGEFFRNQGRQIY-LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CCcccChHHHHHHHHHhhhhcccccc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 8888776665555432 11111 1122357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=256.58 Aligned_cols=194 Identities=24% Similarity=0.320 Sum_probs=152.6
Q ss_pred CCCCCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+ +||||+++++++.. ...+++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 62 ~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nil 139 (283)
T cd05080 62 TL-YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVL 139 (283)
T ss_pred hC-CCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEE
Confidence 44 89999999998765 3468999999999999998865 46999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
+ +.++.+||+|||++........ .....++..|+|||.+. ..++.++|||||||++|+|++|..||......
T Consensus 140 i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 216 (283)
T cd05080 140 L---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK 216 (283)
T ss_pred E---cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch
Confidence 4 5678999999999876543221 11234566799999886 55899999999999999999999998643211
Q ss_pred --HHH------------HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 156 --GIF------------RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 156 --~~~------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+.. .......... +....++.++++++.+||+.+|++|||+++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 217 FEEMIGPKQGQMTVVRLIELLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhcccccccchhhhhhhhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000 0011111111 112357899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=264.91 Aligned_cols=200 Identities=29% Similarity=0.471 Sum_probs=161.1
Q ss_pred CCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+||||+++++++... ..+|++++++ |++|.+.+. .+.+++..+..++.|++.||+|||+.|++||||||+||
T Consensus 74 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 151 (345)
T cd07877 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 151 (345)
T ss_pred CCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHE
Confidence 899999999998643 3478899887 778877664 45799999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+ .+.++.+||+|||++..... ......|++.|+|||.+.+ .++.++||||+||++|+|++|..||.+.+....
T Consensus 152 l---l~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 226 (345)
T cd07877 152 A---VNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226 (345)
T ss_pred E---EcCCCCEEEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9 56678999999999876432 2234568899999998754 478899999999999999999999987766554
Q ss_pred HHHHHhCCCC-----------------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKID-----------------------FES----EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~-----------------------~~~----~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
...+...... .+. ..+...+++++++|.+||+.+|.+|||+.+++.||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 4443321110 000 0122468899999999999999999999999999999865
Q ss_pred CC
Q 021227 211 KV 212 (315)
Q Consensus 211 ~~ 212 (315)
..
T Consensus 307 ~~ 308 (345)
T cd07877 307 HD 308 (345)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=253.91 Aligned_cols=191 Identities=25% Similarity=0.372 Sum_probs=159.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+. ..|+||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+.|++||||||+||+ .
T Consensus 65 ~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nil---i 140 (270)
T cd05056 65 DHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL---V 140 (270)
T ss_pred CCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEE---E
Confidence 899999999998764 5679999999999999997643 5899999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCCccc--ccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFS--DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++.......... ...+++.|+|||.+. ..++.++||||+||++|++++ |..||.+.+..+....
T Consensus 141 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~ 220 (270)
T cd05056 141 SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR 220 (270)
T ss_pred ecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 567899999999987654332211 223456799999886 458899999999999999986 9999998887777776
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+..+... ...+.+|+++.+++.+||..+|.+|||+.+++.
T Consensus 221 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 221 IENGERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHcCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6655422 123468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=251.91 Aligned_cols=193 Identities=25% Similarity=0.342 Sum_probs=162.8
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+||||+++++++.++...++||||+++++|.+++.+. ..+++..+..++.|++.|+.|||++|++||||+|+||+
T Consensus 58 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nil-- 135 (261)
T cd05034 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL-- 135 (261)
T ss_pred CCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEE--
Confidence 37999999999999999999999999999999998764 36899999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
.+.++.+||+|||.+........ .....++..|+|||.+. +.++.++|+||+||++|++++ |+.||.+.+.....
T Consensus 136 -i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05034 136 -VGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214 (261)
T ss_pred -EcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 56678999999999876543211 11223456899999886 458899999999999999998 99999988888887
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+..+.... .....+.++++++.+||+.+|.+|||++++..
T Consensus 215 ~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 215 EQVERGYRMP---RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7776543211 12356899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=249.85 Aligned_cols=193 Identities=26% Similarity=0.352 Sum_probs=161.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.+....++|+||+.|++|.+++.+. ..+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus 49 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nil--- 125 (251)
T cd05041 49 YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCL--- 125 (251)
T ss_pred CCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEE---
Confidence 38999999999999999999999999999999998664 56899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcc---cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVF---SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
++.++.+||+|||++......... ....++..|+|||.+. +.++.++|+||+||++|+|++ |..||.+.......
T Consensus 126 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~ 205 (251)
T cd05041 126 VGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR 205 (251)
T ss_pred EcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH
Confidence 567789999999998755422111 1122356799999876 558999999999999999999 89999888776666
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+.... ..+ ....++.++.+++.+||+.+|.+|||+.++++
T Consensus 206 ~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 206 ERIESGY-RMP--APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHhcCC-CCC--CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 6665432 111 12357899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=250.56 Aligned_cols=189 Identities=27% Similarity=0.399 Sum_probs=159.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++..+. .++||||+.||+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus 57 ~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nil--- 132 (254)
T cd05083 57 HHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL--- 132 (254)
T ss_pred CCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEE---
Confidence 8999999999987654 789999999999999987653 5889999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 161 (315)
.+.++.+||+|||++...... ......+..|+|||.+. +.++.++|+||+||++|+|++ |..||.+.+..+....+
T Consensus 133 i~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 210 (254)
T cd05083 133 VSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV 210 (254)
T ss_pred EcCCCcEEECCCccceecccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 466789999999988654322 12233456799999886 568899999999999999997 99999988887777766
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+.. . .....+++.+.+++.+||+.+|.+|||+++++.
T Consensus 211 ~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 211 EKGYR-M--EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred hCCCC-C--CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 65422 2 223468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=255.21 Aligned_cols=197 Identities=19% Similarity=0.260 Sum_probs=157.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-----------NYSEREAAKLMKTIVGVVECCHSLGVFH 71 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~ivH 71 (315)
.+ +||||+++++++.++...++||||+.+|+|.+++.... .+++..+..++.|++.||+|||++|++|
T Consensus 75 ~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 153 (296)
T cd05095 75 RL-KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVH 153 (296)
T ss_pred hC-CCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 44 89999999999999999999999999999999987642 3677889999999999999999999999
Q ss_pred ccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh--C
Q 021227 72 RDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS--G 145 (315)
Q Consensus 72 ~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~--g 145 (315)
|||||+||++ +.++.++|+|||++........ .....+++.|+|||+.. +.++.++|+||+||++|+|++ |
T Consensus 154 ~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~ 230 (296)
T cd05095 154 RDLATRNCLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK 230 (296)
T ss_pred ccCChheEEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence 9999999995 5678999999999876543221 11233467899999764 568999999999999999998 7
Q ss_pred CCCCCCCCHHHHHHHHHh----CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 146 VPPFWAETEIGIFRQILE----GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 146 ~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..||...+..+....... .......+....+++.+++++.+||+.||.+|||+.++++
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred CCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 899987766555543321 0000011112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=252.18 Aligned_cols=193 Identities=27% Similarity=0.541 Sum_probs=160.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+||||+++++++.+++..++||||++||+|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil- 138 (267)
T cd08224 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVF- 138 (267)
T ss_pred CCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEE-
Confidence 899999999999999999999999999999988854 245899999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAET--EIGI 157 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~ 157 (315)
++.++.++|+|||++....... ......|++.|+|||.+. ..++.++|+||+||++|+|++|..||.... ..+.
T Consensus 139 --~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T cd08224 139 --ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216 (267)
T ss_pred --ECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH
Confidence 4567899999999987654322 223456889999999886 458899999999999999999999996543 3344
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+.+..+... ......++.+++++|.+||..+|++|||+.++++
T Consensus 217 ~~~~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 217 CKKIEKCDYP--PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HhhhhcCCCC--CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4444444322 2222367889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=253.58 Aligned_cols=195 Identities=21% Similarity=0.275 Sum_probs=161.4
Q ss_pred CCCCCCCCcceEEEEEEe-CCeEEEEEeccCCCchhHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 021227 2 HHLSEHQHVVRIHDTYED-KSCVHIVMELCEGGELFDRIVKK--------GNYSEREAAKLMKTIVGVVECCHSLGVFHR 72 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 72 (315)
+.+ +||||+++++++.. +...++++||+.+|+|.+++... ..+++..+..++.|++.||+|||++|++||
T Consensus 63 ~~l-~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 141 (280)
T cd05043 63 YGL-SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHK 141 (280)
T ss_pred HhC-CCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 344 89999999998765 57789999999999999998653 358999999999999999999999999999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCC
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVP 147 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~ 147 (315)
||||+||++ +.++.+||+|||+++....... .....++..|+|||++. ..++.++||||+||++|++++ |..
T Consensus 142 di~p~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 218 (280)
T cd05043 142 DIAARNCVI---DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218 (280)
T ss_pred ccCHhhEEE---cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCC
Confidence 999999994 5678999999999976543321 11234567799999886 448999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 148 PFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
||...+..+....+..+. .+. ....+++++.+++.+||..+|++|||+.+++.
T Consensus 219 p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 219 PYVEIDPFEMAAYLKDGY-RLA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCcCCHHHHHHHHHcCC-CCC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999888777666655542 222 22457899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=259.10 Aligned_cols=205 Identities=30% Similarity=0.552 Sum_probs=171.8
Q ss_pred CCCCCCcceEEEEEE-eCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccccCCCCcee
Q 021227 4 LSEHQHVVRIHDTYE-DKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL--GVFHRDLKPENFL 80 (315)
Q Consensus 4 l~~Hpniv~~~~~~~-~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dikp~nil 80 (315)
-++||.||++|++|. |...+|-|+|||+|.+|.-|+.+++.++|++++.|+.||+.||.||.+. -|||-||||.|||
T Consensus 523 eLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNIL 602 (775)
T KOG1151|consen 523 ELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNIL 602 (775)
T ss_pred ccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEE
Confidence 359999999999996 5577999999999999998999999999999999999999999999965 5999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC--------cccccccCccccchhhhh-----hcCCCchhHHHHHHHHHHHHhCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE--------VFSDVVGSPYYVAPEVLR-----KHYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~ 147 (315)
+.+-+..|.|||+|||+++.+.... ......||.||++||++- .+.+.++||||+|||+|+.+.|+.
T Consensus 603 Lv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrK 682 (775)
T KOG1151|consen 603 LVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRK 682 (775)
T ss_pred EecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCC
Confidence 9776778999999999998875432 234567999999999873 247889999999999999999999
Q ss_pred CCCCC-CHHHHHHH--H-HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 148 PFWAE-TEIGIFRQ--I-LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 148 pf~~~-~~~~~~~~--i-~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
||... +..++++. | ......|+.. |.+|+++++||++||++.-+.|....++..||+|..+
T Consensus 683 PFGhnqsQQdILqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 683 PFGHNQSQQDILQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred CCCCchhHHHHHhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 99654 33333332 2 2223344443 5789999999999999999999999999999999753
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=252.53 Aligned_cols=191 Identities=24% Similarity=0.304 Sum_probs=161.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.. ...++|+||+.+|+|.+++.+. ..+++..+..++.|++.||+|||++|++||||+|+||++
T Consensus 67 ~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~--- 142 (279)
T cd05057 67 DHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--- 142 (279)
T ss_pred CCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---
Confidence 89999999999887 7889999999999999998764 569999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCccc---ccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFS---DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||.+.......... ...++..|+|||.+. ..++.++|+||+||++|++++ |..||.+....+...
T Consensus 143 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 222 (279)
T cd05057 143 KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD 222 (279)
T ss_pred cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 567889999999987664332211 122356799999885 568899999999999999998 999999988887777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+.....+ ...+.++.+++.+||..+|.+|||+.++++
T Consensus 223 ~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 223 LLEKGERLPQP---PICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHhCCCCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 77655332221 347889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=280.01 Aligned_cols=92 Identities=32% Similarity=0.525 Sum_probs=86.8
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++....++|+||||+.|++|.+++...+.+++..++.++.||+.||.|||.+||+||||||+|||+
T Consensus 61 l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl--- 137 (669)
T cd05610 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI--- 137 (669)
T ss_pred cCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---
Confidence 48999999999999999999999999999999999888889999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcc
Q 021227 85 DEDAALKATDFGLSV 99 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~ 99 (315)
+.++.+||+|||+++
T Consensus 138 ~~~g~vkL~DFGls~ 152 (669)
T cd05610 138 SNEGHIKLTDFGLSK 152 (669)
T ss_pred cCCCCEEEEeCCCCc
Confidence 567899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=264.31 Aligned_cols=196 Identities=21% Similarity=0.315 Sum_probs=158.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC---------------------------------------
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--------------------------------------- 43 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--------------------------------------- 43 (315)
++..|||||++++++...+..++|+|||+||+|.+++.+.+
T Consensus 96 ~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (401)
T cd05107 96 HLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESD 175 (401)
T ss_pred hcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccC
Confidence 45459999999999999999999999999999999886431
Q ss_pred -----------------------------------------------------------CCCHHHHHHHHHHHHHHHHHH
Q 021227 44 -----------------------------------------------------------NYSEREAAKLMKTIVGVVECC 64 (315)
Q Consensus 44 -----------------------------------------------------------~~~~~~~~~~~~qi~~~l~~l 64 (315)
.+++..+..++.|++.||.||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 255 (401)
T cd05107 176 GGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL 255 (401)
T ss_pred ccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 256777889999999999999
Q ss_pred HHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHH
Q 021227 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILY 140 (315)
Q Consensus 65 H~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ 140 (315)
|+.|++||||||+||++ +..+.+||+|||++........ .....+++.|+|||.+. ..++.++||||+||++|
T Consensus 256 H~~~ivHrdlkp~NiLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~ 332 (401)
T cd05107 256 ASKNCVHRDLAARNVLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLW 332 (401)
T ss_pred hcCCcCcccCCcceEEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHH
Confidence 99999999999999995 5678899999999876432221 12345678899999886 45889999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 141 ILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 141 ~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+|++ |..||......+...........++ ....++.++.+++.+||..+|.+||++.++++
T Consensus 333 e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 333 EIFTLGGTPYPELPMNEQFYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHcCCCCCCCCCchHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9998 8999977555444433333322222 22357899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=249.34 Aligned_cols=191 Identities=23% Similarity=0.327 Sum_probs=159.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+ ..+++|+||+.+|+|.+++.+. ..+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus 59 ~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~--- 134 (260)
T cd05067 59 QHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL--- 134 (260)
T ss_pred CCcCeeeEEEEEcc-CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEE---
Confidence 89999999998754 5689999999999999988654 46899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
.+.++.++|+|||++........ .....++..|+|||++. ..++.++||||+|+++|++++ |.+||.+.+..+...
T Consensus 135 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 214 (260)
T cd05067 135 VSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214 (260)
T ss_pred EcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH
Confidence 56678999999999876542221 12234567899999986 458899999999999999999 999999888777777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+... +.....+.++.+++.+||..+|++|||+++++.
T Consensus 215 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 215 NLERGYRM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHcCCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 66554321 222457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=248.55 Aligned_cols=192 Identities=21% Similarity=0.327 Sum_probs=160.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+||||+++++++.+ ..+++||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus 58 l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~-- 134 (260)
T cd05073 58 LQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL-- 134 (260)
T ss_pred cCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEE--
Confidence 389999999999988 7789999999999999999763 45788899999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
.+..+.+||+|||.+........ .....++..|+|||.+. +.++.++|+||+||++|++++ |..||.+.+.....
T Consensus 135 -i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~ 213 (260)
T cd05073 135 -VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213 (260)
T ss_pred -EcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 46688999999998876543221 12234567799999986 458889999999999999998 99999988777777
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+..+.. .+.....+.++.+++.+||+.+|++|||+.+++.
T Consensus 214 ~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 214 RALERGYR---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHhCCCC---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 66655422 2223468899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=253.60 Aligned_cols=191 Identities=22% Similarity=0.300 Sum_probs=157.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++... ..++|+||+++|+|.+++..+. .+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 67 ~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill--- 142 (303)
T cd05110 67 DHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV--- 142 (303)
T ss_pred CCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---
Confidence 899999999998764 4679999999999999987654 68999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||++........ .....++..|+|||.+. ..++.++||||+||++|++++ |..||.+........
T Consensus 143 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~ 222 (303)
T cd05110 143 KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD 222 (303)
T ss_pred cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5677899999999976543221 12234567899999886 458999999999999999997 999998877666555
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+. .++. .+.++.++.+++.+||..+|++|||+.+++.
T Consensus 223 ~~~~~~-~~~~--~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 223 LLEKGE-RLPQ--PPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred HHHCCC-CCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 554433 2222 2457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=253.17 Aligned_cols=193 Identities=25% Similarity=0.388 Sum_probs=153.8
Q ss_pred CCCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 5 SEHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+||||+++++++.+. ..+++||||++|++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~ 142 (284)
T cd05079 63 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 142 (284)
T ss_pred CCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE
Confidence 3899999999999875 6789999999999999998665 468999999999999999999999999999999999995
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCC---
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAET--- 153 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--- 153 (315)
+.++.+||+|||++........ .....++..|+|||++. +.++.++||||+||++|+|+++..|+....
T Consensus 143 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~ 219 (284)
T cd05079 143 ---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF 219 (284)
T ss_pred ---cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh
Confidence 5678899999999876543321 12345677899999876 458899999999999999999876643211
Q ss_pred ------------HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 154 ------------EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 154 ------------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.......+..+. .. +.+..+++.+.+|+.+||+.+|.+|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 220 LKMIGPTHGQMTVTRLVRVLEEGK-RL--PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred hhhcccccccccHHHHHHHHHcCc-cC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111122222222 11 123468999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=259.37 Aligned_cols=197 Identities=24% Similarity=0.345 Sum_probs=155.1
Q ss_pred CCCCCCCCcceEEEEEEe-CCeEEEEEeccCCCchhHHHHhC--------------------------------------
Q 021227 2 HHLSEHQHVVRIHDTYED-KSCVHIVMELCEGGELFDRIVKK-------------------------------------- 42 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~-------------------------------------- 42 (315)
.++.+||||+++++++.. +..+++|||||++|+|.+++...
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (343)
T cd05103 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS 144 (343)
T ss_pred HhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence 355689999999998764 45689999999999999988642
Q ss_pred -----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEe
Q 021227 43 -----------------------------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKAT 93 (315)
Q Consensus 43 -----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~ 93 (315)
..+++..+..++.|++.||+|||++||+||||||+||+ .+.++.+||+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil---~~~~~~~kl~ 221 (343)
T cd05103 145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNIL---LSENNVVKIC 221 (343)
T ss_pred cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEE---EcCCCcEEEE
Confidence 23677888999999999999999999999999999999 4567899999
Q ss_pred eccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHhCCCC
Q 021227 94 DFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI-GIFRQILEGKID 167 (315)
Q Consensus 94 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~-~~~~~i~~~~~~ 167 (315)
|||++........ .....+++.|+|||.+. ..++.++||||+||++|++++ |..||.+.... .....+..+..
T Consensus 222 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 300 (343)
T cd05103 222 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR- 300 (343)
T ss_pred ecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-
Confidence 9999876432211 11233567799999875 458999999999999999997 99999775433 33333333322
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 168 FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 168 ~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
...+ ...++++.+++.+||+.+|.+|||+.++++|
T Consensus 301 ~~~~--~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 301 MRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2221 2468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=266.70 Aligned_cols=192 Identities=21% Similarity=0.314 Sum_probs=137.5
Q ss_pred EeCCeEEEEEeccCCCchhHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 18 EDKSCVHIVMELCEGGELFDRIVKKGN--------------------YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 18 ~~~~~~~lv~E~~~gg~L~~~l~~~~~--------------------~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
..+..+++|+||+.+++|.+++..... ..+..+..++.|++.||.|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 355679999999999999988864321 123456789999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCC--CcccccccCccccchhhhh-h----------------------cCCCchhH
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPD--EVFSDVVGSPYYVAPEVLR-K----------------------HYGPEADV 132 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~-~----------------------~~~~~~Di 132 (315)
|||+. ..++.+||+|||++...... .......+|+.|+|||.+. . .++.++||
T Consensus 285 NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 285 NIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99962 34678999999999765332 2234577899999999652 1 13345699
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------CCC------CCCCCCCHHHHHHHHHhcccCCCCC
Q 021227 133 WSAGVILYILLSGVPPFWAETEIGIFRQILEGKID-----------FES------EPWPNISESAKDLIRKMLDQNPKRR 195 (315)
Q Consensus 133 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----------~~~------~~~~~~s~~~~~li~~~l~~~p~~R 195 (315)
||+||++|+|+++..|+... .......+...... ... ..+...+....+||.+||++||.+|
T Consensus 363 wSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999999999977664321 11111112111110 000 0011123456699999999999999
Q ss_pred CCHHHHhcCCCccCCCC
Q 021227 196 LTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 196 ~s~~~~l~h~~~~~~~~ 212 (315)
||+.++|+||||.....
T Consensus 442 ~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 442 ISAKAALAHPYFDREGL 458 (566)
T ss_pred CCHHHHhCCcCcCCCCc
Confidence 99999999999986543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=250.04 Aligned_cols=190 Identities=17% Similarity=0.189 Sum_probs=150.8
Q ss_pred CCCCCcceEEEEEEeCC----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 5 SEHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+|+||++++++..... ..++++|++. .++.+.+......++..+..++.|++.||+|||+++|+||||||+|||
T Consensus 80 ~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil 158 (294)
T PHA02882 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIM 158 (294)
T ss_pred CCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 48999999999776543 3478888874 466666666556789999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC--------cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE--------VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
+ +.++.++|+|||+++...... ......||+.|+|||+..+ .++.++||||+||++|+|++|..||.+
T Consensus 159 l---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 159 V---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred E---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 5 567889999999987653211 1123469999999999864 489999999999999999999999987
Q ss_pred CCH-HH--------HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 152 ETE-IG--------IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 152 ~~~-~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+. .. ....+..+... .+..++++.++++.|+..+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 236 FGHNGNLIHAAKCDFIKRLHEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred cccchHHHHHhHHHHHHHhhhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 632 21 22333333222 2456899999999999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=276.30 Aligned_cols=196 Identities=24% Similarity=0.429 Sum_probs=168.4
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-------GNYSEREAAKLMKTIVGVVECCHSLGVFHRD 73 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 73 (315)
|..+ +|||||+++++.-+....+|++|||.||+|..++.+. ..++......++.||+.|.+||+++++||||
T Consensus 749 m~~f-~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRD 827 (1025)
T KOG1095|consen 749 MSKF-DHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRD 827 (1025)
T ss_pred HhcC-CCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcc
Confidence 3445 8999999999999999999999999999999999875 3589999999999999999999999999999
Q ss_pred CCCCceeeccCCCCCCEEEeeccCcccCCCCCcccc--c-ccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCC
Q 021227 74 LKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD--V-VGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPP 148 (315)
Q Consensus 74 ikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~--~-~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~p 148 (315)
|...|+| ++....|||+|||+|+.+........ . .-...|||||.+. +.++.++|||||||++||++| |..|
T Consensus 828 LAaRNCL---L~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P 904 (1025)
T KOG1095|consen 828 LAARNCL---LDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP 904 (1025)
T ss_pred hhhhhee---ecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence 9999999 56779999999999995544332211 1 1235799999997 679999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 149 FWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 149 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|.+.+..++..-..++. +++.+ ..++..+.++|..||+.+|++||++..+++
T Consensus 905 Y~~~~n~~v~~~~~~gg-RL~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 905 YPSRSNFEVLLDVLEGG-RLDPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCcchHHHHHHHHhCC-ccCCC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999888665554 33332 479999999999999999999999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=241.33 Aligned_cols=198 Identities=48% Similarity=0.817 Sum_probs=171.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++.+..+...++|+||+.+++|.+++.....+++..+..++.+++.++.|||+.|++|+||+|.||++ +
T Consensus 45 ~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~ 121 (244)
T smart00220 45 KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---D 121 (244)
T ss_pred CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---C
Confidence 8999999999999999999999999999999998777669999999999999999999999999999999999994 5
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWA-ETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~ 163 (315)
.++.++++|||.+.............++..|+|||.+. ..++.++|+||+|++++++++|..||.. .......+.+..
T Consensus 122 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~ 201 (244)
T smart00220 122 EDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK 201 (244)
T ss_pred CCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 66899999999988766554445667889999999886 5588899999999999999999999987 555555555555
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
....... .+..++.++.+++.+||..+|++||++.++++||||
T Consensus 202 ~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 202 PKPPFPP-PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cCCCCcc-ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 4443322 222278999999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=268.27 Aligned_cols=204 Identities=33% Similarity=0.486 Sum_probs=163.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCC-C---CHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-Y---SEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-~---~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
..-+|||||++|+.-++.+..||..|.|.. +|.+++...+. . .....+.++.|+++||++||+.+||||||||+|
T Consensus 558 eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQN 636 (903)
T KOG1027|consen 558 ESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQN 636 (903)
T ss_pred hccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCce
Confidence 346899999999999999999999999965 99999977421 1 113468899999999999999999999999999
Q ss_pred eeeccC--CCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhC-CCCCC
Q 021227 79 FLFLSV--DEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSG-VPPFW 150 (315)
Q Consensus 79 il~~~~--~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g-~~pf~ 150 (315)
||+... +....++|+|||+++.+..++. ..+..||.+|+|||++.+ ..+..+||+|+||++|+.++| ..||.
T Consensus 637 ILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 637 ILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred EEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 998643 2346899999999998865543 345679999999999974 467789999999999998885 89995
Q ss_pred CCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 151 AETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 151 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.. .+.-.+|..+......-. +....++++||.+|+.++|..||+|.++|.||+|...
T Consensus 717 d~--~~R~~NIl~~~~~L~~L~-~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 717 DS--LERQANILTGNYTLVHLE-PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred ch--HHhhhhhhcCccceeeec-cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 53 334456776665443211 0111289999999999999999999999999999754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=242.80 Aligned_cols=199 Identities=30% Similarity=0.557 Sum_probs=176.1
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
-.+||.+|-++.+|+.+..+++|.||+.||+|.-.+.+...++|+.++.+-..|+.||.|||++||++||||.+|+|
T Consensus 307 asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvl--- 383 (593)
T KOG0695|consen 307 ASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVL--- 383 (593)
T ss_pred ccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceE---
Confidence 36899999999999999999999999999999877888889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCccc-CCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCC--------CC
Q 021227 84 VDEDAALKATDFGLSVF-YKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWA--------ET 153 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~-~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~--------~~ 153 (315)
++..|.+||+|+|+++. +.++...++++|||.|+|||++++ .|+..+|.|+|||+++||+.|+.||.- .+
T Consensus 384 ldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt 463 (593)
T KOG0695|consen 384 LDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT 463 (593)
T ss_pred EccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch
Confidence 67899999999999975 456677789999999999999985 499999999999999999999999952 23
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC------CHHHHhcCCCccC
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL------TAHEVLCHPWIVD 209 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~------s~~~~l~h~~~~~ 209 (315)
+.-+++-|.+.++..+. .+|-.+..+++..|++||.+|. ...++-.|+||..
T Consensus 464 edylfqvilekqiripr----slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 464 EDYLFQVILEKQIRIPR----SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred hHHHHHHHhhhcccccc----eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 34466777777776654 5788888999999999999996 3678889999863
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=240.19 Aligned_cols=197 Identities=23% Similarity=0.343 Sum_probs=156.7
Q ss_pred CCCCCCCcceEEEEEEeC-----CeEEEEEeccCCCchhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Q 021227 3 HLSEHQHVVRIHDTYEDK-----SCVHIVMELCEGGELFDRIVKK----GNYSEREAAKLMKTIVGVVECCHSLG--VFH 71 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH 71 (315)
+..+|||+++++++...+ ...|++++|...|+|.+.+... ..++|.++..++.+++.||.+||+.. +.|
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH 152 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH 152 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc
Confidence 446899999999876433 3599999999999999988653 36999999999999999999999999 999
Q ss_pred ccCCCCceeeccCCCCCCEEEeeccCcccCCCC-----C-----cccccccCccccchhhhh----hcCCCchhHHHHHH
Q 021227 72 RDLKPENFLFLSVDEDAALKATDFGLSVFYKPD-----E-----VFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGV 137 (315)
Q Consensus 72 ~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~-----~-----~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~ 137 (315)
|||||.||| .++.+.+++.|||.+....-. + ....-..|..|.|||.+. ...+.++|||||||
T Consensus 153 ~DiKP~NIL---ls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGC 229 (302)
T KOG2345|consen 153 RDIKPANIL---LSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGC 229 (302)
T ss_pred cCCCcceeE---ecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhH
Confidence 999999999 456899999999988654211 0 111234688999999885 33789999999999
Q ss_pred HHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 138 ILYILLSGVPPFWAETE--IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 138 il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
++|.|+.|..||...-. ..+.-.+..+++.++... .+|+.+.++|+.||+.||.+||++.+++.+
T Consensus 230 tLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 230 TLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 99999999999954211 112222444555555543 489999999999999999999999999853
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=268.05 Aligned_cols=204 Identities=26% Similarity=0.454 Sum_probs=172.5
Q ss_pred CCCCCCCCcceEEEEEEe-----CCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 2 HHLSEHQHVVRIHDTYED-----KSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
+.+.+|||++.+|++|-. ++.+++|||||.|||.-|++... ..+.|+.++.|++.++.|+.+||++.++||||
T Consensus 70 ~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDi 149 (953)
T KOG0587|consen 70 KKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDI 149 (953)
T ss_pred HhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecc
Confidence 456799999999999953 46799999999999999988654 56899999999999999999999999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~ 147 (315)
|-.||| .+.++.|||+|||.+..+.... ...+.+|||.|||||++. ..|+..+|+||||++..||.-|.+
T Consensus 150 kG~NiL---LT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 150 KGQNVL---LTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred cCceEE---EeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 999999 6789999999999998776543 345789999999999984 237889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 148 PFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
|+.+.-+...+-.|.... ++....+.+.+.++-+||..||.+|..+||+..++|+|||++.
T Consensus 227 Pl~DmHPmraLF~IpRNP-PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 227 PLCDMHPMRALFLIPRNP-PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred CccCcchhhhhccCCCCC-CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 998876655444333321 1222235567899999999999999999999999999999983
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=231.96 Aligned_cols=203 Identities=27% Similarity=0.544 Sum_probs=167.2
Q ss_pred CCCCCCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 2 HHLSEHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+.|..||||++++++..+. ...-+|+||..+.+..... ..++...++.++.+++.||.|||+.||.|||+||.|+
T Consensus 87 ~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNv 163 (338)
T KOG0668|consen 87 QNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNV 163 (338)
T ss_pred HhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCccee
Confidence 4577899999999999865 5688999999886654433 3488899999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPF-WAETEIG 156 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~ 156 (315)
++ ......++|+|+|+|.+..++...+-.+.+..|..||.+- +.|+.+-|+|||||++..|+..+-|| .|.+..+
T Consensus 164 mI--dh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D 241 (338)
T KOG0668|consen 164 MI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 241 (338)
T ss_pred ee--chhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH
Confidence 97 4567899999999999999988888888899999999884 56999999999999999999988887 4555555
Q ss_pred HHHHHHh-------------CCCCC-----------CCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQILE-------------GKIDF-----------ESEPW---------PNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i~~-------------~~~~~-----------~~~~~---------~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
++-.|.+ -.+.. +...| .-+++++.||+.++|..|..+|+|+.|++.
T Consensus 242 QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 242 QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 5544433 11111 11111 125799999999999999999999999999
Q ss_pred CCCccC
Q 021227 204 HPWIVD 209 (315)
Q Consensus 204 h~~~~~ 209 (315)
||||..
T Consensus 322 HpyF~~ 327 (338)
T KOG0668|consen 322 HPYFAP 327 (338)
T ss_pred CchHHH
Confidence 999964
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=245.95 Aligned_cols=194 Identities=23% Similarity=0.343 Sum_probs=150.7
Q ss_pred CCCCCcceEEEEEE--eCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 5 SEHQHVVRIHDTYE--DKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 5 ~~Hpniv~~~~~~~--~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+||||+++++++. +...+++|+||++||+|.+++.+. +.+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 62 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nil- 140 (284)
T cd05081 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNIL- 140 (284)
T ss_pred CCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEE-
Confidence 38999999999864 345789999999999999998764 46899999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcc----cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVF----SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
++.++.+||+|||++......... ....++..|+|||++. ..++.++||||+||++|+|++|..|+.......
T Consensus 141 --i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~ 218 (284)
T cd05081 141 --VESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF 218 (284)
T ss_pred --ECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh
Confidence 566788999999998865432211 1122345699999986 458899999999999999999877754332110
Q ss_pred ---------------HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 ---------------IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
....+......++ ....++.++.+++.+||..+|++|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 219 MRMMGNDKQGQMIVYHLIELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hhhcccccccccchHHHHHHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0111111111111 22467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=260.28 Aligned_cols=195 Identities=23% Similarity=0.419 Sum_probs=163.2
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
-+|-||+-+.+++..++. .||+-+|.|.+|+.++.-. ..|.....+.|++|++.|+.|||.++|||||||..||+
T Consensus 445 TRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIF--- 520 (678)
T KOG0193|consen 445 TRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIF--- 520 (678)
T ss_pred cchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceE---
Confidence 389999999999998887 8999999999999988643 57999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccC---CCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 84 VDEDAALKATDFGLSVFY---KPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~---~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
..+++.|||+|||++... ..........|...|||||+++ ..|+..+|||||||++|||+||..||...+...
T Consensus 521 l~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq 600 (678)
T KOG0193|consen 521 LHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ 600 (678)
T ss_pred EccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence 566799999999998543 2233345567888999999996 238999999999999999999999999777766
Q ss_pred HHHHHHhCCCCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQILEGKIDFE-SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
++=.+-+|-.... .....+++.++++|+..||..++++||++.++|.
T Consensus 601 IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 601 IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 6554444422221 1223467789999999999999999999999885
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=242.70 Aligned_cols=195 Identities=19% Similarity=0.319 Sum_probs=157.8
Q ss_pred CCCCCCCCcceEEEEEEeCC------eEEEEEeccCCCchhHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 021227 2 HHLSEHQHVVRIHDTYEDKS------CVHIVMELCEGGELFDRIVKK------GNYSEREAAKLMKTIVGVVECCHSLGV 69 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~------~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i 69 (315)
+.+ +||||+++++++.... ..++++||+.+|+|.+++... ..+++..+..++.|++.||+|||++||
T Consensus 56 ~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i 134 (273)
T cd05074 56 KEF-DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNF 134 (273)
T ss_pred hcC-CCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 344 8999999999986532 247899999999998876432 247899999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-
Q 021227 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS- 144 (315)
Q Consensus 70 vH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 144 (315)
+||||||+||++ +.++.+||+|||.+........ .....+++.|++||.+. +.++.++||||+||++|+|++
T Consensus 135 ~H~dikp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~ 211 (273)
T cd05074 135 IHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211 (273)
T ss_pred eecccchhhEEE---cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhC
Confidence 999999999995 5678899999999876543221 12234567899999886 448889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 145 GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 145 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|.+||.+.+..+....+..+..... .+..++.+.+++.+||+.+|++|||+.+++.
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 212 GQTPYAGVENSEIYNYLIKGNRLKQ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999988887777776665432211 1357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=251.82 Aligned_cols=197 Identities=26% Similarity=0.346 Sum_probs=153.8
Q ss_pred CCCCCCCcceEEEEEEeCC-eEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCCC
Q 021227 3 HLSEHQHVVRIHDTYEDKS-CVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLG---VFHRDLKP 76 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~-~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dikp 76 (315)
++ +|||+|++++++.+.+ +.+||+||+++|+|.+.+.... +++|....+|+.+++.||+|||... |+||||||
T Consensus 127 ~l-~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKs 205 (361)
T KOG1187|consen 127 RL-RHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKS 205 (361)
T ss_pred cC-CCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCH
Confidence 44 6999999999999988 5999999999999999997664 8999999999999999999999754 99999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCC-CCccccc-ccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKP-DEVFSDV-VGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
+||| ++.+...||+|||+|+.... .....+. .||..|+|||... +..+.++||||+||++.|++||+.|.....
T Consensus 206 sNIL---LD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 206 SNIL---LDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred HHee---ECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC
Confidence 9999 67899999999999966544 3333333 8999999999986 679999999999999999999998876432
Q ss_pred ---HHHHHH----HHHhCCCCC--CCCCC-CCCC--HH---HHHHHHHhcccCCCCCCCHHHHhc
Q 021227 154 ---EIGIFR----QILEGKIDF--ESEPW-PNIS--ES---AKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 154 ---~~~~~~----~i~~~~~~~--~~~~~-~~~s--~~---~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
...... .+.++.... ++... ...+ .+ +..+..+|++.+|.+||++.|+++
T Consensus 283 ~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 283 PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111121 222221111 11101 1223 23 456777999999999999999753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=257.53 Aligned_cols=193 Identities=26% Similarity=0.444 Sum_probs=166.1
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
|+.+ +|||||++++++.+. ..+||||+++-|.|..|+..+ ..++......++.||+.||+|||+.++|||||...||
T Consensus 445 Mrnf-dHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNi 522 (974)
T KOG4257|consen 445 MRNF-DHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNI 522 (974)
T ss_pred HHhC-CCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhhe
Confidence 4455 999999999998765 578999999999999999876 5799999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCccccccc--Cccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG--SPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI 155 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 155 (315)
| +.....|||+|||+++.+..........| ...|||||.++ ..++.++|||-|||.+||+++ |..||.+-...
T Consensus 523 L---VsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 523 L---VSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred e---ecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 9 56678999999999998876655444444 34699999987 779999999999999999886 99999997777
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEV 201 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~ 201 (315)
+++-.+.+|.-.+.+ +++|+.+..++.+||.++|.+||++.++
T Consensus 600 DVI~~iEnGeRlP~P---~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 600 DVIGHIENGERLPCP---PNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred ceEEEecCCCCCCCC---CCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 777777776543322 5899999999999999999999998765
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=244.90 Aligned_cols=193 Identities=22% Similarity=0.378 Sum_probs=154.6
Q ss_pred CCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 6 EHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 6 ~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.||||+++++++.+ +...++||||+++++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 64 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~- 142 (284)
T cd05038 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV- 142 (284)
T ss_pred CCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE-
Confidence 89999999999887 668999999999999999997654 69999999999999999999999999999999999994
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcc----cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVF----SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIG- 156 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~- 156 (315)
+.++.++|+|||.+......... ....++..|+|||.+. ..++.++||||+||++|+|++|..|+.......
T Consensus 143 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 220 (284)
T cd05038 143 --ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL 220 (284)
T ss_pred --cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc
Confidence 56789999999998776532211 1223456799999875 458899999999999999999999986532211
Q ss_pred -------------HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 -------------IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 -------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
...........++. ...++.++.+++.+||+.+|.+|||+.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 221 RMIGIAQGQMIVTRLLELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cccccccccccHHHHHHHHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11122222222221 2357789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=261.48 Aligned_cols=195 Identities=29% Similarity=0.487 Sum_probs=154.3
Q ss_pred CCCCCCCCCcceEEEEEEeCC------eEEEEEeccCCCchhHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 021227 1 MHHLSEHQHVVRIHDTYEDKS------CVHIVMELCEGGELFDRIVKK---GNYSEREAAKLMKTIVGVVECCHSLGVFH 71 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~------~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 71 (315)
||+| +|||||+++++-++.. ...+|||||.||+|...+.+. .+++|.+...++..+..||.|||++||+|
T Consensus 65 lkKL-nh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvH 143 (732)
T KOG4250|consen 65 LKKL-NHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVH 143 (732)
T ss_pred HHHc-CchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCcee
Confidence 4667 5999999999987655 467999999999999999753 57999999999999999999999999999
Q ss_pred ccCCCCceeeccCC-CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCC
Q 021227 72 RDLKPENFLFLSVD-EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPP 148 (315)
Q Consensus 72 ~dikp~nil~~~~~-~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~p 148 (315)
|||||.||++..-. +....||+|||.|+.+..+....+.+||+.|.+||+.. +.|+..+|.||+||++|+..||..|
T Consensus 144 RDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 144 RDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred ccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 99999999976433 44567999999999999998889999999999999986 5699999999999999999999999
Q ss_pred CCCCC----HHHHHHHHHhCCC---------------CCC--CCCCCCCCHH----HHHHHHHhcccCCCCCC
Q 021227 149 FWAET----EIGIFRQILEGKI---------------DFE--SEPWPNISES----AKDLIRKMLDQNPKRRL 196 (315)
Q Consensus 149 f~~~~----~~~~~~~i~~~~~---------------~~~--~~~~~~~s~~----~~~li~~~l~~~p~~R~ 196 (315)
|.... ..++.-.+..++. .+. .+....+++. +-.++..+|..+|.+|.
T Consensus 224 F~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 224 FIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 95421 2223323322111 111 1111123333 34577788999999998
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=281.80 Aligned_cols=199 Identities=19% Similarity=0.220 Sum_probs=150.6
Q ss_pred CC-CCcceEEEEE-------EeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 021227 6 EH-QHVVRIHDTY-------EDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKP 76 (315)
Q Consensus 6 ~H-pniv~~~~~~-------~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp 76 (315)
.| +||++++++| .....++.++||+ +++|.+++... ..+++.++..+++||+.||+|||++||+||||||
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 56 7999999988 3335678889988 56999999653 5699999999999999999999999999999999
Q ss_pred Cceeecc----------------CCCCCCEEEeeccCcccCCCC-----------------CcccccccCccccchhhhh
Q 021227 77 ENFLFLS----------------VDEDAALKATDFGLSVFYKPD-----------------EVFSDVVGSPYYVAPEVLR 123 (315)
Q Consensus 77 ~nil~~~----------------~~~~~~ikl~Dfg~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~ 123 (315)
+|||+.. .+..+.+|++|||+++..... ......+||++|||||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 9999732 133566788888877542110 0011246899999999986
Q ss_pred -hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 124 -KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 124 -~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
..++.++||||+||++|||++|.+|+.... .....+..... +... ....+...+++.+||+++|.+|||+.|++
T Consensus 189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 189 GSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Chhh-hhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 459999999999999999999998875422 22222222211 1111 12245678999999999999999999999
Q ss_pred cCCCccCC
Q 021227 203 CHPWIVDD 210 (315)
Q Consensus 203 ~h~~~~~~ 210 (315)
+||||...
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=254.11 Aligned_cols=198 Identities=28% Similarity=0.476 Sum_probs=166.1
Q ss_pred CCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 8 QHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG---NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 8 pniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
-|+++++..|...+|+|||+|-+. .+|.+.+.+-| .+....++.|+.|++.||..|-+.||+|.||||+|||+ +
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLV--N 570 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILV--N 570 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEe--c
Confidence 378899999999999999999985 58988887654 58899999999999999999999999999999999997 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.....+||||||.|.....+.. ..++-+..|.|||++.+ .|+...|+||+||.+|||+||+..|+|.+...++.-.+.
T Consensus 571 E~k~iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cCcceeeeccCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 5678899999999988766654 44556778999999876 499999999999999999999999999988888777665
Q ss_pred CCCCCCCCCC-------------------------------------------------CCCC-------HHHHHHHHHh
Q 021227 164 GKIDFESEPW-------------------------------------------------PNIS-------ESAKDLIRKM 187 (315)
Q Consensus 164 ~~~~~~~~~~-------------------------------------------------~~~s-------~~~~~li~~~ 187 (315)
.+..|+.... +.++ ..+++|+.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 3333321110 0012 3588999999
Q ss_pred cccCCCCCCCHHHHhcCCCccC
Q 021227 188 LDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 188 l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
|..||.+|.|..|+|.||||+.
T Consensus 730 l~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred hccChhhcCCHHHHhcCCcccC
Confidence 9999999999999999999974
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=234.75 Aligned_cols=205 Identities=24% Similarity=0.299 Sum_probs=168.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHH-----HhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCCCCc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-----VKKGNYSEREAAKLMKTIVGVVECCH-SLGVFHRDLKPEN 78 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l-----~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dikp~n 78 (315)
.+.||||++|+..-.++..+|.||+|+- ||..+. .++..++|..+..|.--.+.||.||- +..|+|||+||+|
T Consensus 120 ~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSN 198 (361)
T KOG1006|consen 120 SNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSN 198 (361)
T ss_pred cCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhh
Confidence 4789999999999888999999999964 553322 23467999999999999999999998 5689999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh---hcCCCchhHHHHHHHHHHHHhCCCCCCCCC-H
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR---KHYGPEADVWSAGVILYILLSGVPPFWAET-E 154 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~ 154 (315)
|| ++..|.|||||||.+-.+...-..+.-.|-..|||||.+. ..|+.++|+||||+++||+.||..|+.+.+ .
T Consensus 199 IL---ldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv 275 (361)
T KOG1006|consen 199 IL---LDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV 275 (361)
T ss_pred eE---EecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH
Confidence 99 7889999999999987765544444456788999999984 349999999999999999999999998865 4
Q ss_pred HHHHHHHHhCCCCCCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 021227 155 IGIFRQILEGKIDFESEP--WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVA 213 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~ 213 (315)
.+++.++..+.++.-... --++|..+..||..||.+|-..||...+++++||+......
T Consensus 276 feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 276 FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 566666666654322111 12478999999999999999999999999999999866443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=246.67 Aligned_cols=193 Identities=23% Similarity=0.381 Sum_probs=164.9
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
|+.+ +|||+|++.+++..+..+|||+|||..|+|.+|+.+.. .++--....++.||.+|+.||..+++|||||...|
T Consensus 317 MKei-kHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARN 395 (1157)
T KOG4278|consen 317 MKEI-KHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 395 (1157)
T ss_pred HHhh-cCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 4556 89999999999999999999999999999999998753 46677788899999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCccccccc---Cccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG---SPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAET 153 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~g---t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 153 (315)
.| +.++..||++|||+++.+..... ....| ...|.|||.+. ..++.++|||+|||++||+.| |-.||.|-+
T Consensus 396 CL---VgEnhiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 396 CL---VGENHIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred cc---ccccceEEeeccchhhhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 99 77899999999999998765432 22223 35699999885 679999999999999999998 889999988
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEV 201 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~ 201 (315)
...++..+.++ +++. ....+++.+.+||..||+++|.+||++.|+
T Consensus 472 lSqVY~LLEkg-yRM~--~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 472 LSQVYGLLEKG-YRMD--GPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHHHHHHhcc-cccc--CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 77776655543 3333 335899999999999999999999998876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=256.72 Aligned_cols=193 Identities=22% Similarity=0.453 Sum_probs=170.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||++|.++........||.|||++|+|..++.++ ++|+..+...+++-|+.|++||-+.|+|||||...|||
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNIL--- 763 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNIL--- 763 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhee---
Confidence 38999999999999999999999999999999999876 78999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCC-cccccc-c--Cccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDE-VFSDVV-G--SPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGI 157 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~-g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 157 (315)
++.+..+|++|||+++.+..+. ...+.. | ..+|.|||.+. .+++.++||||+||++||.++ |..||+..+.+++
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 7889999999999999875543 222222 2 35799999986 789999999999999999775 9999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+..|.++- ++|++ ..+|..+..|+.-||++|-.+||.+.|++.
T Consensus 844 IkaIe~gy-RLPpP--mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 844 IKAIEQGY-RLPPP--MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHhcc-CCCCC--CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 99998763 22222 378999999999999999999999999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=253.65 Aligned_cols=183 Identities=32% Similarity=0.508 Sum_probs=147.9
Q ss_pred CCeEEEEEeccCCCchhHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCc
Q 021227 20 KSCVHIVMELCEGGELFDRIVKKGNY-SEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS 98 (315)
Q Consensus 20 ~~~~~lv~E~~~gg~L~~~l~~~~~~-~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~ 98 (315)
...+||-||||+..++.+++.++... ....++++++||++||.|+|+.|||||||||.||+ .+....|||+|||+|
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIF---Ld~~~~VKIGDFGLA 744 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIF---LDSRNSVKIGDFGLA 744 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeE---EcCCCCeeecccccc
Confidence 35689999999987777777665444 46789999999999999999999999999999999 568889999999999
Q ss_pred ccCC-------------------CCCcccccccCccccchhhhh--h--cCCCchhHHHHHHHHHHHHhCCCCCCCC-CH
Q 021227 99 VFYK-------------------PDEVFSDVVGSPYYVAPEVLR--K--HYGPEADVWSAGVILYILLSGVPPFWAE-TE 154 (315)
Q Consensus 99 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~--~--~~~~~~DiwslG~il~~ll~g~~pf~~~-~~ 154 (315)
.... +....+..+||..|+|||++. . .|+.|+|+||||||++||+. ||... ..
T Consensus 745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER 821 (1351)
T KOG1035|consen 745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER 821 (1351)
T ss_pred hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH
Confidence 8621 111345578999999999985 3 59999999999999999983 46543 34
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
..++.++.++.++.+...+..--+.-..+|..||+.||.+||||.|+|++.|+-
T Consensus 822 a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 822 ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 556677777777666333444446678899999999999999999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=246.45 Aligned_cols=197 Identities=24% Similarity=0.332 Sum_probs=146.8
Q ss_pred CCcceEEEEEEe--------CCeEEEEEeccCCCchhHHHHhC------------------------CCCCHHHHHHHHH
Q 021227 8 QHVVRIHDTYED--------KSCVHIVMELCEGGELFDRIVKK------------------------GNYSEREAAKLMK 55 (315)
Q Consensus 8 pniv~~~~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~ 55 (315)
++++++++++.. ++..++|+||+++|+|.+++... ..+++..+..++.
T Consensus 237 ~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ 316 (507)
T PLN03224 237 ASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMR 316 (507)
T ss_pred hhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHH
Confidence 345677777643 35689999999999999887542 1235677889999
Q ss_pred HHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccc--cccCccccchhhhhhc--------
Q 021227 56 TIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD--VVGSPYYVAPEVLRKH-------- 125 (315)
Q Consensus 56 qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~-------- 125 (315)
|++.||.|||+.+|+||||||+||++ +.++.+||+|||++........... ..+|+.|+|||.+...
T Consensus 317 ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~ 393 (507)
T PLN03224 317 QVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPA 393 (507)
T ss_pred HHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccch
Confidence 99999999999999999999999994 5678899999999876543322222 2347899999987321
Q ss_pred -------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCC-----------HHHHHHHHHhCCCCCCCCCCCCCCH
Q 021227 126 -------------Y--GPEADVWSAGVILYILLSGVP-PFWAET-----------EIGIFRQILEGKIDFESEPWPNISE 178 (315)
Q Consensus 126 -------------~--~~~~DiwslG~il~~ll~g~~-pf~~~~-----------~~~~~~~i~~~~~~~~~~~~~~~s~ 178 (315)
+ ..+.||||+||++|+|++|.. ||.+.. ....++.+......++ .+...++
T Consensus 394 ~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~--~~d~~s~ 471 (507)
T PLN03224 394 PAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS--LLDRNKE 471 (507)
T ss_pred hhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc--cccccCh
Confidence 1 124799999999999999886 664321 1112222233333333 4667899
Q ss_pred HHHHHHHHhcccCC---CCCCCHHHHhcCCCccC
Q 021227 179 SAKDLIRKMLDQNP---KRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 179 ~~~~li~~~l~~~p---~~R~s~~~~l~h~~~~~ 209 (315)
.+++|+.+||..+| .+|+|++|+|+||||..
T Consensus 472 ~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 472 AGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 99999999999876 68999999999999953
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=245.39 Aligned_cols=196 Identities=26% Similarity=0.376 Sum_probs=168.5
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK--KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
|.+| +|||+|++|++..+ +...+|+|++.+|+|.+.+.+ ...|.......++.||+.|+.||..+++|||||...|
T Consensus 165 M~~L-~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARN 242 (1039)
T KOG0199|consen 165 MLKL-QHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARN 242 (1039)
T ss_pred HHhc-cCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhh
Confidence 4456 99999999999888 778899999999999999987 3568899999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccc----cCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV----GSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAE 152 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~----gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 152 (315)
+|+ .....|||+|||+.+.+..+....... -...|+|||.++ ..++.++|+|++||++|||+| |..||.|.
T Consensus 243 lll---asprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 243 LLL---ASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred hee---cccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 995 446789999999999887665443222 234699999997 679999999999999999998 89999999
Q ss_pred CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
....++++|-.+..-... +.+|.++.+++..||..+|.+|||+..+...
T Consensus 320 ~g~qIL~~iD~~erLpRP---k~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 320 RGIQILKNIDAGERLPRP---KYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CHHHHHHhccccccCCCC---CCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 999999998855432222 4689999999999999999999999888543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=252.54 Aligned_cols=196 Identities=23% Similarity=0.421 Sum_probs=166.4
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------NYSEREAAKLMKTIVGVVECC 64 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~l 64 (315)
|+.+..||||+.+.++...++.+++|.|||..|+|.+++..++ .++......++.||+.|++||
T Consensus 355 m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L 434 (609)
T KOG0200|consen 355 LKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL 434 (609)
T ss_pred HHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999999999999999997765 388999999999999999999
Q ss_pred HHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCccc--ccccC--ccccchhhhhh-cCCCchhHHHHHHHH
Q 021227 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS--DVVGS--PYYVAPEVLRK-HYGPEADVWSAGVIL 139 (315)
Q Consensus 65 H~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~--~~~gt--~~y~aPE~~~~-~~~~~~DiwslG~il 139 (315)
++.++|||||...||| +..+..+|++|||+++......... ...|+ ..|||||.+.. .|+.++||||+||++
T Consensus 435 ~~~~~vHRDLAaRNVL---i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 435 ASVPCVHRDLAARNVL---ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILL 511 (609)
T ss_pred hhCCccchhhhhhhEE---ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHH
Confidence 9999999999999999 6677899999999998655444332 12222 34999999974 699999999999999
Q ss_pred HHHHh-CCCCCCCCC-HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 140 YILLS-GVPPFWAET-EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 140 ~~ll~-g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
||++| |..||.+-. ..++++.+..|.....+ ..+++++.++++.||+.+|++||++.++.
T Consensus 512 ~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 512 WEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 99998 899998855 66667767766532222 36799999999999999999999998886
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=239.71 Aligned_cols=197 Identities=20% Similarity=0.286 Sum_probs=162.7
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
-+| +|||||++++++..+..+++|+||++.|+|.+++..+. ...-+....|+.||++|++||.+.++|||||.+.|+
T Consensus 590 sqL-khPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNc 668 (807)
T KOG1094|consen 590 SRL-KHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNC 668 (807)
T ss_pred hcc-CCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccce
Confidence 456 99999999999999999999999999999999998873 234455667999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCccc---ccccCccccchhhh-hhcCCCchhHHHHHHHHHHHH--hCCCCCCCCC
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFS---DVVGSPYYVAPEVL-RKHYGPEADVWSAGVILYILL--SGVPPFWAET 153 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~ 153 (315)
| ++.++.+||+|||+++.+..+.... ..+-..+|||||.+ .++++.++|+|++|+++||++ +...||..-+
T Consensus 669 L---v~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 669 L---VDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred e---ecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 9 7889999999999999776655322 12345789999976 589999999999999999975 5889998888
Q ss_pred HHHHHHHHHhCCCCCC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 154 EIGIFRQILEGKIDFE----SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
..+..++.-.-..... ....+-++..+.++|-+||..|..+|||++++-
T Consensus 746 ~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 746 DEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred HHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 8777766543211111 111245789999999999999999999999984
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=265.46 Aligned_cols=192 Identities=24% Similarity=0.281 Sum_probs=143.6
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCCCCc
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH---SLGVFHRDLKPEN 78 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dikp~n 78 (315)
+++ +|||||++++++.++...|+||||++||+|.+++. .+++..+..++.|++.|++||| +.+|+||||||+|
T Consensus 738 ~~l-~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~N 813 (968)
T PLN00113 738 GKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813 (968)
T ss_pred hhC-CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHh
Confidence 345 89999999999999999999999999999999884 3889999999999999999999 6799999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAET---- 153 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---- 153 (315)
|++ +.++..++. ||........ ....||+.|+|||++. ..++.++||||+||++|||+||+.||....
T Consensus 814 il~---~~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~ 886 (968)
T PLN00113 814 III---DGKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886 (968)
T ss_pred EEE---CCCCceEEE-eccccccccC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence 995 455555654 5544322111 2346889999999986 459999999999999999999999985321
Q ss_pred -HHHHHHHHHhC---------CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 154 -EIGIFRQILEG---------KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 154 -~~~~~~~i~~~---------~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
..+..+..... ..............++.+++.+||+.+|++|||+.|+++.
T Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11111111000 0000000000112357789999999999999999999853
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=211.04 Aligned_cols=161 Identities=27% Similarity=0.379 Sum_probs=127.5
Q ss_pred CchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccc
Q 021227 33 GELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV 111 (315)
Q Consensus 33 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~ 111 (315)
|+|.+++... +++++..++.++.|++.||+|||+++ ||+||+ .+.++.+|+ ||.+....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil---~~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNIL---LTWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEe---EcCccceee--ccceEeecccc----CC
Confidence 6899999764 56999999999999999999999998 999999 567888998 99887654322 36
Q ss_pred cCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCCC---CCCCCCCH--HHHHHH
Q 021227 112 GSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE-IGIFRQILEGKIDFES---EPWPNISE--SAKDLI 184 (315)
Q Consensus 112 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~---~~~~~~s~--~~~~li 184 (315)
||+.|+|||++. +.++.++||||+||++|+|++|..||..... ......+......... .....++. ++++++
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999986 4589999999999999999999999976543 2333333332222111 11122344 699999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCcc
Q 021227 185 RKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 185 ~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
.+||..+|.+|||+.+++.|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=220.28 Aligned_cols=202 Identities=26% Similarity=0.434 Sum_probs=165.7
Q ss_pred CCCCCcceEEEEEEeCC-----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 5 SEHQHVVRIHDTYEDKS-----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
.+|.|++...++.+-.+ .+|+|+|.+.. +|...+.+...++...+.-+++||+.||.|||+.||.||||||.|.
T Consensus 109 FkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNL 187 (449)
T KOG0664|consen 109 FRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNL 187 (449)
T ss_pred hccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccE
Confidence 57999998888876543 47899999964 8888888888899999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
| ++.+..+||||||+++.....+ .+..-+-|-+|.|||++.+ .|+...||||+|||+.||+..+..|...++.
T Consensus 188 L---VNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 188 L---VNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred E---eccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 9 7789999999999998775543 3344556889999999964 5999999999999999999999999998888
Q ss_pred HHHHHHHhCCCCC---------------------CCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021227 156 GIFRQILEGKIDF---------------------ESEPW---------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205 (315)
Q Consensus 156 ~~~~~i~~~~~~~---------------------~~~~~---------~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~ 205 (315)
++++.|.+--..+ ..+.. ..-..+..+++.++|..||++|.+.++++.|+
T Consensus 265 qQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 265 EQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 8777775511111 01111 11235788999999999999999999999999
Q ss_pred CccCC
Q 021227 206 WIVDD 210 (315)
Q Consensus 206 ~~~~~ 210 (315)
+....
T Consensus 345 ~~~e~ 349 (449)
T KOG0664|consen 345 YLEEG 349 (449)
T ss_pred ccccc
Confidence 97653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=236.78 Aligned_cols=203 Identities=27% Similarity=0.472 Sum_probs=174.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+|||||.+++.|-.....++.||||.||+|.+...-.++++|.++..+.+..+.||+|||+.|=+|||||-.||+ .
T Consensus 69 c~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanil---l 145 (829)
T KOG0576|consen 69 CRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANIL---L 145 (829)
T ss_pred CCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCccccccccccee---e
Confidence 3899999999999999999999999999999998877899999999999999999999999999999999999999 6
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhh----hhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVL----RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
++.+.+|++|||.+-.+... .....++|||.|||||+. .+.|...||||++|+..-|+-.-++|....-+...+-
T Consensus 146 td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~ 225 (829)
T KOG0576|consen 146 TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF 225 (829)
T ss_pred cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH
Confidence 78899999999988665432 123468899999999986 3569999999999999999998888877766666555
Q ss_pred HHHhCCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 160 QILEGKIDFES-EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 160 ~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
-..+..+..+. ......++.+.+|++.+|.++|++|||++.+|.|||....
T Consensus 226 LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 226 LMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 55554444332 2233578999999999999999999999999999998654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=218.48 Aligned_cols=203 Identities=29% Similarity=0.518 Sum_probs=151.9
Q ss_pred CCCcceEEEEEE----eCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCCCCce
Q 021227 7 HQHVVRIHDTYE----DKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCH-SLGVFHRDLKPENF 79 (315)
Q Consensus 7 Hpniv~~~~~~~----~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dikp~ni 79 (315)
-.+||+|++.|. ++.|+|+|+|++ |.+|..+|.+. ..++...+..|++||+.||.||| +.||||-||||+||
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENv 219 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENV 219 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCccee
Confidence 347999999997 467999999999 77898888765 57999999999999999999999 67999999999999
Q ss_pred eecc----------------------------------------------------------------------------
Q 021227 80 LFLS---------------------------------------------------------------------------- 83 (315)
Q Consensus 80 l~~~---------------------------------------------------------------------------- 83 (315)
|+..
T Consensus 220 Ll~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~ 299 (590)
T KOG1290|consen 220 LLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPN 299 (590)
T ss_pred eeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccc
Confidence 9600
Q ss_pred --------------------------------------C-----------------------------------------
Q 021227 84 --------------------------------------V----------------------------------------- 84 (315)
Q Consensus 84 --------------------------------------~----------------------------------------- 84 (315)
.
T Consensus 300 ~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~ 379 (590)
T KOG1290|consen 300 QESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPL 379 (590)
T ss_pred ccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccc
Confidence 0
Q ss_pred --------CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC---
Q 021227 85 --------DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE--- 152 (315)
Q Consensus 85 --------~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--- 152 (315)
.....|||+|||.|.... ...+.-+.|..|.|||++.+ .|++.+||||++|++|||+||-..|...
T Consensus 380 v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~ 457 (590)
T KOG1290|consen 380 VNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGE 457 (590)
T ss_pred cCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCC
Confidence 001136777777765432 22234456889999999864 5999999999999999999999888531
Q ss_pred ---CHHHHHHHHHh------------CCCC---C----------CCCCCC---------CC----CHHHHHHHHHhcccC
Q 021227 153 ---TEIGIFRQILE------------GKID---F----------ESEPWP---------NI----SESAKDLIRKMLDQN 191 (315)
Q Consensus 153 ---~~~~~~~~i~~------------~~~~---~----------~~~~~~---------~~----s~~~~~li~~~l~~~ 191 (315)
.+++-+..|.+ |+.. | ....|+ .. ..++.+|+.-||+.+
T Consensus 458 ~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~ 537 (590)
T KOG1290|consen 458 NYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFD 537 (590)
T ss_pred CCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcC
Confidence 12333333333 1110 0 001121 11 356889999999999
Q ss_pred CCCCCCHHHHhcCCCccCCCC
Q 021227 192 PKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 192 p~~R~s~~~~l~h~~~~~~~~ 212 (315)
|++||||.++|+|||+.....
T Consensus 538 PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 538 PEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred ccccccHHHHhcCccccCCCC
Confidence 999999999999999986544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=218.31 Aligned_cols=202 Identities=30% Similarity=0.500 Sum_probs=155.6
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+..+.||+++.+++..++...+|+||++..+..++.. .++..+++.+++.++.||+++|.+|||||||||+|||+
T Consensus 90 ~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~- 165 (418)
T KOG1167|consen 90 RLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLY- 165 (418)
T ss_pred HhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccc-
Confidence 46789999999999999999999999999877777663 47789999999999999999999999999999999998
Q ss_pred cCCCCCCEEEeeccCcccC-----------------CC--C---------------C-----------cccccccCcccc
Q 021227 83 SVDEDAALKATDFGLSVFY-----------------KP--D---------------E-----------VFSDVVGSPYYV 117 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~-----------------~~--~---------------~-----------~~~~~~gt~~y~ 117 (315)
....+.-.|+|||+|... .+ + . ..-...||++|.
T Consensus 166 -n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfR 244 (418)
T KOG1167|consen 166 -NRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFR 244 (418)
T ss_pred -ccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCC
Confidence 456778899999998721 00 0 0 001246899999
Q ss_pred chhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH--------------hCC--C------------
Q 021227 118 APEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAET-EIGIFRQIL--------------EGK--I------------ 166 (315)
Q Consensus 118 aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~--------------~~~--~------------ 166 (315)
|||++. +..++++||||.|||+..++++..||.... +...+..|. .+. +
T Consensus 245 aPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~ 324 (418)
T KOG1167|consen 245 APEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPEL 324 (418)
T ss_pred chHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHH
Confidence 999985 457889999999999999999999985321 111111100 011 0
Q ss_pred --C----------------CCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 167 --D----------------FESEPWP-NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 167 --~----------------~~~~~~~-~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
. .....|. ..+..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 325 ~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 325 RVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred HhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0 0011111 23558999999999999999999999999999974
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=195.47 Aligned_cols=157 Identities=29% Similarity=0.414 Sum_probs=132.2
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI----VKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPEN 78 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~n 78 (315)
..+.|.+|++|+.+-+....++.||.++. ||..+. .+.+.++|..+-+++..++.||.|||+ ..++|||+||+|
T Consensus 101 ~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsN 179 (282)
T KOG0984|consen 101 TVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSN 179 (282)
T ss_pred CCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcce
Confidence 35899999999999999999999999975 665433 344679999999999999999999995 589999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-----hcCCCchhHHHHHHHHHHHHhCCCCCCC-C
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-----KHYGPEADVWSAGVILYILLSGVPPFWA-E 152 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~-~ 152 (315)
|| ++..|.||+||||.+-.+...-..+--.|-..|||||.+. ..|+.++||||||+.+.||.+++.||.. .
T Consensus 180 iL---In~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 180 IL---INYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred EE---EccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 99 7889999999999987765443333345778899999874 3589999999999999999999999975 4
Q ss_pred CHHHHHHHHHhC
Q 021227 153 TEIGIFRQILEG 164 (315)
Q Consensus 153 ~~~~~~~~i~~~ 164 (315)
++.+++.++.+.
T Consensus 257 tpF~qLkqvVee 268 (282)
T KOG0984|consen 257 TPFQQLKQVVEE 268 (282)
T ss_pred CHHHHHHHHhcC
Confidence 677788777765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-29 Score=203.56 Aligned_cols=202 Identities=27% Similarity=0.399 Sum_probs=154.6
Q ss_pred CCCCCCCcceEEE-EEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHD-TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~-~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.|..|.||+.-|+ .|+..+.|.+++||++-|+|.+-+.. .++-|.....++.|+++|+.|+|++++||||||.+|||+
T Consensus 76 ~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLi 154 (378)
T KOG1345|consen 76 FLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILI 154 (378)
T ss_pred eeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEE
Confidence 4678999999888 56888899999999999999887754 457899999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hc--CCCchhHHHHHHHHHHHHhCCCCCCCCC--
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KH--YGPEADVWSAGVILYILLSGVPPFWAET-- 153 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~--~~~~~DiwslG~il~~ll~g~~pf~~~~-- 153 (315)
.+-+. ..|||||||..+.....- ...--+..|.+||.+. +. ..+.+|+|.||+++|..+||.+||....
T Consensus 155 f~~df-~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~ 231 (378)
T KOG1345|consen 155 FDADF-YRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM 231 (378)
T ss_pred ecCCc-cEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc
Confidence 75444 499999999876543211 1122356799999763 22 5788999999999999999999997422
Q ss_pred --HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCcc
Q 021227 154 --EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRR---LTAHEVLCHPWIV 208 (315)
Q Consensus 154 --~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R---~s~~~~l~h~~~~ 208 (315)
..-.+.+...+...--+..+..+|+.+..+.++-|..+|++| .++..-....|..
T Consensus 232 d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 232 DKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred CchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 222233333333332334456789999999999999999999 5555555555653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=226.48 Aligned_cols=192 Identities=24% Similarity=0.357 Sum_probs=164.9
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+| +|||+++++++..... +-||++|+++|+|.+++..+ +++--+....|..||++|+.|||.+++|||||-..|||
T Consensus 754 sl-dHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVL- 830 (1177)
T KOG1025|consen 754 SL-DHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVL- 830 (1177)
T ss_pred cC-CCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhhee-
Confidence 44 9999999999998776 77999999999999999765 57888999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccc-ccc--Cccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSD-VVG--SPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~-~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 156 (315)
+..-..+|++|||+++...+...... ..| .+.|||-|.++ ..|+.++||||+||++||++| |..|+.+....+
T Consensus 831 --VksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 831 --VKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred --ecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 56677899999999998765543222 222 35699999886 669999999999999999998 999999998888
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
+-..+..+.. ++.+ +.++-++.-+|.+||..|+..||+++++.
T Consensus 909 I~dlle~geR-LsqP--piCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 909 IPDLLEKGER-LSQP--PICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred hhHHHhcccc-CCCC--CCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 8777776654 3333 57899999999999999999999998875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=208.56 Aligned_cols=194 Identities=23% Similarity=0.384 Sum_probs=152.1
Q ss_pred CCCCCCcceEEEEEEeCC----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCcc
Q 021227 4 LSEHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS--------LGVFH 71 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~--------~~ivH 71 (315)
|++|+||+.+++.-..++ .++||++|-+.|||+||+.+ ..++-+.+.+++..+++||+|||. -.|.|
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH 339 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH 339 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence 569999999999875443 58999999999999999977 678999999999999999999994 35999
Q ss_pred ccCCCCceeeccCCCCCCEEEeeccCcccCCCCC-----cccccccCccccchhhhhhcCC-------CchhHHHHHHHH
Q 021227 72 RDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPEVLRKHYG-------PEADVWSAGVIL 139 (315)
Q Consensus 72 ~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-------~~~DiwslG~il 139 (315)
||||..||| +..++.+-|+|+|+|....... ..+..+||.+|||||++..... ..+||||||.++
T Consensus 340 RDlKSKNIL---VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 340 RDLKSKNIL---VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred cccccccEE---EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 999999999 6789999999999997664431 2356889999999999964322 358999999999
Q ss_pred HHHHhC----------CCCCCC-----CCHHHHHHHHHhCCCCCC-CCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHH
Q 021227 140 YILLSG----------VPPFWA-----ETEIGIFRQILEGKIDFE-SEPWPNIS--ESAKDLIRKMLDQNPKRRLTAHEV 201 (315)
Q Consensus 140 ~~ll~g----------~~pf~~-----~~~~~~~~~i~~~~~~~~-~~~~~~~s--~~~~~li~~~l~~~p~~R~s~~~~ 201 (315)
||+... ++||.+ .+.+++.+-+.-.+.++. +..|...+ ..+..+|+.||..+|.-|.|+-.+
T Consensus 417 WEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 417 WEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred HHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 999763 578864 344555544444444443 33444332 346678999999999999987544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-29 Score=221.68 Aligned_cols=142 Identities=34% Similarity=0.613 Sum_probs=129.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEecc-CCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELC-EGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~-~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.||||+|++++|+++.+|||+||-- +|.+|+++|..+..++|.++..|++|++.|+++||+.||||||||-+|+. +
T Consensus 627 sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvi---v 703 (772)
T KOG1152|consen 627 SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVI---V 703 (772)
T ss_pred CccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEE---E
Confidence 4999999999999999999999976 35689999999999999999999999999999999999999999999999 6
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc--CCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
+.+|.+||+|||.+....++ ....++||..|.|||++.+. .+..-|||++|+++|-++....||+.
T Consensus 704 d~~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ecCCeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 78999999999988765544 45778999999999999854 58889999999999999999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=193.71 Aligned_cols=162 Identities=44% Similarity=0.789 Sum_probs=144.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.||+|+++++++......++++|++.|++|.+++... ..+++..+..++.+++.++++||+.|++|+||+|.||++
T Consensus 49 ~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~--- 125 (215)
T cd00180 49 NHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL--- 125 (215)
T ss_pred CCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---
Confidence 7899999999999999999999999999999998766 578999999999999999999999999999999999995
Q ss_pred CC-CCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 85 DE-DAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~-~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
+. .+.++|+|||.+....... ......+...|++||.+.. .++.+.|+||+|++++++
T Consensus 126 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------ 187 (215)
T cd00180 126 DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------ 187 (215)
T ss_pred eCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------
Confidence 44 6899999999887654332 1234567889999999864 688999999999999999
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~ 205 (315)
+.+.+++.+|++.+|.+||++.++++++
T Consensus 188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6889999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=207.59 Aligned_cols=192 Identities=24% Similarity=0.355 Sum_probs=150.5
Q ss_pred CCCCCcceEEEEEEeCC----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------CCCcc
Q 021227 5 SEHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS---------LGVFH 71 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---------~~ivH 71 (315)
.+|+||++++++-+... .|+||+||.+.|+|.+|+..+ .+++....+++..++.||+|||+ ..|+|
T Consensus 261 m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaH 339 (534)
T KOG3653|consen 261 MKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAH 339 (534)
T ss_pred ccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccc
Confidence 48999999999876554 899999999999999999654 68999999999999999999995 36999
Q ss_pred ccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhhhcC--C-----CchhHHHHHHHHHH
Q 021227 72 RDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLRKHY--G-----PEADVWSAGVILYI 141 (315)
Q Consensus 72 ~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~--~-----~~~DiwslG~il~~ 141 (315)
||||..||| +..++..-|+|||+|..+.++.. ....+||.+|||||++.+.. . ...||||+|.++||
T Consensus 340 RDlkSkNVL---vK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWE 416 (534)
T KOG3653|consen 340 RDLKSKNVL---VKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWE 416 (534)
T ss_pred ccccccceE---EccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHH
Confidence 999999999 56789999999999988865543 23478999999999996542 2 35899999999999
Q ss_pred HHhCC------------CCCC-----CCCHHHHHHHHHhCCCCCC-CCCCCCC--CHHHHHHHHHhcccCCCCCCCHHH
Q 021227 142 LLSGV------------PPFW-----AETEIGIFRQILEGKIDFE-SEPWPNI--SESAKDLIRKMLDQNPKRRLTAHE 200 (315)
Q Consensus 142 ll~g~------------~pf~-----~~~~~~~~~~i~~~~~~~~-~~~~~~~--s~~~~~li~~~l~~~p~~R~s~~~ 200 (315)
+++.- +||. ..+..++...+.+.+.++. +..|.+. ..-+++.+..||..||+.|.|+.=
T Consensus 417 i~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 417 IASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred HHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 99852 3342 2334455555555443322 1223222 345889999999999999999743
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=233.34 Aligned_cols=202 Identities=29% Similarity=0.492 Sum_probs=163.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+.|||++.......+...++-+||||++ +|+.++...+.++..++..+++|++.|++|+|..||.|||+||+|++ .
T Consensus 378 l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll---~ 453 (601)
T KOG0590|consen 378 LSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLL---V 453 (601)
T ss_pred ccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEE---E
Confidence 4899998888877777666666999999 99999988888999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC-----CcccccccCccccchhhhhh-cCCC-chhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-----EVFSDVVGSPYYVAPEVLRK-HYGP-EADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
..++.+|++|||.+....-+ ......+|+..|+|||++.+ .|.+ ..||||.|+++..|.+|+.||......+.
T Consensus 454 ~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 454 TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 67889999999998765322 22356789999999999874 4654 58999999999999999999976443322
Q ss_pred H--HHHHhCCC---CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 F--RQILEGKI---DFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~--~~i~~~~~---~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
. ........ .-+...+..++...+.+|.+||+++|.+|.|++++++.+||+..
T Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 534 SFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred chhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 1 11111111 11122345678999999999999999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=197.00 Aligned_cols=190 Identities=19% Similarity=0.292 Sum_probs=160.6
Q ss_pred CCCCCcceEEEEEE-eCCeEEEEEeccCCCchhHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 021227 5 SEHQHVVRIHDTYE-DKSCVHIVMELCEGGELFDRIVKK--------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLK 75 (315)
Q Consensus 5 ~~Hpniv~~~~~~~-~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dik 75 (315)
..|||+..+.++.. +....++++.+..-|+|..++... ..++-.+...++.|+..|++|||++|+||.||.
T Consensus 344 ~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiA 423 (563)
T KOG1024|consen 344 ASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIA 423 (563)
T ss_pred CcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhh
Confidence 36999999999875 456788889999889999988732 246777889999999999999999999999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCCCCccccccc-----Cccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCC
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG-----SPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPP 148 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~g-----t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~p 148 (315)
..|.+ +++...|||+|=.+++.+.+... ...| ...|||||.+. ..|+..+|+|||||++|||+| |+.|
T Consensus 424 aRNCv---Idd~LqVkltDsaLSRDLFP~DY--hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~P 498 (563)
T KOG1024|consen 424 ARNCV---IDDQLQVKLTDSALSRDLFPGDY--HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLP 498 (563)
T ss_pred hhcce---ehhheeEEeccchhccccCcccc--cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCC
Confidence 99999 56679999999988887655432 1222 35799999986 569999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 149 FWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 149 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
+..-++.++...+++|..- . ...++|+++..++..||...|++||+.+|+.
T Consensus 499 yaeIDPfEm~~ylkdGyRl-a--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 499 YAEIDPFEMEHYLKDGYRL-A--QPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred ccccCHHHHHHHHhcccee-c--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 9999999999988887432 2 2247999999999999999999999998885
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=186.45 Aligned_cols=157 Identities=45% Similarity=0.753 Sum_probs=135.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+|||++++++.+......++++|++.+++|.+++..... +++..+..++.|++.++.+||+++++|+||+|.||++
T Consensus 55 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v--- 131 (225)
T smart00221 55 KHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL--- 131 (225)
T ss_pred CCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---
Confidence 899999999999999999999999999999999987766 8999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCC--cccccccCccccchhhh-h-hcCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVL-R-KHYGPEADVWSAGVILYILLSGVPPFWA--ETEIGIF 158 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~ 158 (315)
+.++.++|+|||.+....... ......++..|++||.+ . ..++.++|+||+|+++++|++|+.||.. .+...+.
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~ 211 (225)
T smart00221 132 GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS 211 (225)
T ss_pred cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence 556899999999887765442 33446678899999997 3 3477899999999999999999999977 3444677
Q ss_pred HHHHhCC
Q 021227 159 RQILEGK 165 (315)
Q Consensus 159 ~~i~~~~ 165 (315)
+.+..+.
T Consensus 212 ~~~~~~~ 218 (225)
T smart00221 212 DVWSFGV 218 (225)
T ss_pred HHHhcCC
Confidence 7776664
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=182.90 Aligned_cols=195 Identities=26% Similarity=0.421 Sum_probs=146.3
Q ss_pred CCCCCCCCcceEEEEEEe---------------------------CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHH
Q 021227 2 HHLSEHQHVVRIHDTYED---------------------------KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLM 54 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~---------------------------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~ 54 (315)
.+|.+|||||++...|.+ ...+|+||.-++. +|..++... ..+....+.++
T Consensus 270 vhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~l 347 (598)
T KOG4158|consen 270 VHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVIL 347 (598)
T ss_pred cccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHH
Confidence 478899999999998865 3468999998865 898888554 45778889999
Q ss_pred HHHHHHHHHHHHCCCccccCCCCceeeccC-CCCCCEEEeeccCcccCCCC-------CcccccccCccccchhhhhhcC
Q 021227 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSV-DEDAALKATDFGLSVFYKPD-------EVFSDVVGSPYYVAPEVLRKHY 126 (315)
Q Consensus 55 ~qi~~~l~~lH~~~ivH~dikp~nil~~~~-~~~~~ikl~Dfg~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~ 126 (315)
.|+++|+.|||++||.|||+|.+|||+.-. +.-..+.++|||.+.--... ...-..-|.-..||||+.....
T Consensus 348 aQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999999999999999999998532 23456889999976432211 1112344677899999985332
Q ss_pred C-------CchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 021227 127 G-------PEADVWSAGVILYILLSGVPPFWAETEIGIF-RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA 198 (315)
Q Consensus 127 ~-------~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~ 198 (315)
+ .++|.|+.|.+.||+++...||++..+..+- +...+.+++.- ...+++.+++++..+|+.||.+|+|+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPal---p~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPAL---PSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCC---cccCChHHHHHHHHHhcCCccccCCc
Confidence 2 3799999999999999999999985543221 11222222211 13689999999999999999999986
Q ss_pred HHH
Q 021227 199 HEV 201 (315)
Q Consensus 199 ~~~ 201 (315)
.-+
T Consensus 505 ~iA 507 (598)
T KOG4158|consen 505 NIA 507 (598)
T ss_pred cHH
Confidence 443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=201.58 Aligned_cols=192 Identities=28% Similarity=0.516 Sum_probs=172.2
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
...||.+|+++..|+.+...|+++++..||.|+..+.+...+.+...+.+...++.++.++|+.+++|||+|++||+
T Consensus 53 ~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enil--- 129 (612)
T KOG0603|consen 53 VHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVL--- 129 (612)
T ss_pred ccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhccccccee---
Confidence 44699999999999999999999999999999999888888999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.+..|.+++.|||+++.....+.. +||..|||||+++ .....+|.||+|+++++|+||..||.+ ++..+|..
T Consensus 130 ld~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~ 201 (612)
T KOG0603|consen 130 LLLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK 201 (612)
T ss_pred ecccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence 678999999999998876544432 8999999999998 567789999999999999999999988 77788888
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVDD 210 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~~ 210 (315)
.++.++. .++.++++++..++..+|..|.- +.++.+|++|+..
T Consensus 202 ~~~~~p~----~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 202 AELEMPR----ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred hccCCch----hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 7766664 57899999999999999999974 5789999999753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-22 Score=178.96 Aligned_cols=205 Identities=38% Similarity=0.617 Sum_probs=164.3
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG---NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
.+..|++|+++++++......++++|++.|+++.+++.... .+++..+..++.|++.++.|+|+.|++|||+||+||
T Consensus 53 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~ni 132 (384)
T COG0515 53 SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENI 132 (384)
T ss_pred HccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence 34334489999999988888999999999999997776654 799999999999999999999999999999999999
Q ss_pred eeccCCCCC-CEEEeeccCcccCCCCC-------cccccccCccccchhhhhh----cCCCchhHHHHHHHHHHHHhCCC
Q 021227 80 LFLSVDEDA-ALKATDFGLSVFYKPDE-------VFSDVVGSPYYVAPEVLRK----HYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 80 l~~~~~~~~-~ikl~Dfg~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~ 147 (315)
++ +..+ .++++|||.+....... ......||..|+|||.+.+ .++...|+||+|++++++++|..
T Consensus 133 l~---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~ 209 (384)
T COG0515 133 LL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209 (384)
T ss_pred ee---cCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 94 4555 79999999987554332 2456789999999999864 58889999999999999999999
Q ss_pred CCCCCCH----HHHHHHHHhCCCC-CCCCCCCCC----CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 148 PFWAETE----IGIFRQILEGKID-FESEPWPNI----SESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 148 pf~~~~~----~~~~~~i~~~~~~-~~~~~~~~~----s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
||..... ......+...... ......... +..+.+++.+++..+|..|.+..+...++|....
T Consensus 210 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 210 PFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred CCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 9877663 4555555544433 222211111 2578999999999999999999999888766543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=176.27 Aligned_cols=199 Identities=22% Similarity=0.361 Sum_probs=159.1
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCC-ccccCCCCc
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGV-FHRDLKPEN 78 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i-vH~dikp~n 78 (315)
|+.+ .|.|+.++++...++...++|.+||+.|+|.|.+... -.++......+++.++.||+|+|...| +|+.++..|
T Consensus 1 l~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred Cccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 5666 8999999999999999999999999999999999773 568888899999999999999998877 999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCC---CcccccccCccccchhhhhhc--------CCCchhHHHHHHHHHHHHhCCC
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLRKH--------YGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwslG~il~~ll~g~~ 147 (315)
.+ ++....+||+|||+....... .......-...|.|||.++.. .+++.||||+|++++|+++...
T Consensus 80 Cl---vd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 80 CL---VDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ce---eeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99 778899999999987665321 111111234579999998642 4778999999999999999999
Q ss_pred CCCCC----CHHHHHHHHHh-CCCCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 148 PFWAE----TEIGIFRQILE-GKIDFESEPW--PNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 148 pf~~~----~~~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
||... ...++...+.+ +...+.+..+ ...++++..++..||..+|.+||+++++-.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 99752 23456666666 3322322222 145668999999999999999999998854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-20 Score=165.53 Aligned_cols=196 Identities=22% Similarity=0.233 Sum_probs=147.5
Q ss_pred CCCcceEEEEE-EeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 7 HQHVVRIHDTY-EDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 7 Hpniv~~~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
-+++.++++.+ ..+...++||+.+ |.+|.++.... +.|+..++..++.|++.+|.+||+.|++||||||+|+++..
T Consensus 79 ~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~ 157 (322)
T KOG1164|consen 79 PSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQ 157 (322)
T ss_pred CCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecC
Confidence 35899999999 5888899999998 78999977543 57999999999999999999999999999999999999754
Q ss_pred CC--CCCCEEEeeccCcccCC---CC-------Cc-ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCC
Q 021227 84 VD--EDAALKATDFGLSVFYK---PD-------EV-FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPF 149 (315)
Q Consensus 84 ~~--~~~~ikl~Dfg~~~~~~---~~-------~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 149 (315)
.. ....+.|.|||+++... .. .. .....||..|+|+.+-.+ ..+.+.|+||++.++.++..|..||
T Consensus 158 ~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 158 SSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred CCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 32 12579999999998321 11 01 123559999999998764 5899999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 150 WAETEIGIFRQILEGKIDFESE-PWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 150 ~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+.................... .....+.++..+...+-..+...+|....+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 238 EALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred ccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 7655322222222211111111 22345677888888877788888888766643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=184.15 Aligned_cols=165 Identities=37% Similarity=0.565 Sum_probs=136.0
Q ss_pred chhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCC--------C
Q 021227 34 ELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD--------E 105 (315)
Q Consensus 34 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~--------~ 105 (315)
+-...+...++++... +.+++|+|+.||+|||+||+|.+ +..-|.+|++|||+.+..... .
T Consensus 137 Dc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnll---IT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 137 DCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLL---ITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred hhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcce---eeecccccccchhhhhhhhhhccchhhhcc
Confidence 3344444445555443 77999999999999999999999 567899999999997643110 0
Q ss_pred --------cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCC
Q 021227 106 --------VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI 176 (315)
Q Consensus 106 --------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 176 (315)
.-...+|||.|+|||++. +.|+..+|.|++|+|+|+.+.|..||.+.++++++..+......++...+ .+
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de-a~ 284 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE-AL 284 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc-CC
Confidence 012468999999999875 67999999999999999999999999999999999999988888877754 57
Q ss_pred CHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCC
Q 021227 177 SESAKDLIRKMLDQNPKRRL---TAHEVLCHPWIVDD 210 (315)
Q Consensus 177 s~~~~~li~~~l~~~p~~R~---s~~~~l~h~~~~~~ 210 (315)
++++++++.++|+.+|..|. .+-++-+|+||+..
T Consensus 285 p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 89999999999999999995 57788899999753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-21 Score=171.64 Aligned_cols=175 Identities=33% Similarity=0.516 Sum_probs=137.4
Q ss_pred CeEEEEEeccCCCchhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccC
Q 021227 21 SCVHIVMELCEGGELFDRIVKKG---NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGL 97 (315)
Q Consensus 21 ~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~ 97 (315)
.++||.|++|.-.+|.+++.++. .-+......++.|+..|+.| +|.+|||+||.||.+ ..+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhhhhhhh
Confidence 36889999999999999997542 46677899999999999999 999999999999994 4566899999999
Q ss_pred cccCCCCC-------cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCC
Q 021227 98 SVFYKPDE-------VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDF 168 (315)
Q Consensus 98 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 168 (315)
........ .....+||.+||+||.+. +.|+.++||||||++++||+. -..++. ....+..+..+.++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip- 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIP- 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCC-
Confidence 87665443 345678999999999998 569999999999999999997 333332 23344555555543
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 169 ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 169 ~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
+..+... ++-..|+.+||.+.|.+||++.+.-.|+|.
T Consensus 479 -~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 -PEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred -hHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 2222233 456799999999999999988777777664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-21 Score=184.59 Aligned_cols=193 Identities=24% Similarity=0.341 Sum_probs=142.2
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+|||++.+.-+-+.++..|+|-+|... +|+|++..+.-+..-+..-|+.|++.||.-+|+.||+|||||.+|||+
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi-- 153 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI-- 153 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE--
Confidence 46899999999998889999999999965 999999877778888899999999999999999999999999999995
Q ss_pred CCCCCCEEEeeccCcccC--CCC--Ccccccc----cCccccchhhhhh------------cCCCchhHHHHHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFY--KPD--EVFSDVV----GSPYYVAPEVLRK------------HYGPEADVWSAGVILYILL 143 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~--~~~--~~~~~~~----gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll 143 (315)
+.-.-+.|+||..-+.. ... ....-+. .-..|+|||.+.. ..+++.||+|+||+++||+
T Consensus 154 -TSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf 232 (1431)
T KOG1240|consen 154 -TSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF 232 (1431)
T ss_pred -eeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence 45567899999754322 111 1111112 2246999997631 1467899999999999998
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 144 S-GVPPFWAETEIGIFRQILEGKIDFESEPWPN-ISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 144 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
+ |++||.-. ++-....+.-..+...... -+...+.+|..|++.||.+|.||++.|+.
T Consensus 233 ~Eg~PlF~LS----QL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 233 LEGRPLFTLS----QLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hcCCCcccHH----HHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 7 79998421 1111111110000000001 13478999999999999999999999975
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=146.53 Aligned_cols=194 Identities=20% Similarity=0.219 Sum_probs=152.8
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
|..-+.|..+..++.+..+-.+||+.+ |.+|.+.+.-. ..|+.+++...+.|++.-++|+|.++++||||||+|+|..
T Consensus 67 L~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMG 145 (341)
T KOG1163|consen 67 LQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMG 145 (341)
T ss_pred hccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeec
Confidence 344566777888888899999999998 88998887643 5799999999999999999999999999999999999965
Q ss_pred cCCCCCCEEEeeccCcccCCCCC--------cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC-
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE--------VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE- 152 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~- 152 (315)
-..-...+.|+|||+|+...... .-....||..|.|-....+ ..+...|+=|+|.++..+..|..||.+-
T Consensus 146 lgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 146 LGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred cccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 33345689999999998764322 1234679999999776543 3677889999999888889999999874
Q ss_pred --CHHHHHHHHHhCCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCH
Q 021227 153 --TEIGIFRQILEGKIDFESE-PWPNISESAKDLIRKMLDQNPKRRLTA 198 (315)
Q Consensus 153 --~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~l~~~p~~R~s~ 198 (315)
+..+-++.|.+.+...+.+ ....+|.++.-.+..|=..--++-|..
T Consensus 226 a~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 226 AATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred hhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 4566677787776655433 235688899999988877666666653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=151.69 Aligned_cols=195 Identities=18% Similarity=0.261 Sum_probs=153.2
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.|...|.|...|-+.+.+.+-.+|+|++ |.||.|++.-.+ .|+.++++.++.|++.-++|+|++.+|.|||||+|+||
T Consensus 79 lL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLI 157 (449)
T KOG1165|consen 79 LLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLI 157 (449)
T ss_pred HHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceee
Confidence 3567889999999999999999999998 889999888764 69999999999999999999999999999999999998
Q ss_pred ccC--CCCCCEEEeeccCcccCCCCCc--------ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 82 LSV--DEDAALKATDFGLSVFYKPDEV--------FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 82 ~~~--~~~~~ikl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
..- .....|.++|||+|+....... .....||.+||+-..-. ...+.+.|+=|||-++..++.|.+||.
T Consensus 158 Grp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQ 237 (449)
T KOG1165|consen 158 GRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 237 (449)
T ss_pred cCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccc
Confidence 632 2346799999999987754432 23467999999977643 447888999999999999999999998
Q ss_pred C---CCHHHHHHHHHhCCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 021227 151 A---ETEIGIFRQILEGKIDFES-EPWPNISESAKDLIRKMLDQNPKRRLTA 198 (315)
Q Consensus 151 ~---~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~s~ 198 (315)
| .+..+-++.|-+.+...+. ....++|.++...+.-.=..+-.+-|..
T Consensus 238 GLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 238 GLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred cccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 7 4456666666554332221 1123567777777776666666777764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=145.59 Aligned_cols=188 Identities=19% Similarity=0.289 Sum_probs=145.2
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCce
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECCHSLG--VFHRDLKPENF 79 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dikp~ni 79 (315)
+..||||+.+++.+....++.+|..|++.|+|+..+..... .+..++.+++..++.|++|||+.. |.---++...+
T Consensus 243 ifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hv 322 (448)
T KOG0195|consen 243 IFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHV 322 (448)
T ss_pred eecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceE
Confidence 45799999999999999999999999999999999976543 567789999999999999999764 33446778888
Q ss_pred eeccCCCCCCEE--EeeccCcccCCCCCcccccccCccccchhhhhhc----CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 80 LFLSVDEDAALK--ATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH----YGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 80 l~~~~~~~~~ik--l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
++ +++...+ .+|-.++.. . ....-+|.|||||.+..+ --..+|+|||++++|||.|...||...+
T Consensus 323 mi---dedltarismad~kfsfq--e----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 323 MI---DEDLTARISMADTKFSFQ--E----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred Ee---cchhhhheecccceeeee--c----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 84 4444443 344333221 1 123347899999999643 2357999999999999999999999988
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
+.+.--+|.-..++... .+.+|+.+..+++-|++.||.+||.++.+.
T Consensus 394 pmecgmkialeglrv~i--ppgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 394 PMECGMKIALEGLRVHI--PPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred chhhhhhhhhccccccC--CCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 87765555443333322 257999999999999999999999887654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.9e-20 Score=156.08 Aligned_cols=159 Identities=28% Similarity=0.390 Sum_probs=103.2
Q ss_pred EEEEEeccCCCchhHHHH---hCCCC--CHHH--HHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeec
Q 021227 23 VHIVMELCEGGELFDRIV---KKGNY--SERE--AAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDF 95 (315)
Q Consensus 23 ~~lv~E~~~gg~L~~~l~---~~~~~--~~~~--~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Df 95 (315)
.+++|+-+. ++|.+.+. ..... .... ...+..|++..+++||..|++|+||+|+|++ .+.+|.+.|+||
T Consensus 114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfl---l~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFL---LDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEE---E-TTS-EEE--G
T ss_pred hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEE---EcCCCCEEEcCh
Confidence 467888885 47776643 22222 1222 2345589999999999999999999999999 677899999999
Q ss_pred cCcccCCCCCcccccccCccccchhhhhh---------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q 021227 96 GLSVFYKPDEVFSDVVGSPYYVAPEVLRK---------HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKI 166 (315)
Q Consensus 96 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 166 (315)
+......... .....+..|.+||.... .++.+.|.|+||+++|.+++|..||...........
T Consensus 190 ~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------ 261 (288)
T PF14531_consen 190 SSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------ 261 (288)
T ss_dssp GGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------
T ss_pred HHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------
Confidence 8765443222 21334577999997742 278899999999999999999999976543211111
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 021227 167 DFESEPWPNISESAKDLIRKMLDQNPKRR 195 (315)
Q Consensus 167 ~~~~~~~~~~s~~~~~li~~~l~~~p~~R 195 (315)
.|.. + .++|+.++.+|.++|+++|.+|
T Consensus 262 ~f~~-C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 DFSR-C-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GGTT-S-S---HHHHHHHHHHT-SSGGGS
T ss_pred cchh-c-CCcCHHHHHHHHHHccCCcccC
Confidence 1221 1 2789999999999999999988
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.8e-21 Score=178.62 Aligned_cols=203 Identities=33% Similarity=0.586 Sum_probs=169.5
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCCccccCCCCcee
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-VKKG-NYSEREAAKLMKTIVGVVECCH-SLGVFHRDLKPENFL 80 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l-~~~~-~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dikp~nil 80 (315)
+..|+|++++++...+...+++++||..||++++.+ .... ..+...+..++.|+..++.|+| ..++.|||+||+|.+
T Consensus 77 ~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 77 LSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSL 156 (601)
T ss_pred ccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccch
Confidence 445999999999999999999999999999999988 5554 6788899999999999999999 999999999999988
Q ss_pred eccCCCCC-CEEEeeccCcccCCC-CC---ccccccc-Cccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 81 FLSVDEDA-ALKATDFGLSVFYKP-DE---VFSDVVG-SPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 81 ~~~~~~~~-~ikl~Dfg~~~~~~~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
.+.++ .+|+.|||+|..... .. .....+| ++.|+|||...+ ..++..|+||.|+++.-+++|..|+...
T Consensus 157 ---l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 157 ---LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred ---hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 55666 999999999987655 22 2344678 999999999865 4688999999999999999999998654
Q ss_pred CHHH-HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 153 TEIG-IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 153 ~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.... .+.........+....|..++....+++.+++..+|..|.+.+++-.++|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 234 SRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 4322 11122222233445678889999999999999999999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.8e-19 Score=143.90 Aligned_cols=140 Identities=21% Similarity=0.314 Sum_probs=105.2
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccC-CCCce
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDL-KPENF 79 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di-kp~ni 79 (315)
|++|.+||+|++++++ +..+++|||+.|.+|...... . ...++.|++.+|.++|++||+|||| ||+||
T Consensus 55 L~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NI 123 (218)
T PRK12274 55 LRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANW 123 (218)
T ss_pred HHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceE
Confidence 3567678999999986 346899999999988654311 1 2357889999999999999999999 79999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcc--------------cccccCccccchhhhh--hcCC-CchhHHHHHHHHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVF--------------SDVVGSPYYVAPEVLR--KHYG-PEADVWSAGVILYIL 142 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~--------------~~~~gt~~y~aPE~~~--~~~~-~~~DiwslG~il~~l 142 (315)
++ +.++.++|+|||++......... .-...++.|++|+.-. ...+ ...+.++.|+.+|.+
T Consensus 124 Lv---~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~ 200 (218)
T PRK12274 124 LV---QEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRF 200 (218)
T ss_pred EE---cCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHH
Confidence 95 56788999999999865443311 0112467788887542 2334 456777899999999
Q ss_pred HhCCCCCCCCCH
Q 021227 143 LSGVPPFWAETE 154 (315)
Q Consensus 143 l~g~~pf~~~~~ 154 (315)
+||..|+++.++
T Consensus 201 ~~~~~~~~~~~~ 212 (218)
T PRK12274 201 VTRRVLHWEDNE 212 (218)
T ss_pred HhccCCccccCC
Confidence 999999887653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.5e-19 Score=155.17 Aligned_cols=106 Identities=22% Similarity=0.294 Sum_probs=81.9
Q ss_pred CCCCCCCcce-EEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccC-CCCcee
Q 021227 3 HLSEHQHVVR-IHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDL-KPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~-~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di-kp~nil 80 (315)
.+ +||||+. +++. +..|+|||||+|++|.. .. ... ...++.|++.||.|||++||+|||| ||+|||
T Consensus 77 ~L-~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NIL 144 (365)
T PRK09188 77 TV-RGIGVVPQLLAT----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWL 144 (365)
T ss_pred hc-cCCCCCcEEEEc----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEE
Confidence 44 7999984 5542 45799999999999963 21 111 2567899999999999999999999 999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc---------ccccccCccccchhhhh
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV---------FSDVVGSPYYVAPEVLR 123 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~---------~~~~~gt~~y~aPE~~~ 123 (315)
+ +.++.+||+|||+++....... ..+..+++.|.|||.+.
T Consensus 145 v---~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 145 M---GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred E---cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 5 5567899999999986644321 13456888899999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-17 Score=138.03 Aligned_cols=116 Identities=22% Similarity=0.302 Sum_probs=86.9
Q ss_pred CCCCcceEEEEEEeC--------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 6 EHQHVVRIHDTYEDK--------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
.||+|..+.+++.+. +..++||||++|.+|.+.. .+++ ....+++.++..+|+.|++|||++|+
T Consensus 93 ~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~ 164 (232)
T PRK10359 93 RSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKG 164 (232)
T ss_pred HHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChH
Confidence 799999999987643 3578999999999997763 2343 24569999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHH
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILL 143 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll 143 (315)
||++ ++++ ++|+|||............. =++...++.++|+||||+++..+.
T Consensus 165 Nili---~~~g-i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 165 NFIV---SKNG-LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HEEE---eCCC-EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 9995 4456 99999997754422211100 012345778999999999876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.6e-17 Score=132.59 Aligned_cols=91 Identities=13% Similarity=0.149 Sum_probs=73.1
Q ss_pred CCCCCcceEEEEEEeCC---e-EEEEEec--cCCCchhHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCCccccCCCC
Q 021227 5 SEHQHVVRIHDTYEDKS---C-VHIVMEL--CEGGELFDRIVKKGNYSEREAAKLMKTIVGVV-ECCHSLGVFHRDLKPE 77 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~---~-~~lv~E~--~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l-~~lH~~~ivH~dikp~ 77 (315)
.+||||++++++++++. . +.+|+|| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+
T Consensus 58 ~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~ 134 (210)
T PRK10345 58 IDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQ 134 (210)
T ss_pred CCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 37999999999999874 4 3478999 557999999965 457666 35678888777 9999999999999999
Q ss_pred ceeeccCC-CCCCEEEeeccCc
Q 021227 78 NFLFLSVD-EDAALKATDFGLS 98 (315)
Q Consensus 78 nil~~~~~-~~~~ikl~Dfg~~ 98 (315)
||++...+ .+..++|+||+.+
T Consensus 135 NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 135 NILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HEEEeccCCCCCcEEEEECCCC
Confidence 99986443 3458999995433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=129.42 Aligned_cols=74 Identities=24% Similarity=0.284 Sum_probs=65.1
Q ss_pred EEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCccccCCCCceeeccCCCCCCEEEeeccCcccC
Q 021227 24 HIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC-HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFY 101 (315)
Q Consensus 24 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~l-H~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~ 101 (315)
++||||+.|+++.......+++++..+..++.|++.+|.|+ |+.||+||||||+||++. ++.++|+|||++...
T Consensus 93 ~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~~~v~LiDFG~a~~~ 167 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----CCcEEEEEccccccC
Confidence 79999999987766555567899999999999999999999 799999999999999963 367999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.3e-16 Score=153.84 Aligned_cols=140 Identities=21% Similarity=0.298 Sum_probs=120.5
Q ss_pred CCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc----
Q 021227 8 QHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS---- 83 (315)
Q Consensus 8 pniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~---- 83 (315)
|-|+++...+...+..++|+||.+.|+|.+++...+.++|..+..+..|++..+.+||..+||||||||+|+++..
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC
Confidence 4566677777777888999999999999999998888999999999999999999999999999999999999742
Q ss_pred CCCCCCEEEeeccCcccC---CCCCcccccccCccccchhhhhhc-CCCchhHHHHHHHHHHHHhCCC
Q 021227 84 VDEDAALKATDFGLSVFY---KPDEVFSDVVGSPYYVAPEVLRKH-YGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~ 147 (315)
..+..-++|+|||-+.-+ ..+......++|-.+-++|+..+. |+..+|.|.++.++|.|+.|+.
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 234567999999988644 334456677889999999999765 9999999999999999999864
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.7e-16 Score=125.98 Aligned_cols=91 Identities=22% Similarity=0.166 Sum_probs=72.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil~~~~ 84 (315)
.|++|.....+.... .|+||||+.|+++........++++..+..++.|++.++.++|. .||+||||||+||++.
T Consensus 77 ~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-- 152 (190)
T cd05145 77 YEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-- 152 (190)
T ss_pred HhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE--
Confidence 466664444443332 37999999988665443355678899999999999999999999 9999999999999963
Q ss_pred CCCCCEEEeeccCcccCC
Q 021227 85 DEDAALKATDFGLSVFYK 102 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~ 102 (315)
++.++|+|||++....
T Consensus 153 --~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 --DGKPYIIDVSQAVELD 168 (190)
T ss_pred --CCCEEEEEcccceecC
Confidence 5789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.3e-16 Score=149.06 Aligned_cols=201 Identities=36% Similarity=0.522 Sum_probs=168.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
.||-+++..-.+.-....++|++|..|++|...+...+..+++-++..+..+..+++|||...+.|+|++|.|.+ ..
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l---~~ 938 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLL---IA 938 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchh---hc
Confidence 456666555555667789999999999999999988888999999999999999999999999999999999999 67
Q ss_pred CCCCEEEeeccCcccCC------CC--------------------------CcccccccCccccchhhhhh-cCCCchhH
Q 021227 86 EDAALKATDFGLSVFYK------PD--------------------------EVFSDVVGSPYYVAPEVLRK-HYGPEADV 132 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~------~~--------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~Di 132 (315)
..+..+++|||...... .. .......||+.|.+||.+.+ ..+..+|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 88999999998432110 00 00123568999999998764 47888999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCCccC
Q 021227 133 WSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAH---EVLCHPWIVD 209 (315)
Q Consensus 133 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~---~~l~h~~~~~ 209 (315)
|++|+++++.++|.+||.....+..+++|..+...++... -..+.++++++.+++..+|.+|..+. ++-.|++|+.
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQD 1097 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCC
Confidence 9999999999999999999999999999998887776543 25789999999999999999999887 8889999986
Q ss_pred C
Q 021227 210 D 210 (315)
Q Consensus 210 ~ 210 (315)
.
T Consensus 1098 ~ 1098 (1205)
T KOG0606|consen 1098 V 1098 (1205)
T ss_pred C
Confidence 4
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7e-16 Score=129.82 Aligned_cols=193 Identities=19% Similarity=0.249 Sum_probs=139.9
Q ss_pred CCCCcceEEEEEEeCC-----eEEEEEeccCCCchhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccC
Q 021227 6 EHQHVVRIHDTYEDKS-----CVHIVMELCEGGELFDRIVKK----GNYSEREAAKLMKTIVGVVECCHSLG--VFHRDL 74 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~di 74 (315)
.|.|||+++.|+.+.+ ...++.||++.|++..++.+. ..+......+|+.||++||.|||+.. |+|+++
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl 204 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL 204 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence 6999999999987654 478999999999999998753 45889999999999999999999765 999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCC-----CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKP-----DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPP 148 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~p 148 (315)
..+.|+ +..++-||+.--........ ........+-++|.|||.=. .+.+..+|||++|....+|..|..-
T Consensus 205 Tc~tif---iq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 205 TCDTIF---IQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred chhhee---ecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 999999 55788888764221111000 00111233567899998643 4466789999999999999887654
Q ss_pred -CCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 149 -FWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 149 -f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
-.+.+..+.-..+.+..+.... .--++++.+|++.+|..||++.+++.||..-
T Consensus 282 ~tnseS~~~~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 282 STNSESKVEVEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred cCCCcceeehhhhhhhheeeccC-------ccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 3333333333333333222211 2235689999999999999999999999754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-15 Score=136.01 Aligned_cols=198 Identities=24% Similarity=0.288 Sum_probs=159.0
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHCCCccccCCCC
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVG----VVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~----~l~~lH~~~ivH~dikp~ 77 (315)
.+..|+|.++.+..++..+..|+-+|+|. .+|..+...... +++..++....+... ||.++|..+++|-|++|.
T Consensus 173 ~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~ 251 (524)
T KOG0601|consen 173 KIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPA 251 (524)
T ss_pred ccCccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchh
Confidence 34579999999999999999999999995 688777765544 889999999999999 999999999999999999
Q ss_pred ceeeccCCCC-CCEEEeeccCcccCCCCCcc------cccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 78 NFLFLSVDED-AALKATDFGLSVFYKPDEVF------SDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 78 nil~~~~~~~-~~ikl~Dfg~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
||+ ...+ ..++++|||+...+..+... ....|...|++||.+++.++...|++|+|.+..+..+|..++.
T Consensus 252 ~i~---~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 252 NIF---TTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred hee---cccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc
Confidence 999 4555 88999999998877655421 2235778899999999999999999999999998888876664
Q ss_pred CC--CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 151 AE--TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 151 ~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.. +....+++.. .+.+.....+.+....+..|+..+|..|++++.+++|+++.+
T Consensus 329 ~g~~~~W~~~r~~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 329 VGKNSSWSQLRQGY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CCCCCCcccccccc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 43 2222221111 222333456777788999999999999999999999999864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.7e-13 Score=113.67 Aligned_cols=87 Identities=32% Similarity=0.398 Sum_probs=75.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
.|++|+....++.+....++||||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.||++.
T Consensus 57 ~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~--- 129 (211)
T PRK14879 57 RKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS--- 129 (211)
T ss_pred HHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE---
Confidence 578888777777778889999999999999998865432 8889999999999999999999999999999963
Q ss_pred CCCCEEEeeccCccc
Q 021227 86 EDAALKATDFGLSVF 100 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~ 100 (315)
.+.++++|||.+..
T Consensus 130 -~~~~~liDf~~a~~ 143 (211)
T PRK14879 130 -GGKIYLIDFGLAEF 143 (211)
T ss_pred -CCCEEEEECCcccC
Confidence 67899999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.4e-14 Score=117.21 Aligned_cols=76 Identities=26% Similarity=0.242 Sum_probs=65.1
Q ss_pred EEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccccCCCCceeeccCCCCCCEEEeeccCcccC
Q 021227 23 VHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG-VFHRDLKPENFLFLSVDEDAALKATDFGLSVFY 101 (315)
Q Consensus 23 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~ 101 (315)
.++||||+.|++|.........+.+..+..++.|++.++.+||+.| ++||||||+||++. .+.++|+|||.+...
T Consensus 123 ~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~----~~~i~LiDFg~a~~~ 198 (237)
T smart00090 123 NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH----DGKVVIIDVSQSVEL 198 (237)
T ss_pred ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE----CCCEEEEEChhhhcc
Confidence 4799999999888766545556777778899999999999999999 99999999999963 678999999987654
Q ss_pred C
Q 021227 102 K 102 (315)
Q Consensus 102 ~ 102 (315)
.
T Consensus 199 ~ 199 (237)
T smart00090 199 D 199 (237)
T ss_pred C
Confidence 3
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-13 Score=129.17 Aligned_cols=84 Identities=29% Similarity=0.366 Sum_probs=74.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+|++|+....+..+....++||||++|++|.+++. ....++.|++.+|.+||+.|++||||||+||++
T Consensus 394 ~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl---- 461 (535)
T PRK09605 394 RRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV---- 461 (535)
T ss_pred cccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----
Confidence 78999988888777778899999999999988774 457789999999999999999999999999996
Q ss_pred CCCCEEEeeccCcccC
Q 021227 86 EDAALKATDFGLSVFY 101 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~ 101 (315)
.++.++|+|||+++..
T Consensus 462 ~~~~~~liDFGla~~~ 477 (535)
T PRK09605 462 RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ECCcEEEEeCcccccC
Confidence 4578999999998653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.1e-13 Score=109.79 Aligned_cols=85 Identities=31% Similarity=0.359 Sum_probs=68.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
.|+++....-++.+....++||||++|++|.+.+..... .++.|++.+|.++|+.|++|||++|.||++.
T Consensus 55 ~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~--- 124 (199)
T TIGR03724 55 RKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR--- 124 (199)
T ss_pred HHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE---
Confidence 455555444445566677899999999999887754321 8899999999999999999999999999963
Q ss_pred CCCCEEEeeccCcccC
Q 021227 86 EDAALKATDFGLSVFY 101 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~ 101 (315)
.+.++++|||.+...
T Consensus 125 -~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 125 -DDKLYLIDFGLGKYS 139 (199)
T ss_pred -CCcEEEEECCCCcCC
Confidence 688999999987653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.5e-13 Score=113.69 Aligned_cols=87 Identities=25% Similarity=0.349 Sum_probs=66.9
Q ss_pred CCCC--cceEEEEEEeC-Ce---EEEEEeccCC-CchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 6 EHQH--VVRIHDTYEDK-SC---VHIVMELCEG-GELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 6 ~Hpn--iv~~~~~~~~~-~~---~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
.|++ +++.+++...+ .. .++|+|+++| .+|.+++.. .++++.. +.|++.+|.+||++||+||||||+|
T Consensus 98 ~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~N 172 (239)
T PRK01723 98 YEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHN 172 (239)
T ss_pred HhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchh
Confidence 4555 47777765433 22 3599999998 588877744 4566653 5689999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCccc
Q 021227 79 FLFLSVDEDAALKATDFGLSVF 100 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~ 100 (315)
||+ +.++.++|+|||.+..
T Consensus 173 ILv---~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 173 ILL---DPDGKFWLIDFDRGEL 191 (239)
T ss_pred EEE---cCCCCEEEEECCCccc
Confidence 995 4566899999998765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.8e-12 Score=117.79 Aligned_cols=135 Identities=16% Similarity=0.189 Sum_probs=102.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH-SLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++.++.+++.|+|+|-+. .|..++.+. +...+.-.+.||+.||.+|| +.+++|++|..++|+
T Consensus 66 lRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVf--- 137 (690)
T KOG1243|consen 66 LRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVF--- 137 (690)
T ss_pred ccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEE---
Confidence 389999999999999999999999984 566667554 36778888999999999997 788999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCC
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPP 148 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~p 148 (315)
++..|..||++|.++........ ......--.|..|+.+... +-..|.|.|||++++++.|..+
T Consensus 138 Vn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 138 VNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred EcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCcccC
Confidence 78899999999987754332221 1111122246666654211 1346999999999999999433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=8e-12 Score=102.66 Aligned_cols=73 Identities=25% Similarity=0.341 Sum_probs=60.6
Q ss_pred CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCccc
Q 021227 21 SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVF 100 (315)
Q Consensus 21 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~ 100 (315)
...++||||++|++|..... ......++.+++.++.++|+.|++||||+|+||++ +.++.++|+|||.+..
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~~~~~liDfg~~~~ 174 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDDEKIYIIDWPQMVS 174 (198)
T ss_pred CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCCCcEEEEECCcccc
Confidence 34589999999998865432 13567788999999999999999999999999995 5578999999999865
Q ss_pred CC
Q 021227 101 YK 102 (315)
Q Consensus 101 ~~ 102 (315)
..
T Consensus 175 ~~ 176 (198)
T cd05144 175 TD 176 (198)
T ss_pred CC
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.3e-11 Score=96.19 Aligned_cols=83 Identities=25% Similarity=0.370 Sum_probs=71.2
Q ss_pred CCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCCCCceeeccC
Q 021227 8 QHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL---GVFHRDLKPENFLFLSV 84 (315)
Q Consensus 8 pniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dikp~nil~~~~ 84 (315)
+++++++.++...+..++++||+.|+++..+ +......++.+++.+++++|.. +++|||++|+||++
T Consensus 53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~--- 122 (155)
T cd05120 53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV--- 122 (155)
T ss_pred CCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE---
Confidence 6889999999888899999999999877543 5567778899999999999984 79999999999996
Q ss_pred CCCCCEEEeeccCccc
Q 021227 85 DEDAALKATDFGLSVF 100 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~ 100 (315)
++.+.++++|||.+..
T Consensus 123 ~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 123 DDGKILGIIDWEYAGY 138 (155)
T ss_pred ECCcEEEEEecccccC
Confidence 3468899999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1e-11 Score=114.60 Aligned_cols=155 Identities=20% Similarity=0.322 Sum_probs=112.5
Q ss_pred HHHHHHHHHHHH-HCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcc----------cccccCccccchhhh
Q 021227 54 MKTIVGVVECCH-SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF----------SDVVGSPYYVAPEVL 122 (315)
Q Consensus 54 ~~qi~~~l~~lH-~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~----------~~~~gt~~y~aPE~~ 122 (315)
+.++..|+.++| +.++||++|.|++|. .+.++.+||+.|+++.....+... .-......|.|||++
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~---~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIV---VNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhcccchhhhhccCcceeecccchhhee---eccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 345568999999 468999999999999 788999999999988665442111 011234579999998
Q ss_pred hhc-CCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCCCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 021227 123 RKH-YGPEADVWSAGVILYILL-SGVPPFWAETEIGIFRQILEGKIDFESE-PWPNISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 123 ~~~-~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
... .++++|++|+||++|.+. .|+..+.+.+..... ............ .-.++++++++=+.+++..++.-||++.
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD 260 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence 654 788999999999999998 566666554321111 111111111111 1147899999999999999999999999
Q ss_pred HHhcCCCccCCCC
Q 021227 200 EVLCHPWIVDDKV 212 (315)
Q Consensus 200 ~~l~h~~~~~~~~ 212 (315)
+++..+||.+...
T Consensus 261 ~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 261 LLLSIPFFSDPGL 273 (700)
T ss_pred hhhcccccCCchh
Confidence 9999999987643
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.8e-11 Score=96.53 Aligned_cols=76 Identities=21% Similarity=0.215 Sum_probs=58.6
Q ss_pred eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceeeccCCCCCCEEEeeccCccc
Q 021227 22 CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVF 100 (315)
Q Consensus 22 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~ 100 (315)
..++||||++|+.+........... ..+..++.+++.++.++|. .||+||||||+||++. ++.++++|||.+..
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~~~~~liDfg~a~~ 163 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----DGKVYIIDVPQAVE 163 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----CCcEEEEECccccc
Confidence 4589999999854322111111111 6788999999999999999 9999999999999963 78899999998865
Q ss_pred CC
Q 021227 101 YK 102 (315)
Q Consensus 101 ~~ 102 (315)
..
T Consensus 164 ~~ 165 (187)
T cd05119 164 ID 165 (187)
T ss_pred cc
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.5e-11 Score=111.71 Aligned_cols=194 Identities=23% Similarity=0.246 Sum_probs=144.0
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.-|.++++.+..+....+.|+-.|||.|+++...+.-...+.+...+....|++.++.++|+..++|+|++|+||++..
T Consensus 322 l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~ 401 (524)
T KOG0601|consen 322 LGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN 401 (524)
T ss_pred hhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc
Confidence 34688899988888877788899999999988766644456888899999999999999999999999999999999633
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCcccc-chhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV-APEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~-aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
.++..++.|||....+.-.. ....+.-++. .+|++.. .+..+.|++|||.-+.+.++|...-+... ....
T Consensus 402 --~~~~~~~~~~~~~t~~~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~ 474 (524)
T KOG0601|consen 402 --DGFFSKLGDFGCWTRLAFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLT 474 (524)
T ss_pred --chhhhhccccccccccceec--ccccccccccccchhhccccccccccccccccccccccccCcccCcccc---ccee
Confidence 23888999999876422111 1122333444 3555543 37789999999999999999876543322 2233
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
|..+.... .+..+.++..+.+.+...++..|+.+.++..|+=|.
T Consensus 475 i~~~~~p~----~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 IRSGDTPN----LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred eecccccC----CCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 33333221 234557889999999999999999999998877553
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.7e-10 Score=92.28 Aligned_cols=86 Identities=15% Similarity=0.148 Sum_probs=65.1
Q ss_pred CcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCccccCCCCceeeccCCCC
Q 021227 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC-HSLGVFHRDLKPENFLFLSVDED 87 (315)
Q Consensus 9 niv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~l-H~~~ivH~dikp~nil~~~~~~~ 87 (315)
++.+++++ ..-++||||+.|+.+..-..+...++++.+..+..+++.++..+ |+.|+|||||++.||++. +
T Consensus 89 ~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~----~ 160 (197)
T cd05146 89 PCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH----D 160 (197)
T ss_pred CCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE----C
Confidence 45566654 34669999997654432222334566777888899999999999 899999999999999963 4
Q ss_pred CCEEEeeccCcccCC
Q 021227 88 AALKATDFGLSVFYK 102 (315)
Q Consensus 88 ~~ikl~Dfg~~~~~~ 102 (315)
+.+.++|||.+....
T Consensus 161 ~~v~iIDF~qav~~~ 175 (197)
T cd05146 161 GKVWFIDVSQSVEPT 175 (197)
T ss_pred CcEEEEECCCceeCC
Confidence 679999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.8e-10 Score=96.95 Aligned_cols=173 Identities=17% Similarity=0.278 Sum_probs=124.6
Q ss_pred EEEEEeccCCCc-hhHHHH---hC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeec
Q 021227 23 VHIVMELCEGGE-LFDRIV---KK---GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDF 95 (315)
Q Consensus 23 ~~lv~E~~~gg~-L~~~l~---~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Df 95 (315)
..+.|+.++|-. ...++. ++ ..+.+..+..+++.++.+++-||++|.+-||++++|+| +++.+.|.|+|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~l---Vsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFL---VSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCcccee---eecCceEEEEcc
Confidence 778899888753 222221 11 24678889999999999999999999999999999999 667888999985
Q ss_pred cCcccCCCCCcccccccCccccchhhhh-h-----cCCCchhHHHHHHHHHHHHhC-CCCCCCC-------CHHHHHHHH
Q 021227 96 GLSVFYKPDEVFSDVVGSPYYVAPEVLR-K-----HYGPEADVWSAGVILYILLSG-VPPFWAE-------TEIGIFRQI 161 (315)
Q Consensus 96 g~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DiwslG~il~~ll~g-~~pf~~~-------~~~~~~~~i 161 (315)
..-....++......+|.+.|.+||.-+ + .-+...|-+.||+++|+++.| ..||.|- ++.+ ..|
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~I 239 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDI 239 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhh
Confidence 4332223444556678999999999754 2 246789999999999999886 9999762 2222 133
Q ss_pred HhCCCCC------------CCCCCCCCCHHHHHHHHHhcccC--CCCCCCHHH
Q 021227 162 LEGKIDF------------ESEPWPNISESAKDLIRKMLDQN--PKRRLTAHE 200 (315)
Q Consensus 162 ~~~~~~~------------~~~~~~~~s~~~~~li~~~l~~~--p~~R~s~~~ 200 (315)
..+.+.+ ...+|.-++++++.+..+|+... +.-|||++.
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 3332221 22335568899999999998754 347999753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.8e-08 Score=89.41 Aligned_cols=169 Identities=15% Similarity=0.225 Sum_probs=125.5
Q ss_pred CCCCcceEEEEEE----eCCeEEEEEeccCC-CchhHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 021227 6 EHQHVVRIHDTYE----DKSCVHIVMELCEG-GELFDRIVK---------------KGNYSEREAAKLMKTIVGVVECCH 65 (315)
Q Consensus 6 ~Hpniv~~~~~~~----~~~~~~lv~E~~~g-g~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH 65 (315)
.|+|||++.++|. .+..+++|++|.++ ++|.++.-. ....+|..+|.++.|+..||.++|
T Consensus 331 ~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH 410 (655)
T KOG3741|consen 331 CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH 410 (655)
T ss_pred ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH
Confidence 7999999999997 35679999999987 578775432 124788999999999999999999
Q ss_pred HCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhC
Q 021227 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSG 145 (315)
Q Consensus 66 ~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g 145 (315)
+.|+.-+-|.|.+|+ +.++.+++|..-|......+.. + +.+. --++-|.-.||.++.-|.||
T Consensus 411 ssGLAck~L~~~kIl---v~G~~RIriS~C~i~Dvl~~d~------~-------~~le--~~Qq~D~~~lG~ll~aLAt~ 472 (655)
T KOG3741|consen 411 SSGLACKTLDLKKIL---VTGKMRIRISGCGIMDVLQEDP------T-------EPLE--SQQQNDLRDLGLLLLALATG 472 (655)
T ss_pred hcCceeecccHhHeE---eeCcceEEEecccceeeecCCC------C-------cchh--HHhhhhHHHHHHHHHHHhhc
Confidence 999999999999999 5556688888777655443332 0 1111 12356888999999999999
Q ss_pred CCCCCCC-CHHHH-HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 146 VPPFWAE-TEIGI-FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 146 ~~pf~~~-~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
..--+.. ...+. ++.|. +.+|.+++++|..+...++++ -++.+++.+
T Consensus 473 ~~ns~~~d~~~~s~~~~I~-----------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 473 TENSNRTDSTQSSHLTRIT-----------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ccccccccchHHHHHHHhh-----------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 6553222 22222 33332 357899999999999999987 588888754
|
|
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.9e-10 Score=78.15 Aligned_cols=65 Identities=15% Similarity=0.205 Sum_probs=59.4
Q ss_pred hhhccHHHHhcccCC-CCCCcccHHHHHHHHHH-hCCCCCH-HHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDT-DNSGTITFDELKDGLKR-VGSQLME-SEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~-~~~g~i~~~el~~~l~~-~~~~~~~-~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+.++|..+|. +++|.|+.+||+.+++. +|..+++ ++++++++.+|.+++|. +|+||+.++
T Consensus 5 ~ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~ 73 (89)
T cd05022 5 KAIETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELI 73 (89)
T ss_pred HHHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 345678999999999 99999999999999999 9988888 99999999999999987 999998764
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.3e-09 Score=84.34 Aligned_cols=74 Identities=30% Similarity=0.401 Sum_probs=58.8
Q ss_pred EEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeec
Q 021227 16 TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDF 95 (315)
Q Consensus 16 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Df 95 (315)
++.+.....|+|||.+|-.|.+.+... ...+++.+=.-+.-||..||+|+||+++||.+. ++.+.++||
T Consensus 67 ~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDf 135 (204)
T COG3642 67 YDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDF 135 (204)
T ss_pred EEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEEC
Confidence 334556667999999998888888655 255666777778889999999999999999962 344999999
Q ss_pred cCccc
Q 021227 96 GLSVF 100 (315)
Q Consensus 96 g~~~~ 100 (315)
|++..
T Consensus 136 GLg~~ 140 (204)
T COG3642 136 GLGEF 140 (204)
T ss_pred Ccccc
Confidence 99864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.7e-09 Score=89.18 Aligned_cols=89 Identities=22% Similarity=0.175 Sum_probs=69.8
Q ss_pred ceEEEEEEe-----CCeEEEEEeccCCC-chhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 11 VRIHDTYED-----KSCVHIVMELCEGG-ELFDRIVK--KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 11 v~~~~~~~~-----~~~~~lv~E~~~gg-~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
++++.+++. ....++|+|+++|. +|.+++.. ..+.++.....++.++...+.-||..||+|+|+++.|||+.
T Consensus 93 P~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~ 172 (268)
T PRK15123 93 MTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLH 172 (268)
T ss_pred CCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEe
Confidence 344455543 23578999999885 78888753 34567778889999999999999999999999999999985
Q ss_pred cC----CCCCCEEEeeccCcc
Q 021227 83 SV----DEDAALKATDFGLSV 99 (315)
Q Consensus 83 ~~----~~~~~ikl~Dfg~~~ 99 (315)
.. ++...+.++||+.+.
T Consensus 173 ~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 173 LPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred ccccCCCCCceEEEEECCccc
Confidence 31 245789999999764
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.9e-09 Score=83.24 Aligned_cols=75 Identities=27% Similarity=0.436 Sum_probs=65.3
Q ss_pred HHHHhhhh-hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 240 LRVIAERL-NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 240 ~~~i~~~l-~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+..+.... ..+..+++.++|+.+|.|++|+|+.+||..+++.+|..++++|++.+++.+|.+++|. +|++|.+++
T Consensus 78 l~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d~d~dG~i~~~eF~~~~ 154 (160)
T COG5126 78 LTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYDEDGDGEIDYEEFKKLI 154 (160)
T ss_pred HHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcCCCCCceEeHHHHHHHH
Confidence 34444434 3344678999999999999999999999999999999999999999999999999998 999998854
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.5e-09 Score=99.50 Aligned_cols=76 Identities=25% Similarity=0.310 Sum_probs=57.7
Q ss_pred CCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccC
Q 021227 20 KSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVG-VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGL 97 (315)
Q Consensus 20 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~-~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~ 97 (315)
....++||||++|++|.+..... ...+ ...++.+++. .+..+|..|++|+|++|.||++ ..++.++++|||+
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv---~~~g~i~liDfG~ 303 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFV---LKDGKIIALDFGI 303 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEE---CCCCcEEEEeCCC
Confidence 34568999999999998876432 2222 2345555555 4788999999999999999995 5678999999998
Q ss_pred cccC
Q 021227 98 SVFY 101 (315)
Q Consensus 98 ~~~~ 101 (315)
+..+
T Consensus 304 ~~~l 307 (437)
T TIGR01982 304 VGRL 307 (437)
T ss_pred eeEC
Confidence 7654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.6e-09 Score=82.43 Aligned_cols=85 Identities=26% Similarity=0.325 Sum_probs=67.3
Q ss_pred EEEeCCeEEEEEeccCC-CchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEE
Q 021227 16 TYEDKSCVHIVMELCEG-GELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKA 92 (315)
Q Consensus 16 ~~~~~~~~~lv~E~~~g-g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl 92 (315)
+|.|...-.|+|||.+| .++.+++.... +...+....+++++=+.+.-||..+|+||||..+||++.+.+....+.+
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEE
Confidence 56667777799999988 46778876642 2333334789999999999999999999999999999866555566699
Q ss_pred eeccCccc
Q 021227 93 TDFGLSVF 100 (315)
Q Consensus 93 ~Dfg~~~~ 100 (315)
+|||++..
T Consensus 158 Idfgls~~ 165 (229)
T KOG3087|consen 158 IDFGLSSV 165 (229)
T ss_pred Eeecchhc
Confidence 99998754
|
|
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.2e-09 Score=74.58 Aligned_cols=64 Identities=9% Similarity=0.172 Sum_probs=58.3
Q ss_pred hhccHHHHhcccC-CCCCC-cccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMID-TDNSG-TITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d-~~~~g-~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+..+.++|..+| .+++| .|+.+|++.+|+. +|...++++++++++.+|.+++|. +|++|+.+.
T Consensus 6 ~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li 77 (88)
T cd05027 6 AMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFV 77 (88)
T ss_pred HHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3556899999998 79999 5999999999999 899999999999999999999987 999999764
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.7e-09 Score=70.39 Aligned_cols=60 Identities=28% Similarity=0.431 Sum_probs=52.5
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCC----HHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLM----ESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~----~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++|..+|+|++|.|+.+|+..+++.++.... ++.++.+++.+|.+++|. +++||++++
T Consensus 2 l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 66 (66)
T PF13499_consen 2 LKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM 66 (66)
T ss_dssp HHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred HHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence 689999999999999999999999999996654 455555699999999998 999999763
|
... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=2e-08 Score=82.88 Aligned_cols=91 Identities=19% Similarity=0.264 Sum_probs=73.0
Q ss_pred cceEEEEEEeC----CeEEEEEeccCCC-chhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 10 VVRIHDTYEDK----SCVHIVMELCEGG-ELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 10 iv~~~~~~~~~----~~~~lv~E~~~gg-~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
..+.+.+.+.. ...++|+|+++|. +|.+++......+......++.++...++-||..||+|+|+++.|||+...
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~ 154 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPD 154 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCC
Confidence 34555555543 2468999999984 788888765557788889999999999999999999999999999997554
Q ss_pred CCCCCEEEeeccCccc
Q 021227 85 DEDAALKATDFGLSVF 100 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~ 100 (315)
+....+.++||+-+..
T Consensus 155 ~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 155 DGQYRFYLIDLDRMRF 170 (206)
T ss_pred CCceeEEEEcchhcee
Confidence 4456899999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.3e-09 Score=84.64 Aligned_cols=77 Identities=23% Similarity=0.298 Sum_probs=57.4
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----ccccCCCCceeeccC
Q 021227 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV-----FHRDLKPENFLFLSV 84 (315)
Q Consensus 10 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i-----vH~dikp~nil~~~~ 84 (315)
+.+++.... ...++||||++|.++.+. .......+.+++.+|+.||+.++ +|||++|.||++.
T Consensus 55 ~P~~~~~~~--~~~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-- 122 (170)
T cd05151 55 GPKLYYFDP--ETGVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-- 122 (170)
T ss_pred CCceEEEeC--CCCeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--
Confidence 345555543 335799999999887542 11123456899999999999985 9999999999963
Q ss_pred CCCCCEEEeeccCccc
Q 021227 85 DEDAALKATDFGLSVF 100 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~ 100 (315)
++.++++|||.+..
T Consensus 123 --~~~~~liDf~~a~~ 136 (170)
T cd05151 123 --DGRLWLIDWEYAGM 136 (170)
T ss_pred --CCeEEEEecccccC
Confidence 45799999997753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=98.83 E-value=9.7e-09 Score=73.81 Aligned_cols=66 Identities=15% Similarity=0.217 Sum_probs=59.7
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++.+++..+.++|..+|.+++|.|+.+|++.+++..| +++++++.+++.+|.+++|. +|++|+.+.
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~--~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~ 70 (96)
T smart00027 4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLADIDNDGELDKDEFALAM 70 (96)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCCcCHHHHHHHH
Confidence 4567888999999999999999999999999999875 68899999999999998877 999999764
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1e-08 Score=80.29 Aligned_cols=64 Identities=27% Similarity=0.406 Sum_probs=60.6
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+++++|+.+|.|++|.||.+||+.+|+.+|.+.+.++++.+++++|.+++|. +|++|+.++
T Consensus 83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d~d~dg~i~f~ef~~~m 147 (151)
T KOG0027|consen 83 SSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVDVDGDGKVNFEEFVKMM 147 (151)
T ss_pred cHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcCCCCCCeEeHHHHHHHH
Confidence 3558999999999999999999999999999999999999999999999999998 999999875
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.2e-08 Score=79.96 Aligned_cols=67 Identities=30% Similarity=0.480 Sum_probs=63.0
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++...++++|..+|.+++|.|+..|+..+++.+|..+++.++..+++++|.+++|. ++++|+.++
T Consensus 3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~ 70 (151)
T KOG0027|consen 3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLDGDGTIDFEEFLDLM 70 (151)
T ss_pred CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 4567788999999999999999999999999999999999999999999999999987 999999875
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.7e-09 Score=99.29 Aligned_cols=88 Identities=25% Similarity=0.330 Sum_probs=58.9
Q ss_pred CCcceEEEEEEe-CCeEEEEEeccCCCchhHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 8 QHVVRIHDTYED-KSCVHIVMELCEGGELFDR--IVKKG----NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 8 pniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~--l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+.+.+-++|.+ ...-++||||++|+++.+. +...+ .+.+..+..++.|++ ..|++|+|++|.||+
T Consensus 220 ~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIl 292 (537)
T PRK04750 220 SDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIF 292 (537)
T ss_pred CCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeE
Confidence 333444444432 4456799999999999764 33333 244555555666655 599999999999999
Q ss_pred eccCC-CCCCEEEeeccCcccCC
Q 021227 81 FLSVD-EDAALKATDFGLSVFYK 102 (315)
Q Consensus 81 ~~~~~-~~~~ikl~Dfg~~~~~~ 102 (315)
+...+ ..+.++++|||++..+.
T Consensus 293 v~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 293 VSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred EecCCCCCCeEEEEecceEEECC
Confidence 64221 12489999999887654
|
|
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.2e-08 Score=69.51 Aligned_cols=65 Identities=25% Similarity=0.452 Sum_probs=57.2
Q ss_pred hhhccHHHHhcccCC-CC-CCcccHHHHHHHHHH---hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDT-DN-SGTITFDELKDGLKR---VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~-~~-~g~i~~~el~~~l~~---~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+.+..+-++|..+|. |+ +|.|+.+||+.+++. +|.++++++++++++.+|.+++|. +|+||+.++
T Consensus 7 ~~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm 77 (88)
T cd05029 7 QAIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFL 77 (88)
T ss_pred HHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHH
Confidence 345667899999997 67 899999999999974 699999999999999999999887 999998764
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.6e-08 Score=76.98 Aligned_cols=71 Identities=28% Similarity=0.420 Sum_probs=64.7
Q ss_pred hhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCCCHHHHhhcc
Q 021227 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCNLS 314 (315)
Q Consensus 244 ~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~~~~~f~~~~ 314 (315)
...+..+++.+++++|..+|.|++|.|+.+||..+++.+|...++.++.+++..+|..+..+||++|+.++
T Consensus 11 ~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~~~~~idf~~Fl~~m 81 (160)
T COG5126 11 FTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDAGNETVDFPEFLTVM 81 (160)
T ss_pred cccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccCCCCccCHHHHHHHH
Confidence 45678899999999999999999999999999999999999999999999999999933445999999875
|
|
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=98.72 E-value=3e-08 Score=70.92 Aligned_cols=63 Identities=16% Similarity=0.218 Sum_probs=56.0
Q ss_pred hccHHHHhcccCC-CC-CCcccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDT-DN-SGTITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~-~~-~g~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+.++|..+|. |+ +|.|+.+|++.+++. +|..+++++++.+++.+|.+++|. +|++|++++
T Consensus 7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~ 77 (94)
T cd05031 7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLV 77 (94)
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 4568999999997 97 699999999999986 567889999999999999999877 999999764
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.6e-08 Score=70.18 Aligned_cols=64 Identities=17% Similarity=0.241 Sum_probs=54.7
Q ss_pred hhccHHHHhcccC-CCCCC-cccHHHHHHHHHH-h----CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMID-TDNSG-TITFDELKDGLKR-V----GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d-~~~~g-~i~~~el~~~l~~-~----~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+..+.++|..+| .|++| .|+.+||+.+++. + +.+.++.+++++++++|.+++|. ||+||+.++
T Consensus 8 a~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~ 79 (93)
T cd05026 8 AMDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLV 79 (93)
T ss_pred HHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4556888999999 78998 5999999999976 3 34558889999999999999887 999999874
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.3e-08 Score=73.28 Aligned_cols=65 Identities=18% Similarity=0.369 Sum_probs=60.9
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....++...|+.+|.|.+|+||..+|+.+.+.||..++++|+.++++++|.+++|- +-++|+.++
T Consensus 103 dt~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~d~dgevneeEF~~im 168 (172)
T KOG0028|consen 103 DTKEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADRDGDGEVNEEEFIRIM 168 (172)
T ss_pred CcHHHHHHHHHcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhcccccccccHHHHHHHH
Confidence 45667899999999999999999999999999999999999999999999999876 999998875
|
|
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.6e-08 Score=68.86 Aligned_cols=63 Identities=16% Similarity=0.230 Sum_probs=54.9
Q ss_pred hccHHHHhcccC-CCCCC-cccHHHHHHHHHH-hC----CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMID-TDNSG-TITFDELKDGLKR-VG----SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d-~~~~g-~i~~~el~~~l~~-~~----~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+..+.++|..+| .+++| .|+.+|++.+++. +| ...++++++++++.+|.+++|. +|++|+.++
T Consensus 8 ~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~ 78 (92)
T cd05025 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLV 78 (92)
T ss_pred HHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHH
Confidence 356899999997 99999 5999999999986 54 3568999999999999999876 999999865
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2e-07 Score=91.33 Aligned_cols=192 Identities=20% Similarity=0.212 Sum_probs=139.0
Q ss_pred CCCCCcceEEEEEEeCCeEE----EEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 5 SEHQHVVRIHDTYEDKSCVH----IVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~----lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
..|+|++.++.+.-.+.... +..|+|++-++...+...+..+...++.+..++++||.|+|+....|.-+......
T Consensus 239 ~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~ 318 (1351)
T KOG1035|consen 239 IAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSK 318 (1351)
T ss_pred hccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEeccccc
Confidence 47999999999886554333 45689999999998888899999999999999999999999997777766655333
Q ss_pred eccCCCCCCEEEe--eccCcccCCCCCcccccccCccccchhhhhhcC---CCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 81 FLSVDEDAALKAT--DFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHY---GPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 81 ~~~~~~~~~ikl~--Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
-...+..+.+..+ ||+................+..+-+||...... +...|+|.+|.....+..|..+-....
T Consensus 319 ~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~-- 396 (1351)
T KOG1035|consen 319 ESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA-- 396 (1351)
T ss_pred ccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc--
Confidence 2224556666666 888776665544434444566677888775432 334699999999999988876532211
Q ss_pred HHHHHHHhCCCCCCCCCCCCCC-HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 156 GIFRQILEGKIDFESEPWPNIS-ESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s-~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
..... .+..+ ....+.+.+|+.-++++|+++.+++.|+|....
T Consensus 397 -~~~~~-----------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 397 -VPVSL-----------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred -chhhh-----------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 10000 11112 278889999999999999999999999998654
|
|
| >PF14658 EF-hand_9: EF-hand domain | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.7e-08 Score=62.02 Aligned_cols=58 Identities=22% Similarity=0.335 Sum_probs=54.4
Q ss_pred HHhcccCCCCCCcccHHHHHHHHHHhCC-CCCHHHHHHHHHHHhccCC-CC-CHHHHhhcc
Q 021227 257 ELFKMIDTDNSGTITFDELKDGLKRVGS-QLMESEIKDLMDAVRKIFS-RF-SIKTYCNLS 314 (315)
Q Consensus 257 ~~F~~~d~~~~g~i~~~el~~~l~~~~~-~~~~~ei~~~~~~~d~~~~-~~-~~~~f~~~~ 314 (315)
.+|..+|+++.|.+...+++..|+.++. .+++++++++..++|.++. +. ++++|+++|
T Consensus 2 ~~F~~fD~~~tG~V~v~~l~~~Lra~~~~~p~e~~Lq~l~~elDP~g~~~~v~~d~F~~iM 62 (66)
T PF14658_consen 2 TAFDAFDTQKTGRVPVSDLITYLRAVTGRSPEESELQDLINELDPEGRDGSVNFDTFLAIM 62 (66)
T ss_pred cchhhcCCcCCceEeHHHHHHHHHHHcCCCCcHHHHHHHHHHhCCCCCCceEeHHHHHHHH
Confidence 3699999999999999999999999998 8999999999999999987 66 999999987
|
|
| >cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif | Back alignment and domain information |
|---|
Probab=98.62 E-value=7.7e-08 Score=67.94 Aligned_cols=66 Identities=15% Similarity=0.196 Sum_probs=57.2
Q ss_pred hhhhccHHHHhcccCC--CCCCcccHHHHHHHHHH-hCCC----CCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDT--DNSGTITFDELKDGLKR-VGSQ----LMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~--~~~g~i~~~el~~~l~~-~~~~----~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++..+.++|..+|. +++|.|+.+|+..+++. +|.. .+++++..+++.+|.+++|. +|++|+++.
T Consensus 4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~~~g~I~f~eF~~~~ 77 (88)
T cd00213 4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVNKDGKVDFQEFLVLI 77 (88)
T ss_pred HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHH
Confidence 4567789999999999 89999999999999986 5644 45999999999999998776 999998863
|
Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th |
| >cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.6e-07 Score=62.54 Aligned_cols=57 Identities=19% Similarity=0.240 Sum_probs=51.6
Q ss_pred HHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 256 KELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 256 ~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++|..+|.+++|.|+.+|++.+++.+|. ++++++.+++.+|.+++|. ++++|+.+.
T Consensus 2 ~~~F~~~D~~~~G~i~~~el~~~l~~~g~--~~~~~~~i~~~~d~~~~g~i~~~ef~~~~ 59 (67)
T cd00052 2 DQIFRSLDPDGDGLISGDEARPFLGKSGL--PRSVLAQIWDLADTDKDGKLDKEEFAIAM 59 (67)
T ss_pred hHHHHHhCCCCCCcCcHHHHHHHHHHcCC--CHHHHHHHHHHhcCCCCCcCCHHHHHHHH
Confidence 56899999999999999999999999874 8899999999999998876 999998764
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. |
| >cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11 | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.8e-07 Score=64.80 Aligned_cols=65 Identities=14% Similarity=0.142 Sum_probs=55.6
Q ss_pred hhhccHHHHhcc-cCCCCCC-cccHHHHHHHHHHh-----CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKM-IDTDNSG-TITFDELKDGLKRV-----GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~-~d~~~~g-~i~~~el~~~l~~~-----~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+..+|.. +|.+++| .|+.+||+.++... +.+.++.+++++++.+|.+++|. +|+||+.+.
T Consensus 6 ~~i~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~~l~ 78 (89)
T cd05023 6 RCIESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFLNLI 78 (89)
T ss_pred HHHHHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHH
Confidence 345568899999 8888886 99999999999876 44567899999999999999987 999998764
|
S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.1e-07 Score=76.71 Aligned_cols=84 Identities=27% Similarity=0.285 Sum_probs=52.7
Q ss_pred CcceEEEEEEeCCeEEEEEeccC--CCchhHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCCccccCCCCceeeccCC
Q 021227 9 HVVRIHDTYEDKSCVHIVMELCE--GGELFDRIVKKGNYSEREAAKLMKTIVGVVEC-CHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 9 niv~~~~~~~~~~~~~lv~E~~~--gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~-lH~~~ivH~dikp~nil~~~~~ 85 (315)
++.+++++. .-+|||||+. |..+.. +... .++......++.+++..+.. +|+.||+|||+.+.||++.
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~--- 141 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD--- 141 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---
Confidence 456666553 2359999998 655543 3222 22245667788888885555 5799999999999999963
Q ss_pred CCCCEEEeeccCcccCC
Q 021227 86 EDAALKATDFGLSVFYK 102 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~ 102 (315)
++ .+.++|||.+....
T Consensus 142 ~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 142 DG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TT-CEEE--GTTEEETT
T ss_pred cc-eEEEEecCcceecC
Confidence 33 89999999776543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.6e-07 Score=74.12 Aligned_cols=66 Identities=32% Similarity=0.452 Sum_probs=51.0
Q ss_pred CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCc
Q 021227 21 SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS 98 (315)
Q Consensus 21 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~ 98 (315)
..+++||||++|-.|.+.. .+++ .+...+.+++.-+|+.|++|+|.+|.|+++ . ++.++++||+..
T Consensus 116 ~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv---~-~~~i~iID~~~k 181 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV---S-NNGIRIIDTQGK 181 (229)
T ss_pred eEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE---E-CCcEEEEECccc
Confidence 4567899999998886543 2333 244567788999999999999999999995 3 345999999754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.4e-07 Score=58.12 Aligned_cols=49 Identities=22% Similarity=0.419 Sum_probs=45.9
Q ss_pred CCCcccHHHHHHHHHHhCCC-CCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 266 NSGTITFDELKDGLKRVGSQ-LMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 266 ~~g~i~~~el~~~l~~~~~~-~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+|.|+.++|+.+++.+|.+ ++++++..++..+|.+++|. +++||++++
T Consensus 1 ~~G~i~~~~~~~~l~~~g~~~~s~~e~~~l~~~~D~~~~G~I~~~EF~~~~ 51 (54)
T PF13833_consen 1 KDGKITREEFRRALSKLGIKDLSEEEVDRLFREFDTDGDGYISFDEFISMM 51 (54)
T ss_dssp SSSEEEHHHHHHHHHHTTSSSSCHHHHHHHHHHHTTSSSSSEEHHHHHHHH
T ss_pred CcCEECHHHHHHHHHHhCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Confidence 47999999999999889999 99999999999999999998 999999864
|
... |
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.6e-07 Score=67.85 Aligned_cols=70 Identities=29% Similarity=0.413 Sum_probs=64.5
Q ss_pred hhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+.+++...+++.|..+|.+++|+|..+||..+++.+|-....+||..++..+|+++.|+ .|++|..+|
T Consensus 25 ~~l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~k~ei~kll~d~dk~~~g~i~fe~f~~~m 95 (172)
T KOG0028|consen 25 SELTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPKKEEILKLLADVDKEGSGKITFEDFRRVM 95 (172)
T ss_pred ccccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcchHHHHHHHHhhhhccCceechHHHHHHH
Confidence 3456777889999999999999999999999999999999999999999999999999998 999998765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.9e-07 Score=73.99 Aligned_cols=91 Identities=26% Similarity=0.382 Sum_probs=66.8
Q ss_pred CCcceEEEEEEeC---CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------
Q 021227 8 QHVVRIHDTYEDK---SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS------------------ 66 (315)
Q Consensus 8 pniv~~~~~~~~~---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~------------------ 66 (315)
.++.+++.+.... +..++||||++|+++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~ 135 (223)
T cd05154 57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYL 135 (223)
T ss_pred CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchH
Confidence 4567777776654 367899999999888765432 456777777888888888888873
Q ss_pred --------------------------------------CCCccccCCCCceeeccCCCCCCEEEeeccCccc
Q 021227 67 --------------------------------------LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVF 100 (315)
Q Consensus 67 --------------------------------------~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~ 100 (315)
..++|+|++|.||++... ..+.+.++||+.+..
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 136 ERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236899999999996321 146689999997653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.9e-07 Score=69.16 Aligned_cols=69 Identities=30% Similarity=0.504 Sum_probs=59.6
Q ss_pred hhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
..++.++...+.+.|..+|.+++|.|+.+|+..++..+|...+++++..+++.+|.+++|. ++++|++.
T Consensus 3 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~ 72 (149)
T PTZ00184 3 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTL 72 (149)
T ss_pred CccCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHhcCcCCCCcCcHHHHHHH
Confidence 3456677788899999999999999999999999988888888889999999999988876 99999864
|
|
| >KOG0041 consensus Predicted Ca2+-binding protein, EF-Hand protein superfamily [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=7.4e-07 Score=69.98 Aligned_cols=67 Identities=22% Similarity=0.404 Sum_probs=62.5
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhh
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCN 312 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~ 312 (315)
.++..++.....+|+.+|.+.||+|++.||+.+|.++|.+.|.--++.+|+++|.+.+|. +|-+|+=
T Consensus 92 eFsrkqIk~~~~~Fk~yDe~rDgfIdl~ELK~mmEKLgapQTHL~lK~mikeVded~dgklSfreflL 159 (244)
T KOG0041|consen 92 EFSRKQIKDAESMFKQYDEDRDGFIDLMELKRMMEKLGAPQTHLGLKNMIKEVDEDFDGKLSFREFLL 159 (244)
T ss_pred HHHHHHHHHHHHHHHHhcccccccccHHHHHHHHHHhCCchhhHHHHHHHHHhhcccccchhHHHHHH
Confidence 456778888999999999999999999999999999999999999999999999999988 9999974
|
|
| >cd00051 EFh EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.8e-06 Score=55.97 Aligned_cols=60 Identities=37% Similarity=0.562 Sum_probs=55.4
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+..+|..+|.+++|.|+.+|+..+++.++.+.+++++..+++.+|.++++. ++++|..+.
T Consensus 2 ~~~~f~~~d~~~~g~l~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ef~~~~ 62 (63)
T cd00051 2 LREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREVDKDGDGKIDFEEFLELM 62 (63)
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHh
Confidence 567899999999999999999999999999999999999999999988876 999998753
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.8e-08 Score=91.52 Aligned_cols=195 Identities=19% Similarity=0.229 Sum_probs=135.1
Q ss_pred CCCCC-cceEEEEEEeCCeEEEEEeccCCC-chhHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 5 SEHQH-VVRIHDTYEDKSCVHIVMELCEGG-ELFDRI-VKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 5 ~~Hpn-iv~~~~~~~~~~~~~lv~E~~~gg-~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+||| .+..++-++.+....+++++|++| +..... ...-.+.+.+.....+.-+.+++++|+.-=+|+| ||+.
T Consensus 290 ~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~ 365 (829)
T KOG0576|consen 290 VNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG 365 (829)
T ss_pred ccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc
Confidence 48999 777777778888899999999987 222111 1112344556667778888899999998778998 7773
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
.++..|..+|+....+.......+..+++.++|||+.. +.+....|.||+|+=..++.-|-+|-.... ...-.
T Consensus 366 ----s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~ 439 (829)
T KOG0576|consen 366 ----SEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPM 439 (829)
T ss_pred ----cccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCC
Confidence 45788999999988777665567788999999999876 558889999999987667777766643311 11100
Q ss_pred HHhCC--CCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 161 ILEGK--IDFES-EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 161 i~~~~--~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
+-.+. ..... ..|.. ..-+++...|+...|..|+....++.|.+|....
T Consensus 440 ~g~~p~s~~L~~~~aw~~--~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 440 IGNGPNSPMLTDKSAWSP--VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred CCCCCCccccchhhhcCc--ccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 10010 00000 11211 1122588899999999999999999999997654
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=98.28 E-value=2e-06 Score=67.65 Aligned_cols=67 Identities=31% Similarity=0.466 Sum_probs=47.3
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
++.+++..+..+|..+|.+++|.|+.+|+..+++.+|...+..++..++..+|.+++|. ++++|.++
T Consensus 11 ~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~ 78 (158)
T PTZ00183 11 LTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKIDFEEFLDI 78 (158)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHH
Confidence 44556666777777777777777777777777777776667777777777777777665 77777653
|
|
| >PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.2e-06 Score=47.46 Aligned_cols=29 Identities=41% Similarity=0.768 Sum_probs=26.2
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
+++++|+.+|.|+||.|+++|+..+++.+
T Consensus 1 E~~~~F~~~D~d~dG~I~~~Ef~~~~~~L 29 (29)
T PF00036_consen 1 ELKEAFREFDKDGDGKIDFEEFKEMMKKL 29 (29)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHT
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHhC
Confidence 36889999999999999999999998864
|
This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D .... |
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.4e-06 Score=63.54 Aligned_cols=67 Identities=19% Similarity=0.428 Sum_probs=59.4
Q ss_pred hhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCCCHHHHhhc
Q 021227 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCNL 313 (315)
Q Consensus 244 ~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~~~~~f~~~ 313 (315)
...+.+.++.+++++|..+|.|+||.|..++|+..+..+|...++++++.+++++- .+++|.-|+.+
T Consensus 23 Famf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~~~d~elDaM~~Ea~---gPINft~FLTm 89 (171)
T KOG0031|consen 23 FAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKIASDEELDAMMKEAP---GPINFTVFLTM 89 (171)
T ss_pred HHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHhCC---CCeeHHHHHHH
Confidence 34567889999999999999999999999999999999999999999999998853 46688888765
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=4e-06 Score=65.93 Aligned_cols=62 Identities=19% Similarity=0.416 Sum_probs=57.7
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++.+|+.+|.+++|.|+.+|+..++..+|..+++.++..++..+|.+++|. ++++|.+++
T Consensus 90 ~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~l~~~~~~~~~~~~d~~~~g~i~~~ef~~~~ 152 (158)
T PTZ00183 90 EEILKAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMIDEADRNGDGEISEEEFYRIM 152 (158)
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 45789999999999999999999999999999999999999999999998886 999998764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.18 E-value=9.3e-06 Score=66.26 Aligned_cols=78 Identities=17% Similarity=0.118 Sum_probs=62.0
Q ss_pred eEEEEEeccCC-CchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCc
Q 021227 22 CVHIVMELCEG-GELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS 98 (315)
Q Consensus 22 ~~~lv~E~~~g-g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~ 98 (315)
..+||+|-+.| -+|.+++.+. .+.++.....++.++..+++-||+.|+.|+|+.+.||++.. ++...++++||.-+
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~ 177 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKS 177 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecC-CCCeeEEEEEhhcc
Confidence 46799998865 4787777553 35678888999999999999999999999999999999642 12335999999865
Q ss_pred cc
Q 021227 99 VF 100 (315)
Q Consensus 99 ~~ 100 (315)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 43
|
|
| >cd00252 SPARC_EC SPARC_EC; extracellular Ca2+ binding domain (containing 2 EF-hand motifs) of SPARC and related proteins (QR1, SC1/hevin, testican and tsc-36/FRP) | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.2e-06 Score=61.27 Aligned_cols=61 Identities=16% Similarity=0.164 Sum_probs=52.9
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
......+...|..+|.|+||.|+.+||..+. ....+..+..+++.+|.|++|. +++||+..
T Consensus 44 ~~~~~~l~w~F~~lD~d~DG~Ls~~EL~~~~----l~~~e~~~~~f~~~~D~n~Dg~IS~~Ef~~c 105 (116)
T cd00252 44 PMCKDPVGWMFNQLDGNYDGKLSHHELAPIR----LDPNEHCIKPFFESCDLDKDGSISLDEWCYC 105 (116)
T ss_pred HHHHHHHHHHHHHHCCCCCCcCCHHHHHHHH----ccchHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 4556778999999999999999999999765 3445888999999999999988 99999863
|
SPARC (BM-40) is a multifunctional glycoprotein, a matricellular protein, that functions to regulate cell-matrix interactions; binds to such proteins as collagen and vitronectin and binds to endothelial cells thus inhibiting cellular proliferation. The EC domain interacts with a follistatin-like (FS) domain which appears to stabilize Ca2+ binding. The two EF-hands interact canonically but their conserved disulfide bonds confer a tight association between the EF-hand pair and an acid/amphiphilic N-terminal helix. Proposed active form involves a Ca2+ dependent symmetric homodimerization of EC-FS modules. |
| >cd05030 calgranulins Calgranulins: S-100 domain found in proteins belonging to the Calgranulin subgroup of the S100 family of EF-hand calcium-modulated proteins, including S100A8, S100A9, and S100A12 | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.4e-06 Score=58.32 Aligned_cols=65 Identities=14% Similarity=0.209 Sum_probs=54.7
Q ss_pred hhhccHHHHhcccCCC--CCCcccHHHHHHHHH-HhCCCCC----HHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTD--NSGTITFDELKDGLK-RVGSQLM----ESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~--~~g~i~~~el~~~l~-~~~~~~~----~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+..+|..++.. .+|.|+.+|++.+++ .+|..++ +++++.+++.+|.+++|. +|++|+.++
T Consensus 5 ~~i~~~~~~f~~y~~~~~~~~~Is~~El~~ll~~~~g~~~t~~~~~~~v~~i~~~~D~d~dG~I~f~eF~~~~ 77 (88)
T cd05030 5 KAIETIINVFHQYSVRKGHPDTLYKKEFKQLVEKELPNFLKKEKNQKAIDKIFEDLDTNQDGQLSFEEFLVLV 77 (88)
T ss_pred HHHHHHHHHHHHHhccCCCcccCCHHHHHHHHHHHhhHhhccCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHH
Confidence 3455678889999866 579999999999997 5666666 999999999999999887 999999764
|
Note that the S-100 hierarchy, to which this Calgranulin group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. These proteins are expressed mainly in granulocytes, and are involved in inflammation, allergy, and neuritogenesis, as well as in host-parasite response. Calgranulins are modulated not only by calcium, but also by other metals such as zinc and copper. Structural data suggested that calgranulins may exist in multiple structural forms, homodimers, as well as hetero-oligomers. For example, the S100A8/S100A9 complex called calprotectin plays important roles in the regulation of inflammatory processes, wound repair, and regulating zinc-dependent enzymes as well as microbial growth. |
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.7e-05 Score=59.92 Aligned_cols=75 Identities=21% Similarity=0.335 Sum_probs=63.6
Q ss_pred HHHHHhhhhh-hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 239 ALRVIAERLN-EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 239 ~~~~i~~~l~-~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+..+.++++ ..-.+.+..+|+.||.+++|.|.-+.++++|...|..++++||+++++..-.+..|. ||..|+.+
T Consensus 86 FLTmfGekL~gtdpe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt~gDr~~~eEV~~m~r~~p~d~~G~~dy~~~~~~ 162 (171)
T KOG0031|consen 86 FLTMFGEKLNGTDPEEVILNAFKTFDDEGSGKIDEDYLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFDYKAFTYI 162 (171)
T ss_pred HHHHHHHHhcCCCHHHHHHHHHHhcCccCCCccCHHHHHHHHHHhcccCCHHHHHHHHHhCCcccCCceeHHHHHHH
Confidence 3555566663 334557899999999999999999999999999999999999999999999876665 99999865
|
|
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.8e-06 Score=61.70 Aligned_cols=66 Identities=17% Similarity=0.378 Sum_probs=58.4
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccC---CCCCHHHHhhc
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIF---SRFSIKTYCNL 313 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~---~~~~~~~f~~~ 313 (315)
.+++..+++++|..||..+||+|+..+...+|+.+|.++++.|+..-..+.+... ..++|++|+-+
T Consensus 6 ~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~nPT~aeV~k~l~~~~~~~~~~~rl~FE~fLpm 74 (152)
T KOG0030|consen 6 TPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQNPTNAEVLKVLGQPKRREMNVKRLDFEEFLPM 74 (152)
T ss_pred CcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCCCcHHHHHHHHcCcccchhhhhhhhHHHHHHH
Confidence 4566788999999999999999999999999999999999999999999888773 34499999854
|
|
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.2e-05 Score=62.40 Aligned_cols=61 Identities=21% Similarity=0.409 Sum_probs=56.7
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+..+|..+|.+++|.|+.+|+..+++..|..++++++..++..+|.+++|. ++++|..++
T Consensus 85 ~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~ 146 (149)
T PTZ00184 85 EIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMIREADVDGDGQINYEEFVKMM 146 (149)
T ss_pred HHHHHHHhhCCCCCCeEeHHHHHHHHHHHCCCCCHHHHHHHHHhcCCCCCCcCcHHHHHHHH
Confidence 4688999999999999999999999999999999999999999999998887 999998764
|
|
| >KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.1e-05 Score=63.16 Aligned_cols=60 Identities=23% Similarity=0.377 Sum_probs=54.2
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCC-CCCHHHHhhc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFS-RFSIKTYCNL 313 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~-~~~~~~f~~~ 313 (315)
..+++|+.+|.|++|.|+..||+++|..+|..++.+-++-+++++|.-++ .++|++|.+.
T Consensus 125 ~Wr~vF~~~D~D~SG~I~~sEL~~Al~~~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~FI~c 185 (221)
T KOG0037|consen 125 QWRNVFRTYDRDRSGTIDSSELRQALTQLGYRLSPQFYNLLVRKYDRFGGGRIDFDDFIQC 185 (221)
T ss_pred HHHHHHHhcccCCCCcccHHHHHHHHHHcCcCCCHHHHHHHHHHhccccCCceeHHHHHHH
Confidence 46889999999999999999999999999999999999999999998844 4599988764
|
|
| >PF13405 EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J_B 1OE9_B 1W7I_B 1KFU_S 1KFX_S 2BL0_B 1Y1X_B 3MSE_B | Back alignment and domain information |
|---|
Probab=97.83 E-value=1.7e-05 Score=43.82 Aligned_cols=30 Identities=47% Similarity=0.805 Sum_probs=26.1
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHH-HhC
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLK-RVG 283 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~-~~~ 283 (315)
+++++|..+|.|++|.|+.+|+..+++ .+|
T Consensus 1 ~l~~~F~~~D~d~dG~I~~~el~~~l~~~lG 31 (31)
T PF13405_consen 1 RLREAFKMFDKDGDGFIDFEELRAILRKSLG 31 (31)
T ss_dssp HHHHHHHHH-TTSSSEEEHHHHHHHHHHHTT
T ss_pred CHHHHHHHHCCCCCCcCcHHHHHHHHHHhcC
Confidence 368899999999999999999999999 565
|
... |
| >KOG0377 consensus Protein serine/threonine phosphatase RDGC/PPEF, contains STphosphatase and EF-hand domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00011 Score=64.75 Aligned_cols=61 Identities=25% Similarity=0.448 Sum_probs=55.3
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhC----CCCCHHHHHHHHHHHhccCCCC-CHHHHhh
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVG----SQLMESEIKDLMDAVRKIFSRF-SIKTYCN 312 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~----~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~ 312 (315)
...+..+|+.+|+|++|.||.+|+.++.+.++ ..+++.++-++.+.+|.|+||. |++||+.
T Consensus 546 ks~LetiF~~iD~D~SG~isldEF~~a~~l~~sh~~~~i~~~~i~~la~~mD~NkDG~IDlNEfLe 611 (631)
T KOG0377|consen 546 KSSLETIFNIIDADNSGEISLDEFRTAWKLLSSHMNGAISDDEILELARSMDLNKDGKIDLNEFLE 611 (631)
T ss_pred hhhHHHHHHHhccCCCCceeHHHHHHHHHHHHhhcCCCcCHHHHHHHHHhhccCCCCcccHHHHHH
Confidence 34578999999999999999999999888764 6788999999999999999998 9999985
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=7.2e-05 Score=62.89 Aligned_cols=71 Identities=28% Similarity=0.396 Sum_probs=55.8
Q ss_pred CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcc
Q 021227 21 SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV 99 (315)
Q Consensus 21 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~ 99 (315)
+.-.+||||.+|-.|... +++.+.+..++..|+.-+.-.-..||||||+.+-||+ ++++|.+.++||--+.
T Consensus 180 nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIl---V~~dg~~~vIDwPQ~v 250 (304)
T COG0478 180 NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNIL---VTEDGDIVVIDWPQAV 250 (304)
T ss_pred ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEE---EecCCCEEEEeCcccc
Confidence 345699999999777432 2346667777778888777777999999999999999 6678899999996443
|
|
| >KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00026 Score=56.77 Aligned_cols=62 Identities=23% Similarity=0.330 Sum_probs=51.3
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHh-CCCCC------HHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRV-GSQLM------ESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~-~~~~~------~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+++=+|+.+|.+++|.|+.+|+.+++..+ |...+ +..++.++.++|.++||. +|+||+.+.
T Consensus 104 ~Kl~faF~vYD~~~~G~I~reel~~iv~~~~~~~~~~~~e~~~~i~d~t~~e~D~d~DG~IsfeEf~~~v 173 (187)
T KOG0034|consen 104 EKLRFAFRVYDLDGDGFISREELKQILRMMVGENDDMSDEQLEDIVDKTFEEADTDGDGKISFEEFCKVV 173 (187)
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHccCCcchHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 467779999999999999999999999886 43444 445566788999999998 999999763
|
|
| >PLN02964 phosphatidylserine decarboxylase | Back alignment and domain information |
|---|
Probab=97.71 E-value=9.3e-05 Score=70.15 Aligned_cols=65 Identities=20% Similarity=0.328 Sum_probs=58.6
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++...+.++|..+|.|++|.|+++|+..++..++...+++++.++|+.+|.+++|. +++||..++
T Consensus 176 ~e~~fi~~mf~~~D~DgdG~IdfdEFl~lL~~lg~~~seEEL~eaFk~fDkDgdG~Is~dEL~~vL 241 (644)
T PLN02964 176 TERSFARRILAIVDYDEDGQLSFSEFSDLIKAFGNLVAANKKEELFKAADLNGDGVVTIDELAALL 241 (644)
T ss_pred HHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhccCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 34445899999999999999999999999999998889999999999999999988 999998764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=5.2e-06 Score=83.80 Aligned_cols=193 Identities=20% Similarity=0.131 Sum_probs=127.8
Q ss_pred CCCCcceEEEEEE--eCCeEEEEEeccCCCchhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHC-----CCccccC
Q 021227 6 EHQHVVRIHDTYE--DKSCVHIVMELCEGGELFDRIVKK----GNYSEREAAKLMKTIVGVVECCHSL-----GVFHRDL 74 (315)
Q Consensus 6 ~Hpniv~~~~~~~--~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-----~ivH~di 74 (315)
.|+++...+.-.. ....-|.+++||.+|.+++.+.+. ..+.+..+-....+.+.+..-+|.. --+|+++
T Consensus 1287 ~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~L 1366 (2724)
T KOG1826|consen 1287 KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSL 1366 (2724)
T ss_pred hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhh
Confidence 6777766555443 234578899999999999998764 2344444555555557777777753 2789999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
|+-|.++ ..+..+|+.++|+.+...+. ......++++.|++|+..+. .++.++|+|..|+-+|.+..|..+|..
T Consensus 1367 kf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~- 1442 (2724)
T KOG1826|consen 1367 KFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF- 1442 (2724)
T ss_pred hhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH-
Confidence 9999994 45678999999999843332 23345678889999998764 477789999999999999988887632
Q ss_pred CHHHHHHHHHhCCCC----CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 153 TEIGIFRQILEGKID----FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~----~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
..+.+.++... +..+.. .|.++-.....+|-..-..||.-...+..+.|.
T Consensus 1443 ----flq~~Lkgiidn~tf~sIe~l--~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1443 ----FLQPALKGIIDNHTFFSIEKL--KPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred ----HHHHHHcCccccccccccccc--CCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 22333333221 122111 123333344444445566788877777766653
|
|
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00013 Score=54.27 Aligned_cols=64 Identities=20% Similarity=0.365 Sum_probs=53.9
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCCCHHHHhh
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCN 312 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~~~~~f~~ 312 (315)
....+..-+-.+.||++++|.|...||+-+|..+|..++++|++.++.-....+..++|+.|..
T Consensus 84 q~t~edfvegLrvFDkeg~G~i~~aeLRhvLttlGekl~eeEVe~Llag~eD~nG~i~YE~fVk 147 (152)
T KOG0030|consen 84 QGTYEDFVEGLRVFDKEGNGTIMGAELRHVLTTLGEKLTEEEVEELLAGQEDSNGCINYEAFVK 147 (152)
T ss_pred cCcHHHHHHHHHhhcccCCcceeHHHHHHHHHHHHhhccHHHHHHHHccccccCCcCcHHHHHH
Confidence 3445566778889999999999999999999999999999999999976555455569999964
|
|
| >PF13202 EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ_B 1UHI_A 1UHH_B 1EJ3_B 1UHK_A 2ZFD_A 1UHN_A | Back alignment and domain information |
|---|
Probab=97.64 E-value=4.7e-05 Score=39.62 Aligned_cols=24 Identities=42% Similarity=0.754 Sum_probs=21.5
Q ss_pred HHHHhcccCCCCCCcccHHHHHHH
Q 021227 255 LKELFKMIDTDNSGTITFDELKDG 278 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~ 278 (315)
+++.|..+|.|+||.|+.+|+..+
T Consensus 1 l~~~F~~~D~d~DG~is~~E~~~~ 24 (25)
T PF13202_consen 1 LKDAFQQFDTDGDGKISFEEFQRL 24 (25)
T ss_dssp HHHHHHHHTTTSSSEEEHHHHHHH
T ss_pred CHHHHHHHcCCCCCcCCHHHHHHH
Confidence 467899999999999999999875
|
... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00064 Score=55.46 Aligned_cols=86 Identities=23% Similarity=0.278 Sum_probs=66.2
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCC------CchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEG------GELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~g------g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
...+.+|.+++++.+++....+|+|.... -+|.+++ +.+.+++ .+.. .+-.-..||-+++|+.+|++|.
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~ 147 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPH 147 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcc
Confidence 34688999999999999999999998743 3566766 4556766 3333 3445567889999999999999
Q ss_pred ceeeccCCCCC-CEEEee
Q 021227 78 NFLFLSVDEDA-ALKATD 94 (315)
Q Consensus 78 nil~~~~~~~~-~ikl~D 94 (315)
||++...++.. .+.|+|
T Consensus 148 NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 148 NIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cEEEEecCCCceEEEEEe
Confidence 99997666555 788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0036 consensus Predicted mitochondrial carrier protein [Nucleotide transport and metabolism] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00013 Score=63.88 Aligned_cols=63 Identities=21% Similarity=0.277 Sum_probs=57.4
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...++.++|+.+|.++||.|..+|+...++.+|.++++++.+.+++.+|+++.+. +++||.+.
T Consensus 80 ~E~~l~~~F~~iD~~hdG~i~~~Ei~~~l~~~gi~l~de~~~k~~e~~d~~g~~~I~~~e~rd~ 143 (463)
T KOG0036|consen 80 KELELYRIFQSIDLEHDGKIDPNEIWRYLKDLGIQLSDEKAAKFFEHMDKDGKATIDLEEWRDH 143 (463)
T ss_pred hHHHHHHHHhhhccccCCccCHHHHHHHHHHhCCccCHHHHHHHHHHhccCCCeeeccHHHHhh
Confidence 3345789999999999999999999999999999999999999999999999877 99988654
|
|
| >cd05024 S-100A10 S-100A10: A subgroup of the S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00038 Score=48.61 Aligned_cols=61 Identities=10% Similarity=0.187 Sum_probs=48.9
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHH-h----CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKR-V----GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~-~----~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+..+..+|..+. -+.|.++..||+.++++ + ..+-+...++.+++..|.|+||. ||.||+.+
T Consensus 7 i~~lI~~FhkYa-G~~~tLsk~Elk~Ll~~Elp~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~L 73 (91)
T cd05024 7 MEKMMLTFHKFA-GEKNYLNRDDLQKLMEKEFSEFLKNQNDPMAVDKIMKDLDDCRDGKVGFQSFFSL 73 (91)
T ss_pred HHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhHHHHcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 345667777776 34569999999999964 3 34556889999999999999988 99999986
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A10 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00039 Score=64.85 Aligned_cols=81 Identities=27% Similarity=0.364 Sum_probs=57.6
Q ss_pred EeCCeEEEEEeccCCCchhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeecc
Q 021227 18 EDKSCVHIVMELCEGGELFDRIV-KKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFG 96 (315)
Q Consensus 18 ~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg 96 (315)
+-.+.-.++|||++|-.+.+... +..+++.+.+...+.++. +..+-..|++|+|.+|.||+ +..++.+.+.|||
T Consensus 236 e~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~---v~~~g~i~~lDfG 310 (517)
T COG0661 236 EYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNIL---VRSDGRIVLLDFG 310 (517)
T ss_pred hccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceE---EecCCcEEEEcCc
Confidence 44455679999999988887642 234566555444333332 34444699999999999999 5667999999999
Q ss_pred CcccCCC
Q 021227 97 LSVFYKP 103 (315)
Q Consensus 97 ~~~~~~~ 103 (315)
+...+.+
T Consensus 311 i~g~l~~ 317 (517)
T COG0661 311 IVGRLDP 317 (517)
T ss_pred ceecCCH
Confidence 8766543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 315 | ||||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-60 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-58 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-57 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-57 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-57 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-57 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-57 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-56 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-55 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-55 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-55 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-55 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-54 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-53 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-51 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-51 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-51 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-51 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-51 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-50 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-50 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-50 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-49 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-49 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-49 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-49 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-48 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-46 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-46 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-46 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-46 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-45 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-45 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-45 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-45 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-45 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-45 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-45 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-45 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-45 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-45 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-45 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-45 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-45 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-44 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-44 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-44 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-43 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-42 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-42 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-42 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-40 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-40 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-40 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-40 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-40 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-40 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-40 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-39 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-39 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-39 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-39 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-39 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-39 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-39 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-39 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-39 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-39 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-39 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-39 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-39 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-39 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-39 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-39 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-39 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-39 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-39 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-39 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-38 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-38 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-38 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-38 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-38 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-38 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-38 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-38 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-38 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-37 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-36 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-36 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-36 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-33 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-33 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-33 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-33 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-33 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-32 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-32 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-32 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-32 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-32 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-32 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-32 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-31 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-31 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-31 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-31 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-31 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-31 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-31 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-31 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-30 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-30 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-29 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-29 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-29 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-29 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-29 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-29 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-29 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-28 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-28 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-28 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-28 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-28 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-28 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-28 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-28 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-28 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-28 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-28 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-28 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-28 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-28 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-28 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-28 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-28 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-28 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-28 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-28 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-28 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-28 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-28 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-28 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-28 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-28 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-28 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-28 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-28 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-28 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-28 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-28 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-28 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-28 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-28 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-28 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-28 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-28 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-28 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-28 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-28 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-28 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-28 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-28 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-28 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-28 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-28 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-28 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-28 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-28 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-28 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-27 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-27 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-27 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-27 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-27 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-27 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-27 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-27 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-27 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-27 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-27 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-27 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-27 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-27 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-27 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-27 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-27 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-27 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-27 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-27 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-27 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-27 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-27 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-27 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-27 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-27 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-27 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-27 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-27 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-27 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-27 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-27 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-26 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-25 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-25 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-25 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-25 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-25 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-25 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-24 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-24 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-24 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-24 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-24 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-24 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-24 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-24 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-24 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-24 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-24 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-24 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-24 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-24 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-23 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-23 | ||
| 1s6j_A | 87 | N-Terminal Region Of The Ca2+-Saturated Calcium Reg | 2e-23 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-23 | ||
| 1s6i_A | 188 | Ca2+-Regulatory Region (Cld) From Soybean Calcium-D | 3e-23 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-23 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-23 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-23 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-23 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-23 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-23 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-22 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-22 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-22 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-22 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-22 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-22 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-22 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-22 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-22 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-22 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-22 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-22 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-22 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-22 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-21 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-21 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-21 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-21 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-21 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-21 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-21 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-21 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-21 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-21 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-21 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-21 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-21 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-21 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-21 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-21 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-21 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-21 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-20 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-20 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-20 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-20 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-20 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-20 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-20 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-20 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-20 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-20 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-20 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-20 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-20 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-20 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-20 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-20 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-20 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-20 | ||
| 2aao_A | 166 | Regulatory Apparatus Of Calcium Dependent Protein K | 4e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-18 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-18 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-18 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-17 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-17 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-17 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-17 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-17 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-15 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-13 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-12 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-11 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-11 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-11 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-11 | ||
| 3pm8_A | 197 | Cad Domain Of Pff0520w, Calcium Dependent Protein K | 5e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-10 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 3b32_A | 75 | Crystal Structure Of Calcium-Saturated Calmodulin N | 2e-05 | ||
| 1ak8_A | 76 | Nmr Solution Structure Of Cerium-Loaded Calmodulin | 2e-05 | ||
| 1f70_A | 76 | Refined Solution Structure Of Calmodulin N-Terminal | 2e-05 | ||
| 3uct_A | 79 | Structure Of Mn2+-Bound N-Terminal Domain Of Calmod | 3e-05 | ||
| 2lqc_A | 77 | Nmr Solution Structure Of A Ca2+-Calmodulin With A | 3e-05 | ||
| 3k21_A | 191 | Crystal Structure Of Carboxy-Terminus Of Pfc0420w L | 3e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 2llo_A | 80 | Solution Nmr-Derived Structure Of Calmodulin N-Lobe | 3e-05 | ||
| 1sw8_A | 79 | Solution Structure Of The N-Terminal Domain Of Huma | 3e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-05 | ||
| 3ifk_A | 90 | Crystal Structure Of Calcium-Saturated Calmodulin N | 4e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-05 | ||
| 4ds7_A | 147 | Crystal Structure Of Yeast Calmodulin Bound To The | 8e-05 | ||
| 1j7o_A | 76 | Solution Structure Of Calcium-calmodulin N-terminal | 8e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-04 | ||
| 1f54_A | 77 | Solution Structure Of The Apo N-Terminal Domain Of | 1e-04 | ||
| 3o4y_A | 196 | Crystal Structure Of Cad Domain Of The Plasmodium V | 1e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-04 | ||
| 1exr_A | 148 | The 1.0 Angstrom Crystal Structure Of Ca+2 Bound Ca | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 2i08_A | 78 | Solvation Effect In Conformational Changes Of Ef-Ha | 2e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-04 | ||
| 2f2o_A | 179 | Structure Of Calmodulin Bound To A Calcineurin Pept | 2e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-04 | ||
| 4djc_A | 152 | 1.35 A Crystal Structure Of The Nav1.5 Diii-Iv-CaCA | 2e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2ygg_B | 150 | Complex Of Cambr And Cam Length = 150 | 3e-04 | ||
| 1xfu_O | 149 | Crystal Structure Of Anthrax Edema Factor (ef) Trun | 3e-04 | ||
| 1iq5_A | 149 | CalmodulinNEMATODE CA2+CALMODULIN DEPENDENT KINASE | 3e-04 | ||
| 2wel_D | 150 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-04 | ||
| 2be6_A | 150 | 2.0 A Crystal Structure Of The Cav1.2 Iq Domain-CaC | 3e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-04 | ||
| 2bkh_B | 149 | Myosin Vi Nucleotide-Free (Mdinsert2) Crystal Struc | 3e-04 | ||
| 3sg5_A | 448 | Crystal Structure Of Dimeric Gcamp3-D380y, Qp(Linke | 3e-04 | ||
| 2vb6_B | 149 | Myosin Vi (Md-Insert2-Cam, Delta Insert1) Post-Rigo | 3e-04 | ||
| 3u0k_A | 440 | Crystal Structure Of The Genetically Encoded Calciu | 3e-04 | ||
| 1ooj_A | 149 | Structural Genomics Of Caenorhabditis Elegans : Cal | 3e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-04 | ||
| 3sg4_A | 448 | Crystal Structure Of Gcamp3-D380y, Lp(Linker 2) Len | 3e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3o78_A | 415 | The Structure Of Ca2+ Sensor (Case-12) Length = 415 | 4e-04 | ||
| 3o77_A | 415 | The Structure Of Ca2+ Sensor (Case-16) Length = 415 | 4e-04 | ||
| 2ro8_A | 79 | Solution Structure Of Calcium Bound Soybean Calmodu | 4e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 1dmo_A | 148 | Calmodulin, Nmr, 30 Structures Length = 148 | 4e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-04 | ||
| 3ewt_A | 154 | Crystal Structure Of Calmodulin Complexed With A Pe | 4e-04 | ||
| 1cm1_A | 148 | Motions Of Calmodulin-Single-Conformer Refinement L | 4e-04 | ||
| 3evr_A | 411 | Crystal Structure Of Calcium Bound Monomeric Gcamp2 | 4e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 3sg2_A | 449 | Crystal Structure Of Gcamp2-T116v,D381y Length = 44 | 4e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 1prw_A | 149 | Crystal Structure Of Bovine Brain Ca++ Calmodulin I | 4e-04 | ||
| 1up5_B | 148 | Chicken Calmodulin Length = 148 | 4e-04 | ||
| 1cdl_A | 147 | Target Enzyme Recognition By Calmodulin: 2.4 Angstr | 4e-04 | ||
| 3sg7_A | 448 | Crystal Structure Of Gcamp3-Kf(Linker 1) Length = 4 | 4e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-04 | ||
| 2k0j_A | 148 | Solution Structure Of Cam Complexed To Drp1p Length | 4e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-04 | ||
| 1ahr_A | 146 | Calmodulin Mutant With A Two Residue Deletion In Th | 4e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-04 | ||
| 3ekh_A | 449 | Calcium-Saturated Gcamp2 T116vK378W MUTANT MONOMER | 4e-04 | ||
| 3sg3_A | 449 | Crystal Structure Of Gcamp3-D380y Length = 449 | 4e-04 | ||
| 3sg6_A | 450 | Crystal Structure Of Dimeric Gcamp2-Lia(Linker 1) L | 4e-04 | ||
| 3ek8_A | 449 | Calcium-Saturated Gcamp2 T116vG87R MUTANT MONOMER L | 4e-04 | ||
| 2bbm_A | 148 | Solution Structure Of A Calmodulin-Target Peptide C | 4e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-04 | ||
| 2lv6_A | 148 | The Complex Between Ca-calmodulin And Skeletal Musc | 4e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-04 | ||
| 3evu_A | 449 | Crystal Structure Of Calcium Bound Dimeric Gcamp2, | 5e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-04 | ||
| 2lhh_A | 128 | Solution Structure Of Ca2+-Bound Ycam Length = 128 | 5e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-04 | ||
| 2lhi_A | 176 | Solution Structure Of Ca2+CNA1 PEPTIDE-Bound Ycam L | 5e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 1clm_A | 148 | Structure Of Paramecium Tetraurelia Calmodulin At 1 | 6e-04 | ||
| 1lkj_A | 146 | Nmr Structure Of Apo Calmodulin From Yeast Saccharo | 6e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-04 |
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1S6J|A Chain A, N-Terminal Region Of The Ca2+-Saturated Calcium Regulatory Domain (Cld) From Soybean Calcium-Dependent Protein Kinase- Alpha (Cdpk) Length = 87 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1S6I|A Chain A, Ca2+-Regulatory Region (Cld) From Soybean Calcium-Dependent Protein Kinase-Alpha (Cdpk) In The Presence Of Ca2+ And The Junction Domain (Jd) Length = 188 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2AAO|A Chain A, Regulatory Apparatus Of Calcium Dependent Protein Kinase From Arabidopsis Thaliana Length = 166 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PM8|A Chain A, Cad Domain Of Pff0520w, Calcium Dependent Protein Kinase Length = 197 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3B32|A Chain A, Crystal Structure Of Calcium-Saturated Calmodulin N-Terminal Domain Fragment, Residues 1-75 Length = 75 | Back alignment and structure |
|
| >pdb|1AK8|A Chain A, Nmr Solution Structure Of Cerium-Loaded Calmodulin Amino- Terminal Domain (Ce2-Tr1c), 23 Structures Length = 76 | Back alignment and structure |
|
| >pdb|1F70|A Chain A, Refined Solution Structure Of Calmodulin N-Terminal Domain Length = 76 | Back alignment and structure |
|
| >pdb|3UCT|A Chain A, Structure Of Mn2+-Bound N-Terminal Domain Of Calmodulin In The Presence Of Zn2+ Length = 79 | Back alignment and structure |
|
| >pdb|2LQC|A Chain A, Nmr Solution Structure Of A Ca2+-Calmodulin With A Binding Motif (Nscate) Peptide From The N-Terminal Cytoplasmic Domain Of The L-Type Voltage-Cated Calcium Channel Alpha1c Subunit Length = 77 | Back alignment and structure |
|
| >pdb|3K21|A Chain A, Crystal Structure Of Carboxy-Terminus Of Pfc0420w Length = 191 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2LLO|A Chain A, Solution Nmr-Derived Structure Of Calmodulin N-Lobe Bound With Er Alpha Peptide Length = 80 | Back alignment and structure |
|
| >pdb|1SW8|A Chain A, Solution Structure Of The N-Terminal Domain Of Human N60d Calmodulin Refined With Paramagnetism Based Strategy Length = 79 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IFK|A Chain A, Crystal Structure Of Calcium-Saturated Calmodulin N-Terminal Domain Fragment, Residues 1-90 Length = 90 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4DS7|A Chain A, Crystal Structure Of Yeast Calmodulin Bound To The C-Terminal Fragment Of Spindle Pole Body Protein Spc110 Length = 147 | Back alignment and structure |
|
| >pdb|1J7O|A Chain A, Solution Structure Of Calcium-calmodulin N-terminal Domain Length = 76 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1F54|A Chain A, Solution Structure Of The Apo N-Terminal Domain Of Yeast Calmodulin Length = 77 | Back alignment and structure |
|
| >pdb|3O4Y|A Chain A, Crystal Structure Of Cad Domain Of The Plasmodium Vivax Cdpk, Pvx_11610 Length = 196 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1EXR|A Chain A, The 1.0 Angstrom Crystal Structure Of Ca+2 Bound Calmodulin Length = 148 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2I08|A Chain A, Solvation Effect In Conformational Changes Of Ef-Hand Proteins: X-Ray Structure Of Ca2+-Saturated Double Mutant Q41l-K75i Of N-Domain Of Calmodulin Length = 78 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2F2O|A Chain A, Structure Of Calmodulin Bound To A Calcineurin Peptide: A New Way Of Making An Old Binding Mode Length = 179 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4DJC|A Chain A, 1.35 A Crystal Structure Of The Nav1.5 Diii-Iv-CaCAM COMPLEX Length = 152 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YGG|B Chain B, Complex Of Cambr And Cam Length = 150 | Back alignment and structure |
|
| >pdb|1XFU|O Chain O, Crystal Structure Of Anthrax Edema Factor (ef) Truncation Mutant, Ef-delta 64 In Complex With Calmodulin Length = 149 | Back alignment and structure |
|
| >pdb|1IQ5|A Chain A, CalmodulinNEMATODE CA2+CALMODULIN DEPENDENT KINASE KINASE Fragment Length = 149 | Back alignment and structure |
|
| >pdb|2WEL|D Chain D, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 150 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2BE6|A Chain A, 2.0 A Crystal Structure Of The Cav1.2 Iq Domain-CaCAM COMPLEX Length = 150 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2BKH|B Chain B, Myosin Vi Nucleotide-Free (Mdinsert2) Crystal Structure Length = 149 | Back alignment and structure |
|
| >pdb|3SG5|A Chain A, Crystal Structure Of Dimeric Gcamp3-D380y, Qp(Linker 1), Lp(Linker 2) Length = 448 | Back alignment and structure |
|
| >pdb|2VB6|B Chain B, Myosin Vi (Md-Insert2-Cam, Delta Insert1) Post-Rigor State ( Crystal Form 2) Length = 149 | Back alignment and structure |
|
| >pdb|3U0K|A Chain A, Crystal Structure Of The Genetically Encoded Calcium Indicator Rcamp Length = 440 | Back alignment and structure |
|
| >pdb|1OOJ|A Chain A, Structural Genomics Of Caenorhabditis Elegans : Calmodulin Length = 149 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3SG4|A Chain A, Crystal Structure Of Gcamp3-D380y, Lp(Linker 2) Length = 448 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3O78|A Chain A, The Structure Of Ca2+ Sensor (Case-12) Length = 415 | Back alignment and structure |
|
| >pdb|3O77|A Chain A, The Structure Of Ca2+ Sensor (Case-16) Length = 415 | Back alignment and structure |
|
| >pdb|2RO8|A Chain A, Solution Structure Of Calcium Bound Soybean Calmodulin Isoform 1 N-Terminal Domain Length = 79 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1DMO|A Chain A, Calmodulin, Nmr, 30 Structures Length = 148 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EWT|A Chain A, Crystal Structure Of Calmodulin Complexed With A Peptide Length = 154 | Back alignment and structure |
|
| >pdb|1CM1|A Chain A, Motions Of Calmodulin-Single-Conformer Refinement Length = 148 | Back alignment and structure |
|
| >pdb|3EVR|A Chain A, Crystal Structure Of Calcium Bound Monomeric Gcamp2 Length = 411 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SG2|A Chain A, Crystal Structure Of Gcamp2-T116v,D381y Length = 449 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1PRW|A Chain A, Crystal Structure Of Bovine Brain Ca++ Calmodulin In A Compact Form Length = 149 | Back alignment and structure |
|
| >pdb|1UP5|B Chain B, Chicken Calmodulin Length = 148 | Back alignment and structure |
|
| >pdb|1CDL|A Chain A, Target Enzyme Recognition By Calmodulin: 2.4 Angstroms Structure Of A Calmodulin-Peptide Complex Length = 147 | Back alignment and structure |
|
| >pdb|3SG7|A Chain A, Crystal Structure Of Gcamp3-Kf(Linker 1) Length = 448 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2K0J|A Chain A, Solution Structure Of Cam Complexed To Drp1p Length = 148 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1AHR|A Chain A, Calmodulin Mutant With A Two Residue Deletion In The Central Helix Length = 146 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3EKH|A Chain A, Calcium-Saturated Gcamp2 T116vK378W MUTANT MONOMER Length = 449 | Back alignment and structure |
|
| >pdb|3SG3|A Chain A, Crystal Structure Of Gcamp3-D380y Length = 449 | Back alignment and structure |
|
| >pdb|3SG6|A Chain A, Crystal Structure Of Dimeric Gcamp2-Lia(Linker 1) Length = 450 | Back alignment and structure |
|
| >pdb|3EK8|A Chain A, Calcium-Saturated Gcamp2 T116vG87R MUTANT MONOMER Length = 449 | Back alignment and structure |
|
| >pdb|2BBM|A Chain A, Solution Structure Of A Calmodulin-Target Peptide Complex By Multidimensional Nmr Length = 148 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2LV6|A Chain A, The Complex Between Ca-calmodulin And Skeletal Muscle Myosin Light Chain Kinase From Combination Of Nmr And Aqueous And Contrast-matched Saxs Data Length = 148 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EVU|A Chain A, Crystal Structure Of Calcium Bound Dimeric Gcamp2, (#1) Length = 449 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2LHH|A Chain A, Solution Structure Of Ca2+-Bound Ycam Length = 128 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2LHI|A Chain A, Solution Structure Of Ca2+CNA1 PEPTIDE-Bound Ycam Length = 176 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1CLM|A Chain A, Structure Of Paramecium Tetraurelia Calmodulin At 1.8 Angstroms Resolution Length = 148 | Back alignment and structure |
|
| >pdb|1LKJ|A Chain A, Nmr Structure Of Apo Calmodulin From Yeast Saccharomyces Cerevisiae Length = 146 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 497 bits (1281), Expect = e-177
Identities = 121/317 (38%), Positives = 176/317 (55%), Gaps = 20/317 (6%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L H +++++ + ED S +IV EL GGELFD I+K+ +SE +AA+++K +
Sbjct: 75 LKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ H + HRDLKPEN L S ++D +K DFGLS ++ + D +G+ YY+APE
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLR Y + DVWSAGVILYILLSG PPF+ + E I +++ GK F+ W IS+ A
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVD----DKVAPDKPLDSAVLSRLKHFSAMNKLK 236
KDLIRKML +P R+TA + L HPWI D P + ++ ++ F A KL
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLA 313
Query: 237 KMALRVIAERLNE-EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV------------- 282
+ AL +A +L +E L E+F+ +DT+N G + DEL G
Sbjct: 314 QAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQ 373
Query: 283 -GSQLMESEIKDLMDAV 298
+E +I LM +
Sbjct: 374 NEGSTIEDQIDSLMPLL 390
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 13/44 (29%), Positives = 23/44 (52%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
++ FKM D D SG I+ EL + S + E++ +++ V
Sbjct: 419 MERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQV 462
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 494 bits (1274), Expect = e-175
Identities = 107/310 (34%), Positives = 171/310 (55%), Gaps = 13/310 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L H +++++ D +EDK ++V E EGGELF++I+ + + E +AA +MK I+
Sbjct: 100 LKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ H + HRD+KPEN L + + +K DFGLS F+ D D +G+ YY+APE
Sbjct: 159 ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPE 218
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL+K Y + DVWS GVI+YILL G PPF + + I +++ +GK F+ W NIS+ A
Sbjct: 219 VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEA 278
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIV---DDKVAPDKPLDSAVLSRLKHFSAMNKLKK 237
K+LI+ ML + +R TA E L WI ++ D+ LS ++ F KL +
Sbjct: 279 KELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQ 338
Query: 238 MALRVIAERLNE-EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS--------QLME 288
A+ I +L EE L ++FK +D + G + EL +G + + + +E
Sbjct: 339 AAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVE 398
Query: 289 SEIKDLMDAV 298
E+ +++ V
Sbjct: 399 EEVDNILKEV 408
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 492 bits (1268), Expect = e-175
Identities = 111/313 (35%), Positives = 177/313 (56%), Gaps = 16/313 (5%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L H +++++++ +EDK ++V E+ GGELFD I+ + +SE +AA++++ ++
Sbjct: 80 LKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ H + HRDLKPEN L S +DA ++ DFGLS ++ + D +G+ YY+APE
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL Y + DVWS GVILYILLSG PPF E I +++ +GK FE W +SESA
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIV---DDKVAPDKPLDSAVLSRLKHFSAMNKLKK 237
KDLIRKML P R++A + L H WI ++++ D P + ++ F KL +
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQ 318
Query: 238 MALRVIAERL-NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV-----------GSQ 285
AL + +L +++E L +F +D + G + EL +G K + +
Sbjct: 319 AALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDAS 378
Query: 286 LMESEIKDLMDAV 298
+E E+ ++DAV
Sbjct: 379 AVEHEVDQVLDAV 391
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 487 bits (1256), Expect = e-173
Identities = 115/311 (36%), Positives = 186/311 (59%), Gaps = 14/311 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L H ++++++D +EDK ++VME +GGELFD I+ + ++E +AA ++K ++
Sbjct: 90 LKLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
V H + HRDLKPEN L S ++DA +K DFGLS ++ + + +G+ YY+APE
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE 208
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLRK Y + DVWS GVIL+ILL+G PPF +T+ I R++ +GK F+S W N+SE A
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAP----DKPLDSAVLSRLKHFSAMNKLK 236
KDLI++ML + +RR++A + L HPWI + + P + + ++ F KL
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLA 328
Query: 237 KMALRVIAERL-NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQ--------LM 287
+ AL +A +L ++EE L ++F+ ID + G + EL DG ++ + +
Sbjct: 329 QAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQI 388
Query: 288 ESEIKDLMDAV 298
ESE+ ++ A
Sbjct: 389 ESEVDAILGAA 399
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-169
Identities = 109/309 (35%), Positives = 166/309 (53%), Gaps = 9/309 (2%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
L H ++VR+HD+ ++ +++ +L GGELF+ IV + YSE +A+ ++ I+
Sbjct: 64 CRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAP 119
V CH +GV HR+LKPEN L S + AA+K DFGL++ + + + G+P Y++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 120 EVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EVLRK YG D+W+ GVILYILL G PPFW E + +++QI G DF S W ++
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKM 238
AKDLI KML NP +R+TA E L HPWI + LK F+A KLK
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302
Query: 239 ALRVIA--ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
L V+ + + +K ++I+ ++G + + + +L++
Sbjct: 303 ILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDF--ESYTKMCDPGMTAFEPEALGNLVE 360
Query: 297 AVRKIFSRF 305
+ F RF
Sbjct: 361 GL--DFHRF 367
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 460 bits (1185), Expect = e-164
Identities = 100/285 (35%), Positives = 149/285 (52%), Gaps = 6/285 (2%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
L H ++VR+HD+ +++S ++V +L GGELF+ IV + YSE +A+ ++ I+
Sbjct: 82 CRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 140
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ CHS G+ HR+LKPEN L S + AA+K DFGL++ E + G+P Y++PE
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200
Query: 121 VLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
VL+K Y D+W+ GVILYILL G PPFW E + ++ QI G D+ S W ++
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 260
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMA 239
AK LI ML NPK+R+TA + L PWI + + + LK F+A KLK
Sbjct: 261 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAI 320
Query: 240 LRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS 284
L + N L + E + + +
Sbjct: 321 LTTMIATRNLSN---LGRNLLNKKEQGPPSTI-KESSESSQTIDD 361
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 452 bits (1165), Expect = e-161
Identities = 94/273 (34%), Positives = 142/273 (52%), Gaps = 8/273 (2%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN----YSEREAAKLMKT 56
H L H H+V + +TY +++V E +G +L IVK+ + YSE A+ M+
Sbjct: 80 CHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 57 IVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVVGSPY 115
I+ + CH + HRD+KP L S + A +K FG+++ + V VG+P+
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198
Query: 116 YVAPEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP 174
++APEV+ R+ YG DVW GVIL+ILLSG PF+ E +F I++GK W
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWS 257
Query: 175 NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNK 234
+ISESAKDL+R+ML +P R+T +E L HPW+ + K + +L+ F+A K
Sbjct: 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRK 317
Query: 235 LKKMALRVIAERLNEEEIGGLKELFKMIDTDNS 267
LK L ++ G E D +
Sbjct: 318 LKGAVLAAVSSHKFNSFYGDPPEELPDFSEDPT 350
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 441 bits (1136), Expect = e-156
Identities = 100/279 (35%), Positives = 154/279 (55%), Gaps = 15/279 (5%)
Query: 1 MHHLSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLM 54
S+ H+VRI D YE+ + C+ IVME +GGELF RI +G+ ++EREA+++M
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 167
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
K+I ++ HS+ + HRD+KPEN L+ S +A LK TDFG + + +P
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 227
Query: 115 YYVAPEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAE----TEIGIFRQILEGKIDFE 169
YYVAPEVL + Y D+WS GVI+YILL G PPF++ G+ +I G+ +F
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287
Query: 170 SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHF 229
+ W +SE K LIR +L P +R+T E + HPWI+ P PL ++ + +
Sbjct: 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 347
Query: 230 SAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSG 268
+ ++M + R++ E+I ++ K+ D N
Sbjct: 348 RWEDVKEEMTSALATMRVDYEQI----KIKKIEDASNPL 382
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 431 bits (1111), Expect = e-153
Identities = 96/268 (35%), Positives = 145/268 (54%), Gaps = 13/268 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ + H +V+ +H+ YE+K+ V +++EL GGELFD + +K + +E EA + +K I+
Sbjct: 68 LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 61 VECCHSLGVFHRDLKPENFLFLSVD-EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
V HSL + H DLKPEN + L + +K DFGL+ F ++ G+P +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 120 EVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
E++ + G EAD+WS GVI YILLSG PF +T+ + +FE E + N S
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKM 238
AKD IR++L ++PK+R+T + L HPWI LSR M K KK
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD-------TQQALSRKASAVNMEKFKKF 299
Query: 239 ALRVIAERLNEEEIGGLKELFKMIDTDN 266
A R + + GGL ++F+ +
Sbjct: 300 AARKKSNNGSG---GGLNDIFEAQKIEW 324
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 431 bits (1111), Expect = e-153
Identities = 105/248 (42%), Positives = 149/248 (60%), Gaps = 5/248 (2%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ LS H +++++ + +E + + +V+EL GGELFDRIV+KG YSER+AA +K I+
Sbjct: 102 LLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
V H G+ HRDLKPEN L+ + DA LK DFGLS + + V G+P Y APE
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE 220
Query: 121 VLRK-HYGPEADVWSAGVILYILLSGVPPFWAET-EIGIFRQILEGKIDFESEPWPNISE 178
+LR YGPE D+WS G+I YILL G PF+ E + +FR+IL + F S W +S
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKM 238
+AKDL+RK++ +PK+RLT + L HPW+ A + +L+ F+A KLK
Sbjct: 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK--AANFVHMDTAQKKLQEFNARRKLKAA 338
Query: 239 ALRVIAER 246
V+A
Sbjct: 339 VKAVVASS 346
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 423 bits (1090), Expect = e-150
Identities = 92/263 (34%), Positives = 141/263 (53%), Gaps = 19/263 (7%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ H ++V++H+ + D+ +VMEL GGELF+RI KK ++SE EA+ +M+ +V
Sbjct: 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA 118
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAP 119
V H +GV HRDLKPEN LF +++ +K DFG + PD + + +Y AP
Sbjct: 119 VSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 120 EVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETE-------IGIFRQILEGKIDFESE 171
E+L ++ Y D+WS GVILY +LSG PF + + I ++I +G FE E
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238
Query: 172 PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPL---------DSAV 222
W N+S+ AKDLI+ +L +P +RL + + W+ D PL +AV
Sbjct: 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAV 298
Query: 223 LSRLK-HFSAMNKLKKMALRVIA 244
+ +K F A NK K+ +
Sbjct: 299 HTCVKATFHAFNKYKREGFCLQN 321
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 418 bits (1077), Expect = e-148
Identities = 92/273 (33%), Positives = 147/273 (53%), Gaps = 15/273 (5%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ +H +++ + D Y+D V++V EL +GGEL D+I+++ +SEREA+ ++ TI
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDA-ALKATDFGLSVFYKPD-EVFSDVVGSPYYVA 118
VE H+ GV HRDLKP N L++ + +++ DFG + + + + + +VA
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 119 PEVL-RKHYGPEADVWSAGVILYILLSGVPPFWA---ETEIGIFRQILEGKIDFESEPWP 174
PEVL R+ Y D+WS GV+LY +L+G PF +T I +I GK W
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248
Query: 175 NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKH------ 228
++S++AKDL+ KML +P +RLTA VL HPWIV P L+ L
Sbjct: 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAAT 308
Query: 229 FSAMNKLKKMALRVIAE-RLNEEEIGGLKELFK 260
+SA+N+ + L + L + G+K++
Sbjct: 309 YSALNRNQSPVLEPVGRSTLAQRR--GIKKITS 339
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 417 bits (1074), Expect = e-147
Identities = 94/287 (32%), Positives = 142/287 (49%), Gaps = 7/287 (2%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ + H +++ +HD YE+++ V +++EL GGELFD + +K + SE EA +K I+
Sbjct: 69 LRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAA-LKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
V H+ + H DLKPEN + L + +K DFGL+ + F ++ G+P +VAP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 120 EVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
E++ + G EAD+WS GVI YILLSG PF +T+ I DF+ E + SE
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWI--VDDKVAPDKPLDSAVLSRLKHFSAMNKLK 236
AKD IRK+L + ++RLT E L HPWI VD + A + L K + K
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWK 307
Query: 237 KMALRVIA-ERLNEEEIGGLK-ELFKMIDTDNSGTITFDELKDGLKR 281
V L + + + + S T + L
Sbjct: 308 LSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHP 354
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 413 bits (1064), Expect = e-146
Identities = 70/263 (26%), Positives = 129/263 (49%), Gaps = 8/263 (3%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVG 59
++ H++++ +H+++E + ++ E G ++F+RI +ERE + +
Sbjct: 55 LNIAR-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
++ HS + H D++PEN ++ + + +K +FG + KP + F + +P Y AP
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
Query: 120 EVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EV D+WS G ++Y+LLSG+ PF AET I I+ + F+ E + IS
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKM 238
A D + ++L + K R+TA E L HPW+ + + + V+ LKH + L K
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK----IERVSTKVIRTLKHRRYYHTLIKK 288
Query: 239 ALRVIAERLNEEEIGGLKELFKM 261
L ++ G ++ +
Sbjct: 289 DLNMVVSAARISCGGAIRSQKGV 311
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 411 bits (1059), Expect = e-145
Identities = 68/243 (27%), Positives = 121/243 (49%), Gaps = 4/243 (1%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIV 58
+ V+ +H+ YE+ S + +++E GGE+F + + SE + +L+K I+
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 59 GVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVA 118
V H + H DLKP+N L S+ +K DFG+S +++G+P Y+A
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLA 201
Query: 119 PEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNIS 177
PE+L D+W+ G+I Y+LL+ PF E + I + +D+ E + ++S
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261
Query: 178 ESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD-DKVAPDKPLDSAVLSRLKHFSAMNKLK 236
+ A D I+ +L +NP++R TA L H W+ D P +++ S+ + S +
Sbjct: 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSED 321
Query: 237 KMA 239
K +
Sbjct: 322 KTS 324
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 407 bits (1048), Expect = e-144
Identities = 99/218 (45%), Positives = 146/218 (66%), Gaps = 1/218 (0%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M L H +++R+++T+ED + +++VMELC GGELF+R+V K + E +AA++MK ++
Sbjct: 60 MKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
V CH L V HRDLKPENFLFL+ D+ LK DFGL+ +KP ++ VG+PYYV+P+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VL YGPE D WSAGV++Y+LL G PPF A T+ + +I EG F + W N+S A
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPL 218
+ LIR++L ++PK+R+T+ + L H W + + L
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 402 bits (1035), Expect = e-142
Identities = 89/248 (35%), Positives = 138/248 (55%), Gaps = 6/248 (2%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ + H +V+ +HD YE+++ V +++EL GGELFD + +K + SE EA +K I+
Sbjct: 69 LRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAA-LKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
V H+ + H DLKPEN + L + +K DFGL+ + F ++ G+P +VAP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 120 EVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
E++ + G EAD+WS GVI YILLSG PF +T+ I DF+ E + + SE
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWI--VDDKVAPDKPLDSAVLSRLKHFSAMNKLK 236
AKD IRK+L + ++RLT E L HPWI VD++ A + L + + K
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWK 307
Query: 237 KMALRVIA 244
+ +++
Sbjct: 308 L-SFSIVS 314
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 402 bits (1034), Expect = e-141
Identities = 105/265 (39%), Positives = 151/265 (56%), Gaps = 16/265 (6%)
Query: 1 MHHLSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLM 54
S H+V I D YE+ K C+ I+ME EGGELF RI ++G+ ++EREAA++M
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
+ I ++ HS + HRD+KPEN L+ S ++DA LK TDFG + +P
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTP 193
Query: 115 YYVAPEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETE----IGIFRQILEGKIDFE 169
YYVAPEVL + Y D+WS GVI+YILL G PPF++ T G+ R+I G+ F
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253
Query: 170 SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSA-VLSRLKH 228
+ W +SE AK LIR +L +P RLT + + HPWI V P PL +A VL K
Sbjct: 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDK- 312
Query: 229 FSAMNKLKKMALRVIA-ERLNEEEI 252
+++K+ +A R++ +++
Sbjct: 313 -DHWDEVKEEMTSALATMRVDYDQV 336
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 397 bits (1022), Expect = e-140
Identities = 92/224 (41%), Positives = 134/224 (59%), Gaps = 3/224 (1%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
L H ++VR+HD+ +++S ++V +L GGELF+ IV + YSE +A+ ++ I+
Sbjct: 59 CRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 117
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ CHS G+ HR+LKPEN L S + AA+K DFGL++ E + G+P Y++PE
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177
Query: 121 VLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
VL+K Y D+W+ GVILYILL G PPFW E + ++ QI G D+ S W ++
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWIV-DDKVAPDKPLDSAV 222
AK LI ML NPK+R+TA + L PWI ++VA V
Sbjct: 238 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 396 bits (1020), Expect = e-140
Identities = 95/210 (45%), Positives = 133/210 (63%), Gaps = 1/210 (0%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L H +++++ + ED S +IV EL GGELFD I+K+ +SE +AA+++K +
Sbjct: 75 LKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ H + HRDLKPEN L S ++D +K DFGLS ++ + D +G+ YY+APE
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
VLR Y + DVWSAGVILYILLSG PPF+ + E I +++ GK F+ W IS+ A
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 181 KDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210
KDLIRKML +P R+TA + L HPWI
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-139
Identities = 85/224 (37%), Positives = 128/224 (57%), Gaps = 10/224 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ +S H +++++ DTYE + +V +L + GELFD + +K SE+E K+M+ ++ V
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ H L + HRDLKPEN L D+D +K TDFG S P E +V G+P Y+APE
Sbjct: 137 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 121 VLR-------KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW 173
++ YG E D+WS GVI+Y LL+G PPFW ++ + R I+ G F S W
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 174 PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKP 217
+ S++ KDL+ + L P++R TA E L HP+ V +
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 393 bits (1013), Expect = e-139
Identities = 85/223 (38%), Positives = 131/223 (58%), Gaps = 3/223 (1%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ + H +++ +HD +E+K+ V +++EL GGELFD + +K + +E EA + +K I+
Sbjct: 62 LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 61 VECCHSLGVFHRDLKPENFLFLSVD-EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
V HS + H DLKPEN + L + + +K DFG++ + F ++ G+P +VAP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 120 EVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
E++ + G EAD+WS GVI YILLSG PF ET+ I DF+ E + N SE
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSA 221
AKD IR++L ++PKRR+T + L H WI + + DS
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 395 bits (1017), Expect = e-138
Identities = 81/214 (37%), Positives = 129/214 (60%), Gaps = 10/214 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ ++ H H++ + D+YE S + +V +L GELFD + +K SE+E +M++++
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
V H+ + HRDLKPEN L D++ ++ +DFG S +P E ++ G+P Y+APE
Sbjct: 213 VSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 121 VLR-------KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW 173
+L+ YG E D+W+ GVIL+ LL+G PPFW +I + R I+EG+ F S W
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329
Query: 174 PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ S + KDLI ++L +P+ RLTA + L HP+
Sbjct: 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 393 bits (1011), Expect = e-138
Identities = 89/256 (34%), Positives = 129/256 (50%), Gaps = 13/256 (5%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L+ H +++I + ++ + +IV+EL EGGELFD++V E ++
Sbjct: 69 LKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
V+ H G+ HRDLKPEN L S +ED +K TDFG S + + G+P Y+APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 121 VL----RKHYGPEADVWSAGVILYILLSGVPPFWAE-TEIGIFRQILEGKIDFESEPWPN 175
VL Y D WS GVIL+I LSG PPF T++ + QI GK +F E W
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKL 235
+SE A DL++K+L +PK R T E L HPW+ D+ + L + L
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE------DMKRKFQDLLSEENESTAL 300
Query: 236 KKMALRVIAERLNEEE 251
++ + R E
Sbjct: 301 PQVLAQPSTSRKRPRE 316
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 392 bits (1009), Expect = e-137
Identities = 76/275 (27%), Positives = 138/275 (50%), Gaps = 25/275 (9%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVG 59
M+ L H ++ +HD +EDK + +++E GGELFDRI + SE E M+
Sbjct: 102 MNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
++ H + H D+KPEN + + + +++K DFGL+ PDE+ + + AP
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219
Query: 120 EVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
E++ R+ G D+W+ GV+ Y+LLSG+ PF E ++ + + +F+ + + ++S
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLS-------------- 224
AKD I+ +L + P++RLT H+ L HPW+ D + S+ +
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWP 339
Query: 225 -------RLKHFSAMNKLKKMALRVIAERLNEEEI 252
R+ +FS++ K + ++ + +E
Sbjct: 340 APQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKEA 374
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 388 bits (1000), Expect = e-136
Identities = 84/255 (32%), Positives = 134/255 (52%), Gaps = 32/255 (12%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
++ H++V+ + + +E++ ++V E GG + I K+ +++E EA+ +++ +
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV--------VG 112
++ H+ G+ HRDLKPEN L ++ + +K DF L K + S + G
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 113 SPYYVAPEVLRKH------YGPEADVWSAGVILYILLSGVPPFWAE-------------- 152
S Y+APEV+ Y D+WS GVILYILLSG PPF
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243
Query: 153 -TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
+ +F I EGK +F + W +IS +AKDLI K+L ++ K+RL+A +VL HPW+
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC- 302
Query: 212 VAPDKPLDSA-VLSR 225
AP+ L + VL R
Sbjct: 303 -APENTLPTPMVLQR 316
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 394 bits (1013), Expect = e-135
Identities = 90/300 (30%), Positives = 134/300 (44%), Gaps = 10/300 (3%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV-KKGNYSEREAAKLMKTIVG 59
M L H +V +HD +ED + + ++ E GGELF+++ + SE EA + M+ +
Sbjct: 208 MSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
+ H H DLKPEN +F + + LK DFGL+ P + G+ + AP
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EV K G D+WS GV+ YILLSG+ PF E + R + + + + ISE
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIV-DDKVAPDKPLDSAVLSRLKHFSAMNKLKK 237
KD IRK+L +P R+T H+ L HPW+ + D + S SR K K
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS---SRYTKIRDSIKTKY 442
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
A L I L K + S F + + R + +E+ + A
Sbjct: 443 DAWPEPLPPLG--RISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVGEGQSA 500
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-134
Identities = 77/211 (36%), Positives = 125/211 (59%), Gaps = 6/211 (2%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV----KKGNYSEREAAKLMKT 56
+ L H ++++I + +ED ++IVME CEGGEL +RIV + SE A+LMK
Sbjct: 74 LKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 57 IVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY 116
++ + HS V H+DLKPEN LF + +K DFGL+ +K DE ++ G+ Y
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALY 192
Query: 117 VAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI 176
+APEV ++ + D+WSAGV++Y LL+G PF + + ++ + ++ E P +
Sbjct: 193 MAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-L 251
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ A DL+++ML ++P+RR +A +VL H W
Sbjct: 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-129
Identities = 88/254 (34%), Positives = 132/254 (51%), Gaps = 31/254 (12%)
Query: 1 MHHLSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLM 54
S+ H+VRI D YE+ + C+ IVME +GGELF RI +G+ ++EREA+++M
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
K+I ++ HS+ + HRD+KPEN L+ S +A LK TDFG
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------- 166
Query: 115 YYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAE----TEIGIFRQILEGKIDFES 170
A E + Y D+WS GVI+YILL G PPF++ G+ +I G+ +F +
Sbjct: 167 ---AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223
Query: 171 EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFS 230
W +SE K LIR +L P +R+T E + HPWI+ P PL ++ + +
Sbjct: 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE- 282
Query: 231 AMNKLKKMALRVIA 244
+K+ +A
Sbjct: 283 RWEDVKEEMTSALA 296
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 369 bits (950), Expect = e-128
Identities = 84/241 (34%), Positives = 130/241 (53%), Gaps = 10/241 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVG 59
M+ L H ++++++D +E K+ + +VME +GGELFDRI+ + N +E + MK I
Sbjct: 140 MNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE 198
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
+ H + + H DLKPEN L ++ D +K DFGL+ YKP E G+P ++AP
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAKQ-IKIIDFGLARRYKPREKLKVNFGTPEFLAP 257
Query: 120 EVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EV+ D+WS GVI Y+LLSG+ PF + + IL + D E E + +ISE
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKM 238
AK+ I K+L + R++A E L HPW+ D L S + ++ K + +
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLS------DHKLHSRLSAQKKKNRGSDAQDFV 371
Query: 239 A 239
Sbjct: 372 T 372
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 354 bits (911), Expect = e-122
Identities = 85/217 (39%), Positives = 121/217 (55%), Gaps = 7/217 (3%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L+ H +++I + ++ + +IV+EL EGGELFD++V E ++
Sbjct: 194 LKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
V+ H G+ HRDLKPEN L S +ED +K TDFG S + + G+P Y+APE
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311
Query: 121 VL----RKHYGPEADVWSAGVILYILLSGVPPFWAE-TEIGIFRQILEGKIDFESEPWPN 175
VL Y D WS GVIL+I LSG PPF T++ + QI GK +F E W
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212
+SE A DL++K+L +PK R T E L HPW+ D+ +
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 342 bits (878), Expect = e-118
Identities = 80/264 (30%), Positives = 123/264 (46%), Gaps = 50/264 (18%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN---------------- 44
M L H ++ R+++ YED+ + +VMELC GG L D++ +
Sbjct: 82 MKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 45 ------------------------YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80
E+ + +M+ I + H+ G+ HRD+KPENFL
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 81 FLSVDEDAALKATDFGLSVFYKP-----DEVFSDVVGSPYYVAPEVLR---KHYGPEADV 132
F + ++ +K DFGLS + + G+PY+VAPEVL + YGP+ D
Sbjct: 201 FST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 133 WSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNP 192
WSAGV+L++LL G PF + Q+L K+ FE+ + +S A+DL+ +L++N
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNV 319
Query: 193 KRRLTAHEVLCHPWIVDDKVAPDK 216
R A L HPWI K
Sbjct: 320 DERFDAMRALQHPWISQFSDKIYK 343
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 7e-92
Identities = 69/289 (23%), Positives = 118/289 (40%), Gaps = 17/289 (5%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVG 59
+ EH +V+R T +D+ +I +ELC L + + +K + E L++
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTS 129
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKA--TDFGLSVFYKPDE----VFSDVVGS 113
+ HSL + HRDLKP N L + +KA +DFGL S V G+
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 114 PYYVAPEVLR----KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDF 168
++APE+L ++ D++SAG + Y ++S G PF + + +D
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249
Query: 169 ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKH 228
P + A++LI KM+ +P++R +A VL HP+ V R++
Sbjct: 250 L-HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL--EKQLQFFQDVSDRIEK 306
Query: 229 FSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKD 277
S + K R + + + D T ++D
Sbjct: 307 ESLDGPIVKQLERGGRAVVKMDWRENITVPL-QTDLRKFRTYKGGSVRD 354
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 5e-88
Identities = 73/337 (21%), Positives = 124/337 (36%), Gaps = 61/337 (18%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYS-------EREAAKL 53
+ +H +V+R + + ++I +ELC L D + K E L
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 54 MKTIVGVVECCHSLGVFHRDLKPENFLFLS----------VDEDAALKATDFGLSVFYKP 103
++ I V HSL + HRDLKP+N L + E+ + +DFGL
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 104 DEV-----FSDVVGSPYYVAPEVLR--------KHYGPEADVWSAGVILYILLS-GVPPF 149
+ ++ G+ + APE+L + D++S G + Y +LS G PF
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 150 WAETEIGIFRQILEGKIDF---ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
+ I+ G + ++ A DLI +M+D +P +R TA +VL HP
Sbjct: 241 GDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 207 IVDDKVAPDKPLDSA----VLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMI 262
+ L + + +R + + K + VI +
Sbjct: 299 FWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPS----------GDWTVKF 348
Query: 263 DTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVR 299
D D L+R + DL+ A+R
Sbjct: 349 D---------KTFMDNLERYRKYHSSK-LMDLLRALR 375
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 5e-79
Identities = 75/222 (33%), Positives = 110/222 (49%), Gaps = 10/222 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
L+ HQHVV H +ED V +V+ELC L + ++ +E EA ++ IV
Sbjct: 95 HRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLG 153
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV-GSPYYVAP 119
+ H V HRDLK N ++ED +K DFGL+ + D V+ G+P Y+AP
Sbjct: 154 CQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210
Query: 120 EVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EVL +K + E DVWS G I+Y LL G PPF + +I + + P +I+
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINP 266
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDS 220
A LI+KML +P R T +E+L + + P+
Sbjct: 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 308
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 5e-79
Identities = 75/221 (33%), Positives = 109/221 (49%), Gaps = 9/221 (4%)
Query: 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
H HQHVV H +ED V +V+ELC L + ++ +E EA ++ IV
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV-GSPYYVAPE 120
+ H V HRDLK N ++ED +K DFGL+ + D V+ G+P Y+APE
Sbjct: 129 QYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 121 VL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
VL +K + E DVWS G I+Y LL G PPF + +I + + P +I+
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPV 241
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDS 220
A LI+KML +P R T +E+L + + P+
Sbjct: 242 AASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-76
Identities = 49/245 (20%), Positives = 97/245 (39%), Gaps = 40/245 (16%)
Query: 7 HQHVVRIHDTYEDKSCVHI--VMELCEGGELFDRIVKKGN---YSEREAAKLMKTIVGVV 61
H+++V++ E+ + H +ME C G L+ + + N E E +++ +VG +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 62 ECCHSLGVFHRDLKPENFL-FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
G+ HR++KP N + + D + K TDFG + + DE F + G+ Y+ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 121 VLR---------KHYGPEADVWSAGVILYILLSGVPPFWA----ETEIGIFRQILEGKI- 166
+ K YG D+WS GV Y +G PF + +I+ GK
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 167 ----------------DFESEPWPNISESAKD----LIRKMLDQNPKRRLTAHEVLCHPW 206
+ ++S + ++ +L+ + ++ +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 207 IVDDK 211
+ +
Sbjct: 306 DILHR 310
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-76
Identities = 73/234 (31%), Positives = 116/234 (49%), Gaps = 9/234 (3%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H ++V++ + E + ++++ME GGE+FD +V G E+EA + IV V+ CH
Sbjct: 73 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KH 125
+ HRDLK EN L D D +K DFG S + G+P Y APE+ + K
Sbjct: 133 KRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 126 Y-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLI 184
Y GPE DVWS GVILY L+SG PF + + ++L GK + + +S ++L+
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFY--MSTDCENLL 245
Query: 185 RKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKM 238
++ L NP +R T +++ WI + + ++ + M
Sbjct: 246 KRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 2e-76
Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 38/240 (15%)
Query: 1 MHHLSE--HQHVVRIHDTYED-------------KSCVHIVMELCEGGELFDRIVKKGNY 45
+ L+ HQ+VVR + + + KS + I ME CE G L+D I +
Sbjct: 53 VMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112
Query: 46 SER-EAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS------ 98
+R E +L + I+ + HS G+ HRDLKP N DE +K DFGL+
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRS 169
Query: 99 ---------VFYKPDEVFSDVVGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVP 147
+ + +G+ YVA EVL HY + D++S G+I + ++ P
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--P 227
Query: 148 PFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ I +++ I+F + N + K +IR ++D +P +R A +L W+
Sbjct: 228 FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 9e-76
Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 11/220 (5%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY-SEREAAKLMKTIVG 59
L H ++ +++ +ED + V++V+E+C GE+ + + SE EA M I+
Sbjct: 65 HCQLK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV-GSPYYVA 118
+ HS G+ HRDL N L + + +K DFGL+ K + G+P Y++
Sbjct: 124 GMLYLHSHGILHRDLTLSNLL---LTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180
Query: 119 PEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNIS 177
PE+ R +G E+DVWS G + Y LL G PPF +T +++ + P +S
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLS 236
Query: 178 ESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKP 217
AKDLI ++L +NP RL+ VL HP++ + K
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKD 276
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-75
Identities = 80/206 (38%), Positives = 106/206 (51%), Gaps = 9/206 (4%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
L H H+++++ + +VME GGELFD I K G E EA +L + I+ V+
Sbjct: 67 LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR 123
CH V HRDLKPEN L +D K DFGLS E GSP Y APEV+
Sbjct: 127 CHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183
Query: 124 -KHY-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
+ Y GPE D+WS GVILY LL G PF E +F++I G F + ++ S
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVA 239
Query: 182 DLIRKMLDQNPKRRLTAHEVLCHPWI 207
L+ ML +P +R T ++ H W
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-75
Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 11/212 (5%)
Query: 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
+ + H++VV+ + + + ++ +E C GGELFDRI E +A + ++ V
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKP---DEVFSDVVGSPYYVA 118
H +G+ HRD+KPEN L +DE LK +DFGL+ ++ + + + + G+ YVA
Sbjct: 119 VYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 119 PEVL-RKHY-GPEADVWSAGVILYILLSGVPPFWAETE-IGIFRQILEGKIDFESEPWPN 175
PE+L R+ + DVWS G++L +L+G P+ ++ + E PW
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKK 233
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
I + L+ K+L +NP R+T ++ W
Sbjct: 234 IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 5e-75
Identities = 70/226 (30%), Positives = 121/226 (53%), Gaps = 10/226 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
HL H +++R+++ + D+ +++++E GEL+ + K G + E+ +A M+ +
Sbjct: 68 QSHLR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ CH V HRD+KPEN L + LK DFG SV + P + G+ Y+ PE
Sbjct: 127 LHYCHERKVIHRDIKPENLL---MGYKGELKIADFGWSV-HAPSLRRRTMCGTLDYLPPE 182
Query: 121 VL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
++ K + + D+W AGV+ Y L G+PPF + + R+I+ + F P P +S+
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDG 238
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSR 225
+KDLI K+L +P +RL V+ HPW+ + P+ + S+
Sbjct: 239 SKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-74
Identities = 69/215 (32%), Positives = 113/215 (52%), Gaps = 10/215 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
HL H +++R++ + D + V++++E G ++ + K + E+ A + +
Sbjct: 63 QSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ CHS V HRD+KPEN L + LK DFG SV + P +D+ G+ Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGWSV-HAPSSRRTDLCGTLDYLPPE 177
Query: 121 VL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
++ + + + D+WS GV+ Y L G PPF A T +++I + F P ++E
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEG 233
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAP 214
A+DLI ++L NP +R EVL HPWI + P
Sbjct: 234 ARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-74
Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 11/212 (5%)
Query: 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
+ + H++VV+ + + + ++ +E C GGELFDRI E +A + ++ V
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKP---DEVFSDVVGSPYYVA 118
H +G+ HRD+KPEN L +DE LK +DFGL+ ++ + + + + G+ YVA
Sbjct: 119 VYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 119 PEVL-RKHY-GPEADVWSAGVILYILLSGVPPFWAETE-IGIFRQILEGKIDFESEPWPN 175
PE+L R+ + DVWS G++L +L+G P+ ++ + E PW
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKK 233
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
I + L+ K+L +NP R+T ++ W
Sbjct: 234 IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 6e-73
Identities = 72/209 (34%), Positives = 111/209 (53%), Gaps = 13/209 (6%)
Query: 6 EHQHVVRIHDTYEDKSCVHI--VMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
+H +VV++ + +D + H+ V EL G + + + SE +A + ++ +E
Sbjct: 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQARFYFQDLIKGIEY 152
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL 122
H + HRD+KP N L V ED +K DFG+S F D + S+ VG+P ++APE L
Sbjct: 153 LHYQKIIHRDIKPSNLL---VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESL 209
Query: 123 ---RKHY-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
RK + G DVW+ GV LY + G PF E + + +I E P+I+E
Sbjct: 210 SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQ--ALEFPDQPDIAE 267
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
KDLI +MLD+NP+ R+ E+ HPW+
Sbjct: 268 DLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 7e-73
Identities = 67/272 (24%), Positives = 113/272 (41%), Gaps = 32/272 (11%)
Query: 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
H ++R++D +++VME C +L + KK + E K ++ V
Sbjct: 66 QH---SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD---VVGSPYYVA 118
H G+ H DLKP NFL D LK DFG++ +PD VG+ Y+
Sbjct: 122 HTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 119 PEVL------------RKHYGPEADVWSAGVILYILLSGVPPFWAETE-IGIFRQILEGK 165
PE + + P++DVWS G ILY + G PF I I++
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237
Query: 166 IDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSA---- 221
+ E + +D+++ L ++PK+R++ E+L HP++ ++
Sbjct: 238 HEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 295
Query: 222 --VLSRLKHFSAMNKLKKMALRVIAERLNEEE 251
VL +L ++ N + K A + E
Sbjct: 296 KYVLGQLVGLNSPNSILKAAKTLYEHYSGGES 327
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 7e-73
Identities = 82/219 (37%), Positives = 115/219 (52%), Gaps = 9/219 (4%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
L H H+++++ S + +VME GGELFD I K G E+E+ +L + I+ V+
Sbjct: 72 LFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR 123
CH V HRDLKPEN L +D K DFGLS E GSP Y APEV+
Sbjct: 132 CHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 188
Query: 124 -KHY-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
+ Y GPE D+WS+GVILY LL G PF + +F++I +G F + + ++ S
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQY--LNPSVI 244
Query: 182 DLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDS 220
L++ ML +P +R T ++ H W D P D
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDP 283
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 8e-73
Identities = 49/257 (19%), Positives = 101/257 (39%), Gaps = 33/257 (12%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--------YSEREAAK 52
+ + +++ + + V+I+ E E + +
Sbjct: 97 ITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 53 LMKTIVGVVECCHS-LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV 111
++K+++ H+ + HRD+KP N L +D++ +K +DFG S Y D+
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNIL---MDKNGRVKLSDFGESE-YMVDKKIKGSR 211
Query: 112 GSPYYVAPEVLR---KHYGPEADVWSAGVILYILLSGVPPFWAETEI-GIFRQILEGKID 167
G+ ++ PE + G + D+WS G+ LY++ V PF + + +F I I+
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 168 F---------------ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212
+ + +S D ++ L +NP R+T+ + L H W+ D +
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331
Query: 213 APDKPLDSAVLSRLKHF 229
+ + + K
Sbjct: 332 EDLREFSKELYKKRKKL 348
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-72
Identities = 74/212 (34%), Positives = 106/212 (50%), Gaps = 9/212 (4%)
Query: 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
H H ++VR + + + I+ME GGEL++RI G +SE EA + ++ V
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV 129
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAA--LKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
CHS+ + HRDLK EN L +D A LK DFG S VG+P Y+AP
Sbjct: 130 SYCHSMQICHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 186
Query: 120 EVL-RKHY-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG--KIDFESEPWPN 175
EVL R+ Y G ADVWS GV LY++L G PF E +R+ ++ + +
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
IS LI ++ +P R++ E+ H W
Sbjct: 247 ISPECCHLISRIFVADPATRISIPEIKTHSWF 278
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-72
Identities = 76/219 (34%), Positives = 119/219 (54%), Gaps = 10/219 (4%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVEC 63
L H H+++++D + + +V+E GGELFD IV+K +E E + + I+ +E
Sbjct: 65 LLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR 123
CH + HRDLKPEN L +D++ +K DFGLS GSP Y APEV+
Sbjct: 124 CHRHKIVHRDLKPENLL---LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180
Query: 124 -KHY-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
K Y GPE DVWS G++LY++L G PF E +F+++ + + +S A+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDF--LSPGAQ 236
Query: 182 DLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDS 220
LIR+M+ +P +R+T E+ PW + +P++
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEE 275
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-71
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMEL-CEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
EH +++++ D +E++ +VME G +LF I + E A+ + + +V V
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR- 123
+ HRD+K EN + + ED +K DFG + + + ++F G+ Y APEVL
Sbjct: 147 RLKDIIHRDIKDENIV---IAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203
Query: 124 KHY-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
Y GPE ++WS GV LY L+ PF + +E I P+ +S+
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAI---HPPYL-VSKELMS 253
Query: 183 LIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDS 220
L+ +L P+RR T +++ PW+ D +
Sbjct: 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEE 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-71
Identities = 51/240 (21%), Positives = 98/240 (40%), Gaps = 40/240 (16%)
Query: 7 HQHVVRIHDTYEDKSCVHI--VMELCEGGELFDRIVKKGN---YSEREAAKLMKTIVGVV 61
H+++V++ E+ + H +ME C G L+ + + N E E +++ +VG +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 62 ECCHSLGVFHRDLKPENFL-FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
G+ HR++KP N + + D + K TDFG + + DE F + G+ Y+ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 121 VLR---------KHYGPEADVWSAGVILYILLSGVPPFWA----ETEIGIFRQILEGK-- 165
+ K YG D+WS GV Y +G PF + +I+ GK
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 166 -------------IDFESE--PWPNISESAKD----LIRKMLDQNPKRRLTAHEVLCHPW 206
ID+ + ++S + ++ +L+ + ++ +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 4e-71
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 23/232 (9%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
++R++D +++VME C +L + KK + E K ++ V H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD---VVGSPYYVAPEVL- 122
G+ H DLKP NFL D LK DFG++ +PD VG+ Y+ PE +
Sbjct: 146 HGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 123 -----------RKHYGPEADVWSAGVILYILLSGVPPFWAETE-IGIFRQILEGKIDFES 170
+ P++DVWS G ILY + G PF I I++ + E
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261
Query: 171 EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAV 222
+ +D+++ L ++PK+R++ E+L HP++ ++
Sbjct: 262 --PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 311
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 7e-71
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMEL-CEGGELFDRIVKKGNYSEREAAKLMKTIVG 59
+ H V+R+ D +E + +V+E +LFD I +KG E + +V
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDA-ALKATDFGLSVFYKPDEVFSDVVGSPYYVA 118
++ CHS GV HRD+K EN L +D K DFG DE ++D G+ Y
Sbjct: 151 AIQHCHSRGVVHRDIKDENIL---IDLRRGCAKLIDFGSGALLH-DEPYTDFDGTRVYSP 206
Query: 119 PEVLR-KHY-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI 176
PE + Y A VWS G++LY ++ G PF + ++ILE ++ F P ++
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHF---P-AHV 256
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
S LIR+ L P R + E+L PW+
Sbjct: 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 9e-71
Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 32/271 (11%)
Query: 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
H ++R++D +++VME C +L + KK + E K ++ V
Sbjct: 113 QH---SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVA 118
H G+ H DLKP NFL D LK DFG++ +PD V VG+ Y+
Sbjct: 169 HTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 119 PEVL------------RKHYGPEADVWSAGVILYILLSGVPPFWAETE-IGIFRQILEGK 165
PE + + P++DVWS G ILY + G PF I I++
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284
Query: 166 IDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSA---- 221
+ E + +D+++ L ++PK+R++ E+L HP++ ++
Sbjct: 285 HEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 342
Query: 222 --VLSRLKHFSAMNKLKKMALRVIAERLNEE 250
VL +L ++ N + K A + E
Sbjct: 343 KYVLGQLVGLNSPNSILKAAKTLYEHYSGGE 373
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 3e-69
Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEG-GELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
V+R+ D +E +++E E +LFD I ++G E A ++ V CH
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 66 SLGVFHRDLKPENFLFLSVDEDAA-LKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR- 123
+ GV HRD+K EN L +D + LK DFG K D V++D G+ Y PE +R
Sbjct: 167 NCGVLHRDIKDENIL---IDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRY 222
Query: 124 KHY-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
Y G A VWS G++LY ++ G PF + +I+ G++ F +S +
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFF---R-QRVSSECQH 272
Query: 183 LIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKP 217
LIR L P R T E+ HPW+ D + +
Sbjct: 273 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA 307
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 4e-69
Identities = 54/269 (20%), Positives = 98/269 (36%), Gaps = 38/269 (14%)
Query: 7 HQHVVRIHDTYEDKSCVH------IVMELCEGGELFDRIVKKGN---YSEREAAKLMKTI 57
H +VV + + + + ME CEGG+L + + N E L+ I
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 58 VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
+ H + HRDLKPEN + + K D G + E+ ++ VG+ Y+
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 118 APEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI 176
APE+L K Y D WS G + + ++G PF + + + K + + ++
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 177 SES--------------------AKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDK 216
+ + + ++ ML + ++R T + +
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF--------Q 302
Query: 217 PLDSAVLSRLKHFSAMNKLKKMALRVIAE 245
LDS + +L M + V
Sbjct: 303 ALDSILSLKLLSVMNMVSGRVHTYPVTEN 331
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-65
Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 18/222 (8%)
Query: 7 HQHVVRIHD--TYEDKSCVHIVMELCEGG--ELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
H++V+++ D E+K +++VME C G E+ D + +K + +A ++ +E
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLE 123
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVF---YKPDEVFSDVVGSPYYVAP 119
HS G+ H+D+KP N L + LK + G++ + D+ GSP + P
Sbjct: 124 YLHSQGIVHKDIKPGNLL---LTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 120 EVLR--KHY-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI 176
E+ + G + D+WSAGV LY + +G+ PF + +F I +G +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--C 236
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPL 218
DL++ ML+ P +R + ++ H W + P+
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 209 bits (532), Expect = 3e-65
Identities = 35/238 (14%), Positives = 74/238 (31%), Gaps = 36/238 (15%)
Query: 3 HLSEHQHVVRIHDTYEDKSC--VHIVMELCE------GGELFDRIVKKGNYSEREAAKLM 54
+ + ++R+ D + + G L + +L
Sbjct: 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 212
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
++ ++ H G+ H L+P + + +D+ + T F V D S
Sbjct: 213 LQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLV---RDGARVVSSVSR 266
Query: 115 YYVAPEVL------------RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162
+ PE+ R D W+ G+++Y + P + +G I
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF 326
Query: 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI--VDDKVAPDKPL 218
NI + + L+ L + RL + + P + +++ PL
Sbjct: 327 RS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPL 376
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-63
Identities = 33/220 (15%), Positives = 60/220 (27%), Gaps = 21/220 (9%)
Query: 4 LSEHQHVVRIHDTYEDKSCVH--IVMELCEG-----GELFDRIVKKGNYSEREAAK-LMK 55
+ ++ +D + + ++M D + A L
Sbjct: 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTA 201
Query: 56 TIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY 115
++ + S G+ H P+N + D L D K
Sbjct: 202 QLIRLAANLQSKGLVHGHFTPDNLF---IMPDGRLMLGDVSALW--KVGTRGPASSVPVT 256
Query: 116 YVAPEVLRKH---YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE-----GKID 167
Y E L + + W G+ +Y + PF T G
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDS 316
Query: 168 FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ + K LI + L+ + +RRL E + P
Sbjct: 317 LAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-61
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 12/209 (5%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY-SEREAAKLMKTIVG 59
+ +H VR+ +E+ +++ ELC G L G E + ++ +
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
+ HS G+ H D+KP N + K DFGL V G P Y+AP
Sbjct: 169 ALAHLHSQGLVHLDVKPANIF---LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225
Query: 120 EVLRKHYGPEADVWSAGVILYILLSGVP-PFWAETEIGIFRQILEGKIDFESEPWPNISE 178
E+L+ YG ADV+S G+ + + + P E + + L + +S
Sbjct: 226 ELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSS 279
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ ++ ML+ +PK R TA +L P +
Sbjct: 280 ELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-60
Identities = 71/217 (32%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 7 HQHVVRIHDTYEDKS--CVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGV 60
H ++VR +D D++ ++IVME CEGG+L I K + E ++M +
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 61 VECCHSLG-----VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF-SDVVGSP 114
++ CH V HRDLKP N +FL D +K DFGL+ D F VG+P
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPAN-VFL--DGKQNVKLGDFGLARILNHDTSFAKTFVGTP 180
Query: 115 YYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW 173
YY++PE + Y ++D+WS G +LY L + +PPF A ++ + +I EGK
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----RRI 236
Query: 174 PNI-SESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
P S+ ++I +ML+ R + E+L +P I++
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-59
Identities = 54/206 (26%), Positives = 106/206 (51%), Gaps = 12/206 (5%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECC 64
H ++V+ +++E+ ++IVM+ CEGG+LF RI + + E + I ++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD-VVGSPYYVAPEVLR 123
H + HRD+K +N +FL +D ++ DFG++ + +G+PYY++PE+
Sbjct: 142 HDRKILHRDIKSQN-IFL--TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198
Query: 124 -KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP-NISESAK 181
K Y ++D+W+ G +LY L + F A + + +I+ G P + S +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP----PVSLHYSYDLR 254
Query: 182 DLIRKMLDQNPKRRLTAHEVLCHPWI 207
L+ ++ +NP+ R + + +L +I
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFI 280
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-55
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 7 HQHVVRIHDTYED----------------KSCVHIVMELCEGGELFDRIVKKGNY--SER 48
H ++V + ++ C+ I ME C+ G L I K+ +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 49 EAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS 108
A +L + I V+ HS + +RDLKP N +FL + +K DFGL K D +
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSN-IFL--VDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 109 DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKID 167
G+ Y++PE + + YG E D+++ G+IL LL + ++ F + +G I
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF--FTDLRDGIIS 237
Query: 168 FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ K L++K+L + P+ R E+L +
Sbjct: 238 ------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-53
Identities = 46/231 (19%), Positives = 86/231 (37%), Gaps = 28/231 (12%)
Query: 1 MHHLSEHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRI----VKKGNYSEREAAK 52
MH L H +++R+ + +++ + G L++ I K +E +
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD-------- 104
L+ I +E H+ G HRDLKP N L + ++ D G
Sbjct: 139 LLLGICRGLEAIHAKGYAHRDLKPTNIL---LGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 105 --EVFSDVVGSPYYVAPEVL----RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG-I 157
+ ++ + Y APE+ DVWS G +LY ++ G P+ + G
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255
Query: 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208
++ ++ P S + L+ M+ +P +R +L +
Sbjct: 256 VALAVQNQLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-52
Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY----SEREAAKLMKTIVGVVE 62
H +V++ + ++ + + ++IV+EL + G+L I ER K + +E
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEV 121
HS V HRD+KP N +F+ +K D GL F +VG+PYY++PE
Sbjct: 151 HMHSRRVMHRDIKPAN-VFI--TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 122 LR-KHYGPEADVWSAGVILYILLSGVPPFWAETE--IGIFRQILEGKIDFESEPWPNISE 178
+ Y ++D+WS G +LY + + PF+ + + ++I + D+ P + SE
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE 265
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208
+ L+ ++ +P++R V +
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-52
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 4 LSEHQH--VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
+S H V+++ T++D ++ + + GEL I K G++ E IV +
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS---VFYKPDEVFSDVVGSPYYVA 118
E H G+ HRDLKPEN L ++ED ++ TDFG + + VG+ YV+
Sbjct: 144 EYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 119 PEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNIS 177
PE+L K +D+W+ G I+Y L++G+PPF A E IF++I++ + DF P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---P-EKFF 256
Query: 178 ESAKDLIRKMLDQNPKRRLT------AHEVLCHPW 206
A+DL+ K+L + +RL + HP+
Sbjct: 257 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-51
Identities = 33/234 (14%), Positives = 71/234 (30%), Gaps = 29/234 (12%)
Query: 3 HLSEHQHVVRIHDTYEDKSCVH--IVMELCEG------GELFDRIVKKGNYSEREAAKLM 54
+ + ++R+ D + + + L + +L
Sbjct: 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 217
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD--VVG 112
++ ++ H G+ H L+P + + +D+ + T F V V
Sbjct: 218 LQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLVRDGASAVSPIGRGFA 274
Query: 113 SPYYVAPEVLRKH------YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKI 166
P A +L D W+ G+ +Y + P + +G I
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-- 332
Query: 167 DFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI--VDDKVAPDKPL 218
NI + + L+ L + RL + + P + +++ PL
Sbjct: 333 ------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPL 380
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-51
Identities = 59/245 (24%), Positives = 96/245 (39%), Gaps = 40/245 (16%)
Query: 6 EHQHVVRIHDTYEDKSC------------VHIVMELCEGGELFDRIVKKGNYSERE---A 50
EH +VR + + +K+ ++I M+LC L D + + ERE
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 51 AKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS------------ 98
+ I VE HS G+ HRDLKP N +F D +K DFGL
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSN-IFF--TMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 99 -VFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE-I 155
+ VG+ Y++PE + Y + D++S G+IL+ LL PF + E +
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234
Query: 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPD 215
+ K + +++ ML +P R A ++ + +D P
Sbjct: 235 RTLTDVRNLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF-EDLDFPG 290
Query: 216 KPLDS 220
K +
Sbjct: 291 KTVLR 295
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-49
Identities = 35/101 (34%), Positives = 57/101 (56%), Gaps = 1/101 (0%)
Query: 199 HEVLCHPWIVDD-KVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKE 257
H H ++ L S +L LK+F N+LKK+AL +IA+ L + EI L+
Sbjct: 2 HHHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRN 61
Query: 258 LFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+F +D DNSGT++ E+ DGLK++G Q + +I ++ +
Sbjct: 62 IFIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDI 102
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 9e-07
Identities = 16/54 (29%), Positives = 25/54 (46%), Gaps = 5/54 (9%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKD--GLKRVGSQLMESEIKDLMDAV 298
L +E FK D D +G I+ +ELK G + + L++ I L+ V
Sbjct: 126 LKKEV---CLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEV 176
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 5e-49
Identities = 41/231 (17%), Positives = 81/231 (35%), Gaps = 30/231 (12%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY-----SEREAAKLMKTIVGVV 61
++ + + ++ +V EL G L + I N + ++ ++
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185
Query: 62 ECCHSLGVFHRDLKPENFLFLSV--------DEDAALKATDFGLSVFYK---PDEVFSDV 110
E H + H D+KP+NF+ + D A L D G S+ K +F+
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 111 VGSPYYVAPEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFE 169
+ + E+L K + + D + +Y +L G + E G + +
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV-KNEGGECKPEGLFRRLPH 304
Query: 170 SEPWPNI-----------SESAKDLIRKMLDQNPKRRLTAH-EVLCHPWIV 208
+ W + DL+R+ L + ++ T L + IV
Sbjct: 305 LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIV 355
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-48
Identities = 65/264 (24%), Positives = 97/264 (36%), Gaps = 42/264 (15%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSC--------VHIVMELCEGGELFDRIVK---KGNYSERE 49
M LS H ++V+ ++ ELC+G L + + K +G S
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ-LVEFLKKMESRGPLSCDT 137
Query: 50 AAKLMKTIVGVVECCHSLG--VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF 107
K+ V+ H + HRDLK EN L + +K DFG + +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL---LSNQGTIKLCDFGSATTISHYPDY 194
Query: 108 SD-------------VVGSPYYVAPEVL----RKHYGPEADVWSAGVILYILLSGVPPFW 150
S +P Y PE++ G + D+W+ G ILY+L PF
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF- 253
Query: 151 AETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210
E G +I+ GK P LIR ML NP+ RL+ EV+ +
Sbjct: 254 ---EDGAKLRIVNGKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 211 --KVAPDKPLDSAVLSRLKHFSAM 232
V P P+ + + SA
Sbjct: 309 ARNVNPKSPITELLEQNGGYGSAT 332
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-48
Identities = 67/211 (31%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 4 LSEHQH--VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
L +V++ +++D S +++VME GGE+F + + G +SE A IV
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV 121
E HSL + +RDLKPEN L +D+ ++ TDFG + + + G+P +APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEI 209
Query: 122 L-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
+ K Y D W+ GV++Y + +G PPF+A+ I I+ +I+ GK+ F P + S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDL 265
Query: 181 KDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
KDL+R +L + +R +++ H W
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-47
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSERE---AAKLMKTIV 58
++ V K ++I M+LC L D + ++ + +RE + I
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174
Query: 59 GVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV-------- 110
VE HS G+ HRDLKP N +F ++D+ +K DFGL DE V
Sbjct: 175 EAVEFLHSKGLMHRDLKPSN-IFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 111 -----VGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE-IGIFRQILE 163
VG+ Y++PE + +Y + D++S G+IL+ LL F + E + I +
Sbjct: 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN 288
Query: 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
K + +++ ML +P R A +++ +
Sbjct: 289 LKF---PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-47
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 15/212 (7%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+ VV++ ++D +++VME GG+L ++ + E+ A +V ++
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAI 184
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVL 122
HS+G HRD+KP+N L +D+ LK DFG + + + VG+P Y++PEVL
Sbjct: 185 HSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 123 RK-----HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNIS 177
+ +YG E D WS GV LY +L G PF+A++ +G + +I+ K +IS
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301
Query: 178 ESAKDLIRKMLDQNPKRRLT---AHEVLCHPW 206
+ AK+LI L + + RL E+ H +
Sbjct: 302 KEAKNLICAFL-TDREVRLGRNGVEEIKRHLF 332
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-47
Identities = 66/211 (31%), Positives = 111/211 (52%), Gaps = 17/211 (8%)
Query: 4 LSEHQH--VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
LS H ++R+ T++D + ++M+ EGGELF + K + A + +
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV 121
E HS + +RDLKPEN L +D++ +K TDFG + +V + G+P Y+APEV
Sbjct: 120 EYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEV 174
Query: 122 L-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
+ K Y D WS G+++Y +L+G PF+ + + +IL ++ F P P +E
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDV 230
Query: 181 KDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
KDL+ +++ ++ +RL +V HPW
Sbjct: 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-45
Identities = 25/97 (25%), Positives = 48/97 (49%), Gaps = 1/97 (1%)
Query: 202 LCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKM 261
+ H VL K++ + K +K+A+ +IA++ N+ ++ LK F +
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 262 IDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+D D G IT ++LK GL++ G + + L+D +
Sbjct: 61 LDEDGKGYITKEQLKKGLEKDGLK-LPYNFDLLLDQI 96
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-07
Identities = 15/66 (22%), Positives = 30/66 (45%), Gaps = 8/66 (12%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG-----SQLMESEIK 292
+A + ++L+++ + F++ D DN G IT EL L +Q + +K
Sbjct: 110 IAAALDRKQLSKKL---IYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVK 166
Query: 293 DLMDAV 298
++ V
Sbjct: 167 RMIRDV 172
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-45
Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKL-MKTIVGVVECC 64
EH +V + +++D+ + +V++L GG+L + + ++ E E KL + +V ++
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE-ETVKLFICELVMALDYL 131
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK 124
+ + HRD+KP+N L DE + TDF ++ + + + G+ Y+APE+
Sbjct: 132 QNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 125 H----YGPEADVWSAGVILYILLSGVPPFW---AETEIGIFRQILEGKIDFESEPWPNIS 177
Y D WS GV Y LL G P+ + + I + + P S
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P-SAWS 244
Query: 178 ESAKDLIRKMLDQNPKRRL-TAHEVLCHPW 206
+ L++K+L+ NP +R +V P+
Sbjct: 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-45
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKL-MKTIVGVVEC 63
+ + + ++H ++D++ +++VME GG+L + K G E A+ + IV ++
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEV 121
H LG HRD+KP+N L +D ++ DFG + + D VG+P Y++PE+
Sbjct: 178 VHRLGYVHRDIKPDNIL---LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 122 LRK--------HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW 173
L+ YGPE D W+ GV Y + G PF+A++ + +I+ K
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294
Query: 174 P-NISESAKDLIRKMLDQNPKRRLT---AHEVLCHPW 206
+ E A+D I+++L P+ RL A + HP+
Sbjct: 295 DEGVPEEARDFIQRLL-CPPETRLGRGGAGDFRTHPF 330
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 9e-44
Identities = 63/214 (29%), Positives = 111/214 (51%), Gaps = 15/214 (7%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVEC 63
+ + + +H ++D + +++VM+ GG+L + K + E A + +V ++
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEV 121
H L HRD+KP+N L +D + ++ DFG + D S VG+P Y++PE+
Sbjct: 191 VHQLHYVHRDIKPDNIL---MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 122 L------RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW-P 174
L + YGPE D WS GV +Y +L G PF+AE+ + + +I+ K F+
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307
Query: 175 NISESAKDLIRKMLDQNPKR--RLTAHEVLCHPW 206
++SE+AKDLIR+++ R + + HP+
Sbjct: 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-43
Identities = 50/229 (21%), Positives = 96/229 (41%), Gaps = 35/229 (15%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVG 59
L +H HVVR + + + I E C GG L D I + + E E L+ +
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAAL-----------------KATDFGLSVFYK 102
+ HS+ + H D+KP N +F+S K D G
Sbjct: 127 GLRYIHSMSLVHMDIKPSN-IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 103 PDEVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160
+V G ++A EVL+++ + P+AD+++ + + P + + +
Sbjct: 186 SPQVE---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE 239
Query: 161 ILEGKIDFESEPWP-NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208
I +G++ P +S+ +L++ M+ +P+RR +A ++ H ++
Sbjct: 240 IRQGRL----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-43
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
+ +V + + + +++L GG+L + + G +SE + I+ +E
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL 122
H+ V +RDLKP N L +DE ++ +D GL+ + + + VG+ Y+APEVL
Sbjct: 307 HMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVL 362
Query: 123 RKH--YGPEADVWSAGVILYILLSGVPPFWAETEIG---IFRQILEGKIDFESEPWPNIS 177
+K Y AD +S G +L+ LL G PF I R L ++ + S
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFS 418
Query: 178 ESAKDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
+ L+ +L ++ RRL A EV P+
Sbjct: 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-42
Identities = 65/212 (30%), Positives = 110/212 (51%), Gaps = 16/212 (7%)
Query: 4 LSEHQH--VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
L E +H +V + ++ +++++E GGELF ++ ++G + E A + I +
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPE 120
H G+ +RDLKPEN + ++ +K TDFGL V G+ Y+APE
Sbjct: 135 GHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 121 VLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
+L + + D WS G ++Y +L+G PPF E +IL+ K++ P P +++
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQE 247
Query: 180 AKDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
A+DL++K+L +N RL A EV HP+
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-42
Identities = 63/212 (29%), Positives = 112/212 (52%), Gaps = 16/212 (7%)
Query: 4 LSEHQH--VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
L E H +V++H ++ + ++++++ GG+LF R+ K+ ++E + + + +
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPE 120
+ HSLG+ +RDLKPEN L +DE+ +K TDFGLS ++ G+ Y+APE
Sbjct: 140 DHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 121 VLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
V+ + + AD WS GV+++ +L+G PF + IL+ K+ P +S
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPE 252
Query: 180 AKDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
A+ L+R + +NP RL E+ H +
Sbjct: 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
EH + + T++ K + VME GG+L I + A I+ ++
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVLR 123
HS G+ +RDLK +N L +D+D +K DFG+ D + G+P Y+APE+L
Sbjct: 135 HSKGIVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 191
Query: 124 -KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
+ Y D WS GV+LY +L G PF + E +F I + P + + AKD
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKD 247
Query: 183 LIRKMLDQNPKRRLTAH-EVLCHPW 206
L+ K+ + P++RL ++ HP
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQHPL 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-41
Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 4 LSEHQH--VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
L +H + + ++ + VME GGELF + ++ ++E A IV +
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPE 120
E HS V +RD+K EN + +D+D +K TDFGL G+P Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 121 VLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
VL + YG D W GV++Y ++ G PF+ + +F IL +I F P +S
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSPE 231
Query: 180 AKDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
AK L+ +L ++PK+RL A EV+ H +
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H + ++ ++ + VME GG+L I K + E A I+ +
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVLR 123
H G+ +RDLK +N L +D + K DFG+ + G+P Y+APE+L+
Sbjct: 141 HDKGIIYRDLKLDNVL---LDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197
Query: 124 KH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
+ YGP D W+ GV+LY +L G PF AE E +F IL ++ + P + E A
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---P-TWLHEDATG 253
Query: 183 LIRKMLDQNPKRRL------TAHEVLCHPW 206
+++ + +NP RL H +L HP+
Sbjct: 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-40
Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+ + ++H ++ ++ VME GG+L I + G + E A I +
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVLR 123
S G+ +RDLK +N + D + +K DFG+ G+P Y+APE++
Sbjct: 138 QSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194
Query: 124 KH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
YG D W+ GV+LY +L+G PF E E +F+ I+E + + P ++S+ A
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVA 250
Query: 183 LIRKMLDQNPKRRLTAH-----EVLCHPW 206
+ + ++ ++P +RL ++ H +
Sbjct: 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAF 279
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+H +V +H +++ ++ V++ GGELF + ++ + E A I +
Sbjct: 96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYL 155
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVLR 123
HSL + +RDLKPEN L +D + TDFGL + + S G+P Y+APEVL
Sbjct: 156 HSLNIVYRDLKPENIL---LDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 124 KH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
K Y D W G +LY +L G+PPF++ ++ IL + PNI+ SA+
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---K-PNITNSARH 268
Query: 183 LIRKMLDQNPKRRL----TAHEVLCHPW 206
L+ +L ++ +RL E+ H +
Sbjct: 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVF 296
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 67/211 (31%), Positives = 114/211 (54%), Gaps = 21/211 (9%)
Query: 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGV 69
+V +H ++ ++ +H++++ GGELF + ++ ++E E + IV +E H LG+
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 70 FHRDLKPENFLFLSVDEDAALKATDFGLS--VFYKPDEVFSDVVGSPYYVAPEVLRKH-- 125
+RD+K EN L +D + + TDFGLS E D G+ Y+AP+++R
Sbjct: 181 IYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 237
Query: 126 -YGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQILEGKIDFESEPWPNISESA 180
+ D WS GV++Y LL+G PF + E I R+IL+ + + P +S A
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QEMSALA 293
Query: 181 KDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
KDLI+++L ++PK+RL A E+ H +
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 47/210 (22%), Positives = 88/210 (41%), Gaps = 12/210 (5%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+V ++ + V+I MEL EGG L I + G E A + + +E H
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH 167
Query: 66 SLGVFHRDLKPENFLFLSVDED-AALKATDFGLSVFYKPDEVFS------DVVGSPYYVA 118
+ + H D+K +N L + D + DFG ++ +PD + + G+ ++A
Sbjct: 168 TRRILHGDVKADNVL---LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 119 PEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNIS 177
PEV+ + D+WS+ ++ +L+G P+ + +I P P+ +
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCA 283
Query: 178 ESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
I++ L + P R +A E+
Sbjct: 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGK 313
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-39
Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
S H + + +++ + VME GGELF + ++ +SE A IV ++
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 65 HS-LGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL 122
HS V +RDLK EN + +D+D +K TDFGL K G+P Y+APEVL
Sbjct: 265 HSEKNVVYRDLKLENLM---LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 123 RKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
+ YG D W GV++Y ++ G PF+ + +F IL +I F P + AK
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P-RTLGPEAK 377
Query: 182 DLIRKMLDQNPKRRL-----TAHEVLCHPW 206
L+ +L ++PK+RL A E++ H +
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 9e-39
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECC 64
+ VV + YE K + +V+ L GG+L I G + E A I +E
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR- 123
H + +RDLKPEN L +D+ ++ +D GL+V + VG+ Y+APEV++
Sbjct: 303 HRERIVYRDLKPENIL---LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQILEGKIDFESEPWPNISES 179
+ Y D W+ G +LY +++G PF + + R + E ++ S
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQ 415
Query: 180 AKDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
A+ L ++L ++P RL +A EV HP
Sbjct: 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-38
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+ + ++H ++ ++ VME GG+L I + G + E A I +
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV----GSPYYVAPE 120
S G+ +RDLK +N + +D + +K DFG+ K + G+P Y+APE
Sbjct: 459 QSKGIIYRDLKLDNVM---LDSEGHIKIADFGMC---KENIWDGVTTKTFCGTPDYIAPE 512
Query: 121 VL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
++ + YG D W+ GV+LY +L+G PF E E +F+ I+E + + P ++S+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKE 568
Query: 180 AKDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
A + + ++ ++P +RL ++ H +
Sbjct: 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
S H +V +H ++ +S + V+E GG+L + ++ E A I +
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVLR 123
H G+ +RDLK +N L +D + +K TD+G+ +P + S G+P Y+APE+LR
Sbjct: 127 HERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183
Query: 124 KH-YGPEADVWSAGVILYILLSGVPPFW---------AETEIGIFRQILEGKIDFESEPW 173
YG D W+ GV+++ +++G PF TE +F+ ILE +I P
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P- 239
Query: 174 PNISESAKDLIRKMLDQNPKRRLTAH------EVLCHPW 206
++S A +++ L+++PK RL H ++ HP+
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 8/201 (3%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
HQ++V + D E+ C ++VME EG L + I G S A I+ ++ H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPE-VLR 123
+ + HRD+KP+N L +D + LK DFG++ + + V+G+ Y +PE
Sbjct: 130 MRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI-FRQILEGKIDFESEPWPNISESAKD 182
+ D++S G++LY +L G PPF ET + I + I + + ++ +I +S +
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246
Query: 183 LIRKMLDQNPKRR-LTAHEVL 202
+I + +++ R T E+
Sbjct: 247 VILRATEKDKANRYKTIQEMK 267
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-38
Identities = 61/243 (25%), Positives = 104/243 (42%), Gaps = 37/243 (15%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H ++V + + + K +H+V E C+ DR + E + + V C
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFC 118
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL- 122
H HRD+KPEN L + + + +K DFG + + P + + D V + +Y +PE+L
Sbjct: 119 HKHNCIHRDVKPENIL---ITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQI-------------LEG 164
YGP DVW+ G + LLSGVP + ++++ I + + +
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235
Query: 165 KIDFESEPW----------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAP 214
+ PNIS A L++ L +P RLT ++L HP+ + +
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295
Query: 215 DKP 217
D
Sbjct: 296 DLA 298
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-38
Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 35/234 (14%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H ++V+++D K + +V E + +L D +G A + ++ + C
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYC 116
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL- 122
H V HRDLKP+N L ++ + LK DFGL+ F P ++ + + +Y AP+VL
Sbjct: 117 HDRRVLHRDLKPQNLL---INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFR--------------QILE 163
K Y D+WS G I +++G P F +E IFR ++ +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 164 GKIDFESEP-------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210
+F + ES DL+ KML +P +R+TA + L H + ++
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
S H +V +H ++ +S + V+E GG+L + ++ E A I +
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVLR 123
H G+ +RDLK +N L +D + +K TD+G+ +P + S G+P Y+APE+LR
Sbjct: 170 HERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 124 KH-YGPEADVWSAGVILYILLSGVPPFW---------AETEIGIFRQILEGKIDFESEPW 173
YG D W+ GV+++ +++G PF TE +F+ ILE +I P
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P- 282
Query: 174 PNISESAKDLIRKMLDQNPKRRLTAH------EVLCHPW 206
++S A +++ L+++PK RL H ++ HP+
Sbjct: 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV----KKGNYSEREAAKLMKTIVGVVE 62
+ +V + +E K+ + +VM + GG++ I + E A IV +E
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSV-FYKPDEVFSDVVGSPYYVAPEV 121
H + +RDLKPEN L +D+D ++ +D GL+V G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVL---LDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 122 LR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQILEGKIDFESEPWPNI 176
L + Y D ++ GV LY +++ PF A E + +++LE + + P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY---P-DKF 416
Query: 177 SESAKDLIRKMLDQNPKRRL-----TAHEVLCHPW 206
S ++KD +L ++P++RL + + HP
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-37
Identities = 59/239 (24%), Positives = 96/239 (40%), Gaps = 32/239 (13%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H++++ + +H++ E E +L + K + S R + ++ V CHS
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 67 LGVFHRDLKPENFLF--LSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL- 122
HRDLKP+N L E LK DFGL+ F P F+ + + +Y PE+L
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL 210
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFR-------QILEG------ 164
+HY D+WS I +L P F ++EI IF G
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270
Query: 165 ---------KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAP 214
+ + + DL+ ML+ +P +R++A L HP+ + P
Sbjct: 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-37
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 7 HQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
H +V ++DT E +IVME +G L D + +G + + A +++ +
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF----SDVVGSPYYVA 118
H G+ HRD+KP N + + A+K DFG++ + V+G+ Y++
Sbjct: 131 FSHQNGIIHRDVKPANIM---ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 119 PE-VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNIS 177
PE +DV+S G +LY +L+G PPF ++ + + Q + S +S
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247
Query: 178 ESAKDLIRKMLDQNPKRR-LTAHEVL 202
++ K L +NP+ R TA E+
Sbjct: 248 ADLDAVVLKALAKNPENRYQTAAEMR 273
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 36/231 (15%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H ++V + D + C+ +V E E ++ D K + + + ++ V C
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL- 122
H + HRDLKP+N L ++ D ALK DFGL+ F P ++ V + +Y AP+VL
Sbjct: 136 HQHRILHRDLKPQNLL---INSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM 192
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFR-------QILEG------ 164
K Y D+WS G I +++G P F T+ IF +
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 165 --KIDFESEP-------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
+ F+ P + DL+ ML +P +R++A + + HP+
Sbjct: 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-36
Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 37/232 (15%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H+++V + + + K ++V E + + + + K + I+ + C
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFC 140
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL- 122
HS + HRD+KPEN L V + +K DFG + P EV+ D V + +Y APE+L
Sbjct: 141 HSHNIIHRDIKPENIL---VSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV 197
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFR-------QILEG------ 164
YG DVW+ G ++ + G P F +++I I + E
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257
Query: 165 --KIDF----ESEPW----PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
+ E EP P +SE DL +K L +P +R E+L H +
Sbjct: 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-36
Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 36/231 (15%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H ++V +HD + + +V E + + D + + ++ + C
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL- 122
H V HRDLKP+N L ++E LK DFGL+ P + + + V + +Y P++L
Sbjct: 117 HRQKVLHRDLKPQNLL---INERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFR-------QILEG------ 164
Y + D+W G I Y + +G P F T IFR + G
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233
Query: 165 --KIDFESEP-------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
++ P + DL+ K+L + R++A + + HP+
Sbjct: 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-36
Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 38/232 (16%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H+++VR+HD + +V E C+ + FD G+ + ++ + C
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL- 122
HS V HRDLKP+N L ++ + LK +FGL+ F P +S V + +Y P+VL
Sbjct: 118 HSRNVLHRDLKPQNLL---INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 123 -RKHYGPEADVWSAGVILYILLS-GVPPFWAETEIG----IFR----------------- 159
K Y D+WSAG I L + G P F IFR
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 160 -----QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
+ + P ++ + +DL++ +L NP +R++A E L HP+
Sbjct: 235 DYKPYPMYPATTSLVNV-VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-36
Identities = 56/252 (22%), Positives = 94/252 (37%), Gaps = 45/252 (17%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGG-----ELFDRIVKKGNYSEREAAKLMKTIVGVV 61
H+++VR++D ++ + +V E + + ++ +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 62 ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPE 120
CH + HRDLKP+N L +++ LK DFGL+ F P FS V + +Y AP+
Sbjct: 122 AFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 121 VL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFR--------------- 159
VL + Y D+WS G IL +++G P F + IF
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 160 -------------QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
+ L + + + D + +L NP RL+A + L HPW
Sbjct: 239 LPKYNPNIQQRPPRDLRQV--LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
Query: 207 IVDDKVAPDKPL 218
+
Sbjct: 297 FAEYYHHASMGG 308
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-35
Identities = 46/212 (21%), Positives = 98/212 (46%), Gaps = 12/212 (5%)
Query: 6 EHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
+H ++VR +D++E K C+ +V EL G L + + + + I+ +
Sbjct: 83 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGL 142
Query: 62 ECCHSLG--VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
+ H+ + HRDLK +N +F++ ++K D GL+ + + V+G+P ++AP
Sbjct: 143 QFLHTRTPPIIHRDLKCDN-IFIT-GPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAP 199
Query: 120 EVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIG-IFRQILEGKIDFESEPWPNISE 178
E+ + Y DV++ G+ + + + P+ I+R++ G +
Sbjct: 200 EMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIP 257
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210
K++I + QN R + ++L H + ++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 34/229 (14%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H +++ + D + KS + +V + E + + M + +E
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL- 122
H + HRDLKP N L +DE+ LK DFGL+ F P+ ++ V + +Y APE+L
Sbjct: 129 HQHWILHRDLKPNNLL---LDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185
Query: 123 -RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQI-------------LEG 164
+ YG D+W+ G IL LL VP ++++ IF + L
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 165 KIDFESEP-------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
+ F+S P + + DLI+ + NP R+TA + L +
Sbjct: 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 63/243 (25%), Positives = 95/243 (39%), Gaps = 35/243 (14%)
Query: 3 HLSEHQHVVRIHD-----TYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMK 55
EH +VVR+ D + + V +V E + D+ LM+
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPAETIKDLMR 127
Query: 56 TIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY 115
+ ++ H+ + HRDLKPEN L V +K DFGL+ Y + VV + +
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENIL---VTSGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 116 YVAPEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFR-------QILE 163
Y APEVL + Y D+WS G I + P F +E IF
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 164 GKI---DFESEPW---------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
+ P P + ES L+ +ML NP +R++A L H ++ D+
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304
Query: 212 VAP 214
P
Sbjct: 305 GNP 307
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 20/218 (9%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG---NYSEREAAKLMKTIVGVVE 62
+H+++V+ ++ + + I ME GG L + K +E+ K I+ ++
Sbjct: 77 KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 63 CCHSLGVFHRDLKPENFLFLSVD-EDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPE 120
H + HRD+K +N L ++ LK +DFG S + G+ Y+APE
Sbjct: 137 YLHDNQIVHRDIKGDNVL---INTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193
Query: 121 VLRKH---YGPEADVWSAGVILYILLSGVPPFWAETEIG---IFRQILEGKIDFESEPWP 174
++ K YG AD+WS G + + +G PP + E +F+ + K P
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPP-FYELGEPQAAMFK-VGMFK---VHPEIP 248
Query: 175 -NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
++S AK I K + +P +R A+++L ++
Sbjct: 249 ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 25/203 (12%)
Query: 6 EHQHVVRIHDTYED-----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
H +V+I + E +IVME G L EA + I+
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ HS+G+ + DLKPEN + + E+ LK D G F + G+P + APE
Sbjct: 195 LSYLHSIGLVYNDLKPENIM---LTEEQ-LKLIDLGAV---SRINSFGYLYGTPGFQAPE 247
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
++R D+++ G L L +P G+ E +P +S
Sbjct: 248 IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYDSY 297
Query: 181 KDLIRKMLDQNPKRR-LTAHEVL 202
L+R+ +D +P++R TA E+
Sbjct: 298 GRLLRRAIDPDPRQRFTTAEEMS 320
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 61/252 (24%), Positives = 101/252 (40%), Gaps = 42/252 (16%)
Query: 3 HLSEHQHVVRIHD-----TYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMK 55
EH +VVR+ D + ++ + +V E + D++ + +M
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMF 127
Query: 56 TIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY 115
++ ++ HS V HRDLKP+N L V +K DFGL+ Y + VV + +
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNIL---VTSSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 116 YVAPEVL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFR-------QILE 163
Y APEVL + Y D+WS G I + P F +++ I +
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244
Query: 164 GKIDFESEPW---------------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208
+ P +I E KDL+ K L NP +R++A+ L HP+
Sbjct: 245 R---DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
Query: 209 D-DKVAPDKPLD 219
D ++ +
Sbjct: 302 DLERCKENLDSH 313
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 53/192 (27%), Positives = 92/192 (47%), Gaps = 7/192 (3%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
HVV IHD E +++ M L G +L + ++G + A +++ I ++ H+
Sbjct: 93 EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR- 123
G HRD+KPEN L V D DFG++ +++ + VG+ YY+APE
Sbjct: 153 AGATHRDVKPENIL---VSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDL 183
H AD+++ +LY L+G PP+ + + + + I S P I + +
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQGDQ-LSVMGAHINQAIPRPSTVRPGIPVAFDAV 268
Query: 184 IRKMLDQNPKRR 195
I + + +NP+ R
Sbjct: 269 IARGMAKNPEDR 280
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-33
Identities = 21/95 (22%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 216 KPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNE-EEIGGLKELFKMIDTDNSGTITFDE 274
K + L +K F + KL + A+ + +L EE L ++F+ +D + G + E
Sbjct: 2 KHALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKE 61
Query: 275 LKDGLKRV-----------GSQLMESEIKDLMDAV 298
L +G +++ S +E+E+ ++ +V
Sbjct: 62 LIEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQSV 96
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-06
Identities = 12/54 (22%), Positives = 22/54 (40%), Gaps = 5/54 (9%)
Query: 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
L+ E L F+ D+D SG IT +EL +++ + ++
Sbjct: 118 LLLSRER---LLAAFQQFDSDGSGKITNEELGRLFG--VTEVDDETWHQVLQEC 166
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-32
Identities = 54/72 (75%), Positives = 58/72 (80%)
Query: 227 KHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQL 286
K FSAMNK KKMALRVIAE L+EEEI GLKE+F MID D SG ITF+ELK GLKRVG+ L
Sbjct: 1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANL 60
Query: 287 MESEIKDLMDAV 298
ESEI DLM A
Sbjct: 61 KESEILDLMQAA 72
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-07
Identities = 18/61 (29%), Positives = 27/61 (44%), Gaps = 5/61 (8%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
A + + E+ L F D D SG IT DEL+ + G + + I++LM
Sbjct: 87 AATLHLNKIEREDH---LFAAFTYFDKDGSGYITPDELQQACEEFG--VEDVRIEELMRD 141
Query: 298 V 298
V
Sbjct: 142 V 142
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 58/214 (27%), Positives = 114/214 (53%), Gaps = 25/214 (11%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+H +VV ++ +Y + ++ME +GG L D IV + +E + A + + ++ +
Sbjct: 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYL 157
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD---VVGSPYYVAPEV 121
H+ GV HRD+K ++ L + D +K +DFG + + +VG+PY++APEV
Sbjct: 158 HAQGVIHRDIKSDSIL---LTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEV 212
Query: 122 L-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI-------LEGKIDFESEPW 173
+ R Y E D+WS G+++ ++ G PP+++++ + +++ L+
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV----- 267
Query: 174 PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
S +D + +ML ++P+ R TA E+L HP++
Sbjct: 268 ---SPVLRDFLERMLVRDPQERATAQELLDHPFL 298
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+++ ++V D+Y + +VME GG L D +V + E + A + + + +E
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFL 132
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD-VVGSPYYVAPEVL- 122
HS V HRD+K +N L + D ++K TDFG P++ +VG+PY++APEV+
Sbjct: 133 HSNQVIHRDIKSDNIL---LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 123 RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI-------LEGKIDFESEPWPN 175
RK YGP+ D+WS G++ ++ G PP+ E + I L+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL------- 242
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
S +D + + L+ + ++R +A E+L H ++
Sbjct: 243 -SAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-32
Identities = 18/83 (21%), Positives = 45/83 (54%), Gaps = 4/83 (4%)
Query: 218 LDSAVLSRLKHFSAMNKLKKMALRVIAERLN--EEEIGGLKELFKMIDTDNSGTITFDEL 275
+ VL+ +K + + ++ + + ++A L+ I + ELF +DT+++G+++ E+
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61
Query: 276 KDGLKRVGSQLMESEIKDLMDAV 298
L VG + + +I ++ A+
Sbjct: 62 YTVLASVG--IKKWDINRILQAL 82
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-06
Identities = 11/54 (20%), Positives = 21/54 (38%), Gaps = 5/54 (9%)
Query: 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ + LK F ID D G I+ ++ + L ++I + +V
Sbjct: 103 KNIESTF---LKAAFNKIDKDEDGYISKSDIVSLVH--DKVLDNNDIDNFFLSV 151
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 57/227 (25%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV-- 61
H ++V + ++ K + +VM+L GG + D I E ++ L ++ + +
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 62 ECC------HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS------VFYKPDEVFSD 109
E H G HRD+K N L + ED +++ DFG+S ++V
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNIL---LGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 110 VVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI------ 161
VG+P ++APEV+ + Y +AD+WS G+ L +G P+ + +
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245
Query: 162 -LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
LE + + E +S + +I L ++P++R TA E+L H +
Sbjct: 246 SLETGVQ-DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 63/243 (25%), Positives = 98/243 (40%), Gaps = 41/243 (16%)
Query: 1 MHHLSEHQHVVRIHDTY------EDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAK 52
M + H +VV + + +D+ +++V+E K K
Sbjct: 86 MRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIK 144
Query: 53 L-MKTIVGVVECCHSLGVFHRDLKPENFLFLSVDED-AALKATDFGLSVFYKPDEVFSDV 110
L M ++ + HS+G+ HRD+KP+N L +D LK DFG + E
Sbjct: 145 LYMYQLLRSLAYIHSIGICHRDIKPQNLL---LDPPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 111 VGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE----- 163
+ S YY APE++ +Y D+WS G ++ L+ G P F E+ I +I++
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 164 --------------------GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203
F P A DLI ++L+ P RLTA E LC
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 204 HPW 206
HP+
Sbjct: 322 HPF 324
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 30/228 (13%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ + ++V+ T+ + V I MEL + +G ER K+ IV
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 61 VECCHS-LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
+ GV HRD+KP N L +DE +K DFG+S D+ G Y+AP
Sbjct: 137 LYYLKEKHGVIHRDVKPSNIL---LDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193
Query: 120 EVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI----------LE 163
E + Y ADVWS G+ L L +G P+ + F + L
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPLLP 251
Query: 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
G + F S + ++ L ++ ++R +++L H +I +
Sbjct: 252 GHMGF--------SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
+ +V + + +Y + + I+ME GG D +++ G E + A +++ I+ ++
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYL 135
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD---VVGSPYYVAPEV 121
HS HRD+K N L + E +K DFG++ + + VG+P+++APEV
Sbjct: 136 HSEKKIHRDIKAANVL---LSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEV 190
Query: 122 LRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI-------LEGKIDFESEPW 173
+++ Y +AD+WS G+ L G PP + + I LEG +
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN-------Y 243
Query: 174 PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
S+ K+ + L++ P R TA E+L H +I
Sbjct: 244 ---SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 57/245 (23%), Positives = 94/245 (38%), Gaps = 45/245 (18%)
Query: 1 MHHLSEHQHVVRIHDTY------EDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLM 54
M L H ++VR+ + +D+ +++V++ ++ + +
Sbjct: 101 MRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYV 158
Query: 55 KTIV-----GVVECCHSLGVFHRDLKPENFLFLSVDED-AALKATDFGLSVFYKPDEVFS 108
K + + HS G+ HRD+KP+N L +D D A LK DFG + E
Sbjct: 159 KLYMYQLFRSL-AYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 109 DVVGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE--- 163
+ S YY APE++ Y DVWSAG +L LL G P F ++ + +I++
Sbjct: 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274
Query: 164 ----------------------GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEV 201
+ P A L ++L+ P RLT E
Sbjct: 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334
Query: 202 LCHPW 206
H +
Sbjct: 335 CAHSF 339
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 54/264 (20%), Positives = 93/264 (35%), Gaps = 60/264 (22%)
Query: 7 HQHVVRIHDTYEDKS--CVHIVMELCE--------GGELFDRIVKKGNYSEREAAKLMKT 56
H +V+ + + + V ++ + E K L+
Sbjct: 77 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 57 IVGVVECCHSLGVFHRDLKPENFLFLS-VDEDAALKATDFGLS-VFYKPDEVFSD---VV 111
I+ + H+ V HRDLKP N L + E +K D G + +F P + +D VV
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 112 GSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG----K 165
+ +Y APE+L +HY D+W+ G I LL+ P F E +
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256
Query: 166 I-------------DFESEPW--------------------------PNISESAKDLIRK 186
I D + P A L++K
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316
Query: 187 MLDQNPKRRLTAHEVLCHPWIVDD 210
+L +P +R+T+ + + P+ ++D
Sbjct: 317 LLTMDPIKRITSEQAMQDPYFLED 340
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 54/246 (21%), Positives = 102/246 (41%), Gaps = 47/246 (19%)
Query: 1 MHHLSEHQHVVRIHDT---YEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTI 57
+ +L +++ + D ++ + + F ++ + ++ + M I
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQT--LTDYDIRFYMYEI 139
Query: 58 VGVVECCHSLGVFHRDLKPENFLFLSVD-EDAALKATDFGLSVFYKPDEVFSDVVGSPYY 116
+ ++ CHS+G+ HRD+KP N + +D E L+ D+GL+ FY P + ++ V S Y+
Sbjct: 140 LKALDYCHSMGIMHRDVKPHNVM---IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 196
Query: 117 VAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWA-ETEIGIFRQILE---------- 163
PE+L + Y D+WS G +L ++ PF+ +I +
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256
Query: 164 -GKID----------------------FESEPWPNISESAKDLIRKMLDQNPKRRLTAHE 200
K + SE +S A D + K+L + + RLTA E
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
Query: 201 VLCHPW 206
+ HP+
Sbjct: 317 AMEHPY 322
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 60/263 (22%), Positives = 99/263 (37%), Gaps = 64/263 (24%)
Query: 7 HQHVVRIHD--------TYEDKSCVHIVMELCEG--GELFDRIVKKGNYSEREAAKLMKT 56
H++VV + + K +++V + CE L ++ E ++M+
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQM 132
Query: 57 IVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY- 115
++ + H + HRD+K N L + D LK DFGL+ + + + Y
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADFGLARAFSLA---KNSQPNRYT 186
Query: 116 -------YVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIG----IFRQIL 162
Y PE+L + YGP D+W AG I+ + + P TE I + L
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ--L 244
Query: 163 EGKIDFESEPWPNIS----------------------------ESAKDLIRKMLDQNPKR 194
G I E WPN+ A DLI K+L +P +
Sbjct: 245 CGSITPEV--WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 195 RLTAHEVLCHPWIVDDKVAPDKP 217
R+ + + L H + D + D
Sbjct: 303 RIDSDDALNHDFFWSDPMPSDLK 325
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 23/227 (10%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK------GNYSEREAAKLM 54
+ S+ ++V+ + + I MEL FD+ K E K+
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 55 KTIVGVVECCHS-LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS 113
V + L + HRD+KP N L +D +K DFG+S + G
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNIL---LDRSGNIKLCDFGISGQLVDSIAKTRDAGC 188
Query: 114 PYYVAPEVL-----RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ---ILEGK 165
Y+APE + R+ Y +DVWS G+ LY L +G P+ +F Q +++G
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGD 246
Query: 166 I-DFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
+ S S + + L ++ +R E+L HP+I+ +
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 54/248 (21%), Positives = 91/248 (36%), Gaps = 46/248 (18%)
Query: 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
H ++V + + + I ME +GG L + K G E+ K+ ++ +
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 145
Query: 63 CCHS-LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV 121
+ HRD+KP N L V+ +K DFG+S D + + VG+ Y++PE
Sbjct: 146 YLREKHKIMHRDVKPSNIL---VNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPER 201
Query: 122 LR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE----------------- 163
L+ HY ++D+WS G+ L + G P +
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 164 ---GKIDFESEPWPNI--------------------SESAKDLIRKMLDQNPKRRLTAHE 200
K +S P I S +D + K L +NP R +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
Query: 201 VLCHPWIV 208
++ H +I
Sbjct: 322 LMVHAFIK 329
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 30/130 (23%), Positives = 48/130 (36%), Gaps = 9/130 (6%)
Query: 173 WPNISESAKDLIRKM--LDQNPKRRLTAHEVLCHPWIV--DDKVAPDKPLDSAVLSRLKH 228
I++ ++ K+ DQ + A E D A + L S +
Sbjct: 43 EAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLLKDLEDD 102
Query: 229 FSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLME 288
S N+L R L+EE+ L++LF SG +F +LK L + + E
Sbjct: 103 ASGYNRL-----RPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPE 157
Query: 289 SEIKDLMDAV 298
+K L V
Sbjct: 158 GPLKKLFVMV 167
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 9/45 (20%), Positives = 19/45 (42%), Gaps = 1/45 (2%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLM-ESEIKDLMDAV 298
L+ L+ D D SG ++ +E++ L+ + + V
Sbjct: 255 LRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVV 299
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-29
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 25/226 (11%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-----GNYSEREAAKLMK 55
+ V + + V I MEL + D+ K+ E K+
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 56 TIVGVVECCHS-LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
+IV +E HS L V HRD+KP N L ++ +K DFG+S + D G
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVL---INALGQVKMCDFGISGYLVDDVAKDIDAGCK 173
Query: 115 YYVAPEVLR-----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ---ILEGKI 166
Y+APE + K Y ++D+WS G+ + L P+ ++ F+Q ++E
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPS 231
Query: 167 -DFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
++ + S D + L +N K R T E++ HP+ +
Sbjct: 232 PQLPADKF---SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 55/219 (25%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVGVVEC 63
+ HVV+ + +Y + + IVME C G + D I ++ +E E A ++++ + +E
Sbjct: 81 CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD---VVGSPYYVAPE 120
H + HRD+K N L ++ + K DFG++ + + + V+G+P+++APE
Sbjct: 141 LHFMRKIHRDIKAGNIL---LNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPE 195
Query: 121 VL-RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI-------LEGKIDFESEP 172
V+ Y AD+WS G+ + G PP+ + I +
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW---- 251
Query: 173 WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
S++ D +++ L ++P++R TA ++L HP++ K
Sbjct: 252 ----SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 14/212 (6%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H + ++ Y + +VME C G V K E E A + + +
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL-- 122
HS + HRD+K N L + E +K DFG + P F VG+PY++APEV+
Sbjct: 171 HSHNMIHRDVKAGNIL---LSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILA 224
Query: 123 --RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI-LEGKIDFESEPWPNISES 179
Y + DVWS G+ L PP + + I +S W SE
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEY 281
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
++ + L + P+ R T+ +L H +++ ++
Sbjct: 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 54/247 (21%), Positives = 94/247 (38%), Gaps = 49/247 (19%)
Query: 1 MHHLSEHQHVVRIHD-----TYEDKSCVHIVMELCEGGELFD--RIVKKGNY--SEREAA 51
++H H +++ + D +++V EL D +++ S +
Sbjct: 83 LNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQHIQ 137
Query: 52 KLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV 111
M I+ + H GV HRDL P N L + ++ + DF L+ D + V
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNIL---LADNNDITICDFNLAREDTADANKTHYV 194
Query: 112 GSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE------ 163
+Y APE++ K + D+WSAG ++ + + F T +I+E
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 164 -----------------------GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHE 200
+ + P A DLI KML+ NP+RR++ +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313
Query: 201 VLCHPWI 207
L HP+
Sbjct: 314 ALRHPYF 320
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 62/273 (22%), Positives = 102/273 (37%), Gaps = 64/273 (23%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY---SEREAAKLMKTIVGVVECCH 65
+V+ + + + ++ + + EL L++ I KK + S K +I+ ++ H
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELI-KKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV-LRK 124
+ H DLKPEN L + +K DFG S Y+ V++ + S +Y APEV L
Sbjct: 218 KNRIIHCDLKPENILLKQQG-RSGIKVIDFG-SSCYEHQRVYTYIQ-SRFYRAPEVILGA 274
Query: 125 HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE--GKID-------------FE 169
YG D+WS G IL LL+G P E E ++E G
Sbjct: 275 RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS 334
Query: 170 SEPWPNISESAK----------------------------------------DLIRKMLD 189
S+ +P D +++ L+
Sbjct: 335 SKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394
Query: 190 QNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAV 222
+P R+T + L HPW+ P ++V
Sbjct: 395 WDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSV 427
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-28
Identities = 62/245 (25%), Positives = 106/245 (43%), Gaps = 49/245 (20%)
Query: 1 MHHLSEHQHVVRIHD------TYEDKSCVHIVMELCEGGELFD--RIVKKGNYSEREAAK 52
+ H+ H++V+ + D T +D + ++VM D +++K E
Sbjct: 78 LKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQF 132
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG 112
L+ ++ + H+ G+ HRDLKP N V+ED LK DFGL+ + + V
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLA---VNEDCELKILDFGLARQADSE--MTGYVV 187
Query: 113 SPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE------- 163
+ +Y APEV+ Y D+WS G I+ +++G F + ++I++
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247
Query: 164 ---------------------GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
K DF + N S A +L+ KML + ++R+TA E L
Sbjct: 248 EFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306
Query: 203 CHPWI 207
HP+
Sbjct: 307 AHPYF 311
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 49/245 (20%)
Query: 1 MHHLSEHQHVVRIHD------TYEDKSCVHIVMELCEGGELFD--RIVKKGNYSEREAAK 52
+ H+ H++V+ + D + E+ + V++V L D IVK ++
Sbjct: 82 LKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF 136
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG 112
L+ I+ ++ HS + HRDLKP N V+ED LK DFGL+ + + V
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKILDFGLARHTADE--MTGYVA 191
Query: 113 SPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE------- 163
+ +Y APE++ HY D+WS G I+ LL+G F I + IL
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251
Query: 164 ---------------------GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
K++F + + + A DL+ KML + +R+TA + L
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 203 CHPWI 207
H +
Sbjct: 311 AHAYF 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 1 MHHLSE--HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIV 58
+ LS H ++V+++ + C +VME EGG L++ + AA M +
Sbjct: 52 LRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109
Query: 59 GV---VECCHSL---GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG 112
V HS+ + HRDLKP N L V LK DFG + + ++ G
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQ--THMTNNKG 165
Query: 113 SPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESE 171
S ++APEV +Y + DV+S G+IL+ +++ PF EIG + + +
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD---EIGGPAFRIMWAVHNGTR 222
Query: 172 PW--PNISESAKDLIRKMLDQNPKRRLTAHEVL 202
P N+ + + L+ + ++P +R + E++
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIV 255
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 67/248 (27%), Positives = 105/248 (42%), Gaps = 50/248 (20%)
Query: 1 MHHLSEHQHVVRIHD-----TYEDKSCVHIVMELCEGGELFD--RIVKKGNYSEREAAKL 53
+ H++++ I+D T E V+IV +L E D +++K + S
Sbjct: 79 LLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYF 133
Query: 54 MKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV--- 110
+ I+ ++ HS V HRDLKP N L ++ LK DFGL+ PD +
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLL---LNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 111 -VGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE---- 163
V + +Y APE++ K Y D+WS G IL +LS P F + + IL
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250
Query: 164 ------------------------GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAH 199
K+ + + +PN A DL+ KML NP +R+
Sbjct: 251 PSQEDLNCIINLKARNYLLSLPHKNKVPW-NRLFPNADSKALDLLDKMLTFNPHKRIEVE 309
Query: 200 EVLCHPWI 207
+ L HP++
Sbjct: 310 QALAHPYL 317
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 14/95 (14%), Positives = 35/95 (36%)
Query: 204 HPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMID 263
P + + + +P+ + + + ++ + + ++ + + F +D
Sbjct: 2 QPPVANFCLWNLQPIQGSWMGAACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVD 61
Query: 264 TDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
D SGT+ +EL G G +L +M
Sbjct: 62 RDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIF 96
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 52/252 (20%)
Query: 1 MHHLSEHQHVVRIHD------TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLM 54
M + H++++ + + T E+ V++VMEL + ++++ ER + L
Sbjct: 115 MKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLY 171
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
+ + G+ + HS G+ HRDLKP N + V D LK DFGL+ + + V +
Sbjct: 172 QMLCGI-KHLHSAGIIHRDLKPSNIV---VKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
Query: 115 YYVAPEV-LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE---------- 163
YY APEV L Y D+WS G I+ ++ F I + +++E
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287
Query: 164 -----------------GKIDFE-----------SEPWPNISESAKDLIRKMLDQNPKRR 195
+ F SE + A+DL+ KML +P +R
Sbjct: 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347
Query: 196 LTAHEVLCHPWI 207
++ + L HP+I
Sbjct: 348 ISVDDALQHPYI 359
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-27
Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 8/87 (9%)
Query: 212 VAPDKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTIT 271
+ P PL S + + M KL+ L A I GL F+ +D D S ++
Sbjct: 4 LVPRGPLGSHMD---AVDATMEKLRAQCLSRGAS-----GIQGLARFFRQLDRDGSRSLD 55
Query: 272 FDELKDGLKRVGSQLMESEIKDLMDAV 298
DE + GL ++G L ++E + +
Sbjct: 56 ADEFRQGLAKLGLVLDQAEAEGVCRKW 82
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-06
Identities = 11/66 (16%), Positives = 24/66 (36%), Gaps = 7/66 (10%)
Query: 240 LRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLK-------RVGSQLMESEIK 292
LR + +++ + F +D G +T D+L+ R G + ++
Sbjct: 96 LRALRPPMSQAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLR 155
Query: 293 DLMDAV 298
+D
Sbjct: 156 RFLDNF 161
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 32/232 (13%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVH------IVMELCEGGELFD--RIVKKGNYSEREAAK 52
+ S H+++ + + K+ +VME C G + D + K E A
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD--- 109
+ + I+ + H V HRD+K +N L + E+A +K DFG+S + D
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVL---LTENAEVKLVDFGVSA--QLDRTVGRRNT 188
Query: 110 VVGSPYYVAPEVLRKH------YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL- 162
+G+PY++APEV+ Y ++D+WS G+ + G PP ++ R +
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC---DMHPMRALFL 245
Query: 163 ---EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
+S+ W S+ + I L +N +R +++ HP+I D
Sbjct: 246 IPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVGVVEC 63
+H ++V++ Y + I++E C GG + + +E + + + ++ +
Sbjct: 73 CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 64 CHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD-VVGSPYYVAPEVL 122
HS + HRDLK N L + + ++ DFG+S D +G+PY++APEV+
Sbjct: 133 LHSKRIIHRDLKAGNVL---MTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 123 ------RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI-------LEGKIDFE 169
Y +AD+WS G+ L + PP + + +I L +
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW- 248
Query: 170 SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211
S +D ++ LD+NP+ R +A ++L HP++
Sbjct: 249 -------SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-27
Identities = 34/220 (15%), Positives = 63/220 (28%), Gaps = 35/220 (15%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
V R+ D ++ +V E GG L + + S A + M+++ + H
Sbjct: 90 KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHR 147
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHY 126
GV P V D + +
Sbjct: 148 AGVALSIDHPSRVR---VSIDGDVVLAYPA-------------------TMPDA------ 179
Query: 127 GPEADVWSAGVILYILLSGVPPFWAETE---IGIFRQILEGKIDFESEPWPNISESAKDL 183
P+ D+ G LY LL P + + G+ ++ +I +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239
Query: 184 IRKMLDQNPKRRL--TAHEVLCHPWIVDDKVAPDKPLDSA 221
+ + + R T ++ V D+ P+D A
Sbjct: 240 AARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEA 279
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 65/254 (25%), Positives = 108/254 (42%), Gaps = 56/254 (22%)
Query: 1 MHHLSEHQHVVRIHD------TYEDKSCVHIVMELCEGGELFD--RIVKKGNYSEREAAK 52
M + H++++ + + + E+ V+IVMEL + + ++++ ER +
Sbjct: 78 MKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYL 132
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG 112
L + + G+ + HS G+ HRDLKP N + V D LK DFGL+ + + V
Sbjct: 133 LYQMLCGI-KHLHSAGIIHRDLKPSNIV---VKSDCTLKILDFGLARTAGTSFMMTPYVV 188
Query: 113 SPYYVAPEV-LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE-------- 163
+ YY APEV L Y D+WS G I+ ++ G F I + +++E
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248
Query: 164 -------------------GKIDFE-----------SEPWPNISESAKDLIRKMLDQNPK 193
FE SE + A+DL+ KML +
Sbjct: 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308
Query: 194 RRLTAHEVLCHPWI 207
+R++ E L HP+I
Sbjct: 309 KRISVDEALQHPYI 322
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-27
Identities = 56/173 (32%), Positives = 80/173 (46%), Gaps = 36/173 (20%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL-- 122
HS GV HRDLKP N V+ED LK DFGL+ + + V + +Y APEV+
Sbjct: 143 HSAGVVHRDLKPGNLA---VNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS 197
Query: 123 RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE------------------- 163
HY D+WS G I+ +L+G F + + QIL+
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257
Query: 164 ---------GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ DF ++ +P S A DL+ KML+ + +RLTA + L HP+
Sbjct: 258 SYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 45/309 (14%), Positives = 100/309 (32%), Gaps = 60/309 (19%)
Query: 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFD--RIVKKGNYSEREAAKLMKTIVGV 60
L H ++V T+ + + +V G D +E A +++ ++
Sbjct: 81 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD--------EVFSDVVG 112
++ H +G HR +K + L + D + + ++ + V
Sbjct: 141 LDYIHHMGYVHRSVKASHIL---ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 113 SPYYVAPEVLRKH---YGPEADVWSAGVILYILLSGVPPF-------------------- 149
+++PEVL+++ Y ++D++S G+ L +G PF
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257
Query: 150 ----------------WAETEIGIFRQILEGKIDFESEPWPNI------SESAKDLIRKM 187
+ G+ + + P+ S + +
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 188 LDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAV--LSRLKHFSAMNKLKKMALRVIAE 245
L +NP R +A +L H + K + L + ++ + +F + +
Sbjct: 318 LQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVT 377
Query: 246 RLNEEEIGG 254
L E E+
Sbjct: 378 NLEELEVDD 386
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 63/256 (24%), Positives = 104/256 (40%), Gaps = 57/256 (22%)
Query: 1 MHHLSEHQHVVRIHD--------------TYEDKSCVHIVMELCEGGELFD--RIVKKGN 44
+ L +H ++V++ + + + + V+IV E E D ++++G
Sbjct: 62 IRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGP 116
Query: 45 YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD 104
E A M ++ ++ HS V HRDLKP N + ED LK DFGL+ P
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPH 174
Query: 105 EVFSDV----VGSPYYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158
+ + +Y +P +L +Y D+W+AG I +L+G F E+
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 159 RQILE---------------------------GKIDFESEPWPNISESAKDLIRKMLDQN 191
+ ILE ++ P IS A D + ++L +
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL-TQLLPGISREAVDFLEQILTFS 293
Query: 192 PKRRLTAHEVLCHPWI 207
P RLTA E L HP++
Sbjct: 294 PMDRLTAEEALSHPYM 309
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 40/195 (20%), Positives = 77/195 (39%), Gaps = 23/195 (11%)
Query: 25 IVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83
I+ LC+G L+ + K + ++ + IV + H+ G+ H+DLK +N
Sbjct: 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVF--- 162
Query: 84 VDEDAALKATDFGLS------VFYKPDEVFSDVVGSPYYVAPEVLR----------KHYG 127
D + TDFGL + ++ G ++APE++R +
Sbjct: 163 YDNGK-VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221
Query: 128 PEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKM 187
+DV++ G I Y L + PF + I Q+ G + + + D++
Sbjct: 222 KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK--PNLSQIGMGKEISDILLFC 279
Query: 188 LDQNPKRRLTAHEVL 202
+ R T +++
Sbjct: 280 WAFEQEERPTFTKLM 294
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-26
Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 37/200 (18%)
Query: 64 CHSLGVFHRDLKPENFLFLSVD-EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL 122
HSLG+ HRD+KP+N L V+ +D LK DFG + P E + S +Y APE++
Sbjct: 157 IHSLGICHRDIKPQNLL---VNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELM 213
Query: 123 --RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE----------------- 163
Y P D+WS G + L+ G P F ET I +I++
Sbjct: 214 LGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHY 273
Query: 164 GKIDF---ESEPW----PNISES-AKDLIRKMLDQNPKRRLTAHEVLCHPW------IVD 209
++ F +++ W P + S A DL+ ++L P R+ +E + HP+ +
Sbjct: 274 TEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYE 333
Query: 210 DKVAPDKPLDSAVLSRLKHF 229
+V + V +
Sbjct: 334 SEVKNNSNFPHGVNQNIPQL 353
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 50/176 (28%), Positives = 74/176 (42%), Gaps = 36/176 (20%)
Query: 64 CH--SLGVFHRDLKPENFLFLSVD-EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
H S+ V HRD+KP N L V+ D LK DFG + P E + S YY APE
Sbjct: 145 LHLPSVNVCHRDIKPHNVL---VNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPE 201
Query: 121 VL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE--------------- 163
++ +HY D+WS G I ++ G P F + G +I+
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNP 261
Query: 164 ----------GKIDFE---SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
I + S+ ++ A DL+ +L P+ R+ +E LCHP+
Sbjct: 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 44/181 (24%), Positives = 81/181 (44%), Gaps = 13/181 (7%)
Query: 25 IVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83
IV + CEG L+ + + + ++ + + ++ H+ + HRDLK N
Sbjct: 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIF--- 152
Query: 84 VDEDAALKATDFGLS---VFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAG 136
+ ED +K DFGL+ + F + GS ++APEV+R Y ++DV++ G
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 137 VILYILLSGVPPFWAETEIG-IFRQILEGKIDFESEPWP-NISESAKDLIRKMLDQNPKR 194
++LY L++G P+ I + G + + N + K L+ + L +
Sbjct: 213 IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDE 272
Query: 195 R 195
R
Sbjct: 273 R 273
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-25
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVG 59
M +L+ H ++V+++ + +VME G+L+ R++ K + +LM I
Sbjct: 77 MSNLN-HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 60 VVECCHSLG--VFHRDLKPENFLFLSVDEDAA--LKATDFGLSVFYKPDEVFSDVVGSPY 115
+E + + HRDL+ N S+DE+A K DFGLS S ++G+
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--SVHSVSGLLGNFQ 191
Query: 116 YVAPEVLR---KHYGPEADVWSAGVILYILLSGVPPF--WAETEIGIFRQILEGKIDFES 170
++APE + + Y +AD +S +ILY +L+G PF ++ +I I E +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR--- 248
Query: 171 EPWPNISESA----KDLIRKMLDQNPKRRLTAHEVL 202
P I E +++I +PK+R ++
Sbjct: 249 ---PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 59/256 (23%), Positives = 97/256 (37%), Gaps = 58/256 (22%)
Query: 1 MHHLSEHQHVVRIHD-----TYEDKSCVHIVMELCEGGELFD--RIVKKGNYSEREAAKL 53
+ H H++++ I + ++E+ + V+I+ EL + D R++ S+
Sbjct: 63 LKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYF 117
Query: 54 MKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS 113
+ + V+ H V HRDLKP N L ++ + LK DFGL+ +
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLL---INSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 114 P-----------YYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160
+Y APEV+ Y DVWS G IL L P F
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 161 ILE--G---------------------------KIDFESEPWPNISESAKDLIRKMLDQN 191
I G + +P ++ DL+++ML +
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFD 293
Query: 192 PKRRLTAHEVLCHPWI 207
P +R+TA E L HP++
Sbjct: 294 PAKRITAKEALEHPYL 309
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-24
Identities = 44/182 (24%), Positives = 72/182 (39%), Gaps = 20/182 (10%)
Query: 25 IVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV---VECCHSLG--VFHRDLKPENF 79
IV E G L+ + K G + + + + V + H+ + HR+LK N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170
Query: 80 LFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGV 137
L VD+ +K DFGLS + G+P ++APEVLR + ++DV+S GV
Sbjct: 171 L---VDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227
Query: 138 ILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA----KDLIRKMLDQNPK 193
IL+ L + P+ + + I + +I P
Sbjct: 228 ILWELATLQQPWGNLNPAQVVAAVGFKCKR------LEIPRNLNPQVAAIIEGCWTNEPW 281
Query: 194 RR 195
+R
Sbjct: 282 KR 283
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-24
Identities = 61/259 (23%), Positives = 111/259 (42%), Gaps = 60/259 (23%)
Query: 7 HQHVVRIHD--TYEDKSCVH--IVMELCEGGELFDRIVKKGNY---SEREAAKLMKTIVG 59
H++++ D ++ + VH +V E+ G L ++KK + ++ K ++
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA-LIKKYEHRGIPLIYVKQISKQLLL 142
Query: 60 VVECCHS-LGVFHRDLKPENFLFLSVD---EDAALKATDFGLSVFYKPDEVFSDVVGSPY 115
++ H G+ H D+KPEN L VD +K D G + +Y DE +++ + +
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHYTNSIQTRE 200
Query: 116 YVAPEV-LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR------QILE--GKI 166
Y +PEV L +G AD+WS +++ L++G F + + QI+E G++
Sbjct: 201 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 260
Query: 167 D-------------FESE----------PWP---NISESAK----------DLIRKMLDQ 190
F S WP ++E K D + ML
Sbjct: 261 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320
Query: 191 NPKRRLTAHEVLCHPWIVD 209
+P++R A ++ HPW+ D
Sbjct: 321 DPRKRADAGGLVNHPWLKD 339
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 59/277 (21%), Positives = 94/277 (33%), Gaps = 64/277 (23%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY---SEREAAKLMKTIVGVVECCH 65
V + D + + I EL G F+ +K+ N+ + + + H
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFE-FLKENNFQPYPLPHVRHMAYQLCHALRFLH 140
Query: 66 SLGVFHRDLKPENFLFLS----------------VDEDAALKATDFGLSVFYKPDEVFSD 109
+ H DLKPEN LF++ ++ +++ DFG + F E +
Sbjct: 141 ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD--HEHHTT 198
Query: 110 VVGSPYYVAPEV-LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE--GKI 166
+V + +Y PEV L + DVWS G IL+ G F + + G I
Sbjct: 199 IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 167 D------------FESE--PWPNISESAK------------------------DLIRKML 188
F W S + DL+R+ML
Sbjct: 259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318
Query: 189 DQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSR 225
+ +P +R+T E L HP+ S SR
Sbjct: 319 EFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 2e-23
Identities = 52/58 (89%), Positives = 56/58 (96%)
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ +AERL+EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS+LMESEIKDLMDA
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87 | Back alignment and structure |
|---|
Score = 37.1 bits (87), Expect = 6e-04
Identities = 15/38 (39%), Positives = 19/38 (50%), Gaps = 3/38 (7%)
Query: 237 KMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDE 274
K L+ + L E EI K+L D D SGTI + E
Sbjct: 46 KDGLKRVGSELMESEI---KDLMDAADIDKSGTIDYGE 80
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-23
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 21/166 (12%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVG 59
M L H +V++ ++ + E +GG L I + Y + K I
Sbjct: 61 MRCLE-HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD---------- 109
+ HS+ + HRDL N L V E+ + DFGL+ ++ +
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCL---VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 110 -----VVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPF 149
VVG+PY++APE++ + Y + DV+S G++L ++ V
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-23
Identities = 37/184 (20%), Positives = 75/184 (40%), Gaps = 27/184 (14%)
Query: 25 IVMELCEGGELFDRIVKKGNY--SEREAAKLMKTIVGVVECCHSLG--VFHRDLKPENFL 80
++ G L++ + + N+ + +A K + + H+L + L + +
Sbjct: 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145
Query: 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK----HYGPEADVWSAG 136
+DED + + + + +P +VAPE L+K AD+WS
Sbjct: 146 ---IDEDMTARISMADVKFS----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFA 198
Query: 137 VILYILLSGVPPFWAETEIGI-FRQILEGKIDFESE----PWPNISESAKDLIRKMLDQN 191
V+L+ L++ PF + +I K+ E P P IS L++ ++++
Sbjct: 199 VLLWELVTREVPF-----ADLSNMEIG-MKVALEGLRPTIP-PGISPHVSKLMKICMNED 251
Query: 192 PKRR 195
P +R
Sbjct: 252 PAKR 255
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 49/238 (20%), Positives = 85/238 (35%), Gaps = 46/238 (19%)
Query: 7 HQHVVRI--HDTYEDKSCVH--IVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
H++++ D S ++ E G L+D ++ +++ +I +
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGLA 119
Query: 63 CCHSL--------GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV---- 110
H + HRDLK +N L V ++ D GL+V + DV
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 111 -VGSPYYVAPEVLR-------KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI-FRQI 161
VG+ Y+APEVL D+W+ G++L+ + + + F +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236
Query: 162 LEGKIDFESE-----------PWPNISESA------KDLIRKMLDQNPKRRLTAHEVL 202
+ FE PN S L+++ QNP RLTA +
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-22
Identities = 22/88 (25%), Positives = 34/88 (38%), Gaps = 4/88 (4%)
Query: 214 PDKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFD 273
D + + F+A + + L ++ +K++F ++D D SG I D
Sbjct: 3 TDLLSAEDIKKAIGAFTAADSFDHKKFFQMVG-LKKKSADDVKKVFHILDKDKSGFIEED 61
Query: 274 ELKDGLKR---VGSQLMESEIKDLMDAV 298
EL LK L E K LM A
Sbjct: 62 ELGSILKGFSSDARDLSAKETKTLMAAG 89
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 63/259 (24%), Positives = 94/259 (36%), Gaps = 64/259 (24%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY---SEREAAKLMKTIVGVVECCH 65
V++ + +E + IV EL G +D +K+ + K+ I V H
Sbjct: 78 RCVQMLEWFEHHGHICIVFELL-GLSTYD-FIKENGFLPFRLDHIRKMAYQICKSVNFLH 135
Query: 66 SLGVFHRDLKPENFLFLS----------------VDEDAALKATDFGLSVFYKPDEVFSD 109
S + H DLKPEN LF+ + +K DFG + + DE S
Sbjct: 136 SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD--DEHHST 193
Query: 110 VVGSPYYVAPEV-LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE--GKI 166
+V + +Y APEV L + DVWS G IL G F + G +
Sbjct: 194 LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 167 D------------FESE--PWPNISESAK------------------------DLIRKML 188
F + W S + + DLI+KML
Sbjct: 254 PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313
Query: 189 DQNPKRRLTAHEVLCHPWI 207
+ +P +R+T E L HP+
Sbjct: 314 EYDPAKRITLREALKHPFF 332
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 56/278 (20%), Positives = 107/278 (38%), Gaps = 78/278 (28%)
Query: 1 MHHLSEHQHVVRIHD--TYEDKSCVHIVMELCEGGELFD--RIVKKGNYSEREAAKLMKT 56
+ LS H+++V + + ++ V++V + E D +++ ++
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYMET----DLHAVIRANILEPVHKQYVVYQ 117
Query: 57 IVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP-- 114
++ V++ HS G+ HRD+KP N L ++ + +K DFGLS + ++ +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNIL---LNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 115 --------------------YYVAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAE 152
+Y APE+L Y D+WS G IL +L G P F
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234
Query: 153 TEIGIFRQILE-------------------------------------------GKIDFE 169
+ + +I+ + +
Sbjct: 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLK 294
Query: 170 SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
P + +E A DL+ K+L NP +R++A++ L HP++
Sbjct: 295 INPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 43/239 (17%), Positives = 83/239 (34%), Gaps = 46/239 (19%)
Query: 6 EHQHVVRI--HDTYEDKSCVH--IVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVV 61
H++++ D ++ + +V + E G LFD + + + KL + +
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGL 152
Query: 62 ECCHS--------LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV--- 110
H + HRDLK +N L V ++ D GL+V + D+
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 111 --VGSPYYVAPEVLR-------KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI-FRQ 160
VG+ Y+APEVL AD+++ G++ + + + + +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 161 ILEGKIDFES---------------EPWPN--ISESAKDLIRKMLDQNPKRRLTAHEVL 202
++ E W + ++R+ N RLTA +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 50/238 (21%), Positives = 85/238 (35%), Gaps = 46/238 (19%)
Query: 7 HQHVVRI--HDTYEDKSCVH--IVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
H++++ D S ++ + E G L+D +K + KL + V +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLC 148
Query: 63 CCHSL--------GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV---- 110
H+ + HRDLK +N L V ++ D GL+V + D D+
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 111 -VGSPYYVAPEVL-------RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGI-FRQI 161
VG+ Y+ PEVL AD++S G+IL+ + E + + +
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 162 LEGKIDFES---------------EPWPN--ISESAKDLIRKMLDQNPKRRLTAHEVL 202
+ +E W + L+ + NP RLTA V
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-21
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 215 DKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDE 274
D S + + L+ A + I+ ++++ LKE+F+++D D SG I DE
Sbjct: 4 DILSPSDIAAALRDCQAPDSFSPKKFFQISG-MSKKSSSQLKEIFRILDNDQSGFIEEDE 62
Query: 275 LKDGLKRVGSQ---LMESEIKDLMDAV 298
LK L+R S L SE K + A
Sbjct: 63 LKYFLQRFESGARVLTASETKTFLAAA 89
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-21
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 20/214 (9%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
L H +++ + + + +VME GG L + K I
Sbjct: 60 FAMLK-HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARG 117
Query: 61 VECCHSLG---VFHRDLKPENFLFLSVDEDAA--------LKATDFGLSVFYKPDEVFSD 109
+ H + HRDLK N L + + LK TDFGL+ + S
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNIL---ILQKVENGDLSNKILKITDFGLAREWHRTTKMS- 173
Query: 110 VVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDF 168
G+ ++APEV+R + +DVWS GV+L+ LL+G PF + + + K+
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 169 ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
P E L+ + +P R + +L
Sbjct: 234 PI-P-STCPEPFAKLMEDCWNPDPHSRPSFTNIL 265
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-21
Identities = 47/267 (17%), Positives = 85/267 (31%), Gaps = 72/267 (26%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY---SEREAAKLMKTIVGVVECCH 65
++V+ H + + ++ E G L++ I + NY + I+ +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEII-TRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 66 SLGVFHRDLKPENFLFLS----------------------VDEDAALKATDFGLSVFYKP 103
+ + H DLKPEN L + +K DFG + F
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK-- 212
Query: 104 DEVFSDVVGSPYYVAPEV-LRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162
+ ++ + Y APEV L + +D+WS G +L L +G F + +
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME 272
Query: 163 E--GKID---------------FESEP----WPNISESAK-------------------- 181
I + WP + S
Sbjct: 273 SIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332
Query: 182 -DLIRKMLDQNPKRRLTAHEVLCHPWI 207
D + +L +P R + E+L H ++
Sbjct: 333 CDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-20
Identities = 52/55 (94%), Positives = 54/55 (98%)
Query: 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
AERL+EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS+LMESEIKDLMDA
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 55
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-06
Identities = 17/56 (30%), Positives = 25/56 (44%), Gaps = 5/56 (8%)
Query: 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ + EE L F D D SG IT DE++ K G L + I D++ +
Sbjct: 75 LNKLEREEN---LVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEI 125
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 46/246 (18%), Positives = 87/246 (35%), Gaps = 62/246 (25%)
Query: 7 HQHVVRI--HDTYEDKSCVH--IVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
H+++++ + V ++ E G L D + K S E + +T+ +
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLA 135
Query: 63 CCHS----------LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD--- 109
H + HRD+K +N L + + DFGL++ ++ + D
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 110 VVGSPYYVAPEVLRKHYGPE------ADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163
VG+ Y+APEVL + D+++ G++L+ L S + E
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD--------E 244
Query: 164 GKIDFESEPW------------------PNISESA---------KDLIRKMLDQNPKRRL 196
+ FE E P + + + I + D + + RL
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 197 TAHEVL 202
+A V
Sbjct: 305 SAGCVG 310
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-19
Identities = 12/68 (17%), Positives = 28/68 (41%), Gaps = 5/68 (7%)
Query: 236 KKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDG-----LKRVGSQLMESE 290
K A+++ + N I K +F +D + +G IT DE+ ++ + +++
Sbjct: 3 SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62
Query: 291 IKDLMDAV 298
+
Sbjct: 63 RHQVCVEA 70
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-08
Identities = 16/69 (23%), Positives = 23/69 (33%)
Query: 230 SAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMES 289
+L L+ A +F + D D SGTIT DE K K G +
Sbjct: 90 DGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQE 149
Query: 290 EIKDLMDAV 298
+ +
Sbjct: 150 DCEATFRHC 158
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-19
Identities = 21/68 (30%), Positives = 36/68 (52%), Gaps = 1/68 (1%)
Query: 232 MNKLKK-MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESE 290
M+K + + + L EE+ + E F + D +N G + + ELK +K +G +L + E
Sbjct: 1 MSKNRSSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKRE 60
Query: 291 IKDLMDAV 298
I DL+D
Sbjct: 61 ILDLIDEY 68
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 4e-08
Identities = 15/61 (24%), Positives = 31/61 (50%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
+ I +R +EI K F++ D D++G I+ L+ K +G L + E++ +++
Sbjct: 84 VMGEKILKRDPLDEI---KRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEE 140
Query: 298 V 298
Sbjct: 141 F 141
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-18
Identities = 24/83 (28%), Positives = 38/83 (45%), Gaps = 4/83 (4%)
Query: 219 DSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDG 278
+ + L+ + + L++ +K++F+ ID D SG + DELK
Sbjct: 8 AEDIAAALQECQDPDTFEPQKF-FQTSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYF 66
Query: 279 LKRVGSQ---LMESEIKDLMDAV 298
L++ S L ESE K LMDA
Sbjct: 67 LQKFQSDARELTESETKSLMDAA 89
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-18
Identities = 16/68 (23%), Positives = 31/68 (45%), Gaps = 5/68 (7%)
Query: 232 MNKLKKMALRVIAERLNEEEIGGLKELFKMIDTD-NSGTITFDELKDGLKRVGSQLMESE 290
M+ + K E+L EE+ K F + G+I+ EL ++ +G E
Sbjct: 1 MDDIYK----AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEE 56
Query: 291 IKDLMDAV 298
+++++D V
Sbjct: 57 LQEMIDEV 64
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 3e-07
Identities = 21/64 (32%), Positives = 34/64 (53%), Gaps = 6/64 (9%)
Query: 238 MALRVIAER---LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDL 294
M +R + + +EEE L +LF+M D + G I +ELK L+ G + E +I++L
Sbjct: 80 MMVRSMKDDSKGKSEEE---LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEEL 136
Query: 295 MDAV 298
M
Sbjct: 137 MKDG 140
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-17
Identities = 10/71 (14%), Positives = 27/71 (38%), Gaps = 2/71 (2%)
Query: 228 HFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLM 287
H + + L + EE+ L+ +F D + SG + +E + + +
Sbjct: 2 HHHHHHSSGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VR 59
Query: 288 ESEIKDLMDAV 298
++ + + +
Sbjct: 60 PADAEAVFQRL 70
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 49/250 (19%), Positives = 84/250 (33%), Gaps = 57/250 (22%)
Query: 6 EHQHVVR-----IHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
EH ++ R T + + +VME G L + + +L ++
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRG 123
Query: 61 VECCHS---------LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD-- 109
+ H+ + HRDL N L V D +DFGLS+ + +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVL---VKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 110 -------VVGSPYYVAPEVLR--------KHYGPEADVWSAGVILYILLSGV-------- 146
VG+ Y+APEVL + + D+++ G+I + +
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 147 -----PPFWAETEIGIFRQILEGKIDFE------SEPWPNISESA---KDLIRKMLDQNP 192
F E + ++ + E E W S + K+ I DQ+
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 193 KRRLTAHEVL 202
+ RLTA
Sbjct: 301 EARLTAQXAE 310
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 76.3 bits (189), Expect = 3e-17
Identities = 21/56 (37%), Positives = 35/56 (62%)
Query: 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+++ L EE+I KE F + D DNSG+I+ EL ++ +G E+E+ DLM+ +
Sbjct: 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEI 56
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 51.7 bits (125), Expect = 2e-08
Identities = 17/61 (27%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
+ R + +E+E+ E FK+ D + G I+ ELK L +G +L ++E+ +++
Sbjct: 72 LMSRQLKCNDSEQEL---LEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLRE 128
Query: 298 V 298
V
Sbjct: 129 V 129
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-17
Identities = 21/56 (37%), Positives = 35/56 (62%)
Query: 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+A++L EE+I KE F + D D GTIT EL ++ +G E+E++D+++ V
Sbjct: 1 MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 56
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 3e-08
Identities = 16/61 (26%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
M R + + +EEE ++E F++ D D +G I+ EL+ + +G +L + E+ +++
Sbjct: 72 MMARKMKDTDSEEE---IREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIRE 128
Query: 298 V 298
Sbjct: 129 A 129
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-17
Identities = 21/75 (28%), Positives = 37/75 (49%), Gaps = 4/75 (5%)
Query: 224 SRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG 283
+ K + + +K L EE+ ++E F + DTD SGTI ELK ++ +G
Sbjct: 3 YKAKTVVSARRDQKKG----RVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALG 58
Query: 284 SQLMESEIKDLMDAV 298
+ + EIK ++ +
Sbjct: 59 FEPKKEEIKKMISEI 73
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-08
Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
M + ER + EEI + F++ D DNSGTIT +L+ K +G L E E+++++
Sbjct: 89 MMTAKMGERDSREEI---LKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAE 145
Query: 298 V 298
Sbjct: 146 A 146
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-17
Identities = 18/69 (26%), Positives = 31/69 (44%), Gaps = 4/69 (5%)
Query: 230 SAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMES 289
++M + A L+EE I K F M D D G I+ EL ++ +G +
Sbjct: 1 ASMTDQQAEA----RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56
Query: 290 EIKDLMDAV 298
E+ +++ V
Sbjct: 57 ELDAIIEEV 65
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-07
Identities = 17/61 (27%), Positives = 29/61 (47%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
M +R + E + L F++ D + G I +EL + L+ G + E +I+DLM
Sbjct: 81 MMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKD 140
Query: 298 V 298
Sbjct: 141 S 141
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-16
Identities = 16/56 (28%), Positives = 27/56 (48%)
Query: 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ L EEI L+E F+ D D G I +L + ++ +G E E+ +L +
Sbjct: 1 MDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQI 56
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 5e-06
Identities = 15/64 (23%), Positives = 35/64 (54%), Gaps = 5/64 (7%)
Query: 236 KKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLK-RVGSQLMESEIKDL 294
K+ A+ + +E L++ F+ DT+ G I+ EL++ ++ +G Q+ +I+++
Sbjct: 75 PKLLAET-ADMIGVKE---LRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEI 130
Query: 295 MDAV 298
+ V
Sbjct: 131 IRDV 134
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 13/167 (7%)
Query: 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY---SEREAAKLMKTIVGVVECCH 65
++V + + ++ + +V E+ L+D +++ N+ S K + + +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYD-LLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 66 S--LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV-L 122
+ L + H DLKPEN L + + +A+K DFG S + + S +Y +PEV L
Sbjct: 175 TPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLL 231
Query: 123 RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE--GKID 167
Y D+WS G IL + +G P F E+ +I+E G
Sbjct: 232 GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 53/300 (17%), Positives = 96/300 (32%), Gaps = 103/300 (34%)
Query: 7 HQHVVRIHDTYEDKSC--VHI--VMELCEGGELFDRIVKKGNY---SEREAAKLMKTIVG 59
+ VV++ D ++ HI V E+ G + + K NY K+++ ++
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 60 VVECCHS-LGVFHRDLKPENFLFLSVD--------------------------------- 85
++ H+ + H D+KPEN L +
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 86 -------------EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEV-LRKHYGPEAD 131
E +K D G + + + F++ + + Y + EV + Y AD
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 132 VWSAGVILYILLSGVPPFWAETEIGIFR------QILE---------------------- 163
+WS + + L +G F + R I+E
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335
Query: 164 -GKIDFESEPWPNISES---------------AKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
G + ++ P D + ML+ P++R TA E L HPW+
Sbjct: 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-16
Identities = 22/106 (20%), Positives = 36/106 (33%), Gaps = 17/106 (16%)
Query: 209 DDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGG----LKELFKMIDT 264
D +A DK A K +K A I + + E+ ELFK D
Sbjct: 12 DKGLASDKDGKKA------------KDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDK 59
Query: 265 DNSGTITFDELKDGLKR-VGSQLMESEIKDLMDAVRKIFSRFSIKT 309
+ +G + +DE+ G + S ++D+ K
Sbjct: 60 NETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKL 105
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 6e-07
Identities = 8/62 (12%), Positives = 23/62 (37%), Gaps = 3/62 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQ-LMESEIKDLMD 296
+ R++ + + L +F ID + + +E K + ++ + + L
Sbjct: 117 LEFRLMLCYIYDFFE--LTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFK 174
Query: 297 AV 298
+
Sbjct: 175 EL 176
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 5e-16
Identities = 18/52 (34%), Positives = 33/52 (63%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
L+EE+ +KE F + DT+ +G+I + ELK ++ +G + + EI +LM+
Sbjct: 1 LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEY 52
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77 | Back alignment and structure |
|---|
Score = 36.7 bits (86), Expect = 8e-04
Identities = 12/38 (31%), Positives = 20/38 (52%), Gaps = 3/38 (7%)
Query: 237 KMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDE 274
K+A+R + + + EI EL D + +G I FD+
Sbjct: 30 KVAMRALGFDVKKPEI---LELMNEYDREGNGYIGFDD 64
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 72.1 bits (178), Expect = 9e-16
Identities = 22/55 (40%), Positives = 34/55 (61%)
Query: 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
AE+L EE+I KE F + D D GTIT EL ++ +G E+E++D+++ V
Sbjct: 1 AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 55
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 6e-08
Identities = 17/61 (27%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
+ R + E+ +EEE+ E FK+ D D +G I+ EL+ + +G +L + E+ +++
Sbjct: 71 LMARKMKEQDSEEEL---IEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIRE 127
Query: 298 V 298
Sbjct: 128 A 128
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 54/304 (17%), Positives = 96/304 (31%), Gaps = 114/304 (37%)
Query: 1 MHHLSEHQHVVRIHD-----TYEDKSCVHIVMELCEGGELFD--RIVKKGNYSEREAAKL 53
++ L +++R++D ++IV+E+ + D ++ K + E K
Sbjct: 79 LNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADS----DLKKLFKTPIFLTEEHIKT 133
Query: 54 --------MKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE 105
I H G+ HRDLKP N L +++D ++K DFGL+ ++
Sbjct: 134 ILYNLLLGENFI-------HESGIIHRDLKPANCL---LNQDCSVKVCDFGLARTINSEK 183
Query: 106 VFSDVVGSP-----------------------YYVAPEVL--RKHYGPEADVWSAGVILY 140
+ V +Y APE++ +++Y D+WS G I
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243
Query: 141 ILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI------------------------ 176
LL+ + + + G F P N
Sbjct: 244 ELLNMLQSHINDPTNR--FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTE 301
Query: 177 -------SESAKDLIR--------------------------KMLDQNPKRRLTAHEVLC 203
I+ ML NP +R+T + L
Sbjct: 302 DDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361
Query: 204 HPWI 207
HP++
Sbjct: 362 HPYL 365
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-15
Identities = 14/56 (25%), Positives = 31/56 (55%), Gaps = 1/56 (1%)
Query: 244 AERLNEEEIGGLKELFKMIDT-DNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+L+ ++ L+ F+ +T + SG ++ D++ L+ +G Q +S I+ L+D
Sbjct: 4 VSKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEF 59
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-07
Identities = 14/65 (21%), Positives = 34/65 (52%), Gaps = 7/65 (10%)
Query: 238 MALRVIAERLN----EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKD 293
+ R + E +N ++E L+E F++ D + +G I+ D +++ L + L ++
Sbjct: 75 IGARFLGEEVNPEQMQQE---LREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDA 131
Query: 294 LMDAV 298
++D +
Sbjct: 132 MIDEI 136
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-15
Identities = 11/50 (22%), Positives = 29/50 (58%)
Query: 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
++++ KE F++ D++ +G IT + L+ LK+ G ++ + ++ +
Sbjct: 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEA 51
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 5e-08
Identities = 13/61 (21%), Positives = 28/61 (45%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
M R + + +E+ + ++ F+ D + +G I L+D L +G +L E + +
Sbjct: 67 MMGRRMKQTTSEDIL---RQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGI 123
Query: 298 V 298
Sbjct: 124 T 124
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 3e-15
Identities = 14/60 (23%), Positives = 32/60 (53%)
Query: 239 ALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
A + +L +++I +KE F MID D G ++ +++K +++G + E+ ++
Sbjct: 4 AASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKEA 63
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-07
Identities = 11/61 (18%), Positives = 25/61 (40%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
+ ++ +EE I + F M D + + + +KD L+ +G + E++
Sbjct: 75 IFSDKLSGTDSEETI---RNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKE 131
Query: 298 V 298
Sbjct: 132 A 132
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 4e-15
Identities = 16/50 (32%), Positives = 29/50 (58%)
Query: 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
EE+ ++E F + D D +GTI ELK ++ +G + + EIK ++ +
Sbjct: 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEI 51
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 51.7 bits (125), Expect = 1e-08
Identities = 18/62 (29%), Positives = 35/62 (56%), Gaps = 3/62 (4%)
Query: 237 KMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
+ + ++E+ +EEI + FK+ D D +G I+F LK K +G L + E+++++D
Sbjct: 66 TVMTQKMSEKDTKEEI---LKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMID 122
Query: 297 AV 298
Sbjct: 123 EA 124
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-14
Identities = 9/44 (20%), Positives = 24/44 (54%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ LFK ID + G ++++E+K + + + E ++ + ++
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSI 45
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 2e-06
Identities = 15/62 (24%), Positives = 32/62 (51%), Gaps = 5/62 (8%)
Query: 237 KMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
K + + L++++IG LK L+K++D D G +T +E+ K+ G ++ + +
Sbjct: 60 KFYGSIQGQDLSDDKIG-LKVLYKLMDVDGDGKLTKEEVTSFFKKHG----IEKVAEQVM 114
Query: 297 AV 298
Sbjct: 115 KA 116
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 48/228 (21%)
Query: 1 MHHLSEHQHVVRIHD-----TYEDKSCVHIVMELCEGGELFD--RIVKKGNYSEREAAK- 52
++ L+ H HVV++ D E +++V+E+ + D ++ + Y K
Sbjct: 106 LNRLN-HDHVVKVLDIVIPKDVEKFDELYVVLEIADS----DFKKLFRTPVYLTELHIKT 160
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVV 111
L+ ++ V+ HS G+ HRDLKP N L V++D ++K DFGL+ P+ S +
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 112 GSP---------------------------YYVAPEVL--RKHYGPEADVWSAGVILYIL 142
SP +Y APE++ +++Y DVWS G I L
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
Query: 143 LSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQ 190
L+ + A + G F P K R DQ
Sbjct: 278 LNMIKENVAYHADR--GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQ 323
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 16/42 (38%), Positives = 25/42 (59%), Gaps = 1/42 (2%)
Query: 165 KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206
D +E +P S A L+++ML NP +R+T +E L HP+
Sbjct: 359 GTDL-AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-14
Identities = 16/56 (28%), Positives = 29/56 (51%), Gaps = 1/56 (1%)
Query: 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+A ++I + +FK DT+ G I+ EL D LK +G + E++ +M +
Sbjct: 1 MAAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEI 55
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 48/210 (22%), Positives = 80/210 (38%), Gaps = 17/210 (8%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ S H ++VR+ K ++IVMEL +GG+ + +G + L++ +
Sbjct: 166 LKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDA 222
Query: 61 VECC---HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
S HRDL N L V E LK +DFG+S + V
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCL---VTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 118 ---APEVLR-KHYGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEGKIDFESEP 172
APE L Y E+DVWS G++L+ G P+ + + +G
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG---GRLPC 336
Query: 173 WPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
++ L+ + P +R + +
Sbjct: 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-14
Identities = 22/93 (23%), Positives = 33/93 (35%), Gaps = 9/93 (9%)
Query: 216 KPLDSAVLS--RLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTD--NSGTIT 271
K L ++VL L + L L + EI L ELFK I + + G I
Sbjct: 9 KHLCTSVLGCFDLDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLIN 68
Query: 272 FDELKDGLKRVGSQLMESEIKDLMDAVRKIFSR 304
+E + L + + D V +F
Sbjct: 69 KEEFQLALFK-----TNKKESLFADRVFDLFDT 96
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 6e-14
Identities = 9/44 (20%), Positives = 24/44 (54%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ LFK ID + G ++++E+K + + + E ++ + ++
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSI 45
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-07
Identities = 11/46 (23%), Positives = 19/46 (41%), Gaps = 3/46 (6%)
Query: 237 KMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282
K + NE+ + + +FK ID D +G I +E +
Sbjct: 23 KAFVSKKRAIKNEQLL---QLIFKSIDADGNGEIDQNEFAKFYGSI 65
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-13
Identities = 15/67 (22%), Positives = 30/67 (44%), Gaps = 2/67 (2%)
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQL--MESEIKDLMDAV 298
+ E L+ + + L + F D D+ G + DE+ R+ + + +++ + DAV
Sbjct: 24 QFNVEDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAV 83
Query: 299 RKIFSRF 305
R F
Sbjct: 84 RVFFLHK 90
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-05
Identities = 10/69 (14%), Positives = 19/69 (27%), Gaps = 2/69 (2%)
Query: 230 SAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMES 289
A + + ++D D GT+ DELK +K + +
Sbjct: 105 EANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQE 162
Query: 290 EIKDLMDAV 298
+
Sbjct: 163 AAYTFFEKA 171
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-13
Identities = 16/77 (20%), Positives = 35/77 (45%), Gaps = 3/77 (3%)
Query: 225 RLKHFSAMNKLKKMAL---RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR 281
+ + ++++ K L + ++ ++ G KE + D + +G I LK L++
Sbjct: 1 KAQQEERLDEINKQFLDDPKYSSDEDLPSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK 60
Query: 282 VGSQLMESEIKDLMDAV 298
+G E+K L+ V
Sbjct: 61 LGVPKTHLELKKLIGEV 77
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 1e-12
Identities = 12/89 (13%), Positives = 34/89 (38%), Gaps = 2/89 (2%)
Query: 207 IVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDN 266
+++ + L+ +V L+ + ++ + + L + ++E+ L FK
Sbjct: 21 LLEQFGLIEAGLEDSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFKNE--CP 78
Query: 267 SGTITFDELKDGLKRVGSQLMESEIKDLM 295
SG + + K+ + Q + +
Sbjct: 79 SGVVNEETFKEIYSQFFPQGDSTTYAHFL 107
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-12
Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 3/66 (4%)
Query: 236 KKMALRVIAERLNE---EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIK 292
A R I RL++ + + F+ DT + TI+ +E + R L + +
Sbjct: 4 MATADRDILARLHKAVTSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFD 63
Query: 293 DLMDAV 298
L + +
Sbjct: 64 RLWNEM 69
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-12
Identities = 18/69 (26%), Positives = 31/69 (44%), Gaps = 4/69 (5%)
Query: 230 SAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMES 289
++M + A L+EE I K F M D D G I+ EL ++ +G +
Sbjct: 1 ASMTDQQAEA----RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56
Query: 290 EIKDLMDAV 298
E+ +++ V
Sbjct: 57 ELDAIIEEV 65
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 45/197 (22%), Positives = 80/197 (40%), Gaps = 14/197 (7%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC- 64
+H ++V++ + +I+ E G L D + ++ N E A L+ +
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAME 332
Query: 65 --HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS-PY-YVAPE 120
HR+L N L V E+ +K DFGLS D + P + APE
Sbjct: 333 YLEKKNFIHRNLAARNCL---VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 121 VLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
L + ++DVW+ GV+L+ + + G+ P+ ++ + + + E E
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRMERPEGCPE 446
Query: 179 SAKDLIRKMLDQNPKRR 195
+L+R NP R
Sbjct: 447 KVYELMRACWQWNPSDR 463
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-11
Identities = 19/67 (28%), Positives = 31/67 (46%), Gaps = 3/67 (4%)
Query: 234 KLKKMALRV---IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESE 290
K K+ A + +E EI KE F +ID + G I D+L++ +G +++E
Sbjct: 3 KAKRRAAEGSSNVFSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNE 62
Query: 291 IKDLMDA 297
D M
Sbjct: 63 ELDAMIK 69
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-07
Identities = 16/61 (26%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
M + E+ I FK++D D G+I L++ L G + EIK++ A
Sbjct: 83 MFGEKLKGADPEDVI---MGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAA 139
Query: 298 V 298
Sbjct: 140 F 140
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256 | Back alignment and structure |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 16/140 (11%), Positives = 36/140 (25%), Gaps = 10/140 (7%)
Query: 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPL 218
+ +G + + P + R + R WI+
Sbjct: 8 VKASDGNLLGDPGRIPLSKRESIKWQRPRFTRQALMRCCLI-----KWILSSAAPQGSDS 62
Query: 219 DSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDG 278
+ L L ++ + + ++E+ L FK +G + D K
Sbjct: 63 SDSELELSTVRHQPEGLDQLQAQ---TKFTKKELQSLYRGFKNE--CPTGLVDEDTFKLI 117
Query: 279 LKRVGSQLMESEIKDLMDAV 298
+ Q + +
Sbjct: 118 YSQFFPQGDATTYAHFLFNA 137
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67 | Back alignment and structure |
|---|
Score = 56.7 bits (138), Expect = 4e-11
Identities = 7/44 (15%), Positives = 18/44 (40%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
K +F+ D + G ++ DE ++ + +I + +
Sbjct: 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEI 46
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 46/190 (24%), Positives = 73/190 (38%), Gaps = 26/190 (13%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEG---GELFDRIVKKGNYSEREAAKLMKTI 57
L + + + +VM+L G +LF+ +K S + L +
Sbjct: 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK--LSLKTVLMLADQM 112
Query: 58 VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS--------D 109
+ VE HS HRD+KP+NFL + DFGL+ Y+ +
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
Query: 110 VVGSPYYVAPEVLRKHYGPEA----DVWSAGVILYILLSGVPPFW----AETEIGIFRQI 161
+ G+ Y + + H G E D+ S G +L L G P W A T+ + +I
Sbjct: 173 LTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKI 228
Query: 162 LEGKIDFESE 171
E K+ E
Sbjct: 229 SEKKVATSIE 238
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-11
Identities = 15/60 (25%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG--SQLMESEIKDLMDAVRKIFSRF 305
++ + +K F ID D G IT + + +R S++ K LMD++ ++ F
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNF 60
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-06
Identities = 14/61 (22%), Positives = 22/61 (36%), Gaps = 2/61 (3%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
M V G L F+ +DT+ I+ DE +G L ++ DA
Sbjct: 79 MKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDA 136
Query: 298 V 298
+
Sbjct: 137 I 137
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-11
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 16/95 (16%)
Query: 213 APDKPLDSAVLSRLKHFSAMNK------LKKMALRVIAERLNEEEIGGLKELFKMIDTDN 266
A D + L A + L+ ++ + +K++FK ID D
Sbjct: 3 AKDLLKADDIKKALDAVKAEGSFNHKKFFALVGLK----AMSAND---VKKVFKAIDADA 55
Query: 267 SGTITFDELKDGLKR---VGSQLMESEIKDLMDAV 298
SG I +ELK LK G L ++E K + A
Sbjct: 56 SGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAA 90
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-11
Identities = 12/51 (23%), Positives = 24/51 (47%), Gaps = 4/51 (7%)
Query: 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ +EI L + FK +D DNSG+++ +E ++ ++D
Sbjct: 1 DADEIKRLGKRFKKLDLDNSGSLSVEEFMSLP----ELQQNPLVQRVIDIF 47
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-05
Identities = 15/60 (25%), Positives = 31/60 (51%), Gaps = 4/60 (6%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR-VGSQLMESEIKDLMD 296
+ + E++ L+ F++ D D G I+ EL LK VG+ L +++++ ++D
Sbjct: 63 GVSQFSVKGDKEQK---LRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVD 119
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 9e-11
Identities = 14/50 (28%), Positives = 25/50 (50%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
++ +I KE F MID + G I ++L D L +G + ++ +M
Sbjct: 1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMS 50
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 5e-07
Identities = 13/61 (21%), Positives = 25/61 (40%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
M + E+ I + F D + SG I D L++ L +G + + E+ ++
Sbjct: 64 MFGEKLNGTDPEDVI---RNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYRE 120
Query: 298 V 298
Sbjct: 121 A 121
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 45/182 (24%), Positives = 74/182 (40%), Gaps = 32/182 (17%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MH L ++ ++VR+ + ++ + +VME+ GG L +V K E + + + + V
Sbjct: 390 MHQL-DNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQV 445
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
HR+L N L + K +DFGLS D+ YY
Sbjct: 446 SMGMKYLEEKNFVHRNLAARNVL---LVNRHYAKISDFGLSKALGADD--------SYYT 494
Query: 118 ------------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILE 163
APE + + + +DVWS GV ++ LS G P+ + I +
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554
Query: 164 GK 165
GK
Sbjct: 555 GK 556
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-10
Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 11/166 (6%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H ++V++ + +I+ E G L D + ++ N E A L+ +
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAME 125
Query: 66 ---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS-PY-YVAPE 120
HRDL N L V E+ +K DFGLS D + P + APE
Sbjct: 126 YLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 121 VLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
L + ++DVW+ GV+L+ + + G+ P+ ++ + +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-10
Identities = 18/81 (22%), Positives = 32/81 (39%), Gaps = 5/81 (6%)
Query: 221 AVLSRLKHFSAMNKLKKMALRVIAE--RLNEEEIGGLKELFKMIDTD--NSGTITFDELK 276
+S+ K +AM ++A EE+ L ELFK + + + G I +E +
Sbjct: 3 CSVSKKKKKNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQ 62
Query: 277 DGLKRVGSQLMESEIKDLMDA 297
L R ++ + D
Sbjct: 63 LALFRNRNR-RNLFADRIFDV 82
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 14/52 (26%), Positives = 22/52 (42%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ + L E F+ +DTD SG I+ EL L G + + L+
Sbjct: 21 RHMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMY 72
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-06
Identities = 12/47 (25%), Positives = 22/47 (46%)
Query: 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
I ++E F+ D+ G + +E++ L G Q+ E + LM
Sbjct: 92 ILSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKF 138
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 5e-04
Identities = 16/69 (23%), Positives = 25/69 (36%), Gaps = 16/69 (23%)
Query: 237 KMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
AL + ++L M D ++SG ITFDE K L +
Sbjct: 50 NAALSSAGVPFSLATT---EKLLHMYDKNHSGEITFDEFK--------DLHHFILS---- 94
Query: 297 AVRKIFSRF 305
+R+ F +
Sbjct: 95 -MREGFRKR 102
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-10
Identities = 46/180 (25%), Positives = 75/180 (41%), Gaps = 31/180 (17%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M LS H +V+++ +++ + +V E E G L D + + A L+ + V
Sbjct: 57 MMKLS-HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDV 113
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
E V HRDL N L V E+ +K +DFG++ F D+ Y
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCL---VGENQVIKVSDFGMTRFVLDDQ---------YTS 161
Query: 118 -----------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
+PEV Y ++DVWS GV+++ + S G P+ + + I G
Sbjct: 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 38/175 (21%), Positives = 72/175 (41%), Gaps = 28/175 (16%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
H +++R+ + I+ E E G L + + E +L+ + G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 66 ---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV----- 117
++ HRDL N L V+ + K +DFGLS + D Y
Sbjct: 162 YLANMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRVLEDDP-------EATYTTSGGK 211
Query: 118 ------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
APE + + + +DVWS G++++ +++ G P+W + + + I +G
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 2e-10
Identities = 11/65 (16%), Positives = 28/65 (43%), Gaps = 5/65 (7%)
Query: 239 ALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDEL-----KDGLKRVGSQLMESEIKD 293
++ ++ N IG K +F +D +++G I+ DE+ + +G+ +++
Sbjct: 2 NSKLTSDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHK 61
Query: 294 LMDAV 298
Sbjct: 62 DAVEA 66
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-09
Identities = 16/68 (23%), Positives = 23/68 (33%)
Query: 231 AMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESE 290
KL L A+ LF ++D D +G IT DE K K G +
Sbjct: 87 GWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSED 146
Query: 291 IKDLMDAV 298
++
Sbjct: 147 CEETFRVC 154
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 41/180 (22%), Positives = 71/180 (39%), Gaps = 31/180 (17%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M + ++ HV R+ S V ++ +L G L D + + + + L+ V +
Sbjct: 71 MASV-DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQI 126
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
+ + + HRDL N L V +K TDFGL+ +E Y
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGAEE--------KEYH 175
Query: 118 -----------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
A E + + Y ++DVWS GV ++ L++ G P+ I + +G
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 39/165 (23%), Positives = 69/165 (41%), Gaps = 12/165 (7%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC-- 64
H+ +V+++ ++ ++IV E G L D + K +L+ +
Sbjct: 238 HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 65 -HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS-PY-YVAPEV 121
+ HRDL+ N L V E+ K DFGL+ + +E + P + APE
Sbjct: 296 VERMNYVHRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 122 LR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
+ ++DVWS G++L L + G P+ + Q+ G
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 44/181 (24%), Positives = 70/181 (38%), Gaps = 32/181 (17%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MH L ++ ++VR+ + + +VME+ GG L + G E + + + + V
Sbjct: 64 MHQL-DNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQV 119
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
HRDL N L + K +DFGLS D+ YY
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVL---LVNRHYAKISDFGLSKALGADD--------SYYT 168
Query: 118 ------------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILE 163
APE + + + +DVWS GV ++ LS G P+ + I +
Sbjct: 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
Query: 164 G 164
G
Sbjct: 229 G 229
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 39/165 (23%), Positives = 69/165 (41%), Gaps = 12/165 (7%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC-- 64
H+ +V+++ ++ ++IV E G L D + K +L+ +
Sbjct: 321 HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 65 -HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS-PY-YVAPEV 121
+ HRDL+ N L V E+ K DFGL+ + +E + P + APE
Sbjct: 379 VERMNYVHRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 122 LR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
+ ++DVWS G++L L + G P+ + Q+ G
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-10
Identities = 18/83 (21%), Positives = 32/83 (38%), Gaps = 11/83 (13%)
Query: 227 KHFSAMNKLKKMALRVI-----------AERLNEEEIGGLKELFKMIDTDNSGTITFDEL 275
K F + ++ L I E E++ KE + D +N G I L
Sbjct: 13 KAFGILKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSL 72
Query: 276 KDGLKRVGSQLMESEIKDLMDAV 298
K ++++G E+K ++ V
Sbjct: 73 KRMMEKLGVPKTHLEMKKMISEV 95
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 39/175 (22%), Positives = 74/175 (42%), Gaps = 28/175 (16%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH 65
+H +++R+ V IV E E G L + + + ++ +L+ + G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMK 161
Query: 66 ---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV----- 117
+G HRDL N L ++ + K +DFGL + D Y
Sbjct: 162 YLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLGRVLEDDP-------EAAYTTRGGK 211
Query: 118 ------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
+PE + + + +DVWS G++L+ ++S G P+W + + + + EG
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 43/180 (23%), Positives = 75/180 (41%), Gaps = 31/180 (17%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M +LS H+ +V+++ + + I+ E G L + + + + +L++ V
Sbjct: 73 MMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDV 129
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
E S HRDL N L V++ +K +DFGLS + DE Y
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDE---------YTS 177
Query: 118 -----------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
PEVL + ++D+W+ GV+++ + S G P+ T I +G
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 46/180 (25%), Positives = 72/180 (40%), Gaps = 29/180 (16%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M H +++R+ IV E E G L + + + + +L+ + GV
Sbjct: 104 MGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGV 160
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
LG HRDL N L VD + K +DFGLS + D Y
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVL---VDSNLVCKVSDFGLSRVLEDDP-------DAAYT 210
Query: 118 -----------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
APE + + + +DVWS GV+++ +L+ G P+W T + + EG
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-10
Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 31/180 (17%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M LS H +V+ + + ++IV E G L + + + + E ++L++ V
Sbjct: 57 MMKLS-HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDV 113
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
E S HRDL N L VD D +K +DFG++ + D+ Y
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCL---VDRDLCVKVSDFGMTRYVLDDQ---------YVS 161
Query: 118 -----------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
APEV Y ++DVW+ G++++ + S G P+ T + ++ +G
Sbjct: 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 7e-10
Identities = 44/181 (24%), Positives = 72/181 (39%), Gaps = 33/181 (18%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M L ++ ++VR+ E +S +VME+ E G L + + + ++ +++ + V
Sbjct: 72 MQQL-DNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQV 126
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
HRDL N L + K +DFGLS + DE YY
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVL---LVTQHYAKISDFGLSKALRADE--------NYYK 175
Query: 118 APEVLR---KHYGPEA----------DVWSAGVILYILLS-GVPPFWAETEIGIFRQILE 163
A + K Y PE DVWS GV+++ S G P+ + + +
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
Query: 164 G 164
G
Sbjct: 236 G 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 34/181 (18%), Positives = 59/181 (32%), Gaps = 29/181 (16%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M LS H+H+V + +V E + G L + K N + ++ +
Sbjct: 66 MSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQL 122
Query: 61 VECCH---SLGVFHRDLKPENFL-----FLSVDEDAALKATDFGLSVFYKPDEVFSDVVG 112
H + H ++ +N L +K +D G+S+ P +
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 113 SPYY------VAPEVL--RKHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILE 163
V PE + K+ D WS G L+ + S G P A + +
Sbjct: 176 --ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233
Query: 164 G 164
Sbjct: 234 R 234
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 46/191 (24%), Positives = 77/191 (40%), Gaps = 28/191 (14%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEG---GELFDRIVKKGNYSEREAAKLMKTI 57
+ + I + +VMEL G +LF+ +K +S + L +
Sbjct: 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRK--FSLKTVLLLADQM 114
Query: 58 VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS--------D 109
+ +E HS HRD+KP+NFL + + DFGL+ Y+ +
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174
Query: 110 VVGSPYYVAPEVLRKHYGPEA----DVWSAG-VILYILLSGVPPFW----AETEIGIFRQ 160
+ G+ Y + + H G E D+ S G V++Y L +P W A T+ + +
Sbjct: 175 LTGTARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYER 229
Query: 161 ILEGKIDFESE 171
I E K+ E
Sbjct: 230 ISEKKMSTPIE 240
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-09
Identities = 10/50 (20%), Positives = 20/50 (40%), Gaps = 1/50 (2%)
Query: 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQ-LMESEIKDLMDAV 298
+ L +F+ +D D SG I+ EL+ L ++ ++
Sbjct: 4 PDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMF 53
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-06
Identities = 15/45 (33%), Positives = 22/45 (48%)
Query: 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
I + +F+ D DNSG I +ELK L G +L + L+
Sbjct: 73 ITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIR 117
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
MH L +H++++R++ + +V EL G L DR+ + + L + V V
Sbjct: 75 MHSL-DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQV 130
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYY 116
E S HRDL N L + +K DFGL + D+ +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLL---LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 117 V---APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFW 150
APE L+ + + +D W GV L+ + + G P+
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 226
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 9/45 (20%), Positives = 20/45 (44%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEI 291
+ G ++++ D D++G I EL D + + +L +
Sbjct: 5 FANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDK 49
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 40.4 bits (94), Expect = 3e-04
Identities = 10/74 (13%), Positives = 27/74 (36%), Gaps = 4/74 (5%)
Query: 233 NKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMES-EI 291
N L + + ++ + + +++F D +G + E+ +K + + S
Sbjct: 179 NFLLQFKMDASSQVERKRD---FEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISG 235
Query: 292 KDLMDAVRKIFSRF 305
DL + +
Sbjct: 236 GDLDKFRECLLTHC 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 42/182 (23%), Positives = 73/182 (40%), Gaps = 36/182 (19%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M +L H H+V++ E++ I+MEL GEL + + N + + L+ + +
Sbjct: 67 MKNLD-HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQI 122
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
+ S+ HRD+ N L V +K DFGLS + YY
Sbjct: 123 CKAMAYLESINCVHRDIAVRNIL---VASPECVKLGDFGLS---------RYIEDEDYYK 170
Query: 118 -----------APEVLRKHYG---PEADVWSAGVILYILLS-GVPPFWAETEIGIFRQIL 162
+PE + ++ +DVW V ++ +LS G PF+ + +
Sbjct: 171 ASVTRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
Query: 163 EG 164
+G
Sbjct: 229 KG 230
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 41/180 (22%), Positives = 71/180 (39%), Gaps = 31/180 (17%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M + ++ HV R+ S V ++ +L G L D + + + + L+ V +
Sbjct: 71 MASV-DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQI 126
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
+ + + HRDL N L V +K TDFGL+ +E Y
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGAEE--------KEYH 175
Query: 118 -----------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
A E + + Y ++DVWS GV ++ L++ G P+ I + +G
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 37/171 (21%), Positives = 60/171 (35%), Gaps = 43/171 (25%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFD--------RIVKKGNYSEREAAK 52
+ +L H ++V + ++ E C G+L + I K + + E +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 53 LMKTIVGVVECCH----------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK 102
L + ++ + S HRDL N L + K DFGL+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLA---- 192
Query: 103 PDEVFSDVVGSPYYV------------APEVLRKH-YGPEADVWSAGVILY 140
D+ YV APE + Y E+DVWS G+ L+
Sbjct: 193 -----RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 32/180 (17%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M H H+V++ + V I+MELC GEL + + + A L+ +
Sbjct: 445 MRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQL 500
Query: 61 VECC---HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
S HRD+ N L V + +K DFGLS + S YY
Sbjct: 501 STALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLS---------RYMEDSTYYK 548
Query: 118 -----------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
APE + + + +DVW GV ++ +L GV PF + +I G
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 608
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-09
Identities = 7/52 (13%), Positives = 18/52 (34%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
EE++ + + G I+ D +++G + K + +
Sbjct: 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELY 60
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-07
Identities = 14/62 (22%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 237 KMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
+ + ++ N EE+ ++F D + +G +T ++K+ L G L + E D ++
Sbjct: 71 EYLSICVHDKDNVEEL---IKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALN 127
Query: 297 AV 298
A
Sbjct: 128 AF 129
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 36/169 (21%), Positives = 65/169 (38%), Gaps = 43/169 (25%)
Query: 1 MHHLSEHQHVVRIHD--TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMK--- 55
M HL +H+++V + T+ ++ E C G+L + + +K E + A +
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 56 -TIVGVVECCH----------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD 104
+ ++ S HRD+ N L + K DFGL+
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL---LTNGHVAKIGDFGLA------ 211
Query: 105 EVFSDVVGSPYYV------------APEVLRKH-YGPEADVWSAGVILY 140
D++ Y+ APE + Y ++DVWS G++L+
Sbjct: 212 ---RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 36/172 (20%), Positives = 72/172 (41%), Gaps = 15/172 (8%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L +H H+VR+ S + +V + G L D + + + L+ V +
Sbjct: 69 IGSL-DHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQI 124
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
+ + G+ HR+L N L + + ++ DFG++ PD+ + +
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVL---LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 118 ---APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
A E + Y ++DVWS GV ++ L++ G P+ + + +G
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 13/171 (7%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M L H +V++H + ++I+ E G L D + K S++ KL+ +
Sbjct: 237 MKTLQ-HDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQI 293
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS-PY- 115
E HRDL+ N L V K DFGL+ + +E + P
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANIL---VSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
Query: 116 YVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
+ APE + + ++DVWS G++L +++ G P+ + + R + G
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 6e-09
Identities = 45/180 (25%), Positives = 69/180 (38%), Gaps = 32/180 (17%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M H H+V++ + V I+MELC GEL + + + A L+ +
Sbjct: 70 MRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQL 125
Query: 61 VECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
S HRD+ N L V + +K DFGLS + + YY
Sbjct: 126 STALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLSRYMEDST---------YYK 173
Query: 118 -----------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
APE + + + +DVW GV ++ +L GV PF + +I G
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 233
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 6e-09
Identities = 14/69 (20%), Positives = 27/69 (39%)
Query: 230 SAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMES 289
+NK + + ++ K + D + +G I LK L+++G
Sbjct: 25 EGINKQFLDDPKYSNDEDLPSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHL 84
Query: 290 EIKDLMDAV 298
E+K L+ V
Sbjct: 85 ELKRLIREV 93
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-09
Identities = 14/61 (22%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
++ + +EEE ++E F++ D D +G I+ EL+ + +G +L + E+ +++
Sbjct: 17 YFQSLMKDTDSEEE---IREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIRE 73
Query: 298 V 298
Sbjct: 74 A 74
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 8e-09
Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 17/173 (9%)
Query: 1 MHHLSEHQHVVRIHD--TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIV 58
M L HQ +VR++ T E ++I+ E E G L D + K + + KL+
Sbjct: 62 MKQLQ-HQRLVRLYAVVTQEP---IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAA 116
Query: 59 GVVECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS-P 114
+ E HRDL+ N L V + + K DFGL+ + +E + P
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 115 Y-YVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
+ APE + + ++DVWS G++L +++ G P+ T + + + G
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 9e-09
Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 26/129 (20%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDE--VFSDVVGSPYYVAPE- 120
H+ + HRD+K N L +DE+ K TDFG+S + D+ + + V G+ Y+ PE
Sbjct: 156 HTRAIIHRDVKSINIL---LDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY 212
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPF-------------WAET--EIGIFRQI---- 161
++ ++DV+S GV+L+ +L WA G QI
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272
Query: 162 LEGKIDFES 170
L KI ES
Sbjct: 273 LADKIRPES 281
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 9e-09
Identities = 14/52 (26%), Positives = 29/52 (55%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
++ + LKE FK+ D D +G I+ EL+ + +G +L + E++ ++
Sbjct: 3 MDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEA 54
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92 | Back alignment and structure |
|---|
Score = 37.2 bits (87), Expect = 8e-04
Identities = 11/61 (18%), Positives = 25/61 (40%), Gaps = 3/61 (4%)
Query: 237 KMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
+ + + E+L +EE+ +++ K D D G + ++E + V + L
Sbjct: 32 RHVMINLGEKLTDEEV---EQMIKEADLDGDGQVNYEEFVKMMMTVRGGGGGNGWSRLRR 88
Query: 297 A 297
Sbjct: 89 K 89
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 19/173 (10%)
Query: 1 MHHLSEHQHVVRIHDT-YEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVG 59
M L H ++V++ E+K ++IV E G L D ++ S L+K +
Sbjct: 240 MTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLD 297
Query: 60 VVECCHSL---GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS--P 114
V E L HRDL N L V ED K +DFGL+ E S P
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVL---VSEDNVAKVSDFGLT-----KEASSTQDTGKLP 349
Query: 115 Y-YVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
+ APE LR K + ++DVWS G++L+ + S G P+ + ++ +G
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 1e-08
Identities = 48/174 (27%), Positives = 74/174 (42%), Gaps = 21/174 (12%)
Query: 1 MHHLSEHQHVVRIHDT-YEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVG 59
M L H ++V++ E+K ++IV E G L D + + S L+K +
Sbjct: 68 MTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLD 125
Query: 60 VVECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPY 115
V E HRDL N L V ED K +DFGL+ +
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVL---VSEDNVAKVSDFGLTKEASSTQD------TGKL 176
Query: 116 YV---APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
V APE LR K + ++DVWS G++L+ + S G P+ + ++ +G
Sbjct: 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} PDB: 2kqy_A Length = 109 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-08
Identities = 17/55 (30%), Positives = 28/55 (50%), Gaps = 3/55 (5%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQ---LMESEIKDLMDAV 298
L+ + +K++F ++D D SG I +EL+ LK S L +E K + A
Sbjct: 36 LSSKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAG 90
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 42/192 (21%), Positives = 78/192 (40%), Gaps = 28/192 (14%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEG---GELFDRIVKKGNYSEREAAKLMKTI 57
L+ + ++ ++ +V++L G +L D +K +S + A K +
Sbjct: 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRK--FSVKTVAMAAKQM 115
Query: 58 VGVVECCHSLGVFHRDLKPENFLF-LSVDEDAA-LKATDFGLSVFYK--------PDEVF 107
+ V+ H + +RD+KP+NFL ++A + DFG+ FY+ P
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 108 SDVVGSPYYVAPEVLRKHYGPEA----DVWSAGVILYILLSGVPPFW----AETEIGIFR 159
++ G+ Y++ + H G E D+ + G + L G P W A T +
Sbjct: 176 KNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-WQGLKAATNKQKYE 231
Query: 160 QILEGKIDFESE 171
+I E K
Sbjct: 232 RIGEKKQSTPLR 243
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 36/185 (19%), Positives = 64/185 (34%), Gaps = 38/185 (20%)
Query: 6 EHQHVVRI------HDTYEDKSCVHIVMELCEGGELFD---RIVKKGNYSEREAAKLMKT 56
+H HV ++ +++ + G+L N L++
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 57 IVGVVECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS 113
+V + S HRDL N + + ED + DFGLS +
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCM---LAEDMTVCVADFGLS---------RKIYSG 190
Query: 114 PYYV------------APEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159
YY A E L + Y +DVW+ GV ++ +++ G P+ I+
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250
Query: 160 QILEG 164
++ G
Sbjct: 251 YLIGG 255
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-08
Identities = 8/65 (12%), Positives = 24/65 (36%), Gaps = 2/65 (3%)
Query: 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS--QLMESEIKDLMDAVRK 300
I E + +K + +D G I+ ++ + R+ +L + ++ +
Sbjct: 4 ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLR 63
Query: 301 IFSRF 305
+ +
Sbjct: 64 VADQL 68
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-07
Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 3/64 (4%)
Query: 238 MALRVIAERLNEEEIG---GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDL 294
A + + EE+ ++ IDTD G ++ E K L+ VG L + +
Sbjct: 84 NATDSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITC 143
Query: 295 MDAV 298
+ +
Sbjct: 144 FNTL 147
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 2e-08
Identities = 31/88 (35%), Positives = 49/88 (55%), Gaps = 6/88 (6%)
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEV 121
H HRD+K N L +DE K +DFGL+ + + S +VG+ Y+APE
Sbjct: 150 HENHHIHRDIKSANIL---LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206
Query: 122 LRKHYGPEADVWSAGVILYILLSGVPPF 149
LR P++D++S GV+L +++G+P
Sbjct: 207 LRGEITPKSDIYSFGVVLLEIITGLPAV 234
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-08
Identities = 8/51 (15%), Positives = 16/51 (31%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF 305
+ F D D +G I + K + ++ + D A+
Sbjct: 6 IAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEAL 56
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-06
Identities = 12/54 (22%), Positives = 19/54 (35%), Gaps = 2/54 (3%)
Query: 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+R E L + DTD G +T + L G + E + A+
Sbjct: 90 DRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAAL 141
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-08
Identities = 12/70 (17%), Positives = 28/70 (40%), Gaps = 3/70 (4%)
Query: 230 SAMNKLKKMALRVIAER--LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLM 287
A L+ L I + + +I L F +D +GT++ ++ + + + L
Sbjct: 4 RASTLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIPELAINPLG 63
Query: 288 ESEIKDLMDA 297
+ I + +
Sbjct: 64 D-RIINAFFS 72
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 9e-05
Identities = 19/74 (25%), Positives = 30/74 (40%), Gaps = 2/74 (2%)
Query: 226 LKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR-VGS 284
L HF + +K E LN L F++ D D I+ DEL L+ VG
Sbjct: 87 LAHFRPIEDNEKSKDVNGPEPLNSRSNK-LHFAFRLYDLDKDDKISRDELLQVLRMMVGV 145
Query: 285 QLMESEIKDLMDAV 298
+ + ++ + D
Sbjct: 146 NISDEQLGSIADRT 159
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 Length = 204 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-08
Identities = 10/67 (14%), Positives = 23/67 (34%), Gaps = 2/67 (2%)
Query: 233 NKLKKMALRVIAERLNEEEIGGLKELFK-MIDTDNSGTITFDELKDGLKRVGSQLMESEI 291
+ + + L+E +K ++ SGT+ E K K ++ +
Sbjct: 3 QQFSWEEAEEN-GAVGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYV 61
Query: 292 KDLMDAV 298
+ + A
Sbjct: 62 EAMFRAF 68
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-08
Identities = 9/65 (13%), Positives = 26/65 (40%), Gaps = 1/65 (1%)
Query: 242 VIAERLNEEEIGGLKELFK-MIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK 300
+ A +L++ + + +F D ++ G I +D+ + +K++ + + R
Sbjct: 1 MAAHQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARA 60
Query: 301 IFSRF 305
Sbjct: 61 TLKLI 65
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 6e-06
Identities = 12/70 (17%), Positives = 22/70 (31%), Gaps = 3/70 (4%)
Query: 229 FSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLME 288
+ M + + E L E + +F + DT I E G + +
Sbjct: 86 WLKMWA-ECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IPK 142
Query: 289 SEIKDLMDAV 298
S+ D +
Sbjct: 143 SDCDAAFDTL 152
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-08
Identities = 10/59 (16%), Positives = 23/59 (38%), Gaps = 6/59 (10%)
Query: 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQL------MESEIKDLMDAV 298
+ + E++ D D SG + EL++ ++ + + E+K +D
Sbjct: 9 QSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQY 67
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 13/75 (17%), Positives = 30/75 (40%), Gaps = 3/75 (4%)
Query: 232 MNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEI 291
+ + L+ ++ +E + F++ D D +G I +EL LK + + +
Sbjct: 173 LPVQENFLLKFQGIKMCGKE---FNKAFELYDQDGNGYIDENELDALLKDLCEKNKQELD 229
Query: 292 KDLMDAVRKIFSRFS 306
+ + +K S
Sbjct: 230 INNISTYKKNIMALS 244
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 14/64 (21%), Positives = 29/64 (45%), Gaps = 3/64 (4%)
Query: 233 NKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIK 292
+ + L + + EE + ++ DTD+SG I +ELK+ LK + + ++
Sbjct: 86 TEENFLLLFRCQQLKSCEE---FMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDD 142
Query: 293 DLMD 296
+
Sbjct: 143 TKLA 146
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-08
Identities = 14/53 (26%), Positives = 29/53 (54%), Gaps = 1/53 (1%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG-SQLMESEIKDLMDAV 298
+ +++ + FK+ D + G I FDE K +++VG L ++E+++ M
Sbjct: 2 VRQDDEEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEA 54
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 35/184 (19%), Positives = 69/184 (37%), Gaps = 37/184 (20%)
Query: 6 EHQHVVR-----IHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREA---AKLMKTI 57
H +V+R I + + +++ + G+L ++ + + L+K +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 58 VGVVECCH---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
V + + HRDL N + + +D + DFGLS +
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCM---LRDDMTVCVADFGLS---------KKIYSGD 201
Query: 115 YYV------------APEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160
YY A E L Y ++DVW+ GV ++ + + G+ P+ ++
Sbjct: 202 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261
Query: 161 ILEG 164
+L G
Sbjct: 262 LLHG 265
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 36/164 (21%)
Query: 1 MHHLSEHQHVVRIHD--TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIV 58
+ +L H+++V+ T + + + ++ME G L + + N ++ + +K V
Sbjct: 77 LRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAV 133
Query: 59 GVVECC-----HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGS 113
+ C S HRDL N L V+ + +K DFGL+ + D+
Sbjct: 134 QI--CKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDK-------- 180
Query: 114 PYYVAPEVLR---KHYGPEA----------DVWSAGVILYILLS 144
YY + Y PE DVWS GV L+ LL+
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 42/173 (24%), Positives = 67/173 (38%), Gaps = 33/173 (19%)
Query: 1 MHHLSEHQHVVRIHD--TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIV 58
+ L +V+ + + +VME G L D + + + + +A++L+
Sbjct: 78 LKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSS 134
Query: 59 GVVECC---HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY 115
+ + S HRDL N L V+ +A +K DFGL+ D+ Y
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNIL---VESEAHVKIADFGLAKLLPLDK--------DY 183
Query: 116 YVAPEVLR---KHYGPEA----------DVWSAGVILYILLS-GVPPFWAETE 154
YV E + Y PE+ DVWS GV+LY L + E
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-08
Identities = 11/61 (18%), Positives = 23/61 (37%), Gaps = 4/61 (6%)
Query: 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV----GSQLMESEIKDLMDAVRKIFSR 304
LK+ F D D +G + + + + + G +E++ L +A +F
Sbjct: 3 AIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDY 62
Query: 305 F 305
Sbjct: 63 L 63
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 12/54 (22%), Positives = 21/54 (38%), Gaps = 2/54 (3%)
Query: 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
N +K + M D + G I DE L +G + ++E + + V
Sbjct: 94 ASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQV 145
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-08
Identities = 17/47 (36%), Positives = 25/47 (53%), Gaps = 3/47 (6%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQ---LMESEIKDLMDAV 298
+K+ F +ID D SG I DELK L+ + L ++E K + A
Sbjct: 44 IKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAG 90
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 47/220 (21%), Positives = 83/220 (37%), Gaps = 39/220 (17%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH- 65
HVVR+ ++MEL G+L + ++ +++
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 66 ---------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY 116
+ HRDL N + V ED +K DFG++ D+ + YY
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMT---------RDIYETDYY 194
Query: 117 V------------APEVLRKH-YGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQIL 162
+PE L+ + +DVWS GV+L+ I P+ + + R ++
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254
Query: 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
EG + + N + +L+R NPK R + E++
Sbjct: 255 EGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-08
Identities = 11/49 (22%), Positives = 25/49 (51%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLM 295
+ ++ KE F++ID D G I+ ++++ +G E E+ ++
Sbjct: 51 FTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMV 99
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 12/61 (19%), Positives = 21/61 (34%), Gaps = 4/61 (6%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
+ IA E+ I F + D + G + LK L G + + E+ +
Sbjct: 114 IFGDRIAGTDEEDVI---VNAFNLFD-EGDGKCKEETLKRSLTTWGEKFSQDEVDQALSE 169
Query: 298 V 298
Sbjct: 170 A 170
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 6e-08
Identities = 18/67 (26%), Positives = 29/67 (43%), Gaps = 10/67 (14%)
Query: 235 LKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQ---LMESEI 291
K+ L + ++ +K+ F +ID D SG I DELK L+ L ++E
Sbjct: 30 FAKVGLA----SKSLDD---VKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAET 82
Query: 292 KDLMDAV 298
K +
Sbjct: 83 KAFLADG 89
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-08
Identities = 41/179 (22%), Positives = 71/179 (39%), Gaps = 34/179 (18%)
Query: 6 EHQHVVRIHDT-YEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H +V+ + + +V+ + G+L + I + + L+ + V +
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGM 141
Query: 65 H---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV---- 117
S HRDL N + +DE +K DFGL+ D+ YY
Sbjct: 142 KYLASKKFVHRDLAARNCM---LDEKFTVKVADFGLA---------RDMYDKEYYSVHNK 189
Query: 118 ----------APEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
A E L+ + ++DVWS GV+L+ L++ G PP+ I +L+G
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 6e-08
Identities = 18/54 (33%), Positives = 29/54 (53%), Gaps = 6/54 (11%)
Query: 248 NEEEIGGLKELFKMIDTDNSGTITFDELKD---GLKRVGSQLMESEIKDLMDAV 298
+ + +KE+F+++D D SG I +ELK G G L ++E K L+ A
Sbjct: 39 TDAQ---VKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAG 89
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 7e-08
Identities = 13/50 (26%), Positives = 23/50 (46%)
Query: 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ L+ F+ D D G IT DEL+ + +G L + E+ ++
Sbjct: 2 RAGLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREA 51
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 8e-08
Identities = 41/193 (21%), Positives = 73/193 (37%), Gaps = 30/193 (15%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGG----ELFDRIVKKGNYSEREAAKLMKT 56
L + +++ +V+EL G +LFD + +S + +
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRT--FSLKTVLMIAIQ 113
Query: 57 IVGVVECCHSLGVFHRDLKPENFLF--LSVDEDAALKATDFGLSVFYKPDEVFS------ 108
++ +E HS + +RD+KPENFL + DF L+ Y E
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 109 --DVVGSPYYVAPEVLRKHYGPEA----DVWSAGVILYILLSGVPPFW----AETEIGIF 158
+ G+ Y++ + H G E D+ + G + L G P W A+T +
Sbjct: 174 HKSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERY 229
Query: 159 RQILEGKIDFESE 171
++I + K E
Sbjct: 230 QKIGDTKRATPIE 242
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 8e-08
Identities = 22/81 (27%), Positives = 35/81 (43%), Gaps = 2/81 (2%)
Query: 25 IVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84
+VME G +L + G + + +L ++ V+E H H D+K N L L
Sbjct: 129 MVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLL-LGY 186
Query: 85 DEDAALKATDFGLSVFYKPDE 105
+ D+GLS Y P+
Sbjct: 187 KNPDQVYLADYGLSYRYCPNG 207
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 8e-08
Identities = 10/64 (15%), Positives = 18/64 (28%), Gaps = 3/64 (4%)
Query: 236 KKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMES-EIKDL 294
++ + + +E F SG T E K L G + I +
Sbjct: 5 NGKSIAGDQKAVPTQETHVWYRTFM--MEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQV 62
Query: 295 MDAV 298
+
Sbjct: 63 YNTF 66
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 4e-04
Identities = 14/51 (27%), Positives = 24/51 (47%), Gaps = 1/51 (1%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF 305
LK FK+ D D +G+I +EL D V + L + + + +F +
Sbjct: 95 LKWYFKLYDADGNGSIDKNELLDMFMAVQA-LNGQQTLSPEEFINLVFHKI 144
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 44/194 (22%), Positives = 75/194 (38%), Gaps = 42/194 (21%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFD------RIVKKGNYSEREAAKLM 54
M + +H++++ + +++++E G L + + +Y+ +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 55 KTIVGVVECCH----------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD 104
+ +V C + S HRDL N L V ED +K DFGL+
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLA------ 238
Query: 105 EVFSDVVGSPYYV------------APEVLRKH-YGPEADVWSAGVILY-ILLSGVPPFW 150
D+ YY APE L Y ++DVWS GV+L+ I G P+
Sbjct: 239 ---RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295
Query: 151 AETEIGIFRQILEG 164
+F+ + EG
Sbjct: 296 GVPVEELFKLLKEG 309
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-07
Identities = 11/54 (20%), Positives = 21/54 (38%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK 300
++ KE F + D IT ++ D + +G +EI ++ K
Sbjct: 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSK 55
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 9e-07
Identities = 14/62 (22%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 240 LRVIAERLNEEEIGGLKEL---FKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
L ++ N ++ G ++ ++ D + +GT+ EL+ L +G ++ E E+++LM
Sbjct: 69 LPMLQAAANNKDQGTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMK 128
Query: 297 AV 298
Sbjct: 129 GQ 130
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 39/179 (21%), Positives = 70/179 (39%), Gaps = 34/179 (18%)
Query: 6 EHQHVVRIHDT-YEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H +V+ + + +V+ + G+L + I + + L+ + V +
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGM 205
Query: 65 H---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV---- 117
S HRDL N + +DE +K DFGL+ D+ +
Sbjct: 206 KFLASKKFVHRDLAARNCM---LDEKFTVKVADFGLA---------RDMYDKEFDSVHNK 253
Query: 118 ----------APEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
A E L+ + ++DVWS GV+L+ L++ G PP+ I +L+G
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 37/162 (22%), Positives = 64/162 (39%), Gaps = 32/162 (19%)
Query: 1 MHHLSEHQHVVRIHD--TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIV 58
+ L +H ++V+ + + ++ME G L D + + + + KL++
Sbjct: 65 LKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 121
Query: 59 GVV---ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY 115
+ E + HRDL N L V+ + +K DFGL+ D+ +
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK--------EF 170
Query: 116 YVAPEVLR---KHYGPEA----------DVWSAGVILYILLS 144
+ E Y PE+ DVWS GV+LY L +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-07
Identities = 10/54 (18%), Positives = 26/54 (48%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK 300
N++++ KE F++ D G I + + D ++ +G +E+ ++ +
Sbjct: 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKS 57
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-07
Identities = 11/63 (17%), Positives = 28/63 (44%), Gaps = 3/63 (4%)
Query: 240 LRVIAERLNEEEIGGLKEL---FKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
L ++ G ++ F++ D + +G + EL+ L +G ++ E E++ ++
Sbjct: 71 LPMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLA 130
Query: 297 AVR 299
Sbjct: 131 GHE 133
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-07
Identities = 12/61 (19%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
+ E+ + E FK D + G I+ EL+ L +G +L + ++ +++
Sbjct: 72 YEGLMDCEQGTFADY---MEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKL 128
Query: 298 V 298
Sbjct: 129 T 129
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 3e-05
Identities = 11/53 (20%), Positives = 26/53 (49%), Gaps = 2/53 (3%)
Query: 246 RLNEEEIGGLKELFKMID--TDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
+L+++EI LK++F++ D G + +L D + +G ++ +
Sbjct: 2 KLSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGG 54
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 39/162 (24%), Positives = 64/162 (39%), Gaps = 32/162 (19%)
Query: 1 MHHLSEHQHVVRIHD--TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIV 58
+ L +H ++V+ + + ++ME G L D + + + + KL++
Sbjct: 96 LKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 152
Query: 59 GVV---ECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY 115
+ E + HRDL N L V+ + +K DFGL+ D+ Y
Sbjct: 153 QICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK--------EY 201
Query: 116 YVAPEVLR---KHYGPEA----------DVWSAGVILYILLS 144
Y E Y PE+ DVWS GV+LY L +
Sbjct: 202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 39/171 (22%), Positives = 62/171 (36%), Gaps = 44/171 (25%)
Query: 1 MHHLSEHQHVVRIHD--TYEDKSCVHIVMELCEGGELFD------RIVKKGNYSEREAAK 52
+ H+ H +VV + T + +++E C+ G L + + K
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 53 LMKTIVGVVECCH----------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK 102
T+ ++ S HRDL N L + E +K DFGL+
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL---LSEKNVVKICDFGLA---- 195
Query: 103 PDEVFSDVVGSPYYV------------APEVLRKH-YGPEADVWSAGVILY 140
D+ P YV APE + Y ++DVWS GV+L+
Sbjct: 196 -----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 20/54 (37%), Positives = 33/54 (61%)
Query: 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
++L EE+I KE F + D D GTIT EL ++ +G E+E++D+++ V
Sbjct: 304 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 357
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 17/61 (27%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
M R + + +EEEI +E F++ D D +G I+ EL+ + +G +L + E+ +++
Sbjct: 373 MMARKMKDTDSEEEI---REAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIRE 429
Query: 298 V 298
Sbjct: 430 A 430
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 39/178 (21%), Positives = 61/178 (34%), Gaps = 52/178 (29%)
Query: 1 MHHLSEHQHVVRIHD--TYEDKSCVHIVMELCEGGELFD-----RIVKKGNYSEREAAKL 53
M L H+++V + T ++ E C G+L + R + E E K
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 54 MKTIVGVVECCH------------------SLGVFHRDLKPENFLFLSVDEDAALKATDF 95
++ + HRDL N L V +K DF
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL---VTHGKVVKICDF 216
Query: 96 GLSVFYKPDEVFSDVVGSPYYV------------APEVLRKH-YGPEADVWSAGVILY 140
GL+ D++ YV APE L + Y ++DVWS G++L+
Sbjct: 217 GLA---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 Length = 78 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-07
Identities = 14/50 (28%), Positives = 28/50 (56%), Gaps = 4/50 (8%)
Query: 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
++ ++ +FK DT+ G I+ EL D L+ +GS + E++ +M +
Sbjct: 2 ADD---MERIFKRFDTNGDGKISLSELTDALRTLGSTSAD-EVQRMMAEI 47
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-07
Identities = 11/63 (17%), Positives = 30/63 (47%), Gaps = 3/63 (4%)
Query: 236 KKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLM 295
+ E+ + F++ D +++G ++ +L+ L +G +L ++E+ +L+
Sbjct: 69 VNEKELDATTKAKTED---FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELL 125
Query: 296 DAV 298
V
Sbjct: 126 KGV 128
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-05
Identities = 12/47 (25%), Positives = 22/47 (46%)
Query: 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
K++F + D G I D L D L+ +G ++D+++A
Sbjct: 2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINA 48
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 42/162 (25%), Positives = 60/162 (37%), Gaps = 34/162 (20%)
Query: 1 MHHLSEHQHVVRIHD--TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIV 58
+ L H+H+++ + + +VME G L D + + A+L+
Sbjct: 87 LRTL-YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQ 141
Query: 59 GVVECC---HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPY 115
+ E H+ HRDL N L +D D +K DFGL+ Y
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHE--------Y 190
Query: 116 YVAPEVLR---KHYGPEA----------DVWSAGVILYILLS 144
Y E Y PE DVWS GV LY LL+
Sbjct: 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 38/180 (21%), Positives = 63/180 (35%), Gaps = 30/180 (16%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFD----RIVKKGNYSEREAAKLMKTIVGVV 61
HQ++VR I++EL GG+L + S L+ +
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 62 ECCHSL---GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV- 117
C L HRD+ N L K DFG++ D+ + YY
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRAGYYRK 242
Query: 118 -----------APEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
PE + + + D WS GV+L+ + S G P+ +++ + + G
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-07
Identities = 16/61 (26%), Positives = 29/61 (47%), Gaps = 3/61 (4%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
+ +E+ + F+ +D + +GTI EL+ L +G L SE+++LM
Sbjct: 64 YRKPIKTPTEQSKEM---LDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKE 120
Query: 298 V 298
V
Sbjct: 121 V 121
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145 | Back alignment and structure |
|---|
Score = 47.1 bits (113), Expect = 7e-07
Identities = 11/49 (22%), Positives = 24/49 (48%)
Query: 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
++E F++ D DN G ++ +EL L+ +G +E+ + +
Sbjct: 2 ASADQIQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQL 50
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 43/194 (22%), Positives = 74/194 (38%), Gaps = 42/194 (21%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFD------RIVKKGNYSEREAAKLM 54
M + +H++++ + +++++E G L + + +Y +
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 55 KTIVGVVECCH----------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD 104
T +V C + S HRDL N L V E+ +K DFGL+
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIADFGLA------ 204
Query: 105 EVFSDVVGSPYYV------------APEVLRKH-YGPEADVWSAGVILY-ILLSGVPPFW 150
D+ YY APE L Y ++DVWS GV+++ I G P+
Sbjct: 205 ---RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261
Query: 151 AETEIGIFRQILEG 164
+F+ + EG
Sbjct: 262 GIPVEELFKLLKEG 275
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 39/180 (21%), Positives = 63/180 (35%), Gaps = 30/180 (16%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFD----RIVKKGNYSEREAAKLMKTIVGVV 61
HQ++VR I+MEL GG+L + S L+ +
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 62 ECCHSL---GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV- 117
C L HRD+ N L K DFG++ D+ + YY
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRASYYRK 201
Query: 118 -----------APEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
PE + + + D WS GV+L+ + S G P+ +++ + + G
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 39/179 (21%), Positives = 68/179 (37%), Gaps = 34/179 (18%)
Query: 6 EHQHVVRIHDT-YEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECC 64
H +V+ + + H+++ G+L I + L+ + V
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGM 137
Query: 65 H---SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV---- 117
HRDL N + +DE +K DFGL+ D++ YY
Sbjct: 138 EYLAEQKFVHRDLAARNCM---LDESFTVKVADFGLA---------RDILDREYYSVQQH 185
Query: 118 ----------APEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
A E L+ + + ++DVWS GV+L+ LL+ G PP+ + + +G
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 3e-07
Identities = 46/317 (14%), Positives = 93/317 (29%), Gaps = 91/317 (28%)
Query: 55 KTIV-----GVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD 109
K ++ V + + H L + + DE +L P EV +
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTL-TPDEVKSLLLKYLDCRPQDLPREVLT- 324
Query: 110 VVGSPYYVA--PEVLRKH-----YGPEADVWSAGVILYILLSGVPP------FWAETEIG 156
+P ++ E +R + I+ L+ + P F +
Sbjct: 325 --TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD---RLS 379
Query: 157 IFRQILEGKIDFESEP-------WPNISES-----AKDLIRK-MLDQNPKR-RLTAHEVL 202
+F I P W ++ +S L + ++++ PK ++ +
Sbjct: 380 VFPP--SAHI-----PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 203 C------------HPWIVD----------DKVAPDKPLDSAVLSRLK-HFSAMNKLKKMA 239
H IVD D + P LD S + H + ++M
Sbjct: 433 LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP-YLDQYFYSHIGHHLKNIEHPERMT 491
Query: 240 L-------------RVIAERLNEEEIGGLKELFK--------MIDTDNSGTITFDELKDG 278
L ++ + G + + + D D + + D
Sbjct: 492 LFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
Query: 279 LKRVGSQLMESEIKDLM 295
L ++ L+ S+ DL+
Sbjct: 552 LPKIEENLICSKYTDLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 2e-04
Identities = 57/354 (16%), Positives = 102/354 (28%), Gaps = 128/354 (36%)
Query: 12 RIHDTYEDKSCVHIVME-----LCEGGELFD-----RI-----VKKGNYSEREAAKL--- 53
I S + + L ++F R+ +++ R A +
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156
Query: 54 -M----KTIVGV-------VECCHSLGVF----------HRDLKPENFLFLSVDEDAALK 91
+ KT V + V+C +F L+ L +D + +
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 92 ATDFGLSVFYKPDEV---FSDVVGSPYYVAPE---VLRKHYGPEADVWSAGVILY----- 140
+ D ++ + + ++ S Y VL +V +A
Sbjct: 217 S-DHSSNIKLRIHSIQAELRRLLKSKPY--ENCLLVLL-------NVQNAKAWNAFNLSC 266
Query: 141 -ILLSGVPPFWAET-EIGIFRQILEGK---IDFESEPWPNISESAKDLIRKMLDQNPKRR 195
ILL+ T + + I + + K L+ K LD P+
Sbjct: 267 KILLT--------TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ-D 317
Query: 196 LTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGL 255
L EVL P L +IAE + +
Sbjct: 318 L-PREVL--------TTNP-----------------------RRLSIIAESIRD------ 339
Query: 256 KELFKMIDT-DNSGTITFDELKDGLKRVGSQLMESEIKDLMDA-VRKIFSRFSI 307
+ T DN + D+L + ++ES + L A RK+F R S+
Sbjct: 340 -----GLATWDNWKHVNCDKL--------TTIIESSLNVLEPAEYRKMFDRLSV 380
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-07
Identities = 12/70 (17%), Positives = 27/70 (38%), Gaps = 4/70 (5%)
Query: 231 AMNKLKKMALRVIAE--RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLME 288
+ +KL + L+ + R +++E+ + F SG + E + K+
Sbjct: 4 SQSKLSQDQLQDLVRSTRFDKKELQQWYKGFF--KDCPSGHLNKSEFQKIYKQFFPFGDP 61
Query: 289 SEIKDLMDAV 298
S + + V
Sbjct: 62 SAFAEYVFNV 71
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-07
Identities = 14/76 (18%), Positives = 25/76 (32%), Gaps = 10/76 (13%)
Query: 233 NKLKKMALRVIAE--RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESE 290
+KL+ ++ + E E EI + F SG ++ +E K S+
Sbjct: 6 SKLRPEVMQDLLESTDFTEHEIQEWYKGFL--RDCPSGHLSMEEFKKIYGNFFPYGDASK 63
Query: 291 IKDLMDAVRKIFSRFS 306
+F F
Sbjct: 64 F------AEHVFRTFD 73
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 43/194 (22%), Positives = 74/194 (38%), Gaps = 42/194 (21%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFD------RIVKKGNYSEREAAKLM 54
M + +H++++ + +++++E G L + + +Y +
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 55 KTIVGVVECCH----------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD 104
T +V C + S HRDL N L V E+ +K DFGL+
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIADFGLA------ 250
Query: 105 EVFSDVVGSPYYV------------APEVLRKH-YGPEADVWSAGVILY-ILLSGVPPFW 150
D+ YY APE L Y ++DVWS GV+++ I G P+
Sbjct: 251 ---RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307
Query: 151 AETEIGIFRQILEG 164
+F+ + EG
Sbjct: 308 GIPVEELFKLLKEG 321
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 7e-07
Identities = 40/194 (20%), Positives = 69/194 (35%), Gaps = 45/194 (23%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFD------RIVKKGNYSEREAAKLM 54
+ L H +++ + E + +++ +E G L D + ++ +
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 55 KTIVGVVECCH----------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD 104
+ ++ HRDL N L V E+ K DFGLS +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLS---RGQ 192
Query: 105 EVFSDVVGSPYYV------------APEVLRKH-YGPEADVWSAGVILY-ILLSGVPPFW 150
E YV A E L Y +DVWS GV+L+ I+ G P+
Sbjct: 193 E---------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243
Query: 151 AETEIGIFRQILEG 164
T ++ ++ +G
Sbjct: 244 GMTCAELYEKLPQG 257
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-07
Identities = 11/57 (19%), Positives = 26/57 (45%), Gaps = 2/57 (3%)
Query: 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDL-MDAVRKIFSRF 305
EE+ + LF + D+ ++ EL + L +V ++ + + +D R + +
Sbjct: 1 EEVRQFRRLFAQLAGDD-MEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVM 56
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-05
Identities = 13/48 (27%), Positives = 19/48 (39%)
Query: 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
I + ++K D D SGTI EL + G L E ++
Sbjct: 74 NNIKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRR 121
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 8e-07
Identities = 15/82 (18%), Positives = 32/82 (39%), Gaps = 4/82 (4%)
Query: 25 IVMELCEGGELFD--RIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82
+V+ G L + K SER ++ ++ +E H H ++ EN +
Sbjct: 135 LVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF-V 192
Query: 83 SVDEDAALKATDFGLSVFYKPD 104
++ + + +G + Y P
Sbjct: 193 DPEDQSQVTLAGYGFAFRYCPS 214
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140 | Back alignment and structure |
|---|
Score = 46.3 bits (111), Expect = 1e-06
Identities = 17/62 (27%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 240 LRVIAERLNEEEIGGLKEL---FKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
L+V+ + G +E F++ D D +G I EL+ L +G +L E+ +L+
Sbjct: 60 LQVLNRPNGFDMPGDPEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLK 119
Query: 297 AV 298
V
Sbjct: 120 GV 121
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 3e-05
Identities = 10/46 (21%), Positives = 19/46 (41%)
Query: 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLM 295
+ K+ F + D +G I + D L+ G +EI ++
Sbjct: 2 TDDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIE 47
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 29/139 (20%), Positives = 52/139 (37%), Gaps = 19/139 (13%)
Query: 25 IVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83
++M+ G +L +S + +L I+ ++E H H D+K N L L+
Sbjct: 129 MIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL-LN 186
Query: 84 VDEDAALKATDFGLSVFYKPDEVFSDV--------VGSPYYVAPEVLRKHYGPEA----D 131
+ D+GL+ Y P+ V G+ + + + H G D
Sbjct: 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGD 243
Query: 132 VWSAGVILYILLSGVPPFW 150
+ G + L+G P W
Sbjct: 244 LEILGYCMIQWLTGHLP-W 261
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 6/51 (11%), Positives = 20/51 (39%), Gaps = 1/51 (1%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA 297
++ + L F+ +D + G ++ +L+ + + + I +
Sbjct: 23 FSQASLLRLHHRFRALDRNKKGYLSRMDLQQ-IGALAVNPLGDRIIESFFP 72
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-06
Identities = 16/74 (21%), Positives = 28/74 (37%), Gaps = 1/74 (1%)
Query: 226 LKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR-VGS 284
L HF + L F++ D D G I+ E+ L+ VG
Sbjct: 87 LAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGV 146
Query: 285 QLMESEIKDLMDAV 298
Q+ E +++++ D
Sbjct: 147 QVTEEQLENIADRT 160
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-06
Identities = 7/62 (11%), Positives = 22/62 (35%), Gaps = 4/62 (6%)
Query: 238 MALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQ-LMESEIKDLMD 296
+ + E L + F ++ IT + L+ +G + + + + + ++
Sbjct: 28 VMAEKMDVEEFVSE---LCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVR 84
Query: 297 AV 298
Sbjct: 85 EG 86
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-05
Identities = 12/75 (16%), Positives = 33/75 (44%), Gaps = 3/75 (4%)
Query: 235 LKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDL 294
L++ + + E +++E+ + + + D D G + E + R+ ++ME L
Sbjct: 62 LRRNSGILGIEGMSKED---AQGMVREGDLDGDGALNQTEFCVLMVRLSPEMMEDAETWL 118
Query: 295 MDAVRKIFSRFSIKT 309
A+ + ++ +
Sbjct: 119 EKALTQELCNHNLSS 133
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 4e-06
Identities = 26/84 (30%), Positives = 42/84 (50%), Gaps = 6/84 (7%)
Query: 69 VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPE-VLRKH 125
+ HRD+K N L +DE+ DFGL+ + V + V G+ ++APE +
Sbjct: 155 IIHRDVKAANIL---LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 211
Query: 126 YGPEADVWSAGVILYILLSGVPPF 149
+ DV+ GV+L L++G F
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAF 235
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A Length = 83 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-06
Identities = 9/58 (15%), Positives = 21/58 (36%), Gaps = 6/58 (10%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLM------ESEIKDLMDAV 298
+ + L+ FK +D + G +T EL+ + + + + L+
Sbjct: 1 MACKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMA 58
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 110 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-06
Identities = 11/53 (20%), Positives = 22/53 (41%), Gaps = 2/53 (3%)
Query: 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
R+ EE+ F+ + D S I+ K+ + S+L E+ + +
Sbjct: 15 RITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTK--SKLSIPELSYIWELS 65
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 9e-06
Identities = 30/206 (14%), Positives = 65/206 (31%), Gaps = 21/206 (10%)
Query: 17 YEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMK-TIVGVVECCHSLGVFHRDLK 75
+ + IV+E GG +++ K + S A ++ + SL HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLS-SLATAKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 76 PENFLFLSVD--------EDAALKATDFGLSVF-----YKPDEVFSDVVGSPYYVAPEVL 122
N L + GL V E VV + ++
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249
Query: 123 RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKD 182
+ D++ ++ + + + + + + + + + + K
Sbjct: 250 TGDGDYQFDIYR--LMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQ 307
Query: 183 LIRKMLDQNPKRRLT---AHEVLCHP 205
+ RK + + + L A ++LC
Sbjct: 308 IKRK-IQEFHRTMLNFSSATDLLCQH 332
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 41/188 (21%), Positives = 67/188 (35%), Gaps = 41/188 (21%)
Query: 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFD-----RIVKKGNYSEREAAKLMKTIVGV 60
+HQH+VR + + +V E G+L K + A + +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 61 VECCH----------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV 110
+ L HRDL N L V + +K DFG+S D+
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCL---VGQGLVVKIGDFGMS---------RDI 208
Query: 111 VGSPYYV------------APEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIG 156
+ YY PE + + E+DVWS GV+L+ + + G P++ +
Sbjct: 209 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268
Query: 157 IFRQILEG 164
I +G
Sbjct: 269 AIDCITQG 276
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 31/97 (31%), Positives = 40/97 (41%), Gaps = 26/97 (26%)
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV-------- 117
S HRDL N L + E +K DFGL+ D+ P YV
Sbjct: 211 SRKCIHRDLAARNIL---LSEKNVVKICDFGLA---------RDIYKDPDYVRKGDARLP 258
Query: 118 ----APEVLRKH-YGPEADVWSAGVILY-ILLSGVPP 148
APE + Y ++DVWS GV+L+ I G P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 44/198 (22%), Positives = 74/198 (37%), Gaps = 47/198 (23%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFD------RIVKKGNYSEREAAKLM 54
+ +L H+H+V+ + D + +V E + G+L + AK
Sbjct: 71 LTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 55 KTIVGVVECCH----------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD 104
+ ++ S HRDL N L V + +K DFG+S
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL---VGANLLVKIGDFGMS------ 180
Query: 105 EVFSDVVGSPYYV------------APEVLRKHYG---PEADVWSAGVILYILLS-GVPP 148
DV + YY PE + Y E+DVWS GVIL+ + + G P
Sbjct: 181 ---RDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 149 FWAETEIGIFRQILEGKI 166
++ + + I +G++
Sbjct: 236 WFQLSNTEVIECITQGRV 253
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 95 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-05
Identities = 8/52 (15%), Positives = 21/52 (40%), Gaps = 2/52 (3%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
++ E E+F D D G ++ E+++ + + L + + +
Sbjct: 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLK--TGLPSTLLAHIWSLC 53
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-05
Identities = 10/52 (19%), Positives = 16/52 (30%), Gaps = 2/52 (3%)
Query: 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLM 295
E L+ E + F SG +T E K ++ + M
Sbjct: 8 VEELSATECHQWYKKFM--TECPSGQLTLYEFKQFFGLKNLSPSANKYVEQM 57
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 12/51 (23%), Positives = 23/51 (45%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF 305
L+ FK+ D D +G I EL + +K + + +E + +F +
Sbjct: 90 LRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKI 140
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 Length = 92 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-05
Identities = 11/53 (20%), Positives = 22/53 (41%), Gaps = 2/53 (3%)
Query: 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
++ +E+ FK I D +G I K+ + S+L E+ + +
Sbjct: 2 KITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTK--SKLPILELSHIWELS 52
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 39/191 (20%), Positives = 72/191 (37%), Gaps = 46/191 (24%)
Query: 6 EHQHVVRIHD--TYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV--- 60
+H +VV + T + ++ C G+L + +V + +S+ + +T+
Sbjct: 70 QHPNVVCLLGVVTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 61 ---VECCH----------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF 107
V S V H+DL N L V + +K +D GL
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL---VYDKLNVKISDLGLF--------- 175
Query: 108 SDVVGSPYYV------------APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAET 153
+V + YY APE + + ++D+WS GV+L+ + S G+ P+ +
Sbjct: 176 REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
Query: 154 EIGIFRQILEG 164
+ I
Sbjct: 236 NQDVVEMIRNR 246
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-05
Identities = 10/60 (16%), Positives = 24/60 (40%), Gaps = 1/60 (1%)
Query: 247 LNEEEIGGLKELFK-MIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF 305
LN+ + +K F +D ++ G+I ++ +D + R S +++
Sbjct: 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDE 61
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 9e-05
Identities = 11/63 (17%), Positives = 24/63 (38%), Gaps = 2/63 (3%)
Query: 236 KKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLM 295
K +A L + LFK +D G + +E ++ K L +++ +
Sbjct: 88 KTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVY 145
Query: 296 DAV 298
+ +
Sbjct: 146 NVI 148
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} Length = 111 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 9e-05
Identities = 9/52 (17%), Positives = 23/52 (44%), Gaps = 2/52 (3%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ + ++LF D SG +T + + L + S L ++++ + +
Sbjct: 8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILMQ--SSLPQAQLASIWNLS 57
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 9e-05
Identities = 44/196 (22%), Positives = 67/196 (34%), Gaps = 50/196 (25%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFD-----RIVKKGNYSEREAAKLMKTIVGV- 60
H HV++++ + +++E + G L R V G +
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 61 --------VECCH----------SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK 102
+ + + HRDL N L V E +K +DFGLS
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL---VAEGRKMKISDFGLS---- 197
Query: 103 PDEVFSDVVGSPYYV------------APEVLRKH-YGPEADVWSAGVILY-ILLSGVPP 148
DV YV A E L H Y ++DVWS GV+L+ I+ G P
Sbjct: 198 -----RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 149 FWAETEIGIFRQILEG 164
+ +F + G
Sbjct: 253 YPGIPPERLFNLLKTG 268
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A Length = 165 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 1e-04
Identities = 12/45 (26%), Positives = 22/45 (48%)
Query: 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
+ KE F +D D SGT+ EL+ + +G +L + ++
Sbjct: 69 LNAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVK 113
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 14/58 (24%), Positives = 24/58 (41%), Gaps = 7/58 (12%)
Query: 246 RLNEEE-------IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMD 296
+ E + G ++ F DTD SGT+ EL+ L +G +L + +
Sbjct: 89 TMGFNEFKELWAVLNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAK 146
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 Length = 224 | Back alignment and structure |
|---|
Score = 40.0 bits (93), Expect = 4e-04
Identities = 12/91 (13%), Positives = 26/91 (28%), Gaps = 8/91 (8%)
Query: 216 KPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDEL 275
+P + L+ ++ + + + E+ L FK SG + +
Sbjct: 17 RPSKDKIEDELEMTMVCHRPEGLEQLEAQTNFTKRELQVLYRGFKNE--CPSGVVNEETF 74
Query: 276 KDGLKRVGSQLMESEIKDLMDAVRKIFSRFS 306
K + S +F+ F
Sbjct: 75 KQIYAQFFPHGDASTYAH------YLFNAFD 99
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A Length = 76 | Back alignment and structure |
|---|
Score = 37.2 bits (87), Expect = 5e-04
Identities = 11/54 (20%), Positives = 27/54 (50%), Gaps = 7/54 (12%)
Query: 249 EEEIGGLKELFKMIDTD--NSGTITFDELKDGLKRVGSQLMES--EIKDLMDAV 298
EE +K F++ + I+ +ELK ++ +G L++ + ++++ V
Sbjct: 4 PEE---IKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEV 54
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 26/108 (24%)
Query: 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV------------A 118
HRDL N L V E+ +K DFGLS ++ + YY
Sbjct: 197 HRDLATRNCL---VGENMVVKIADFGLS---------RNIYSADYYKADGNDAIPIRWMP 244
Query: 119 PEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEG 164
PE + + Y E+DVW+ GV+L+ + S G+ P++ + + +G
Sbjct: 245 PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG 292
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.73 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.47 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 99.44 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.43 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 99.41 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.21 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 99.2 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 99.13 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 99.12 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 99.11 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 99.11 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 99.1 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 99.09 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 99.07 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 99.07 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 99.06 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 99.06 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 99.02 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.01 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 99.01 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 99.0 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 99.0 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 99.0 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 99.0 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 98.99 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 98.98 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 98.98 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 98.98 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 98.97 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 98.96 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 98.96 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 98.95 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 98.94 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 98.94 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 98.94 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 98.93 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 98.92 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 98.92 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 98.91 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 98.9 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 98.9 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 98.88 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 98.88 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 98.88 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 98.87 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 98.87 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 98.87 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.87 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 98.86 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 98.86 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 98.85 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 98.85 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 98.84 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 98.83 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 98.83 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 98.83 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 98.82 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 98.81 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 98.81 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 98.8 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 98.8 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 98.8 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 98.8 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 98.8 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 98.79 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 98.78 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 98.77 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 98.76 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 98.75 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 98.75 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 98.75 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 98.75 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 98.74 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 98.74 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 98.74 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 98.73 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 98.73 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 98.73 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 98.72 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 98.71 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.7 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 98.7 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 98.7 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 98.68 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 98.68 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 98.67 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 98.65 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 98.65 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 98.64 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 98.63 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 98.62 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.62 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 98.62 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 98.61 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 98.61 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 98.61 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 98.6 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 98.6 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 98.59 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 98.59 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.59 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.58 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 98.58 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 98.57 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 98.57 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.56 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 98.56 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 98.55 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.55 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.54 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 98.54 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 98.54 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 98.54 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 98.52 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 98.52 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 98.51 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.51 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.5 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 98.5 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 98.5 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 98.5 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 98.5 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 98.5 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 98.5 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 98.49 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 98.49 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 98.48 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 98.47 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 98.46 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 98.46 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 98.44 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 98.44 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 98.44 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.43 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 98.43 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 98.42 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 98.41 | |
| 1snl_A | 103 | Nucleobindin 1, calnuc; EF-hand, calcium-binding, | 98.41 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 98.41 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 98.41 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 98.41 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 98.4 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 98.39 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 98.39 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.39 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 98.38 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 98.37 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 98.37 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 98.36 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 98.36 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 98.36 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 98.35 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 98.35 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 98.35 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 98.34 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.34 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 98.33 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 98.33 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 98.33 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 98.32 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 98.32 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 98.31 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 98.31 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 98.31 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 98.29 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 98.29 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 98.28 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 98.26 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 98.26 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 98.26 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 98.26 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 98.25 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 98.25 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 98.24 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 98.24 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 98.24 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 98.24 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 98.22 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 98.22 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 98.21 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.21 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 98.18 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 98.18 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 98.18 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 98.18 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 98.17 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 98.17 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 98.17 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 98.16 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 98.15 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 98.15 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 98.12 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 98.12 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 98.12 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 98.11 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 98.11 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 98.11 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 98.1 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 98.09 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 98.09 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 98.08 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 98.08 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 98.07 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 98.07 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 98.06 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 98.06 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 98.05 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 98.05 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 98.05 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 98.04 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 98.03 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 98.02 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 98.01 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 98.01 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 98.0 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 97.99 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 97.99 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 97.98 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 97.98 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 97.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.97 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 97.96 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 97.9 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 97.9 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 97.89 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 97.89 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 97.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.89 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 97.88 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 97.85 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 97.85 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 97.84 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 97.79 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 97.77 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 97.74 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.69 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 97.64 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.63 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 97.62 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 97.61 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 97.55 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 97.52 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 97.47 | |
| 2zkm_X | 799 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 97.32 | |
| 1sra_A | 151 | Sparc; extracellular matrix protein, calcium-bindi | 97.26 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 97.18 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 97.17 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.11 |
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-62 Score=455.15 Aligned_cols=312 Identities=37% Similarity=0.681 Sum_probs=282.9
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.+ +|||||++++++++.+.+|+|||||.||+|.+++...+++++..++.++.||+.||.|||++||+||||||+||++
T Consensus 91 ~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 169 (494)
T 3lij_A 91 KLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLL 169 (494)
T ss_dssp TTC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred HhC-CCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEE
Confidence 344 8999999999999999999999999999999999888899999999999999999999999999999999999998
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
...+..+.+||+|||++............+||+.|+|||++.+.++.++||||+||++|+|++|.+||.+.+..+....+
T Consensus 170 ~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 249 (494)
T 3lij_A 170 ESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249 (494)
T ss_dssp SCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 65555678999999999887766666678899999999999888999999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC----CCCCCCCCHHHHHHHHhhHhhhHHHH
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK----VAPDKPLDSAVLSRLKHFSAMNKLKK 237 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (315)
..+...++.+.|+.+|+++++||.+||+.||.+|||+.|+|+||||+... .....+.....+.++++|...+++++
T Consensus 250 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~q 329 (494)
T 3lij_A 250 EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQ 329 (494)
T ss_dssp HHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHH
T ss_pred HhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHH
Confidence 99999888888889999999999999999999999999999999997532 11233445567888999999999999
Q ss_pred HHHHHHhhhh-hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCC--------CCCHHHHHHHHHHHhccCCCC-CH
Q 021227 238 MALRVIAERL-NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS--------QLMESEIKDLMDAVRKIFSRF-SI 307 (315)
Q Consensus 238 ~~~~~i~~~l-~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~--------~~~~~ei~~~~~~~d~~~~~~-~~ 307 (315)
.++..++..+ +.+++.+++++|..+|.|++|.|+.+|+..+++.+|. ..++++++.+++.+|.+++|. ++
T Consensus 330 a~l~~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~ 409 (494)
T 3lij_A 330 AALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDY 409 (494)
T ss_dssp HHHHHHHHHSCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEH
T ss_pred HHHHHHHHhcccHHHHHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcH
Confidence 9999998877 7889999999999999999999999999999999864 456899999999999999988 99
Q ss_pred HHHhhcc
Q 021227 308 KTYCNLS 314 (315)
Q Consensus 308 ~~f~~~~ 314 (315)
+||++++
T Consensus 410 ~EF~~~~ 416 (494)
T 3lij_A 410 SEFVTVA 416 (494)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-61 Score=450.87 Aligned_cols=312 Identities=36% Similarity=0.660 Sum_probs=279.8
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+++ +||||+++++++++.+.+|+|||||.||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 81 ~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 159 (484)
T 3nyv_A 81 KQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159 (484)
T ss_dssp TTC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhC-CCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 455 8999999999999999999999999999999999988999999999999999999999999999999999999998
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
...+.++.+||+|||++.............||+.|+|||++.+.++.++||||+||++|+|++|.+||.+.+..+....+
T Consensus 160 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 239 (484)
T 3nyv_A 160 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239 (484)
T ss_dssp SSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 65567889999999999877666666677899999999999888999999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC---CCCCCCCHHHHHHHHhhHhhhHHHHH
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV---APDKPLDSAVLSRLKHFSAMNKLKKM 238 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (315)
..+...++.+.|..+|+++++||.+||+.||.+|||+.|+|+||||+.... ....+.....+.++++|...+++++.
T Consensus 240 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa 319 (484)
T 3nyv_A 240 EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQA 319 (484)
T ss_dssp HHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHH
Confidence 999988888888899999999999999999999999999999999975432 22345567778899999999999999
Q ss_pred HHHHHhhhh-hhhhhccHHHHhcccCCCCCCcccHHHHHHHH----HHhCCCCC-------HHHHHHHHHHHhccCCCC-
Q 021227 239 ALRVIAERL-NEEEIGGLKELFKMIDTDNSGTITFDELKDGL----KRVGSQLM-------ESEIKDLMDAVRKIFSRF- 305 (315)
Q Consensus 239 ~~~~i~~~l-~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l----~~~~~~~~-------~~ei~~~~~~~d~~~~~~- 305 (315)
++..++..+ +.+++..++++|..+|.|++|.|+.+|+..++ +.+|...+ +++++.+++.+|.+++|.
T Consensus 320 ~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i 399 (484)
T 3nyv_A 320 ALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYI 399 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEE
T ss_pred HHHHHHhccCcHHHHHHHHHHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeE
Confidence 999998766 78899999999999999999999999995544 44577677 899999999999999998
Q ss_pred CHHHHhhcc
Q 021227 306 SIKTYCNLS 314 (315)
Q Consensus 306 ~~~~f~~~~ 314 (315)
+++||++++
T Consensus 400 ~~~Ef~~~~ 408 (484)
T 3nyv_A 400 EYSEFVTVA 408 (484)
T ss_dssp EHHHHHHHH
T ss_pred eHHHHHHHH
Confidence 999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-61 Score=449.87 Aligned_cols=309 Identities=39% Similarity=0.668 Sum_probs=276.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+.+.+|+|||||.||+|.+.+.+.+.+++..++.++.|++.||.|||++||+||||||+||++...+
T Consensus 79 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~ 158 (486)
T 3mwu_A 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158 (486)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS
T ss_pred CCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC
Confidence 89999999999999999999999999999999998888999999999999999999999999999999999999986556
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGK 165 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 165 (315)
.++.+||+|||++............+||+.|+|||++.+.++.++||||+||++|+|++|.+||.+.+..+....+..+.
T Consensus 159 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 238 (486)
T 3mwu_A 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238 (486)
T ss_dssp TTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 67889999999998776666666778999999999999889999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC----CCHHHHHHHHhhHhhhHHHHHHHH
Q 021227 166 IDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKP----LDSAVLSRLKHFSAMNKLKKMALR 241 (315)
Q Consensus 166 ~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 241 (315)
..++.+.|..+|+++++||.+||+.||.+|||+.|+|+||||+......... .....+.++++|....++++..+.
T Consensus 239 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 318 (486)
T 3mwu_A 239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALL 318 (486)
T ss_dssp CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHH
T ss_pred CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHH
Confidence 8888888889999999999999999999999999999999998765433221 224456788999999999999999
Q ss_pred HHhhhh-hhhhhccHHHHhcccCCCCCCcccHHHHHHHH----HHhCCCCC----------HHHHHHHHHHHhccCCCC-
Q 021227 242 VIAERL-NEEEIGGLKELFKMIDTDNSGTITFDELKDGL----KRVGSQLM----------ESEIKDLMDAVRKIFSRF- 305 (315)
Q Consensus 242 ~i~~~l-~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l----~~~~~~~~----------~~ei~~~~~~~d~~~~~~- 305 (315)
.++..+ +.+++..++++|..+|.|+||.|+.+|+..++ +.+|...+ +++++.+++.+|.+++|.
T Consensus 319 ~ia~~l~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I 398 (486)
T 3mwu_A 319 YMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSI 398 (486)
T ss_dssp HHHHHHCCHHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSB
T ss_pred HHHHHhccHHHHHHHHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcC
Confidence 998777 78899999999999999999999999996554 44566655 999999999999999988
Q ss_pred CHHHHhhcc
Q 021227 306 SIKTYCNLS 314 (315)
Q Consensus 306 ~~~~f~~~~ 314 (315)
+++||++.+
T Consensus 399 ~~~Ef~~~~ 407 (486)
T 3mwu_A 399 EYSEFIASA 407 (486)
T ss_dssp CHHHHHHHH
T ss_pred cHHHHHHHH
Confidence 999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-62 Score=453.43 Aligned_cols=311 Identities=34% Similarity=0.627 Sum_probs=281.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+ +||||++++++++++..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||++.
T Consensus 102 ~l-~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 102 SL-DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE 180 (504)
T ss_dssp TC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred hC-CCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEe
Confidence 44 89999999999999999999999999999999998888999999999999999999999999999999999999975
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
..+....+||+|||++.............||+.|+|||++.+.++.++||||+||++|+|++|.+||.+.+..+....+.
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 44444589999999998877666666788999999999998889999999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC---CCHHHHHHHHhhHhhhHHHHHH
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKP---LDSAVLSRLKHFSAMNKLKKMA 239 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 239 (315)
.+...++.+.|+.+|+++++||.+||+.||.+|||++|+|+||||+......... .....+.++++|...+++++..
T Consensus 261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~ 340 (504)
T 3q5i_A 261 KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAA 340 (504)
T ss_dssp HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHH
T ss_pred cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHH
Confidence 9988888777888999999999999999999999999999999998765432211 2245577889999999999999
Q ss_pred HHHHhhhh-hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHh--------CCCCCHHHHHHHHHHHhccCCCC-CHHH
Q 021227 240 LRVIAERL-NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV--------GSQLMESEIKDLMDAVRKIFSRF-SIKT 309 (315)
Q Consensus 240 ~~~i~~~l-~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~--------~~~~~~~ei~~~~~~~d~~~~~~-~~~~ 309 (315)
+..++..+ +.+++..++++|..+|.|++|.|+.+|+..+++.+ |...++++++.+++.+|.+++|. +++|
T Consensus 341 l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~E 420 (504)
T 3q5i_A 341 ILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSE 420 (504)
T ss_dssp HHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHH
T ss_pred HHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHH
Confidence 99998777 88899999999999999999999999999999988 56788999999999999999987 9999
Q ss_pred Hhhcc
Q 021227 310 YCNLS 314 (315)
Q Consensus 310 f~~~~ 314 (315)
|++++
T Consensus 421 F~~~~ 425 (504)
T 3q5i_A 421 FISVC 425 (504)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-59 Score=403.44 Aligned_cols=200 Identities=34% Similarity=0.598 Sum_probs=183.7
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.| +|||||+++++|++++++|+|||||+||+|.+++.+.+.++|..++.++.||+.||+|||++||+||||||+|||
T Consensus 87 ~~l-~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNIL- 164 (311)
T 4aw0_A 87 SRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL- 164 (311)
T ss_dssp TTC-CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE-
T ss_pred HhC-CCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeE-
Confidence 455 899999999999999999999999999999999999899999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCC---CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
++.++.+||+|||+|+..... ....+.+||+.|||||++.+ .|+.++||||+||++|+|+||.+||.+.+..++
T Consensus 165 --l~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 242 (311)
T 4aw0_A 165 --LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI 242 (311)
T ss_dssp --ECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred --EcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 567889999999999876432 23456899999999999975 599999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCccC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHE------VLCHPWIVD 209 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~------~l~h~~~~~ 209 (315)
+.+|.++.+.++. .+|+++++||.+||++||.+|||++| +++||||+.
T Consensus 243 ~~~i~~~~~~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 243 FAKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HHHHHHTCCCCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHcCCCCCCc----ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999998877653 68999999999999999999999998 478999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-58 Score=397.15 Aligned_cols=201 Identities=30% Similarity=0.563 Sum_probs=182.2
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
|+.| +|||||+++++|++++.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 80 l~~l-~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 158 (304)
T 3ubd_A 80 LVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENIL 158 (304)
T ss_dssp CCCC-CCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred HHHC-CCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeE
Confidence 3455 899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
.+.++.+||+|||+|+.... .....+.+||+.|||||++. +.|+.++||||+||++|+|+||.+||.+.+..+++
T Consensus 159 ---l~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 235 (304)
T 3ubd_A 159 ---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235 (304)
T ss_dssp ---ECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ---EcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH
Confidence 56788999999999986543 33445688999999999997 45999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
..|.++...++ ..+|+++++||.+||++||++||| ++|+++||||+.
T Consensus 236 ~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 236 TMILKAKLGMP----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHcCCCCCC----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 99999877654 368999999999999999999998 589999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-58 Score=393.53 Aligned_cols=196 Identities=40% Similarity=0.704 Sum_probs=170.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+|||||+++++|++++.+|+||||| +|+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+||| ++
T Consensus 71 ~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NIL---l~ 146 (275)
T 3hyh_A 71 RHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLL---LD 146 (275)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE---EC
T ss_pred CCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeE---EC
Confidence 8999999999999999999999999 6799999999999999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||+|+.........+.+||+.|||||++.+. ++.++||||+||++|+|+||+.||.+.+..++++.+..
T Consensus 147 ~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~ 226 (275)
T 3hyh_A 147 EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 226 (275)
T ss_dssp TTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 7889999999999887666666778999999999999754 46899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
+...++ ..+|+++++||.+||++||++|||++|+++||||+.
T Consensus 227 ~~~~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 227 GVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp TCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred CCCCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 877665 368999999999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-58 Score=402.20 Aligned_cols=201 Identities=29% Similarity=0.595 Sum_probs=181.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+|||||+++++|++++.+|||||||+||+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+||| ++
T Consensus 129 ~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL---l~ 204 (346)
T 4fih_A 129 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL---LT 204 (346)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---EC
T ss_pred CCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEE---EC
Confidence 899999999999999999999999999999998865 67999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||+|+..... ....+.+||+.|||||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..|..
T Consensus 205 ~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 284 (346)
T 4fih_A 205 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 284 (346)
T ss_dssp TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 7889999999999876543 34567899999999999974 599999999999999999999999999999999988877
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
... +....+..+|+++++||.+||++||++|||++|+|+||||++..
T Consensus 285 ~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 285 NLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SSC-CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCC-CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 532 33345567999999999999999999999999999999998653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=391.45 Aligned_cols=202 Identities=23% Similarity=0.418 Sum_probs=174.9
Q ss_pred CCCCCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCC
Q 021227 2 HHLSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG--VFHRDLK 75 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dik 75 (315)
+.| +|||||+++++|++ ++.+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+|||||
T Consensus 80 ~~l-~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlK 158 (290)
T 3fpq_A 80 KGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 158 (290)
T ss_dssp HTC-CCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCC
T ss_pred HhC-CCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccC
Confidence 345 89999999999976 3568999999999999999999899999999999999999999999999 9999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCC-CH
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAE-TE 154 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~ 154 (315)
|+|||+ .+.++.+||+|||+|+... .....+.+||+.|||||++.+.|+.++||||+||++|+|+||+.||.+. +.
T Consensus 159 p~NILl--~~~~g~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~ 235 (290)
T 3fpq_A 159 CDNIFI--TGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA 235 (290)
T ss_dssp GGGEEE--SSTTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred hhheeE--ECCCCCEEEEeCcCCEeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH
Confidence 999996 2357899999999997643 3345678899999999999888999999999999999999999999765 45
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
..+...+..+..+ ......+|+++++||.+||++||++|||++|+|+||||++
T Consensus 236 ~~~~~~i~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 236 AQIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHTTTCCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHcCCCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 5566666655332 2223467899999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=403.35 Aligned_cols=203 Identities=29% Similarity=0.590 Sum_probs=182.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.| +|||||+++++|++++.+|||||||+||+|.+++. .+++++..++.++.||+.||+|||++|||||||||+|||
T Consensus 204 ~l-~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NIL-- 279 (423)
T 4fie_A 204 DY-QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSIL-- 279 (423)
T ss_dssp HC-CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEE--
T ss_pred hC-CCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEE--
Confidence 34 89999999999999999999999999999999885 467999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
++.++.+||+|||+|+..... ....+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..
T Consensus 280 -l~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~ 358 (423)
T 4fie_A 280 -LTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 358 (423)
T ss_dssp -ECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred -EcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence 567889999999999876543 34567899999999999974 599999999999999999999999999999999988
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
|..... +....+..+|+++++||.+||++||.+|||++|+|+||||+...
T Consensus 359 i~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 359 IRDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHSCC-CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHcCCC-CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 877643 23345568999999999999999999999999999999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=399.53 Aligned_cols=199 Identities=25% Similarity=0.536 Sum_probs=180.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+|||||+++++|++++.+|||||||+||+|.+++... ..++|..++.++.||+.||+|||++||+||||||+|||
T Consensus 81 ~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL--- 157 (350)
T 4b9d_A 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF--- 157 (350)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEE---
T ss_pred CCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEE---
Confidence 8999999999999999999999999999999999754 45799999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||+|+...... ...+.+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+.+..+++.+|
T Consensus 158 l~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 237 (350)
T 4b9d_A 158 LTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237 (350)
T ss_dssp ECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 5678899999999998765432 2345789999999999975 5999999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
..+.... .+..+|+++++||.+||++||++|||++|+|+||||+..
T Consensus 238 ~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 238 ISGSFPP---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HcCCCCC---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9886542 235789999999999999999999999999999999754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=391.39 Aligned_cols=205 Identities=25% Similarity=0.375 Sum_probs=178.3
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.| +|||||+++++|++++.+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||+
T Consensus 105 ~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 183 (336)
T 4g3f_A 105 AGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183 (336)
T ss_dssp TTC-CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE
T ss_pred HhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE
Confidence 445 8999999999999999999999999999999999988999999999999999999999999999999999999995
Q ss_pred ccCCCCC-CEEEeeccCcccCCCCCc------ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 82 LSVDEDA-ALKATDFGLSVFYKPDEV------FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 82 ~~~~~~~-~ikl~Dfg~~~~~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
+.++ .+||+|||+|+....... ....+||+.|||||++.+ .|+.++||||+||++|+|+||.+||.+.+
T Consensus 184 ---~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 184 ---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp ---CTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred ---eCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 4455 699999999987654321 233579999999999975 59999999999999999999999999988
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCccCCC
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEV-------------LCHPWIVDDK 211 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~-------------l~h~~~~~~~ 211 (315)
..++...|......+. ..++.+|+++++||.+||++||.+|||+.|+ |+|||+....
T Consensus 261 ~~~~~~~i~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 261 RGPLCLKIASEPPPIR-EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp CSCCHHHHHHSCCGGG-GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHHHHHcCCCCch-hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 7777888887655432 2346799999999999999999999999997 6899997653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=379.41 Aligned_cols=202 Identities=32% Similarity=0.524 Sum_probs=166.3
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+.+|||||+++++|++++++|+|||||+||+|.+++ +.+++.+++.+++|++.||+|||++||+||||||+|||+.
T Consensus 75 ~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~ 151 (361)
T 4f9c_A 75 VAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN 151 (361)
T ss_dssp HTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred HhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe
Confidence 4568999999999999999999999999999999988 4599999999999999999999999999999999999963
Q ss_pred cCCCCCCEEEeeccCcccCCCCC-----------------------------cccccccCccccchhhhhh--cCCCchh
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE-----------------------------VFSDVVGSPYYVAPEVLRK--HYGPEAD 131 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~D 131 (315)
...+.+||+|||+|+...... ...+.+||+.|+|||++.+ .|+.++|
T Consensus 152 --~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~D 229 (361)
T 4f9c_A 152 --RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAID 229 (361)
T ss_dssp --TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHH
T ss_pred --CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccc
Confidence 345799999999997543221 1234679999999999864 4899999
Q ss_pred HHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC--------------------------------------C-------
Q 021227 132 VWSAGVILYILLSGVPPFWA-ETEIGIFRQILEG--------------------------------------K------- 165 (315)
Q Consensus 132 iwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~--------------------------------------~------- 165 (315)
|||+||++|+|++|+.||.+ .+..+++..|... .
T Consensus 230 iWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~ 309 (361)
T 4f9c_A 230 MWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLT 309 (361)
T ss_dssp HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------
T ss_pred hhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccc
Confidence 99999999999999999954 4555555444320 0
Q ss_pred -----CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 166 -----IDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 166 -----~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.......|..+|+++++||++||++||++|+|++|+|+||||++
T Consensus 310 ~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 310 SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp ------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 00112346678999999999999999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=379.84 Aligned_cols=204 Identities=26% Similarity=0.434 Sum_probs=175.6
Q ss_pred CCCCCCCcceEEEEEEe------CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 021227 3 HLSEHQHVVRIHDTYED------KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKP 76 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp 76 (315)
+| +|||||++++++.. .+++|||||||. |+|.+++.+.+++++..++.+++||+.||+|||++|||||||||
T Consensus 109 ~l-~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP 186 (398)
T 4b99_A 109 HF-KHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKP 186 (398)
T ss_dssp HC-CCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred hc-CCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCc
Confidence 44 89999999999864 467999999996 68999998889999999999999999999999999999999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCCC-----CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCC
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKPD-----EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPF 149 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 149 (315)
+||| ++.++.+||+|||+|+.+... ....+.+||+.|||||++.+ .++.++||||+||++|+|++|++||
T Consensus 187 ~NIl---~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF 263 (398)
T 4b99_A 187 SNLL---VNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263 (398)
T ss_dssp GGEE---ECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred cccc---cCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC
Confidence 9999 567899999999999865332 23456799999999999864 4799999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCCCC---------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 150 WAETEIGIFRQILEGKIDFESE---------------------------PWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 150 ~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
.+.+..+++..|......++.. .++.+|+++++||.+||++||.+|||++|+|
T Consensus 264 ~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 343 (398)
T 4b99_A 264 PGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL 343 (398)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 9999999888887543322211 1245799999999999999999999999999
Q ss_pred cCCCccCCC
Q 021227 203 CHPWIVDDK 211 (315)
Q Consensus 203 ~h~~~~~~~ 211 (315)
+||||+...
T Consensus 344 ~Hp~f~~~~ 352 (398)
T 4b99_A 344 RHPFLAKYH 352 (398)
T ss_dssp TSGGGTTTC
T ss_pred cCHhhCcCC
Confidence 999998653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-53 Score=396.36 Aligned_cols=206 Identities=34% Similarity=0.637 Sum_probs=191.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
++|||||+++++|++++.+|+|||||+||+|++++.. .+.+++..++.+++||+.||.|||++||+||||||+|||+..
T Consensus 211 l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~ 290 (573)
T 3uto_A 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290 (573)
T ss_dssp TCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC
Confidence 3899999999999999999999999999999999964 468999999999999999999999999999999999999742
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+..+.+||+|||+|+.+.......+.+||+.|||||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..|.
T Consensus 291 -~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~ 369 (573)
T 3uto_A 291 -KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369 (573)
T ss_dssp -SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred -CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 2457999999999998887777778899999999999975 49999999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.....++...++.+|+++++||.+||++||.+|||+.|+|+||||+...
T Consensus 370 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 370 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp TTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 9988888888889999999999999999999999999999999998653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=389.43 Aligned_cols=197 Identities=28% Similarity=0.471 Sum_probs=178.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+|||||+++++|++++++|+|||||+||+|.+++.+.+.++|..++.++.||+.||.|||++|||||||||+||| +
T Consensus 249 ~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNIL---l 325 (689)
T 3v5w_A 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL---L 325 (689)
T ss_dssp SCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE---E
T ss_pred CCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeE---E
Confidence 4899999999999999999999999999999999999999999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-h-cCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-K-HYGPEADVWSAGVILYILLSGVPPFWAE---TEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~ 159 (315)
+.+|.+||+|||+|+...... ..+.+||+.|||||++. + .|+.++||||+||++|+|++|.+||.+. +..++..
T Consensus 326 d~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~ 404 (689)
T 3v5w_A 326 DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404 (689)
T ss_dssp CTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH
T ss_pred eCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 678999999999998765443 45689999999999985 3 5999999999999999999999999763 4556677
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
.+......++ ..+|+++++||.+||++||.+|++ ++|+++||||+.
T Consensus 405 ~i~~~~~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 405 MTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHCCCCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred hhcCCCCCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 7777766554 468999999999999999999998 799999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=377.54 Aligned_cols=239 Identities=42% Similarity=0.765 Sum_probs=215.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++++++.+|+|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||++....
T Consensus 68 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~ 147 (444)
T 3soa_A 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL 147 (444)
T ss_dssp CBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS
T ss_pred CCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999986555
Q ss_pred CCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+....+..
T Consensus 148 ~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 227 (444)
T 3soa_A 148 KGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227 (444)
T ss_dssp TTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 67899999999997765433 3355789999999999975 599999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHhhHhhhHHHHHHHHHH
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVI 243 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 243 (315)
+...++.+.|+.+|+++++||.+||+.||.+|||+.|+|+||||+..............+..+++|...+++++.++..+
T Consensus 228 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~ 307 (444)
T 3soa_A 228 GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVM 307 (444)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEE
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999988899999999999999999999999999999999999764333333445677888999999999998887766
Q ss_pred h
Q 021227 244 A 244 (315)
Q Consensus 244 ~ 244 (315)
.
T Consensus 308 ~ 308 (444)
T 3soa_A 308 L 308 (444)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=357.02 Aligned_cols=197 Identities=21% Similarity=0.382 Sum_probs=161.1
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
++| +|||||++++++.+ +.+|||||||+||+|.+++... +++++..+..++.||+.||+|||++|||||||||+|||
T Consensus 87 ~~l-~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NIL 164 (307)
T 3omv_A 87 RKT-RHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIF 164 (307)
T ss_dssp TTC-CCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEE
T ss_pred HhC-CCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEE
Confidence 455 89999999998764 5689999999999999999764 67999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCC---CcccccccCccccchhhhhh----cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLRK----HYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
++.++.+||+|||+|+..... ....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+
T Consensus 165 ---l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 165 ---LHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp ---EETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ---ECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 567889999999999865432 23345789999999999852 48999999999999999999999998866
Q ss_pred HHHHHHH-HHhCCCCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 154 EIGIFRQ-ILEGKIDFE-SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 154 ~~~~~~~-i~~~~~~~~-~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
....... +..+...+. ...++.+|+++++++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 242 NRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp CHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred hHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 5444444 444332222 2345678999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=357.60 Aligned_cols=194 Identities=21% Similarity=0.355 Sum_probs=171.8
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-------------GNYSEREAAKLMKTIVGVVECCHSLG 68 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~ 68 (315)
++| +|||||++++++.+++.+|+|||||+||+|.+++.+. ..+++..+..++.||+.||+|||+++
T Consensus 70 ~~l-~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 148 (299)
T 4asz_A 70 TNL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH 148 (299)
T ss_dssp TTC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhC-CCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456 8999999999999999999999999999999999764 36999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh
Q 021227 69 VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS 144 (315)
Q Consensus 69 ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 144 (315)
|+||||||+||| ++.++.+||+|||+|+....... .....||+.|||||++. +.|+.++||||+||++|||+|
T Consensus 149 iiHRDlKp~NIL---l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt 225 (299)
T 4asz_A 149 FVHRDLATRNCL---VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225 (299)
T ss_dssp CCCSCCSGGGEE---ECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cccCccCHhhEE---ECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHc
Confidence 999999999999 56788999999999976543322 22356899999999986 569999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 145 -GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 145 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
|+.||.+.+..++...+..+..... .+.+|+++.+++.+||+.||++|||++++.
T Consensus 226 ~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 226 YGKQPWYQLSNNEVIECITQGRVLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp TTCCTTTTSCHHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999999999999999988764322 246899999999999999999999999984
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=363.33 Aligned_cols=239 Identities=40% Similarity=0.743 Sum_probs=213.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+|+|||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++...+
T Consensus 86 ~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~ 165 (362)
T 2bdw_A 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 165 (362)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS
T ss_pred CCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC
Confidence 89999999999999999999999999999999998888999999999999999999999999999999999999986555
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 164 (315)
..+.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+....+..+
T Consensus 166 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~ 245 (362)
T 2bdw_A 166 KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 245 (362)
T ss_dssp TTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 567899999999987766655566789999999999875 5999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHhhHhhhHHHHHHHHHHh
Q 021227 165 KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVIA 244 (315)
Q Consensus 165 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 244 (315)
...++...|..+|+++++||.+||+.||.+|||+.++|+||||...............+..+++|...++++..++..+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 325 (362)
T 2bdw_A 246 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMI 325 (362)
T ss_dssp CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 98888888889999999999999999999999999999999997643323333456677888899888888887776654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=358.93 Aligned_cols=199 Identities=28% Similarity=0.460 Sum_probs=156.2
Q ss_pred CCCCCCCCcceEEEEEEeCC------------eEEEEEeccCCCchhHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHH
Q 021227 2 HHLSEHQHVVRIHDTYEDKS------------CVHIVMELCEGGELFDRIVKKGN---YSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~------------~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
+.| +|||||+++++|.+.+ .+|+|||||+||+|.+++...+. .++..++.++.||+.||+|||+
T Consensus 58 ~~l-~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~ 136 (299)
T 4g31_A 58 AKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS 136 (299)
T ss_dssp TTC-CCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhC-CCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH
Confidence 455 8999999999997654 37999999999999999987654 4456789999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc-------------ccccccCccccchhhhhh-cCCCchhH
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-------------FSDVVGSPYYVAPEVLRK-HYGPEADV 132 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~Di 132 (315)
+||+||||||+||| ++.++.+||+|||+|+....... ..+.+||+.|||||++.+ .|+.++||
T Consensus 137 ~~IiHRDlKp~NIL---l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Di 213 (299)
T 4g31_A 137 KGLMHRDLKPSNIF---FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213 (299)
T ss_dssp TTCCCCCCCGGGEE---ECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHH
T ss_pred CcCccccCcHHHeE---ECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHH
Confidence 99999999999999 56778999999999987644321 234679999999999974 59999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 133 WSAGVILYILLSGVPPFWAETE-IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 133 wslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
||+||++|+|++ ||.+... ...+..+..... + +.++..++++++||.+||++||.+|||+.|+++||||+..
T Consensus 214 wSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~--p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 214 FSLGLILFELLY---PFSTQMERVRTLTDVRNLKF--P-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCC--C-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCC--C-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 999999999996 7765432 233444444332 1 1234567888999999999999999999999999999754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=355.88 Aligned_cols=195 Identities=22% Similarity=0.352 Sum_probs=165.3
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK---------------GNYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
++| +|||||++++++.+++.+|||||||+||+|.+++.+. +++++.++..++.|++.||+|||+
T Consensus 98 ~~l-~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 176 (329)
T 4aoj_A 98 TML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176 (329)
T ss_dssp TTC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 455 8999999999999999999999999999999998653 359999999999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHH
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYIL 142 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 142 (315)
++||||||||+||| ++.++.+||+|||+++...... ......||+.|||||++. +.|+.++|||||||++|||
T Consensus 177 ~~iiHRDLKp~NIL---l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~El 253 (329)
T 4aoj_A 177 LHFVHRDLATRNCL---VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253 (329)
T ss_dssp TTCCCSCCCGGGEE---EETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCeecccccHhhEE---ECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHH
Confidence 99999999999999 5678899999999998664332 223467999999999987 4599999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 143 LS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 143 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+| |+.||.+.+..+.+..+..+.... ....+|+++.+++.+||+.||++|||+.|++.
T Consensus 254 lt~G~~Pf~~~~~~~~~~~i~~g~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 254 FTYGKQPWYQLSNTEAIDCITQGRELE---RPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HTTSCCTTCSSCHHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCCCC---CcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 99 999999999999999888875321 22468999999999999999999999999975
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=352.88 Aligned_cols=193 Identities=20% Similarity=0.355 Sum_probs=171.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------------GNYSEREAAKLMKTIVGVVECCHSLGV 69 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~i 69 (315)
+|||||++++++.+++.+|+|||||+||+|.+++..+ ..+++..+..++.||+.||+|||+++|
T Consensus 87 ~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i 166 (308)
T 4gt4_A 87 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV 166 (308)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 8999999999999999999999999999999999653 358999999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-
Q 021227 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS- 144 (315)
Q Consensus 70 vH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 144 (315)
|||||||+||| ++.++.+||+|||+++...... ...+..||+.|||||++. +.|+.++|||||||++|||+|
T Consensus 167 iHRDLK~~NIL---l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~ 243 (308)
T 4gt4_A 167 VHKDLATRNVL---VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 243 (308)
T ss_dssp CCSCCSGGGEE---ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCccccceE---ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhC
Confidence 99999999999 5678899999999998654332 234567999999999986 569999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 145 GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 145 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
|..||.+.+..++...+..+..... ...+|+++.+++.+||+.||.+|||+.|++++
T Consensus 244 g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 244 GLQPYCGYSNQDVVEMIRNRQVLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TCCTTTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8999999999999999887654322 24689999999999999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=352.08 Aligned_cols=207 Identities=40% Similarity=0.688 Sum_probs=188.7
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.+ +||||++++++|++++.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 70 ~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll 148 (361)
T 2yab_A 70 RQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148 (361)
T ss_dssp TTC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhC-CCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 345 7999999999999999999999999999999999888899999999999999999999999999999999999996
Q ss_pred ccCCC-CCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 82 LSVDE-DAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 82 ~~~~~-~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
...+. ...+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.+.
T Consensus 149 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~ 228 (361)
T 2yab_A 149 LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228 (361)
T ss_dssp SCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred eCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 42211 23799999999988766666667889999999999874 59999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.+..+...++...|+.+|+++++||.+||..||.+|||+.|+++||||+.
T Consensus 229 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 229 NITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 99999888877777889999999999999999999999999999999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=354.81 Aligned_cols=196 Identities=24% Similarity=0.344 Sum_probs=165.3
Q ss_pred CCCCCCCcceEEEEEEe-CCeEEEEEeccCCCchhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYED-KSCVHIVMELCEGGELFDRIVKK----------------GNYSEREAAKLMKTIVGVVECCH 65 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH 65 (315)
++.+|||||++++++.+ ++.+|||||||+||+|.+++.+. ..+++..+..++.||+.||+|||
T Consensus 123 ~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH 202 (353)
T 4ase_A 123 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 202 (353)
T ss_dssp HHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH
T ss_pred HcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh
Confidence 45567999999999865 46789999999999999999753 34899999999999999999999
Q ss_pred HCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHH
Q 021227 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYI 141 (315)
Q Consensus 66 ~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ 141 (315)
+++||||||||+||| ++.++.+||+|||+|+....... ..+..||+.|||||++. +.|+.++|||||||++||
T Consensus 203 ~~~iiHRDLK~~NIL---l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~E 279 (353)
T 4ase_A 203 SRKCIHRDLAARNIL---LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 279 (353)
T ss_dssp HTTCCCSCCSGGGEE---ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCCeecCccCcccee---eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHH
Confidence 999999999999999 56788999999999987654332 23467899999999986 559999999999999999
Q ss_pred HHh-CCCCCCCCC-HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 142 LLS-GVPPFWAET-EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 142 ll~-g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
|+| |..||.+.+ .......+..+.. ++. ...+|+++.++|.+||+.||.+|||+.|+++|
T Consensus 280 l~t~G~~Pf~~~~~~~~~~~~i~~g~~-~~~--p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 280 IFSLGASPYPGVKIDEEFCRRLKEGTR-MRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HTTTSCCSSTTCCCSHHHHHHHHHTCC-CCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHHcCCC-CCC--CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 998 999998865 3445555555532 222 24689999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=341.82 Aligned_cols=199 Identities=36% Similarity=0.670 Sum_probs=183.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++++++.+|+||||++||+|.+++...+++++..++.++.|++.||+|||++||+||||||+||+ ++
T Consensus 72 ~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIl---l~ 148 (328)
T 3fe3_A 72 NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL---LD 148 (328)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE---EC
T ss_pred CCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEE---Ec
Confidence 799999999999999999999999999999999988899999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH-Y-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++............+||+.|+|||++.+. + +.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 149 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 228 (328)
T 3fe3_A 149 ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228 (328)
T ss_dssp TTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 7889999999999877766666778899999999998744 4 5789999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
+....+. .+|+++.+++.+||+.||.+|||++|+++||||....
T Consensus 229 ~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 229 GKYRIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp CCCCCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCCCCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 8776553 5799999999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=341.41 Aligned_cols=237 Identities=43% Similarity=0.756 Sum_probs=195.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+.+.+++||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++...+
T Consensus 106 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~ 185 (349)
T 2w4o_A 106 SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA 185 (349)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSS
T ss_pred CCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCC
Confidence 79999999999999999999999999999999998888899999999999999999999999999999999999975545
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAET-EIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~ 163 (315)
.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. .......+..
T Consensus 186 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~ 265 (349)
T 2w4o_A 186 PDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265 (349)
T ss_dssp TTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT
T ss_pred CCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh
Confidence 688999999999987655555556789999999999874 58999999999999999999999998755 4447778888
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHhhHhhhHHHHHHHHHH
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVI 243 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 243 (315)
....+..+.++.++++++++|.+||+.||.+|||+.|+++||||....... .........++++....++++......
T Consensus 266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (349)
T 2w4o_A 266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF--VHMDTAQKKLQEFNARRKLKAAVKAVV 343 (349)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCC--SCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccch--hhhcchHHHHHHHHHHHHHHHHHHHHH
Confidence 877777777788999999999999999999999999999999998654332 234566677888888888888776665
Q ss_pred h
Q 021227 244 A 244 (315)
Q Consensus 244 ~ 244 (315)
+
T Consensus 344 ~ 344 (349)
T 2w4o_A 344 A 344 (349)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=346.96 Aligned_cols=238 Identities=36% Similarity=0.665 Sum_probs=194.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+||||+++++++++++.+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 84 ~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~ 163 (351)
T 3c0i_A 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLL 163 (351)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEE
Confidence 8999999999999999999999999999998877643 358999999999999999999999999999999999998
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
...+....+||+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+. ..+...
T Consensus 164 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~ 242 (351)
T 3c0i_A 164 ASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFE 242 (351)
T ss_dssp CSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHH
T ss_pred ecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHH
Confidence 6545566799999999987654432 345689999999999864 5899999999999999999999999875 456777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHhhHhhhHHHHHH
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMA 239 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (315)
.+..+...++...|+.+|++++++|.+||+.||.+|||+.++++||||+..............+.+++++...++++...
T Consensus 243 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 322 (351)
T 3c0i_A 243 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAV 322 (351)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC-----
T ss_pred HHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHH
Confidence 78888777666666789999999999999999999999999999999986432222333455677788887777777776
Q ss_pred HHHHh
Q 021227 240 LRVIA 244 (315)
Q Consensus 240 ~~~i~ 244 (315)
+..++
T Consensus 323 ~~~~~ 327 (351)
T 3c0i_A 323 LAAVS 327 (351)
T ss_dssp -----
T ss_pred HHHHH
Confidence 66554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=347.86 Aligned_cols=206 Identities=30% Similarity=0.606 Sum_probs=188.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++++.+.+|+|||||+||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++..
T Consensus 58 l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~ 137 (321)
T 1tki_A 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc
Confidence 38999999999999999999999999999999999765 47999999999999999999999999999999999999742
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
..++.+||+|||++.............||+.|+|||++.+. ++.++||||+||++|+|++|..||.+.+..+....+.
T Consensus 138 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 216 (321)
T 1tki_A 138 -RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp -SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 23689999999999887766666677899999999998754 7999999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.+...++...|+.+|++++++|.+||..||.+|||+.|+|+||||+...
T Consensus 217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred cCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 9988887777778999999999999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=343.36 Aligned_cols=199 Identities=31% Similarity=0.573 Sum_probs=178.1
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||||+++++++++.+.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 80 ~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIL--- 156 (353)
T 3txo_A 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL--- 156 (353)
T ss_dssp TTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE---
T ss_pred ccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEE---
Confidence 45899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||+++.... .....+.+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+++..|
T Consensus 157 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 236 (353)
T 3txo_A 157 LDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236 (353)
T ss_dssp ECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56788999999999976432 33445678999999999986 45999999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCccC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA------HEVLCHPWIVD 209 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~------~~~l~h~~~~~ 209 (315)
..+...++. .++++++++|.+||++||.+||++ +++++||||+.
T Consensus 237 ~~~~~~~p~----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 237 LNDEVVYPT----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HcCCCCCCC----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 998877654 589999999999999999999998 89999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=341.76 Aligned_cols=208 Identities=39% Similarity=0.715 Sum_probs=186.2
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||||++++++++++..+|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||++.+
T Consensus 72 ~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~ 151 (342)
T 2qr7_A 72 YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVD 151 (342)
T ss_dssp HTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESS
T ss_pred hcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEec
Confidence 45899999999999999999999999999999999998889999999999999999999999999999999999999743
Q ss_pred CC-CCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHH
Q 021227 84 VD-EDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWA---ETEIGI 157 (315)
Q Consensus 84 ~~-~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~---~~~~~~ 157 (315)
.+ ..+.+||+|||++...... ....+.+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+ .+..++
T Consensus 152 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~ 231 (342)
T 2qr7_A 152 ESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231 (342)
T ss_dssp SSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH
T ss_pred CCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH
Confidence 22 2246999999999866433 33456789999999999874 489999999999999999999999986 467788
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
...+..+...++...|+.+|+++++||.+||..||.+|||+.++++||||....
T Consensus 232 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 232 LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp HHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred HHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 899999998888888889999999999999999999999999999999997643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=340.38 Aligned_cols=202 Identities=35% Similarity=0.590 Sum_probs=161.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+.+.+|+|||||.||+|.+++...+++++..++.++.|++.||+|||++||+||||||+||++.. +
T Consensus 74 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~ 152 (361)
T 3uc3_A 74 RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-S 152 (361)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-S
T ss_pred CCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-C
Confidence 799999999999999999999999999999999988889999999999999999999999999999999999999632 2
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCC-chhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGP-EADVWSAGVILYILLSGVPPFWAETE----IGIFR 159 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~ 159 (315)
..+.+||+|||++.............||+.|+|||++.+ .++. ++||||+||++|+|++|..||.+... .....
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~ 232 (361)
T 3uc3_A 153 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232 (361)
T ss_dssp SSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH
T ss_pred CCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH
Confidence 334599999999876544444556789999999999864 4544 48999999999999999999987543 45556
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+......++. ...+|+++++||.+||+.||.+|||+.|+++||||...
T Consensus 233 ~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 233 RILSVKYSIPD--DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHTTCCCCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHhcCCCCCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 66665554443 34689999999999999999999999999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=337.23 Aligned_cols=217 Identities=39% Similarity=0.722 Sum_probs=171.2
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+.+||||+++++++.++...|+|||||+||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||++.
T Consensus 61 ~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~ 140 (325)
T 3kn6_A 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFT 140 (325)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred HhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEe
Confidence 35569999999999999999999999999999999999989999999999999999999999999999999999999985
Q ss_pred cCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCC-------
Q 021227 83 SVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAET------- 153 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~------- 153 (315)
..+....+||+|||++...... .......||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+
T Consensus 141 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 220 (325)
T 3kn6_A 141 DENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220 (325)
T ss_dssp C----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC
T ss_pred cCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc
Confidence 5444558999999999765433 2345567899999999986 458999999999999999999999998643
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLD 219 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~ 219 (315)
..+....+..+...++...|+.+|+++++||.+||+.||.+|||+.++++||||+.....+..+..
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~ 286 (325)
T 3kn6_A 221 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLM 286 (325)
T ss_dssp HHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCS
T ss_pred HHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCC
Confidence 356788888888877777777899999999999999999999999999999999987655554443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=335.14 Aligned_cols=197 Identities=34% Similarity=0.595 Sum_probs=180.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++++.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+ ++
T Consensus 63 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl---l~ 139 (337)
T 1o6l_A 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LD 139 (337)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE---EC
T ss_pred CCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEE---EC
Confidence 899999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCC-CCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||+++... ......+.+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+..
T Consensus 140 ~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 219 (337)
T 1o6l_A 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219 (337)
T ss_dssp TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 78899999999997643 333455678999999999986 4589999999999999999999999999999999999988
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
....++. .+|++++++|.+||+.||.+|| +++|+++||||..
T Consensus 220 ~~~~~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 220 EEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 8766653 6899999999999999999999 9999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=341.29 Aligned_cols=209 Identities=33% Similarity=0.668 Sum_probs=189.1
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||++++++++++..+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 103 ~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIl 181 (387)
T 1kob_A 103 NQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181 (387)
T ss_dssp TTC-CSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhC-CCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeE
Confidence 345 8999999999999999999999999999999988765 47999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
+.. +..+.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+...
T Consensus 182 l~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~ 260 (387)
T 1kob_A 182 CET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 260 (387)
T ss_dssp ESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred Eec-CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 732 2457899999999988766655566789999999999864 58999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
.+......++...+..+|+++++||.+||+.||.+|||+.|+++||||+....
T Consensus 261 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 261 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 99998888887778889999999999999999999999999999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=337.56 Aligned_cols=205 Identities=40% Similarity=0.720 Sum_probs=185.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.++..+|+|||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++...+
T Consensus 72 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 151 (326)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS
T ss_pred CCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC
Confidence 79999999999999999999999999999999998888999999999999999999999999999999999999964322
Q ss_pred -CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 -EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 -~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
....+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 231 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred CCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh
Confidence 23389999999998776555556678999999999987 4589999999999999999999999999999999998888
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
....++...++.+|+.+++||.+||+.||.+|||+.|+++||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 87777665567889999999999999999999999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=330.35 Aligned_cols=207 Identities=47% Similarity=0.912 Sum_probs=191.8
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+ +||||+++++++.+++.+++||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++.
T Consensus 62 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 140 (277)
T 3f3z_A 62 SL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFL 140 (277)
T ss_dssp TC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred hC-CCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEe
Confidence 45 89999999999999999999999999999999998888999999999999999999999999999999999999975
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
..+.++.+||+|||++.............||+.|+|||++.+.++.++||||+|+++|+|++|..||.+.+..+....+.
T Consensus 141 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 220 (277)
T 3f3z_A 141 TDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR 220 (277)
T ss_dssp SSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 54678899999999998777666666778999999999998889999999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+...++...+..+|+++.++|.+||+.||.+|||+.++++||||+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 221 EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred hCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 988877766666899999999999999999999999999999999754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=334.57 Aligned_cols=201 Identities=26% Similarity=0.497 Sum_probs=182.6
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
..+.+||||+++++++++.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 75 ~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl- 153 (353)
T 2i0e_A 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM- 153 (353)
T ss_dssp TCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE-
T ss_pred HhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEE-
Confidence 3455899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
++.++.+||+|||++.... ......+.+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..++.+
T Consensus 154 --l~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~ 231 (353)
T 2i0e_A 154 --LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231 (353)
T ss_dssp --ECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred --EcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 5678899999999997643 233445678999999999986 458999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
.+......++. .+|++++++|.+||+.||.+||+ ++++++||||+.
T Consensus 232 ~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 232 SIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHhCCCCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99998776653 68999999999999999999994 699999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=340.14 Aligned_cols=199 Identities=31% Similarity=0.577 Sum_probs=177.1
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+|||||+++++|++++.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 109 ~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NIL--- 185 (396)
T 4dc2_A 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL--- 185 (396)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE---
T ss_pred cCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEE---
Confidence 35899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccC-CCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC---------
Q 021227 84 VDEDAALKATDFGLSVFY-KPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE--------- 152 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--------- 152 (315)
++.++.+||+|||+++.. .......+.+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.
T Consensus 186 l~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~ 265 (396)
T 4dc2_A 186 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265 (396)
T ss_dssp ECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C
T ss_pred ECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh
Confidence 567889999999999763 34445567889999999999874 5899999999999999999999999642
Q ss_pred CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCccC
Q 021227 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA------HEVLCHPWIVD 209 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~------~~~l~h~~~~~ 209 (315)
......+.+......++. .+|+++++||.+||+.||.+||++ +|+++||||+.
T Consensus 266 ~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 266 TEDYLFQVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp CHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred hHHHHHHHHhccccCCCC----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 334567777777766653 589999999999999999999985 89999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=333.85 Aligned_cols=199 Identities=31% Similarity=0.503 Sum_probs=181.4
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++.+.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+ +
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl---l 151 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---L 151 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE---E
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEE---E
Confidence 4899999999999999999999999999999999988889999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||+++.... .....+.+||+.|+|||++.+ .++.++|+||+||++|+|++|..||.+.+..+....+.
T Consensus 152 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 231 (345)
T 1xjd_A 152 DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231 (345)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 6788999999999976432 233456789999999999864 58999999999999999999999999999999999998
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAH-EVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~-~~l~h~~~~~~ 210 (315)
.+...++. .+|++++++|.+||+.||.+|||+. ++++||||+..
T Consensus 232 ~~~~~~p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 232 MDNPFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HCCCCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred hCCCCCCc----ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 88766543 5899999999999999999999998 99999999753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=329.41 Aligned_cols=196 Identities=31% Similarity=0.636 Sum_probs=180.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++++...+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+ +
T Consensus 63 l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl---l 139 (318)
T 1fot_A 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL---L 139 (318)
T ss_dssp CCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE---E
T ss_pred CCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE---E
Confidence 3899999999999999999999999999999999998889999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
+.++.+||+|||++...... ..+.+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 140 ~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 217 (318)
T 1fot_A 140 DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217 (318)
T ss_dssp CTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred cCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 67889999999999865432 345789999999999864 589999999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
+...++. .++++++++|.+||+.||.+|| +++++++||||+.
T Consensus 218 ~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 218 AELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp CCCCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CCCCCCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 8766653 6899999999999999999999 9999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=341.36 Aligned_cols=215 Identities=43% Similarity=0.822 Sum_probs=178.8
Q ss_pred CCCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 4 LSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
+.+||||++++++|+. +.++|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+
T Consensus 111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 190 (400)
T 1nxk_A 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190 (400)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcc
Confidence 3589999999999986 678999999999999999997753 5999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEI- 155 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 155 (315)
|||+...+.++.+||+|||++..........+.+||+.|+|||++. +.++.++||||+||++|+|++|..||.+....
T Consensus 191 Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 270 (400)
T 1nxk_A 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS
T ss_pred eEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 9997544447899999999998766555556778999999999986 55999999999999999999999999875432
Q ss_pred ---HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC
Q 021227 156 ---GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPL 218 (315)
Q Consensus 156 ---~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~ 218 (315)
.....+..+...++...|..+|+++++||.+||+.||.+|||+.|+++||||......+..+.
T Consensus 271 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~ 336 (400)
T 1nxk_A 271 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 336 (400)
T ss_dssp SCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCCCBC
T ss_pred ccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCCCcc
Confidence 255667778888887778899999999999999999999999999999999987655444433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=321.20 Aligned_cols=207 Identities=43% Similarity=0.816 Sum_probs=191.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++..++||||+.||+|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||++...+
T Consensus 63 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~ 142 (284)
T 3kk8_A 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 142 (284)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS
T ss_pred CCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC
Confidence 79999999999999999999999999999999998888999999999999999999999999999999999999986555
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 164 (315)
..+.+||+|||++.............||+.|+|||++.+ .++.++||||+|+++|+|++|..||.+.+.......+..+
T Consensus 143 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 222 (284)
T 3kk8_A 143 KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 222 (284)
T ss_dssp TTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc
Confidence 566799999999987766655566789999999999864 4899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 165 KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 165 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
...++...+..++++++++|.+||+.||.+|||+.|+++||||.....
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 223 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 888888888899999999999999999999999999999999986543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=322.54 Aligned_cols=205 Identities=37% Similarity=0.677 Sum_probs=176.2
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
.+ +||||+++++++.+.+.+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|
T Consensus 76 ~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~N 154 (285)
T 3is5_A 76 SL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPEN 154 (285)
T ss_dssp TC-CCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred hC-CCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHH
Confidence 44 899999999999999999999999999999998854 3679999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
|++...+..+.+||+|||++.............||+.|+|||++.+.++.++||||+||++|+|++|..||.+.+..+..
T Consensus 155 Il~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~ 234 (285)
T 3is5_A 155 ILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ 234 (285)
T ss_dssp EEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99865566789999999999876655555667899999999999888999999999999999999999999999988888
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
..+......+.... ..+++++.++|.+||+.||.+|||+.|+++||||++
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 235 QKATYKEPNYAVEC-RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred hhhccCCccccccc-CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 77777665554332 347999999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=329.78 Aligned_cols=208 Identities=37% Similarity=0.649 Sum_probs=175.2
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
++.+||||+++++++.+++.+|+||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||++.
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 145 (316)
T 2ac3_A 66 QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCE 145 (316)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred HhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEc
Confidence 34589999999999999999999999999999999998888999999999999999999999999999999999999975
Q ss_pred cCCCCCCEEEeeccCcccCCCC--------CcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCC
Q 021227 83 SVDEDAALKATDFGLSVFYKPD--------EVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPP 148 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~--------~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~p 148 (315)
..+....+||+|||++...... .......||+.|+|||++. ..++.++||||+||++|+|++|..|
T Consensus 146 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 225 (316)
T 2ac3_A 146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225 (316)
T ss_dssp CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCC
Confidence 4444456999999998765321 1123456999999999985 3489999999999999999999999
Q ss_pred CCCCC---------------HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 149 FWAET---------------EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 149 f~~~~---------------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
|.+.. .......+..+...++...+..+|+++++||.+||+.||.+|||+.|+++||||+..
T Consensus 226 f~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp CCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred CcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 98754 345677788887777655556789999999999999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=331.71 Aligned_cols=199 Identities=31% Similarity=0.573 Sum_probs=176.4
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||||+++++++++++.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 66 ~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl--- 142 (345)
T 3a8x_A 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL--- 142 (345)
T ss_dssp TTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE---
T ss_pred cCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE---
Confidence 45899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCC---------C
Q 021227 84 VDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWA---------E 152 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~---------~ 152 (315)
++.++.+||+|||+++... ......+.+||+.|+|||++.+ .++.++||||+||++|+|++|..||.. .
T Consensus 143 l~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 222 (345)
T 3a8x_A 143 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222 (345)
T ss_dssp ECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------
T ss_pred ECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc
Confidence 5678899999999997643 3344556789999999999874 589999999999999999999999975 3
Q ss_pred CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCccC
Q 021227 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA------HEVLCHPWIVD 209 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~------~~~l~h~~~~~ 209 (315)
......+.+......++. .+|++++++|.+||+.||.+|||+ +++++||||..
T Consensus 223 ~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 223 TEDYLFQVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp CHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred cHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 445566777777666553 689999999999999999999995 89999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=331.00 Aligned_cols=198 Identities=34% Similarity=0.645 Sum_probs=181.6
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.+ +||||++++++++++..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 96 ~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl- 173 (350)
T 1rdq_E 96 QAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL- 173 (350)
T ss_dssp TTC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE-
T ss_pred HhC-CCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEE-
Confidence 344 899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
++.++.+||+|||++...... ..+.+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 174 --l~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~ 249 (350)
T 1rdq_E 174 --IDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249 (350)
T ss_dssp --ECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred --ECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH
Confidence 567889999999999876433 34568999999999986 4589999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
+..+...++. .+|++++++|.+||+.||.+||+ ++++++||||..
T Consensus 250 i~~~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 250 IVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHCCCCCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHcCCCCCCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 9998776653 58999999999999999999998 999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=332.15 Aligned_cols=199 Identities=32% Similarity=0.582 Sum_probs=181.1
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
..+||||+++++++++.+.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 95 ~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl--- 171 (373)
T 2r5t_A 95 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL--- 171 (373)
T ss_dssp CCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE---
T ss_pred hCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE---
Confidence 35899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||+++... ......+.+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.+..+.+..|
T Consensus 172 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 251 (373)
T 2r5t_A 172 LDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251 (373)
T ss_dssp ECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH
T ss_pred ECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 5678899999999997643 3334556789999999999874 5899999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCccC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA----HEVLCHPWIVD 209 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~----~~~l~h~~~~~ 209 (315)
......++ +.++++++++|.+||+.||.+||++ .++++||||+.
T Consensus 252 ~~~~~~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 252 LNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHSCCCCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HhcccCCC----CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 98866554 3689999999999999999999986 69999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=336.25 Aligned_cols=206 Identities=38% Similarity=0.702 Sum_probs=187.2
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.+.+.+++||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 141 ~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 219 (373)
T 2x4f_A 141 NQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENIL 219 (373)
T ss_dssp TTC-CCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEE
Confidence 445 8999999999999999999999999999999988664 46999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
+.. +..+.+||+|||++.............||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 220 l~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 298 (373)
T 2x4f_A 220 CVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298 (373)
T ss_dssp EEE-TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred Eec-CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 632 456789999999998876666556678999999999986 458999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.+......++...++.+++++++||.+||+.||.+|||+.|+++||||..
T Consensus 299 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 299 NILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99988887777777789999999999999999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=338.15 Aligned_cols=202 Identities=33% Similarity=0.584 Sum_probs=179.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+|||||+++++|+++..+|+|||||+||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+||| +
T Consensus 126 l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NIL---l 201 (410)
T 3v8s_A 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML---L 201 (410)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---E
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHee---E
Confidence 4899999999999999999999999999999998865 57999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhhhc-----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLRKH-----YGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+.++.+||+|||+++....... ..+.+||+.|+|||++.+. ++.++||||+||++|+|++|..||.+.+..+.
T Consensus 202 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 281 (410)
T 3v8s_A 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 281 (410)
T ss_dssp CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH
Confidence 6788999999999987654432 3467899999999998532 78999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKR--RLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~--R~s~~~~l~h~~~~~~ 210 (315)
+..|..+...+..+.+..+|+++++||.+||+.+|.+ |++++|+++||||+..
T Consensus 282 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 282 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 9998876433333444579999999999999999988 9999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=326.09 Aligned_cols=195 Identities=22% Similarity=0.283 Sum_probs=153.6
Q ss_pred CCCCCcceEEEEEEeCC----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccc
Q 021227 5 SEHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL--------GVFHR 72 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~ 72 (315)
.+|||||++++++.+++ .+|||||||+||+|.+++.+ .+++++.+..++.|++.||+|||++ +|+||
T Consensus 54 l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHR 132 (303)
T 3hmm_A 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECS
T ss_pred CCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeec
Confidence 38999999999998654 58999999999999999965 4689999999999999999999987 99999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCCCc-----ccccccCccccchhhhhh-------cCCCchhHHHHHHHHH
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-----FSDVVGSPYYVAPEVLRK-------HYGPEADVWSAGVILY 140 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~ 140 (315)
||||+||| ++.++.+||+|||+++....... ..+.+||+.|||||++.+ .++.++|||||||++|
T Consensus 133 DlKp~NIL---l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~ 209 (303)
T 3hmm_A 133 DLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209 (303)
T ss_dssp CCCGGGEE---ECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred cCCcccEE---ECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHH
Confidence 99999999 56789999999999976644321 234679999999999854 3678999999999999
Q ss_pred HHHhCCCCCCC---------------CCHHHHHHHHHhCCCCCCCCC-CC--CCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 141 ILLSGVPPFWA---------------ETEIGIFRQILEGKIDFESEP-WP--NISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 141 ~ll~g~~pf~~---------------~~~~~~~~~i~~~~~~~~~~~-~~--~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
||+||.+||.. .........+.....+++.+. +. ..++.+.+++.+||+.||++|||+.|++
T Consensus 210 El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 289 (303)
T 3hmm_A 210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289 (303)
T ss_dssp HHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred HHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 99999776532 123344444544444332211 11 1345788999999999999999999987
Q ss_pred c
Q 021227 203 C 203 (315)
Q Consensus 203 ~ 203 (315)
+
T Consensus 290 ~ 290 (303)
T 3hmm_A 290 K 290 (303)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=334.57 Aligned_cols=198 Identities=36% Similarity=0.682 Sum_probs=173.5
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++.+.+.+++||||+ +|+|.+++.+.+++++..++.++.|++.||.|||++||+||||||+||+ +
T Consensus 66 l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl---l 141 (336)
T 3h4j_B 66 LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL---L 141 (336)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEE---E
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEE---E
Confidence 38999999999999999999999999 7899999988899999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++..........+.+||+.|+|||++.+. .++++||||+||++|+|++|..||.+.........+.
T Consensus 142 ~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~ 221 (336)
T 3h4j_B 142 DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN 221 (336)
T ss_dssp CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC
T ss_pred cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 67889999999999887766666778899999999998644 3789999999999999999999998765544433333
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+...++ ..+|++++++|.+||+.||.+|||++|+++||||+..
T Consensus 222 ~~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 222 SCVYVMP----DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SSCCCCC----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred cCCCCCc----ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 3322222 3589999999999999999999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=327.14 Aligned_cols=209 Identities=30% Similarity=0.557 Sum_probs=184.0
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+.+||||+++++++.+.+.+|+||||+.||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 84 ~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl 163 (327)
T 3lm5_A 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163 (327)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred hccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEE
Confidence 3557899999999999999999999999999999988553 67999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
+......+.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+...
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 243 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL 243 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 7544457899999999998776555556678999999999986 458999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.+......++...+..+++.++++|.+||+.||.+|||++++|+||||+...
T Consensus 244 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 244 NISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 9988888888877888999999999999999999999999999999998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=336.56 Aligned_cols=198 Identities=33% Similarity=0.593 Sum_probs=179.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.+.+.+|+||||++||+|.+++.+.+.+++..++.++.|++.||+|||+ +||+||||||+|||
T Consensus 205 l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIl--- 281 (446)
T 4ejn_A 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM--- 281 (446)
T ss_dssp CSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEE---
T ss_pred CCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEE---
Confidence 38999999999999999999999999999999999888899999999999999999999998 99999999999999
Q ss_pred CCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||++.... ........+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+
T Consensus 282 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 361 (446)
T 4ejn_A 282 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361 (446)
T ss_dssp ECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 5667899999999997643 233445678999999999986 45999999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
......++. .+++++++||.+||+.||.+|| |++|+++||||..
T Consensus 362 ~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 362 LMEEIRFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhCCCCCCc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 888776653 5899999999999999999999 9999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=318.92 Aligned_cols=202 Identities=30% Similarity=0.542 Sum_probs=175.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++.+++.+|+|||||.||+|.+++.+. .+++..++.++.|++.||.|||++||+||||||+||+ +
T Consensus 74 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil---~ 149 (297)
T 3fxz_A 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL---L 149 (297)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---E
T ss_pred CCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE---E
Confidence 38999999999999999999999999999999988664 6999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 229 (297)
T 3fxz_A 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229 (297)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 677899999999987665433 334568999999999986 458999999999999999999999999988877666655
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
..... .......+|+.++++|.+||+.||.+|||+.|+++||||+...
T Consensus 230 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 230 TNGTP-ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHCSC-CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred hCCCC-CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 43321 1222346899999999999999999999999999999998653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=332.92 Aligned_cols=201 Identities=40% Similarity=0.814 Sum_probs=185.8
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||++++++++.....|+||||++||+|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+ +
T Consensus 157 ~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl---~ 233 (365)
T 2y7j_A 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL---L 233 (365)
T ss_dssp TTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE---E
T ss_pred cCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE---E
Confidence 4899999999999999999999999999999999988888999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-------HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....
T Consensus 234 ~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 313 (365)
T 2y7j_A 234 DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313 (365)
T ss_dssp CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 6788999999999987766666667889999999998852 378899999999999999999999999999889
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
...+..+...++.+.|..+|+++.++|.+||+.||.+|||+.++++||||+
T Consensus 314 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 314 LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 999988887777666778999999999999999999999999999999996
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=319.03 Aligned_cols=202 Identities=30% Similarity=0.484 Sum_probs=172.8
Q ss_pred CCCCcceEEEEEEeCC-----eEEEEEeccCCCchhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 6 EHQHVVRIHDTYEDKS-----CVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+||||+++++++.+.. .+++||||+. |+|.+++..... +++..++.++.|++.||+|||++||+||||||+|
T Consensus 72 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 150 (308)
T 3g33_A 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPEN 150 (308)
T ss_dssp CCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred CCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 5999999999998765 5899999997 599999977644 9999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|+ ++.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..+.
T Consensus 151 il---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 227 (308)
T 3g33_A 151 IL---VTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227 (308)
T ss_dssp EE---ECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred EE---EcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99 5677899999999998776665566778999999999985 5599999999999999999999999999998888
Q ss_pred HHHHHhCCCCCCCCC-----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 158 FRQILEGKIDFESEP-----------------------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~-----------------------~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
...+.......+... .+.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 877765322222111 135789999999999999999999999999999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=329.75 Aligned_cols=197 Identities=26% Similarity=0.513 Sum_probs=177.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+|||||+++++|++...+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+ ++
T Consensus 73 ~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl---l~ 149 (384)
T 4fr4_A 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNIL---LD 149 (384)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---EC
T ss_pred CCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeE---EC
Confidence 899999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWA---ETEIGIF 158 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~---~~~~~~~ 158 (315)
.++.+||+|||++..........+.+||+.|+|||++. ..++.++||||+||++|+|++|..||.+ ....+..
T Consensus 150 ~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~ 229 (384)
T 4fr4_A 150 EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229 (384)
T ss_dssp TTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH
T ss_pred CCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH
Confidence 78899999999998876666667788999999999985 2489999999999999999999999975 3455666
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCccC
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-AHEVLCHPWIVD 209 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-~~~~l~h~~~~~ 209 (315)
..+......++. .+|+++.++|.+||+.||.+||+ ++++++||||..
T Consensus 230 ~~~~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 230 HTFETTVVTYPS----AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHCCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHhhcccCCCC----cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 666666655543 58999999999999999999998 999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=324.91 Aligned_cols=197 Identities=31% Similarity=0.552 Sum_probs=175.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+|+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+ ++
T Consensus 79 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nil---l~ 155 (327)
T 3a62_A 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIM---LN 155 (327)
T ss_dssp CCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE---EC
T ss_pred CCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeE---EC
Confidence 799999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++..... ........||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 235 (327)
T 3a62_A 156 HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235 (327)
T ss_dssp TTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 778999999999875432 23344567999999999986 4589999999999999999999999999999999999988
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
....++. .++++++++|.+||..||.+|| ++.++++||||+.
T Consensus 236 ~~~~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 236 CKLNLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp TCCCCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred CCCCCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 7766543 5899999999999999999999 8999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=339.72 Aligned_cols=199 Identities=39% Similarity=0.686 Sum_probs=182.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++.+.+.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+ +
T Consensus 73 l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIl---l 149 (476)
T 2y94_A 73 FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL---L 149 (476)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEE---E
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEE---E
Confidence 3899999999999999999999999999999999988889999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++..........+.+||+.|+|||++.+. .+.++||||+||++|+|++|..||.+.+.......+.
T Consensus 150 ~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 229 (476)
T 2y94_A 150 DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC 229 (476)
T ss_dssp CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH
T ss_pred ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 67789999999999887666666678899999999998754 4789999999999999999999999988888888888
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+....+ ..++++++++|.+||+.||.+|||++++++||||+..
T Consensus 230 ~~~~~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 230 DGIFYTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp TTCCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred cCCcCCC----ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 8765544 3589999999999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=323.14 Aligned_cols=205 Identities=41% Similarity=0.693 Sum_probs=183.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++...+
T Consensus 73 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~ 152 (321)
T 2a2a_A 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN 152 (321)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT
T ss_pred CCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCC
Confidence 79999999999999999999999999999999998888899999999999999999999999999999999999963211
Q ss_pred C-CCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 E-DAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~-~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
. ...+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 232 (321)
T 2a2a_A 153 IPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232 (321)
T ss_dssp SSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred CCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 1 1279999999998776655556678999999999986 4589999999999999999999999999999999999888
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
....++...+..+|+.++++|.+||+.||.+|||+.|+++||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 233 VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 77766655456789999999999999999999999999999999743
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=336.16 Aligned_cols=201 Identities=31% Similarity=0.609 Sum_probs=177.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||++++++|++++.+|+|||||.||+|.+++.+ .+.+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 131 ~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL--- 207 (437)
T 4aw2_A 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL--- 207 (437)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---
T ss_pred CCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHee---
Confidence 4899999999999999999999999999999999987 478999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
++.++.+||+|||+++....... ....+||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+..
T Consensus 208 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 287 (437)
T 4aw2_A 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287 (437)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred EcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh
Confidence 56788999999999976654332 23468999999999985 34899999999999999999999999999999
Q ss_pred HHHHHHHhCC--CCCCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccC
Q 021227 156 GIFRQILEGK--IDFESEPWPNISESAKDLIRKMLDQNPKR--RLTAHEVLCHPWIVD 209 (315)
Q Consensus 156 ~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~l~~~p~~--R~s~~~~l~h~~~~~ 209 (315)
+.+..|.... ..++. .+..+|+++++||++||..+|++ |++++|+++||||+.
T Consensus 288 ~~~~~i~~~~~~~~~p~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 288 ETYGKIMNHKERFQFPT-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp HHHHHHHTHHHHCCCCS-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred HHHHhhhhccccccCCc-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 9888887643 23322 23568999999999999998888 999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=318.21 Aligned_cols=206 Identities=45% Similarity=0.850 Sum_probs=187.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++...+
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~ 143 (304)
T 2jam_A 64 KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE 143 (304)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS
T ss_pred CCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC
Confidence 89999999999999999999999999999999998888999999999999999999999999999999999999975446
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 164 (315)
.++.+||+|||++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+..+
T Consensus 144 ~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (304)
T 2jam_A 144 ENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG 222 (304)
T ss_dssp TTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC
T ss_pred CCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 7889999999998754332 3344679999999999864 5899999999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 165 KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 165 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
...++...+..+|++++++|.+||..||.+|||++++++||||.....
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 223 YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 888777777889999999999999999999999999999999986543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=318.03 Aligned_cols=205 Identities=41% Similarity=0.814 Sum_probs=187.9
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||||+++++++.+++.+++||||++||+|.+++.....+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 80 l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil--- 156 (298)
T 1phk_A 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL--- 156 (298)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE---
T ss_pred hcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE---
Confidence 44699999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-------KHYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
++.++.+||+|||++.............||+.|+|||++. ..++.++||||+|+++|+|++|..||.+.+...
T Consensus 157 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 236 (298)
T 1phk_A 157 LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236 (298)
T ss_dssp ECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH
Confidence 5677899999999998776665556678999999999874 247889999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
....+..+...++.+.++.+|++++++|.+||+.||.+|||+.++++||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 237 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 9999998888877777778999999999999999999999999999999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=316.29 Aligned_cols=204 Identities=29% Similarity=0.531 Sum_probs=168.8
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+++ +||||+++++++.+++.+|+|||||.| ++.+.+.. .+.+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 56 ~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil 133 (292)
T 3o0g_A 56 KEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL 133 (292)
T ss_dssp TTC-CCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hcC-CCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 345 899999999999999999999999986 55555544 678999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh-c-CCCchhHHHHHHHHHHHHhCCCC-CCCCCHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK-H-YGPEADVWSAGVILYILLSGVPP-FWAETEIG 156 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~ 156 (315)
++.++.+||+|||++...... .......||+.|+|||++.+ . ++.++||||+||++|+|++|..| |.+.+..+
T Consensus 134 ---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~ 210 (292)
T 3o0g_A 134 ---INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp ---ECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred ---EcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 567789999999999766432 33445678999999999864 3 79999999999999999987776 56667777
Q ss_pred HHHHHHhCCCCCCCC-------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 157 IFRQILEGKIDFESE-------------------------PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
....+......+... ..+.+++++++||.+||+.||.+|||++|+++||||+..
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 776665421111111 123578999999999999999999999999999999853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=337.16 Aligned_cols=205 Identities=28% Similarity=0.452 Sum_probs=168.9
Q ss_pred CCCCCcceEEEEEEeCC------eEEEEEeccCCCchhHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 021227 5 SEHQHVVRIHDTYEDKS------CVHIVMELCEGGELFDRI---VKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLK 75 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~------~~~lv~E~~~gg~L~~~l---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dik 75 (315)
.+||||+++++++...+ .+|+||||+.++.+.... .....+++..++.++.|++.||+|||++||+|||||
T Consensus 89 l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 168 (394)
T 4e7w_A 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIK 168 (394)
T ss_dssp CCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred CCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCC
Confidence 38999999999996543 388999999875433222 235689999999999999999999999999999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
|+||++. ..++.+||+|||+++............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+
T Consensus 169 p~Nill~--~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 169 PQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp GGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEEc--CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999962 2678999999999987766666667789999999999853 48999999999999999999999999998
Q ss_pred HHHHHHHHHhCC-----------------CCCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 154 EIGIFRQILEGK-----------------IDFES--------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 154 ~~~~~~~i~~~~-----------------~~~~~--------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
..+.+..+.+.. ..++. ...+.+++++++||.+||+.||.+|||+.|+++||||+
T Consensus 247 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 247 GIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 877776665411 01110 01234889999999999999999999999999999998
Q ss_pred CCC
Q 021227 209 DDK 211 (315)
Q Consensus 209 ~~~ 211 (315)
...
T Consensus 327 ~~~ 329 (394)
T 4e7w_A 327 ELR 329 (394)
T ss_dssp TTT
T ss_pred hhc
Confidence 653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=316.85 Aligned_cols=204 Identities=28% Similarity=0.494 Sum_probs=168.4
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.+++.+|+||||+.+ +|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 55 ~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 132 (288)
T 1ob3_A 55 KEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL 132 (288)
T ss_dssp GGC-CCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred Hhc-CCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 344 899999999999999999999999976 898888764 67999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
++.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.
T Consensus 133 ---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 209 (288)
T 1ob3_A 133 ---INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (288)
T ss_dssp ---ECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ---EcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 567789999999998765432 22345678999999999863 489999999999999999999999999888777
Q ss_pred HHHHHhCCCCCCC-------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDFES-------------------------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
...+......... .....++++++++|.+||+.||.+|||++|+++||||++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 7666542111000 0123578999999999999999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=317.34 Aligned_cols=207 Identities=46% Similarity=0.838 Sum_probs=189.0
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+ +||||+++++++.+.+.+|+|+||+.|++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||++.
T Consensus 77 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~ 155 (287)
T 2wei_A 77 KL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155 (287)
T ss_dssp TC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred hc-cCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEe
Confidence 44 89999999999999999999999999999999998888999999999999999999999999999999999999986
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
..+..+.+||+|||++.............||+.|+|||++.+.++.++||||+|+++|+|++|..||.+.+..+....+.
T Consensus 156 ~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (287)
T 2wei_A 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (287)
T ss_dssp CSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 54556789999999998766555555567899999999998889999999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+...++.+.+..+|++++++|.+||+.||.+|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred cCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 888777766677899999999999999999999999999999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=318.62 Aligned_cols=205 Identities=26% Similarity=0.478 Sum_probs=173.5
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLK 75 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dik 75 (315)
+.+ +||||+++++++.+++.+|+||||++ |+|.+++... ..+++..+..++.|++.||.|||++||+|||||
T Consensus 58 ~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlk 135 (317)
T 2pmi_A 58 KEL-KHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLK 135 (317)
T ss_dssp TTC-CBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred Hhc-CCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 445 89999999999999999999999998 5898888653 359999999999999999999999999999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
|+||+ ++.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.
T Consensus 136 p~NIl---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 136 PQNLL---INKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp GGGEE---ECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hHHeE---EcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999 567789999999999766432 23345678999999999864 4899999999999999999999999999
Q ss_pred CHHHHHHHHHhCCCCCCCC------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 153 TEIGIFRQILEGKIDFESE------------------------------PWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~------------------------------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
+..+....+.......+.. ....+++++++||.+||+.||.+|||+.|++
T Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 213 NDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp SHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 8888777765421111100 1125789999999999999999999999999
Q ss_pred cCCCccCCC
Q 021227 203 CHPWIVDDK 211 (315)
Q Consensus 203 ~h~~~~~~~ 211 (315)
+||||....
T Consensus 293 ~hp~f~~~~ 301 (317)
T 2pmi_A 293 HHPWFAEYY 301 (317)
T ss_dssp TSGGGGGGC
T ss_pred CChhhhccc
Confidence 999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=323.39 Aligned_cols=207 Identities=25% Similarity=0.479 Sum_probs=170.2
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.+++.+++||||+.| +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 55 ~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl 132 (324)
T 3mtl_A 55 KDL-KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLL 132 (324)
T ss_dssp SCC-CCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEE
T ss_pred Hhc-CCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEE
Confidence 344 899999999999999999999999974 888888765 45999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
++.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.
T Consensus 133 ---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 209 (324)
T 3mtl_A 133 ---INERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ 209 (324)
T ss_dssp ---ECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ---ECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 566789999999998765432 23345678999999999864 489999999999999999999999999998888
Q ss_pred HHHHHhCCCCCCCCCC--------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 158 FRQILEGKIDFESEPW--------------------------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~--------------------------~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
...+......+....| +.+++++++||.+||+.||.+|||++|+|+||||....
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 210 LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 7777653222222222 35789999999999999999999999999999998754
Q ss_pred CC
Q 021227 212 VA 213 (315)
Q Consensus 212 ~~ 213 (315)
..
T Consensus 290 ~~ 291 (324)
T 3mtl_A 290 ER 291 (324)
T ss_dssp ST
T ss_pred cc
Confidence 43
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.74 Aligned_cols=201 Identities=26% Similarity=0.498 Sum_probs=184.3
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
..+.+||||++++++|++...+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 396 ~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NIL- 474 (674)
T 3pfq_A 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM- 474 (674)
T ss_dssp TCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEE-
T ss_pred HhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEE-
Confidence 3456899999999999999999999999999999999998889999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCC-CCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYK-PDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
++.++.+||+|||+++... ......+.+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..++++
T Consensus 475 --l~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~ 552 (674)
T 3pfq_A 475 --LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552 (674)
T ss_dssp --ECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred --EcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 5678899999999998643 334456688999999999987 559999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCccC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTA-----HEVLCHPWIVD 209 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~-----~~~l~h~~~~~ 209 (315)
.|......++. .+|+++++||.+||++||.+||++ +|+++||||+.
T Consensus 553 ~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 553 SIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHSSCCCCCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHhCCCCCCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 99998877664 689999999999999999999997 99999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=321.45 Aligned_cols=208 Identities=28% Similarity=0.522 Sum_probs=169.9
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.+ +||||+++++++.+++.+|+||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 88 ~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll 165 (329)
T 3gbz_A 88 KEL-QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLL 165 (329)
T ss_dssp GGC-CCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HHc-CCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEE
Confidence 345 899999999999999999999999975 999999988899999999999999999999999999999999999997
Q ss_pred ccC--CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 82 LSV--DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 82 ~~~--~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
... +..+.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 245 (329)
T 3gbz_A 166 SVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID 245 (329)
T ss_dssp EC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence 432 34567999999998765432 23345678999999999864 48999999999999999999999999998888
Q ss_pred HHHHHHhCCCCCCCCCCC--------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 157 IFRQILEGKIDFESEPWP--------------------------NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~--------------------------~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
....+......++...|+ .+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 246 QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 777776532222211111 168999999999999999999999999999999865
Q ss_pred C
Q 021227 211 K 211 (315)
Q Consensus 211 ~ 211 (315)
.
T Consensus 326 ~ 326 (329)
T 3gbz_A 326 D 326 (329)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=329.91 Aligned_cols=201 Identities=29% Similarity=0.564 Sum_probs=174.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||++++++|++++.+|+|||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 118 ~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL--- 194 (412)
T 2vd5_A 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL--- 194 (412)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHee---
Confidence 38999999999999999999999999999999999875 47999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh--------hcCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR--------KHYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
++.++.+||+|||+++....... ....+||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+
T Consensus 195 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 195 LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 56788999999999987654432 23468999999999986 348999999999999999999999999999
Q ss_pred HHHHHHHHHhCC--CCCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCccCC
Q 021227 154 EIGIFRQILEGK--IDFESEPWPNISESAKDLIRKMLDQNPKRR---LTAHEVLCHPWIVDD 210 (315)
Q Consensus 154 ~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~l~~~p~~R---~s~~~~l~h~~~~~~ 210 (315)
..+.+..|.... ..++. ....+|+++++||++||. +|.+| ++++|+++||||+..
T Consensus 275 ~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 275 TAETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp HHHHHHHHHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhcccCcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 988888887643 22221 124689999999999999 99998 599999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=313.14 Aligned_cols=202 Identities=33% Similarity=0.626 Sum_probs=177.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
++ +||||+++++++.+....++||||++||+|.+++.+.+++++..+..++.|++.||.|||++||+||||||+||+
T Consensus 65 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nil-- 141 (279)
T 3fdn_A 65 HL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL-- 141 (279)
T ss_dssp TC-CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEE--
T ss_pred cC-CCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEE--
Confidence 44 799999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||++....... .....||+.|+|||++.+ .++.++||||+|+++|+|++|..||.+.+..+....+
T Consensus 142 -i~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 219 (279)
T 3fdn_A 142 -LGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219 (279)
T ss_dssp -ECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred -EcCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 5678899999999886543332 345678999999999864 4889999999999999999999999999998888888
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVA 213 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~ 213 (315)
......++. .++++++++|.+||+.||.+|||+.|+++||||+.....
T Consensus 220 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 220 SRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp HHTCCCCCT----TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred HhCCCCCCC----cCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence 887665543 589999999999999999999999999999999865443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=318.10 Aligned_cols=201 Identities=27% Similarity=0.514 Sum_probs=168.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++.+++||||+.| +|.+.+... ..+++..++.++.|++.||.|||++||+||||||+||+ +
T Consensus 77 ~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl---~ 152 (311)
T 3niz_A 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLL---I 152 (311)
T ss_dssp CCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE---E
T ss_pred CCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEE---E
Confidence 799999999999999999999999985 787777654 46999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+
T Consensus 153 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 232 (311)
T 3niz_A 153 NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232 (311)
T ss_dssp CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 67789999999999876432 33345678999999999864 4899999999999999999999999987766666555
Q ss_pred HhCCCCCCCCC--------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 162 LEGKIDFESEP--------------------------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~--------------------------~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
........... .+.+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 44111111111 23478899999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=336.59 Aligned_cols=203 Identities=41% Similarity=0.718 Sum_probs=170.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.. ..+|+||||+.||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+...+
T Consensus 198 ~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 198 NHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp CCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS
T ss_pred CCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC
Confidence 89999999999864 45889999999999999998888999999999999999999999999999999999999986555
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETE-IGIFRQ 160 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~ 160 (315)
....+||+|||++..........+..||+.|+|||++. ..++.++||||+||++|+|++|..||.+... ......
T Consensus 277 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~ 356 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 356 (419)
T ss_dssp SSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH
T ss_pred CcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH
Confidence 56789999999998876665566788999999999974 3478899999999999999999999976543 345566
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
+..+...+....+..+++++++||.+||+.||.+|||++|+++||||+.
T Consensus 357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 6777766666666789999999999999999999999999999999964
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=316.21 Aligned_cols=197 Identities=35% Similarity=0.647 Sum_probs=173.2
Q ss_pred CCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+ +..+|+||||+++|+|.+++ ..+++++..+..++.|++.||.|||++||+||||||+||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil--- 169 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL--- 169 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE---
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE---
Confidence 89999999999987 67899999999999998754 4567999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhhc----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRKH----YGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
++.++.+||+|||++....... ......||+.|+|||++.+. ++.++||||+||++|+|++|..||.+.......
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 5677899999999998765432 33456899999999998643 377899999999999999999999998888888
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
..+......++. .+.++++++++|.+||+.||.+|||+.|+++||||+
T Consensus 250 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 888777655543 357899999999999999999999999999999995
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=329.16 Aligned_cols=203 Identities=29% Similarity=0.492 Sum_probs=168.0
Q ss_pred CCCCCCCcceEEEEEEeCC--eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYEDKS--CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
++.+||||+++++++..++ .+|+|||||. |+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 64 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl 141 (388)
T 3oz6_A 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNIL 141 (388)
T ss_dssp HTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeE
Confidence 4556999999999997544 7999999997 588888765 57999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCC----------------------CCcccccccCccccchhhhhh--cCCCchhHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKP----------------------DEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAG 136 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG 136 (315)
++.++.+||+|||+++.... .......+||+.|+|||++.+ .++.++||||+|
T Consensus 142 ---l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 218 (388)
T 3oz6_A 142 ---LNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218 (388)
T ss_dssp ---ECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred ---EcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHH
Confidence 56788999999999976532 112344689999999999864 589999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-------------------------------------------CCC
Q 021227 137 VILYILLSGVPPFWAETEIGIFRQILEGKIDFES-------------------------------------------EPW 173 (315)
Q Consensus 137 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------------------------~~~ 173 (315)
|++|+|++|.+||.+.+..+.+..+......+.. ...
T Consensus 219 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (388)
T 3oz6_A 219 CILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298 (388)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccc
Confidence 9999999999999999988887777532111100 011
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 174 PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 174 ~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
..+++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 299 ~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred ccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 2678999999999999999999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=313.51 Aligned_cols=204 Identities=27% Similarity=0.561 Sum_probs=177.3
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.+ +||||+++++++...+..++||||++||+|.+++. ...+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 97 ~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl- 173 (321)
T 2c30_A 97 RDY-QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSIL- 173 (321)
T ss_dssp TTC-CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE-
T ss_pred HhC-CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE-
Confidence 345 89999999999999999999999999999999875 457999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
++.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+...
T Consensus 174 --l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~ 251 (321)
T 2c30_A 174 --LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251 (321)
T ss_dssp --ECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred --ECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5667899999999987664432 234568999999999986 458999999999999999999999999998888887
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.+....... ......++++++++|.+||+.||.+|||+.++++||||....
T Consensus 252 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 252 RLRDSPPPK-LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHSSCCC-CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHhcCCCCC-cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 777654322 122346899999999999999999999999999999998643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=318.03 Aligned_cols=202 Identities=31% Similarity=0.596 Sum_probs=171.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++.+++..|+|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+ +
T Consensus 62 l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl---l 138 (323)
T 3tki_A 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL---L 138 (323)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE---E
T ss_pred CCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEE---E
Confidence 3899999999999999999999999999999999988888999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC---CcccccccCccccchhhhhhc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Q 021227 85 DEDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEI-GIF 158 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~ 158 (315)
+.++.+||+|||++...... .......||+.|+|||++.+. ++.++||||+||++|+|++|..||.+.... ...
T Consensus 139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 218 (323)
T 3tki_A 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218 (323)
T ss_dssp CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH
T ss_pred eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 67789999999999765322 223456899999999998643 477899999999999999999999876543 233
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
......... ...+..+++++.+||.+||+.||.+|||++|+++||||....
T Consensus 219 ~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 219 SDWKEKKTY--LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHTTCTT--STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHhccccc--CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 333333222 233567899999999999999999999999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=327.02 Aligned_cols=203 Identities=20% Similarity=0.329 Sum_probs=166.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+|||||++++++.+++.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 84 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIl--- 160 (389)
T 3gni_B 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHIL--- 160 (389)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---
T ss_pred CCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE---
Confidence 8999999999999999999999999999999999876 67999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCC--------CcccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 84 VDEDAALKATDFGLSVFYKPD--------EVFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
++.++.+||+|||.+...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.
T Consensus 161 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 161 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp ECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 567889999999987643211 11233578999999999864 5899999999999999999999999876
Q ss_pred CHHHHHHHHHhCCCC------------------------------------------CCCCCCCCCCHHHHHHHHHhccc
Q 021227 153 TEIGIFRQILEGKID------------------------------------------FESEPWPNISESAKDLIRKMLDQ 190 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~s~~~~~li~~~l~~ 190 (315)
+.......+..+... ...+.+..+++++++||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 320 (389)
T 3gni_B 241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320 (389)
T ss_dssp CSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCS
T ss_pred CHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhc
Confidence 554444333222111 01112345789999999999999
Q ss_pred CCCCCCCHHHHhcCCCccCCC
Q 021227 191 NPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 191 ~p~~R~s~~~~l~h~~~~~~~ 211 (315)
||.+|||+.|+|+||||+...
T Consensus 321 dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 321 NPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp CTTTSCCHHHHTTSGGGGGC-
T ss_pred CcccCCCHHHHhcCHHHHHHh
Confidence 999999999999999998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=310.49 Aligned_cols=200 Identities=32% Similarity=0.644 Sum_probs=179.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+|+||||++||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||+ ++
T Consensus 72 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil---~~ 148 (284)
T 2vgo_A 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL---MG 148 (284)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE---EC
T ss_pred CCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE---Ec
Confidence 799999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 164 (315)
.++.+||+|||++....... .....||+.|+|||++.+ .++.++||||+|+++|+|++|..||...+..+....+...
T Consensus 149 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 227 (284)
T 2vgo_A 149 YKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227 (284)
T ss_dssp TTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred CCCCEEEecccccccCcccc-cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc
Confidence 67899999999986654322 345679999999999874 5899999999999999999999999999888888888877
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 021227 165 KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVA 213 (315)
Q Consensus 165 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~ 213 (315)
...++ +.+|++++++|.+||+.||.+|||++++++||||+.....
T Consensus 228 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~ 272 (284)
T 2vgo_A 228 DLKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272 (284)
T ss_dssp CCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred ccCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence 65544 3589999999999999999999999999999999865433
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=334.12 Aligned_cols=197 Identities=30% Similarity=0.512 Sum_probs=176.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+|||||++++++++++.+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 242 ~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNIL--- 318 (576)
T 2acx_A 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL--- 318 (576)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE---
T ss_pred CCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEE---
Confidence 89999999999999999999999999999999987654 4999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE----TEIGIF 158 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~ 158 (315)
++.++.+||+|||++............+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+. ....+.
T Consensus 319 ld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~ 398 (576)
T 2acx_A 319 LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398 (576)
T ss_dssp ECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH
T ss_pred EeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH
Confidence 56788999999999988766655566789999999999874 5999999999999999999999999875 345666
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
..+......++ ..+|+++++||.+||+.||.+|| |++|+++||||+.
T Consensus 399 ~~i~~~~~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 399 RLVKEVPEEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHhhcccccCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 66766655444 46899999999999999999999 8999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.08 Aligned_cols=202 Identities=23% Similarity=0.414 Sum_probs=171.8
Q ss_pred CCCCCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCC
Q 021227 2 HHLSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG--VFHRDLK 75 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dik 75 (315)
+.+ +||||+++++++.+ +..+++||||++||+|.+++.+.+.+++..++.++.|++.||.|||++| |+|||||
T Consensus 80 ~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dik 158 (290)
T 1t4h_A 80 KGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 158 (290)
T ss_dssp TTC-CCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCC
T ss_pred HhC-CCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCC
Confidence 345 89999999999875 4669999999999999999988889999999999999999999999999 9999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCC-CH
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAE-TE 154 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~ 154 (315)
|+||++ ...++.+||+|||++...... ......||+.|+|||++.+.++.++||||+||++|+|++|..||.+. +.
T Consensus 159 p~Nil~--~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 235 (290)
T 1t4h_A 159 CDNIFI--TGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA 235 (290)
T ss_dssp GGGEEE--SSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred HHHEEE--ECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH
Confidence 999996 236789999999998754433 33456799999999999888999999999999999999999999884 44
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
......+..+.... ......++++.++|.+||+.||.+|||+.++++||||++
T Consensus 236 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 236 AQIYRRVTSGVKPA--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHTTTCCCG--GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHhccCCcc--ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 55555554443221 122457899999999999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=310.55 Aligned_cols=204 Identities=41% Similarity=0.718 Sum_probs=178.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+...+++||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||++...+
T Consensus 66 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 145 (283)
T 3bhy_A 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN 145 (283)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS
T ss_pred CCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC
Confidence 79999999999999999999999999999999998888999999999999999999999999999999999999974322
Q ss_pred -CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 -EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 -~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
....+||+|||++.............||+.|+|||++. +.++.++||||+|+++|+|++|..||.+.+..+....+..
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 225 (283)
T 3bhy_A 146 VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 225 (283)
T ss_dssp SSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh
Confidence 23489999999998776555555677999999999986 4589999999999999999999999999999888888888
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
....++...++.+++.+++++.+||..||.+|||+.++++||||+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 226 VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 7766655555678999999999999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=317.29 Aligned_cols=213 Identities=46% Similarity=0.822 Sum_probs=156.1
Q ss_pred CCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 5 SEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
.+||||+++++++.. +..+++|||||+||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 79 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~N 158 (336)
T 3fhr_A 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158 (336)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred cCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 589999999999986 556899999999999999998764 69999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|++...+..+.+||+|||++...... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+......
T Consensus 159 Ill~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 159 LLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp EEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred EEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 99865555778999999999765433 234567899999999985 4588999999999999999999999987655433
Q ss_pred ----HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC
Q 021227 158 ----FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPL 218 (315)
Q Consensus 158 ----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~ 218 (315)
...+......++...+..+|++++++|.+||+.||.+|||+.|+++||||+.....+..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 302 (336)
T 3fhr_A 238 SPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302 (336)
T ss_dssp -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBC
T ss_pred hhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCcc
Confidence 3344445555666667789999999999999999999999999999999987655554444
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=316.60 Aligned_cols=203 Identities=41% Similarity=0.726 Sum_probs=175.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++..+. +|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++...+
T Consensus 73 ~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~ 151 (322)
T 2ycf_A 73 NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 151 (322)
T ss_dssp CCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS
T ss_pred CCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC
Confidence 8999999999998765 899999999999999998888999999999999999999999999999999999999975544
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETE-IGIFRQ 160 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~ 160 (315)
....+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||..... ......
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 231 (322)
T 2ycf_A 152 EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231 (322)
T ss_dssp SSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH
T ss_pred CCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH
Confidence 55679999999998776555445667999999999873 4588999999999999999999999976543 244555
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
+..+...+....+..+++++.++|.+||+.||.+|||+.++++||||..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 6666665554445678999999999999999999999999999999964
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=314.45 Aligned_cols=196 Identities=31% Similarity=0.578 Sum_probs=170.2
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCC-chhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGG-ELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg-~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.+++.+++||||+.+| +|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 84 ~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl 162 (335)
T 3dls_A 84 SRV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIV 162 (335)
T ss_dssp TTC-CCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhC-CCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEE
Confidence 345 8999999999999999999999999776 99999988889999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH-Y-GPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
++.++.+||+|||++.............||+.|+|||++.+. + +.++||||+||++|+|++|..||.....
T Consensus 163 ---l~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---- 235 (335)
T 3dls_A 163 ---IAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---- 235 (335)
T ss_dssp ---ECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----
T ss_pred ---EcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----
Confidence 466789999999999887766666677899999999998643 4 7899999999999999999999976321
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
...... .....+|++++++|.+||+.||.+|||+.++++||||+...
T Consensus 236 --~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 236 --TVEAAI----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp --GTTTCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred --HHhhcc----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 111111 12235899999999999999999999999999999998643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=314.47 Aligned_cols=196 Identities=26% Similarity=0.409 Sum_probs=165.2
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+||||+++++++.+++.+|+||||+ +|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl--- 189 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF--- 189 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE---
Confidence 48999999999999999999999999 66888887664 56999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
++.++.+||+|||++.............||+.|+|||++.+.++.++||||+||++|+|++|..||.+... ...+..
T Consensus 190 l~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~ 266 (311)
T 3p1a_A 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQ 266 (311)
T ss_dssp ECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTT
T ss_pred ECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhc
Confidence 46678999999999987765555556779999999999988899999999999999999999877765433 333333
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
+.. +......+++++.++|.+||+.||.+|||++|+++||||++
T Consensus 267 ~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 267 GYL--PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp TCC--CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred cCC--CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 322 22223468999999999999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=307.14 Aligned_cols=198 Identities=39% Similarity=0.680 Sum_probs=169.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+.+.+|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||+ ++
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil---~~ 145 (276)
T 2h6d_A 69 RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL---LD 145 (276)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEE---EC
T ss_pred CCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEE---EC
Confidence 799999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++.............||+.|+|||++.+. .+.++||||+|+++|+|++|..||.+.........+..
T Consensus 146 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 225 (276)
T 2h6d_A 146 AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG 225 (276)
T ss_dssp TTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 7789999999999877655555567799999999998754 36799999999999999999999999988888888887
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+....+ ..+++++.++|.+||+.||.+|||+.++++||||++.
T Consensus 226 ~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 226 GVFYIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp CCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CcccCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 765443 3578999999999999999999999999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=319.38 Aligned_cols=205 Identities=38% Similarity=0.699 Sum_probs=176.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----------------------------------------CCCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----------------------------------------KGNY 45 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----------------------------------------~~~~ 45 (315)
+||||+++++++.+++.+++|||||+||+|.+++.. ...+
T Consensus 86 ~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (345)
T 3hko_A 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQ 165 (345)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHH
T ss_pred CCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccc
Confidence 799999999999999999999999999999988742 1124
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC-----cccccccCccccchh
Q 021227 46 SEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPE 120 (315)
Q Consensus 46 ~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE 120 (315)
++..++.++.|++.||+|||++||+||||||+||++.. +....+||+|||++....... ......||+.|+|||
T Consensus 166 ~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 244 (345)
T 3hko_A 166 REKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence 67889999999999999999999999999999999632 233489999999997543211 234567999999999
Q ss_pred hhh---hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 021227 121 VLR---KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT 197 (315)
Q Consensus 121 ~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s 197 (315)
++. ..++.++|||||||++|+|++|..||.+.+..+....+......++.+.+..++++++++|.+||+.||.+|||
T Consensus 245 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred hhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 985 45899999999999999999999999999999999999988887777777779999999999999999999999
Q ss_pred HHHHhcCCCccCCC
Q 021227 198 AHEVLCHPWIVDDK 211 (315)
Q Consensus 198 ~~~~l~h~~~~~~~ 211 (315)
+.++++||||+...
T Consensus 325 ~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 325 AMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHSHHHHTTS
T ss_pred HHHHhcChhhccCh
Confidence 99999999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=333.69 Aligned_cols=199 Identities=28% Similarity=0.465 Sum_probs=160.3
Q ss_pred CCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+|||||++++++... ..+|+||||+.| +|.+.+. ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 119 ~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NI 195 (464)
T 3ttj_A 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195 (464)
T ss_dssp CCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhE
Confidence 899999999999654 467999999976 4666663 3599999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
| ++.++.+||+|||+++...........+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+.+..+.+
T Consensus 196 l---l~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~ 272 (464)
T 3ttj_A 196 V---VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 272 (464)
T ss_dssp E---ECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred E---EeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9 56788999999999987766655667889999999999864 5999999999999999999999999999988877
Q ss_pred HHHHhCCCCC----------------------CCCCCC----C------------CCHHHHHHHHHhcccCCCCCCCHHH
Q 021227 159 RQILEGKIDF----------------------ESEPWP----N------------ISESAKDLIRKMLDQNPKRRLTAHE 200 (315)
Q Consensus 159 ~~i~~~~~~~----------------------~~~~~~----~------------~s~~~~~li~~~l~~~p~~R~s~~~ 200 (315)
..|.+..... ....++ . .++++++||.+||+.||.+|||++|
T Consensus 273 ~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 352 (464)
T 3ttj_A 273 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352 (464)
T ss_dssp HHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence 7765421111 000000 0 1578999999999999999999999
Q ss_pred HhcCCCccCC
Q 021227 201 VLCHPWIVDD 210 (315)
Q Consensus 201 ~l~h~~~~~~ 210 (315)
+|+||||...
T Consensus 353 ~L~Hp~~~~~ 362 (464)
T 3ttj_A 353 ALQHPYINVW 362 (464)
T ss_dssp HHTSTTTGGG
T ss_pred HhcChhhhhc
Confidence 9999999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=319.05 Aligned_cols=199 Identities=30% Similarity=0.550 Sum_probs=167.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
.||||+++++++.+++.+|+||| +.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 114 ~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~--- 189 (390)
T 2zmd_A 114 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--- 189 (390)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES---
T ss_pred CCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE---
Confidence 37999999999999999999999 56889999999888999999999999999999999999999999999999972
Q ss_pred CCCCEEEeeccCcccCCCCC---cccccccCccccchhhhhh------------cCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 86 EDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLRK------------HYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
++.+||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 190 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 268 (390)
T 2zmd_A 190 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268 (390)
T ss_dssp -SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence 4789999999998764432 2345679999999999853 58899999999999999999999998
Q ss_pred CC-CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 151 AE-TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 151 ~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
+. .....+..+......+..+ ...+++++++|.+||+.||.+|||+.|+++||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 269 QIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp TCCCHHHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hhhHHHHHHHHHhCccccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 75 3445566666554443332 24588999999999999999999999999999998543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=314.70 Aligned_cols=203 Identities=28% Similarity=0.506 Sum_probs=171.6
Q ss_pred CCCCcceEEEEEEe--------CCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 021227 6 EHQHVVRIHDTYED--------KSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKP 76 (315)
Q Consensus 6 ~Hpniv~~~~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp 76 (315)
+||||+++++++.+ ++.+|+|||||.| +|.+.+... ..+++..++.++.|++.||+|||++||+||||||
T Consensus 74 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 152 (351)
T 3mi9_A 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA 152 (351)
T ss_dssp CCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred cCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCH
Confidence 79999999999987 4578999999986 776666554 6799999999999999999999999999999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCC-----CCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCC
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKP-----DEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPF 149 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 149 (315)
+||+ ++.++.+||+|||++..... ........||+.|+|||++.+ .++.++||||+||++|+|++|.+||
T Consensus 153 ~NIl---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 153 ANVL---ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp GGEE---ECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred HHEE---EcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 9999 56778999999999976542 222345678999999998864 4899999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCCCCCCCCC----------------------------CHHHHHHHHHhcccCCCCCCCHHHH
Q 021227 150 WAETEIGIFRQILEGKIDFESEPWPNI----------------------------SESAKDLIRKMLDQNPKRRLTAHEV 201 (315)
Q Consensus 150 ~~~~~~~~~~~i~~~~~~~~~~~~~~~----------------------------s~~~~~li~~~l~~~p~~R~s~~~~ 201 (315)
.+.+.......+......++...|+.. ++++++||.+||+.||.+|||++|+
T Consensus 230 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 309 (351)
T 3mi9_A 230 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309 (351)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH
Confidence 999988888877764444444444332 7889999999999999999999999
Q ss_pred hcCCCccCCCC
Q 021227 202 LCHPWIVDDKV 212 (315)
Q Consensus 202 l~h~~~~~~~~ 212 (315)
|+||||.....
T Consensus 310 l~hp~f~~~~~ 320 (351)
T 3mi9_A 310 LNHDFFWSDPM 320 (351)
T ss_dssp HTSGGGGSSSC
T ss_pred hCCCCcCCCCC
Confidence 99999986543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=311.13 Aligned_cols=203 Identities=29% Similarity=0.548 Sum_probs=168.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+++||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+ ++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil---~~ 136 (311)
T 4agu_A 60 KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENIL---IT 136 (311)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---EC
T ss_pred CCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEE---Ec
Confidence 799999999999999999999999999999998887888999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+.
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 137 KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp TTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7789999999999776533 23345679999999999864 48999999999999999999999999988777665554
Q ss_pred hCCC-------------------CCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKI-------------------DFESE--------PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~-------------------~~~~~--------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.... ..+.. .++.+|+++.+||.+||+.||.+|||++|+++||||+...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp HHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 3110 00100 1246899999999999999999999999999999998654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=306.88 Aligned_cols=201 Identities=36% Similarity=0.558 Sum_probs=179.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++..++||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+ ++
T Consensus 73 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil---~~ 149 (294)
T 2rku_A 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LN 149 (294)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE---EC
T ss_pred CCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEE---Ec
Confidence 899999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+|+++|+|++|..||.+....+....+..
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 229 (294)
T 2rku_A 150 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 229 (294)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh
Confidence 7789999999999765432 23345679999999999864 489999999999999999999999999988888888877
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVA 213 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~ 213 (315)
.....+ ..+++++.+++.+||+.||.+|||++++++||||......
T Consensus 230 ~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 230 NEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp TCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ccCCCc----cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 665444 3688999999999999999999999999999999876443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=312.67 Aligned_cols=199 Identities=36% Similarity=0.557 Sum_probs=179.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+++.+|+||||+.|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+ ++
T Consensus 99 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl---~~ 175 (335)
T 2owb_A 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LN 175 (335)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE---EC
T ss_pred CCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEE---Ec
Confidence 899999999999999999999999999999999988889999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+..
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 255 (335)
T 2owb_A 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 255 (335)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc
Confidence 6789999999999766432 23345679999999999864 489999999999999999999999999988888888887
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
....++ ..+++++.++|.+||+.||.+|||+.|+++||||....
T Consensus 256 ~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 256 NEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp TCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred CCCCCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 765544 35899999999999999999999999999999998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=306.75 Aligned_cols=199 Identities=33% Similarity=0.606 Sum_probs=148.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+.+..|+||||+++++|.+++... +++++..++.++.|++.||.|||++||+||||||+||+ +
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil---i 145 (278)
T 3cok_A 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLL---L 145 (278)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEE---E
T ss_pred CCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE---E
Confidence 8999999999999999999999999999999998765 67999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++...... .......||+.|+|||++. ..++.++||||+||++|+|++|..||...+.......+.
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 225 (278)
T 3cok_A 146 TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225 (278)
T ss_dssp CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC
T ss_pred cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh
Confidence 67789999999998765432 2233467899999999986 458899999999999999999999998766544444433
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
...... ...++++++++|.+||+.||.+|||++++++||||....
T Consensus 226 ~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 226 LADYEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp SSCCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred hcccCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 332222 235899999999999999999999999999999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=327.42 Aligned_cols=197 Identities=28% Similarity=0.511 Sum_probs=175.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+||||++++++|++...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 243 ~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NIL- 321 (543)
T 3c4z_A 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL- 321 (543)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE-
T ss_pred CCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEE-
Confidence 8999999999999999999999999999999998764 36999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC----CHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE----TEI 155 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~ 155 (315)
++.++.+||+|||++........ ....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+. ...
T Consensus 322 --l~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~ 399 (543)
T 3c4z_A 322 --LDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK 399 (543)
T ss_dssp --ECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH
T ss_pred --EeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH
Confidence 56788999999999987654433 344689999999999875 5999999999999999999999999875 456
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
++...+......++ ..+|++++++|.+||++||.+||+ ++++++||||+.
T Consensus 400 ~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 400 ELKQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHhhcccCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 77777877766554 368999999999999999999996 589999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=317.17 Aligned_cols=200 Identities=22% Similarity=0.391 Sum_probs=168.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+.+.+|+||||+ |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+..
T Consensus 94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172 (360)
T ss_dssp TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcc
Confidence 6999999999999999999999999 899999997754 5999999999999999999999999999999999999742
Q ss_pred C----------------------CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHH
Q 021227 84 V----------------------DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILY 140 (315)
Q Consensus 84 ~----------------------~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ 140 (315)
. ...+.+||+|||++...... .....||+.|+|||++. ..++.++||||+||++|
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 1 23788999999999764432 34567999999999986 45999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC---------------------CCC---------------------CCCH
Q 021227 141 ILLSGVPPFWAETEIGIFRQILEGKIDFESE---------------------PWP---------------------NISE 178 (315)
Q Consensus 141 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~s~ 178 (315)
+|++|..||.+.+..+....+......++.. .|+ ..++
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 9999999999988877776665533222110 000 1247
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 179 ~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
.+.+||.+||+.||.+|||++|+|+||||+
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 788999999999999999999999999995
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=303.75 Aligned_cols=198 Identities=23% Similarity=0.402 Sum_probs=164.6
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+.+||||+++++++.+++.+++||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||
T Consensus 67 l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NI 146 (289)
T 1x8b_A 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNI 146 (289)
T ss_dssp SCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred hCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHE
Confidence 348999999999999999999999999999999999764 6799999999999999999999999999999999999
Q ss_pred eeccCC----------------CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc--CCCchhHHHHHHHHHH
Q 021227 80 LFLSVD----------------EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYI 141 (315)
Q Consensus 80 l~~~~~----------------~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ 141 (315)
++...+ ....+||+|||.+....... ...||+.|+|||++.+. +++++||||+||++|+
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 223 (289)
T 1x8b_A 147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223 (289)
T ss_dssp EEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHH
T ss_pred EEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHH
Confidence 975332 55689999999987765432 34589999999998754 5679999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 142 LLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 142 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
|++|.+|+..... ...+..+.... ....++++++++|.+||+.||.+|||+.++++||||...
T Consensus 224 l~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 224 AAGAEPLPRNGDQ---WHEIRQGRLPR---IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HTTCCCCCSSSHH---HHHHHTTCCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HhcCCCCCcchhH---HHHHHcCCCCC---CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 9999988765433 34444444322 224689999999999999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=318.26 Aligned_cols=204 Identities=27% Similarity=0.467 Sum_probs=170.3
Q ss_pred CCCCCCCCcceEEEEEEe--------------------------------------CCeEEEEEeccCCCchhHHHH---
Q 021227 2 HHLSEHQHVVRIHDTYED--------------------------------------KSCVHIVMELCEGGELFDRIV--- 40 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~--------------------------------------~~~~~lv~E~~~gg~L~~~l~--- 40 (315)
+.+ +|||||+++++|.. +..+++||||++| +|.+.+.
T Consensus 55 ~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~ 132 (383)
T 3eb0_A 55 KVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI 132 (383)
T ss_dssp TTC-CCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHH
T ss_pred HHc-CCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHH
Confidence 445 89999999999943 3458999999985 7665554
Q ss_pred -hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccch
Q 021227 41 -KKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119 (315)
Q Consensus 41 -~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aP 119 (315)
..+.+++..++.++.||+.||+|||++||+||||||+||++. ..++.+||+|||++.............||+.|+||
T Consensus 133 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aP 210 (383)
T 3eb0_A 133 RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAP 210 (383)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCH
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCH
Confidence 457899999999999999999999999999999999999962 35789999999999877666666677899999999
Q ss_pred hhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------CCCCC---C-----C
Q 021227 120 EVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGK-----------------IDFES---E-----P 172 (315)
Q Consensus 120 E~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----------------~~~~~---~-----~ 172 (315)
|++.+ .++.++||||+||++|+|++|..||.+.+..+.+..+.... ..++. . .
T Consensus 211 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (383)
T 3eb0_A 211 ELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290 (383)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHS
T ss_pred HHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhC
Confidence 98864 48999999999999999999999999998887777765411 01111 0 1
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 173 WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 173 ~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
...+|+++++||.+||+.||.+|||+.|+++||||+.
T Consensus 291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 1247899999999999999999999999999999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=319.75 Aligned_cols=200 Identities=33% Similarity=0.599 Sum_probs=172.3
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+.+||||+++++++.++..+|+||||+.||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 115 l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl--- 191 (355)
T 1vzo_A 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL--- 191 (355)
T ss_dssp HHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE---
T ss_pred ccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE---
Confidence 34799999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCCC----CH
Q 021227 84 VDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWAE----TE 154 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~----~~ 154 (315)
++.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||... ..
T Consensus 192 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 271 (355)
T 1vzo_A 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 271 (355)
T ss_dssp ECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred ECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH
Confidence 5678899999999987653322 2334679999999999863 3789999999999999999999999753 34
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVDD 210 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~~ 210 (315)
..+...+......++ ..+++.++++|.+||+.||.+|| |++++++||||...
T Consensus 272 ~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 272 AEISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHhccCCCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 555556665544433 46899999999999999999999 99999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=311.70 Aligned_cols=202 Identities=28% Similarity=0.439 Sum_probs=173.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+.+.+++||||+.| +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+ +
T Consensus 70 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil---~ 145 (346)
T 1ua2_A 70 SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL---L 145 (346)
T ss_dssp CCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE---E
T ss_pred CCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEE---E
Confidence 799999999999999999999999986 888887654 46999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i 225 (346)
T 1ua2_A 146 DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225 (346)
T ss_dssp CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 67789999999999876433 33445779999999999853 4889999999999999999999999999988888777
Q ss_pred HhCCCCCCCCC------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 162 LEGKIDFESEP------------------------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 162 ~~~~~~~~~~~------------------------~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
........... +..+++++++||.+||+.||.+|||+.|+++||||....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 65322211111 145679999999999999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=326.24 Aligned_cols=201 Identities=30% Similarity=0.467 Sum_probs=158.6
Q ss_pred CCCCcceEEEEEEe-----CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYED-----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+|||||++++++.. ...+|+||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 110 ~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NIL 188 (458)
T 3rp9_A 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL 188 (458)
T ss_dssp CCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred CCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEE
Confidence 89999999999943 36799999998 5699999988888999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC----------------------------cccccccCccccchhhh-h-hcCCCch
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE----------------------------VFSDVVGSPYYVAPEVL-R-KHYGPEA 130 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~ 130 (315)
++.++.+||+|||+++...... .....+||+.|+|||++ . ..++.++
T Consensus 189 ---l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~ 265 (458)
T 3rp9_A 189 ---VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI 265 (458)
T ss_dssp ---ECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHH
T ss_pred ---ECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHh
Confidence 5678899999999998654221 23456789999999986 3 4599999
Q ss_pred hHHHHHHHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHHHhC--C------------
Q 021227 131 DVWSAGVILYILLS-----------GVPPFWAETE--------------------IGIFRQILEG--K------------ 165 (315)
Q Consensus 131 DiwslG~il~~ll~-----------g~~pf~~~~~--------------------~~~~~~i~~~--~------------ 165 (315)
||||+||++|+|++ |.+||.+.+. .+.+..|... .
T Consensus 266 DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 345 (458)
T 3rp9_A 266 DVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE 345 (458)
T ss_dssp HHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCH
T ss_pred HHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCH
Confidence 99999999999999 7788876542 1222222210 0
Q ss_pred --------C-----CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 166 --------I-----DFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 166 --------~-----~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
. ......++.+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 346 DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 0 00011245679999999999999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=322.31 Aligned_cols=205 Identities=25% Similarity=0.452 Sum_probs=158.9
Q ss_pred CCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 6 EHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKK---------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 6 ~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
+|||||++++++.+ +..+|+||||+.| +|.+++... ..+++..++.++.||+.||+|||++||+||||
T Consensus 76 ~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dl 154 (405)
T 3rgf_A 76 KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 154 (405)
T ss_dssp CCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred CCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCc
Confidence 79999999999954 7789999999975 787777532 24999999999999999999999999999999
Q ss_pred CCCceeeccC-CCCCCEEEeeccCcccCCCC----CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCC
Q 021227 75 KPENFLFLSV-DEDAALKATDFGLSVFYKPD----EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 75 kp~nil~~~~-~~~~~ikl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~ 147 (315)
||+|||+... +..+.+||+|||++...... ......+||+.|+|||++.+ .++.++||||+||++|+|++|.+
T Consensus 155 kp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 234 (405)
T 3rgf_A 155 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234 (405)
T ss_dssp CGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCC
Confidence 9999997433 56789999999999866432 22345679999999999864 48999999999999999999999
Q ss_pred CCCCCCH---------HHHHHHHHhCCCCCCCCCCCC----------------------------------CCHHHHHHH
Q 021227 148 PFWAETE---------IGIFRQILEGKIDFESEPWPN----------------------------------ISESAKDLI 184 (315)
Q Consensus 148 pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~----------------------------------~s~~~~~li 184 (315)
||.+... .+.+..+......+....|.. .++++.+||
T Consensus 235 pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll 314 (405)
T 3rgf_A 235 IFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 314 (405)
T ss_dssp TTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHH
T ss_pred CCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHH
Confidence 9987654 244444443222222222221 277899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 185 RKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 185 ~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.+||+.||.+|||++|+|+||||....
T Consensus 315 ~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 315 QKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred HHHccCCcccCCCHHHHhcChhhccCC
Confidence 999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=313.43 Aligned_cols=205 Identities=26% Similarity=0.421 Sum_probs=171.0
Q ss_pred CCCCCCCCcceEEEEEEeCC----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 2 HHLSEHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
+.+ +||||+++++++.... ..|+||||++||+|.+++...+++++..+..++.|++.||+|||++||+||||||+
T Consensus 67 ~~l-~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~ 145 (311)
T 3ork_A 67 AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 145 (311)
T ss_dssp CCC-CCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred HcC-CCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence 344 8999999999997654 34999999999999999988889999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
||++ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.
T Consensus 146 Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 146 NIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp GEEE---ETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred HEEE---cCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9995 567889999999997654322 2234568999999999874 5899999999999999999999999999
Q ss_pred CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+..+....+.......+......+|+++.++|.+||+.||.+||++.+++.|+|+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 223 SPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp SHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 9888877777665554444455789999999999999999999999999999999743
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=316.92 Aligned_cols=199 Identities=29% Similarity=0.463 Sum_probs=170.2
Q ss_pred CCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+||||+++++++... ..+|+||||+ |++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||
T Consensus 82 ~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NI 159 (367)
T 1cm8_A 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL 159 (367)
T ss_dssp CBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHE
Confidence 799999999999876 3569999999 7899988865 6799999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+ ++.++.+||+|||+++.... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.
T Consensus 160 l---l~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 234 (367)
T 1cm8_A 160 A---VNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234 (367)
T ss_dssp E---ECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred E---EcCCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9 56788999999999986543 2345789999999999864 589999999999999999999999999988777
Q ss_pred HHHHHhCCCCC-----------------------CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDF-----------------------ES----EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~-----------------------~~----~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+..+......+ .. ..++..++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 235 l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 77665421111 01 1234679999999999999999999999999999999864
Q ss_pred C
Q 021227 211 K 211 (315)
Q Consensus 211 ~ 211 (315)
.
T Consensus 315 ~ 315 (367)
T 1cm8_A 315 H 315 (367)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=302.24 Aligned_cols=206 Identities=29% Similarity=0.509 Sum_probs=167.2
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK--------KGNYSEREAAKLMKTIVGVVECCHSLGVFHRD 73 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d 73 (315)
+.+ +||||+++++++.+++..++||||++||+|.+++.. .+.+++..+..++.|++.||.|||++|++|||
T Consensus 68 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 146 (303)
T 2vwi_A 68 SQC-HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRD 146 (303)
T ss_dssp CCC-CCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred hhc-CCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 344 899999999999999999999999999999998864 45699999999999999999999999999999
Q ss_pred CCCCceeeccCCCCCCEEEeeccCcccCCCCC------cccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhC
Q 021227 74 LKPENFLFLSVDEDAALKATDFGLSVFYKPDE------VFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSG 145 (315)
Q Consensus 74 ikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g 145 (315)
|||+||+ ++.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|
T Consensus 147 l~p~Nil---~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 223 (303)
T 2vwi_A 147 VKAGNIL---LGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223 (303)
T ss_dssp CSGGGEE---ECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHS
T ss_pred CChhhEE---EcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhC
Confidence 9999999 5667899999999987654321 223457899999999986 3589999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCC------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 146 VPPFWAETEIGIFRQILEGKIDF------ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 146 ~~pf~~~~~~~~~~~i~~~~~~~------~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
..||.+................. .......+++++++++.+||+.||.+|||+.++++||||+...
T Consensus 224 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 224 AAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp SCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 99998877655554444432211 1122356899999999999999999999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=301.39 Aligned_cols=202 Identities=31% Similarity=0.602 Sum_probs=171.3
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+||||+++++++.+++..|+||||++|++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+ +
T Consensus 62 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil---~ 138 (276)
T 2yex_A 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL---L 138 (276)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE---E
T ss_pred cCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEE---E
Confidence 3899999999999999999999999999999999987778999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCC---CcccccccCccccchhhhhh-c-CCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHH
Q 021227 85 DEDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLRK-H-YGPEADVWSAGVILYILLSGVPPFWAETEI-GIF 158 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~ 158 (315)
+.++.+||+|||.+...... .......||+.|+|||++.+ . ++.++||||+||++|+|++|..||.+.... ...
T Consensus 139 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 218 (276)
T 2yex_A 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218 (276)
T ss_dssp CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH
T ss_pred ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 66789999999998765322 12345678999999999864 3 477899999999999999999999876542 233
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
..+....... ..+..++++++++|.+||+.||.+|||++|+++||||+...
T Consensus 219 ~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 219 SDWKEKKTYL--NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHTTCTTS--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHhhhccccc--CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 3344333222 23457899999999999999999999999999999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=318.96 Aligned_cols=202 Identities=27% Similarity=0.416 Sum_probs=166.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+||||+++++++...+.+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 156 ~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl- 233 (429)
T 3kvw_A 156 DNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL- 233 (429)
T ss_dssp TSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE-
T ss_pred cCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE-
Confidence 379999999999999999999999996 58999887653 59999999999999999999999999999999999996
Q ss_pred cCCCCCC--EEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 83 SVDEDAA--LKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 83 ~~~~~~~--ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
+.++. +||+|||++..... ...+.+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 234 --~~~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~ 309 (429)
T 3kvw_A 234 --KQQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309 (429)
T ss_dssp --SSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred --ccCCCcceEEeecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 44444 99999999876433 2345789999999999864 59999999999999999999999999998887776
Q ss_pred HHHhCCCCCC--------------------------------------------------CCC-----CCCCCHHHHHHH
Q 021227 160 QILEGKIDFE--------------------------------------------------SEP-----WPNISESAKDLI 184 (315)
Q Consensus 160 ~i~~~~~~~~--------------------------------------------------~~~-----~~~~s~~~~~li 184 (315)
.+.......+ ... ....++++.+||
T Consensus 310 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli 389 (429)
T 3kvw_A 310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389 (429)
T ss_dssp HHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHH
T ss_pred HHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHH
Confidence 6653210000 000 012478899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 185 RKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 185 ~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
.+||+.||.+|||++|+|+||||+....
T Consensus 390 ~~~L~~dP~~Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 390 KQCLEWDPAVRMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp HHHTCSSTTTSCCHHHHHTSTTTC----
T ss_pred HHHCCCChhhCCCHHHHhCChhhccCCC
Confidence 9999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=309.58 Aligned_cols=201 Identities=28% Similarity=0.488 Sum_probs=167.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.+.+.+|+||||+.|++|.++....+.+++..+..++.|++.||.|||++||+||||||+||+ ++
T Consensus 82 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil---~~ 158 (331)
T 4aaa_A 82 RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL---VS 158 (331)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE---EC
T ss_pred CCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEE---Ec
Confidence 799999999999999999999999999999888777788999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 159 QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 7789999999999765432 33345679999999999864 58999999999999999999999999988777665554
Q ss_pred hCCC-------------------CCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 163 EGKI-------------------DFES--------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~-------------------~~~~--------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.... ..+. ..++.+|+++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred HHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 2110 0000 012367999999999999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=307.55 Aligned_cols=196 Identities=27% Similarity=0.458 Sum_probs=171.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV-KKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++..++||||+. |+|.+++. ..+++++..+..++.|++.||.|||++||+||||||+||++
T Consensus 112 ~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--- 187 (348)
T 1u5q_A 112 RHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL--- 187 (348)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---
T ss_pred CCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---
Confidence 79999999999999999999999997 57777775 45789999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++...... ....||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+..+....
T Consensus 188 ~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 264 (348)
T 1u5q_A 188 SEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 264 (348)
T ss_dssp ETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 56789999999998765432 3467999999999983 4589999999999999999999999999888777777
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+........ ....+|+.++++|.+||+.||.+|||++++++||||...
T Consensus 265 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 265 IAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHhcCCCCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 766543222 224689999999999999999999999999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=320.38 Aligned_cols=202 Identities=26% Similarity=0.461 Sum_probs=160.4
Q ss_pred CCCCcceEEEEEEeC-----CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDK-----SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+||||+++++++... ..+|+||||+. |+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 83 ~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NIL 161 (432)
T 3n9x_A 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL 161 (432)
T ss_dssp CCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeE
Confidence 799999999999876 67999999996 599999988888999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC-----------------------cccccccCccccchhhh-h-hcCCCchhHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE-----------------------VFSDVVGSPYYVAPEVL-R-KHYGPEADVWSA 135 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~Diwsl 135 (315)
++.++.+||+|||+++...... .....+||+.|+|||++ . ..++.++||||+
T Consensus 162 ---l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSl 238 (432)
T 3n9x_A 162 ---LNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238 (432)
T ss_dssp ---ECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred ---ECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchH
Confidence 5678899999999998764322 23567899999999986 3 459999999999
Q ss_pred HHHHHHHHh-----------CCCCCCCCC-----------------HHHHHHHHHh------------------------
Q 021227 136 GVILYILLS-----------GVPPFWAET-----------------EIGIFRQILE------------------------ 163 (315)
Q Consensus 136 G~il~~ll~-----------g~~pf~~~~-----------------~~~~~~~i~~------------------------ 163 (315)
||++|+|++ |.++|.+.+ ....+..|..
T Consensus 239 G~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 318 (432)
T 3n9x_A 239 GCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318 (432)
T ss_dssp HHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred HHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHh
Confidence 999999998 455555543 1122222211
Q ss_pred CCCCCCC---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 164 GKIDFES---EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 164 ~~~~~~~---~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.....+. ..++.+|+++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 319 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred CCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 1100000 01356899999999999999999999999999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=302.96 Aligned_cols=202 Identities=31% Similarity=0.476 Sum_probs=172.9
Q ss_pred CCCCcceEEEEEE-----eCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 6 EHQHVVRIHDTYE-----DKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 6 ~Hpniv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+||||+++++++. ....+++||||+. |+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 72 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~N 150 (326)
T 1blx_A 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 150 (326)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHH
Confidence 7999999999997 5678999999997 59999987753 49999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
|+ ++.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+.
T Consensus 151 il---i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (326)
T 1blx_A 151 IL---VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227 (326)
T ss_dssp EE---ECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eE---EcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 99 5667899999999998765444455678999999999986 4589999999999999999999999999988877
Q ss_pred HHHHHhCCCCCC-----------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 158 FRQILEGKIDFE-----------------------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 158 ~~~i~~~~~~~~-----------------------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
...+........ ...++.++++++++|.+||+.||.+|||+.++++||||+...
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 777654211000 012346899999999999999999999999999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=315.90 Aligned_cols=204 Identities=27% Similarity=0.451 Sum_probs=166.9
Q ss_pred CCCCCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 021227 3 HLSEHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIV----KKGNYSEREAAKLMKTIVGVVECCHSLGVFHR 72 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 72 (315)
.+ +|||||+++++|... ..+++||||+.+ +|.+.+. ....+++..++.++.||+.||.|||++||+||
T Consensus 103 ~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 180 (420)
T 1j1b_A 103 KL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 180 (420)
T ss_dssp TC-CCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred Hc-CCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 44 899999999998532 247799999986 5555443 34679999999999999999999999999999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
||||+|||+. .+.+.+||+|||+++............||+.|+|||++.+ .++.++||||+||++|+|++|+.||.
T Consensus 181 Dlkp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 181 DIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp CCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCChhhEEEe--CCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 9999999963 2456789999999987765555566789999999999853 58999999999999999999999999
Q ss_pred CCCHHHHHHHHHhC-----------------CCCCCC---CC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021227 151 AETEIGIFRQILEG-----------------KIDFES---EP-----WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205 (315)
Q Consensus 151 ~~~~~~~~~~i~~~-----------------~~~~~~---~~-----~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~ 205 (315)
+.+..+.+..+.+. ...++. .. .+.+++++++||.+||+.||.+|||+.|+++||
T Consensus 259 ~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 259 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 98877766665431 111111 01 135689999999999999999999999999999
Q ss_pred CccCC
Q 021227 206 WIVDD 210 (315)
Q Consensus 206 ~~~~~ 210 (315)
||...
T Consensus 339 ~f~~~ 343 (420)
T 1j1b_A 339 FFDEL 343 (420)
T ss_dssp GGGGG
T ss_pred hhccc
Confidence 99754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=306.22 Aligned_cols=198 Identities=30% Similarity=0.538 Sum_probs=163.1
Q ss_pred CCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCC
Q 021227 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDE 86 (315)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~ 86 (315)
||||+++++++.+++.+|+||| +.+|+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+|||+.
T Consensus 68 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~---- 142 (343)
T 3dbq_A 68 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---- 142 (343)
T ss_dssp CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----
T ss_pred CCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----
Confidence 3999999999999999999999 55789999999999999999999999999999999999999999999999973
Q ss_pred CCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh------------hcCCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 87 DAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR------------KHYGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 87 ~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++|..||.+
T Consensus 143 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 46799999999987644322 23567999999999985 3478899999999999999999999987
Q ss_pred C-CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 152 E-TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 152 ~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
. ........+......... ....++++.++|.+||+.||.+|||+.|+++||||+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 223 IINQISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCSHHHHHHHHHCTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hhhHHHHHHHHhcCCcccCC--cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 4 334445555544332222 235678999999999999999999999999999998543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=300.57 Aligned_cols=201 Identities=27% Similarity=0.353 Sum_probs=158.0
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSL-GVFHRDLKPEN 78 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dikp~n 78 (315)
..+||||+++++++.+++..++||||+.| +|.+++.. ...+++..++.++.|++.||+|||++ ||+||||||+|
T Consensus 62 ~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~N 140 (290)
T 3fme_A 62 TVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 140 (290)
T ss_dssp TCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGG
T ss_pred hCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHH
Confidence 35899999999999999999999999975 77666643 46899999999999999999999998 99999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhh----h-hcCCCchhHHHHHHHHHHHHhCCCCCCC-C
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVL----R-KHYGPEADVWSAGVILYILLSGVPPFWA-E 152 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~----~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~ 152 (315)
|+ ++.++.+||+|||++.............||+.|+|||++ . ..++.++||||+||++|+|++|..||.. .
T Consensus 141 il---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (290)
T 3fme_A 141 VL---INALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217 (290)
T ss_dssp CE---ECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred EE---ECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence 99 466789999999999876655554556799999999996 2 3488999999999999999999999986 3
Q ss_pred CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
................ .....+|+++.+++.+||+.||.+|||+.|+++||||+..
T Consensus 218 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 218 TPFQQLKQVVEEPSPQ--LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred chHHHHHHHhccCCCC--cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 4444444444433221 2224689999999999999999999999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=311.27 Aligned_cols=202 Identities=25% Similarity=0.395 Sum_probs=168.3
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL-GVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.+++.+|+||||++||+|.+++.+.+.+++..+..++.|++.||.|||+. ||+||||||+||+
T Consensus 86 ~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil 164 (360)
T 3eqc_A 86 HEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 164 (360)
T ss_dssp GGC-CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEE
T ss_pred HHC-CCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEE
Confidence 344 89999999999999999999999999999999998888999999999999999999999986 9999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
++.++.+||+|||++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||...+..+...
T Consensus 165 ---~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 240 (360)
T 3eqc_A 165 ---VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240 (360)
T ss_dssp ---ECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH
T ss_pred ---ECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 566789999999998654222 2244679999999999874 58999999999999999999999998776544322
Q ss_pred ------------------------------------------HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 021227 160 ------------------------------------------QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT 197 (315)
Q Consensus 160 ------------------------------------------~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s 197 (315)
.+..... +......+|+++++||.+||+.||.+|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 318 (360)
T 3eqc_A 241 MFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERAD 318 (360)
T ss_dssp HHC------------------------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCC
T ss_pred HhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCC
Confidence 2222211 11122357899999999999999999999
Q ss_pred HHHHhcCCCccCC
Q 021227 198 AHEVLCHPWIVDD 210 (315)
Q Consensus 198 ~~~~l~h~~~~~~ 210 (315)
++|+++||||+..
T Consensus 319 ~~ell~hp~~~~~ 331 (360)
T 3eqc_A 319 LKQLMVHAFIKRS 331 (360)
T ss_dssp HHHHHTSHHHHHH
T ss_pred HHHHhhChHhhcc
Confidence 9999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=313.83 Aligned_cols=198 Identities=30% Similarity=0.482 Sum_probs=156.5
Q ss_pred CCCCcceEEEEEEeCC------eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYEDKS------CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+||||+++++++.... .+|+||||+.| +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 82 ~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NI 158 (371)
T 2xrw_A 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158 (371)
T ss_dssp CCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHE
Confidence 8999999999998765 78999999975 7878775 4599999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
+ ++.++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.+
T Consensus 159 l---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 235 (371)
T 2xrw_A 159 V---VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 235 (371)
T ss_dssp E---ECTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred E---EcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9 56678999999999987655544556789999999999864 5899999999999999999999999999888877
Q ss_pred HHHHhCCCCCCCC-----------------C--------------CC-------CCCHHHHHHHHHhcccCCCCCCCHHH
Q 021227 159 RQILEGKIDFESE-----------------P--------------WP-------NISESAKDLIRKMLDQNPKRRLTAHE 200 (315)
Q Consensus 159 ~~i~~~~~~~~~~-----------------~--------------~~-------~~s~~~~~li~~~l~~~p~~R~s~~~ 200 (315)
..+.......... . ++ ..++++++||.+||+.||.+|||++|
T Consensus 236 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 315 (371)
T 2xrw_A 236 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315 (371)
T ss_dssp HHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHH
Confidence 7776532211100 0 00 11578999999999999999999999
Q ss_pred HhcCCCccC
Q 021227 201 VLCHPWIVD 209 (315)
Q Consensus 201 ~l~h~~~~~ 209 (315)
+|+||||+.
T Consensus 316 ~l~hp~~~~ 324 (371)
T 2xrw_A 316 ALQHPYINV 324 (371)
T ss_dssp HHHSHHHHT
T ss_pred HhCCcchhh
Confidence 999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=314.93 Aligned_cols=204 Identities=23% Similarity=0.465 Sum_probs=176.6
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDR------IVK--KGNYSEREAAKLMKTIVGVVECCHS-LGVFHR 72 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~------l~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~ 72 (315)
+.+ +||||+++++++.+.+.+|+||||++||+|.++ +.+ ...+++..+..++.|++.||.|||+ +||+||
T Consensus 98 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~ 176 (348)
T 2pml_X 98 TDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176 (348)
T ss_dssp TTC-CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred HhC-CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence 345 799999999999999999999999999999988 655 5789999999999999999999999 999999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc--CCC-chhHHHHHHHHHHHHhCCCCC
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH--YGP-EADVWSAGVILYILLSGVPPF 149 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiwslG~il~~ll~g~~pf 149 (315)
||||+||+ ++.++.+||+|||.+...... ......||+.|+|||++.+. ++. ++||||+||++|+|++|..||
T Consensus 177 dl~p~Nil---~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 177 DVKPSNIL---MDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp CCCGGGEE---ECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCChHhEE---EcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999 567789999999999776443 34556799999999998643 555 899999999999999999999
Q ss_pred CCCCH-HHHHHHHHhCCCCCCCCC---------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 150 WAETE-IGIFRQILEGKIDFESEP---------------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 150 ~~~~~-~~~~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+.+. .+....+..+...++... ...+|+++.++|.+||+.||.+|||+.|+++||||+..
T Consensus 253 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 253 SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp CCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred CCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 98776 778888877766554321 14689999999999999999999999999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=301.12 Aligned_cols=202 Identities=27% Similarity=0.476 Sum_probs=166.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+ +||||+++++++++++.+|+||||++||+|.+++.+.+++++..+..++.|++.||+|||++||+||||||+||+
T Consensus 67 ~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil-- 143 (294)
T 4eqm_A 67 QL-SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL-- 143 (294)
T ss_dssp TC-CBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE--
T ss_pred cC-CCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE--
Confidence 44 899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
++.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+...
T Consensus 144 -~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~ 222 (294)
T 4eqm_A 144 -IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222 (294)
T ss_dssp -ECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH
T ss_pred -ECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 5677899999999998664432 2234679999999999864 48899999999999999999999999988877665
Q ss_pred HHHhCCCC-CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 160 QILEGKID-FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 160 ~i~~~~~~-~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
........ ......+.+|+.+.++|.+||..||.+||+..+.+.+.|..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 223 KHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 55544332 22233457899999999999999999999665666655543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=303.77 Aligned_cols=202 Identities=26% Similarity=0.442 Sum_probs=167.4
Q ss_pred CCCCCCcceEEEEEEe------CCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCC
Q 021227 4 LSEHQHVVRIHDTYED------KSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLK 75 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~------~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dik 75 (315)
+.+||||+++++++.. ...+|+||||++||+|.+++... ..+++..++.++.|++.||.|||++||+|||||
T Consensus 77 l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 156 (326)
T 2x7f_A 77 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK 156 (326)
T ss_dssp HCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred ccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 3489999999999987 56899999999999999999764 579999999999999999999999999999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCC
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPP 148 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~p 148 (315)
|+||+ ++.++.+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..|
T Consensus 157 p~NIl---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 157 GQNVL---LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp GGGEE---ECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred HHHEE---EcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999 467789999999998765432 2234567999999999984 3488999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 149 FWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 149 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
|.+.+.......+...... ......+|+.++++|.+||..||.+|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 234 LCDMHPMRALFLIPRNPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp TTTSCHHHHHHHHHHSCCC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CCCCcHHHHHHHhhcCccc--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 9998887776666654332 22234689999999999999999999999999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=297.89 Aligned_cols=199 Identities=28% Similarity=0.475 Sum_probs=174.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++.++..+|+||||+.|++|.+++. .+++++..+..++.|++.||.|||++||+||||||+||+ ++
T Consensus 78 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil---~~ 153 (303)
T 3a7i_A 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVL---LS 153 (303)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---EC
T ss_pred CCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEE---EC
Confidence 89999999999999999999999999999999885 467999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 EDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
.++.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+..
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 233 (303)
T 3a7i_A 154 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK 233 (303)
T ss_dssp TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc
Confidence 77899999999997665433 234567999999999986 4589999999999999999999999999888877777766
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.... .....+++++.++|.+||+.||.+|||+.++++||||....
T Consensus 234 ~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 234 NNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp SCCC---CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred CCCC---CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 5432 22346899999999999999999999999999999997543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=306.44 Aligned_cols=203 Identities=27% Similarity=0.495 Sum_probs=166.0
Q ss_pred CCCCCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+.+||||+++++++.+ ....++||||+.|++|.+++. .+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 86 ~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil 162 (330)
T 3nsz_A 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 162 (330)
T ss_dssp HHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 34469999999999998 678999999999999988773 4899999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWA-ETEIGI 157 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~ 157 (315)
+. .....+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.. .+..+.
T Consensus 163 ~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 240 (330)
T 3nsz_A 163 ID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 240 (330)
T ss_dssp EE--TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred Ec--CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH
Confidence 62 2344899999999987766666666789999999999864 589999999999999999999999954 333333
Q ss_pred HHHH-------------HhCCCCCC--------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 158 FRQI-------------LEGKIDFE--------------------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 158 ~~~i-------------~~~~~~~~--------------------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
+..+ ........ ......+++++++||.+||+.||.+|||++|+|+|
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 241 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3222 11111111 11122379999999999999999999999999999
Q ss_pred CCccCC
Q 021227 205 PWIVDD 210 (315)
Q Consensus 205 ~~~~~~ 210 (315)
|||+..
T Consensus 321 p~f~~~ 326 (330)
T 3nsz_A 321 PYFYTV 326 (330)
T ss_dssp GGGTTC
T ss_pred ccHhhh
Confidence 999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=313.87 Aligned_cols=199 Identities=29% Similarity=0.480 Sum_probs=155.9
Q ss_pred CCCCcceEEEEEEeC------CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYEDK------SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~------~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+||||+++++++... ..+|+|+||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 86 ~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 163 (367)
T 2fst_X 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 163 (367)
T ss_dssp CCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhE
Confidence 799999999999754 6689999999 7899888754 6799999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+ ++.++.+||+|||+++..... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.
T Consensus 164 l---l~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 238 (367)
T 2fst_X 164 A---VNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238 (367)
T ss_dssp E---ECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred E---ECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9 567889999999999765432 345689999999999864 589999999999999999999999999988777
Q ss_pred HHHHHhCCCC-----------------------CCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKID-----------------------FESE----PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~-----------------------~~~~----~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+..+.+.... .+.. .++..++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 239 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 239 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 7666542111 0111 124578999999999999999999999999999999865
Q ss_pred C
Q 021227 211 K 211 (315)
Q Consensus 211 ~ 211 (315)
.
T Consensus 319 ~ 319 (367)
T 2fst_X 319 H 319 (367)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=299.28 Aligned_cols=202 Identities=27% Similarity=0.470 Sum_probs=173.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV-KKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++.+|+||||+.||+|.+++. ....+++..+..++.|++.||.|||+.|++||||||+||+ +
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil---~ 158 (314)
T 3com_A 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL---L 158 (314)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---E
T ss_pred CCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEE---E
Confidence 89999999999999999999999999999999986 4568999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+.
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 238 (314)
T 3com_A 159 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP 238 (314)
T ss_dssp CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 667899999999997654432 2345678999999999864 58999999999999999999999999888776665555
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
..... .......+++++.++|.+||..||.+|||+.++++||||....
T Consensus 239 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 239 TNPPP-TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HSCCC-CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred cCCCc-ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 44321 1112235789999999999999999999999999999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=298.39 Aligned_cols=202 Identities=27% Similarity=0.526 Sum_probs=172.0
Q ss_pred CCCCCCCCcceEEEEE--EeCCeEEEEEeccCCCchhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 2 HHLSEHQHVVRIHDTY--EDKSCVHIVMELCEGGELFDRIVK--KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~--~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
+.+ +||||+++++++ .+.+.+|+||||+.+| |.+++.. .+.+++..+..++.|++.||.|||++||+||||||+
T Consensus 61 ~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 138 (305)
T 2wtk_C 61 RRL-RHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPG 138 (305)
T ss_dssp TTC-CCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred Hhc-CCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcc
Confidence 345 799999999998 4556899999999876 6676665 357999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCC---CcccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
||+ ++.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+
T Consensus 139 NIl---~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 139 NLL---LTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp GEE---ECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cEE---EcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999 566789999999999765422 22345679999999999864 247799999999999999999999999
Q ss_pred CCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 021227 152 ETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 152 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
.+..+....+..+...++ ..+++++.++|.+||+.||.+|||+.++++||||+....
T Consensus 216 ~~~~~~~~~i~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 216 DNIYKLFENIGKGSYAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSHHHHHHHHHHCCCCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred chHHHHHHHHhcCCCCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 999888888888766544 368999999999999999999999999999999986543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=319.05 Aligned_cols=189 Identities=17% Similarity=0.243 Sum_probs=156.3
Q ss_pred CCCCcceEE-------EEEEeCCe-----------------EEEEEeccCCCchhHHHHhCCCCCH-------HHHHHHH
Q 021227 6 EHQHVVRIH-------DTYEDKSC-----------------VHIVMELCEGGELFDRIVKKGNYSE-------REAAKLM 54 (315)
Q Consensus 6 ~Hpniv~~~-------~~~~~~~~-----------------~~lv~E~~~gg~L~~~l~~~~~~~~-------~~~~~~~ 54 (315)
+|||||+++ +++++.+. .|+||||+ +|+|.+++.+.+.+++ ..+..++
T Consensus 134 ~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~ 212 (377)
T 3byv_A 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLT 212 (377)
T ss_dssp CSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHH
T ss_pred CCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHH
Confidence 899999998 88876643 89999999 6799999987655665 7888899
Q ss_pred HHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-h---------
Q 021227 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-K--------- 124 (315)
Q Consensus 55 ~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~--------- 124 (315)
.||+.||+|||++||+||||||+||| ++.++.+||+|||+++.... ......| +.|+|||++. .
T Consensus 213 ~qi~~aL~~LH~~~ivHrDikp~NIl---l~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~ 286 (377)
T 3byv_A 213 LQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDR 286 (377)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEE---ECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCC
T ss_pred HHHHHHHHHHHhCCeecCCCCHHHEE---EcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccc
Confidence 99999999999999999999999999 45678999999999986432 3445678 9999999986 4
Q ss_pred --cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 125 --HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 125 --~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
.++.++|||||||++|+|++|..||.+.+.......+. ..++.+|++++++|.+||+.||.+|||+.|++
T Consensus 287 ~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 287 RTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred cccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 59999999999999999999999998765443332222 12357899999999999999999999999999
Q ss_pred cCCCccC
Q 021227 203 CHPWIVD 209 (315)
Q Consensus 203 ~h~~~~~ 209 (315)
+||||+.
T Consensus 359 ~hp~f~~ 365 (377)
T 3byv_A 359 ETPEYEQ 365 (377)
T ss_dssp TSHHHHH
T ss_pred hChHHHH
Confidence 9999963
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=298.27 Aligned_cols=202 Identities=25% Similarity=0.454 Sum_probs=169.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++.+++||||++||+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+ +
T Consensus 74 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil---~ 150 (302)
T 2j7t_A 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVL---M 150 (302)
T ss_dssp CCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE---E
T ss_pred CCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEE---E
Confidence 899999999999999999999999999999998865 467999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 85 DEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+.++.+||+|||++..... ........||+.|+|||++. ..++.++||||+||++|+|++|..||...+....
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 230 (302)
T 2j7t_A 151 TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230 (302)
T ss_dssp CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 6678999999998753211 11123457899999999873 3478899999999999999999999999888877
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
...+........ .....+|+++.++|.+||..||.+|||+.++++||||....
T Consensus 231 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 231 LLKIAKSDPPTL-LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHhccCCccc-CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 777766543221 12246789999999999999999999999999999998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=304.54 Aligned_cols=203 Identities=27% Similarity=0.447 Sum_probs=167.7
Q ss_pred CCCCcceEEEEEEeCCe-------EEEEEeccCCCchhHH----HHhCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccc
Q 021227 6 EHQHVVRIHDTYEDKSC-------VHIVMELCEGGELFDR----IVKKGNYSEREAAKLMKTIVGVVECCH--SLGVFHR 72 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~-------~~lv~E~~~gg~L~~~----l~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~ 72 (315)
+||||+++++++...+. +++||||+.|+ |.+. +.....+++..+..++.|++.||.||| ++||+||
T Consensus 77 ~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~ 155 (360)
T 3e3p_A 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHR 155 (360)
T ss_dssp CCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCS
T ss_pred CCCCcccHHHhhhccccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence 79999999999976433 88999999875 4333 334578999999999999999999999 9999999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
||||+||++. ..++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.
T Consensus 156 Dlkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 156 DIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp CCCGGGEEEE--TTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCHHHEEEe--CCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 9999999962 2478999999999988766665566789999999999853 38999999999999999999999999
Q ss_pred CCCHHHHHHHHHhCCCCCC----------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 151 AETEIGIFRQILEGKIDFE----------------------------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 151 ~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
+.+....+..+.......+ .......++++++||.+||+.||.+|||+.|+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 234 GDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 9988877777654211100 001123578999999999999999999999999
Q ss_pred cCCCccCCC
Q 021227 203 CHPWIVDDK 211 (315)
Q Consensus 203 ~h~~~~~~~ 211 (315)
+||||+...
T Consensus 314 ~hp~f~~~~ 322 (360)
T 3e3p_A 314 CHPYFDELH 322 (360)
T ss_dssp TSGGGGGGG
T ss_pred cCccccccC
Confidence 999998654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=303.97 Aligned_cols=180 Identities=26% Similarity=0.446 Sum_probs=145.4
Q ss_pred eEEEEEeccCCCchhHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCc
Q 021227 22 CVHIVMELCEGGELFDRIVKKGN---YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS 98 (315)
Q Consensus 22 ~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~ 98 (315)
.+++|||||+||+|.+++.+... .++..+..++.|++.||+|||++||+||||||+||+ ++.++.+||+|||++
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl---l~~~~~~kL~DfG~a 211 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIF---FTMDDVVKVGDFGLV 211 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE---ECTTCCEEECCCTTC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEE---EeCCCCEEEeecCcc
Confidence 38999999999999999987543 566679999999999999999999999999999999 566789999999999
Q ss_pred ccCCCCC-------------cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q 021227 99 VFYKPDE-------------VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG 164 (315)
Q Consensus 99 ~~~~~~~-------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 164 (315)
....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..|+.. .......+...
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~ 289 (332)
T 3qd2_B 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL 289 (332)
T ss_dssp EECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT
T ss_pred cccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc
Confidence 8765432 2234579999999999864 589999999999999999999877522 22333333333
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 165 KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 165 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
... ..+...+++++++|.+||+.||.+|||+.|+++||||++
T Consensus 290 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 290 KFP---LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp CCC---HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred CCC---cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 221 112346788999999999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=299.13 Aligned_cols=198 Identities=25% Similarity=0.362 Sum_probs=162.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN---YSEREAAKLMKTIVGVVECCHSLG--VFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dikp~nil 80 (315)
+||||+++++++.+.+.+++||||+.||+|.+++.+.+. +++..+..++.|++.||+|||++| |+||||||+||+
T Consensus 92 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIl 171 (309)
T 3p86_A 92 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171 (309)
T ss_dssp CCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEE
T ss_pred CCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEE
Confidence 799999999999999999999999999999999977653 999999999999999999999999 999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
++.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+..
T Consensus 172 ---l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~ 248 (309)
T 3p86_A 172 ---VDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV 248 (309)
T ss_dssp ---ECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred ---EeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5678899999999987544332 2345679999999999874 4899999999999999999999999999888887
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCcc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC--HPWIV 208 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~--h~~~~ 208 (315)
..+......... ...+++++.++|.+||+.||.+|||+.++++ .++++
T Consensus 249 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 249 AAVGFKCKRLEI--PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHSCCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHhcCCCCCC--CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 777544433322 2468999999999999999999999999986 34444
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=307.23 Aligned_cols=195 Identities=21% Similarity=0.327 Sum_probs=168.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------NYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
.+.+||||+++++++.+++.+|+||||+.||+|.+++...+ .+++..+..++.||+.||.|||+
T Consensus 142 ~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 221 (370)
T 2psq_A 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221 (370)
T ss_dssp HSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 34589999999999999999999999999999999997653 48999999999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHH
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYIL 142 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 142 (315)
+||+||||||+||+ ++.++.+||+|||++....... ......+|+.|+|||++. ..++.++|||||||++|+|
T Consensus 222 ~~ivHrDlkp~NIl---l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el 298 (370)
T 2psq_A 222 QKCIHRDLAARNVL---VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298 (370)
T ss_dssp TTEECSCCCGGGEE---ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CCeeccccchhhEE---ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999 5678899999999998654332 123355788999999986 4589999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 143 LS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 143 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
++ |..||.+.+..+....+..+.... ....+++++.++|.+||+.||.+|||+.|+++
T Consensus 299 lt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 299 FTLGGSPYPGIPVEELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99 999999988887777777664321 22468999999999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=296.40 Aligned_cols=202 Identities=27% Similarity=0.427 Sum_probs=164.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK---GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
+||||+++++++.+.+.+++||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++.
T Consensus 77 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 156 (295)
T 2clq_A 77 KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN 156 (295)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE
Confidence 8999999999999999999999999999999999765 2567999999999999999999999999999999999962
Q ss_pred cCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWAETE-IGI 157 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~ 157 (315)
..++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||..... ...
T Consensus 157 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 234 (295)
T 2clq_A 157 --TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234 (295)
T ss_dssp --TTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH
T ss_pred --CCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH
Confidence 237899999999997664322 2345679999999999863 278999999999999999999999976432 222
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
........ ........++++++++|.+||+.||.+|||+.++++||||+...
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 235 MFKVGMFK--VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHC--CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHhhcccc--ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 22211111 11222346899999999999999999999999999999998654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=294.68 Aligned_cols=201 Identities=33% Similarity=0.573 Sum_probs=164.3
Q ss_pred CCCCCCCCcceEEEEEEe-------------CCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC
Q 021227 2 HHLSEHQHVVRIHDTYED-------------KSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSL 67 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~-------------~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~ 67 (315)
+.+ +||||+++++++.+ ...+|+||||++||+|.+++... ..+++..++.++.|++.||+|||++
T Consensus 57 ~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 135 (303)
T 1zy4_A 57 ASL-NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135 (303)
T ss_dssp TTC-CCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT
T ss_pred Hhc-CchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC
Confidence 345 89999999999865 45789999999999999999765 3688999999999999999999999
Q ss_pred CCccccCCCCceeeccCCCCCCEEEeeccCcccCCCC---------------CcccccccCccccchhhhhh--cCCCch
Q 021227 68 GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD---------------EVFSDVVGSPYYVAPEVLRK--HYGPEA 130 (315)
Q Consensus 68 ~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~ 130 (315)
||+||||||+||+ ++.++.+||+|||++...... .......||+.|+|||++.+ .++.++
T Consensus 136 ~i~H~dlkp~Nil---~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 212 (303)
T 1zy4_A 136 GIIHRDLKPMNIF---IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI 212 (303)
T ss_dssp TCCCSCCCGGGEE---ECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHH
T ss_pred CeecccCCHHhEE---EcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchh
Confidence 9999999999999 567789999999998765421 12234678999999999863 589999
Q ss_pred hHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 131 DVWSAGVILYILLSGVPPFWA-ETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 131 DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
||||+||++|+|++ ||.. .+.......+......++.......++.++++|.+||+.||.+|||+.++++||||+.
T Consensus 213 Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 213 DMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred hHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 99999999999998 5543 3445566667666666666555678899999999999999999999999999999974
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=306.15 Aligned_cols=200 Identities=18% Similarity=0.232 Sum_probs=173.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-------GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+||||+++++++.++...|+|||||.||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 132 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 211 (367)
T 3l9p_A 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 211 (367)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred CCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhh
Confidence 8999999999999999999999999999999999764 358999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCC---CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKP---DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAET 153 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 153 (315)
||+...+.+..+||+|||+++.... ........||+.|+|||++. +.++.++|||||||++|+|++ |..||.+.+
T Consensus 212 Ill~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp EEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9975444566799999999875421 12223456899999999986 558999999999999999998 999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
..+....+..+..... ...+++++.+++.+||+.||.+|||+.+++++.|+.
T Consensus 292 ~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 292 NQEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9998888887653322 246899999999999999999999999999887664
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=313.02 Aligned_cols=205 Identities=29% Similarity=0.411 Sum_probs=159.4
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+.+|||||++++++.+++.+|+|||||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 73 ~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll 151 (432)
T 3p23_A 73 ESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILI 151 (432)
T ss_dssp HSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEE
T ss_pred hccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEE
Confidence 34589999999999999999999999996 59999987653 46677788999999999999999999999999999997
Q ss_pred ccC--CCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHh-CCCCCC
Q 021227 82 LSV--DEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLS-GVPPFW 150 (315)
Q Consensus 82 ~~~--~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~-g~~pf~ 150 (315)
... +....+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++ |..||.
T Consensus 152 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp CCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred ecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 532 234568899999998765332 234567999999999985 347889999999999999999 999996
Q ss_pred CCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 151 AETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 151 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
..........+...... ........+..++++|.+||+.||.+|||+.++++||||..
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 232 KSLQRQANILLGACSLD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp STTTHHHHHHTTCCCCT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred hhhHHHHHHHhccCCcc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 65544332222211111 11112234667899999999999999999999999999964
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=301.87 Aligned_cols=201 Identities=23% Similarity=0.458 Sum_probs=165.3
Q ss_pred CCCCcceEEEEEEeCC--eEEEEEeccCCCchhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDKS--CVHIVMELCEGGELFDRIVKKG---NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+||||+++++++.+.. .+|+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 65 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl 144 (319)
T 4euu_A 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144 (319)
T ss_dssp CCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence 7999999999998765 7899999999999999997643 3999999999999999999999999999999999999
Q ss_pred ec-cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh---------hcCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 81 FL-SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR---------KHYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 81 ~~-~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
+. ..+..+.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.
T Consensus 145 l~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 224 (319)
T 4euu_A 145 RVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (319)
T ss_dssp EEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred EeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 52 22566789999999998876666666678999999999884 458899999999999999999999996
Q ss_pred CCC----HHHHHHHHHhCCCC-------------------CC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021227 151 AET----EIGIFRQILEGKID-------------------FE--SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205 (315)
Q Consensus 151 ~~~----~~~~~~~i~~~~~~-------------------~~--~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~ 205 (315)
... ..+....+..+... ++ ......+++.+.++|.+||+.||.+|||++|+|+||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 432 24455555543321 01 111123467899999999999999999999999987
Q ss_pred C
Q 021227 206 W 206 (315)
Q Consensus 206 ~ 206 (315)
-
T Consensus 305 ~ 305 (319)
T 4euu_A 305 S 305 (319)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=297.98 Aligned_cols=203 Identities=30% Similarity=0.423 Sum_probs=167.8
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
..|++|+++++++++++.+|+||||+ +++|.+++...+ ++++..+..++.|++.||+|||++||+||||||+||++.
T Consensus 74 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 152 (339)
T 1z57_A 74 NSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFV 152 (339)
T ss_dssp TCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 35778999999999999999999999 889999998765 689999999999999999999999999999999999974
Q ss_pred cCCC----------------CCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhC
Q 021227 83 SVDE----------------DAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSG 145 (315)
Q Consensus 83 ~~~~----------------~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g 145 (315)
..+. ++.+||+|||++...... .....||+.|+|||++.+ .++.++||||+||++|+|++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 230 (339)
T 1z57_A 153 QSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230 (339)
T ss_dssp CCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence 3221 678999999998764432 345679999999999864 589999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCCC----------------CCC------------------------CCCCHHHHHHHH
Q 021227 146 VPPFWAETEIGIFRQILEGKIDFES----------------EPW------------------------PNISESAKDLIR 185 (315)
Q Consensus 146 ~~pf~~~~~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~ 185 (315)
..||.+.+..+....+......++. ..| ...++++.+||.
T Consensus 231 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 310 (339)
T 1z57_A 231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ 310 (339)
T ss_dssp SCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence 9999998877655554332111110 001 123577899999
Q ss_pred HhcccCCCCCCCHHHHhcCCCccCC
Q 021227 186 KMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 186 ~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+||+.||.+|||+.|+++||||+..
T Consensus 311 ~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 311 KMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred HHhCcCcccccCHHHHhcCHHHHHH
Confidence 9999999999999999999999754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=306.61 Aligned_cols=201 Identities=31% Similarity=0.523 Sum_probs=167.4
Q ss_pred CCCCcceEEEEEEeC-----CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDK-----SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+||||+++++++... ..+|+||||+. |+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 83 ~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 160 (364)
T 3qyz_A 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 160 (364)
T ss_dssp CCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEE
Confidence 799999999999765 47899999997 489888854 57999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
++.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.
T Consensus 161 ---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 161 ---LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp ---ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred ---ECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 5678899999999997654322 124468999999999874 3389999999999999999999999998877
Q ss_pred HHHHHHHHhCCCCCC-----------------------C----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 155 IGIFRQILEGKIDFE-----------------------S----EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~-----------------------~----~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+....+......++ . ..++.+++++.+||.+||+.||.+|||+.|+|+||||
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp GGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 666666543111100 0 0124678999999999999999999999999999999
Q ss_pred cCCC
Q 021227 208 VDDK 211 (315)
Q Consensus 208 ~~~~ 211 (315)
+...
T Consensus 318 ~~~~ 321 (364)
T 3qyz_A 318 EQYY 321 (364)
T ss_dssp TTTC
T ss_pred hhcc
Confidence 8753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=306.31 Aligned_cols=200 Identities=27% Similarity=0.368 Sum_probs=165.4
Q ss_pred CCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCCccccCCCCceeec
Q 021227 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCH--SLGVFHRDLKPENFLFL 82 (315)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dikp~nil~~ 82 (315)
|++|+++++++...+.+|+||||+. |+|.+++... +.+++..++.++.|++.||.||| +.||+||||||+|||+.
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~ 193 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLC 193 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEES
T ss_pred ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEe
Confidence 4469999999999999999999996 5999998765 46999999999999999999999 57999999999999963
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
. +..+.+||+|||++...... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.+..+
T Consensus 194 ~-~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i 270 (382)
T 2vx3_A 194 N-PKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270 (382)
T ss_dssp S-TTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred c-CCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2 45678999999999876432 345789999999999874 5899999999999999999999999999888877776
Q ss_pred HhCCCCCC-----------------------------------CCCCCC-------------------------CCHHHH
Q 021227 162 LEGKIDFE-----------------------------------SEPWPN-------------------------ISESAK 181 (315)
Q Consensus 162 ~~~~~~~~-----------------------------------~~~~~~-------------------------~s~~~~ 181 (315)
......++ .+.... .+++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (382)
T 2vx3_A 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350 (382)
T ss_dssp HHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHH
T ss_pred HHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHH
Confidence 54211110 000000 014789
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 182 DLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 182 ~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+||.+||+.||.+|||++|+|+||||+..
T Consensus 351 dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 351 DLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=299.25 Aligned_cols=197 Identities=23% Similarity=0.338 Sum_probs=168.2
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHH
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------NYSEREAAKLMKTIVGVVECCH 65 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH 65 (315)
+.+.+||||+++++++.+.+.+|+||||++||+|.+++...+ .+++..++.++.|++.||.|||
T Consensus 80 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 159 (327)
T 1fvr_A 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 159 (327)
T ss_dssp TTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 455689999999999999999999999999999999997654 6999999999999999999999
Q ss_pred HCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHh
Q 021227 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLS 144 (315)
Q Consensus 66 ~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~ 144 (315)
++||+||||||+||++ +.++.+||+|||++.............+++.|+|||++.+ .++.++||||+||++|+|++
T Consensus 160 ~~~ivH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 236 (327)
T 1fvr_A 160 QKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236 (327)
T ss_dssp HTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred hCCccCCCCccceEEE---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHc
Confidence 9999999999999994 5678999999999875433333334557889999999864 48999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 145 -GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 145 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
|..||.+.+..+....+..+... .....++++++++|.+||+.||.+|||+.+++++
T Consensus 237 ~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 237 LGGTPYCGMTCAELYEKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TSCCTTTTCCHHHHHHHGGGTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCcHHHHHHHhhcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999988888877665322 2224689999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.27 Aligned_cols=205 Identities=21% Similarity=0.345 Sum_probs=159.3
Q ss_pred CCCCCCCCcceEEEEEEeCCeE------EEEEeccCCCchhHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCC
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCV------HIVMELCEGGELFDRIVKKG------NYSEREAAKLMKTIVGVVECCHSLGV 69 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~------~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i 69 (315)
+.+ +||||+++++++.+.... ++||||+.||+|.+++.... .+++..+..++.|++.||+|||++||
T Consensus 80 ~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 158 (323)
T 3qup_A 80 KEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF 158 (323)
T ss_dssp TTC-CCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHC-CCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 445 899999999999887665 99999999999999886532 59999999999999999999999999
Q ss_pred ccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHh-
Q 021227 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLS- 144 (315)
Q Consensus 70 vH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~- 144 (315)
+||||||+||+ ++.++.+||+|||++........ .....+++.|+|||++.+ .++.++||||+||++|+|++
T Consensus 159 vH~Dikp~NIl---i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~ 235 (323)
T 3qup_A 159 IHRDLAARNCM---LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235 (323)
T ss_dssp CCSCCSGGGEE---ECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCCcceEE---EcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhC
Confidence 99999999999 46678999999999976544322 123456788999999864 48999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCCCccCCCCC
Q 021227 145 GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-------AHEVLCHPWIVDDKVA 213 (315)
Q Consensus 145 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-------~~~~l~h~~~~~~~~~ 213 (315)
|..||.+.+..+....+..+..... .+.+++++.+++.+||+.||.+||| +++++.|+|+......
T Consensus 236 g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 236 GQTPYAGIENAEIYNYLIGGNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp SCCTTTTCCGGGHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred CCCCccccChHHHHHHHhcCCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 9999999888888887776653222 2468999999999999999999999 7888899999875443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=297.73 Aligned_cols=195 Identities=23% Similarity=0.391 Sum_probs=167.4
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.+++.+|+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 105 ~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl 183 (325)
T 3kul_A 105 GQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVL 183 (325)
T ss_dssp TTC-CCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhC-CCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEE
Confidence 345 8999999999999999999999999999999999654 68999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETE 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 154 (315)
++.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++ |..||.+...
T Consensus 184 ---l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 184 ---VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp ---ECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred ---ECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 56788999999999987643321 22334677899999987 558999999999999999999 9999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+....+..+.... ....+++++.++|.+||..||.+|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 261 RDVISSVEEGYRLP---APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCC---CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 88888887763222 22468999999999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=305.26 Aligned_cols=201 Identities=27% Similarity=0.406 Sum_probs=159.4
Q ss_pred CCCCcceEEEEEEe-----CCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYED-----KSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+||||+++++++.. ...+|+||||+. |+|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNI 165 (362)
T ss_dssp CCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHE
Confidence 79999999999953 347899999997 5787777654 4799999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+ ++.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+.
T Consensus 166 l---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 L---LADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp E---ECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred E---EcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9 5667899999999998665555555678999999999886 4589999999999999999999999999888777
Q ss_pred HHHHHhCCC------------------------CCCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 158 FRQILEGKI------------------------DFESEP----WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 158 ~~~i~~~~~------------------------~~~~~~----~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
...+..... ..+... .+.+++.+.+||.+||+.||.+|||+.|+++||||+.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 766643111 111111 2356899999999999999999999999999999986
Q ss_pred C
Q 021227 210 D 210 (315)
Q Consensus 210 ~ 210 (315)
.
T Consensus 323 ~ 323 (362)
T 3pg1_A 323 L 323 (362)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=289.85 Aligned_cols=195 Identities=22% Similarity=0.384 Sum_probs=169.6
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
++ +||||+++++++.+++.+|+||||++||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 61 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~ 139 (269)
T 4hcu_A 61 KL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 139 (269)
T ss_dssp TC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred hC-CCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE
Confidence 44 7999999999999999999999999999999999654 569999999999999999999999999999999999995
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGI 157 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 157 (315)
+.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||+||++|+|++ |..||.+.+..+.
T Consensus 140 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~ 216 (269)
T 4hcu_A 140 ---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 216 (269)
T ss_dssp ---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred ---cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 567899999999997654332 123345678899999987 558999999999999999999 9999999999888
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
...+..+.....+ ..+++++.+++.+||+.||.+|||+.+++++
T Consensus 217 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 217 VEDISTGFRLYKP---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCccCCCC---CcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 8888776433322 3579999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=304.16 Aligned_cols=195 Identities=22% Similarity=0.348 Sum_probs=170.2
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHC
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------NYSEREAAKLMKTIVGVVECCHSL 67 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~~ 67 (315)
+.+||||+++++++.+++..++||||++||+|.+++.... .+++..+..++.|++.||+|||++
T Consensus 131 l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 210 (382)
T 3tt0_A 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK 210 (382)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 3489999999999999999999999999999999997753 499999999999999999999999
Q ss_pred CCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHH
Q 021227 68 GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILL 143 (315)
Q Consensus 68 ~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll 143 (315)
||+||||||+||+ ++.++.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|+
T Consensus 211 ~ivH~Dlkp~NIl---l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (382)
T 3tt0_A 211 KCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287 (382)
T ss_dssp TCCCSCCCGGGEE---ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred CEecCCCCcceEE---EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence 9999999999999 5667899999999998664432 223456788999999986 45899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 144 S-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 144 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
+ |..||.+.+..+....+..+..... ...+++++.+++.+||+.||.+|||+.|++++
T Consensus 288 t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 288 TLGGSPYPGVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TTSCCSSTTCCHHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9 9999999998888888877643222 24689999999999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.92 Aligned_cols=204 Identities=31% Similarity=0.511 Sum_probs=168.1
Q ss_pred CCCCCCCcceEEEEEE--------------eCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021227 3 HLSEHQHVVRIHDTYE--------------DKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG 68 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~--------------~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 68 (315)
.+ +||||+++++++. +...+|+||||+. |+|.+++. .+++++..++.++.|++.||+|||++|
T Consensus 64 ~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ 140 (320)
T 2i6l_A 64 RL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSAN 140 (320)
T ss_dssp TC-CCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hc-CCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCC
Confidence 44 8999999999984 4578999999997 59988884 467999999999999999999999999
Q ss_pred CccccCCCCceeeccCCCCCCEEEeeccCcccCCCC----CcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHH
Q 021227 69 VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD----EVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYIL 142 (315)
Q Consensus 69 ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~l 142 (315)
|+||||||+||++. ..++.+||+|||++...... .......+|+.|+|||++. ..++.++|||||||++|+|
T Consensus 141 i~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el 218 (320)
T 2i6l_A 141 VLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218 (320)
T ss_dssp CBCCCCSGGGEEEE--TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHH
T ss_pred EecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHH
Confidence 99999999999962 35678999999999865432 2233456799999999875 4589999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCC----------------------CC----CCCCCCCHHHHHHHHHhcccCCCCCC
Q 021227 143 LSGVPPFWAETEIGIFRQILEGKIDF----------------------ES----EPWPNISESAKDLIRKMLDQNPKRRL 196 (315)
Q Consensus 143 l~g~~pf~~~~~~~~~~~i~~~~~~~----------------------~~----~~~~~~s~~~~~li~~~l~~~p~~R~ 196 (315)
++|..||.+.+..+....+....... +. ..++.+|++++++|.+||+.||.+||
T Consensus 219 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 298 (320)
T 2i6l_A 219 LTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298 (320)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC
Confidence 99999999988877776665432211 00 01246899999999999999999999
Q ss_pred CHHHHhcCCCccCCC
Q 021227 197 TAHEVLCHPWIVDDK 211 (315)
Q Consensus 197 s~~~~l~h~~~~~~~ 211 (315)
|++|+++||||+...
T Consensus 299 t~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 299 TAEEALSHPYMSIYS 313 (320)
T ss_dssp CHHHHHTSHHHHTTC
T ss_pred CHHHHhCCccccccc
Confidence 999999999998653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=291.96 Aligned_cols=199 Identities=33% Similarity=0.576 Sum_probs=170.8
Q ss_pred CCCCcceEEEEEE--eCCeEEEEEeccCCCchhHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CccccC
Q 021227 6 EHQHVVRIHDTYE--DKSCVHIVMELCEGGELFDRIVKK----GNYSEREAAKLMKTIVGVVECCHSLG-----VFHRDL 74 (315)
Q Consensus 6 ~Hpniv~~~~~~~--~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~di 74 (315)
+||||+++++++. .+..+|+||||++||+|.+++... ..+++..++.++.|++.||.|||+.| |+||||
T Consensus 63 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl 142 (279)
T 2w5a_A 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142 (279)
T ss_dssp CCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCC
T ss_pred CCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEecc
Confidence 7999999999885 467899999999999999998753 34999999999999999999999999 999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCCCc-ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPDEV-FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
||+||+ ++.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+|+++|+|++|..||.+.
T Consensus 143 ~p~NIl---~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 143 KPANVF---LDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp SGGGEE---ECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred chhhEE---EcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 999999 46778999999999876544322 234578999999999864 5899999999999999999999999999
Q ss_pred CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+..+....+..+..... ...+|+++.++|.+||+.||.+|||+.|+++|+|+...
T Consensus 220 ~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 220 SQKELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp SHHHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred CHHHHHHHHhhcccccC---CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 88888888887765322 23689999999999999999999999999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.52 Aligned_cols=203 Identities=30% Similarity=0.472 Sum_probs=157.8
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY-------SEREAAKLMKTIVGVVECCHSLGVFHRDLKP 76 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~-------~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp 76 (315)
+.+|||||++++++.+++.+|+|||||. |+|.+++...+.. ++..++.++.||+.||+|||++||+||||||
T Consensus 65 l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp 143 (434)
T 2rio_A 65 SDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP 143 (434)
T ss_dssp HTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred ccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence 3589999999999999999999999996 5999999765433 2334678999999999999999999999999
Q ss_pred CceeeccC----------CCCCCEEEeeccCcccCCCCCc-----ccccccCccccchhhhh--------hcCCCchhHH
Q 021227 77 ENFLFLSV----------DEDAALKATDFGLSVFYKPDEV-----FSDVVGSPYYVAPEVLR--------KHYGPEADVW 133 (315)
Q Consensus 77 ~nil~~~~----------~~~~~ikl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~--------~~~~~~~Diw 133 (315)
+||++... +..+.+||+|||++........ .....||+.|+|||++. ..++.++|||
T Consensus 144 ~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 223 (434)
T 2rio_A 144 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223 (434)
T ss_dssp GGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHH
T ss_pred HhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhH
Confidence 99997532 2456899999999987654321 23467999999999985 3488999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 134 SAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEP---WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 134 slG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
|+||++|+|++ |..||.+....+ ..+..+....+... ...++++++++|.+||+.||.+|||+.++++||||..
T Consensus 224 SlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 224 SMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 99999999999 999997654433 34444444333221 1235689999999999999999999999999999964
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=286.26 Aligned_cols=193 Identities=22% Similarity=0.372 Sum_probs=169.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++.+++||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+ .
T Consensus 61 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil---~ 137 (268)
T 3sxs_A 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCL---V 137 (268)
T ss_dssp CCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEE---E
T ss_pred CCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEE---E
Confidence 79999999999999999999999999999999997754 5999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++........ .....+|+.|+|||++.+ .++.++||||+|+++|+|++ |..||...+..+....
T Consensus 138 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 217 (268)
T 3sxs_A 138 DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217 (268)
T ss_dssp CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH
Confidence 6788999999999976654432 223456778999999874 58999999999999999999 9999999998888888
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
+..+.....+ ..+|+++.+++.+||+.||.+|||+.+++++
T Consensus 218 ~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 218 VSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHTTCCCCCC---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCC---CcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7776543333 3578999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=309.63 Aligned_cols=198 Identities=18% Similarity=0.200 Sum_probs=148.5
Q ss_pred CCCCcceEE-------EEEEeCC-----------------eEEEEEeccCCCchhHHHHhC-CCCCHHHH------HHHH
Q 021227 6 EHQHVVRIH-------DTYEDKS-----------------CVHIVMELCEGGELFDRIVKK-GNYSEREA------AKLM 54 (315)
Q Consensus 6 ~Hpniv~~~-------~~~~~~~-----------------~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~------~~~~ 54 (315)
+||||++++ +++...+ ++|+|||||+ |+|.+++... ..+++... ..++
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~ 200 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILT 200 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHH
Confidence 699988866 5665443 3899999998 7999999764 33444444 5777
Q ss_pred HHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh---cCCCchh
Q 021227 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK---HYGPEAD 131 (315)
Q Consensus 55 ~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~D 131 (315)
.||+.||+|||++||+||||||+||| ++.++.+||+|||++...... .....+|+.|+|||++.+ .++.++|
T Consensus 201 ~qi~~aL~~LH~~~ivHrDikp~NIl---l~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~D 275 (371)
T 3q60_A 201 AQLIRLAANLQSKGLVHGHFTPDNLF---IMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALN 275 (371)
T ss_dssp HHHHHHHHHHHHTTEEETTCSGGGEE---ECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHH
T ss_pred HHHHHHHHHHHHCCCccCcCCHHHEE---ECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCcccc
Confidence 99999999999999999999999999 567789999999999865432 224567799999999864 5899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021227 132 VWSAGVILYILLSGVPPFWAETEIGI--FRQ---ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206 (315)
Q Consensus 132 iwslG~il~~ll~g~~pf~~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~ 206 (315)
|||+||++|+|++|..||.+...... +.. .......+..+.++.+|++++++|.+||+.||.+|||+.++++|||
T Consensus 276 iwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp HHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 99999999999999999987643210 000 1111122233334578999999999999999999999999999999
Q ss_pred ccC
Q 021227 207 IVD 209 (315)
Q Consensus 207 ~~~ 209 (315)
|+.
T Consensus 356 f~~ 358 (371)
T 3q60_A 356 FLQ 358 (371)
T ss_dssp HHH
T ss_pred HHH
Confidence 964
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=294.79 Aligned_cols=195 Identities=23% Similarity=0.315 Sum_probs=168.3
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCC------------------------CCHHHHHHHHHHH
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN------------------------YSEREAAKLMKTI 57 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~------------------------~~~~~~~~~~~qi 57 (315)
+.+ +||||+++++++.+++.+++||||++||+|.+++..... +++..+..++.|+
T Consensus 81 ~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 159 (314)
T 2ivs_A 81 KQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159 (314)
T ss_dssp TTC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred hhC-CCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence 445 899999999999999999999999999999999987543 8999999999999
Q ss_pred HHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHH
Q 021227 58 VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVW 133 (315)
Q Consensus 58 ~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Diw 133 (315)
+.||.|||++||+||||||+||++ +.++.+||+|||++........ .....+|+.|+|||++. ..++.++|||
T Consensus 160 ~~~l~~lH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 236 (314)
T 2ivs_A 160 SQGMQYLAEMKLVHRDLAARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236 (314)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHHCCCcccccchheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHH
Confidence 999999999999999999999995 5678899999999976644322 22345788999999986 4589999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 134 SAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 134 slG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|+||++|+|++ |..||.+.+.......+..+... .....+++++.+++.+||+.||.+|||+.++++
T Consensus 237 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 237 SFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999 99999998887777777665422 222468999999999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.81 Aligned_cols=196 Identities=24% Similarity=0.398 Sum_probs=160.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCCCCceee
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG---VFHRDLKPENFLF 81 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dikp~nil~ 81 (315)
.+||||+++++++.+++.+++||||++|++|.+++ +.+++++..+..++.|++.||.|||++| |+||||||+||++
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~ 141 (271)
T 3dtc_A 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILI 141 (271)
T ss_dssp CCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEE
T ss_pred cCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEE
Confidence 37999999999999999999999999999998887 4568999999999999999999999999 8999999999997
Q ss_pred ccCC-----CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 82 LSVD-----EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 82 ~~~~-----~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
.... .++.+||+|||++........ ....||+.|+|||++.+ .++.++||||+|+++|+|++|..||.+.+..
T Consensus 142 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 220 (271)
T 3dtc_A 142 LQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220 (271)
T ss_dssp SSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred ecccccccccCcceEEccCCcccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4322 267899999999976544332 34679999999999864 4899999999999999999999999998888
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.....+.......+. ...+++++.+++.+||+.||.+|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 221 AVAYGVAMNKLALPI--PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhhhcCCCCCCC--CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 877777766544433 24689999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=289.56 Aligned_cols=193 Identities=22% Similarity=0.378 Sum_probs=169.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++.+++||||+.||+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+ +
T Consensus 77 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil---i 153 (283)
T 3gen_A 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL---V 153 (283)
T ss_dssp CCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEE---E
T ss_pred CCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEE---E
Confidence 799999999999999999999999999999999976 467999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+|+++|+|++ |..||.+.+..+....
T Consensus 154 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~ 233 (283)
T 3gen_A 154 NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233 (283)
T ss_dssp CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH
Confidence 6788999999999976543321 22345678899999986 558999999999999999998 9999999998888888
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
+..+...... ..+++.+.+++.+||+.+|.+|||+.++++|
T Consensus 234 ~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 234 IAQGLRLYRP---HLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HhcccCCCCC---CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 8876443332 3578999999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.49 Aligned_cols=200 Identities=28% Similarity=0.425 Sum_probs=160.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSL-GVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dikp~nil~~ 82 (315)
.+||||+++++++.+++.+|+||||+ ++.+..+... .+.+++..+..++.|++.||.|||++ ||+||||||+||+
T Consensus 81 ~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil-- 157 (318)
T 2dyl_A 81 HDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL-- 157 (318)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEE--
T ss_pred cCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEE--
Confidence 48999999999999999999999999 5555554443 46899999999999999999999995 9999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCC-CCHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWA-ETEI 155 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~ 155 (315)
++.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.. ....
T Consensus 158 -~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (318)
T 2dyl_A 158 -LDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236 (318)
T ss_dssp -ECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred -ECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH
Confidence 5677899999999997765555455667999999999983 3488999999999999999999999987 4566
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
+....+........ +....+++++.++|.+||+.||.+|||++++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 237 EVLTKVLQEEPPLL-PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHHHSCCCCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHhccCCCCC-CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 66666666543322 223468999999999999999999999999999999974
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=303.41 Aligned_cols=195 Identities=24% Similarity=0.335 Sum_probs=161.5
Q ss_pred CCCCCCcceEEEEEEeCC-eEEEEEeccCCCchhHHHHhCCC--------------------------------------
Q 021227 4 LSEHQHVVRIHDTYEDKS-CVHIVMELCEGGELFDRIVKKGN-------------------------------------- 44 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~-------------------------------------- 44 (315)
+.+||||+++++++.+.+ .+++|||||+||+|.+++.....
T Consensus 82 l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (359)
T 3vhe_A 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQS 161 (359)
T ss_dssp HCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------
T ss_pred hcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccc
Confidence 458999999999998765 49999999999999999976543
Q ss_pred ----------------------------CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeecc
Q 021227 45 ----------------------------YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFG 96 (315)
Q Consensus 45 ----------------------------~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg 96 (315)
+++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg 238 (359)
T 3vhe_A 162 SASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFG 238 (359)
T ss_dssp ----------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCG
T ss_pred ccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEecc
Confidence 8999999999999999999999999999999999994 567899999999
Q ss_pred CcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHhCCCCCCC
Q 021227 97 LSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI-GIFRQILEGKIDFES 170 (315)
Q Consensus 97 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~-~~~~~i~~~~~~~~~ 170 (315)
++....... ......||+.|+|||++. ..++.++||||+||++|+|++ |..||.+.... .....+..+.. ..
T Consensus 239 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~- 316 (359)
T 3vhe_A 239 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MR- 316 (359)
T ss_dssp GGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CC-
T ss_pred ceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-CC-
Confidence 997654332 223466889999999986 458999999999999999998 99999886643 34444444322 22
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 171 EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 171 ~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
....+++++.+++.+||+.||.+|||+.|+++|
T Consensus 317 -~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 -APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 124589999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=302.90 Aligned_cols=197 Identities=32% Similarity=0.519 Sum_probs=162.8
Q ss_pred CCCCcceEEEEEEeCCeE------EEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYEDKSCV------HIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~------~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+||||+++++++...+.. |+||||+. |+|.+.+. ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 99 ~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 175 (371)
T 4exu_A 99 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 175 (371)
T ss_dssp CCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHe
Confidence 799999999999887654 99999997 58877663 4599999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+ ++.++.+||+|||++...... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.
T Consensus 176 l---l~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 250 (371)
T 4exu_A 176 A---VNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 250 (371)
T ss_dssp E---ECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred E---ECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 9 567789999999999765432 345678999999999864 589999999999999999999999999888777
Q ss_pred HHHHHhCCCCC-----------------------CCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDF-----------------------ESE----PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~-----------------------~~~----~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
...+....... +.. .++.+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 251 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 251 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 76664411110 000 124579999999999999999999999999999999754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=297.82 Aligned_cols=194 Identities=20% Similarity=0.310 Sum_probs=168.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC------------------------CCCCHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK------------------------GNYSEREAAKLMKTIV 58 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~qi~ 58 (315)
.+ +||||+++++++.+++.+|+||||++||+|.+++... ..+++..+..++.||+
T Consensus 106 ~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 184 (343)
T 1luf_A 106 EF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184 (343)
T ss_dssp TC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHH
T ss_pred hC-CCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHH
Confidence 44 8999999999999999999999999999999999764 5799999999999999
Q ss_pred HHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHH
Q 021227 59 GVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWS 134 (315)
Q Consensus 59 ~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Diws 134 (315)
.||.|||++||+||||||+||++ +.++.+||+|||++....... ......||+.|+|||++. +.++.++||||
T Consensus 185 ~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s 261 (343)
T 1luf_A 185 AGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 261 (343)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHH
Confidence 99999999999999999999994 567899999999987543221 223456789999999986 45899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 135 AGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 135 lG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+||++|+|++ |..||.+.+..+....+..+...... ..+++++.+++.+||+.||.+|||+.++++
T Consensus 262 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 262 YGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999999 99999999998888888876543222 468999999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=296.18 Aligned_cols=201 Identities=28% Similarity=0.458 Sum_probs=165.8
Q ss_pred CCCCcceEEEEEEeC-----CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDK-----SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+||||+++++++..+ ...|+||||+. |+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 67 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil 144 (353)
T 2b9h_A 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL 144 (353)
T ss_dssp CCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred cCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 799999999998764 77999999997 589888865 57999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC-----------cccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE-----------VFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~ 147 (315)
++.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..
T Consensus 145 ---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 221 (353)
T 2b9h_A 145 ---INSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221 (353)
T ss_dssp ---ECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ---EcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCC
Confidence 5678899999999997654321 122357899999999875 458999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCC------------------------CCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 021227 148 PFWAETEIGIFRQILEGKI------------------------DFESE----PWPNISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~------------------------~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
||.+.+..+....+..... ..+.. .++.++++++++|.+||+.||.+|||+.
T Consensus 222 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (353)
T 2b9h_A 222 IFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301 (353)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence 9999887666555432100 00100 1246899999999999999999999999
Q ss_pred HHhcCCCccCCC
Q 021227 200 EVLCHPWIVDDK 211 (315)
Q Consensus 200 ~~l~h~~~~~~~ 211 (315)
|+++||||+...
T Consensus 302 ell~hp~~~~~~ 313 (353)
T 2b9h_A 302 EALEHPYLQTYH 313 (353)
T ss_dssp HHHTSGGGTTTC
T ss_pred HHhcCccccccC
Confidence 999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=305.37 Aligned_cols=201 Identities=25% Similarity=0.415 Sum_probs=157.7
Q ss_pred CCCCcceEEEEEE----eCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCc
Q 021227 6 EHQHVVRIHDTYE----DKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSL-GVFHRDLKPEN 78 (315)
Q Consensus 6 ~Hpniv~~~~~~~----~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dikp~n 78 (315)
.||||+++++++. +...+|+||||+ +++|.+.+.+. +.+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 4899999999998 567899999999 55676766554 5699999999999999999999998 99999999999
Q ss_pred eeeccCC----------------------------------------------CCCCEEEeeccCcccCCCCCccccccc
Q 021227 79 FLFLSVD----------------------------------------------EDAALKATDFGLSVFYKPDEVFSDVVG 112 (315)
Q Consensus 79 il~~~~~----------------------------------------------~~~~ikl~Dfg~~~~~~~~~~~~~~~g 112 (315)
||+...+ ....+||+|||++...... .....|
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~g 255 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQ 255 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCC
Confidence 9974211 1138999999999765432 345679
Q ss_pred Cccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCCCC----------------
Q 021227 113 SPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAET------EIGIFRQILEGKIDFE---------------- 169 (315)
Q Consensus 113 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~---------------- 169 (315)
|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+ .......+.......+
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 999999999864 48999999999999999999999997654 2233333222000000
Q ss_pred ---------C-------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 170 ---------S-------------EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 170 ---------~-------------~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
. ......++++++||.+||+.||.+|||+.|+|+||||++
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0 001123567899999999999999999999999999963
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=297.46 Aligned_cols=203 Identities=24% Similarity=0.339 Sum_probs=148.5
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCC
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-----KGNYSEREAAKLMKTIVGVVECCHSL-GVFHRDLKPE 77 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dikp~ 77 (315)
..+||||+++++++.+++..++||||+.| +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+
T Consensus 77 ~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~ 155 (327)
T 3aln_A 77 SSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPS 155 (327)
T ss_dssp SCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGG
T ss_pred cCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHH
Confidence 35899999999999999999999999986 77777653 56799999999999999999999999 9999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-----hcCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-----KHYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
||++ +.++.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.
T Consensus 156 NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 156 NILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp GEEE---ETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred HEEE---cCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 9995 567899999999998765544444557999999999982 34899999999999999999999999875
Q ss_pred CH-HHHHHHHHhCC-CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 153 TE-IGIFRQILEGK-IDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 153 ~~-~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.. .+....+..+. ..++...+..+++++.+++.+||+.||.+|||+.++++||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp -------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred chHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 43 22222222221 122233345689999999999999999999999999999999743
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=289.98 Aligned_cols=191 Identities=25% Similarity=0.374 Sum_probs=154.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++. ++..|+||||+.||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 74 ~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--- 149 (281)
T 1mp8_A 74 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--- 149 (281)
T ss_dssp CCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---
Confidence 8999999999985 456889999999999999997654 79999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++ |..||.+.+..+....
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~ 229 (281)
T 1mp8_A 150 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229 (281)
T ss_dssp EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH
Confidence 4578899999999977644332 22345678999999986 458999999999999999996 9999999888777777
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+..+.... ..+.+|+++.+++.+||+.||.+|||+.++++
T Consensus 230 i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 230 IENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 77654322 23478999999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.96 Aligned_cols=192 Identities=34% Similarity=0.585 Sum_probs=166.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCC-CchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEG-GELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.||||+++++++.+++.+++|+|++.+ ++|.+++...+.+++..++.++.|++.||+|||++||+||||||+||++.
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~-- 183 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID-- 183 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--
Confidence 589999999999999999999999986 89999998888999999999999999999999999999999999999962
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-c-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-H-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
..++.+||+|||++...... ......||+.|+|||++.+ . ++.++|||||||++|+|++|..||.... .+.
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~ 256 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII 256 (320)
T ss_dssp TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH
T ss_pred CCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhh
Confidence 25688999999998776543 2345679999999999864 3 4678999999999999999999997642 233
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+...++ ..+++++.++|.+||+.||.+|||++++++||||+..
T Consensus 257 ~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 257 RGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ccccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 3333332 3689999999999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.02 Aligned_cols=195 Identities=24% Similarity=0.323 Sum_probs=166.4
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.+++.+|+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 167 ~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil 245 (377)
T 3cbl_A 167 KQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCL 245 (377)
T ss_dssp TTC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhC-CCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEE
Confidence 445 8999999999999999999999999999999999765 46999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcc---cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVF---SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI 155 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 155 (315)
++.++.+||+|||++......... ....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.+..
T Consensus 246 ---~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~ 322 (377)
T 3cbl_A 246 ---VTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322 (377)
T ss_dssp ---ECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH
T ss_pred ---EcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 567789999999998765433211 1123567899999986 568999999999999999998 99999998888
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+....+..+... + ....+|+++.++|.+||+.||.+|||+.++++
T Consensus 323 ~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 323 QTREFVEKGGRL-P--CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 877777665322 1 12458999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=299.18 Aligned_cols=197 Identities=20% Similarity=0.293 Sum_probs=165.4
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-----------------------CCCHHHHHHHHHHHHHH
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-----------------------NYSEREAAKLMKTIVGV 60 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~~~~~~~~~~~qi~~~ 60 (315)
+.+||||+++++++.+++.+++||||++||+|.+++.... .+++..+..++.|++.|
T Consensus 105 l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 184 (344)
T 1rjb_A 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 184 (344)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHH
T ss_pred hcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHH
Confidence 3489999999999999999999999999999999997653 27999999999999999
Q ss_pred HHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHH
Q 021227 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAG 136 (315)
Q Consensus 61 l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG 136 (315)
|.|||++||+||||||+||++ +.++.+||+|||++........ .....||+.|+|||++. +.++.++||||||
T Consensus 185 L~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 261 (344)
T 1rjb_A 185 MEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 261 (344)
T ss_dssp HHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHhCCcccCCCChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHH
Confidence 999999999999999999995 5678999999999976543321 23455788999999986 5589999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021227 137 VILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205 (315)
Q Consensus 137 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~ 205 (315)
|++|+|+| |..||.+.........+.......+. ...+++++.+++.+||+.||.+|||+.+++++.
T Consensus 262 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 262 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 99999998 99999887655444444444333322 246799999999999999999999999998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=295.19 Aligned_cols=197 Identities=32% Similarity=0.522 Sum_probs=162.5
Q ss_pred CCCCcceEEEEEEeCCe------EEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYEDKSC------VHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~------~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+||||+++++++.+... +|+||||+. |+|.+++. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 81 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NI 157 (353)
T 3coi_A 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 157 (353)
T ss_dssp CCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred CCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 79999999999987754 599999997 58887763 3599999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+ ++.++.+||+|||++...... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.
T Consensus 158 l---~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 232 (353)
T 3coi_A 158 A---VNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232 (353)
T ss_dssp E---ECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH
T ss_pred e---ECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9 567789999999998765432 345678999999999864 589999999999999999999999999887776
Q ss_pred HHHHHhCCC-----------------------CC----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKI-----------------------DF----ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~-----------------------~~----~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+..+..... .. -...++.++++++++|.+||+.||.+|||+.++++||||...
T Consensus 233 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 233 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 666543110 00 012235689999999999999999999999999999999754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=295.08 Aligned_cols=192 Identities=21% Similarity=0.332 Sum_probs=163.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+ +..++||||+.||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+ +
T Consensus 73 ~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil---~ 148 (325)
T 3kex_A 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVL---L 148 (325)
T ss_dssp CCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEE---E
T ss_pred CCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEE---E
Confidence 89999999999874 5688999999999999999765 57999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||++....... ......||+.|+|||++. +.++.++||||+||++|+|++ |..||.+....+...
T Consensus 149 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 228 (325)
T 3kex_A 149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228 (325)
T ss_dssp SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH
T ss_pred CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH
Confidence 667899999999998764432 223456788999999987 569999999999999999999 999999988777777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.+..+...... ..+++++.+++.+||+.||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 229 LLEKGERLAQP---QICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHTTCBCCCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHcCCCCCCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77765433222 3578899999999999999999999999865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=296.96 Aligned_cols=198 Identities=19% Similarity=0.205 Sum_probs=161.5
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
|.+||||+++++++.+++..++||||+ ||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||++.
T Consensus 61 l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~ 139 (330)
T 2izr_A 61 LGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG 139 (330)
T ss_dssp HCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred hhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec
Confidence 458999999999999999999999999 99999999764 6899999999999999999999999999999999999964
Q ss_pred cCCC--CCCEEEeeccCcccCCCCCc--------ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 83 SVDE--DAALKATDFGLSVFYKPDEV--------FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 83 ~~~~--~~~ikl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
.... ...+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 140 ~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~ 219 (330)
T 2izr_A 140 RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219 (330)
T ss_dssp CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence 2211 12399999999986543321 245679999999999874 489999999999999999999999987
Q ss_pred ---CCHHHHHHHHHhCCCCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 152 ---ETEIGIFRQILEGKIDFESEP-WPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 152 ---~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
....+.+..+.......+... ...+| ++.+++.+||+.||.+|||++++++
T Consensus 220 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 220 LKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 344555555544333332211 12244 9999999999999999999988864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=293.45 Aligned_cols=195 Identities=22% Similarity=0.325 Sum_probs=163.8
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHH
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG------------------NYSEREAAKLMKTIVGVVECCH 65 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~~~~~~~~~~~qi~~~l~~lH 65 (315)
+.+||||+++++++.+++..++||||++||+|.+++.... .+++..+..++.|++.||.|||
T Consensus 83 l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 162 (313)
T 1t46_A 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162 (313)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 3489999999999999999999999999999999997654 4899999999999999999999
Q ss_pred HCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHH
Q 021227 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYI 141 (315)
Q Consensus 66 ~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ 141 (315)
++||+||||||+||++ +.++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+
T Consensus 163 ~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 239 (313)
T 1t46_A 163 SKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239 (313)
T ss_dssp HTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HCCeecCCCccceEEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHH
Confidence 9999999999999995 5678999999999977654332 23355788999999886 458999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 142 LLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 142 ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|++ |..||.+.................. ....+++++.+++.+||+.||.+|||+.++++
T Consensus 240 llt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCCcccchhHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999 9999988665444433333222222 22468999999999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=294.22 Aligned_cols=202 Identities=25% Similarity=0.402 Sum_probs=165.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.|++++.+++++...+.+|+||||+ +++|.+++... .++++..++.++.||+.||.|||++||+||||||+||++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~ 158 (355)
T 2eu9_A 80 NKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158 (355)
T ss_dssp SCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESC
T ss_pred CceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence 4556999999999999999999999 56777777665 37999999999999999999999999999999999999743
Q ss_pred C----------------CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCC
Q 021227 84 V----------------DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGV 146 (315)
Q Consensus 84 ~----------------~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~ 146 (315)
. +..+.+||+|||++...... .....||+.|+|||++. ..++.++||||+||++|+|++|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 236 (355)
T 2eu9_A 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236 (355)
T ss_dssp CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence 2 35789999999999764332 34567999999999986 45899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCCC----------------CCC------------------------CCCCHHHHHHHHH
Q 021227 147 PPFWAETEIGIFRQILEGKIDFES----------------EPW------------------------PNISESAKDLIRK 186 (315)
Q Consensus 147 ~pf~~~~~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~~ 186 (315)
.||.+.+..+....+.......+. ..| ...++++.+||.+
T Consensus 237 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 316 (355)
T 2eu9_A 237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR 316 (355)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence 999998876655554432111110 001 1124588999999
Q ss_pred hcccCCCCCCCHHHHhcCCCccCC
Q 021227 187 MLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 187 ~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
||+.||.+|||+.|+++||||+..
T Consensus 317 ~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 317 MLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred HhcCChhhCcCHHHHhcChhhcCC
Confidence 999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=288.56 Aligned_cols=197 Identities=30% Similarity=0.540 Sum_probs=162.5
Q ss_pred CCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCC
Q 021227 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDE 86 (315)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~ 86 (315)
||||+++++++.+++.+|+||| +.+++|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||++.
T Consensus 87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---- 161 (313)
T 3cek_A 87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---- 161 (313)
T ss_dssp CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----
T ss_pred CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----
Confidence 7999999999999999999999 55789999999888999999999999999999999999999999999999972
Q ss_pred CCCEEEeeccCcccCCCCCc---ccccccCccccchhhhhh------------cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 87 DAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLRK------------HYGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 87 ~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
++.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 162 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 162 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 37899999999976643321 234578999999999853 578899999999999999999999987
Q ss_pred CC-HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 152 ET-EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 152 ~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.. .......+......... ....++++.++|.+||+.||.+|||+.|+++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 242 IINQISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCSHHHHHHHHHCTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHHHHHHHHhcccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 53 44444555544333222 23568999999999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.72 Aligned_cols=200 Identities=19% Similarity=0.221 Sum_probs=164.4
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+.+||||+++++++.++...++||||+ |++|.+++...+ ++++..+..++.|++.||+|||++||+||||||+||++
T Consensus 61 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 139 (298)
T 1csn_A 61 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139 (298)
T ss_dssp HTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred HHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe
Confidence 3568999999999999999999999999 999999998754 69999999999999999999999999999999999996
Q ss_pred ccC--CCCCCEEEeeccCcccCCCCCc--------ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 82 LSV--DEDAALKATDFGLSVFYKPDEV--------FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 82 ~~~--~~~~~ikl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
... ...+.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 140 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 219 (298)
T 1csn_A 140 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 219 (298)
T ss_dssp CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcc
Confidence 432 2234599999999986644321 245679999999999864 58999999999999999999999998
Q ss_pred CC---CHHHHHHHHHhCCCCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 151 AE---TEIGIFRQILEGKIDFE-SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 151 ~~---~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+. ...+....+.......+ ....+.+|+++.+++.+||+.||.+|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 220 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 73 44455555444322221 1122468999999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=290.02 Aligned_cols=196 Identities=23% Similarity=0.326 Sum_probs=169.4
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------GNYSEREAAKLMKTIVGVVECCHSLGVFH 71 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 71 (315)
+.+ +||||+++++++.+++..++||||++||+|.+++... .++++..+..++.|++.||.|||++||+|
T Consensus 83 ~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 161 (322)
T 1p4o_A 83 KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 161 (322)
T ss_dssp GGC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred Hhc-CCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 344 8999999999999999999999999999999988653 45799999999999999999999999999
Q ss_pred ccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CC
Q 021227 72 RDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GV 146 (315)
Q Consensus 72 ~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~ 146 (315)
|||||+||+ ++.++.+||+|||++....... ......||+.|+|||++. +.++.++||||+||++|+|++ |.
T Consensus 162 ~dikp~NIl---i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 238 (322)
T 1p4o_A 162 RDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238 (322)
T ss_dssp SCCSGGGEE---ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred CCCccceEE---EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCC
Confidence 999999999 5667899999999987654332 122345788999999986 458999999999999999999 89
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 147 PPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 147 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.||.+.+..+....+..+..... ...+++++.+++.+||+.||.+|||+.+++++
T Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 239 QPYQGLSNEQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccccCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999998888888877654322 24689999999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=288.47 Aligned_cols=197 Identities=28% Similarity=0.451 Sum_probs=158.3
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.+ +||||+++++++.+++.+|+||||++|++|.+++...+++++..+..++.|++.||.|||++||+||||||+||+
T Consensus 89 ~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl- 166 (309)
T 2h34_A 89 GRL-QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENIL- 166 (309)
T ss_dssp TTC-CCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE-
T ss_pred hhc-CCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEE-
Confidence 345 899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
++.++.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+.....
T Consensus 167 --~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (309)
T 2h34_A 167 --VSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG 244 (309)
T ss_dssp --ECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH
T ss_pred --EcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH
Confidence 4567899999999987654332 223467899999999986 45899999999999999999999999887765444
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHhc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-TAHEVLC 203 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-s~~~~l~ 203 (315)
..+.. ....+....+.+|+++.++|.+||+.||.+|| |++++++
T Consensus 245 ~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 245 AHINQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHS-CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHhcc-CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 44443 33333334467899999999999999999999 7887764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=296.24 Aligned_cols=195 Identities=21% Similarity=0.405 Sum_probs=157.7
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.+.+.+++||||++||+|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 101 ~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 179 (373)
T 2qol_A 101 GQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNIL 179 (373)
T ss_dssp TTC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhC-CCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEE
Confidence 345 8999999999999999999999999999999999765 47999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETE 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 154 (315)
++.++.+||+|||++........ .....+|+.|+|||++. +.++.++|||||||++|+|++ |..||.+.+.
T Consensus 180 ---l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 180 ---INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp ---ECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred ---EcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 56788999999999976643321 11233567899999986 558999999999999999998 9999999998
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+....+..+.... ....+++++.+++.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 257 QDVIKAVDEGYRLP---PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHTTEECC---CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCC---CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 88888777653221 12368999999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=282.65 Aligned_cols=194 Identities=22% Similarity=0.381 Sum_probs=168.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+ +||||+++++++.+++.+++||||++||+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 59 ~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili 137 (267)
T 3t9t_A 59 KL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137 (267)
T ss_dssp TC-CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE
T ss_pred hC-CCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE
Confidence 44 7999999999999999999999999999999999765 569999999999999999999999999999999999994
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGI 157 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 157 (315)
+.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||+|+++|+|++ |..||.+.+..+.
T Consensus 138 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 214 (267)
T 3t9t_A 138 ---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 214 (267)
T ss_dssp ---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred ---CCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH
Confidence 567899999999987654322 122345778999999987 458999999999999999999 9999999998888
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
...+..+.....+ ..+++++.+++.+||+.||.+|||+.++++
T Consensus 215 ~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 215 VEDISTGFRLYKP---RLASTHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp HHHHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCcCCCC---ccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8888776433222 357999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=292.92 Aligned_cols=194 Identities=21% Similarity=0.331 Sum_probs=168.7
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHC
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----------------NYSEREAAKLMKTIVGVVECCHSL 67 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~~ 67 (315)
+.+||||+++++++.+++.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++
T Consensus 97 l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 176 (334)
T 2pvf_A 97 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176 (334)
T ss_dssp HCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3489999999999999999999999999999999997653 389999999999999999999999
Q ss_pred CCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHH
Q 021227 68 GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILL 143 (315)
Q Consensus 68 ~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll 143 (315)
||+||||||+||+ ++.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|+
T Consensus 177 ~ivH~Dlkp~NIl---l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 253 (334)
T 2pvf_A 177 KCIHRDLAARNVL---VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253 (334)
T ss_dssp TEECSCCSGGGEE---ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred CeeCCCCccceEE---EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHH
Confidence 9999999999999 56778999999999976654322 22345688999999986 45899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 144 S-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 144 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+ |..||.+.+..+....+..+.... ....+++++.+++.+||+.||.+|||+.++++
T Consensus 254 t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 254 TLGGSPYPGIPVEELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp TTSCCSSTTCCHHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCcCcCCHHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9 999999999888888877764322 22468999999999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=280.25 Aligned_cols=192 Identities=18% Similarity=0.304 Sum_probs=164.8
Q ss_pred CCCCCCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCC
Q 021227 2 HHLSEHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLG--VFHRDLK 75 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dik 75 (315)
+.+ +||||+++++++.+. +.+++||||++||+|.+++.... .+++..+..++.|++.||+|||++| ++|||||
T Consensus 62 ~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dik 140 (271)
T 3kmu_A 62 RIF-SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN 140 (271)
T ss_dssp CCC-SCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCS
T ss_pred Hhc-CCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCc
Confidence 445 899999999999887 78999999999999999998765 4899999999999999999999999 9999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc-C---CCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH-Y---GPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~---~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
|+||+ ++.++.++++|||++..... ....||+.|+|||++.+. + +.++||||+||++|+|++|..||.+
T Consensus 141 p~Nil---~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 141 SRSVM---IDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp GGGEE---ECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred cceEE---EcCCcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999 56778899999987754322 345789999999998643 3 3379999999999999999999999
Q ss_pred CCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 152 ETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 152 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+....+........ ....+|+++.+++.+||+.||.+|||++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 214 LSNMEIGMKVALEGLRPT--IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp SCHHHHHHHHHHSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cChHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 888887777766544333 23468999999999999999999999999974
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=288.48 Aligned_cols=196 Identities=42% Similarity=0.806 Sum_probs=157.2
Q ss_pred CCCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 4 LSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
+.+||||+++++++.+ +..+|+||||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+
T Consensus 67 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~ 146 (299)
T 3m2w_A 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 146 (299)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred hccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 3589999999999987 778999999999999999998764 6999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
||++...+.++.+||+|||++..... ..++.++||||+||++|+|++|..||.+......
T Consensus 147 Nil~~~~~~~~~~kl~Dfg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 206 (299)
T 3m2w_A 147 NLLYTSKRPNAILKLTDFGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206 (299)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred HEEEecCCCCCcEEEecccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence 99975444478999999998864321 3467789999999999999999999987655433
Q ss_pred HHHH----HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 021227 158 FRQI----LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLD 219 (315)
Q Consensus 158 ~~~i----~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~ 219 (315)
...+ ..+...++...+..+|++++++|.+||+.||.+|||+.|+++||||+.....+..+..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~ 272 (299)
T 3m2w_A 207 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 272 (299)
T ss_dssp -CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBCS
T ss_pred hHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCCc
Confidence 2111 1122222222235689999999999999999999999999999999887655555443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=291.43 Aligned_cols=200 Identities=19% Similarity=0.236 Sum_probs=172.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-------NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+||||+++++++.++...|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 91 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~N 170 (327)
T 2yfx_A 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARN 170 (327)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred CCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhH
Confidence 89999999999999999999999999999999998753 48999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAET 153 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 153 (315)
|++...+....+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++ |..||.+.+
T Consensus 171 Ili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 171 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp EEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 997544466789999999986543222 223456789999999986 558999999999999999998 999999998
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
..+....+..+..... ...+++.+.++|.+||+.||.+|||+.+++++.|+.
T Consensus 251 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 251 NQEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 8888888877643322 246899999999999999999999999999988764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=299.50 Aligned_cols=204 Identities=25% Similarity=0.453 Sum_probs=160.8
Q ss_pred CCCCcceEEEEEEeCC----eEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCCCCc
Q 021227 6 EHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSL-GVFHRDLKPEN 78 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dikp~n 78 (315)
.||||+++++++...+ .+++||||+ |++|.+++... +.+++..+..++.||+.||+|||++ ||+||||||+|
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~N 162 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 162 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHH
Confidence 4999999999998654 799999999 88999998763 5699999999999999999999998 99999999999
Q ss_pred eeeccC---CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 021227 79 FLFLSV---DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAET- 153 (315)
Q Consensus 79 il~~~~---~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~- 153 (315)
|++... +..+.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 997432 34458999999999765432 345679999999999874 48999999999999999999999998654
Q ss_pred -----HHHHHHHHHhCCCCCCC--------------------------------------CCCCCCCHHHHHHHHHhccc
Q 021227 154 -----EIGIFRQILEGKIDFES--------------------------------------EPWPNISESAKDLIRKMLDQ 190 (315)
Q Consensus 154 -----~~~~~~~i~~~~~~~~~--------------------------------------~~~~~~s~~~~~li~~~l~~ 190 (315)
.......+.......+. .....+++++++||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence 22223332221000000 00123467899999999999
Q ss_pred CCCCCCCHHHHhcCCCccCCCC
Q 021227 191 NPKRRLTAHEVLCHPWIVDDKV 212 (315)
Q Consensus 191 ~p~~R~s~~~~l~h~~~~~~~~ 212 (315)
||.+|||++|+++||||+....
T Consensus 321 dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 321 DPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp STTTCBCHHHHHTCGGGTTCTT
T ss_pred CccccCCHHHHhhChhhhcccC
Confidence 9999999999999999987543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=289.94 Aligned_cols=193 Identities=33% Similarity=0.602 Sum_probs=161.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEec-cCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMEL-CEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~-~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+.+..++|+|| +.|++|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||++.
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 173 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID-- 173 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--
Confidence 799999999999999999999999 78999999998888899999999999999999999999999999999999962
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH-Y-GPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
..++.+||+|||++....... .....||+.|+|||++.+. + +.++||||+||++|+|++|..||.+.. .+.
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~ 246 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EIL 246 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH
T ss_pred CCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHh
Confidence 267889999999988765433 3456799999999998643 3 458999999999999999999997632 233
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.....++ ..++++++++|.+||+.||.+|||++|+++||||+...
T Consensus 247 ~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 247 EAELHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HTCCCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred hhccCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 3333333 36899999999999999999999999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=294.58 Aligned_cols=192 Identities=26% Similarity=0.385 Sum_probs=158.4
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.+++..++||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 62 ~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil 140 (310)
T 3s95_A 62 RCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCL 140 (310)
T ss_dssp TTC-CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred HhC-CCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEE
Confidence 345 799999999999999999999999999999999987 467999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcc---------------cccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHh
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVF---------------SDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLS 144 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~---------------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~ 144 (315)
++.++.+||+|||++......... ....||+.|+|||++.+ .++.++||||+||++|+|++
T Consensus 141 ---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 217 (310)
T 3s95_A 141 ---VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217 (310)
T ss_dssp ---ECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ---ECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhc
Confidence 567889999999999765432211 14679999999999874 58999999999999999999
Q ss_pred CCCCCCCCCHHH-----HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 145 GVPPFWAETEIG-----IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 145 g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|..||....... ........ ...+.+|+++.+++.+||+.||.+|||+.++++
T Consensus 218 g~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 218 RVNADPDYLPRTMDFGLNVRGFLDR------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TCCSSTTTSCBCTTSSBCHHHHHHH------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcchhhhHHHHhhhhhccccc------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999986532110 00111110 012367889999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=291.48 Aligned_cols=197 Identities=20% Similarity=0.272 Sum_probs=157.1
Q ss_pred CCCCCCCCcceEEEEEEeCC----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------
Q 021227 2 HHLSEHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL---------- 67 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---------- 67 (315)
+.+ +||||+++++++.+.. .+++|||||+||+|.+++.. ..+++..+..++.|++.||+|||+.
T Consensus 73 ~~l-~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~ 150 (322)
T 3soc_A 73 PGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKP 150 (322)
T ss_dssp TTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEEC
T ss_pred hcC-CCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCC
Confidence 345 8999999999998744 47999999999999999865 4699999999999999999999999
Q ss_pred CCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhhh------cCCCchhHHHHHHH
Q 021227 68 GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLRK------HYGPEADVWSAGVI 138 (315)
Q Consensus 68 ~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~i 138 (315)
||+||||||+||+ ++.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+||+
T Consensus 151 ~ivH~Dlkp~Nil---l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 227 (322)
T 3soc_A 151 AISHRDIKSKNVL---LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227 (322)
T ss_dssp EEECSCCSGGGEE---ECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHH
T ss_pred CEEeCCCChHhEE---ECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHH
Confidence 9999999999999 56778999999999976543322 234679999999999864 46678999999999
Q ss_pred HHHHHhCCCCCCCC----------------CHHHHHHHHHhCCCCCCCCC-CC--CCCHHHHHHHHHhcccCCCCCCCHH
Q 021227 139 LYILLSGVPPFWAE----------------TEIGIFRQILEGKIDFESEP-WP--NISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 139 l~~ll~g~~pf~~~----------------~~~~~~~~i~~~~~~~~~~~-~~--~~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
+|+|+||..||.+. ........+........... +. ..++++.++|.+||+.||.+|||+.
T Consensus 228 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 307 (322)
T 3soc_A 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307 (322)
T ss_dssp HHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999753 22333333333322221111 11 1345699999999999999999999
Q ss_pred HHhc
Q 021227 200 EVLC 203 (315)
Q Consensus 200 ~~l~ 203 (315)
++++
T Consensus 308 ell~ 311 (322)
T 3soc_A 308 CVGE 311 (322)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=301.37 Aligned_cols=197 Identities=15% Similarity=0.148 Sum_probs=156.4
Q ss_pred CCCCCcceEEEEEEeC----CeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 5 SEHQHVVRIHDTYEDK----SCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~----~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
.+||||+++++++.+. ...|+||||| ||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||
T Consensus 105 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Ni 183 (364)
T 3op5_A 105 LKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL 183 (364)
T ss_dssp CSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHE
Confidence 3799999999999765 5689999999 99999999776 6799999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCc--------ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEV--------FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
|+.. +.++.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 184 ll~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 184 LLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9641 2678999999999976543221 133559999999999875 48999999999999999999999998
Q ss_pred CCCHH-HHHHHHHh----CCCCCCC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 151 AETEI-GIFRQILE----GKIDFES--EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 151 ~~~~~-~~~~~i~~----~~~~~~~--~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+.... ........ ....+.. .....+|+++.+++..||..+|.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 263 DNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp GGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 63221 11111110 0000000 001367999999999999999999999998864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=289.10 Aligned_cols=191 Identities=19% Similarity=0.269 Sum_probs=157.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+++..++||||++||+|.+++.+.+. +++..+..++.|++.||.|||++||+||||||+||++...
T Consensus 70 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE 149 (289)
T ss_dssp CCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC
T ss_pred CCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC
Confidence 799999999999999999999999999999999987654 9999999999999999999999999999999999997432
Q ss_pred CC-----CCCEEEeeccCcccCCCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHH
Q 021227 85 DE-----DAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSG-VPPFWAETEIG 156 (315)
Q Consensus 85 ~~-----~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~ 156 (315)
.. .+.+||+|||++...... ....||+.|+|||++. ..++.++||||+||++|+|++| .+||.......
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~ 226 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred CcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH
Confidence 21 122999999998655332 2355889999999986 4589999999999999999995 55555555544
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
... ........+ ...++++.+++.+||+.||.+|||+.+++++
T Consensus 227 ~~~-~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 227 KLQ-FYEDRHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHH-HHHTTCCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHH-HhhccCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 443 333333332 2467889999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=284.62 Aligned_cols=191 Identities=21% Similarity=0.279 Sum_probs=164.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++ ..+.+++||||+.|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +
T Consensus 76 ~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~ 151 (291)
T 1xbb_A 76 DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---V 151 (291)
T ss_dssp CCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---E
T ss_pred CCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---e
Confidence 899999999999 566789999999999999999988889999999999999999999999999999999999995 4
Q ss_pred CCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
.++.+||+|||++........ .....+|+.|+|||++.+ .++.++||||+|+++|+|++ |..||.+.+..+...
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 231 (291)
T 1xbb_A 152 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 231 (291)
T ss_dssp ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 577999999999976644332 122346788999999864 58899999999999999999 999999998888888
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+.... ....+|+++.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 232 MLEKGERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 777654321 22468999999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.68 Aligned_cols=192 Identities=22% Similarity=0.403 Sum_probs=161.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+.+.+++||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+ +
T Consensus 104 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl---~ 180 (333)
T 1mqb_A 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL---V 180 (333)
T ss_dssp CCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE---E
T ss_pred CCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEE---E
Confidence 8999999999999999999999999999999999765 67999999999999999999999999999999999999 4
Q ss_pred CCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
+.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++ |..||.+.+..+..
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 260 (333)
T 1mqb_A 181 NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 260 (333)
T ss_dssp CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 6788999999999976543221 12234678899999986 458999999999999999998 99999999888888
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+..+.... ....+++++.+++.+||+.||.+|||+.++++
T Consensus 261 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 261 KAINDGFRLP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp HHHHTTCCCC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHCCCcCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8887653221 22468999999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.90 Aligned_cols=197 Identities=15% Similarity=0.142 Sum_probs=158.8
Q ss_pred CCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 5 SEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+||||+++++++.+ +..+|+||||| |++|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 105 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 183 (345)
T 2v62_A 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLL 183 (345)
T ss_dssp CSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred ccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEE
Confidence 389999999999988 78899999999 9999999987778999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC--------cccccccCccccchhhhhhc-CCCchhHHHHHHHHHHHHhCCCCCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE--------VFSDVVGSPYYVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFWA 151 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~ 151 (315)
+.. +..+.+||+|||+++...... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+
T Consensus 184 l~~-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 184 LGY-KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EES-SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred Ecc-CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 643 223499999999997653221 12446799999999998754 89999999999999999999999965
Q ss_pred --CCHHHHHHHHHhCCCCCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 152 --ETEIGIFRQILEGKIDFES-----EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 152 --~~~~~~~~~i~~~~~~~~~-----~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+...............+. .....+|++++++|.+||+.||.+|||++++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 263 NLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp GTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2333222221111111111 001268999999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=300.54 Aligned_cols=193 Identities=23% Similarity=0.350 Sum_probs=163.4
Q ss_pred CCCCCCCCcceEEEEEEeCC-eEEEEEeccCCCchhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 2 HHLSEHQHVVRIHDTYEDKS-CVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+.+ +||||+++++++.+.. .+|+|||||+||+|.+++.+.+. +++..+..++.|++.||+|||++||+||||||+|
T Consensus 241 ~~l-~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 319 (450)
T 1k9a_A 241 TQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 319 (450)
T ss_dssp HTC-CCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred Hhc-cCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhh
Confidence 345 8999999999987654 79999999999999999987643 7999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 156 (315)
|| ++.++.+||+|||+++...... ....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.+..+
T Consensus 320 il---l~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 394 (450)
T 1k9a_A 320 VL---VSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394 (450)
T ss_dssp EE---ECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT
T ss_pred EE---ECCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99 5677899999999997543322 2346788999999986 558999999999999999998 999999887777
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
....+..+.. + .....+|+++.++|.+||+.||.+|||+.++++
T Consensus 395 ~~~~i~~~~~-~--~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 395 VVPRVEKGYK-M--DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHTTCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCC-C--CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7777776532 1 222468999999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=282.30 Aligned_cols=195 Identities=26% Similarity=0.395 Sum_probs=159.4
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCCCCc
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLG--VFHRDLKPEN 78 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dikp~n 78 (315)
+.+ +||||+++++++.+.. ++||||++||+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|
T Consensus 78 ~~l-~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~N 154 (287)
T 4f0f_A 78 SNL-NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPN 154 (287)
T ss_dssp TTC-CCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGG
T ss_pred HhC-CCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcce
Confidence 345 8999999999997766 6999999999999888655 57999999999999999999999999 9999999999
Q ss_pred eeeccCC--CCCCEEEeeccCcccCCCCCcccccccCccccchhhhh---hcCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 79 FLFLSVD--EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR---KHYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 79 il~~~~~--~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
|++...+ ....+||+|||++..... ......||+.|+|||++. ..++.++||||+||++|+|++|..||...+
T Consensus 155 il~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 155 IFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp EEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9964322 122499999999875433 334577999999999983 347899999999999999999999998754
Q ss_pred H--HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 154 E--IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 154 ~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
. ......+....... .....+|+++.++|.+||+.||.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 233 YGKIKFINMIREEGLRP--TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCHHHHHHHHHHSCCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHhccCCCC--CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3 33344444443332 223478999999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.35 Aligned_cols=194 Identities=22% Similarity=0.337 Sum_probs=166.4
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+.+ +|||||++++++. +..+|+|||||.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 238 ~~l-~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 315 (454)
T 1qcf_A 238 KTL-QHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315 (454)
T ss_dssp TTC-CCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred hhC-CCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 455 8999999999987 56789999999999999999754 3689999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI 155 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 155 (315)
| ++.++.+||+|||+++....... .....+|+.|+|||++. +.++.++|||||||++|+|+| |..||.+.+..
T Consensus 316 l---l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 316 L---VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp E---ECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred E---ECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 9 56788999999999987643221 12344678899999986 569999999999999999999 99999999988
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+....+..+... + ....+|+++.++|.+||..||.+|||+++++.
T Consensus 393 ~~~~~i~~~~~~-~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 393 EVIRALERGYRM-P--RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHTCCC-C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 888888776322 2 22468999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=294.56 Aligned_cols=196 Identities=21% Similarity=0.333 Sum_probs=156.4
Q ss_pred CCCCCCCCCcceEEEEEE-eCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 1 MHHLSEHQHVVRIHDTYE-DKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~-~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
|+.+ +||||+++++++. .++..++||||+.||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 144 l~~l-~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 222 (373)
T 3c1x_A 144 MKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 222 (373)
T ss_dssp STTC-CCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHhC-CCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchhe
Confidence 3455 8999999999864 556889999999999999999765 468999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCC-----cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWA 151 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~ 151 (315)
|+ ++.++.+||+|||+++...... ......+|+.|+|||++. +.++.++||||+||++|+|++ |.+||.+
T Consensus 223 Il---l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~ 299 (373)
T 3c1x_A 223 CM---LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299 (373)
T ss_dssp EE---ECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred EE---ECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence 99 5677899999999997653322 112345778999999986 458999999999999999999 7888887
Q ss_pred CCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 152 ETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 152 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+....+..+.....+ ..+++++.+++.+||+.||.+|||+.++++
T Consensus 300 ~~~~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 300 VNTFDITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp SCSSCHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7766666666666533222 368999999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=292.34 Aligned_cols=198 Identities=21% Similarity=0.298 Sum_probs=158.8
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
.+ +||||+++++++.+++.+++||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 91 ~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N 169 (321)
T 2qkw_B 91 FC-RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSIN 169 (321)
T ss_dssp SC-CCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTT
T ss_pred hC-CCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHH
Confidence 44 89999999999999999999999999999999886543 58999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCC---CcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
|+ ++.++.+||+|||++...... .......||+.|+|||++. +.++.++||||+||++|+|++|..||.+...
T Consensus 170 il---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 170 IL---LDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp EE---ECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred EE---ECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 99 567889999999998764322 2223456899999999985 5699999999999999999999999976443
Q ss_pred HHHH-------HHHHhCCCC------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 155 IGIF-------RQILEGKID------FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 155 ~~~~-------~~i~~~~~~------~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.+.. .....+... ......+..++.+.+++.+||+.||.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2111 111111111 0111112346779999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=288.50 Aligned_cols=192 Identities=21% Similarity=0.271 Sum_probs=162.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.++. .++|+||+.+|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 75 ~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll--- 150 (327)
T 3poz_A 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--- 150 (327)
T ss_dssp CBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---
T ss_pred CCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---
Confidence 8999999999998765 77899999999999999774 679999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||+++....... .....||+.|+|||++. +.++.++||||+||++|+|++ |..||.+.+..+...
T Consensus 151 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 230 (327)
T 3poz_A 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230 (327)
T ss_dssp EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH
Confidence 5678899999999976543322 22345688999999986 458999999999999999999 999999888777776
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.+..+.... ..+.++.++.+++.+||+.||.+|||+.+++++
T Consensus 231 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 231 ILEKGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHTTCCCC---CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 666554222 224689999999999999999999999999853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=289.92 Aligned_cols=195 Identities=24% Similarity=0.328 Sum_probs=162.2
Q ss_pred CCCCCCcceEEEEEEeCC-eEEEEEeccCCCchhHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHH
Q 021227 4 LSEHQHVVRIHDTYEDKS-CVHIVMELCEGGELFDRIVKKGN----------------YSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~----------------~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
+.+||||+++++++.+.+ .+++||||++||+|.+++..... +++..+..++.|++.||.|||+
T Consensus 87 l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 166 (316)
T 2xir_A 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166 (316)
T ss_dssp HCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred cccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh
Confidence 447999999999988754 59999999999999999977644 8999999999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHH
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYIL 142 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 142 (315)
+||+||||||+||++ +.++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|
T Consensus 167 ~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 243 (316)
T 2xir_A 167 RKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243 (316)
T ss_dssp TTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCcccccCccceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHH
Confidence 999999999999995 5678999999999976543322 23456788999999986 4589999999999999999
Q ss_pred Hh-CCCCCCCCCH-HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 143 LS-GVPPFWAETE-IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 143 l~-g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
++ |..||.+... ......+..+... . ....+++++.+++.+||+.||.+|||+.++++|
T Consensus 244 ~t~g~~p~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 244 FSLGASPYPGVKIDEEFCRRLKEGTRM-R--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HTTSCCSSTTCCCSHHHHHHHHHTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCCcccchhHHHHHHhccCccC-C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 98 9999987653 3444444444321 1 123579999999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=281.84 Aligned_cols=197 Identities=23% Similarity=0.436 Sum_probs=153.9
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||++++++. ....+++||||+.|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 75 ~~l-~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil 152 (289)
T 3og7_A 75 RKT-RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIF 152 (289)
T ss_dssp TTC-CCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhC-CCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 344 899999999954 566789999999999999998544 57999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCC---CCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKP---DEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
+ +.++.+||+|||++..... ........||+.|+|||++. ..++.++||||+||++|+|++|..||.+..
T Consensus 153 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 153 L---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp E---ETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred E---CCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 5 5678999999999875532 22234467999999999984 347889999999999999999999998754
Q ss_pred -HHHHHHHHHhCCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 154 -EIGIFRQILEGKIDFES-EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 154 -~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.......+..+...... .....+|+++++++.+||+.+|.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 230 NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44455555555443332 233568999999999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=293.65 Aligned_cols=194 Identities=20% Similarity=0.326 Sum_probs=162.1
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--------------GNYSEREAAKLMKTIVGVVECCHSLGVF 70 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~iv 70 (315)
.+||||+++++++.+++.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+
T Consensus 107 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 186 (333)
T 2i1m_A 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCI 186 (333)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred cCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 48999999999999999999999999999999998653 3589999999999999999999999999
Q ss_pred cccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-C
Q 021227 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-G 145 (315)
Q Consensus 71 H~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g 145 (315)
||||||+||++ +.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |
T Consensus 187 H~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 263 (333)
T 2i1m_A 187 HRDVAARNVLL---TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 263 (333)
T ss_dssp CSCCSGGGCEE---EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cCCcccceEEE---CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCC
Confidence 99999999995 5678999999999976533221 23355788999999886 458999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 146 VPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 146 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..||.+.........+......... ...+++++.+++.+||+.||.+|||+.++++
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 264 LNPYPGILVNSKFYKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp CCSSTTCCSSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccchhHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999886654444444433332222 2357899999999999999999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=287.40 Aligned_cols=194 Identities=22% Similarity=0.284 Sum_probs=159.4
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.++. .++|+||+.+|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 72 ~~l-~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 149 (327)
T 3lzb_A 72 ASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149 (327)
T ss_dssp TTC-CBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhC-CCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEE
Confidence 344 8999999999998765 78999999999999999774 67999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI 155 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 155 (315)
+ +.++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++ |..||.+.+..
T Consensus 150 ~---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 150 V---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp E---EETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred E---cCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 5 5577899999999976543322 22345678899999986 458999999999999999999 99999998887
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+....+..+..... .+.+++++.+++.+||..||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 227 EISSILEKGERLPQ---PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp GHHHHHHTTCCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77777666543222 2468999999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=280.51 Aligned_cols=192 Identities=23% Similarity=0.331 Sum_probs=166.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+++.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 67 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~-- 144 (288)
T 3kfa_A 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV-- 144 (288)
T ss_dssp CCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE--
T ss_pred CCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE--
Confidence 7999999999999999999999999999999999764 459999999999999999999999999999999999994
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+|+++|+|++ |..||.+.+......
T Consensus 145 -~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~ 223 (288)
T 3kfa_A 145 -GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223 (288)
T ss_dssp -CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred -cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5678999999999976654332 23345688999999986 558999999999999999999 999999888777776
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+...... .....+|+++.+++.+||..||.+|||+.++++
T Consensus 224 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 224 LLEKDYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhccCCC---CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 66654322 223468999999999999999999999999974
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=281.62 Aligned_cols=193 Identities=24% Similarity=0.290 Sum_probs=165.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++ ..+.+++||||+.||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 68 ~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili--- 143 (287)
T 1u59_A 68 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL--- 143 (287)
T ss_dssp CCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---
T ss_pred CCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---
Confidence 899999999999 455689999999999999998654 569999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
+.++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++ |..||.+.+..+..
T Consensus 144 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 223 (287)
T 1u59_A 144 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 223 (287)
T ss_dssp EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH
T ss_pred cCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 4678999999999987643322 12345688999999986 458999999999999999998 99999998888887
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~ 205 (315)
..+..+.... ..+.+|+++.++|.+||+.||.+|||+.+++++.
T Consensus 224 ~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 224 AFIEQGKRME---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCcCC---CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 7777654321 2246899999999999999999999999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=283.10 Aligned_cols=194 Identities=21% Similarity=0.334 Sum_probs=163.3
Q ss_pred CCCCCCCcceEEEEE-EeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTY-EDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
++ +||||+++++++ .+++..++||||+.||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 82 ~l-~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil 160 (298)
T 3f66_A 82 DF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 160 (298)
T ss_dssp TC-CCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred hC-CCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEE
Confidence 44 799999999985 5667889999999999999999764 56899999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC-----cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAET 153 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 153 (315)
.+.++.+||+|||++....... ......||+.|+|||.+. ..++.++||||+||++|+|++ |.+||.+.+
T Consensus 161 ---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 161 ---LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp ---ECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred ---ECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 5678899999999997654332 123356788999999986 458999999999999999999 677887777
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 154 EIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 154 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+....+..+...... ..+++++.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 238 TFDITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTTHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 77777777766544333 357899999999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=284.09 Aligned_cols=194 Identities=20% Similarity=0.312 Sum_probs=154.2
Q ss_pred CCCCCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 3 HLSEHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
.+ +||||+++++++.. ...+++||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||
T Consensus 67 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Ni 145 (295)
T 3ugc_A 67 SL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI 145 (295)
T ss_dssp TC-CCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred hC-CCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhE
Confidence 44 79999999999854 466999999999999999997754 599999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
++ +.++.+||+|||++....... ......+++.|+|||++. ..++.++||||+||++|+|++|..|+.....
T Consensus 146 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 222 (295)
T 3ugc_A 146 LV---ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 222 (295)
T ss_dssp EE---EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH
T ss_pred EE---cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH
Confidence 95 567889999999998764332 122345777899999986 4589999999999999999999999865322
Q ss_pred H----------------HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 155 I----------------GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 155 ~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
. .....+.... .. +....+|+++.+++.+||+.||.+|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 223 EFMRMIGNDKQGQMIVFHLIELLKNNG-RL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTC-CC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhcCccccchhHHHHHHHHhccC-cC--CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 1222222222 11 223468999999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=285.49 Aligned_cols=192 Identities=19% Similarity=0.279 Sum_probs=157.3
Q ss_pred CCCCcceEEEEEEeCC-----eEEEEEeccCCCchhHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 6 EHQHVVRIHDTYEDKS-----CVHIVMELCEGGELFDRIVK------KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~-----~~~lv~E~~~gg~L~~~l~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
+||||+++++++.+.. ..++||||+.+|+|.+++.. ...+++..++.++.|++.||.|||++||+||||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~di 173 (313)
T 3brb_A 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173 (313)
T ss_dssp CCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCC
T ss_pred CCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 7999999999998755 45999999999999999843 356999999999999999999999999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPF 149 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf 149 (315)
||+||+ ++.++.+||+|||++....... ......+++.|+|||++. ..++.++|||||||++|+|++ |..||
T Consensus 174 kp~NIl---i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 250 (313)
T 3brb_A 174 AARNCM---LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250 (313)
T ss_dssp SGGGEE---ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CcceEE---EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999 5667899999999987654332 122345788999999986 458999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 150 WAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 150 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+....+....+..+.... ....+++++.+++.+||..||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 251 PGVQNHEMYDYLLHGHRLK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp TTCCGGGHHHHHHTTCCCC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHcCCCCC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9988877777777654322 22468999999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=284.36 Aligned_cols=195 Identities=21% Similarity=0.322 Sum_probs=164.2
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +||||+++++++.+.+.+++||||++|++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 84 ~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl 162 (319)
T 2y4i_B 84 RQT-RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVF 162 (319)
T ss_dssp TTC-CCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEE
T ss_pred hcC-CCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEE
Confidence 344 89999999999999999999999999999999987654 6999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCC------CCcccccccCccccchhhhhh----------cCCCchhHHHHHHHHHHHHh
Q 021227 81 FLSVDEDAALKATDFGLSVFYKP------DEVFSDVVGSPYYVAPEVLRK----------HYGPEADVWSAGVILYILLS 144 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwslG~il~~ll~ 144 (315)
+. ++.+||+|||++..... ........||+.|+|||++.+ .++.++||||+||++|+|++
T Consensus 163 ~~----~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 238 (319)
T 2y4i_B 163 YD----NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238 (319)
T ss_dssp EC------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH
T ss_pred Ee----CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 62 57899999998765421 122234568999999999853 36889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 145 GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 145 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|..||.+.........+..+..... ....+++++.+++.+||..||.+|||+.++++
T Consensus 239 g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 239 REWPFKTQPAEAIIWQMGTGMKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp SSCSSSSCCHHHHHHHHHTTCCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHhccCCCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999988888877776643322 22357899999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=279.33 Aligned_cols=191 Identities=23% Similarity=0.352 Sum_probs=160.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.++ ..|+||||+.|++|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 71 ~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~--- 146 (281)
T 3cc6_A 71 DHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV--- 146 (281)
T ss_dssp CCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---
T ss_pred CCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---
Confidence 799999999998765 468999999999999999765 469999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++ |..||......+....
T Consensus 147 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~ 226 (281)
T 3cc6_A 147 ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226 (281)
T ss_dssp EETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH
T ss_pred CCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH
Confidence 4577999999999876644322 23345788999999986 458999999999999999998 9999988777777776
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+..+..... ...+++.+.+++.+||..||.+|||+.++++
T Consensus 227 ~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 266 (281)
T 3cc6_A 227 LEKGDRLPK---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266 (281)
T ss_dssp HHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 666543222 2468999999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=280.64 Aligned_cols=193 Identities=28% Similarity=0.473 Sum_probs=164.6
Q ss_pred CCCCcceEEEEEEe----------------CCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC
Q 021227 6 EHQHVVRIHDTYED----------------KSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSL 67 (315)
Q Consensus 6 ~Hpniv~~~~~~~~----------------~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~ 67 (315)
+||||+++++++.. ...+++||||++||+|.+++.+. ..+++..+..++.|++.||.|||++
T Consensus 62 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 141 (284)
T 2a19_B 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK 141 (284)
T ss_dssp CCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 79999999999865 45689999999999999999754 6799999999999999999999999
Q ss_pred CCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCC
Q 021227 68 GVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGV 146 (315)
Q Consensus 68 ~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~ 146 (315)
||+||||||+||++ +.++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|.
T Consensus 142 ~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~ 218 (284)
T 2a19_B 142 KLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC 218 (284)
T ss_dssp TEECSCCSGGGEEE---EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCC
T ss_pred CeeeccCCHHHEEE---cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcC
Confidence 99999999999995 4678899999999987766555556779999999999864 5899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 147 PPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 147 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.|+... ......+..+.. ...++++++++|.+||+.||.+|||+.|++++.|...
T Consensus 219 ~~~~~~--~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 219 DTAFET--SKFFTDLRDGII------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp SSHHHH--HHHHHHHHTTCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred CcchhH--HHHHHHhhcccc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 987532 233444444322 1357899999999999999999999999999887654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=302.15 Aligned_cols=192 Identities=22% Similarity=0.338 Sum_probs=165.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+|||||++++++.++..+|+||||+.||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 274 ~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll-- 351 (495)
T 1opk_A 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV-- 351 (495)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred CCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE--
Confidence 8999999999999999999999999999999999764 459999999999999999999999999999999999994
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||+++....... .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.+..+..+
T Consensus 352 -~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~ 430 (495)
T 1opk_A 352 -GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430 (495)
T ss_dssp -CGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred -CCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5678999999999987643322 12344678899999986 558999999999999999999 999999988777777
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+. .. .....+++++.++|.+||+.||.+|||+.++++
T Consensus 431 ~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 431 LLEKDY-RM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHTTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCC-CC--CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 665542 22 223468999999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=279.35 Aligned_cols=193 Identities=22% Similarity=0.338 Sum_probs=157.6
Q ss_pred CCCCCCCCcceEEEEEEeC-CeEEEEEeccCCCchhHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 2 HHLSEHQHVVRIHDTYEDK-SCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+.+ +||||+++++++.+. +.+|+||||++||+|.+++.+.+. +++..+..++.|++.||+|||++|++||||||+|
T Consensus 69 ~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 147 (278)
T 1byg_A 69 TQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 147 (278)
T ss_dssp TTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HhC-CCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcce
Confidence 345 899999999997544 579999999999999999976543 8999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 156 (315)
|+ ++.++.+||+|||++....... ....+++.|+|||++. ..++.++||||+|+++|+|++ |..||.+.+..+
T Consensus 148 il---~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 222 (278)
T 1byg_A 148 VL---VSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222 (278)
T ss_dssp EE---ECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred EE---EeCCCcEEEeeccccccccccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99 5667899999999987554332 3346788999999986 458999999999999999998 999999888777
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
....+..+.. ......+|+++.+++.+||+.||.+|||+.++++
T Consensus 223 ~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 223 VVPRVEKGYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHTTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 7777665432 2223468999999999999999999999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=308.84 Aligned_cols=191 Identities=21% Similarity=0.282 Sum_probs=163.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+|||||+++++++++ .+++|||||.||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+ +
T Consensus 428 ~hpnIv~l~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~ 503 (635)
T 4fl3_A 428 DNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---V 503 (635)
T ss_dssp CCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---E
T ss_pred CCCCEeeEEEEEecC-CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---e
Confidence 799999999999754 588999999999999999888899999999999999999999999999999999999995 4
Q ss_pred CCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
.++.+||+|||+++....... .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 504 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~ 583 (635)
T 4fl3_A 504 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 583 (635)
T ss_dssp ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 677999999999986644321 223456788999999874 69999999999999999998 999999999988888
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+..... ...+|+++.++|.+||+.||.+|||+.++++
T Consensus 584 ~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 584 MLEKGERMGC---PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHTTCCCCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCCCC---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 8877653222 2468999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=297.96 Aligned_cols=198 Identities=23% Similarity=0.463 Sum_probs=162.0
Q ss_pred CCCCcceEEEEEEeCC--eEEEEEeccCCCchhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDKS--CVHIVMELCEGGELFDRIVKKG---NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+||||+++++++.+.. ..|+|||||+||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 65 ~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 144 (396)
T 4eut_A 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144 (396)
T ss_dssp CCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEE
Confidence 7999999999998765 7899999999999999986543 3999999999999999999999999999999999999
Q ss_pred ecc-CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh---------hcCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 81 FLS-VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR---------KHYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 81 ~~~-~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
+.. .+..+.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.
T Consensus 145 l~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~ 224 (396)
T 4eut_A 145 RVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (396)
T ss_dssp EEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred EeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 521 2556779999999998876666556678999999999885 357889999999999999999999996
Q ss_pred C----CCHHHHHHHHHhCCCCC---------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 151 A----ETEIGIFRQILEGKIDF---------------------ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 151 ~----~~~~~~~~~i~~~~~~~---------------------~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+ ....+....+..+.... .......+++.+.++|.+||+.||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 4 23345555565544321 00111234568899999999999999999999854
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=281.04 Aligned_cols=193 Identities=27% Similarity=0.522 Sum_probs=153.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+||||+++++++.+++.+++||||+.||+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 90 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl- 168 (310)
T 2wqm_A 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF- 168 (310)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE-
T ss_pred CCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEE-
Confidence 899999999999999999999999999999998864 467999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAE--TEIGI 157 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~ 157 (315)
++.++.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+. +....
T Consensus 169 --~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 246 (310)
T 2wqm_A 169 --ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246 (310)
T ss_dssp --ECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH
T ss_pred --EcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH
Confidence 4677899999999987654332 233467899999999986 45899999999999999999999999764 34455
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
...+...... ......++++++++|.+||..||.+|||+.++++
T Consensus 247 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 247 CKKIEQCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHTTCSC--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhhcccCC--CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5556554432 2233568999999999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=279.69 Aligned_cols=192 Identities=21% Similarity=0.322 Sum_probs=161.6
Q ss_pred CCCCcceEEEEEEeCCeE-EEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCV-HIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~-~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+.+.. ++||||+.+|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 80 ~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil--- 156 (298)
T 3pls_A 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCM--- 156 (298)
T ss_dssp CCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE---
T ss_pred CCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE---
Confidence 899999999999876655 999999999999999976 357899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCC-----cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 156 (315)
.+.++.+||+|||++....... ......+|+.|+|||.+.+ .++.++||||+||++|+|++ |.+||...+..+
T Consensus 157 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~ 236 (298)
T 3pls_A 157 LDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236 (298)
T ss_dssp ECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG
T ss_pred EcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH
Confidence 5677899999999997654322 2234567889999999874 58999999999999999999 556666666666
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
....+..+..... ...+++++.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 237 LTHFLAQGRRLPQ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCCCC---CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 6666666543222 2468999999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=297.31 Aligned_cols=198 Identities=22% Similarity=0.328 Sum_probs=163.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+ +.+|+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 237 ~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill-- 313 (452)
T 1fmk_A 237 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV-- 313 (452)
T ss_dssp CCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE--
Confidence 89999999999876 6789999999999999999643 569999999999999999999999999999999999994
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||+++....... .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+....+...
T Consensus 314 -~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~ 392 (452)
T 1fmk_A 314 -GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 392 (452)
T ss_dssp -CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred -CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5678999999999986543321 22345678899999986 568999999999999999999 999999999888888
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCccCC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC--HPWIVDD 210 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~--h~~~~~~ 210 (315)
.+..+... + ..+.+|+++.++|.+||+.||.+|||++++++ ..++...
T Consensus 393 ~i~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 393 QVERGYRM-P--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHTTCCC-C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHcCCCC-C--CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 88765322 1 22468999999999999999999999999986 3555443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=279.13 Aligned_cols=192 Identities=20% Similarity=0.318 Sum_probs=164.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.++. .++|+||+.+|+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 79 ~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili--- 154 (291)
T 1u46_A 79 DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL--- 154 (291)
T ss_dssp CCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---
T ss_pred CCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---
Confidence 7999999999998765 88999999999999998764 579999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
+.++.+||+|||++........ .....+|+.|+|||++.+ .++.++||||+|+++|+|++ |..||.+.+..+..
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 234 (291)
T 1u46_A 155 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 234 (291)
T ss_dssp EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH
Confidence 4577899999999877644322 223457888999999864 58899999999999999999 99999999988888
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+......++. ...+|+++.+++.+||..||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 235 HKIDKEGERLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCCCCCC--CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 888776544433 2468999999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=311.32 Aligned_cols=203 Identities=24% Similarity=0.377 Sum_probs=164.6
Q ss_pred CCCCcceEEEEEEe------CCeEEEEEeccCCCchhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 021227 6 EHQHVVRIHDTYED------KSCVHIVMELCEGGELFDRIVKKG---NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKP 76 (315)
Q Consensus 6 ~Hpniv~~~~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp 76 (315)
+||||+++++++.+ ++..|+|||||+||+|.+++.... .+++..++.++.|++.||+|||+.||+||||||
T Consensus 70 ~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP 149 (676)
T 3qa8_A 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKP 149 (676)
T ss_dssp CBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCS
T ss_pred CCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCH
Confidence 89999999999866 678899999999999999997654 699999999999999999999999999999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
+||++...+....+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+....
T Consensus 150 ~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~ 229 (676)
T 3qa8_A 150 ENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229 (676)
T ss_dssp TTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH
T ss_pred HHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch
Confidence 99997654445569999999998876666566678999999999986 55899999999999999999999999775433
Q ss_pred HHHHHH--------------HhCCCCC------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 156 GIFRQI--------------LEGKIDF------ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 156 ~~~~~i--------------~~~~~~~------~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
..+... ..+...+ +....+.+++.+.++|.+||..||.+|||+.++++||||.
T Consensus 230 ~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 230 VQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp HHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred hhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence 221000 0111111 1112234678999999999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=284.26 Aligned_cols=200 Identities=19% Similarity=0.222 Sum_probs=158.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCCCC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG----NYSEREAAKLMKTIVGVVECCHSL---GVFHRDLKPE 77 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dikp~ 77 (315)
.+||||+++++++.+.+..++||||+.||+|.+++.... ++++..+..++.|++.||+|||++ ||+||||||+
T Consensus 84 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 379999999999999999999999999999999997643 499999999999999999999999 9999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCC--
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAE-- 152 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-- 152 (315)
||+ ++.++.+||+|||++....... ......||+.|+|||++. +.++.++||||+||++|+|++|..||...
T Consensus 164 Nil---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (326)
T 3uim_A 164 NIL---LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240 (326)
T ss_dssp GEE---ECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred hEE---ECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccc
Confidence 999 5677899999999997654322 234456999999999985 55899999999999999999999999521
Q ss_pred ---CHHHHHHHHHhCCCC----------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 153 ---TEIGIFRQILEGKID----------FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 153 ---~~~~~~~~i~~~~~~----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
........+...... .........++++.+++.+||+.||.+|||+.++++|-+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 111111111110000 0011112234789999999999999999999999987643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.06 Aligned_cols=191 Identities=23% Similarity=0.336 Sum_probs=164.1
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG--NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+ +..++||||+.|++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 66 ~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil--- 141 (279)
T 1qpc_A 66 QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL--- 141 (279)
T ss_dssp CCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE---
T ss_pred CCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEE---
Confidence 89999999999875 45889999999999999886543 6999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
++.++.+||+|||++........ .....+++.|+|||++. +.++.++||||+||++|+|++ |..||.+.+..+...
T Consensus 142 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 221 (279)
T 1qpc_A 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221 (279)
T ss_dssp ECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred EcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 46778999999999987654332 22345678899999986 558999999999999999999 999999998888888
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+.... ....+++++.+++.+||..||.+|||++++++
T Consensus 222 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 222 NLERGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcccCCC---CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 877653222 22468999999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=279.12 Aligned_cols=194 Identities=25% Similarity=0.368 Sum_probs=158.0
Q ss_pred CCCCCCCcceEEEEEEeC--CeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 3 HLSEHQHVVRIHDTYEDK--SCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~--~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
.+ +||||+++++++.+. +.+++||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||
T Consensus 79 ~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Ni 157 (302)
T 4e5w_A 79 NL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV 157 (302)
T ss_dssp TC-CCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred hC-CCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheE
Confidence 44 799999999999877 679999999999999999954 46799999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCC--
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAE-- 152 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-- 152 (315)
++ +.++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++|..|+...
T Consensus 158 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 234 (302)
T 4e5w_A 158 LV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234 (302)
T ss_dssp EE---EETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred EE---cCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh
Confidence 95 5577999999999987654432 23456888899999986 45889999999999999999999875321
Q ss_pred ------------CH-HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 153 ------------TE-IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 153 ------------~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.. ......+..+. .. ...+.+|+++.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 235 LFLKMIGPTHGQMTVTRLVNTLKEGK-RL--PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHCSCCGGGHHHHHHHHHHTTC-CC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHhhccCCcccccCHHHHHHHHhccC-CC--CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11 22223333322 22 223468999999999999999999999999974
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=282.75 Aligned_cols=195 Identities=25% Similarity=0.356 Sum_probs=160.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK---KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
+||||+++++++.+++..++||||++||+|.+++.. ..++++..+..++.|++.||.|||++||+||||||+||+
T Consensus 88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil-- 165 (307)
T 2nru_A 88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL-- 165 (307)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE--
T ss_pred CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEE--
Confidence 799999999999999999999999999999999864 356999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIG--- 156 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--- 156 (315)
++.++.+||+|||++....... ......||+.|+|||++.+.++.++|||||||++|+|++|..||.+.....
T Consensus 166 -i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 -LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp -ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred -EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 5678899999999987654322 123457999999999998889999999999999999999999998754322
Q ss_pred -HHHHHHhCCCCC-------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 -IFRQILEGKIDF-------ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 -~~~~i~~~~~~~-------~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
....+......+ ........++.+.+++.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 222222221110 01111235678999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=279.89 Aligned_cols=197 Identities=19% Similarity=0.194 Sum_probs=156.9
Q ss_pred CCCC-cceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQH-VVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpn-iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.|++ +..+..++.++...++||||+ |++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||++..
T Consensus 62 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 140 (296)
T 3uzp_A 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140 (296)
T ss_dssp TTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred hcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEec
Confidence 4555 555555667888999999999 8999999974 467999999999999999999999999999999999999743
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--------ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--------FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAET- 153 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~- 153 (315)
.+.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+..
T Consensus 141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 141 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 35778999999999976644322 245679999999999874 58999999999999999999999998632
Q ss_pred --HHHHHHHHHhCCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 154 --EIGIFRQILEGKIDFES-EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 154 --~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..+....+.......+. ...+.+|+++.+++.+||+.||.+|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 22233333332222221 112468999999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=281.41 Aligned_cols=195 Identities=23% Similarity=0.358 Sum_probs=153.5
Q ss_pred CCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCccc
Q 021227 5 SEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH--------SLGVFHR 72 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------~~~ivH~ 72 (315)
.+||||+++++++.+ ...+++||||++||+|.+++ +...+++..+..++.|++.||+||| ++||+||
T Consensus 59 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 137 (301)
T 3q4u_A 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137 (301)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHH-TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECS
T ss_pred ccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHH-hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecC
Confidence 489999999998654 35689999999999999998 4567999999999999999999999 9999999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCCCc-----ccccccCccccchhhhhh-------cCCCchhHHHHHHHHH
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-----FSDVVGSPYYVAPEVLRK-------HYGPEADVWSAGVILY 140 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~ 140 (315)
||||+||+ ++.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+||++|
T Consensus 138 Dlkp~Nil---l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~ 214 (301)
T 3q4u_A 138 DLKSKNIL---VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214 (301)
T ss_dssp CCCGGGEE---ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred CCChHhEE---EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHH
Confidence 99999999 56778999999999876543322 223579999999999864 3457899999999999
Q ss_pred HHHhC----------CCCCCCCC----HHHHHHHHHh-CCCCCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 141 ILLSG----------VPPFWAET----EIGIFRQILE-GKIDFESEP---WPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 141 ~ll~g----------~~pf~~~~----~~~~~~~i~~-~~~~~~~~~---~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
+|++| ..||.... .......... .......+. ...+++++.+++.+||+.||.+|||+.+++
T Consensus 215 el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 294 (301)
T 3q4u_A 215 EVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294 (301)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 99999 88886532 2222333222 211111110 012557899999999999999999999997
Q ss_pred c
Q 021227 203 C 203 (315)
Q Consensus 203 ~ 203 (315)
+
T Consensus 295 ~ 295 (301)
T 3q4u_A 295 K 295 (301)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=280.17 Aligned_cols=196 Identities=23% Similarity=0.305 Sum_probs=154.4
Q ss_pred CCCCCcceEEEEEEeC----CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccc
Q 021227 5 SEHQHVVRIHDTYEDK----SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL--------GVFHR 72 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------~ivH~ 72 (315)
.+||||+++++++.+. ..+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++ ||+||
T Consensus 88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 166 (337)
T 3mdy_A 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166 (337)
T ss_dssp CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECS
T ss_pred hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEec
Confidence 4899999999999887 789999999999999999955 4799999999999999999999998 99999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCCCc-----ccccccCccccchhhhhhc-CCCc------hhHHHHHHHHH
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV-----FSDVVGSPYYVAPEVLRKH-YGPE------ADVWSAGVILY 140 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~------~DiwslG~il~ 140 (315)
||||+||+ ++.++.+||+|||++........ .....||+.|+|||++.+. ++.. +||||+||++|
T Consensus 167 Dikp~Nil---l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 243 (337)
T 3mdy_A 167 DLKSKNIL---VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243 (337)
T ss_dssp CCCGGGEE---ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHH
T ss_pred ccchHHEE---ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHH
Confidence 99999999 56778999999999976543322 1245799999999998643 4443 89999999999
Q ss_pred HHHhC----------CCCCCCC-----CHHHHHHHHHhCCCCCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 141 ILLSG----------VPPFWAE-----TEIGIFRQILEGKIDFESEP---WPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 141 ~ll~g----------~~pf~~~-----~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
+|++| ..||... ........+.........+. ...+++++.+++.+||+.||.+|||+.+++
T Consensus 244 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 244 EVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 99999 7777542 22223222322222211111 124567899999999999999999999998
Q ss_pred cC
Q 021227 203 CH 204 (315)
Q Consensus 203 ~h 204 (315)
++
T Consensus 324 ~~ 325 (337)
T 3mdy_A 324 KT 325 (337)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.53 Aligned_cols=193 Identities=24% Similarity=0.328 Sum_probs=162.4
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+.+ +|||||++++++.+ +.+|+|||||.||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 391 ~~l-~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL 468 (613)
T 2ozo_A 391 HQL-DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468 (613)
T ss_dssp TTC-CCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhC-CCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEE
Confidence 445 89999999999987 5689999999999999998654 56999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcc----cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVF----SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETE 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 154 (315)
+ +.++.+||+|||+++........ ....+|+.|+|||++. +.++.++|||||||++|+|++ |..||.+.+.
T Consensus 469 l---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 469 L---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp E---EETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred E---cCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 5 56789999999999876433211 1234568899999986 569999999999999999998 9999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
.+....+..+.... ....+++++.++|.+||..+|.+|||+.+++
T Consensus 546 ~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 546 PEVMAFIEQGKRME---CPPECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 88888887764321 2246899999999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=283.45 Aligned_cols=195 Identities=22% Similarity=0.334 Sum_probs=159.9
Q ss_pred CCCCCCCcceEEEEEE--eCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 3 HLSEHQHVVRIHDTYE--DKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~--~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
.+ +||||+++++++. +.+.+|+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||
T Consensus 80 ~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NI 158 (327)
T 3lxl_A 80 AL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNI 158 (327)
T ss_dssp TC-CCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred hc-CCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhE
Confidence 44 8999999999986 56779999999999999999976 35699999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
++ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.....
T Consensus 159 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 159 LV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp EE---EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred EE---CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 95 5678899999999986643321 233567888999999864 489999999999999999999999865432
Q ss_pred H---------------HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 155 I---------------GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 155 ~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
. .....+..+. .. ...+.+++++.++|.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 236 EFLRMMGCERDVPALSRLLELLEEGQ-RL--PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHCC----CCHHHHHHHHHHTTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhhcccccccccHHHHHHHhhccc-CC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 2223333322 22 2234689999999999999999999999999643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=280.27 Aligned_cols=199 Identities=19% Similarity=0.188 Sum_probs=157.3
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
+.+|++|..+..++.++...++||||+ ||+|.+++.. .+++++..+..++.|++.||+|||++||+||||||+||++.
T Consensus 61 l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 139 (296)
T 4hgt_A 61 MQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp HTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred hcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeee
Confidence 334445555666668889999999999 8999999875 46799999999999999999999999999999999999974
Q ss_pred cCCCCCCEEEeeccCcccCCCCC--------cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE--------VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
..+.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+
T Consensus 140 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 33678899999999998664432 1235679999999999874 58999999999999999999999997643
Q ss_pred H---HHHHHHHHhCCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 154 E---IGIFRQILEGKIDFES-EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 154 ~---~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
. ......+.......+. .....+|+++.+++.+||+.||.+|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 220 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 2 1222222222222211 112457899999999999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=286.38 Aligned_cols=206 Identities=24% Similarity=0.338 Sum_probs=153.5
Q ss_pred CCCCCCcceEEEEEEe-----CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CC
Q 021227 4 LSEHQHVVRIHDTYED-----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL---------GV 69 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---------~i 69 (315)
..+||||+++++.+.. ...+|+|||||+||+|.+++... ..++..+..++.|++.||.|||+. ||
T Consensus 63 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~i 141 (336)
T 3g2f_A 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141 (336)
T ss_dssp TCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCE
T ss_pred hccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccce
Confidence 3589999999986542 34689999999999999999654 459999999999999999999999 99
Q ss_pred ccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---------cccccccCccccchhhhhh--------cCCCchhH
Q 021227 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---------VFSDVVGSPYYVAPEVLRK--------HYGPEADV 132 (315)
Q Consensus 70 vH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~Di 132 (315)
+||||||+||| ++.++.+||+|||++....... ......||+.|+|||++.+ .++.++||
T Consensus 142 vH~Dikp~Nil---l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 218 (336)
T 3g2f_A 142 SHRDLNSRNVL---VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218 (336)
T ss_dssp ECSSCSGGGEE---ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHH
T ss_pred eecccccceEE---EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccch
Confidence 99999999999 4567899999999997654321 1234579999999999864 46778999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC------------------HHHHHHHHHhCCCCCC-CCCC---CCCCHHHHHHHHHhccc
Q 021227 133 WSAGVILYILLSGVPPFWAET------------------EIGIFRQILEGKIDFE-SEPW---PNISESAKDLIRKMLDQ 190 (315)
Q Consensus 133 wslG~il~~ll~g~~pf~~~~------------------~~~~~~~i~~~~~~~~-~~~~---~~~s~~~~~li~~~l~~ 190 (315)
|||||++|+|++|..||.... .......+........ +..+ ..+++++.++|.+||+.
T Consensus 219 wslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (336)
T 3g2f_A 219 YALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298 (336)
T ss_dssp HHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCS
T ss_pred HHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcC
Confidence 999999999999976653211 1111111222111111 1111 22556899999999999
Q ss_pred CCCCCCCHHHHh------cCCCccCCCCC
Q 021227 191 NPKRRLTAHEVL------CHPWIVDDKVA 213 (315)
Q Consensus 191 ~p~~R~s~~~~l------~h~~~~~~~~~ 213 (315)
||.+|||+.|++ -++|-++....
T Consensus 299 dP~~Rps~~e~l~~L~~ll~~~~~~~~~~ 327 (336)
T 3g2f_A 299 DAEARLTAQXAEERMAELMMIWERNKSVS 327 (336)
T ss_dssp SGGGSCCHHHHHHHHHHHHHCCCC-----
T ss_pred ChhhCcchHHHHHHHHHHHHHHHhcccCC
Confidence 999999999994 56777665443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=276.93 Aligned_cols=191 Identities=23% Similarity=0.337 Sum_probs=157.0
Q ss_pred CCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+||||+++++++.+ ...+++||||+++|+|.+++.+. ++++..+..++.|++.||.|||++||+||||||+||+
T Consensus 91 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil--- 166 (318)
T 3lxp_A 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVL--- 166 (318)
T ss_dssp CCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE---
T ss_pred CCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEE---
Confidence 79999999999988 46899999999999999988654 5999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEI--- 155 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--- 155 (315)
++.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|..||......
T Consensus 167 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 246 (318)
T 3lxp_A 167 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246 (318)
T ss_dssp ECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred EcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh
Confidence 56778999999999987654332 234567888999999874 5889999999999999999999998654221
Q ss_pred ------------HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 156 ------------GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 156 ------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.....+..+. .. .....+|+++.++|.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 247 LIGIAQGQMTVLRLTELLERGE-RL--PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHCSCCHHHHHHHHHHHHHTTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcccccchhHHHHHHHHhccc-CC--CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1222222222 21 223468999999999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=283.64 Aligned_cols=187 Identities=16% Similarity=0.201 Sum_probs=152.7
Q ss_pred EEEEEEe-CCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCC-
Q 021227 13 IHDTYED-KSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDA- 88 (315)
Q Consensus 13 ~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~- 88 (315)
+++++.. ++.+|+||||+ ||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++ +.++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~---~~~~~ 197 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV---DPEDQ 197 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE---ETTEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---cCCCC
Confidence 7888876 78899999999 99999999876 789999999999999999999999999999999999996 4455
Q ss_pred -CEEEeeccCcccCCCCC--------cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHH
Q 021227 89 -ALKATDFGLSVFYKPDE--------VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE--TEIG 156 (315)
Q Consensus 89 -~ikl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~ 156 (315)
.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. +...
T Consensus 198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 277 (352)
T 2jii_A 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED 277 (352)
T ss_dssp EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH
Confidence 89999999997654321 1234579999999999875 5899999999999999999999999875 3333
Q ss_pred HHHHH---HhCCCCCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQI---LEGKIDFE--SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i---~~~~~~~~--~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
..... ......+. ...+..+++++.+++.+||+.||.+|||++++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 278 IMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 33322 22222221 2223467999999999999999999999999974
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=275.15 Aligned_cols=188 Identities=27% Similarity=0.449 Sum_probs=149.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG---NYSEREAAKLMKTIVGVVECCHS---LGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dikp~ni 79 (315)
+||||+++++++.+ ..++||||++||+|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+||
T Consensus 59 ~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NI 136 (307)
T 2eva_A 59 NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136 (307)
T ss_dssp CCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGE
T ss_pred CCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHE
Confidence 89999999998874 4789999999999999997654 47899999999999999999999 8999999999999
Q ss_pred eeccCCCCC-CEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC--CHH
Q 021227 80 LFLSVDEDA-ALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE--TEI 155 (315)
Q Consensus 80 l~~~~~~~~-~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~ 155 (315)
++ +.++ .+||+|||++...... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||... ...
T Consensus 137 ll---~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 211 (307)
T 2eva_A 137 LL---VAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211 (307)
T ss_dssp EE---ETTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH
T ss_pred EE---eCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH
Confidence 96 3344 4899999998755332 234568999999999874 5899999999999999999999999754 333
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.....+..+.. ......+|+.+.+++.+||+.||.+|||++++++
T Consensus 212 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 212 RIMWAVHNGTR---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHHTTCC---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCC---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 34444444322 2223568999999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=297.68 Aligned_cols=197 Identities=22% Similarity=0.329 Sum_probs=167.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+|||||++++++.+ +.+|+||||+.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 320 ~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll-- 396 (535)
T 2h8h_A 320 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV-- 396 (535)
T ss_dssp CCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE--
Confidence 79999999999876 6789999999999999999643 569999999999999999999999999999999999995
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||+++....... .....++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+...
T Consensus 397 -~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~ 475 (535)
T 2h8h_A 397 -GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 475 (535)
T ss_dssp -CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH
T ss_pred -cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5678999999999976543221 12345678899999986 568999999999999999999 999999999888888
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC--CCccC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH--PWIVD 209 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h--~~~~~ 209 (315)
.+..+... + ....+++++.++|.+||+.||.+|||++++++. .++..
T Consensus 476 ~i~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 476 QVERGYRM-P--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHHcCCCC-C--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 88765321 1 224689999999999999999999999999863 55543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=298.77 Aligned_cols=191 Identities=25% Similarity=0.370 Sum_probs=162.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+||||+++++++.+ +..|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 449 ~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl--- 524 (656)
T 2j0j_A 449 DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--- 524 (656)
T ss_dssp CCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---
Confidence 89999999999854 5689999999999999999765 469999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++ |..||.+.+..+....
T Consensus 525 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~ 604 (656)
T 2j0j_A 525 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604 (656)
T ss_dssp EETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred eCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 4578999999999987644332 12345678999999986 458999999999999999997 9999999998888888
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+..+.... ..+.+|+++.++|.+||..||.+|||+.++++
T Consensus 605 i~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 605 IENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCC---CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 87764322 22468999999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.96 Aligned_cols=194 Identities=22% Similarity=0.328 Sum_probs=155.8
Q ss_pred CCCCcceEEEEEE----eCCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 6 EHQHVVRIHDTYE----DKSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 6 ~Hpniv~~~~~~~----~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
+||||+++++++. .....++||||+.+|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~ 163 (317)
T 2buj_A 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPT 163 (317)
T ss_dssp CCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 8999999999997 34578999999999999998875 467999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCCc----------ccccccCccccchhhhhh----cCCCchhHHHHHHHHHHHH
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDEV----------FSDVVGSPYYVAPEVLRK----HYGPEADVWSAGVILYILL 143 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll 143 (315)
||+ ++.++.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 164 NIl---~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 240 (317)
T 2buj_A 164 NIL---LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240 (317)
T ss_dssp GEE---ECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred HEE---EcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence 999 56778999999998865432110 123457999999999853 2689999999999999999
Q ss_pred hCCCCCCCCCH--HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 021227 144 SGVPPFWAETE--IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205 (315)
Q Consensus 144 ~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~ 205 (315)
+|..||..... ......+. ....++ ..+.+++++.++|.+||+.||.+|||+.+++++-
T Consensus 241 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 241 FGEGPYDMVFQKGDSVALAVQ-NQLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HSSCTTHHHHHTTSCHHHHHH-CC--CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hCCCChhhhhcccchhhHHhh-ccCCCC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 99999954111 11122222 222222 2356899999999999999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=281.64 Aligned_cols=193 Identities=29% Similarity=0.479 Sum_probs=139.4
Q ss_pred CCCCCCcceEEEEEE--------eCCeEEEEEeccCCCchhHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--Cc
Q 021227 4 LSEHQHVVRIHDTYE--------DKSCVHIVMELCEGGELFDRIVK---KGNYSEREAAKLMKTIVGVVECCHSLG--VF 70 (315)
Q Consensus 4 l~~Hpniv~~~~~~~--------~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--iv 70 (315)
+.+||||+++++++. ....+++||||+. |+|.+++.. .+++++..+..++.|++.||.|||++| |+
T Consensus 82 l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~iv 160 (337)
T 3ll6_A 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII 160 (337)
T ss_dssp HTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCB
T ss_pred hccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Confidence 446999999999994 4456899999996 688888765 467999999999999999999999999 99
Q ss_pred cccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcc-------------cccccCccccchhhhh----hcCCCchhHH
Q 021227 71 HRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF-------------SDVVGSPYYVAPEVLR----KHYGPEADVW 133 (315)
Q Consensus 71 H~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~Diw 133 (315)
||||||+||+ ++.++.+||+|||++......... ....||+.|+|||++. ..++.++|||
T Consensus 161 H~Dikp~NIl---~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~ 237 (337)
T 3ll6_A 161 HRDLKVENLL---LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW 237 (337)
T ss_dssp CCCCCGGGCE---ECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHH
T ss_pred EccCCcccEE---ECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHH
Confidence 9999999999 566789999999999876433211 1456899999999972 3478899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 021227 134 SAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPW 206 (315)
Q Consensus 134 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~ 206 (315)
||||++|+|++|..||.+........ .....+ .....++.+.++|.+||+.||.+|||+.|++++.+
T Consensus 238 slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 238 ALGCILYLLCFRQHPFEDGAKLRIVN----GKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp HHHHHHHHHHHSSCCC----------------CCCC--TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCcchhHHHhhc----CcccCC--cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999997765543322 222222 23457788999999999999999999999997643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=279.23 Aligned_cols=196 Identities=22% Similarity=0.322 Sum_probs=159.1
Q ss_pred CCCCCcceEEEEEEeCC----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCccc
Q 021227 5 SEHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH--------SLGVFHR 72 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH--------~~~ivH~ 72 (315)
.+||||+++++++.+.. .+|+||||+++|+|.+++.+ .++++..++.++.|++.||.||| +.||+||
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 171 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeC
Confidence 48999999999998876 89999999999999999965 47999999999999999999999 8999999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCCC-----cccccccCccccchhhhhhc-------CCCchhHHHHHHHHH
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPEVLRKH-------YGPEADVWSAGVILY 140 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~ 140 (315)
||||+||+ ++.++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|
T Consensus 172 Dlkp~NIl---l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 248 (342)
T 1b6c_B 172 DLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248 (342)
T ss_dssp CCSGGGEE---ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEE---ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHH
Confidence 99999999 5667899999999997654433 22445799999999998643 336899999999999
Q ss_pred HHHhC----------CCCCCCC-----CHHHHHHHHHhCCCCCCCCC-C--CCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 141 ILLSG----------VPPFWAE-----TEIGIFRQILEGKIDFESEP-W--PNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 141 ~ll~g----------~~pf~~~-----~~~~~~~~i~~~~~~~~~~~-~--~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
+|++| ..||... ........+.........+. + ..+++.+.+++.+||+.||.+|||+.+++
T Consensus 249 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 249 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 99999 7888764 23444444444433322211 1 13446899999999999999999999998
Q ss_pred cC
Q 021227 203 CH 204 (315)
Q Consensus 203 ~h 204 (315)
++
T Consensus 329 ~~ 330 (342)
T 1b6c_B 329 KT 330 (342)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=283.98 Aligned_cols=190 Identities=17% Similarity=0.206 Sum_probs=153.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-----KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.||||+++++++..++..|+|||||+||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIl 204 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFI 204 (365)
T ss_dssp GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEE
Confidence 499999999999999999999999999999999974 467999999999999999999999999999999999999
Q ss_pred ecc--------CCCCCCEEEeeccCcccCC---CCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCC
Q 021227 81 FLS--------VDEDAALKATDFGLSVFYK---PDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPP 148 (315)
Q Consensus 81 ~~~--------~~~~~~ikl~Dfg~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 148 (315)
+.. .+..+.+||+|||+++... ........+||+.|+|||++.+ .++.++|||||||++|+|+||..|
T Consensus 205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 284 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284 (365)
T ss_dssp ECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred ecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence 643 1227899999999996542 3334456789999999999874 489999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 149 FWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 149 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|........ .....+.. ...++.+.+++.+||+.+|.+|++..+.+.
T Consensus 285 f~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 285 KVKNEGGEC-----KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp CEEEETTEE-----EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred cccCCCCce-----eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 965432100 00001111 124678999999999999999976544443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=289.48 Aligned_cols=200 Identities=19% Similarity=0.203 Sum_probs=162.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.|.+|++|..+..++.+....++||||+ |++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 58 ~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl 136 (483)
T 3sv0_A 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136 (483)
T ss_dssp HTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEE
Confidence 4556678888888888999999999999 8999999975 4679999999999999999999999999999999999997
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCc--------ccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEV--------FSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
...+..+.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 137 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~ 216 (483)
T 3sv0_A 137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (483)
T ss_dssp CCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 4335788999999999987644322 125679999999999864 5899999999999999999999999874
Q ss_pred C---HHHHHHHHHhCCCCCCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 153 T---EIGIFRQILEGKIDFES-EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 153 ~---~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
. ..+.+..+......... .....+++++.++|.+||+.+|.+||++.++++
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 217 KAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3 34444444332221111 111367899999999999999999999988753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=274.48 Aligned_cols=194 Identities=20% Similarity=0.299 Sum_probs=156.3
Q ss_pred CCCCCCCcceEEEEEEeCC--eEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 3 HLSEHQHVVRIHDTYEDKS--CVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
.+ +||||+++++++.+.+ .+++||||++||+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 98 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NI 176 (326)
T 2w1i_A 98 SL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI 176 (326)
T ss_dssp TC-CCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred hC-CCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceE
Confidence 44 7999999999987654 789999999999999999876 4699999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
++ +.++.+||+|||++........ .....+++.|+|||++. ..++.++||||+||++|+|++|..||.....
T Consensus 177 li---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 253 (326)
T 2w1i_A 177 LV---ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253 (326)
T ss_dssp EE---EETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH
T ss_pred EE---cCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH
Confidence 95 5578999999999987654322 22345678899999986 4588999999999999999999999864311
Q ss_pred H----------------HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 155 I----------------GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 155 ~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
. ...+.+..+. ..+ ....+|+++.++|.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 254 EFMRMIGNDKQGQMIVFHLIELLKNNG-RLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTC-CCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhccccchhhhHHHHHHHhhcCC-CCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 1122222221 111 22468999999999999999999999999974
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=288.15 Aligned_cols=179 Identities=17% Similarity=0.164 Sum_probs=140.4
Q ss_pred CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCCCCceeeccCC-------------
Q 021227 20 KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCH-SLGVFHRDLKPENFLFLSVD------------- 85 (315)
Q Consensus 20 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dikp~nil~~~~~------------- 85 (315)
++.+|+|||||+||++.+.+.+ +.+++..++.++.||+.||+||| ++||+||||||+|||+...+
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~ 212 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEE
T ss_pred cCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccc
Confidence 7889999999999987776644 67899999999999999999999 99999999999999975422
Q ss_pred ----CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHH
Q 021227 86 ----EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVI-LYILLSGVPPFWAETE-IGIFR 159 (315)
Q Consensus 86 ----~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~-~~~~~ 159 (315)
....+||+|||+++..... ..+||+.|+|||++.+..+.++||||+|++ .+++++|..||.+... .....
T Consensus 213 ~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~ 288 (336)
T 2vuw_A 213 TIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTD 288 (336)
T ss_dssp EEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHH
T ss_pred cccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHH
Confidence 1128999999999866433 357999999999998777899999998766 7788999999854211 12233
Q ss_pred HHHhCC-CC--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh-cCCCcc
Q 021227 160 QILEGK-ID--FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL-CHPWIV 208 (315)
Q Consensus 160 ~i~~~~-~~--~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l-~h~~~~ 208 (315)
.+.... .. .....++.+|+++++||.+||++| |++|+| +||||+
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 289 KMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 333221 11 111123457899999999999976 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=296.73 Aligned_cols=186 Identities=26% Similarity=0.363 Sum_probs=152.6
Q ss_pred CCCCCCCcceEEEEEEeCCe-----EEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 3 HLSEHQHVVRIHDTYEDKSC-----VHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~-----~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
.+ +||||+++++++.+.+. .|+||||++|++|.+++.. ++++..+..++.||+.||.|||++||+||||||+
T Consensus 135 ~l-~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~ 211 (681)
T 2pzi_A 135 EV-VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPE 211 (681)
T ss_dssp GC-CCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred hc-CCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChH
Confidence 44 79999999999987665 7999999999999987754 7999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
||++. . +.+||+|||++...... ....||+.|+|||++.+.++.++|||||||++|+|++|.+||.+....
T Consensus 212 NIll~---~-~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-- 282 (681)
T 2pzi_A 212 NIMLT---E-EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD-- 282 (681)
T ss_dssp GEEEC---S-SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS--
T ss_pred HeEEe---C-CcEEEEecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc--
Confidence 99963 3 38999999999876543 456799999999999877899999999999999999999998653110
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
. . .........++.+.++|.+||+.||.+||+..+++.|+|+.
T Consensus 283 ------~-~-~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 283 ------G-L-PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------S-C-CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------c-c-cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 0 01111123468899999999999999999988888887763
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=277.45 Aligned_cols=173 Identities=16% Similarity=0.223 Sum_probs=142.7
Q ss_pred CeEEEEEeccCCCchhHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEe
Q 021227 21 SCVHIVMELCEGGELFDRIVK-------KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKAT 93 (315)
Q Consensus 21 ~~~~lv~E~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~ 93 (315)
..++++|+++ +++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||| ++.++.+||+
T Consensus 178 ~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NIL---l~~~~~~kL~ 253 (413)
T 3dzo_A 178 LSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLT 253 (413)
T ss_dssp CSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE---ECTTCCEEEC
T ss_pred cceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEE---EecCCeEEEE
Confidence 3578888877 5799888741 234788899999999999999999999999999999999 5677889999
Q ss_pred eccCcccCCCCCcccccccCccccchhhh----------hh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 94 DFGLSVFYKPDEVFSDVVGSPYYVAPEVL----------RK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 94 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
|||+++..... ....+| +.|+|||++ .+ .++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 254 DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~ 330 (413)
T 3dzo_A 254 GFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF 330 (413)
T ss_dssp CGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG
T ss_pred eccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH
Confidence 99998764332 455678 999999998 32 37889999999999999999999998765443322221
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
..+..+|++++++|.+||+.||.+|||+.++++||||.
T Consensus 331 --------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 331 --------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp --------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred --------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 22346899999999999999999999999999999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=256.40 Aligned_cols=167 Identities=17% Similarity=0.160 Sum_probs=135.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++++++++++.+|+||||++|++|.+++.+ + ....++..++.|++.||+|||++||+||||||+||++ +
T Consensus 89 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~ 163 (286)
T 3uqc_A 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---S 163 (286)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---E
T ss_pred CCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---c
Confidence 899999999999999999999999999999999843 3 4667889999999999999999999999999999995 5
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR---QIL 162 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~ 162 (315)
.++.+||+++| |++| ++.++|||||||++|+|++|..||.+.+..+... ...
T Consensus 164 ~~g~~kl~~~~-------------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 218 (286)
T 3uqc_A 164 IDGDVVLAYPA-------------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT 218 (286)
T ss_dssp TTSCEEECSCC-------------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT
T ss_pred CCCCEEEEecc-------------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh
Confidence 67889988543 3333 6889999999999999999999998765422110 011
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+.........+.+|++++++|.+||+.||.+| |+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 111111112235689999999999999999999 9999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=269.22 Aligned_cols=142 Identities=19% Similarity=0.199 Sum_probs=108.9
Q ss_pred CCCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
|+++..||||+++++++++++.+|||||||+|++|.+++.+.+++++. .|+.||+.||+|+|++|||||||||+|||
T Consensus 295 l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNIL 371 (569)
T 4azs_A 295 LTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVM 371 (569)
T ss_dssp HHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEE
T ss_pred HHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEE
Confidence 356779999999999999999999999999999999999988888875 47899999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPP 148 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~p 148 (315)
++.++.+||+|||+|+..... ....+.+||+.|||||++.+.+...+|+||+|++++.+.+|..|
T Consensus 372 ---L~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 372 ---VDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---ECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred ---ECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence 567889999999999876443 33456789999999999998888899999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-24 Score=202.74 Aligned_cols=131 Identities=22% Similarity=0.195 Sum_probs=109.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+||||+++..++.+....|+|||||+||+|.+++.+ +..++.|++.||.|||++||+||||||+|||+.
T Consensus 397 ~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~--- 465 (540)
T 3en9_A 397 KDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD--- 465 (540)
T ss_dssp GGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---
T ss_pred CCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---
Confidence 899999555555567778999999999999998854 678999999999999999999999999999963
Q ss_pred CCCCEEEeeccCcccCCCCCc--------ccccccCccccchhhhh---hcCCCchhHHHHHHHHHHHHhCCCCC
Q 021227 86 EDAALKATDFGLSVFYKPDEV--------FSDVVGSPYYVAPEVLR---KHYGPEADVWSAGVILYILLSGVPPF 149 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf 149 (315)
. .+||+|||+++....... ..+..||+.|+|||++. ..|+..+|+||.++-..+-..++.+|
T Consensus 466 ~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 466 K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3 999999999988755322 23568999999999986 34888899999998888877777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=8.7e-19 Score=150.78 Aligned_cols=89 Identities=22% Similarity=0.278 Sum_probs=71.3
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCCCCE
Q 021227 11 VRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAAL 90 (315)
Q Consensus 11 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~i 90 (315)
+++.+++.. +..|+||||++||+|.+ + ....+..++.|++.||.|||++||+||||||+|||+ + ++.+
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~v 231 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGI 231 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEE
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcE
Confidence 444444443 45689999999999987 4 123456799999999999999999999999999996 3 7899
Q ss_pred EEeeccCcccCCCCCcccccccCccccchhhhh
Q 021227 91 KATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR 123 (315)
Q Consensus 91 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~ 123 (315)
||+|||++.. +..++|||.+.
T Consensus 232 kl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp EECCCTTCEE------------TTSTTHHHHHH
T ss_pred EEEECCCCeE------------CCCCCHHHHHH
Confidence 9999998853 45678999874
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.47 E-value=5.8e-14 Score=114.11 Aligned_cols=111 Identities=31% Similarity=0.432 Sum_probs=85.7
Q ss_pred cCCCccCCCCCCCCCCCHHHHHHHHhhHhhhHHHHHHHHHHhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 203 CHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 203 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
.|||.+... .+..++...++.++++|...+++++..+..++..++.+++..+.++|..+|.|++|.|+.+|+..+++.+
T Consensus 8 ~~~~~~~~~-~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~ 86 (197)
T 3pm8_A 8 SSGRENLYF-QGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKI 86 (197)
T ss_dssp ----------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred cchHhhhcc-CCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHh
Confidence 478987654 4466788899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 283 GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 283 ~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
|...++.++..+++.+|.+++|. +|+||++..
T Consensus 87 g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~ 119 (197)
T 3pm8_A 87 GYQKIPPDIHQVLRDIDSNASGQIHYTDFLAAT 119 (197)
T ss_dssp C----CHHHHHHHHC-------CEEHHHHHHTT
T ss_pred CCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 99999999999999999999987 999998764
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.3e-13 Score=111.36 Aligned_cols=110 Identities=25% Similarity=0.334 Sum_probs=93.4
Q ss_pred cCCCccCCCCCCCCCCCHHHHHHHHhhHhhhHHHHHHHHHHhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 203 CHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 203 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
.|||+-+.. .+..+++..++.++++|...+++++..+..++..++.+++..+.++|..+|.|++|.|+.+|+..+++.+
T Consensus 3 ~~~~~~~~~-~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~ 81 (191)
T 3k21_A 3 HHHHHSSGR-ENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKD 81 (191)
T ss_dssp ------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred CCccccCCc-cccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHc
Confidence 477776543 3455678899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 283 GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 283 ~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
|...+ .++..+++.+|.+++|. +|+||++++
T Consensus 82 g~~~~-~~~~~l~~~~D~d~~g~i~~~EF~~~~ 113 (191)
T 3k21_A 82 GLKLP-YNFDLLLDQIDSDGSGKIDYTEFIAAA 113 (191)
T ss_dssp TCCCC-TTHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred CCCcH-HHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 99888 89999999999999987 999998764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=7.1e-14 Score=118.51 Aligned_cols=72 Identities=18% Similarity=0.217 Sum_probs=58.4
Q ss_pred eEEEEEeccCC-C----chhHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCCCCceeeccCCCCCCEEEeec
Q 021227 22 CVHIVMELCEG-G----ELFDRIVKKGNYSEREAAKLMKTIVGVVECCH-SLGVFHRDLKPENFLFLSVDEDAALKATDF 95 (315)
Q Consensus 22 ~~~lv~E~~~g-g----~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dikp~nil~~~~~~~~~ikl~Df 95 (315)
..++||||+.+ | +|.+.... .++..+..++.|++.||.||| +.||+||||||+|||+ +. .++|+||
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl---~~--~~~liDF 213 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY---ID--KVYFIDM 213 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEE---SS--SEEECCC
T ss_pred CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---cC--cEEEEEC
Confidence 56899999942 3 56554322 345678899999999999999 9999999999999996 33 8999999
Q ss_pred cCcccC
Q 021227 96 GLSVFY 101 (315)
Q Consensus 96 g~~~~~ 101 (315)
|+|...
T Consensus 214 G~a~~~ 219 (258)
T 1zth_A 214 GQAVTL 219 (258)
T ss_dssp TTCEET
T ss_pred cccccC
Confidence 998654
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.2e-13 Score=97.79 Aligned_cols=70 Identities=21% Similarity=0.341 Sum_probs=65.5
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhccC
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLSL 315 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~~ 315 (315)
.++.+++.+++++|..+|.|++|.|+.+|++.+++.+|..+++++++++++++|.+++|. +|+||+++++
T Consensus 29 ~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m~ 99 (100)
T 2lv7_A 29 DIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLLG 99 (100)
T ss_dssp CCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHHHTC
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHHHhC
Confidence 356778888999999999999999999999999999999999999999999999999987 9999999874
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.21 E-value=5.1e-13 Score=118.46 Aligned_cols=71 Identities=20% Similarity=0.211 Sum_probs=55.2
Q ss_pred EEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCCCC-------CCEEEeecc
Q 021227 24 HIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDED-------AALKATDFG 96 (315)
Q Consensus 24 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~~~-------~~ikl~Dfg 96 (315)
+|||||++|++|.... ....+..++.|++.+|.|||++|||||||||.|||+....+. ..+.|+||+
T Consensus 187 ~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~ 260 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFP 260 (397)
T ss_dssp EEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCT
T ss_pred eEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeC
Confidence 6999999998886532 223456789999999999999999999999999997542211 138899998
Q ss_pred Cccc
Q 021227 97 LSVF 100 (315)
Q Consensus 97 ~~~~ 100 (315)
-+..
T Consensus 261 Q~V~ 264 (397)
T 4gyi_A 261 QMVS 264 (397)
T ss_dssp TCEE
T ss_pred Cccc
Confidence 6543
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=99.20 E-value=7.1e-11 Score=94.23 Aligned_cols=95 Identities=19% Similarity=0.369 Sum_probs=87.8
Q ss_pred CCHHHHHHHHhhHhhhHHHHHHHHHHhhhhh--hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHH
Q 021227 218 LDSAVLSRLKHFSAMNKLKKMALRVIAERLN--EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLM 295 (315)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~--~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~ 295 (315)
+...++.++++|...+.+++..+..++..+. .+++..++++|..+|.|++|.|+.+|+..+++.+|.. ..++..++
T Consensus 2 ~~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~--~~~~~~~~ 79 (180)
T 3mse_B 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGIK--KWDINRIL 79 (180)
T ss_dssp CCHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCC--HHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCC--HHHHHHHH
Confidence 4577899999999999999999999999887 8899999999999999999999999999999999864 68999999
Q ss_pred HHHhccCCCC-CHHHHhhcc
Q 021227 296 DAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 296 ~~~d~~~~~~-~~~~f~~~~ 314 (315)
+.+|.+++|. +++||++++
T Consensus 80 ~~~D~d~~g~i~~~Ef~~~~ 99 (180)
T 3mse_B 80 QALDINDRGNITYTEFMAGC 99 (180)
T ss_dssp HHHCTTCCSEECHHHHHHHH
T ss_pred HHhCCCCCCcCcHHHHHHHH
Confidence 9999999987 999998754
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=99.13 E-value=5.8e-11 Score=84.90 Aligned_cols=65 Identities=12% Similarity=0.144 Sum_probs=58.2
Q ss_pred hhhccHHHHhcccC-CCCC-CcccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMID-TDNS-GTITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d-~~~~-g~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+.++|..+| .|++ |.|+.+||+.+++. +|.+.++++++++++++|.+++|. ||+||+.++
T Consensus 7 ~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~ 79 (101)
T 3nso_A 7 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSL 79 (101)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 34567899999997 8887 99999999999986 467899999999999999999998 999999864
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1.1e-10 Score=81.93 Aligned_cols=73 Identities=23% Similarity=0.341 Sum_probs=66.9
Q ss_pred HHhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 242 VIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 242 ~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++..++.++...+.++|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +|+||+.+.
T Consensus 9 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~ 82 (90)
T 1avs_A 9 EARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMM 82 (90)
T ss_dssp SHHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHH
T ss_pred HHHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 3555677888899999999999999999999999999999999999999999999999999987 999998753
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.11 E-value=3.5e-11 Score=96.67 Aligned_cols=98 Identities=20% Similarity=0.419 Sum_probs=90.4
Q ss_pred CCCHHHHHHHHhhHhhhHHHHHHHHHHhhhh-hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHh-----------CC
Q 021227 217 PLDSAVLSRLKHFSAMNKLKKMALRVIAERL-NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV-----------GS 284 (315)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~-----------~~ 284 (315)
++...++.++++|...+.+++.++..++..+ +.+++..+.++|..+|.|++|.|+.+|+..+++.+ |.
T Consensus 3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~ 82 (191)
T 3khe_A 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDS 82 (191)
T ss_dssp CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccc
Confidence 4567789999999999999999999999888 88999999999999999999999999999999988 77
Q ss_pred CCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 285 QLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 285 ~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++.++..+++.+|.+++|. +++||+++.
T Consensus 83 ~~~~~~~~~~~~~~D~d~~g~i~~~ef~~~~ 113 (191)
T 3khe_A 83 SQIEAEVDHILQSVDFDRNGYIEYSEFVTVC 113 (191)
T ss_dssp HHHHHHHHHHHHHTCTTCSSSEEHHHHHHHH
T ss_pred hhhHHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 788999999999999999987 999998763
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=99.11 E-value=8.8e-11 Score=81.61 Aligned_cols=70 Identities=26% Similarity=0.468 Sum_probs=62.3
Q ss_pred hhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 244 ~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+..+++++...++++|..+|.|++|.|+.+|+..+++.+| ..+++++..+++.+|.+++|. +++||+.+.
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 72 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFA 72 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 4566778888999999999999999999999999999999 999999999999999999987 999998763
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.3e-10 Score=89.66 Aligned_cols=88 Identities=64% Similarity=0.851 Sum_probs=78.6
Q ss_pred HhhHhhhHHHHHHHHHHhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-
Q 021227 227 KHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF- 305 (315)
Q Consensus 227 ~~~~~~~~~~~~~~~~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~- 305 (315)
++|...+.+++..+..++..++++++..+.++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|.
T Consensus 1 ~~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i 80 (166)
T 2aao_A 1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAADVDNSGTI 80 (166)
T ss_dssp -----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHCTTCCSSB
T ss_pred CchhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeE
Confidence 3577788999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred CHHHHhhcc
Q 021227 306 SIKTYCNLS 314 (315)
Q Consensus 306 ~~~~f~~~~ 314 (315)
+++||+.+.
T Consensus 81 ~~~ef~~~~ 89 (166)
T 2aao_A 81 DYKEFIAAT 89 (166)
T ss_dssp CHHHHHHHH
T ss_pred cHHHHHHHH
Confidence 999998753
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.9e-10 Score=81.09 Aligned_cols=65 Identities=17% Similarity=0.163 Sum_probs=59.5
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+.++...++++|..+|.|++|.|+.+|++.+++.+| ++++++.++++.+|.+++|. +|+||+.++
T Consensus 4 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~ 69 (92)
T 1fi6_A 4 TDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAAF 69 (92)
T ss_dssp CHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 456778899999999999999999999999999987 67999999999999999987 999999764
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.5e-10 Score=78.57 Aligned_cols=67 Identities=25% Similarity=0.513 Sum_probs=62.0
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++...++++|..+|.+++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||+++.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 69 (77)
T 2joj_A 2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYIGFDDFLDIM 69 (77)
T ss_dssp CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCCSSSSEEEHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHH
Confidence 3566778999999999999999999999999999999999999999999999999987 999998764
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=99.06 E-value=2.2e-10 Score=83.62 Aligned_cols=66 Identities=20% Similarity=0.334 Sum_probs=59.3
Q ss_pred hhhhccHHHHhcccC-CCCCC-cccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMID-TDNSG-TITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d-~~~~g-~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+++..++++|..+| .|++| .|+.+||+.+++. +|..+++++++++++++|.+++|. +|+||+.++
T Consensus 18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m 91 (113)
T 2lnk_A 18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFL 91 (113)
T ss_dssp HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHHHHH
T ss_pred hhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 355677999999999 89997 9999999999987 777889999999999999999987 999999764
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=2e-10 Score=81.46 Aligned_cols=65 Identities=15% Similarity=0.139 Sum_probs=59.2
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+.++...++++|..+|.|++|.|+.+|++.+++.+| ++++++.++++.+|.+++|. +++||+.++
T Consensus 5 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~ 70 (95)
T 1c07_A 5 SPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFALAF 70 (95)
T ss_dssp CSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHHHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 456778899999999999999999999999999886 67999999999999999987 999998764
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.01 E-value=2e-10 Score=79.89 Aligned_cols=72 Identities=74% Similarity=0.970 Sum_probs=65.3
Q ss_pred HhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 243 i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++..++.++...++++|..+|.+++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +|+||+.+.
T Consensus 13 ~~~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~ 85 (87)
T 1s6j_A 13 MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAAT 85 (87)
T ss_dssp SSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHTTCC
T ss_pred HHHHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 444566677788999999999999999999999999999999999999999999999999987 999999864
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=99.01 E-value=2.3e-10 Score=79.53 Aligned_cols=70 Identities=17% Similarity=0.231 Sum_probs=63.9
Q ss_pred hhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHH---HHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESE---IKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 244 ~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~e---i~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+..++++++..++++|..+|.+++|.|+.+|+..+++.+|..+++.+ +..+++.+|.+++|. +| ||+.++
T Consensus 5 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~~~~ 78 (86)
T 1j7q_A 5 ARALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPE-EWLTLC 78 (86)
T ss_dssp CCCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTT-HHHHHH
T ss_pred cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhCCCCCCcCCH-HHHHHH
Confidence 34566778889999999999999999999999999999999999999 999999999999886 99 998764
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.00 E-value=6.6e-10 Score=78.66 Aligned_cols=65 Identities=17% Similarity=0.358 Sum_probs=60.1
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+....++++|..+|.|++|.|+.+|+..+++.+|..+++++++++++.+|.+++|. +|+||+.+.
T Consensus 26 ~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~ 91 (94)
T 2kz2_A 26 DSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM 91 (94)
T ss_dssp SCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred CHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 45567899999999999999999999999999999999999999999999999987 999998764
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.00 E-value=7.5e-10 Score=72.74 Aligned_cols=61 Identities=11% Similarity=0.260 Sum_probs=57.5
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++++|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||+.+.
T Consensus 2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~ 63 (67)
T 1tiz_A 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCI 63 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHH
Confidence 5789999999999999999999999999999999999999999999999987 999998763
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=5.5e-10 Score=80.34 Aligned_cols=65 Identities=17% Similarity=0.258 Sum_probs=56.6
Q ss_pred hhhccHHHHhcccC-CCCC-CcccHHHHHHHHHH-hC----CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMID-TDNS-GTITFDELKDGLKR-VG----SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d-~~~~-g~i~~~el~~~l~~-~~----~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+.++|..+| .|++ |.|+.+||+.+++. +| ...++++++++++++|.+++|. ||+||+.++
T Consensus 10 ~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m 82 (104)
T 3zwh_A 10 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFL 82 (104)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHH
Confidence 45677899999997 6775 89999999999986 54 5578999999999999999998 999999864
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=2.6e-10 Score=84.11 Aligned_cols=64 Identities=13% Similarity=0.215 Sum_probs=58.6
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+.++|..+|.| +|.|+.+||+.+|+. +|...++++++++++++|.|++|. ||+||++++
T Consensus 12 ~~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm 81 (121)
T 4drw_A 12 HAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLI 81 (121)
T ss_dssp HHHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence 3467889999999988 899999999999987 789999999999999999999998 999999875
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=7.1e-10 Score=77.96 Aligned_cols=68 Identities=12% Similarity=0.212 Sum_probs=61.8
Q ss_pred hhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++.++...++++|..+|.|++|.|+.+|+..+++.+| +++++++.+++.+|.+++|. +++||+.+.
T Consensus 19 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dg~I~~~EF~~~~ 87 (91)
T 2pmy_A 19 ADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRPADAEAVFQRLDADRDGAITFQEFARGF 87 (91)
T ss_dssp CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEECHHHHTHHH
T ss_pred ccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC--cCHHHHHHHHHHhCCCCCCCEeHHHHHHHH
Confidence 445667888899999999999999999999999999998 68999999999999999987 999998764
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=98.98 E-value=7.9e-10 Score=79.84 Aligned_cols=65 Identities=11% Similarity=0.115 Sum_probs=59.1
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++.++...++++|..+|. ++|.|+.+|++.+++.+| ++++++.++++.+|.+++|. ||+||+.++
T Consensus 9 ls~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~d~dG~id~~EF~~~m 74 (106)
T 1eh2_A 9 VKPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFAVAM 74 (106)
T ss_dssp SCHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTT--CCHHHHHHHHHHHCSSCSSBCCHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence 346778889999999999 999999999999999886 68999999999999999998 999999764
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=6.4e-10 Score=78.43 Aligned_cols=65 Identities=17% Similarity=0.258 Sum_probs=55.3
Q ss_pred hhhccHHHHhcccC-CCCC-CcccHHHHHHHHHH-hC----CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMID-TDNS-GTITFDELKDGLKR-VG----SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d-~~~~-g~i~~~el~~~l~~-~~----~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..++++|..+| .|++ |.|+.+||+.+++. +| .+.++++++++++++|.+++|. ||+||++++
T Consensus 7 ~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~ 79 (93)
T 4eto_A 7 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFL 79 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 45667899999997 6775 89999999999986 55 4568999999999999999998 999999864
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=98.98 E-value=7.1e-10 Score=77.98 Aligned_cols=67 Identities=21% Similarity=0.379 Sum_probs=61.7
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+....+.++|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +|+||+.+.
T Consensus 4 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~ 71 (92)
T 2kn2_A 4 DTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQVNYEEFVKMM 71 (92)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCCSSEEHHHHHHHH
T ss_pred CccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 4556678999999999999999999999999999999999999999999999999987 999998753
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=98.97 E-value=2.5e-11 Score=106.08 Aligned_cols=135 Identities=21% Similarity=0.257 Sum_probs=94.9
Q ss_pred CCCCHHHHHHHHHhc---ccCCCCCCCHHHHhcC------CCccCCCCC--------------------C---CCCCCHH
Q 021227 174 PNISESAKDLIRKML---DQNPKRRLTAHEVLCH------PWIVDDKVA--------------------P---DKPLDSA 221 (315)
Q Consensus 174 ~~~s~~~~~li~~~l---~~~p~~R~s~~~~l~h------~~~~~~~~~--------------------~---~~~~~~~ 221 (315)
.+++.+..+|.+++. ..+|..|.+.++.+.| +|....... . .......
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~ 94 (323)
T 1ij5_A 15 KKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLAS 94 (323)
T ss_dssp HHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHH
Confidence 456788999999998 8999999999998888 777543110 0 0011122
Q ss_pred HHHHHH-hhHhhhHHHHHHHHHHhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhc
Q 021227 222 VLSRLK-HFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK 300 (315)
Q Consensus 222 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~ 300 (315)
++.+++ +|..++.+++ ++..++.+++..+.++|..+|.|++|.|+.+|+..+++.+|..+++.++..++..+|.
T Consensus 95 vl~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~~~~~~~i~~l~~~~D~ 169 (323)
T 1ij5_A 95 LLKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVEN 169 (323)
T ss_dssp HHHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcC
Confidence 344444 4555555544 3456788889999999999999999999999999999999999999999999999999
Q ss_pred cCCCC-CHHHHhhc
Q 021227 301 IFSRF-SIKTYCNL 313 (315)
Q Consensus 301 ~~~~~-~~~~f~~~ 313 (315)
+++|. +|.+|+.+
T Consensus 170 d~~G~I~f~ef~~l 183 (323)
T 1ij5_A 170 DTKGRMSYITLVAV 183 (323)
T ss_dssp CCSSTHHHHHHTTS
T ss_pred CCCCcCcHHHHHhh
Confidence 99987 99999865
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.96 E-value=5.7e-10 Score=79.69 Aligned_cols=64 Identities=13% Similarity=0.123 Sum_probs=58.4
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++...++++|..+|.|++|.|+.+|++.+++.+| ++++++.++++.+|.+++|. +|+||+.++
T Consensus 7 ~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~--l~~~~l~~i~~~~D~d~dG~i~~~EF~~~~ 71 (99)
T 1qjt_A 7 SSGNPVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFFVAL 71 (99)
T ss_dssp TTTCTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHHHHH
T ss_pred hhhHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 35677899999999999999999999999999876 68999999999999999988 999999764
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=98.96 E-value=7.7e-10 Score=79.02 Aligned_cols=65 Identities=15% Similarity=0.193 Sum_probs=58.3
Q ss_pred hhhccHHHHhcccC-CCCCC-cccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMID-TDNSG-TITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d-~~~~g-~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++..++++|..+| .|++| .|+.+||+.+++. +|...++.+++++++++|.+++|. +|+||+.++
T Consensus 7 ~~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~ 79 (99)
T 2y5i_A 7 GAMDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFVVLV 79 (99)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcCcHHHHHHHH
Confidence 45667899999997 89987 9999999999987 678889999999999999999987 999999764
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=9.5e-10 Score=80.32 Aligned_cols=66 Identities=14% Similarity=0.100 Sum_probs=59.5
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++.++...++++|..+|.|++|.|+.+|++.+++ +..++++++..+++.+|.+++|. +|+||+.++
T Consensus 8 ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~--~~~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~ 74 (111)
T 2kgr_A 8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILM--QSSLPQAQLASIWNLSDIDQDGKLTAEEFILAM 74 (111)
T ss_dssp SCHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHH--TTCCCHHHHHHHHHHHCSSCCSEEEHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH--hCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 3456677899999999999999999999999998 67789999999999999999987 999998764
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=98.94 E-value=1.5e-09 Score=83.49 Aligned_cols=63 Identities=19% Similarity=0.317 Sum_probs=59.6
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhccC
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLSL 315 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~~ 315 (315)
..+.++|..+|.|++|.|+.+||+.+++.+|..+++.+++++++.+|.+++|. +|+||+++++
T Consensus 83 ~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~m~ 146 (148)
T 2lmt_A 83 EEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADFDGDGMINYEEFVWMIS 146 (148)
T ss_dssp HHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSCCSSEEHHHHHHHHT
T ss_pred HHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 45889999999999999999999999999999999999999999999999998 9999998763
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=98.94 E-value=1.3e-09 Score=76.79 Aligned_cols=64 Identities=11% Similarity=0.212 Sum_probs=57.7
Q ss_pred hhhccHHHHhcccCCCCCC---cccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSG---TITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g---~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+.++|..+| +++| .|+.+||+.+++. +|...++++++++++.+|.+++|. +|+||+.+.
T Consensus 6 ~~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~ 78 (92)
T 3rm1_A 6 KAVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFMAFV 78 (92)
T ss_dssp HHHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHHHHHHHH
Confidence 34567899999999 6666 9999999999999 899999999999999999999987 999999764
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=98.94 E-value=6.3e-10 Score=78.88 Aligned_cols=65 Identities=14% Similarity=0.208 Sum_probs=52.6
Q ss_pred hhhccHHHHhcccC-CCC-CCcccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMID-TDN-SGTITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d-~~~-~g~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++..++++|..+| .|+ +|.|+.+||+.+++. +|...++++++++++++|.+++|. +|+||+.++
T Consensus 6 ~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~ 78 (95)
T 1j55_A 6 TAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFV 78 (95)
T ss_dssp HHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 45667899999999 688 589999999999987 566788999999999999999987 999999764
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.93 E-value=8.3e-10 Score=87.72 Aligned_cols=70 Identities=30% Similarity=0.471 Sum_probs=65.7
Q ss_pred hhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++++++.+++++|..+|.|++|.|+.+||..+++.+|..+++.++..++..+|.++++. +|++|+.++
T Consensus 3 ~~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~ 73 (176)
T 2lhi_A 3 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALM 73 (176)
T ss_dssp CCCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTTCSSCSSSBCTTHHHHHH
T ss_pred CcCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCChhHHHHHHHHHHhCcCCCccchHHHHHHHH
Confidence 4577899999999999999999999999999999999999999999999999999999887 999998764
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=98.92 E-value=8.8e-10 Score=97.37 Aligned_cols=74 Identities=27% Similarity=0.430 Sum_probs=68.6
Q ss_pred HHHhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 241 ~~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....++++++++.+++++|..+|.|++|.|+.+||..+|+.+|..++++|++++++.+|.+++|. +|+||++++
T Consensus 290 ePs~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lm 364 (440)
T 3u0k_A 290 EPTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTIDFPEFLIMM 364 (440)
T ss_dssp CCBCBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCSSSEEHHHHHHHH
T ss_pred HhhHhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 44456788999999999999999999999999999999999999999999999999999999987 999998764
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.92 E-value=6.1e-10 Score=74.15 Aligned_cols=64 Identities=20% Similarity=0.381 Sum_probs=59.1
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....++++|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||+.+.
T Consensus 4 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 68 (71)
T 2b1u_A 4 GLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYEEFARML 68 (71)
T ss_dssp THHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSSSSSEEETTHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3456899999999999999999999999999999999999999999999999987 999998764
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.91 E-value=2.5e-09 Score=77.53 Aligned_cols=66 Identities=23% Similarity=0.336 Sum_probs=62.0
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++...++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +|+||+.+.
T Consensus 28 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~i~~~eF~~~~ 94 (107)
T 2d58_A 28 PSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKKLIGEVSSGSGETFSYPDFLRMM 94 (107)
T ss_dssp HHHHHHHHHHHTTSCCCTTSCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSEECHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 567788999999999999999999999999999999999999999999999999987 999998764
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=98.90 E-value=5.6e-09 Score=80.32 Aligned_cols=66 Identities=20% Similarity=0.274 Sum_probs=62.0
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+++..++++|..+|.|++|.|+.+|+..+++.+|..+++.+++++++.+|.+++|. +|+||+.++
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I~~~eF~~~~ 110 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKRLIREVSSGSEETFSYSDFLRMM 110 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCTTEECHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 467788999999999999999999999999999999999999999999999999987 999999764
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.90 E-value=1.9e-10 Score=83.79 Aligned_cols=66 Identities=15% Similarity=0.172 Sum_probs=59.2
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++.++...++++|..+|.|++|.|+.+|++.+++.+| ++++++.++++.+|.+++|. +|+||+.++
T Consensus 16 ls~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~d~dG~I~~~EF~~~m 82 (110)
T 1iq3_A 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGALTLPEFCAAF 82 (110)
T ss_dssp CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSSSCSEEEHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence 3556778899999999999999999999999998876 67889999999999999998 999999764
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.9e-09 Score=85.62 Aligned_cols=62 Identities=31% Similarity=0.439 Sum_probs=58.2
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+.++|+.+|.|++|.|+.+||+.+++.+|..+++++++++++++| +++|. +|+||++++
T Consensus 83 ~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d-d~dG~I~~~EF~~~m 145 (176)
T 2lhi_A 83 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALL 145 (176)
T ss_dssp HHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH-TTSSCBCTTHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc-CCCCeEeHHHHHHHH
Confidence 346889999999999999999999999999999999999999999999 88887 999999875
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.1e-09 Score=76.79 Aligned_cols=65 Identities=15% Similarity=0.131 Sum_probs=55.2
Q ss_pred hhhccHHHHhcccCCCC---CCcccHHHHHHHHHHhC-CCC----CHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDN---SGTITFDELKDGLKRVG-SQL----MESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~---~g~i~~~el~~~l~~~~-~~~----~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..++++|..+|.++ +|.|+.+||+.+++..+ ..+ ++++++++++++|.+++|. +|+||+.++
T Consensus 8 ~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~m 81 (100)
T 3nxa_A 8 KAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLI 81 (100)
T ss_dssp HHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 44567899999999964 79999999999998753 333 3789999999999999998 999999875
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=98.88 E-value=2.3e-09 Score=83.63 Aligned_cols=64 Identities=19% Similarity=0.284 Sum_probs=57.9
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhc--cCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK--IFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~--~~~~~-~~~~f~~~~ 314 (315)
....+.++|+.+|.+++|.|+.+||+.+++.+|.++++++++++++.+|. +++|. +|+||+.++
T Consensus 83 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m 149 (159)
T 3i5g_C 83 AADEFMEAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDIREDIDGNIKYEDLMKKV 149 (159)
T ss_dssp CHHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTCCCCSSCCEEHHHHHHHH
T ss_pred hHHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCCCeEeHHHHHHHH
Confidence 34568999999999999999999999999999999999999999999994 77776 999998754
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=98.87 E-value=5.7e-10 Score=79.12 Aligned_cols=65 Identities=15% Similarity=0.263 Sum_probs=58.2
Q ss_pred hhhccHHHHhcccC-CCCCC-cccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMID-TDNSG-TITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d-~~~~g-~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++..++++|..+| .|++| .|+.+||+.+++. +|...++.+++++++++|.+++|. +|+||+.++
T Consensus 9 ~~~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~ 81 (95)
T 2wcb_A 9 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLV 81 (95)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSSSTTSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence 45667999999999 89998 9999999999987 677889999999999999999987 999999764
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=98.87 E-value=2.5e-09 Score=72.59 Aligned_cols=61 Identities=23% Similarity=0.504 Sum_probs=56.8
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++++|..+|.|++|.|+.+|+..+++.+| .++++++..+++.+|.+++|. +++||+.+.
T Consensus 3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~ 64 (78)
T 1k9u_A 3 DDMERIFKRFDTNGDGKISLSELTDALRTLG-STSADEVQRMMAEIDTDGDGFIDFNEFISFC 64 (78)
T ss_dssp CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH-TCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 3578999999999999999999999999999 999999999999999999987 999998763
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=98.87 E-value=7e-10 Score=72.72 Aligned_cols=60 Identities=15% Similarity=0.257 Sum_probs=55.8
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++|..+|.|++|.|+.+|+..+++.+|...++++++.+++.+|.+++|. +++||+.+.
T Consensus 2 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 62 (66)
T 3li6_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFY 62 (66)
T ss_dssp CCHHHHHHCTTCSSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHccCCCcHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 357899999999999999999999999998899999999999999999987 999999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=1.1e-09 Score=92.62 Aligned_cols=88 Identities=18% Similarity=0.210 Sum_probs=70.1
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----------------
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS----------------- 66 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~----------------- 66 (315)
|..|..+.++++++.+.+..|+||||++|.+|.+.+ .+......++.++..+|+.||+
T Consensus 66 l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~ 140 (263)
T 3tm0_A 66 LEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140 (263)
T ss_dssp HTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHH
T ss_pred HhcCCCCCeEEEEEecCCceEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHH
Confidence 334678889999999999999999999999887653 1223345788999999999998
Q ss_pred ------------------------------------------CCCccccCCCCceeeccCCCCCCEEEeeccCcc
Q 021227 67 ------------------------------------------LGVFHRDLKPENFLFLSVDEDAALKATDFGLSV 99 (315)
Q Consensus 67 ------------------------------------------~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~ 99 (315)
.+++|||++|.||++ ++...+.|+||+.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred HHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE---ECCcEEEEEEchhcc
Confidence 458999999999996 334556799998653
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=98.86 E-value=1.1e-09 Score=84.85 Aligned_cols=62 Identities=26% Similarity=0.397 Sum_probs=57.7
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...++++|+.+|.|++|.|+.+||+.+++.+|.++++++++++++.+|.+ +|. +|+||+.++
T Consensus 84 ~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D~~-dG~I~y~EF~~~m 146 (153)
T 3i5g_B 84 EDALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAPLK-NKQFNYNKMVDIK 146 (153)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCCEE-TTEECHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhCCC-cCEEcHHHHHHHh
Confidence 35689999999999999999999999999999999999999999999987 666 999999875
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=98.86 E-value=9.3e-10 Score=75.75 Aligned_cols=65 Identities=22% Similarity=0.260 Sum_probs=59.7
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhC--CCCCHHHHHH----HHHHHhccCCCC-CHHHHhhc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG--SQLMESEIKD----LMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~--~~~~~~ei~~----~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+....+.++|..+|.|++|.|+.+|+..+++.+| ..++++++.. +++.+|.+++|. +++||+..
T Consensus 3 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~I~~~eF~~~ 74 (83)
T 1yx7_A 3 CKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADKNSDGKISKEEFLNA 74 (83)
T ss_dssp SCSCTHHHHHHHHHSSSCSSSCSHHHHHHHHHHHTTCTTTTTTTTHHHHHHHHTTTCSSSCSCCSHHHHHHH
T ss_pred ccHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHccccCCCHHHHHHHHHHHHHHhCCCCCCCCcHHHHHHh
Confidence 45667899999999999999999999999999999 8899999999 999999999987 99999865
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=98.85 E-value=4.9e-09 Score=75.58 Aligned_cols=65 Identities=14% Similarity=0.131 Sum_probs=59.6
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+....+.++|..+|.|++|.|+.+|+..+++.+|..+++++++++++.+|.+++|. +|+||+.+.
T Consensus 21 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~e~~~l~~~~d~~~~g~i~~~eF~~~~ 86 (105)
T 1wlz_A 21 SHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF 86 (105)
T ss_dssp HTHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred chHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCCCcHHHHHHHH
Confidence 34556899999999999999999999999999999999999999999999999887 999998764
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=98.85 E-value=3.4e-09 Score=74.59 Aligned_cols=65 Identities=15% Similarity=0.211 Sum_probs=59.5
Q ss_pred hhhccHHHHhcccC-CCCCC-cccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMID-TDNSG-TITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d-~~~~g-~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++...++++|..+| .|++| .|+.+|+..+++. +|..+++++++.+++.+|.+++|. +|+||+.+.
T Consensus 6 ~~~~~l~~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 78 (93)
T 1k2h_A 6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLV 78 (93)
T ss_dssp HHHHHHHHHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHCCCCHHHHHHHHHHHHHCTTSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 45567899999999 79999 9999999999998 999999999999999999999987 999998764
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=98.84 E-value=3.3e-09 Score=79.97 Aligned_cols=62 Identities=11% Similarity=0.118 Sum_probs=56.8
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++...++++|..+| |++|.|+.+|++.+|+..| ++++++.++++.+|.+++|. ||+||+.++
T Consensus 48 ~e~~~l~~~F~~fD-d~dG~Is~~El~~~l~~~g--l~~~el~~I~~~~D~d~dG~Ld~~EF~~am 110 (139)
T 2jq6_A 48 KDKPTYDEIFYTLS-PVNGKITGANAKKEMVKSK--LPNTVLGKIWKLADVDKDGLLDDEEFALAN 110 (139)
T ss_dssp GTHHHHHHHHHHSC-CSSSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCSSCCSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHHhC-CCCCeECHHHHHHHHHHhC--cCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 45667899999999 9999999999999999976 78999999999999999998 999999765
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.7e-09 Score=81.54 Aligned_cols=66 Identities=26% Similarity=0.434 Sum_probs=61.2
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++..++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +|+||++++
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 68 (143)
T 2obh_A 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVM 68 (143)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeeeHHHHHHHH
Confidence 456778999999999999999999999999999999999999999999999999987 999998764
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=98.83 E-value=1.4e-08 Score=77.50 Aligned_cols=63 Identities=24% Similarity=0.429 Sum_probs=59.1
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+.++|+.+|.|++|.|+.+|++.+++.+|..+++++++++++.+|.+++|. +++||+.++
T Consensus 78 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~eF~~~~ 141 (143)
T 2obh_A 78 KEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIM 141 (143)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 356889999999999999999999999999999999999999999999999987 999999875
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=98.83 E-value=1.5e-09 Score=78.29 Aligned_cols=65 Identities=14% Similarity=0.206 Sum_probs=56.0
Q ss_pred hhhccHHHHhcccC-CCCC-CcccHHHHHHHHHH-hCCCC-CHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMID-TDNS-GTITFDELKDGLKR-VGSQL-MESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d-~~~~-g~i~~~el~~~l~~-~~~~~-~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++..++++|..+| .|++ |.|+.+||+.+++. +|... ++++++++++++|.+++|. ||+||+.++
T Consensus 19 ~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~ 88 (106)
T 2h2k_A 19 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLI 88 (106)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 45677999999999 7986 79999999999986 67554 3579999999999999997 999999764
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=98.82 E-value=3.8e-09 Score=87.00 Aligned_cols=89 Identities=16% Similarity=0.181 Sum_probs=80.1
Q ss_pred HHhhHhhhHHHHHHHHHHhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC
Q 021227 226 LKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF 305 (315)
Q Consensus 226 ~~~~~~~~~~~~~~~~~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~ 305 (315)
...+...+.+++.....++..++.+++..++++|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.+++|.
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~ 103 (220)
T 3sjs_A 24 ACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGH 103 (220)
T ss_dssp HHHHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHCTTCSSC
T ss_pred hhccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCc
Confidence 45566666777777777888899999999999999999999999999999999999999999999999999999999987
Q ss_pred -CHHHHhhcc
Q 021227 306 -SIKTYCNLS 314 (315)
Q Consensus 306 -~~~~f~~~~ 314 (315)
+++||+++.
T Consensus 104 I~~~EF~~~~ 113 (220)
T 3sjs_A 104 ISFYEFMAMY 113 (220)
T ss_dssp BCHHHHHHHH
T ss_pred CCHHHHHHHH
Confidence 999998763
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=98.81 E-value=2e-09 Score=72.61 Aligned_cols=63 Identities=19% Similarity=0.274 Sum_probs=58.3
Q ss_pred hccHHHHhccc-CCCCC-CcccHHHHHHHHHHhCCCC--CHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMI-DTDNS-GTITFDELKDGLKRVGSQL--MESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~-d~~~~-g~i~~~el~~~l~~~~~~~--~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...++++|..+ |.+++ |.|+.+|+..+++.+|..+ +++++..+++.+|.+++|. +|+||+.+.
T Consensus 4 ~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~ 71 (76)
T 1qx2_A 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMM 71 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 45688999999 99999 9999999999999999999 9999999999999999987 999998764
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=98.81 E-value=5.4e-09 Score=80.22 Aligned_cols=69 Identities=30% Similarity=0.483 Sum_probs=63.6
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++.+++..++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +|+||+.++
T Consensus 3 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~ 72 (148)
T 1exr_A 3 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLM 72 (148)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHH
Confidence 456678888999999999999999999999999999999999999999999999999987 999998753
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.1e-08 Score=78.86 Aligned_cols=66 Identities=24% Similarity=0.383 Sum_probs=61.2
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++...++++|..+|.|++|.|+.+|+..+++.+|..+++++++++++.+|.+++|. +|+||+.++
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~D~d~dg~I~~~eF~~~~ 112 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNMM 112 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSCSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHH
Confidence 356778999999999999999999999999999999999999999999999999887 999998764
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=7.2e-09 Score=75.87 Aligned_cols=65 Identities=15% Similarity=0.191 Sum_probs=57.4
Q ss_pred hhhccHHHHhcccCC-CCCC-cccHHHHHHHHH-HhCCC-----CCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDT-DNSG-TITFDELKDGLK-RVGSQ-----LMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~-~~~g-~i~~~el~~~l~-~~~~~-----~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++..++++|..+|. |++| .|+.+||+.+++ .+|.. .++.+++.+++.+|.+++|. +|+||+.++
T Consensus 9 ~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~ 82 (113)
T 1xk4_C 9 RNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLM 82 (113)
T ss_dssp HHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHHHHH
Confidence 345678999999995 9999 999999999999 78752 68999999999999999987 999999764
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.4e-09 Score=74.44 Aligned_cols=64 Identities=28% Similarity=0.469 Sum_probs=58.3
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhC-CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG-SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~-~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+....++ +|..+|.|++|.|+.+|+..+++.+| ..++++++..+++.+|.+++|. +++||+.+.
T Consensus 6 ~~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 71 (81)
T 1c7v_A 6 DEEEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLI 71 (81)
T ss_dssp -CHHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHH
T ss_pred cHHHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 4456688 99999999999999999999999999 9999999999999999999987 999998763
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=98.80 E-value=7.1e-09 Score=75.22 Aligned_cols=65 Identities=28% Similarity=0.307 Sum_probs=59.7
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....++++|..+|.|++|.|+.+|+..+++.+ |..+++++++.+++.+|.+++|. +++||+.+.
T Consensus 39 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 107 (109)
T 1bu3_A 39 KSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDSDGDGAIGVDEWAALV 107 (109)
T ss_dssp SCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred hhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 345578999999999999999999999999999 88899999999999999999987 999999764
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=98.80 E-value=2.2e-09 Score=75.57 Aligned_cols=64 Identities=27% Similarity=0.377 Sum_probs=56.8
Q ss_pred hhhccHHHHhcccC-CCCCC-cccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMID-TDNSG-TITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d-~~~~g-~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++..++++|..+| .|++| .|+.+|++.+++.. |. +++.+++.+++.+|.+++|. +|+||+.++
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~-~~~~~i~~~~~~~D~d~dG~I~f~EF~~~~ 76 (92)
T 2kax_A 7 KALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGE-MKESSIDDLMKSLDKNSDQEIDFKEYSVFL 76 (92)
T ss_dssp HHHHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTT-TCCTTHHHHHHHHTTTCSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCC-CCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 45667999999999 99999 99999999999873 34 88899999999999999987 999999764
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=98.79 E-value=6.2e-09 Score=75.53 Aligned_cols=64 Identities=30% Similarity=0.407 Sum_probs=59.2
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+.++|..+|.|++|.|+.+|+..+++.+ |..+++++++.+++.+|.+++|. +|+||+.++
T Consensus 39 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (109)
T 5pal_A 39 TDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFAKMV 106 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 34568899999999999999999999999999 99999999999999999999987 999999764
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=98.78 E-value=1.4e-09 Score=77.76 Aligned_cols=64 Identities=14% Similarity=0.189 Sum_probs=56.5
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHH-----hCC--CCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKR-----VGS--QLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~-----~~~--~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++..++++|..+|.+ +|.|+.+||+.+++. +|. ..++++++++++++|.+++|. +|+||+.++
T Consensus 7 ~~~~~l~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~d~dG~I~f~EF~~~~ 78 (100)
T 1psr_A 7 RSIIGMIDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLL 78 (100)
T ss_dssp HHHHHHHHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 4567799999999976 799999999999987 555 678889999999999999987 999999764
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=98.77 E-value=9.5e-09 Score=74.50 Aligned_cols=65 Identities=31% Similarity=0.374 Sum_probs=59.6
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....++++|..+|.|++|.|+.+|+..+++.+ |..+++++++.+++.+|.+++|. +++||+++.
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (109)
T 1rwy_A 38 KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLV 106 (109)
T ss_dssp SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred chHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 455678999999999999999999999999999 78899999999999999999987 999998764
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=98.76 E-value=1.2e-08 Score=80.72 Aligned_cols=70 Identities=30% Similarity=0.502 Sum_probs=62.8
Q ss_pred hhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 244 ~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+..++.+++..++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +++||+.+
T Consensus 2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~EF~~~ 72 (179)
T 2f2o_A 2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTM 72 (179)
T ss_dssp ----CCSHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCcHHHHHHH
Confidence 44567788899999999999999999999999999999999999999999999999999987 99999875
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=98.75 E-value=3.1e-09 Score=75.38 Aligned_cols=64 Identities=11% Similarity=0.202 Sum_probs=56.0
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++..++++|..+|. ++|.|+.+||+.+++. +|..+++++++++++++|.+++|. +|+||+.++
T Consensus 6 ~~~~~l~~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~~~~~~ev~~l~~~~D~d~dG~I~f~EF~~~~ 75 (96)
T 1a4p_A 6 HAMETMMFTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLI 75 (96)
T ss_dssp HHHHHHHHHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHcC-CCCeECHHHHHHHHHHHcccccccccCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 456678999999994 5679999999999987 667789999999999999999987 999999764
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=98.75 E-value=6.2e-09 Score=75.54 Aligned_cols=64 Identities=25% Similarity=0.287 Sum_probs=59.1
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....++++|..+|.|++|.|+.+|+..+++.+ |..+++++++.+++.+|.+++|. +++||+++.
T Consensus 40 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~EF~~~~ 107 (109)
T 3fs7_A 40 TPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDTDGDGKIGVEEFQSLV 107 (109)
T ss_dssp CHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 44568899999999999999999999999999 88999999999999999999987 999999864
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.75 E-value=9.7e-09 Score=77.75 Aligned_cols=63 Identities=13% Similarity=0.188 Sum_probs=58.4
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhC-CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVG-SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~-~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...++++|..+|.|++|.|+.+|++.+++.+| ..+++++++.+++.+|.+++|. +|+||+.++
T Consensus 39 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~~~D~d~dG~I~~~EF~~~~ 103 (135)
T 3h4s_E 39 VSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVREGDLDGDGALNQTEFCVLM 103 (135)
T ss_dssp HHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHHHHCSSCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 45688999999999999999999999999999 5999999999999999999987 999999764
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=98.75 E-value=7.7e-09 Score=74.90 Aligned_cols=65 Identities=26% Similarity=0.351 Sum_probs=59.4
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....++++|..+|.|++|.|+.+|+..+++.+ |..+++++++.+++.+|.+++|. +++||+.+.
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (108)
T 2pvb_A 38 KSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFAAMI 106 (108)
T ss_dssp SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred hHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 345578999999999999999999999999999 78899999999999999999987 999998764
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=98.74 E-value=1e-08 Score=78.26 Aligned_cols=72 Identities=31% Similarity=0.485 Sum_probs=64.8
Q ss_pred HhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 243 i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
|+..++.+++..+.++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +++||+.+.
T Consensus 1 m~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~ef~~~~ 73 (147)
T 4ds7_A 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGNHAIEFSEFLALM 73 (147)
T ss_dssp ---CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSEEEHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHH
Confidence 356678889999999999999999999999999999999999999999999999999999987 999998753
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=98.74 E-value=2.5e-09 Score=75.44 Aligned_cols=65 Identities=8% Similarity=0.092 Sum_probs=57.7
Q ss_pred hhhccHHHHhcccCC-CCCC-cccHHHHHHHH-HHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDT-DNSG-TITFDELKDGL-KRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~-~~~g-~i~~~el~~~l-~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+....+.++|..+|. |++| .|+.+|++.++ +.+|..+++.+++.+++.+|.+++|. +|+||+.+.
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~ 75 (93)
T 1xk4_A 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILV 75 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCcCeECHHHHHHHHHHHCcccCCHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 345678999999999 9999 99999999999 78887777788999999999999987 999998764
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=98.74 E-value=7.8e-09 Score=75.09 Aligned_cols=65 Identities=34% Similarity=0.397 Sum_probs=59.4
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....++++|..+|.|++|.|+.+|+..+++.+ |..+++++++.+++.+|.+++|. +++||+++.
T Consensus 39 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 107 (110)
T 1pva_A 39 MSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLV 107 (110)
T ss_dssp SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred chHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 445678999999999999999999999999999 78899999999999999999987 999998764
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=98.73 E-value=1.7e-08 Score=78.31 Aligned_cols=73 Identities=21% Similarity=0.328 Sum_probs=66.7
Q ss_pred HHhhhhhhhhhccHHHHhcccCCCC-CCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 242 VIAERLNEEEIGGLKELFKMIDTDN-SGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 242 ~i~~~l~~e~~~~l~~~F~~~d~~~-~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++..++++++..++++|..+|.|+ +|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +++||+.+.
T Consensus 7 ~~~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~ 81 (161)
T 1dtl_A 7 AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMM 81 (161)
T ss_dssp TGGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 3456677888999999999999999 999999999999999999999999999999999999887 999998753
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=98.73 E-value=5.1e-09 Score=80.52 Aligned_cols=68 Identities=25% Similarity=0.479 Sum_probs=63.9
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++++.+++++|..+|.|++|.|+.+|+..+++.+|..+++.++..++..+|.+++|. ++.+|+..+
T Consensus 4 lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~ 72 (148)
T 2lmt_A 4 LTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENNNNGQLNFTEFCGIM 72 (148)
T ss_dssp CCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHHTTSTTEEEHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcccCCCCcccHHHHHHHH
Confidence 67788999999999999999999999999999999999999999999999999999987 999998753
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=98.73 E-value=5.3e-09 Score=73.06 Aligned_cols=65 Identities=25% Similarity=0.447 Sum_probs=58.7
Q ss_pred hhhccHHHHhcccC-CCCCC-cccHHHHHHHHHH---hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMID-TDNSG-TITFDELKDGLKR---VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d-~~~~g-~i~~~el~~~l~~---~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+....++++|..+| .|++| .|+.+|++.+++. +|..+++.+++.+++.+|.+++|. +|+||+.+.
T Consensus 7 ~~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 77 (90)
T 1k8u_A 7 QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFL 77 (90)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHhcccCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 34557899999999 59999 9999999999998 998999999999999999999987 999998753
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=98.72 E-value=4.6e-08 Score=74.92 Aligned_cols=63 Identities=21% Similarity=0.371 Sum_probs=58.6
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+.++|..+|.|++|.|+.+|++.+++.+|..++++++.++++.+|.+++|. +|+||+.++
T Consensus 82 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~ 145 (148)
T 1exr_A 82 EEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMM 145 (148)
T ss_dssp HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 345788999999999999999999999999999999999999999999999987 999999764
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=98.71 E-value=7.6e-09 Score=79.45 Aligned_cols=71 Identities=24% Similarity=0.410 Sum_probs=65.5
Q ss_pred hhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 244 ~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+..++++++..+.++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +++||+++.
T Consensus 2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~ 73 (153)
T 3ox6_A 2 DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELM 73 (153)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSTTCCCHHHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCccCcHHHHHHHH
Confidence 45577888999999999999999999999999999999999999999999999999999887 999998753
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.70 E-value=1.1e-08 Score=81.97 Aligned_cols=70 Identities=74% Similarity=0.974 Sum_probs=64.9
Q ss_pred hhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++++++..++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +++||+.++
T Consensus 2 ~~ls~~~~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~ 72 (188)
T 1s6i_A 2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAAT 72 (188)
T ss_dssp CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHH
Confidence 3567788999999999999999999999999999999999999999999999999999987 999998753
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=98.70 E-value=2.3e-08 Score=88.35 Aligned_cols=65 Identities=17% Similarity=0.356 Sum_probs=60.1
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhccC
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLSL 315 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~~ 315 (315)
....++++|+.+|.|++|.|+.+||+.+++.+|..+++++++++++++|.+++|. +|+||++++.
T Consensus 373 ~eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~DgDGkIsyeEFvkmMt 438 (440)
T 3u0k_A 373 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMT 438 (440)
T ss_dssp -CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHC
T ss_pred hHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHhC
Confidence 3456889999999999999999999999999999999999999999999999987 9999998763
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.70 E-value=1.8e-08 Score=76.55 Aligned_cols=66 Identities=17% Similarity=0.384 Sum_probs=60.6
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++..++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +++||+.+.
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~ 68 (142)
T 2bl0_C 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKIQFPEFLSMM 68 (142)
T ss_dssp CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCeeeHHHHHHHH
Confidence 456778999999999999999999999999999999999999999999999999987 999998753
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=98.68 E-value=9.7e-09 Score=74.36 Aligned_cols=65 Identities=32% Similarity=0.411 Sum_probs=59.0
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....++.+|..+|.|++|.|+.+|+..+++.+ |..+++++++.+++.+|.+++|. +++||+.+.
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (108)
T 1rro_A 38 MSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMV 106 (108)
T ss_dssp SCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHHHHHHHH
T ss_pred ccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 345568899999999999999999999999998 67899999999999999999987 999999764
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=98.68 E-value=2.6e-08 Score=77.08 Aligned_cols=69 Identities=19% Similarity=0.317 Sum_probs=64.0
Q ss_pred hhhhhhhccHHHHhcccC-CCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMID-TDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d-~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++++++..++++|..+| .|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +++||+.+.
T Consensus 6 ~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~ 76 (158)
T 2jnf_A 6 KLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFGNGDIDFDSFKIIG 76 (158)
T ss_dssp TSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHCTTCCSEECHHHHHHHH
T ss_pred hCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 456778889999999999 999999999999999999999999999999999999999987 999998764
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=98.67 E-value=2e-08 Score=77.91 Aligned_cols=72 Identities=26% Similarity=0.403 Sum_probs=65.9
Q ss_pred HhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 243 i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....++.+++..+.++|..+|.+++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +++||+.+.
T Consensus 13 ~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~ 85 (161)
T 3fwb_A 13 LNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDSEGRHLMKYDDFYIVM 85 (161)
T ss_dssp TTTTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSCEEHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCCCCeEeHHHHHHHH
Confidence 345677888999999999999999999999999999999999999999999999999999987 999998753
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=98.65 E-value=4e-09 Score=71.51 Aligned_cols=65 Identities=20% Similarity=0.234 Sum_probs=58.2
Q ss_pred hhhccHHHHhcccCC-CCCC-cccHHHHHHHHHH-hCCCC-CHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDT-DNSG-TITFDELKDGLKR-VGSQL-MESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~-~~~g-~i~~~el~~~l~~-~~~~~-~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++...++++|..+|. |++| .|+.+|+..+++. +|... ++.+++.+++.+|.+++|. +|+||+.+.
T Consensus 4 ~~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 73 (78)
T 1cb1_A 4 KSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLV 73 (78)
T ss_dssp CCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHH
T ss_pred hHHHHHHHHHHHHhccCCCcCEeCHHHHHHHHHHHhhhhcccHHHHHHHHHHhcCCCCCCCcHHHHHHHH
Confidence 345678999999999 9999 9999999999986 88777 8899999999999999987 999998764
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=98.65 E-value=3.2e-08 Score=77.47 Aligned_cols=69 Identities=30% Similarity=0.450 Sum_probs=64.1
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++.+++..+.++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +++||+++.
T Consensus 21 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 90 (169)
T 3qrx_A 21 GLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTIDFEEFLTMM 90 (169)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHH
Confidence 456788889999999999999999999999999999999999999999999999999987 999998763
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=98.64 E-value=3.5e-08 Score=76.57 Aligned_cols=72 Identities=24% Similarity=0.352 Sum_probs=66.7
Q ss_pred HHhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 242 VIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 242 ~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.++..++++++..+.++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+++|. +++||+.+
T Consensus 9 ~~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~ 81 (162)
T 1top_A 9 EARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVM 81 (162)
T ss_dssp HHHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHH
T ss_pred HhhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCcEeHHHHHHH
Confidence 3556788899999999999999999999999999999999999999999999999999999887 99999875
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.63 E-value=3.6e-08 Score=78.38 Aligned_cols=65 Identities=17% Similarity=0.284 Sum_probs=58.9
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHH-HhCCC-C------CHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLK-RVGSQ-L------MESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~-~~~~~-~------~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....++.+|..+|.|++|.|+.+|++.+++ .+|.. + ++++++.+++.+|.+++|. +|+||+.++
T Consensus 95 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~ 168 (179)
T 3a8r_A 95 GFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDPTNLGYIEMEDLEALL 168 (179)
T ss_dssp CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHSTTCCSEECHHHHHHHH
T ss_pred CHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3456799999999999999999999999999 88876 6 8999999999999999997 999999764
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=98.62 E-value=3.9e-08 Score=76.10 Aligned_cols=66 Identities=26% Similarity=0.511 Sum_probs=57.6
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCCCHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~~~~~f~~~~ 314 (315)
.++++++.+++++|..+|.|++|.|+.+||..+++.+|..+++.++..++...+ ..++|++|+.++
T Consensus 9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~~---~~i~f~ef~~~~ 74 (153)
T 3i5g_B 9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRVPPDDELNAMLKECP---GQLNFTAFLTLF 74 (153)
T ss_dssp TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSCCCHHHHHHHHHTSS---SCCCSHHHHHTT
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCccHHHHHHHHHhcc---CCccHHHHHHHH
Confidence 478899999999999999999999999999999999999999999888775432 235999998765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.62 E-value=3.2e-08 Score=85.56 Aligned_cols=134 Identities=19% Similarity=0.229 Sum_probs=88.7
Q ss_pred cceEEEEEEeCC---eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------------------
Q 021227 10 VVRIHDTYEDKS---CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-------------------- 66 (315)
Q Consensus 10 iv~~~~~~~~~~---~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-------------------- 66 (315)
+.+++....+.. ..|+|||+++|.+|.+... ..++.++...++.|+...++.||+
T Consensus 75 vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~ 152 (304)
T 3sg8_A 75 IPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINE 152 (304)
T ss_dssp CCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHH
T ss_pred CCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHH
Confidence 345555544333 3578999999988875433 347888888999999999999996
Q ss_pred --------------------------------------CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCccc
Q 021227 67 --------------------------------------LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS 108 (315)
Q Consensus 67 --------------------------------------~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~ 108 (315)
..++|+|++|.||++... ....+.++||+.+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~ 231 (304)
T 3sg8_A 153 DNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFI 231 (304)
T ss_dssp HHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHH
T ss_pred HHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHH
Confidence 136999999999996321 14568999999876543221110
Q ss_pred ccccCccc---cchhhhh---hcCCC------------chhHHHHHHHHHHHHhCCCCC
Q 021227 109 DVVGSPYY---VAPEVLR---KHYGP------------EADVWSAGVILYILLSGVPPF 149 (315)
Q Consensus 109 ~~~gt~~y---~aPE~~~---~~~~~------------~~DiwslG~il~~ll~g~~pf 149 (315)
....+ .+|+... ..|+. -.+.|++|.++|.+.+|..+|
T Consensus 232 ---~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 232 ---SLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp ---TTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred ---HHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11111 2333221 11211 258999999999999998876
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=98.62 E-value=4.4e-09 Score=82.04 Aligned_cols=68 Identities=18% Similarity=0.349 Sum_probs=59.0
Q ss_pred hhhhhhhccHHHHhcccCC--CCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMIDT--DNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~--~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++++++.+++++|..+|. |++|.|+.+||..+|+.+|..++++++..++.. +.+++|. +|++|++++
T Consensus 2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~~-d~~~~g~i~f~eFl~~~ 72 (159)
T 3i5g_C 2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGGT-KKMGEKAYKLEEILPIY 72 (159)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTCC-SSTTSCEECHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHcc-cccCCCcccHHHHHHHH
Confidence 4677899999999999995 899999999999999999999999999998754 5566665 999998753
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=98.61 E-value=9.2e-08 Score=73.90 Aligned_cols=65 Identities=17% Similarity=0.335 Sum_probs=60.5
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....+..+|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||+.+.
T Consensus 88 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 153 (158)
T 2jnf_A 88 QMQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDADGSGTVDFEEFMGVM 153 (158)
T ss_dssp TTSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCSSCCSEECSHHHHHHT
T ss_pred hHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 44567999999999999999999999999999999999999999999999999987 999999865
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=98.61 E-value=1.5e-07 Score=73.56 Aligned_cols=63 Identities=24% Similarity=0.419 Sum_probs=58.7
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.+++|. +++||+++.
T Consensus 100 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 163 (169)
T 3qrx_A 100 REEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIM 163 (169)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCCSSSSCBCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCEeHHHHHHHH
Confidence 446788999999999999999999999999999999999999999999999987 999999864
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=98.61 E-value=4.1e-08 Score=75.05 Aligned_cols=65 Identities=17% Similarity=0.352 Sum_probs=60.0
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....+..+|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +|+||+.++
T Consensus 80 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~ 145 (148)
T 1m45_A 80 AKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDV 145 (148)
T ss_dssp CCTHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHH
T ss_pred ccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 34456899999999999999999999999999999999999999999999999987 999999764
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.60 E-value=4.1e-08 Score=74.59 Aligned_cols=63 Identities=16% Similarity=0.267 Sum_probs=58.9
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.+++|. +|+||+.+.
T Consensus 75 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 138 (143)
T 3j04_B 75 EDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFNYVEFTRIL 138 (143)
T ss_dssp HHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTCCSSSCCCSTHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHH
Confidence 456899999999999999999999999999999999999999999999999987 999999764
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=98.59 E-value=1.5e-07 Score=72.01 Aligned_cols=63 Identities=19% Similarity=0.427 Sum_probs=58.8
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHH-hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKR-VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~-~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.+++|.|+.+|+..+++. +|..+++++++.+++.+|.+++|. +++||+.+.
T Consensus 87 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 151 (153)
T 3ox6_A 87 VKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMM 151 (153)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 456889999999999999999999999999 899999999999999999999987 999999865
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.59 E-value=1.3e-07 Score=71.60 Aligned_cols=63 Identities=19% Similarity=0.313 Sum_probs=58.4
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+..+|..+|.|++|.|+.+|++.+++.+|..+++++++.+++.+| +++|. +++||+++.
T Consensus 77 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~ 140 (142)
T 2bl0_C 77 SEDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE-TEKGQIRYDNFINTM 140 (142)
T ss_dssp CHHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC-CSSSEECSHHHHTTT
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCcEeHHHHHHHH
Confidence 3456889999999999999999999999999999999999999999999 99887 999999864
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=98.59 E-value=5.6e-08 Score=75.92 Aligned_cols=63 Identities=24% Similarity=0.314 Sum_probs=58.8
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.+++|. +|+||+.+.
T Consensus 94 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~I~~~eF~~~~ 157 (166)
T 2mys_B 94 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVI 157 (166)
T ss_pred HHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCCCCCCeEeHHHHHHHH
Confidence 356889999999999999999999999999999999999999999999999987 999999764
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=98.58 E-value=8.4e-08 Score=73.17 Aligned_cols=67 Identities=15% Similarity=0.265 Sum_probs=61.4
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHH---hccCCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV---RKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~---d~~~~~~-~~~~f~~~~ 314 (315)
++++++..++++|..+|.+++|.|+.+|+..+++.+|..+++.++..+++.+ |.++ |. ++++|+.+.
T Consensus 2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~~~~d~~~-g~i~~~eF~~~~ 72 (149)
T 2mys_C 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNA-AAITFEEFLPML 72 (149)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhhhccccC-CcCcHHHHHHHH
Confidence 4567788899999999999999999999999999999999999999999999 9888 65 999998753
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=98.58 E-value=1.8e-07 Score=71.12 Aligned_cols=61 Identities=31% Similarity=0.459 Sum_probs=57.2
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+| +++|. +++||+++.
T Consensus 84 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~l 145 (147)
T 4ds7_A 84 QELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS-DGSGEINIKQFAALL 145 (147)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS-SSCSSEEHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHH
Confidence 46788999999999999999999999999999999999999999999 98887 999999864
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=98.57 E-value=2.6e-08 Score=70.85 Aligned_cols=65 Identities=15% Similarity=0.137 Sum_probs=56.8
Q ss_pred hhhccHHHHhcccC-CCCCC-cccHHHHHHHHHH-h----CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMID-TDNSG-TITFDELKDGLKR-V----GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d-~~~~g-~i~~~el~~~l~~-~----~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+....+.++|..+| .|++| .|+.+|++.+++. + |..+++.+++.+++.+|.+++|. +|+||+.+.
T Consensus 10 ~~~~~l~~~F~~~Dd~d~~G~~I~~~el~~~l~~~~~~~~~~~~~~~~~~~l~~~~D~~~dg~I~~~EF~~~~ 82 (99)
T 1qls_A 10 RCIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLI 82 (99)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCcCeeCHHHHHHHHHHHcchhccccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 34567899999998 99999 9999999999984 4 36788999999999999999987 999998753
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=98.57 E-value=9.9e-08 Score=73.86 Aligned_cols=64 Identities=17% Similarity=0.380 Sum_probs=59.3
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+..+|..+|.+++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +|+||+++.
T Consensus 94 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 158 (161)
T 3fwb_A 94 PLDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDLDGDGEINENEFIAIC 158 (161)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCSSSSSSEEHHHHHHHH
T ss_pred cHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3456889999999999999999999999999999999999999999999999987 999999764
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=98.56 E-value=9e-08 Score=73.83 Aligned_cols=65 Identities=17% Similarity=0.344 Sum_probs=59.6
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHH--HhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDA--VRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~--~d~~~~~~-~~~~f~~~~ 314 (315)
.....+..+|..+|.|++|.|+.+|++.+++.+|..++++++..+++. +|.+++|. +|+||+.+.
T Consensus 81 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 148 (156)
T 1wdc_C 81 GTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKV 148 (156)
T ss_dssp CCHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHH
T ss_pred ChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCCcEeHHHHHHHH
Confidence 344568999999999999999999999999999999999999999999 99999987 999998764
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=98.55 E-value=2.4e-07 Score=71.74 Aligned_cols=64 Identities=23% Similarity=0.399 Sum_probs=58.9
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+..+|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||+.+.
T Consensus 94 ~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 158 (162)
T 1top_A 94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMM 158 (162)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999999987 999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.55 E-value=1.3e-07 Score=83.56 Aligned_cols=91 Identities=23% Similarity=0.384 Sum_probs=70.9
Q ss_pred CCCcceEEEEEEeC---CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----------------
Q 021227 7 HQHVVRIHDTYEDK---SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS----------------- 66 (315)
Q Consensus 7 Hpniv~~~~~~~~~---~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~----------------- 66 (315)
+..+.+++.++.+. +..|+||||++|..+.+.. -..+++.....++.++..+|+.||+
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~ 174 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNY 174 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCH
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCc
Confidence 45688899988776 4588999999998775421 2347888899999999999999997
Q ss_pred -----------------------------------------CCCccccCCCCceeeccCCCCCCEEEeeccCccc
Q 021227 67 -----------------------------------------LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVF 100 (315)
Q Consensus 67 -----------------------------------------~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~ 100 (315)
.+++|||++|.||++... ....+.++||+.+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~-~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 175 FQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT-EPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS-SSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC-CCcEEEEECcccccc
Confidence 368999999999996321 113469999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.54 E-value=5.3e-08 Score=81.81 Aligned_cols=79 Identities=15% Similarity=0.190 Sum_probs=60.1
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------
Q 021227 10 VVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG--------------------- 68 (315)
Q Consensus 10 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--------------------- 68 (315)
+.+++.+..+++..++||||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~ 148 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRM 148 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHH
Confidence 667999988888899999999998883 2 1122 2356677778888888643
Q ss_pred -------------------------------------CccccCCCCceeeccCCCCCCEEEeeccCcc
Q 021227 69 -------------------------------------VFHRDLKPENFLFLSVDEDAALKATDFGLSV 99 (315)
Q Consensus 69 -------------------------------------ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~ 99 (315)
++|||++|.||++ ++++.+.|+|||.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 149 EAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEEEECCCTTCE
T ss_pred hcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEEEEEcchhcc
Confidence 9999999999996 344556799999764
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=98.54 E-value=4.3e-08 Score=75.17 Aligned_cols=63 Identities=16% Similarity=0.288 Sum_probs=56.8
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+.++|..+|.|++|.|+.+|++.+++.+|..+++++++.+++.+| +++|. +|+||+.+.
T Consensus 85 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~ 148 (151)
T 1w7j_B 85 TYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE-DSNGCINYEAFLKHI 148 (151)
T ss_dssp ---CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC-CTTSEEEHHHHHHHT
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc-CCCCeEeHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999 99987 999999864
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.54 E-value=7.2e-08 Score=72.94 Aligned_cols=62 Identities=21% Similarity=0.372 Sum_probs=57.6
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|. ++|. +|+||+.++
T Consensus 75 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~-~dg~i~~~eF~~~~ 137 (140)
T 1ggw_A 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV-KDGMVNYHDFVQMI 137 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC-SSCCSTTTHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccC-CCCcEeHHHHHHHH
Confidence 4568899999999999999999999999999999999999999999999 8887 999998764
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.54 E-value=5.5e-08 Score=73.92 Aligned_cols=65 Identities=25% Similarity=0.405 Sum_probs=59.6
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....+..+|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.+++|. +++||+.+.
T Consensus 73 ~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 138 (145)
T 2bl0_B 73 EQSKEMLDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSVSGDGAINYESFVDML 138 (145)
T ss_dssp GGHHHHHHHHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHH
T ss_pred ccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence 34456899999999999999999999999999999999999999999999999987 999998763
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.52 E-value=1.1e-07 Score=76.83 Aligned_cols=67 Identities=22% Similarity=0.375 Sum_probs=56.5
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+++..++++|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||+.+.
T Consensus 32 ~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~ 99 (204)
T 3e3r_A 32 GASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEFLRAL 99 (204)
T ss_dssp --------CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHT
T ss_pred CchhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHH
Confidence 3567788999999999999999999999999999999999999999999999999987 999998764
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=98.52 E-value=1.1e-07 Score=69.55 Aligned_cols=65 Identities=15% Similarity=0.107 Sum_probs=58.3
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++.++....+++|..+|. ++|.|+.+|++.++++.| +.++++.++++.+|.+++|. |++||+..|
T Consensus 27 it~ee~~~y~~iF~~lD~-~dG~Isg~elr~~~~~sg--Lp~~~L~~Iw~laD~d~dG~Ld~~EF~~aM 92 (121)
T 3fia_A 27 ITVEERAKHDQQFHSLKP-ISGFITGDQARNFFFQSG--LPQPVLAQIWALADMNNDGRMDQVEFSIAM 92 (121)
T ss_dssp CCHHHHHHHHHHHHHTCC-BTTBEEHHHHHHHHGGGC--CCHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeECHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCCHHHHHHHH
Confidence 456788889999999998 899999999999999764 57999999999999999998 999998754
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=98.51 E-value=8.2e-09 Score=74.75 Aligned_cols=65 Identities=31% Similarity=0.380 Sum_probs=59.7
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....++++|..+|.|++|.|+.+|+..+++.+ |..+++++++.+++.+|.+++|. +++||+.+.
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 106 (108)
T 2kyc_A 38 KSSSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARVLTASETKTFLAAADHDGDGKIGAEEFQEMV 106 (108)
T ss_dssp CCSSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCCCCTTTTHHHHTTTCCSSSSCCCSSHHHHHH
T ss_pred ccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 456779999999999999999999999999999 78899999999999999999987 999998764
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=98.51 E-value=1.1e-07 Score=73.28 Aligned_cols=62 Identities=13% Similarity=0.257 Sum_probs=57.6
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.+ +|. +|+||+.+.
T Consensus 86 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~-dg~i~~~eF~~~~ 148 (156)
T 1wdc_B 86 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMI 148 (156)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHH
T ss_pred HHHHHHHHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcCCC-CCEEeHHHHHHHH
Confidence 34688999999999999999999999999999999999999999999999 887 999998764
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.3e-07 Score=72.01 Aligned_cols=63 Identities=19% Similarity=0.362 Sum_probs=58.1
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+..+|..+|.+++|.|+.+|++.+++.+|..++++++..+++. |.+++|. +|+||+.+.
T Consensus 83 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d~~~dg~i~~~eF~~~~ 146 (149)
T 2mys_C 83 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHI 146 (149)
T ss_pred hHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCcEeHHHHHHHH
Confidence 34568899999999999999999999999999999999999999999 9999887 999999764
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=98.50 E-value=1.6e-07 Score=76.34 Aligned_cols=64 Identities=17% Similarity=0.290 Sum_probs=58.6
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHh-CCCCCHHHHHHH----HHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRV-GSQLMESEIKDL----MDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~-~~~~~~~ei~~~----~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+..+|..+|.|++|.|+.+|+..+++.+ |..+++++++.+ ++.+|.+++|. +|+||+.+.
T Consensus 111 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D~d~dG~Is~~EF~~~~ 180 (208)
T 2ct9_A 111 RSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISFTEFVKVL 180 (208)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHCSSSSSSEEHHHHHHTT
T ss_pred HHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 44568899999999999999999999999997 999999999998 99999999997 999999865
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.50 E-value=7e-08 Score=76.32 Aligned_cols=59 Identities=8% Similarity=0.090 Sum_probs=55.1
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHh----CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRV----GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~----~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++++|+.+| |++|.|+.+|++.+++.+ |..+++++++.+++.+| +++|. +|+||++++
T Consensus 77 ~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d-d~dG~I~~~EF~~~~ 140 (174)
T 2i7a_A 77 HYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS-DSVGRVSFPSLVCFL 140 (174)
T ss_dssp HHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS-CTTSEECHHHHHHHH
T ss_pred HHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc-CCCCeEcHHHHHHHH
Confidence 5889999999 999999999999999999 99999999999999999 88887 999998764
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=2.5e-07 Score=74.07 Aligned_cols=57 Identities=23% Similarity=0.222 Sum_probs=50.9
Q ss_pred HHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 257 ELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 257 ~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.+++|. +++||+..
T Consensus 117 ~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~ 174 (195)
T 1qv0_A 117 AVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQ 174 (195)
T ss_dssp HHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHH
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHH
Confidence 8999999999999999999999999999999999999999999999988 99999875
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.50 E-value=2.8e-07 Score=74.44 Aligned_cols=66 Identities=20% Similarity=0.280 Sum_probs=60.2
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHh-CCCCCHHHHHHHHHH----HhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV-GSQLMESEIKDLMDA----VRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~-~~~~~~~ei~~~~~~----~d~~~~~~-~~~~f~~~~ 314 (315)
......+..+|..+|.|++|.|+.+|+..+++.+ |..++++++..+++. +|.+++|. +|+||+.+.
T Consensus 110 ~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~ 181 (202)
T 2bec_A 110 NSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEFTKSL 181 (202)
T ss_dssp TSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHHHHHHHCSSCSSSEEHHHHHHTT
T ss_pred ccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHH
Confidence 3445678899999999999999999999999999 999999999999999 99999997 999999864
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=5.7e-08 Score=77.90 Aligned_cols=72 Identities=15% Similarity=0.254 Sum_probs=63.4
Q ss_pred HHhhhhhhhhhccHHHHhcccCCCCCCcccHHHHH-----HHHHHhCCCCCHH-----HHHHHHHHHhccCCCC-CHHHH
Q 021227 242 VIAERLNEEEIGGLKELFKMIDTDNSGTITFDELK-----DGLKRVGSQLMES-----EIKDLMDAVRKIFSRF-SIKTY 310 (315)
Q Consensus 242 ~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~-----~~l~~~~~~~~~~-----ei~~~~~~~d~~~~~~-~~~~f 310 (315)
.++..++++++..++++|..+|.|++|.|+.+|+. .+++.+|...++. ++..+++.+|.+++|. +++||
T Consensus 9 ~~~~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF 88 (195)
T 1qv0_A 9 LKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQF 88 (195)
T ss_dssp CSCCTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHH
T ss_pred cCcccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcCCCCCceEcHHHH
Confidence 34455578889999999999999999999999999 7888899888876 6999999999999987 99999
Q ss_pred hhc
Q 021227 311 CNL 313 (315)
Q Consensus 311 ~~~ 313 (315)
+.+
T Consensus 89 ~~~ 91 (195)
T 1qv0_A 89 LDG 91 (195)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.50 E-value=1.2e-07 Score=74.48 Aligned_cols=67 Identities=13% Similarity=0.147 Sum_probs=60.0
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHH----HHHHhCCCCCHHHHH-----------HHHHHHhccCCCC-CHHHHh
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKD----GLKRVGSQLMESEIK-----------DLMDAVRKIFSRF-SIKTYC 311 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~----~l~~~~~~~~~~ei~-----------~~~~~~d~~~~~~-~~~~f~ 311 (315)
+++++..++++|..+|.|++|.|+.+|+.. +++.+|..+++.++. .+++.+|.+++|. +++||+
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef~ 81 (176)
T 1nya_A 2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFI 81 (176)
T ss_dssp CSHHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHH
T ss_pred cHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 356778899999999999999999999999 688899999988887 8899999999987 999998
Q ss_pred hcc
Q 021227 312 NLS 314 (315)
Q Consensus 312 ~~~ 314 (315)
++.
T Consensus 82 ~~~ 84 (176)
T 1nya_A 82 RVT 84 (176)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=98.49 E-value=3.1e-07 Score=73.23 Aligned_cols=59 Identities=22% Similarity=0.276 Sum_probs=55.7
Q ss_pred HHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 256 KELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 256 ~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||+++.
T Consensus 112 ~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~eF~~~~ 171 (191)
T 1uhk_A 112 DALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQH 171 (191)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHHH
T ss_pred HHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 38999999999999999999999999999999999999999999999988 999998753
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=98.49 E-value=2.5e-08 Score=76.57 Aligned_cols=68 Identities=19% Similarity=0.389 Sum_probs=57.7
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhcc--CCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKI--FSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~--~~~~-~~~~f~~~~ 314 (315)
++++++..++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.+ ++|. +++||+.+.
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~~~g~i~~~eF~~~~ 74 (151)
T 1w7j_B 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPML 74 (151)
T ss_dssp -------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCcCCCCcCcHHHHHHHH
Confidence 5667888999999999999999999999999999999999999999999999998 8887 999998753
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=98.48 E-value=3.7e-07 Score=72.06 Aligned_cols=63 Identities=17% Similarity=0.373 Sum_probs=56.7
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||+.+.
T Consensus 83 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 146 (179)
T 2f2o_A 83 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM 146 (179)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHS
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHH
Confidence 345789999999999999999999999999999999999999999999999987 999998764
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=98.47 E-value=1.9e-07 Score=71.14 Aligned_cols=61 Identities=23% Similarity=0.358 Sum_probs=56.3
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|++.+++.+|..+++++++.+++.+ +++|. +|+||++++
T Consensus 83 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~l 144 (146)
T 2qac_A 83 VEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF--SSEDNIDYKLFCEDI 144 (146)
T ss_dssp HHHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHH--CSSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHc--CCCCcCcHHHHHHHH
Confidence 45688999999999999999999999999999999999999999999 77777 999999864
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=98.46 E-value=1.7e-07 Score=76.98 Aligned_cols=61 Identities=18% Similarity=0.164 Sum_probs=55.3
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+|++.+++.+|..+++++++.+++.+| +++|. +|+||++++
T Consensus 117 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d-d~dg~I~~~eF~~~~ 178 (220)
T 3sjs_A 117 ELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA-RGMAFCDLNCWIAIC 178 (220)
T ss_dssp HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC---CCSEEHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHH
Confidence 45889999999999999999999999999999999999999999999 98887 999998764
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=98.46 E-value=3.2e-08 Score=75.66 Aligned_cols=64 Identities=20% Similarity=0.313 Sum_probs=55.9
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHH-hccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV-RKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~-d~~~~~~-~~~~f~~~~ 314 (315)
++..++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+ |.+++|. +++||+.+.
T Consensus 2 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D~~~~g~i~~~eF~~~~ 67 (148)
T 1m45_A 2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLI 67 (148)
T ss_dssp -CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHH
T ss_pred hHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhCCCCCCeEcHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999 9999887 999998753
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=98.44 E-value=9.7e-08 Score=77.07 Aligned_cols=63 Identities=22% Similarity=0.250 Sum_probs=56.3
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh--CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV--GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~--~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+ |..+++++++++++.+|.+++|. +|+||++++
T Consensus 128 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l 193 (197)
T 3pm8_A 128 KEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDLNGDGEIDFHEFMLMM 193 (197)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHC----CCHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence 3468899999999999999999999999998 77889999999999999999988 999999864
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=98.44 E-value=1.4e-07 Score=75.92 Aligned_cols=62 Identities=10% Similarity=0.120 Sum_probs=58.0
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+||..++ .+|..++++++..+++.+|.+++|. +|+||++++
T Consensus 125 ~~~l~~~F~~~D~d~~G~Is~~El~~~l-~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~l 187 (196)
T 3dtp_E 125 EDVIVNAFNLFDEGDGKCKEETLKRSLT-TWGEKFSQDEVDQALSEAPIDGNGLIDIKKFAQIL 187 (196)
T ss_dssp HHHHHHHHHTTCSSSSCCBHHHHHHHHH-HSSSCCCHHHHHHHHHSSCEETTEECHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCCHHHHHHHHHHcCCCCCCEEeHHHHHHHH
Confidence 4568899999999999999999999999 9999999999999999999999987 999999864
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=98.44 E-value=9.6e-08 Score=77.59 Aligned_cols=69 Identities=14% Similarity=0.155 Sum_probs=58.1
Q ss_pred hhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCC--CCCHHHHHHHH-------HHHhccCCCC-CHHHHhhc
Q 021227 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS--QLMESEIKDLM-------DAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~--~~~~~ei~~~~-------~~~d~~~~~~-~~~~f~~~ 313 (315)
..++.+++..++++|..+|.|++|.|+.+|+..+++.+|. .++++++..++ +.+|.+++|. +++||+++
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~~~ 106 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWVEA 106 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHHHH
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHH
Confidence 4566778899999999999999999999999999999998 89999999999 9999999987 99999875
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=98.43 E-value=2.6e-07 Score=72.08 Aligned_cols=65 Identities=23% Similarity=0.487 Sum_probs=57.8
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCC-CCCHHHHHHHHHHHhccCCC-CCHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-QLMESEIKDLMDAVRKIFSR-FSIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~-~~~~~ei~~~~~~~d~~~~~-~~~~~f~~~~ 314 (315)
.++.+++..++++|..+|.|++|.|+.+|+..+++.+|. .+++.++..+++.. +| ++|+||+++.
T Consensus 18 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~----dg~i~~~eF~~~~ 84 (166)
T 2mys_B 18 MFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA----SGPINFTVFLTMF 84 (166)
T ss_pred hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHC----CCCcCHHHHHHHH
Confidence 567788899999999999999999999999999999999 99999999999874 44 4999998753
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=98.43 E-value=2.9e-07 Score=73.81 Aligned_cols=62 Identities=23% Similarity=0.342 Sum_probs=57.1
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+.++|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.+++|. +++||+++.
T Consensus 93 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 155 (191)
T 1y1x_A 93 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELS 155 (191)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 35788999999999999999999999999999999999999999999999987 999998753
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=98.42 E-value=1.4e-07 Score=72.02 Aligned_cols=62 Identities=18% Similarity=0.188 Sum_probs=49.9
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhC--------CCCCHHHHHHHH----HHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVG--------SQLMESEIKDLM----DAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~--------~~~~~~ei~~~~----~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|+.+|.|++|.|+.+|+..+++.++ ..++++++.+++ +.+|.+++|. +++||+.++
T Consensus 68 ~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~ 142 (143)
T 3a4u_B 68 ELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDDKNNDGYIDYAEFAKSL 142 (143)
T ss_dssp HHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CCHHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred HHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCCHHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence 3577889999999999999999999998874 578899997776 9999999987 999999864
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=98.41 E-value=1.9e-07 Score=74.63 Aligned_cols=69 Identities=10% Similarity=0.222 Sum_probs=62.6
Q ss_pred hhhhhhhhccHHHHhccc-CCCCCCcccHHHHHHHHHHh----CCCCCHHHHHHHH-----------HHHhccCCCC-CH
Q 021227 245 ERLNEEEIGGLKELFKMI-DTDNSGTITFDELKDGLKRV----GSQLMESEIKDLM-----------DAVRKIFSRF-SI 307 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~-d~~~~g~i~~~el~~~l~~~----~~~~~~~ei~~~~-----------~~~d~~~~~~-~~ 307 (315)
..++.++...++++|..+ |.|++|.|+.+|+..+++.+ |...++.++..++ +.+|.+++|. ++
T Consensus 4 ~~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~~ 83 (191)
T 2ccm_A 4 HQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQVTK 83 (191)
T ss_dssp CCCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEH
T ss_pred hhccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeECH
Confidence 345667788899999999 99999999999999999998 9999999999999 9999999987 99
Q ss_pred HHHhhc
Q 021227 308 KTYCNL 313 (315)
Q Consensus 308 ~~f~~~ 313 (315)
+||+++
T Consensus 84 ~Ef~~~ 89 (191)
T 2ccm_A 84 EEWLKM 89 (191)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=98.41 E-value=2.2e-07 Score=66.65 Aligned_cols=63 Identities=16% Similarity=0.213 Sum_probs=53.7
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHH-----hCCCCCH-----------HHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKR-----VGSQLME-----------SEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~-----~~~~~~~-----------~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...++.+|..+|.|++|.|+.+|+..+++. +|...++ ..+..+++.+|.+++|. +++||++++
T Consensus 19 ~~~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~g~~~~~~~~~~~~e~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~ 98 (103)
T 1snl_A 19 RFNPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLAST 98 (103)
T ss_dssp CCCHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHH
T ss_pred cCCHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHHhccCCCCccHHHHHHHHHHHHHHHHHHcCCCCCCcCCHHHHHHHH
Confidence 346899999999999999999999999986 4655443 35899999999999997 999998764
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=98.41 E-value=5.8e-07 Score=68.95 Aligned_cols=65 Identities=26% Similarity=0.425 Sum_probs=58.9
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHH-hCCCCCHHHHHHHHHH----HhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKR-VGSQLMESEIKDLMDA----VRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~-~~~~~~~~ei~~~~~~----~d~~~~~~-~~~~f~~~~ 314 (315)
.....+..+|..+|.|++|.|+.+|+..+++. +|..++++++..+++. +|.+++|. +++||+++.
T Consensus 72 ~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 142 (155)
T 3ll8_B 72 DKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVV 142 (155)
T ss_dssp CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred CHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 34457899999999999999999999999999 6999999999999999 99999987 999998764
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=98.41 E-value=2.6e-07 Score=68.95 Aligned_cols=60 Identities=15% Similarity=0.257 Sum_probs=48.2
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++|..+|.|++|.|+.+|+..+++.+|...+++++..+++.+|.+++|. +++||+++.
T Consensus 2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 62 (134)
T 1jfj_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFY 62 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHT
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCeEcHHHHHHHH
Confidence 567788888888888888888888888887788888888888888888776 888887654
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=98.41 E-value=3.9e-07 Score=70.74 Aligned_cols=61 Identities=16% Similarity=0.097 Sum_probs=56.2
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+| ++++++..+++.+|.+++|. +++||+++.
T Consensus 97 ~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~--~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~ 158 (166)
T 3akb_A 97 RPFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAALDTDGDGKVGETEIVPAF 158 (166)
T ss_dssp HHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSBCCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 34588999999999999999999999999998 89999999999999999987 999998764
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=98.40 E-value=3.6e-07 Score=71.73 Aligned_cols=62 Identities=23% Similarity=0.287 Sum_probs=57.5
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+.++|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||+.++
T Consensus 74 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 136 (172)
T 2znd_A 74 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGC 136 (172)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 45789999999999999999999999999999999999999999999999987 999998753
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=98.39 E-value=2e-07 Score=73.30 Aligned_cols=64 Identities=14% Similarity=0.207 Sum_probs=57.9
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHh-C-------CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV-G-------SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~-~-------~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++..++++|..+| |++|.|+.+|+..+++.+ | ..+++.++..+++.+|.+++|. +++||+.+.
T Consensus 1 e~~~~l~~~F~~~D-d~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~ 73 (173)
T 1alv_A 1 EEVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLW 73 (173)
T ss_dssp CHHHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred CchhHHHHHHHHHh-CCCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHHHHH
Confidence 35667999999999 999999999999999998 6 7889999999999999999987 999998753
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=98.39 E-value=1.7e-07 Score=72.61 Aligned_cols=64 Identities=27% Similarity=0.408 Sum_probs=56.9
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+..+|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||+++.
T Consensus 93 ~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 157 (161)
T 1dtl_A 93 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFM 157 (161)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 3445789999999999999999999999999999999999999999999999987 999998763
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=98.39 E-value=6.1e-08 Score=74.82 Aligned_cols=67 Identities=18% Similarity=0.322 Sum_probs=58.2
Q ss_pred hhhhhhccHHHHhcccCC--CCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDT--DNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~--~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++++..++++|..+|. |++|.|+.+|+..+++.+|..+++.++..+ +.+|.+++|. +++||+.+.
T Consensus 3 ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D~~~~g~i~~~eF~~~~ 72 (156)
T 1wdc_C 3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKMGEKSLPFEEFLPAY 72 (156)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSSTTSCEECHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhCCCCCCeeeHHHHHHHH
Confidence 456778889999999999 999999999999999999999999999999 8888888876 999998653
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.38 E-value=2.4e-07 Score=70.19 Aligned_cols=63 Identities=22% Similarity=0.403 Sum_probs=56.0
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++++..++++|..+|.|++|.|+.+|+..+++.+|..+++.++..++.. ++|. +|+||+++.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~----~~g~i~~~eF~~~~ 65 (143)
T 3j04_B 2 DQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSE----APGPINFTMFLTMF 65 (143)
T ss_dssp CHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSCCCCHHHHHTTTTT----SSSCCCHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHh----CCCCcCHHHHHHHH
Confidence 46778889999999999999999999999999999999999999998877 5555 999998753
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=98.37 E-value=4.2e-07 Score=73.78 Aligned_cols=58 Identities=19% Similarity=0.256 Sum_probs=54.5
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+..+|..+|.|++|.|+.+|+..+++.+| +++++++.+++.+|.+++|. +++||+.+.
T Consensus 130 ~~~~F~~~D~d~~G~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~ 188 (208)
T 2hpk_A 130 SNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQEAAYTFFEKADTDKSGKLERTELVHLF 188 (208)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHTT--SCTTHHHHHHHHHCTTCCSSBCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCCHHHHHHHHHHhC--cCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 78899999999999999999999999999 88999999999999999987 999998753
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=98.36 E-value=7.6e-07 Score=69.77 Aligned_cols=61 Identities=21% Similarity=0.272 Sum_probs=56.0
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+| +++++++.+++.+|.+++|. +++||+.+.
T Consensus 93 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g--~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~ 154 (174)
T 1q80_A 93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDAIDTNNDGLLSLEEFVIAG 154 (174)
T ss_dssp HTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT--CCGGGHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC--CCHHHHHHHHHHhCCCCCceEeHHHHHHHH
Confidence 46689999999999999999999999999996 78899999999999999987 999998764
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=98.36 E-value=2.2e-07 Score=74.15 Aligned_cols=67 Identities=18% Similarity=0.322 Sum_probs=60.5
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHH-----HHHHHhCCCCCHH-----HHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELK-----DGLKRVGSQLMES-----EIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~-----~~l~~~~~~~~~~-----ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+.+++..++++|..+|.|++|.|+.+|+. .+++.+|...++. ++..+++.+|.+++|. +++||+.+
T Consensus 10 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~ 87 (191)
T 1uhk_A 10 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEG 87 (191)
T ss_dssp TCHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHH
T ss_pred CCHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHHHhCcCCCCcCcHHHHHHH
Confidence 356778889999999999999999999999 7888899988877 7999999999999987 99999875
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=98.35 E-value=4.1e-07 Score=72.91 Aligned_cols=62 Identities=27% Similarity=0.386 Sum_probs=54.8
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...++++|..+|.|++|.|+.+|+..++..+|..++++++..+++.+|.+++|. +++||+.+
T Consensus 26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~ 88 (191)
T 1y1x_A 26 NQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDL 88 (191)
T ss_dssp TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHH
Confidence 457889999999999999999999999977778889999999999999998886 99999865
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=98.35 E-value=2.6e-07 Score=74.49 Aligned_cols=67 Identities=15% Similarity=0.170 Sum_probs=60.3
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCC-----CCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-----QLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~-----~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+++..+++ |..+|.|++|.|+.+|+..+++.+|. .+++++++.+++.+|.+++|. +++||+.+.
T Consensus 27 ~~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~~~~ 99 (198)
T 1juo_A 27 FPGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELW 99 (198)
T ss_dssp CTTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHH
T ss_pred CCccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHHHHH
Confidence 44567888999 99999999999999999999999986 689999999999999999987 999998753
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=98.34 E-value=1.1e-07 Score=70.63 Aligned_cols=59 Identities=19% Similarity=0.310 Sum_probs=51.6
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++...++++|+.+| |.|+.+|++.+++.+|. ++++++++++++|.+++|. +|+||+.++
T Consensus 47 ~~~~~l~~aF~~fD----G~I~~~El~~~l~~lG~--t~~ei~~~~~~~D~d~dG~I~~~EF~~~~ 106 (123)
T 2kld_A 47 NTVDDISESLRQGG----GKLNFDELRQDLKGKGH--TDAEIEAIFTKYDQDGDQELTEHEHQQMR 106 (123)
T ss_dssp ----CCSCSSTTTT----TCEEHHHHHHHTTTCCS--SHHHHHHHHHHHSSSSCCEECSHHHHHCS
T ss_pred hHHHHHHHHHHHhC----CCCCHHHHHHHHHHhCC--CHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence 44566788999998 99999999999999998 9999999999999999987 999999876
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=98.34 E-value=6.3e-07 Score=69.02 Aligned_cols=67 Identities=19% Similarity=0.375 Sum_probs=56.9
Q ss_pred hhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 244 ~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...++.+++..++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++. ++|. +|++|+.+.
T Consensus 9 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~----~~g~i~~~eF~~~~ 76 (156)
T 1wdc_B 9 LTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKE----APGPLNFTMFLSIF 76 (156)
T ss_dssp ---CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHTT----SSSCCCHHHHHHHH
T ss_pred hccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHh----CCCcCcHHHHHHHH
Confidence 345677888899999999999999999999999999999999999999998863 5555 999998753
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.33 E-value=4.2e-07 Score=71.92 Aligned_cols=66 Identities=18% Similarity=0.290 Sum_probs=59.4
Q ss_pred hhhhhccHHHHhccc-CCCCCCcccHHHHHHHHHHhC----CCCCHHHHHHH-----------HHHHhccCCCC-CHHHH
Q 021227 248 NEEEIGGLKELFKMI-DTDNSGTITFDELKDGLKRVG----SQLMESEIKDL-----------MDAVRKIFSRF-SIKTY 310 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~-d~~~~g~i~~~el~~~l~~~~----~~~~~~ei~~~-----------~~~~d~~~~~~-~~~~f 310 (315)
+.++...++++|..+ |.|++|.|+.+|+..+++.++ ..+++.++..+ ++.+|.+++|. +++||
T Consensus 3 s~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~Ef 82 (185)
T 2sas_A 3 NDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEY 82 (185)
T ss_dssp CHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred CHHHHHHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHHH
Confidence 456677899999999 999999999999999999998 88899888866 99999999987 99999
Q ss_pred hhc
Q 021227 311 CNL 313 (315)
Q Consensus 311 ~~~ 313 (315)
+.+
T Consensus 83 ~~~ 85 (185)
T 2sas_A 83 LAM 85 (185)
T ss_dssp HHH
T ss_pred HHH
Confidence 865
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=98.33 E-value=2.3e-07 Score=76.15 Aligned_cols=62 Identities=13% Similarity=0.168 Sum_probs=57.5
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCC-CCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGS-QLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~-~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+|+..+++.+|. .+++++++.+++.+|.+++|. +|+||+.++
T Consensus 130 ~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~ 193 (219)
T 3cs1_A 130 FELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKNGTGSVTFDEFAAWA 193 (219)
T ss_dssp HHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCTTSSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 46889999999999999999999999999987 788899999999999999987 999998764
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=98.33 E-value=8.3e-07 Score=71.12 Aligned_cols=63 Identities=21% Similarity=0.271 Sum_probs=55.4
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHH--hCCCCCH---HHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKR--VGSQLME---SEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~--~~~~~~~---~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++. .|..+++ +++.++++.+|.+++|. +|+||++++
T Consensus 121 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~ 189 (191)
T 3k21_A 121 KKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDKNNDGKIDFHEFSEMM 189 (191)
T ss_dssp HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCHHHHHHHHHHHHHHCSSSSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCHhHHHHHHHHHHHhcCCCCCeECHHHHHHHH
Confidence 356889999999999999999999999998 4566775 47999999999999987 999999865
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=98.32 E-value=6.6e-07 Score=71.42 Aligned_cols=60 Identities=15% Similarity=0.163 Sum_probs=55.4
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+|+..+++.+| ++++++..+++.+|.+++|. +++||+.+.
T Consensus 109 ~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g--~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 169 (191)
T 2ccm_A 109 KYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IPKSDCDAAFDTLSDGGKTMVTREIFARLW 169 (191)
T ss_dssp HHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT--CCHHHHHHHHHHHTTTTTSCCBHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence 4588999999999999999999999999887 88999999999999999987 999998753
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=98.32 E-value=5.7e-07 Score=70.71 Aligned_cols=61 Identities=20% Similarity=0.225 Sum_probs=56.4
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++.+|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+| +++|. +++||+.++
T Consensus 77 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dg~i~~~eF~~~~ 138 (173)
T 1alv_A 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCL 138 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT-CSSSCBCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHH
Confidence 45889999999999999999999999999999999999999999999 88876 999998763
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.31 E-value=6.3e-07 Score=70.33 Aligned_cols=60 Identities=20% Similarity=0.237 Sum_probs=55.9
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+|+..+++.+| ++++++..+++.+|.+++|. +++||+.+.
T Consensus 102 ~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g--~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~ 162 (176)
T 1nya_A 102 PVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTNGNGELSLDELLTAV 162 (176)
T ss_dssp HHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 4578999999999999999999999999998 89999999999999999997 999998764
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.31 E-value=6.1e-07 Score=71.51 Aligned_cols=61 Identities=18% Similarity=0.238 Sum_probs=56.1
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++ |..++++++..+++.+|.+++|. +++||+++.
T Consensus 122 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~--~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 183 (191)
T 3khe_A 122 RERLLAAFQQFDSDGSGKITNEELGRLFG--VTEVDDETWHQVLQECDKNNDGEVDFEEFVEMM 183 (191)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHTT--SSCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCcCcCCHHHHHHHHc--cCCCCHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 34688999999999999999999999998 88899999999999999999987 999998764
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=98.31 E-value=3.1e-07 Score=72.15 Aligned_cols=63 Identities=16% Similarity=0.265 Sum_probs=56.6
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhC-CCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVG-SQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~-~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+...++++|..+|.|++|.|+.+|+..+++.+| ..+++.++..+++.+|.+++|. +++||+.+
T Consensus 5 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~ef~~~ 69 (172)
T 2znd_A 5 DQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGV 69 (172)
T ss_dssp -CHHHHHHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSSSSSEECHHHHHHH
T ss_pred chhHHHHHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHH
Confidence 455689999999999999999999999999888 7789999999999999999887 99999875
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=98.29 E-value=9.4e-07 Score=72.99 Aligned_cols=62 Identities=18% Similarity=0.276 Sum_probs=53.4
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHh------------CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRV------------GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~------------~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++.+|+.+|.|++|.|+.+|+..+++.+ +...++++++.+++.+|.+++|. +++||++++
T Consensus 138 ~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~ 212 (229)
T 3dd4_A 138 EKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESC 212 (229)
T ss_dssp HHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCSSCSSBCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcCCCCCcEeHHHHHHHH
Confidence 467899999999999999999999999987 56678899999999999999997 999998764
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=98.29 E-value=7.9e-07 Score=70.46 Aligned_cols=60 Identities=22% Similarity=0.290 Sum_probs=53.3
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCC--------CC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFS--------RF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~--------~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+|+..+++ +..++++++.++++.+|.+++ |. +|+||++++
T Consensus 108 ~~~~~~F~~~D~d~~G~I~~~El~~~l~--~~~~~~~~~~~~~~~~d~~~d~~~~~~~~G~i~~~eF~~~l 176 (180)
T 3mse_B 108 TFLKAAFNKIDKDEDGYISKSDIVSLVH--DKVLDNNDIDNFFLSVHSIKKGIPREHIINKISFQEFKDYM 176 (180)
T ss_dssp CHHHHHHHHHCTTCSSCBCHHHHHHHTT--TSSCCHHHHHHHHHHHHTC---------CCCBCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHc--CCCCCHHHHHHHHHHhhhccCcccccccCCeeeHHHHHHHH
Confidence 5688999999999999999999999998 678999999999999999988 66 999999764
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=98.28 E-value=3.7e-07 Score=69.49 Aligned_cols=64 Identities=13% Similarity=0.172 Sum_probs=58.5
Q ss_pred hhhhhccHHHHhcccCCCC-CCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCCCHHHHhhcc
Q 021227 248 NEEEIGGLKELFKMIDTDN-SGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCNLS 314 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~-~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~~~~~f~~~~ 314 (315)
..+++..++++|..+|.|+ +|.|+.+|+..+++.+|..+++.++..+++.+|.+ +++++|+.+.
T Consensus 9 ~~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~---i~~~eF~~~~ 73 (146)
T 2qac_A 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYGDN---LTYEQYLEYL 73 (146)
T ss_dssp HHHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSE---ECHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC---CCHHHHHHHH
Confidence 3467788999999999999 99999999999999999999999999999999987 9999998653
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.26 E-value=7.7e-07 Score=67.14 Aligned_cols=60 Identities=17% Similarity=0.305 Sum_probs=53.2
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++..++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++ +++|. +++||+.+.
T Consensus 3 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~----~~~g~i~~~eF~~~~ 63 (140)
T 1ggw_A 3 DDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES----TLPAEVDMEQFLQVL 63 (140)
T ss_dssp CCTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT----TSCSSEEHHHHHHHH
T ss_pred hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHh----CCCCcCcHHHHHHHH
Confidence 4567899999999999999999999999999999999999999987 66666 999998754
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.26 E-value=8.1e-07 Score=67.31 Aligned_cols=57 Identities=21% Similarity=0.502 Sum_probs=52.6
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++. +++|. +++||+.+.
T Consensus 7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~---~~~g~i~~~eF~~~~ 64 (145)
T 2bl0_B 7 IQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ---LNAKEFDLATFKTVY 64 (145)
T ss_dssp HHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH---HTSSEECHHHHHHHH
T ss_pred HHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh---cCCCeEcHHHHHHHH
Confidence 8999999999999999999999999999999999999999988 66665 999998764
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=98.26 E-value=1.3e-06 Score=69.37 Aligned_cols=62 Identities=21% Similarity=0.271 Sum_probs=55.1
Q ss_pred ccHHHHh--cccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELF--KMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F--~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+.+.| ..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||+.+.
T Consensus 100 ~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~ef~~~~ 164 (186)
T 2hps_A 100 AVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRDEFLVTV 164 (186)
T ss_dssp TTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence 4445555 6779999999999999999999999999999999999999999997 999998753
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=98.26 E-value=1.4e-06 Score=67.82 Aligned_cols=60 Identities=22% Similarity=0.336 Sum_probs=54.6
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+.++|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+ +++|. +++||+.++
T Consensus 70 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~ 130 (165)
T 1k94_A 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY--SKNGRIFFDDYVACC 130 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHH--CBTTBCBHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHH
Confidence 3578999999999999999999999999999999999999999999 66665 999998753
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=98.25 E-value=7.6e-07 Score=80.27 Aligned_cols=69 Identities=29% Similarity=0.478 Sum_probs=63.0
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+..+++..++++|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.+++|. +++||+++.
T Consensus 305 ~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~DgdG~IsfeEFl~ll 374 (450)
T 3sg6_A 305 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMM 374 (450)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTSSSSEEHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcccHHHHHHHH
Confidence 455677788999999999999999999999999999999999999999999999999987 999998753
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=4.3e-07 Score=72.10 Aligned_cols=62 Identities=16% Similarity=0.254 Sum_probs=56.4
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCC-----CCCHHHHHH----HHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGS-----QLMESEIKD----LMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~-----~~~~~ei~~----~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+|+..+++.+|. .++++++.. +++.+|.+++|. +++||+.++
T Consensus 98 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~ 169 (183)
T 1dgu_A 98 IKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVI 169 (183)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCTTSSSEEEHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 46899999999999999999999999999987 688888886 999999999997 999998764
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=98.24 E-value=5.5e-07 Score=73.62 Aligned_cols=63 Identities=16% Similarity=0.230 Sum_probs=55.7
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCC-----CCCHHHHHH----HHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-----QLMESEIKD----LMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~-----~~~~~ei~~----~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...++.+|..+|.|++|.|+.+|+..+++.++. .++++++++ +++.+|.+++|. +|+||+.++
T Consensus 128 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D~d~dG~Is~~EF~~~~ 200 (214)
T 2l4h_A 128 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVI 200 (214)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHCCSCCSSBCSHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 346889999999999999999999999999875 788788775 999999999987 999998754
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=98.24 E-value=1.4e-06 Score=67.93 Aligned_cols=58 Identities=16% Similarity=0.152 Sum_probs=52.9
Q ss_pred HHhcccCCCCCCcccHHHHHHHHHHhCC-----CCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 257 ELFKMIDTDNSGTITFDELKDGLKRVGS-----QLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 257 ~~F~~~d~~~~g~i~~~el~~~l~~~~~-----~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+.|..+|.|++|.|+.+|+..+++.+|. .++++++..+++.+|.+++|. +++||+++.
T Consensus 5 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~ 68 (167)
T 1gjy_A 5 YGYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELW 68 (167)
T ss_dssp HHHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCBCHHHHHHHH
T ss_pred HHHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 4588999999999999999999999987 689999999999999999987 999998763
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.24 E-value=3e-06 Score=68.90 Aligned_cols=63 Identities=24% Similarity=0.226 Sum_probs=55.0
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhC-----CCCCH-HHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVG-----SQLME-SEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~-----~~~~~-~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..++..++ ...+. +.+..+++.+|.+++|. +++||+.+.
T Consensus 92 ~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~ 161 (211)
T 2ggz_A 92 EQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDINNDGELTLEEFINGM 161 (211)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 34678999999999999999999999999987 56665 45999999999999987 999998753
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=98.24 E-value=1.8e-06 Score=77.84 Aligned_cols=63 Identities=17% Similarity=0.373 Sum_probs=58.9
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+.++|+.+|.|++|.|+.+||+.+++.+|..+++++++.+++.+|.+++|. +|+||+++.
T Consensus 384 ~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~D~DG~IsfdEFv~~L 447 (450)
T 3sg6_A 384 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM 447 (450)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTSSSSEEHHHHHHHH
T ss_pred hhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 346889999999999999999999999999999999999999999999999987 999999864
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=98.22 E-value=2.6e-06 Score=67.37 Aligned_cols=63 Identities=17% Similarity=0.297 Sum_probs=53.1
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh----CCC----CC----HHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV----GSQ----LM----ESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~----~~~----~~----~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+ |.. ++ ++++.++++.+|.+++|. +++||+.++
T Consensus 91 ~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~ 166 (183)
T 1s6c_A 91 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESX 166 (183)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 3467899999999999999999999999887 632 33 489999999999999998 999998764
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=98.22 E-value=7.8e-07 Score=71.58 Aligned_cols=67 Identities=16% Similarity=0.397 Sum_probs=58.3
Q ss_pred hhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCCCHHHHhhcc
Q 021227 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCNLS 314 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~~~~~f~~~~ 314 (315)
..++.+++..+.++|..+|.|++|.|+.+||..+++.+|..++..++..++..+ ...++|++|+++.
T Consensus 49 ~~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~---~g~i~~~eF~~~~ 115 (196)
T 3dtp_E 49 AMFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA---PGPINFTMFLTIF 115 (196)
T ss_dssp CSSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS---SSCCBHHHHHHHH
T ss_pred hhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc---cCCCcHHHHHHHH
Confidence 346677888999999999999999999999999999999999999999999876 2334999998763
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=98.21 E-value=1.4e-06 Score=67.46 Aligned_cols=63 Identities=11% Similarity=0.125 Sum_probs=54.6
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHH----HHhCCCCCHHHHHHH-----------HHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGL----KRVGSQLMESEIKDL-----------MDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l----~~~~~~~~~~ei~~~-----------~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+..++++|..+|.|++|.|+.+|+..++ +.+|..+++.++..+ ++.+|.+++|. +++||+.+.
T Consensus 3 ~~~l~~~F~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~ 81 (166)
T 3akb_A 3 ERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFVTGA 81 (166)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCEEHHHHHHTH
T ss_pred HHHHHHHHhHHcCCCCCCcCHHHHHHHHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 4568999999999999999999999975 556999998888866 69999999987 999998753
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.21 E-value=4.5e-07 Score=72.51 Aligned_cols=61 Identities=25% Similarity=0.386 Sum_probs=55.5
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|++.+++.+| ++++++..+++.+|.+++|. +|+||++++
T Consensus 81 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~ 142 (188)
T 1s6i_A 81 EENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQDNDGQIDYGEFAAMM 142 (188)
T ss_dssp CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSSSSSEEETTHHHHTT
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcEeHHHHHHHH
Confidence 35689999999999999999999999999887 67889999999999999987 999999865
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=98.18 E-value=2.1e-06 Score=69.07 Aligned_cols=60 Identities=23% Similarity=0.369 Sum_probs=55.0
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++++|..+|.|++|.|+.+|++.+++.+|..+++++++.+++.+ +++|. +++||+++.
T Consensus 103 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~--d~dg~i~~~eF~~~~ 163 (198)
T 1juo_A 103 NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY--STNGKITFDDYIACC 163 (198)
T ss_dssp HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHT--CSSSSEEHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHH
Confidence 4688999999999999999999999999999999999999999999 67776 999998753
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.18 E-value=3.8e-06 Score=67.44 Aligned_cols=62 Identities=19% Similarity=0.209 Sum_probs=54.3
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhC------CCCCH-HHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVG------SQLME-SEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~------~~~~~-~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+|+..++..++ ...+. +.+..+|+.+|.+++|. +++||+.+.
T Consensus 88 ~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~ 157 (198)
T 2r2i_A 88 QKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDINGDGELSLEEFMEGV 157 (198)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 4578899999999999999999999999886 55665 45999999999999998 999998764
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.18 E-value=1.3e-06 Score=70.67 Aligned_cols=62 Identities=19% Similarity=0.199 Sum_probs=45.7
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...+..+|..+|.|++|.|+++|+..++..++...+++++..+|+.+|.+++|. +++||..+
T Consensus 58 ~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~ 120 (204)
T 1jba_A 58 TQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDI 120 (204)
T ss_dssp HHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSSCSSCBCHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 345667777777777777777777777777776667777777777777777776 77777654
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=98.18 E-value=1.2e-06 Score=68.20 Aligned_cols=58 Identities=10% Similarity=0.145 Sum_probs=51.0
Q ss_pred HHhcccCCCCCCcccHHHHHHHHHHhCC-----CCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 257 ELFKMIDTDNSGTITFDELKDGLKRVGS-----QLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 257 ~~F~~~d~~~~g~i~~~el~~~l~~~~~-----~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..|..+|.|++|.|+.+|+..+++.+|. .+++.++..+++.+|.+++|. +++||++++
T Consensus 3 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~ 66 (165)
T 1k94_A 3 YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELW 66 (165)
T ss_dssp HHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHH
T ss_pred HHHHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 3588899999999999999999999986 678999999999999998887 999998753
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.17 E-value=6.8e-07 Score=70.68 Aligned_cols=61 Identities=16% Similarity=0.257 Sum_probs=55.1
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+| ++++++..+++.+|.+++|. +++||+.+.
T Consensus 104 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g--~~~~~~~~~~~~~D~d~dG~i~~~ef~~~~ 165 (185)
T 2sas_A 104 QNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLNRYKELY 165 (185)
T ss_dssp HHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHTTTTSCCSHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhC--CCHHHHHHHHHHhcCCCCCcCcHHHHHHHH
Confidence 35688999999999999999999999998887 67889999999999999988 999998753
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=98.17 E-value=4e-07 Score=75.10 Aligned_cols=71 Identities=18% Similarity=0.263 Sum_probs=61.3
Q ss_pred HhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHH-HHHHhCCCCCHHHHHHHHHHH---------hccCCCC-CHHHHh
Q 021227 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKD-GLKRVGSQLMESEIKDLMDAV---------RKIFSRF-SIKTYC 311 (315)
Q Consensus 243 i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~-~l~~~~~~~~~~ei~~~~~~~---------d~~~~~~-~~~~f~ 311 (315)
+...++.+++..++++|..+|.|++|.|+.+|+.. +++.+|...++.++..+++.+ |.+++|. +|+||+
T Consensus 41 l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I~~~EF~ 120 (226)
T 2lvv_A 41 IPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRAFDKAKDLGNKVKGVGEEDLVEFL 120 (226)
T ss_dssp SCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHHHHHHHHHHHHHSCCCCCSCBCHH
T ss_pred hchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhcccCCCCCCCCcCCHHHHH
Confidence 44556788899999999999999999999999998 556678888888888888888 9999886 999998
Q ss_pred hc
Q 021227 312 NL 313 (315)
Q Consensus 312 ~~ 313 (315)
++
T Consensus 121 ~~ 122 (226)
T 2lvv_A 121 EF 122 (226)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=98.17 E-value=1.7e-06 Score=67.57 Aligned_cols=60 Identities=23% Similarity=0.365 Sum_probs=54.6
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+.++|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+ +++|. +++||+++.
T Consensus 72 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~ 132 (167)
T 1gjy_A 72 NGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRY--STSGKITFDDYIACC 132 (167)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHT--CBTTBEEHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHh--CcCCcCcHHHHHHHH
Confidence 4588999999999999999999999999999999999999999999 66766 999998753
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.4e-06 Score=70.24 Aligned_cols=64 Identities=14% Similarity=0.266 Sum_probs=56.5
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHH-------HhCCCCCHHHHHHHHHHHhc-cCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLK-------RVGSQLMESEIKDLMDAVRK-IFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~-------~~~~~~~~~ei~~~~~~~d~-~~~~~-~~~~f~~~~ 314 (315)
....+..+|..+|.|++|.|+.+|+..+++ ..|...++++++.+++.+|. +++|. +++||+++.
T Consensus 107 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~~d~dg~Is~~EF~~~~ 179 (204)
T 3e3r_A 107 REAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEFQDYY 179 (204)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSCSSCCSCEEHHHHHHHH
T ss_pred HHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhccCCCCcCcHHHHHHHH
Confidence 345688999999999999999999999998 45777889999999999998 99987 999998753
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=98.15 E-value=7.2e-07 Score=74.89 Aligned_cols=69 Identities=16% Similarity=0.157 Sum_probs=61.0
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCH------HHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLME------SEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~------~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+.+.+...++++|..+|.|++|.|+.+|+..+++.+|..++. .++..+++.+|.+++|. +++||+.+.
T Consensus 9 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~Ef~~~~ 84 (263)
T 2f33_A 9 QSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQRDDGKIGIVELAHVL 84 (263)
T ss_dssp TTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHTTGGGCCBCHHHHHHHT
T ss_pred hcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHhhcCCCccchHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 4566777889999999999999999999999999998766554 89999999999999887 999998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=3.1e-06 Score=77.82 Aligned_cols=62 Identities=24% Similarity=0.295 Sum_probs=56.0
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+.++|+.+|.|++|.|+.+|+..++.. ...++++++++++++|.+++|. +|+||++++
T Consensus 416 ~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~--~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 478 (484)
T 3nyv_A 416 SRERLERAFRMFDSDNSGKISSTELATIFGV--SDVDSETWKSVLSEVDKNNDGEVDFDEFQQML 478 (484)
T ss_dssp HHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH--TTCCHHHHHHHHHHHCTTCCSEEEHHHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHH
Confidence 3456889999999999999999999999987 5678999999999999999998 999999864
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=98.12 E-value=8.2e-07 Score=72.79 Aligned_cols=71 Identities=18% Similarity=0.294 Sum_probs=57.7
Q ss_pred HhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHH-hCCCCCHHHHHHHHHHH---------hccCCCC-CHHHHh
Q 021227 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR-VGSQLMESEIKDLMDAV---------RKIFSRF-SIKTYC 311 (315)
Q Consensus 243 i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~-~~~~~~~~ei~~~~~~~---------d~~~~~~-~~~~f~ 311 (315)
+...++.+++..++++|..+|.|++|.|+.+|+..+++. +|...++.++..++..+ +.+++|. +|+||+
T Consensus 38 ~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~d~~g~I~~~EF~ 117 (219)
T 3cs1_A 38 IPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEFL 117 (219)
T ss_dssp SCCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHHHHHHHHHHHHHHHTSCCCSSBCHH
T ss_pred hcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHhhhhccCCCCcCCHHHHH
Confidence 345567788999999999999999999999999999988 79888877777766544 3366665 999988
Q ss_pred hc
Q 021227 312 NL 313 (315)
Q Consensus 312 ~~ 313 (315)
.+
T Consensus 118 ~~ 119 (219)
T 3cs1_A 118 EF 119 (219)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=98.12 E-value=2.7e-06 Score=70.05 Aligned_cols=60 Identities=17% Similarity=0.332 Sum_probs=53.6
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+||..+++.+ |...+ ++..+++.+|.+++|. +|+||+.++
T Consensus 133 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~--e~~~~~~~~D~d~dG~Is~~EF~~~~ 196 (226)
T 2lvv_A 133 FELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDIT--DATTVFNEIDTNGSGVVTFDEFSCWA 196 (226)
T ss_dssp HHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCC--SCHHHHHHHCCSCSSCEEHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHH--HHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 468899999999999999999999999987 66554 5999999999999997 999999864
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=98.12 E-value=6.4e-06 Score=67.73 Aligned_cols=63 Identities=19% Similarity=0.263 Sum_probs=54.9
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHH----HhCCCCCHHHHHHHHH----HHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLK----RVGSQLMESEIKDLMD----AVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~----~~~~~~~~~ei~~~~~----~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++ ..|..+++++++++++ .+|.+++|. +++||+.+.
T Consensus 121 ~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~EF~~~~ 192 (226)
T 2zfd_A 121 DDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLV 192 (226)
T ss_dssp HHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 44688999999999999999999999995 6788999988876664 999999997 999998753
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.3e-06 Score=67.95 Aligned_cols=61 Identities=26% Similarity=0.346 Sum_probs=48.4
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+| +++++++.+++.+|.+++|. +++||+...
T Consensus 98 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~--~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 159 (166)
T 2aao_A 98 EDHLFAAFTYFDKDGSGYITPDELQQACEEFG--VEDVRIEELMRDVDQDNDGRIDYNEFVAMM 159 (166)
T ss_dssp THHHHHHHHHHCTTCSSSBCHHHHHHHTCC----------CCHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 34688999999999999999999999998776 56889999999999999987 999998764
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=98.11 E-value=3.4e-06 Score=67.10 Aligned_cols=63 Identities=24% Similarity=0.303 Sum_probs=54.7
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh----C--------CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV----G--------SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~----~--------~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..++..+ | ...+++++..+++.+|.+++|. +++||..++
T Consensus 98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~ef~~~~ 173 (190)
T 1g8i_A 98 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGS 173 (190)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEEEHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCCCCCcEeHHHHHHHH
Confidence 3467889999999999999999999999873 3 3577899999999999999998 999998753
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=98.11 E-value=1.4e-06 Score=68.29 Aligned_cols=64 Identities=20% Similarity=0.249 Sum_probs=54.8
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhC----CCCCHHH-HH--------HHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG----SQLMESE-IK--------DLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~----~~~~~~e-i~--------~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++..++++|..+|.|++|.|+.+|+..+++.+| ..+++.+ +. .+++.+| ++|. +++||+++.
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~l~~~~D--~~g~i~~~EF~~~~ 79 (174)
T 1q80_A 2 DLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVA--GGKGIDETTFINSM 79 (174)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEESHHHHHHHHHHHHHHSSCCTTHHHHHHHHHHHHHHHTGGGTT--TTSCEEHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHhcC--CCCeEcHHHHHHHH
Confidence 45677899999999999999999999999999998 8888888 64 5778888 6665 999998753
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=98.10 E-value=7.1e-06 Score=65.24 Aligned_cols=63 Identities=21% Similarity=0.365 Sum_probs=54.8
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh------------CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV------------GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~------------~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+ +...+++++..+++.+|.+++|. +++||..+.
T Consensus 98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~ 173 (190)
T 2l2e_A 98 NDKLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQLTLEEFCEGS 173 (190)
T ss_dssp HHHHHHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTCCSSCCBCHHHHHHHH
T ss_pred HHHHHHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3467889999999999999999999998873 34578999999999999999987 999998753
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=98.09 E-value=5.8e-06 Score=69.41 Aligned_cols=63 Identities=17% Similarity=0.282 Sum_probs=55.5
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh----C--------CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV----G--------SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~----~--------~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+ | ...+++++..+|+.+|.+++|. +++||+.++
T Consensus 164 ~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~ 239 (256)
T 2jul_A 164 HEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDGVVTIDEFLETC 239 (256)
T ss_dssp HHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCSTTCSBCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCCCCCcEeHHHHHHHH
Confidence 3467899999999999999999999999877 5 3457899999999999999988 999998753
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.09 E-value=4.9e-06 Score=68.40 Aligned_cols=63 Identities=17% Similarity=0.289 Sum_probs=54.1
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh----CCC----C----CHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV----GSQ----L----MESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~----~~~----~----~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...++.+|..+|.|++|.|+.+|+..+++.+ |.. + .++++..+++.+|.+++|. +++||+.++
T Consensus 124 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~ 199 (224)
T 1s1e_A 124 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESC 199 (224)
T ss_dssp HHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTTCSSCEEHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 3457899999999999999999999999876 532 2 3589999999999999998 999998753
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.1e-06 Score=70.98 Aligned_cols=65 Identities=9% Similarity=0.151 Sum_probs=57.6
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++.+++..+.++|..+|.|++|.|+.+|+..+ +.+|...+ +..+++.+|.+++|. +|+||+++.
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~~~---~~~l~~~~D~d~dg~i~~~EF~~~~ 87 (202)
T 2bec_A 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVNPL---GDRIIESFFPDGSQRVDFPGFVRVL 87 (202)
T ss_dssp CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHSTT---HHHHHHTTSCSSCCCCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCCcc---HHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 456778889999999999999999999999999 88886655 999999999999987 999998763
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.6e-06 Score=66.39 Aligned_cols=60 Identities=15% Similarity=0.269 Sum_probs=43.9
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCC-CCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQ-LMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~-~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+.++|..+|.|++|.|+++|+..++...... ..++.+..+|+.+|.+++|. +.+||..+
T Consensus 39 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~ 100 (155)
T 3ll8_B 39 LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQV 100 (155)
T ss_dssp THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCTTCSSCBCHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 56777777888888888888887777765433 44677788888888887776 77777654
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.07 E-value=8e-06 Score=65.83 Aligned_cols=63 Identities=22% Similarity=0.192 Sum_probs=54.5
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh----C-------------CCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV----G-------------SQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~----~-------------~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...+..+|..+|.|++|.|+.+|+..+++.+ | ...+++++..+++.+|.+++|. +++||+.+
T Consensus 94 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~ 173 (204)
T 1jba_A 94 EHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEG 173 (204)
T ss_dssp THHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccccccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHH
Confidence 3468899999999999999999999999887 3 1156789999999999999987 99999876
Q ss_pred c
Q 021227 314 S 314 (315)
Q Consensus 314 ~ 314 (315)
.
T Consensus 174 ~ 174 (204)
T 1jba_A 174 A 174 (204)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=98.07 E-value=4.7e-06 Score=67.36 Aligned_cols=63 Identities=19% Similarity=0.174 Sum_probs=54.9
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh----C----CCCC------HHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV----G----SQLM------ESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~----~----~~~~------~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++.+ | ..++ ++++..+++.+|.+++|. +++||+.+.
T Consensus 106 ~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~ 183 (207)
T 2d8n_A 106 NQKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKLTEKEFIEGT 183 (207)
T ss_dssp STTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTCCTTCCEEHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCcccccccHHHHHHHHHHHcCCCCCCcCcHHHHHHHH
Confidence 4568899999999999999999999999886 6 4444 478999999999999988 999998763
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=98.06 E-value=1e-05 Score=65.31 Aligned_cols=63 Identities=21% Similarity=0.200 Sum_probs=54.5
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHH----HhCCCCCHHHHHHHH----HHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLK----RVGSQLMESEIKDLM----DAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~----~~~~~~~~~ei~~~~----~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..+++ ..|..++++++++++ +.+|.+++|. +++||+.+.
T Consensus 110 ~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~ 181 (207)
T 2ehb_A 110 HEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDIDEWKDFV 181 (207)
T ss_dssp HHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 44588999999999999999999999985 568899998886666 5999999997 999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=4.1e-07 Score=83.83 Aligned_cols=63 Identities=21% Similarity=0.329 Sum_probs=39.3
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+.++|..+|.|++|.|+.+|+..+++.+|..+++++++++++++|.+++|. +++||++++
T Consensus 416 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~ 479 (486)
T 3mwu_A 416 RERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEML 479 (486)
T ss_dssp HHHHHHHHHHHCSSCSSSBCSSCC--------------------CCCCSSCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 356889999999999999999999999999999999999999999999999998 999999764
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=98.05 E-value=2.7e-06 Score=71.74 Aligned_cols=62 Identities=10% Similarity=0.109 Sum_probs=56.4
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCC----CCCHHHHHH----HHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGS----QLMESEIKD----LMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~----~~~~~ei~~----~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+|+..+++.++. .+++++++. +++.+|.+++|. +++||+.++
T Consensus 196 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~D~d~dG~is~~EF~~~~ 266 (272)
T 2be4_A 196 RDFEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMNKDGKIQKSELALCL 266 (272)
T ss_dssp HHHHHHHHHHCTTCCSEEETHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHHHHHCCSTTCEEEHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCeecHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 35789999999999999999999999998876 789999888 999999999997 999999865
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=98.05 E-value=7.7e-06 Score=68.50 Aligned_cols=64 Identities=19% Similarity=0.279 Sum_probs=57.8
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHh----CCCCCHHHHHH----HHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRV----GSQLMESEIKD----LMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~----~~~~~~~ei~~----~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+.++|..+|.|++|.|+.+|+..+++.+ |..+++.++.. +++.+|.+++|. +++||+++.
T Consensus 101 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~ 173 (263)
T 2f33_A 101 SCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLL 173 (263)
T ss_dssp CHHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSSSSSCBCHHHHHHHS
T ss_pred HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHH
Confidence 34568999999999999999999999999988 89999999988 999999999987 999998764
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=98.05 E-value=2.1e-06 Score=74.68 Aligned_cols=61 Identities=20% Similarity=0.223 Sum_probs=57.4
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHH-HHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGL-KRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l-~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+..+|..+|.|++|.|+.+|+..++ ..+|..++++++..++..+|.+++|. +|+||+.++
T Consensus 254 ~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~ls~~e~~~l~~~~D~d~dG~Is~~EF~~~~ 316 (323)
T 1ij5_A 254 VLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLV 316 (323)
T ss_dssp HHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHH
Confidence 68899999999999999999999999 99999999999999999999999997 999998764
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=98.04 E-value=2.3e-06 Score=84.43 Aligned_cols=70 Identities=14% Similarity=0.358 Sum_probs=64.3
Q ss_pred hhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++.+++..+.++|..+|.|++|.|+.+|+..+++.+|..+++.+++.+++.+|.+++|. +|+||+.++
T Consensus 717 ~~l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~ 787 (863)
T 1sjj_A 717 KGISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDPNRMGVVTFQAFIDFM 787 (863)
T ss_dssp CCSSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHCTTSCSEEETTHHHHTH
T ss_pred cCCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 4455677889999999999999999999999999999999999999999999999999987 999998764
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=98.03 E-value=4.6e-06 Score=67.43 Aligned_cols=66 Identities=20% Similarity=0.259 Sum_probs=39.5
Q ss_pred hhhhhhccHHHHhcccCCC--CCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 247 LNEEEIGGLKELFKMIDTD--NSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~--~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
++.+++..+.++|..+|.| ++|.|+.+|+..++.. +....+..+..+++.+|.+++|. +++||+.+
T Consensus 31 ~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~ 99 (207)
T 2ehb_A 31 FTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR-NRNRRNLFADRIFDVFDVKRNGVIEFGEFVRS 99 (207)
T ss_dssp CCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHS-CTTCCCHHHHHHHHHHCTTCSSEECHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhc-cccccHHHHHHHHHHhcCCCCCeEeHHHHHHH
Confidence 4455566666666666666 6666666666666654 22233445556666666666665 66666553
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=98.02 E-value=2.4e-06 Score=72.02 Aligned_cols=67 Identities=18% Similarity=0.406 Sum_probs=59.1
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHH----HhCC--CCCHHHHHHHH----HHHhccCCCC-CHHHHhhc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLK----RVGS--QLMESEIKDLM----DAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~----~~~~--~~~~~ei~~~~----~~~d~~~~~~-~~~~f~~~ 313 (315)
+...+...++++|..+|.|++|.|+.+|+..+++ .+|. .++++++..++ +.+|.+++|. +++||+++
T Consensus 5 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~lg~~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~ 82 (272)
T 2be4_A 5 FANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMSAYDATFDGRLQIEELANM 82 (272)
T ss_dssp CCCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHHSTTSCCCHHHHHHHHHHHSCHHHHTCCSEEEHHHHHHH
T ss_pred HHhcCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhcCCCCCcEeHHHHHHH
Confidence 3455667799999999999999999999999999 8998 89999998765 7889999987 99999876
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=98.01 E-value=6.6e-06 Score=65.40 Aligned_cols=60 Identities=18% Similarity=0.294 Sum_probs=56.3
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+..+|..+|.|++|.|+++|+..++..++...+++++..+|+.+|.+++|. +++||..+
T Consensus 64 ~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~ 124 (190)
T 1fpw_A 64 FANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTI 124 (190)
T ss_dssp HHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcEeHHHHHHHHHHHccCCcHHHHHHHHHHhcCCCCCcCcHHHHHHH
Confidence 4789999999999999999999999999998889999999999999999997 99999865
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=98.01 E-value=3.1e-06 Score=78.29 Aligned_cols=61 Identities=21% Similarity=0.363 Sum_probs=54.9
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+.++|+.+|.|++|.|+.+|+..++.. ..+++++++++++++|.+++|. +++||++++
T Consensus 434 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~--~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~ 495 (504)
T 3q5i_A 434 EERLRRAFNLFDTDKSGKITKEELANLFGL--TSISEKTWNDVLGEADQNKDNMIDFDEFVSMM 495 (504)
T ss_dssp HHHHHHHHHHHCTTCCSEECHHHHHHHTTC--SCCCHHHHHHHHHTTCSSCSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHhh--CCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 456899999999999999999999998776 4578999999999999999998 999999864
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=98.00 E-value=8.2e-06 Score=64.81 Aligned_cols=62 Identities=24% Similarity=0.358 Sum_probs=54.4
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHh----C--------CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRV----G--------SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~----~--------~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+|+..++..+ | ...+++++..+|+.+|.+++|. +++||..+.
T Consensus 99 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~ 173 (190)
T 1fpw_A 99 EKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGS 173 (190)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 457889999999999999999999999883 4 2367899999999999999998 999998753
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=97.99 E-value=7.1e-06 Score=65.81 Aligned_cols=62 Identities=15% Similarity=0.125 Sum_probs=57.1
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...+..+|..+|.|++|.|+++|+..++..++...+++++..+|+.+|.+++|. +++||..+
T Consensus 51 ~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~Ef~~~ 113 (198)
T 2r2i_A 51 NKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDVDGNGCIDRGELLNI 113 (198)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHHHHHCTTCSSCEEHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHHHHHhcCCCCCcCcHHHHHHH
Confidence 345889999999999999999999999999998888999999999999999998 99999865
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=97.99 E-value=6.7e-07 Score=84.42 Aligned_cols=62 Identities=15% Similarity=0.184 Sum_probs=4.4
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++++|..+|.|++|.|+++|++.+++.+|...++++++++|+++|.+++|. +|+||+.++
T Consensus 11 ~~l~~~F~~fD~d~dG~Is~~El~~~l~~lg~~~s~~el~~lf~~~D~d~~G~I~f~EF~~~~ 73 (624)
T 1djx_A 11 HWIHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHSQTDSLEDEEIETFY 73 (624)
T ss_dssp ---------------------------------------------------------CTTHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 36889999999999999999999999999999999999999999999998887 999998754
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=97.98 E-value=3.3e-06 Score=62.77 Aligned_cols=56 Identities=21% Similarity=0.405 Sum_probs=51.1
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+..+|..+|.|++|.|+.+|+..+++.+|... +..+++.+|.+++|. +++||+++.
T Consensus 77 ~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~----~~~~~~~~D~~~dg~i~~~ef~~~l 133 (134)
T 1jfj_A 77 LKVLYKLMDVDGDGKLTKEEVTSFFKKHGIEK----VAEQVMKADANGDGYITLEEFLEFS 133 (134)
T ss_dssp HHHHHHHHCCSSSSEEEHHHHHHHHTTTTCHH----HHHHHHHHHCSSSSEEEHHHHHHHH
T ss_pred HHHHHHHHCCCCCCccCHHHHHHHHHHhCHHH----HHHHHHHhCCCCCCcEeHHHHHHHh
Confidence 78999999999999999999999999887654 999999999999987 999999764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.9e-06 Score=78.31 Aligned_cols=62 Identities=19% Similarity=0.364 Sum_probs=54.7
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+.++|+.+|.|++|.|+.+|+..++.. ...++++++++++++|.+++|. +++||+.++
T Consensus 424 ~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~--~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~ 486 (494)
T 3lij_A 424 SKDKLESAFQKFDQDGNGKISVDELASVFGL--DHLESKTWKEMISGIDSNNDGDVDFEEFCKMI 486 (494)
T ss_dssp CHHHHHHHHHHHCTTCSSEECHHHHHHHC-C--CSCCCHHHHHHHHTTCSSSSSSEEHHHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 3456889999999999999999999998875 6788999999999999999998 999999864
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=97.98 E-value=5.6e-06 Score=68.07 Aligned_cols=65 Identities=20% Similarity=0.289 Sum_probs=34.7
Q ss_pred hhhhhhccHHHHhcccCCC--CCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhh
Q 021227 247 LNEEEIGGLKELFKMIDTD--NSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCN 312 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~--~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~ 312 (315)
++.+++..+.++|..+|.| ++|.|+.+|+..++.. +....+..+..+++.+|.+++|. +++||+.
T Consensus 42 ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~-~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~ 109 (226)
T 2zfd_A 42 FSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK-TNKKESLFADRVFDLFDTKHNGILGFEEFAR 109 (226)
T ss_dssp CCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHS-CSSCCCHHHHHHHHHHCSSCSSSBCHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhc-cCcccHHHHHHHHHHHcCCCCCcCcHHHHHH
Confidence 3445555555566666555 5566666666555544 22223334455555555555554 5555554
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=97.96 E-value=8.2e-06 Score=64.87 Aligned_cols=61 Identities=15% Similarity=0.154 Sum_probs=56.5
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
..+.++|..+|.|++|.|+++|+..++..++...+++++..+|+.+|.+++|. +++||..+
T Consensus 63 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~ 124 (190)
T 2l2e_A 63 AFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYDLDNNGLISYDEMLRI 124 (190)
T ss_dssp HHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHCTTSCSCBCHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHhHccCCCCCcCcHHHHHHH
Confidence 35788999999999999999999999999998899999999999999999987 99999875
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.90 E-value=1.6e-05 Score=64.48 Aligned_cols=62 Identities=13% Similarity=0.176 Sum_probs=57.0
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...+.++|..+|.|++|.|+++|+..++..++....++++..+|+.+|.+++|. +++||.++
T Consensus 56 ~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~ 118 (211)
T 2ggz_A 56 NKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYFKLYDADGNGSIDKNELLDM 118 (211)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHHHHHHCTTCSSSBCHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHHHHHhcCCCCCcCcHHHHHHH
Confidence 445889999999999999999999999999988888999999999999999997 99999865
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=97.90 E-value=1.4e-05 Score=64.42 Aligned_cols=61 Identities=13% Similarity=0.110 Sum_probs=56.8
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
..+.++|..+|.|++|.|+++|+..++..++...+++++..+|+.+|.+++|. +++||..+
T Consensus 71 ~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~ 132 (207)
T 2d8n_A 71 AYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEVLEI 132 (207)
T ss_dssp HHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCTTCSSEECHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcCCCCCeEcHHHHHHH
Confidence 46889999999999999999999999999998888999999999999999997 99999865
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=97.89 E-value=1.3e-05 Score=63.17 Aligned_cols=62 Identities=11% Similarity=0.196 Sum_probs=55.9
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...+..+|..+|.|++|.|+++|+..++..++...+++++..+|+.+|.+++|. +++||..+
T Consensus 55 ~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~ 117 (183)
T 1s6c_A 55 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDI 117 (183)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSCEEHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCHHHHHHHHHHHhCCCCCCeEcHHHHHHH
Confidence 345788999999999999999999999998887788999999999999999998 99999865
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.89 E-value=1.3e-05 Score=63.77 Aligned_cols=60 Identities=18% Similarity=0.211 Sum_probs=55.8
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+.++|..+|.|++|.|+++|+..++..++...+++++..+|+.+|.+++|. +++||..+
T Consensus 64 ~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~ 124 (193)
T 1bjf_A 64 FAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEI 124 (193)
T ss_dssp HHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHHhhcCCCCCCeECHHHHHHH
Confidence 4688999999999999999999999999988888999999999999999998 99999865
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.89 E-value=1.7e-05 Score=63.05 Aligned_cols=63 Identities=17% Similarity=0.217 Sum_probs=52.8
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh----C--CCCC------HHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV----G--SQLM------ESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~----~--~~~~------~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.|++|.|+.+|+..++..+ | ..++ +.++..+|+.+|.+++|. +++||..+.
T Consensus 98 ~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~ 173 (193)
T 1bjf_A 98 EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGA 173 (193)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEECHHHHHHHH
T ss_pred HHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 3457889999999999999999999999874 4 2233 456999999999999997 999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00016 Score=58.31 Aligned_cols=122 Identities=18% Similarity=0.107 Sum_probs=76.9
Q ss_pred CchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCccccc
Q 021227 33 GELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV 110 (315)
Q Consensus 33 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~ 110 (315)
-+|.+.+.. ..+++|++++.++.|.+.+|.-+-. +.-..+=+.|..|+ +..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~---l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIR---VWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEE---EETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceE---EecCCceeccc-cccc-----------
Confidence 367787764 4789999999999999999877632 11122333457777 45667666553 1110
Q ss_pred ccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 021227 111 VGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQ 190 (315)
Q Consensus 111 ~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 190 (315)
.....+.|||......+.+.=|||||+++|.-+--..| ...-+.+|+.+..||..|..-
T Consensus 98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence 12335668887654456778899999999988754333 111246899999999999765
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.88 E-value=1.8e-05 Score=62.35 Aligned_cols=52 Identities=13% Similarity=0.133 Sum_probs=41.0
Q ss_pred CCCCCCcccHHHHHHHHHHh------CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 263 DTDNSGTITFDELKDGLKRV------GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 263 d~~~~g~i~~~el~~~l~~~------~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+.|++|.|+.+||+.+|+.+ |..+++++++.++..+|.+++|. +|+||++++
T Consensus 14 ~~~~dG~I~~~EL~~~l~~l~~~~~~g~~~~~~~~~~l~~~~D~d~~G~I~f~EF~~~~ 72 (174)
T 2i7a_A 14 LVPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRLDQEEFARLW 72 (174)
T ss_dssp SCC-CCCEEHHHHHHHHHHHHC-----CCCCHHHHHHHHHHHCSSCSSEECHHHHHHHH
T ss_pred cCCCCCcCCHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 46788888888888888887 56778888888888888888876 888888653
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=97.85 E-value=1.2e-05 Score=77.41 Aligned_cols=67 Identities=25% Similarity=0.285 Sum_probs=61.3
Q ss_pred hhhhh-hccHHHHhcccCCCCCCcccHHHHHHHHHHh--------CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 247 LNEEE-IGGLKELFKMIDTDNSGTITFDELKDGLKRV--------GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~-~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~--------~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++++ ...++++|..+| |++|.|+.+||..+++.+ |..+++++++.++..+|.+++|. +|+||++++
T Consensus 525 ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~d~~G~I~f~EF~~l~ 601 (714)
T 3bow_A 525 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILW 601 (714)
T ss_dssp CSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCCSSCSSBCHHHHHHHH
T ss_pred CChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 55666 788999999999 999999999999999997 78899999999999999999987 999999764
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=97.85 E-value=1.3e-05 Score=77.17 Aligned_cols=61 Identities=16% Similarity=0.237 Sum_probs=57.0
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++++|+.+|.|++|.|+.+|++.+++.+|..+++++++.+++.+| +++|. +|+||+.++
T Consensus 605 ~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D-d~dG~Isf~EF~~~l 666 (714)
T 3bow_A 605 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCL 666 (714)
T ss_dssp HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS-CTTCEECHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHH
Confidence 56889999999999999999999999999999999999999999999 88887 999998764
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=97.84 E-value=1.6e-06 Score=68.81 Aligned_cols=66 Identities=15% Similarity=0.178 Sum_probs=57.2
Q ss_pred hhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHh------CCCCCHHHHHHHH---------HHHhccCCCC-CH
Q 021227 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV------GSQLMESEIKDLM---------DAVRKIFSRF-SI 307 (315)
Q Consensus 244 ~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~------~~~~~~~ei~~~~---------~~~d~~~~~~-~~ 307 (315)
+..++.+++..++++|..+|.|++|.|+.+|+..+++.+ |..+++.++..++ +.+|.+++|. ++
T Consensus 5 ~~~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~~~~~~~~~f~~~D~d~dg~I~~ 84 (186)
T 2hps_A 5 TESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLRVADQLGLAPGVRISVEEAAVN 84 (186)
T ss_dssp CHHHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCTTCEEEHHHHHHH
T ss_pred cccccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHhcCCCCCCcccH
Confidence 345667888899999999999999999999999999877 8888899999985 8888888775 77
Q ss_pred HH
Q 021227 308 KT 309 (315)
Q Consensus 308 ~~ 309 (315)
+|
T Consensus 85 ~E 86 (186)
T 2hps_A 85 AT 86 (186)
T ss_dssp HH
T ss_pred HH
Confidence 77
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.79 E-value=1.7e-05 Score=65.17 Aligned_cols=62 Identities=11% Similarity=0.196 Sum_probs=56.1
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...+..+|..+|.|++|.|+++|+..++..++....++++..+|+.+|.+++|. +++||..+
T Consensus 88 ~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~ 150 (224)
T 1s1e_A 88 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDI 150 (224)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCCSEECHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCHHHHHHHHHHHHcCCCCCeECHHHHHHH
Confidence 345788999999999999999999999998887778999999999999999998 99999865
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=97.77 E-value=1.5e-05 Score=63.35 Aligned_cols=60 Identities=12% Similarity=0.207 Sum_probs=55.3
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+..+|..+|.|++|.|+++|+..++..++...+++++..+|+.+|.+++|. +++||..+
T Consensus 64 ~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~ 124 (190)
T 1g8i_A 64 FATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDI 124 (190)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSEEEHHHHHHH
T ss_pred HHHHHHHHHhcCCCCeEeHHHHHHHHHHhcCCCHHHHHHHHHHhhcCCCCCeECHHHHHHH
Confidence 4789999999999999999999999998887788999999999999999997 99999865
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=97.74 E-value=1.9e-05 Score=66.19 Aligned_cols=61 Identities=16% Similarity=0.186 Sum_probs=56.3
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
..+..+|..+|.|++|.|+++|+..++..++...+++++..+|+.+|.+++|. +++||..+
T Consensus 129 ~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~Ef~~~ 190 (256)
T 2jul_A 129 TYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDINKDGCITKEEMLAI 190 (256)
T ss_dssp HHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCHHHHHHHHHHHTCCSSSSCBCHHHHHHH
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccChHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 45788999999999999999999999999888888999999999999999987 99999875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=4.5e-05 Score=64.28 Aligned_cols=84 Identities=17% Similarity=0.251 Sum_probs=62.8
Q ss_pred CcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------
Q 021227 9 HVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL--------------------- 67 (315)
Q Consensus 9 niv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------------------- 67 (315)
-+.+++.+.++++..++|||+++|.++.+..... ......+..++...|.-||..
T Consensus 81 PVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~ 156 (272)
T 4gkh_A 81 PLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSR 156 (272)
T ss_dssp CCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHH
T ss_pred CcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHH
Confidence 3678889999999999999999998887655332 223345666777777777741
Q ss_pred -------------------------------------CCccccCCCCceeeccCCCCCCEEEeeccCcc
Q 021227 68 -------------------------------------GVFHRDLKPENFLFLSVDEDAALKATDFGLSV 99 (315)
Q Consensus 68 -------------------------------------~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~ 99 (315)
.++|+|+.+.||++ ++.+.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 157 MNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred HHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECcccc
Confidence 27899999999995 445566799998764
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=97.64 E-value=9.2e-06 Score=65.78 Aligned_cols=65 Identities=11% Similarity=0.184 Sum_probs=54.5
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++.+++..+.++|..+|.|++|.|+.+|+..++ .+|...+. +++++.+|.+++|. +|+||+.+.
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~lg~~~~~---~~l~~~~d~~~~g~i~~~EF~~~~ 87 (208)
T 2ct9_A 22 GFSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-ELAINPLG---DRIINAFFSEGEDQVNFRGFMRTL 87 (208)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-HHHTSTTH---HHHHHTTSCTTCSCEEHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCcH---HHHHHHHcCCCCCcCcHHHHHHHH
Confidence 4567888899999999999999999999999864 67766654 45788889999887 999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.0002 Score=61.57 Aligned_cols=89 Identities=13% Similarity=0.166 Sum_probs=59.8
Q ss_pred cceEEEEEE-eCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------
Q 021227 10 VVRIHDTYE-DKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL--------------------- 67 (315)
Q Consensus 10 iv~~~~~~~-~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------------------- 67 (315)
+.+.+.+.. ..+..++|||+++|.++.+... ..++......++.++...|+.||+.
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~ 151 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILL 151 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHH
Confidence 556666664 4566789999999988865321 2345666666666666666666642
Q ss_pred ---------------------------------------CCccccCCCCceeeccCCCCCC-EEEeeccCccc
Q 021227 68 ---------------------------------------GVFHRDLKPENFLFLSVDEDAA-LKATDFGLSVF 100 (315)
Q Consensus 68 ---------------------------------------~ivH~dikp~nil~~~~~~~~~-ikl~Dfg~~~~ 100 (315)
.++|+|++|.||++.....++. +.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 152 LSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999632112344 58999997654
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=97.62 E-value=5.6e-05 Score=62.21 Aligned_cols=60 Identities=15% Similarity=0.272 Sum_probs=54.4
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+..+|..+|.|++|.|+++|+..++..+.....++++..+|+.+|.+++|. +.+||..+
T Consensus 103 ~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~ 163 (229)
T 3dd4_A 103 YAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQEKLNWAFNLYDINKDGYITKEEMLDI 163 (229)
T ss_dssp HHHHHHHTTCSSCCSSCCHHHHHHHHHHHHHSCHHHHHHHHHHHHCTTCSSCCBHHHHHHH
T ss_pred HHHHHHHHcCCCCCCeEeHHHHHHHHHHHcCCChHHHHHHHHHHhCCCCCCeECHHHHHHH
Confidence 3678999999999999999999999998877777899999999999999998 99999865
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=97.61 E-value=6e-05 Score=74.59 Aligned_cols=61 Identities=13% Similarity=0.183 Sum_probs=56.7
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+.++|..+|.|++|.|+.+|++.+++.+|..+++++++.+++.+| +++|. +|+||++++
T Consensus 607 ~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~ 668 (900)
T 1qxp_A 607 RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCL 668 (900)
T ss_dssp HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS-CSSSBCCHHHHHHHH
T ss_pred HHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHH
Confidence 56899999999999999999999999999999999999999999999 88876 999998753
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=4.7e-05 Score=60.08 Aligned_cols=59 Identities=8% Similarity=0.074 Sum_probs=44.9
Q ss_pred HHHHhcccCCCCCCc-ccHHHHHHHHHHhCCC-CCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 255 LKELFKMIDTDNSGT-ITFDELKDGLKRVGSQ-LMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 255 l~~~F~~~d~~~~g~-i~~~el~~~l~~~~~~-~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
..++|..+|.|++|. |+++|+..++...... ..++++...|+.+|.+++|. +.+||..+
T Consensus 62 ~~~l~~~~D~d~~G~~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~ 123 (183)
T 1dgu_A 62 KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRL 123 (183)
T ss_dssp HHHHHHHHSCSSSSCCCCHHHHHHHHHHHSTTCCHHHHHHHHHHHHCTTCSSEEEHHHHHHH
T ss_pred HHHHHHHhCCCCCCCEecHHHHHHHHHHhcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHH
Confidence 357788888888888 8888888887766533 33568888888888888886 88887654
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=97.52 E-value=3.9e-05 Score=58.27 Aligned_cols=62 Identities=5% Similarity=-0.147 Sum_probs=25.0
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCC-----CCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGS-----QLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~-----~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
......|..+|.|++|.|+++|+..++..+.. ...++++..+|+.+|.+++|. +++||..+.
T Consensus 27 ~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l 94 (143)
T 3a4u_B 27 AASFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAI 94 (143)
T ss_dssp ------------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTC
T ss_pred CCCHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHH
Confidence 34457899999999999999999998876521 134678999999999999998 999998754
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0002 Score=56.44 Aligned_cols=69 Identities=9% Similarity=0.272 Sum_probs=51.4
Q ss_pred HHHHhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhc---cCCC-CCHHHHhhc
Q 021227 240 LRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK---IFSR-FSIKTYCNL 313 (315)
Q Consensus 240 ~~~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~---~~~~-~~~~~f~~~ 313 (315)
+..++......++.++++.|..+| ++|.|+.+||..+ +|...++.++.++++.+|. ++++ +++++|+.+
T Consensus 15 l~~~~~~~~~~~~~~~~~~F~~~D--~dG~I~~~el~~~---lg~~~~~~~~~~i~~~~d~~~~~~~~~i~~~ef~~~ 87 (179)
T 3a8r_A 15 LQFVTAKVGNDGWAAVEKRFNQLQ--VDGVLLRSRFGKC---IGMDGSDEFAVQMFDSLARKRGIVKQVLTKDELKDF 87 (179)
T ss_dssp HHHHHHHHCCCCHHHHHHHHHHHC--BTTBEEGGGHHHH---HTCCSCHHHHHHHHHHHHHHHTCCSSEECHHHHHHH
T ss_pred HHHHHhccchhhHHHHHHHHhccC--CCCCCcHHHHHHH---HCCCCcHHHHHHHHHHHHHhccCCCCCcCHHHHHHH
Confidence 455565555566778889999998 7899999999875 4777788888888888874 3333 488888754
|
| >2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B | Back alignment and structure |
|---|
Probab=97.32 E-value=8.7e-05 Score=71.93 Aligned_cols=62 Identities=11% Similarity=0.099 Sum_probs=40.1
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHh-CCC---------CCHHHHHHHHHHHhcc----CCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRV-GSQ---------LMESEIKDLMDAVRKI----FSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~-~~~---------~~~~ei~~~~~~~d~~----~~~~-~~~~f~~~~ 314 (315)
.++.++|..+|.+++|.|+.+||+..|+.+ |.. +++++++++++++|.+ ++|. ++++|+.++
T Consensus 219 ~el~~aF~~fD~d~~g~Is~~eL~~fL~~~Qge~~~~~~~~~~~t~ee~~~iI~~~d~d~~~~~dg~is~eeF~~~L 295 (799)
T 2zkm_X 219 PEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFL 295 (799)
T ss_dssp HHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHHHHHHH
T ss_pred HHHHHHHHHhccCCCCeEcHHHHHHHHHHhcCCcccccccccCCCHHHHHHHHHHhhcccccccCCccchhhhhhcc
Confidence 468999999999999999999999999998 565 7899999999999987 6776 999998764
|
| >1sra_A Sparc; extracellular matrix protein, calcium-binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.3 | Back alignment and structure |
|---|
Probab=97.26 E-value=3.7e-05 Score=58.04 Aligned_cols=59 Identities=14% Similarity=0.148 Sum_probs=51.6
Q ss_pred hccHHHHhcccCCC-CCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhh
Q 021227 252 IGGLKELFKMIDTD-NSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCN 312 (315)
Q Consensus 252 ~~~l~~~F~~~d~~-~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~ 312 (315)
+..+...|..+|.| +||.|+..|+..+.+.+. ..+.-+..+++.+|.+++|. +++||+.
T Consensus 76 ~~~l~W~F~~lD~n~~DG~Isr~EL~~i~~~l~--~~e~cv~~ff~~cD~d~Dg~ISl~Ew~~ 136 (151)
T 1sra_A 76 IFPVHWQFGQLDQHPIDGYLSHTELAPLRAPLI--PMEHCTTRFFETCDLDNDKYIALDEWAG 136 (151)
T ss_dssp HHHHHHHHHHHCCTTCSSEECTTTTGGGGSTTS--TTGGGHHHHHHHHCTTCSSSEEHHHHHH
T ss_pred hhHHHhHHHHHCCCCCCCcCcHHHHHHHHHHhc--ChHHHHHHHHHHhCCCCCCcCCHHHHHH
Confidence 44689999999997 999999999998876543 56788999999999999998 9999985
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.18 E-value=9.1e-05 Score=55.50 Aligned_cols=60 Identities=7% Similarity=0.035 Sum_probs=29.7
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHh-CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRV-GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~-~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+++|..+|.|++|.|+++|+..++... ......+++...|+.+|.+++|. +.+||..+.
T Consensus 5 ~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l 66 (135)
T 3h4s_E 5 EKSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNS 66 (135)
T ss_dssp --------------CCCC-----------CHHHHHHHHHHHHHHHSBTTTTBBCHHHHHHHG
T ss_pred HHHHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 4688999999999999999999887643 33335788999999999999998 999987653
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00062 Score=48.56 Aligned_cols=57 Identities=9% Similarity=0.119 Sum_probs=48.0
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.++.++|..+| ++|.|+++|+..++.. .....+++...|+.+|.+++|. +.+||..+
T Consensus 10 ~ei~~~~~~~D--~~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~ 67 (109)
T 3fs7_A 10 KDIESALSSCQ--AADSFNYKSFFSTVGL--SSKTPDQIKKVFGILDQDKSGFIEEEELQLF 67 (109)
T ss_dssp HHHHHHHHHTC--STTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHSTTCSSSBCHHHHHTT
T ss_pred HHHHHHHHhcC--CCCcCcHHHHHHHHhc--CCCcHHHHHHHHHHHCCCCCCeEeHHHHHHH
Confidence 45678888888 8999999999988764 3457889999999999999998 99998765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 315 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-76 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-72 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-70 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-70 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-69 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-64 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-62 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-56 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-52 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-51 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-51 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-51 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-49 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-48 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-45 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-44 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-41 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-28 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 8e-14 | |
| d1s6ja_ | 87 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 5e-13 | |
| d1s6ia_ | 182 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 2e-10 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-10 | |
| d1f54a_ | 77 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 4e-09 | |
| d1avsa_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 1e-07 | |
| d1oqpa_ | 77 | a.39.1.5 (A:) Caltractin (centrin 2) {Green algae | 1e-07 | |
| d1oqpa_ | 77 | a.39.1.5 (A:) Caltractin (centrin 2) {Green algae | 0.002 | |
| d2pq3a1 | 73 | a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T | 2e-07 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 2e-07 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 0.002 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 3e-07 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 5e-06 | |
| d1wrka1 | 82 | a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens) | 3e-07 | |
| d1m45a_ | 146 | a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye | 6e-07 | |
| d1jc2a_ | 75 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 1e-06 | |
| d1uhka1 | 187 | a.39.1.5 (A:3-189) Calcium-regulated photoprotein | 1e-06 | |
| d1qv0a_ | 189 | a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr | 1e-06 | |
| d1dtla_ | 156 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 2e-06 | |
| d1dtla_ | 156 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 0.002 | |
| d2sasa_ | 185 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 2e-06 | |
| d2opoa1 | 81 | a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che | 3e-06 | |
| d2opoa1 | 81 | a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che | 0.003 | |
| d1topa_ | 162 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 5e-06 | |
| d1topa_ | 162 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 2e-05 | |
| d1fi5a_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), | 6e-06 | |
| d1tiza_ | 67 | a.39.1.5 (A:) Calmodulin-related protein T21P5.17 | 6e-06 | |
| d1auib_ | 165 | a.39.1.5 (B:) Calcineurin regulatory subunit (B-ch | 6e-06 | |
| d1jbaa_ | 189 | a.39.1.5 (A:) Guanylate cyclase activating protein | 6e-06 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 7e-06 | |
| d1wdcb_ | 142 | a.39.1.5 (B:) Myosin Essential Chain {Bay scallop | 1e-05 | |
| d1y1xa_ | 182 | a.39.1.8 (A:) Programmed cell death 6 protein-like | 1e-05 | |
| d1w7jb1 | 139 | a.39.1.5 (B:11-149) Myosin Essential Chain {Human | 2e-05 | |
| d1nyaa_ | 176 | a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth | 2e-05 | |
| d1nyaa_ | 176 | a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth | 0.004 | |
| d1jfja_ | 134 | a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histoly | 2e-05 | |
| d2scpa_ | 174 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 3e-05 | |
| d1qx2a_ | 76 | a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [Tax | 3e-05 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 3e-05 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 5e-04 | |
| d1df0a1 | 186 | a.39.1.8 (A:515-700) Calpain large subunit, C-term | 4e-05 | |
| d1bjfa_ | 181 | a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId | 4e-05 | |
| d1alva_ | 173 | a.39.1.8 (A:) Calpain small (regulatory) subunit ( | 5e-05 | |
| d1wdcc_ | 152 | a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop | 5e-05 | |
| d1cb1a_ | 78 | a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [Tax | 6e-05 | |
| d1fw4a_ | 65 | a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: | 6e-05 | |
| d1pvaa_ | 109 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 9e-05 | |
| d2hf5a1 | 33 | a.39.1.5 (A:81-113) Troponin C {Human (Homo sapien | 1e-04 | |
| d2fcea1 | 61 | a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [ | 1e-04 | |
| d1rroa_ | 108 | a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) | 1e-04 | |
| d2zfda1 | 183 | a.39.1.5 (A:32-214) Calcineurin B-like protein 2 { | 2e-04 | |
| d1snla_ | 99 | a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo | 3e-04 | |
| d1g8ia_ | 187 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 3e-04 | |
| d1hqva_ | 181 | a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous | 4e-04 | |
| d3c1va1 | 93 | a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sa | 5e-04 | |
| d5pala_ | 109 | a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis | 5e-04 | |
| d1qxpa2 | 188 | a.39.1.8 (A:515-702) Calpain large subunit, C-term | 5e-04 | |
| d1juoa_ | 172 | a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: | 0.001 | |
| d1s6ca_ | 178 | a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera | 0.002 | |
| d1wlza1 | 83 | a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {H | 0.002 | |
| d1omra_ | 201 | a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: | 0.002 | |
| d1ggwa_ | 140 | a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharo | 0.002 | |
| d2zkmx1 | 170 | a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human | 0.003 | |
| d1fpwa_ | 190 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 0.004 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 233 bits (595), Expect = 4e-76
Identities = 107/238 (44%), Positives = 156/238 (65%), Gaps = 3/238 (1%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+H + H ++V + D YE ++++M+L GGELFDRIV+KG Y+ER+A++L+ ++
Sbjct: 61 LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
V+ H LG+ HRDLKPEN L+ S+DED+ + +DFGLS P V S G+P YVAPE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179
Query: 121 VLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
VL K Y D WS GVI YILL G PPF+ E + +F QIL+ + +F+S W +IS+S
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKK 237
AKD IR +++++P++R T + L HPWI D A DK + +V ++K A +K K+
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT-ALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 223 bits (570), Expect = 9e-72
Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 25/274 (9%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVG 59
M+ L H ++ +HD +EDK + +++E GGELFDRI + SE E M+
Sbjct: 80 MNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 138
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
++ H + H D+KPEN + + +++K DFGL+ PDE+ + + AP
Sbjct: 139 GLKHMHEHSIVHLDIKPENIM-CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
E++ + G D+W+ GV+ Y+LLSG+ PF E ++ + + +F+ + + ++S
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD---------------------KVAPDKP 217
AKD I+ +L + P++RLT H+ L HPW+ D + D P
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWP 317
Query: 218 LDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEE 251
+ R+ +FS++ K + ++ + +E
Sbjct: 318 APQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 5e-70
Identities = 70/259 (27%), Positives = 129/259 (49%), Gaps = 7/259 (2%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVG 59
+ +++ H++++ +H+++E + ++ E G ++F+RI +ERE + +
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
++ HS + H D++PEN + + +K +FG + KP + F + +P Y AP
Sbjct: 114 ALQFLHSHNIGHFDIRPENII-YQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EV + D+WS G ++Y+LLSG+ PF AET I I+ + F+ E + IS
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKM 238
A D + ++L + K R+TA E L HPW+ + + + V+ LKH + L K
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQ----KIERVSTKVIRTLKHRRYYHTLIKK 288
Query: 239 ALRVIAERLNEEEIGGLKE 257
L ++ G ++
Sbjct: 289 DLNMVVSAARISCGGAIRS 307
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 216 bits (552), Expect = 5e-70
Identities = 84/214 (39%), Positives = 127/214 (59%), Gaps = 10/214 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ +S H +++++ DTYE + +V +L + GELFD + +K SE+E K+M+ ++ V
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ H L + HRDLKPEN L +D+D +K TDFG S P E +V G+P Y+APE
Sbjct: 123 ICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 121 VL-------RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW 173
++ YG E D+WS GVI+Y LL+G PPFW ++ + R I+ G F S W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 174 PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ S++ KDL+ + L P++R TA E L HP+
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 1e-69
Identities = 97/263 (36%), Positives = 149/263 (56%), Gaps = 11/263 (4%)
Query: 1 MHHLSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLM 54
S+ H+VRI D YE+ + C+ IVME +GGELF RI +G+ ++EREA+++M
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
K+I ++ HS+ + HRD+KPEN L+ S +A LK TDFG + + +P
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177
Query: 115 YYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEI----GIFRQILEGKIDFE 169
YYVAPEVL + Y D+WS GVI+YILL G PPF++ + G+ +I G+ +F
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 170 SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHF 229
+ W +SE K LIR +L P +R+T E + HPWI+ P PL ++ + +
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 230 SAMNKLKKMALRVIAERLNEEEI 252
+ ++M + R++ E+I
Sbjct: 298 RWEDVKEEMTSALATMRVDYEQI 320
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 213 bits (543), Expect = 1e-67
Identities = 80/243 (32%), Positives = 115/243 (47%), Gaps = 6/243 (2%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVG 59
M L H +V +HD +ED + + ++ E GGELF+++ + N SE EA + M+ +
Sbjct: 77 MSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
+ H H DLKPEN +F + LK DFGL+ P + G+ + AP
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EV K G D+WS GV+ YILLSG+ PF E + R + + + + ISE
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKM 238
KD IRK+L +P R+T H+ L HPW+ + SR K K
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS--SRYTKIRDSIKTKYD 312
Query: 239 ALR 241
A
Sbjct: 313 AWP 315
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-64
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 9/211 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ H +++R++ + D + V++++E G ++ + K + E+ A + +
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 118
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ CHS V HRD+KPEN L + LK DFG SV P + + G+ Y+ PE
Sbjct: 119 LSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPE 174
Query: 121 VLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
++ + + + D+WS GV+ Y L G PPF A T +++I + F ++E
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEG 230
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210
A+DLI ++L NP +R EVL HPWI +
Sbjct: 231 ARDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-62
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 12/211 (5%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M L H V+++ T++D ++ + + GEL I K G++ E IV
Sbjct: 62 MSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYV 117
+E H G+ HRDLKPEN L ++ED ++ TDFG + P+ + VG+ YV
Sbjct: 121 LEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 118 APEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI 176
+PE+L K +D+W+ G I+Y L++G+PPF A E IF++I++ + DF
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKF 233
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
A+DL+ K+L + +RL E+ + +
Sbjct: 234 FPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 4e-62
Identities = 57/220 (25%), Positives = 107/220 (48%), Gaps = 12/220 (5%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVGVVECCH 65
H ++V++ D + ++ + I++E C GG + +++ +E + + K + + H
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVL-- 122
+ HRDLK N L D +K DFG+S + + +G+PY++APEV+
Sbjct: 128 DNKIIHRDLKAGNIL---FTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 123 ----RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
+ Y +ADVWS G+ L + PP + + +I + + ++P S
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSS 243
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPL 218
+ KD ++K L++N R T ++L HP++ D P + L
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 283
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-61
Identities = 83/209 (39%), Positives = 126/209 (60%), Gaps = 3/209 (1%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ + H +V+ +H+ YE+K+ V +++EL GGELFD + +K + +E EA + +K I+
Sbjct: 67 LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAA-LKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
V HSL + H DLKPEN + L + +K DFGL+ F ++ G+P +VAP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
E++ + G EAD+WS GVI YILLSG PF +T+ + +FE E + N S
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
AKD IR++L ++PK+R+T + L HPWI
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 7e-61
Identities = 62/254 (24%), Positives = 110/254 (43%), Gaps = 18/254 (7%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L H + ++ Y + +VME C G V K E E A + +
Sbjct: 69 LQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+ HS + HRD+K N L + E +K DFG + P + VG+PY++APE
Sbjct: 128 LAYLHSHNMIHRDVKAGNIL---LSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPE 181
Query: 121 VLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI 176
V+ Y + DVWS G+ L PP + + I + + + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHW 239
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLK 236
SE ++ + L + P+ R T+ +L H +++ ++ P +D ++ R K A+ +L
Sbjct: 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP-PTVIMD--LIQRTK--DAVRELD 294
Query: 237 KMALRVIAERLNEE 250
+ R + + L +E
Sbjct: 295 NLQYRKMKKILFQE 308
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-60
Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 10/212 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
L+ H++VV+ + + + ++ +E C GGELFDRI E +A + ++
Sbjct: 57 NKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 115
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYV 117
V H +G+ HRD+KPEN L +DE LK +DFGL+ ++ + + + + G+ YV
Sbjct: 116 VVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 118 APEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN 175
APE+L+ + + DVWS G++L +L+G P+ ++ + K + PW
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKK 231
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
I + L+ K+L +NP R+T ++ W
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKKDRWY 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-60
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 8/209 (3%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M + ++V D+Y + +VME GG L D + + E + A + + +
Sbjct: 71 MRENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQA 128
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAP 119
+E HS V HRD+K +N L + D ++K TDFG P++ S +VG+PY++AP
Sbjct: 129 LEFLHSNQVIHRDIKSDNIL---LGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EV+ K YGP+ D+WS G++ ++ G PP+ E + I E + +S
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSA 244
Query: 179 SAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+D + + LD + ++R +A E+L H ++
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-58
Identities = 46/208 (22%), Positives = 90/208 (43%), Gaps = 12/208 (5%)
Query: 7 HQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
H ++VR +D++E K C+ +V EL G L + + + + I+ ++
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 63 CCHSLG--VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
H+ + HRDLK +N ++K D GL+ K V+G+P ++APE
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPE 183
Query: 121 VLRKHYGPEADVWSAGVILYILLSGVPPFWAETEIG-IFRQILEGKIDFESEPWPNISES 179
+ + Y DV++ G+ + + + P+ I+R++ G +
Sbjct: 184 MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KPASFDKVAIPE 241
Query: 180 AKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
K++I + QN R + ++L H +
Sbjct: 242 VKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 4e-56
Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 20/220 (9%)
Query: 1 MHHLSEHQHVVRIHDTYEDKS--CVHIVMELCEGGELFDRIVK----KGNYSEREAAKLM 54
+ L H ++VR +D D++ ++IVME CEGG+L I K + E ++M
Sbjct: 57 LRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 55 KTIVGVVECCHSLG-----VFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFS- 108
+ ++ CH V HRDLKP N +D +K DFGL+ D F+
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVF---LDGKQNVKLGDFGLARILNHDTSFAK 172
Query: 109 DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKID 167
VG+PYY++PE + Y ++D+WS G +LY L + +PPF A ++ + +I EGK
Sbjct: 173 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232
Query: 168 FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
S+ ++I +ML+ R + E+L +P I
Sbjct: 233 ---RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-54
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 10/210 (4%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ EH + + T++ K + VME GG+L I + A I+
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 115
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAP 119
++ HS G+ +RDLK +N L D+D +K DFG+ D + G+P Y+AP
Sbjct: 116 LQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
E+L + Y D WS GV+LY +L G PF + E +F I + + +
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEK 228
Query: 179 SAKDLIRKMLDQNPKRRLTAH-EVLCHPWI 207
AKDL+ K+ + P++RL ++ HP
Sbjct: 229 EAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-53
Identities = 54/249 (21%), Positives = 93/249 (37%), Gaps = 47/249 (18%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+H + ++V + + + I ME +GG L + K G E+ K+ ++
Sbjct: 58 LHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 61 VECCHS-LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAP 119
+ + HRD+KP N L V+ +K DFG+S D + + VG+ Y++P
Sbjct: 117 LTYLREKHKIMHRDVKPSNIL---VNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSP 172
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETE---IGIFRQILEGKIDFESE---- 171
E L+ HY ++D+WS G+ L + G P +F +EG
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 172 ---------------------------------PWPNISESAKDLIRKMLDQNPKRRLTA 198
P S +D + K L +NP R
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 199 HEVLCHPWI 207
+++ H +I
Sbjct: 293 KQLMVHAFI 301
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (442), Expect = 1e-52
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ + +V + + + +++L GG+L + + G +SE + I+
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+E H+ V +RDLKP N L +DE ++ +D GL+ + + VG+ Y+APE
Sbjct: 120 LEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPE 175
Query: 121 VLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
VL+ Y AD +S G +L+ LL G PF +I + E + S
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSP 234
Query: 179 SAKDLIRKMLDQNPKRRLT-----AHEVLCHPWI 207
+ L+ +L ++ RRL A EV P+
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 6e-52
Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVGVVECCH 65
H +++ Y + IV + CEG L+ + + + + + + + ++ H
Sbjct: 63 HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVL 122
+ + HRDLK N + ED +K DFGL+ F + GS ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIF---LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 123 R----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFE--SEPWPNI 176
R Y ++DV++ G++LY L++G P+ ++ S+ N
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEVLCH 204
++ K L+ + L + R ++L
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 169 bits (430), Expect = 1e-51
Identities = 48/213 (22%), Positives = 94/213 (44%), Gaps = 7/213 (3%)
Query: 1 MHHLSEHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKT 56
L+ H +V ++DT E ++ +IVME +G L D + +G + + A +++
Sbjct: 61 AAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 119
Query: 57 IVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFG-LSVFYKPDEVFSDVVGSPY 115
+ H G+ HRD+KP N + + + + ++ + V+G+
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 116 YVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP 174
Y++PE R +DV+S G +LY +L+G PPF ++ + + Q + S
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 175 NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+S ++ K L +NP+ R + +
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-51
Identities = 60/237 (25%), Positives = 97/237 (40%), Gaps = 31/237 (13%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ LS H +++ + D + KS + +V + E + M +
Sbjct: 54 LQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQG 112
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAP 119
+E H + HRDLKP N L +DE+ LK DFGL+ F P+ ++ V + +Y AP
Sbjct: 113 LEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169
Query: 120 EVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWP--- 174
E+L + YG D+W+ G IL LL VP ++++ +I E E WP
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 175 ---------------------NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210
+ DLI+ + NP R+TA + L + +
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (428), Expect = 5e-51
Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 15/213 (7%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M + H ++R+ T++D + ++M+ EGGELF + K + A +
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 116
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
+E HS + +RDLKPEN L +D++ +K TDFG + + +V + G+P Y+APE
Sbjct: 117 LEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPE 171
Query: 121 VLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
V+ K Y D WS G+++Y +L+G PF+ + + +IL ++ F P +E
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNED 227
Query: 180 AKDLIRKMLDQNPKRRL-----TAHEVLCHPWI 207
KDL+ +++ ++ +RL +V HPW
Sbjct: 228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-51
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 1 MHHLS-EHQHVVRIHDTYEDKSCVHIVMELCEGG-ELFDRIVKKGNYSEREAAKLMKTIV 58
+ +S V+R+ D +E +++E E +LFD I ++G E A ++
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 59 GVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVA 118
V CH+ GV HRD+K EN L LK DFG K D V++D G+ Y
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSP 177
Query: 119 PEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI 176
PE +R +++G A VWS G++LY ++ G PF + EI + G++ F +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVFFR----QRV 227
Query: 177 SESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
S + LIR L P R T E+ HPW+ D
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-49
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 14/216 (6%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ + H + + ++ + VME GGELF + ++ ++E A IV
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAP 119
+E HS V +RD+K EN + +D+D +K TDFGL G+P Y+AP
Sbjct: 118 LEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 120 EVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISE 178
EVL YG D W GV++Y ++ G PF+ + +F IL +I F +S
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSP 230
Query: 179 SAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209
AK L+ +L ++PK+RL A EV+ H + +
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 5e-48
Identities = 65/217 (29%), Positives = 114/217 (52%), Gaps = 13/217 (5%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ H+ + +V +H ++ ++ +H++++ GGELF + ++ ++E E + IV
Sbjct: 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKP--DEVFSDVVGSPYYVA 118
+E H LG+ +RD+K EN L +D + + TDFGLS + E D G+ Y+A
Sbjct: 142 LEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 119 PEVLR---KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN 175
P+++R + D WS GV++Y LL+G PF + E +I + E
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258
Query: 176 ISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWI 207
+S AKDLI+++L ++PK+RL A E+ H +
Sbjct: 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-47
Identities = 57/258 (22%), Positives = 102/258 (39%), Gaps = 46/258 (17%)
Query: 1 MHHLSEHQHVVRIHDTYED--------KSCVHIVMELCEGGELFDRIVKKGNYSEREAAK 52
+ L +H++VV + + K +++V + CE ++ E +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE-----VF 107
+M+ ++ + H + HRD+K N L + D LK DFGL+ + + +
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 108 SDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGK 165
++ V + +Y PE+L + YGP D+W AG I+ + + P TE I +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 166 IDFESEPWPNI----------------------------SESAKDLIRKMLDQNPKRRLT 197
E WPN+ A DLI K+L +P +R+
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 198 AHEVLCHPWIVDDKVAPD 215
+ + L H + D + D
Sbjct: 299 SDDALNHDFFWSDPMPSD 316
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-47
Identities = 67/278 (24%), Positives = 107/278 (38%), Gaps = 43/278 (15%)
Query: 7 HQHVVRIHDTYEDKSCVH----IVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
H++++ I+D + ++ G +L+ + K + S + I+ ++
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLK 123
Query: 63 CCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVA 118
HS V HRDLKP N L ++ LK DFGL+ PD ++ V + +Y A
Sbjct: 124 YIHSANVLHRDLKPSNLL---LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 119 PEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW--- 173
PE++ Y D+WS G IL +LS P F + + IL E
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 174 ------------------------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
PN A DL+ KML NP +R+ + L HP++
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
Query: 210 DKVAPDKPLDSAVLSRLKHFSAMNK--LKKMALRVIAE 245
D+P+ A + K LK++ A
Sbjct: 301 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETAR 338
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-46
Identities = 66/241 (27%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 1 MHHLS--EHQHVVRIHD-----TYEDKSCVHIVMELCEGGEL-FDRIVKKGNYSEREAAK 52
+ HL EH +VVR+ D + ++ + +V E + + V +
Sbjct: 61 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 120
Query: 53 LMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVG 112
+M ++ ++ HS V HRDLKP+N L V +K DFGL+ Y + VV
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNIL---VTSSGQIKLADFGLARIYSFQMALTSVVV 177
Query: 113 SPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESE 171
+ +Y APEVL Y D+WS G I + P F +++ +IL+ E
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 172 PWP-----------------------NISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208
WP +I E KDL+ K L NP +R++A+ L HP+
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
Query: 209 D 209
D
Sbjct: 298 D 298
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-46
Identities = 59/266 (22%), Positives = 97/266 (36%), Gaps = 39/266 (14%)
Query: 1 MHHLSEHQHVVRIHDTY------EDKSCVHIVMELCEGG---ELFDRIVKKGNYSEREAA 51
M L H ++VR+ + +D+ +++V++ K
Sbjct: 67 MRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 52 KLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVV 111
M + + HS G+ HRD+KP+N L + A LK DFG + E +
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 112 GSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEG----- 164
S YY APE++ Y DVWSAG +L LL G P F ++ + +I++
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 165 --------------------KIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204
+ P A L ++L+ P RLT E H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 205 PWIVDDKVAPDKPLDSAVLSRLKHFS 230
+ + + K + L +F+
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFT 329
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (388), Expect = 2e-45
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 31/229 (13%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
H ++V+++D K + +V E + V +G A + ++ + CH
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAPEVLR-- 123
V HRDLKP+N L ++ + LK DFGL+ F P ++ + + +Y AP+VL
Sbjct: 119 RRVLHRDLKPQNLL---INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 124 KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNI------- 176
K Y D+WS G I +++G P F +E +I S+ WPN+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 177 ------------------SESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
ES DL+ KML +P +R+TA + L H +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-45
Identities = 46/209 (22%), Positives = 85/209 (40%), Gaps = 14/209 (6%)
Query: 1 MHHLSEHQHVVRIHDT-YEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTI 57
M L H ++V++ E+K ++IV E G L D + +G K +
Sbjct: 54 MTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 58 VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYV 117
+E HRDL N L V ED K +DFGL+ + +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVL---VSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWT 167
Query: 118 APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPN 175
APE LR K + ++DVWS G++L+ + S G P+ + ++ +G ++ +
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDG 224
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCH 204
+ ++++ + R + ++
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 152 bits (385), Expect = 1e-44
Identities = 54/244 (22%), Positives = 101/244 (41%), Gaps = 43/244 (17%)
Query: 1 MHHLSEHQHVVRIHDTYEDKS--CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIV 58
+ +L +++ + D +D +V E + ++ + M I+
Sbjct: 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEIL 139
Query: 59 GVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVA 118
++ CHS+G+ HRD+KP N + E L+ D+GL+ FY P + ++ V S Y+
Sbjct: 140 KALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 197
Query: 119 PEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETE----IGIFRQILEGKIDFE--- 169
PE+L + Y D+WS G +L ++ PF+ + + ++L + ++
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 170 ---------------------------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
SE +S A D + K+L + + RLTA E +
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
Query: 203 CHPW 206
HP+
Sbjct: 318 EHPY 321
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-44
Identities = 42/232 (18%), Positives = 83/232 (35%), Gaps = 33/232 (14%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK------------------ 42
M L H+++V + ++++ E C G+L + + K
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 43 -----GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGL 97
+ + + +E HRDL N L V +K DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL---VTHGKVVKICDFGL 210
Query: 98 SVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAE 152
+ D V + ++APE L Y ++DVWS G++L+ + S GV P+
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204
F ++++ + +E +++ + ++R + +
Sbjct: 271 PVDANFYKLIQNGFKM--DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-44
Identities = 47/222 (21%), Positives = 87/222 (39%), Gaps = 24/222 (10%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------------GN 44
+ L H +++ + E + +++ +E G L D + K
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 45 YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD 104
S ++ + ++ HRDL N L V E+ K DFGLS +
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLSRGQEVY 180
Query: 105 EVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQIL 162
+ ++A E L Y +DVWS GV+L+ ++S G P+ T ++ ++
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240
Query: 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204
+G + E N + DL+R+ + P R + ++L
Sbjct: 241 QG---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-43
Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 43/252 (17%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSC------VHIVMELCEGGELFDRIVKKGNYSEREAAKLM 54
+ H+ H++V+ + D + ++VM G +++K E L+
Sbjct: 71 LKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLV 127
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
++ + H+ G+ HRDLKP N V+ED LK DFGL+ + D + V +
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLA---VNEDCELKILDFGLA--RQADSEMTGYVVTR 182
Query: 115 YYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEP 172
+Y APEV+ Y D+WS G I+ +++G F + ++I++ +E
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
Query: 173 W---------------------------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHP 205
N S A +L+ KML + ++R+TA E L HP
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302
Query: 206 WIVDDKVAPDKP 217
+ D+P
Sbjct: 303 YFESLHDTEDEP 314
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-43
Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 33/238 (13%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ L H+++VR+HD + +V E C+ G+ + ++
Sbjct: 55 LKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVAP 119
+ CHS V HRDLKP+N L + + LK +FGL+ F P +S V + +Y P
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 120 EVL--RKHYGPEADVWSAGVILYILLSG-VPPFWAETEIGIFRQILEGKIDFESEPW--- 173
+VL K Y D+WSAG I L + P F ++I E W
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 174 ----------------------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
P ++ + +DL++ +L NP +R++A E L HP+ D
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (378), Expect = 3e-43
Identities = 66/213 (30%), Positives = 113/213 (53%), Gaps = 16/213 (7%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ ++ +V++ +++D S +++VME GGE+F + + G +SE A IV
Sbjct: 95 LQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPE 120
E HSL + +RDLKPEN L +D+ ++ TDFG + K + G+P +APE
Sbjct: 154 FEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPE 208
Query: 121 VLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
++ K Y D W+ GV++Y + +G PPF+A+ I I+ +I+ GK+ F + S
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSD 264
Query: 180 AKDLIRKMLDQNPKRRL-----TAHEVLCHPWI 207
KDL+R +L + +R +++ H W
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-43
Identities = 45/215 (20%), Positives = 85/215 (39%), Gaps = 17/215 (7%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
M L + ++VR+ E +S + +VME+ E G L + + + ++ +L+ +
Sbjct: 62 MQQLD-NPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF----SDVVGSPYY 116
++ HRDL N L K +DFGLS + DE + + +
Sbjct: 120 MKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 117 VAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWP 174
APE + + ++DVWS GV+++ S G P+ + + +G+
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPA 233
Query: 175 NISESAKDLIRKMLDQNPKRRLTAHEV---LCHPW 206
DL+ + + R V L + +
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-43
Identities = 49/217 (22%), Positives = 84/217 (38%), Gaps = 18/217 (8%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV-KKGNYSEREAAKLMKTIVG 59
MH L + ++VR+ + ++ + +VME+ GG L +V K+ A+L+ +
Sbjct: 63 MHQLD-NPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD----VVGSPY 115
++ HRDL N L + K +DFGLS D+ +
Sbjct: 121 GMKYLEEKNFVHRDLAARNVL---LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 116 YVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPW 173
+ APE + + + +DVWS GV ++ LS G P+ + I +GK E
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECP 234
Query: 174 PNISESAKDLIRKMLDQNPKRRLTAHEV---LCHPWI 207
P L+ + R V + +
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-42
Identities = 43/203 (21%), Positives = 83/203 (40%), Gaps = 11/203 (5%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI-VKKGNYSEREAAKLMKTIVGVVECCH 65
H+ +V+++ + + I+ E G L + + + + ++ ++ K + +E
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLR 123
S HRDL N L V++ +K +DFGLS + DE + PEVL
Sbjct: 118 SKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 124 -KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
+ ++D+W+ GV+++ + S G P+ T I +G SE
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---RLYRPHLASEKVY 231
Query: 182 DLIRKMLDQNPKRRLTAHEVLCH 204
++ + R T +L +
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-42
Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 33/238 (13%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCE-GGELFDRIVKKGNYSEREAAKLMKTIVG 59
+ L+ H ++V++ D ++ +++V E + F + ++
Sbjct: 55 LKELN-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLS-VFYKPDEVFSDVVGSPYYVA 118
+ CHS V HRDLKP+N L + + A+K DFGL+ F P ++ V + +Y A
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 119 PEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW--- 173
PE+L K+Y D+WS G I +++ F ++EI +I + W
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 174 ----------------------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209
P + E + L+ +ML +P +R++A L HP+ D
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-42
Identities = 45/210 (21%), Positives = 82/210 (39%), Gaps = 15/210 (7%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN--YSEREAAKLMKTIVGVVECC 64
H+ +V+++ ++ ++IV E G L D + + + + I +
Sbjct: 71 HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVL 122
+ HRDL+ N L V E+ K DFGL+ + +E + APE
Sbjct: 130 ERMNYVHRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 123 R-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
+ ++DVWS G++L L + G P+ + Q+ G + P ES
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESL 243
Query: 181 KDLIRKMLDQNPKRRLTAHEVL--CHPWIV 208
DL+ + + P+ R T + +
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (365), Expect = 6e-42
Identities = 39/235 (16%), Positives = 72/235 (30%), Gaps = 17/235 (7%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
+ + I + +VMEL +S + L ++
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 115
Query: 61 VECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF--------SDVVG 112
+E HS HRD+KP+NFL + + DFGL+ Y+ ++ G
Sbjct: 116 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 113 SPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPF---WAETEIGIFRQILEGKIDF 168
+ Y + D+ S G +L G P+ A T+ + +I E K+
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235
Query: 169 ESEP-WPNISESAKDLIRKMLDQNPKRRLTA---HEVLCHPWIVDDKVAPDKPLD 219
E + + ++ + + + D D
Sbjct: 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH-RQGFSYDYVFD 289
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-41
Identities = 42/209 (20%), Positives = 81/209 (38%), Gaps = 14/209 (6%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVG 59
MH L H++++R++ + +V EL G L DR+ K G++ ++ +
Sbjct: 65 MHSLD-HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPY 115
+ S HRDL N L + +K DFGL ++ +
Sbjct: 123 GMGYLESKRFIHRDLAARNLL---LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 116 YVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPW 173
+ APE L+ + + +D W GV L+ + + G P+ I +I +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--P 237
Query: 174 PNISESAKDLIRKMLDQNPKRRLTAHEVL 202
+ + +++ + P+ R T +
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (362), Expect = 2e-41
Identities = 43/205 (20%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCH 65
H +V+ + + V I+ E E G L + + G ++ + +++ I ++
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDV------VGSPYYVAP 119
+ HRDL N L V+ + K +DFGLS F + D + AP
Sbjct: 146 DMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 120 EVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNIS 177
E ++ + + +DVWS G++++ ++S G P+W T + I + D+ P +
Sbjct: 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCP 259
Query: 178 ESAKDLIRKMLDQNPKRRLTAHEVL 202
+ L+ ++ R +++
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (359), Expect = 3e-41
Identities = 46/201 (22%), Positives = 79/201 (39%), Gaps = 10/201 (4%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY--SEREAAKLMKTIVGVVECC 64
H ++V++ + +I+ E G L D + + S + I +E
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVL 122
HRDL N L V E+ +K DFGLS D + + APE L
Sbjct: 132 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 123 R-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
+ ++DVW+ GV+L+ + + + ++ ++LE D+ E E
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--DYRMERPEGCPEKVY 246
Query: 182 DLIRKMLDQNPKRRLTAHEVL 202
+L+R NP R + E+
Sbjct: 247 ELMRACWQWNPSDRPSFAEIH 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 6e-41
Identities = 46/209 (22%), Positives = 85/209 (40%), Gaps = 12/209 (5%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN-YSEREAAKLMKTIVG 59
M LS H +V+++ +++ + +V E E G L D + + ++ + +
Sbjct: 54 MMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 112
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYV 117
+ V HRDL N L V E+ +K +DFG++ F D+ + +
Sbjct: 113 GMAYLEEACVIHRDLAARNCL---VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 169
Query: 118 APEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPN 175
+PEV Y ++DVWS GV+++ + S G P+ + + I G F
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRL 226
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCH 204
S ++ + P+ R +L
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-41
Identities = 61/251 (24%), Positives = 101/251 (40%), Gaps = 39/251 (15%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCV----HIVMELCEGGELFDRIVKKGNYSEREAAKLMKT 56
+ H+ H++V+ + D + + + + G + IVK ++ L+
Sbjct: 71 LKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 57 IVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYY 116
I+ ++ HS + HRDLKP N +ED LK DFGL+ D+ + V + +Y
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWY 184
Query: 117 VAPEVL--RKHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGKIDFESEPW- 173
APE++ HY D+WS G I+ LL+G F I + IL +E
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 174 --------------------------PNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207
+ A DL+ KML + +R+TA + L H +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304
Query: 208 VDDKVAPDKPL 218
D+P+
Sbjct: 305 AQYHDPDDEPV 315
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-40
Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 13/209 (6%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVG 59
M H H+V++ + V I+MELC GEL + + + +
Sbjct: 62 MRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYV 117
+ S HRD+ N L V + +K DFGLS + + + S ++
Sbjct: 120 ALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 118 APEVLR-KHYGPEADVWSAGVILY-ILLSGVPPFWAETEIGIFRQILEGKIDFESEPWPN 175
APE + + + +DVW GV ++ IL+ GV PF + +I G+ PN
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPN 233
Query: 176 ISESAKDLIRKMLDQNPKRRLTAHEVLCH 204
+ L+ K +P RR E+
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-40
Identities = 43/202 (21%), Positives = 78/202 (38%), Gaps = 13/202 (6%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY--SEREAAKLMKTIVGVVECC 64
HQ +VR++ + ++I+ E E G L D + + + + I +
Sbjct: 67 HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVF--SDVVGSPYYVAPEVL 122
HRDL+ N L K DFGL+ + +E + APE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 123 R-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESA 180
+ ++DVWS G++L +++ G P+ T + + + G + N E
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEEL 239
Query: 181 KDLIRKMLDQNPKRRLTAHEVL 202
L+R + P+ R T +
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLR 261
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-38
Identities = 45/225 (20%), Positives = 83/225 (36%), Gaps = 28/225 (12%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN---------------- 44
+ +L H ++V + ++ E C G+L + + +K +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 45 --YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK 102
+ + + S HRDL N L + K DFGL+ K
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIK 196
Query: 103 PDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGI 157
D V + ++APE + Y E+DVWS G+ L+ L S G P+
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
F ++++ S + D+++ D +P +R T +++
Sbjct: 257 FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (340), Expect = 3e-38
Identities = 40/225 (17%), Positives = 80/225 (35%), Gaps = 35/225 (15%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNY--------------------- 45
+ ++V++ + ++ E G+L + + +
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 46 ---SEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYK 102
S E + + + + HRDL N L V E+ +K DFGLS
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL---VGENMVVKIADFGLSRNIY 191
Query: 103 PDE---VFSDVVGSPYYVAPEVLRKH-YGPEADVWSAGVILYILLS-GVPPFWAETEIGI 157
+ + ++ PE + + Y E+DVW+ GV+L+ + S G+ P++ +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
+ +G I N +L+R + P R + +
Sbjct: 252 IYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 1e-37
Identities = 56/252 (22%), Positives = 99/252 (39%), Gaps = 51/252 (20%)
Query: 1 MHHLSEHQHVVRIHDTY------EDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLM 54
+ H++++ + + + E+ V++VMEL + + + L+
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLL 125
Query: 55 KTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSP 114
++ ++ HS G+ HRDLKP N V D LK DFGL+ + + V +
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNI---VVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182
Query: 115 YYVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILEGK-------- 165
YY APEV+ Y D+WS G I+ ++ F I + +++E
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 166 ------------------------------IDFESEPWPNISESAKDLIRKMLDQNPKRR 195
+SE + A+DL+ KML +P +R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 196 LTAHEVLCHPWI 207
++ + L HP+I
Sbjct: 303 ISVDDALQHPYI 314
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-37
Identities = 44/203 (21%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCH 65
H +++R+ + I+ E E G L + +K G +S + +++ I ++
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEV 121
++ HRDL N L V+ + K +DFGLS + D S + APE
Sbjct: 128 NMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 122 LR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISES 179
+ + + +DVWS G++++ +++ G P+W + + + I +G F + +
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCPSA 241
Query: 180 AKDLIRKMLDQNPKRRLTAHEVL 202
L+ + Q RR +++
Sbjct: 242 IYQLMMQCWQQERARRPKFADIV 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-37
Identities = 41/203 (20%), Positives = 71/203 (34%), Gaps = 11/203 (5%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
+ HV R+ + I + G L K N + I +
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR 123
+ HRDL N L V +K TDFGL+ +E ++A E +
Sbjct: 130 RRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 124 -KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAK 181
+ Y ++DVWS GV ++ L++ G P+ I + +G+ P +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTIDVY 243
Query: 182 DLIRKMLDQNPKRRLTAHEVLCH 204
++ K + R E++
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIE 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 5e-37
Identities = 44/223 (19%), Positives = 89/223 (39%), Gaps = 27/223 (12%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRI----------------VKKGN 44
M + +H++++ + +++++E G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 45 YSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPD 104
S ++ + +E S HRDL N L V ED +K DFGL+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 188
Query: 105 EVFS---DVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159
+ + + ++APE L + Y ++DVWS GV+L+ + + G P+ +F+
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
+ EG + N + ++R P +R T +++
Sbjct: 249 LLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (324), Expect = 6e-36
Identities = 35/236 (14%), Positives = 75/236 (31%), Gaps = 17/236 (7%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGV 60
L+ + ++ ++ +V++L + +S + A K ++
Sbjct: 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 113
Query: 61 VECCHSLGVFHRDLKPENFLF--LSVDEDAALKATDFGLSVFYKPDEV--------FSDV 110
V+ H + +RD+KP+NFL + + DFG+ FY+ ++
Sbjct: 114 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 111 VGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIG---IFRQILEGKI 166
G+ Y++ + D+ + G + L G P+ + +I E K
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233
Query: 167 DFE-SEPWPNISESAKDLIRKMLDQNPKRRLTAHEV--LCHPWIVDDKVAPDKPLD 219
E E + + + L + D+ D
Sbjct: 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-35
Identities = 41/207 (19%), Positives = 84/207 (40%), Gaps = 15/207 (7%)
Query: 7 HQHVVRIHDT-YEDKSCVHIVMELCEGGELFD-RIVKKGNYSEREAAKLMKTIVGVVECC 64
H +V+ + + +V+ + G+L + + N + ++ + ++
Sbjct: 87 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 65 HSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSD-----VVGSPYYVAP 119
S HRDL N + +DE +K DFGL+ E S ++A
Sbjct: 147 ASKKFVHRDLAARNCM---LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 120 EVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNIS 177
E L+ + + ++DVWS GV+L+ L++ G PP+ I +L+G+
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQPEYCP 260
Query: 178 ESAKDLIRKMLDQNPKRRLTAHEVLCH 204
+ +++ K + R + E++
Sbjct: 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-34
Identities = 46/217 (21%), Positives = 87/217 (40%), Gaps = 22/217 (10%)
Query: 1 MHHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGN----------YSEREA 50
M + HVVR+ ++MEL G+L + S +
Sbjct: 77 MKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 51 AKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VF 107
++ I + ++ HRDL N + V ED +K DFG++ +
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 108 SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGV-PPFWAETEIGIFRQILEGK 165
+ +++PE L+ + +DVWS GV+L+ + + P+ + + R ++EG
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252
Query: 166 IDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202
+ + N + +L+R NPK R + E++
Sbjct: 253 LL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 6e-33
Identities = 46/226 (20%), Positives = 81/226 (35%), Gaps = 27/226 (11%)
Query: 1 MHHLSEHQHVVRIHD-TYEDKSCVHIVMELCEGGELFDRIVKKGNY-------------- 45
+ H+ H +VV + + + +++E C+ G L + K N
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 46 --SEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKP 103
+ + +E S HRDL N L + E +K DFGL+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL---LSEKNVVKICDFGLARDIYK 186
Query: 104 DEVF---SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGV-PPFWAETEIGIF 158
D + D ++APE + + Y ++DVWS GV+L+ + S P+ F
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204
+ L+ + + P +R T E++ H
Sbjct: 247 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 7e-33
Identities = 42/238 (17%), Positives = 81/238 (34%), Gaps = 46/238 (19%)
Query: 7 HQHVVRIHDTYEDK----SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVE 62
H++++ + + +V + E G LFD + + + KL + +
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 114
Query: 63 CCHS--------LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE-----VFSD 109
H + HRDLK +N L V ++ D GL+V + +
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 110 VVGSPYYVAPEVLR-------KHYGPEADVWSAGVILYILLSGVPPFWAETEIG------ 156
VG+ Y+APEVL AD+++ G++ + + +
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231
Query: 157 ---------IFRQILEGKIDFESEPWPNISES---AKDLIRKMLDQNPKRRLTAHEVL 202
+ + + E K+ E+ ++R+ N RLTA +
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (272), Expect = 6e-28
Identities = 50/276 (18%), Positives = 101/276 (36%), Gaps = 61/276 (22%)
Query: 2 HHLSEHQHVVRIHDTYED--KSCVHIVMELCEGG---ELFDRIVKKGNYSEREAAKLMKT 56
H++++ D + + VH+VM G + + ++ K
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 57 IV-GVVECCHSLGVFHRDLKPENFLFLSVD---EDAALKATDFGLSVFYKPDEVFSDVVG 112
++ G+ G+ H D+KPEN L VD +K D G + +Y +++ +
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQ 191
Query: 113 SPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI---------- 161
+ Y +PEVL +G AD+WS +++ L++G F + +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 162 ----------------------------------LEGKIDFESEPWPNISESAKDLIRKM 187
LE + + + + ++ D + M
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 188 LDQNPKRRLTAHEVLCHPWI-----VDDKVAPDKPL 218
L +P++R A ++ HPW+ +++ PD+ L
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDREL 347
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 68.5 bits (166), Expect = 8e-14
Identities = 21/99 (21%), Positives = 33/99 (33%)
Query: 214 PDKPLDSAVLSRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFD 273
D + L+ L + LR L+EE+ L++LF SG +F
Sbjct: 83 GDAAAEKQRLASLLKDLEDDASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQ 142
Query: 274 ELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCN 312
+LK L + + E +K L V
Sbjct: 143 DLKQVLAKYADTIPEGPLKKLFVMVENDTKGRMSYITLV 181
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 61.5 bits (149), Expect = 5e-13
Identities = 52/58 (89%), Positives = 56/58 (96%)
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ +AERL+EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS+LMESEIKDLMDA
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 56.6 bits (135), Expect = 2e-10
Identities = 43/45 (95%), Positives = 45/45 (100%)
Query: 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLME 288
AERL+EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS+LME
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELME 45
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 56.7 bits (136), Expect = 2e-10
Identities = 23/136 (16%), Positives = 44/136 (32%), Gaps = 18/136 (13%)
Query: 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS 66
V +++ + ++MEL + + +++ I+ V +
Sbjct: 73 GLAVPKVYAWEGN----AVLMELIDAK-------ELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHY 126
G+ H DL N L + + DF SV + + + + Y
Sbjct: 122 RGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGEEGWREILERDVRNII-TYFSRTY 176
Query: 127 GPEADVWSAGVILYIL 142
E D+ S I IL
Sbjct: 177 RTEKDINS--AIDRIL 190
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 50.4 bits (120), Expect = 4e-09
Identities = 20/55 (36%), Positives = 33/55 (60%)
Query: 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ L EE+I KE F + D DN+G+I+ EL ++ +G E+E+ DLM+ +
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEI 55
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 46.5 bits (110), Expect = 1e-07
Identities = 16/54 (29%), Positives = 26/54 (48%)
Query: 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
L+EE I K F M D D G I+ EL ++ +G + E+ +++ V
Sbjct: 6 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEV 59
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 46.0 bits (109), Expect = 1e-07
Identities = 19/54 (35%), Positives = 32/54 (59%), Gaps = 3/54 (5%)
Query: 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
ER + EE + + F++ D DNSGTIT +L+ K +G L E E+++++
Sbjct: 4 ERDSREE---ILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEA 54
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 34.1 bits (78), Expect = 0.002
Identities = 11/45 (24%), Positives = 21/45 (46%), Gaps = 3/45 (6%)
Query: 237 KMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR 281
+ + + E L EEE+ +E+ D ++ I DE +K+
Sbjct: 32 RRVAKELGENLTEEEL---QEMIAEADRNDDNEIDEDEFIRIMKK 73
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Score = 45.7 bits (108), Expect = 2e-07
Identities = 20/54 (37%), Positives = 31/54 (57%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK 300
L EE+I KE F + D D GTIT EL ++ +G E+E++D+++ V
Sbjct: 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 55
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 45.2 bits (107), Expect = 2e-07
Identities = 16/51 (31%), Positives = 29/51 (56%), Gaps = 4/51 (7%)
Query: 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLM-ESEIKDLMDAV 298
EEE + FK+ D + G I FDE K +++VG + + ++E+++ M
Sbjct: 1 EEE---ILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEA 48
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 34.0 bits (78), Expect = 0.002
Identities = 14/47 (29%), Positives = 22/47 (46%), Gaps = 3/47 (6%)
Query: 235 LKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR 281
K + +V E L + E+ +E K D D +G I E D +K+
Sbjct: 24 FKFIMQKVGEEPLTDAEV---EEAMKEADEDGNGVIDIPEFMDLIKK 67
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 47.1 bits (111), Expect = 3e-07
Identities = 20/57 (35%), Positives = 33/57 (57%)
Query: 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK 300
+ L EE+I KE F + D DN+G+I+ EL ++ +G E+E+ DLM+ +
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDV 57
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 43.7 bits (102), Expect = 5e-06
Identities = 25/129 (19%), Positives = 56/129 (43%), Gaps = 8/129 (6%)
Query: 175 NISESAKDLIR---KMLDQNPKRRLTAHEV--LCHPWIVDDKVAPDKPLDSAVLSRLKHF 229
N++E + + D++ +++ E+ + + A L + + H
Sbjct: 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQ 62
Query: 230 SAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMES 289
++ + R + +E+E+ E FK+ D + G I+ ELK L +G +L ++
Sbjct: 63 IEFSEFLALMSRQLKSNDSEQEL---LEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDA 119
Query: 290 EIKDLMDAV 298
E+ D++ V
Sbjct: 120 EVDDMLREV 128
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 45.0 bits (106), Expect = 3e-07
Identities = 14/59 (23%), Positives = 28/59 (47%), Gaps = 1/59 (1%)
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNS-GTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ E+L EE+ K F + G+I+ EL ++ +G E+++++D V
Sbjct: 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEV 61
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 45.8 bits (107), Expect = 6e-07
Identities = 13/59 (22%), Positives = 25/59 (42%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCNL 313
K++F + D G I D L D L+ +G ++D+++A + S+
Sbjct: 4 NKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQIT 62
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 43.4 bits (102), Expect = 1e-06
Identities = 18/55 (32%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
A+ +EEE L F++ D + G I +EL + L+ G ++E +I+DLM
Sbjct: 3 AKGKSEEE---LANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDS 54
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Score = 45.7 bits (107), Expect = 1e-06
Identities = 10/47 (21%), Positives = 21/47 (44%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKD 293
N IG K +F +D +++G I+ DE+ + + + +
Sbjct: 6 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQ 52
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Score = 45.8 bits (107), Expect = 1e-06
Identities = 11/54 (20%), Positives = 23/54 (42%)
Query: 240 LRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKD 293
+++ + N I K +F +D + +G IT DE+ +E+ +
Sbjct: 1 VKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQ 54
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 44.9 bits (105), Expect = 2e-06
Identities = 12/56 (21%), Positives = 26/56 (46%), Gaps = 1/56 (1%)
Query: 241 RVIAERLNEEEIGGLKELFKMIDTD-NSGTITFDELKDGLKRVGSQLMESEIKDLM 295
+ E+L EE+ K F + G+I+ EL ++ +G E+++++
Sbjct: 2 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMI 57
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 35.7 bits (81), Expect = 0.002
Identities = 16/44 (36%), Positives = 25/44 (56%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
L +LF+M D + G I +ELK L+ G + E +I++LM
Sbjct: 93 LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDG 136
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 45.4 bits (106), Expect = 2e-06
Identities = 10/60 (16%), Positives = 24/60 (40%), Gaps = 1/60 (1%)
Query: 247 LNEEEIGGLKELFK-MIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF 305
LN+ + +K F +D ++ G+I ++ +D + R S +++
Sbjct: 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDE 61
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Score = 42.2 bits (99), Expect = 3e-06
Identities = 16/50 (32%), Positives = 28/50 (56%), Gaps = 1/50 (2%)
Query: 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
++I + +FK DT+ G I+ EL D LK +GS + E++ +M +
Sbjct: 2 PQDIADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPD-EVRRMMAEI 50
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Score = 34.1 bits (78), Expect = 0.003
Identities = 15/62 (24%), Positives = 23/62 (37%), Gaps = 9/62 (14%)
Query: 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK 300
+ L ++ + IDTD G I+FDE + + L+ V K
Sbjct: 29 GDALKTLGSVTPDEVRRMMAEIDTDGDGFISFDEFT--------DFARAN-RGLVKDVSK 79
Query: 301 IF 302
IF
Sbjct: 80 IF 81
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 43.8 bits (102), Expect = 5e-06
Identities = 18/69 (26%), Positives = 31/69 (44%), Gaps = 4/69 (5%)
Query: 230 SAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMES 289
++M + A L+EE I K F M D D G I+ EL ++ +G +
Sbjct: 1 ASMTDQQAEARAF----LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56
Query: 290 EIKDLMDAV 298
E+ +++ V
Sbjct: 57 ELDAIIEEV 65
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 41.8 bits (97), Expect = 2e-05
Identities = 27/140 (19%), Positives = 53/140 (37%), Gaps = 11/140 (7%)
Query: 167 DFESEPWPNISESAKDLIR---KMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVL 223
D ++E +SE + M D + ++ E+ ++ ++
Sbjct: 5 DQQAEARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEE 64
Query: 224 -----SRLKHFSAMNKLKKMALRVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDG 278
S F + ++ A+ +EEE L F++ D + G I +EL +
Sbjct: 65 VDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEE---LANCFRIFDKNADGFIDIEELGEI 121
Query: 279 LKRVGSQLMESEIKDLMDAV 298
L+ G + E +I+DLM
Sbjct: 122 LRATGEHVTEEDIEDLMKDS 141
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Score = 41.5 bits (97), Expect = 6e-06
Identities = 19/51 (37%), Positives = 28/51 (54%), Gaps = 3/51 (5%)
Query: 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
EEE L +LF+M D + G I +ELK L+ G + E +I++LM
Sbjct: 13 TEEE---LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDG 60
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 41.1 bits (96), Expect = 6e-06
Identities = 7/44 (15%), Positives = 18/44 (40%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
K +F+ D + G ++ DE ++ + +I + +
Sbjct: 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEI 46
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} Length = 165 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.5 bits (101), Expect = 6e-06
Identities = 15/70 (21%), Positives = 30/70 (42%), Gaps = 1/70 (1%)
Query: 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIF 302
+ + +EI L + FK +D DNSG+++ +E + + L++ + D+ D
Sbjct: 6 MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQ-RVIDIFDTDGNGE 64
Query: 303 SRFSIKTYCN 312
F
Sbjct: 65 VDFKEFIEGV 74
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.7 bits (102), Expect = 6e-06
Identities = 10/55 (18%), Positives = 21/55 (38%), Gaps = 1/55 (1%)
Query: 245 ERLNEEEIGGLKELFKMIDTD-NSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ + L+E +K + SGT+ E K K ++ ++ + A
Sbjct: 13 GAVGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAF 67
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 43.0 bits (100), Expect = 7e-06
Identities = 21/56 (37%), Positives = 33/56 (58%)
Query: 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK 300
E+L EE+I KE F + D D GTIT EL ++ +G E+E++D+++ V
Sbjct: 1 EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 56
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 142 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 42.3 bits (98), Expect = 1e-05
Identities = 13/49 (26%), Positives = 29/49 (59%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLM 295
L +++I +KE F MID D G ++ +++K +++G + E+ ++
Sbjct: 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAML 49
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Score = 43.1 bits (100), Expect = 1e-05
Identities = 16/52 (30%), Positives = 25/52 (48%), Gaps = 2/52 (3%)
Query: 244 AERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLM 295
A +N+ + L E F+ +DTD SG I+ EL L G + + L+
Sbjct: 11 ARHMNDNQ--ELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLL 60
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 2e-05
Identities = 9/44 (20%), Positives = 20/44 (45%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
KE F++ D G I + + D ++ +G +E+ ++
Sbjct: 2 FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNP 45
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Score = 41.9 bits (97), Expect = 2e-05
Identities = 11/55 (20%), Positives = 23/55 (41%), Gaps = 4/55 (7%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRV----GSQLMESEIKDLMDAVRKIFSRF 305
LK+ F D D +G + + + + + G +E++ L +A +F
Sbjct: 9 LKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYL 63
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Score = 35.4 bits (80), Expect = 0.004
Identities = 16/118 (13%), Positives = 32/118 (27%), Gaps = 4/118 (3%)
Query: 167 DFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRL 226
E + N D + K LT + + + +
Sbjct: 46 AAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVK 105
Query: 227 KHFSAMNKLKKMALRVIAERLNEEEIGG----LKELFKMIDTDNSGTITFDELKDGLK 280
+K + +G E F +DT+ +G ++ DEL ++
Sbjct: 106 GIVGMCDKNADGQINADEFAAWLTALGMSKAEAAEAFNQVDTNGNGELSLDELLTAVR 163
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} Length = 134 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Score = 41.3 bits (95), Expect = 2e-05
Identities = 9/56 (16%), Positives = 25/56 (44%)
Query: 257 ELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCN 312
LFK ID + G ++++E+K + + + E ++ + ++ + +
Sbjct: 4 ALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFA 59
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Score = 41.6 bits (96), Expect = 3e-05
Identities = 9/45 (20%), Positives = 17/45 (37%)
Query: 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIK 292
++ + +K F ID D G IT + + +R +
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEH 45
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} Length = 76 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.5 bits (92), Expect = 3e-05
Identities = 13/60 (21%), Positives = 29/60 (48%), Gaps = 7/60 (11%)
Query: 248 NEEEIGGLKELFKMIDTD--NSGTITFDELKDGLKRVGSQLM--ESEIKDLMDAVRKIFS 303
+ EE +K F++ + I+ +ELK ++ +G L+ S + ++++ V K
Sbjct: 3 SPEE---IKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGD 59
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 3e-05
Identities = 17/55 (30%), Positives = 31/55 (56%)
Query: 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFS 303
EE+ ++E F + D D +GTI ELK ++ +G + + EIK ++ + K +
Sbjct: 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGT 56
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 5e-04
Identities = 18/113 (15%), Positives = 45/113 (39%), Gaps = 1/113 (0%)
Query: 186 KMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFSAMNKLKKMALRVIAE 245
+ D + + E+ + + ++ + MN + + + +
Sbjct: 13 DLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTV-MTQK 71
Query: 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
++ + + FK+ D D +G I+F LK K +G L + E+++++D
Sbjct: 72 MSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEA 124
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} Length = 186 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Score = 41.3 bits (96), Expect = 4e-05
Identities = 14/71 (19%), Positives = 31/71 (43%), Gaps = 3/71 (4%)
Query: 237 KMALRVIAERLNEEEIG-GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDL- 294
++ + NEE+IG G + LF + I+ EL+ L+RV ++ + +
Sbjct: 1 EIEANIEEIEANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFS 59
Query: 295 MDAVRKIFSRF 305
++ + +
Sbjct: 60 IETCKIMVDML 70
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.3 bits (96), Expect = 4e-05
Identities = 12/64 (18%), Positives = 23/64 (35%), Gaps = 4/64 (6%)
Query: 234 KLKKMALRVIAE--RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEI 291
KL+ ++ + E E EI + F SG ++ +E K S+
Sbjct: 3 KLRPEVMQDLLESTDFTEHEIQEWYKGFL--RDCPSGHLSMEEFKKIYGNFFPYGDASKF 60
Query: 292 KDLM 295
+ +
Sbjct: 61 AEHV 64
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} Length = 173 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Score = 41.1 bits (95), Expect = 5e-05
Identities = 11/57 (19%), Positives = 26/57 (45%), Gaps = 2/57 (3%)
Query: 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDL-MDAVRKIFSRF 305
EE+ + LF + D+ ++ EL + L +V ++ + + +D R + +
Sbjct: 1 EEVRQFRRLFAQLAGDD-MEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVM 56
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 152 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 40.4 bits (93), Expect = 5e-05
Identities = 11/68 (16%), Positives = 28/68 (41%), Gaps = 2/68 (2%)
Query: 247 LNEEEIGGLKELFKMIDT--DNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSR 304
L+++EI LK++F++ D G + +L D + +G ++ + +
Sbjct: 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGGTHKMGEKS 60
Query: 305 FSIKTYCN 312
+ +
Sbjct: 61 LPFEEFLP 68
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} Length = 78 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Score = 38.7 bits (90), Expect = 6e-05
Identities = 10/56 (17%), Positives = 24/56 (42%), Gaps = 4/56 (7%)
Query: 249 EEEIGGLKELFKMIDT--DNSGTITFDELKDGLKRVGSQLMES--EIKDLMDAVRK 300
++ LK +F+ + ++ +ELK ++ L++ + DL + K
Sbjct: 3 QKSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDK 58
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 65 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Score = 38.5 bits (89), Expect = 6e-05
Identities = 15/50 (30%), Positives = 29/50 (58%), Gaps = 3/50 (6%)
Query: 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
EEEI +E F++ D D +G I+ EL+ + +G +L + E+ +++
Sbjct: 2 EEEI---REAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREA 48
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 39.1 bits (91), Expect = 9e-05
Identities = 19/47 (40%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAV 298
+K++FK ID D SG I +ELK LK G L ++E K + A
Sbjct: 43 VKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAA 89
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 33 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 36.8 bits (86), Expect = 1e-04
Identities = 13/36 (36%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG 283
+EEEI +E F++ D D +G I+ EL+ + +G
Sbjct: 1 SEEEI---REAFRVFDKDGNGYISAAELRHVMTNLG 33
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 61 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.3 bits (86), Expect = 1e-04
Identities = 10/44 (22%), Positives = 27/44 (61%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAV 298
+ F++ D +++G ++ +L+ L +G +L ++E+ +L+ V
Sbjct: 3 FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGV 46
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.4 bits (89), Expect = 1e-04
Identities = 22/55 (40%), Positives = 32/55 (58%), Gaps = 3/55 (5%)
Query: 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAV 298
L++ +K++F+ ID D SG + DELK L++ +L ESE K LMDA
Sbjct: 35 LSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAA 89
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 183 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 39.1 bits (90), Expect = 2e-04
Identities = 13/56 (23%), Positives = 21/56 (37%), Gaps = 3/56 (5%)
Query: 247 LNEEEIGGLKELFKMIDTD--NSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK 300
+ EI L ELFK I + + G I +E + L + + + D
Sbjct: 11 FSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKKESL-FADRVFDLFDT 65
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} Length = 99 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (86), Expect = 3e-04
Identities = 6/39 (15%), Positives = 18/39 (46%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKD 293
K F + D ++ G + EL+ + ++ + + ++
Sbjct: 18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEE 56
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (89), Expect = 3e-04
Identities = 9/64 (14%), Positives = 20/64 (31%), Gaps = 4/64 (6%)
Query: 234 KLKKMALRVIAE--RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEI 291
KLK + + E+E+ + F SG + + K+ ++
Sbjct: 4 KLKPEVVEELTRKTYFTEKEVQQWYKGFI--KDCPSGQLDAAGFQKIYKQFFPFGDPTKF 61
Query: 292 KDLM 295
+
Sbjct: 62 ATFV 65
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 38.2 bits (87), Expect = 4e-04
Identities = 10/59 (16%), Positives = 22/59 (37%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCNL 313
L +F+ +D D SG I+ +EL+ L + ++ ++ +
Sbjct: 21 LWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFT 79
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} Length = 93 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Score = 36.4 bits (84), Expect = 5e-04
Identities = 10/59 (16%), Positives = 20/59 (33%), Gaps = 7/59 (11%)
Query: 249 EEEIGGLKELFKMIDT--DNSGTITFDELKDGLKRVGSQLM-----ESEIKDLMDAVRK 300
E+ + + F + + ELK+ L R + E+ + LM +
Sbjct: 5 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDS 63
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Score = 36.9 bits (85), Expect = 5e-04
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 255 LKELFKMIDTDNSGTITFDELKD---GLKRVGSQLMESEIKDLMDAV 298
+KE+F+++D D SG I +ELK G G L ++E K L+ A
Sbjct: 43 VKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAG 89
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Score = 38.2 bits (88), Expect = 5e-04
Identities = 16/63 (25%), Positives = 30/63 (47%), Gaps = 3/63 (4%)
Query: 245 ERLNEEEI-GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDL-MDAVRKIF 302
+ L+EEEI K LF + D+ I+ EL+ L R+ S+ + +++ R +
Sbjct: 11 KVLSEEEIDDNFKTLFSKLAGDD-MEISVKELQTILNRIISKHKDLRTNGFSLESCRSMV 69
Query: 303 SRF 305
+
Sbjct: 70 NLM 72
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} Length = 172 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.0 bits (85), Expect = 0.001
Identities = 11/56 (19%), Positives = 17/56 (30%), Gaps = 3/56 (5%)
Query: 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF 305
+ L F + G I DEL+ L + G + R + S
Sbjct: 4 QTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNL--ETCRLMVSML 56
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.3 bits (83), Expect = 0.002
Identities = 8/50 (16%), Positives = 15/50 (30%), Gaps = 2/50 (4%)
Query: 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLM 295
+ E+ L FK + SG + + K + S +
Sbjct: 9 NFTKRELQVLYRGFK--NECPSGVVNEETFKQIYAQFFPHGDASTYAHYL 56
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} Length = 83 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Score = 34.7 bits (79), Expect = 0.002
Identities = 13/54 (24%), Positives = 23/54 (42%), Gaps = 3/54 (5%)
Query: 238 MALRVIAERLNE---EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLME 288
A R I RL++ + + F+ DT + TI+ +E + R L +
Sbjct: 2 TADRDILARLHKAVTSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTD 55
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} Length = 201 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Score = 36.4 bits (83), Expect = 0.002
Identities = 13/68 (19%), Positives = 21/68 (30%), Gaps = 4/68 (5%)
Query: 230 SAMNKLKKMALRVIAE--RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLM 287
S L K L + + EEE+ + F SG IT E + + +
Sbjct: 3 SKSGALSKEILEELQLNTKFTEEELSSWYQSFL--KECPSGRITRQEFQTIYSKFFPEAD 60
Query: 288 ESEIKDLM 295
+
Sbjct: 61 PKAYAQHV 68
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 140 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 35.4 bits (80), Expect = 0.002
Identities = 11/57 (19%), Positives = 20/57 (35%)
Query: 256 KELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCN 312
K+ F + D +G I + D L+ G +EI ++ + N
Sbjct: 8 KQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIESTLPAEVDMEQFLQVLN 64
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 170 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.8 bits (82), Expect = 0.003
Identities = 6/54 (11%), Positives = 18/54 (33%), Gaps = 3/54 (5%)
Query: 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLM---DAVRKIFSRF 305
+ E+F +T + L + + + + D V+ + ++
Sbjct: 80 IDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKY 133
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 190 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 35.2 bits (80), Expect = 0.004
Identities = 21/121 (17%), Positives = 49/121 (40%), Gaps = 13/121 (10%)
Query: 172 PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSA---------- 221
P+ + + A L + D++ + E + + ++ L A
Sbjct: 57 PFGSPEDFANHLFT-VFDKDNNGFIHFEEFITVLSTTS-RGTLEEKLSWAFELYDLNHDG 114
Query: 222 VLSRLKHFSAMNKLKKMALRVIAERLNEEEIGG-LKELFKMIDTDNSGTITFDELKDGLK 280
++ + + + + KM ++ +E +K++FK++D + G IT DE ++G K
Sbjct: 115 YITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSK 174
Query: 281 R 281
Sbjct: 175 V 175
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.72 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 99.46 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.45 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.42 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.41 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 99.37 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 99.34 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.3 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.29 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 99.26 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 99.25 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 99.22 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.21 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 99.19 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 99.1 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 99.03 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.01 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.98 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 98.96 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 98.96 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 98.93 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 98.88 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.88 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.82 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.81 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 98.8 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 98.78 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 98.77 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 98.77 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 98.76 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 98.75 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 98.73 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 98.72 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 98.72 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.71 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 98.7 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 98.67 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 98.67 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.67 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.65 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.62 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.61 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 98.6 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 98.59 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 98.59 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 98.58 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 98.58 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.55 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 98.55 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 98.54 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.53 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 98.5 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 98.48 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 98.48 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 98.47 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 98.47 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.47 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 98.46 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 98.46 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 98.42 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.39 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.38 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 98.35 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 98.34 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 98.31 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 98.31 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 98.3 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 98.29 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 98.29 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.27 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 98.21 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 98.19 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 98.18 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 98.16 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 98.16 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 98.15 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 98.14 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 98.11 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 98.1 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 98.1 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 98.09 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 98.08 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 98.07 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.06 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 98.03 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 98.03 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 98.02 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 98.01 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 97.99 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 97.98 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 97.89 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 97.89 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 97.84 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.84 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 97.84 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 97.81 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 97.78 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 97.76 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 97.73 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 97.67 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 97.62 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 97.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.6 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 97.49 | |
| d1j7qa_ | 86 | Calcium vector protein {Amphioxus (Branchiostoma l | 97.45 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 97.42 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 97.37 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 97.31 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 97.31 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 97.17 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 97.04 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 96.88 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 96.85 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 96.82 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.81 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 96.62 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 96.48 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 96.38 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.99 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 95.97 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 95.96 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 95.92 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 95.67 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 95.63 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 95.57 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 95.43 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 95.41 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 95.3 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 95.22 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 95.05 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 95.02 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 95.02 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 94.87 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 94.71 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 94.7 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 94.69 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 94.67 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 94.27 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 94.24 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 94.23 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 94.15 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 94.13 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 93.99 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 93.92 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 93.84 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 93.65 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 93.41 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 93.38 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.21 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 93.05 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 92.91 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 92.74 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 92.58 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 92.51 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 92.43 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 92.24 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.15 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 91.55 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 91.41 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 90.9 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 90.73 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 89.9 | |
| d1sraa_ | 151 | C-terminal (EC) domain of BM-40/SPARC/osteonectin | 89.62 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 88.74 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 88.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 88.39 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 87.88 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 87.4 | |
| d1pula1 | 103 | Hypothetical protein c32e8.3 {Caenorhabditis elega | 82.34 | |
| d1qasa1 | 94 | Phosphoinositide-specific phospholipase C, isozyme | 81.32 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-58 Score=398.01 Aligned_cols=225 Identities=45% Similarity=0.860 Sum_probs=186.2
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+ +|||||++++++++++.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||++.
T Consensus 63 ~l-~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~ 141 (307)
T d1a06a_ 63 KI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141 (307)
T ss_dssp TC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred hC-CCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeec
Confidence 44 89999999999999999999999999999999999889999999999999999999999999999999999999987
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
..+.++.+||+|||+++.........+.+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+....+
T Consensus 142 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i 221 (307)
T d1a06a_ 142 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 221 (307)
T ss_dssp SSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 667789999999999988776666677889999999999975 5899999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHhh
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHF 229 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (315)
..+...++.+.++.+|+++++||.+||++||.+|||++|+++||||+..... ..........++++.
T Consensus 222 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~-~~~~~~~~~~~~~~~ 288 (307)
T d1a06a_ 222 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL-DKNIHQSVSEQIKKN 288 (307)
T ss_dssp HTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCC-CCCCHHHHHHHHHHH
T ss_pred hccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCcc-ccccchhHHHHHHHH
Confidence 9998888888888999999999999999999999999999999999754322 233334444444433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=381.43 Aligned_cols=198 Identities=33% Similarity=0.632 Sum_probs=182.0
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+ +|||||++++++.+++.+|+|||||+||+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||
T Consensus 62 ~l-~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nil-- 138 (263)
T d2j4za1 62 HL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL-- 138 (263)
T ss_dssp TC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE--
T ss_pred hc-CCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccce--
Confidence 44 899999999999999999999999999999999998889999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhc-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKH-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
++.++.+||+|||++....... .....||+.|+|||++.+. ++.++||||+||++|+|++|+.||.+.+..+.+..+
T Consensus 139 -l~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 216 (263)
T d2j4za1 139 -LGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216 (263)
T ss_dssp -ECTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred -ecCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 5667899999999998765433 3557899999999999754 899999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.+....++. .+|+++++||.+||++||.+|||++|+|+||||++
T Consensus 217 ~~~~~~~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 217 SRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HTTCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HcCCCCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 888766553 58999999999999999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-56 Score=377.46 Aligned_cols=202 Identities=32% Similarity=0.606 Sum_probs=173.1
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+ +|||||++++++++++.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 59 ~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NIL-- 135 (271)
T d1nvra_ 59 ML-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL-- 135 (271)
T ss_dssp TC-CCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE--
T ss_pred hC-CCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEE--
Confidence 44 899999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCC---CcccccccCccccchhhhhhc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-
Q 021227 83 SVDEDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLRKH--YGPEADVWSAGVILYILLSGVPPFWAETEIG- 156 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~- 156 (315)
++.++.+||+|||+|+..... ....+.+||+.|||||++.+. ++.++||||+||++|+|+||++||.+.+...
T Consensus 136 -l~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 214 (271)
T d1nvra_ 136 -LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214 (271)
T ss_dssp -ECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred -ECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH
Confidence 456789999999999876432 224567899999999998643 4678999999999999999999998765433
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
....+..... ....++.+|+++++||.+||+.||++|||++|+|+||||++.
T Consensus 215 ~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 215 EYSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHTTCT--TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHhcCCC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 3333333322 223456799999999999999999999999999999999753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.1e-55 Score=386.04 Aligned_cols=208 Identities=33% Similarity=0.672 Sum_probs=191.5
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
++| +|||||+++++|++++++|+|||||+||+|.+++.+. .++++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 81 ~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NIL 159 (352)
T d1koba_ 81 NQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 159 (352)
T ss_dssp TTC-CSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhC-CCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccc
Confidence 455 8999999999999999999999999999999887665 46999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFR 159 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 159 (315)
+.. ...+.+||+|||+|..........+..||+.|+|||++.+ .++.++||||+||++|+|+||..||.+.+..+.+.
T Consensus 160 l~~-~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~ 238 (352)
T d1koba_ 160 CET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 238 (352)
T ss_dssp ESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred ccc-cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 632 3568999999999998877776777889999999999874 49999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
.+..+...++...++.+|+++++||.+||++||.+|||++|+|+||||+...
T Consensus 239 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 239 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999998888888889999999999999999999999999999999998654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.2e-55 Score=385.70 Aligned_cols=205 Identities=35% Similarity=0.644 Sum_probs=189.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+|||||+++++|++++.+|+|||||+||+|.+++.+ .+++++..++.++.||+.||.|||++||+||||||+|||+..
T Consensus 81 ~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~- 159 (350)
T d1koaa2 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT- 159 (350)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-
T ss_pred CCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-
Confidence 899999999999999999999999999999999854 467999999999999999999999999999999999999742
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
+.++.+||+|||+++.........+..||+.|||||++.+ .++.++||||+||++|+|++|..||.+.+..+.+..|..
T Consensus 160 ~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 239 (350)
T d1koaa2 160 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239 (350)
T ss_dssp TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 3468999999999998877776677899999999999875 489999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
....++...++.+|+++++||.+||++||++|||++|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 240 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp TCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 988888777788999999999999999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=369.73 Aligned_cols=201 Identities=23% Similarity=0.417 Sum_probs=174.6
Q ss_pred CCCCCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCC
Q 021227 2 HHLSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLG--VFHRDLK 75 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dik 75 (315)
+++ +|||||+++++|++ +..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+|||||
T Consensus 63 ~~l-~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiK 141 (270)
T d1t4ha_ 63 KGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 141 (270)
T ss_dssp TTC-CCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCC
T ss_pred HhC-CCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcC
Confidence 455 89999999999975 4568999999999999999998889999999999999999999999999 9999999
Q ss_pred CCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhhcCCCchhHHHHHHHHHHHHhCCCCCCCC-CH
Q 021227 76 PENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRKHYGPEADVWSAGVILYILLSGVPPFWAE-TE 154 (315)
Q Consensus 76 p~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~ 154 (315)
|+|||+ .+.++.+||+|||+++.... ....+.+||+.|+|||++.+.++.++||||+||++|+|++|+.||.+. +.
T Consensus 142 p~NILl--~~~~~~~Kl~DFGla~~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~ 218 (270)
T d1t4ha_ 142 CDNIFI--TGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA 218 (270)
T ss_dssp GGGEEE--SSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred hhhcee--eCCCCCEEEeecCcceeccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccH
Confidence 999996 34578999999999976443 334567899999999999988999999999999999999999999765 45
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
.++.+.+..+..+ ......++++++++|.+||++||++|||++|+|+||||+
T Consensus 219 ~~~~~~i~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 219 AQIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHTTTCCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHcCCCC--cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 5566666655332 222346789999999999999999999999999999995
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=373.65 Aligned_cols=201 Identities=30% Similarity=0.540 Sum_probs=176.4
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+|||||+++++|.+++.+|+|||||+||+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 74 l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl--- 149 (293)
T d1yhwa1 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL--- 149 (293)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---
T ss_pred CCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---
Confidence 3899999999999999999999999999999987754 579999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||+++...... .....+||+.|+|||++.+ .|+.++||||+||++|+|+||..||.+.+..+....+.
T Consensus 150 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~ 229 (293)
T d1yhwa1 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229 (293)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 567899999999998765433 3456789999999999974 58999999999999999999999999988877776665
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
..... ....++.+|+++++||.+||++||.+|||++|+|+||||+..
T Consensus 230 ~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 230 TNGTP-ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHCSC-CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred hCCCC-CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 54321 223345789999999999999999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-55 Score=377.09 Aligned_cols=205 Identities=40% Similarity=0.715 Sum_probs=188.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+|||||+++++|++++++|+|||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||++...+
T Consensus 71 ~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 150 (293)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS
T ss_pred CCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCC
Confidence 89999999999999999999999999999999998888999999999999999999999999999999999999975332
Q ss_pred -CCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 86 -EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 86 -~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
....+||+|||++..........+..||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.+..+..
T Consensus 151 ~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 230 (293)
T d1jksa_ 151 VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230 (293)
T ss_dssp SSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred CcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 234699999999988877666677889999999999974 599999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
....++...++.+|+++++||++||+.||.+|||++|+|+||||+..
T Consensus 231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 231 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 88877766667899999999999999999999999999999999753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-54 Score=371.29 Aligned_cols=203 Identities=41% Similarity=0.826 Sum_probs=189.4
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
|..|||||++++++++++++|+|||||+||+|.+++..++++++..++.++.||+.||+|||++||+||||||+||+
T Consensus 66 l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil--- 142 (277)
T d1phka_ 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL--- 142 (277)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE---
T ss_pred hcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE---
Confidence 44699999999999999999999999999999999998899999999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-------HYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
++.++.+||+|||++.............||+.|+|||.+.+ .++.++||||+||++|+|++|+.||.+.+...
T Consensus 143 l~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~ 222 (277)
T d1phka_ 143 LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222 (277)
T ss_dssp ECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence 56789999999999988776666667889999999998852 36889999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
....+..+...++.+.++++|+++++||.+||++||++|||++|+|+||||+.
T Consensus 223 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 99999999888887777899999999999999999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=374.05 Aligned_cols=198 Identities=33% Similarity=0.602 Sum_probs=177.9
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+|||||+++++|++++.+|+|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||| ++
T Consensus 66 ~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIl---l~ 142 (288)
T d1uu3a_ 66 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL---LN 142 (288)
T ss_dssp CSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE---EC
T ss_pred CCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccc---cC
Confidence 899999999999999999999999999999999998899999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCC---CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQI 161 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 161 (315)
.++.+||+|||+|+..... ....+.+||+.|+|||++.+ .|+.++||||+||++|+|++|..||.+.+..++..+|
T Consensus 143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i 222 (288)
T d1uu3a_ 143 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 222 (288)
T ss_dssp TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH
Confidence 7789999999999876432 22345789999999999974 5899999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCccCC
Q 021227 162 LEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHE------VLCHPWIVDD 210 (315)
Q Consensus 162 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~------~l~h~~~~~~ 210 (315)
.++.+.++. .+|+++++||.+||++||.+|||++| +++||||+.-
T Consensus 223 ~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 223 IKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HTTCCCCCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HcCCCCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 988776653 68999999999999999999999998 4789999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=385.46 Aligned_cols=216 Identities=43% Similarity=0.798 Sum_probs=184.8
Q ss_pred CCCCCCcceEEEEEEe----CCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 4 LSEHQHVVRIHDTYED----KSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
+.+|||||+++++|++ +.++|+|||||+||+|.+++.++ .+++|.+++.++.||+.||+|||++||+||||||+
T Consensus 61 ~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~ 140 (335)
T d2ozaa1 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 140 (335)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred hcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence 4589999999999986 46799999999999999999775 36999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIG 156 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 156 (315)
|||+...+..+.+||+|||+++............||+.|+|||++.+ .|+.++||||+||++|+|+||++||.+.+..+
T Consensus 141 NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp GEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred ccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence 99987656678999999999988777666677889999999999875 59999999999999999999999998766444
Q ss_pred HH----HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 021227 157 IF----RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLD 219 (315)
Q Consensus 157 ~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~ 219 (315)
.. ..+..+...++...+..+|+++++||.+||++||++|||+.|+++||||......+..+..
T Consensus 221 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~ 287 (335)
T d2ozaa1 221 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 287 (335)
T ss_dssp -------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCEES
T ss_pred HHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCCcC
Confidence 33 3344455556655566799999999999999999999999999999999876655554433
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=374.61 Aligned_cols=199 Identities=33% Similarity=0.588 Sum_probs=183.4
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+ +|||||+++++|++++.+|+|||||+||+|.+++.+.+.++|..++.++.||+.||+|||++||+||||||+|||
T Consensus 61 ~l-~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL-- 137 (337)
T d1o6la_ 61 NT-RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM-- 137 (337)
T ss_dssp SC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE--
T ss_pred hC-CCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeE--
Confidence 44 899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCC-CCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKP-DEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
++.++.+||+|||+|+.... .....+.+||+.|+|||++. +.|+.++||||+||++|+|++|++||.+.+..++.+.
T Consensus 138 -l~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~ 216 (337)
T d1o6la_ 138 -LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216 (337)
T ss_dssp -ECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -ecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH
Confidence 56788999999999987643 34456688999999999986 5599999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
+..+.+.++ +.+|+++++||.+||++||.+|++ ++|+++||||..
T Consensus 217 i~~~~~~~p----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 217 ILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhcCCCCCC----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 999877665 368999999999999999999994 999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=373.47 Aligned_cols=201 Identities=27% Similarity=0.487 Sum_probs=177.0
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+|||||++++++.+++.+|+|||||+||+|.+++.+ .+++++..++.++.||+.||.|||++||+||||||+||| +
T Consensus 67 ~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIl---l 143 (288)
T d2jfla1 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL---F 143 (288)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---E
T ss_pred CCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhhee---E
Confidence 899999999999999999999999999999998765 467999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh------hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR------KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+.++.+||+|||+|...... ....+..||+.|+|||++. ..|+.++||||+||++|+|+||.+||.+.+..+.
T Consensus 144 ~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~ 223 (288)
T d2jfla1 144 TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 223 (288)
T ss_dssp CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH
Confidence 66789999999998765332 2234578999999999983 3478999999999999999999999999988888
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+..+..+..... ...+.+|+++++||.+||++||.+|||++|+++||||+..
T Consensus 224 ~~~i~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 224 LLKIAKSEPPTL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHcCCCCCC-CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 888887754322 2235789999999999999999999999999999999743
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-53 Score=369.77 Aligned_cols=200 Identities=27% Similarity=0.441 Sum_probs=178.7
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.| +|||||++++++.+++.+|+|||||.||+|..++..++++++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 70 ~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl 148 (309)
T d1u5ra_ 70 QKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 148 (309)
T ss_dssp TTC-CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred HHC-CCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE
Confidence 455 8999999999999999999999999999998888888899999999999999999999999999999999999994
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
+.++.+||+|||++...... ....||+.|+|||++. +.|+.++||||+||++|+|++|..||.+.+..+.
T Consensus 149 ---~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~ 222 (309)
T d1u5ra_ 149 ---SEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (309)
T ss_dssp ---ETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ---CCCCCEEEeecccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 56789999999999865432 4568999999999984 3489999999999999999999999999998888
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
+..+..+...... ...+|+++++||.+||+.||.+|||++|+|+||||...
T Consensus 223 ~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 223 LYHIAQNESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHSCCCCCS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHhCCCCCCC--CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 8888776543322 24689999999999999999999999999999999754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=376.67 Aligned_cols=205 Identities=30% Similarity=0.618 Sum_probs=189.0
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG-NYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
.+|||||+++++|++++++|+|||||+||+|.+++.+.+ ++++.+++.++.||+.||+|||++||+||||||+|||+..
T Consensus 58 l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~ 137 (321)
T d1tkia_ 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC
Confidence 389999999999999999999999999999999997665 7999999999999999999999999999999999999742
Q ss_pred CCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+....+||+|||++.............||+.|+|||.+. ..++.++||||+||++|+|++|..||.+.+..+.+..|.
T Consensus 138 -~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~ 216 (321)
T d1tkia_ 138 -RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp -SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 345689999999998877666666788999999999986 458999999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
++...++...++.+|+++++||.+||++||.+|||++|+++||||+..
T Consensus 217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 998888877778899999999999999999999999999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=361.92 Aligned_cols=200 Identities=34% Similarity=0.593 Sum_probs=165.3
Q ss_pred CCCCCCCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----C
Q 021227 1 MHHLSEHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVK----KGNYSEREAAKLMKTIVGVVECCHSLG-----V 69 (315)
Q Consensus 1 l~~l~~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i 69 (315)
|+++ +|||||++++++.+ ++.+|+|||||+||+|.+++.+ .+.+++..++.++.|++.||+|||++| |
T Consensus 57 l~~l-~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~I 135 (269)
T d2java1 57 LREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 135 (269)
T ss_dssp TTSC-CCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----
T ss_pred HHHC-CCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCE
Confidence 3455 89999999999965 5678999999999999998864 467999999999999999999999976 9
Q ss_pred ccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCC
Q 021227 70 FHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 70 vH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 147 (315)
+||||||+||| ++.++.+||+|||+++...... ...+..||+.|+|||++.+ .|+.++||||+||++|+|+||+.
T Consensus 136 iHrDiKp~NIl---l~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~ 212 (269)
T d2java1 136 LHRDLKPANVF---LDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212 (269)
T ss_dssp ----CCGGGEE---ECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EeCcCchhhcC---cCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCC
Confidence 99999999999 5667899999999998765433 3456789999999999964 59999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 148 PFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
||.+.+..++...+..+..... ...+|+++++||.+||+.||.+|||++|+++|||+
T Consensus 213 Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 213 PFTAFSQKELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCCCSSHHHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999988765432 24689999999999999999999999999999995
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-52 Score=365.83 Aligned_cols=197 Identities=31% Similarity=0.640 Sum_probs=181.6
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+|||||++++++++++.+|+|||||.||+|..++.....+++..++.++.||+.||+|||++||+||||||+||| +
T Consensus 61 l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIL---l 137 (316)
T d1fota_ 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL---L 137 (316)
T ss_dssp CCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE---E
T ss_pred ccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchhee---E
Confidence 3899999999999999999999999999999999999999999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQILE 163 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 163 (315)
+.++.+||+|||+|+..... ..+.+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+..+....+..
T Consensus 138 ~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 215 (316)
T d1fota_ 138 DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215 (316)
T ss_dssp CTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred cCCCCEEEecCccceEeccc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 67889999999999876543 346789999999999975 499999999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 021227 164 GKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVDD 210 (315)
Q Consensus 164 ~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~~ 210 (315)
+...++ +.+|++++++|.+||++||.+|+ |++++++||||+..
T Consensus 216 ~~~~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 216 AELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CCCCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CCCCCC----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 876654 36899999999999999999996 99999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=370.40 Aligned_cols=202 Identities=25% Similarity=0.396 Sum_probs=167.6
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~nil 80 (315)
+.+ +|||||+++++|++++++|+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||
T Consensus 59 ~~l-~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NIL 137 (322)
T d1s9ja_ 59 HEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 137 (322)
T ss_dssp GGC-CCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEE
T ss_pred HhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHee
Confidence 445 8999999999999999999999999999999999988999999999999999999999997 59999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIF- 158 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~- 158 (315)
++.++.+||+|||+|...... ...+.+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+.....
T Consensus 138 ---l~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~ 213 (322)
T d1s9ja_ 138 ---VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213 (322)
T ss_dssp ---ECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred ---ECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 567789999999999865432 2346789999999999974 5999999999999999999999999875432210
Q ss_pred -----------------------------------------HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 021227 159 -----------------------------------------RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT 197 (315)
Q Consensus 159 -----------------------------------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s 197 (315)
..+.... ++......+|+++++||.+||+.||.+|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~t 291 (322)
T d1s9ja_ 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291 (322)
T ss_dssp HC------------------------------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcC
Confidence 0111110 011111246899999999999999999999
Q ss_pred HHHHhcCCCccCC
Q 021227 198 AHEVLCHPWIVDD 210 (315)
Q Consensus 198 ~~~~l~h~~~~~~ 210 (315)
++|+|+||||+..
T Consensus 292 a~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 292 LKQLMVHAFIKRS 304 (322)
T ss_dssp HHHHHTSHHHHHH
T ss_pred HHHHhhCHhhCcC
Confidence 9999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=362.50 Aligned_cols=198 Identities=30% Similarity=0.503 Sum_probs=181.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+|||||++++++++++.+|+|||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+||| .
T Consensus 60 ~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL---~ 136 (320)
T d1xjda_ 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---L 136 (320)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE---E
T ss_pred CCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCccccee---e
Confidence 5899999999999999999999999999999999999899999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||+++..... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..++...+.
T Consensus 137 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 216 (320)
T d1xjda_ 137 DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 216 (320)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 67889999999999866433 33445789999999999974 59999999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCccC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAH-EVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~-~~l~h~~~~~ 209 (315)
.+.+.++ +.+|+++++||.+||++||.+|||+. ++++||||+.
T Consensus 217 ~~~~~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 217 MDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HCCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cCCCCCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 8876554 36899999999999999999999995 8999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-52 Score=366.09 Aligned_cols=199 Identities=33% Similarity=0.633 Sum_probs=182.3
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+.+ +|||||++++++.+...+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||
T Consensus 96 ~~l-~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NIL- 173 (350)
T d1rdqe_ 96 QAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL- 173 (350)
T ss_dssp TTC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE-
T ss_pred HHc-CCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcc-
Confidence 445 899999999999999999999999999999999998899999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQ 160 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 160 (315)
++.++.+||+|||+|+..... ..+..||+.|||||++.+ .++.++||||+||++|+|+||..||.+.+....+..
T Consensus 174 --l~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~ 249 (350)
T d1rdqe_ 174 --IDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249 (350)
T ss_dssp --ECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred --cCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH
Confidence 566789999999999876543 346789999999999875 489999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVDD 210 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~~ 210 (315)
|..+...++ ..+|+++.+||++||++||.+|+ |++++++||||+..
T Consensus 250 i~~~~~~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 250 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HhcCCCCCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 998876654 36899999999999999999995 99999999999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.2e-52 Score=369.12 Aligned_cols=200 Identities=28% Similarity=0.438 Sum_probs=172.7
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.+|||||+++++|++++.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||| +
T Consensus 64 ~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NIL---l 140 (364)
T d1omwa3 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL---L 140 (364)
T ss_dssp SCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE---E
T ss_pred CCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeE---E
Confidence 3899999999999999999999999999999999999899999999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-h-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-K-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
+.++.+||+|||+|+...... .....||+.|+|||++. + .|+.++||||+||++|+|+||+.||.+.+...... +.
T Consensus 141 ~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~ 218 (364)
T d1omwa3 141 DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-ID 218 (364)
T ss_dssp CSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HH
T ss_pred cCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HH
Confidence 678899999999998765443 34578999999999985 3 48999999999999999999999998754322222 12
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLT-----AHEVLCHPWIVD 209 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s-----~~~~l~h~~~~~ 209 (315)
......+...+..+|+++++||.+||++||.+||| ++|+++||||+.
T Consensus 219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 22222233334579999999999999999999999 799999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=360.36 Aligned_cols=203 Identities=27% Similarity=0.416 Sum_probs=175.7
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
+|||||++++++.+++++|+|||||.|+++..+....+.+++..++.+++||+.||+|||++||+||||||+||| .+
T Consensus 58 ~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIl---i~ 134 (299)
T d1ua2a_ 58 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL---LD 134 (299)
T ss_dssp CCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE---EC
T ss_pred CCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEE---ec
Confidence 899999999999999999999999999888776666778999999999999999999999999999999999999 56
Q ss_pred CCCCEEEeeccCcccCCCC-CcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
.++.+||+|||+++..... ....+.+||+.|+|||++. ..|+.++||||+||++|+|+||.+||.+.+..+++..|.
T Consensus 135 ~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~ 214 (299)
T d1ua2a_ 135 ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214 (299)
T ss_dssp TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH
Confidence 7899999999999776443 3344578999999999985 348999999999999999999999999999988888876
Q ss_pred hCCCCCCCCC------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 163 EGKIDFESEP------------------------WPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 163 ~~~~~~~~~~------------------------~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
+....+.... ++.+|+++++||.+||+.||++|||++|+|+||||++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 215 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 5221111110 235789999999999999999999999999999998654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=343.02 Aligned_cols=192 Identities=34% Similarity=0.586 Sum_probs=167.6
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCC-CchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEG-GELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~g-g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
.|||||+++++|++++.+|+||||+.| +++.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||+.
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~-- 144 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID-- 144 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--
T ss_pred CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--
Confidence 599999999999999999999999986 57888888888999999999999999999999999999999999999963
Q ss_pred CCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-c-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-H-YGPEADVWSAGVILYILLSGVPPFWAETEIGIFRQIL 162 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 162 (315)
.+.+.+||+|||++...... ...+..||+.|+|||++.+ . ++.++||||+||++|+|++|..||.+. ..+.
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~ 217 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEII 217 (273)
T ss_dssp TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHH
T ss_pred cCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHh
Confidence 34578999999999765433 3456789999999999864 3 467899999999999999999999763 2355
Q ss_pred hCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 163 EGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 163 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
.+...++ +.+|+++++||.+||++||++|||++|+++||||++.
T Consensus 218 ~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 218 RGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred hcccCCC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 5555444 3689999999999999999999999999999999754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=342.69 Aligned_cols=202 Identities=30% Similarity=0.432 Sum_probs=172.4
Q ss_pred CCCCcceEEEEEEe-----CCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYED-----KSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+|||||+++++|.. +..+|++||||.||.+...... ...+++..++.++.|++.||+|||++||+||||||+||
T Consensus 68 ~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NI 147 (305)
T d1blxa_ 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 147 (305)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEE
Confidence 79999999999853 3578999999998877544433 36799999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
| .+..+.+||+|||++.............||+.|+|||++. ..|+.++||||+||++|+|++|++||.+.+..+.+
T Consensus 148 L---i~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 224 (305)
T d1blxa_ 148 L---VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224 (305)
T ss_dssp E---ECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred E---EcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9 5678899999999998776666667788999999999986 55999999999999999999999999999988888
Q ss_pred HHHHhCCCCC-----------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 159 RQILEGKIDF-----------------------ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 159 ~~i~~~~~~~-----------------------~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
..+....... ....+..+|+++++||.+||++||++|||++|+|+||||++-
T Consensus 225 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 7775421110 011234578999999999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=341.70 Aligned_cols=206 Identities=25% Similarity=0.432 Sum_probs=170.9
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+++ +|||||++++++++++++|+|||||.|+.+...... .+.+++..++.++.|++.||+|||++|||||||||+|||
T Consensus 56 ~~l-~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl 134 (298)
T d1gz8a_ 56 KEL-NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 134 (298)
T ss_dssp TTC-CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhC-CCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchhee
Confidence 455 899999999999999999999999976544333222 467999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCC-CcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPD-EVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
.+.++.+||+|||+|+..... .......||+.|+|||++.. .++.++||||+||++|+|++|+.||.+.+..+.
T Consensus 135 ---~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~ 211 (298)
T d1gz8a_ 135 ---INTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211 (298)
T ss_dssp ---ECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ---ecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH
Confidence 567789999999999766433 34455789999999998753 368999999999999999999999999988877
Q ss_pred HHHHHhCCCCCCCC-------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 021227 158 FRQILEGKIDFESE-------------------------PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDK 211 (315)
Q Consensus 158 ~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~ 211 (315)
+..+......+... ..+.+|+++++||++||++||.+|||++|+|+||||++..
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 77665421111111 0235789999999999999999999999999999998643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=351.92 Aligned_cols=197 Identities=20% Similarity=0.307 Sum_probs=168.8
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-----------------------CCCCHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-----------------------GNYSEREAAKLMKTIVG 59 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----------------------~~~~~~~~~~~~~qi~~ 59 (315)
++.+|||||++++++.+.+.+|+|||||+||+|.+++.++ +.+++..+..++.|++.
T Consensus 96 ~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 175 (325)
T d1rjba_ 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 175 (325)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred HhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHH
Confidence 3458999999999999999999999999999999999654 24899999999999999
Q ss_pred HHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHH
Q 021227 60 VVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSA 135 (315)
Q Consensus 60 ~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Diwsl 135 (315)
||+|||++||+||||||+||+ .+.++.+||+|||+|+....... ..+..||+.|||||++. +.++.++||||+
T Consensus 176 gl~yLH~~~IiHRDlKp~Nil---l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~ 252 (325)
T d1rjba_ 176 GMEFLEFKSCVHRDLAARNVL---VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252 (325)
T ss_dssp HHHHHHHTTEEETTCSGGGEE---EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHhCCeeeccCchhccc---cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccch
Confidence 999999999999999999999 56778999999999976544332 23466899999999986 569999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 136 GVILYILLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 136 G~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
||++|||+| |.+||.+.+..+.+..+......++. ...+|+++++||.+||+.||++|||++|+++|
T Consensus 253 Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999997 89999987665666666655544433 24689999999999999999999999999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=339.35 Aligned_cols=193 Identities=22% Similarity=0.293 Sum_probs=167.0
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+++ +|||||+++++++++ .+|+|||||+||+|.+++.+..++++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 63 ~~l-~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill 140 (277)
T d1xbba_ 63 QQL-DNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 140 (277)
T ss_dssp HTC-CCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred HhC-CCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc
Confidence 345 899999999999755 578999999999999999998999999999999999999999999999999999999994
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEI 155 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 155 (315)
+.++.+||+|||+++....... .....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..
T Consensus 141 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 141 ---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217 (277)
T ss_dssp ---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ---cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence 5678999999999987644322 22356899999999986 558999999999999999998 89999999988
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
++...+.++.... ....+|++++++|.+||+.||.+|||+++++
T Consensus 218 ~~~~~i~~~~~~~---~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 218 EVTAMLEKGERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVE 261 (277)
T ss_dssp HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHHcCCCCC---CCcccCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 8888887764322 2246899999999999999999999999984
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=337.88 Aligned_cols=198 Identities=24% Similarity=0.416 Sum_probs=161.5
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+++ +|||||+++++.. ++.+++|||||+||+|.+++... +++++..+..++.||+.||+|||++|||||||||+|||
T Consensus 59 ~~l-~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiL 136 (276)
T d1uwha_ 59 RKT-RHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIF 136 (276)
T ss_dssp TTC-CCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhC-CCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEE
Confidence 455 8999999999865 45689999999999999999764 57999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCC---CcccccccCccccchhhhh----hcCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPD---EVFSDVVGSPYYVAPEVLR----KHYGPEADVWSAGVILYILLSGVPPFWAET 153 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 153 (315)
++.++.+||+|||+|+..... ....+..||+.|||||++. +.|+.++||||+||++|||+||+.||.+.+
T Consensus 137 ---l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 137 ---LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp ---EETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ---EcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 566889999999999766432 2334567999999999985 237899999999999999999999998866
Q ss_pred HHH-HHHHHHhCCCCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 154 EIG-IFRQILEGKIDFE-SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 154 ~~~-~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
... ....+..+...+. ......+|++++++|.+||+.||++|||++|++++
T Consensus 214 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 214 NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 544 4444444433322 22345789999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-48 Score=338.63 Aligned_cols=195 Identities=22% Similarity=0.400 Sum_probs=161.5
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+++ +|||||++++++.+++.+|+|||||+||+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||
T Consensus 82 ~~l-~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 82 GQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL 160 (299)
T ss_dssp TTC-CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhC-CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEE
Confidence 455 8999999999999999999999999999999988764 57999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcc------cccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVF------SDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAE 152 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 152 (315)
++.++.+||+|||+++........ ....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.
T Consensus 161 ---l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 161 ---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp ---ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ---ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 567889999999999876543221 1245789999999986 569999999999999999998 89999999
Q ss_pred CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+..++...+..+.... ....+|+++++++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 238 TNQDVINAIEQDYRLP---PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp CHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9998888887764322 22468999999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-48 Score=336.88 Aligned_cols=204 Identities=27% Similarity=0.461 Sum_probs=170.7
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+++ +|||||++++++.+++..|+++||+.|+.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 55 ~~l-~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIl- 132 (286)
T d1ob3a_ 55 KEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL- 132 (286)
T ss_dssp GGC-CCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE-
T ss_pred HhC-CCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceee-
Confidence 455 899999999999999999999999998877777766788999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
++.++.+|++|||.+....... ......|++.|+|||.+.+ .++.++||||+||++|+|++|+.||.+.+..+..
T Consensus 133 --l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~ 210 (286)
T d1ob3a_ 133 --INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210 (286)
T ss_dssp --ECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred --EcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH
Confidence 5678899999999997764432 2345678999999999853 4799999999999999999999999999888877
Q ss_pred HHHHhCCCCCC-------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 159 RQILEGKIDFE-------------------------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 159 ~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.++......+. ....+.+|+++++||++||++||++|||++|+|+||||++
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 77654211111 0112457899999999999999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.8e-49 Score=336.41 Aligned_cols=199 Identities=28% Similarity=0.452 Sum_probs=167.4
Q ss_pred CCCCCcceEEEEEEeCC----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 5 SEHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+|||||++++++.+.. .+|+|||||+||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+||+
T Consensus 64 ~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIl 143 (277)
T d1o6ya_ 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 143 (277)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccc
Confidence 48999999999998654 48999999999999999988899999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCC----CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPD----EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
++.++.++++|||.+...... ....+.+||+.|+|||++.+ .+++++||||+||++|+|+||.+||.+.+..
T Consensus 144 ---l~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 220 (277)
T d1o6ya_ 144 ---ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 220 (277)
T ss_dssp ---EETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ---cCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH
Confidence 556789999999988654332 23345689999999999875 4899999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHhcCCCc
Q 021227 156 GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-TAHEVLCHPWI 207 (315)
Q Consensus 156 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-s~~~~l~h~~~ 207 (315)
+....+......++...++.+|++++++|.+||++||.+|| |++++ .|+|.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 221 SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence 88888888777766666778999999999999999999999 55554 45554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=330.70 Aligned_cols=193 Identities=22% Similarity=0.387 Sum_probs=160.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+|||||++++++.+++.+++|||||++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||| +
T Consensus 58 ~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nil---l 134 (263)
T d1sm2a_ 58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL---V 134 (263)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEE---E
T ss_pred CCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhhee---e
Confidence 8999999999999999999999999999999988655 56899999999999999999999999999999999999 5
Q ss_pred CCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFRQ 160 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 160 (315)
+.++.+||+|||+++....... .....||+.|+|||++. +.++.++||||+||++|||+| |.+||...+..++...
T Consensus 135 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~ 214 (263)
T d1sm2a_ 135 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214 (263)
T ss_dssp CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH
T ss_pred cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 6788999999999987654332 23467899999999987 459999999999999999999 6788888888888888
Q ss_pred HHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 161 ILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 161 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
+..+.....+ ..+|+++.+++.+||+.||++|||++|+++|
T Consensus 215 i~~~~~~~~p---~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 215 ISTGFRLYKP---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCc---cccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 8876443322 4679999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=335.66 Aligned_cols=195 Identities=24% Similarity=0.303 Sum_probs=168.2
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+|||||+++++++++ .+|+|||||+||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 67 ~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill--- 142 (285)
T d1u59a_ 67 DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL--- 142 (285)
T ss_dssp CCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---
T ss_pred CCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---
Confidence 899999999998765 578999999999999987654 679999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
+.++.+||+|||+++....... .....||+.|+|||++. +.++.++||||+||++|||+| |..||.+.+..++.
T Consensus 143 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~ 222 (285)
T d1u59a_ 143 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222 (285)
T ss_dssp EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH
T ss_pred ccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 5678999999999987654332 22356899999999986 569999999999999999998 99999998888888
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCCCc
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEV---LCHPWI 207 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~---l~h~~~ 207 (315)
..+.++.... ..+.+|+++.++|.+||+.||++|||+.++ |+|+|+
T Consensus 223 ~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 223 AFIEQGKRME---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCC---CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 8888765322 224789999999999999999999999888 456665
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=341.05 Aligned_cols=203 Identities=27% Similarity=0.402 Sum_probs=168.5
Q ss_pred CCCCcceEEEEEEe------CCeEEEEEeccCCCchhHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 021227 6 EHQHVVRIHDTYED------KSCVHIVMELCEGGELFDR---IVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKP 76 (315)
Q Consensus 6 ~Hpniv~~~~~~~~------~~~~~lv~E~~~gg~L~~~---l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp 76 (315)
+|||||+++++|.. ..++|+|||||++|.+... ......+++..++.++.||+.||+|||++||+||||||
T Consensus 71 ~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp 150 (350)
T d1q5ka_ 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKP 150 (350)
T ss_dssp CCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG
T ss_pred CCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCc
Confidence 89999999999953 3468999999987643332 23456799999999999999999999999999999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
+|||+. .+...+||+|||++..........+..||+.|+|||.+. ..++.++||||+||++|+|++|.+||.+.+.
T Consensus 151 ~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 151 QNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp GGEEEC--TTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred ceEEEe--cCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 999962 234589999999998877776677789999999999875 3589999999999999999999999999888
Q ss_pred HHHHHHHHhC-----------------CCCCC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 021227 155 IGIFRQILEG-----------------KIDFE--------SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVD 209 (315)
Q Consensus 155 ~~~~~~i~~~-----------------~~~~~--------~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~ 209 (315)
.+.+..+.+. ...++ ....+.+|+++.+||.+||++||++|||+.|+|+||||++
T Consensus 229 ~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 7777666431 00111 1123457999999999999999999999999999999976
Q ss_pred C
Q 021227 210 D 210 (315)
Q Consensus 210 ~ 210 (315)
.
T Consensus 309 ~ 309 (350)
T d1q5ka_ 309 L 309 (350)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=323.84 Aligned_cols=195 Identities=23% Similarity=0.374 Sum_probs=171.7
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK-KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
++ +|||||++++++.+++.+++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 55 ~l-~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nil- 132 (258)
T d1k2pa_ 55 NL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL- 132 (258)
T ss_dssp TC-CCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEE-
T ss_pred hc-CCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEE-
Confidence 44 899999999999999999999999999999988654 467999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGI 157 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 157 (315)
++.++.+||+|||+++....... .....||+.|+|||++. +.++.++||||+||++|||+| |+.||.+.+..++
T Consensus 133 --l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~ 210 (258)
T d1k2pa_ 133 --VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210 (258)
T ss_dssp --ECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred --EcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH
Confidence 56788999999999976654332 23466899999999987 559999999999999999998 8999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
...+.++..... ...+|+++++||.+||+.||++|||++++++|
T Consensus 211 ~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 211 AEHIAQGLRLYR---PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCC---cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 988887643322 24688999999999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-47 Score=330.51 Aligned_cols=192 Identities=22% Similarity=0.299 Sum_probs=163.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeecc
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLS 83 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~ 83 (315)
+|||||++++++.+++.+|+|||||++|+|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 71 ~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NIL--- 147 (287)
T d1opja_ 71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL--- 147 (287)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE---
T ss_pred CCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEE---
Confidence 8999999999999999999999999999999998764 57899999999999999999999999999999999999
Q ss_pred CCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHH
Q 021227 84 VDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPP-FWAETEIGIFR 159 (315)
Q Consensus 84 ~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~ 159 (315)
++.++.+||+|||+++....... .....||+.|+|||++. +.|+.++||||+||++|+|++|..| |.+.+.....+
T Consensus 148 l~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~ 227 (287)
T d1opja_ 148 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227 (287)
T ss_dssp ECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred ECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH
Confidence 56678999999999987654332 23345889999999986 5699999999999999999996555 55566666666
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.+..+. . .+....+|+++++||.+||+.||++|||++|+++
T Consensus 228 ~i~~~~-~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 228 LLEKDY-R--MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHTTC-C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCC-C--CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 555542 2 2233578999999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=330.65 Aligned_cols=199 Identities=23% Similarity=0.332 Sum_probs=169.2
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
++ +|||||++++++.+ +.+|+|||||++|+|.+++... .++++..+..++.||+.||+|||++||+||||||+|||
T Consensus 64 ~l-~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIl 141 (272)
T d1qpca_ 64 QL-QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (272)
T ss_dssp HC-CCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred hC-CCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhee
Confidence 34 89999999998765 5678999999999999877543 36999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 156 (315)
++.++.+||+|||+|+....... .....||+.|+|||++. +.++.++||||+||++|||+| |.+||...+..+
T Consensus 142 ---l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~ 218 (272)
T d1qpca_ 142 ---VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (272)
T ss_dssp ---ECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred ---eecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH
Confidence 56789999999999987754432 23467899999999987 569999999999999999999 566777788888
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCccC
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC--HPWIVD 209 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~--h~~~~~ 209 (315)
....+..+..... ...+|+++++|+.+||+.||++|||++++++ ++||..
T Consensus 219 ~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 219 VIQNLERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCC---cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 8888877643322 2468999999999999999999999999987 677753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=337.67 Aligned_cols=204 Identities=32% Similarity=0.557 Sum_probs=171.2
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
++.+||||+++++++++...+++||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 84 ~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nil-- 161 (322)
T d1vzoa_ 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL-- 161 (322)
T ss_dssp HHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE--
T ss_pred hccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCcccee--
Confidence 444569999999999999999999999999999999999899999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCC--CcccccccCccccchhhhhh---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPD--EVFSDVVGSPYYVAPEVLRK---HYGPEADVWSAGVILYILLSGVPPFWAETEIGI 157 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 157 (315)
++.++.+||+|||+++..... ....+..|++.|+|||.+.+ .++.++||||+||++|+|++|..||.+.+..+.
T Consensus 162 -l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~ 240 (322)
T d1vzoa_ 162 -LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240 (322)
T ss_dssp -ECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred -ecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 566789999999999765432 23345779999999999853 478899999999999999999999987654433
Q ss_pred HHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 021227 158 FRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRL-----TAHEVLCHPWIVD 209 (315)
Q Consensus 158 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~-----s~~~~l~h~~~~~ 209 (315)
...+..+.........+.+|+++++||.+||++||.+|| |++|+++||||+.
T Consensus 241 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 241 QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 333333222222223346899999999999999999999 5899999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=326.57 Aligned_cols=194 Identities=25% Similarity=0.376 Sum_probs=158.2
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+++ +|||||++++++. ++.+|+|||||++|+|.+++... +++++..+..++.||+.||.|||++||+||||||+||+
T Consensus 63 ~~l-~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIl 140 (273)
T d1mp8a_ 63 RQF-DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 140 (273)
T ss_dssp HTC-CCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhC-CCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhee
Confidence 345 8999999999996 46789999999999999887654 57999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCc--ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEV--FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 156 (315)
+ +.++.+||+|||+++....... .....||+.|+|||++. +.++.++||||+||++|||+| |.+||.+.+..+
T Consensus 141 l---~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~ 217 (273)
T d1mp8a_ 141 V---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217 (273)
T ss_dssp E---EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred e---cCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH
Confidence 4 5678899999999987643322 23456899999999986 569999999999999999997 899999999888
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+...+..+... +.++.+|+++++||.+||+.||.+|||++|+++
T Consensus 218 ~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~ 261 (273)
T d1mp8a_ 218 VIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261 (273)
T ss_dssp HHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 88888876532 234578999999999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=330.09 Aligned_cols=204 Identities=27% Similarity=0.461 Sum_probs=169.4
Q ss_pred CCCCCCCcceEEEEEEe--------CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccC
Q 021227 3 HLSEHQHVVRIHDTYED--------KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDL 74 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~di 74 (315)
.+ +||||+++++++.. ++++|+|||||.++.+.........+++..++.++.|++.||.|||++||+||||
T Consensus 65 ~l-~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDl 143 (318)
T d3blha1 65 LL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDM 143 (318)
T ss_dssp HC-CCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred Hh-cCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCc
Confidence 44 89999999999855 4578999999988777655555678999999999999999999999999999999
Q ss_pred CCCceeeccCCCCCCEEEeeccCcccCCCC-----CcccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCC
Q 021227 75 KPENFLFLSVDEDAALKATDFGLSVFYKPD-----EVFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVP 147 (315)
Q Consensus 75 kp~nil~~~~~~~~~ikl~Dfg~~~~~~~~-----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~ 147 (315)
||+||| ++.++.+||+|||++...... ....+.+||+.|+|||++. ..+++++||||+||++|+|++|+.
T Consensus 144 Kp~NIL---l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~ 220 (318)
T d3blha1 144 KAANVL---ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220 (318)
T ss_dssp CGGGEE---ECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred Cchhee---ecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCC
Confidence 999999 567889999999999765422 2233467999999999985 358999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCCCCCC----------------------------CCHHHHHHHHHhcccCCCCCCCHH
Q 021227 148 PFWAETEIGIFRQILEGKIDFESEPWPN----------------------------ISESAKDLIRKMLDQNPKRRLTAH 199 (315)
Q Consensus 148 pf~~~~~~~~~~~i~~~~~~~~~~~~~~----------------------------~s~~~~~li~~~l~~~p~~R~s~~ 199 (315)
||.+.+..+....+......++...+.. .++++++||.+||++||++|||++
T Consensus 221 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~ 300 (318)
T d3blha1 221 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300 (318)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 9999998888777766433333222211 377889999999999999999999
Q ss_pred HHhcCCCccCC
Q 021227 200 EVLCHPWIVDD 210 (315)
Q Consensus 200 ~~l~h~~~~~~ 210 (315)
|+|+||||+..
T Consensus 301 elL~Hpff~~~ 311 (318)
T d3blha1 301 DALNHDFFWSD 311 (318)
T ss_dssp HHHHSGGGSSS
T ss_pred HHHcChhhccC
Confidence 99999999854
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=327.77 Aligned_cols=197 Identities=23% Similarity=0.335 Sum_probs=170.4
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------------GNYSEREAAKLMKTIVGVVECCH 65 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH 65 (315)
.++.+|||||++++++.+++.+|+|||||+||+|.+++.+. ..+++..+..++.||+.||.|||
T Consensus 65 ~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH 144 (309)
T d1fvra_ 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144 (309)
T ss_dssp TTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh
Confidence 45668999999999999999999999999999999998643 56999999999999999999999
Q ss_pred HCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh
Q 021227 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS 144 (315)
Q Consensus 66 ~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 144 (315)
++||+||||||+||| .+.++.+||+|||+++............||+.|+|||.+. +.++.++|||||||++|+|++
T Consensus 145 ~~~iiHrDlkp~NIL---~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~ 221 (309)
T d1fvra_ 145 QKQFIHRDLAARNIL---VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221 (309)
T ss_dssp HTTEECSCCSGGGEE---ECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred cCCccccccccceEE---EcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHh
Confidence 999999999999999 5667899999999998665444444567899999999986 559999999999999999999
Q ss_pred C-CCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 145 G-VPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 145 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
| .+||.+.+..++...+.++.. .+.+..+|+++++||.+||+.||++|||++|++++
T Consensus 222 ~~~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 222 LGGTPYCGMTCAELYEKLPQGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TSCCTTTTCCHHHHHHHGGGTCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHhcCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6 568888999998888877532 22335789999999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.3e-47 Score=331.88 Aligned_cols=203 Identities=27% Similarity=0.491 Sum_probs=166.3
Q ss_pred CCCCCCCcceEEEEEEe--CCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 3 HLSEHQHVVRIHDTYED--KSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
.+.+||||++++++|+. ...+|+|||||.+|+|.... +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 85 ~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NIL 161 (328)
T d3bqca1 85 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161 (328)
T ss_dssp HHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceE
Confidence 45579999999999984 46799999999999997653 56999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAET-EIGI 157 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~ 157 (315)
+. .+++.+||+|||+|.............||+.|+|||.+.+ .++.++||||+||++|++++|..||.... ....
T Consensus 162 i~--~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~ 239 (328)
T d3bqca1 162 ID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239 (328)
T ss_dssp EE--TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred Ec--CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH
Confidence 63 3456799999999988777666677889999999999753 48999999999999999999999997643 3322
Q ss_pred HHHHHh-------------CCCC--------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 158 FRQILE-------------GKID--------------------FESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 158 ~~~i~~-------------~~~~--------------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
...+.. .... +....+..+|+++++||++||++||.+|||++|+|+|
T Consensus 240 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222211 0000 1111223478999999999999999999999999999
Q ss_pred CCccCC
Q 021227 205 PWIVDD 210 (315)
Q Consensus 205 ~~~~~~ 210 (315)
|||+.-
T Consensus 320 p~F~~v 325 (328)
T d3bqca1 320 PYFYTV 325 (328)
T ss_dssp GGGTTS
T ss_pred cccCCC
Confidence 999753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=320.76 Aligned_cols=200 Identities=23% Similarity=0.327 Sum_probs=164.9
Q ss_pred CCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeec
Q 021227 5 SEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVK--KGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFL 82 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~ 82 (315)
.+|||||++++++.+ +.+++|||||++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 69 l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIl-- 145 (285)
T d1fmka3 69 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL-- 145 (285)
T ss_dssp CCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE--
T ss_pred cccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEE--
Confidence 389999999999865 457899999999999888754 357999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeeccCcccCCCCC--cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 83 SVDEDAALKATDFGLSVFYKPDE--VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 83 ~~~~~~~ikl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
++.++.+||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++ |.+|+.+....+.+
T Consensus 146 -l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~ 224 (285)
T d1fmka3 146 -VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224 (285)
T ss_dssp -ECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred -ECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4567899999999998764333 223467899999999986 569999999999999999999 46666777888888
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCccCCC
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC--HPWIVDDK 211 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~--h~~~~~~~ 211 (315)
..+..+... +..+.+|+++++++.+||+.||++|||+++++. ++||....
T Consensus 225 ~~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 225 DQVERGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHhcCCC---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 888765422 233578999999999999999999999999988 88997654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-46 Score=318.94 Aligned_cols=195 Identities=22% Similarity=0.385 Sum_probs=161.0
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+++ +|||||++++++.+.+..++|||||.+|++.+.+... +.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 64 ~~l-~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NIL 142 (283)
T d1mqba_ 64 GQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 142 (283)
T ss_dssp HTC-CCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred Hhc-CCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEE
Confidence 345 8999999999999999999999999999999887655 67999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhC-CCCCCCCCH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSG-VPPFWAETE 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~ 154 (315)
++.++.+||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|||++| .+|+.+.+.
T Consensus 143 ---l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~ 219 (283)
T d1mqba_ 143 ---VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219 (283)
T ss_dssp ---ECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ---ECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH
Confidence 5678999999999998764332 122356899999999986 5699999999999999999985 566667778
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 155 IGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 155 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
.++...+..+.... ....+|+++++++.+||+.||++|||+.|+++
T Consensus 220 ~~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 220 HEVMKAINDGFRLP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHTTCCCC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCCCC---CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 88888877664322 22468999999999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=332.32 Aligned_cols=200 Identities=30% Similarity=0.491 Sum_probs=168.0
Q ss_pred CCCCCCCcceEEEEEEeCC------eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCC
Q 021227 3 HLSEHQHVVRIHDTYEDKS------CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKP 76 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~------~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp 76 (315)
++ +|||||+++++|...+ ++|+||||| |++|...+ +.+++++..++.++.||+.||+|||++||+||||||
T Consensus 73 ~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp 149 (346)
T d1cm8a_ 73 HM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP 149 (346)
T ss_dssp HC-CBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred hc-CCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCc
Confidence 44 8999999999998654 579999999 55666654 567899999999999999999999999999999999
Q ss_pred CceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 77 ENFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 77 ~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
+||| .+.++.+|++|||+++.... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.
T Consensus 150 ~NIL---~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 150 GNLA---VNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp GGEE---ECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred chhh---cccccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 9999 56789999999999987643 3356789999999999853 478999999999999999999999999887
Q ss_pred HHHHHHHHhCCCC-----------------------CC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 155 IGIFRQILEGKID-----------------------FE----SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 155 ~~~~~~i~~~~~~-----------------------~~----~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
...+..+...... .. ....+.+|+++++||.+||+.||.+|||++|+|+||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f 304 (346)
T d1cm8a_ 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304 (346)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 7766554432111 11 11234679999999999999999999999999999999
Q ss_pred cCC
Q 021227 208 VDD 210 (315)
Q Consensus 208 ~~~ 210 (315)
+..
T Consensus 305 ~~~ 307 (346)
T d1cm8a_ 305 ESL 307 (346)
T ss_dssp TTT
T ss_pred CcC
Confidence 864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=321.84 Aligned_cols=195 Identities=22% Similarity=0.355 Sum_probs=170.4
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------------GNYSEREAAKLMKTIVGVVECCHS 66 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~ 66 (315)
++.+|||||++++++.+++.+++|||||++|+|.+++... ..+++..+..++.||+.||+|||+
T Consensus 74 ~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~ 153 (299)
T d1fgka_ 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 153 (299)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh
Confidence 3458999999999999999999999999999999999654 348999999999999999999999
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHHH
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYIL 142 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 142 (315)
+|||||||||+||| .+.++.+||+|||+++...... ......||+.|+|||++. +.|+.++|||||||++|+|
T Consensus 154 ~~ivHrDiKp~NiL---l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~el 230 (299)
T d1fgka_ 154 KKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230 (299)
T ss_dssp TTCCCSCCSGGGEE---ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCEEeeeeccccee---ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHh
Confidence 99999999999999 5678899999999998664332 223467899999999986 5699999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 143 LS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 143 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
++ |.+||.+.+..++...+..+... + ....+|+++++||.+||+.||.+|||+.|+++
T Consensus 231 l~~g~~p~~~~~~~~~~~~i~~~~~~-~--~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 231 FTLGGSPYPGVPVEELFKLLKEGHRM-D--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCC-C--CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHcCCCC-C--CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 98 79999999998888887765322 2 23468999999999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=325.33 Aligned_cols=196 Identities=23% Similarity=0.318 Sum_probs=156.2
Q ss_pred CCCCCCCcceEEEEEEe-CCeEEEEEeccCCCchhHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 021227 3 HLSEHQHVVRIHDTYED-KSCVHIVMELCEGGELFDRIVKK----------------GNYSEREAAKLMKTIVGVVECCH 65 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH 65 (315)
++.+|||||.+++++.+ +..+++|||||+||+|.+++... ..+++..+..++.||+.||+|||
T Consensus 72 ~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH 151 (299)
T d1ywna1 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 151 (299)
T ss_dssp HHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH
T ss_pred hhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH
Confidence 34689999999999865 45789999999999999998653 24899999999999999999999
Q ss_pred HCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhh-hcCCCchhHHHHHHHHHH
Q 021227 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYI 141 (315)
Q Consensus 66 ~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ 141 (315)
++||+||||||+||| ++.++.+||+|||+|+...... ......||+.|+|||++. +.++.++||||+||++|+
T Consensus 152 ~~~ivHrDlKp~NIL---l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~e 228 (299)
T d1ywna1 152 SRKCIHRDLAARNIL---LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 228 (299)
T ss_dssp HTTCCCSCCCGGGEE---ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCCCcCCcCCcccee---ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHH
Confidence 999999999999999 5667899999999997654332 233467999999999986 459999999999999999
Q ss_pred HHhC-CCCCCCCCHH-HHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 142 LLSG-VPPFWAETEI-GIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 142 ll~g-~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
|+|| .+||.+.+.. .....+..+. .++ ....+|+++++++.+||+.||++|||++|+++|
T Consensus 229 llt~~~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 229 IFSLGASPYPGVKIDEEFCRRLKEGT-RMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHTTSCCSSTTCCCSHHHHHHHHHTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCC-CCC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9986 5678776543 3444444443 222 224689999999999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=317.65 Aligned_cols=205 Identities=27% Similarity=0.467 Sum_probs=172.2
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
+++ +|||||++++++.+...+++|+|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 56 ~~l-~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIl- 133 (292)
T d1unla_ 56 KEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL- 133 (292)
T ss_dssp TTC-CCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE-
T ss_pred Hhc-CcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccc-
Confidence 455 899999999999999999999999999999988888889999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC-cccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHH
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE-VFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPF-WAETEIGI 157 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~ 157 (315)
.+..+.+||+|||.+....... ......+++.|+|||++.+ .++.++||||+||++|+|++|..|| .+.+..+.
T Consensus 134 --i~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~ 211 (292)
T d1unla_ 134 --INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp --ECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred --cccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH
Confidence 4567899999999998765433 3344567889999998863 3789999999999999999999885 55666666
Q ss_pred HHHHHhCCCCC-------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 021227 158 FRQILEGKIDF-------------------------ESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 158 ~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~ 210 (315)
...+....... .....+.+|+++++||++||++||.+|||++|+|+||||++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred HHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 66654311111 111224578999999999999999999999999999999753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=318.22 Aligned_cols=191 Identities=20% Similarity=0.324 Sum_probs=164.5
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+|||||++++++.++ .+++|||||++|++.+++... +++++..+..++.|++.||.|||++||+||||||+||++
T Consensus 69 ~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll--- 144 (273)
T d1u46a_ 69 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL--- 144 (273)
T ss_dssp CCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---
T ss_pred CCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---
Confidence 899999999999764 678999999999999877654 679999999999999999999999999999999999995
Q ss_pred CCCCCEEEeeccCcccCCCCCc----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIF 158 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 158 (315)
+.++.+||+|||+++....... .....|++.|+|||++. +.++.++|||||||++|||+| |..||.+.+..+..
T Consensus 145 ~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~ 224 (273)
T d1u46a_ 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224 (273)
T ss_dssp EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred ccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH
Confidence 4567899999999987644322 22345788999999987 458999999999999999998 89999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 159 RQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 159 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
..+.+....++. .+.+|++++++|.+||+.||++|||+.+++
T Consensus 225 ~~i~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 225 HKIDKEGERLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp HHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHhCCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 998877654433 357899999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=327.69 Aligned_cols=202 Identities=30% Similarity=0.517 Sum_probs=165.1
Q ss_pred CCCCcceEEEEEEeCC-----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCcee
Q 021227 6 EHQHVVRIHDTYEDKS-----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFL 80 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil 80 (315)
+||||+++++++..+. .+|++ +|+.||+|.+++.. +++++..++.++.|++.||+|||++||+||||||+|||
T Consensus 64 ~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NIL 141 (345)
T d1pmea_ 64 RHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 141 (345)
T ss_dssp CCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEE
Confidence 8999999999997653 35555 55668999999855 57999999999999999999999999999999999999
Q ss_pred eccCCCCCCEEEeeccCcccCCCCC----cccccccCccccchhhhh--hcCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 021227 81 FLSVDEDAALKATDFGLSVFYKPDE----VFSDVVGSPYYVAPEVLR--KHYGPEADVWSAGVILYILLSGVPPFWAETE 154 (315)
Q Consensus 81 ~~~~~~~~~ikl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 154 (315)
++.++.+||+|||++....... .....+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.
T Consensus 142 ---l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 142 ---LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp ---ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---ECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 5677899999999997654322 234567999999999985 3478999999999999999999999998887
Q ss_pred HHHHHHHHhCCCC--------------------C---CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 021227 155 IGIFRQILEGKID--------------------F---ES----EPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWI 207 (315)
Q Consensus 155 ~~~~~~i~~~~~~--------------------~---~~----~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~ 207 (315)
.+........... . .. ..++.+|+++++||.+||++||.+|||++|+|+||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~ 298 (345)
T d1pmea_ 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298 (345)
T ss_dssp HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 6655544321100 0 00 1135688999999999999999999999999999999
Q ss_pred cCCCC
Q 021227 208 VDDKV 212 (315)
Q Consensus 208 ~~~~~ 212 (315)
+....
T Consensus 299 ~~~~~ 303 (345)
T d1pmea_ 299 EQYYD 303 (345)
T ss_dssp TTTCC
T ss_pred ccCCC
Confidence 86544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-46 Score=314.44 Aligned_cols=193 Identities=22% Similarity=0.304 Sum_probs=159.2
Q ss_pred CCCCCCCCcceEEEEEEe-CCeEEEEEeccCCCchhHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCc
Q 021227 2 HHLSEHQHVVRIHDTYED-KSCVHIVMELCEGGELFDRIVKK--GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPEN 78 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~n 78 (315)
+++ +|||||++++++.+ ++.+|+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 55 ~~l-~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~N 133 (262)
T d1byga_ 55 TQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 133 (262)
T ss_dssp TTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HhC-CCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHh
Confidence 455 89999999999854 56789999999999999998654 358999999999999999999999999999999999
Q ss_pred eeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 021227 79 FLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIG 156 (315)
Q Consensus 79 il~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 156 (315)
|+ .+.++.+||+|||+++..... .....+|+.|+|||++. +.+++++|||||||++|||+| |.+||.+.+..+
T Consensus 134 il---~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~ 208 (262)
T d1byga_ 134 VL---VSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208 (262)
T ss_dssp EE---ECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred he---ecCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 99 567899999999999865433 23456899999999986 569999999999999999998 799999888888
Q ss_pred HHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 157 IFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 157 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+...+.++.... ..+.++++++++|.+||+.||.+|||+.++++
T Consensus 209 ~~~~i~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 209 VVPRVEKGYKMD---APDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HHHHHTTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCC---CCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 888887653222 22468999999999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=320.90 Aligned_cols=192 Identities=21% Similarity=0.267 Sum_probs=163.3
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSV 84 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~ 84 (315)
+|||||++++++.++ ..++++||+.+|+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 69 ~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll--- 144 (317)
T d1xkka_ 69 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--- 144 (317)
T ss_dssp CCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---
T ss_pred CCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---
Confidence 899999999999875 467888999999998887664 679999999999999999999999999999999999994
Q ss_pred CCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 021227 85 DEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLS-GVPPFWAETEIGIFR 159 (315)
Q Consensus 85 ~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 159 (315)
+.++.+||+|||+++....... .....||+.|+|||++. +.++.++||||+||++|||+| |.+||.+.+..++..
T Consensus 145 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~ 224 (317)
T d1xkka_ 145 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 224 (317)
T ss_dssp EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH
T ss_pred CCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 5678999999999987654332 23356899999999986 559999999999999999998 899999888878877
Q ss_pred HHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 160 QILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 160 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
.+..+.... ..+.+|+++.+++.+||+.||.+|||+.|++.|
T Consensus 225 ~i~~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 225 ILEKGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCC---CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 777764322 224689999999999999999999999999876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=325.72 Aligned_cols=198 Identities=27% Similarity=0.447 Sum_probs=154.9
Q ss_pred CCCCcceEEEEEE------eCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYE------DKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~------~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+|||||+++++|. +.+++|+|||||.|+.+ +.+ ...+++..++.+++||+.||.|||++||+||||||+||
T Consensus 74 ~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Ni 150 (355)
T d2b1pa1 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150 (355)
T ss_dssp CCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccc
Confidence 8999999999996 34789999999976544 444 35699999999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAETEIGIF 158 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 158 (315)
| .+.++.+|++|||++.............||+.|+|||++.+ .+++++||||+||++|+|++|++||.+.+.....
T Consensus 151 l---~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~ 227 (355)
T d2b1pa1 151 V---VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_dssp E---ECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred c---cccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH
Confidence 9 56678999999999887766666667789999999999874 5899999999999999999999999998877766
Q ss_pred HHHHhCCC----------------------CCCCCC----------------CCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 021227 159 RQILEGKI----------------------DFESEP----------------WPNISESAKDLIRKMLDQNPKRRLTAHE 200 (315)
Q Consensus 159 ~~i~~~~~----------------------~~~~~~----------------~~~~s~~~~~li~~~l~~~p~~R~s~~~ 200 (315)
..+..... ...... ....|+++++||++||..||++||||+|
T Consensus 228 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e 307 (355)
T d2b1pa1 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307 (355)
T ss_dssp HHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 65543111 111100 0124678999999999999999999999
Q ss_pred HhcCCCccC
Q 021227 201 VLCHPWIVD 209 (315)
Q Consensus 201 ~l~h~~~~~ 209 (315)
+|+||||+.
T Consensus 308 lL~Hpw~~~ 316 (355)
T d2b1pa1 308 ALQHPYINV 316 (355)
T ss_dssp HHTSTTTGG
T ss_pred HhcCcccCC
Confidence 999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-45 Score=314.34 Aligned_cols=195 Identities=20% Similarity=0.275 Sum_probs=168.1
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC------------------------CCCHHHHHHHHHHH
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG------------------------NYSEREAAKLMKTI 57 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------------------------~~~~~~~~~~~~qi 57 (315)
+++ +||||+++++++.+.+..++||||+.+|+|.+++.... .+++..+..++.|+
T Consensus 71 ~~l-~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 149 (301)
T d1lufa_ 71 AEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149 (301)
T ss_dssp HTC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred Hhc-CCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence 345 89999999999999999999999999999999986532 38899999999999
Q ss_pred HHHHHHHHHCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCC---cccccccCccccchhhhhh-cCCCchhHH
Q 021227 58 VGVVECCHSLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDE---VFSDVVGSPYYVAPEVLRK-HYGPEADVW 133 (315)
Q Consensus 58 ~~~l~~lH~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Diw 133 (315)
+.||+|||++|||||||||+||| ++.++.+||+|||+++...... ...+..||+.|+|||++.+ .++.++|||
T Consensus 150 ~~gl~ylH~~~ivHrDlKp~NIL---ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVw 226 (301)
T d1lufa_ 150 AAGMAYLSERKFVHRDLATRNCL---VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 226 (301)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEE---ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHhhhcccCCeEeeEEcccceE---ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhc
Confidence 99999999999999999999999 5667899999999997654332 2234678999999999874 599999999
Q ss_pred HHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 134 SAGVILYILLSGV-PPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 134 slG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
||||++|||++|. +||.+.+..+....+.++.... ....+|+++.+++.+||+.+|++|||+.|+++
T Consensus 227 S~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 227 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999985 7899999999999988876432 22478999999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=324.76 Aligned_cols=203 Identities=28% Similarity=0.445 Sum_probs=165.1
Q ss_pred CCCCCCCcceEEEEEEeC-----CeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCC
Q 021227 3 HLSEHQHVVRIHDTYEDK-----SCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPE 77 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ 77 (315)
+| +|||||++++++... ...++|+||+.||+|.+++ ..+++++..++.++.||+.||+|||++||+||||||+
T Consensus 73 ~l-~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~-~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~ 150 (348)
T d2gfsa1 73 HM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 150 (348)
T ss_dssp HC-CCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred hc-CCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhc-ccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCc
Confidence 44 899999999999643 3345566777899999987 4467999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCEEEeeccCcccCCCCCcccccccCccccchhhhhh--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 78 NFLFLSVDEDAALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLRK--HYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 78 nil~~~~~~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
||| .+.++.+|++|||++.... ....+..||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..
T Consensus 151 NIL---i~~~~~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~ 225 (348)
T d2gfsa1 151 NLA---VNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225 (348)
T ss_dssp GEE---ECTTCCEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccc---ccccccccccccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH
Confidence 999 5678999999999987543 33456779999999998753 3789999999999999999999999999888
Q ss_pred HHHHHHHhCCCCCC-----------------------CC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 021227 156 GIFRQILEGKIDFE-----------------------SE----PWPNISESAKDLIRKMLDQNPKRRLTAHEVLCHPWIV 208 (315)
Q Consensus 156 ~~~~~i~~~~~~~~-----------------------~~----~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~ 208 (315)
.....+........ .. .+..+|+++++||.+||+.||.+|||++|+|+||||+
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 77777654322111 00 1246799999999999999999999999999999998
Q ss_pred CCCC
Q 021227 209 DDKV 212 (315)
Q Consensus 209 ~~~~ 212 (315)
+...
T Consensus 306 ~~~~ 309 (348)
T d2gfsa1 306 QYHD 309 (348)
T ss_dssp TTCC
T ss_pred CCCC
Confidence 7543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=315.26 Aligned_cols=195 Identities=23% Similarity=0.328 Sum_probs=164.8
Q ss_pred CCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHH
Q 021227 4 LSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKG------------------NYSEREAAKLMKTIVGVVECCH 65 (315)
Q Consensus 4 l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~~~~~~~~~~~qi~~~l~~lH 65 (315)
+.+|||||++++++++++.+|+|||||+||+|.+++.+.. .+++..+..++.||+.||+|||
T Consensus 83 l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH 162 (311)
T d1t46a_ 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162 (311)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4589999999999999999999999999999999987543 5899999999999999999999
Q ss_pred HCCCccccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHH
Q 021227 66 SLGVFHRDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYI 141 (315)
Q Consensus 66 ~~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ 141 (315)
++|++||||||+||+ ++..+.+|++|||.++....... .....||+.|+|||++. +.++.++|||||||++|+
T Consensus 163 ~~~ivHrDLKp~NIl---~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~e 239 (311)
T d1t46a_ 163 SKNCIHRDLAARNIL---LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239 (311)
T ss_dssp HTTCCCSCCSGGGEE---EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCCeeeccccccccc---ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHH
Confidence 999999999999999 55678999999999987654322 23467899999999987 558999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 142 LLS-GVPPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 142 ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
|+| |.+||.+.+..+.+..+......... ...+|+++.+||.+||+.||++|||++|+++
T Consensus 240 llt~g~p~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 998 67777776665555554443333322 2468999999999999999999999999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=308.45 Aligned_cols=195 Identities=23% Similarity=0.321 Sum_probs=169.7
Q ss_pred CCCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 021227 2 HHLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK----------GNYSEREAAKLMKTIVGVVECCHSLGVFH 71 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 71 (315)
+++ +|||||++++++..+...++|||||.+|+|.+++... ..+++..+..++.|++.||.|||+++|+|
T Consensus 78 ~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivH 156 (308)
T d1p4oa_ 78 KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156 (308)
T ss_dssp GGC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHc-CCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 345 8999999999999999999999999999999988643 24789999999999999999999999999
Q ss_pred ccCCCCceeeccCCCCCCEEEeeccCcccCCCCCc---ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhC-C
Q 021227 72 RDLKPENFLFLSVDEDAALKATDFGLSVFYKPDEV---FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSG-V 146 (315)
Q Consensus 72 ~dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~ 146 (315)
|||||+||| ++.++.+||+|||+++....... .....||+.|+|||.+. +.++.++||||+||++|||+|| .
T Consensus 157 rDlk~~NiL---ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~ 233 (308)
T d1p4oa_ 157 RDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233 (308)
T ss_dssp SCCSGGGEE---ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred ceEcCCcee---ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCC
Confidence 999999999 56788999999999986543322 23356899999999987 4588999999999999999998 5
Q ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 021227 147 PPFWAETEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLC 203 (315)
Q Consensus 147 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~ 203 (315)
+||.+.+..+.+..+.++..... .+.+|+.+.++|.+||+.+|++|||++++++
T Consensus 234 ~p~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 234 QPYQGLSNEQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88999999999998887654322 2468999999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=306.50 Aligned_cols=196 Identities=20% Similarity=0.300 Sum_probs=161.5
Q ss_pred CCCCCCCCcceEEEEEEe-CCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCce
Q 021227 2 HHLSEHQHVVRIHDTYED-KSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENF 79 (315)
Q Consensus 2 ~~l~~Hpniv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~ni 79 (315)
+++ +|||||++++++.+ ++.+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 83 ~~l-~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NI 161 (311)
T d1r0pa_ 83 KDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNC 161 (311)
T ss_dssp HTC-CCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HhC-CCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhE
Confidence 345 89999999999765 57899999999999999988754 4678889999999999999999999999999999999
Q ss_pred eeccCCCCCCEEEeeccCcccCCCCCc-----ccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCC-C
Q 021227 80 LFLSVDEDAALKATDFGLSVFYKPDEV-----FSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWA-E 152 (315)
Q Consensus 80 l~~~~~~~~~ikl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~ 152 (315)
| ++.++.+||+|||+++....... .....||+.|+|||.+. +.++.++||||||+++|||+||..||.. .
T Consensus 162 L---l~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 162 M---LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp E---ECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred e---ECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 9 56788999999999987643322 22356899999999986 5699999999999999999997776654 4
Q ss_pred CHHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 021227 153 TEIGIFRQILEGKIDFESEPWPNISESAKDLIRKMLDQNPKRRLTAHEVLCH 204 (315)
Q Consensus 153 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l~h 204 (315)
+..+....+..+.....+ +.+++++.++|.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~~~i~~g~~~~~p---~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 239 NTFDITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ----CHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCc---ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 455566667666533222 4689999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=299.33 Aligned_cols=195 Identities=22% Similarity=0.286 Sum_probs=153.2
Q ss_pred CCCCCcceEEEEEEeCC----eEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCccc
Q 021227 5 SEHQHVVRIHDTYEDKS----CVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHS--------LGVFHR 72 (315)
Q Consensus 5 ~~Hpniv~~~~~~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~--------~~ivH~ 72 (315)
.+|||||++++++.+++ .+|+|||||++|+|.+++.+. ++++..+..++.|++.||+|+|+ +||+||
T Consensus 54 ~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHr 132 (303)
T d1vjya_ 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred CCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecc
Confidence 48999999999997654 689999999999999999664 68999999999999999999996 699999
Q ss_pred cCCCCceeeccCCCCCCEEEeeccCcccCCCCC-----cccccccCccccchhhhhhc-------CCCchhHHHHHHHHH
Q 021227 73 DLKPENFLFLSVDEDAALKATDFGLSVFYKPDE-----VFSDVVGSPYYVAPEVLRKH-------YGPEADVWSAGVILY 140 (315)
Q Consensus 73 dikp~nil~~~~~~~~~ikl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~ 140 (315)
||||+||| ++.++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|
T Consensus 133 DlKp~NIL---l~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~ 209 (303)
T d1vjya_ 133 DLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209 (303)
T ss_dssp CCCGGGEE---ECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred ccCccceE---EcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHH
Confidence 99999999 5678999999999998764432 22356799999999998642 577899999999999
Q ss_pred HHHhCCCCCCC---------------CCHHHHHHHHHhCCCCCCCCC-C--CCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 141 ILLSGVPPFWA---------------ETEIGIFRQILEGKIDFESEP-W--PNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 141 ~ll~g~~pf~~---------------~~~~~~~~~i~~~~~~~~~~~-~--~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
||+||..||.. .........+......++.+. + ...+..+.+++.+||+.||++|||+.|++
T Consensus 210 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~ 289 (303)
T d1vjya_ 210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289 (303)
T ss_dssp HHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred HHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 99999887632 123334444444333222111 1 11234688999999999999999999987
Q ss_pred c
Q 021227 203 C 203 (315)
Q Consensus 203 ~ 203 (315)
+
T Consensus 290 ~ 290 (303)
T d1vjya_ 290 K 290 (303)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-42 Score=300.27 Aligned_cols=206 Identities=17% Similarity=0.161 Sum_probs=159.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIV-KKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.+.+|++|+.+.+++.+++.+++|||||. |++.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 58 ~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~ 136 (299)
T d1ckia_ 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 136 (299)
T ss_dssp HSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred HccCCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccc
Confidence 45456667778888899999999999995 45555554 45689999999999999999999999999999999999998
Q ss_pred ccCCCCCCEEEeeccCcccCCCCC--------cccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 021227 82 LSVDEDAALKATDFGLSVFYKPDE--------VFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFWAE 152 (315)
Q Consensus 82 ~~~~~~~~ikl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 152 (315)
...+.+..+||+|||+|+...... ...+..||+.|+|||++.+ .++.++||||+||++|+|+||..||.+.
T Consensus 137 ~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~ 216 (299)
T d1ckia_ 137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216 (299)
T ss_dssp CCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred cccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccccc
Confidence 666677889999999998764332 2235679999999999875 4899999999999999999999999876
Q ss_pred CHHHHHHHH---HhCCCCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHH---HhcCCCccC
Q 021227 153 TEIGIFRQI---LEGKIDFE-SEPWPNISESAKDLIRKMLDQNPKRRLTAHE---VLCHPWIVD 209 (315)
Q Consensus 153 ~~~~~~~~i---~~~~~~~~-~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~---~l~h~~~~~ 209 (315)
........+ .......+ ....+.+|+++.+++.+||+.+|.+||++++ +|+|+|.+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 217 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp C-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 544332222 11111111 1123468999999999999999999999874 466766543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.3e-41 Score=289.53 Aligned_cols=199 Identities=18% Similarity=0.214 Sum_probs=161.5
Q ss_pred CCCCCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceee
Q 021227 3 HLSEHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKK-GNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLF 81 (315)
Q Consensus 3 ~l~~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~ 81 (315)
.|.+||||+.+++++.++...++||||| ||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 56 ~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili 134 (293)
T d1csna_ 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 134 (293)
T ss_dssp HTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred HhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceee
Confidence 4567799999999999999999999999 68998888765 479999999999999999999999999999999999997
Q ss_pred ccC--CCCCCEEEeeccCcccCCCC--------CcccccccCccccchhhhhh-cCCCchhHHHHHHHHHHHHhCCCCCC
Q 021227 82 LSV--DEDAALKATDFGLSVFYKPD--------EVFSDVVGSPYYVAPEVLRK-HYGPEADVWSAGVILYILLSGVPPFW 150 (315)
Q Consensus 82 ~~~--~~~~~ikl~Dfg~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 150 (315)
... ...+.+||+|||+|+..... ....+..||+.|||||++.+ .++.++||||+||++|+|+||..||.
T Consensus 135 ~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 532 23678999999999865432 12335679999999999875 49999999999999999999999997
Q ss_pred CC---CHHHHHHHHHhCCCCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 021227 151 AE---TEIGIFRQILEGKIDFE-SEPWPNISESAKDLIRKMLDQNPKRRLTAHEVL 202 (315)
Q Consensus 151 ~~---~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~l~~~p~~R~s~~~~l 202 (315)
+. +.......+.......+ ....+.+|+++.+++..|+..+|++||+.+.+.
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp SCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 64 33444444433222111 112246899999999999999999999876653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-37 Score=273.05 Aligned_cols=203 Identities=26% Similarity=0.479 Sum_probs=149.8
Q ss_pred CCCCcceEEEEEEe--CCeEEEEEeccCCCchhHH-H--HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCCCCce
Q 021227 6 EHQHVVRIHDTYED--KSCVHIVMELCEGGELFDR-I--VKKGNYSEREAAKLMKTIVGVVECCHS-LGVFHRDLKPENF 79 (315)
Q Consensus 6 ~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~-l--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dikp~ni 79 (315)
.|||||++++++.. ....+++++++.++..... . .....+++..+..++.|++.||+|||+ .||+||||||+||
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NI 157 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 157 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHe
Confidence 58999999998864 4567777777766543322 2 233679999999999999999999997 9999999999999
Q ss_pred eeccCCCC---CCEEEeeccCcccCCCCCcccccccCccccchhhhh-hcCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q 021227 80 LFLSVDED---AALKATDFGLSVFYKPDEVFSDVVGSPYYVAPEVLR-KHYGPEADVWSAGVILYILLSGVPPFWAETEI 155 (315)
Q Consensus 80 l~~~~~~~---~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 155 (315)
|+...+.. ..+|++|||.+..... .....+||+.|+|||++. ..++.++||||+||++++|++|+.||.+....
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred eeeccCcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence 97533221 3599999999875533 335578999999999886 55899999999999999999999999754321
Q ss_pred ------HHHHHHHh--CCC----------------------CC--------------CCCCCCCCCHHHHHHHHHhcccC
Q 021227 156 ------GIFRQILE--GKI----------------------DF--------------ESEPWPNISESAKDLIRKMLDQN 191 (315)
Q Consensus 156 ------~~~~~i~~--~~~----------------------~~--------------~~~~~~~~s~~~~~li~~~l~~~ 191 (315)
........ +.. .. ....+...++++++||.+||.+|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 11111110 000 00 00011234688999999999999
Q ss_pred CCCCCCHHHHhcCCCccCC
Q 021227 192 PKRRLTAHEVLCHPWIVDD 210 (315)
Q Consensus 192 p~~R~s~~~~l~h~~~~~~ 210 (315)
|.+|||++|+|+||||++.
T Consensus 316 P~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTC
T ss_pred hhHCcCHHHHhcCcccCCC
Confidence 9999999999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.72 E-value=1e-18 Score=139.80 Aligned_cols=110 Identities=22% Similarity=0.214 Sum_probs=82.8
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCCCCceeeccCC
Q 021227 6 EHQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSLGVFHRDLKPENFLFLSVD 85 (315)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dikp~nil~~~~~ 85 (315)
.|+++++.+++.. .++||||++++.+.+ +++..+..++.|++.+++|||++||+||||||+|||+.
T Consensus 72 ~~~~v~~~~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~--- 137 (191)
T d1zara2 72 QGLAVPKVYAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS--- 137 (191)
T ss_dssp TTSSSCCEEEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---
T ss_pred cCCCcceEEEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee---
Confidence 6889998887632 269999999876532 56667788999999999999999999999999999963
Q ss_pred CCCCEEEeeccCcccCCCCCcccccccCccccc------hhhhhhcCCCchhHHHHHH
Q 021227 86 EDAALKATDFGLSVFYKPDEVFSDVVGSPYYVA------PEVLRKHYGPEADVWSAGV 137 (315)
Q Consensus 86 ~~~~ikl~Dfg~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DiwslG~ 137 (315)
+ ..++|+|||.|.....+.. ..|.. .+.+.+.|+.++|+||+.-
T Consensus 138 ~-~~~~liDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 138 E-EGIWIIDFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp T-TEEEECCCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred C-CCEEEEECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 3 3589999999876543221 11222 1233467899999999753
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=99.46 E-value=3.4e-14 Score=96.15 Aligned_cols=75 Identities=20% Similarity=0.340 Sum_probs=69.1
Q ss_pred HHHhhhhhhhhhccHHHHhcccCCCC-CCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhccC
Q 021227 241 RVIAERLNEEEIGGLKELFKMIDTDN-SGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLSL 315 (315)
Q Consensus 241 ~~i~~~l~~e~~~~l~~~F~~~d~~~-~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~~ 315 (315)
...+..++++++..++++|..+|.++ +|.|+..||+.+++.+|..+++++++++++++|.+++|. +|+||+.+++
T Consensus 3 k~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~ 79 (82)
T d1wrka1 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMV 79 (82)
T ss_dssp HHHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 34566788999999999999999995 799999999999999999999999999999999999987 9999999863
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.45 E-value=1.8e-14 Score=98.82 Aligned_cols=75 Identities=71% Similarity=0.942 Sum_probs=70.5
Q ss_pred HHHhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhccC
Q 021227 241 RVIAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLSL 315 (315)
Q Consensus 241 ~~i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~~ 315 (315)
..|+..++.+++..++++|..+|.|++|.|+.+|++.+|+.+|..+++++++++++.+|.+++|. +|+||+++|.
T Consensus 11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~I~~~EFl~am~ 86 (87)
T d1s6ja_ 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATV 86 (87)
T ss_dssp HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHTTCCC
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHc
Confidence 45677888999999999999999999999999999999999999999999999999999999988 9999999874
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.42 E-value=1.3e-13 Score=93.20 Aligned_cols=69 Identities=25% Similarity=0.377 Sum_probs=65.5
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++++++.+++++|..+|.|++|.|+.+|++.+++.+|..+++.++++++..+|.+++|. +|+||++++
T Consensus 7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m 76 (81)
T d1avsa_ 7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMM 76 (81)
T ss_dssp HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 467788899999999999999999999999999999999999999999999999999987 999999876
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.41 E-value=7.5e-14 Score=93.58 Aligned_cols=70 Identities=30% Similarity=0.460 Sum_probs=66.2
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhccC
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLSL 315 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~~ 315 (315)
.++.+++.+++++|..+|.|++|.|+.+|++.+++.+|..+++.++.++++.+|.+++|. +|+||++++.
T Consensus 3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~ 73 (77)
T d1f54a_ 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMS 73 (77)
T ss_dssp CCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHT
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 467788999999999999999999999999999999999999999999999999999988 9999998863
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=99.37 E-value=1.9e-13 Score=90.54 Aligned_cols=68 Identities=29% Similarity=0.478 Sum_probs=64.9
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++++.+++++|..+|.+++|.|+.+|++.+++.+|..++++++..+++.+|.+++|. +|+||++++
T Consensus 2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m 70 (73)
T d2pq3a1 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMM 70 (73)
T ss_dssp CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 56788999999999999999999999999999999999999999999999999999987 999999876
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=99.34 E-value=5e-13 Score=90.25 Aligned_cols=65 Identities=26% Similarity=0.507 Sum_probs=61.1
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++..++++|..+|.|++|.|+.+|++.+++.+| .+++.++.++++++|.+++|. +|+||+.++
T Consensus 2 ~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~ 67 (81)
T d2opoa1 2 PQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFA 67 (81)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 57888999999999999999999999999999999 589999999999999999998 999999865
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.30 E-value=1.2e-12 Score=84.44 Aligned_cols=62 Identities=18% Similarity=0.394 Sum_probs=58.9
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+++++|+.+|.+++|.|+.+|++.+++.+|..+++.++..+++.+|.+++|. +|+||++++
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 35899999999999999999999999999999999999999999999999988 999999875
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.29 E-value=1.9e-12 Score=85.89 Aligned_cols=62 Identities=24% Similarity=0.441 Sum_probs=59.2
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++++|+.+|.+++|.|+.+|++.+|+.+|..+++++++++++++|.+++|. +|+||++++
T Consensus 9 eel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m 71 (75)
T d1jc2a_ 9 EELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKMM 71 (75)
T ss_dssp HHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHHH
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 46899999999999999999999999999999999999999999999999988 999999875
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.26 E-value=4.8e-12 Score=82.03 Aligned_cols=61 Identities=11% Similarity=0.260 Sum_probs=57.9
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++++|..+|.|++|.|+.+|++.+++.+|..+++++++.+++.+|.+++|. +|+||++++
T Consensus 2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m 63 (67)
T d1tiza_ 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCI 63 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHH
T ss_pred hHHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 3689999999999999999999999999999999999999999999999987 999999864
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.25 E-value=4.7e-12 Score=84.58 Aligned_cols=64 Identities=23% Similarity=0.414 Sum_probs=60.3
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....++++|..+|.|++|.|+.+|++.+++.+|..+++.++.++++.+|.+++|. +|+||++++
T Consensus 7 ~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m 71 (77)
T d1oqpa_ 7 SREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIM 71 (77)
T ss_dssp HHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 3456899999999999999999999999999999999999999999999999988 999999875
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=99.22 E-value=2.5e-12 Score=86.76 Aligned_cols=62 Identities=27% Similarity=0.435 Sum_probs=59.0
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++++|..+|.|++|.|+.+||+.+++.+|.++++++++.++..+|.+++|. +|+||+.++
T Consensus 15 e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m 77 (81)
T d1fi5a_ 15 EELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFM 77 (81)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHH
Confidence 46899999999999999999999999999999999999999999999999988 999999875
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.21 E-value=6.7e-12 Score=79.66 Aligned_cols=59 Identities=19% Similarity=0.417 Sum_probs=56.5
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhh
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCN 312 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~ 312 (315)
+++++|..+|++++|.|+.+|++.+|+.+|.++++.+++.+++.+|.+++|. +|+||+.
T Consensus 2 el~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 2 DFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred hHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence 5789999999999999999999999999999999999999999999999988 9999973
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.19 E-value=2.6e-12 Score=83.48 Aligned_cols=61 Identities=26% Similarity=0.477 Sum_probs=57.7
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCC-CCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQ-LMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~-~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++++|..+|.+++|.|+.+||+.+++.+|.. +++++++.+++.+|.+++|. +|+||++++
T Consensus 3 el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m 65 (68)
T d1c7va_ 3 EILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLI 65 (68)
T ss_dssp HHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHH
T ss_pred HHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 57899999999999999999999999999985 79999999999999999998 999999876
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=99.10 E-value=3.9e-11 Score=85.39 Aligned_cols=62 Identities=31% Similarity=0.441 Sum_probs=57.9
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++++|+.+|.|++|.|+.+||+.+++.+ |..+++++++++++++|.+++|. +|+||++++
T Consensus 41 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D~d~dG~I~~~EF~~~m 106 (109)
T d5pala_ 41 AQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFAKMV 106 (109)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhCCCCCCCEeHHHHHHHH
Confidence 468999999999999999999999999887 67899999999999999999998 999999875
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=3.1e-10 Score=76.67 Aligned_cols=63 Identities=14% Similarity=0.149 Sum_probs=58.9
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
....+.++|..+|.+++|.|+.+|++.+|+.+|..++++++..+++.+|.+++|. +|.||++.
T Consensus 18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~ 81 (83)
T d1wlza1 18 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSR 81 (83)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHHHHHHH
Confidence 3456899999999999999999999999999999999999999999999999987 99999864
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.01 E-value=1.1e-10 Score=82.97 Aligned_cols=62 Identities=35% Similarity=0.430 Sum_probs=57.2
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++++|+.+|.|++|.|+.+||+.+++.+ |..+++++++++++.+|.+++|. +|+||.+++
T Consensus 41 ~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~d~dG~I~~~EF~~~m 106 (109)
T d1pvaa_ 41 NDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLV 106 (109)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCCCCcCcEeHHHHHHHH
Confidence 457899999999999999999999999887 67899999999999999999998 999999875
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.98 E-value=2e-10 Score=81.45 Aligned_cols=64 Identities=27% Similarity=0.350 Sum_probs=58.1
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhC---CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVG---SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~---~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....++++|..+|.+++|.|+.+|+..+++.++ ..+++++++++++.+|.+++|. +|+||++++
T Consensus 38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~m 105 (107)
T d2pvba_ 38 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFAAMI 105 (107)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred CHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 344689999999999999999999999999985 5689999999999999999988 999999875
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=98.96 E-value=3.6e-10 Score=80.45 Aligned_cols=64 Identities=31% Similarity=0.373 Sum_probs=58.1
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhC---CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVG---SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~---~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....++++|..+|.|++|.|+.+|++.+++.++ ..+++++++.+++.+|.+++|. +|+||++++
T Consensus 39 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~~~D~d~dG~i~~~EF~~~m 106 (109)
T d1rwya_ 39 SADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLV 106 (109)
T ss_dssp CHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred CHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 344678999999999999999999999999885 4689999999999999999998 999999875
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.96 E-value=1.5e-10 Score=82.26 Aligned_cols=66 Identities=32% Similarity=0.411 Sum_probs=59.2
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHh---CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV---GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~---~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
......++++|..+|.|++|.|+.+|++.+++.+ |..+++++++.+++.+|.+++|. +|+||++++
T Consensus 37 ~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~d~dG~I~~~EF~~~m 106 (108)
T d1rroa_ 37 KMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMV 106 (108)
T ss_dssp GSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHHHHHHHH
T ss_pred cCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 3445568999999999999999999999999887 45689999999999999999998 999999875
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.93 E-value=2.5e-10 Score=75.64 Aligned_cols=62 Identities=19% Similarity=0.326 Sum_probs=53.8
Q ss_pred ccHHHHhcccCCC--CCCcccHHHHHHHHHHhCCCCC--HHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTD--NSGTITFDELKDGLKRVGSQLM--ESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~--~~g~i~~~el~~~l~~~~~~~~--~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+++++|..+|.+ ++|.|+.+||+.+++.+|..++ +.+++++++.+|.+++|. +|+||++++
T Consensus 5 eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m 71 (76)
T d1qx2a_ 5 EEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMM 71 (76)
T ss_dssp HHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHH
Confidence 4588999998553 5799999999999999987765 558999999999999988 999999875
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.88 E-value=1.3e-09 Score=75.01 Aligned_cols=65 Identities=17% Similarity=0.192 Sum_probs=59.3
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+++++....+++|..+|.|++|.|+.+|+..++++.| ++++++..+++.+|.+++|. +++||+..
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~a 68 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAA 68 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc--CCHHHHHHHHHHhCCCCCCeecHHHHHHH
Confidence 4567888899999999999999999999999999976 57899999999999999998 99999753
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.88 E-value=6.3e-10 Score=77.01 Aligned_cols=65 Identities=15% Similarity=0.163 Sum_probs=58.7
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+++++.....++|..+|.|++|.|+.+|+..++++.| ++++++..+++.+|.+++|. +++||+..
T Consensus 4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~a 69 (95)
T d1c07a_ 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFALA 69 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC--CCHHHHHHHHHHhCCCCCCeEcHHHHHHH
Confidence 4567778899999999999999999999999998875 57899999999999999998 99999764
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.82 E-value=2.6e-09 Score=79.83 Aligned_cols=63 Identities=14% Similarity=0.299 Sum_probs=57.2
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCCCHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~~~~~f~~~~ 314 (315)
...+.++|+.+|.+++|.|+.+|++.+++.+|..+++++++++++.+|.++..++|+||++++
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~~G~I~y~eF~~~l 137 (142)
T d1wdcb_ 75 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVEGGKFDYVKFTAMI 137 (142)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEETTEECHHHHHHHH
T ss_pred hhhHHHhhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhCCCCCEEcHHHHHHHH
Confidence 456889999999999999999999999999999999999999999999885334999999864
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.81 E-value=3.9e-09 Score=79.19 Aligned_cols=62 Identities=31% Similarity=0.439 Sum_probs=58.2
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+.++|+.+|.+++|.|+.+|++.++..+|..+++++++++++.+| +++|. +|+||++++
T Consensus 82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dG~I~~~eF~~~m 144 (146)
T d1lkja_ 82 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALL 144 (146)
T ss_dssp HHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC-CSSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc-CCCCeEeHHHHHHHh
Confidence 356889999999999999999999999999999999999999999999 88887 999999876
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=98.80 E-value=3.1e-09 Score=73.09 Aligned_cols=64 Identities=16% Similarity=0.155 Sum_probs=55.7
Q ss_pred hhccHHHHhccc-CCCCC-CcccHHHHHHHHHHhC-----CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMI-DTDNS-GTITFDELKDGLKRVG-----SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~-d~~~~-g~i~~~el~~~l~~~~-----~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+..+.++|..+ |.+++ |+|+.+||+++++.++ .+.++++++++++++|.+++|. ||+||+.++
T Consensus 7 ~i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm 78 (93)
T d1zfsa1 7 AMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLV 78 (93)
T ss_dssp HHHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHH
Confidence 456788999887 78875 9999999999999876 4568999999999999999998 999999864
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=98.78 E-value=5e-10 Score=74.38 Aligned_cols=65 Identities=17% Similarity=0.186 Sum_probs=55.4
Q ss_pred hhhccHHHHhcccCC--CCCCcccHHHHHHHHHHh--CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDT--DNSGTITFDELKDGLKRV--GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~--~~~g~i~~~el~~~l~~~--~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....+..+|..+|. +++|.|+.+|++.+++.+ +...++++++.+++++|.+++|. ||+||++++
T Consensus 4 ~~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~ 73 (78)
T d1cb1a_ 4 KSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLV 73 (78)
T ss_dssp CCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHH
T ss_pred hhHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence 446678999999865 346899999999999998 45567788999999999999997 999999875
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.77 E-value=2.8e-09 Score=79.45 Aligned_cols=62 Identities=21% Similarity=0.379 Sum_probs=57.2
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+.++|+.+|.+++|.|+.+|++.+|+.+|.+++++|++++++.+|.+ +|. +|+||++++
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-dG~I~y~eF~~~m 137 (140)
T d1ggwa_ 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVK-DGMVNYHDFVQMI 137 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCS-SCCSTTTHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCCC-CCEEeHHHHHHHH
Confidence 44588999999999999999999999999999999999999999999988 665 999999874
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=98.77 E-value=6.5e-09 Score=71.06 Aligned_cols=65 Identities=12% Similarity=0.137 Sum_probs=56.1
Q ss_pred hhhccHHHHhccc-CCCCCC-cccHHHHHHHHHHhC-----CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMI-DTDNSG-TITFDELKDGLKRVG-----SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~-d~~~~g-~i~~~el~~~l~~~~-----~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+..+|..+ |.+++| .|+.+|++++|+... .+.++.+++++++++|.|+||. ||+||+.++
T Consensus 6 ~~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~ 78 (93)
T d1ksoa_ 6 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSL 78 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHH
Confidence 3456688899876 999999 699999999998863 4567999999999999999998 999999864
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=98.76 E-value=3.3e-09 Score=73.50 Aligned_cols=65 Identities=12% Similarity=0.147 Sum_probs=55.2
Q ss_pred hhhccHHHHhccc-CCCCC-CcccHHHHHHHHHHhCC--CCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMI-DTDNS-GTITFDELKDGLKRVGS--QLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~-d~~~~-g~i~~~el~~~l~~~~~--~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+.+..+.++|..+ |.+++ |.|+.+||+.+++..+. ..++++++++++++|.|++|. ||+||+.++
T Consensus 11 ~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~ 80 (98)
T d1yuta1 11 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLI 80 (98)
T ss_dssp HHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHH
Confidence 4456788999887 77775 99999999999998754 356778999999999999998 999999874
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=98.75 E-value=7.7e-09 Score=70.87 Aligned_cols=64 Identities=19% Similarity=0.296 Sum_probs=55.3
Q ss_pred hhccHHHHhccc-CCCCC-CcccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMI-DTDNS-GTITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~-d~~~~-g~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+..+.++|..+ |.+++ |.|+.+|++++|+. ++.+.++++++++++++|.|+||. ||+||+.++
T Consensus 7 ~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm 78 (93)
T d3c1va1 7 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFL 78 (93)
T ss_dssp HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHH
Confidence 456788999987 66665 47999999999987 456789999999999999999998 999999864
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=98.73 E-value=1.9e-09 Score=73.82 Aligned_cols=64 Identities=13% Similarity=0.196 Sum_probs=55.5
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHh-----CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV-----GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~-----~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+..+|..+|.+ +|.|+.+||+.+++.. +...++..++.+++.+|.+++|. ||+||+.++
T Consensus 6 ~~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li 75 (92)
T d1a4pa_ 6 HAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLI 75 (92)
T ss_dssp HHHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHH
Confidence 3466789999999977 8999999999999874 44567889999999999999998 999998764
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=98.72 E-value=3.9e-09 Score=71.55 Aligned_cols=65 Identities=25% Similarity=0.445 Sum_probs=56.9
Q ss_pred hhhccHHHHhccc-CCCCCC-cccHHHHHHHHHH---hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMI-DTDNSG-TITFDELKDGLKR---VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~-d~~~~g-~i~~~el~~~l~~---~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+.++|..+ |++++| +|+..|++++++. .+...++.+++++++++|.|+||. ||+||+.+.
T Consensus 6 ~ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~ 76 (89)
T d1k8ua_ 6 QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFL 76 (89)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHH
Confidence 3456788899877 999998 7999999999998 567778899999999999999998 999999864
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=98.72 E-value=2.1e-08 Score=74.93 Aligned_cols=64 Identities=20% Similarity=0.366 Sum_probs=59.5
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....++++|+.+|.|++|.|+.+|++..++.+|..+++++++++++.+|.+++|. +|+||+++.
T Consensus 80 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~d~dG~i~~~eF~~~l 144 (146)
T d1exra_ 80 SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMM 144 (146)
T ss_dssp HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHH
T ss_pred hHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHh
Confidence 3456889999999999999999999999999999999999999999999999987 999999864
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.71 E-value=3.2e-09 Score=80.57 Aligned_cols=64 Identities=27% Similarity=0.408 Sum_probs=57.5
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+.++|+.+|.+++|.|+.+|++.++..+|..+++++++++++.+|.+++|. +|+||++++
T Consensus 89 ~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~~~l 153 (156)
T d1dtla_ 89 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFM 153 (156)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 3356789999999999999999999999999999999999999999999999988 999999864
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.70 E-value=2.8e-08 Score=73.77 Aligned_cols=63 Identities=24% Similarity=0.429 Sum_probs=59.4
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+..+|..+|.+++|.|+..++..+++.+|..+++.++..+++.+|.+++|. +|+||++++
T Consensus 78 ~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~d~dG~i~~~EF~~~m 141 (141)
T d2obha1 78 KEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIM 141 (141)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCCEeHHHHHHhC
Confidence 456889999999999999999999999999999999999999999999999988 999999874
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=98.67 E-value=1.2e-08 Score=76.39 Aligned_cols=69 Identities=30% Similarity=0.483 Sum_probs=64.1
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++.+++..++++|..+|.+++|.|+.+|+..++...|..+++..+..+++.+|.+++|. +|++|++.+
T Consensus 2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~ 71 (146)
T d1exra_ 2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLM 71 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcCCCCCCcccHHHHHHHH
Confidence 466788889999999999999999999999999999999999999999999999998887 999998753
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.67 E-value=1.2e-08 Score=76.33 Aligned_cols=63 Identities=24% Similarity=0.314 Sum_probs=59.1
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+.++|+.+|.+++|.|+.+|++.+++.+|.+++++|++++++.+|.+++|. +|++|+.++
T Consensus 76 ~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~d~dg~I~y~eF~~~l 139 (145)
T d2mysb_ 76 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVI 139 (145)
T ss_pred HHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHh
Confidence 345889999999999999999999999999999999999999999999999987 999999875
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.67 E-value=3.5e-08 Score=75.12 Aligned_cols=63 Identities=24% Similarity=0.404 Sum_probs=58.5
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+.++|+.+|.|++|.|+.+|++.++...|...++++++.+++.+|.+++|. +|+||++++
T Consensus 95 ~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l 158 (162)
T d1topa_ 95 EEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMM 158 (162)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCCCCCCcEEHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999999988 999999874
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.65 E-value=8.6e-09 Score=71.04 Aligned_cols=64 Identities=11% Similarity=0.120 Sum_probs=57.2
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
++.++.....++|..+| +++|.|+.+|++.++.+.| +..++++.++..+|.+++|. +++||+..
T Consensus 4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g--l~~~~L~~Iw~~~D~~~dG~l~~~EF~~a 68 (95)
T d2jxca1 4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFAVA 68 (95)
T ss_dssp SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS--CCHHHHHHHHHHHCTTCSSEEEHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCeEcHHHHHHH
Confidence 45677888999999999 8999999999999998766 57889999999999999998 99999753
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.62 E-value=1.3e-08 Score=79.19 Aligned_cols=69 Identities=75% Similarity=0.981 Sum_probs=64.9
Q ss_pred hhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
..++++++..++++|..+|.|++|.|+.+|+..+++.+|..+++.+++.+++.+|.++++. ++++|+..
T Consensus 2 ~~Lt~~ei~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~ 71 (182)
T d1s6ia_ 2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAA 71 (182)
T ss_dssp CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccccccchhhhhhhhccccccchHHHHHHH
Confidence 4678889999999999999999999999999999999999999999999999999999988 99999864
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=98.61 E-value=6.4e-09 Score=70.24 Aligned_cols=65 Identities=8% Similarity=0.071 Sum_probs=55.4
Q ss_pred hhhccHHHHhccc-CCCCCCc-ccHHHHHHHHHH-hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMI-DTDNSGT-ITFDELKDGLKR-VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~-d~~~~g~-i~~~el~~~l~~-~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+..+|..+ |.+++|. ++.+|++.+++. +|...++.+++++++++|.|++|. ||+||+.+.
T Consensus 7 ~ai~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~ 75 (87)
T d1xk4a1 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILV 75 (87)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3455678888877 8999985 599999999975 677778889999999999999998 999999874
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.60 E-value=3e-08 Score=74.04 Aligned_cols=62 Identities=19% Similarity=0.377 Sum_probs=56.0
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
....+.++|+.+|.+++|.|+.+|++.+++.+|..+++++++.+++. +.+++|. +|+||+..
T Consensus 79 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dG~I~y~eF~~~ 141 (145)
T d2mysc_ 79 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKH 141 (145)
T ss_pred hHHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHhh-cCCCCCeEEHHHHHHH
Confidence 44568899999999999999999999999999999999999999985 7788886 99999864
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=98.59 E-value=5.2e-08 Score=75.90 Aligned_cols=63 Identities=21% Similarity=0.165 Sum_probs=58.2
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
....+..+|..+|.|++|.|+.+|++.+++.+|..+++++++.+++.+|.+++|. +++||..+
T Consensus 103 ~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~ 166 (187)
T d1uhka1 103 IRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQ 166 (187)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHH
T ss_pred HHHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCCCCCCEeHHHHHHH
Confidence 3445789999999999999999999999999999999999999999999999988 99999763
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.59 E-value=2.6e-08 Score=75.06 Aligned_cols=63 Identities=17% Similarity=0.302 Sum_probs=56.5
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccC--CCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIF--SRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~--~~~-~~~~f~~~~ 314 (315)
...+.++|+.+|.+++|.|+.+|++.+++.+|..++++|++++++.+|.+. +|. +|++|+..+
T Consensus 81 ~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~ 146 (152)
T d1wdcc_ 81 FADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKV 146 (152)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHH
T ss_pred HHhhhhhhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCEEEHHHHHHHH
Confidence 456889999999999999999999999999999999999999999999654 455 999998753
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=98.58 E-value=4.6e-08 Score=76.39 Aligned_cols=61 Identities=21% Similarity=0.160 Sum_probs=53.2
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
..+..+|..+|.|++|.|+.+|+..+++.+|..++++++..+++.+|.+++|. +++||..+
T Consensus 107 ~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~ 168 (189)
T d1qv0a_ 107 EWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQ 168 (189)
T ss_dssp HHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHH
T ss_pred HHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHH
Confidence 35677899999999999999999999999999999999999999999999988 99999865
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.58 E-value=1.5e-08 Score=75.83 Aligned_cols=63 Identities=17% Similarity=0.369 Sum_probs=58.5
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
....+.++|..+|.+++|.|+.+|+..+++.+|.+++++++..++..+|.+++|. +|+||+..
T Consensus 79 ~~~~l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~ 142 (146)
T d1m45a_ 79 KTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIED 142 (146)
T ss_dssp CTHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHH
T ss_pred hHHHHHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCCCCCCcEEHHHHHHH
Confidence 3456899999999999999999999999999999999999999999999999987 99999854
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.55 E-value=4.2e-08 Score=73.05 Aligned_cols=64 Identities=20% Similarity=0.402 Sum_probs=56.5
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCC-CCHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSR-FSIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~-~~~~~f~~~~ 314 (315)
++++++.+++++|..+|.+++|.|+.+|+..+++.+|..+++.++..+++ ++++ ++|++|+.+.
T Consensus 1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~----~~~~~i~~~eF~~~~ 65 (142)
T d1wdcb_ 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPLNFTMFLSIF 65 (142)
T ss_dssp CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT----TSSSCCCHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHH----hccCccccccccccc
Confidence 35788899999999999999999999999999999999999999998885 3444 5999999764
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=4.9e-08 Score=74.53 Aligned_cols=60 Identities=25% Similarity=0.386 Sum_probs=54.3
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCCCHHHHhhc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCNL 313 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~~~~~f~~~ 313 (315)
..++++|+.+|.|++|.|+.+|++.+++.+|.++++++++.+++.+|.++ .++|++|+..
T Consensus 70 ~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d~~g-~i~~~eFi~~ 129 (165)
T d1k94a_ 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYSKNG-RIFFDDYVAC 129 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHCBTT-BCBHHHHHHH
T ss_pred chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcCCCC-cCcHHHHHHH
Confidence 34688999999999999999999999999999999999999999998753 4699999865
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=98.54 E-value=3.4e-08 Score=72.48 Aligned_cols=60 Identities=15% Similarity=0.257 Sum_probs=56.1
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...+|+.+|.|++|.|+.+|+..+++.++...+++++..+++.+|.+++|. +++||+++.
T Consensus 2 ae~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~ 62 (134)
T d1jfja_ 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFY 62 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHT
T ss_pred HHHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhhccccccccccccccc
Confidence 357899999999999999999999999999999999999999999999988 999998754
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=98.53 E-value=7.8e-08 Score=64.56 Aligned_cols=65 Identities=15% Similarity=0.220 Sum_probs=54.0
Q ss_pred hhhccHHHHhccc-CCCCCC-cccHHHHHHHHHHh-----CCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMI-DTDNSG-TITFDELKDGLKRV-----GSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~-d~~~~g-~i~~~el~~~l~~~-----~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+.++|..+ +.++++ +|+.+||+++++.. +.+.++..++++++.+|.|+||. ||+||+.+.
T Consensus 5 ~ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li 77 (87)
T d1e8aa_ 5 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLV 77 (87)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHH
Confidence 3456788899877 556554 79999999999984 34567899999999999999998 999999874
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=98.50 E-value=1.6e-08 Score=70.28 Aligned_cols=65 Identities=15% Similarity=0.155 Sum_probs=54.4
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCC-------CCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-------QLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~-------~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+.+..+.++|..++ +++|.|+.+||+++++..+. +.++..++++++++|.|++|. +|+||+.+.
T Consensus 6 E~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li 78 (100)
T d1psra_ 6 ERSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLL 78 (100)
T ss_dssp HHHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHH
Confidence 455667788888886 78899999999999998753 245667999999999999998 999999864
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=98.48 E-value=8.9e-08 Score=74.38 Aligned_cols=61 Identities=23% Similarity=0.371 Sum_probs=57.3
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+.+.|..+|.+++|.|+.+|++.+++.+|..+++++++.+++.+|.+++|. +|+||++++
T Consensus 85 ~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~~~dg~I~~~eF~~~~ 146 (182)
T d1y1xa_ 85 SMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELS 146 (182)
T ss_dssp HHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred ccccchhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcccCCCCCcCHHHHHHHH
Confidence 4678899999999999999999999999999999999999999999999988 999999865
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=6.2e-08 Score=71.78 Aligned_cols=65 Identities=26% Similarity=0.448 Sum_probs=60.7
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+++..+++++|..+|.|++|.|+.+|+..+++..|..++++.+..++..+|.+++|. ++++|+..
T Consensus 2 ~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~ 67 (141)
T d2obha1 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTV 67 (141)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhccCCCCeechHHHHHH
Confidence 467778999999999999999999999999999999999999999999999999887 99999864
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=4.9e-08 Score=67.82 Aligned_cols=61 Identities=15% Similarity=0.200 Sum_probs=51.6
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCC----------------CCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQ----------------LMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~----------------~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++.+|..+|.|++|.|+.+|+..+++.++.. ..+..++.+++++|.|++|. +++||++.+
T Consensus 17 ~~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~~~~ 94 (99)
T d1snla_ 17 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLAST 94 (99)
T ss_dssp CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHH
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHH
Confidence 47899999999999999999999999875311 12456889999999999998 999999764
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=5.7e-08 Score=71.89 Aligned_cols=64 Identities=16% Similarity=0.297 Sum_probs=55.3
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....+.++|+.+|.+++|.|+.+|++.+++.+|..+++++++.+++. +.+++|. +|+||+...
T Consensus 74 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dg~I~~~eF~~~l 138 (139)
T d1w7jb1 74 GTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG-HEDSNGCINYEAFLKHI 138 (139)
T ss_dssp ----CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTT-CCCTTSEEEHHHHHHHT
T ss_pred cHHHHHHHhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCeEeHHHHHHHh
Confidence 344568899999999999999999999999999999999999999975 7788877 999999764
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.47 E-value=6.9e-08 Score=73.42 Aligned_cols=69 Identities=25% Similarity=0.383 Sum_probs=63.4
Q ss_pred hhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
..++.+++.+++++|..+|+|++|.|+.+|++.+++..+..+++.++..++..+|.++++. ++.+|+..
T Consensus 12 ~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~e~~~~ 81 (162)
T d1topa_ 12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVM 81 (162)
T ss_dssp HHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheeccCCCCCeeeehhhhh
Confidence 4567788889999999999999999999999999999999999999999999999998887 99988753
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=1.1e-08 Score=72.47 Aligned_cols=65 Identities=15% Similarity=0.189 Sum_probs=57.7
Q ss_pred hhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 247 LNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
++.++.....++|..+|++++|.|+.+|++.++.+.| +.++++..+++.+|.+++|. +++||+..
T Consensus 16 lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~--L~~~~L~~Iw~l~D~d~dG~l~~~EF~~a 81 (110)
T d1iq3a_ 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGALTLPEFCAA 81 (110)
T ss_dssp CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSSSCSEEEHHHHHHH
T ss_pred cCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc--cchHHHHHHHHHhccCCCCeECHHHHHHH
Confidence 4567888899999999999999999999999987765 56778999999999999998 99999754
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.46 E-value=7.3e-08 Score=71.90 Aligned_cols=62 Identities=18% Similarity=0.292 Sum_probs=55.3
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhcc--CCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKI--FSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~--~~~~-~~~~f~~~~ 314 (315)
++++++|..+|.|++|.|+.+|+..+|+.+|..++..++..++..++.+ ++|. +|++|+.+.
T Consensus 4 eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~ 68 (145)
T d2mysc_ 4 DDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAITFEEFLPML 68 (145)
T ss_pred HHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHhhcccccCccchhHHHHHH
Confidence 4689999999999999999999999999999999999999999998766 4544 999998753
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=98.42 E-value=1e-07 Score=74.02 Aligned_cols=64 Identities=27% Similarity=0.393 Sum_probs=58.9
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
++...++++|..+|.|++|.|+.+|+..+|+.+|..+++.+++.+++.+|.++++. ++++|...
T Consensus 15 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d~d~~~~i~~~ef~~~ 79 (182)
T d1y1xa_ 15 NDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDL 79 (182)
T ss_dssp CTTSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHH
T ss_pred CcHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhccccccccccccccccccc
Confidence 34457999999999999999999999999999999999999999999999998877 99999764
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.39 E-value=2.8e-07 Score=69.50 Aligned_cols=69 Identities=22% Similarity=0.344 Sum_probs=63.1
Q ss_pred hhhhhhhhhccHHHHhcccCCCC-CCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhh
Q 021227 244 AERLNEEEIGGLKELFKMIDTDN-SGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCN 312 (315)
Q Consensus 244 ~~~l~~e~~~~l~~~F~~~d~~~-~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~ 312 (315)
.+.++++++..++++|..+|.++ +|.|+.+|+..+++.+|...++.++.+++..++.++++. .+++|..
T Consensus 5 ~~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 75 (156)
T d1dtla_ 5 VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLV 75 (156)
T ss_dssp GGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHH
T ss_pred HHHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhhccCCCccchhhhhh
Confidence 45678889999999999999995 899999999999999999999999999999999998877 8888875
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.38 E-value=1.7e-07 Score=69.88 Aligned_cols=68 Identities=31% Similarity=0.490 Sum_probs=62.5
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.++++++..++++|..+|.|++|.|+.+|+..++...|..+++.++..++...+.++.+. ++++|...
T Consensus 3 ~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 71 (146)
T d1lkja_ 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLAL 71 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCSSSCCEEEHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhccCCcccccHHHHHHH
Confidence 467889999999999999999999999999999999999999999999999999888776 99888764
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.35 E-value=2.2e-07 Score=64.20 Aligned_cols=58 Identities=14% Similarity=0.175 Sum_probs=52.6
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...++|+.+|.+++|.|+.+|+..+++..| ++++++..+++.+|.+++|. +++||+..
T Consensus 12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~--L~~~~L~~i~~~~D~d~dG~L~~~EF~~a 70 (99)
T d1qjta_ 12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFFVA 70 (99)
T ss_dssp HHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHHHH
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHcC--CcHHHHHHHHHHHcCCCCCccCHHHHHHH
Confidence 456899999999999999999999998765 68999999999999999997 99999864
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.34 E-value=4.1e-08 Score=73.95 Aligned_cols=67 Identities=18% Similarity=0.302 Sum_probs=56.3
Q ss_pred hhhhhhccHHHHhcccCC--CCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 247 LNEEEIGGLKELFKMIDT--DNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d~--~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++++++.+++++|..+|. |++|.|+.+|+..+|+.+|..++++++..+.. .+.++++. +|++|+.+.
T Consensus 1 Ls~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~~~-~~~~~~~~i~~~eFl~~~ 70 (152)
T d1wdcc_ 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGG-THKMGEKSLPFEEFLPAY 70 (152)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHTTC-CSSTTSCEECHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhhhh-hhcccccccccccccccc
Confidence 356788889999999994 88999999999999999999999999988754 45566665 999998753
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=98.31 E-value=1.5e-07 Score=79.62 Aligned_cols=68 Identities=26% Similarity=0.327 Sum_probs=62.9
Q ss_pred hhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 246 RLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 246 ~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.++.++...++++|..+|.|++|.|+.+|++.+++.+|..+++.++..++..+|.+++|. +|.+|+++
T Consensus 115 ~l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~ 183 (321)
T d1ij5a_ 115 MLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTKGRMSYITLVAV 183 (321)
T ss_dssp CCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHHCCSSTHHHHHHTTS
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCCcccHHHHHHHHHHHhhcCCccccchhhhhh
Confidence 345677778999999999999999999999999999999999999999999999999998 99999875
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.31 E-value=2.8e-07 Score=68.22 Aligned_cols=60 Identities=17% Similarity=0.316 Sum_probs=51.7
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+....+++|..+|.+++|.|+.+|+..+|+.+|..++++++..+ +.+++|. ++++|+.+.
T Consensus 3 ~~~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~~~t~~ei~~~----~~~~~~~i~~~eF~~~~ 63 (140)
T d1ggwa_ 3 DDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEI----ESTLPAEVDMEQFLQVL 63 (140)
T ss_dssp CCTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHH----HTTSCSSEEHHHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCeECHHHHHHHHHHHHhhhHHHhhhhh----hccccccccchhhhhhh
Confidence 34567999999999999999999999999999999999987654 5566666 999998764
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=98.30 E-value=5e-07 Score=69.15 Aligned_cols=62 Identities=19% Similarity=0.191 Sum_probs=55.5
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....++.+|..+|.|++|.|+.+|++.+++.+| +++++++.+++.+|.+++|. +++||+...
T Consensus 100 ~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~--~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~ 162 (176)
T d1nyaa_ 100 LGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTNGNGELSLDELLTAV 162 (176)
T ss_dssp HHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHHccCCChhhhHHHHHHHHHhcC--CcHHHHHHHHHHHCCCCCCcEeHHHHHHHH
Confidence 344578899999999999999999999999886 57899999999999999988 999998753
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=98.29 E-value=5.2e-07 Score=70.17 Aligned_cols=61 Identities=13% Similarity=0.166 Sum_probs=52.4
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++++|+.+|+|++|.|+..|+..+++.+|..++++.++.++.. +.+++|. +|++|+.++
T Consensus 93 ~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~-~~~~dg~i~f~eFi~~~ 154 (188)
T d1qxpa2 93 RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVAR-FADDELIIDFDNFVRCL 154 (188)
T ss_dssp HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHH-TSCSSSBCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHH-hcCCCCcCCHHHHHHHH
Confidence 347889999999999999999999999999999998877777766 5577766 999998764
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.29 E-value=2.2e-07 Score=71.97 Aligned_cols=65 Identities=15% Similarity=0.225 Sum_probs=57.7
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCC-CCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQ-LMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~-~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
++...+.++|..+|.|++|.|+.+|+..+++.++.. .+.++++.+++.+|.+++|. +++||++++
T Consensus 16 ~~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EFl~~~ 82 (181)
T d1hqva_ 16 PDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVW 82 (181)
T ss_dssp SCHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSBCHHHHHHHH
T ss_pred ccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccchhhhHHHhhh
Confidence 445668999999999999999999999999888754 78999999999999998877 999999864
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.27 E-value=1e-07 Score=50.69 Aligned_cols=30 Identities=30% Similarity=0.632 Sum_probs=27.9
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhC
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVG 283 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~ 283 (315)
+++++|+.||.|++|.|+.+||+.+|+.+|
T Consensus 4 el~eAF~~FDkDg~G~Is~~EL~~vm~~lG 33 (33)
T d2hf5a1 4 EIREAFRVFDKDGNGYISAAELRHVMTNLG 33 (33)
T ss_dssp HHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence 689999999999999999999999998765
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=2.6e-07 Score=70.38 Aligned_cols=68 Identities=19% Similarity=0.271 Sum_probs=54.0
Q ss_pred HhhhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 243 IAERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 243 i~~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
|...++++++..++++|..+|+|++|.|+.+|++.++.....+ .++.+++.+|.+++|. +|+||++..
T Consensus 6 ~~t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~~~~~----~~~~l~~~~d~~~~g~i~~~EFl~~~ 74 (165)
T d1auib_ 6 MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNP----LVQRVIDIFDTDGNGEVDFKEFIEGV 74 (165)
T ss_dssp CCCSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHHHTCT----THHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HcCCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhccCCH----HHHHHHHHHccccchhhhhhhhhhhc
Confidence 3445778888899999999999999999999988776654433 4677888999998887 999998653
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=98.19 E-value=1.1e-06 Score=67.24 Aligned_cols=62 Identities=19% Similarity=0.213 Sum_probs=55.0
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.....+..+|..+|.|++|.|+.+|+..+++.+|. +++++..+++.+|.+++|. +++||+.+
T Consensus 91 ~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~--~~~~~~~~f~~~D~d~dG~Is~~Ef~~~ 153 (174)
T d2scpa_ 91 VVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGL--DKTMAPASFDAIDTNNDGLLSLEEFVIA 153 (174)
T ss_dssp HHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CGGGHHHHHHHHCTTCSSEECHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCccccCCHHHHHHHHHHHhh--hhHHHHHHHhhcCCCCCCcEeHHHHHHH
Confidence 34455789999999999999999999999998874 6778999999999999998 99999875
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.18 E-value=7.6e-07 Score=66.17 Aligned_cols=64 Identities=28% Similarity=0.429 Sum_probs=50.9
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++++.+++++|..+|.+++|.|+.+|+..+++.+|...+..++ ++.++.++++. +|++|+..+
T Consensus 2 ~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~~---~~~~~~~~~g~i~~~eF~~~~ 66 (145)
T d2mysb_ 2 DETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEE---LDAMIKEASGPINFTVFLTMF 66 (145)
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHHH---HHHHHHhccCceeechhhhhh
Confidence 56788889999999999999999999999999999966554433 33444556654 999999754
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.16 E-value=1.9e-07 Score=68.89 Aligned_cols=61 Identities=20% Similarity=0.397 Sum_probs=53.6
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhc--cCCCC-CHHHHhhcc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRK--IFSRF-SIKTYCNLS 314 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~--~~~~~-~~~~f~~~~ 314 (315)
+++++|..+|.+++|.|+.+|+..+|+.+|..+++.++..++..++. ++++. +|++|..+.
T Consensus 1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~~~~~~~~~i~~~ef~~~~ 64 (139)
T d1w7jb1 1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPML 64 (139)
T ss_dssp CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHH
T ss_pred CHHHHHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHhcccccCCceeeeccchhh
Confidence 47899999999999999999999999999999999999999987764 45555 999997653
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.16 E-value=1.6e-06 Score=66.90 Aligned_cols=61 Identities=23% Similarity=0.298 Sum_probs=55.0
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.++.+|+.+|.+++|.|+.+|++.+++..|..+++++++.+++.+|.+++|. +|++|+..+
T Consensus 87 ~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d~~~dg~Is~~eF~~~~ 148 (181)
T d1hqva_ 87 DWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGC 148 (181)
T ss_dssp HHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHCSSCSSCBCHHHHHHHH
T ss_pred ccccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3678899999999999999999999999999999999999999999998877 999998653
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.15 E-value=4.2e-07 Score=70.36 Aligned_cols=60 Identities=17% Similarity=0.272 Sum_probs=53.5
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...+..+|..+|.|++|.|+.+|++.+++.+| +++++++.+++.+|.+++|. +++||..+
T Consensus 104 ~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~--l~~~~~~~~f~~~D~d~dG~i~~~EF~~~ 164 (185)
T d2sasa_ 104 QNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLNRYKEL 164 (185)
T ss_dssp HHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHTTTTSCCSHHHHHHH
T ss_pred HHHHHHHHHHHccCCCccCCHHHHHHHHHHcC--CCHHHHHHHHHHcCCCCCCCCcHHHHHHH
Confidence 34578899999999999999999999998766 57788999999999999988 99999864
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.14 E-value=2.5e-07 Score=68.97 Aligned_cols=62 Identities=21% Similarity=0.366 Sum_probs=51.9
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhcc-CCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKI-FSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~-~~~~-~~~~f~~~~ 314 (315)
+.++++|..+|.+++|.|+.+|+..+++.+|..+++++++.++...... .++. ++++|.+++
T Consensus 2 ~~~k~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~~~~~~~~~i~~~ef~~~~ 65 (146)
T d1m45a_ 2 RANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLI 65 (146)
T ss_dssp CCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHH
T ss_pred hHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhccccccccccccccchhhhhh
Confidence 3568899999999999999999999999999999999999999765544 4444 999998764
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.11 E-value=1.8e-06 Score=67.15 Aligned_cols=130 Identities=17% Similarity=0.132 Sum_probs=78.5
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHhhH-hh----hHHHHHHHHHHhhhhhhhhh
Q 021227 178 ESAKDLIRKMLDQNPKRRLTAHEVLCHPWIVDDKVAPDKPLDSAVLSRLKHFS-AM----NKLKKMALRVIAERLNEEEI 252 (315)
Q Consensus 178 ~~~~~li~~~l~~~p~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~i~~~l~~e~~ 252 (315)
.+++.+.++-....|.-+.|..|..+- +... ..+.....+.++-+.- .. -.+.. .+..+.........
T Consensus 21 ~ei~~~~~~F~~~~~~G~i~~~Ef~~~--l~~~----~~~~~~~~~~~lf~~~D~d~dG~I~f~E-f~~~l~~~~~~~~~ 93 (189)
T d1jbaa_ 21 AQLQEWYKKFLEECPSGTLFMHEFKRF--FKVP----DNEEATQYVEAMFRAFDTNGDNTIDFLE-YVAALNLVLRGTLE 93 (189)
T ss_dssp HHHHHHHHHHHSSSTTCCEEHHHHHHH--HHCC----SSSTTHHHHHHHHHHHCCSSSSEECHHH-HHHHHHHHSSCCCT
T ss_pred HHHHHHHHHhcccCCCCeeeHHHHHHH--HHHc----CCCccHHHHHHHHHHhccCCCCeEeehh-HHHHHHhhcccchH
Confidence 456777777667777778877775321 1111 1122233333332110 00 01111 12222222223334
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhC-----------------CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVG-----------------SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~-----------------~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++.+|+.+|.|++|.|+.+|+..+++.+. ....++.++.+|+.+|.+++|. +++||..++
T Consensus 94 ~~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF~~~~ 173 (189)
T d1jbaa_ 94 HKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGA 173 (189)
T ss_dssp HHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHH
T ss_pred HHHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 5678899999999999999999988776541 1122567789999999999997 999999865
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.10 E-value=2.2e-06 Score=66.05 Aligned_cols=63 Identities=16% Similarity=0.242 Sum_probs=51.2
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh-----CCCCCHHH----HHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV-----GSQLMESE----IKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~-----~~~~~~~e----i~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...++.+|+.+|.|++|.|+.+|+..+++.+ +..+++++ ++.+++++|.+++|. +++||..++
T Consensus 94 ~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~dG~Is~~EF~~~~ 166 (180)
T d1xo5a_ 94 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVI 166 (180)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3468889999999999999999999999877 34455444 556888999999987 999998764
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=98.10 E-value=1e-06 Score=68.46 Aligned_cols=61 Identities=18% Similarity=0.224 Sum_probs=51.7
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|+.+|.|++|.|+.+|+..+++.+|..++++.+ +++...|.+++|. +|++|+.++
T Consensus 91 ~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~-~~~~~~d~d~dg~I~f~eFi~~~ 152 (186)
T d1df0a1 91 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLH-QVIVARFADDELIIDFDNFVRCL 152 (186)
T ss_dssp HHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHH-HHHHHHHCCSTTEECHHHHHHHH
T ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHH-HHHHHHHcCCCCeEeHHHHHHHH
Confidence 347789999999999999999999999999999887654 5666789998887 999998754
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=98.09 E-value=4.8e-06 Score=55.75 Aligned_cols=63 Identities=10% Similarity=0.180 Sum_probs=51.4
Q ss_pred hhccHHHHhccc-CCCCC-CcccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 251 EIGGLKELFKMI-DTDNS-GTITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 251 ~~~~l~~~F~~~-d~~~~-g~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+..+..+|..+ ..+++ +.++.+|+++++++ ++.+.+...++.+++.+|.|+||. ||+||+.+
T Consensus 7 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~l 77 (90)
T d3cr5x1 7 AVVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAF 77 (90)
T ss_dssp HHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHH
Confidence 345677888876 45555 58999999999987 345566788999999999999988 99999876
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.08 E-value=2.2e-06 Score=66.04 Aligned_cols=64 Identities=17% Similarity=0.156 Sum_probs=55.2
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHhC------------CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRVG------------SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~------------~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....++.+|..+|.|++|.|+.+|+..+++... ....++.++.+|+++|.+++|. +++||+...
T Consensus 93 ~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~ 169 (181)
T d1bjfa_ 93 LEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGA 169 (181)
T ss_dssp HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEECHHHHHHHH
T ss_pred hHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 344678899999999999999999999998753 2456789999999999999998 999998753
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.07 E-value=2.2e-06 Score=66.49 Aligned_cols=63 Identities=22% Similarity=0.247 Sum_probs=52.6
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhC------------CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVG------------SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~------------~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...++.+|+.+|.|++|.|+.+|+..+++.+. ....++.++.+++++|.+++|. +++||...+
T Consensus 95 ~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~~~~ 170 (187)
T d1g8ia_ 95 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGS 170 (187)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEEEHHHHHHHH
T ss_pred hhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 34588899999999999999999999887542 2234678999999999999997 999998753
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.06 E-value=6.2e-07 Score=69.45 Aligned_cols=60 Identities=25% Similarity=0.407 Sum_probs=55.2
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.+++|.|+.++++.+++.+| +++.++..+++.+|.+++|. +|+||++++
T Consensus 82 e~l~~aF~~~D~d~~G~i~~~el~~~l~~~g--l~~~ev~~~f~~~D~d~DG~Is~~EF~~~m 142 (182)
T d1s6ia_ 82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQDNDGQIDYGEFAAMM 142 (182)
T ss_dssp CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSSSSSEEETTHHHHTT
T ss_pred HHHHHHHHHHhhcCCCccchhhhhhhhhhcC--ccHHHHHHHHHHhhcCCCCeEeHHHHHHHH
Confidence 4678899999999999999999999998876 68899999999999999988 999999886
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.03 E-value=1.9e-06 Score=65.90 Aligned_cols=66 Identities=17% Similarity=0.216 Sum_probs=57.0
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCC-----CCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQ-----LMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~-----~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++...+++.|..++ ++||.|+..||+.+|+.+|.. ++.+++..++..+|.+++|. +|+||+.+.
T Consensus 2 p~~~~~~~~~~F~~~~-~~dG~Is~~EL~~~L~~~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I~f~EF~~~~ 73 (172)
T d1juoa_ 2 PGQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELW 73 (172)
T ss_dssp TTCCCCTTHHHHHHHH-TTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHH
T ss_pred CcchHHHHHHHHHHhC-CCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHHCCCCCCceehHHHHHHH
Confidence 3456677899999986 789999999999999999854 56899999999999999988 999998753
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=98.03 E-value=2.6e-06 Score=65.13 Aligned_cols=60 Identities=20% Similarity=0.223 Sum_probs=48.6
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
....+|+.+|.+++|.|+.+|++.+|+..|..+++++++.++ ..+.+++|. +++||+.++
T Consensus 78 ~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~~~~-~~d~d~~G~i~~~EF~~~~ 138 (173)
T d1alva_ 78 KWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMII-RRYSDEGGNMDFDNFISCL 138 (173)
T ss_dssp HHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHH-HHHTCSSSCBCHHHHHHHH
T ss_pred HHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHHHhh-ccccCCCCeEeHHHHHHHH
Confidence 356788889999999999999999999999888887777666 455577777 999998754
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=98.02 E-value=2e-06 Score=62.64 Aligned_cols=58 Identities=24% Similarity=0.462 Sum_probs=51.2
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhccC
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLSL 315 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~~ 315 (315)
.++.+|+.+|.+++|.|+.+|+..+++.++. +++.++++++|.+++|. +++||+.++.
T Consensus 76 ~~~~~F~~~D~~~~g~i~~~el~~~~~~~~~----~~~~~~~~~~D~d~dG~is~~EF~~~~l 134 (134)
T d1jfja_ 76 GLKVLYKLMDVDGDGKLTKEEVTSFFKKHGI----EKVAEQVMKADANGDGYITLEEFLEFSL 134 (134)
T ss_dssp HHHHHHHHHCCSSSSEEEHHHHHHHHTTTTC----HHHHHHHHHHHCSSSSEEEHHHHHHHHC
T ss_pred cccccccccccccCCcccHHHHHHHHHhcCc----HHHHHHHHHHCCCCCCCCCHHHHHHHhC
Confidence 4578999999999999999999999886654 58889999999999998 9999998763
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=98.01 E-value=1.6e-06 Score=73.03 Aligned_cols=62 Identities=19% Similarity=0.217 Sum_probs=56.7
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCC-CCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGS-QLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~-~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..+..+|..+|.|++|.|+.+|++.++..+|. .+++.++..+++.+|.+++|. +|+||+.++
T Consensus 253 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~m 316 (321)
T d1ij5a_ 253 LVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLV 316 (321)
T ss_dssp HHHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHH
T ss_pred hHHHHHHHHHhcCCCCCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 34567899999999999999999999999997 488999999999999999988 999999875
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.99 E-value=3.7e-06 Score=64.22 Aligned_cols=59 Identities=22% Similarity=0.352 Sum_probs=49.6
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCCCHHHHhhcc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRFSIKTYCNLS 314 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~~~~~f~~~~ 314 (315)
..+.|+.+|.+++|.|+.+|+..++..+|..+++++++.+++++|.++ .+++++|.+++
T Consensus 79 ~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d~~g-~i~~~eF~~~~ 137 (172)
T d1juoa_ 79 WRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYSTNG-KITFDDYIACC 137 (172)
T ss_dssp HHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTCSSS-SEEHHHHHHHH
T ss_pred hhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHHhcC-CcCHHHHHHHH
Confidence 567899999999999999999999999999999999998888876442 24777776653
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.98 E-value=3.5e-06 Score=65.52 Aligned_cols=63 Identities=22% Similarity=0.282 Sum_probs=53.3
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCC------------CCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGS------------QLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~------------~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
...++.+|+.+|.|++|.|+.+|+..+++.... ...++.++++|+++|.+++|. +++||...+
T Consensus 98 ~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~~~~ 173 (190)
T d1fpwa_ 98 EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGS 173 (190)
T ss_dssp THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 456889999999999999999999999987632 122678999999999999998 999998754
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=97.89 E-value=3.4e-06 Score=64.49 Aligned_cols=63 Identities=14% Similarity=0.235 Sum_probs=54.9
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCC--------CCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQ--------LMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~--------~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+++++++++|..+| +.+|.|+..||+.+|..+|.. ++.+.+..++...|.+++|. ++++|+++
T Consensus 1 ee~~~~r~~F~~~d-~~dg~I~~~EL~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~~d~d~~g~i~~~ef~~~ 72 (173)
T d1alva_ 1 EEVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYL 72 (173)
T ss_dssp CHHHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHH
T ss_pred ChHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHhCCCcchhhhccCCHHHHHHHHHHhccCCCCcccchhhhhh
Confidence 46778999999999 458999999999999988633 56789999999999999987 99999875
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=97.89 E-value=5.3e-06 Score=56.09 Aligned_cols=64 Identities=16% Similarity=0.122 Sum_probs=51.8
Q ss_pred hhccHHHHhccc-CCCCC-CcccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 251 EIGGLKELFKMI-DTDNS-GTITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 251 ~~~~l~~~F~~~-d~~~~-g~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.+..+..+|..+ ..+++ +.++.+||+.+++. ++.+-+...++++++.+|.|+||. ||+||+.+.
T Consensus 7 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li 78 (95)
T d1qlsa_ 7 CIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLI 78 (95)
T ss_dssp HHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHH
Confidence 345577888765 45565 68999999999976 555667888999999999999988 999998763
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.84 E-value=6.9e-06 Score=62.16 Aligned_cols=65 Identities=23% Similarity=0.316 Sum_probs=54.7
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHh-CCCCC----HHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV-GSQLM----ESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~-~~~~~----~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
.....+..+|..+|.|++|.|+.+|+...++.. +..++ +..+..++.++|.+++|. +++||.+++
T Consensus 82 ~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dG~Is~~EF~~i~ 152 (165)
T d1auib_ 82 DKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVV 152 (165)
T ss_dssp CHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTTSSSSEEHHHHHHHH
T ss_pred hhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence 345568999999999999999999999998764 44444 666888999999999998 999998764
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.84 E-value=8.4e-06 Score=41.27 Aligned_cols=31 Identities=29% Similarity=0.559 Sum_probs=27.5
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhC
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVG 283 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~ 283 (315)
+++.+.|..||+|+||.|+.+|+..+++..|
T Consensus 4 eELae~FRifDkNaDGyiD~eEl~~ilr~tG 34 (34)
T d1ctda_ 4 EELANAFRIFDKNADGYIDIEELGEILRATG 34 (34)
T ss_dssp HHHHHHHHTTCCSSSSCBCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCcccccHHHHHHHHHhcC
Confidence 4588999999999999999999999988654
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.84 E-value=6.6e-06 Score=63.78 Aligned_cols=60 Identities=20% Similarity=0.215 Sum_probs=44.9
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+..+|..+|.|++|.|++.|+..++..+.....++.+..+++.+|.+++|. +.+|+..+
T Consensus 59 ~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~~~F~~~D~d~~g~i~~~E~~~~ 119 (189)
T d1jbaa_ 59 YVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDI 119 (189)
T ss_dssp HHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSSCSSCBCHHHHHHH
T ss_pred HHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHhhhccCCCCcccHhHHHHH
Confidence 4677778888888888888888777777766666777777888888777776 77777654
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=97.81 E-value=2.6e-05 Score=59.88 Aligned_cols=62 Identities=16% Similarity=0.218 Sum_probs=50.8
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHH----hCCCCCHHH----HHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKR----VGSQLMESE----IKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~----~~~~~~~~e----i~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++.+|..+|.|++|.|+.+|++.++.. .|...++.+ +..+++++|.+++|. +++||..++
T Consensus 91 ~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~ 161 (183)
T d2zfda1 91 DKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLV 161 (183)
T ss_dssp HHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHH
T ss_pred HHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 35788999999999999999999987754 366666655 556788899999998 999998754
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=97.78 E-value=1.2e-05 Score=54.21 Aligned_cols=63 Identities=16% Similarity=0.224 Sum_probs=47.1
Q ss_pred hhccHHHHhcccC-CCCC-CcccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 251 EIGGLKELFKMID-TDNS-GTITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 251 ~~~~l~~~F~~~d-~~~~-g~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+..+..+|..+. .+++ ++++.+|++.+++. ++.+.+...++++++.+|.++||. ||+||+.+
T Consensus 7 ai~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~l 77 (94)
T d1j55a_ 7 AMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVF 77 (94)
T ss_dssp HHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHH
Confidence 3445778888764 4444 58999999999987 334455678999999999999998 99999876
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.76 E-value=3.6e-05 Score=60.01 Aligned_cols=62 Identities=18% Similarity=0.153 Sum_probs=51.8
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCC--------------CHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQL--------------MESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~--------------~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...++.+|+.+|.|++|.|+.+|+...++.+.... .++.++.+|+.+|.+++|. +++||+..
T Consensus 98 ~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~ 174 (201)
T d1omra_ 98 NQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKKDDDKLTEKEFIEG 174 (201)
T ss_dssp GGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTCCTTCCBCHHHHHHH
T ss_pred HHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 34688999999999999999999999888764322 2456789999999999987 99999864
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.73 E-value=1.9e-05 Score=61.10 Aligned_cols=59 Identities=19% Similarity=0.328 Sum_probs=54.8
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...+|..+|.+++|.|+++|+..++..++....++.++.+|+.+|.+++|. +.+|+..+
T Consensus 65 ~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~~e~~~~~F~~~D~d~dG~is~~E~~~~ 124 (190)
T d1fpwa_ 65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTI 124 (190)
T ss_dssp HHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHHHHH
T ss_pred HHHHHHHhCcCCCCcccHHHHHHHHHHHccCchHHHHHHHHHHhccCCCCcCcHHHHHHH
Confidence 468999999999999999999999999998888999999999999999998 99998765
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=97.67 E-value=9.1e-06 Score=62.81 Aligned_cols=64 Identities=27% Similarity=0.324 Sum_probs=53.6
Q ss_pred hhhh-ccHHHHhcccCCCCCCcccHHHHHHHHHHhCC--------CCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 249 EEEI-GGLKELFKMIDTDNSGTITFDELKDGLKRVGS--------QLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 249 ~e~~-~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~--------~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
.+++ ..++++|..+| +++|.|+..||..+|..+|. .++.+++..++..+|.+++|. +|+||.++
T Consensus 13 ~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~ 86 (186)
T d1df0a1 13 EEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYIL 86 (186)
T ss_dssp CSCSCHHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCSSSSEECHHHHHHH
T ss_pred HHHHHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 3444 35889999998 89999999999999988753 357889999999999999987 99999875
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.62 E-value=6.5e-05 Score=57.27 Aligned_cols=62 Identities=15% Similarity=0.235 Sum_probs=49.8
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhC------------CCCCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVG------------SQLMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~------------~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
..++.+|..+|.|++|.|+.+|+...+..+. ....+..++.+|+.+|.+++|. +++||....
T Consensus 87 ~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~DG~Is~~EF~~~i 161 (178)
T d1s6ca_ 87 EKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESC 161 (178)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHT
T ss_pred HHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 4578899999999999999999988765431 2233667889999999999998 999998754
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=3e-05 Score=58.51 Aligned_cols=48 Identities=10% Similarity=0.222 Sum_probs=22.3
Q ss_pred CCCCcccHHHHHHHHHHhCCC-----CCHHHHHHHHHHHhccCCCC-CHHHHhh
Q 021227 265 DNSGTITFDELKDGLKRVGSQ-----LMESEIKDLMDAVRKIFSRF-SIKTYCN 312 (315)
Q Consensus 265 ~~~g~i~~~el~~~l~~~~~~-----~~~~ei~~~~~~~d~~~~~~-~~~~f~~ 312 (315)
+.+|.|+.+||+.+|+..|.. ++.+.++.++..+|.+++|. +|+||..
T Consensus 11 ~~dG~I~~~EL~~~L~~~g~~~~~~~~s~~~~~~li~~~D~~~~G~i~~~EF~~ 64 (165)
T d1k94a_ 11 GQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKE 64 (165)
T ss_dssp GGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 344555555555555444432 23344444555555444444 5555443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.60 E-value=1.8e-05 Score=64.31 Aligned_cols=85 Identities=16% Similarity=0.203 Sum_probs=57.8
Q ss_pred CCCcceEEEEEEeCCeEEEEEeccCCCchhHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------
Q 021227 7 HQHVVRIHDTYEDKSCVHIVMELCEGGELFDRIVKKGNYSEREAAKLMKTIVGVVECCHSL------------------- 67 (315)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~------------------- 67 (315)
+=-+.+++.+.++++..++||++++|.++.+... +......++.++...++.||+.
T Consensus 69 ~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~ 143 (263)
T d1j7la_ 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELD 143 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHH
T ss_pred cCCCCcEEEEEecCCceEEEEEeccccccccccc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHH
Confidence 3336778888899999999999999987754331 1112233444555555555531
Q ss_pred ----------------------------------------CCccccCCCCceeeccCCCCCCEEEeeccCcc
Q 021227 68 ----------------------------------------GVFHRDLKPENFLFLSVDEDAALKATDFGLSV 99 (315)
Q Consensus 68 ----------------------------------------~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~ 99 (315)
.++|+|+.|.||++ ++++.+-|+||+.+.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 144 YLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred HHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceee---cCCceEEEeechhcc
Confidence 37899999999995 344555799998664
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=97.49 E-value=5.3e-05 Score=58.09 Aligned_cols=60 Identities=15% Similarity=0.239 Sum_probs=45.5
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCC-CCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQ-LMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~-~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
....+|..+|.|++|.|++.|+..++..+-.. ..++.+..+++.+|.+++|. +.+|+..+
T Consensus 55 ~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~e~~~~ 116 (183)
T d2zfda1 55 FADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQM 116 (183)
T ss_dssp HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHH
T ss_pred HHHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhcccccCCCCCccHHHHHHH
Confidence 35788888888888888888888877766433 34667888888888888887 77777654
|
| >d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=97.45 E-value=0.00013 Score=43.87 Aligned_cols=70 Identities=17% Similarity=0.273 Sum_probs=60.4
Q ss_pred hhhhhhhhccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhcc-CCCC--CHHHHhhcc
Q 021227 245 ERLNEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKI-FSRF--SIKTYCNLS 314 (315)
Q Consensus 245 ~~l~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~-~~~~--~~~~f~~~~ 314 (315)
+.+.+++..+..++|..||.|..+.-..++-..++.++|..++..|.+.++++.+-. ++.. .-+|++.+.
T Consensus 6 ralgpeekdecmkifdifdrnaeniapvsdtmdmltklgqtytkreteaimkeargpkgdkknigpeewltlc 78 (86)
T d1j7qa_ 6 RALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPEEWLTLC 78 (86)
T ss_dssp CCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTTHHHHHH
T ss_pred cccCchhHHHHHHHHHHHhccccccCCcchHHHHHHHhhhHHhHHHHHHHHHHhcCCCCccccCCHHHHHHHH
Confidence 446678888999999999999999999999999999999999999999999999966 4444 667877653
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=97.42 E-value=0.00016 Score=47.20 Aligned_cols=63 Identities=16% Similarity=0.234 Sum_probs=48.2
Q ss_pred hccHHHHhcccC-CCCC-CcccHHHHHHHHHH-hC----CC-CCHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 252 IGGLKELFKMID-TDNS-GTITFDELKDGLKR-VG----SQ-LMESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 252 ~~~l~~~F~~~d-~~~~-g~i~~~el~~~l~~-~~----~~-~~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+..+..+|..+. .+++ +.++..|++.+++. ++ .+ -+..-++.+++.+|.|+||. ||.||+.+.
T Consensus 9 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li 80 (83)
T d1xk4c1 9 IETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLM 80 (83)
T ss_dssp HHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHH
Confidence 445677887764 3444 69999999999986 33 22 24556899999999999988 999999763
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=97.37 E-value=5.7e-06 Score=64.12 Aligned_cols=65 Identities=22% Similarity=0.301 Sum_probs=40.2
Q ss_pred hhhhh-ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCC--------CCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 248 NEEEI-GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQ--------LMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 248 ~~e~~-~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~--------~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+.+++ ..++++|..+| +++|.|+..||+.++...+.. ++.+.++.++..+|.+++|. +|+||..+
T Consensus 14 s~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d~~G~i~~~EF~~l 88 (188)
T d1qxpa2 14 SEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNIL 88 (188)
T ss_dssp -------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHH
T ss_pred CHHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCCCCCcccHHHHHHH
Confidence 34444 35889999999 558999999998887655432 56688999999999999987 99999865
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.31 E-value=7.6e-05 Score=56.87 Aligned_cols=59 Identities=12% Similarity=0.245 Sum_probs=45.9
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...+|..+|.|++|.|+++|+..++..+.....++.+..+++.+|.+++|. +.+|+..+
T Consensus 53 ~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~e~~~~ 112 (178)
T d1s6ca_ 53 AHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDI 112 (178)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSCEEHHHHHHH
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHHhccchHHHHHHHHHhhccCCCCeecHHHHHHH
Confidence 467888888888888888888887776665566778888888888888877 77777654
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.31 E-value=9.1e-05 Score=57.63 Aligned_cols=59 Identities=14% Similarity=0.159 Sum_probs=52.7
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...+|..+|.|++|.|++.|+..++..+.....++.+..+|+.+|.+++|. +.+||..+
T Consensus 65 ~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~is~~E~~~~ 124 (201)
T d1omra_ 65 AQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNGTISKNEVLEI 124 (201)
T ss_dssp HHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSCGGGSHHHHHHHHCTTCSSSBCHHHHHHH
T ss_pred HHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHHHHccCCCCccCHHHHHHH
Confidence 567899999999999999999999988877777888999999999999998 99988754
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.17 E-value=7.2e-05 Score=57.16 Aligned_cols=59 Identities=19% Similarity=0.244 Sum_probs=46.6
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
..++|..+|.+++|.|+++|+..++...-....++.+..+++.+|.+++|. +.+||..+
T Consensus 61 ~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~ 120 (181)
T d1bjfa_ 61 AEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEI 120 (181)
T ss_dssp HHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHH
T ss_pred HHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchHHHHHHHHHHhccCCCCeecHHHHHHH
Confidence 467888888888888888888888877766666778888888888888887 77777654
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.04 E-value=0.00021 Score=54.83 Aligned_cols=59 Identities=12% Similarity=0.240 Sum_probs=51.6
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
...+|..+|.+++|.|+++|+..++..+.....++.+..+|+.+|.+++|. +.+|+..+
T Consensus 62 ~~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~e~l~~~F~~~D~d~dG~i~~~El~~~ 121 (187)
T d1g8ia_ 62 ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDI 121 (187)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSEEEHHHHHHH
T ss_pred HHHHHHHhCcCCCCCCcHHHHHHHHHHhccCchhhhHHHHHHHHhcCCCCeEcHHHHHHH
Confidence 456899999999999999999999988766666888999999999999998 88887654
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=96.88 E-value=0.00046 Score=52.73 Aligned_cols=66 Identities=15% Similarity=0.216 Sum_probs=50.7
Q ss_pred hhhhhccHHHHhcccCCCCCCcccHHHHHHH-----HHHhCCCCCHHHHHHHHHHHhccC-----CC-CCHHHHhhc
Q 021227 248 NEEEIGGLKELFKMIDTDNSGTITFDELKDG-----LKRVGSQLMESEIKDLMDAVRKIF-----SR-FSIKTYCNL 313 (315)
Q Consensus 248 ~~e~~~~l~~~F~~~d~~~~g~i~~~el~~~-----l~~~~~~~~~~ei~~~~~~~d~~~-----~~-~~~~~f~~~ 313 (315)
+++.++.++++|..+|.|++|.|+.+|+... ++.+|...++.++...+.+.+... .+ +++++|...
T Consensus 9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~e~~~~ 85 (189)
T d1qv0a_ 9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDG 85 (189)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHhhhccccCCCceehHHHHHH
Confidence 4567778999999999999999999999764 456788888888887777776442 22 377777654
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=96.85 E-value=0.00025 Score=53.95 Aligned_cols=67 Identities=22% Similarity=0.334 Sum_probs=48.7
Q ss_pred hhhhhhccHHHHhcc-cCCCCCCcccHHHHHHHHHHhCC----CCCH-----------HHHHHHHHHHhccCCCC-CHHH
Q 021227 247 LNEEEIGGLKELFKM-IDTDNSGTITFDELKDGLKRVGS----QLME-----------SEIKDLMDAVRKIFSRF-SIKT 309 (315)
Q Consensus 247 l~~e~~~~l~~~F~~-~d~~~~g~i~~~el~~~l~~~~~----~~~~-----------~ei~~~~~~~d~~~~~~-~~~~ 309 (315)
++..+...++.+|.. +|.|++|.|+.+|+..+++.++. .... .....+....+.++++. ++++
T Consensus 2 lt~~q~~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~ 81 (185)
T d2sasa_ 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEE 81 (185)
T ss_dssp CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHH
T ss_pred cCHHHHHHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeH
Confidence 345677789999996 59999999999999999877641 1222 22344566677777776 9999
Q ss_pred Hhhc
Q 021227 310 YCNL 313 (315)
Q Consensus 310 f~~~ 313 (315)
|...
T Consensus 82 ~~~~ 85 (185)
T d2sasa_ 82 YLAM 85 (185)
T ss_dssp HHHH
T ss_pred hhHH
Confidence 8754
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.82 E-value=0.0011 Score=50.38 Aligned_cols=59 Identities=8% Similarity=0.091 Sum_probs=50.2
Q ss_pred HHHHhcccCCC-CCCcccHHHHHHHHHHhC-CCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 255 LKELFKMIDTD-NSGTITFDELKDGLKRVG-SQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 255 l~~~F~~~d~~-~~g~i~~~el~~~l~~~~-~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
..++|..+|.+ ++|.|+++|+..++..+. ....++.+..+|+.+|.+++|. +.+|+..+
T Consensus 59 ~~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~ 120 (180)
T d1xo5a_ 59 KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRL 120 (180)
T ss_dssp HHHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHH
T ss_pred HHHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHH
Confidence 46789999987 689999999999998775 4455788999999999999998 98888764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.81 E-value=0.00039 Score=55.77 Aligned_cols=26 Identities=12% Similarity=0.215 Sum_probs=22.3
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCch
Q 021227 10 VVRIHDTYEDKSCVHIVMELCEGGEL 35 (315)
Q Consensus 10 iv~~~~~~~~~~~~~lv~E~~~gg~L 35 (315)
+.+++.+..+++..++|||+++|-++
T Consensus 68 vP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 68 CAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCceeeecccccceEEEEEeeecccc
Confidence 66788888888899999999998665
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=96.62 E-value=0.00096 Score=50.05 Aligned_cols=34 Identities=26% Similarity=0.336 Sum_probs=29.7
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhC
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG 283 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~ 283 (315)
...++++++|+.+|.|++|.|+.+|+..+++.++
T Consensus 3 ~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~~ 36 (174)
T d2scpa_ 3 LWVQKMKTYFNRIDFDKDGAITRMDFESMAERFA 36 (174)
T ss_dssp HHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHccCCCCcEeHHHHHHHHHHHh
Confidence 3566789999999999999999999999887664
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=96.48 E-value=0.00089 Score=50.86 Aligned_cols=65 Identities=17% Similarity=0.169 Sum_probs=46.4
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHH-----hCCCCCHHHHHHHHHHHhccC------CCCCHHHHhhc
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKR-----VGSQLMESEIKDLMDAVRKIF------SRFSIKTYCNL 313 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~-----~~~~~~~~ei~~~~~~~d~~~------~~~~~~~f~~~ 313 (315)
+..+..++++|..+|.|++|.|+.+|+...+.. +|...++.++...+...+... ..+++.+|+..
T Consensus 8 p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (187)
T d1uhka1 8 PRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEG 83 (187)
T ss_dssp HHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhccCccHHHHHHHHHHhhhhcccccccccccHHHHHHH
Confidence 345677899999999999999999999776644 566667777666666555331 12377777643
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.38 E-value=0.00097 Score=50.14 Aligned_cols=60 Identities=12% Similarity=0.099 Sum_probs=37.4
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHhCCC----------CCHHHHHHHHHHHhccCC----CC-CHHHHhhc
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRVGSQ----------LMESEIKDLMDAVRKIFS----RF-SIKTYCNL 313 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~----------~~~~ei~~~~~~~d~~~~----~~-~~~~f~~~ 313 (315)
++..+|..+|.|++|.||.+||...|...+.. .+++.+.++++.+..+.+ |. ++++|+..
T Consensus 79 ei~~~F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ls~d~F~~f 153 (170)
T d2zkmx1 79 EIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWF 153 (170)
T ss_dssp HHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHccccccccCCeECHHHHHHH
Confidence 47789999999999999999999999886543 577889999999987743 44 99999873
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.99 E-value=0.0035 Score=53.68 Aligned_cols=28 Identities=21% Similarity=0.298 Sum_probs=22.7
Q ss_pred CCccccCCCCceeeccCCCCCCEEEeeccCcc
Q 021227 68 GVFHRDLKPENFLFLSVDEDAALKATDFGLSV 99 (315)
Q Consensus 68 ~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~ 99 (315)
.++|||+.|.|||+ ++ +.++++||..+.
T Consensus 224 ~LiHGDl~~gNIlv---~~-~~~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFA---SE-HETKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEE---CS-SCEEECCCTTCE
T ss_pred ceeccCCcCCceeE---cC-CceEEechhhcc
Confidence 58999999999996 33 348999998764
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=95.97 E-value=0.0075 Score=41.38 Aligned_cols=55 Identities=11% Similarity=0.233 Sum_probs=41.4
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+.+++..+| .+|.|++.|+...+.. ..-+++++..+|+.+|.+++|. +.+|+..+
T Consensus 11 i~~~~~~~~--~~G~idf~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~ 66 (109)
T d5pala_ 11 INKAISAFK--DPGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFIEEEELKGV 66 (109)
T ss_dssp HHHHHHHTC--STTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHCTTCSSEECHHHHHTH
T ss_pred HHHHHHhcC--CCCcCcHHHHHHHHHh--cCCCHHHHHHHHhhhcCCCCCeEcHHHHHHH
Confidence 445555544 4689999999865532 2346889999999999999998 99998654
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.96 E-value=9.8e-05 Score=55.90 Aligned_cols=58 Identities=10% Similarity=0.019 Sum_probs=38.1
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
..+..+|...|.+++|.|+++|+...++.+. .+.+|..+|+.+|.+++|. +.+||...
T Consensus 45 ~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~---~r~ei~~~F~~~d~d~~~~it~~el~~f 103 (170)
T d2zkmx1 45 SACHLPKGKNDAINPEDFPEPVYKSFLMSLC---PRPEIDEIFTSYHAKAKPYMTKEHLTKF 103 (170)
T ss_dssp HHTTCCCCTTCEECGGGCCHHHHHHHHHHHS---CCHHHHTTCC--------CCCHHHHHHH
T ss_pred HHHhhhhccccccCCCccCHHHHHHHHhccC---CHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 3555667778888999999999998888774 3578888999999888775 77776543
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=95.92 E-value=0.0075 Score=41.36 Aligned_cols=47 Identities=11% Similarity=0.152 Sum_probs=38.3
Q ss_pred CCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 265 DNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 265 ~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+++|.|+++|+..++.. ...+++++..+|+.+|.+++|. +.+|+..+
T Consensus 19 d~dG~idf~EF~~~~~~--~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~ 66 (109)
T d1pvaa_ 19 KAEGSFNHKKFFALVGL--KAMSANDVKKVFKAIDADASGFIEEEELKFV 66 (109)
T ss_dssp CSTTCCCHHHHHHHHTC--TTSCHHHHHHHHHHHCTTCSSSBCHHHHHTG
T ss_pred CCCCCCcHHHHHHHHHH--ccCCHHHHHHHhhCccCCCcCeEcHHHHHHH
Confidence 56789999999776532 2346889999999999999998 99998755
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=95.67 E-value=0.0055 Score=40.74 Aligned_cols=33 Identities=15% Similarity=0.306 Sum_probs=28.4
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
.....+.++|..+|.|+||.|+++|+..++..+
T Consensus 49 ~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l 81 (93)
T d3c1va1 49 TDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI 81 (93)
T ss_dssp CSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Confidence 344568999999999999999999999988765
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=95.63 E-value=0.0068 Score=40.18 Aligned_cols=32 Identities=13% Similarity=0.254 Sum_probs=27.6
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
....+.++|..+|.|+||.|+++|+..++..+
T Consensus 47 ~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 78 (92)
T d1a4pa_ 47 DPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGL 78 (92)
T ss_dssp CTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHH
Confidence 34568999999999999999999998887654
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=95.57 E-value=0.0051 Score=38.07 Aligned_cols=29 Identities=24% Similarity=0.548 Sum_probs=25.9
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
.++.++|..+|.|++|.|+++|+..++++
T Consensus 37 ~~i~~~~~~~D~d~dg~I~~~EF~~~m~~ 65 (67)
T d1tiza_ 37 EDIVKFFEEIDVDGNGELNADEFTSCIEK 65 (67)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 35789999999999999999999998875
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=95.43 E-value=0.0077 Score=39.38 Aligned_cols=32 Identities=16% Similarity=0.344 Sum_probs=27.8
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
....+.++++.+|.|+||.|+++|+..++..+
T Consensus 49 ~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l 80 (87)
T d1e8aa_ 49 DKAVIDEIFQGLDANQDEQVDFQEFISLVAIA 80 (87)
T ss_dssp SHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence 44578999999999999999999998887654
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=95.41 E-value=0.0047 Score=45.89 Aligned_cols=60 Identities=13% Similarity=0.195 Sum_probs=42.0
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhC----CCCCHHHHHH-----------HHHHHhccCCCC-CHHHHhh
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVG----SQLMESEIKD-----------LMDAVRKIFSRF-SIKTYCN 312 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~----~~~~~~ei~~-----------~~~~~d~~~~~~-~~~~f~~ 312 (315)
+.++++|+.+|.|++|.|+.+|++.++..++ ......++.. ++...+.++++. ++.++..
T Consensus 7 ~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 82 (176)
T d1nyaa_ 7 DRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIR 82 (176)
T ss_dssp HHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccHHHHHH
Confidence 4578999999999999999999999987653 3344334433 344444555554 7777654
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.30 E-value=0.0045 Score=31.08 Aligned_cols=27 Identities=15% Similarity=0.245 Sum_probs=24.0
Q ss_pred CHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 287 MESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 287 ~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+++|+.+.|+.+|+|.||+ |.+||-.+
T Consensus 2 sEeELae~FRifDkNaDGyiD~eEl~~i 29 (34)
T d1ctda_ 2 SEEELANAFRIFDKNADGYIDIEELGEI 29 (34)
T ss_dssp HHHHHHHHHHTTCCSSSSCBCHHHHHHH
T ss_pred CHHHHHHHHHHHccCCcccccHHHHHHH
Confidence 5789999999999999999 99998654
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=95.22 E-value=0.012 Score=38.51 Aligned_cols=30 Identities=23% Similarity=0.429 Sum_probs=26.9
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
..+.++++.+|.|+||.|+++|+..++..+
T Consensus 49 ~~v~~i~~~~D~n~DG~IdF~EF~~l~~~l 78 (87)
T d1xk4a1 49 KGADVWFKELDINTDGAVNFQEFLILVIKM 78 (87)
T ss_dssp TCHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 458899999999999999999999988764
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=95.05 E-value=0.0056 Score=40.69 Aligned_cols=32 Identities=16% Similarity=0.282 Sum_probs=28.1
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
....+.++++.+|.|+||.|+++|+..++..+
T Consensus 50 ~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l 81 (93)
T d1ksoa_ 50 RECDYNKFMSVLDTNKDCEVDFVEYVRSLACL 81 (93)
T ss_dssp CHHHHHHHHHHHHHTTTCEECHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 44578999999999999999999999888765
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=95.02 E-value=0.018 Score=39.36 Aligned_cols=55 Identities=9% Similarity=0.126 Sum_probs=41.6
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+.+++..+ +.+|.|++.|+...+... ..++.++..+|+.+|.+++|. +.+||..+
T Consensus 11 i~~~~~~~--~~~~~i~f~eF~~~~~~~--~~~~~~~~~~F~~~D~d~~G~I~~~El~~~ 66 (109)
T d1rwya_ 11 IKKAIGAF--TAADSFDHKKFFQMVGLK--KKSADDVKKVFHILDKDKSGFIEEDELGSI 66 (109)
T ss_dssp HHHHHHTT--CSTTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHSTTCSSEECHHHHHTH
T ss_pred HHHHHHhc--ccCCCcCHHHHHHHHccc--cCCHHHHHHHhhcccCCCCCcCcHHHHHHH
Confidence 34444444 345889999997776432 246889999999999999998 99998765
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=95.02 E-value=0.016 Score=37.23 Aligned_cols=30 Identities=33% Similarity=0.540 Sum_probs=26.6
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
.++.++|..+|.|++|.|+++|+..+++..
T Consensus 41 ~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~ 70 (81)
T d2opoa1 41 DEVRRMMAEIDTDGDGFISFDEFTDFARAN 70 (81)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHHC
Confidence 357899999999999999999999988764
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=94.87 E-value=0.0093 Score=37.86 Aligned_cols=30 Identities=23% Similarity=0.568 Sum_probs=27.1
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
..+.+++..+|.|++|.|+++|+..++.++
T Consensus 45 ~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~ 74 (76)
T d1qx2a_ 45 STLDEMIEEVDKNGDGEVSFEEFLVMMKKI 74 (76)
T ss_dssp CSHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCcCcHHHHHHHHHHH
Confidence 458999999999999999999999988765
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=94.71 E-value=0.011 Score=39.23 Aligned_cols=32 Identities=16% Similarity=0.405 Sum_probs=27.7
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
....+.++|+.+|.|+||.|+++|+..++..+
T Consensus 50 ~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l 81 (93)
T d1zfsa1 50 DADAVDKIMKELDENGDGEVDFQEFVVLVAAL 81 (93)
T ss_dssp CHHHHHHHHHHHTTTCCSEECSHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 34568899999999999999999999988655
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=94.70 E-value=0.019 Score=29.69 Aligned_cols=28 Identities=18% Similarity=0.179 Sum_probs=25.0
Q ss_pred CHHHHHHHHHHHhccCCCC-CHHHHhhcc
Q 021227 287 MESEIKDLMDAVRKIFSRF-SIKTYCNLS 314 (315)
Q Consensus 287 ~~~ei~~~~~~~d~~~~~~-~~~~f~~~~ 314 (315)
+++|+.+.|+.+|++++|. +.+|+..++
T Consensus 1 seeel~eAF~~FDkDg~G~Is~~EL~~vm 29 (33)
T d2hf5a1 1 SEEEIREAFRVFDKDGNGYISAAELRHVM 29 (33)
T ss_dssp CHHHHHHHHHHHSSSCCSCBCHHHHHHHT
T ss_pred CHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 5789999999999999998 999987765
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=94.69 E-value=0.015 Score=39.07 Aligned_cols=32 Identities=22% Similarity=0.335 Sum_probs=28.0
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
....+.++|+.+|.|+||.|+++|+..++..+
T Consensus 50 ~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 81 (100)
T d1psra_ 50 GTNYLADVFEKKDKNEDKKIDFSEFLSLLGDI 81 (100)
T ss_dssp TCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence 45668899999999999999999999888764
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=94.67 E-value=0.017 Score=36.60 Aligned_cols=30 Identities=23% Similarity=0.335 Sum_probs=26.6
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
.++.++|..+|.|++|.|+++|+..+|++.
T Consensus 45 ~e~~~~~~~~D~d~~G~I~~~EF~~~m~k~ 74 (77)
T d1oqpa_ 45 EELQEMIAEADRNDDNEIDEDEFIRIMKKT 74 (77)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHcc
Confidence 357889999999999999999999998764
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=94.27 E-value=0.043 Score=37.18 Aligned_cols=55 Identities=7% Similarity=0.038 Sum_probs=42.5
Q ss_pred HHHHhcccCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 255 LKELFKMIDTDNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 255 l~~~F~~~d~~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+..++...+. +|.|++.|+...+... .-+.+++...|+.+|.+++|. +.+||..+
T Consensus 10 i~~~~~~~~~--~gsi~~~eF~~~~~l~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~ 65 (107)
T d2pvba_ 10 VAAALAACSA--ADSFKHKEFFAKVGLA--SKSLDDVKKAFYVIDQDKSGFIEEDELKLF 65 (107)
T ss_dssp HHHHHHHTCS--TTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHCTTCSSSBCHHHHHTG
T ss_pred HHHHHHhccC--CCCcCHHHHHHHHhcc--cCCHHHHHHHHHhhccCCCCcCcHHHHHHH
Confidence 4555665554 4679999998766532 236789999999999999998 99999875
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.24 E-value=0.023 Score=39.41 Aligned_cols=66 Identities=9% Similarity=0.084 Sum_probs=51.7
Q ss_pred hhhhhhccHHHHhcccC---CCCCCcccHHHHHHHHHHhCCC--CCHHHHHHHHHHHhccCC--------CC-CHHHHhh
Q 021227 247 LNEEEIGGLKELFKMID---TDNSGTITFDELKDGLKRVGSQ--LMESEIKDLMDAVRKIFS--------RF-SIKTYCN 312 (315)
Q Consensus 247 l~~e~~~~l~~~F~~~d---~~~~g~i~~~el~~~l~~~~~~--~~~~ei~~~~~~~d~~~~--------~~-~~~~f~~ 312 (315)
++..++..+.+.|+... .+.+|.|+.++++..+..+... ..+.-.+.+|+.+|.+++ |. ||.||+.
T Consensus 22 fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~~~~~g~I~f~efv~ 101 (118)
T d1tuza_ 22 YSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSC 101 (118)
T ss_dssp HCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCCCCCSCCEEHHHHHH
T ss_pred CCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccccCCCceeeHHHHHH
Confidence 56677777777786442 3578999999999999877542 457888999999999975 55 9999975
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=94.23 E-value=0.022 Score=37.29 Aligned_cols=32 Identities=19% Similarity=0.361 Sum_probs=27.3
Q ss_pred hhccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 251 EIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 251 ~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
....+.++++.+|.|+||.|+++|+..++..+
T Consensus 50 d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~l 81 (90)
T d3cr5x1 50 EQEVVDKVMETLDSDGDGECDFQEFMAFVAMI 81 (90)
T ss_dssp SHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 34568999999999999999999998877654
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=94.15 E-value=0.035 Score=35.67 Aligned_cols=30 Identities=17% Similarity=0.317 Sum_probs=25.9
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
...+.++++.+|.|+||.|+++|+..++-.
T Consensus 53 ~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~ 82 (83)
T d1xk4c1 53 EKVIEHIMEDLDTNADKQLSFEEFIMLMAR 82 (83)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence 346899999999999999999999877653
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=94.13 E-value=0.011 Score=37.71 Aligned_cols=31 Identities=26% Similarity=0.625 Sum_probs=27.3
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhC
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVG 283 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~ 283 (315)
..+.+++..+|.|+||.|+++|+..++.++.
T Consensus 47 ~~v~~~~~~~D~d~dG~Idf~EF~~l~~~la 77 (78)
T d1cb1a_ 47 RTLDDLFQELDKNGDGEVSFEEFQVLVKKIS 77 (78)
T ss_dssp CCSSHHHHHTCCCSSSSEEHHHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCcCcHHHHHHHHHHHh
Confidence 4578899999999999999999999888763
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=93.99 E-value=0.023 Score=37.59 Aligned_cols=33 Identities=24% Similarity=0.497 Sum_probs=28.1
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
.....+.++++.+|.|+||.|+++|+..++..+
T Consensus 49 ~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~l 81 (95)
T d1qlsa_ 49 KDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGL 81 (95)
T ss_dssp CCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence 344569999999999999999999998877654
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.92 E-value=0.016 Score=38.84 Aligned_cols=28 Identities=21% Similarity=0.364 Sum_probs=25.0
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
.+..+|..+|.|+||.||++|+..++++
T Consensus 69 ~v~~~~~~~D~d~DG~Is~~EF~~~~~~ 96 (99)
T d1snla_ 69 MREHVMKNVDTNQDRLVTLEEFLASTQR 96 (99)
T ss_dssp HHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred HHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 4788999999999999999999988763
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=93.84 E-value=0.0083 Score=37.21 Aligned_cols=29 Identities=31% Similarity=0.481 Sum_probs=25.5
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
..+..+|..+|.|++|.|+++|+..+|++
T Consensus 39 ~e~~~~~~~~D~d~dG~i~~~EF~~~m~r 67 (68)
T d1c7va_ 39 AEVEEAMKEADEDGNGVIDIPEFMDLIKK 67 (68)
T ss_dssp HHHHHHHHHHCSSGGGSEEHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 45788899999999999999999988763
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=93.65 E-value=0.026 Score=37.67 Aligned_cols=31 Identities=23% Similarity=0.454 Sum_probs=27.1
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
...+.+++..+|.|+||.|+++|+..++..+
T Consensus 53 ~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l 83 (98)
T d1yuta1 53 VGSLDEKMKSLDVNQDSELKFNEYWRLIGEL 83 (98)
T ss_dssp SSCHHHHHHHHCTTCCSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 3468999999999999999999999887654
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=93.41 E-value=0.039 Score=36.40 Aligned_cols=34 Identities=15% Similarity=0.324 Sum_probs=26.7
Q ss_pred hhhhccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 249 EEEIGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 249 ~e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
+.....+.++++.+|.|+||.|+++|+..++-.+
T Consensus 48 ~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~l 81 (94)
T d1j55a_ 48 GKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAI 81 (94)
T ss_dssp ----CHHHHHHHHHCSSSSSSEEHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 3445679999999999999999999998877654
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=93.38 E-value=0.02 Score=37.54 Aligned_cols=31 Identities=16% Similarity=0.265 Sum_probs=27.2
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
-..+.++++.+|.|+||.|+++|+..++..+
T Consensus 49 ~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~l 79 (89)
T d1k8ua_ 49 DAEIARLMEDLDRNKDQEVNFQEYVTFLGAL 79 (89)
T ss_dssp SHHHHHHHHHHHHTTTCEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence 3468999999999999999999999887754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.21 E-value=0.011 Score=50.48 Aligned_cols=14 Identities=36% Similarity=0.548 Sum_probs=12.4
Q ss_pred CccccCCCCceeec
Q 021227 69 VFHRDLKPENFLFL 82 (315)
Q Consensus 69 ivH~dikp~nil~~ 82 (315)
++|+|+.+.||++.
T Consensus 220 ~CHnDL~~~NiL~~ 233 (395)
T d1nw1a_ 220 FCHNDLQEGNILLP 233 (395)
T ss_dssp EECSCCCGGGEEEE
T ss_pred EEecCCCcccEeec
Confidence 57999999999974
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=93.05 E-value=0.037 Score=35.51 Aligned_cols=30 Identities=37% Similarity=0.545 Sum_probs=26.0
Q ss_pred hccHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 252 IGGLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 252 ~~~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
..++.+++..+|.|++|.|+++|+..++.+
T Consensus 51 ~~el~~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 51 PEELQEMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 345889999999999999999999888753
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=92.91 E-value=0.031 Score=35.74 Aligned_cols=29 Identities=34% Similarity=0.536 Sum_probs=25.2
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
.++.++|..+|.|++|.|+++|+..+++.
T Consensus 51 ~ev~~~~~~~D~d~dg~I~~~EF~~~m~~ 79 (81)
T d1fi5a_ 51 DDIEELMKDGDKNNDGRIDYDEFLEFMKG 79 (81)
T ss_dssp HHHHHHHHHHCSSSSSSEEHHHHHHHHSC
T ss_pred HHHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence 34788999999999999999999988763
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=92.74 E-value=0.042 Score=33.38 Aligned_cols=27 Identities=19% Similarity=0.492 Sum_probs=23.4
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHH
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGL 279 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l 279 (315)
.++.+++..+|.|++|.|+++|+..+|
T Consensus 39 ~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 39 EEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp HHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 347889999999999999999998753
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.58 E-value=0.044 Score=34.42 Aligned_cols=28 Identities=32% Similarity=0.569 Sum_probs=25.2
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
.+.++|..+|.|++|.|+++|+..+|+.
T Consensus 46 e~~~~~~~~D~d~dg~I~~~EF~~~m~~ 73 (75)
T d1jc2a_ 46 DIEDLMKDSDKNNDGRIDFDEFLKMMEG 73 (75)
T ss_dssp HHHHHHHHHCSSSCSEECHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 4788999999999999999999988764
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=92.51 E-value=0.1 Score=35.21 Aligned_cols=47 Identities=13% Similarity=0.129 Sum_probs=36.8
Q ss_pred CCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhhc
Q 021227 265 DNSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCNL 313 (315)
Q Consensus 265 ~~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~~ 313 (315)
+.+|.+++.++...+.. ...+.+++.++|+.+|.+++|. +.+||..+
T Consensus 19 ~~~~s~~~~~F~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~ 66 (108)
T d1rroa_ 19 QDPDTFEPQKFFQTSGL--SKMSASQVKDIFRFIDNDQSGYLDGDELKYF 66 (108)
T ss_dssp CSTTCCCHHHHHHHHSG--GGSCHHHHHHHHHHHCTTCSSEECTHHHHTG
T ss_pred ccCCCccHHHHHHHHcc--CcCCHHHHHHHHhhhcCCCCCeEcHHHHHHH
Confidence 45677999998554322 2346889999999999999998 99998765
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.43 E-value=0.04 Score=35.19 Aligned_cols=28 Identities=36% Similarity=0.565 Sum_probs=24.8
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
++.++|..+|.|++|.|+++|+..++.+
T Consensus 51 e~~~~~~~~D~d~~g~I~~~eF~~~m~~ 78 (81)
T d1avsa_ 51 ELDAIIEEVDEDGSGTIDFEEFLVMMVR 78 (81)
T ss_dssp HHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 4788999999999999999999988753
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=92.24 E-value=0.04 Score=34.37 Aligned_cols=29 Identities=31% Similarity=0.591 Sum_probs=25.4
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
..+.+++..+|.+++|.|+++|+..+|.+
T Consensus 44 ~~~~~~~~~~D~d~~g~I~f~eF~~~m~~ 72 (73)
T d2pq3a1 44 AELQDMINEVDADGNGTIDFPEFLTMMAR 72 (73)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 35789999999999999999999988753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.15 E-value=0.013 Score=48.16 Aligned_cols=30 Identities=33% Similarity=0.451 Sum_probs=24.3
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcc
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSV 99 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~ 99 (315)
.|+||+|+.++||++ +++...-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~---~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFF---LGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEE---ETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhc---ccccceeEecccccc
Confidence 579999999999996 445556899999763
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=91.55 E-value=0.095 Score=31.21 Aligned_cols=25 Identities=24% Similarity=0.581 Sum_probs=21.8
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHH
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKD 277 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~ 277 (315)
.++..+|..+|.|++|.|+++|+.+
T Consensus 37 ~ei~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 37 AEVDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcEeHHHhcC
Confidence 3578899999999999999999853
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=91.41 E-value=0.058 Score=35.34 Aligned_cols=28 Identities=25% Similarity=0.517 Sum_probs=24.4
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
.+.++++..|.|++|.|+++|+..++..
T Consensus 44 ~l~~i~~~~D~d~dG~l~~~EF~~a~~l 71 (92)
T d1fi6a_ 44 ELSHIWELSDFDKDGALTLDEFCAAFHL 71 (92)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCeecHHHHHHHHHH
Confidence 5788999999999999999999876653
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=90.90 E-value=0.066 Score=33.68 Aligned_cols=28 Identities=25% Similarity=0.427 Sum_probs=24.7
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHH
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLK 280 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~ 280 (315)
..+.+++..+|.+++|.|+++|+..++.
T Consensus 46 ~e~~~~~~~~D~~~~g~I~~~eF~~~m~ 73 (77)
T d1f54a_ 46 AEVNDLMNEIDVDGNHQIEFSEFLALMS 73 (77)
T ss_dssp HHHHHHHHTTCCSSCCEEEHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 3578999999999999999999988764
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.73 E-value=0.038 Score=36.55 Aligned_cols=27 Identities=19% Similarity=0.404 Sum_probs=24.1
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHH
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLK 280 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~ 280 (315)
.+.++++..|.|++|.|+++|+..+|.
T Consensus 45 ~l~~i~~~~D~d~dG~l~~~EF~~am~ 71 (95)
T d1c07a_ 45 LLAHIWSLCDTKDCGKLSKDQFALAFH 71 (95)
T ss_dssp HHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 477899999999999999999988765
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=89.90 E-value=0.075 Score=35.34 Aligned_cols=29 Identities=28% Similarity=0.429 Sum_probs=25.6
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHHh
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKRV 282 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~~ 282 (315)
.+.+++...|.|++|.|+++|+..+|+..
T Consensus 46 ~L~~i~~~~D~d~dG~L~~~EF~~am~Li 74 (99)
T d1qjta_ 46 ILGKIWDLADTDGKGVLSKQEFFVALRLV 74 (99)
T ss_dssp HHHHHHHHHCCSSSSSCCSHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCccCHHHHHHHHHHH
Confidence 47889999999999999999999888643
|
| >d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Osteonectin domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.62 E-value=0.031 Score=40.23 Aligned_cols=57 Identities=12% Similarity=0.175 Sum_probs=45.4
Q ss_pred cHHHHhcccCCC-CCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHHhccCCCC-CHHHHhh
Q 021227 254 GLKELFKMIDTD-NSGTITFDELKDGLKRVGSQLMESEIKDLMDAVRKIFSRF-SIKTYCN 312 (315)
Q Consensus 254 ~l~~~F~~~d~~-~~g~i~~~el~~~l~~~~~~~~~~ei~~~~~~~d~~~~~~-~~~~f~~ 312 (315)
.+.-.|..+|.| +||.|+..|++.+...+ ...+.=+..+++..|.++|+. ++.|++.
T Consensus 78 ~v~W~F~~LD~n~~D~~L~~~EL~~l~~~L--~~~e~C~~~F~~~CD~n~D~~Is~~EW~~ 136 (151)
T d1sraa_ 78 PVHWQFGQLDQHPIDGYLSHTELAPLRAPL--IPMEHCTTRFFETCDLDNDKYIALDEWAG 136 (151)
T ss_dssp HHHHHHHHHCCTTCSSEECTTTTGGGGSTT--STTGGGHHHHHHHHCTTCSSSEEHHHHHH
T ss_pred cceeehhhcCCCCCCCccCHHHHHHHHHhh--cCCchHHHHHHHHhcCCCCCcCCHHHHHH
Confidence 456779999999 59999999998754322 334556899999999999987 9999874
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.74 E-value=0.12 Score=33.90 Aligned_cols=28 Identities=21% Similarity=0.326 Sum_probs=24.4
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
.+.+++...|.|++|.|+++|+..++..
T Consensus 44 ~L~~Iw~~~D~~~dG~l~~~EF~~a~~L 71 (95)
T d2jxca1 44 ILGRVWELSDIDHDGMLDRDEFAVAMFL 71 (95)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCeEcHHHHHHHHHH
Confidence 4789999999999999999999776653
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.55 E-value=0.14 Score=34.65 Aligned_cols=29 Identities=21% Similarity=0.386 Sum_probs=25.1
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHH
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKR 281 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~ 281 (315)
..+.+++...|.|++|.|+++|+..+|..
T Consensus 56 ~~L~~Iw~l~D~d~dG~l~~~EF~~am~L 84 (110)
T d1iq3a_ 56 PELSYIWELSDADCDGALTLPEFCAAFHL 84 (110)
T ss_dssp CCHHHHHHHHCSSSCSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHhccCCCCeECHHHHHHHHHH
Confidence 34788899999999999999999887764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=88.39 E-value=0.16 Score=41.55 Aligned_cols=28 Identities=18% Similarity=0.203 Sum_probs=21.6
Q ss_pred CCCccccCCCCceeeccCCCCCCEEEeeccCcc
Q 021227 67 LGVFHRDLKPENFLFLSVDEDAALKATDFGLSV 99 (315)
Q Consensus 67 ~~ivH~dikp~nil~~~~~~~~~ikl~Dfg~~~ 99 (315)
.+++|+|+.|.|||+ ++ + ..++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~---~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILW---RD-G-PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEE---SS-S-EEECCCTTCC
T ss_pred ceeecCCCCcccEEE---eC-C-ceEEechhcc
Confidence 468999999999995 22 2 4589998664
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=87.88 E-value=0.068 Score=34.59 Aligned_cols=25 Identities=36% Similarity=0.618 Sum_probs=22.4
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHH
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDG 278 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~ 278 (315)
++.++|..+|.|++|.|+++|+..+
T Consensus 60 e~~~l~~~~D~d~~g~I~~~EFl~a 84 (87)
T d1s6ja_ 60 EIKDLMDAADIDKSGTIDYGEFIAA 84 (87)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHTTC
T ss_pred HHHHHHHHcCCCCCCeEeHHHHHHH
Confidence 5789999999999999999999653
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.40 E-value=0.33 Score=30.66 Aligned_cols=26 Identities=8% Similarity=0.385 Sum_probs=22.9
Q ss_pred cHHHHhcccCCCCCCcccHHHHHHHH
Q 021227 254 GLKELFKMIDTDNSGTITFDELKDGL 279 (315)
Q Consensus 254 ~l~~~F~~~d~~~~g~i~~~el~~~l 279 (315)
++..+|..+|.+++|.|++.|+...+
T Consensus 57 e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 57 QFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp HHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHhhccccCCCCcEeHHHHHHHh
Confidence 46888999999999999999997654
|
| >d1pula1 a.39.1.11 (A:18-120) Hypothetical protein c32e8.3 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: p25-alpha domain: Hypothetical protein c32e8.3 species: Caenorhabditis elegans [TaxId: 6239]
Probab=82.34 E-value=3 Score=27.33 Aligned_cols=64 Identities=9% Similarity=0.075 Sum_probs=48.5
Q ss_pred hhhccHHHHhcccCCCCCCcccHHHHHHHHHHhC----CCCCHHHHHHHHHHHhccCCCCCHHHHhhc
Q 021227 250 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG----SQLMESEIKDLMDAVRKIFSRFSIKTYCNL 313 (315)
Q Consensus 250 e~~~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~----~~~~~~ei~~~~~~~d~~~~~~~~~~f~~~ 313 (315)
.+++..-+.|..+-.-..-.++-..+..+++..+ ..+|..+++-+|..+...+.+++|++|...
T Consensus 5 ~~l~~~F~aF~~FG~~~~~em~~~~f~Kl~kdc~lid~K~~T~tdvDIiF~K~k~k~~ri~f~~F~~a 72 (103)
T d1pula1 5 ADVKKRWDAFTKFGAATATEMTGKNFDKWLKDAGVLDNKAITGTMTGIAFSKVTGPKKKATFDETKKV 72 (103)
T ss_dssp HHHHHHHHHHHHHTCSSSSCCCHHHHHHHHHHHTSCCSSSSCHHHHHHHHHHHTCSSSCCCHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcCCCHHHHHHHHHHcCCCcCCCCCccchhhhhHhhcCCCCCcCHHHHHHH
Confidence 3444555666666543334789899999998854 359999999999999988877899999753
|
| >d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=81.32 E-value=2 Score=27.58 Aligned_cols=59 Identities=8% Similarity=0.097 Sum_probs=44.1
Q ss_pred ccHHHHhcccCCCCCCcccHHHHHHHHHHhC-C-CCCHHHHHHHHHHHhcc-----CCCCCHHHHhh
Q 021227 253 GGLKELFKMIDTDNSGTITFDELKDGLKRVG-S-QLMESEIKDLMDAVRKI-----FSRFSIKTYCN 312 (315)
Q Consensus 253 ~~l~~~F~~~d~~~~g~i~~~el~~~l~~~~-~-~~~~~ei~~~~~~~d~~-----~~~~~~~~f~~ 312 (315)
.++..+|..+-. +.+.++.++|...|+.-. . ..+++.+.++++.+..+ ...+++++|+.
T Consensus 8 ~ei~~if~~ys~-~~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~ 73 (94)
T d1qasa1 8 AEIDRAFEEAAG-SAETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLM 73 (94)
T ss_dssp HHHHHHHHHHHT-TSSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHH
T ss_pred HHHHHHHHHHhC-CCCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHH
Confidence 346777877744 446899999999999864 3 47888899999998755 23358888875
|